Unnamed: 0,Unnamed: 1,Unnamed: 2,Unnamed: 3,April,May,June,July,August,September,October,November,December,January,February,March,Total
District,,,,,,,,,,,,,,,,
Agar Malwa,1.1,Total number of pregnant women Registered for ANC,TOTAL,1051.0,1202.0,1301.0,1262.0,971.0,1160.0,828.0,1036.0,1031.0,1038.0,1175.0,1291.0,13346.0
Agar Malwa,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,721.0,770.0,908.0,828.0,651.0,848.0,544.0,677.0,691.0,643.0,783.0,850.0,8914.0
Agar Malwa,1.2,Number of Pregnant women registered under JSY,TOTAL,1033.0,1190.0,1301.0,1262.0,956.0,1154.0,830.0,1036.0,1035.0,1042.0,1139.0,1333.0,13311.0
Agar Malwa,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,855.0,878.0,1083.0,1040.0,1163.0,1011.0,936.0,921.0,939.0,909.0,913.0,1127.0,11775.0
Agar Malwa,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1035.0,1199.0,1278.0,1254.0,969.0,1155.0,822.0,993.0,1050.0,1022.0,1154.0,1272.0,13203.0
Agar Malwa,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,898.0,1038.0,1163.0,1215.0,1137.0,1043.0,975.0,860.0,1012.0,954.0,984.0,1204.0,12483.0
Agar Malwa,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1050.0,1196.0,1277.0,1268.0,995.0,1164.0,821.0,1034.0,1109.0,1050.0,1178.0,1359.0,13501.0
Agar Malwa,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,43.0,44.0,54.0,47.0,55.0,48.0,56.0,55.0,72.0,50.0,61.0,66.0,651.0
Agar Malwa,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,4.0,5.0,3.0,4.0,2.0,3.0,18.0,8.0,7.0,12.0,10.0,8.0,84.0
Agar Malwa,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,390.0,392.0,447.0,444.0,433.0,734.0,611.0,399.0,411.0,387.0,438.0,526.0,5612.0
Agar Malwa,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,11.0,6.0,22.0,15.0,12.0,20.0,46.0,21.0,7.0,12.0,26.0,13.0,211.0
Agar Malwa,1.8,Number of pregnancy test kits used at SC level,TOTAL,711.0,795.0,990.0,954.0,813.0,967.0,708.0,762.0,831.0,887.0,890.0,976.0,10284.0
Agar Malwa,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Agar Malwa,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,10.0,12.0,18.0,26.0,13.0,37.0,20.0,24.0,19.0,19.0,25.0,4.0,227.0
Agar Malwa,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,10.0,12.0,18.0,27.0,13.0,37.0,20.0,24.0,19.0,19.0,25.0,4.0,228.0
Agar Malwa,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,4.0,3.0,8.0,4.0,0.0,4.0,11.0,11.0,15.0,16.0,14.0,2.0,92.0
Agar Malwa,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,2.0,4.0,0.0,0.0,1.0,0.0,2.0,4.0,1.0,0.0,14.0
Agar Malwa,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,594.0,685.0,783.0,873.0,942.0,1103.0,946.0,1036.0,880.0,858.0,909.0,921.0,10530.0
Agar Malwa,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,0.0,3.0,2.0,0.0,0.0,0.0,0.0,11.0,0.0,0.0,15.0,40.0,71.0
Agar Malwa,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,436.0,460.0,707.0,790.0,867.0,973.0,836.0,983.0,872.0,881.0,859.0,635.0,9299.0
Agar Malwa,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,239.0,288.0,257.0,504.0,376.0,359.0,613.0,648.0,511.0,367.0,468.0,1428.0,6058.0
Agar Malwa,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Agar Malwa,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Agar Malwa,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Agar Malwa,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Agar Malwa,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Agar Malwa,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,3.0,5.0,0.0,0.0,0.0,0.0,1.0,9.0,5.0,23.0
Agar Malwa,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Agar Malwa,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,3.0,5.0,0.0,0.0,0.0,0.0,1.0,9.0,5.0,23.0
Agar Malwa,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Agar Malwa,4.1.1.a,Number of male live births,TOTAL,303.0,354.0,408.0,458.0,476.0,588.0,489.0,529.0,459.0,421.0,460.0,463.0,5408.0
Agar Malwa,4.1.1.b,Number of female live births,TOTAL,289.0,328.0,379.0,428.0,467.0,533.0,462.0,507.0,421.0,443.0,456.0,451.0,5164.0
Agar Malwa,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,592.0,682.0,787.0,886.0,943.0,1121.0,951.0,1036.0,880.0,864.0,916.0,914.0,10572.0
Agar Malwa,4.1.2,Number of still births,TOTAL,12.0,15.0,15.0,14.0,17.0,15.0,13.0,23.0,19.0,13.0,18.0,11.0,185.0
Agar Malwa,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,14.0,22.0,4.0,6.0,1.0,1.0,3.0,13.0,16.0,18.0,15.0,16.0,129.0
Agar Malwa,4.2.1,Number of Newborns weighed at birth,TOTAL,584.0,672.0,777.0,863.0,932.0,1094.0,940.0,1024.0,871.0,851.0,895.0,911.0,10414.0
Agar Malwa,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,45.0,40.0,67.0,89.0,72.0,84.0,77.0,122.0,67.0,91.0,125.0,114.0,993.0
Agar Malwa,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,578.0,672.0,771.0,873.0,940.0,1093.0,937.0,1002.0,866.0,838.0,888.0,878.0,10336.0
Agar Malwa,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,4.0,11.0,13.0,10.0,7.0,10.0,0.0,0.0,0.0,0.0,0.0,10.0,65.0
Agar Malwa,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,10.0,10.0,16.0,5.0,2.0,8.0,13.0,5.0,16.0,10.0,10.0,18.0,123.0
Agar Malwa,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,7.0,10.0,5.0,14.0,17.0,11.0,14.0,8.0,10.0,12.0,20.0,23.0,151.0
Agar Malwa,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Agar Malwa,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,21.0,31.0,34.0,29.0,26.0,29.0,27.0,13.0,26.0,22.0,30.0,51.0,339.0
Agar Malwa,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Agar Malwa,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,21.0,41.0,47.0,44.0,43.0,29.0,56.0,316.0,146.0,102.0,90.0,64.0,999.0
Agar Malwa,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,17.0,23.0,17.0,59.0,25.0,29.0,90.0,12.0,15.0,22.0,30.0,71.0,410.0
Agar Malwa,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,19.0,37.0,52.0,24.0,22.0,72.0,186.0,188.0,106.0,237.0,53.0,51.0,1047.0
Agar Malwa,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,4.0,4.0,2.0,10.0,5.0,2.0,5.0,2.0,6.0,10.0,7.0,6.0,63.0
Agar Malwa,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,601.0,697.0,798.0,892.0,947.0,1128.0,954.0,1039.0,892.0,882.0,900.0,880.0,10610.0
Agar Malwa,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,600.0,625.0,526.0,661.0,677.0,744.0,836.0,839.0,792.0,810.0,818.0,789.0,8717.0
Agar Malwa,6.3,PNC maternal complications attended,TOTAL,8.0,4.0,8.0,4.0,0.0,2.0,10.0,5.0,9.0,11.0,16.0,13.0,90.0
Agar Malwa,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,8.0,16.0,5.0,0.0,9.0,0.0,6.0,10.0,18.0,18.0,30.0,21.0,141.0
Agar Malwa,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,3.0,3.0,2.0,0.0,5.0,0.0,0.0,1.0,1.0,2.0,4.0,3.0,24.0
Agar Malwa,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,11.0,19.0,7.0,0.0,14.0,0.0,6.0,11.0,19.0,20.0,34.0,24.0,165.0
Agar Malwa,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,30.0,60.0,26.0,79.0,36.0,9.0,25.0,41.0,32.0,128.0,118.0,101.0,685.0
Agar Malwa,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,30.0,66.0,46.0,72.0,40.0,71.0,41.0,50.0,24.0,175.0,207.0,194.0,1016.0
Agar Malwa,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,60.0,126.0,72.0,151.0,76.0,80.0,66.0,91.0,56.0,303.0,325.0,295.0,1701.0
Agar Malwa,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,35.0,55.0,50.0,60.0,25.0,50.0,25.0,1.0,20.0,42.0,30.0,100.0,493.0
Agar Malwa,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0
Agar Malwa,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,1.0,4.0
Agar Malwa,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Agar Malwa,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,2.0,6.0
Agar Malwa,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Agar Malwa,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,8.0,5.0,6.0,15.0,16.0,0.0,0.0,0.0,0.0,50.0
Agar Malwa,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,19.0,3.0,1.0,181.0,217.0,211.0,38.0,397.0,610.0,300.0,264.0,107.0,2348.0
Agar Malwa,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,22.0,7.0,0.0,71.0,93.0,70.0,18.0,233.0,135.0,90.0,127.0,68.0,934.0
Agar Malwa,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Agar Malwa,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,41.0,10.0,1.0,260.0,315.0,287.0,71.0,646.0,745.0,390.0,391.0,175.0,3332.0
Agar Malwa,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Agar Malwa,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,10.0,0.0,2.0,9.0,0.0,1.0,0.0,23.0
Agar Malwa,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,5.0,4.0,0.0,5.0,2.0,6.0,0.0,9.0,6.0,9.0,0.0,46.0,92.0
Agar Malwa,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Agar Malwa,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,5.0,4.0,0.0,6.0,2.0,16.0,0.0,11.0,15.0,9.0,1.0,46.0,115.0
Agar Malwa,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Agar Malwa,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0
Agar Malwa,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,1.0,0.0,1.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,7.0
Agar Malwa,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,5.0,4.0,0.0,2.0,0.0,6.0,0.0,4.0,6.0,1.0,4.0,0.0,32.0
Agar Malwa,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Agar Malwa,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,5.0,5.0,0.0,3.0,0.0,6.0,2.0,9.0,6.0,1.0,4.0,0.0,41.0
Agar Malwa,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Agar Malwa,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,104.0,121.0,196.0,264.0,284.0,232.0,245.0,263.0,250.0,258.0,267.0,252.0,2736.0
Agar Malwa,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,4.0,6.0,13.0,12.0,11.0,19.0,8.0,7.0,7.0,2.0,7.0,96.0
Agar Malwa,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,8.0,16.0,12.0,23.0,17.0,14.0,18.0,8.0,4.0,20.0,33.0,76.0,249.0
Agar Malwa,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,48.0,10.0,17.0,12.0,32.0,16.0,25.0,29.0,15.0,204.0
Agar Malwa,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Agar Malwa,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,112.0,141.0,214.0,348.0,323.0,274.0,294.0,311.0,277.0,310.0,331.0,350.0,3285.0
Agar Malwa,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,3.0,0.0,0.0,3.0,0.0,16.0,9.0,6.0,8.0,19.0,34.0,75.0,173.0
Agar Malwa,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Agar Malwa,9.06,Number of IUCD removals,TOTAL,84.0,55.0,77.0,91.0,97.0,100.0,125.0,117.0,149.0,152.0,168.0,177.0,1392.0
Agar Malwa,9.07,Number of Oral Pills cycles distributed,TOTAL,1156.0,1558.0,1746.0,1798.0,2477.0,2698.0,2183.0,2335.0,2236.0,2651.0,3018.0,2917.0,26773.0
Agar Malwa,9.08,Number of Condom pieces distributed,TOTAL,12839.0,16646.0,27198.0,31407.0,28665.0,19355.0,20432.0,19145.0,17554.0,20540.0,22301.0,16076.0,252158.0
Agar Malwa,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,15.0,0.0,0.0,0.0,0.0,2100.0,0.0,0.0,0.0,0.0,54.0,2169.0
Agar Malwa,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,2.0,20.0,12.0,8.0,17.0,22.0,21.0,0.0,102.0
Agar Malwa,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Agar Malwa,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,9.11.2.b,Number of failures following female sterilization,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,3.0
Agar Malwa,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,2.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Agar Malwa,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,641.0,730.0,787.0,891.0,936.0,1143.0,998.0,1084.0,899.0,902.0,995.0,905.0,10911.0
Agar Malwa,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,828.0,952.0,974.0,958.0,969.0,1029.0,985.0,302.0,14.0,19.0,11.0,1.0,7042.0
Agar Malwa,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,908.0,929.0,1067.0,1090.0,1029.0,1065.0,966.0,1018.0,565.0,245.0,74.0,53.0,9009.0
Agar Malwa,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1013.0,1011.0,1003.0,1147.0,1022.0,1155.0,954.0,910.0,1013.0,639.0,274.0,156.0,10297.0
Agar Malwa,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,881.0,952.0,1103.0,935.0,1166.0,5037.0
Agar Malwa,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,690.0,912.0,1101.0,1182.0,3885.0
Agar Malwa,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,629.0,926.0,1191.0,2746.0
Agar Malwa,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,600.0,690.0,736.0,834.0,901.0,1055.0,929.0,1039.0,866.0,891.0,967.0,658.0,10166.0
Agar Malwa,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,828.0,951.0,974.0,962.0,969.0,1033.0,987.0,1029.0,976.0,1133.0,947.0,1168.0,11957.0
Agar Malwa,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,911.0,928.0,1068.0,1087.0,1029.0,1065.0,966.0,1026.0,1129.0,1156.0,1159.0,1201.0,12725.0
Agar Malwa,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1011.0,1000.0,1002.0,1149.0,1022.0,1154.0,960.0,941.0,1011.0,1099.0,1145.0,1309.0,12803.0
Agar Malwa,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,566.0,674.0,731.0,820.0,891.0,1052.0,919.0,846.0,853.0,879.0,961.0,875.0,10067.0
Agar Malwa,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,824.0,950.0,972.0,959.0,920.0,1032.0,980.0,314.0,19.0,14.0,2.0,29.0,7015.0
Agar Malwa,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,909.0,931.0,1068.0,1087.0,1023.0,1064.0,972.0,1000.0,557.0,268.0,74.0,94.0,9047.0
Agar Malwa,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1009.0,1017.0,999.0,1135.0,1037.0,1138.0,966.0,908.0,1006.0,611.0,265.0,180.0,10271.0
Agar Malwa,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,958.0,1119.0,1055.0,1185.0,1123.0,1187.0,898.0,956.0,896.0,991.0,939.0,1024.0,12331.0
Agar Malwa,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,512.0,667.0,813.0,893.0,779.0,775.0,689.0,757.0,852.0,962.0,856.0,1039.0,9594.0
Agar Malwa,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,16.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,4.0,0.0,22.0
Agar Malwa,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,455.0,543.0,529.0,601.0,568.0,528.0,477.0,496.0,497.0,518.0,488.0,549.0,6249.0
Agar Malwa,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,423.0,490.0,458.0,550.0,502.0,497.0,396.0,443.0,431.0,484.0,507.0,498.0,5679.0
Agar Malwa,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,878.0,1033.0,987.0,1151.0,1070.0,1025.0,873.0,939.0,928.0,1002.0,995.0,1047.0,11928.0
Agar Malwa,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,742.0,910.0,970.0,999.0,850.0,845.0,736.0,816.0,871.0,1034.0,930.0,1226.0,10929.0
Agar Malwa,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,738.0,912.0,970.0,991.0,849.0,844.0,716.0,816.0,871.0,1034.0,930.0,1226.0,10897.0
Agar Malwa,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,2.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Agar Malwa,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,161.0,212.0,290.0,226.0,106.0,115.0,61.0,71.0,68.0,104.0,126.0,175.0,1715.0
Agar Malwa,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,129.0,217.0,287.0,206.0,109.0,117.0,65.0,61.0,75.0,100.0,147.0,162.0,1675.0
Agar Malwa,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,290.0,429.0,577.0,432.0,215.0,232.0,126.0,132.0,143.0,204.0,273.0,337.0,3390.0
Agar Malwa,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,180.0,247.0,245.0,368.0,279.0,201.0,196.0,172.0,306.0,801.0,388.0,362.0,3745.0
Agar Malwa,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,526.0,554.0,623.0,784.0,684.0,868.0,707.0,507.0,975.0,1196.0,742.0,761.0,8927.0
Agar Malwa,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,485.0,515.0,596.0,745.0,627.0,911.0,683.0,558.0,844.0,1181.0,778.0,768.0,8691.0
Agar Malwa,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,2.0,2.0,3.0,2.0,19.0,2.0,32.0
Agar Malwa,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,4.0,1.0,3.0,1.0,6.0,11.0,6.0,22.0,22.0,30.0,106.0
Agar Malwa,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,523.0,543.0,577.0,581.0,563.0,570.0,558.0,572.0,572.0,572.0,569.0,619.0,6819.0
Agar Malwa,10.4.2,Number of Immunisation sessions held during the month,TOTAL,496.0,527.0,557.0,575.0,553.0,558.0,528.0,539.0,543.0,564.0,532.0,631.0,6603.0
Agar Malwa,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,405.0,414.0,432.0,448.0,434.0,443.0,402.0,422.0,419.0,439.0,426.0,506.0,5190.0
Agar Malwa,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,921.0,1045.0,1007.0,1119.0,1067.0,1091.0,868.0,1044.0,901.0,1140.0,958.0,1017.0,12178.0
Agar Malwa,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,362.0,304.0,559.0,7049.0,1444.0,463.0,485.0,387.0,585.0,10228.0,950.0,457.0,23273.0
Agar Malwa,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,298.0,284.0,656.0,7276.0,1338.0,436.0,511.0,338.0,521.0,12561.0,947.0,479.0,25645.0
Agar Malwa,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,17.0,21.0,22.0,0.0,1.0,0.0,2.0,9.0,72.0
Agar Malwa,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,173.0,136.0,131.0,213.0,223.0,184.0,194.0,242.0,298.0,272.0,330.0,360.0,2756.0
Agar Malwa,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,2.0,0.0,5.0,5.0,9.0,162.0,102.0,7.0,1.0,0.0,0.0,0.0,293.0
Agar Malwa,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,20.0,0.0,48.0,0.0,0.0,0.0,0.0,35.0,4.0,0.0,0.0,0.0,107.0
Agar Malwa,13.1,Number of Patients operated for cataract,TOTAL,121.0,219.0,92.0,166.0,357.0,264.0,264.0,323.0,518.0,387.0,358.0,225.0,3294.0
Agar Malwa,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,121.0,50.0,92.0,166.0,357.0,264.0,264.0,323.0,518.0,387.0,410.0,225.0,3177.0
Agar Malwa,13.3,Number of School children detected with Refractive errors,TOTAL,40.0,50.0,0.0,45.0,89.0,56.0,130.0,89.0,108.0,19.0,23.0,0.0,649.0
Agar Malwa,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,98.0,0.0,0.0,0.0,105.0
Agar Malwa,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,3.0,3.0,2.0,2.0,3.0,3.0,2.0,2.0,2.0,2.0,2.0,-1.0
Agar Malwa,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2.0,1.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Agar Malwa,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,371.0,429.0,434.0,497.0,479.0,476.0,489.0,477.0,485.0,504.0,515.0,520.0,-1.0
Agar Malwa,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,4.0,4.0,3.0,4.0,4.0,3.0,4.0,3.0,3.0,3.0,3.0,-1.0
Agar Malwa,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,2.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,4.0
Agar Malwa,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,3.0,3.0,5.0,3.0,4.0,3.0,3.0,3.0,3.0,1.0,1.0,1.0,-1.0
Agar Malwa,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,63.0,88.0,102.0,98.0,132.0,91.0,85.0,48.0,62.0,60.0,103.0,57.0,989.0
Agar Malwa,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,2.0,2.0,1.0,3.0,3.0,2.0,2.0,1.0,1.0,1.0,1.0,-1.0
Agar Malwa,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Agar Malwa,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,286.0,395.0,407.0,337.0,111.0,282.0,302.0,215.0,203.0,233.0,236.0,311.0,3318.0
Agar Malwa,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,375.0,528.0,653.0,457.0,414.0,360.0,559.0,332.0,274.0,357.0,341.0,725.0,5375.0
Agar Malwa,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,156.0,373.0,439.0,351.0,123.0,269.0,225.0,289.0,325.0,145.0,158.0,289.0,3142.0
Agar Malwa,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,660.0,974.0,970.0,806.0,1102.0,1232.0,1213.0,1133.0,906.0,1120.0,2085.0,1928.0,14129.0
Agar Malwa,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,442.0,768.0,846.0,688.0,234.0,551.0,527.0,504.0,528.0,378.0,394.0,600.0,6460.0
Agar Malwa,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1035.0,1502.0,1623.0,1263.0,1516.0,1592.0,1772.0,1465.0,1180.0,1477.0,2426.0,2653.0,19504.0
Agar Malwa,14.10.2.a,Number of death cases of Inpatient males,TOTAL,3.0,7.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Agar Malwa,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,5.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Agar Malwa,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,5.0,12.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19.0
Agar Malwa,14.11,In-Patient Head Count at midnight,TOTAL,828.0,1196.0,632.0,1645.0,1095.0,1232.0,1480.0,1037.0,1267.0,1183.0,1280.0,1461.0,14336.0
Agar Malwa,14.12.1,OPD attendance (All),TOTAL,20416.0,28552.0,23129.0,24555.0,28986.0,34051.0,28152.0,28030.0,25785.0,25528.0,34946.0,37199.0,339329.0
Agar Malwa,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,0.0,0.0,0.0,8.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Agar Malwa,14.14.a,Number of patients given AYUSH treatment,TOTAL,2705.0,3075.0,1901.0,3075.0,2410.0,2530.0,1831.0,1604.0,5556.0,912.0,923.0,755.0,27277.0
Agar Malwa,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,14.14.c,Number of Adolescents counselled,TOTAL,85.0,77.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,162.0
Agar Malwa,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2294.0,2503.0,2950.0,3510.0,3033.0,3800.0,2546.0,3498.0,3147.0,2952.0,3345.0,3030.0,36608.0
Agar Malwa,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,44.0,44.0,44.0,64.0,64.0,55.0,44.0,45.0,33.0,55.0,54.0,56.0,602.0
Agar Malwa,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,2.0,10.0,31.0,34.0,27.0,29.0,42.0,31.0,39.0,17.0,59.0,23.0,344.0
Agar Malwa,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,0.0,2.0,35.0,58.0,21.0,43.0,22.0,20.0,46.0,143.0,80.0,37.0,507.0
Agar Malwa,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,271.0,340.0,637.0,588.0,325.0,444.0,247.0,439.0,530.0,565.0,612.0,421.0,5419.0
Agar Malwa,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,273.0,352.0,703.0,680.0,373.0,516.0,311.0,490.0,615.0,725.0,751.0,481.0,6270.0
Agar Malwa,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,15.2,Number of Widal tests conducted,Number tested,387.0,337.0,369.0,298.0,348.0,597.0,398.0,162.0,292.0,207.0,435.0,453.0,4283.0
Agar Malwa,15.3.a,Number of VDRL tests conducted on males,Number tested,3.0,0.0,7.0,50.0,26.0,0.0,0.0,12.0,3.0,5.0,4.0,3.0,113.0
Agar Malwa,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,1.0,0.0,190.0,48.0,38.0,6.0,37.0,56.0,55.0,123.0,140.0,42.0,736.0
Agar Malwa,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,246.0,228.0,12.0,283.0,346.0,296.0,187.0,330.0,400.0,314.0,288.0,287.0,3217.0
Agar Malwa,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,250.0,228.0,209.0,381.0,410.0,302.0,224.0,398.0,458.0,442.0,432.0,332.0,4066.0
Agar Malwa,15.4.1,Number of blood smears examined for Malaria,TOTAL,4800.0,4540.0,5602.0,6110.0,4972.0,6999.0,5261.0,4732.0,4826.0,4284.0,5396.0,2977.0,60499.0
Agar Malwa,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,8.0,5.0,9.0,6.0,9.0,10.0,12.0,2.0,1.0,2.0,4.0,2.0,70.0
Agar Malwa,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,1.0,5.0,4.0,1.0,1.0,0.0,0.0,0.0,12.0
Agar Malwa,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Agar Malwa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Agar Malwa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Agar Malwa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Agar Malwa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Agar Malwa,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Agar Malwa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Agar Malwa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Agar Malwa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Agar Malwa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Agar Malwa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Agar Malwa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Agar Malwa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,3.0,1.0,,,,1.0,1.0,6.0
Agar Malwa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,,,1.0
Agar Malwa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,3.0,1.0,,,1.0,1.0,1.0,7.0
Agar Malwa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,1.0,,,,2.0,,,,,,4.0
Agar Malwa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,1.0,,1.0
Agar Malwa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,1.0,,,,2.0,,,,1.0,,5.0
Agar Malwa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,1.0,,,,,1.0,1.0,1.0,1.0,1.0,7.0
Agar Malwa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Agar Malwa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,1.0,,,,,1.0,1.0,1.0,1.0,1.0,7.0
Agar Malwa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Agar Malwa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Agar Malwa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Agar Malwa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,1.0,,,,1.0,,2.0
Agar Malwa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Agar Malwa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,1.0,,,,1.0,,2.0
Agar Malwa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Agar Malwa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Agar Malwa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Agar Malwa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,1.0,,,,,,1.0,,,,3.0
Agar Malwa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,,,,,,1.0,2.0,,,,4.0
Agar Malwa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,2.0,1.0,,,,,1.0,3.0,,,,7.0
Agar Malwa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Agar Malwa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Agar Malwa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Agar Malwa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,2.0,,,,1.0,1.0,,,1.0,,5.0
Agar Malwa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Agar Malwa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,2.0,,,,2.0,1.0,,,1.0,,6.0
Agar Malwa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,,,,,,1.0,,,,,2.0
Agar Malwa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,,,1.0,,,2.0,,,,1.0,,5.0
Agar Malwa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,,,1.0,,,2.0,1.0,,,1.0,,7.0
Agar Malwa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Agar Malwa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Agar Malwa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Agar Malwa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,1.0,,,,,,,4.0,,,6.0
Agar Malwa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,1.0,1.0,1.0,,,1.0,,,,,4.0
Agar Malwa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,2.0,1.0,1.0,,,1.0,,4.0,,,10.0
Agar Malwa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Agar Malwa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Agar Malwa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Agar Malwa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,1.0,1.0,3.0,2.0,3.0,,,10.0
Agar Malwa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,1.0,5.0,2.0,3.0,,6.0,3.0,2.0,1.0,2.0,3.0,28.0
Agar Malwa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,1.0,5.0,2.0,3.0,1.0,7.0,6.0,4.0,4.0,2.0,3.0,38.0
Agar Malwa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,1.0,,,,1.0,,2.0
Agar Malwa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,2.0,2.0,1.0,1.0,,1.0,,,1.0,3.0,12.0
Agar Malwa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,2.0,2.0,1.0,1.0,1.0,1.0,,,2.0,3.0,14.0
Agar Malwa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Agar Malwa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Agar Malwa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Agar Malwa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Agar Malwa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Agar Malwa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Agar Malwa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Agar Malwa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Agar Malwa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,1.0,,,,,,,1.0
Agar Malwa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Agar Malwa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Agar Malwa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Agar Malwa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Agar Malwa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Agar Malwa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,9.0,1.0,1.0,5.0,1.0,1.0,3.0,1.0,2.0,3.0,,27.0
Agar Malwa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Agar Malwa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,9.0,1.0,2.0,5.0,1.0,2.0,3.0,1.0,2.0,3.0,,29.0
Agar Malwa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,2.0,2.0,,1.0,,,2.0,,1.0,,,9.0
Agar Malwa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Agar Malwa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,2.0,2.0,,1.0,,,2.0,,1.0,,,9.0
Agar Malwa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,1.0,1.0,,,1.0,,,,3.0
Agar Malwa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Agar Malwa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,1.0,1.0,1.0,,,1.0,,,,4.0
Agar Malwa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Agar Malwa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Agar Malwa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Agar Malwa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Agar Malwa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Agar Malwa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Agar Malwa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Agar Malwa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Agar Malwa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,3.0,4.0,2.0,1.0,4.0,4.0,4.0,3.0,1.0,2.0,4.0,2.0,34.0
Agar Malwa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,13.0,20.0,37.0,18.0,16.0,17.0,20.0,19.0,17.0,21.0,22.0,25.0,245.0
Agar Malwa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,16.0,24.0,39.0,19.0,20.0,22.0,24.0,22.0,18.0,23.0,26.0,27.0,280.0
Alirajpur,1.1,Total number of pregnant women Registered for ANC,TOTAL,1666.0,1966.0,2221.0,2254.0,1996.0,1860.0,1807.0,1865.0,1928.0,2064.0,2223.0,2361.0,24211.0
Alirajpur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1046.0,1254.0,1396.0,1502.0,1327.0,1187.0,1118.0,1104.0,1291.0,1388.0,1429.0,1547.0,15589.0
Alirajpur,1.2,Number of Pregnant women registered under JSY,TOTAL,1651.0,1966.0,2220.0,2261.0,1978.0,1857.0,1799.0,1858.0,1892.0,2018.0,2190.0,2320.0,24010.0
Alirajpur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1164.0,1558.0,1714.0,1724.0,1682.0,1634.0,1558.0,1451.0,1524.0,1619.0,1780.0,1758.0,19166.0
Alirajpur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,746.0,603.0,699.0,642.0,571.0,517.0,566.0,622.0,607.0,628.0,720.0,894.0,7815.0
Alirajpur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1094.0,1493.0,1806.0,1774.0,1521.0,1434.0,1324.0,1312.0,1443.0,1479.0,1499.0,1665.0,17844.0
Alirajpur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1669.0,1951.0,2221.0,2256.0,1990.0,1873.0,1803.0,1835.0,1938.0,2051.0,2222.0,2375.0,24184.0
Alirajpur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,185.0,165.0,134.0,147.0,178.0,163.0,125.0,189.0,241.0,233.0,154.0,171.0,2085.0
Alirajpur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,11.0,7.0,10.0,15.0,8.0,14.0,15.0,16.0,16.0,17.0,15.0,29.0,173.0
Alirajpur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,928.0,1001.0,945.0,1087.0,945.0,958.0,1029.0,988.0,1102.0,1031.0,1417.0,1194.0,12625.0
Alirajpur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,26.0,39.0,79.0,54.0,58.0,96.0,107.0,25.0,37.0,36.0,42.0,36.0,635.0
Alirajpur,1.8,Number of pregnancy test kits used at SC level,TOTAL,251.0,233.0,222.0,231.0,448.0,289.0,310.0,367.0,367.0,316.0,350.0,355.0,3739.0
Alirajpur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,68.0,90.0,131.0,172.0,175.0,82.0,76.0,16.0,80.0,11.0,7.0,11.0,919.0
Alirajpur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,359.0,395.0,567.0,491.0,441.0,424.0,420.0,480.0,455.0,527.0,410.0,519.0,5488.0
Alirajpur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,427.0,485.0,698.0,663.0,616.0,506.0,496.0,496.0,535.0,538.0,417.0,530.0,6407.0
Alirajpur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,179.0,366.0,527.0,580.0,544.0,482.0,454.0,408.0,495.0,508.0,401.0,488.0,5432.0
Alirajpur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,4.0,0.0,8.0,2.0,6.0,1.0,4.0,0.0,0.0,0.0,25.0
Alirajpur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,872.0,1312.0,1299.0,957.0,972.0,920.0,840.0,864.0,877.0,892.0,939.0,1409.0,12153.0
Alirajpur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,415.0,127.0,142.0,105.0,88.0,80.0,82.0,153.0,86.0,83.0,95.0,100.0,1556.0
Alirajpur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,619.0,927.0,1021.0,823.0,917.0,765.0,746.0,831.0,746.0,794.0,842.0,1234.0,10265.0
Alirajpur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,494.0,903.0,795.0,707.0,642.0,555.0,556.0,554.0,590.0,623.0,641.0,1007.0,8067.0
Alirajpur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,4.0,0.0,11.0
Alirajpur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,25.0,43.0,34.0,21.0,28.0,18.0,21.0,28.0,25.0,37.0,16.0,,296.0
Alirajpur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Alirajpur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Alirajpur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Alirajpur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,2.0,1.0,0.0,1.0,1.0,3.0,6.0,3.0,7.0,7.0,31.0
Alirajpur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Alirajpur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,2.0,1.0,0.0,1.0,1.0,3.0,6.0,3.0,7.0,7.0,31.0
Alirajpur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,5.0,4.0,4.0,10.0,11.0,8.0,7.0,6.0,,,,35.0,90.0
Alirajpur,4.1.1.a,Number of male live births,TOTAL,656.0,925.0,1008.0,810.0,815.0,709.0,673.0,703.0,716.0,738.0,704.0,1008.0,9465.0
Alirajpur,4.1.1.b,Number of female live births,TOTAL,660.0,910.0,1011.0,822.0,806.0,723.0,679.0,669.0,697.0,699.0,669.0,954.0,9299.0
Alirajpur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1316.0,1835.0,2019.0,1632.0,1621.0,1432.0,1352.0,1372.0,1413.0,1437.0,1373.0,1962.0,18764.0
Alirajpur,4.1.2,Number of still births,TOTAL,17.0,19.0,19.0,19.0,21.0,24.0,12.0,27.0,25.0,26.0,16.0,24.0,249.0
Alirajpur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,37.0,41.0,43.0,27.0,41.0,49.0,40.0,40.0,27.0,24.0,28.0,25.0,422.0
Alirajpur,4.2.1,Number of Newborns weighed at birth,TOTAL,1192.0,1642.0,1810.0,1557.0,1486.0,1299.0,1214.0,1286.0,1302.0,1333.0,1262.0,1689.0,17072.0
Alirajpur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,255.0,158.0,204.0,171.0,292.0,283.0,190.0,152.0,160.0,145.0,151.0,182.0,2343.0
Alirajpur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1306.0,1821.0,2005.0,1624.0,1591.0,1417.0,1338.0,1347.0,1411.0,1433.0,1360.0,1824.0,18477.0
Alirajpur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,79.0,91.0,84.0,59.0,106.0,102.0,69.0,33.0,88.0,58.0,71.0,121.0,961.0
Alirajpur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,12.0,53.0,103.0,76.0,73.0,61.0,60.0,44.0,62.0,42.0,57.0,95.0,738.0
Alirajpur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,5.0,33.0,50.0,43.0,33.0,30.0,33.0,30.0,26.0,14.0,22.0,60.0,379.0
Alirajpur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Alirajpur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,96.0,177.0,237.0,178.0,212.0,193.0,162.0,107.0,176.0,114.0,150.0,276.0,2078.0
Alirajpur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,5.0,4.0,4.0,,11.0,8.0,7.0,6.0,3.0,8.0,,,56.0
Alirajpur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,30.0,132.0,330.0,121.0,200.0,181.0,159.0,144.0,139.0,120.0,154.0,200.0,1910.0
Alirajpur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,5.0,8.0,0.0,0.0,13.0,8.0,10.0,21.0,5.0,4.0,17.0,30.0,121.0
Alirajpur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,92.0,180.0,274.0,97.0,93.0,104.0,85.0,104.0,97.0,73.0,94.0,149.0,1442.0
Alirajpur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,1.0,1.0,2.0,1.0,3.0,4.0,5.0,5.0,11.0,25.0,34.0,13.0,105.0
Alirajpur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,726.0,1260.0,1095.0,1053.0,923.0,914.0,881.0,808.0,953.0,836.0,821.0,1437.0,11707.0
Alirajpur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,695.0,899.0,907.0,1009.0,953.0,908.0,825.0,761.0,858.0,795.0,681.0,1235.0,10526.0
Alirajpur,6.3,PNC maternal complications attended,TOTAL,7.0,16.0,60.0,53.0,26.0,33.0,22.0,33.0,26.0,22.0,16.0,18.0,332.0
Alirajpur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,22.0,29.0,16.0,11.0,18.0,16.0,23.0,38.0,40.0,50.0,52.0,64.0,379.0
Alirajpur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,22.0,29.0,16.0,11.0,18.0,16.0,23.0,38.0,40.0,50.0,52.0,64.0,379.0
Alirajpur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,2.0,0.0,1.0,0.0,2.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,8.0
Alirajpur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,48.0,41.0,46.0,56.0,50.0,52.0,129.0,98.0,122.0,102.0,118.0,95.0,957.0
Alirajpur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,289.0,271.0,312.0,312.0,282.0,292.0,379.0,359.0,384.0,385.0,298.0,297.0,3860.0
Alirajpur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,337.0,312.0,358.0,368.0,332.0,344.0,508.0,457.0,506.0,487.0,416.0,392.0,4817.0
Alirajpur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,247.0,269.0,263.0,320.0,286.0,280.0,401.0,358.0,402.0,402.0,312.0,323.0,3863.0
Alirajpur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Alirajpur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Alirajpur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Alirajpur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Alirajpur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,5.0,4.0,30.0,9.0,27.0,20.0,38.0,165.0,215.0,163.0,18.0,694.0
Alirajpur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,16.0,9.0,51.0,61.0,86.0,84.0,51.0,176.0,580.0,945.0,495.0,139.0,2693.0
Alirajpur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,5.0,7.0,5.0,8.0,4.0,5.0,1.0,9.0,23.0,79.0,33.0,19.0,198.0
Alirajpur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Alirajpur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,21.0,21.0,60.0,99.0,99.0,116.0,72.0,223.0,768.0,1239.0,691.0,176.0,3585.0
Alirajpur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,1.0,2.0,1.0,2.0,2.0,1.0,4.0,4.0,6.0,3.0,4.0,30.0
Alirajpur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,1.0,4.0,4.0,6.0,3.0,1.0,22.0
Alirajpur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0
Alirajpur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Alirajpur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,1.0,0.0,0.0,0.0,3.0,1.0,4.0,4.0,7.0,3.0,1.0,24.0
Alirajpur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Alirajpur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,1.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Alirajpur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,3.0
Alirajpur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Alirajpur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,1.0,3.0,2.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,7.0
Alirajpur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Alirajpur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,274.0,268.0,346.0,308.0,366.0,350.0,327.0,270.0,257.0,321.0,274.0,262.0,3623.0
Alirajpur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,65.0,24.0,15.0,6.0,17.0,6.0,44.0,41.0,49.0,22.0,24.0,4.0,317.0
Alirajpur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,56.0,56.0,74.0,81.0,128.0,81.0,112.0,133.0,74.0,119.0,78.0,101.0,1093.0
Alirajpur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,101.0,76.0,141.0,126.0,119.0,133.0,118.0,135.0,144.0,102.0,70.0,89.0,1354.0
Alirajpur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Alirajpur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,496.0,424.0,576.0,521.0,630.0,570.0,601.0,579.0,524.0,564.0,446.0,456.0,6387.0
Alirajpur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,63.0,42.0,107.0,108.0,128.0,161.0,126.0,146.0,132.0,107.0,75.0,116.0,1311.0
Alirajpur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Alirajpur,9.06,Number of IUCD removals,TOTAL,109.0,78.0,69.0,78.0,122.0,89.0,146.0,116.0,162.0,162.0,148.0,130.0,1409.0
Alirajpur,9.07,Number of Oral Pills cycles distributed,TOTAL,3621.0,3611.0,3932.0,4697.0,5198.0,5168.0,5680.0,5847.0,5470.0,5417.0,5389.0,5527.0,59557.0
Alirajpur,9.08,Number of Condom pieces distributed,TOTAL,6068.0,6108.0,6503.0,7298.0,7535.0,7385.0,8127.0,8165.0,7734.0,7967.0,7677.0,7817.0,88384.0
Alirajpur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,7.0,5.0,7.0,24.0
Alirajpur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,3.0
Alirajpur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,,,1.0,1.0,1.0,2.0,1.0,,1.0,,1.0,-1.0
Alirajpur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1353.0,1708.0,2092.0,1897.0,1739.0,1600.0,1420.0,1429.0,1485.0,1574.0,1719.0,2050.0,20066.0
Alirajpur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1210.0,1280.0,1558.0,1794.0,1721.0,1592.0,1433.0,605.0,334.0,133.0,78.0,130.0,11868.0
Alirajpur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1090.0,1310.0,1356.0,1551.0,1696.0,1578.0,1423.0,1560.0,924.0,361.0,120.0,164.0,13133.0
Alirajpur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1173.0,1219.0,1375.0,1426.0,1457.0,1620.0,1455.0,1491.0,1510.0,833.0,413.0,331.0,14303.0
Alirajpur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,767.0,1041.0,1233.0,1518.0,1230.0,5789.0
Alirajpur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,442.0,935.0,1219.0,1274.0,3870.0
Alirajpur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,524.0,987.0,991.0,2502.0
Alirajpur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,815.0,1146.0,1315.0,989.0,1018.0,963.0,810.0,807.0,909.0,937.0,1043.0,1524.0,12276.0
Alirajpur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1225.0,1281.0,1555.0,1789.0,1704.0,1589.0,1344.0,864.0,1170.0,1171.0,1501.0,1323.0,16516.0
Alirajpur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1091.0,1327.0,1354.0,1545.0,1708.0,1576.0,1344.0,1541.0,1172.0,1185.0,1280.0,1309.0,16432.0
Alirajpur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1182.0,1222.0,1357.0,1412.0,1463.0,1607.0,1389.0,1482.0,1547.0,1113.0,1194.0,1130.0,16098.0
Alirajpur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,706.0,909.0,1036.0,920.0,923.0,903.0,779.0,738.0,793.0,723.0,969.0,1364.0,10763.0
Alirajpur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1227.0,1315.0,1534.0,1799.0,1774.0,1610.0,1407.0,616.0,393.0,366.0,280.0,321.0,12642.0
Alirajpur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1109.0,1325.0,1348.0,1551.0,1703.0,1597.0,1396.0,1546.0,907.0,570.0,323.0,333.0,13708.0
Alirajpur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1209.0,1223.0,1371.0,1429.0,1476.0,1647.0,1424.0,1484.0,1521.0,812.0,463.0,403.0,14462.0
Alirajpur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1235.0,1430.0,1612.0,1571.0,1595.0,1369.0,1266.0,1252.0,1437.0,1381.0,1522.0,1478.0,17148.0
Alirajpur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,393.0,539.0,752.0,776.0,666.0,564.0,518.0,577.0,650.0,665.0,725.0,722.0,7547.0
Alirajpur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,625.0,733.0,819.0,767.0,812.0,688.0,662.0,605.0,729.0,700.0,771.0,746.0,8657.0
Alirajpur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,574.0,687.0,764.0,758.0,772.0,696.0,597.0,552.0,708.0,677.0,740.0,705.0,8230.0
Alirajpur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1199.0,1420.0,1583.0,1525.0,1584.0,1384.0,1259.0,1157.0,1437.0,1377.0,1511.0,1451.0,16887.0
Alirajpur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,886.0,967.0,1227.0,1390.0,1200.0,1109.0,1027.0,1190.0,1417.0,1310.0,1447.0,1361.0,14531.0
Alirajpur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,888.0,970.0,1238.0,1384.0,1205.0,1102.0,1021.0,1195.0,1419.0,1319.0,1433.0,1364.0,14538.0
Alirajpur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,159.0,223.0,168.0,189.0,175.0,158.0,151.0,200.0,219.0,249.0,225.0,202.0,2318.0
Alirajpur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,165.0,213.0,183.0,206.0,169.0,145.0,152.0,197.0,213.0,257.0,208.0,220.0,2328.0
Alirajpur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,324.0,436.0,351.0,395.0,344.0,303.0,303.0,397.0,432.0,506.0,433.0,422.0,4646.0
Alirajpur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,355.0,325.0,305.0,452.0,374.0,265.0,284.0,325.0,377.0,422.0,379.0,474.0,4337.0
Alirajpur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,857.0,962.0,1054.0,1399.0,1242.0,1233.0,1140.0,1123.0,1242.0,1396.0,1326.0,1234.0,14208.0
Alirajpur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,846.0,898.0,1042.0,1390.0,1288.0,1240.0,1124.0,1093.0,1242.0,1341.0,1281.0,1144.0,13929.0
Alirajpur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,5.0,1.0,2.0,1.0,0.0,0.0,12.0,0.0,0.0,0.0,0.0,24.0
Alirajpur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,105.0,2.0,0.0,0.0,0.0,108.0
Alirajpur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,749.0,790.0,785.0,838.0,832.0,823.0,795.0,804.0,813.0,825.0,827.0,821.0,9702.0
Alirajpur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,683.0,729.0,741.0,796.0,773.0,771.0,691.0,763.0,778.0,741.0,804.0,745.0,9015.0
Alirajpur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,560.0,577.0,593.0,623.0,640.0,649.0,581.0,616.0,664.0,622.0,681.0,657.0,7463.0
Alirajpur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1255.0,1410.0,1577.0,1738.0,1584.0,1342.0,1250.0,1211.0,1438.0,1540.0,1566.0,1446.0,17357.0
Alirajpur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,128.0,123.0,218.0,5526.0,345.0,168.0,193.0,288.0,202.0,5134.0,584.0,296.0,13205.0
Alirajpur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,36.0,33.0,65.0,4988.0,247.0,77.0,61.0,71.0,75.0,5965.0,462.0,157.0,12237.0
Alirajpur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,4.0
Alirajpur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,9.0,3.0,2.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,15.0
Alirajpur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,351.0,487.0,608.0,939.0,1041.0,1104.0,833.0,642.0,618.0,632.0,651.0,859.0,8765.0
Alirajpur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,15.0,12.0,13.0,11.0,5.0,11.0,29.0,99.0,50.0,75.0,74.0,33.0,427.0
Alirajpur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,71.0,4.0,83.0,12.0,216.0,308.0,14.0,296.0,25.0,285.0,239.0,75.0,1628.0
Alirajpur,13.1,Number of Patients operated for cataract,TOTAL,10.0,16.0,24.0,20.0,85.0,71.0,266.0,74.0,218.0,76.0,83.0,137.0,1080.0
Alirajpur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,10.0,16.0,24.0,21.0,85.0,47.0,258.0,77.0,218.0,66.0,83.0,137.0,1042.0
Alirajpur,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,4.0,54.0,148.0,65.0,40.0,15.0,0.0,0.0,0.0,326.0
Alirajpur,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,56.0,86.0,25.0,80.0,110.0,100.0,457.0
Alirajpur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,1.0,1.0,1.0,1.0,4.0,4.0,2.0,2.0,1.0,1.0,-1.0
Alirajpur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,1.0,5.0,4.0,3.0,5.0,4.0,2.0,4.0,6.0,4.0,1.0,-1.0
Alirajpur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,415.0,437.0,428.0,449.0,472.0,411.0,415.0,465.0,427.0,566.0,523.0,480.0,-1.0
Alirajpur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,2.0,2.0,2.0,1.0,1.0,4.0,4.0,3.0,3.0,2.0,2.0,-1.0
Alirajpur,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,4.0,4.0,7.0,5.0,5.0,5.0,6.0,2.0,1.0,6.0,5.0,1.0,-1.0
Alirajpur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,60.0,110.0,76.0,0.0,102.0,101.0,48.0,26.0,33.0,41.0,39.0,110.0,746.0
Alirajpur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,,2.0,2.0,1.0,1.0,2.0,2.0,2.0,2.0,1.0,1.0,-1.0
Alirajpur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,,0.0,0.0,,,0.0,0.0,0.0,0.0,,,-1.0
Alirajpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,340.0,444.0,490.0,418.0,371.0,569.0,454.0,1032.0,1001.0,704.0,880.0,753.0,7456.0
Alirajpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,279.0,817.0,482.0,663.0,565.0,1205.0,1197.0,1136.0,940.0,805.0,948.0,965.0,10002.0
Alirajpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,494.0,569.0,702.0,658.0,374.0,905.0,444.0,506.0,838.0,539.0,704.0,813.0,7546.0
Alirajpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,614.0,1587.0,1284.0,1134.0,1179.0,1580.0,1778.0,1888.0,1691.0,1165.0,1252.0,2662.0,17814.0
Alirajpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,834.0,1013.0,1192.0,1076.0,745.0,1474.0,898.0,1538.0,1839.0,1243.0,1584.0,1566.0,15002.0
Alirajpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,893.0,2404.0,1766.0,1797.0,1744.0,2785.0,2975.0,3024.0,2631.0,1970.0,2200.0,3627.0,27816.0
Alirajpur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,3.0,4.0,5.0,4.0,28.0,3.0,4.0,5.0,5.0,6.0,6.0,0.0,73.0
Alirajpur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,7.0,4.0,6.0,5.0,36.0,5.0,5.0,3.0,5.0,3.0,5.0,7.0,91.0
Alirajpur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,10.0,8.0,11.0,9.0,64.0,8.0,9.0,8.0,10.0,9.0,11.0,7.0,164.0
Alirajpur,14.11,In-Patient Head Count at midnight,TOTAL,2145.0,1902.0,2722.0,2107.0,750.0,2118.0,2137.0,1905.0,1968.0,1713.0,1583.0,2027.0,23077.0
Alirajpur,14.12.1,OPD attendance (All),TOTAL,21241.0,28936.0,31180.0,31416.0,31198.0,46008.0,32695.0,34166.0,32582.0,31743.0,32833.0,35890.0,389888.0
Alirajpur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,20.0,17.0,58.0,20.0,20.0,25.0,26.0,171.0,166.0,165.0,155.0,175.0,1018.0
Alirajpur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,149.0,350.0,389.0,393.0,351.0,320.0,350.0,79.0,62.0,55.0,45.0,66.0,2609.0
Alirajpur,14.14.a,Number of patients given AYUSH treatment,TOTAL,1.0,4.0,1.0,0.0,1.0,2.0,1.0,833.0,151.0,698.0,489.0,1.0,2182.0
Alirajpur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,12.0
Alirajpur,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0,200.0
Alirajpur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2816.0,4230.0,4506.0,3567.0,4173.0,4341.0,3869.0,5548.0,3943.0,4522.0,5160.0,4818.0,51493.0
Alirajpur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,176.0,322.0,384.0,324.0,300.0,417.0,493.0,396.0,390.0,340.0,375.0,407.0,4324.0
Alirajpur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,122.0,79.0,95.0,214.0,27.0,188.0,209.0,835.0,405.0,316.0,296.0,186.0,2972.0
Alirajpur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,4.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,1.0,0.0,0.0,8.0
Alirajpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,247.0,228.0,247.0,361.0,18.0,162.0,229.0,545.0,319.0,311.0,375.0,212.0,3254.0
Alirajpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Alirajpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,688.0,835.0,791.0,825.0,386.0,709.0,351.0,592.0,1030.0,856.0,985.0,913.0,8961.0
Alirajpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0
Alirajpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1057.0,1142.0,1133.0,1400.0,431.0,1059.0,789.0,1972.0,1754.0,1483.0,1656.0,1311.0,15187.0
Alirajpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,5.0,2.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,1.0,0.0,0.0,11.0
Alirajpur,15.2,Number of Widal tests conducted,Number tested,538.0,780.0,787.0,748.0,797.0,889.0,1129.0,1230.0,265.0,971.0,993.0,1021.0,10148.0
Alirajpur,15.3.a,Number of VDRL tests conducted on males,Number tested,99.0,156.0,187.0,199.0,194.0,195.0,218.0,322.0,174.0,194.0,212.0,198.0,2348.0
Alirajpur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,189.0,189.0,165.0,184.0,204.0,190.0,232.0,279.0,234.0,254.0,276.0,334.0,2730.0
Alirajpur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,264.0,388.0,445.0,340.0,347.0,439.0,349.0,391.0,496.0,619.0,431.0,283.0,4792.0
Alirajpur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,552.0,733.0,797.0,723.0,745.0,824.0,799.0,992.0,904.0,1067.0,919.0,815.0,9870.0
Alirajpur,15.4.1,Number of blood smears examined for Malaria,TOTAL,3914.0,7034.0,6806.0,8265.0,9976.0,12530.0,11929.0,9939.0,11797.0,6401.0,7976.0,7471.0,104038.0
Alirajpur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,35.0,80.0,86.0,85.0,86.0,233.0,221.0,201.0,232.0,50.0,51.0,22.0,1382.0
Alirajpur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,24.0,30.0,16.0,24.0,35.0,189.0,260.0,338.0,276.0,66.0,54.0,18.0,1330.0
Alirajpur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,14000.0,6000.0,10500.0,10000.0,,,,,9500.0,,,,50000.0
Alirajpur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,5000.0,10000.0,10000.0,10000.0,,,,,0.0,,,,35000.0
Alirajpur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,176.0,,,,176.0
Alirajpur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,13000.0,5500.0,10500.0,7500.0,,,,,2000.0,,,,38500.0
Alirajpur,16.1.1,Stock position of DPT vaccines,5. Total Stock,6000.0,10500.0,10000.0,12500.0,0.0,0.0,0.0,0.0,7324.0,0.0,0.0,0.0,46324.0
Alirajpur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,0.0,,,,,,,4000.0,,,,4000.0
Alirajpur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,0.0,,,,,,,0.0,,,,0.0
Alirajpur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,0.0,,,,,,,32.0,,,,32.0
Alirajpur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,0.0,,,,,,,1500.0,,,,1500.0
Alirajpur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2468.0,0.0,0.0,0.0,2468.0
Alirajpur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,13500.0,7500.0,7000.0,6000.0,,,,,15000.0,,,,49000.0
Alirajpur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,10000.0,10000.0,15000.0,10000.0,,,,,0.0,,,,45000.0
Alirajpur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,176.0,,,,176.0
Alirajpur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,16000.0,10500.0,16000.0,13500.0,,,,,8000.0,,,,64000.0
Alirajpur,16.1.2,Stock position of OPV vaccines,5. Total Stock,7500.0,7000.0,6000.0,2500.0,0.0,0.0,0.0,0.0,6824.0,0.0,0.0,0.0,29824.0
Alirajpur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,6000.0,5500.0,9500.0,15000.0,,,,,10000.0,,,,46000.0
Alirajpur,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,10000.0,15000.0,5000.0,,,,,0.0,,,,40000.0
Alirajpur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,112.0,,,,112.0
Alirajpur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,10500.0,6000.0,9500.0,13000.0,,,,,3000.0,,,,42000.0
Alirajpur,16.1.3,Stock position of TT vaccines,5. Total Stock,5500.0,9500.0,15000.0,7000.0,0.0,0.0,0.0,0.0,6888.0,0.0,0.0,0.0,43888.0
Alirajpur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,0.0,,,,,,,0.0,,,,0.0
Alirajpur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,0.0,,,,,,,0.0,,,,0.0
Alirajpur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,0.0,,,,,,,0.0,,,,0.0
Alirajpur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,0.0,,,,,,,0.0,,,,0.0
Alirajpur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,6400.0,6500.0,7500.0,3000.0,,,,,10500.0,,,,33900.0
Alirajpur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,8000.0,5000.0,10000.0,,,,,5000.0,,,,38000.0
Alirajpur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,176.0,,,,176.0
Alirajpur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,9900.0,7000.0,9500.0,6500.0,,,,,4000.0,,,,36900.0
Alirajpur,16.1.5,Stock position of BCG vaccines,5. Total Stock,6500.0,7500.0,3000.0,6500.0,0.0,0.0,0.0,0.0,11324.0,0.0,0.0,0.0,34824.0
Alirajpur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4500.0,4000.0,6250.0,6500.0,,,,,2500.0,,,,23750.0
Alirajpur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,5000.0,5000.0,0.0,,,,,5000.0,,,,20000.0
Alirajpur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,70.0,,,,70.0
Alirajpur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,5500.0,2750.0,4750.0,4250.0,,,,,2000.0,,,,19250.0
Alirajpur,16.1.6,Stock position of Measles vaccines,5. Total Stock,4000.0,6250.0,6500.0,2250.0,0.0,0.0,0.0,0.0,5430.0,0.0,0.0,0.0,24430.0
Alirajpur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,0.0,,,,,,,0.0,,,,0.0
Alirajpur,16.1.7,Stock position of JE vaccines,2. Stocks Received,,0.0,,,,,,,0.0,,,,0.0
Alirajpur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,0.0,,,,,,,0.0,,,,0.0
Alirajpur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,0.0,,,,,,,0.0,,,,0.0
Alirajpur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,8000.0,5000.0,9000.0,14000.0,,,,,5900.0,,,,41900.0
Alirajpur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,7500.0,10000.0,15000.0,2000.0,,,,,2500.0,,,,37000.0
Alirajpur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,112.0,,,,112.0
Alirajpur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,10500.0,6000.0,10000.0,8000.0,,,,,2000.0,,,,36500.0
Alirajpur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,5000.0,9000.0,14000.0,8000.0,0.0,0.0,0.0,0.0,6288.0,0.0,0.0,0.0,42288.0
Alirajpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,500.0,,,,500.0
Alirajpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,0.0,,,,0.0
Alirajpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,103.0,,,,103.0
Alirajpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,0.0,,,,0.0
Alirajpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,397.0,0.0,0.0,0.0,397.0
Alirajpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,50000.0,,,,50000.0
Alirajpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,0.0,,,,0.0
Alirajpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,1900.0,,,,1900.0
Alirajpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,0.0,,,,0.0
Alirajpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,48100.0,0.0,0.0,0.0,48100.0
Alirajpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,700.0,,,,700.0
Alirajpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,0.0,,,,0.0
Alirajpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,650.0,,,,650.0
Alirajpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,0.0,,,,0.0
Alirajpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0,0.0,0.0,0.0,50.0
Alirajpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,0.0,,,,0.0
Alirajpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,0.0,,,,0.0
Alirajpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,0.0,,,,0.0
Alirajpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,0.0,,,,0.0
Alirajpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Alirajpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Alirajpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Alirajpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Alirajpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,300.0,300.0,,,600.0
Alirajpur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,600.0,600.0,,,1200.0
Alirajpur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,0.0,0.0,,,0.0
Alirajpur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,600.0,440.0,,,1040.0
Alirajpur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,300.0,460.0,0.0,0.0,760.0
Alirajpur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,3400.0,1900.0,,,5300.0
Alirajpur,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,0.0,300.0,,,300.0
Alirajpur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,0.0,0.0,,,0.0
Alirajpur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,1500.0,0.0,,,1500.0
Alirajpur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1900.0,2200.0,0.0,0.0,4100.0
Alirajpur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Alirajpur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Alirajpur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Alirajpur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Alirajpur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,25000.0,31200.0,,,56200.0
Alirajpur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,6200.0,0.0,,,6200.0
Alirajpur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,0.0,0.0,,,0.0
Alirajpur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,0.0,400.0,,,400.0
Alirajpur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,31200.0,30800.0,0.0,0.0,62000.0
Alirajpur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Alirajpur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,0.0,,,0.0
Alirajpur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Alirajpur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,0.0,,,0.0
Alirajpur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,25000.0,,,25000.0
Alirajpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,20000.0,,,20000.0
Alirajpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Alirajpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,20000.0,,,20000.0
Alirajpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25000.0,0.0,0.0,25000.0
Alirajpur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Alirajpur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Alirajpur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Alirajpur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Alirajpur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Alirajpur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Alirajpur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Alirajpur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Alirajpur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Alirajpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Alirajpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Alirajpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Alirajpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Alirajpur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,1.0,,,1.0
Alirajpur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,2305.0,0.0,,,2305.0
Alirajpur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Alirajpur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,0.0,,,0.0
Alirajpur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2305.0,1.0,0.0,0.0,2306.0
Alirajpur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,2800.0,,,2800.0
Alirajpur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,0.0,,,0.0
Alirajpur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Alirajpur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,700.0,,,700.0
Alirajpur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2100.0,0.0,0.0,2100.0
Alirajpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,700.0,1800.0,3500.0,4800.0,,,,,3700.0,,,,14500.0
Alirajpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,3000.0,3300.0,3300.0,3300.0,,,,,0.0,,,,12900.0
Alirajpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,0.0,,,,0.0
Alirajpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1900.0,1600.0,2000.0,2500.0,,,,,2600.0,,,,10600.0
Alirajpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1800.0,3500.0,4800.0,5600.0,0.0,0.0,0.0,0.0,1100.0,0.0,0.0,0.0,16800.0
Alirajpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,9000.0,3200.0,26800.0,36400.0,,,,,77600.0,,,,153000.0
Alirajpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,12000.0,24000.0,24000.0,24000.0,,,,,26000.0,,,,110000.0
Alirajpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,0.0,,,,0.0
Alirajpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,17800.0,400.0,15800.0,21600.0,,,,,44000.0,,,,99600.0
Alirajpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,3200.0,26800.0,35000.0,38800.0,0.0,0.0,0.0,0.0,59600.0,0.0,0.0,0.0,163400.0
Alirajpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1700.0,1800.0,200.0,800.0,,,,,2000.0,,,,6500.0
Alirajpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2000.0,0.0,2000.0,2000.0,,,,,0.0,,,,6000.0
Alirajpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,0.0,,,,0.0
Alirajpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1900.0,1600.0,1400.0,900.0,,,,,1900.0,,,,7700.0
Alirajpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1800.0,200.0,800.0,1900.0,0.0,0.0,0.0,0.0,100.0,0.0,0.0,0.0,4800.0
Alirajpur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,1.0,2.0,,1.0,1.0,1.0,,3.0,,,9.0
Alirajpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Alirajpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Alirajpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Alirajpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,1.0,1.0,,1.0,,1.0,,,,,4.0
Alirajpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,1.0,,,,,,,,,,,,1.0
Alirajpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,,1.0,1.0,,1.0,,1.0,,,,,5.0
Alirajpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,3.0,3.0,3.0,,2.0,7.0,4.0,,3.0,8.0,4.0,2.0,39.0
Alirajpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,1.0,,1.0,,,,,,,,2.0
Alirajpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,3.0,3.0,4.0,,3.0,7.0,4.0,,3.0,8.0,4.0,2.0,41.0
Alirajpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,6.0,6.0,6.0,8.0,8.0,8.0,3.0,9.0,9.0,6.0,1.0,3.0,73.0
Alirajpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,1.0,,1.0,2.0,2.0,,,,,,7.0
Alirajpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,6.0,7.0,7.0,8.0,9.0,10.0,5.0,9.0,9.0,6.0,1.0,3.0,80.0
Alirajpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,2.0,2.0,,4.0,2.0,5.0,7.0,3.0,1.0,3.0,30.0
Alirajpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,2.0,3.0,,1.0,1.0,2.0,1.0,1.0,,3.0,1.0,2.0,17.0
Alirajpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,3.0,3.0,2.0,3.0,1.0,6.0,3.0,6.0,7.0,6.0,2.0,5.0,47.0
Alirajpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,1.0,1.0,1.0,1.0,2.0,,,,,,,,6.0
Alirajpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Alirajpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,1.0,1.0,1.0,1.0,2.0,,,,,,,,6.0
Alirajpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,1.0,,,1.0,,1.0,,,,,,4.0
Alirajpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,3.0,1.0,,,1.0,1.0,2.0,,,,,,8.0
Alirajpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,4.0,2.0,,,2.0,1.0,3.0,,,,,,12.0
Alirajpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Alirajpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Alirajpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Alirajpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,4.0,12.0,4.0,9.0,11.0,13.0,9.0,11.0,7.0,2.0,1.0,2.0,85.0
Alirajpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,4.0,5.0,8.0,11.0,11.0,17.0,14.0,15.0,6.0,9.0,,5.0,105.0
Alirajpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,8.0,17.0,12.0,20.0,22.0,30.0,23.0,26.0,13.0,11.0,1.0,7.0,190.0
Alirajpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Alirajpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Alirajpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Alirajpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,1.0,,,,,,,,1.0
Alirajpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Alirajpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Alirajpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Alirajpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,,,,,,,,,,,1.0
Alirajpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Alirajpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,1.0,,,,,1.0,2.0
Alirajpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,1.0,1.0,,,1.0,3.0,2.0,4.0,,2.0,14.0
Alirajpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,1.0,1.0,,,2.0,3.0,2.0,4.0,,3.0,16.0
Alirajpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Alirajpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Alirajpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Alirajpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Alirajpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Alirajpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,2.0,5.0,3.0,1.0,2.0,2.0,11.0,,,5.0,,,31.0
Alirajpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,3.0,1.0,3.0,,2.0,,,2.0,,,11.0
Alirajpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,5.0,6.0,2.0,5.0,2.0,13.0,,,7.0,,,42.0
Alirajpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Alirajpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Alirajpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Alirajpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Alirajpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Alirajpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,1.0,,,1.0,,,2.0
Alirajpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,1.0,1.0,,,1.0,,,3.0
Alirajpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,1.0,2.0,,,2.0,,,5.0
Alirajpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Alirajpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Alirajpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Alirajpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,1.0,,,,1.0
Alirajpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Alirajpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Alirajpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Alirajpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Alirajpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Alirajpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Alirajpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Alirajpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,1.0,,,,,,,1.0
Alirajpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Alirajpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,1.0,,,2.0,,1.0,,1.0,,,5.0
Alirajpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Alirajpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,1.0,,,2.0,,1.0,,1.0,,,5.0
Alirajpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Alirajpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,1.0,1.0,1.0,2.0,1.0,1.0,,1.0,,,,9.0
Alirajpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Alirajpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,1.0,1.0,1.0,2.0,1.0,1.0,,1.0,,,,9.0
Alirajpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Alirajpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Alirajpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Alirajpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,1.0,,,,,,,1.0
Alirajpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Alirajpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,1.0,,1.0,1.0,2.0,2.0,,2.0,,,,10.0
Alirajpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Alirajpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,1.0,,1.0,1.0,2.0,2.0,,2.0,,,,10.0
Alirajpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,2.0,,,2.0
Alirajpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,,3.0,1.0,2.0,3.0,3.0,2.0,,3.0,1.0,7.0,28.0
Alirajpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,1.0,,1.0,,,1.0,,,,3.0
Alirajpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,3.0,,3.0,2.0,2.0,4.0,3.0,2.0,1.0,5.0,1.0,7.0,33.0
Alirajpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,1.0,,1.0,,1.0,2.0,,,5.0
Alirajpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,2.0,2.0,1.0,1.0,4.0,2.0,3.0,1.0,2.0,4.0,1.0,23.0
Alirajpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,1.0,1.0,,2.0,,,,,1.0,,5.0
Alirajpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,2.0,3.0,2.0,2.0,6.0,3.0,3.0,2.0,4.0,5.0,1.0,33.0
Alirajpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,,,,,1.0,,,,,,,2.0
Alirajpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,,,,,,1.0,,,,,,2.0
Alirajpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Alirajpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,,1.0,,,1.0,1.0,,,,,,5.0
Alirajpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Alirajpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,,,,,,,1.0,2.0,,1.0,,5.0
Alirajpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,2.0,,,,,,1.0,,,,3.0
Alirajpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,,2.0,,,,,1.0,3.0,,1.0,,8.0
Alirajpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,,,1.0,,2.0,1.0,,,1.0,1.0,,7.0
Alirajpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,3.0,2.0,4.0,6.0,8.0,3.0,3.0,4.0,9.0,5.0,1.0,50.0
Alirajpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1.0,,3.0,2.0,,5.0,5.0,6.0,7.0,7.0,4.0,5.0,45.0
Alirajpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,4.0,3.0,5.0,7.0,6.0,15.0,9.0,9.0,11.0,17.0,10.0,6.0,102.0
Alirajpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,,,,,2.0,,1.0,4.0,,,,9.0
Alirajpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,3.0,4.0,6.0,5.0,11.0,11.0,9.0,12.0,9.0,10.0,10.0,12.0,102.0
Alirajpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,10.0,9.0,8.0,8.0,11.0,16.0,22.0,21.0,19.0,22.0,12.0,15.0,173.0
Alirajpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,15.0,13.0,14.0,13.0,22.0,29.0,31.0,34.0,32.0,32.0,22.0,27.0,284.0
Anuppur,1.1,Total number of pregnant women Registered for ANC,TOTAL,1399.0,1214.0,1610.0,2006.0,1434.0,1708.0,1757.0,2049.0,1857.0,1856.0,1823.0,1969.0,20682.0
Anuppur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1058.0,955.0,1235.0,1413.0,987.0,1139.0,999.0,1137.0,1078.0,1087.0,1051.0,1079.0,13218.0
Anuppur,1.2,Number of Pregnant women registered under JSY,TOTAL,1329.0,1207.0,1787.0,1997.0,1360.0,1675.0,1715.0,1968.0,1801.0,1697.0,1654.0,1784.0,19974.0
Anuppur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1004.0,1054.0,1204.0,1365.0,1071.0,1255.0,1279.0,1394.0,1314.0,1335.0,1561.0,1366.0,15202.0
Anuppur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1134.0,1041.0,1392.0,1712.0,1146.0,1392.0,1150.0,1284.0,1256.0,1336.0,1336.0,1354.0,15533.0
Anuppur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,953.0,982.0,1094.0,1292.0,1054.0,1195.0,1107.0,1151.0,1144.0,1169.0,1449.0,1211.0,13801.0
Anuppur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1310.0,1261.0,1546.0,1825.0,1379.0,1563.0,2056.0,1869.0,1845.0,1741.0,1720.0,1700.0,19815.0
Anuppur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,117.0,72.0,109.0,211.0,153.0,238.0,220.0,212.0,229.0,305.0,269.0,191.0,2326.0
Anuppur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,6.0,6.0,4.0,0.0,1.0,8.0,9.0,0.0,0.0,6.0,7.0,18.0,65.0
Anuppur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,193.0,221.0,294.0,492.0,324.0,485.0,500.0,837.0,921.0,639.0,688.0,792.0,6386.0
Anuppur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,23.0,5.0,19.0,26.0,34.0,55.0,70.0,93.0,118.0,10.0,31.0,25.0,509.0
Anuppur,1.8,Number of pregnancy test kits used at SC level,TOTAL,718.0,593.0,837.0,1016.0,778.0,932.0,824.0,1020.0,865.0,867.0,902.0,937.0,10289.0
Anuppur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,8.0,34.0,49.0,33.0,34.0,23.0,32.0,24.0,6.0,13.0,20.0,276.0
Anuppur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,72.0,66.0,86.0,71.0,91.0,72.0,73.0,75.0,72.0,96.0,81.0,82.0,937.0
Anuppur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,72.0,74.0,120.0,120.0,124.0,106.0,96.0,107.0,96.0,102.0,94.0,102.0,1213.0
Anuppur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,37.0,39.0,67.0,78.0,93.0,73.0,46.0,73.0,56.0,56.0,71.0,50.0,739.0
Anuppur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,4.0,7.0,0.0,3.0,2.0,5.0,1.0,2.0,,0.0,,24.0
Anuppur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,865.0,747.0,1045.0,982.0,1046.0,1019.0,939.0,915.0,924.0,841.0,788.0,898.0,11009.0
Anuppur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,13.0,70.0,,53.0,147.0,30.0,45.0,163.0,111.0,44.0,25.0,53.0,754.0
Anuppur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,863.0,747.0,1002.0,935.0,1015.0,944.0,855.0,850.0,845.0,759.0,697.0,858.0,10370.0
Anuppur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,654.0,598.0,726.0,659.0,907.0,690.0,718.0,763.0,672.0,585.0,510.0,743.0,8225.0
Anuppur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,18.0,18.0,2.0,5.0,18.0,5.0,7.0,8.0,16.0,10.0,48.0,32.0,187.0
Anuppur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,17.0,9.0,13.0,39.0
Anuppur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Anuppur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Anuppur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Anuppur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Anuppur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,0.0,,,,,,,,0.0
Anuppur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,13.0,7.0,24.0,13.0,24.0,23.0,20.0,16.0,9.0,1.0,13.0,16.0,179.0
Anuppur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anuppur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,13.0,7.0,24.0,13.0,24.0,23.0,20.0,16.0,9.0,1.0,13.0,16.0,179.0
Anuppur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,11.0,6.0,7.0,24.0
Anuppur,4.1.1.a,Number of male live births,TOTAL,477.0,389.0,610.0,565.0,588.0,523.0,526.0,535.0,501.0,460.0,442.0,521.0,6137.0
Anuppur,4.1.1.b,Number of female live births,TOTAL,436.0,412.0,529.0,539.0,592.0,579.0,501.0,479.0,495.0,486.0,433.0,480.0,5961.0
Anuppur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,913.0,801.0,1139.0,1104.0,1180.0,1102.0,1027.0,1014.0,996.0,946.0,875.0,1001.0,12098.0
Anuppur,4.1.2,Number of still births,TOTAL,29.0,26.0,31.0,16.0,35.0,24.0,24.0,30.0,23.0,19.0,20.0,21.0,298.0
Anuppur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,22.0,18.0,28.0,77.0,45.0,55.0,26.0,52.0,59.0,54.0,53.0,50.0,539.0
Anuppur,4.2.1,Number of Newborns weighed at birth,TOTAL,897.0,792.0,1131.0,1070.0,1151.0,1090.0,992.0,986.0,987.0,931.0,875.0,970.0,11872.0
Anuppur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,44.0,65.0,53.0,178.0,164.0,93.0,106.0,101.0,107.0,98.0,158.0,102.0,1269.0
Anuppur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,909.0,800.0,1137.0,1075.0,1164.0,1093.0,995.0,988.0,988.0,938.0,872.0,979.0,11938.0
Anuppur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,29.0,,1.0,1.0,,1.0,8.0,1.0,1.0,1.0,,4.0,47.0
Anuppur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,23.0,1.0,13.0,,,,,,,3.0,9.0,49.0
Anuppur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,19.0,13.0,35.0,29.0,32.0,23.0,20.0,16.0,9.0,14.0,30.0,35.0,275.0
Anuppur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anuppur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,48.0,36.0,37.0,43.0,32.0,24.0,28.0,17.0,10.0,15.0,33.0,48.0,371.0
Anuppur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,14.0,,,14.0
Anuppur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,34.0,43.0,37.0,46.0,34.0,68.0,95.0,35.0,25.0,57.0,45.0,118.0,637.0
Anuppur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,6.0,10.0,6.0,20.0,0.0,12.0,12.0,20.0,12.0,4.0,14.0,5.0,121.0
Anuppur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,34.0,43.0,26.0,29.0,34.0,53.0,77.0,28.0,13.0,30.0,44.0,166.0,577.0
Anuppur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,52.0,13.0,35.0,10.0,11.0,21.0,25.0,14.0,3.0,6.0,4.0,11.0,205.0
Anuppur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,737.0,665.0,930.0,1032.0,1094.0,1043.0,907.0,939.0,903.0,858.0,806.0,942.0,10856.0
Anuppur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,463.0,474.0,686.0,835.0,726.0,763.0,612.0,684.0,626.0,589.0,527.0,677.0,7662.0
Anuppur,6.3,PNC maternal complications attended,TOTAL,19.0,15.0,6.0,21.0,34.0,9.0,8.0,11.0,11.0,9.0,6.0,4.0,153.0
Anuppur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,6.0,8.0,12.0,18.0,6.0,8.0,4.0,3.0,8.0,11.0,5.0,7.0,96.0
Anuppur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,0.0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,0.0,0.0,,4.0
Anuppur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,6.0,8.0,12.0,18.0,7.0,8.0,4.0,3.0,11.0,11.0,5.0,7.0,100.0
Anuppur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,0.0,0.0,0.0,0.0
Anuppur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,62.0,52.0,130.0,38.0,37.0,85.0,102.0,62.0,33.0,33.0,31.0,145.0,810.0
Anuppur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,100.0,32.0,50.0,76.0,72.0,362.0,119.0,491.0,57.0,79.0,63.0,140.0,1641.0
Anuppur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,162.0,84.0,180.0,114.0,109.0,447.0,221.0,553.0,90.0,112.0,94.0,285.0,2451.0
Anuppur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,0.0,0.0,0.0,0.0,,,,0.0,,0.0,,0.0
Anuppur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,1.0,,2.0,,2.0,5.0
Anuppur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,,8.0,22.0,4.0,0.0,0.0,15.0,29.0,32.0,10.0,6.0,126.0
Anuppur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Anuppur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anuppur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,8.0,22.0,4.0,0.0,0.0,16.0,29.0,34.0,10.0,8.0,131.0
Anuppur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Anuppur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,3.0,,,28.0,100.0,122.0,166.0,79.0,26.0,524.0
Anuppur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,,11.0,14.0,8.0,60.0,55.0,138.0,1092.0,1196.0,358.0,197.0,3129.0
Anuppur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,1.0,,,4.0
Anuppur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anuppur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,11.0,17.0,8.0,61.0,85.0,238.0,1214.0,1363.0,437.0,223.0,3657.0
Anuppur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Anuppur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Anuppur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,,38.0,32.0,4.0,9.0,0.0,4.0,14.0,17.0,28.0,12.0,158.0
Anuppur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Anuppur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anuppur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,38.0,32.0,4.0,9.0,0.0,4.0,14.0,17.0,28.0,12.0,158.0
Anuppur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Anuppur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Anuppur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,0.0,,0.0
Anuppur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,0.0,2.0,3.0,9.0,0.0,5.0,0.0,0.0,,,,19.0
Anuppur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anuppur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,0.0,2.0,3.0,9.0,0.0,5.0,0.0,0.0,,0.0,,19.0
Anuppur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Anuppur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,57.0,100.0,91.0,209.0,193.0,154.0,152.0,139.0,194.0,148.0,126.0,164.0,1727.0
Anuppur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,9.0,3.0,10.0,,3.0,4.0,4.0,46.0,3.0,4.0,3.0,89.0
Anuppur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,7.0,12.0,8.0,5.0,5.0,4.0,1.0,2.0,43.0,103.0,71.0,87.0,348.0
Anuppur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,0.0,0.0,0.0,27.0,0.0,0.0,1.0,2.0,,,,30.0
Anuppur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Anuppur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,64.0,121.0,102.0,224.0,225.0,161.0,157.0,146.0,285.0,254.0,201.0,254.0,2194.0
Anuppur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,33.0,81.0,49.0,40.0,37.0,67.0,21.0,7.0,87.0,76.0,107.0,605.0
Anuppur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Anuppur,9.06,Number of IUCD removals,TOTAL,81.0,131.0,95.0,117.0,135.0,156.0,162.0,177.0,198.0,153.0,152.0,148.0,1705.0
Anuppur,9.07,Number of Oral Pills cycles distributed,TOTAL,636.0,724.0,674.0,1696.0,2955.0,2177.0,1785.0,1960.0,2371.0,1805.0,1965.0,1911.0,20659.0
Anuppur,9.08,Number of Condom pieces distributed,TOTAL,2328.0,4362.0,3687.0,10358.0,13619.0,11314.0,9310.0,7494.0,14316.0,9858.0,10328.0,10914.0,107888.0
Anuppur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,,,,,0.0,,0.0,0.0,0.0
Anuppur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,43.0,20.0,13.0,29.0,16.0,25.0,19.0,41.0,23.0,37.0,29.0,41.0,336.0
Anuppur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,,,,,,,,1.0,,0.0,0.0,1.0
Anuppur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,1.0,,2.0,10.0,0.0,0.0,13.0
Anuppur,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,1.0,,0.0,0.0,1.0
Anuppur,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,1.0,,1.0,1.0,0.0,0.0,3.0
Anuppur,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,0.0,,0.0,,0.0
Anuppur,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,0.0,,0.0,,0.0
Anuppur,9.12,Number of Institutions having NSV trained doctors,TOTAL,,1.0,1.0,2.0,1.0,1.0,1.0,2.0,3.0,1.0,2.0,2.0,-1.0
Anuppur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,975.0,926.0,1327.0,1523.0,1377.0,1420.0,1131.0,1220.0,1150.0,1050.0,1046.0,1084.0,14229.0
Anuppur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,985.0,930.0,1194.0,1403.0,1142.0,1297.0,1222.0,521.0,77.0,65.0,35.0,16.0,8887.0
Anuppur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1048.0,923.0,1120.0,1467.0,1046.0,1225.0,1143.0,1283.0,411.0,210.0,78.0,87.0,10041.0
Anuppur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1104.0,976.0,1089.0,1348.0,1084.0,1081.0,1139.0,1179.0,1225.0,426.0,210.0,126.0,10987.0
Anuppur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,906.0,965.0,1032.0,1072.0,1071.0,5046.0
Anuppur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,6.0,783.0,897.0,1026.0,1157.0,3869.0
Anuppur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21.0,682.0,867.0,1103.0,2673.0
Anuppur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,612.0,601.0,841.0,1175.0,1023.0,1032.0,837.0,837.0,893.0,805.0,727.0,850.0,10233.0
Anuppur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,995.0,922.0,1194.0,1406.0,1138.0,1292.0,1195.0,770.0,913.0,994.0,1017.0,1118.0,12954.0
Anuppur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1048.0,909.0,1124.0,1473.0,1049.0,1224.0,1133.0,1109.0,981.0,1008.0,1021.0,1225.0,13304.0
Anuppur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1109.0,984.0,1091.0,1344.0,1078.0,1082.0,1124.0,1004.0,1096.0,994.0,964.0,1169.0,13039.0
Anuppur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,557.0,498.0,766.0,1077.0,961.0,936.0,793.0,816.0,792.0,638.0,663.0,669.0,9166.0
Anuppur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,983.0,928.0,1190.0,1388.0,1145.0,1293.0,1208.0,479.0,154.0,86.0,86.0,50.0,8990.0
Anuppur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1037.0,915.0,1126.0,1445.0,1047.0,1218.0,1132.0,1237.0,468.0,220.0,146.0,101.0,10092.0
Anuppur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1104.0,977.0,1089.0,1333.0,1081.0,1088.0,1128.0,1136.0,1130.0,451.0,257.0,151.0,10925.0
Anuppur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,917.0,959.0,1303.0,1466.0,1112.0,1245.0,1102.0,1017.0,1048.0,1244.0,1084.0,1201.0,13698.0
Anuppur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,281.0,252.0,443.0,467.0,420.0,291.0,306.0,540.0,613.0,797.0,643.0,856.0,5909.0
Anuppur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Anuppur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,497.0,489.0,697.0,753.0,553.0,591.0,570.0,464.0,511.0,662.0,562.0,626.0,6975.0
Anuppur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,420.0,468.0,602.0,713.0,516.0,554.0,526.0,442.0,456.0,602.0,526.0,545.0,6370.0
Anuppur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,917.0,957.0,1299.0,1466.0,1069.0,1145.0,1096.0,906.0,967.0,1264.0,1088.0,1171.0,13345.0
Anuppur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,927.0,924.0,1111.0,1264.0,938.0,1016.0,902.0,1113.0,1080.0,1281.0,1092.0,1253.0,12901.0
Anuppur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,928.0,922.0,1112.0,1263.0,916.0,1005.0,903.0,956.0,1055.0,1280.0,1087.0,1249.0,12676.0
Anuppur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Anuppur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,217.0,132.0,223.0,218.0,172.0,170.0,111.0,186.0,134.0,208.0,184.0,229.0,2184.0
Anuppur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,205.0,128.0,222.0,224.0,168.0,158.0,107.0,158.0,129.0,186.0,153.0,223.0,2061.0
Anuppur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,422.0,260.0,445.0,442.0,340.0,328.0,218.0,344.0,263.0,394.0,337.0,452.0,4245.0
Anuppur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,788.0,658.0,1042.0,1287.0,1025.0,1109.0,932.0,1062.0,1172.0,1168.0,1038.0,1223.0,12504.0
Anuppur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,875.0,703.0,1057.0,1357.0,1328.0,1381.0,1272.0,1312.0,1288.0,1239.0,1122.0,1238.0,14172.0
Anuppur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,728.0,582.0,986.0,1343.0,1073.0,1242.0,1032.0,1096.0,1093.0,1310.0,1025.0,1071.0,12581.0
Anuppur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,1.0
Anuppur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Anuppur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,0.0,0.0,0.0,0.0,11.0,0.0,0.0,0.0,,7.0,,18.0
Anuppur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,864.0,871.0,865.0,901.0,865.0,907.0,893.0,877.0,866.0,893.0,898.0,883.0,10583.0
Anuppur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,840.0,824.0,851.0,896.0,826.0,890.0,847.0,866.0,859.0,860.0,875.0,873.0,10307.0
Anuppur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,663.0,677.0,688.0,720.0,633.0,586.0,546.0,688.0,721.0,720.0,707.0,698.0,8047.0
Anuppur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Anuppur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,878.0,955.0,1268.0,1362.0,1107.0,1172.0,1107.0,965.0,1027.0,1757.0,1170.0,1245.0,14013.0
Anuppur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,362.0,316.0,575.0,4160.0,1346.0,419.0,432.0,524.0,779.0,5497.0,1014.0,513.0,15937.0
Anuppur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,250.0,293.0,478.0,5255.0,1552.0,646.0,440.0,453.0,703.0,5501.0,1092.0,491.0,17154.0
Anuppur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,2.0,0.0,,2.0
Anuppur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,0.0,,0.0
Anuppur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,0.0,,0.0
Anuppur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,0.0,,0.0
Anuppur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,0.0,,0.0
Anuppur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,5.0,2.0,4.0,7.0,7.0,0.0,37.0,4.0,24.0,0.0,5.0,97.0
Anuppur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,68.0,116.0,154.0,131.0,171.0,180.0,85.0,266.0,155.0,163.0,128.0,171.0,1788.0
Anuppur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,2.0,13.0,56.0,33.0,43.0,24.0,59.0,66.0,56.0,314.0,47.0,12.0,725.0
Anuppur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,4.0,2.0,,66.0,104.0,1.0,5.0,,4.0,,1.0,187.0
Anuppur,13.1,Number of Patients operated for cataract,TOTAL,,,2.0,3.0,2.0,17.0,48.0,100.0,50.0,1426.0,182.0,156.0,1986.0
Anuppur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,2.0,3.0,2.0,17.0,42.0,26.0,50.0,2242.0,180.0,156.0,2720.0
Anuppur,13.3,Number of School children detected with Refractive errors,TOTAL,4.0,,,10.0,10.0,248.0,253.0,334.0,247.0,24.0,37.0,0.0,1167.0
Anuppur,13.4,Number of children provided free glasses,TOTAL,,,,10.0,,110.0,385.0,15.0,217.0,263.0,40.0,81.0,1121.0
Anuppur,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Anuppur,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Anuppur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,3.0,4.0,3.0,3.0,3.0,2.0,1.0,1.0,2.0,2.0,2.0,-1.0
Anuppur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,1.0,1.0,1.0,2.0,,,1.0,1.0,1.0,,1.0,,-1.0
Anuppur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,488.0,466.0,599.0,686.0,674.0,593.0,617.0,750.0,705.0,630.0,692.0,691.0,-1.0
Anuppur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,7.0,7.0,6.0,6.0,5.0,4.0,4.0,4.0,3.0,3.0,-1.0
Anuppur,14.05,Number of RKS meetings held during the month,TOTAL,6.0,9.0,12.0,9.0,6.0,3.0,5.0,3.0,3.0,2.0,0.0,10.0,68.0
Anuppur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,5.0,9.0,9.0,10.0,6.0,7.0,4.0,4.0,4.0,4.0,4.0,3.0,-1.0
Anuppur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,92.0,86.0,77.0,73.0,26.0,91.0,73.0,62.0,78.0,,11.0,81.0,750.0
Anuppur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,3.0,2.0,2.0,1.0,2.0,2.0,2.0,2.0,2.0,2.0,1.0,-1.0
Anuppur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,0.0,,,,,,,,0.0,-1.0
Anuppur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,92.0,129.0,149.0,98.0,120.0,127.0,128.0,115.0,94.0,201.0,67.0,61.0,1381.0
Anuppur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,626.0,696.0,773.0,981.0,1040.0,1141.0,797.0,661.0,582.0,972.0,866.0,565.0,9700.0
Anuppur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,87.0,164.0,148.0,81.0,105.0,102.0,88.0,104.0,100.0,260.0,66.0,119.0,1424.0
Anuppur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1323.0,1106.0,1499.0,1543.0,1369.0,1658.0,1793.0,1285.0,1399.0,1650.0,1403.0,1448.0,17476.0
Anuppur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,179.0,293.0,297.0,179.0,225.0,229.0,216.0,219.0,194.0,461.0,133.0,180.0,2805.0
Anuppur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1949.0,1802.0,2272.0,2524.0,2409.0,2799.0,2590.0,1946.0,1981.0,2622.0,2269.0,2013.0,27176.0
Anuppur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,5.0,8.0,20.0,20.0,14.0,16.0,13.0,16.0,11.0,16.0,6.0,12.0,157.0
Anuppur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,15.0,11.0,14.0,7.0,13.0,11.0,10.0,5.0,7.0,13.0,9.0,117.0
Anuppur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,7.0,23.0,31.0,34.0,21.0,29.0,24.0,26.0,16.0,23.0,19.0,21.0,274.0
Anuppur,14.11,In-Patient Head Count at midnight,TOTAL,1124.0,970.0,1163.0,1903.0,3074.0,3777.0,3596.0,2309.0,2245.0,2176.0,2455.0,2221.0,27013.0
Anuppur,14.12.1,OPD attendance (All),TOTAL,22281.0,26504.0,32714.0,34390.0,37066.0,45552.0,30304.0,27835.0,26745.0,27088.0,39552.0,36472.0,386503.0
Anuppur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,16.0,16.0,24.0,19.0,30.0,55.0,15.0,42.0,46.0,33.0,64.0,35.0,395.0
Anuppur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,15.0,0.0,0.0,0.0,0.0,27.0,0.0,15.0,9.0,,0.0,,66.0
Anuppur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,88.0,88.0,126.0,147.0,137.0,106.0,123.0,88.0,65.0,89.0,173.0,157.0,1387.0
Anuppur,14.14.a,Number of patients given AYUSH treatment,TOTAL,490.0,395.0,410.0,514.0,566.0,342.0,316.0,455.0,456.0,266.0,79.0,412.0,4701.0
Anuppur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,79.0,7.0,5.0,93.0
Anuppur,14.14.c,Number of Adolescents counselled,TOTAL,67.0,212.0,161.0,181.0,198.0,211.0,284.0,219.0,256.0,167.0,143.0,197.0,2296.0
Anuppur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1870.0,2080.0,2361.0,2816.0,2033.0,3298.0,3106.0,3556.0,3404.0,3312.0,3324.0,3601.0,34761.0
Anuppur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,93.0,102.0,155.0,209.0,134.0,166.0,175.0,214.0,137.0,155.0,108.0,178.0,1826.0
Anuppur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,47.0,148.0,29.0,143.0,122.0,160.0,122.0,147.0,142.0,83.0,77.0,157.0,1377.0
Anuppur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,2.0,1.0,7.0,2.0,1.0,4.0,6.0,1.0,0.0,0.0,0.0,24.0
Anuppur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,38.0,167.0,31.0,99.0,145.0,186.0,168.0,139.0,292.0,233.0,224.0,180.0,1902.0
Anuppur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,1.0,1.0,1.0,0.0,1.0,4.0,1.0,0.0,0.0,0.0,0.0,9.0
Anuppur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,419.0,716.0,604.0,885.0,609.0,1014.0,781.0,1094.0,910.0,684.0,805.0,797.0,9318.0
Anuppur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,22.0,0.0,1.0,74.0,0.0,4.0,31.0,8.0,6.0,2.0,2.0,0.0,150.0
Anuppur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,504.0,1031.0,664.0,1127.0,876.0,1360.0,1071.0,1380.0,1344.0,1000.0,1106.0,1134.0,12597.0
Anuppur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,22.0,3.0,3.0,82.0,2.0,6.0,39.0,15.0,7.0,2.0,2.0,0.0,183.0
Anuppur,15.2,Number of Widal tests conducted,Number tested,228.0,342.0,290.0,588.0,387.0,821.0,826.0,553.0,309.0,238.0,511.0,830.0,5923.0
Anuppur,15.3.a,Number of VDRL tests conducted on males,Number tested,466.0,442.0,33.0,48.0,16.0,102.0,92.0,55.0,16.0,56.0,31.0,63.0,1420.0
Anuppur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,7.0,177.0,30.0,145.0,196.0,110.0,97.0,463.0,158.0,68.0,110.0,168.0,1729.0
Anuppur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,436.0,483.0,404.0,287.0,104.0,461.0,777.0,679.0,484.0,483.0,608.0,722.0,5928.0
Anuppur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,909.0,1102.0,467.0,480.0,316.0,673.0,966.0,1197.0,658.0,607.0,749.0,953.0,9077.0
Anuppur,15.4.1,Number of blood smears examined for Malaria,TOTAL,3136.0,2199.0,3062.0,5336.0,8001.0,10822.0,7556.0,3732.0,2323.0,1194.0,1801.0,2187.0,51349.0
Anuppur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,6.0,9.0,14.0,27.0,110.0,103.0,151.0,61.0,47.0,42.0,38.0,36.0,644.0
Anuppur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,12.0,17.0,7.0,64.0,82.0,190.0,189.0,203.0,75.0,12.0,15.0,29.0,895.0
Anuppur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2550.0,2150.0,2440.0,8290.0,10690.0,8640.0,7290.0,4140.0,5340.0,3840.0,10440.0,5240.0,71050.0
Anuppur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,10000.0,10000.0,15000.0,,5000.0,5000.0,5000.0,0.0,10000.0,0.0,10000.0,80000.0
Anuppur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,0.0,0.0,0.0,0.0,,0.0,,0.0
Anuppur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,10400.0,9710.0,4150.0,12600.0,2050.0,6350.0,8150.0,3800.0,1500.0,3400.0,5200.0,3600.0,70910.0
Anuppur,16.1.1,Stock position of DPT vaccines,5. Total Stock,2150.0,2440.0,8290.0,10690.0,8640.0,7290.0,4140.0,5340.0,3840.0,10440.0,5240.0,11640.0,80140.0
Anuppur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,0.0,,,,,,340.0,240.0,890.0,1540.0,6240.0,9250.0
Anuppur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,0.0,,,,,6140.0,0.0,1000.0,5000.0,10000.0,5000.0,27140.0
Anuppur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,0.0,,,,,,,,,0.0,,0.0
Anuppur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,0.0,,,,,5800.0,100.0,350.0,4350.0,5300.0,6500.0,22400.0
Anuppur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,340.0,240.0,890.0,1540.0,6240.0,4740.0,13990.0
Anuppur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,6800.0,7900.0,5400.0,19900.0,9200.0,4500.0,12200.0,0.0,4500.0,4000.0,3920.0,2920.0,81240.0
Anuppur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,12000.0,20000.0,20000.0,10000.0,,18000.0,0.0,10500.0,10000.0,4000.0,135420.0,10000.0,249920.0
Anuppur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,0.0,,,,0.0,0.0,0.0,0.0,,0.0,,0.0
Anuppur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,10900.0,22500.0,5500.0,20700.0,4700.0,10300.0,12200.0,6000.0,10500.0,4080.0,136420.0,8000.0,251800.0
Anuppur,16.1.2,Stock position of OPV vaccines,5. Total Stock,7900.0,5400.0,19900.0,9200.0,4500.0,12200.0,0.0,4500.0,4000.0,3920.0,2920.0,4920.0,79360.0
Anuppur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2000.0,7300.0,4800.0,11050.0,8150.0,4550.0,7250.0,6600.0,7300.0,6500.0,6650.0,8050.0,80200.0
Anuppur,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,10000.0,10000.0,10000.0,,10000.0,10000.0,5000.0,0.0,5000.0,10000.0,,80000.0
Anuppur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,0.0,,,,0.0,0.0,0.0,0.0,,0.0,,0.0
Anuppur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,4700.0,12800.0,3750.0,12900.0,3600.0,7300.0,10650.0,4300.0,800.0,4850.0,8600.0,5400.0,79650.0
Anuppur,16.1.3,Stock position of TT vaccines,5. Total Stock,7300.0,4500.0,11050.0,8150.0,4550.0,7250.0,6600.0,7300.0,6500.0,6650.0,8050.0,2650.0,80550.0
Anuppur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Anuppur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,0.0,,,,,,,,,,,0.0
Anuppur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Anuppur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Anuppur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anuppur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,4700.0,3250.0,4240.0,3290.0,2890.0,1990.0,6140.0,5240.0,11940.0,9240.0,9940.0,5740.0,68600.0
Anuppur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,10000.0,0.0,13000.0,,10000.0,5000.0,10000.0,0.0,5000.0,0.0,5000.0,68000.0
Anuppur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,0.0,,,,0.0,0.0,0.0,0.0,,0.0,,0.0
Anuppur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,11450.0,9010.0,950.0,13400.0,900.0,5850.0,5900.0,3300.0,2700.0,4300.0,4200.0,5200.0,67160.0
Anuppur,16.1.5,Stock position of BCG vaccines,5. Total Stock,3250.0,4240.0,3290.0,2890.0,1990.0,6140.0,5240.0,11940.0,9240.0,9940.0,5740.0,5540.0,69440.0
Anuppur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,15775.0,2825.0,3190.0,2865.0,2065.0,1590.0,575.0,0.0,2725.0,550.0,1750.0,2125.0,36035.0
Anuppur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,2500.0,0.0,5000.0,,5000.0,0.0,7500.0,0.0,5000.0,5000.0,2500.0,32500.0
Anuppur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,0.0,,,,0.0,0.0,,,,0.0,,0.0
Anuppur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,12950.0,2135.0,325.0,5800.0,475.0,6350.0,575.0,4775.0,2175.0,3800.0,4625.0,3550.0,47535.0
Anuppur,16.1.6,Stock position of Measles vaccines,5. Total Stock,2825.0,3190.0,2865.0,2065.0,1590.0,240.0,0.0,2725.0,550.0,1750.0,2125.0,1075.0,21000.0
Anuppur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,0.0,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Anuppur,16.1.7,Stock position of JE vaccines,2. Stocks Received,,0.0,,,,0.0,0.0,0.0,0.0,,,,0.0
Anuppur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,0.0,,,,0.0,0.0,0.0,0.0,,,,0.0
Anuppur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,0.0,,,,0.0,0.0,0.0,0.0,,,,0.0
Anuppur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anuppur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1350.0,1250.0,850.0,3100.0,4300.0,2250.0,2950.0,800.0,5000.0,2900.0,9450.0,4750.0,38950.0
Anuppur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,10000.0,10000.0,5000.0,15000.0,,10000.0,5000.0,10000.0,0.0,10000.0,0.0,5000.0,80000.0
Anuppur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,0.0,,,,0.0,0.0,0.0,0.0,,0.0,,0.0
Anuppur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,10100.0,10400.0,2750.0,13800.0,2050.0,9300.0,7150.0,5800.0,2100.0,3450.0,4700.0,2350.0,73950.0
Anuppur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1250.0,850.0,3100.0,4300.0,2250.0,2950.0,800.0,5000.0,2900.0,9450.0,4750.0,7400.0,45000.0
Anuppur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1054.0,889.0,,,,,,,,,0.0,0.0,1943.0
Anuppur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,0.0,,,,,,,,,0.0,0.0,0.0
Anuppur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,0.0,,,,,,,,,0.0,0.0,0.0
Anuppur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,165.0,0.0,,,,,,,,,0.0,0.0,165.0
Anuppur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,889.0,889.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1778.0
Anuppur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,22496.0,22496.0,,,,,,,,,0.0,0.0,44992.0
Anuppur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,0.0,,,,,,,,,0.0,0.0,0.0
Anuppur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,0.0,,,,,,,,,0.0,0.0,0.0
Anuppur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,0.0,,,,,,,,,0.0,0.0,0.0
Anuppur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,22496.0,22496.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,44992.0
Anuppur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,726.0,726.0,,,,,,,,,0.0,0.0,1452.0
Anuppur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,,,,,,,,,0.0,0.0,0.0
Anuppur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,,,,,,,,,0.0,0.0,0.0
Anuppur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,,,,,,,,,0.0,0.0,0.0
Anuppur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,726.0,726.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1452.0
Anuppur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,585.0,585.0,,,,,,,,,0.0,0.0,1170.0
Anuppur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,,,,,,,,,0.0,0.0,0.0
Anuppur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,,,,,,,,,0.0,0.0,0.0
Anuppur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,,,,,,,,,0.0,0.0,0.0
Anuppur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,585.0,585.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1170.0
Anuppur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,686.0,486.0,,,,,,,,,0.0,0.0,1172.0
Anuppur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,0.0,,,,,,,,,0.0,0.0,0.0
Anuppur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,0.0,,,,,,,,,0.0,0.0,0.0
Anuppur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,200.0,0.0,,,,,,,,,0.0,0.0,200.0
Anuppur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,486.0,486.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,972.0
Anuppur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,9700.0,8600.0,5000.0,3800.0,3200.0,1450.0,800.0,700.0,100.0,24000.0,21200.0,19500.0,98050.0
Anuppur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,0.0,,,,,,,25000.0,0.0,0.0,,25000.0
Anuppur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Anuppur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,1100.0,3600.0,1200.0,600.0,1750.0,650.0,100.0,600.0,1100.0,2800.0,1700.0,1350.0,16550.0
Anuppur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,8600.0,5000.0,3800.0,3200.0,1450.0,800.0,700.0,100.0,24000.0,21200.0,19500.0,18150.0,106500.0
Anuppur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,17500.0,33000.0,44500.0,42000.0,37100.0,34300.0,32500.0,30600.0,22800.0,7500.0,5000.0,48050.0,354850.0
Anuppur,16.3.02,Stock Position of Gloves,2. Stocks Received,20000.0,17500.0,,,,,,,,,0.0,,37500.0
Anuppur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Anuppur,16.3.02,Stock Position of Gloves,4. Stock Distributed,4500.0,6000.0,2500.0,4900.0,2800.0,1800.0,1900.0,7800.0,15300.0,2500.0,150.0,450.0,50600.0
Anuppur,16.3.02,Stock Position of Gloves,5. Total Stock,33000.0,44500.0,42000.0,37100.0,34300.0,32500.0,30600.0,22800.0,7500.0,5000.0,4850.0,47600.0,341750.0
Anuppur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,0.0,,,,,,,1.0,0.0,0.0,,1.0
Anuppur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,0.0,,,,,,,,,0.0,,0.0
Anuppur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,0.0,,,,,,,,,0.0,,0.0
Anuppur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,0.0,,,,,,,1.0,0.0,0.0,,1.0
Anuppur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anuppur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,100.0,100.0,24000.0,19000.0,16000.0,9500.0,7000.0,5000.0,3100.0,1500.0,500.0,4900.0,90700.0
Anuppur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,25000.0,,,,,,,,,5000.0,,30000.0
Anuppur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Anuppur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,1100.0,5000.0,3000.0,6500.0,2500.0,2000.0,1900.0,1600.0,1000.0,600.0,,25200.0
Anuppur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,100.0,24000.0,19000.0,16000.0,9500.0,7000.0,5000.0,3100.0,1500.0,500.0,4900.0,4900.0,95500.0
Anuppur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,0.0,,,,,,,,,0.0,,0.0
Anuppur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,0.0,,0.0
Anuppur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Anuppur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,0.0,,0.0
Anuppur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anuppur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,2.0,1.0,1.0,1.0,1.0,,,8.0,4.0,0.0,0.0,,18.0
Anuppur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,0.0,,,,,10.0,0.0,0.0,0.0,0.0,,10.0
Anuppur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,0.0,,,,,,,,,0.0,,0.0
Anuppur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,1.0,0.0,,,1.0,,2.0,4.0,4.0,0.0,0.0,,12.0
Anuppur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,1.0,1.0,1.0,1.0,0.0,0.0,8.0,4.0,0.0,0.0,0.0,0.0,16.0
Anuppur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,1162000.0,1102000.0,942000.0,786000.0,734900.0,709000.0,530500.0,295800.0,4148300.0,5958700.0,4813700.0,3863700.0,25046600.0
Anuppur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,0.0,,,,,,4040000.0,2901000.0,0.0,0.0,,6941000.0
Anuppur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Anuppur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,60000.0,160000.0,156000.0,51100.0,25900.0,178500.0,234700.0,187500.0,1090600.0,1145000.0,950000.0,318000.0,4557300.0
Anuppur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,1102000.0,942000.0,786000.0,734900.0,709000.0,530500.0,295800.0,4148300.0,5958700.0,4813700.0,3863700.0,3545700.0,27430300.0
Anuppur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,3000.0,1720.0,130.0,,,,,,,,0.0,,4850.0
Anuppur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,0.0,,,,,,,,,0.0,,0.0
Anuppur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Anuppur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,1280.0,1590.0,130.0,,,,,,,,0.0,,3000.0
Anuppur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,1720.0,130.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1850.0
Anuppur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,0.0,,,,,,,,,0.0,,0.0
Anuppur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,0.0,,,,,,,,,0.0,,0.0
Anuppur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Anuppur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,0.0,,,,,,,,,0.0,,0.0
Anuppur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Anuppur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,1315.0,1290.0,1000.0,400.0,390.0,230.0,190.0,135.0,80.0,380.0,1340.0,930.0,7680.0
Anuppur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,0.0,300.0,,,,,0.0,1715.0,970.0,0.0,,2985.0
Anuppur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Anuppur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,25.0,290.0,900.0,10.0,160.0,40.0,55.0,55.0,1415.0,10.0,410.0,10.0,3380.0
Anuppur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,1290.0,1000.0,400.0,390.0,230.0,190.0,135.0,80.0,380.0,1340.0,930.0,920.0,7285.0
Anuppur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,15000.0,10205.0,19450.0,14750.0,2995.0,18200.0,7500.0,47100.0,44660.0,42160.0,39000.0,500.0,261520.0
Anuppur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,20000.0,,,101500.0,,42200.0,0.0,0.0,0.0,0.0,,163700.0
Anuppur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Anuppur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,4795.0,10755.0,4700.0,11755.0,86295.0,10700.0,2600.0,2440.0,2500.0,3160.0,38500.0,0.0,178200.0
Anuppur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,10205.0,19450.0,14750.0,2995.0,18200.0,7500.0,47100.0,44660.0,42160.0,39000.0,500.0,500.0,247020.0
Anuppur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,9800.0,8800.0,9300.0,800.0,2600.0,2600.0,2600.0,2000.0,2000.0,2000.0,2000.0,2000.0,46500.0
Anuppur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,6600.0,0.0,9900.0,,,,,,,0.0,,16500.0
Anuppur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,0.0,8500.0,,,,,,,,0.0,,8500.0
Anuppur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1000.0,6100.0,,8100.0,,,600.0,0.0,0.0,0.0,0.0,1000.0,16800.0
Anuppur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,8800.0,9300.0,800.0,2600.0,2600.0,2600.0,2000.0,2000.0,2000.0,2000.0,2000.0,1000.0,37700.0
Anuppur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,6000.0,13000.0,13000.0,42000.0,99000.0,99000.0,99000.0,98000.0,138000.0,112000.0,101000.0,100000.0,920000.0
Anuppur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,70000.0,30000.0,30000.0,90000.0,,,80000.0,40000.0,60000.0,10000.0,0.0,,410000.0
Anuppur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,0.0,,,,,,,,,0.0,,0.0
Anuppur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,63000.0,30000.0,1000.0,33000.0,,,81000.0,0.0,86000.0,21000.0,1000.0,3000.0,319000.0
Anuppur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,13000.0,13000.0,42000.0,99000.0,99000.0,99000.0,98000.0,138000.0,112000.0,101000.0,100000.0,97000.0,1011000.0
Anuppur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1600.0,1400.0,1400.0,1300.0,1300.0,1300.0,1100.0,700.0,700.0,600.0,600.0,400.0,12400.0
Anuppur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,0.0,0.0,4000.0,,,,,4000.0,0.0,0.0,,8000.0
Anuppur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,0.0,,,,,,,,,0.0,,0.0
Anuppur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,200.0,0.0,100.0,4000.0,,200.0,400.0,0.0,4100.0,0.0,200.0,200.0,9400.0
Anuppur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1400.0,1400.0,1300.0,1300.0,1300.0,1100.0,700.0,700.0,600.0,600.0,400.0,200.0,11000.0
Anuppur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,3.0,,1.0,1.0,1.0,1.0,1.0,,1.0,3.0,,,12.0
Anuppur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,,,,,,,3.0,,,,,4.0
Anuppur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Anuppur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,,,,,,,3.0,,,,,4.0
Anuppur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,1.0,,,1.0,,2.0
Anuppur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Anuppur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,1.0,,,1.0,,2.0
Anuppur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,4.0,2.0,,,1.0,2.0,,,2.0,3.0,1.0,17.0
Anuppur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Anuppur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,4.0,2.0,,,1.0,2.0,,,2.0,3.0,1.0,17.0
Anuppur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,3.0,2.0,5.0,2.0,8.0,3.0,12.0,4.0,4.0,3.0,1.0,49.0
Anuppur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Anuppur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,3.0,2.0,5.0,2.0,8.0,3.0,12.0,4.0,4.0,3.0,1.0,49.0
Anuppur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,1.0,,,,2.0,2.0,,,,2.0,8.0
Anuppur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Anuppur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,1.0,,,,2.0,2.0,,,,2.0,8.0
Anuppur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Anuppur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Anuppur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Anuppur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Anuppur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,1.0,,,,,,,,,,,,1.0
Anuppur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,,,,,,,,,,,1.0
Anuppur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Anuppur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Anuppur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Anuppur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,4.0,5.0,2.0,5.0,3.0,2.0,6.0,2.0,3.0,5.0,3.0,42.0
Anuppur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,2.0,,,,,,1.0,1.0,2.0,,7.0
Anuppur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,4.0,7.0,2.0,5.0,3.0,2.0,6.0,3.0,4.0,7.0,3.0,49.0
Anuppur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Anuppur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,1.0,,1.0,,1.0,,2.0,5.0
Anuppur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,,,,1.0,1.0,,,,,,,3.0
Anuppur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,,,1.0,2.0,,1.0,,1.0,,2.0,8.0
Anuppur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Anuppur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,1.0,,,1.0,1.0,1.0,,,4.0
Anuppur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Anuppur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,1.0,,,1.0,1.0,1.0,,,4.0
Anuppur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,1.0,,,,1.0,2.0
Anuppur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,1.0,,,,1.0,1.0,,,,3.0
Anuppur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,1.0,1.0,,,,4.0,,1.0,3.0,1.0,11.0
Anuppur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,1.0,2.0,,,,6.0,1.0,1.0,3.0,2.0,16.0
Anuppur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Anuppur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,2.0,,,1.0,,,,,3.0
Anuppur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Anuppur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,2.0,,,1.0,,,,,3.0
Anuppur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,1.0,1.0,,,,4.0,,,,,7.0
Anuppur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,1.0,1.0,,,4.0,3.0,3.0,5.0,2.0,20.0
Anuppur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,2.0,,,,,1.0,,1.0,1.0,,5.0
Anuppur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,,4.0,2.0,1.0,,,9.0,3.0,4.0,6.0,2.0,32.0
Anuppur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Anuppur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Anuppur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Anuppur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Anuppur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Anuppur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,2.0,3.0,2.0,1.0,2.0,1.0,2.0,2.0,6.0,,3.0,25.0
Anuppur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,4.0,4.0,2.0,1.0,,,3.0,9.0,1.0,3.0,1.0,7.0,35.0
Anuppur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,5.0,6.0,5.0,3.0,1.0,2.0,4.0,11.0,3.0,9.0,1.0,10.0,60.0
Anuppur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Anuppur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,,,1.0,,,2.0,2.0,4.0,,2.0,12.0
Anuppur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,3.0,1.0,2.0,2.0,,,1.0,4.0,4.0,7.0,3.0,,27.0
Anuppur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,3.0,2.0,2.0,2.0,1.0,,1.0,6.0,6.0,11.0,3.0,2.0,39.0
Anuppur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Anuppur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,1.0,,1.0
Anuppur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Anuppur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,1.0,,1.0
Anuppur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Anuppur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Anuppur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Anuppur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Anuppur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Anuppur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Anuppur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Anuppur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Anuppur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Anuppur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Anuppur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Anuppur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,1.0,,,,,,,,,1.0
Anuppur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Anuppur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Anuppur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Anuppur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,1.0,,,,,1.0
Anuppur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Anuppur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,,1.0,1.0,2.0,1.0,,1.0,,,,,8.0
Anuppur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Anuppur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,,1.0,1.0,2.0,1.0,,1.0,,,,,8.0
Anuppur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,,1.0,2.0,1.0,,,,1.0,,,6.0
Anuppur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,3.0,5.0,5.0,1.0,6.0,2.0,2.0,8.0,1.0,6.0,3.0,44.0
Anuppur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,1.0,,2.0,,1.0,3.0,,,1.0,8.0
Anuppur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,4.0,5.0,7.0,3.0,9.0,2.0,3.0,11.0,2.0,6.0,4.0,58.0
Anuppur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Anuppur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,5.0,3.0,2.0,4.0,2.0,6.0,3.0,4.0,2.0,2.0,4.0,5.0,42.0
Anuppur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,2.0,2.0
Anuppur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,5.0,3.0,2.0,4.0,2.0,6.0,3.0,4.0,2.0,2.0,4.0,7.0,44.0
Anuppur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,1.0,2.0,,1.0,,,,,,,4.0
Anuppur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,1.0,6.0,,,,1.0,3.0,1.0,1.0,,14.0
Anuppur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,2.0,,1.0,,1.0,2.0,,,,,6.0
Anuppur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,4.0,8.0,1.0,1.0,1.0,3.0,3.0,1.0,1.0,,24.0
Anuppur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,1.0,1.0,,,,,2.0
Anuppur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,4.0,1.0,3.0,1.0,4.0,2.0,2.0,3.0,4.0,1.0,1.0,26.0
Anuppur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,2.0,2.0,4.0,4.0,3.0,5.0,2.0,4.0,8.0,7.0,6.0,47.0
Anuppur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,6.0,3.0,7.0,5.0,7.0,8.0,5.0,7.0,12.0,8.0,7.0,75.0
Anuppur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Anuppur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,2.0,1.0,2.0,,2.0,3.0,3.0,3.0,2.0,,2.0,21.0
Anuppur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,1.0,3.0,,3.0,9.0,4.0,11.0,2.0,3.0,7.0,2.0,45.0
Anuppur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,3.0,4.0,2.0,3.0,11.0,7.0,14.0,5.0,5.0,7.0,4.0,66.0
Anuppur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,5.0,3.0,2.0,,3.0,2.0,3.0,1.0,1.0,2.0,,22.0
Anuppur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,7.0,7.0,14.0,10.0,17.0,15.0,18.0,17.0,9.0,11.0,17.0,34.0,176.0
Anuppur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,8.0,32.0,41.0,29.0,53.0,47.0,44.0,39.0,41.0,34.0,38.0,39.0,445.0
Anuppur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,15.0,44.0,58.0,41.0,70.0,65.0,64.0,59.0,51.0,46.0,57.0,73.0,643.0
Ashok Nagar,1.1,Total number of pregnant women Registered for ANC,TOTAL,1493.0,1913.0,1966.0,2079.0,1875.0,1990.0,1918.0,1813.0,1788.0,1770.0,1991.0,2615.0,23211.0
Ashok Nagar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,855.0,926.0,1084.0,905.0,1032.0,1050.0,839.0,915.0,1041.0,1081.0,1254.0,1496.0,12478.0
Ashok Nagar,1.2,Number of Pregnant women registered under JSY,TOTAL,1493.0,1909.0,1968.0,2077.0,1863.0,1990.0,1918.0,1813.0,1610.0,1759.0,1991.0,2605.0,22996.0
Ashok Nagar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1044.0,1241.0,1156.0,1360.0,1328.0,1396.0,1352.0,1439.0,1458.0,1413.0,1591.0,1873.0,16651.0
Ashok Nagar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1451.0,1825.0,1960.0,2068.0,1870.0,1990.0,1918.0,1734.0,1613.0,1706.0,1304.0,1723.0,21162.0
Ashok Nagar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1301.0,1353.0,1670.0,1760.0,1786.0,1710.0,1641.0,1664.0,1713.0,1530.0,1638.0,2369.0,20135.0
Ashok Nagar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1438.0,1882.0,1956.0,2074.0,1870.0,1990.0,1918.0,1822.0,1719.0,1770.0,1991.0,2592.0,23022.0
Ashok Nagar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,42.0,50.0,79.0,64.0,84.0,60.0,57.0,47.0,133.0,143.0,92.0,111.0,962.0
Ashok Nagar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,6.0,3.0,3.0,5.0,11.0,5.0,3.0,1.0,4.0,2.0,6.0,6.0,55.0
Ashok Nagar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,505.0,331.0,331.0,656.0,422.0,445.0,568.0,596.0,622.0,607.0,460.0,677.0,6220.0
Ashok Nagar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,17.0,16.0,19.0,43.0,44.0,24.0,28.0,70.0,34.0,33.0,18.0,18.0,364.0
Ashok Nagar,1.8,Number of pregnancy test kits used at SC level,TOTAL,422.0,517.0,548.0,691.0,603.0,644.0,390.0,591.0,599.0,547.0,786.0,869.0,7207.0
Ashok Nagar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,12.0,16.0,50.0,0.0,1.0,0.0,4.0,4.0,2.0,0.0,0.0,0.0,89.0
Ashok Nagar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,87.0,128.0,191.0,272.0,284.0,343.0,273.0,319.0,290.0,344.0,298.0,363.0,3192.0
Ashok Nagar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,99.0,144.0,241.0,272.0,285.0,343.0,277.0,323.0,292.0,344.0,298.0,363.0,3281.0
Ashok Nagar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,65.0,114.0,220.0,210.0,202.0,234.0,239.0,293.0,273.0,303.0,249.0,297.0,2699.0
Ashok Nagar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,1.0,0.0,18.0,21.0
Ashok Nagar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,739.0,926.0,1042.0,1238.0,1328.0,1271.0,1182.0,1304.0,1174.0,1100.0,1059.0,1384.0,13747.0
Ashok Nagar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,117.0,132.0,94.0,62.0,108.0,66.0,77.0,53.0,79.0,48.0,50.0,101.0,987.0
Ashok Nagar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,457.0,747.0,1022.0,1205.0,1212.0,1249.0,1003.0,1121.0,1177.0,1181.0,1208.0,1407.0,12989.0
Ashok Nagar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,232.0,378.0,556.0,590.0,627.0,398.0,508.0,656.0,543.0,380.0,543.0,463.0,5874.0
Ashok Nagar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Ashok Nagar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Ashok Nagar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Ashok Nagar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Ashok Nagar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,20.0,27.0,7.0,7.0,12.0,0.0,0.0,16.0,2.0,3.0,0.0,38.0,132.0
Ashok Nagar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ashok Nagar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,20.0,27.0,7.0,7.0,12.0,0.0,0.0,16.0,2.0,3.0,0.0,38.0,132.0
Ashok Nagar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Ashok Nagar,4.1.1.a,Number of male live births,TOTAL,426.0,544.0,644.0,752.0,825.0,814.0,712.0,817.0,729.0,729.0,690.0,860.0,8542.0
Ashok Nagar,4.1.1.b,Number of female live births,TOTAL,390.0,506.0,607.0,739.0,767.0,781.0,731.0,789.0,708.0,703.0,661.0,878.0,8260.0
Ashok Nagar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,816.0,1050.0,1251.0,1491.0,1592.0,1595.0,1443.0,1606.0,1437.0,1432.0,1351.0,1738.0,16802.0
Ashok Nagar,4.1.2,Number of still births,TOTAL,26.0,32.0,37.0,37.0,30.0,31.0,23.0,26.0,36.0,21.0,13.0,23.0,335.0
Ashok Nagar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,22.0,28.0,68.0,65.0,62.0,28.0,19.0,18.0,25.0,29.0,26.0,42.0,432.0
Ashok Nagar,4.2.1,Number of Newborns weighed at birth,TOTAL,801.0,1050.0,1209.0,1409.0,1574.0,1595.0,1443.0,1606.0,1398.0,1436.0,1347.0,1738.0,16606.0
Ashok Nagar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,91.0,91.0,124.0,172.0,184.0,203.0,186.0,228.0,165.0,151.0,127.0,238.0,1960.0
Ashok Nagar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,724.0,940.0,1193.0,1458.0,1589.0,1517.0,1432.0,1582.0,1389.0,1433.0,1325.0,1713.0,16295.0
Ashok Nagar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,4.0,0.0,11.0,12.0,2.0,0.0,0.0,0.0,0.0,0.0,9.0,38.0
Ashok Nagar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,18.0,16.0,20.0,29.0,16.0,40.0,7.0,22.0,16.0,31.0,18.0,29.0,262.0
Ashok Nagar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,80.0,56.0,108.0,80.0,74.0,105.0,43.0,49.0,46.0,120.0,30.0,79.0,870.0
Ashok Nagar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ashok Nagar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,98.0,76.0,128.0,120.0,102.0,147.0,50.0,71.0,62.0,151.0,48.0,117.0,1170.0
Ashok Nagar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Ashok Nagar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,87.0,73.0,113.0,92.0,83.0,107.0,20.0,50.0,56.0,85.0,21.0,75.0,862.0
Ashok Nagar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,11.0,11.0,19.0,29.0,25.0,4.0,7.0,8.0,8.0,11.0,2.0,10.0,145.0
Ashok Nagar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,15.0,19.0,27.0,60.0,65.0,125.0,23.0,25.0,30.0,73.0,42.0,51.0,555.0
Ashok Nagar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,7.0,10.0,13.0,15.0,16.0,15.0,10.0,9.0,8.0,7.0,0.0,10.0,120.0
Ashok Nagar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,790.0,967.0,1157.0,1313.0,1410.0,1380.0,1245.0,1410.0,1250.0,1181.0,1193.0,1461.0,14757.0
Ashok Nagar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,471.0,474.0,445.0,494.0,516.0,497.0,475.0,585.0,894.0,893.0,784.0,588.0,7116.0
Ashok Nagar,6.3,PNC maternal complications attended,TOTAL,12.0,27.0,21.0,7.0,26.0,24.0,28.0,19.0,9.0,23.0,3.0,6.0,205.0
Ashok Nagar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,10.0,22.0,16.0,16.0,7.0,12.0,18.0,7.0,12.0,11.0,14.0,23.0,168.0
Ashok Nagar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Ashok Nagar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,10.0,22.0,16.0,16.0,7.0,12.0,18.0,7.0,12.0,13.0,14.0,23.0,170.0
Ashok Nagar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Ashok Nagar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,36.0,59.0,100.0,95.0,79.0,146.0,92.0,66.0,114.0,54.0,56.0,98.0,995.0
Ashok Nagar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,183.0,259.0,239.0,187.0,314.0,381.0,327.0,293.0,308.0,275.0,268.0,418.0,3452.0
Ashok Nagar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,219.0,318.0,339.0,282.0,393.0,527.0,419.0,359.0,422.0,329.0,324.0,516.0,4447.0
Ashok Nagar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,50.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,22.0,77.0
Ashok Nagar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,0.0,0.0,3.0,3.0,1.0,1.0,4.0,0.0,9.0,22.0
Ashok Nagar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ashok Nagar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,1.0,0.0,0.0,3.0,3.0,1.0,1.0,4.0,0.0,9.0,22.0
Ashok Nagar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Ashok Nagar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,1.0,71.0,63.0,100.0,57.0,373.0,666.0
Ashok Nagar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,3.0,0.0,0.0,0.0,5.0,9.0,525.0,993.0,578.0,416.0,571.0,3100.0
Ashok Nagar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,1.0,13.0,75.0,57.0,8.0,48.0,205.0
Ashok Nagar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ashok Nagar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,4.0,3.0,0.0,0.0,0.0,5.0,11.0,609.0,1131.0,735.0,481.0,992.0,3971.0
Ashok Nagar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Ashok Nagar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Ashok Nagar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,3.0,3.0,2.0,0.0,0.0,4.0,7.0,18.0,10.0,1.0,20.0,68.0
Ashok Nagar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ashok Nagar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,3.0,3.0,2.0,0.0,0.0,4.0,7.0,18.0,10.0,1.0,22.0,70.0
Ashok Nagar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Ashok Nagar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,3.0,13.0,4.0,3.0,0.0,0.0,16.0,22.0,2.0,7.0,1.0,18.0,89.0
Ashok Nagar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ashok Nagar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,3.0,13.0,4.0,3.0,0.0,0.0,16.0,22.0,2.0,7.0,1.0,18.0,89.0
Ashok Nagar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Ashok Nagar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,142.0,204.0,243.0,192.0,230.0,230.0,230.0,205.0,197.0,206.0,189.0,171.0,2439.0
Ashok Nagar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,4.0,4.0,5.0,10.0,14.0,22.0,7.0,4.0,7.0,2.0,2.0,3.0,84.0
Ashok Nagar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,26.0,56.0,49.0,60.0,31.0,36.0,30.0,31.0,30.0,36.0,39.0,69.0,493.0
Ashok Nagar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,139.0,62.0,40.0,65.0,58.0,18.0,103.0,0.0,71.0,75.0,0.0,44.0,675.0
Ashok Nagar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ashok Nagar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,311.0,326.0,337.0,327.0,333.0,306.0,370.0,240.0,305.0,319.0,230.0,287.0,3691.0
Ashok Nagar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,28.0,1.0,13.0,2.0,2.0,21.0,26.0,8.0,80.0,5.0,24.0,24.0,234.0
Ashok Nagar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Ashok Nagar,9.06,Number of IUCD removals,TOTAL,112.0,78.0,162.0,120.0,137.0,142.0,172.0,119.0,233.0,136.0,140.0,100.0,1651.0
Ashok Nagar,9.07,Number of Oral Pills cycles distributed,TOTAL,1093.0,1095.0,936.0,1075.0,1724.0,2119.0,1301.0,2756.0,2520.0,2395.0,2313.0,2667.0,21994.0
Ashok Nagar,9.08,Number of Condom pieces distributed,TOTAL,1816.0,4976.0,12434.0,19996.0,7365.0,12845.0,13069.0,17801.0,14155.0,11293.0,7963.0,14559.0,138272.0
Ashok Nagar,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,20.0,378.0,11.0,9.0,22.0,2.0,2.0,8.0,14.0,32.0,6.0,6.0,510.0
Ashok Nagar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Ashok Nagar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,5.0
Ashok Nagar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Ashok Nagar,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,0.0,0.0,0.0,1.0,2.0,5.0,2.0,8.0,0.0,1.0,2.0,22.0
Ashok Nagar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,9.12,Number of Institutions having NSV trained doctors,TOTAL,5.0,6.0,6.0,6.0,6.0,6.0,6.0,5.0,7.0,6.0,3.0,4.0,-1.0
Ashok Nagar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,849.0,1105.0,1273.0,1471.0,1608.0,1589.0,1454.0,1660.0,1506.0,1499.0,1366.0,1746.0,17126.0
Ashok Nagar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,925.0,1293.0,1361.0,1596.0,1401.0,1762.0,1931.0,741.0,0.0,5.0,14.0,10.0,11039.0
Ashok Nagar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1154.0,1096.0,1326.0,1385.0,1239.0,1424.0,1961.0,1615.0,580.0,137.0,97.0,100.0,12114.0
Ashok Nagar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1125.0,1421.0,1290.0,1436.0,1388.0,1343.0,1468.0,1553.0,1495.0,576.0,202.0,317.0,13614.0
Ashok Nagar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,960.0,1302.0,1592.0,1614.0,2047.0,7515.0
Ashok Nagar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,986.0,1308.0,1634.0,2137.0,6065.0
Ashok Nagar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,976.0,1390.0,2232.0,4598.0
Ashok Nagar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,719.0,930.0,1054.0,1213.0,1323.0,879.0,1222.0,1301.0,1165.0,1127.0,1109.0,1405.0,13447.0
Ashok Nagar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,925.0,1293.0,1369.0,1601.0,1401.0,1749.0,1931.0,1701.0,1302.0,1589.0,1622.0,2060.0,18543.0
Ashok Nagar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1154.0,1096.0,1330.0,1381.0,1239.0,1417.0,1961.0,1620.0,1451.0,1452.0,1732.0,2240.0,18073.0
Ashok Nagar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1104.0,1411.0,1289.0,1442.0,1388.0,1339.0,1369.0,1551.0,1490.0,1543.0,1597.0,2555.0,18078.0
Ashok Nagar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,699.0,908.0,1009.0,1177.0,1283.0,831.0,1145.0,821.0,1117.0,1099.0,1038.0,1353.0,12480.0
Ashok Nagar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,925.0,1293.0,1372.0,1600.0,1401.0,1762.0,1913.0,925.0,0.0,5.0,14.0,13.0,11223.0
Ashok Nagar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1154.0,1096.0,1330.0,1375.0,1239.0,1424.0,1963.0,1700.0,504.0,137.0,103.0,103.0,12128.0
Ashok Nagar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1089.0,1411.0,1294.0,1442.0,1388.0,1343.0,1474.0,1546.0,1493.0,568.0,205.0,319.0,13572.0
Ashok Nagar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,902.0,1130.0,1356.0,1618.0,1272.0,1401.0,1552.0,1423.0,1298.0,1408.0,1524.0,2356.0,17240.0
Ashok Nagar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,862.0,1031.0,1111.0,1319.0,1208.0,1275.0,1190.0,1029.0,1265.0,1309.0,1103.0,2411.0,15113.0
Ashok Nagar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,530.0,604.0,711.0,769.0,719.0,594.0,854.0,767.0,570.0,536.0,452.0,1066.0,8172.0
Ashok Nagar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,538.0,542.0,630.0,672.0,693.0,565.0,804.0,717.0,501.0,488.0,464.0,1122.0,7736.0
Ashok Nagar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1068.0,1146.0,1341.0,1441.0,1412.0,1159.0,1658.0,1484.0,1071.0,1024.0,916.0,2188.0,15908.0
Ashok Nagar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,887.0,1114.0,1194.0,1438.0,1178.0,1428.0,1231.0,1197.0,1242.0,1366.0,1650.0,1981.0,15906.0
Ashok Nagar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,886.0,1107.0,1193.0,1470.0,1180.0,1442.0,1223.0,1196.0,1240.0,1366.0,1647.0,2011.0,15961.0
Ashok Nagar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,138.0,189.0,289.0,279.0,246.0,315.0,871.0,299.0,263.0,265.0,263.0,815.0,4232.0
Ashok Nagar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,124.0,177.0,268.0,254.0,234.0,306.0,719.0,244.0,241.0,251.0,254.0,799.0,3871.0
Ashok Nagar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,262.0,366.0,557.0,533.0,480.0,621.0,1590.0,543.0,504.0,516.0,517.0,1614.0,8103.0
Ashok Nagar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,0.0,0.0,0.0,0.0,29.0,0.0,13.0,0.0,37.0,224.0,101.0,270.0,674.0
Ashok Nagar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,616.0,837.0,912.0,867.0,1066.0,1438.0,1226.0,1235.0,1241.0,1362.0,1206.0,2177.0,14183.0
Ashok Nagar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,933.0,717.0,832.0,941.0,1005.0,1208.0,1152.0,1287.0,1277.0,1542.0,1248.0,2483.0,14625.0
Ashok Nagar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,5.0
Ashok Nagar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,2.0,9.0,2.0,4.0,20.0
Ashok Nagar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,667.0,865.0,861.0,905.0,867.0,851.0,825.0,846.0,860.0,873.0,890.0,1137.0,10447.0
Ashok Nagar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,619.0,815.0,826.0,871.0,836.0,839.0,813.0,839.0,846.0,854.0,883.0,1136.0,10177.0
Ashok Nagar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,499.0,685.0,630.0,683.0,685.0,706.0,715.0,686.0,692.0,716.0,749.0,818.0,8264.0
Ashok Nagar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,925.0,1082.0,1372.0,2114.0,1745.0,1228.0,1583.0,1425.0,1331.0,1504.0,1611.0,2378.0,18298.0
Ashok Nagar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,657.0,775.0,1146.0,2884.0,2104.0,791.0,1013.0,1342.0,982.0,4635.0,1363.0,2456.0,20148.0
Ashok Nagar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,468.0,509.0,755.0,3340.0,2054.0,585.0,635.0,552.0,610.0,4311.0,2263.0,1288.0,17370.0
Ashok Nagar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,3.0,3.0,9.0
Ashok Nagar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,285.0,834.0,975.0,716.0,902.0,857.0,665.0,476.0,327.0,370.0,408.0,623.0,7438.0
Ashok Nagar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,202.0,396.0,486.0,518.0,687.0,665.0,693.0,204.0,286.0,260.0,362.0,720.0,5479.0
Ashok Nagar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,134.0,144.0,142.0,150.0,21.0,240.0,244.0,358.0,228.0,206.0,382.0,712.0,2961.0
Ashok Nagar,13.1,Number of Patients operated for cataract,TOTAL,0.0,12.0,10.0,63.0,81.0,26.0,32.0,81.0,54.0,80.0,103.0,675.0,1217.0
Ashok Nagar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,12.0,10.0,63.0,81.0,26.0,32.0,81.0,54.0,80.0,103.0,675.0,1217.0
Ashok Nagar,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,10.0,22.0,34.0,49.0,21.0,476.0,0.0,0.0,612.0
Ashok Nagar,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,52.0,0.0,0.0,497.0,0.0,369.0,918.0
Ashok Nagar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,4.0,5.0,5.0,4.0,4.0,5.0,4.0,4.0,5.0,4.0,5.0,-1.0
Ashok Nagar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,1.0,1.0,2.0,2.0,2.0,2.0,2.0,1.0,3.0,2.0,2.0,2.0,-1.0
Ashok Nagar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,395.0,618.0,641.0,734.0,579.0,603.0,580.0,646.0,714.0,697.0,624.0,687.0,-1.0
Ashok Nagar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,3.0,4.0,4.0,2.0,4.0,3.0,4.0,4.0,4.0,3.0,4.0,-1.0
Ashok Nagar,14.05,Number of RKS meetings held during the month,TOTAL,3.0,2.0,3.0,3.0,2.0,1.0,1.0,0.0,1.0,1.0,2.0,1.0,20.0
Ashok Nagar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,7.0,7.0,8.0,8.0,7.0,8.0,9.0,7.0,8.0,6.0,6.0,7.0,-1.0
Ashok Nagar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,7.0,38.0,56.0,8.0,47.0,5.0,136.0,6.0,13.0,22.0,10.0,10.0,358.0
Ashok Nagar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,3.0,4.0,4.0,4.0,5.0,4.0,3.0,3.0,5.0,5.0,4.0,-1.0
Ashok Nagar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,1.0,3.0,1.0,0.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,-1.0
Ashok Nagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,119.0,312.0,447.0,262.0,270.0,344.0,290.0,351.0,220.0,141.0,220.0,317.0,3293.0
Ashok Nagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,454.0,980.0,936.0,828.0,743.0,1070.0,788.0,830.0,480.0,957.0,628.0,1175.0,9869.0
Ashok Nagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,70.0,170.0,231.0,172.0,141.0,242.0,146.0,130.0,155.0,93.0,94.0,173.0,1817.0
Ashok Nagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1035.0,1905.0,1778.0,1931.0,1970.0,2212.0,2234.0,2175.0,2105.0,1808.0,1980.0,2617.0,23750.0
Ashok Nagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,189.0,482.0,678.0,434.0,411.0,586.0,436.0,481.0,375.0,234.0,314.0,490.0,5110.0
Ashok Nagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1489.0,2885.0,2714.0,2759.0,2713.0,3282.0,3022.0,3005.0,2585.0,2765.0,2608.0,3792.0,33619.0
Ashok Nagar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,8.0,18.0,10.0,19.0,11.0,7.0,20.0,21.0,20.0,28.0,16.0,9.0,187.0
Ashok Nagar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,10.0,6.0,8.0,8.0,8.0,9.0,17.0,8.0,14.0,13.0,7.0,10.0,118.0
Ashok Nagar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,18.0,24.0,18.0,27.0,19.0,16.0,37.0,29.0,34.0,41.0,23.0,19.0,305.0
Ashok Nagar,14.11,In-Patient Head Count at midnight,TOTAL,3807.0,6042.0,4381.0,5964.0,5739.0,5448.0,6882.0,4953.0,1613.0,5262.0,4993.0,3067.0,58151.0
Ashok Nagar,14.12.1,OPD attendance (All),TOTAL,16632.0,28821.0,30801.0,31153.0,37536.0,47221.0,34764.0,29645.0,33194.0,29427.0,37157.0,46639.0,402990.0
Ashok Nagar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,33.0,40.0,13.0,10.0,22.0,11.0,14.0,214.0,512.0,383.0,417.0,167.0,1836.0
Ashok Nagar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,66.0,33.0,29.0,35.0,28.0,66.0,54.0,33.0,129.0,49.0,69.0,87.0,678.0
Ashok Nagar,14.14.a,Number of patients given AYUSH treatment,TOTAL,4.0,4.0,4.0,0.0,0.0,0.0,4.0,4.0,0.0,0.0,98.0,623.0,741.0
Ashok Nagar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1134.0,2256.0,2662.0,2850.0,2858.0,2774.0,2502.0,2889.0,7090.0,2898.0,2183.0,2641.0,34737.0
Ashok Nagar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,29.0,7.0,39.0,90.0,86.0,49.0,30.0,28.0,44.0,63.0,30.0,39.0,534.0
Ashok Nagar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,25.0,71.0,108.0,143.0,108.0,156.0,86.0,91.0,135.0,92.0,96.0,147.0,1258.0
Ashok Nagar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,1.0,1.0,1.0,1.0,1.0,2.0,0.0,0.0,0.0,7.0
Ashok Nagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,61.0,135.0,161.0,167.0,146.0,226.0,119.0,499.0,540.0,183.0,366.0,214.0,2817.0
Ashok Nagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,3.0
Ashok Nagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,304.0,594.0,542.0,625.0,436.0,461.0,506.0,612.0,394.0,446.0,396.0,591.0,5907.0
Ashok Nagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Ashok Nagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,390.0,800.0,811.0,935.0,690.0,843.0,711.0,1202.0,1069.0,721.0,858.0,952.0,9982.0
Ashok Nagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,1.0,0.0,1.0,1.0,2.0,2.0,1.0,2.0,0.0,1.0,0.0,11.0
Ashok Nagar,15.2,Number of Widal tests conducted,Number tested,36.0,273.0,342.0,464.0,81.0,99.0,479.0,421.0,178.0,164.0,310.0,317.0,3164.0
Ashok Nagar,15.3.a,Number of VDRL tests conducted on males,Number tested,11.0,5.0,0.0,14.0,0.0,0.0,0.0,27.0,62.0,39.0,52.0,69.0,279.0
Ashok Nagar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,45.0,14.0,11.0,11.0,0.0,0.0,0.0,60.0,122.0,114.0,112.0,169.0,658.0
Ashok Nagar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,175.0,71.0,18.0,1.0,107.0,2.0,22.0,160.0,139.0,295.0,230.0,425.0,1645.0
Ashok Nagar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,231.0,90.0,29.0,26.0,107.0,2.0,22.0,247.0,323.0,448.0,394.0,663.0,2582.0
Ashok Nagar,15.4.1,Number of blood smears examined for Malaria,TOTAL,3032.0,6782.0,5541.0,6595.0,8886.0,7241.0,7469.0,5363.0,5275.0,3806.0,5018.0,13063.0,78071.0
Ashok Nagar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,10.0,35.0,73.0,71.0,64.0,113.0,151.0,30.0,14.0,5.0,3.0,11.0,580.0
Ashok Nagar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,1.0,3.0,1.0,1.0,34.0,41.0,32.0,8.0,0.0,0.0,0.0,121.0
Ashok Nagar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Ashok Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Ashok Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Ashok Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Ashok Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ashok Nagar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,,,,,,,,,,,,1.0
Ashok Nagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,,,,,,2.0,,,,1.0,,4.0
Ashok Nagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Ashok Nagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,,,,,,2.0,,,,1.0,,4.0
Ashok Nagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,,,2.0,,,,,,,,,3.0
Ashok Nagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Ashok Nagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,,,2.0,,,,,,,,,3.0
Ashok Nagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,1.0,30.0,1.0,2.0,3.0,13.0,4.0,6.0,9.0,1.0,3.0,73.0
Ashok Nagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Ashok Nagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,1.0,30.0,1.0,2.0,3.0,13.0,4.0,6.0,9.0,1.0,3.0,73.0
Ashok Nagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,5.0,4.0,6.0,10.0,6.0,20.0,2.0,5.0,3.0,5.0,2.0,70.0
Ashok Nagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,1.0,,1.0
Ashok Nagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,5.0,4.0,6.0,10.0,6.0,20.0,2.0,5.0,3.0,6.0,2.0,71.0
Ashok Nagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,,,,1.0,3.0,1.0,1.0,2.0,1.0,10.0
Ashok Nagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ashok Nagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,,,,1.0,3.0,1.0,1.0,2.0,1.0,10.0
Ashok Nagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ashok Nagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ashok Nagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Ashok Nagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,2.0,,1.0,,1.0,1.0,5.0
Ashok Nagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ashok Nagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,2.0,,1.0,,1.0,1.0,5.0
Ashok Nagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ashok Nagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ashok Nagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Ashok Nagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,13.0,9.0,4.0,,5.0,6.0,6.0,4.0,1.0,2.0,1.0,53.0
Ashok Nagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,4.0,5.0,2.0,2.0,6.0,5.0,5.0,1.0,2.0,2.0,1.0,37.0
Ashok Nagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,4.0,17.0,14.0,6.0,2.0,11.0,11.0,11.0,5.0,3.0,4.0,2.0,90.0
Ashok Nagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Ashok Nagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,1.0,2.0,,,3.0
Ashok Nagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,1.0,1.0,,,,,2.0
Ashok Nagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,1.0,1.0,1.0,2.0,,,5.0
Ashok Nagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Ashok Nagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,1.0,,,,,,,,,,,1.0
Ashok Nagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Ashok Nagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Ashok Nagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,,,1.0,1.0,,1.0,1.0,,,,5.0
Ashok Nagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,,,1.0,1.0,,2.0,1.0,,,,6.0
Ashok Nagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Ashok Nagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,,,,,,,,1.0,,,,2.0
Ashok Nagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,1.0,1.0,,4.0,,,1.0,,1.0,,,8.0
Ashok Nagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,1.0,1.0,,4.0,,,1.0,1.0,1.0,,,10.0
Ashok Nagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Ashok Nagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Ashok Nagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Ashok Nagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Ashok Nagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,1.0,,,,,,,,1.0
Ashok Nagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Ashok Nagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Ashok Nagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,1.0,,,,,,1.0,,,,,3.0
Ashok Nagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,1.0,,,,,,1.0,,,,,3.0
Ashok Nagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,2.0,6.0,,,1.0,1.0,1.0,2.0,,,,15.0
Ashok Nagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Ashok Nagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,2.0,6.0,,1.0,1.0,1.0,1.0,2.0,,,,16.0
Ashok Nagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,2.0,,1.0,,1.0,,1.0,3.0,,,8.0
Ashok Nagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,2.0,,1.0,,1.0,,1.0,3.0,,,8.0
Ashok Nagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Ashok Nagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,,,1.0,,2.0,,1.0,,1.0,,,6.0
Ashok Nagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Ashok Nagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,,1.0,1.0,,2.0,,1.0,1.0,1.0,,,8.0
Ashok Nagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Ashok Nagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,1.0,1.0
Ashok Nagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Ashok Nagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Ashok Nagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Ashok Nagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,2.0,,1.0,,3.0
Ashok Nagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,2.0,,,,1.0,,2.0,2.0,3.0,1.0,,,11.0
Ashok Nagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,2.0,1.0,,,2.0,11.0,7.0,25.0,13.0,1.0,4.0,67.0
Ashok Nagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,3.0,2.0,1.0,,1.0,2.0,13.0,9.0,30.0,14.0,2.0,4.0,81.0
Balaghat,1.1,Total number of pregnant women Registered for ANC,TOTAL,2441.0,2947.0,2839.0,2609.0,2192.0,2639.0,2397.0,2638.0,2478.0,2451.0,2433.0,2919.0,30983.0
Balaghat,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1712.0,1992.0,2000.0,1740.0,1453.0,1882.0,1703.0,1820.0,1791.0,1833.0,1764.0,2071.0,21761.0
Balaghat,1.2,Number of Pregnant women registered under JSY,TOTAL,2402.0,2901.0,2836.0,2503.0,2104.0,2609.0,2380.0,2638.0,2478.0,2451.0,2433.0,2919.0,30654.0
Balaghat,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2429.0,2560.0,2673.0,2527.0,2415.0,2416.0,2380.0,2412.0,2320.0,2404.0,2296.0,2425.0,29257.0
Balaghat,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2034.0,2453.0,2428.0,2163.0,1888.0,2245.0,2089.0,2281.0,2220.0,2222.0,2266.0,2772.0,27061.0
Balaghat,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1966.0,2337.0,2605.0,2506.0,2096.0,1999.0,2334.0,2226.0,2299.0,2164.0,2204.0,2433.0,27169.0
Balaghat,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2288.0,2868.0,2694.0,2560.0,2312.0,2621.0,2330.0,2696.0,2597.0,2474.0,2370.0,2897.0,30707.0
Balaghat,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,108.0,79.0,56.0,89.0,55.0,103.0,164.0,132.0,73.0,91.0,88.0,98.0,1136.0
Balaghat,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,53.0,0.0,0.0,0.0,54.0
Balaghat,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1200.0,1525.0,1736.0,1359.0,1163.0,1602.0,1459.0,1646.0,1790.0,1721.0,1739.0,1912.0,18852.0
Balaghat,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,4.0,11.0,8.0,15.0,4.0,10.0,22.0,9.0,21.0,69.0,4.0,12.0,189.0
Balaghat,1.8,Number of pregnancy test kits used at SC level,TOTAL,507.0,777.0,779.0,591.0,675.0,823.0,503.0,990.0,805.0,516.0,905.0,887.0,8758.0
Balaghat,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,1.0,12.0,4.0,4.0,5.0,19.0,6.0,24.0,34.0,30.0,34.0,31.0,204.0
Balaghat,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,133.0,228.0,234.0,198.0,243.0,170.0,193.0,196.0,189.0,172.0,112.0,161.0,2229.0
Balaghat,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,134.0,240.0,238.0,202.0,248.0,189.0,199.0,220.0,223.0,202.0,146.0,192.0,2433.0
Balaghat,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,98.0,134.0,183.0,138.0,195.0,96.0,123.0,137.0,144.0,98.0,83.0,102.0,1531.0
Balaghat,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,3.0,14.0,7.0,11.0,3.0,2.0,3.0,5.0,7.0,2.0,5.0,62.0
Balaghat,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1777.0,1915.0,2063.0,1800.0,2055.0,1987.0,2133.0,1973.0,1879.0,1732.0,1636.0,1880.0,22830.0
Balaghat,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,102.0,248.0,130.0,395.0,147.0,230.0,247.0,206.0,119.0,76.0,117.0,162.0,2179.0
Balaghat,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1652.0,1710.0,1946.0,1696.0,1814.0,1895.0,2051.0,1826.0,1789.0,1671.0,1578.0,1439.0,21067.0
Balaghat,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1525.0,1616.0,1745.0,1592.0,1726.0,1769.0,1911.0,1660.0,1618.0,1550.0,1449.0,1237.0,19398.0
Balaghat,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,270.0,183.0,289.0,238.0,274.0,298.0,261.0,218.0,233.0,197.0,226.0,197.0,2884.0
Balaghat,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Balaghat,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Balaghat,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Balaghat,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,10.0,21.0
Balaghat,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,286.0,280.0,263.0,230.0,277.0,273.0,295.0,258.0,249.0,277.0,230.0,277.0,3195.0
Balaghat,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balaghat,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,286.0,285.0,263.0,230.0,277.0,273.0,295.0,258.0,255.0,277.0,230.0,287.0,3216.0
Balaghat,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,159.0,125.0,160.0,134.0,155.0,169.0,157.0,110.0,140.0,139.0,143.0,111.0,1702.0
Balaghat,4.1.1.a,Number of male live births,TOTAL,1168.0,1219.0,1362.0,1191.0,1335.0,1244.0,1246.0,1195.0,1184.0,1037.0,1006.0,1155.0,14342.0
Balaghat,4.1.1.b,Number of female live births,TOTAL,987.0,1117.0,1175.0,1026.0,1196.0,1189.0,1299.0,1150.0,1125.0,1065.0,972.0,1084.0,13385.0
Balaghat,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2155.0,2336.0,2537.0,2217.0,2531.0,2433.0,2545.0,2345.0,2309.0,2102.0,1978.0,2239.0,27727.0
Balaghat,4.1.2,Number of still births,TOTAL,53.0,52.0,60.0,44.0,69.0,55.0,61.0,71.0,36.0,37.0,41.0,43.0,622.0
Balaghat,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,13.0,12.0,25.0,26.0,25.0,20.0,41.0,29.0,28.0,29.0,35.0,56.0,339.0
Balaghat,4.2.1,Number of Newborns weighed at birth,TOTAL,2054.0,2184.0,2419.0,1838.0,2445.0,2374.0,2437.0,2267.0,2233.0,2030.0,1963.0,2238.0,26482.0
Balaghat,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,274.0,219.0,204.0,427.0,304.0,276.0,227.0,287.0,236.0,220.0,232.0,197.0,3103.0
Balaghat,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2078.0,2254.0,2468.0,2163.0,2401.0,2375.0,2485.0,2297.0,2229.0,1982.0,1929.0,2198.0,26859.0
Balaghat,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,3.0,11.0,9.0,2.0,8.0,8.0,10.0,9.0,18.0,7.0,13.0,14.0,112.0
Balaghat,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,57.0,74.0,55.0,48.0,34.0,50.0,51.0,53.0,36.0,49.0,47.0,63.0,617.0
Balaghat,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,7.0,8.0,65.0,86.0,10.0,10.0,6.0,16.0,45.0,12.0,9.0,16.0,290.0
Balaghat,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balaghat,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,67.0,93.0,129.0,136.0,52.0,68.0,67.0,78.0,99.0,68.0,69.0,93.0,1019.0
Balaghat,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Balaghat,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,104.0,142.0,84.0,96.0,41.0,37.0,35.0,49.0,65.0,124.0,68.0,115.0,960.0
Balaghat,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,54.0,48.0,56.0,41.0,34.0,22.0,23.0,14.0,10.0,12.0,20.0,28.0,362.0
Balaghat,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,204.0,217.0,98.0,82.0,34.0,46.0,26.0,33.0,44.0,106.0,98.0,136.0,1124.0
Balaghat,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,65.0,68.0,89.0,83.0,68.0,8.0,5.0,8.0,7.0,9.0,4.0,4.0,418.0
Balaghat,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1806.0,1834.0,2309.0,1961.0,2341.0,2283.0,2517.0,2168.0,2146.0,2007.0,1896.0,1422.0,24690.0
Balaghat,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1328.0,1225.0,1684.0,1425.0,1524.0,1339.0,1367.0,1665.0,1386.0,1642.0,1694.0,1363.0,17642.0
Balaghat,6.3,PNC maternal complications attended,TOTAL,29.0,13.0,8.0,12.0,3.0,7.0,0.0,9.0,12.0,4.0,4.0,15.0,116.0
Balaghat,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,2.0,12.0,4.0,8.0,5.0,4.0,10.0,6.0,2.0,1.0,7.0,2.0,63.0
Balaghat,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,9.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,7.0,22.0
Balaghat,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,2.0,12.0,13.0,11.0,5.0,4.0,10.0,6.0,2.0,1.0,10.0,9.0,85.0
Balaghat,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,9.0,23.0,24.0,36.0,22.0,29.0,26.0,24.0,15.0,32.0,39.0,27.0,306.0
Balaghat,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,38.0,82.0,52.0,82.0,52.0,38.0,30.0,31.0,45.0,52.0,62.0,48.0,612.0
Balaghat,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,47.0,105.0,76.0,118.0,74.0,67.0,56.0,55.0,60.0,84.0,101.0,75.0,918.0
Balaghat,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,4.0,0.0,12.0,4.0,17.0,15.0,29.0,2.0,9.0,22.0,0.0,65.0,179.0
Balaghat,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,11.0,0.0,26.0,4.0,11.0,42.0,74.0,24.0,16.0,26.0,38.0,29.0,301.0
Balaghat,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,4.0,4.0,4.0,4.0,4.0,0.0,2.0,23.0,22.0,16.0,28.0,112.0
Balaghat,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balaghat,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,16.0,4.0,42.0,12.0,32.0,61.0,103.0,28.0,48.0,70.0,54.0,122.0,592.0
Balaghat,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Balaghat,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,20.0,18.0,24.0,16.0,40.0,222.0,28.0,160.0,171.0,228.0,175.0,82.0,1184.0
Balaghat,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,122.0,63.0,142.0,117.0,757.0,1408.0,339.0,638.0,1004.0,780.0,684.0,412.0,6466.0
Balaghat,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,8.0,27.0,1.0,45.0,9.0,56.0,35.0,13.0,132.0,86.0,88.0,118.0,618.0
Balaghat,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balaghat,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,150.0,108.0,167.0,178.0,806.0,1686.0,402.0,811.0,1307.0,1094.0,947.0,612.0,8268.0
Balaghat,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Balaghat,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,44.0,96.0,50.0,75.0,63.0,30.0,67.0,54.0,33.0,12.0,12.0,47.0,583.0
Balaghat,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Balaghat,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balaghat,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,44.0,96.0,50.0,75.0,71.0,30.0,67.0,54.0,33.0,12.0,12.0,47.0,591.0
Balaghat,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Balaghat,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,30.0,30.0,0.0,6.0,8.0,19.0,0.0,0.0,13.0,17.0,0.0,0.0,123.0
Balaghat,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,27.0,69.0,29.0,50.0,56.0,73.0,45.0,50.0,20.0,22.0,22.0,35.0,498.0
Balaghat,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,7.0,8.0,10.0,9.0,10.0,33.0,29.0,12.0,9.0,57.0,29.0,60.0,273.0
Balaghat,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balaghat,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,64.0,107.0,39.0,65.0,74.0,125.0,74.0,62.0,42.0,96.0,51.0,95.0,894.0
Balaghat,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Balaghat,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,66.0,150.0,199.0,346.0,337.0,203.0,201.0,185.0,212.0,212.0,229.0,208.0,2548.0
Balaghat,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,16.0,21.0,12.0,17.0,12.0,25.0,32.0,16.0,51.0,27.0,34.0,35.0,298.0
Balaghat,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,33.0,35.0,154.0,229.0,219.0,252.0,235.0,238.0,180.0,197.0,184.0,142.0,2098.0
Balaghat,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,411.0,361.0,322.0,360.0,363.0,242.0,214.0,118.0,132.0,167.0,114.0,162.0,2966.0
Balaghat,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balaghat,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,526.0,567.0,687.0,952.0,931.0,722.0,682.0,557.0,575.0,603.0,561.0,547.0,7910.0
Balaghat,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,420.0,51.0,93.0,537.0,160.0,245.0,314.0,249.0,328.0,258.0,354.0,354.0,3363.0
Balaghat,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Balaghat,9.06,Number of IUCD removals,TOTAL,167.0,250.0,212.0,286.0,423.0,332.0,315.0,325.0,285.0,241.0,204.0,220.0,3260.0
Balaghat,9.07,Number of Oral Pills cycles distributed,TOTAL,1438.0,1949.0,2498.0,3221.0,2973.0,3422.0,3469.0,3820.0,3534.0,3999.0,3783.0,3498.0,37604.0
Balaghat,9.08,Number of Condom pieces distributed,TOTAL,6386.0,9557.0,16053.0,15393.0,13495.0,14999.0,17903.0,15957.0,14747.0,16075.0,11499.0,13408.0,165472.0
Balaghat,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,7.0,4.0,0.0,2.0,0.0,0.0,0.0,13.0
Balaghat,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,9.0,1.0,0.0,3.0,2.0,15.0,0.0,17.0,5.0,0.0,0.0,0.0,52.0
Balaghat,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,3.0
Balaghat,9.11.2.b,Number of failures following female sterilization,TOTAL,6.0,13.0,4.0,2.0,5.0,6.0,3.0,1.0,2.0,1.0,0.0,0.0,43.0
Balaghat,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,9.12,Number of Institutions having NSV trained doctors,TOTAL,16.0,7.0,9.0,25.0,25.0,6.0,7.0,6.0,6.0,6.0,7.0,6.0,-1.0
Balaghat,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2136.0,2686.0,2687.0,2554.0,2783.0,2461.0,2729.0,2624.0,2415.0,2175.0,2037.0,2365.0,29652.0
Balaghat,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1649.0,2281.0,2323.0,2385.0,2310.0,2235.0,2468.0,488.0,0.0,1.0,0.0,1.0,16141.0
Balaghat,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1813.0,1957.0,2250.0,2418.0,2232.0,2351.0,2247.0,2521.0,580.0,121.0,39.0,7.0,18536.0
Balaghat,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2028.0,2025.0,2022.0,2324.0,2198.0,2322.0,2414.0,2264.0,2470.0,821.0,185.0,48.0,21121.0
Balaghat,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1966.0,2353.0,2013.0,2480.0,2265.0,11077.0
Balaghat,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1746.0,1936.0,2303.0,2757.0,8742.0
Balaghat,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1269.0,2064.0,2667.0,6000.0
Balaghat,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1805.0,2025.0,1526.0,2018.0,2270.0,2023.0,2267.0,2071.0,2079.0,1764.0,1570.0,1887.0,23305.0
Balaghat,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1685.0,2313.0,2323.0,2405.0,2301.0,2226.0,2458.0,2105.0,1977.0,1949.0,2463.0,2286.0,26491.0
Balaghat,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1806.0,1968.0,2228.0,2419.0,2244.0,2341.0,2256.0,2482.0,2007.0,2104.0,2304.0,2783.0,26942.0
Balaghat,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2011.0,2020.0,2026.0,2327.0,2187.0,2333.0,2403.0,2242.0,2366.0,1889.0,2128.0,2623.0,26555.0
Balaghat,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1466.0,1600.0,1800.0,1729.0,1788.0,1644.0,1927.0,1701.0,1751.0,1395.0,1255.0,1489.0,19545.0
Balaghat,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1640.0,2257.0,2340.0,2385.0,2312.0,2225.0,2469.0,481.0,0.0,17.0,30.0,1.0,16157.0
Balaghat,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1809.0,1914.0,2246.0,2426.0,2236.0,2342.0,2255.0,2456.0,690.0,139.0,67.0,6.0,18586.0
Balaghat,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2032.0,2002.0,2021.0,2333.0,2186.0,2325.0,2419.0,2210.0,2390.0,807.0,221.0,54.0,21000.0
Balaghat,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1689.0,2477.0,2664.0,2644.0,2362.0,2313.0,2365.0,2177.0,1862.0,2292.0,2155.0,2683.0,27683.0
Balaghat,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,947.0,1581.0,1872.0,1963.0,1383.0,1656.0,1660.0,1455.0,1449.0,1762.0,1738.0,1808.0,19274.0
Balaghat,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,900.0,1275.0,1427.0,1350.0,1152.0,1179.0,1097.0,1136.0,963.0,1109.0,1133.0,1408.0,14129.0
Balaghat,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,900.0,1277.0,1300.0,1246.0,1118.0,1048.0,1048.0,1080.0,947.0,1081.0,1025.0,1348.0,13418.0
Balaghat,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1800.0,2552.0,2727.0,2596.0,2270.0,2227.0,2145.0,2216.0,1910.0,2190.0,2158.0,2756.0,27547.0
Balaghat,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1783.0,2115.0,2302.0,2592.0,1717.0,1950.0,1988.0,2036.0,2203.0,2619.0,2192.0,2698.0,26195.0
Balaghat,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1763.0,2114.0,2294.0,2582.0,1710.0,1949.0,1997.0,2029.0,2180.0,2609.0,2186.0,2705.0,26118.0
Balaghat,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,568.0,562.0,551.0,659.0,441.0,469.0,378.0,394.0,416.0,510.0,443.0,563.0,5954.0
Balaghat,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,513.0,577.0,558.0,591.0,403.0,452.0,404.0,391.0,413.0,465.0,369.0,509.0,5645.0
Balaghat,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1081.0,1139.0,1109.0,1250.0,844.0,921.0,782.0,785.0,829.0,975.0,812.0,1072.0,11599.0
Balaghat,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,610.0,838.0,1049.0,3170.0,2235.0,2405.0,2037.0,1893.0,1712.0,2902.0,1422.0,1615.0,21888.0
Balaghat,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,616.0,798.0,1009.0,3352.0,3365.0,3453.0,3979.0,2907.0,2545.0,2958.0,1460.0,1439.0,27881.0
Balaghat,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,653.0,941.0,1451.0,5501.0,3068.0,3687.0,3926.0,3073.0,2872.0,3712.0,1774.0,1545.0,32203.0
Balaghat,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,0.0,5.0,4.0,5.0,4.0,8.0,4.0,6.0,7.0,8.0,52.0
Balaghat,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,17.0,20.0,35.0,30.0,23.0,29.0,23.0,42.0,44.0,31.0,26.0,20.0,340.0
Balaghat,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1500.0,1674.0,1572.0,1588.0,1545.0,1541.0,1535.0,1522.0,1550.0,1588.0,1549.0,1571.0,18735.0
Balaghat,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1448.0,1638.0,1549.0,1544.0,1529.0,1506.0,1496.0,1496.0,1529.0,1575.0,1542.0,1578.0,18430.0
Balaghat,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1179.0,1387.0,1272.0,1269.0,1248.0,1244.0,1249.0,1251.0,1264.0,1274.0,1261.0,1273.0,15171.0
Balaghat,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1630.0,2467.0,2634.0,3658.0,2276.0,2238.0,2362.0,2229.0,1888.0,3975.0,2180.0,2738.0,30275.0
Balaghat,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,105.0,140.0,54.0,14579.0,1613.0,422.0,393.0,173.0,162.0,16220.0,470.0,356.0,34687.0
Balaghat,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,26.0,41.0,12.0,13995.0,1420.0,519.0,267.0,44.0,68.0,15187.0,403.0,248.0,32230.0
Balaghat,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,9.0,4.0,5.0,8.0,0.0,4.0,10.0,17.0,25.0,0.0,2.0,35.0,119.0
Balaghat,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,157.0,224.0,274.0,212.0,374.0,285.0,258.0,244.0,222.0,275.0,317.0,375.0,3217.0
Balaghat,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,28.0,42.0,32.0,80.0,25.0,65.0,59.0,128.0,210.0,89.0,25.0,74.0,857.0
Balaghat,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,13.0,35.0,41.0,52.0,161.0,50.0,64.0,94.0,84.0,85.0,67.0,42.0,788.0
Balaghat,13.1,Number of Patients operated for cataract,TOTAL,2.0,3.0,2.0,0.0,0.0,188.0,449.0,313.0,387.0,235.0,459.0,200.0,2238.0
Balaghat,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,3.0,3.0,2.0,0.0,0.0,188.0,449.0,313.0,387.0,235.0,459.0,200.0,2239.0
Balaghat,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,98.0,102.0,156.0,435.0,8.0,12.0,0.0,0.0,811.0
Balaghat,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,10.0,150.0,168.0,498.0,149.0,26.0,0.0,0.0,1001.0
Balaghat,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,9.0,10.0,10.0,8.0,9.0,7.0,9.0,8.0,10.0,10.0,7.0,9.0,-1.0
Balaghat,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,22.0,22.0,22.0,24.0,23.0,24.0,16.0,12.0,14.0,18.0,17.0,18.0,-1.0
Balaghat,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1411.0,1543.0,1442.0,1512.0,1474.0,1300.0,1666.0,1279.0,1676.0,1519.0,1421.0,1512.0,-1.0
Balaghat,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,10.0,10.0,11.0,11.0,11.0,11.0,10.0,10.0,11.0,10.0,11.0,11.0,-1.0
Balaghat,14.05,Number of RKS meetings held during the month,TOTAL,6.0,11.0,9.0,7.0,8.0,5.0,2.0,4.0,7.0,7.0,5.0,6.0,77.0
Balaghat,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,28.0,33.0,32.0,33.0,31.0,32.0,31.0,25.0,28.0,29.0,24.0,27.0,-1.0
Balaghat,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,78.0,91.0,69.0,50.0,17.0,188.0,107.0,6.0,166.0,149.0,158.0,253.0,1332.0
Balaghat,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,8.0,6.0,8.0,9.0,8.0,6.0,7.0,6.0,4.0,5.0,7.0,6.0,-1.0
Balaghat,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,1.0,2.0,2.0,3.0,2.0,3.0,2.0,0.0,0.0,0.0,-1.0
Balaghat,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,296.0,434.0,447.0,411.0,374.0,448.0,489.0,508.0,518.0,466.0,425.0,339.0,5155.0
Balaghat,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1214.0,1007.0,934.0,787.0,750.0,991.0,958.0,879.0,1018.0,1064.0,970.0,998.0,11570.0
Balaghat,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,375.0,557.0,538.0,576.0,578.0,630.0,662.0,598.0,505.0,664.0,481.0,523.0,6687.0
Balaghat,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1785.0,2350.0,3040.0,2593.0,2727.0,3332.0,2776.0,2827.0,2859.0,2795.0,3018.0,3070.0,33172.0
Balaghat,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,671.0,991.0,985.0,987.0,952.0,1078.0,1151.0,1106.0,1023.0,1130.0,906.0,862.0,11842.0
Balaghat,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2999.0,3357.0,3974.0,3380.0,3477.0,4323.0,3734.0,3706.0,3877.0,3859.0,3988.0,4068.0,44742.0
Balaghat,14.10.2.a,Number of death cases of Inpatient males,TOTAL,1199.0,48.0,40.0,37.0,5.0,40.0,11.0,24.0,11.0,6.0,35.0,44.0,1500.0
Balaghat,14.10.2.b,Number of death cases of Inpatient females,TOTAL,29.0,33.0,73.0,30.0,9.0,35.0,20.0,21.0,4.0,5.0,20.0,35.0,314.0
Balaghat,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,1228.0,81.0,113.0,67.0,14.0,75.0,31.0,45.0,15.0,11.0,55.0,79.0,1814.0
Balaghat,14.11,In-Patient Head Count at midnight,TOTAL,2281.0,2443.0,2650.0,1868.0,2634.0,3677.0,3395.0,3359.0,3195.0,3128.0,3869.0,3837.0,36336.0
Balaghat,14.12.1,OPD attendance (All),TOTAL,54578.0,61291.0,64966.0,68272.0,71152.0,93991.0,77539.0,73359.0,68865.0,56086.0,64003.0,72351.0,826453.0
Balaghat,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,286.0,285.0,279.0,508.0,355.0,273.0,277.0,298.0,255.0,341.0,230.0,386.0,3773.0
Balaghat,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,29.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,36.0
Balaghat,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,241.0,287.0,151.0,155.0,193.0,531.0,291.0,401.0,787.0,639.0,617.0,820.0,5113.0
Balaghat,14.14.a,Number of patients given AYUSH treatment,TOTAL,6901.0,4405.0,6078.0,6632.0,7222.0,6694.0,7760.0,9054.0,9439.0,7539.0,9732.0,12650.0,94106.0
Balaghat,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,61.0,0.0,36.0,37.0,35.0,169.0
Balaghat,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3210.0,4033.0,5444.0,5018.0,4694.0,5666.0,4735.0,6052.0,6617.0,5230.0,5919.0,6483.0,63101.0
Balaghat,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,26.0,50.0,59.0,92.0,69.0,71.0,83.0,147.0,114.0,119.0,66.0,70.0,966.0
Balaghat,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,126.0,230.0,322.0,106.0,300.0,238.0,373.0,382.0,282.0,212.0,402.0,388.0,3361.0
Balaghat,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3.0,7.0,2.0,3.0,4.0,2.0,7.0,3.0,5.0,2.0,7.0,8.0,53.0
Balaghat,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,234.0,218.0,381.0,174.0,292.0,408.0,336.0,338.0,366.0,243.0,405.0,355.0,3750.0
Balaghat,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,6.0,4.0,2.0,4.0,4.0,6.0,3.0,4.0,3.0,4.0,3.0,45.0
Balaghat,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,802.0,1244.0,1900.0,1305.0,1698.0,1747.0,1149.0,1444.0,1157.0,1089.0,1263.0,1532.0,16330.0
Balaghat,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,0.0,0.0,0.0,3.0,1.0,0.0,0.0,0.0,0.0,2.0,2.0,10.0
Balaghat,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1162.0,1692.0,2603.0,1585.0,2290.0,2393.0,1858.0,2164.0,1805.0,1544.0,2070.0,2275.0,23441.0
Balaghat,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,7.0,13.0,6.0,5.0,11.0,7.0,13.0,6.0,9.0,5.0,13.0,13.0,108.0
Balaghat,15.2,Number of Widal tests conducted,Number tested,84.0,151.0,185.0,301.0,294.0,468.0,346.0,433.0,151.0,154.0,292.0,367.0,3226.0
Balaghat,15.3.a,Number of VDRL tests conducted on males,Number tested,19.0,19.0,26.0,7.0,21.0,4.0,6.0,5.0,6.0,12.0,10.0,39.0,174.0
Balaghat,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,16.0,28.0,29.0,59.0,15.0,8.0,6.0,6.0,5.0,31.0,9.0,77.0,289.0
Balaghat,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,21.0,26.0,53.0,35.0,92.0,63.0,32.0,27.0,35.0,26.0,67.0,115.0,592.0
Balaghat,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,56.0,73.0,108.0,101.0,128.0,75.0,44.0,38.0,46.0,69.0,86.0,231.0,1055.0
Balaghat,15.4.1,Number of blood smears examined for Malaria,TOTAL,10929.0,15322.0,18572.0,23971.0,24886.0,27667.0,24688.0,25536.0,18733.0,15474.0,15577.0,16420.0,237775.0
Balaghat,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,30.0,35.0,67.0,138.0,112.0,71.0,93.0,137.0,173.0,72.0,41.0,30.0,999.0
Balaghat,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,48.0,147.0,524.0,189.0,444.0,255.0,499.0,1146.0,758.0,160.0,151.0,169.0,4490.0
Balaghat,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Balaghat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Balaghat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Balaghat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Balaghat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balaghat,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,2.0,2.0,2.0,2.0,3.0,2.0,3.0,2.0,,1.0,,19.0
Balaghat,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,6.0,5.0,,,1.0,1.0,13.0
Balaghat,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Balaghat,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,6.0,5.0,,,1.0,1.0,13.0
Balaghat,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,,8.0
Balaghat,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Balaghat,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,,8.0
Balaghat,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,3.0,1.0,2.0,3.0,6.0,6.0,3.0,6.0,5.0,35.0
Balaghat,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,,,,,,,,,,,1.0
Balaghat,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,,,3.0,1.0,2.0,3.0,6.0,6.0,3.0,6.0,5.0,36.0
Balaghat,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,2.0,1.0,1.0,1.0,1.0,9.0,8.0,,1.0,4.0,12.0,40.0
Balaghat,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Balaghat,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,2.0,1.0,1.0,1.0,1.0,9.0,8.0,,1.0,4.0,12.0,40.0
Balaghat,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,,,,,2.0,3.0,1.0,1.0,,,8.0
Balaghat,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,1.0,1.0,1.0,1.0,1.0,,,5.0
Balaghat,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,,,,1.0,3.0,4.0,2.0,2.0,,,13.0
Balaghat,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,2.0,2.0
Balaghat,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Balaghat,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,2.0,2.0
Balaghat,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,2.0,1.0,,1.0,,4.0
Balaghat,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,1.0,2.0,3.0,3.0,,,,,9.0
Balaghat,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,1.0,2.0,3.0,5.0,1.0,,1.0,,13.0
Balaghat,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Balaghat,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Balaghat,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Balaghat,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,,2.0,,2.0,2.0,5.0,,,1.0,2.0,15.0
Balaghat,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,2.0,1.0,2.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,15.0
Balaghat,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,3.0,1.0,4.0,2.0,3.0,3.0,7.0,1.0,1.0,2.0,3.0,30.0
Balaghat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Balaghat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Balaghat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Balaghat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Balaghat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Balaghat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,1.0,,,,,1.0,,1.0,3.0,,7.0
Balaghat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,1.0,,,1.0,,1.0,2.0,5.0
Balaghat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,1.0,,,1.0,,1.0,1.0,1.0,4.0,2.0,12.0
Balaghat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Balaghat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Balaghat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,1.0,1.0,,,1.0,3.0
Balaghat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,1.0,2.0,,,1.0,4.0
Balaghat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Balaghat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Balaghat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Balaghat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,1.0,,,,1.0,,,,,,2.0
Balaghat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,1.0,6.0,2.0,1.0,1.0,1.0,12.0
Balaghat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,8.0,12.0,18.0,10.0,6.0,4.0,3.0,61.0
Balaghat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,1.0,4.0,2.0,2.0,5.0,5.0,3.0,22.0
Balaghat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,9.0,17.0,26.0,14.0,12.0,10.0,7.0,95.0
Balaghat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Balaghat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Balaghat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Balaghat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,1.0,,,,1.0
Balaghat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Balaghat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,2.0,1.0,2.0,1.0,2.0,2.0,,6.0,8.0,10.0,3.0,9.0,46.0
Balaghat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,,,,,,3.0,6.0,11.0,8.0,7.0,3.0,39.0
Balaghat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,3.0,1.0,2.0,1.0,2.0,2.0,3.0,12.0,19.0,18.0,10.0,12.0,85.0
Balaghat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,1.0,,1.0,,,2.0
Balaghat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,,,,,,,,,2.0,1.0,,4.0
Balaghat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Balaghat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,,,,,,,1.0,,3.0,1.0,,6.0
Balaghat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Balaghat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,2.0,,,,,,,,,2.0
Balaghat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Balaghat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,2.0,,,,,,,,,2.0
Balaghat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Balaghat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Balaghat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Balaghat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Balaghat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Balaghat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,,1.0,,,,1.0,,1.0,1.0,,5.0
Balaghat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Balaghat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,,1.0,,,,1.0,,1.0,1.0,,5.0
Balaghat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Balaghat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,,,,,,,,,,,1.0
Balaghat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Balaghat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,,,,,,,,,,,1.0
Balaghat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Balaghat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Balaghat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Balaghat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Balaghat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Balaghat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,1.0,2.0,3.0,4.0,1.0,2.0,4.0,,1.0,1.0,19.0
Balaghat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Balaghat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,1.0,2.0,3.0,4.0,1.0,2.0,4.0,,1.0,1.0,19.0
Balaghat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,2.0,,,1.0,,,3.0
Balaghat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,5.0,,,,,3.0,5.0,5.0,4.0,5.0,14.0,1.0,42.0
Balaghat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,1.0,,1.0,,,4.0,2.0,8.0
Balaghat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,5.0,,,,,4.0,7.0,6.0,4.0,6.0,18.0,3.0,53.0
Balaghat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Balaghat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,1.0,1.0,2.0,,,,8.0,1.0,3.0,3.0,2.0,21.0
Balaghat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Balaghat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,1.0,1.0,2.0,,,,8.0,1.0,4.0,3.0,2.0,22.0
Balaghat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Balaghat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,1.0,1.0,,,1.0,,,,1.0,,,5.0
Balaghat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,,,,,,,1.0,,,,2.0
Balaghat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,2.0,1.0,,,1.0,,1.0,1.0,1.0,,,8.0
Balaghat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Balaghat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,4.0,,,,,,,1.0,,,,2.0,7.0
Balaghat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,2.0,,1.0,2.0,3.0,8.0
Balaghat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,4.0,,,,,,,3.0,,1.0,2.0,5.0,15.0
Balaghat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,1.0,1.0,,1.0,,,3.0
Balaghat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,5.0,,,,,,1.0,3.0,4.0,5.0,10.0,14.0,42.0
Balaghat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,2.0,1.0,,,,,1.0,11.0,22.0,22.0,28.0,20.0,107.0
Balaghat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,7.0,1.0,,,,,3.0,15.0,26.0,28.0,38.0,34.0,152.0
Balaghat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,1.0,1.0,2.0,1.0,1.0,3.0,3.0,2.0,3.0,1.0,19.0
Balaghat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,7.0,2.0,4.0,2.0,2.0,1.0,1.0,19.0,13.0,11.0,13.0,11.0,86.0
Balaghat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,4.0,6.0,6.0,6.0,7.0,20.0,29.0,76.0,76.0,73.0,67.0,48.0,418.0
Balaghat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,11.0,9.0,11.0,9.0,11.0,22.0,31.0,98.0,92.0,86.0,83.0,60.0,523.0
Barwani,1.1,Total number of pregnant women Registered for ANC,TOTAL,2839.0,3767.0,4129.0,4352.0,3532.0,3556.0,3206.0,3581.0,3694.0,3685.0,4196.0,4151.0,44688.0
Barwani,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1761.0,2221.0,2485.0,2683.0,2229.0,2358.0,2070.0,2310.0,2287.0,2360.0,2934.0,2845.0,28543.0
Barwani,1.2,Number of Pregnant women registered under JSY,TOTAL,2839.0,3684.0,4075.0,4232.0,3293.0,3392.0,3010.0,3423.0,3504.0,3524.0,3962.0,3909.0,42847.0
Barwani,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2737.0,3216.0,3137.0,3396.0,2987.0,3215.0,2762.0,2951.0,3039.0,2828.0,3168.0,3429.0,36865.0
Barwani,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1810.0,2472.0,2697.0,3024.0,2501.0,2622.0,2387.0,2686.0,2564.0,2752.0,3263.0,3196.0,31974.0
Barwani,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2279.0,2954.0,3381.0,3350.0,2731.0,2615.0,2602.0,2756.0,2900.0,2684.0,2917.0,3352.0,34521.0
Barwani,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2891.0,3748.0,4044.0,4313.0,3316.0,3556.0,3156.0,3544.0,3694.0,3685.0,4196.0,4151.0,44294.0
Barwani,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,109.0,187.0,153.0,175.0,147.0,99.0,93.0,156.0,84.0,87.0,142.0,199.0,1631.0
Barwani,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,42.0,7.0,6.0,23.0,10.0,12.0,7.0,13.0,8.0,17.0,14.0,24.0,183.0
Barwani,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2434.0,2897.0,3978.0,4303.0,3577.0,3275.0,2814.0,2615.0,2980.0,2780.0,3304.0,3882.0,38839.0
Barwani,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,93.0,39.0,126.0,89.0,185.0,138.0,133.0,64.0,111.0,144.0,296.0,328.0,1746.0
Barwani,1.8,Number of pregnancy test kits used at SC level,TOTAL,625.0,879.0,1040.0,1476.0,1294.0,943.0,1190.0,1295.0,1445.0,1324.0,1514.0,1539.0,14564.0
Barwani,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,205.0,259.0,312.0,483.0,365.0,323.0,332.0,553.0,528.0,557.0,689.0,786.0,5392.0
Barwani,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,677.0,1014.0,1144.0,1106.0,807.0,921.0,759.0,681.0,743.0,806.0,511.0,514.0,9683.0
Barwani,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,882.0,1273.0,1456.0,1589.0,1172.0,1244.0,1091.0,1234.0,1271.0,1363.0,1200.0,1300.0,15075.0
Barwani,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,667.0,981.0,839.0,1002.0,740.0,792.0,788.0,842.0,983.0,1244.0,908.0,936.0,10722.0
Barwani,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,13.0,5.0,32.0,32.0,16.0,7.0,8.0,22.0,22.0,29.0,20.0,23.0,229.0
Barwani,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1618.0,2135.0,2156.0,1922.0,2179.0,1978.0,1854.0,1880.0,1929.0,1916.0,1976.0,2268.0,23811.0
Barwani,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,401.0,402.0,254.0,209.0,319.0,233.0,176.0,330.0,275.0,174.0,196.0,220.0,3189.0
Barwani,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1295.0,1647.0,1928.0,1472.0,1414.0,1805.0,945.0,1672.0,1827.0,1627.0,1481.0,1503.0,18616.0
Barwani,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1174.0,1360.0,1444.0,1243.0,1221.0,1459.0,766.0,1494.0,1549.0,1462.0,1255.0,1508.0,15935.0
Barwani,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,14.0,26.0,31.0,14.0,37.0,25.0,36.0,26.0,26.0,50.0,47.0,33.0,365.0
Barwani,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,,0.0,,0.0,,,,0.0,0.0,,,0.0
Barwani,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,,0.0,,0.0,,,,0.0,0.0,,,0.0
Barwani,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,,0.0,,0.0,,,,0.0,0.0,,,0.0
Barwani,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,116.0,128.0,105.0,129.0,123.0,144.0,123.0,130.0,146.0,132.0,129.0,157.0,1562.0
Barwani,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barwani,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,116.0,128.0,105.0,129.0,123.0,144.0,123.0,130.0,146.0,132.0,129.0,157.0,1562.0
Barwani,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,10.0,19.0,19.0,12.0,24.0,19.0,27.0,20.0,16.0,21.0,23.0,16.0,226.0
Barwani,4.1.1.a,Number of male live births,TOTAL,1294.0,1798.0,1881.0,1785.0,1665.0,1615.0,1540.0,1627.0,1738.0,1670.0,1669.0,1843.0,20125.0
Barwani,4.1.1.b,Number of female live births,TOTAL,1170.0,1599.0,1728.0,1714.0,1689.0,1565.0,1398.0,1478.0,1429.0,1601.0,1493.0,1694.0,18558.0
Barwani,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2464.0,3397.0,3609.0,3499.0,3354.0,3180.0,2938.0,3105.0,3167.0,3271.0,3162.0,3537.0,38683.0
Barwani,4.1.2,Number of still births,TOTAL,73.0,48.0,45.0,40.0,54.0,79.0,59.0,46.0,68.0,64.0,64.0,73.0,713.0
Barwani,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,94.0,140.0,143.0,150.0,174.0,162.0,149.0,170.0,184.0,189.0,219.0,206.0,1980.0
Barwani,4.2.1,Number of Newborns weighed at birth,TOTAL,2463.0,3379.0,3601.0,3416.0,3330.0,3148.0,2932.0,3101.0,3167.0,3271.0,3162.0,3537.0,38507.0
Barwani,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,183.0,353.0,395.0,350.0,398.0,384.0,410.0,418.0,420.0,409.0,428.0,469.0,4617.0
Barwani,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2357.0,3277.0,3487.0,3284.0,3187.0,3148.0,2930.0,3090.0,3167.0,3271.0,3162.0,3537.0,37897.0
Barwani,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,52.0,60.0,39.0,93.0,79.0,81.0,178.0,123.0,127.0,13.0,91.0,120.0,1056.0
Barwani,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,89.0,160.0,147.0,145.0,54.0,169.0,141.0,257.0,261.0,187.0,212.0,188.0,2010.0
Barwani,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,396.0,450.0,398.0,373.0,465.0,430.0,339.0,431.0,388.0,422.0,406.0,611.0,5109.0
Barwani,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barwani,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,537.0,670.0,584.0,611.0,598.0,680.0,658.0,811.0,776.0,622.0,709.0,919.0,8175.0
Barwani,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,8.0,19.0,1.0,1.0,2.0,0.0,,,0.0,7.0,8.0,20.0,66.0
Barwani,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,522.0,646.0,552.0,589.0,673.0,665.0,537.0,642.0,553.0,526.0,560.0,764.0,7229.0
Barwani,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,25.0,42.0,23.0,354.0,25.0,23.0,39.0,43.0,120.0,23.0,66.0,36.0,819.0
Barwani,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,95.0,244.0,204.0,148.0,313.0,186.0,271.0,346.0,380.0,273.0,219.0,272.0,2951.0
Barwani,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,378.0,392.0,313.0,337.0,330.0,328.0,297.0,360.0,377.0,405.0,304.0,335.0,4156.0
Barwani,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2245.0,2945.0,3167.0,2796.0,3049.0,3059.0,2736.0,2754.0,2742.0,3106.0,2962.0,3344.0,34905.0
Barwani,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2215.0,2677.0,2580.0,2690.0,2777.0,2766.0,2288.0,2434.0,2553.0,2849.0,2616.0,3089.0,31534.0
Barwani,6.3,PNC maternal complications attended,TOTAL,122.0,131.0,133.0,151.0,144.0,160.0,139.0,405.0,156.0,295.0,360.0,167.0,2363.0
Barwani,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,70.0,86.0,109.0,88.0,90.0,96.0,87.0,107.0,122.0,119.0,130.0,128.0,1232.0
Barwani,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,9.0,16.0,9.0,14.0,8.0,2.0,7.0,12.0,8.0,14.0,15.0,14.0,128.0
Barwani,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,79.0,102.0,118.0,102.0,98.0,98.0,94.0,119.0,130.0,133.0,145.0,142.0,1360.0
Barwani,7.2,Number of MTPs conducted at Private Facilities,TOTAL,8.0,5.0,8.0,16.0,0.0,0.0,0.0,1.0,1.0,8.0,0.0,0.0,47.0
Barwani,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,7.0,125.0,74.0,19.0,25.0,62.0,43.0,140.0,136.0,90.0,91.0,87.0,899.0
Barwani,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,14.0,171.0,140.0,146.0,66.0,358.0,59.0,553.0,583.0,807.0,840.0,643.0,4380.0
Barwani,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,21.0,296.0,214.0,165.0,91.0,420.0,102.0,693.0,719.0,897.0,931.0,730.0,5279.0
Barwani,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,30.0,0.0,0.0,10.0,0.0,0.0,6.0,0.0,10.0,56.0
Barwani,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,2.0,4.0,3.0,4.0,4.0,5.0,1.0,3.0,3.0,2.0,1.0,32.0
Barwani,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barwani,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,2.0,4.0,3.0,4.0,4.0,5.0,1.0,3.0,3.0,2.0,1.0,32.0
Barwani,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,,,,0.0,0.0,,,,,,,0.0
Barwani,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,43.0,14.0,0.0,168.0,134.0,145.0,103.0,221.0,41.0,35.0,46.0,11.0,961.0
Barwani,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,99.0,59.0,112.0,285.0,484.0,337.0,276.0,258.0,406.0,286.0,741.0,455.0,3798.0
Barwani,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,76.0,140.0,161.0,399.0,419.0,349.0,99.0,331.0,462.0,425.0,527.0,279.0,3667.0
Barwani,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barwani,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,218.0,213.0,273.0,852.0,1037.0,831.0,478.0,810.0,909.0,746.0,1314.0,745.0,8426.0
Barwani,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,,,,0.0,0.0,1.0,,,,,,1.0
Barwani,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Barwani,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,1.0,5.0,1.0,3.0,0.0,3.0,8.0,19.0,1.0,10.0,2.0,2.0,55.0
Barwani,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barwani,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,1.0,5.0,1.0,3.0,0.0,3.0,8.0,19.0,1.0,10.0,3.0,2.0,56.0
Barwani,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,,,,1.0,0.0,,1.0,4.0,3.0,1.0,1.0,11.0
Barwani,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,5.0,1.0,0.0,0.0,0.0,0.0,8.0,0.0,14.0
Barwani,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Barwani,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,12.0,16.0,31.0,27.0,28.0,25.0,29.0,44.0,37.0,42.0,29.0,30.0,350.0
Barwani,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barwani,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,12.0,16.0,31.0,27.0,33.0,26.0,29.0,44.0,37.0,42.0,38.0,30.0,365.0
Barwani,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,,,,0.0,0.0,1.0,1.0,,3.0,1.0,,6.0
Barwani,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,168.0,262.0,256.0,157.0,136.0,133.0,124.0,117.0,140.0,570.0,292.0,231.0,2586.0
Barwani,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,31.0,23.0,39.0,29.0,21.0,21.0,25.0,47.0,38.0,49.0,78.0,58.0,459.0
Barwani,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,36.0,50.0,56.0,29.0,55.0,42.0,58.0,121.0,246.0,124.0,110.0,123.0,1050.0
Barwani,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,172.0,24.0,137.0,273.0,91.0,139.0,149.0,143.0,192.0,201.0,174.0,603.0,2298.0
Barwani,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barwani,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,407.0,359.0,488.0,488.0,303.0,335.0,356.0,428.0,616.0,944.0,654.0,1015.0,6393.0
Barwani,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,152.0,172.0,126.0,117.0,133.0,51.0,76.0,141.0,255.0,268.0,259.0,626.0,2376.0
Barwani,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,,,,0.0,0.0,,,2.0,,,,2.0
Barwani,9.06,Number of IUCD removals,TOTAL,107.0,177.0,164.0,206.0,164.0,200.0,92.0,132.0,130.0,143.0,136.0,115.0,1766.0
Barwani,9.07,Number of Oral Pills cycles distributed,TOTAL,4197.0,6213.0,4684.0,5043.0,5341.0,4872.0,5091.0,4985.0,5019.0,5774.0,5086.0,6666.0,62971.0
Barwani,9.08,Number of Condom pieces distributed,TOTAL,11140.0,18492.0,14058.0,16061.0,21440.0,17214.0,16126.0,16815.0,15325.0,38686.0,35529.0,42424.0,263310.0
Barwani,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,6.0,0.0,0.0,10.0,1.0,6.0,0.0,0.0,2.0,25.0
Barwani,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Barwani,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2284.0,3201.0,3269.0,2989.0,3179.0,3111.0,2836.0,2984.0,3038.0,3207.0,3097.0,3821.0,37016.0
Barwani,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2238.0,2854.0,3322.0,3645.0,3298.0,3158.0,3016.0,1044.0,140.0,28.0,37.0,33.0,22813.0
Barwani,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2657.0,2715.0,3238.0,3432.0,3244.0,3337.0,2882.0,3109.0,1096.0,252.0,163.0,47.0,26172.0
Barwani,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2753.0,3028.0,3117.0,3262.0,3075.0,3200.0,2893.0,3087.0,3166.0,1243.0,393.0,133.0,29350.0
Barwani,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1979.0,2919.0,3124.0,3119.0,3743.0,14884.0
Barwani,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1844.0,2827.0,2962.0,3462.0,11097.0
Barwani,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,1692.0,2533.0,3265.0,7494.0
Barwani,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1374.0,2075.0,2210.0,1920.0,2139.0,2010.0,1884.0,1945.0,1976.0,1981.0,1984.0,2476.0,23974.0
Barwani,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2256.0,2828.0,3296.0,3640.0,3300.0,2810.0,2862.0,2869.0,3006.0,3148.0,3144.0,3758.0,36917.0
Barwani,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2667.0,2718.0,3244.0,3427.0,3239.0,3032.0,2744.0,2985.0,2873.0,3070.0,3066.0,3492.0,36557.0
Barwani,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2764.0,3034.0,3129.0,3272.0,3080.0,2868.0,2811.0,3078.0,3087.0,2830.0,2859.0,3376.0,36188.0
Barwani,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1341.0,2046.0,2078.0,1841.0,2106.0,1969.0,1880.0,1855.0,1876.0,1770.0,1873.0,2393.0,23028.0
Barwani,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2230.0,2789.0,3334.0,3591.0,3305.0,3115.0,3011.0,1233.0,12.0,23.0,48.0,5.0,22696.0
Barwani,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2647.0,2723.0,3224.0,3379.0,3235.0,3324.0,2870.0,3080.0,1097.0,250.0,133.0,29.0,25991.0
Barwani,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2748.0,3035.0,3137.0,3225.0,3086.0,3192.0,2887.0,3068.0,3127.0,1193.0,296.0,105.0,29099.0
Barwani,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2607.0,3078.0,3192.0,3299.0,2621.0,2661.0,2416.0,2603.0,2410.0,2751.0,2764.0,3528.0,33930.0
Barwani,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1146.0,1709.0,1737.0,2716.0,1966.0,1721.0,1880.0,2472.0,2751.0,2682.0,2531.0,2767.0,26078.0
Barwani,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1305.0,1559.0,1589.0,1695.0,1385.0,1471.0,1287.0,1444.0,1353.0,1385.0,1504.0,1875.0,17852.0
Barwani,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1306.0,1463.0,1553.0,1566.0,1242.0,1291.0,1176.0,1293.0,1254.0,1341.0,1344.0,1835.0,16664.0
Barwani,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2611.0,3022.0,3142.0,3261.0,2627.0,2762.0,2463.0,2737.0,2607.0,2726.0,2848.0,3710.0,34516.0
Barwani,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1603.0,2005.0,2208.0,2586.0,2034.0,1954.0,2005.0,2548.0,2835.0,2834.0,2335.0,2845.0,27792.0
Barwani,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1553.0,1928.0,2186.0,2555.0,1984.0,1748.0,1935.0,2476.0,2696.0,2696.0,2335.0,2843.0,26935.0
Barwani,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,580.0,682.0,828.0,1063.0,671.0,738.0,675.0,1003.0,1129.0,1185.0,1034.0,1185.0,10773.0
Barwani,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,578.0,629.0,750.0,1013.0,626.0,653.0,642.0,893.0,1080.0,1143.0,928.0,1184.0,10119.0
Barwani,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1158.0,1311.0,1578.0,2076.0,1297.0,1391.0,1317.0,1896.0,2209.0,2328.0,1962.0,2369.0,20892.0
Barwani,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,804.0,1087.0,1261.0,1675.0,1504.0,1688.0,3750.0,1288.0,1556.0,1793.0,1546.0,1697.0,19649.0
Barwani,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1165.0,1545.0,1503.0,1779.0,1865.0,2075.0,4004.0,1622.0,1535.0,1602.0,1586.0,1754.0,22035.0
Barwani,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1082.0,1437.0,1555.0,1712.0,1762.0,1923.0,3780.0,1530.0,1508.0,1501.0,1528.0,1509.0,20827.0
Barwani,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1507.0,1689.0,1768.0,1789.0,2114.0,1750.0,1730.0,1757.0,1748.0,1790.0,1700.0,1793.0,21135.0
Barwani,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1397.0,1621.0,1713.0,1760.0,2033.0,1669.0,1635.0,1702.0,1722.0,1741.0,1730.0,1758.0,20481.0
Barwani,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1251.0,1454.0,1476.0,1586.0,1479.0,1550.0,1518.0,1579.0,1625.0,1571.0,1550.0,1665.0,18304.0
Barwani,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2621.0,3080.0,3142.0,3555.0,2663.0,2765.0,2502.0,2754.0,2609.0,3081.0,2935.0,3705.0,35412.0
Barwani,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,0.0,0.0,16546.0,2722.0,0.0,2.0,2.0,4.0,18853.0,1327.0,0.0,39456.0
Barwani,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,16004.0,3370.0,0.0,0.0,0.0,3.0,18766.0,1447.0,0.0,39590.0
Barwani,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,2.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Barwani,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,1.0,1.0,0.0,3.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Barwani,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,3.0,15.0,4.0,1.0,2.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,33.0
Barwani,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,845.0,904.0,758.0,1136.0,1377.0,1102.0,944.0,836.0,930.0,823.0,914.0,1262.0,11831.0
Barwani,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,147.0,64.0,52.0,63.0,84.0,85.0,96.0,77.0,60.0,62.0,62.0,41.0,893.0
Barwani,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,122.0,27.0,196.0,196.0,187.0,124.0,88.0,90.0,108.0,196.0,243.0,163.0,1740.0
Barwani,13.1,Number of Patients operated for cataract,TOTAL,259.0,427.0,492.0,376.0,399.0,355.0,299.0,315.0,483.0,413.0,344.0,720.0,4882.0
Barwani,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,259.0,427.0,492.0,376.0,399.0,355.0,299.0,315.0,483.0,413.0,344.0,720.0,4882.0
Barwani,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,35.0,303.0,294.0,167.0,175.0,134.0,129.0,0.0,140.0,1377.0
Barwani,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,17.0,137.0,242.0,215.0,303.0,110.0,0.0,123.0,1147.0
Barwani,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Barwani,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,7.0,7.0,8.0,9.0,8.0,6.0,8.0,5.0,7.0,6.0,4.0,-1.0
Barwani,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,1.0,2.0,2.0,5.0,6.0,9.0,6.0,7.0,8.0,7.0,9.0,7.0,-1.0
Barwani,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1037.0,1058.0,1050.0,1184.0,1058.0,1171.0,1088.0,1242.0,1212.0,1170.0,1277.0,1358.0,-1.0
Barwani,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,10.0,10.0,9.0,9.0,10.0,9.0,10.0,10.0,7.0,9.0,9.0,8.0,-1.0
Barwani,14.05,Number of RKS meetings held during the month,TOTAL,5.0,6.0,5.0,4.0,2.0,3.0,2.0,3.0,2.0,2.0,3.0,5.0,42.0
Barwani,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,10.0,11.0,12.0,13.0,17.0,18.0,18.0,15.0,17.0,17.0,17.0,13.0,-1.0
Barwani,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,80.0,209.0,159.0,93.0,49.0,112.0,300.0,211.0,123.0,139.0,195.0,83.0,1753.0
Barwani,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,5.0,5.0,4.0,4.0,6.0,5.0,3.0,3.0,4.0,3.0,3.0,-1.0
Barwani,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,1.0,2.0,2.0,1.0,0.0,1.0,1.0,1.0,1.0,2.0,-1.0
Barwani,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1180.0,924.0,1098.0,746.0,6010.0,764.0,539.0,1065.0,789.0,1003.0,1146.0,1924.0,17188.0
Barwani,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3622.0,3105.0,2933.0,3071.0,2309.0,2350.0,908.0,2568.0,2331.0,2723.0,2493.0,3666.0,32079.0
Barwani,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1061.0,781.0,1173.0,702.0,2025.0,841.0,610.0,897.0,1167.0,869.0,916.0,1349.0,12391.0
Barwani,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,6142.0,6439.0,6521.0,5973.0,7680.0,4737.0,2796.0,5330.0,5829.0,4759.0,5729.0,5164.0,67099.0
Barwani,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2241.0,1705.0,2271.0,1448.0,8035.0,1605.0,1149.0,1962.0,1956.0,1872.0,2062.0,3273.0,29579.0
Barwani,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,9764.0,9544.0,9454.0,9044.0,9989.0,7087.0,3704.0,7898.0,8160.0,7482.0,8222.0,8830.0,99178.0
Barwani,14.10.2.a,Number of death cases of Inpatient males,TOTAL,36.0,43.0,52.0,16.0,2.0,2.0,2.0,49.0,29.0,28.0,43.0,46.0,348.0
Barwani,14.10.2.b,Number of death cases of Inpatient females,TOTAL,23.0,26.0,39.0,23.0,1.0,0.0,1.0,29.0,26.0,21.0,28.0,29.0,246.0
Barwani,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,59.0,69.0,91.0,39.0,3.0,2.0,3.0,78.0,55.0,49.0,71.0,75.0,594.0
Barwani,14.11,In-Patient Head Count at midnight,TOTAL,1665.0,772.0,709.0,622.0,679.0,321.0,803.0,739.0,626.0,663.0,668.0,677.0,8944.0
Barwani,14.12.1,OPD attendance (All),TOTAL,66290.0,81119.0,88375.0,95718.0,104739.0,115937.0,111912.0,74278.0,85885.0,68515.0,87600.0,96673.0,1077041.0
Barwani,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,202.0,361.0,321.0,477.0,501.0,347.0,236.0,280.0,273.0,371.0,432.0,438.0,4239.0
Barwani,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,10.0,0.0,0.0,0.0,0.0,10.0,1.0,5.0,8.0,4.0,38.0
Barwani,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,480.0,462.0,542.0,198.0,303.0,327.0,278.0,871.0,961.0,1236.0,1541.0,1056.0,8255.0
Barwani,14.14.a,Number of patients given AYUSH treatment,TOTAL,777.0,1793.0,966.0,2215.0,2247.0,1491.0,2188.0,2234.0,2693.0,2824.0,2135.0,2262.0,23825.0
Barwani,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,231.0,0.0,0.0,231.0
Barwani,14.14.c,Number of Adolescents counselled,TOTAL,32.0,17.0,105.0,126.0,49.0,9.0,7.0,149.0,506.0,543.0,401.0,544.0,2488.0
Barwani,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,9198.0,10738.0,10801.0,11045.0,7625.0,8379.0,7639.0,8201.0,12032.0,10595.0,13144.0,14333.0,123730.0
Barwani,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,555.0,760.0,751.0,1113.0,365.0,484.0,516.0,589.0,822.0,824.0,850.0,801.0,8430.0
Barwani,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,227.0,175.0,269.0,225.0,196.0,281.0,304.0,268.0,257.0,268.0,262.0,263.0,2995.0
Barwani,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,6.0,11.0,6.0,9.0,0.0,5.0,9.0,9.0,12.0,3.0,9.0,8.0,87.0
Barwani,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,153.0,501.0,241.0,351.0,347.0,299.0,414.0,612.0,596.0,650.0,350.0,261.0,4775.0
Barwani,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3.0,4.0,0.0,3.0,0.0,7.0,8.0,6.0,6.0,2.0,7.0,4.0,50.0
Barwani,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1190.0,1567.0,973.0,1536.0,1075.0,1055.0,1241.0,1067.0,863.0,768.0,998.0,981.0,13314.0
Barwani,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,2.0,0.0,7.0,0.0,2.0,0.0,0.0,0.0,0.0,1.0,0.0,12.0
Barwani,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1570.0,2243.0,1483.0,2112.0,1618.0,1635.0,1959.0,1947.0,1716.0,1686.0,1610.0,1505.0,21084.0
Barwani,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,9.0,17.0,6.0,19.0,0.0,14.0,17.0,15.0,18.0,5.0,17.0,12.0,149.0
Barwani,15.2,Number of Widal tests conducted,Number tested,1543.0,1910.0,2240.0,2460.0,1025.0,1320.0,1838.0,1779.0,1593.0,1872.0,3020.0,2826.0,23426.0
Barwani,15.3.a,Number of VDRL tests conducted on males,Number tested,212.0,136.0,125.0,128.0,117.0,280.0,37.0,139.0,366.0,236.0,322.0,450.0,2548.0
Barwani,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,260.0,313.0,161.0,189.0,177.0,371.0,107.0,300.0,334.0,390.0,791.0,379.0,3772.0
Barwani,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,569.0,1113.0,575.0,817.0,291.0,629.0,353.0,274.0,739.0,963.0,628.0,773.0,7724.0
Barwani,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1041.0,1562.0,861.0,1134.0,585.0,1280.0,497.0,713.0,1439.0,1589.0,1741.0,1602.0,14044.0
Barwani,15.4.1,Number of blood smears examined for Malaria,TOTAL,10316.0,15122.0,12051.0,17173.0,14559.0,18901.0,18602.0,18616.0,27423.0,10414.0,11418.0,15333.0,189928.0
Barwani,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,18.0,38.0,40.0,44.0,63.0,82.0,138.0,134.0,89.0,90.0,26.0,29.0,791.0
Barwani,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,7.0,11.0,4.0,20.0,11.0,61.0,88.0,141.0,122.0,40.0,20.0,14.0,539.0
Barwani,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,4000.0,3000.0,8500.0,10000.0,9000.0,16500.0,23000.0,15000.0,9500.0,8500.0,5000.0,3500.0,115500.0
Barwani,16.1.1,Stock position of DPT vaccines,2. Stocks Received,20000.0,20000.0,15000.0,10000.0,20000.0,20000.0,10000.0,0.0,0.0,10000.0,0.0,10000.0,135000.0
Barwani,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,21000.0,14500.0,13500.0,11000.0,12500.0,13500.0,18000.0,5500.0,1000.0,13500.0,1500.0,5500.0,131000.0
Barwani,16.1.1,Stock position of DPT vaccines,5. Total Stock,3000.0,8500.0,10000.0,9000.0,16500.0,23000.0,15000.0,9500.0,8500.0,5000.0,3500.0,8000.0,119500.0
Barwani,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,0.0,,0.0,0.0,0.0,0.0,16000.0,13000.0,14000.0,2500.0,9000.0,54500.0
Barwani,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,0.0,,0.0,0.0,0.0,26500.0,0.0,10000.0,0.0,10000.0,0.0,46500.0
Barwani,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,0.0,,0.0,0.0,0.0,10500.0,3000.0,9000.0,11500.0,3500.0,8000.0,45500.0
Barwani,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,16000.0,13000.0,14000.0,2500.0,9000.0,1000.0,55500.0
Barwani,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,9500.0,5500.0,3000.0,500.0,0.0,500.0,500.0,6000.0,11000.0,319500.0,3000.0,16000.0,375000.0
Barwani,16.1.2,Stock position of OPV vaccines,2. Stocks Received,23000.0,20000.0,20000.0,15000.0,15500.0,24000.0,20000.0,25000.0,335500.0,15000.0,20000.0,0.0,533000.0
Barwani,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,27000.0,22500.0,22500.0,15500.0,15000.0,24000.0,14500.0,20000.0,27000.0,331500.0,7000.0,3500.0,530000.0
Barwani,16.1.2,Stock position of OPV vaccines,5. Total Stock,5500.0,3000.0,500.0,0.0,500.0,500.0,6000.0,11000.0,319500.0,3000.0,16000.0,12500.0,378000.0
Barwani,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,5500.0,9500.0,11000.0,12500.0,14000.0,14500.0,7500.0,5000.0,22000.0,9000.0,12500.0,6500.0,129500.0
Barwani,16.1.3,Stock position of TT vaccines,2. Stocks Received,20000.0,15000.0,15000.0,10000.0,15000.0,15000.0,5000.0,25000.0,0.0,10000.0,0.0,5000.0,135000.0
Barwani,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.1.3,Stock position of TT vaccines,4. Stock Distributed,16000.0,13500.0,13500.0,8500.0,14500.0,22000.0,7500.0,8000.0,13000.0,6500.0,6000.0,10000.0,139000.0
Barwani,16.1.3,Stock position of TT vaccines,5. Total Stock,9500.0,11000.0,12500.0,14000.0,14500.0,7500.0,5000.0,22000.0,9000.0,12500.0,6500.0,1500.0,125500.0
Barwani,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,0.0,0.0,1000.0,500.0,3000.0,8500.0,4000.0,500.0,5500.0,0.0,0.0,6000.0,29000.0
Barwani,16.1.5,Stock position of BCG vaccines,2. Stocks Received,13000.0,10000.0,10000.0,10000.0,20000.0,5000.0,10000.0,15000.0,7500.0,10000.0,15000.0,3000.0,128500.0
Barwani,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,13000.0,9000.0,10500.0,7500.0,14500.0,9500.0,13500.0,10000.0,13000.0,10000.0,9000.0,8250.0,127750.0
Barwani,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,1000.0,500.0,3000.0,8500.0,4000.0,500.0,5500.0,0.0,0.0,6000.0,750.0,29750.0
Barwani,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1000.0,0.0,4750.0,14250.0,11000.0,5750.0,1750.0,2250.0,1750.0,1000.0,0.0,4500.0,48000.0
Barwani,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,10000.0,160000.0,0.0,0.0,2000.0,7500.0,5000.0,10000.0,5000.0,10000.0,5000.0,224500.0
Barwani,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,11000.0,5250.0,150500.0,3250.0,5250.0,6000.0,7000.0,5500.0,10750.0,6000.0,5500.0,7250.0,223250.0
Barwani,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,4750.0,14250.0,11000.0,5750.0,1750.0,2250.0,1750.0,1000.0,0.0,4500.0,2250.0,49250.0
Barwani,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Barwani,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Barwani,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Barwani,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,6000.0,7000.0,5000.0,2500.0,9000.0,17500.0,18000.0,10000.0,3000.0,0.0,5000.0,4000.0,87000.0
Barwani,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,20000.0,10000.0,12500.0,16000.0,20000.0,15000.0,10000.0,0.0,5000.0,5000.0,0.0,0.0,113500.0
Barwani,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,19000.0,12000.0,15000.0,9500.0,11500.0,14500.0,18500.0,7000.0,8000.0,0.0,1000.0,2500.0,118500.0
Barwani,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,7000.0,5000.0,2500.0,9000.0,17500.0,18000.0,9500.0,3000.0,0.0,5000.0,4000.0,1500.0,82000.0
Barwani,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,3250.0,850.0,850.0,3000.0,850.0,850.0,3850.0,850.0,1450.0,1450.0,1450.0,1450.0,20150.0
Barwani,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,3000.0,0.0,0.0,3000.0,0.0,3000.0,0.0,0.0,0.0,12000.0,21000.0
Barwani,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,2400.0,0.0,850.0,2150.0,0.0,0.0,3000.0,2400.0,0.0,0.0,0.0,5250.0,16050.0
Barwani,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,850.0,850.0,3000.0,850.0,850.0,3850.0,850.0,1450.0,1450.0,1450.0,1450.0,8200.0,25100.0
Barwani,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,69720.0,17560.0,37560.0,47640.0,22080.0,22080.0,82080.0,37200.0,60000.0,52320.0,25200.0,15120.0,488560.0
Barwani,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,126000.0,130320.0,0.0,60000.0,0.0,60000.0,0.0,0.0,0.0,30000.0,406320.0
Barwani,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,32160.0,0.0,115920.0,155880.0,0.0,,44880.0,37200.0,7680.0,27120.0,10080.0,45120.0,476040.0
Barwani,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,37560.0,17560.0,47640.0,22080.0,22080.0,82080.0,37200.0,60000.0,52320.0,25200.0,15120.0,0.0,418840.0
Barwani,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1800.0,1800.0,1800.0,1800.0,1200.0,1200.0,5000.0,600.0,8000.0,8000.0,8000.0,8000.0,47200.0
Barwani,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,24000.0,0.0,3800.0,0.0,15000.0,0.0,0.0,0.0,20000.0,62800.0
Barwani,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,24600.0,0.0,0.0,4400.0,7600.0,0.0,0.0,0.0,19000.0,55600.0
Barwani,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1800.0,1800.0,1800.0,1200.0,1200.0,5000.0,600.0,8000.0,8000.0,8000.0,8000.0,9000.0,54400.0
Barwani,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,780.0,780.0,780.0,780.0,1680.0,1680.0,4680.0,1680.0,1600.0,1600.0,1600.0,1600.0,19240.0
Barwani,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,900.0,0.0,3000.0,0.0,3000.0,0.0,0.0,0.0,0.0,6900.0
Barwani,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,3000.0,3080.0,0.0,0.0,,0.0,6080.0
Barwani,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,780.0,780.0,780.0,1680.0,1680.0,4680.0,1680.0,1600.0,1600.0,1600.0,1600.0,1600.0,20060.0
Barwani,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1000.0,1000.0,1000.0,1000.0,5000.0,4000.0,4000.0,4000.0,1000.0,6000.0,2000.0,2000.0,32000.0
Barwani,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,5000.0,0.0,0.0,5000.0,15000.0
Barwani,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,1000.0,1000.0,0.0,0.0,3000.0,0.0,4000.0,0.0,2000.0,11000.0
Barwani,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,1000.0,1000.0,1000.0,5000.0,4000.0,4000.0,4000.0,1000.0,6000.0,2000.0,2000.0,5000.0,36000.0
Barwani,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Barwani,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Barwani,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Barwani,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Barwani,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Barwani,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Barwani,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Barwani,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Barwani,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Barwani,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Barwani,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Barwani,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Barwani,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Barwani,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Barwani,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Barwani,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Barwani,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Barwani,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Barwani,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Barwani,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Barwani,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Barwani,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Barwani,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Barwani,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Barwani,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,2205800.0,2220000.0,2220000.0,2220000.0,2220000.0,2220000.0,1500000.0,1500000.0,1500000.0,5400000.0,2160000.0,1660000.0,27025800.0
Barwani,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,5354260.0,0.0,,0.0,0.0,0.0,0.0,0.0,6000000.0,0.0,0.0,0.0,11354260.0
Barwani,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,5340060.0,0.0,,0.0,0.0,700000.0,0.0,0.0,2100000.0,3240000.0,500000.0,0.0,11880060.0
Barwani,16.3.07,Stock Position of IFA Tablets,5. Total Stock,2220000.0,2220000.0,2220000.0,2220000.0,2220000.0,1520000.0,1500000.0,1500000.0,5400000.0,2160000.0,1660000.0,1660000.0,26500000.0
Barwani,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,,,0.0,856.0,41176.0,41176.0,41176.0,4176.0,4176.0,4176.0,4176.0,141088.0
Barwani,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,,,49856.0,51120.0,0.0,0.0,0.0,0.0,0.0,0.0,97424.0,198400.0
Barwani,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,,,49000.0,10800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,59800.0
Barwani,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,856.0,41176.0,41176.0,41176.0,41176.0,4176.0,4176.0,4176.0,101600.0,279688.0
Barwani,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,0.0,0.0,0.0,0.0,,,0.0,,,0.0
Barwani,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,0.0,0.0,0.0,0.0,,,0.0,,,0.0
Barwani,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,0.0,0.0,0.0,0.0,,,0.0,,,0.0
Barwani,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,0.0,0.0,0.0,0.0,,,0.0,,,0.0
Barwani,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,300.0,200.0,200.0,15.0,15.0,15.0,15.0,15.0,15.0,25.0,25.0,25.0,865.0
Barwani,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,2815.0,0.0,0.0,0.0,0.0,0.0,3310.0,0.0,0.0,0.0,6125.0
Barwani,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,100.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,3300.0,0.0,0.0,0.0,6400.0
Barwani,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,200.0,200.0,15.0,15.0,15.0,15.0,15.0,15.0,25.0,25.0,25.0,25.0,590.0
Barwani,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,0.0,0.0,0.0,3200.0,0.0,0.0,0.0,,3200.0
Barwani,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Barwani,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Barwani,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,,2000.0
Barwani,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1200.0,0.0,0.0,0.0,0.0,1200.0
Barwani,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,100.0,1900.0,3000.0,4600.0,6400.0,6100.0,3300.0,4900.0,200.0,4200.0,34700.0
Barwani,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,3300.0,3300.0,6600.0,6600.0,6600.0,6600.0,3300.0,3300.0,3300.0,0.0,4000.0,0.0,46900.0
Barwani,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Barwani,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3300.0,3200.0,4800.0,5500.0,5000.0,4800.0,3600.0,6100.0,1700.0,4700.0,0.0,3600.0,46300.0
Barwani,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,100.0,1900.0,3000.0,4600.0,6400.0,6100.0,3300.0,4900.0,200.0,4200.0,600.0,35300.0
Barwani,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,46000.0,3000.0,17200.0,31200.0,48600.0,60600.0,56400.0,34400.0,34000.0,48800.0,74800.0,96800.0,551800.0
Barwani,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,106000.0,24000.0,274000.0,24000.0,48000.0,100000.0,0.0,40000.0,70000.0,70000.0,70000.0,0.0,826000.0
Barwani,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Barwani,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,149000.0,9800.0,260000.0,6600.0,36000.0,104200.0,22000.0,40400.0,55200.0,44000.0,48000.0,4400.0,779600.0
Barwani,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,3000.0,17200.0,31200.0,48600.0,60600.0,56400.0,34400.0,34000.0,48800.0,74800.0,96800.0,92400.0,598200.0
Barwani,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,1500.0,1500.0,12500.0,8500.0,400.0,400.0,6400.0,2000.0,4000.0,10000.0,10000.0,57200.0
Barwani,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4000.0,2000.0,36000.0,0.0,4000.0,0.0,6000.0,2000.0,2000.0,6000.0,6000.0,0.0,68000.0
Barwani,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barwani,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2500.0,2000.0,25000.0,4000.0,8500.0,0.0,0.0,6400.0,0.0,0.0,6000.0,2000.0,56400.0
Barwani,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1500.0,1500.0,12500.0,8500.0,4000.0,400.0,6400.0,2000.0,4000.0,10000.0,10000.0,8000.0,68800.0
Barwani,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,2.0,,1.0,,,,5.0,1.0,2.0,1.0,12.0
Barwani,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,2.0,,,1.0,1.0,4.0
Barwani,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Barwani,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,2.0,,,1.0,1.0,4.0
Barwani,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,3.0,1.0,,,2.0,1.0,,1.0,,1.0,1.0,10.0
Barwani,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Barwani,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,3.0,1.0,,,2.0,1.0,,1.0,,1.0,1.0,10.0
Barwani,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,3.0,2.0,5.0,2.0,12.0,14.0,5.0,9.0,10.0,13.0,6.0,83.0
Barwani,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,1.0,,,,3.0,,,,4.0
Barwani,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,3.0,2.0,5.0,3.0,12.0,14.0,5.0,12.0,10.0,13.0,6.0,87.0
Barwani,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,1.0,2.0,4.0,5.0,6.0,11.0,10.0,25.0,14.0,16.0,9.0,104.0
Barwani,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,1.0,1.0,,,3.0
Barwani,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,1.0,2.0,4.0,5.0,6.0,11.0,11.0,26.0,15.0,16.0,9.0,107.0
Barwani,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,5.0,1.0,3.0,3.0,2.0,5.0,4.0,11.0,3.0,3.0,7.0,4.0,51.0
Barwani,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,3.0,1.0,2.0,,1.0,1.0,,,4.0,4.0,,,16.0
Barwani,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,8.0,2.0,5.0,3.0,3.0,6.0,4.0,11.0,7.0,7.0,7.0,4.0,67.0
Barwani,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,1.0,,,,1.0,,,,1.0,,,3.0
Barwani,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Barwani,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,1.0,,,,1.0,,,,1.0,,,3.0
Barwani,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,,1.0,,,3.0,3.0,2.0,,2.0,1.0,13.0
Barwani,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,1.0,1.0,2.0,1.0,1.0,,,1.0,2.0,5.0,15.0
Barwani,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,2.0,1.0,2.0,2.0,1.0,4.0,3.0,2.0,1.0,4.0,6.0,28.0
Barwani,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Barwani,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Barwani,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Barwani,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,3.0,4.0,10.0,7.0,7.0,6.0,12.0,16.0,11.0,6.0,5.0,88.0
Barwani,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,2.0,3.0,7.0,5.0,6.0,6.0,9.0,6.0,1.0,4.0,3.0,54.0
Barwani,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,5.0,7.0,17.0,12.0,13.0,12.0,21.0,22.0,12.0,10.0,8.0,142.0
Barwani,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Barwani,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Barwani,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Barwani,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,,,,,,,,,,1.0
Barwani,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Barwani,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,,1.0,1.0,2.0,1.0,3.0,1.0,1.0,,,11.0
Barwani,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,3.0,,3.0,,,,2.0,,,9.0
Barwani,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,1.0,4.0,1.0,5.0,1.0,3.0,1.0,3.0,,,20.0
Barwani,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Barwani,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,,,2.0,1.0,,,,3.0,1.0,,8.0
Barwani,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,4.0,6.0,3.0,4.0,3.0,14.0,8.0,2.0,6.0,6.0,4.0,7.0,67.0
Barwani,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,5.0,6.0,3.0,4.0,5.0,15.0,8.0,2.0,6.0,9.0,5.0,7.0,75.0
Barwani,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Barwani,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Barwani,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Barwani,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Barwani,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,2.0,,1.0,,4.0,1.0,,1.0,,,1.0,10.0
Barwani,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,,1.0,3.0,2.0,1.0,3.0,6.0,3.0,4.0,2.0,4.0,30.0
Barwani,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,2.0,,,,,1.0,8.0,,,,1.0,,12.0
Barwani,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,3.0,2.0,1.0,4.0,2.0,6.0,12.0,6.0,4.0,4.0,3.0,5.0,52.0
Barwani,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Barwani,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Barwani,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Barwani,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Barwani,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Barwani,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,2.0,1.0,,4.0,2.0,8.0,8.0,3.0,4.0,1.0,4.0,1.0,38.0
Barwani,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,5.0,2.0,,4.0,2.0,5.0,5.0,8.0,10.0,6.0,4.0,5.0,56.0
Barwani,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,7.0,3.0,,8.0,4.0,13.0,13.0,11.0,15.0,7.0,8.0,6.0,95.0
Barwani,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Barwani,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,1.0,,,1.0,5.0,1.0,,1.0,,,,10.0
Barwani,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,1.0,1.0,3.0,2.0,1.0,,,,2.0,10.0
Barwani,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,1.0,,1.0,2.0,8.0,3.0,1.0,1.0,,,2.0,20.0
Barwani,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Barwani,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,1.0,1.0,,,2.0
Barwani,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Barwani,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,1.0,1.0,,,2.0
Barwani,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Barwani,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,1.0,,,,,,,1.0,1.0,,1.0,4.0
Barwani,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Barwani,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,1.0,,,,,,,1.0,1.0,,1.0,4.0
Barwani,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Barwani,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,3.0,,2.0,1.0,,2.0,,2.0,2.0,3.0,,16.0
Barwani,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Barwani,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,3.0,,2.0,1.0,,2.0,,2.0,2.0,3.0,,16.0
Barwani,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Barwani,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,1.0,1.0,,,,2.0,,2.0,,7.0
Barwani,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Barwani,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,1.0,1.0,,,,2.0,,2.0,,7.0
Barwani,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Barwani,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,1.0,1.0,,,,,,,2.0
Barwani,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Barwani,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,1.0,1.0,,,,,,,2.0
Barwani,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Barwani,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,3.0,1.0,2.0,2.0,1.0,4.0,6.0,1.0,1.0,1.0,3.0,26.0
Barwani,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Barwani,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,3.0,1.0,2.0,2.0,1.0,4.0,6.0,1.0,1.0,1.0,3.0,26.0
Barwani,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,1.0,,,3.0,2.0,2.0,2.0,1.0,2.0,1.0,1.0,16.0
Barwani,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,4.0,5.0,6.0,,10.0,9.0,5.0,5.0,11.0,6.0,1.0,3.0,65.0
Barwani,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,1.0,1.0,,,,1.0,,2.0,,,1.0,7.0
Barwani,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,6.0,7.0,7.0,,13.0,11.0,8.0,7.0,14.0,8.0,2.0,5.0,88.0
Barwani,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,1.0,1.0,,,,2.0,,,,2.0,6.0
Barwani,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,6.0,8.0,3.0,2.0,10.0,8.0,10.0,3.0,7.0,5.0,6.0,72.0
Barwani,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,1.0,2.0,,,3.0,,1.0,,,,,8.0
Barwani,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,5.0,7.0,11.0,4.0,2.0,13.0,8.0,13.0,3.0,7.0,5.0,8.0,86.0
Barwani,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,1.0,,,2.0,1.0,,1.0,,,,1.0,7.0
Barwani,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,3.0,2.0,1.0,,1.0,,3.0,1.0,1.0,,,12.0
Barwani,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,1.0,,,,1.0,,,,,2.0
Barwani,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,4.0,2.0,2.0,2.0,2.0,,5.0,1.0,1.0,,1.0,21.0
Barwani,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,1.0,,1.0,2.0,,,1.0,,1.0,7.0
Barwani,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,3.0,9.0,3.0,2.0,7.0,4.0,8.0,4.0,4.0,3.0,6.0,54.0
Barwani,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,,15.0,2.0,5.0,7.0,6.0,9.0,6.0,4.0,3.0,4.0,63.0
Barwani,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,3.0,25.0,6.0,7.0,15.0,12.0,17.0,10.0,9.0,6.0,11.0,124.0
Barwani,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,1.0,,,,,2.0,1.0,1.0,,,6.0
Barwani,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,4.0,10.0,5.0,4.0,10.0,6.0,6.0,7.0,7.0,6.0,5.0,12.0,82.0
Barwani,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,3.0,6.0,13.0,9.0,9.0,8.0,11.0,8.0,9.0,5.0,4.0,10.0,95.0
Barwani,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,7.0,17.0,19.0,13.0,19.0,14.0,17.0,17.0,17.0,12.0,9.0,22.0,183.0
Barwani,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,2.0,2.0,3.0,1.0,,,,,,1.0,10.0
Barwani,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,6.0,5.0,14.0,9.0,8.0,11.0,7.0,8.0,6.0,8.0,7.0,7.0,96.0
Barwani,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,21.0,37.0,23.0,27.0,36.0,42.0,35.0,25.0,22.0,52.0,26.0,29.0,375.0
Barwani,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,28.0,42.0,39.0,38.0,47.0,54.0,42.0,33.0,28.0,60.0,33.0,37.0,481.0
Betul,1.1,Total number of pregnant women Registered for ANC,TOTAL,2014.0,2279.0,2788.0,3140.0,2743.0,2905.0,2438.0,2453.0,2828.0,2881.0,2728.0,2848.0,32045.0
Betul,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1371.0,1669.0,1840.0,1922.0,1907.0,1896.0,1603.0,1591.0,1905.0,1922.0,1881.0,1989.0,21496.0
Betul,1.2,Number of Pregnant women registered under JSY,TOTAL,1986.0,2243.0,2753.0,3110.0,2709.0,2870.0,2390.0,2415.0,2797.0,2842.0,2406.0,2616.0,31137.0
Betul,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1970.0,2149.0,2273.0,2338.0,2156.0,2472.0,2264.0,2170.0,2309.0,2492.0,2450.0,2710.0,27753.0
Betul,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1250.0,1418.0,1643.0,1890.0,1718.0,1888.0,1633.0,1649.0,1741.0,1713.0,1738.0,1857.0,20138.0
Betul,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1989.0,1977.0,2387.0,2584.0,2282.0,2350.0,2286.0,2184.0,2389.0,2450.0,2409.0,2640.0,27927.0
Betul,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1895.0,2284.0,2768.0,3080.0,2650.0,2824.0,2372.0,2336.0,2692.0,2790.0,2696.0,2849.0,31236.0
Betul,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,84.0,119.0,85.0,130.0,118.0,56.0,74.0,85.0,189.0,185.0,160.0,281.0,1566.0
Betul,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,2.0,3.0,15.0,8.0,5.0,2.0,4.0,1.0,3.0,1.0,15.0,59.0
Betul,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1109.0,1442.0,1668.0,2202.0,1827.0,1922.0,1793.0,1680.0,2235.0,2049.0,2038.0,2119.0,22084.0
Betul,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,8.0,18.0,54.0,36.0,61.0,20.0,37.0,55.0,43.0,16.0,9.0,30.0,387.0
Betul,1.8,Number of pregnancy test kits used at SC level,TOTAL,1217.0,1249.0,1616.0,2200.0,1672.0,1700.0,1451.0,1472.0,1752.0,1522.0,1324.0,1515.0,18690.0
Betul,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,41.0,157.0,141.0,100.0,163.0,180.0,127.0,152.0,101.0,103.0,77.0,116.0,1458.0
Betul,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,253.0,285.0,313.0,380.0,372.0,387.0,291.0,311.0,340.0,357.0,321.0,411.0,4021.0
Betul,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,294.0,442.0,454.0,480.0,535.0,567.0,418.0,463.0,441.0,460.0,398.0,527.0,5479.0
Betul,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,258.0,347.0,294.0,336.0,356.0,410.0,269.0,356.0,380.0,338.0,322.0,470.0,4136.0
Betul,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,1.0,0.0,11.0,1.0,4.0,2.0,5.0,1.0,0.0,10.0,1.0,36.0
Betul,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1340.0,1473.0,1574.0,1640.0,1614.0,1612.0,1468.0,1453.0,1391.0,1412.0,1399.0,1878.0,18254.0
Betul,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,42.0,32.0,56.0,47.0,64.0,137.0,70.0,53.0,42.0,27.0,37.0,392.0,999.0
Betul,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1291.0,1443.0,1555.0,1542.0,1300.0,1318.0,1311.0,1251.0,1536.0,1334.0,1043.0,1424.0,16348.0
Betul,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,861.0,1001.0,1048.0,1018.0,1056.0,1028.0,944.0,987.0,960.0,959.0,956.0,1253.0,12071.0
Betul,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,4.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,6.0
Betul,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,158.0,175.0,208.0,134.0,172.0,186.0,153.0,173.0,193.0,202.0,160.0,198.0,2112.0
Betul,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Betul,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Betul,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Betul,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,45.0,9.0,38.0,34.0,27.0,33.0,20.0,19.0,26.0,33.0,17.0,16.0,317.0
Betul,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Betul,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,45.0,9.0,38.0,34.0,27.0,33.0,20.0,19.0,26.0,33.0,17.0,16.0,317.0
Betul,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,100.0,91.0,131.0,79.0,108.0,105.0,87.0,95.0,78.0,104.0,91.0,108.0,1177.0
Betul,4.1.1.a,Number of male live births,TOTAL,920.0,1110.0,1151.0,1190.0,1177.0,1227.0,1043.0,1057.0,1005.0,1048.0,1049.0,1293.0,13270.0
Betul,4.1.1.b,Number of female live births,TOTAL,851.0,952.0,1066.0,1035.0,1121.0,1102.0,970.0,1020.0,979.0,991.0,891.0,1278.0,12256.0
Betul,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1771.0,2062.0,2217.0,2225.0,2298.0,2329.0,2013.0,2077.0,1984.0,2039.0,1940.0,2571.0,25526.0
Betul,4.1.2,Number of still births,TOTAL,29.0,35.0,30.0,35.0,32.0,50.0,31.0,28.0,34.0,46.0,25.0,23.0,398.0
Betul,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,53.0,66.0,47.0,59.0,99.0,112.0,126.0,145.0,91.0,91.0,124.0,90.0,1103.0
Betul,4.2.1,Number of Newborns weighed at birth,TOTAL,1758.0,2035.0,2138.0,2189.0,2236.0,2176.0,1994.0,2067.0,1940.0,2018.0,1933.0,2533.0,25017.0
Betul,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,179.0,247.0,241.0,456.0,300.0,343.0,266.0,265.0,348.0,217.0,207.0,617.0,3686.0
Betul,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1718.0,2005.0,2105.0,2178.0,2212.0,2233.0,1966.0,2044.0,1781.0,1989.0,1912.0,2528.0,24671.0
Betul,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,4.0,12.0,39.0,42.0,44.0,72.0,56.0,53.0,65.0,54.0,66.0,38.0,545.0
Betul,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,120.0,139.0,124.0,103.0,96.0,78.0,132.0,127.0,218.0,173.0,135.0,149.0,1594.0
Betul,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,116.0,114.0,154.0,125.0,132.0,138.0,98.0,98.0,138.0,122.0,102.0,96.0,1433.0
Betul,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Betul,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,240.0,265.0,317.0,270.0,272.0,288.0,286.0,278.0,421.0,349.0,303.0,283.0,3572.0
Betul,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,2.0,9.0,13.0,6.0,,,,,,,,,30.0
Betul,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,166.0,150.0,188.0,176.0,174.0,163.0,171.0,221.0,278.0,262.0,196.0,220.0,2365.0
Betul,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,25.0,38.0,53.0,44.0,67.0,66.0,70.0,65.0,57.0,69.0,51.0,63.0,668.0
Betul,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,171.0,136.0,243.0,162.0,168.0,192.0,158.0,150.0,269.0,223.0,199.0,136.0,2207.0
Betul,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,36.0,42.0,42.0,41.0,13.0,12.0,44.0,43.0,52.0,25.0,61.0,51.0,462.0
Betul,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1478.0,1689.0,1912.0,1901.0,1943.0,1959.0,1774.0,1777.0,1671.0,1744.0,1653.0,2030.0,21531.0
Betul,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,891.0,1304.0,1126.0,1133.0,1285.0,1210.0,1167.0,1685.0,1701.0,1734.0,1642.0,2047.0,16925.0
Betul,6.3,PNC maternal complications attended,TOTAL,19.0,9.0,2.0,11.0,12.0,19.0,7.0,4.0,6.0,5.0,16.0,14.0,124.0
Betul,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,15.0,26.0,11.0,69.0,54.0,52.0,43.0,75.0,57.0,33.0,16.0,28.0,479.0
Betul,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,3.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,5.0
Betul,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,15.0,26.0,11.0,69.0,57.0,52.0,44.0,76.0,57.0,33.0,16.0,28.0,484.0
Betul,7.2,Number of MTPs conducted at Private Facilities,TOTAL,36.0,17.0,32.0,47.0,43.0,38.0,32.0,28.0,19.0,42.0,37.0,47.0,418.0
Betul,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,53.0,22.0,50.0,63.0,70.0,71.0,52.0,54.0,56.0,64.0,49.0,26.0,630.0
Betul,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,116.0,115.0,129.0,153.0,160.0,137.0,255.0,171.0,181.0,241.0,205.0,240.0,2103.0
Betul,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,169.0,137.0,179.0,216.0,230.0,208.0,307.0,225.0,237.0,305.0,254.0,266.0,2733.0
Betul,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Betul,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,2.0,0.0,2.0,3.0,4.0,3.0,10.0,13.0,5.0,5.0,5.0,4.0,56.0
Betul,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,3.0,2.0,0.0,2.0,0.0,0.0,2.0,2.0,0.0,0.0,1.0,1.0,13.0
Betul,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Betul,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,5.0,2.0,2.0,5.0,4.0,3.0,12.0,16.0,5.0,5.0,6.0,5.0,70.0
Betul,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Betul,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,14.0,14.0,0.0,0.0,0.0,39.0,140.0,41.0,64.0,16.0,328.0
Betul,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,96.0,76.0,138.0,353.0,270.0,475.0,311.0,1576.0,1886.0,941.0,956.0,551.0,7629.0
Betul,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,10.0,11.0,11.0,8.0,13.0,17.0,5.0,26.0,33.0,36.0,16.0,31.0,217.0
Betul,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Betul,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,106.0,87.0,163.0,375.0,283.0,492.0,316.0,1641.0,2059.0,1018.0,1036.0,598.0,8174.0
Betul,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Betul,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Betul,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,2.0,1.0,,,,,,9.0,0.0,0.0,0.0,0.0,12.0
Betul,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Betul,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,2.0,1.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,13.0
Betul,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,4.0,6.0,,,,,,,,10.0
Betul,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,1.0,1.0,3.0,1.0,0.0,3.0,14.0,8.0,6.0,1.0,6.0,44.0
Betul,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,9.0,2.0,2.0,7.0,3.0,9.0,5.0,3.0,3.0,2.0,0.0,1.0,46.0
Betul,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Betul,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,9.0,3.0,3.0,10.0,4.0,9.0,8.0,17.0,11.0,8.0,1.0,7.0,90.0
Betul,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,9.0,11.0,14.0,7.0,10.0,9.0,4.0,,14.0,17.0,12.0,12.0,119.0
Betul,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,134.0,181.0,268.0,287.0,218.0,200.0,226.0,182.0,207.0,182.0,149.0,204.0,2438.0
Betul,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,20.0,9.0,7.0,16.0,11.0,11.0,6.0,6.0,9.0,7.0,4.0,4.0,110.0
Betul,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,112.0,80.0,163.0,59.0,93.0,137.0,190.0,118.0,196.0,142.0,136.0,133.0,1559.0
Betul,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,24.0,25.0,22.0,55.0,22.0,19.0,40.0,42.0,31.0,39.0,52.0,58.0,429.0
Betul,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Betul,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,290.0,295.0,460.0,417.0,344.0,367.0,462.0,348.0,443.0,370.0,341.0,399.0,4536.0
Betul,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,122.0,82.0,97.0,132.0,80.0,119.0,141.0,92.0,69.0,145.0,188.0,144.0,1411.0
Betul,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,4.0,7.0,,14.0,15.0,22.0,62.0
Betul,9.06,Number of IUCD removals,TOTAL,429.0,222.0,193.0,179.0,224.0,190.0,243.0,265.0,214.0,211.0,203.0,219.0,2792.0
Betul,9.07,Number of Oral Pills cycles distributed,TOTAL,7701.0,6373.0,7127.0,6538.0,6380.0,8153.0,7419.0,7143.0,8582.0,8615.0,8889.0,8912.0,91832.0
Betul,9.08,Number of Condom pieces distributed,TOTAL,60395.0,57233.0,45861.0,42040.0,46684.0,59537.0,65083.0,74987.0,66332.0,70995.0,70814.0,76011.0,735972.0
Betul,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,0.0,12.0,26.0
Betul,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,9.12,Number of Institutions having NSV trained doctors,TOTAL,9.0,8.0,7.0,6.0,7.0,8.0,4.0,7.0,7.0,4.0,7.0,6.0,-1.0
Betul,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1747.0,2139.0,2228.0,2108.0,2253.0,2193.0,2083.0,2043.0,1931.0,3097.0,2044.0,2675.0,26541.0
Betul,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1636.0,2168.0,2250.0,2257.0,2094.0,2290.0,2357.0,902.0,522.0,450.0,73.0,41.0,17040.0
Betul,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1709.0,1932.0,2130.0,2456.0,2065.0,2235.0,2251.0,2255.0,1230.0,588.0,98.0,50.0,18999.0
Betul,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1734.0,1990.0,1959.0,2347.0,2136.0,2231.0,2251.0,2262.0,2318.0,1070.0,268.0,87.0,20653.0
Betul,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1385.0,1742.0,1970.0,1893.0,2352.0,9342.0
Betul,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1342.0,1697.0,2011.0,2309.0,7359.0
Betul,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1264.0,1838.0,2471.0,5573.0
Betul,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1077.0,1396.0,1474.0,1406.0,1413.0,1336.0,1327.0,1415.0,1296.0,1303.0,1383.0,1831.0,16657.0
Betul,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1636.0,2168.0,2250.0,2257.0,2092.0,2290.0,2357.0,1504.0,1659.0,2033.0,1809.0,1965.0,24020.0
Betul,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1709.0,1932.0,2130.0,2456.0,2069.0,2235.0,2253.0,2257.0,2029.0,1986.0,1944.0,2029.0,25029.0
Betul,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1734.0,1990.0,1959.0,2343.0,2131.0,2231.0,2199.0,2255.0,2306.0,2022.0,1921.0,2145.0,25236.0
Betul,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1055.0,1405.0,1386.0,1331.0,1329.0,1277.0,1230.0,1127.0,1006.0,625.0,788.0,885.0,13444.0
Betul,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1636.0,2168.0,2250.0,2257.0,2093.0,2290.0,2357.0,853.0,502.0,399.0,46.0,58.0,16909.0
Betul,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1709.0,1930.0,2127.0,2456.0,2069.0,2235.0,2251.0,2201.0,1211.0,479.0,41.0,56.0,18765.0
Betul,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1734.0,1990.0,1961.0,2343.0,2131.0,2231.0,2199.0,2207.0,2301.0,958.0,268.0,93.0,20416.0
Betul,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1505.0,2095.0,2574.0,2453.0,2019.0,2204.0,1978.0,1926.0,1977.0,2373.0,2282.0,2730.0,26116.0
Betul,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,767.0,1260.0,1332.0,1329.0,1462.0,1700.0,1344.0,1610.0,1807.0,2021.0,1777.0,2079.0,18488.0
Betul,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,765.0,1114.0,1312.0,1275.0,991.0,1121.0,1031.0,1014.0,1016.0,1228.0,1217.0,1818.0,13902.0
Betul,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,737.0,981.0,1262.0,1180.0,1037.0,1078.0,948.0,918.0,962.0,1145.0,1062.0,1904.0,13214.0
Betul,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1502.0,2095.0,2574.0,2455.0,2028.0,2199.0,1979.0,1932.0,1978.0,2373.0,2279.0,3722.0,27116.0
Betul,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1534.0,1861.0,2114.0,1950.0,1981.0,1986.0,1844.0,1997.0,2200.0,2368.0,2200.0,2504.0,24539.0
Betul,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1542.0,1860.0,2111.0,1950.0,1982.0,1986.0,1844.0,1987.0,2200.0,2367.0,2200.0,2504.0,24533.0
Betul,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,42.0,46.0,125.0,0.0,72.0,82.0,37.0,2.0,0.0,22.0,0.0,0.0,428.0
Betul,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,37.0,44.0,104.0,0.0,39.0,74.0,33.0,4.0,0.0,22.0,0.0,0.0,357.0
Betul,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,79.0,90.0,229.0,0.0,111.0,156.0,70.0,6.0,0.0,44.0,0.0,0.0,785.0
Betul,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,811.0,1185.0,1395.0,1606.0,1567.0,1539.0,1332.0,1336.0,1446.0,1648.0,1415.0,1513.0,16793.0
Betul,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1340.0,1674.0,1937.0,2067.0,2366.0,2441.0,2172.0,2222.0,2192.0,2210.0,2195.0,2154.0,24970.0
Betul,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1304.0,1713.0,2011.0,2150.0,2336.0,2316.0,2056.0,2058.0,2142.0,2304.0,2140.0,2156.0,24686.0
Betul,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,1.0,0.0,3.0,6.0,2.0,0.0,0.0,0.0,0.0,12.0
Betul,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,11.0,8.0,2.0,23.0,18.0,9.0,1.0,2.0,2.0,6.0,82.0
Betul,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1503.0,1612.0,1632.0,1609.0,1601.0,1647.0,1628.0,1631.0,1507.0,1574.0,1593.0,1585.0,19122.0
Betul,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1444.0,1579.0,1629.0,1600.0,1584.0,1634.0,1613.0,1622.0,1515.0,1563.0,1586.0,1588.0,18957.0
Betul,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1229.0,1299.0,1341.0,1320.0,1188.0,1369.0,1389.0,1376.0,1375.0,1391.0,1429.0,1421.0,16127.0
Betul,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1503.0,2086.0,2574.0,2421.0,2007.0,2191.0,1915.0,1899.0,1982.0,2373.0,2279.0,2562.0,25792.0
Betul,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,218.0,331.0,350.0,7134.0,2370.0,431.0,322.0,257.0,184.0,8991.0,1693.0,207.0,22488.0
Betul,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,120.0,188.0,107.0,5147.0,1237.0,215.0,203.0,117.0,43.0,7229.0,1283.0,110.0,15999.0
Betul,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,2.0,0.0,7.0
Betul,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,906.0,1065.0,1204.0,1433.0,1518.0,1507.0,1645.0,1547.0,1530.0,1435.0,1677.0,1924.0,17391.0
Betul,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,1.0,53.0,14.0,28.0,25.0,23.0,33.0,35.0,48.0,43.0,5.0,6.0,314.0
Betul,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,113.0,97.0,186.0,120.0,129.0,136.0,174.0,196.0,160.0,234.0,192.0,323.0,2060.0
Betul,13.1,Number of Patients operated for cataract,TOTAL,94.0,39.0,80.0,162.0,170.0,331.0,188.0,470.0,400.0,679.0,585.0,385.0,3583.0
Betul,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,92.0,39.0,79.0,160.0,168.0,330.0,186.0,461.0,399.0,671.0,578.0,378.0,3541.0
Betul,13.3,Number of School children detected with Refractive errors,TOTAL,14.0,12.0,15.0,92.0,258.0,384.0,302.0,252.0,910.0,41.0,175.0,184.0,2639.0
Betul,13.4,Number of children provided free glasses,TOTAL,0.0,9.0,11.0,83.0,70.0,480.0,2.0,294.0,0.0,210.0,150.0,15.0,1324.0
Betul,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,6.0,6.0,7.0,6.0,7.0,7.0,6.0,6.0,7.0,5.0,5.0,-1.0
Betul,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2.0,4.0,2.0,3.0,3.0,2.0,4.0,4.0,2.0,4.0,6.0,4.0,-1.0
Betul,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,902.0,884.0,957.0,1096.0,1011.0,1014.0,950.0,1008.0,1030.0,1077.0,1028.0,1038.0,-1.0
Betul,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,8.0,9.0,7.0,7.0,8.0,8.0,8.0,7.0,7.0,6.0,6.0,-1.0
Betul,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,2.0,2.0,6.0
Betul,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,9.0,9.0,7.0,6.0,6.0,8.0,8.0,6.0,7.0,4.0,7.0,7.0,-1.0
Betul,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,0.0,39.0,71.0,0.0,48.0,35.0,46.0,0.0,0.0,0.0,1.0,1.0,241.0
Betul,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,6.0,6.0,6.0,6.0,4.0,5.0,6.0,5.0,5.0,4.0,4.0,5.0,-1.0
Betul,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Betul,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,967.0,273.0,875.0,990.0,920.0,1509.0,1338.0,1210.0,764.0,584.0,861.0,715.0,11006.0
Betul,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1211.0,804.0,1159.0,1216.0,1387.0,1694.0,1561.0,1247.0,1518.0,1336.0,1453.0,1571.0,16157.0
Betul,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,974.0,317.0,828.0,1131.0,1171.0,1520.0,1392.0,1208.0,738.0,653.0,842.0,685.0,11459.0
Betul,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2314.0,1851.0,2126.0,2288.0,2606.0,2850.0,3339.0,3384.0,4487.0,2821.0,2615.0,3011.0,33692.0
Betul,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1941.0,590.0,1703.0,2121.0,2091.0,3029.0,2730.0,2418.0,1502.0,1237.0,1703.0,1400.0,22465.0
Betul,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3525.0,2655.0,3285.0,3504.0,3993.0,4544.0,4900.0,4631.0,6005.0,4157.0,4068.0,4582.0,49849.0
Betul,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,37.0,0.0,50.0,41.0,0.0,39.0,26.0,36.0,28.0,13.0,270.0
Betul,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,24.0,0.0,27.0,23.0,0.0,18.0,24.0,24.0,18.0,12.0,170.0
Betul,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,61.0,0.0,77.0,64.0,0.0,57.0,50.0,60.0,46.0,25.0,440.0
Betul,14.11,In-Patient Head Count at midnight,TOTAL,3481.0,2750.0,2444.0,3607.0,2445.0,2621.0,4513.0,2351.0,3231.0,2273.0,2495.0,2813.0,35024.0
Betul,14.12.1,OPD attendance (All),TOTAL,54522.0,48345.0,70767.0,79654.0,80743.0,121258.0,96729.0,87618.0,84462.0,68044.0,81323.0,90072.0,963537.0
Betul,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,109.0,68.0,126.0,264.0,252.0,326.0,265.0,1156.0,1816.0,839.0,774.0,393.0,6388.0
Betul,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Betul,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,583.0,666.0,515.0,520.0,599.0,512.0,629.0,669.0,803.0,797.0,689.0,635.0,7617.0
Betul,14.14.a,Number of patients given AYUSH treatment,TOTAL,2601.0,2601.0,2598.0,2968.0,2915.0,4451.0,3249.0,4057.0,3720.0,2834.0,3861.0,3399.0,39254.0
Betul,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,14.14.c,Number of Adolescents counselled,TOTAL,65.0,65.0,69.0,67.0,67.0,340.0,190.0,199.0,137.0,143.0,161.0,160.0,1663.0
Betul,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3756.0,4326.0,5395.0,5417.0,5603.0,6493.0,5671.0,7128.0,8944.0,8042.0,7656.0,8105.0,76536.0
Betul,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,155.0,169.0,140.0,138.0,129.0,142.0,88.0,202.0,139.0,136.0,152.0,116.0,1706.0
Betul,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,134.0,145.0,64.0,98.0,113.0,121.0,145.0,170.0,108.0,121.0,133.0,91.0,1443.0
Betul,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3.0,2.0,0.0,1.0,1.0,2.0,3.0,2.0,4.0,1.0,7.0,2.0,28.0
Betul,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,171.0,127.0,58.0,110.0,175.0,190.0,299.0,321.0,321.0,387.0,299.0,178.0,2636.0
Betul,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,2.0,0.0,1.0,0.0,2.0,3.0,3.0,2.0,0.0,4.0,0.0,19.0
Betul,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,656.0,736.0,549.0,688.0,784.0,1024.0,787.0,1269.0,1158.0,929.0,1144.0,1312.0,11036.0
Betul,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,1.0,1.0,4.0,1.0,14.0,10.0,0.0,1.0,0.0,32.0
Betul,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,961.0,1008.0,671.0,896.0,1072.0,1335.0,1231.0,1760.0,1587.0,1437.0,1576.0,1581.0,15115.0
Betul,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,5.0,4.0,0.0,3.0,2.0,8.0,7.0,19.0,16.0,1.0,12.0,2.0,79.0
Betul,15.2,Number of Widal tests conducted,Number tested,307.0,359.0,456.0,463.0,690.0,946.0,914.0,845.0,483.0,357.0,493.0,782.0,7095.0
Betul,15.3.a,Number of VDRL tests conducted on males,Number tested,36.0,27.0,31.0,49.0,121.0,66.0,91.0,2.0,471.0,38.0,190.0,25.0,1147.0
Betul,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,50.0,62.0,73.0,75.0,409.0,129.0,197.0,62.0,23.0,26.0,80.0,27.0,1213.0
Betul,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,513.0,361.0,440.0,545.0,737.0,889.0,567.0,1147.0,578.0,315.0,1052.0,1294.0,8438.0
Betul,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,599.0,450.0,544.0,669.0,1267.0,1084.0,855.0,1211.0,1072.0,379.0,1322.0,1346.0,10798.0
Betul,15.4.1,Number of blood smears examined for Malaria,TOTAL,19528.0,27984.0,21526.0,26180.0,32725.0,28107.0,27366.0,31772.0,24463.0,14974.0,20137.0,25784.0,300546.0
Betul,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,44.0,68.0,45.0,61.0,1275.0,69.0,63.0,127.0,89.0,28.0,33.0,1398.0,3300.0
Betul,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,37.0,108.0,52.0,128.0,137.0,67.0,79.0,946.0,492.0,63.0,61.0,26.0,2196.0
Betul,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1150.0,2250.0,2850.0,1150.0,1300.0,1450.0,2750.0,1100.0,2450.0,1300.0,1950.0,1400.0,21100.0
Betul,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,0.0,2000.0,0.0,1500.0,0.0,1000.0,16500.0
Betul,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,850.0,1400.0,3700.0,1850.0,1850.0,2700.0,1650.0,650.0,1150.0,850.0,550.0,500.0,17700.0
Betul,16.1.1,Stock position of DPT vaccines,5. Total Stock,2300.0,2850.0,1150.0,1300.0,1450.0,750.0,1100.0,2450.0,1300.0,1950.0,1400.0,1900.0,19900.0
Betul,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,0.0,,0.0,224.0,1374.0,774.0,1492.0,642.0,4506.0
Betul,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,0.0,,1300.0,1300.0,0.0,1500.0,0.0,1000.0,5100.0
Betul,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,0.0,,1076.0,150.0,600.0,782.0,850.0,650.0,4108.0
Betul,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,224.0,1374.0,774.0,1492.0,642.0,992.0,5498.0
Betul,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,800.0,2025.0,2525.0,950.0,1025.0,1050.0,2350.0,500.0,650.0,1600.0,2290.0,1640.0,17405.0
Betul,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,0.0,1000.0,2000.0,13900.0,11900.0,1000.0,41800.0
Betul,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1050.0,1500.0,3575.0,1925.0,1975.0,2700.0,1850.0,850.0,1050.0,13210.0,12550.0,800.0,43035.0
Betul,16.1.2,Stock position of OPV vaccines,5. Total Stock,1750.0,2525.0,950.0,1025.0,1050.0,350.0,500.0,650.0,1600.0,2290.0,1640.0,1840.0,16170.0
Betul,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,550.0,2000.0,2450.0,900.0,1100.0,1200.0,2500.0,900.0,2150.0,1150.0,2150.0,1350.0,18400.0
Betul,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,0.0,2000.0,0.0,2000.0,0.0,1500.0,17500.0
Betul,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.1.3,Stock position of TT vaccines,4. Stock Distributed,550.0,1550.0,3550.0,1800.0,1900.0,2700.0,1600.0,750.0,1000.0,1000.0,800.0,850.0,18050.0
Betul,16.1.3,Stock position of TT vaccines,5. Total Stock,2000.0,2450.0,900.0,1100.0,1200.0,500.0,900.0,2150.0,1150.0,2150.0,1350.0,2000.0,17850.0
Betul,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,900.0,2050.0,2700.0,1250.0,1300.0,1500.0,2900.0,1150.0,2650.0,1800.0,2950.0,1800.0,22950.0
Betul,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,0.0,2000.0,0.0,2000.0,0.0,1000.0,17000.0
Betul,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,850.0,1350.0,3450.0,1950.0,1800.0,2600.0,1750.0,500.0,850.0,850.0,1150.0,500.0,17600.0
Betul,16.1.5,Stock position of BCG vaccines,5. Total Stock,2050.0,2700.0,1250.0,1300.0,1500.0,900.0,1150.0,2650.0,1800.0,2950.0,1800.0,2300.0,22350.0
Betul,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1300.0,2250.0,2600.0,650.0,800.0,900.0,100.0,550.0,950.0,1600.0,1200.0,700.0,13600.0
Betul,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,1000.0,2000.0,1000.0,1000.0,2000.0,21000.0
Betul,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1050.0,1650.0,3950.0,1850.0,1950.0,2800.0,1550.0,600.0,1350.0,1400.0,1500.0,850.0,20500.0
Betul,16.1.6,Stock position of Measles vaccines,5. Total Stock,2250.0,2600.0,650.0,800.0,850.0,100.0,550.0,950.0,1600.0,1200.0,700.0,1850.0,14100.0
Betul,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,850.0,2000.0,2550.0,700.0,800.0,850.0,2100.0,350.0,1750.0,550.0,1400.0,900.0,14800.0
Betul,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,0.0,2000.0,0.0,1500.0,0.0,1000.0,16500.0
Betul,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,900.0,1450.0,3850.0,1900.0,1950.0,2750.0,1750.0,600.0,1200.0,650.0,500.0,200.0,17700.0
Betul,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1950.0,2550.0,700.0,800.0,850.0,100.0,350.0,1750.0,550.0,1400.0,900.0,1700.0,13600.0
Betul,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,600.0,,300.0,300.0,600.0,600.0,600.0,300.0,300.0,50.0,3650.0
Betul,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,600.0,,,600.0,600.0,600.0,0.0,0.0,0.0,0.0,0.0,3000.0,5400.0
Betul,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,600.0,,600.0,300.0,600.0,900.0,0.0,0.0,300.0,0.0,250.0,0.0,3550.0
Betul,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,300.0,300.0,0.0,600.0,600.0,300.0,300.0,50.0,3050.0,5500.0
Betul,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,30000.0,30000.0,,5040.0,0.0,20000.0,8960.0,3920.0,45360.0,25200.0,5040.0,173520.0
Betul,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,3000.0,30000.0,30000.0,55440.0,25200.0,200000.0,0.0,0.0,151200.0,0.0,0.0,30000.0,524840.0
Betul,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,3000.0,30000.0,60000.0,50400.0,30240.0,180000.0,11040.0,5040.0,109760.0,20160.0,20160.0,17040.0,536840.0
Betul,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,30000.0,0.0,5040.0,0.0,20000.0,8960.0,3920.0,45360.0,25200.0,5040.0,18000.0,161520.0
Betul,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,0.0,,5000.0,3000.0,26000.0,17000.0,13000.0,7000.0,71000.0
Betul,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,11000.0,5000.0,,0.0,40000.0,30000.0,0.0,0.0,48000.0,134000.0
Betul,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,11000.0,5000.0,,2000.0,17000.0,39000.0,4000.0,6000.0,4200.0,88200.0
Betul,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,3000.0,26000.0,17000.0,13000.0,7000.0,50800.0,116800.0
Betul,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0
Betul,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,0.0,,0.0,0.0,,0.0,0.0,12000.0,12000.0
Betul,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0
Betul,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0
Betul,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12000.0,12000.0
Betul,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0
Betul,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0
Betul,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0
Betul,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0
Betul,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,3000.0,,,,,,4500.0,6300.0,2000.0,700.0,2700.0,1500.0,20700.0
Betul,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,5000.0,,,,,,10000.0,,,3000.0,,,18000.0
Betul,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Betul,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,2500.0,,,,,,8200.0,4300.0,1300.0,1000.0,1200.0,1400.0,19900.0
Betul,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,5500.0,0.0,0.0,0.0,0.0,0.0,6300.0,2000.0,700.0,2700.0,1500.0,100.0,18800.0
Betul,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,7000.0,,,,,,500.0,500.0,500.0,100.0,100.0,2300.0,11000.0
Betul,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,5000.0,,,3000.0,,8000.0
Betul,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Betul,16.3.02,Stock Position of Gloves,4. Stock Distributed,4000.0,,,,,,400.0,5000.0,100.0,,800.0,1300.0,11600.0
Betul,16.3.02,Stock Position of Gloves,5. Total Stock,3000.0,0.0,0.0,0.0,0.0,0.0,100.0,500.0,400.0,100.0,2300.0,1000.0,7400.0
Betul,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,4.0,,,,,,5.0,,5.0,5.0,5.0,5.0,29.0
Betul,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Betul,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Betul,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,0.0,,,5.0,5.0
Betul,16.3.03,Stock Position of MVA Syringes,5. Total Stock,4.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,5.0,5.0,5.0,0.0,24.0
Betul,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,50000.0,400000.0,40000.0,26000.0,19000.0,14000.0,549000.0
Betul,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,500000.0,,,,,500000.0
Betul,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Betul,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,10000.0,425000.0,14000.0,7000.0,5000.0,6000.0,467000.0
Betul,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,40000.0,475000.0,26000.0,19000.0,14000.0,8000.0,582000.0
Betul,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Betul,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Betul,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Betul,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Betul,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,30.0,,,,,,10.0,10.0,10.0,15.0,10.0,,85.0
Betul,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Betul,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Betul,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,10.0,,,,,,,,5.0,5.0,5.0,,25.0
Betul,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,20.0,0.0,0.0,0.0,0.0,0.0,10.0,10.0,5.0,10.0,5.0,0.0,60.0
Betul,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,20000.0,152000.0,475000.0,603000.0,573000.0,553000.0,2376000.0
Betul,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,500000.0,500000.0,1000000.0,500000.0,,,2500000.0
Betul,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Betul,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,368000.0,177000.0,872000.0,530000.0,500000.0,400000.0,2847000.0
Betul,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,152000.0,475000.0,603000.0,573000.0,73000.0,153000.0,2029000.0
Betul,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,97000.0,135000.0,3000.0,200.0,200.0,235400.0
Betul,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,135000.0,232000.0,,,2000.0,,369000.0
Betul,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Betul,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,38000.0,,132000.0,2800.0,2000.0,200.0,175000.0
Betul,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,97000.0,329000.0,3000.0,200.0,200.0,0.0,429400.0
Betul,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,4500.0,,,,,,15000.0,,100000.0,55000.0,25000.0,35000.0,234500.0
Betul,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,100000.0,,,,,,100000.0
Betul,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Betul,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,2500.0,,,,,,45000.0,,45000.0,30000.0,20000.0,18000.0,160500.0
Betul,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,2000.0,0.0,0.0,0.0,0.0,0.0,70000.0,0.0,55000.0,25000.0,5000.0,17000.0,174000.0
Betul,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,400.0,,3400.0,,,,1000.0,3000.0,5000.0,700.0,200.0,400.0,14100.0
Betul,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,5000.0,2000.0,,,,,7000.0
Betul,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Betul,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,150.0,,3400.0,,,,3000.0,0.0,4300.0,500.0,,100.0,11450.0
Betul,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,250.0,0.0,0.0,0.0,0.0,0.0,3000.0,5000.0,700.0,200.0,200.0,300.0,9650.0
Betul,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,7000.0,,,,,,300.0,3000.0,60000.0,41000.0,25000.0,12000.0,148300.0
Betul,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,30000.0,,,,,,,6000.0,23000.0,,,,59000.0
Betul,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Betul,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,5000.0,,,,,,200.0,3000.0,42000.0,16000.0,13000.0,4000.0,83200.0
Betul,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,32000.0,0.0,0.0,0.0,0.0,0.0,100.0,6000.0,41000.0,25000.0,12000.0,8000.0,124100.0
Betul,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,7900.0,11900.0,15200.0,12200.0,10300.0,6300.0,8900.0,5000.0,6900.0,3600.0,1800.0,3500.0,93500.0
Betul,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6600.0,6600.0,6600.0,3300.0,3300.0,3300.0,0.0,3300.0,0.0,0.0,3300.0,3500.0,39800.0
Betul,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2600.0,3300.0,9600.0,5200.0,7300.0,4000.0,3900.0,1400.0,3300.0,1800.0,1600.0,1000.0,45000.0
Betul,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,11900.0,15200.0,12200.0,10300.0,6300.0,5600.0,5000.0,6900.0,3600.0,1800.0,3500.0,6000.0,88300.0
Betul,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,22000.0,26000.0,26800.0,14800.0,6000.0,12000.0,38000.0,23200.0,15200.0,15200.0,15200.0,15200.0,229600.0
Betul,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,12000.0,10000.0,10000.0,10000.0,20000.0,20000.0,0.0,292000.0,0.0,0.0,0.0,200000.0,574000.0
Betul,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,8000.0,9200.0,22000.0,18800.0,14000.0,14000.0,14800.0,300000.0,0.0,0.0,0.0,0.0,400800.0
Betul,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,26000.0,26800.0,14800.0,6000.0,12000.0,18000.0,23200.0,15200.0,15200.0,15200.0,15200.0,215200.0,402800.0
Betul,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,6800.0,9600.0,10200.0,7700.0,5700.0,4700.0,6200.0,4300.0,6900.0,4400.0,3100.0,1300.0,70900.0
Betul,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4000.0,4000.0,4000.0,8600.0,2000.0,2000.0,0.0,4000.0,0.0,0.0,2000.0,2000.0,32600.0
Betul,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Betul,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1200.0,3400.0,6500.0,10600.0,3000.0,2500.0,1900.0,1400.0,2500.0,1300.0,3800.0,1500.0,39600.0
Betul,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,9600.0,10200.0,7700.0,5700.0,4700.0,4200.0,4300.0,6900.0,4400.0,3100.0,1300.0,1800.0,63900.0
Betul,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,6.0,2.0,2.0,1.0,3.0,1.0,,1.0,1.0,,4.0,23.0
Betul,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,1.0,,1.0,1.0,1.0,1.0,2.0,,6.0,1.0,,14.0
Betul,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,1.0,,,,,,,,,1.0
Betul,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,1.0,,2.0,1.0,1.0,1.0,2.0,,6.0,1.0,,15.0
Betul,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,2.0,1.0,4.0,,5.0,,5.0,,3.0,2.0,4.0,26.0
Betul,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Betul,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,2.0,1.0,4.0,,5.0,,5.0,,3.0,2.0,4.0,26.0
Betul,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,8.0,16.0,16.0,25.0,21.0,26.0,14.0,23.0,14.0,25.0,18.0,13.0,219.0
Betul,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,1.0,,4.0,1.0,,7.0
Betul,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,8.0,16.0,16.0,25.0,21.0,26.0,15.0,24.0,14.0,29.0,19.0,13.0,226.0
Betul,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,2.0,5.0,5.0,3.0,9.0,12.0,10.0,2.0,7.0,5.0,5.0,67.0
Betul,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,1.0,,,1.0,,,,,,,2.0
Betul,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,2.0,6.0,5.0,3.0,10.0,12.0,10.0,2.0,7.0,5.0,5.0,69.0
Betul,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,2.0,2.0,1.0,3.0,2.0,2.0,2.0,,1.0,2.0,,17.0
Betul,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,,1.0,,,,2.0,,,,,,4.0
Betul,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,2.0,3.0,1.0,3.0,2.0,4.0,2.0,,1.0,2.0,,21.0
Betul,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,1.0,1.0,,,,,,,,,2.0
Betul,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,1.0,,,,,,,,,,1.0
Betul,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,2.0,1.0,,,,,,,,,3.0
Betul,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,2.0,4.0,4.0,,1.0,8.0,2.0,2.0,2.0,1.0,5.0,3.0,34.0
Betul,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,2.0,,3.0,5.0,4.0,3.0,2.0,1.0,1.0,1.0,,22.0
Betul,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,2.0,6.0,4.0,3.0,6.0,12.0,5.0,4.0,3.0,2.0,6.0,3.0,56.0
Betul,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Betul,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Betul,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Betul,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,6.0,3.0,1.0,5.0,7.0,5.0,4.0,4.0,8.0,3.0,1.0,48.0
Betul,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,6.0,4.0,2.0,8.0,10.0,3.0,4.0,2.0,3.0,,,2.0,44.0
Betul,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,7.0,10.0,5.0,9.0,15.0,10.0,9.0,6.0,7.0,8.0,3.0,3.0,92.0
Betul,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Betul,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Betul,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,1.0,,,,,,1.0,,2.0
Betul,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,2.0,,,,,,1.0,,3.0
Betul,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,2.0,,,1.0,1.0,,,,,,4.0
Betul,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,5.0,4.0,4.0,4.0,,6.0,5.0,3.0,3.0,2.0,4.0,2.0,42.0
Betul,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,2.0,3.0,1.0,1.0,,1.0,2.0,,1.0,,11.0
Betul,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,5.0,4.0,8.0,7.0,1.0,8.0,6.0,4.0,5.0,2.0,5.0,2.0,57.0
Betul,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,2.0,3.0,,1.0,,,,6.0
Betul,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,6.0,3.0,2.0,1.0,5.0,4.0,15.0,7.0,2.0,10.0,8.0,64.0
Betul,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,17.0,14.0,14.0,13.0,22.0,27.0,39.0,36.0,20.0,27.0,29.0,45.0,303.0
Betul,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,18.0,20.0,17.0,15.0,23.0,34.0,46.0,51.0,28.0,29.0,39.0,53.0,373.0
Betul,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Betul,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Betul,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Betul,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,1.0,,,,1.0
Betul,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,1.0,3.0,1.0,,2.0,,,,1.0,,9.0
Betul,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,8.0,19.0,13.0,3.0,12.0,19.0,19.0,14.0,26.0,18.0,16.0,16.0,183.0
Betul,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,14.0,10.0,14.0,5.0,19.0,19.0,23.0,25.0,31.0,15.0,20.0,13.0,208.0
Betul,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,22.0,30.0,28.0,11.0,32.0,38.0,44.0,39.0,57.0,33.0,37.0,29.0,400.0
Betul,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Betul,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,1.0,,2.0,,,,,1.0,4.0
Betul,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Betul,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,1.0,,2.0,1.0,,,,1.0,5.0
Betul,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,2.0,1.0,,,2.0,,,1.0,7.0
Betul,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,10.0,10.0,12.0,12.0,19.0,25.0,22.0,26.0,28.0,12.0,14.0,18.0,208.0
Betul,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,20.0,22.0,22.0,26.0,33.0,30.0,55.0,42.0,37.0,58.0,37.0,43.0,425.0
Betul,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,30.0,32.0,35.0,38.0,54.0,56.0,77.0,68.0,67.0,70.0,51.0,62.0,640.0
Betul,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,1.0,2.0,,,,,,,,,,3.0
Betul,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,4.0,2.0,3.0,2.0,1.0,3.0,3.0,1.0,2.0,,4.0,27.0
Betul,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,10.0,11.0,16.0,8.0,13.0,10.0,16.0,28.0,25.0,18.0,19.0,13.0,187.0
Betul,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,12.0,16.0,20.0,11.0,15.0,11.0,19.0,31.0,26.0,20.0,19.0,17.0,217.0
Betul,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Betul,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,1.0,,,1.0
Betul,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Betul,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,1.0,,,1.0
Betul,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Betul,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Betul,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Betul,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Betul,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Betul,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,,,1.0,,,,,,,,,2.0
Betul,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Betul,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,,,1.0,,,,,,,,,2.0
Betul,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Betul,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,2.0,1.0,,1.0,,,,,,5.0
Betul,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Betul,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,2.0,1.0,,1.0,,,,,,5.0
Betul,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Betul,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,1.0,1.0,5.0,2.0,7.0,,2.0,1.0,,,19.0
Betul,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Betul,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,1.0,1.0,5.0,2.0,7.0,,2.0,1.0,,,19.0
Betul,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Betul,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,2.0,1.0,1.0,3.0,2.0,,1.0,1.0,,1.0,,12.0
Betul,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Betul,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,2.0,1.0,1.0,3.0,2.0,,1.0,1.0,,1.0,,12.0
Betul,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,2.0,4.0,4.0,2.0,,4.0,2.0,1.0,1.0,5.0,,3.0,28.0
Betul,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,12.0,28.0,35.0,10.0,24.0,21.0,25.0,36.0,23.0,28.0,29.0,29.0,300.0
Betul,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,10.0,12.0,7.0,11.0,6.0,10.0,11.0,8.0,9.0,7.0,10.0,102.0
Betul,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,15.0,42.0,51.0,19.0,35.0,31.0,37.0,48.0,32.0,42.0,36.0,42.0,430.0
Betul,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,1.0,,,1.0,,1.0,,,,3.0
Betul,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,11.0,15.0,6.0,5.0,8.0,10.0,7.0,7.0,5.0,1.0,5.0,16.0,96.0
Betul,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,2.0,2.0,2.0,,,1.0,1.0,1.0,1.0,,,,10.0
Betul,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,13.0,17.0,8.0,6.0,8.0,11.0,9.0,8.0,7.0,1.0,5.0,16.0,109.0
Betul,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,1.0,1.0,1.0,,2.0,1.0,,,,,7.0
Betul,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,,1.0,5.0,4.0,2.0,6.0,2.0,1.0,3.0,1.0,2.0,28.0
Betul,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,,1.0,,2.0,1.0,1.0,1.0,1.0,,,,8.0
Betul,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,1.0,3.0,6.0,7.0,3.0,9.0,4.0,2.0,3.0,1.0,2.0,43.0
Betul,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,1.0,,,,1.0,2.0
Betul,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,10.0,9.0,6.0,3.0,6.0,4.0,4.0,6.0,8.0,4.0,6.0,66.0
Betul,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,8.0,3.0,4.0,1.0,6.0,8.0,10.0,8.0,9.0,15.0,11.0,84.0
Betul,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,18.0,12.0,10.0,4.0,12.0,12.0,15.0,14.0,17.0,19.0,18.0,152.0
Betul,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,3.0,,,,,,3.0
Betul,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,8.0,12.0,9.0,10.0,8.0,7.0,17.0,10.0,11.0,5.0,4.0,5.0,106.0
Betul,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,9.0,20.0,24.0,18.0,22.0,32.0,30.0,12.0,17.0,23.0,22.0,13.0,242.0
Betul,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,17.0,32.0,33.0,28.0,30.0,39.0,50.0,22.0,28.0,28.0,26.0,18.0,351.0
Betul,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,1.0,2.0,2.0,7.0,3.0,3.0,1.0,2.0,2.0,23.0
Betul,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,11.0,18.0,11.0,13.0,20.0,26.0,22.0,27.0,19.0,24.0,13.0,20.0,224.0
Betul,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,29.0,60.0,79.0,71.0,82.0,98.0,80.0,86.0,125.0,124.0,73.0,82.0,989.0
Betul,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,40.0,78.0,90.0,85.0,104.0,126.0,109.0,116.0,147.0,149.0,88.0,104.0,1236.0
Bhind,1.1,Total number of pregnant women Registered for ANC,TOTAL,2970.0,3520.0,3777.0,3532.0,3083.0,3747.0,2659.0,3007.0,2725.0,2842.0,3442.0,4121.0,39425.0
Bhind,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1536.0,1802.0,2019.0,1850.0,1733.0,1892.0,1285.0,1575.0,1489.0,1635.0,1861.0,2054.0,20731.0
Bhind,1.2,Number of Pregnant women registered under JSY,TOTAL,2947.0,3513.0,3736.0,3532.0,3075.0,3739.0,2659.0,3007.0,2515.0,2580.0,3359.0,4028.0,38690.0
Bhind,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2004.0,2244.0,2366.0,2569.0,2604.0,2938.0,2498.0,2813.0,2476.0,2328.0,2426.0,2695.0,29961.0
Bhind,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2789.0,3352.0,3532.0,3424.0,2905.0,3597.0,2520.0,2751.0,2365.0,2518.0,3257.0,3791.0,36801.0
Bhind,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2420.0,3039.0,3061.0,3332.0,2816.0,3097.0,3115.0,2775.0,2688.0,2237.0,2530.0,3695.0,34805.0
Bhind,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2939.0,3511.0,3751.0,3526.0,3059.0,3664.0,2639.0,3021.0,2632.0,2810.0,3398.0,4066.0,39016.0
Bhind,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,154.0,188.0,74.0,153.0,165.0,214.0,175.0,161.0,158.0,196.0,180.0,289.0,2107.0
Bhind,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,3.0,3.0,2.0,1.0,9.0,36.0,5.0,4.0,4.0,12.0,2.0,84.0
Bhind,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1380.0,1744.0,1859.0,2298.0,1755.0,2413.0,1950.0,2196.0,1729.0,2271.0,2218.0,2294.0,24107.0
Bhind,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,91.0,96.0,146.0,183.0,104.0,112.0,92.0,493.0,429.0,56.0,350.0,445.0,2597.0
Bhind,1.8,Number of pregnancy test kits used at SC level,TOTAL,1030.0,731.0,627.0,1120.0,751.0,1032.0,626.0,591.0,706.0,873.0,1307.0,1186.0,10580.0
Bhind,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,8.0,4.0,7.0,2.0,3.0,2.0,0.0,2.0,1.0,19.0,0.0,29.0,77.0
Bhind,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,104.0,193.0,209.0,241.0,389.0,381.0,353.0,355.0,329.0,275.0,203.0,152.0,3184.0
Bhind,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,112.0,197.0,216.0,243.0,392.0,383.0,353.0,357.0,330.0,294.0,203.0,181.0,3261.0
Bhind,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,83.0,154.0,170.0,187.0,365.0,372.0,348.0,345.0,323.0,296.0,212.0,180.0,3035.0
Bhind,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,1.0,0.0,0.0,2.0,0.0,1.0,5.0,1.0,13.0,2.0,11.0,36.0
Bhind,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,917.0,1368.0,1622.0,1973.0,2778.0,2626.0,2334.0,2325.0,2042.0,1905.0,1845.0,1836.0,23571.0
Bhind,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,54.0,129.0,90.0,85.0,51.0,55.0,81.0,136.0,52.0,99.0,21.0,56.0,909.0
Bhind,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,604.0,1067.0,700.0,1050.0,1816.0,1946.0,2138.0,2344.0,2276.0,1860.0,1933.0,1953.0,19687.0
Bhind,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,417.0,506.0,753.0,1366.0,1736.0,2024.0,1690.0,1727.0,1560.0,1375.0,1240.0,1264.0,15658.0
Bhind,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,111.0,77.0,126.0,283.0,314.0,210.0,394.0,174.0,130.0,233.0,388.0,317.0,2757.0
Bhind,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,45.0,105.0,63.0,156.0,215.0,137.0,156.0,159.0,76.0,110.0,83.0,77.0,1382.0
Bhind,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,8.0,5.0,3.0,9.0,11.0,13.0,9.0,18.0,13.0,8.0,11.0,12.0,120.0
Bhind,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhind,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,8.0,5.0,3.0,9.0,11.0,13.0,9.0,18.0,13.0,8.0,11.0,12.0,120.0
Bhind,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,20.0,35.0,21.0,59.0,87.0,74.0,99.0,75.0,38.0,61.0,27.0,26.0,622.0
Bhind,4.1.1.a,Number of male live births,TOTAL,567.0,871.0,957.0,1237.0,1756.0,1664.0,1460.0,1423.0,1267.0,1299.0,1297.0,1252.0,15050.0
Bhind,4.1.1.b,Number of female live births,TOTAL,499.0,792.0,934.0,1157.0,1599.0,1448.0,1365.0,1379.0,1158.0,1196.0,1174.0,1128.0,13829.0
Bhind,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1066.0,1663.0,1891.0,2394.0,3355.0,3112.0,2825.0,2802.0,2425.0,2495.0,2471.0,2380.0,28879.0
Bhind,4.1.2,Number of still births,TOTAL,11.0,9.0,16.0,10.0,32.0,41.0,36.0,42.0,25.0,28.0,9.0,12.0,271.0
Bhind,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,26.0,13.0,18.0,30.0,57.0,25.0,49.0,69.0,37.0,57.0,55.0,57.0,493.0
Bhind,4.2.1,Number of Newborns weighed at birth,TOTAL,1045.0,1652.0,1863.0,2388.0,3350.0,3108.0,2853.0,2798.0,2400.0,2443.0,2144.0,1876.0,27920.0
Bhind,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,132.0,143.0,145.0,248.0,288.0,476.0,454.0,297.0,266.0,300.0,160.0,226.0,3135.0
Bhind,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1019.0,1650.0,1862.0,2388.0,3348.0,3103.0,2834.0,2790.0,2368.0,2385.0,2100.0,1994.0,27841.0
Bhind,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,9.0,18.0,19.0,22.0,20.0,32.0,16.0,27.0,11.0,13.0,9.0,2.0,198.0
Bhind,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,72.0,71.0,74.0,65.0,101.0,72.0,59.0,60.0,54.0,55.0,28.0,18.0,729.0
Bhind,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,60.0,72.0,68.0,101.0,95.0,63.0,55.0,48.0,59.0,37.0,33.0,54.0,745.0
Bhind,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhind,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,141.0,161.0,161.0,188.0,216.0,167.0,130.0,135.0,124.0,105.0,70.0,74.0,1672.0
Bhind,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,10.0,8.0,6.0,14.0,17.0,23.0,21.0,51.0,31.0,45.0,30.0,29.0,285.0
Bhind,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,158.0,161.0,152.0,193.0,228.0,168.0,128.0,177.0,145.0,148.0,115.0,104.0,1877.0
Bhind,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,13.0,22.0,13.0,25.0,16.0,5.0,4.0,3.0,6.0,3.0,3.0,2.0,115.0
Bhind,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,111.0,121.0,115.0,132.0,152.0,143.0,90.0,165.0,136.0,122.0,111.0,97.0,1495.0
Bhind,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,13.0,24.0,13.0,27.0,32.0,31.0,33.0,59.0,44.0,51.0,36.0,46.0,409.0
Bhind,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,974.0,1469.0,1690.0,2291.0,3225.0,2978.0,2683.0,2707.0,2331.0,2329.0,2074.0,2013.0,26764.0
Bhind,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,851.0,1287.0,1469.0,1415.0,2549.0,2591.0,2126.0,2215.0,1936.0,1765.0,1456.0,1434.0,21094.0
Bhind,6.3,PNC maternal complications attended,TOTAL,63.0,92.0,71.0,770.0,120.0,96.0,87.0,108.0,95.0,87.0,74.0,95.0,1758.0
Bhind,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,8.0,9.0,12.0,13.0,17.0,8.0,10.0,20.0,38.0,16.0,23.0,23.0,197.0
Bhind,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,8.0,9.0,12.0,13.0,17.0,8.0,10.0,20.0,38.0,16.0,23.0,23.0,197.0
Bhind,7.2,Number of MTPs conducted at Private Facilities,TOTAL,15.0,8.0,10.0,12.0,19.0,19.0,15.0,12.0,16.0,17.0,18.0,15.0,176.0
Bhind,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,4.0,17.0,14.0,31.0,27.0,30.0,4.0,11.0,15.0,24.0,9.0,23.0,209.0
Bhind,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,97.0,181.0,170.0,306.0,441.0,451.0,458.0,540.0,231.0,317.0,435.0,578.0,4205.0
Bhind,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,101.0,198.0,184.0,337.0,468.0,481.0,462.0,551.0,246.0,341.0,444.0,601.0,4414.0
Bhind,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0,2.0,1.0,0.0,6.0
Bhind,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,1.0,0.0,1.0,3.0,3.0,3.0,2.0,3.0,3.0,2.0,8.0,29.0
Bhind,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,2.0,4.0,2.0,2.0,1.0,4.0,3.0,6.0,7.0,3.0,2.0,37.0
Bhind,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhind,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,3.0,4.0,3.0,5.0,4.0,8.0,5.0,11.0,12.0,6.0,10.0,72.0
Bhind,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,9.0,5.0,0.0,13.0,10.0,39.0,28.0,400.0,484.0,425.0,296.0,168.0,1877.0
Bhind,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,31.0,11.0,6.0,15.0,21.0,64.0,40.0,607.0,904.0,757.0,560.0,351.0,3367.0
Bhind,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,15.0,10.0,4.0,1.0,1.0,7.0,4.0,51.0,72.0,514.0,71.0,36.0,786.0
Bhind,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhind,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,55.0,26.0,10.0,29.0,32.0,110.0,72.0,1058.0,1460.0,1696.0,927.0,555.0,6030.0
Bhind,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,4.0,7.0,0.0,4.0,2.0,2.0,1.0,1.0,3.0,7.0,7.0,38.0
Bhind,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhind,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,4.0,7.0,0.0,4.0,2.0,2.0,1.0,1.0,3.0,7.0,7.0,38.0
Bhind,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,2.0
Bhind,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,4.0,1.0,1.0,8.0,16.0
Bhind,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,2.0,3.0,2.0,11.0
Bhind,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhind,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,5.0,1.0,0.0,0.0,0.0,5.0,4.0,4.0,10.0,29.0
Bhind,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bhind,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,553.0,524.0,723.0,887.0,1101.0,995.0,1021.0,909.0,698.0,689.0,771.0,795.0,9666.0
Bhind,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,20.0,27.0,38.0,73.0,55.0,26.0,54.0,27.0,26.0,19.0,18.0,25.0,408.0
Bhind,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,24.0,22.0,31.0,30.0,38.0,41.0,36.0,49.0,55.0,46.0,33.0,56.0,461.0
Bhind,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,70.0,89.0,127.0,105.0,111.0,137.0,93.0,158.0,81.0,136.0,139.0,131.0,1377.0
Bhind,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhind,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,667.0,662.0,919.0,1095.0,1305.0,1199.0,1204.0,1143.0,860.0,890.0,961.0,1007.0,11912.0
Bhind,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,45.0,66.0,98.0,103.0,91.0,106.0,75.0,58.0,18.0,25.0,34.0,46.0,765.0
Bhind,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,9.06,Number of IUCD removals,TOTAL,445.0,634.0,296.0,514.0,388.0,334.0,390.0,469.0,509.0,434.0,468.0,512.0,5393.0
Bhind,9.07,Number of Oral Pills cycles distributed,TOTAL,5161.0,5990.0,4054.0,6568.0,8380.0,9541.0,9027.0,7402.0,6864.0,9175.0,7608.0,9062.0,88832.0
Bhind,9.08,Number of Condom pieces distributed,TOTAL,10024.0,11374.0,12351.0,6038.0,12401.0,11679.0,10570.0,11754.0,13155.0,16188.0,11989.0,13371.0,140894.0
Bhind,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,14.0,4.0,7.0,19.0,29.0,83.0,63.0,88.0,61.0,103.0,66.0,57.0,594.0
Bhind,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,9.12,Number of Institutions having NSV trained doctors,TOTAL,11.0,10.0,8.0,8.0,12.0,11.0,10.0,14.0,14.0,13.0,13.0,14.0,-1.0
Bhind,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1091.0,1577.0,1775.0,2073.0,3034.0,2924.0,2573.0,2611.0,2342.0,2290.0,2048.0,2107.0,26445.0
Bhind,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1907.0,2277.0,2163.0,2297.0,2544.0,3305.0,3515.0,1012.0,138.0,72.0,29.0,11.0,19270.0
Bhind,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2268.0,2548.0,2193.0,2395.0,2254.0,2664.0,2894.0,3390.0,1238.0,525.0,373.0,221.0,22963.0
Bhind,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2307.0,2695.0,2512.0,2364.0,2283.0,2359.0,2435.0,2863.0,3116.0,1400.0,716.0,348.0,25398.0
Bhind,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2671.0,3102.0,2833.0,3144.0,3236.0,14986.0
Bhind,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0,2343.0,2461.0,2969.0,3345.0,11133.0
Bhind,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,78.0,1736.0,2612.0,3283.0,7719.0
Bhind,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,926.0,1491.0,1713.0,1998.0,2998.0,2819.0,2379.0,2434.0,2173.0,2222.0,1912.0,1979.0,25044.0
Bhind,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1907.0,2278.0,2184.0,2293.0,2544.0,3305.0,3514.0,3323.0,3247.0,2892.0,3092.0,3212.0,33791.0
Bhind,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2268.0,2548.0,2193.0,2397.0,2254.0,2665.0,2894.0,3393.0,3487.0,3049.0,3035.0,3411.0,33594.0
Bhind,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2307.0,2695.0,2512.0,2366.0,2283.0,2357.0,2435.0,2862.0,3082.0,2998.0,2864.0,3490.0,32251.0
Bhind,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,899.0,1442.0,1638.0,1819.0,2753.0,2613.0,2247.0,2218.0,1995.0,1966.0,1620.0,1611.0,22821.0
Bhind,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1907.0,2278.0,2184.0,2290.0,2544.0,3305.0,3515.0,1081.0,172.0,166.0,35.0,2.0,19479.0
Bhind,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2268.0,2548.0,2193.0,2400.0,2254.0,2665.0,2894.0,3397.0,1216.0,617.0,393.0,159.0,23004.0
Bhind,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2307.0,2695.0,2512.0,2366.0,2283.0,2358.0,2435.0,2863.0,3053.0,1146.0,603.0,390.0,25011.0
Bhind,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1894.0,2754.0,3637.0,3336.0,2967.0,3421.0,3007.0,3032.0,2793.0,2298.0,2362.0,2855.0,34356.0
Bhind,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1485.0,2173.0,2053.0,2432.0,1981.0,2114.0,1783.0,2114.0,2648.0,2318.0,2542.0,2971.0,26614.0
Bhind,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bhind,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1028.0,1495.0,1931.0,1732.0,1584.0,1808.0,1593.0,1611.0,1447.0,1190.0,1233.0,1463.0,18115.0
Bhind,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,881.0,1310.0,1705.0,1595.0,1386.0,1610.0,1406.0,1417.0,1278.0,1060.0,1125.0,1303.0,16076.0
Bhind,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1909.0,2805.0,3636.0,3327.0,2970.0,3418.0,2999.0,3028.0,2725.0,2250.0,2358.0,2766.0,34191.0
Bhind,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1800.0,2274.0,2234.0,2718.0,2214.0,2397.0,2154.0,2313.0,2732.0,2603.0,2847.0,3205.0,29491.0
Bhind,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1796.0,2274.0,2232.0,2718.0,2216.0,2406.0,2154.0,2315.0,2732.0,2605.0,2847.0,3193.0,29488.0
Bhind,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,581.0,871.0,1220.0,1049.0,886.0,804.0,702.0,825.0,1004.0,902.0,1039.0,1158.0,11041.0
Bhind,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,517.0,750.0,1097.0,904.0,779.0,702.0,637.0,694.0,870.0,816.0,883.0,1045.0,9694.0
Bhind,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1098.0,1621.0,2317.0,1953.0,1665.0,1506.0,1339.0,1519.0,1874.0,1718.0,1922.0,2203.0,20735.0
Bhind,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,410.0,497.0,823.0,962.0,867.0,875.0,1067.0,1229.0,1257.0,1483.0,1577.0,1821.0,12868.0
Bhind,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1859.0,2124.0,2507.0,2888.0,2585.0,2895.0,2512.0,2592.0,2748.0,2707.0,2610.0,2857.0,30884.0
Bhind,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1895.0,2219.0,2768.0,3057.0,2757.0,2994.0,2820.0,2862.0,2829.0,2927.0,2934.0,2852.0,32914.0
Bhind,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,3.0,1.0,0.0,0.0,0.0,0.0,5.0
Bhind,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,0.0,0.0,0.0,0.0,1.0,7.0,1.0,0.0,0.0,0.0,0.0,11.0
Bhind,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1396.0,1482.0,1508.0,1534.0,1559.0,1568.0,1510.0,1583.0,1550.0,1517.0,1559.0,1605.0,18371.0
Bhind,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1365.0,1477.0,1499.0,1526.0,1552.0,1568.0,1508.0,1582.0,1549.0,1515.0,1555.0,1599.0,18295.0
Bhind,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1111.0,1223.0,1202.0,1275.0,1241.0,1218.0,1201.0,1255.0,1219.0,1183.0,1333.0,1344.0,14805.0
Bhind,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1854.0,2743.0,3648.0,3336.0,2970.0,3411.0,3000.0,3015.0,2668.0,2485.0,2285.0,2828.0,34243.0
Bhind,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,957.0,1101.0,1018.0,9911.0,2817.0,925.0,871.0,1166.0,1112.0,14280.0,2662.0,1610.0,38430.0
Bhind,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,607.0,627.0,466.0,11059.0,2120.0,750.0,611.0,818.0,833.0,15320.0,2555.0,1289.0,37055.0
Bhind,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bhind,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,903.0,1714.0,1752.0,1762.0,1744.0,1594.0,1291.0,1195.0,1191.0,963.0,852.0,829.0,15790.0
Bhind,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,124.0,79.0,257.0,15.0,54.0,131.0,82.0,62.0,19.0,14.0,16.0,0.0,853.0
Bhind,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,135.0,150.0,131.0,247.0,217.0,199.0,330.0,394.0,346.0,323.0,308.0,181.0,2961.0
Bhind,13.1,Number of Patients operated for cataract,TOTAL,31.0,9.0,137.0,0.0,11.0,12.0,27.0,211.0,241.0,123.0,30.0,136.0,968.0
Bhind,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,31.0,9.0,5.0,0.0,11.0,12.0,16.0,211.0,241.0,123.0,30.0,136.0,825.0
Bhind,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,34.0,0.0,44.0,95.0,59.0,239.0,108.0,60.0,23.0,31.0,693.0
Bhind,13.4,Number of children provided free glasses,TOTAL,17.0,27.0,22.0,7.0,40.0,50.0,44.0,99.0,112.0,30.0,7.0,22.0,477.0
Bhind,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,7.0,7.0,7.0,7.0,7.0,6.0,6.0,6.0,7.0,4.0,5.0,-1.0
Bhind,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,4.0,3.0,3.0,3.0,3.0,4.0,4.0,4.0,4.0,8.0,8.0,8.0,-1.0
Bhind,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,801.0,993.0,827.0,837.0,868.0,977.0,872.0,1032.0,1016.0,1032.0,1104.0,1032.0,-1.0
Bhind,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,8.0,8.0,8.0,8.0,8.0,7.0,7.0,7.0,8.0,5.0,5.0,-1.0
Bhind,14.05,Number of RKS meetings held during the month,TOTAL,1.0,4.0,3.0,1.0,0.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,17.0
Bhind,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,10.0,9.0,9.0,10.0,10.0,10.0,9.0,15.0,15.0,18.0,11.0,14.0,-1.0
Bhind,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,26.0,38.0,31.0,67.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,162.0
Bhind,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,4.0,4.0,4.0,5.0,4.0,5.0,-1.0
Bhind,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,4.0,4.0,3.0,-1.0
Bhind,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,304.0,819.0,908.0,700.0,631.0,702.0,515.0,427.0,945.0,806.0,473.0,461.0,7691.0
Bhind,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1634.0,2514.0,2689.0,2322.0,2032.0,2411.0,1886.0,1721.0,767.0,302.0,1984.0,1799.0,22061.0
Bhind,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,208.0,512.0,569.0,443.0,426.0,471.0,325.0,285.0,1856.0,597.0,309.0,227.0,6228.0
Bhind,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2143.0,2438.0,3856.0,4023.0,5062.0,4609.0,4100.0,2399.0,1259.0,1251.0,2755.0,1170.0,35065.0
Bhind,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,512.0,1331.0,1477.0,1143.0,1057.0,1173.0,840.0,712.0,2801.0,1403.0,782.0,688.0,13919.0
Bhind,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3777.0,4952.0,6545.0,6345.0,7094.0,7020.0,5986.0,4120.0,2026.0,1553.0,4739.0,2969.0,57126.0
Bhind,14.10.2.a,Number of death cases of Inpatient males,TOTAL,10.0,16.0,27.0,31.0,24.0,31.0,34.0,25.0,20.0,24.0,25.0,28.0,295.0
Bhind,14.10.2.b,Number of death cases of Inpatient females,TOTAL,11.0,15.0,18.0,18.0,16.0,34.0,25.0,25.0,7.0,9.0,16.0,14.0,208.0
Bhind,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,21.0,31.0,45.0,49.0,40.0,65.0,59.0,50.0,27.0,33.0,41.0,42.0,503.0
Bhind,14.11,In-Patient Head Count at midnight,TOTAL,3420.0,5285.0,6499.0,6131.0,6792.0,6455.0,5261.0,5032.0,3943.0,3583.0,989.0,2835.0,56225.0
Bhind,14.12.1,OPD attendance (All),TOTAL,43515.0,73561.0,72376.0,74125.0,85791.0,96128.0,69665.0,71874.0,60143.0,56452.0,54419.0,92656.0,850705.0
Bhind,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,32.0,69.0,87.0,60.0,53.0,77.0,53.0,31.0,52.0,57.0,79.0,86.0,736.0
Bhind,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,8.0,5.0,3.0,3.0,3.0,3.0,3.0,18.0,1.0,1.0,1.0,1.0,50.0
Bhind,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,163.0,348.0,240.0,247.0,545.0,588.0,356.0,508.0,580.0,310.0,358.0,280.0,4523.0
Bhind,14.14.a,Number of patients given AYUSH treatment,TOTAL,891.0,616.0,1682.0,1663.0,1524.0,2131.0,2007.0,1265.0,1637.0,1495.0,1744.0,1844.0,18499.0
Bhind,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,105.0,196.0,252.0,177.0,115.0,205.0,168.0,163.0,223.0,123.0,124.0,236.0,2087.0
Bhind,14.14.c,Number of Adolescents counselled,TOTAL,66.0,67.0,34.0,18.0,32.0,32.0,46.0,45.0,72.0,59.0,36.0,45.0,552.0
Bhind,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6710.0,9695.0,9591.0,11211.0,11054.0,11549.0,9360.0,11711.0,8966.0,6964.0,8073.0,9328.0,114212.0
Bhind,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,288.0,439.0,445.0,537.0,519.0,693.0,523.0,675.0,441.0,359.0,365.0,363.0,5647.0
Bhind,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,29.0,50.0,54.0,95.0,118.0,144.0,69.0,64.0,69.0,23.0,34.0,69.0,818.0
Bhind,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,5.0,2.0,4.0,4.0,7.0,1.0,2.0,0.0,1.0,0.0,0.0,26.0
Bhind,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,38.0,61.0,63.0,89.0,117.0,165.0,91.0,116.0,93.0,59.0,62.0,136.0,1090.0
Bhind,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,5.0,1.0,5.0,5.0,2.0,0.0,1.0,0.0,0.0,0.0,2.0,22.0
Bhind,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,467.0,921.0,1248.0,1860.0,1480.0,1722.0,1101.0,1837.0,691.0,667.0,605.0,551.0,13150.0
Bhind,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,12.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,46.0,0.0,1.0,61.0
Bhind,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,534.0,1032.0,1365.0,2044.0,1715.0,2031.0,1261.0,2017.0,853.0,749.0,701.0,756.0,15058.0
Bhind,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,22.0,3.0,9.0,10.0,9.0,1.0,3.0,0.0,47.0,0.0,3.0,109.0
Bhind,15.2,Number of Widal tests conducted,Number tested,559.0,849.0,1011.0,876.0,1191.0,1427.0,1188.0,940.0,643.0,349.0,563.0,804.0,10400.0
Bhind,15.3.a,Number of VDRL tests conducted on males,Number tested,20.0,40.0,32.0,42.0,35.0,46.0,56.0,48.0,51.0,38.0,61.0,70.0,539.0
Bhind,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,36.0,38.0,40.0,72.0,40.0,44.0,19.0,30.0,52.0,49.0,62.0,77.0,559.0
Bhind,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,25.0,45.0,12.0,118.0,438.0,473.0,38.0,28.0,22.0,21.0,316.0,325.0,1861.0
Bhind,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,81.0,123.0,84.0,232.0,513.0,563.0,113.0,106.0,125.0,108.0,439.0,472.0,2959.0
Bhind,15.4.1,Number of blood smears examined for Malaria,TOTAL,10446.0,11717.0,16849.0,17812.0,21623.0,25603.0,19642.0,14134.0,10956.0,6028.0,10343.0,12912.0,178065.0
Bhind,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,53.0,211.0,412.0,749.0,534.0,644.0,545.0,213.0,163.0,27.0,14.0,24.0,3589.0
Bhind,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,0.0,0.0,0.0,3.0,4.0,7.0,54.0,53.0,0.0,0.0,0.0,122.0
Bhind,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Bhind,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Bhind,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Bhind,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Bhind,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Bhind,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Bhind,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Bhind,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Bhind,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Bhind,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bhind,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bhind,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bhind,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bhind,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bhind,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Bhind,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Bhind,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Bhind,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Bhind,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Bhind,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Bhind,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Bhind,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Bhind,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Bhind,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Bhind,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Bhind,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Bhind,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Bhind,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Bhind,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Bhind,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Bhind,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Bhind,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhind,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,2.0,1.0,,2.0,,,3.0,2.0,,,7.0,17.0
Bhind,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,2.0,4.0,1.0,2.0,1.0,2.0,3.0,,1.0,,,17.0
Bhind,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,1.0,,,,,,,,1.0
Bhind,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,2.0,4.0,1.0,3.0,1.0,2.0,3.0,,1.0,,,18.0
Bhind,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,2.0,1.0,,,,,1.0,1.0,2.0,4.0,1.0,12.0
Bhind,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bhind,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,2.0,1.0,,,,,1.0,1.0,2.0,4.0,1.0,12.0
Bhind,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,2.0,9.0,10.0,13.0,7.0,9.0,8.0,4.0,3.0,2.0,5.0,74.0
Bhind,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,1.0,,1.0,1.0,1.0,,,,,4.0,8.0
Bhind,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,2.0,10.0,10.0,14.0,8.0,10.0,8.0,4.0,3.0,2.0,9.0,82.0
Bhind,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,2.0,,1.0,6.0,5.0,6.0,1.0,2.0,2.0,3.0,6.0,35.0
Bhind,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,4.0,4.0
Bhind,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,2.0,,1.0,6.0,5.0,6.0,1.0,2.0,2.0,3.0,10.0,39.0
Bhind,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,1.0,,,4.0,5.0
Bhind,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,1.0,,,,,,1.0,,,2.0
Bhind,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,1.0,,,,,1.0,1.0,,4.0,7.0
Bhind,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,1.0,,,,,,,,1.0,2.0
Bhind,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,1.0,,1.0
Bhind,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,1.0,,,,,,,1.0,1.0,3.0
Bhind,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,1.0,1.0,1.0,,,,,,1.0,3.0,8.0
Bhind,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,3.0,2.0,1.0,1.0,,,,,4.0,11.0
Bhind,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,1.0,4.0,3.0,1.0,1.0,,,,1.0,7.0,19.0
Bhind,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bhind,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bhind,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Bhind,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,2.0,2.0,,,2.0,2.0,1.0,4.0,8.0,21.0
Bhind,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,2.0,,,2.0,1.0,,,,,5.0
Bhind,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,4.0,2.0,,2.0,3.0,2.0,1.0,4.0,8.0,26.0
Bhind,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Bhind,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Bhind,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Bhind,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,1.0,1.0,,,,,,,,,2.0
Bhind,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Bhind,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,1.0,,,,2.0,,1.0,,4.0
Bhind,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,1.0,1.0,,1.0,3.0
Bhind,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,1.0,,,,3.0,1.0,1.0,1.0,7.0
Bhind,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Bhind,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,1.0,3.0,1.0,2.0,3.0,3.0,3.0,,1.0,,18.0
Bhind,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,3.0,8.0,11.0,10.0,6.0,11.0,11.0,7.0,7.0,,2.0,78.0
Bhind,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,4.0,9.0,14.0,11.0,8.0,14.0,14.0,10.0,7.0,1.0,2.0,96.0
Bhind,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bhind,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Bhind,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Bhind,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Bhind,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Bhind,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,1.0,,4.0,1.0,2.0,,,3.0,3.0,15.0
Bhind,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,6.0,2.0,5.0,2.0,3.0,4.0,17.0,39.0
Bhind,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,1.0,1.0,,11.0,3.0,7.0,2.0,3.0,7.0,20.0,55.0
Bhind,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Bhind,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Bhind,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Bhind,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Bhind,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Bhind,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,3.0,,,1.0,1.0,2.0,2.0,2.0,1.0,2.0,4.0,19.0
Bhind,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,7.0,10.0,16.0,12.0,8.0,20.0,8.0,18.0,9.0,12.0,12.0,20.0,152.0
Bhind,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,8.0,13.0,16.0,12.0,9.0,21.0,10.0,20.0,11.0,13.0,14.0,24.0,171.0
Bhind,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Bhind,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,1.0,,1.0,1.0,2.0,,,1.0,,,1.0,9.0
Bhind,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,6.0,3.0,14.0,6.0,3.0,15.0,7.0,14.0,6.0,8.0,9.0,9.0,100.0
Bhind,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,8.0,4.0,14.0,7.0,4.0,17.0,7.0,15.0,7.0,8.0,9.0,10.0,110.0
Bhind,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bhind,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Bhind,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bhind,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Bhind,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bhind,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,2.0,,,,,,,,,,1.0,,3.0
Bhind,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bhind,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,2.0,,,,,,,,,,1.0,,3.0
Bhind,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bhind,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,1.0,1.0,,,,,,,,,2.0
Bhind,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Bhind,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,1.0,1.0,,,,,,,,,2.0
Bhind,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bhind,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,1.0,,1.0
Bhind,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bhind,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,1.0,,1.0
Bhind,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bhind,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,1.0,1.0,,,,,,,2.0
Bhind,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bhind,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,1.0,1.0,,,,,,,2.0
Bhind,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bhind,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,,2.0,1.0,,,2.0,,1.0,2.0,1.0,10.0
Bhind,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Bhind,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,,2.0,1.0,,,2.0,,1.0,2.0,1.0,10.0
Bhind,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,2.0,1.0,,,,,,1.0,,,1.0,,5.0
Bhind,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,7.0,7.0,4.0,5.0,5.0,4.0,4.0,2.0,2.0,1.0,2.0,44.0
Bhind,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,1.0,1.0,,1.0,2.0,2.0,2.0,1.0,2.0,,2.0,15.0
Bhind,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,9.0,8.0,4.0,6.0,7.0,6.0,7.0,3.0,4.0,2.0,4.0,64.0
Bhind,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Bhind,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,1.0,3.0,3.0,1.0,,5.0,,2.0,,2.0,17.0
Bhind,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Bhind,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,1.0,3.0,3.0,1.0,,5.0,,2.0,,2.0,17.0
Bhind,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,1.0,,1.0,,,,,,2.0
Bhind,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Bhind,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,1.0,,1.0,,,,,,2.0
Bhind,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,3.0,,2.0,,,,,,5.0
Bhind,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Bhind,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,1.0,,,,,,2.0,1.0,4.0
Bhind,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Bhind,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,1.0,,,,,,3.0,1.0,5.0
Bhind,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Bhind,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,2.0,,1.0,1.0,2.0,,,1.0,1.0,,3.0,12.0
Bhind,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,2.0,4.0,4.0,1.0,1.0,2.0,3.0,,2.0,19.0
Bhind,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,2.0,,3.0,5.0,6.0,1.0,1.0,3.0,4.0,,5.0,31.0
Bhind,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,,,,,1.0,,,,,,2.0
Bhind,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,2.0,,2.0,,5.0,1.0,1.0,1.0,,,1.0,14.0
Bhind,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,2.0,4.0,1.0,3.0,5.0,2.0,2.0,4.0,4.0,1.0,1.0,30.0
Bhind,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,2.0,5.0,4.0,3.0,3.0,10.0,4.0,3.0,5.0,4.0,1.0,2.0,46.0
Bhopal,1.1,Total number of pregnant women Registered for ANC,TOTAL,5213.0,5240.0,5313.0,5689.0,4840.0,4843.0,4306.0,4768.0,4781.0,4478.0,4909.0,4923.0,59303.0
Bhopal,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2764.0,2839.0,3584.0,3626.0,3032.0,2937.0,2786.0,3264.0,3180.0,3156.0,3529.0,3468.0,38165.0
Bhopal,1.2,Number of Pregnant women registered under JSY,TOTAL,4304.0,4271.0,4406.0,4778.0,3835.0,4850.0,3427.0,3965.0,3821.0,3631.0,4003.0,4177.0,49468.0
Bhopal,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3469.0,3751.0,5033.0,4516.0,4651.0,4709.0,4088.0,4916.0,5280.0,4978.0,4738.0,4736.0,54865.0
Bhopal,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3841.0,3888.0,3279.0,4289.0,4115.0,4735.0,3520.0,4929.0,4376.0,3881.0,3594.0,3622.0,48069.0
Bhopal,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4063.0,3760.0,4239.0,4078.0,4409.0,4657.0,3486.0,4614.0,4017.0,3826.0,3639.0,4043.0,48831.0
Bhopal,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4960.0,5286.0,5320.0,6196.0,6406.0,7098.0,5358.0,6426.0,5577.0,5708.0,6209.0,6293.0,70837.0
Bhopal,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,369.0,610.0,350.0,726.0,492.0,631.0,383.0,446.0,569.0,371.0,649.0,454.0,6050.0
Bhopal,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,24.0,28.0,14.0,43.0,11.0,19.0,21.0,19.0,25.0,15.0,24.0,14.0,257.0
Bhopal,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,4468.0,4340.0,4578.0,4787.0,5194.0,5098.0,4248.0,5580.0,4403.0,2011.0,3775.0,3073.0,51555.0
Bhopal,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,170.0,320.0,228.0,266.0,173.0,222.0,182.0,264.0,243.0,151.0,111.0,150.0,2480.0
Bhopal,1.8,Number of pregnancy test kits used at SC level,TOTAL,22.0,107.0,188.0,188.0,159.0,223.0,256.0,244.0,271.0,246.0,254.0,273.0,2431.0
Bhopal,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,28.0,66.0,60.0,39.0,46.0,65.0,36.0,59.0,66.0,42.0,50.0,67.0,624.0
Bhopal,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,62.0,58.0,84.0,98.0,113.0,91.0,103.0,105.0,98.0,88.0,119.0,94.0,1113.0
Bhopal,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,90.0,124.0,144.0,137.0,159.0,156.0,139.0,164.0,164.0,130.0,169.0,161.0,1737.0
Bhopal,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,65.0,80.0,110.0,104.0,99.0,134.0,116.0,136.0,135.0,102.0,137.0,132.0,1350.0
Bhopal,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,13.0,3.0,0.0,0.0,2.0,2.0,0.0,0.0,5.0,0.0,19.0,44.0
Bhopal,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2340.0,2420.0,2756.0,2738.0,3196.0,3164.0,2872.0,3058.0,2943.0,2755.0,2722.0,2692.0,33656.0
Bhopal,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,854.0,691.0,730.0,921.0,445.0,276.0,807.0,844.0,387.0,32.0,681.0,53.0,6721.0
Bhopal,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2006.0,2215.0,2573.0,2429.0,2670.0,3120.0,2430.0,2904.0,2925.0,2614.0,2635.0,2576.0,31097.0
Bhopal,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,803.0,686.0,859.0,1446.0,1531.0,818.0,1236.0,1060.0,1023.0,858.0,1495.0,1055.0,12870.0
Bhopal,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,534.0,651.0,622.0,398.0,514.0,584.0,578.0,653.0,843.0,707.0,580.0,676.0,7340.0
Bhopal,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,788.0,870.0,1063.0,979.0,1097.0,1124.0,1005.0,1005.0,1075.0,949.0,990.0,1063.0,12008.0
Bhopal,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Bhopal,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Bhopal,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Bhopal,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,16.0,32.0,29.0,28.0,21.0,30.0,13.0,20.0,24.0,13.0,19.0,11.0,256.0
Bhopal,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,449.0,477.0,486.0,609.0,572.0,596.0,535.0,602.0,530.0,584.0,495.0,598.0,6533.0
Bhopal,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhopal,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,465.0,509.0,515.0,637.0,593.0,626.0,548.0,622.0,554.0,597.0,514.0,609.0,6789.0
Bhopal,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,376.0,442.0,461.0,466.0,571.0,581.0,497.0,569.0,544.0,549.0,525.0,517.0,6098.0
Bhopal,4.1.1.a,Number of male live births,TOTAL,1663.0,1773.0,2021.0,1964.0,2248.0,2269.0,2077.0,2169.0,2175.0,1965.0,2037.0,1936.0,24297.0
Bhopal,4.1.1.b,Number of female live births,TOTAL,1506.0,1564.0,1871.0,1821.0,2160.0,2115.0,1888.0,2022.0,1935.0,1825.0,1790.0,1876.0,22373.0
Bhopal,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3169.0,3337.0,3892.0,3785.0,4408.0,4384.0,3965.0,4191.0,4110.0,3790.0,3827.0,3812.0,46670.0
Bhopal,4.1.2,Number of still births,TOTAL,76.0,87.0,100.0,90.0,99.0,85.0,78.0,73.0,109.0,84.0,97.0,127.0,1105.0
Bhopal,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,497.0,589.0,519.0,685.0,582.0,635.0,507.0,579.0,600.0,617.0,838.0,681.0,7329.0
Bhopal,4.2.1,Number of Newborns weighed at birth,TOTAL,3081.0,3255.0,3839.0,3729.0,4291.0,4280.0,3903.0,4080.0,4044.0,3739.0,3799.0,3779.0,45819.0
Bhopal,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,340.0,389.0,452.0,463.0,539.0,610.0,585.0,582.0,519.0,412.0,482.0,522.0,5895.0
Bhopal,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2904.0,3156.0,3764.0,3646.0,4196.0,4157.0,3764.0,3991.0,3952.0,3608.0,3653.0,3634.0,44425.0
Bhopal,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,22.0,12.0,5.0,14.0,13.0,13.0,4.0,29.0,16.0,23.0,33.0,22.0,206.0
Bhopal,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,70.0,101.0,120.0,56.0,65.0,83.0,79.0,81.0,80.0,101.0,103.0,111.0,1050.0
Bhopal,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,687.0,726.0,598.0,710.0,787.0,792.0,648.0,732.0,678.0,579.0,719.0,861.0,8517.0
Bhopal,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhopal,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,779.0,839.0,723.0,780.0,865.0,888.0,731.0,842.0,774.0,703.0,855.0,994.0,9773.0
Bhopal,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,218.0,202.0,128.0,249.0,211.0,165.0,121.0,140.0,160.0,108.0,103.0,160.0,1965.0
Bhopal,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,769.0,586.0,571.0,805.0,779.0,945.0,761.0,796.0,797.0,779.0,902.0,928.0,9418.0
Bhopal,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,128.0,74.0,77.0,103.0,95.0,128.0,109.0,96.0,162.0,90.0,125.0,204.0,1391.0
Bhopal,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,735.0,802.0,652.0,957.0,1002.0,967.0,705.0,882.0,837.0,729.0,887.0,1062.0,10217.0
Bhopal,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,205.0,165.0,144.0,134.0,153.0,247.0,190.0,207.0,214.0,185.0,163.0,121.0,2128.0
Bhopal,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,3149.0,3343.0,3839.0,3719.0,4298.0,4359.0,3738.0,3988.0,4110.0,3789.0,3823.0,3663.0,45818.0
Bhopal,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1476.0,2346.0,1794.0,2427.0,3091.0,2981.0,3026.0,2923.0,3058.0,3515.0,3368.0,3132.0,33137.0
Bhopal,6.3,PNC maternal complications attended,TOTAL,47.0,11.0,5.0,7.0,13.0,20.0,15.0,8.0,5.0,6.0,7.0,66.0,210.0
Bhopal,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,119.0,131.0,154.0,156.0,128.0,147.0,108.0,174.0,158.0,210.0,203.0,190.0,1878.0
Bhopal,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,3.0,7.0,6.0,12.0,1.0,1.0,1.0,1.0,4.0,0.0,6.0,4.0,46.0
Bhopal,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,122.0,138.0,160.0,168.0,129.0,148.0,109.0,175.0,162.0,210.0,209.0,194.0,1924.0
Bhopal,7.2,Number of MTPs conducted at Private Facilities,TOTAL,265.0,401.0,373.0,406.0,346.0,392.0,315.0,322.0,410.0,315.0,457.0,403.0,4405.0
Bhopal,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,498.0,519.0,253.0,281.0,163.0,253.0,198.0,267.0,252.0,228.0,420.0,279.0,3611.0
Bhopal,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,743.0,962.0,522.0,912.0,757.0,1235.0,703.0,981.0,1023.0,956.0,935.0,880.0,10609.0
Bhopal,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1241.0,1481.0,775.0,1193.0,920.0,1488.0,901.0,1248.0,1275.0,1184.0,1355.0,1159.0,14220.0
Bhopal,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,9.0,23.0,22.0,11.0,16.0,24.0,7.0,21.0,25.0,6.0,265.0,15.0,444.0
Bhopal,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,6.0,2.0,1.0,11.0
Bhopal,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,23.0,12.0,15.0,12.0,25.0,18.0,10.0,25.0,33.0,44.0,37.0,32.0,286.0
Bhopal,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhopal,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,23.0,12.0,15.0,12.0,25.0,18.0,11.0,25.0,34.0,50.0,39.0,33.0,297.0
Bhopal,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,1.0,4.0,0.0,4.0,8.0,8.0,8.0,13.0,20.0,21.0,17.0,63.0,167.0
Bhopal,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,12.0,0.0,6.0,0.0,0.0,0.0,0.0,18.0
Bhopal,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,18.0,9.0,21.0,37.0,24.0,44.0,31.0,314.0,523.0,222.0,190.0,22.0,1455.0
Bhopal,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,138.0,98.0,123.0,96.0,103.0,132.0,69.0,404.0,481.0,473.0,366.0,203.0,2686.0
Bhopal,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhopal,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,156.0,107.0,144.0,133.0,127.0,188.0,100.0,724.0,1004.0,695.0,556.0,225.0,4159.0
Bhopal,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,383.0,173.0,362.0,293.0,109.0,84.0,289.0,152.0,252.0,411.0,157.0,225.0,2890.0
Bhopal,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,1.0,7.0,5.0,8.0,8.0,6.0,5.0,12.0,9.0,5.0,7.0,0.0,73.0
Bhopal,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,29.0,42.0,73.0,45.0,59.0,88.0,56.0,97.0,92.0,182.0,23.0,30.0,816.0
Bhopal,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhopal,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,30.0,49.0,78.0,53.0,67.0,94.0,61.0,109.0,101.0,187.0,30.0,30.0,889.0
Bhopal,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,294.0,233.0,357.0,291.0,56.0,67.0,353.0,53.0,152.0,339.0,133.0,156.0,2484.0
Bhopal,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,5.0,6.0,1.0,6.0,6.0,2.0,5.0,9.0,23.0,8.0,8.0,7.0,86.0
Bhopal,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,79.0,129.0,111.0,151.0,158.0,139.0,104.0,143.0,127.0,188.0,125.0,99.0,1553.0
Bhopal,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhopal,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,84.0,135.0,112.0,157.0,164.0,141.0,109.0,152.0,150.0,196.0,133.0,106.0,1639.0
Bhopal,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,21.0,172.0,71.0,52.0,95.0,93.0,68.0,30.0,135.0,326.0,152.0,198.0,1413.0
Bhopal,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,71.0,90.0,89.0,159.0,111.0,106.0,103.0,144.0,132.0,133.0,144.0,144.0,1426.0
Bhopal,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,23.0,15.0,24.0,30.0,33.0,23.0,26.0,27.0,25.0,31.0,24.0,26.0,307.0
Bhopal,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,79.0,96.0,83.0,61.0,49.0,58.0,49.0,52.0,58.0,114.0,44.0,33.0,776.0
Bhopal,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,503.0,246.0,338.0,296.0,319.0,219.0,199.0,217.0,293.0,392.0,244.0,172.0,3438.0
Bhopal,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bhopal,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,676.0,447.0,534.0,546.0,512.0,406.0,377.0,440.0,508.0,670.0,456.0,375.0,5947.0
Bhopal,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,318.0,275.0,255.0,288.0,237.0,176.0,96.0,222.0,258.0,334.0,168.0,261.0,2888.0
Bhopal,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,76.0,119.0,114.0,177.0,156.0,215.0,148.0,79.0,218.0,134.0,172.0,154.0,1762.0
Bhopal,9.06,Number of IUCD removals,TOTAL,282.0,165.0,128.0,129.0,168.0,205.0,465.0,310.0,297.0,126.0,158.0,288.0,2721.0
Bhopal,9.07,Number of Oral Pills cycles distributed,TOTAL,5375.0,5338.0,5711.0,5843.0,6762.0,8294.0,8195.0,3581.0,7309.0,6373.0,7347.0,11305.0,81433.0
Bhopal,9.08,Number of Condom pieces distributed,TOTAL,34632.0,70272.0,52549.0,48514.0,56607.0,70029.0,43323.0,24348.0,51027.0,65566.0,74029.0,86246.0,677142.0
Bhopal,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,4.0,0.0,0.0,6.0,14.0,9.0,112.0,167.0,85.0,117.0,514.0
Bhopal,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,1.0,0.0,5.0,1.0,0.0,0.0,7.0,0.0,0.0,5.0,1.0,20.0
Bhopal,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,9.11.2.b,Number of failures following female sterilization,TOTAL,2.0,1.0,3.0,4.0,6.0,10.0,3.0,0.0,2.0,0.0,3.0,2.0,36.0
Bhopal,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,9.12,Number of Institutions having NSV trained doctors,TOTAL,6.0,7.0,8.0,13.0,10.0,14.0,9.0,4.0,8.0,7.0,9.0,9.0,-1.0
Bhopal,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3089.0,3247.0,3825.0,3721.0,4367.0,4376.0,3926.0,4170.0,4079.0,3809.0,3805.0,3811.0,46225.0
Bhopal,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3350.0,3115.0,3718.0,3134.0,2970.0,3706.0,2841.0,1025.0,476.0,276.0,228.0,368.0,25207.0
Bhopal,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3346.0,3182.0,3484.0,3185.0,2824.0,3587.0,2646.0,4102.0,1572.0,725.0,493.0,360.0,29506.0
Bhopal,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3421.0,2999.0,3537.0,3106.0,2943.0,3645.0,2290.0,4135.0,3258.0,1439.0,925.0,650.0,32348.0
Bhopal,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3234.0,3036.0,2984.0,3300.0,3397.0,15954.0
Bhopal,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2261.0,2567.0,3058.0,3375.0,11261.0
Bhopal,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,1830.0,2540.0,3482.0,7864.0
Bhopal,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2927.0,3132.0,3501.0,3453.0,4044.0,3865.0,3710.0,3825.0,3577.0,3526.0,3621.0,3518.0,42699.0
Bhopal,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3309.0,2981.0,3517.0,3140.0,2963.0,1977.0,2816.0,4098.0,3278.0,3117.0,3222.0,3495.0,37913.0
Bhopal,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3269.0,2996.0,3489.0,3195.0,2819.0,3603.0,2616.0,4001.0,3420.0,3012.0,3199.0,3475.0,39094.0
Bhopal,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3426.0,2938.0,3471.0,3060.0,2920.0,3623.0,2284.0,3792.0,3227.0,2672.0,3035.0,3847.0,38295.0
Bhopal,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2633.0,2972.0,3008.0,3082.0,3499.0,3695.0,3399.0,3334.0,3125.0,2572.0,3213.0,3005.0,37537.0
Bhopal,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,3317.0,2977.0,3485.0,3120.0,2946.0,1985.0,2817.0,1001.0,714.0,514.0,449.0,370.0,23695.0
Bhopal,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,3256.0,2996.0,3455.0,3198.0,2813.0,3583.0,2614.0,3709.0,1855.0,903.0,683.0,441.0,29506.0
Bhopal,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3395.0,2941.0,3527.0,3138.0,2908.0,3650.0,2284.0,3652.0,3167.0,1683.0,1017.0,675.0,32037.0
Bhopal,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3351.0,3229.0,4589.0,3378.0,3296.0,3893.0,2758.0,4116.0,3256.0,3021.0,3302.0,3695.0,41884.0
Bhopal,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1061.0,1220.0,1576.0,2394.0,1598.0,2012.0,1568.0,2153.0,2081.0,1903.0,1900.0,2578.0,22044.0
Bhopal,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1645.0,1609.0,2340.0,1684.0,1746.0,1981.0,1433.0,2131.0,1656.0,1397.0,1661.0,1920.0,21203.0
Bhopal,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1455.0,1492.0,2111.0,1580.0,1524.0,1836.0,1223.0,1947.0,1507.0,1203.0,1501.0,1755.0,19134.0
Bhopal,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3100.0,3101.0,4451.0,3264.0,3270.0,3817.0,2656.0,4078.0,3163.0,2600.0,3162.0,3675.0,40337.0
Bhopal,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2740.0,2494.0,2746.0,3027.0,2546.0,3444.0,2166.0,3593.0,2932.0,2593.0,3014.0,3211.0,34506.0
Bhopal,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2745.0,2486.0,2726.0,3028.0,2527.0,3445.0,2171.0,3570.0,2923.0,2589.0,3014.0,3207.0,34431.0
Bhopal,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,530.0,616.0,816.0,733.0,433.0,821.0,645.0,1320.0,592.0,665.0,815.0,678.0,8664.0
Bhopal,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,442.0,535.0,684.0,638.0,477.0,672.0,598.0,1832.0,542.0,424.0,665.0,718.0,8227.0
Bhopal,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,972.0,1151.0,1500.0,1371.0,910.0,1493.0,1243.0,3152.0,1134.0,1089.0,1480.0,1396.0,16891.0
Bhopal,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1566.0,1300.0,1751.0,1746.0,1358.0,1811.0,1379.0,2002.0,1746.0,1663.0,1650.0,1945.0,19917.0
Bhopal,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1174.0,1167.0,1486.0,1332.0,1342.0,1370.0,1273.0,1402.0,1418.0,1346.0,1436.0,1615.0,16361.0
Bhopal,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1295.0,1295.0,1459.0,1405.0,1585.0,1537.0,1243.0,1400.0,1443.0,1221.0,1290.0,1553.0,16726.0
Bhopal,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,0.0,0.0,6.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,12.0
Bhopal,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,22.0,5.0,0.0,0.0,0.0,5.0,8.0,4.0,0.0,9.0,8.0,5.0,66.0
Bhopal,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1590.0,1414.0,1374.0,1460.0,1417.0,1626.0,1278.0,1970.0,1566.0,1174.0,1558.0,1706.0,18133.0
Bhopal,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1558.0,1369.0,1314.0,1424.0,1346.0,1613.0,1255.0,1919.0,1519.0,1120.0,1525.0,1678.0,17640.0
Bhopal,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,691.0,761.0,536.0,769.0,1017.0,1201.0,985.0,1340.0,1209.0,856.0,1094.0,1370.0,11829.0
Bhopal,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3371.0,3183.0,4470.0,3461.0,3621.0,3903.0,2738.0,4108.0,3306.0,3028.0,3315.0,3721.0,42225.0
Bhopal,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,694.0,603.0,1192.0,2095.0,2629.0,1307.0,546.0,729.0,1027.0,3716.0,1232.0,761.0,16531.0
Bhopal,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,504.0,394.0,678.0,2581.0,2794.0,831.0,451.0,547.0,1098.0,4146.0,1020.0,564.0,15608.0
Bhopal,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,2.0,10.0
Bhopal,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,832.0,1120.0,4791.0,936.0,3198.0,1133.0,1478.0,823.0,1558.0,722.0,2052.0,2566.0,21209.0
Bhopal,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,82.0,210.0,159.0,153.0,89.0,113.0,98.0,48.0,34.0,87.0,26.0,35.0,1134.0
Bhopal,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,371.0,380.0,637.0,587.0,1382.0,871.0,1840.0,463.0,1806.0,418.0,2866.0,1661.0,13282.0
Bhopal,13.1,Number of Patients operated for cataract,TOTAL,670.0,940.0,796.0,861.0,905.0,1678.0,751.0,1465.0,2188.0,1544.0,1458.0,1365.0,14621.0
Bhopal,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,657.0,932.0,787.0,843.0,898.0,1670.0,743.0,1460.0,2170.0,1528.0,1449.0,1362.0,14499.0
Bhopal,13.3,Number of School children detected with Refractive errors,TOTAL,12.0,0.0,8.0,8.0,39.0,22.0,72.0,118.0,8.0,2.0,7.0,104.0,400.0
Bhopal,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,61.0,66.0,0.0,0.0,0.0,0.0,127.0
Bhopal,13.5,Number of eyes collected through eye donation,TOTAL,25.0,8.0,20.0,6.0,4.0,17.0,11.0,4.0,14.0,18.0,14.0,6.0,147.0
Bhopal,13.6,Number of eyes utilised for corneal transplant,TOTAL,25.0,3.0,13.0,6.0,3.0,10.0,10.0,2.0,10.0,8.0,5.0,5.0,100.0
Bhopal,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,5.0,5.0,5.0,5.0,6.0,5.0,5.0,5.0,4.0,6.0,6.0,-1.0
Bhopal,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2.0,3.0,2.0,4.0,4.0,5.0,5.0,2.0,1.0,1.0,2.0,2.0,-1.0
Bhopal,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1089.0,1106.0,1090.0,368.0,990.0,1219.0,336.0,1468.0,1246.0,776.0,1166.0,367.0,-1.0
Bhopal,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,10.0,8.0,7.0,8.0,9.0,8.0,8.0,7.0,9.0,9.0,9.0,-1.0
Bhopal,14.05,Number of RKS meetings held during the month,TOTAL,4.0,2.0,4.0,1.0,3.0,3.0,5.0,3.0,2.0,3.0,4.0,5.0,39.0
Bhopal,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,11.0,13.0,11.0,13.0,12.0,11.0,11.0,9.0,11.0,8.0,10.0,10.0,-1.0
Bhopal,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1224.0,816.0,873.0,583.0,1875.0,1777.0,1817.0,1095.0,1134.0,1145.0,1616.0,1090.0,15045.0
Bhopal,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,4.0,4.0,5.0,4.0,4.0,3.0,2.0,3.0,2.0,3.0,4.0,-1.0
Bhopal,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,21.0,25.0,17.0,19.0,39.0,29.0,25.0,12.0,35.0,28.0,24.0,22.0,-1.0
Bhopal,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1136.0,1378.0,1939.0,1576.0,1865.0,2690.0,2013.0,2410.0,2240.0,1993.0,2180.0,2046.0,23466.0
Bhopal,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3490.0,4684.0,4948.0,5322.0,8300.0,10529.0,7915.0,6303.0,6800.0,6179.0,8616.0,7799.0,80885.0
Bhopal,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,890.0,1044.0,1451.0,1328.0,1505.0,1978.0,1558.0,2138.0,2107.0,1975.0,1650.0,1473.0,19097.0
Bhopal,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,5897.0,7217.0,9173.0,9071.0,12131.0,8796.0,11600.0,10752.0,10790.0,9945.0,13090.0,12461.0,120923.0
Bhopal,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2026.0,2422.0,3390.0,2904.0,3370.0,4668.0,3571.0,4548.0,4347.0,3968.0,3830.0,3519.0,42563.0
Bhopal,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,9387.0,11901.0,14121.0,14393.0,20431.0,19325.0,19515.0,17055.0,17590.0,16124.0,21706.0,20260.0,201808.0
Bhopal,14.10.2.a,Number of death cases of Inpatient males,TOTAL,70.0,139.0,109.0,115.0,143.0,169.0,146.0,126.0,155.0,187.0,173.0,182.0,1714.0
Bhopal,14.10.2.b,Number of death cases of Inpatient females,TOTAL,50.0,88.0,59.0,61.0,96.0,117.0,109.0,77.0,89.0,92.0,128.0,130.0,1096.0
Bhopal,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,120.0,227.0,168.0,176.0,239.0,286.0,255.0,203.0,244.0,279.0,301.0,312.0,2810.0
Bhopal,14.11,In-Patient Head Count at midnight,TOTAL,7791.0,13965.0,17370.0,23864.0,27674.0,38078.0,31322.0,25057.0,28522.0,27568.0,38861.0,31065.0,311137.0
Bhopal,14.12.1,OPD attendance (All),TOTAL,254675.0,338620.0,313499.0,291802.0,434556.0,438157.0,273020.0,358867.0,369179.0,362759.0,416988.0,424872.0,4276994.0
Bhopal,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,2990.0,3437.0,3147.0,3249.0,4363.0,4952.0,3326.0,4089.0,5007.0,4442.0,5014.0,4414.0,48430.0
Bhopal,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,103.0,109.0,295.0,250.0,257.0,312.0,288.0,263.0,300.0,262.0,303.0,259.0,3001.0
Bhopal,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2309.0,4022.0,3693.0,2709.0,4469.0,4436.0,2251.0,3663.0,3843.0,3966.0,4650.0,4905.0,44916.0
Bhopal,14.14.a,Number of patients given AYUSH treatment,TOTAL,5930.0,6434.0,5868.0,5655.0,3516.0,4327.0,4436.0,3915.0,3977.0,3402.0,4319.0,5008.0,56787.0
Bhopal,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1826.0,2893.0,2558.0,2117.0,4814.0,3083.0,2638.0,4002.0,2819.0,2088.0,2262.0,2173.0,33273.0
Bhopal,14.14.c,Number of Adolescents counselled,TOTAL,193.0,492.0,451.0,331.0,473.0,572.0,551.0,1138.0,437.0,364.0,1233.0,2909.0,9144.0
Bhopal,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,24850.0,33745.0,28816.0,34073.0,43424.0,46077.0,44944.0,40524.0,41567.0,32220.0,46145.0,46092.0,462477.0
Bhopal,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,715.0,1758.0,1777.0,1097.0,1536.0,1784.0,2256.0,1966.0,2264.0,1479.0,1665.0,1397.0,19694.0
Bhopal,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,908.0,1631.0,854.0,1365.0,1926.0,2190.0,1827.0,1340.0,2074.0,1971.0,2308.0,1841.0,20235.0
Bhopal,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,4.0,14.0,6.0,6.0,6.0,17.0,7.0,8.0,10.0,2.0,14.0,6.0,100.0
Bhopal,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,639.0,1380.0,691.0,1286.0,2091.0,2256.0,1621.0,1156.0,1820.0,1820.0,2233.0,1612.0,18605.0
Bhopal,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,4.0,2.0,2.0,2.0,7.0,1.0,4.0,1.0,0.0,4.0,2.0,30.0
Bhopal,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3617.0,4022.0,3719.0,4224.0,4598.0,5119.0,3259.0,4803.0,4477.0,3706.0,3933.0,4145.0,49622.0
Bhopal,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,3.0,7.0,1.0,1.0,4.0,2.0,10.0,11.0,3.0,0.0,2.0,1.0,45.0
Bhopal,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,5164.0,7033.0,5264.0,6875.0,8615.0,9565.0,6707.0,7299.0,8371.0,7497.0,8474.0,7598.0,88462.0
Bhopal,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,8.0,25.0,9.0,9.0,12.0,26.0,18.0,23.0,14.0,2.0,20.0,9.0,175.0
Bhopal,15.2,Number of Widal tests conducted,Number tested,1812.0,3843.0,1684.0,2623.0,2913.0,4043.0,3996.0,2748.0,2233.0,2717.0,2878.0,3168.0,34658.0
Bhopal,15.3.a,Number of VDRL tests conducted on males,Number tested,301.0,417.0,211.0,485.0,311.0,427.0,834.0,494.0,548.0,525.0,447.0,538.0,5538.0
Bhopal,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,333.0,612.0,412.0,832.0,1024.0,1656.0,765.0,794.0,722.0,845.0,907.0,742.0,9644.0
Bhopal,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,2436.0,2952.0,2261.0,2941.0,3420.0,2741.0,2260.0,3476.0,3175.0,2333.0,3554.0,4026.0,35575.0
Bhopal,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,3070.0,3981.0,2884.0,4258.0,4755.0,4824.0,3859.0,4764.0,4445.0,3703.0,4908.0,5306.0,50757.0
Bhopal,15.4.1,Number of blood smears examined for Malaria,TOTAL,11324.0,13495.0,11551.0,14933.0,21012.0,25124.0,16479.0,12757.0,11661.0,7815.0,13424.0,12534.0,172109.0
Bhopal,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,334.0,308.0,113.0,181.0,239.0,281.0,262.0,213.0,158.0,139.0,186.0,118.0,2532.0
Bhopal,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,153.0,373.0,16.0,22.0,52.0,62.0,63.0,77.0,140.0,45.0,57.0,53.0,1113.0
Bhopal,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,17400.0,850.0,14500.0,25440.0,10640.0,9480.0,37690.0,19310.0,17460.0,24060.0,33750.0,,210580.0
Bhopal,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,30000.0,30000.0,0.0,20000.0,30000.0,10000.0,10000.0,20000.0,20000.0,0.0,,170000.0
Bhopal,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Bhopal,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,16550.0,16350.0,19060.0,14800.0,21160.0,1789.0,28380.0,11850.0,13400.0,10310.0,1500.0,,155149.0
Bhopal,16.1.1,Stock position of DPT vaccines,5. Total Stock,850.0,14500.0,25440.0,10640.0,9480.0,37691.0,19310.0,17460.0,24060.0,33750.0,32250.0,0.0,225431.0
Bhopal,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,852.0,335.0,976.0,,2163.0
Bhopal,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,1000.0,2000.0,,4000.0
Bhopal,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Bhopal,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1517.0,359.0,605.0,,2481.0
Bhopal,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,335.0,976.0,2371.0,0.0,3682.0
Bhopal,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,72180.0,0.0,25190.0,7890.0,12390.0,25260.0,49980.0,46560.0,48260.0,34740.0,46700.0,,369150.0
Bhopal,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,,0.0,20000.0,200000.0,60000.0,20000.0,20000.0,40000.0,40000.0,40000.0,,440000.0
Bhopal,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Bhopal,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,24980.0,,17300.0,15500.0,187140.0,35280.0,23420.0,18300.0,53520.0,28040.0,43400.0,,446880.0
Bhopal,16.1.2,Stock position of OPV vaccines,5. Total Stock,47200.0,0.0,7890.0,12390.0,25250.0,49980.0,46560.0,48260.0,34740.0,46700.0,43300.0,0.0,362270.0
Bhopal,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,23700.0,,22500.0,9850.0,4300.0,10930.0,22780.0,21560.0,22560.0,21360.0,29860.0,,189400.0
Bhopal,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,,0.0,0.0,20000.0,30000.0,10000.0,10000.0,10000.0,20000.0,0.0,,100000.0
Bhopal,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Bhopal,16.1.3,Stock position of TT vaccines,4. Stock Distributed,11500.0,,12650.0,5550.0,13370.0,18150.0,11220.0,9000.0,11200.0,11500.0,1500.0,,105640.0
Bhopal,16.1.3,Stock position of TT vaccines,5. Total Stock,12200.0,0.0,9850.0,4300.0,10930.0,22780.0,21560.0,22560.0,21360.0,29860.0,28360.0,0.0,183760.0
Bhopal,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Bhopal,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Bhopal,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Bhopal,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Bhopal,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,21280.0,,15180.0,25730.0,15810.0,28790.0,16790.0,17640.0,17050.0,26080.0,36830.0,,221180.0
Bhopal,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,,20000.0,0.0,20000.0,20000.0,10000.0,10000.0,20000.0,20000.0,0.0,,120000.0
Bhopal,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Bhopal,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,7550.0,,9450.0,9920.0,7020.0,32000.0,9150.0,10590.0,10970.0,9250.0,2100.0,,108000.0
Bhopal,16.1.5,Stock position of BCG vaccines,5. Total Stock,13730.0,0.0,25730.0,15810.0,28790.0,16790.0,17640.0,17050.0,26080.0,36830.0,34730.0,0.0,233180.0
Bhopal,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3675.0,,460.0,0.0,23645.0,16995.0,11860.0,3435.0,450.0,2575.0,1550.0,,64645.0
Bhopal,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,,7500.0,30000.0,30000.0,5000.0,0.0,5000.0,10000.0,3000.0,0.0,,95500.0
Bhopal,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,10.0
Bhopal,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3640.0,,7950.0,6355.0,36650.0,10135.0,8425.0,7985.0,7875.0,4025.0,1550.0,,94590.0
Bhopal,16.1.6,Stock position of Measles vaccines,5. Total Stock,5035.0,0.0,0.0,23645.0,16995.0,11860.0,3435.0,450.0,2575.0,1550.0,0.0,0.0,65545.0
Bhopal,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Bhopal,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Bhopal,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Bhopal,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Bhopal,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,11940.0,,13850.0,27030.0,14030.0,10060.0,16280.0,14140.0,12190.0,20600.0,34470.0,,174590.0
Bhopal,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,,30000.0,0.0,10000.0,20000.0,10000.0,10000.0,20000.0,20000.0,0.0,,120000.0
Bhopal,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Bhopal,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,10250.0,,16820.0,13000.0,13970.0,13780.0,12130.0,11950.0,11590.0,6130.0,700.0,,110320.0
Bhopal,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1690.0,0.0,27030.0,14030.0,10060.0,16280.0,14150.0,12190.0,20600.0,34470.0,33770.0,0.0,184270.0
Bhopal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2200.0,2100.0,1395.0,1145.0,6840.0
Bhopal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0,3000.0
Bhopal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,705.0,250.0,1745.0,2800.0
Bhopal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2100.0,1395.0,1145.0,2400.0,7040.0
Bhopal,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,419440.0,585700.0,447700.0,371700.0,309710.0,197125.0,358525.0,322525.0,218425.0,143445.0,381945.0,345945.0,4102185.0
Bhopal,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,300000.0,0.0,30000.0,0.0,0.0,300000.0,0.0,0.0,0.0,300000.0,0.0,30000.0,960000.0
Bhopal,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,133740.0,138000.0,106000.0,61990.0,112585.0,138600.0,36000.0,104100.0,74980.0,61500.0,36000.0,369945.0,1373440.0
Bhopal,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,585700.0,447700.0,371700.0,309710.0,197125.0,358525.0,322525.0,218425.0,143445.0,381945.0,345945.0,6000.0,3688745.0
Bhopal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,900.0,2400.0,0.0,2300.0,3400.0,2900.0,12400.0,8400.0,8000.0,5800.0,3400.0,600.0,50500.0
Bhopal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,2100.0,0.0,0.0,1500.0,0.0,10000.0,0.0,0.0,0.0,2400.0,0.0,41100.0,57100.0
Bhopal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,600.0,0.0,0.0,400.0,500.0,500.0,4000.0,400.0,2200.0,7500.0,2800.0,7000.0,25900.0
Bhopal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,2400.0,2400.0,0.0,3400.0,2900.0,12400.0,8400.0,8000.0,5800.0,700.0,600.0,34700.0,81700.0
Bhopal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,30000.0,14000.0,9400.0,19600.0,16300.0,5500.0,5100.0,700.0,700.0,101300.0
Bhopal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,24000.0,0.0,0.0,0.0,0.0,0.0,102000.0,126000.0
Bhopal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,16000.0,4600.0,13800.0,3300.0,10800.0,400.0,1700.0,0.0,1500.0,52100.0
Bhopal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,14000.0,9400.0,19600.0,16300.0,5500.0,5100.0,3400.0,700.0,101200.0,175200.0
Bhopal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,4265.0,9265.0,8365.0,7865.0,7365.0,5965.0,5965.0,5565.0,5565.0,4365.0,,0.0,64550.0
Bhopal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,5000.0
Bhopal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Bhopal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,900.0,500.0,500.0,1400.0,0.0,300.0,100.0,1200.0,1765.0,,0.0,6665.0
Bhopal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,9265.0,8365.0,7865.0,7365.0,5965.0,5965.0,5665.0,5465.0,4365.0,2600.0,0.0,0.0,62885.0
Bhopal,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,1050.0,1050.0,50.0,100.0,0.0,0.0,2950.0,2500.0,2500.0,1050.0,400.0,4100.0,15750.0
Bhopal,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,50.0,0.0,0.0,8000.0,0.0,0.0,0.0,0.0,7000.0,0.0,15050.0
Bhopal,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,1000.0,0.0,100.0,0.0,0.0,450.0,0.0,1450.0,650.0,3300.0,1850.0,8800.0
Bhopal,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,1050.0,50.0,100.0,0.0,0.0,8000.0,2500.0,2500.0,1050.0,400.0,4100.0,2250.0,22000.0
Bhopal,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Bhopal,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,27500.0,27500.0,27500.0,27400.0,15300.0,15200.0,12100.0,9600.0,7000.0,4000.0,28900.0,30800.0,232800.0
Bhopal,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25000.0,5000.0,0.0,30000.0
Bhopal,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,100.0,12100.0,100.0,3100.0,2500.0,2600.0,3000.0,100.0,31000.0,17100.0,71700.0
Bhopal,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,27500.0,27500.0,27400.0,15300.0,15200.0,12100.0,9600.0,7000.0,4000.0,28900.0,2900.0,13700.0,191100.0
Bhopal,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Bhopal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Bhopal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,2973560.0,2808360.0,36460.0,2686260.0,2728760.0,3186200.0,2096700.0,1143900.0,915400.0,145644.0,3261700.0,1075700.0,23058644.0
Bhopal,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,400000.0,750000.0,0.0,0.0,0.0,0.0,0.0,0.0,3000000.0,4150000.0
Bhopal,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,165200.0,96000.0,,357500.0,292560.0,1089500.0,952800.0,750000.0,3293700.0,46655.0,2186000.0,495100.0,9725015.0
Bhopal,16.3.07,Stock Position of IFA Tablets,5. Total Stock,2808360.0,2712360.0,36460.0,2728760.0,3186200.0,2096700.0,1143900.0,393900.0,-2378300.0,98989.0,1075700.0,3580600.0,17483629.0
Bhopal,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,2675900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2675900.0
Bhopal,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,2675900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2675900.0
Bhopal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,1003.0,933.0,260.0,165.0,700.0,525.0,465.0,255.0,255.0,744.0,489.0,1399.0,7193.0
Bhopal,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,4500.0,0.0,0.0,0.0,0.0,5000.0,0.0,1000.0,5600.0,16100.0
Bhopal,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,70.0,673.0,95.0,3965.0,175.0,60.0,40.0,170.0,4511.0,255.0,90.0,260.0,10364.0
Bhopal,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,933.0,260.0,165.0,700.0,525.0,465.0,425.0,85.0,744.0,489.0,1399.0,6739.0,12929.0
Bhopal,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,90950.0,74150.0,29150.0,18120.0,7030.0,6430.0,4120.0,4120.0,2120.0,144900.0,98800.0,75800.0,555690.0
Bhopal,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,120000.0,0.0,0.0,0.0,0.0,200000.0,0.0,0.0,0.0,320000.0
Bhopal,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bhopal,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,16800.0,45000.0,11030.0,131090.0,600.0,2310.0,0.0,2000.0,144820.0,46100.0,23000.0,9050.0,431800.0
Bhopal,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,74150.0,29150.0,18120.0,7030.0,6430.0,4120.0,4120.0,2120.0,57300.0,98800.0,75800.0,66750.0,443890.0
Bhopal,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4735.0,3335.0,1112.0,885.0,1235.0,2935.0,3335.0,6135.0,10435.0,8535.0,10535.0,,53212.0
Bhopal,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,615.0,3123.0,6600.0,6600.0,6600.0,6600.0,6600.0,6600.0,6600.0,6600.0,,56538.0
Bhopal,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Bhopal,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1400.0,2838.0,3350.0,6250.0,4900.0,6200.0,3800.0,2300.0,8500.0,4600.0,11815.0,,55953.0
Bhopal,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3335.0,1112.0,885.0,1235.0,2935.0,3335.0,6135.0,10435.0,8535.0,10535.0,5320.0,0.0,53797.0
Bhopal,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,20750.0,3950.0,2850.0,450.0,9130.0,16000.0,2000.0,7300.0,38000.0,6000.0,6000.0,,112430.0
Bhopal,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,25000.0,50000.0,20000.0,20000.0,40000.0,20000.0,20000.0,50000.0,,245000.0
Bhopal,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Bhopal,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,16800.0,1100.0,2400.0,16320.0,43130.0,34000.0,14700.0,9300.0,52000.0,20000.0,39100.0,,248850.0
Bhopal,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,3950.0,2850.0,450.0,9130.0,16000.0,2000.0,7300.0,38000.0,6000.0,6000.0,16900.0,0.0,108580.0
Bhopal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2150.0,4522.0,3772.0,572.0,250.0,3872.0,3772.0,1312.0,2572.0,3452.0,3452.0,,29698.0
Bhopal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4472.0,0.0,0.0,2000.0,4000.0,2000.0,2000.0,2000.0,4000.0,4000.0,1000.0,,25472.0
Bhopal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Bhopal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2100.0,750.0,3200.0,2322.0,378.0,2100.0,4460.0,740.0,3120.0,4000.0,2000.0,,25170.0
Bhopal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,4522.0,3772.0,572.0,250.0,3872.0,3772.0,1312.0,2572.0,3452.0,3452.0,2452.0,0.0,30000.0
Bhopal,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,5.0,6.0,1.0,6.0,1.0,,1.0,1.0,1.0,3.0,8.0,4.0,37.0
Bhopal,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,7.0,6.0,12.0,3.0,8.0,5.0,5.0,2.0,6.0,5.0,4.0,6.0,69.0
Bhopal,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,3.0,,5.0,2.0,1.0,1.0,2.0,3.0,1.0,6.0,2.0,,26.0
Bhopal,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,10.0,6.0,17.0,5.0,9.0,6.0,7.0,5.0,7.0,11.0,6.0,6.0,95.0
Bhopal,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,7.0,8.0,6.0,12.0,3.0,8.0,6.0,8.0,8.0,4.0,5.0,1.0,76.0
Bhopal,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,1.0,,1.0,,,,4.0,,,,1.0,,7.0
Bhopal,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,8.0,8.0,7.0,12.0,3.0,8.0,10.0,8.0,8.0,4.0,6.0,1.0,83.0
Bhopal,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,7.0,5.0,2.0,8.0,3.0,2.0,4.0,5.0,4.0,9.0,50.0
Bhopal,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,,1.0,,,1.0,2.0,,3.0,,,8.0
Bhopal,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,,7.0,6.0,2.0,8.0,4.0,4.0,4.0,8.0,4.0,9.0,58.0
Bhopal,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,5.0,6.0,9.0,7.0,8.0,12.0,6.0,14.0,6.0,7.0,7.0,6.0,93.0
Bhopal,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,3.0,,3.0,2.0,1.0,4.0,2.0,3.0,3.0,4.0,1.0,26.0
Bhopal,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,5.0,9.0,9.0,10.0,10.0,13.0,10.0,16.0,9.0,10.0,11.0,7.0,119.0
Bhopal,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,1.0,1.0,2.0,,1.0,3.0,3.0,1.0,1.0,13.0
Bhopal,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,,,,,,,,,,1.0
Bhopal,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,,1.0,1.0,2.0,,1.0,3.0,3.0,1.0,1.0,14.0
Bhopal,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,1.0,,1.0,,,,,2.0
Bhopal,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bhopal,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,1.0,,1.0,,,,,2.0
Bhopal,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,,,,1.0,1.0,,,1.0,,1.0,5.0
Bhopal,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,1.0,,1.0,,3.0,,5.0
Bhopal,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,1.0,,,,1.0,2.0,,1.0,1.0,3.0,1.0,10.0
Bhopal,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bhopal,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bhopal,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Bhopal,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,1.0,3.0,4.0,3.0,6.0,2.0,3.0,5.0,1.0,4.0,4.0,37.0
Bhopal,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,2.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,5.0,3.0,19.0
Bhopal,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,3.0,4.0,5.0,4.0,7.0,3.0,5.0,6.0,2.0,9.0,7.0,56.0
Bhopal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Bhopal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,1.0,,,,,,,,,,2.0
Bhopal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,1.0,,,2.0,2.0,,,,,,5.0
Bhopal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,1.0,2.0,,,2.0,2.0,,,,,,8.0
Bhopal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Bhopal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,4.0,1.0,2.0,4.0,2.0,1.0,2.0,1.0,1.0,2.0,4.0,26.0
Bhopal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,2.0,1.0,3.0,5.0,2.0,2.0,2.0,1.0,4.0,2.0,25.0
Bhopal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,5.0,3.0,3.0,7.0,7.0,3.0,4.0,3.0,2.0,6.0,6.0,51.0
Bhopal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,1.0,,,,,2.0,1.0,2.0,1.0,,,7.0
Bhopal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,5.0,4.0,10.0,9.0,6.0,11.0,11.0,17.0,12.0,8.0,31.0,20.0,144.0
Bhopal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,14.0,17.0,17.0,7.0,3.0,16.0,7.0,18.0,13.0,19.0,22.0,25.0,178.0
Bhopal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,19.0,22.0,27.0,16.0,9.0,27.0,20.0,36.0,27.0,28.0,53.0,45.0,329.0
Bhopal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bhopal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,1.0,1.0,,,,3.0,,1.0,,1.0,,,7.0
Bhopal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,1.0,,1.0,,,,1.0,,,3.0
Bhopal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,1.0,,1.0,,4.0,,1.0,,2.0,,,10.0
Bhopal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,1.0,,1.0,,,,,,2.0
Bhopal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,2.0,,2.0,4.0,3.0,6.0,6.0,2.0,2.0,5.0,3.0,35.0
Bhopal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,1.0,1.0,5.0,4.0,4.0,,5.0,2.0,22.0
Bhopal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,2.0,,2.0,6.0,4.0,12.0,10.0,6.0,2.0,10.0,5.0,59.0
Bhopal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Bhopal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,,,,1.0,,,,,,2.0
Bhopal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,1.0,,,,1.0,,,2.0
Bhopal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,1.0,,,1.0,1.0,,,1.0,,,4.0
Bhopal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Bhopal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,12.0,16.0,17.0,13.0,15.0,30.0,19.0,19.0,14.0,17.0,26.0,35.0,233.0
Bhopal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,25.0,25.0,34.0,21.0,28.0,44.0,32.0,43.0,47.0,54.0,58.0,49.0,460.0
Bhopal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,37.0,41.0,51.0,34.0,43.0,74.0,51.0,62.0,62.0,71.0,84.0,84.0,694.0
Bhopal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,1.0,,1.0,1.0,,,,,1.0,4.0
Bhopal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,3.0,,5.0,3.0,12.0,12.0,9.0,2.0,6.0,7.0,3.0,8.0,70.0
Bhopal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,2.0,11.0,5.0,2.0,7.0,8.0,13.0,4.0,8.0,4.0,11.0,7.0,82.0
Bhopal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,5.0,11.0,10.0,6.0,19.0,21.0,23.0,6.0,14.0,11.0,14.0,16.0,156.0
Bhopal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bhopal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Bhopal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bhopal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,1.0,,,,,1.0
Bhopal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bhopal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,1.0,,2.0,,,1.0,,,3.0,,,1.0,8.0
Bhopal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bhopal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,1.0,,2.0,,,1.0,,,3.0,,,1.0,8.0
Bhopal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bhopal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,1.0,4.0,2.0,,,2.0,4.0,3.0,1.0,2.0,1.0,21.0
Bhopal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Bhopal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,1.0,4.0,2.0,,,2.0,4.0,3.0,1.0,2.0,1.0,21.0
Bhopal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bhopal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,3.0,,,4.0,2.0,2.0,4.0,1.0,2.0,1.0,1.0,2.0,22.0
Bhopal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bhopal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,3.0,,,4.0,2.0,2.0,4.0,1.0,2.0,1.0,1.0,2.0,22.0
Bhopal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bhopal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Bhopal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bhopal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,1.0,,,,,,,,1.0
Bhopal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bhopal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,1.0,1.0,1.0,5.0,2.0,,5.0,2.0,3.0,4.0,2.0,28.0
Bhopal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Bhopal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,1.0,1.0,1.0,5.0,2.0,,5.0,2.0,3.0,4.0,2.0,28.0
Bhopal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,1.0,1.0,,1.0,1.0,1.0,,,,,6.0
Bhopal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,9.0,16.0,15.0,14.0,18.0,16.0,20.0,18.0,17.0,18.0,19.0,19.0,199.0
Bhopal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,3.0,8.0,4.0,5.0,2.0,3.0,4.0,5.0,2.0,,,3.0,39.0
Bhopal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,12.0,25.0,20.0,20.0,20.0,20.0,25.0,24.0,19.0,18.0,19.0,22.0,244.0
Bhopal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Bhopal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,3.0,2.0,5.0,,2.0,5.0,5.0,2.0,8.0,5.0,3.0,1.0,41.0
Bhopal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Bhopal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,3.0,2.0,6.0,,2.0,6.0,5.0,2.0,8.0,5.0,3.0,1.0,43.0
Bhopal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,2.0,,,,1.0,,,,,3.0
Bhopal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,,1.0,,1.0,1.0,1.0,,1.0,,,,6.0
Bhopal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Bhopal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,,1.0,2.0,1.0,1.0,1.0,1.0,1.0,,,,9.0
Bhopal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,1.0,1.0,,,,,,,,1.0,,3.0
Bhopal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,3.0,9.0,10.0,7.0,7.0,4.0,9.0,14.0,18.0,7.0,14.0,4.0,106.0
Bhopal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,6.0,7.0,11.0,14.0,3.0,7.0,8.0,2.0,20.0,13.0,8.0,100.0
Bhopal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,4.0,16.0,18.0,18.0,21.0,7.0,16.0,22.0,20.0,27.0,28.0,12.0,209.0
Bhopal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,2.0,1.0,,1.0,1.0,1.0,,4.0,,,,10.0
Bhopal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,3.0,25.0,13.0,11.0,43.0,25.0,32.0,13.0,43.0,35.0,25.0,31.0,299.0
Bhopal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,6.0,23.0,16.0,16.0,31.0,34.0,38.0,22.0,48.0,28.0,31.0,34.0,327.0
Bhopal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,9.0,50.0,30.0,27.0,75.0,60.0,71.0,35.0,95.0,63.0,56.0,65.0,636.0
Bhopal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,1.0,,,1.0,,,,,,1.0,3.0
Bhopal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,16.0,,8.0,3.0,15.0,4.0,5.0,3.0,6.0,5.0,3.0,4.0,72.0
Bhopal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,5.0,12.0,17.0,14.0,18.0,15.0,13.0,12.0,11.0,17.0,9.0,10.0,153.0
Bhopal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,21.0,12.0,26.0,17.0,33.0,20.0,18.0,15.0,17.0,22.0,12.0,15.0,228.0
Burhanpur,1.1,Total number of pregnant women Registered for ANC,TOTAL,1749.0,1811.0,1968.0,1906.0,1766.0,1749.0,1565.0,1564.0,1756.0,1775.0,1989.0,1934.0,21532.0
Burhanpur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1020.0,1020.0,1183.0,1065.0,1236.0,1185.0,1129.0,974.0,1260.0,1157.0,1001.0,1043.0,13273.0
Burhanpur,1.2,Number of Pregnant women registered under JSY,TOTAL,1587.0,1688.0,1577.0,1793.0,1673.0,1668.0,1465.0,1482.0,1684.0,1705.0,1501.0,1534.0,19357.0
Burhanpur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1194.0,1303.0,1373.0,1484.0,1523.0,1527.0,1324.0,1307.0,1486.0,1535.0,1432.0,1486.0,16974.0
Burhanpur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1545.0,1673.0,1847.0,1685.0,1614.0,1579.0,1425.0,1552.0,1609.0,1696.0,1480.0,1610.0,19315.0
Burhanpur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1264.0,1298.0,1446.0,1587.0,1620.0,1499.0,1416.0,1366.0,1480.0,1567.0,1590.0,1533.0,17666.0
Burhanpur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1663.0,1523.0,1921.0,1959.0,1872.0,1866.0,1425.0,1638.0,1661.0,2100.0,1747.0,1930.0,21305.0
Burhanpur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,282.0,203.0,127.0,323.0,266.0,259.0,156.0,207.0,204.0,254.0,254.0,256.0,2791.0
Burhanpur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,24.0,18.0,14.0,31.0,17.0,13.0,51.0,18.0,23.0,26.0,20.0,31.0,286.0
Burhanpur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,939.0,787.0,1010.0,999.0,966.0,880.0,1087.0,1105.0,933.0,979.0,762.0,936.0,11383.0
Burhanpur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,135.0,89.0,119.0,57.0,164.0,122.0,29.0,12.0,48.0,89.0,14.0,133.0,1011.0
Burhanpur,1.8,Number of pregnancy test kits used at SC level,TOTAL,34.0,71.0,55.0,631.0,585.0,705.0,587.0,709.0,859.0,457.0,464.0,363.0,5520.0
Burhanpur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,36.0,27.0,44.0,74.0,59.0,63.0,29.0,40.0,65.0,30.0,27.0,19.0,513.0
Burhanpur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,110.0,115.0,136.0,76.0,125.0,87.0,186.0,134.0,118.0,145.0,157.0,132.0,1521.0
Burhanpur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,146.0,142.0,180.0,150.0,184.0,150.0,215.0,174.0,183.0,175.0,184.0,151.0,2034.0
Burhanpur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,124.0,106.0,150.0,130.0,152.0,124.0,166.0,140.0,166.0,160.0,142.0,137.0,1697.0
Burhanpur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,2.0,3.0,2.0,0.0,17.0,4.0,4.0,1.0,0.0,11.0,0.0,0.0,44.0
Burhanpur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1027.0,1037.0,1063.0,1071.0,1298.0,1209.0,1005.0,967.0,1019.0,939.0,937.0,1072.0,12644.0
Burhanpur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,108.0,106.0,276.0,57.0,60.0,71.0,288.0,325.0,410.0,83.0,102.0,494.0,2380.0
Burhanpur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1027.0,1037.0,943.0,1071.0,1269.0,1135.0,1014.0,981.0,1011.0,962.0,954.0,1075.0,12479.0
Burhanpur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,749.0,734.0,911.0,1058.0,1123.0,1060.0,954.0,942.0,971.0,871.0,859.0,963.0,11195.0
Burhanpur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,248.0,254.0,242.0,247.0,152.0,126.0,124.0,132.0,123.0,72.0,24.0,20.0,1764.0
Burhanpur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,2.0,62.0,49.0,10.0,26.0,43.0,22.0,34.0,26.0,21.0,37.0,48.0,380.0
Burhanpur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,67.0,42.0,59.0,62.0,78.0,68.0,67.0,54.0,64.0,66.0,60.0,83.0,770.0
Burhanpur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Burhanpur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,67.0,42.0,59.0,62.0,78.0,68.0,67.0,54.0,64.0,66.0,60.0,83.0,770.0
Burhanpur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,2.0,33.0,24.0,3.0,23.0,36.0,20.0,28.0,22.0,19.0,27.0,19.0,256.0
Burhanpur,4.1.1.a,Number of male live births,TOTAL,580.0,618.0,682.0,614.0,776.0,708.0,601.0,590.0,599.0,667.0,602.0,665.0,7702.0
Burhanpur,4.1.1.b,Number of female live births,TOTAL,581.0,614.0,589.0,592.0,708.0,667.0,624.0,571.0,607.0,664.0,595.0,661.0,7473.0
Burhanpur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1161.0,1232.0,1271.0,1206.0,1484.0,1375.0,1225.0,1161.0,1206.0,1331.0,1197.0,1326.0,15175.0
Burhanpur,4.1.2,Number of still births,TOTAL,14.0,13.0,23.0,27.0,27.0,30.0,23.0,20.0,24.0,20.0,23.0,24.0,268.0
Burhanpur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,21.0,36.0,25.0,30.0,28.0,28.0,32.0,39.0,24.0,34.0,35.0,35.0,367.0
Burhanpur,4.2.1,Number of Newborns weighed at birth,TOTAL,1132.0,1210.0,1240.0,1178.0,1459.0,1349.0,1199.0,1153.0,1193.0,1143.0,1106.0,1186.0,14548.0
Burhanpur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,223.0,437.0,317.0,101.0,111.0,123.0,339.0,373.0,196.0,513.0,255.0,273.0,3261.0
Burhanpur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1148.0,1222.0,1257.0,1184.0,1473.0,1374.0,1117.0,1161.0,1178.0,1169.0,1040.0,1140.0,14463.0
Burhanpur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,23.0,36.0,57.0,60.0,72.0,63.0,6.0,23.0,62.0,21.0,10.0,35.0,468.0
Burhanpur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,14.0,22.0,7.0,23.0,22.0,14.0,33.0,37.0,59.0,55.0,19.0,52.0,357.0
Burhanpur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,161.0,42.0,59.0,117.0,78.0,68.0,67.0,95.0,64.0,66.0,60.0,83.0,960.0
Burhanpur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Burhanpur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,198.0,100.0,123.0,200.0,172.0,145.0,106.0,155.0,185.0,142.0,89.0,170.0,1785.0
Burhanpur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,62.0,7.0,4.0,15.0,36.0,15.0,4.0,5.0,7.0,20.0,25.0,200.0
Burhanpur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,71.0,47.0,73.0,99.0,57.0,58.0,175.0,169.0,205.0,154.0,78.0,175.0,1361.0
Burhanpur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,75.0,42.0,30.0,36.0,49.0,26.0,12.0,17.0,27.0,6.0,13.0,13.0,346.0
Burhanpur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,27.0,47.0,54.0,53.0,43.0,34.0,58.0,123.0,77.0,43.0,24.0,76.0,659.0
Burhanpur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,28.0,31.0,23.0,30.0,47.0,62.0,54.0,37.0,34.0,36.0,38.0,58.0,478.0
Burhanpur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,831.0,1091.0,1221.0,1022.0,1200.0,1191.0,1029.0,957.0,1073.0,968.0,539.0,949.0,12071.0
Burhanpur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,531.0,638.0,694.0,659.0,989.0,810.0,1026.0,788.0,764.0,493.0,468.0,673.0,8533.0
Burhanpur,6.3,PNC maternal complications attended,TOTAL,22.0,44.0,13.0,5.0,17.0,2.0,2.0,8.0,8.0,62.0,15.0,10.0,208.0
Burhanpur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,2.0,8.0,10.0,13.0,8.0,10.0,8.0,11.0,2.0,12.0,21.0,9.0,114.0
Burhanpur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,3.0,4.0,1.0,11.0,8.0,3.0,3.0,3.0,2.0,0.0,2.0,40.0
Burhanpur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,2.0,11.0,14.0,14.0,19.0,18.0,11.0,14.0,5.0,14.0,21.0,11.0,154.0
Burhanpur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,22.0,11.0,4.0,13.0,7.0,5.0,10.0,7.0,11.0,3.0,13.0,106.0
Burhanpur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,23.0,12.0,218.0,207.0,71.0,88.0,114.0,121.0,137.0,139.0,152.0,131.0,1413.0
Burhanpur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,185.0,185.0,215.0,199.0,232.0,252.0,265.0,168.0,178.0,184.0,137.0,140.0,2340.0
Burhanpur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,208.0,197.0,433.0,406.0,303.0,340.0,379.0,289.0,315.0,323.0,289.0,271.0,3753.0
Burhanpur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,43.0,1.0,0.0,0.0,0.0,44.0
Burhanpur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,1.0,3.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,7.0
Burhanpur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,4.0,4.0,0.0,3.0,4.0,4.0,2.0,4.0,0.0,5.0,3.0,5.0,38.0
Burhanpur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Burhanpur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,4.0,5.0,3.0,3.0,5.0,4.0,2.0,47.0,2.0,5.0,4.0,5.0,89.0
Burhanpur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,5.0,20.0,40.0,53.0,25.0,109.0,46.0,78.0,51.0,0.0,427.0
Burhanpur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,38.0,38.0,113.0,91.0,103.0,82.0,87.0,243.0,199.0,223.0,246.0,81.0,1544.0
Burhanpur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,102.0,151.0,114.0,79.0,120.0,106.0,74.0,188.0,174.0,146.0,161.0,94.0,1509.0
Burhanpur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Burhanpur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,140.0,189.0,232.0,190.0,263.0,241.0,186.0,540.0,419.0,447.0,458.0,175.0,3480.0
Burhanpur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0
Burhanpur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,23.0,50.0,36.0,50.0,19.0,38.0,33.0,36.0,53.0,39.0,77.0,75.0,529.0
Burhanpur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,41.0,58.0,49.0,45.0,57.0,35.0,44.0,81.0,96.0,93.0,73.0,70.0,742.0
Burhanpur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Burhanpur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,64.0,108.0,85.0,95.0,76.0,73.0,77.0,117.0,149.0,132.0,150.0,145.0,1271.0
Burhanpur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,1.0,0.0,0.0,3.0,0.0,1.0,6.0,5.0,5.0,1.0,22.0
Burhanpur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,4.0,4.0,12.0,25.0,35.0,21.0,21.0,32.0,47.0,30.0,0.0,0.0,231.0
Burhanpur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,22.0,15.0,17.0,8.0,0.0,0.0,0.0,3.0,2.0,0.0,0.0,0.0,67.0
Burhanpur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Burhanpur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,26.0,19.0,29.0,33.0,35.0,21.0,21.0,35.0,49.0,30.0,0.0,0.0,298.0
Burhanpur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,2.0,0.0,1.0,0.0,0.0,3.0,0.0,2.0,2.0,5.0,5.0,4.0,24.0
Burhanpur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,159.0,138.0,170.0,145.0,247.0,203.0,226.0,238.0,349.0,112.0,124.0,100.0,2211.0
Burhanpur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,71.0,19.0,23.0,51.0,106.0,59.0,40.0,43.0,55.0,26.0,13.0,22.0,528.0
Burhanpur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,18.0,10.0,19.0,10.0,55.0,39.0,57.0,82.0,70.0,89.0,71.0,60.0,580.0
Burhanpur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,98.0,104.0,114.0,103.0,110.0,108.0,142.0,49.0,225.0,99.0,104.0,122.0,1378.0
Burhanpur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Burhanpur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,346.0,271.0,326.0,309.0,518.0,409.0,465.0,412.0,699.0,326.0,312.0,304.0,4697.0
Burhanpur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,65.0,22.0,7.0,25.0,35.0,35.0,1.0,30.0,230.0,32.0,72.0,7.0,561.0
Burhanpur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,2.0,0.0,0.0,4.0,0.0,5.0,4.0,3.0,5.0,2.0,25.0
Burhanpur,9.06,Number of IUCD removals,TOTAL,104.0,105.0,123.0,73.0,130.0,101.0,100.0,112.0,158.0,111.0,146.0,74.0,1337.0
Burhanpur,9.07,Number of Oral Pills cycles distributed,TOTAL,5145.0,5583.0,5686.0,5418.0,6307.0,6151.0,6531.0,6910.0,5679.0,6730.0,6709.0,6663.0,73512.0
Burhanpur,9.08,Number of Condom pieces distributed,TOTAL,8716.0,9450.0,10510.0,11207.0,10701.0,13078.0,11861.0,11130.0,20232.0,11654.0,11817.0,10781.0,141137.0
Burhanpur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,5.0,0.0,0.0,0.0,6.0,6.0,0.0,2.0,5.0,15.0,21.0,12.0,72.0
Burhanpur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,4.0,7.0
Burhanpur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Burhanpur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,6.0
Burhanpur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,2.0,2.0,1.0,2.0,1.0,2.0,3.0,3.0,11.0,10.0,10.0,-1.0
Burhanpur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1308.0,1421.0,1428.0,1279.0,1683.0,1580.0,1437.0,1518.0,1346.0,1313.0,1398.0,1582.0,17293.0
Burhanpur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1437.0,1298.0,1321.0,1400.0,1270.0,1365.0,1438.0,136.0,52.0,111.0,0.0,1.0,9829.0
Burhanpur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1144.0,1157.0,1273.0,1339.0,1331.0,1248.0,1376.0,1356.0,273.0,171.0,74.0,19.0,10761.0
Burhanpur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1207.0,1200.0,1217.0,1385.0,1304.0,1269.0,1299.0,1328.0,1245.0,401.0,140.0,26.0,12021.0
Burhanpur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1324.0,1412.0,1438.0,1335.0,1221.0,6730.0
Burhanpur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1121.0,1291.0,1414.0,1370.0,5196.0
Burhanpur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1090.0,1332.0,1169.0,3591.0
Burhanpur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,869.0,932.0,954.0,909.0,1291.0,1089.0,914.0,955.0,948.0,831.0,902.0,1066.0,11660.0
Burhanpur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1436.0,1298.0,1314.0,1403.0,1265.0,1377.0,1433.0,1423.0,1459.0,1479.0,1328.0,1106.0,16321.0
Burhanpur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1136.0,1162.0,1275.0,1352.0,1335.0,1233.0,1393.0,1354.0,1431.0,1389.0,1503.0,1368.0,15931.0
Burhanpur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1214.0,1204.0,1219.0,1378.0,1313.0,1285.0,1302.0,1343.0,1208.0,1467.0,1450.0,1391.0,15774.0
Burhanpur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,818.0,954.0,954.0,817.0,1279.0,1086.0,954.0,942.0,938.0,831.0,894.0,945.0,11412.0
Burhanpur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1335.0,1273.0,1311.0,1428.0,1270.0,1373.0,1426.0,142.0,52.0,108.0,7.0,28.0,9753.0
Burhanpur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1196.0,1150.0,1271.0,1333.0,1337.0,1237.0,1391.0,1326.0,286.0,144.0,85.0,44.0,10800.0
Burhanpur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1218.0,1199.0,1218.0,1391.0,1318.0,1275.0,1309.0,1324.0,1193.0,387.0,147.0,59.0,12038.0
Burhanpur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1160.0,1264.0,1340.0,1500.0,1461.0,1266.0,1400.0,1282.0,1355.0,1466.0,1426.0,1486.0,16406.0
Burhanpur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,271.0,443.0,560.0,797.0,989.0,792.0,843.0,913.0,1046.0,642.0,641.0,598.0,8535.0
Burhanpur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,0.0,12.0
Burhanpur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,614.0,640.0,691.0,753.0,756.0,660.0,718.0,680.0,725.0,757.0,667.0,706.0,8367.0
Burhanpur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,529.0,586.0,608.0,710.0,693.0,620.0,682.0,597.0,637.0,666.0,648.0,701.0,7677.0
Burhanpur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1143.0,1226.0,1299.0,1463.0,1449.0,1280.0,1400.0,1277.0,1362.0,1423.0,1315.0,1407.0,16044.0
Burhanpur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,901.0,934.0,1116.0,1128.0,1073.0,944.0,1050.0,1180.0,1206.0,1289.0,1232.0,1344.0,13397.0
Burhanpur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,897.0,936.0,1117.0,1104.0,1073.0,943.0,1049.0,1180.0,1206.0,1290.0,1227.0,1339.0,13361.0
Burhanpur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,288.0,337.0,413.0,288.0,338.0,249.0,280.0,201.0,263.0,226.0,226.0,330.0,3439.0
Burhanpur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,261.0,312.0,383.0,247.0,361.0,207.0,257.0,197.0,272.0,217.0,229.0,226.0,3169.0
Burhanpur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,549.0,649.0,796.0,535.0,699.0,456.0,537.0,398.0,535.0,443.0,455.0,556.0,6608.0
Burhanpur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,293.0,270.0,428.0,415.0,874.0,359.0,530.0,716.0,601.0,979.0,838.0,714.0,7017.0
Burhanpur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,454.0,411.0,609.0,819.0,1301.0,566.0,695.0,1144.0,1306.0,1127.0,871.0,1021.0,10324.0
Burhanpur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,350.0,350.0,453.0,1191.0,1031.0,687.0,727.0,1040.0,1246.0,1106.0,917.0,1064.0,10162.0
Burhanpur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,5.0,2.0,9.0
Burhanpur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,10.0,12.0,0.0,0.0,3.0,7.0,6.0,19.0,22.0,45.0,52.0,32.0,208.0
Burhanpur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,593.0,596.0,624.0,592.0,663.0,594.0,608.0,595.0,620.0,638.0,637.0,600.0,7360.0
Burhanpur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,569.0,584.0,611.0,584.0,650.0,577.0,600.0,588.0,621.0,651.0,621.0,589.0,7245.0
Burhanpur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,545.0,525.0,575.0,529.0,577.0,548.0,575.0,571.0,603.0,549.0,510.0,504.0,6611.0
Burhanpur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1158.0,1251.0,1325.0,1463.0,1451.0,1267.0,1237.0,1286.0,1362.0,2073.0,1448.0,1298.0,16619.0
Burhanpur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,621.0,725.0,944.0,5544.0,1783.0,785.0,793.0,848.0,1481.0,6320.0,1057.0,637.0,21538.0
Burhanpur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,452.0,476.0,788.0,5484.0,1577.0,516.0,570.0,504.0,1192.0,5988.0,682.0,437.0,18666.0
Burhanpur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,3.0,1.0,1.0,0.0,0.0,0.0,6.0
Burhanpur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,200.0,168.0,139.0,287.0,168.0,156.0,176.0,181.0,247.0,200.0,236.0,231.0,2389.0
Burhanpur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,39.0,2.0,5.0,3.0,12.0,41.0,40.0,33.0,29.0,78.0,133.0,95.0,510.0
Burhanpur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Burhanpur,13.1,Number of Patients operated for cataract,TOTAL,94.0,28.0,57.0,44.0,181.0,370.0,342.0,310.0,285.0,283.0,164.0,286.0,2444.0
Burhanpur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,93.0,28.0,56.0,44.0,176.0,365.0,336.0,309.0,279.0,270.0,162.0,284.0,2402.0
Burhanpur,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,53.0,67.0,90.0,142.0,0.0,18.0,37.0,407.0
Burhanpur,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,84.0,80.0,142.0,31.0,18.0,14.0,369.0
Burhanpur,13.5,Number of eyes collected through eye donation,TOTAL,2.0,0.0,0.0,0.0,1.0,4.0,30.0,0.0,12.0,0.0,0.0,2.0,51.0
Burhanpur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,4.0,3.0,4.0,-1.0
Burhanpur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,13.0,11.0,6.0,10.0,11.0,11.0,13.0,13.0,12.0,13.0,13.0,13.0,-1.0
Burhanpur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,298.0,353.0,280.0,334.0,344.0,344.0,348.0,347.0,419.0,445.0,680.0,461.0,-1.0
Burhanpur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,5.0,4.0,5.0,-1.0
Burhanpur,14.05,Number of RKS meetings held during the month,TOTAL,1.0,1.0,0.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,14.0
Burhanpur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,11.0,10.0,8.0,6.0,11.0,9.0,4.0,11.0,11.0,12.0,11.0,12.0,-1.0
Burhanpur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,0.0,2.0,0.0,0.0,2.0,0.0,1.0,0.0,0.0,6.0,3.0,3.0,17.0
Burhanpur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,4.0,3.0,4.0,-1.0
Burhanpur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,-1.0
Burhanpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,290.0,325.0,327.0,251.0,374.0,372.0,340.0,358.0,218.0,184.0,218.0,335.0,3592.0
Burhanpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,841.0,1069.0,1003.0,830.0,994.0,995.0,1098.0,1010.0,888.0,793.0,1005.0,1188.0,11714.0
Burhanpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,160.0,261.0,335.0,213.0,351.0,279.0,341.0,273.0,160.0,165.0,280.0,231.0,3049.0
Burhanpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2116.0,2052.0,2307.0,2183.0,2406.0,2393.0,2040.0,2427.0,2142.0,1937.0,2698.0,2267.0,26968.0
Burhanpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,450.0,586.0,662.0,464.0,725.0,651.0,681.0,631.0,378.0,349.0,498.0,566.0,6641.0
Burhanpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2957.0,3121.0,3310.0,3013.0,3400.0,3388.0,3138.0,3437.0,3030.0,2730.0,3703.0,3455.0,38682.0
Burhanpur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,11.0,16.0,6.0,12.0,7.0,7.0,9.0,7.0,19.0,19.0,15.0,16.0,144.0
Burhanpur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,12.0,15.0,6.0,9.0,8.0,8.0,12.0,8.0,6.0,6.0,6.0,8.0,104.0
Burhanpur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,23.0,31.0,12.0,21.0,15.0,15.0,21.0,15.0,25.0,25.0,21.0,24.0,248.0
Burhanpur,14.11,In-Patient Head Count at midnight,TOTAL,638.0,669.0,794.0,713.0,960.0,945.0,864.0,956.0,1018.0,839.0,1081.0,637.0,10114.0
Burhanpur,14.12.1,OPD attendance (All),TOTAL,29117.0,32660.0,34044.0,33701.0,39359.0,45802.0,36674.0,41348.0,40441.0,41088.0,53844.0,56879.0,484957.0
Burhanpur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,140.0,105.0,54.0,80.0,158.0,158.0,144.0,163.0,135.0,137.0,296.0,160.0,1730.0
Burhanpur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,23.0,21.0,22.0,163.0,135.0,121.0,118.0,72.0,675.0
Burhanpur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,129.0,57.0,80.0,90.0,229.0,297.0,361.0,426.0,471.0,193.0,395.0,317.0,3045.0
Burhanpur,14.14.a,Number of patients given AYUSH treatment,TOTAL,1723.0,1774.0,2407.0,1933.0,2076.0,2340.0,2268.0,3006.0,2918.0,2443.0,2114.0,3155.0,28157.0
Burhanpur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1209.0,843.0,927.0,641.0,723.0,581.0,478.0,583.0,562.0,670.0,726.0,843.0,8786.0
Burhanpur,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,153.0,136.0,160.0,203.0,239.0,239.0,219.0,262.0,287.0,263.0,2161.0
Burhanpur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4988.0,5982.0,6287.0,6196.0,6696.0,6713.0,5649.0,6743.0,6559.0,5588.0,6171.0,6752.0,74324.0
Burhanpur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,374.0,395.0,424.0,415.0,460.0,488.0,392.0,482.0,310.0,319.0,381.0,288.0,4728.0
Burhanpur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,355.0,85.0,64.0,93.0,293.0,150.0,337.0,144.0,289.0,182.0,107.0,193.0,2292.0
Burhanpur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,4.0,7.0,4.0,5.0,7.0,4.0,6.0,3.0,10.0,1.0,8.0,4.0,63.0
Burhanpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,296.0,301.0,573.0,352.0,414.0,386.0,444.0,791.0,512.0,483.0,491.0,293.0,5336.0
Burhanpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,8.0,2.0,3.0,7.0,9.0,2.0,4.0,8.0,7.0,2.0,1.0,3.0,56.0
Burhanpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1113.0,1477.0,1376.0,1169.0,1286.0,1462.0,790.0,832.0,975.0,907.0,1167.0,1226.0,13780.0
Burhanpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,3.0
Burhanpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1764.0,1863.0,2013.0,1614.0,1993.0,1998.0,1571.0,1767.0,1776.0,1572.0,1765.0,1712.0,21408.0
Burhanpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,12.0,9.0,7.0,13.0,17.0,6.0,11.0,11.0,17.0,3.0,9.0,7.0,122.0
Burhanpur,15.2,Number of Widal tests conducted,Number tested,295.0,550.0,472.0,300.0,364.0,397.0,570.0,399.0,582.0,650.0,1151.0,1250.0,6980.0
Burhanpur,15.3.a,Number of VDRL tests conducted on males,Number tested,4.0,17.0,23.0,68.0,39.0,6.0,5.0,5.0,4.0,4.0,6.0,54.0,235.0
Burhanpur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,61.0,76.0,65.0,58.0,51.0,66.0,114.0,67.0,70.0,133.0,227.0,237.0,1225.0
Burhanpur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,425.0,466.0,366.0,365.0,598.0,885.0,434.0,443.0,460.0,487.0,711.0,993.0,6633.0
Burhanpur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,490.0,559.0,454.0,491.0,688.0,957.0,553.0,515.0,534.0,624.0,944.0,1284.0,8093.0
Burhanpur,15.4.1,Number of blood smears examined for Malaria,TOTAL,2327.0,2915.0,3702.0,3798.0,4905.0,6512.0,7297.0,6506.0,3914.0,2915.0,4448.0,4537.0,53776.0
Burhanpur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,12.0,11.0,26.0,21.0,35.0,90.0,63.0,36.0,10.0,1.0,4.0,3.0,312.0
Burhanpur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,1.0,2.0,5.0,29.0,38.0,63.0,76.0,24.0,5.0,2.0,3.0,249.0
Burhanpur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1201.0,200.0,,1830.0,3430.0,3230.0,,2565.0,2815.0,2661.0,2957.0,2602.0,23491.0
Burhanpur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,2000.0,,2000.0,500.0,500.0,,500.0,0.0,500.0,0.0,0.0,6000.0
Burhanpur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1001.0,770.0,,400.0,700.0,715.0,,250.0,154.0,204.0,355.0,556.0,5105.0
Burhanpur,16.1.1,Stock position of DPT vaccines,5. Total Stock,200.0,1430.0,0.0,3430.0,3230.0,3015.0,0.0,2815.0,2661.0,2957.0,2602.0,2046.0,24386.0
Burhanpur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,,0.0,0.0,0.0,,160.0,475.0,0.0,500.0,145.0,1280.0
Burhanpur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,,450.0,0.0,500.0,0.0,0.0,950.0
Burhanpur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,,135.0,475.0,0.0,355.0,140.0,1105.0
Burhanpur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,475.0,0.0,500.0,145.0,5.0,1125.0
Burhanpur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,346.0,146.0,,1051.0,876.0,851.0,,576.0,321.0,5948.0,244.0,300.0,10659.0
Burhanpur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,1000.0,,500.0,725.0,750.0,,0.0,8700.0,500.0,8700.0,1500.0,22375.0
Burhanpur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,200.0,445.0,,675.0,675.0,300.0,,255.0,3073.0,6204.0,8644.0,789.0,21260.0
Burhanpur,16.1.2,Stock position of OPV vaccines,5. Total Stock,146.0,701.0,0.0,876.0,926.0,1301.0,0.0,321.0,5948.0,244.0,300.0,1011.0,11774.0
Burhanpur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,250.0,150.0,,2120.0,2320.0,1720.0,,1755.0,2055.0,976.0,1072.0,517.0,12935.0
Burhanpur,16.1.3,Stock position of TT vaccines,2. Stocks Received,500.0,2000.0,,1000.0,200.0,1000.0,,500.0,0.0,500.0,0.0,1000.0,6700.0
Burhanpur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,600.0,600.0,,800.0,800.0,365.0,,200.0,1079.0,404.0,555.0,720.0,6123.0
Burhanpur,16.1.3,Stock position of TT vaccines,5. Total Stock,150.0,1550.0,0.0,2320.0,1720.0,2355.0,0.0,2055.0,976.0,1072.0,517.0,797.0,13512.0
Burhanpur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,350.0,150.0,,0.0,450.0,800.0,,350.0,1135.0,552.0,1598.0,998.0,6383.0
Burhanpur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,500.0,1000.0,,1000.0,1000.0,500.0,,1000.0,0.0,1500.0,0.0,0.0,6500.0
Burhanpur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,700.0,650.0,,550.0,650.0,325.0,,215.0,583.0,454.0,600.0,712.0,5439.0
Burhanpur,16.1.5,Stock position of BCG vaccines,5. Total Stock,150.0,500.0,0.0,450.0,800.0,975.0,0.0,1135.0,552.0,1598.0,998.0,286.0,7444.0
Burhanpur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,878.0,303.0,,125.0,250.0,800.0,,410.0,710.0,814.0,1164.0,859.0,6313.0
Burhanpur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,1000.0,,500.0,1000.0,500.0,,500.0,1000.0,1000.0,0.0,0.0,5500.0
Burhanpur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,575.0,553.0,,375.0,450.0,615.0,,200.0,494.0,650.0,805.0,650.0,5367.0
Burhanpur,16.1.6,Stock position of Measles vaccines,5. Total Stock,303.0,750.0,0.0,250.0,800.0,685.0,0.0,710.0,1216.0,1164.0,359.0,209.0,6446.0
Burhanpur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1211.0,611.0,,1231.0,2101.0,2001.0,,1221.0,2171.0,1707.0,1903.0,1648.0,15805.0
Burhanpur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,1500.0,,1500.0,600.0,500.0,,1000.0,0.0,500.0,0.0,500.0,6100.0
Burhanpur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,600.0,820.0,,630.0,700.0,400.0,,50.0,464.0,304.0,255.0,556.0,4779.0
Burhanpur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,611.0,1291.0,0.0,2101.0,2001.0,2101.0,0.0,2171.0,1707.0,1903.0,1648.0,1592.0,17126.0
Burhanpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,7200.0,6600.0,,10800.0,10800.0,15800.0,,10294.0,10054.0,13054.0,13054.0,12362.0,110018.0
Burhanpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,3000.0,,0.0,5000.0,0.0,,0.0,3000.0,0.0,0.0,0.0,11000.0
Burhanpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,600.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,600.0
Burhanpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,600.0,0.0,,0.0,0.0,1306.0,,240.0,0.0,0.0,692.0,500.0,3338.0
Burhanpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,6600.0,9000.0,0.0,10800.0,15800.0,14494.0,0.0,10054.0,13054.0,13054.0,12362.0,11862.0,117080.0
Burhanpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,93940.0,71260.0,,278840.0,230840.0,200600.0,,166860.0,109740.0,127600.0,115600.0,49600.0,1444880.0
Burhanpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,256760.0,,0.0,60000.0,30000.0,,0.0,48000.0,0.0,0.0,58400.0,453160.0
Burhanpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,72620.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,72620.0
Burhanpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,22680.0,0.0,,48000.0,90040.0,15120.0,,57120.0,30140.0,12000.0,66000.0,0.0,341100.0
Burhanpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,71260.0,255400.0,0.0,230840.0,200800.0,215480.0,0.0,109740.0,127600.0,115600.0,49600.0,108000.0,1484320.0
Burhanpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2700.0,900.0,,24300.0,10500.0,10500.0,,2600.0,3200.0,16231.0,13831.0,11731.0,96493.0
Burhanpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,600.0,,0.0,6000.0,3000.0,,3000.0,16600.0,0.0,0.0,1000.0,30200.0
Burhanpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,1800.0,0.0,,13800.0,6000.0,6100.0,,2400.0,3569.0,2400.0,2100.0,400.0,38569.0
Burhanpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,900.0,1500.0,0.0,10500.0,10500.0,7400.0,0.0,3200.0,16231.0,13831.0,11731.0,12331.0,88124.0
Burhanpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,9610.0,9610.0,,5770.0,5470.0,7170.0,,9814.0,11914.0,10614.0,7314.0,6114.0,83400.0
Burhanpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,,0.0,3000.0,3000.0,,3000.0,0.0,0.0,0.0,0.0,9000.0
Burhanpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,1200.0,,300.0,600.0,6.0,,900.0,1300.0,3300.0,1200.0,3390.0,12196.0
Burhanpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,9610.0,8410.0,0.0,5470.0,7870.0,10164.0,0.0,11914.0,10614.0,7314.0,6114.0,2724.0,80204.0
Burhanpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,4500.0,4500.0,,11500.0,11500.0,11500.0,,11500.0,10000.0,9000.0,9000.0,6000.0,89000.0
Burhanpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,2000.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,500.0,2500.0
Burhanpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,,1500.0,1000.0,0.0,3000.0,0.0,5500.0
Burhanpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,4500.0,6500.0,0.0,11500.0,11500.0,11500.0,0.0,10000.0,9000.0,9000.0,6000.0,6500.0,86000.0
Burhanpur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,7290.0,7290.0,,0.0,0.0,9500.0,,3000.0,6500.0,5000.0,3000.0,2300.0,43880.0
Burhanpur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,,0.0,10000.0,0.0,,5000.0,0.0,0.0,0.0,0.0,15000.0
Burhanpur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,7290.0,,0.0,500.0,4200.0,,1500.0,1500.0,2000.0,700.0,1250.0,18940.0
Burhanpur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,7290.0,0.0,0.0,0.0,9500.0,5300.0,0.0,6500.0,5000.0,3000.0,2300.0,1050.0,39940.0
Burhanpur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,36138.0,30138.0,,80000.0,6000.0,10000.0,,3000.0,8500.0,10000.0,7000.0,5000.0,195776.0
Burhanpur,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,59000.0,,0.0,100000.0,0.0,,12000.0,10000.0,0.0,0.0,5000.0,186000.0
Burhanpur,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.3.02,Stock Position of Gloves,4. Stock Distributed,6000.0,4200.0,,2000.0,6000.0,4450.0,,6500.0,8500.0,3000.0,2000.0,3000.0,45650.0
Burhanpur,16.3.02,Stock Position of Gloves,5. Total Stock,30138.0,84938.0,0.0,78000.0,100000.0,5550.0,0.0,8500.0,10000.0,7000.0,5000.0,7000.0,336126.0
Burhanpur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,11.0,11.0
Burhanpur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,11.0
Burhanpur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,2000.0,178500.0,,168000.0,167000.0,166000.0,,160000.0,155000.0,5000.0,2000.0,1300.0,1004800.0
Burhanpur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,200000.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,200000.0
Burhanpur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,23500.0,8500.0,,1000.0,1000.0,2000.0,,5000.0,150000.0,3000.0,700.0,500.0,195200.0
Burhanpur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,178500.0,170000.0,0.0,167000.0,166000.0,164000.0,0.0,155000.0,5000.0,2000.0,1300.0,800.0,1009600.0
Burhanpur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,,0.0,0.0,7000.0,,3000.0,1500.0,500.0,100.0,0.0,12100.0
Burhanpur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,,0.0,10000.0,0.0,,0.0,0.0,0.0,0.0,0.0,10000.0
Burhanpur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,,0.0,3000.0,0.0,,1500.0,1000.0,400.0,0.0,0.0,5900.0
Burhanpur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,7000.0,7000.0,0.0,1500.0,500.0,100.0,100.0,0.0,16200.0
Burhanpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,30.0,30.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,60.0
Burhanpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,30.0,30.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,60.0
Burhanpur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,10700.0,5700.0,,2000000.0,920000.0,9000000.0,,400000.0,208000.0,160000.0,80000.0,60000.0,12844400.0
Burhanpur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,,0.0,150000.0,0.0,0.0,10000.0,160000.0
Burhanpur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,5000.0,3700.0,,1080000.0,20000.0,3000000.0,,192000.0,198000.0,80000.0,20000.0,10000.0,4608700.0
Burhanpur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,5700.0,2000.0,0.0,920000.0,900000.0,6000000.0,0.0,208000.0,160000.0,80000.0,60000.0,60000.0,8395700.0
Burhanpur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,,5000.0,31138.0,30000.0,,5720.0,4856.0,856.0,7056.0,4456.0,89082.0
Burhanpur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,6512.0,,26138.0,0.0,0.0,,0.0,0.0,9000.0,0.0,0.0,41650.0
Burhanpur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,3512.0,,6000.0,1138.0,20280.0,,864.0,4000.0,2800.0,2600.0,2000.0,43194.0
Burhanpur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,3000.0,0.0,25138.0,30000.0,9720.0,0.0,4856.0,856.0,7056.0,4456.0,2456.0,87538.0
Burhanpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,4000.0,57300.0,,25000.0,19500.0,10882.0,,500.0,600.0,400.0,250.0,200.0,118632.0
Burhanpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,,1000.0,0.0,0.0,0.0,15000.0,16000.0
Burhanpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,2650.0,7300.0,,5500.0,5618.0,3000.0,,900.0,200.0,150.0,50.0,3000.0,28368.0
Burhanpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,1350.0,50000.0,0.0,19500.0,13882.0,7882.0,0.0,600.0,400.0,250.0,200.0,12200.0,106264.0
Burhanpur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,1098.0,1098.0,,100.0,150.0,20.0,,20.0,970.0,500.0,1000.0,640.0,5596.0
Burhanpur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,,50.0,0.0,0.0,,1000.0,2000.0,1000.0,0.0,0.0,4050.0
Burhanpur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,398.0,,0.0,130.0,0.0,,50.0,2470.0,500.0,360.0,10.0,3918.0
Burhanpur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,1098.0,700.0,0.0,150.0,20.0,20.0,0.0,970.0,500.0,1000.0,640.0,630.0,5728.0
Burhanpur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,99650.0,89600.0,,30000.0,155000.0,48000.0,,5000.0,169000.0,160000.0,143200.0,132400.0,1031850.0
Burhanpur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,,200000.0,0.0,0.0,,200000.0,0.0,0.0,0.0,0.0,400000.0
Burhanpur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,10000.0,9600.0,,75000.0,107000.0,7100.0,,36000.0,9000.0,16800.0,10800.0,4800.0,286100.0
Burhanpur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,89650.0,80000.0,0.0,155000.0,48000.0,40900.0,0.0,169000.0,160000.0,143200.0,132400.0,127600.0,1145750.0
Burhanpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,100.0,1000.0,,500.0,500.0,2300.0,,1600.0,3300.0,1000.0,1000.0,1000.0,12300.0
Burhanpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,3300.0,3300.0,,3300.0,3300.0,3300.0,,2500.0,0.0,2000.0,2000.0,4600.0,27600.0
Burhanpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2400.0,1100.0,,500.0,500.0,1600.0,,800.0,2300.0,2000.0,2000.0,0.0,13200.0
Burhanpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1000.0,3200.0,0.0,3300.0,3300.0,4000.0,0.0,3300.0,1000.0,1000.0,1000.0,5600.0,26700.0
Burhanpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,6200.0,200.0,,28200.0,28200.0,18000.0,,26900.0,60900.0,47800.0,85800.0,69200.0,371400.0
Burhanpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,36000.0,,24000.0,24000.0,30000.0,,40000.0,0.0,50000.0,50000.0,0.0,254000.0
Burhanpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,6000.0,2400.0,,22200.0,22200.0,4900.0,,6000.0,43100.0,12000.0,19200.0,3200.0,141200.0
Burhanpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,200.0,33800.0,0.0,30000.0,30000.0,43100.0,0.0,60900.0,17800.0,85800.0,116600.0,66000.0,484200.0
Burhanpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,200.0,200.0,,3700.0,3700.0,1600.0,,1300.0,3000.0,1000.0,0.0,0.0,14700.0
Burhanpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,2000.0,,2000.0,2000.0,2000.0,,2000.0,0.0,0.0,0.0,0.0,10000.0
Burhanpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Burhanpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,,1700.0,1700.0,300.0,,300.0,2000.0,1000.0,0.0,0.0,7000.0
Burhanpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,200.0,2200.0,0.0,4000.0,4000.0,3300.0,0.0,3000.0,1000.0,0.0,0.0,0.0,17700.0
Burhanpur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,4.0,,,,,,,,,,5.0
Burhanpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,1.0,,,,1.0
Burhanpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,,,1.0
Burhanpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,1.0,,1.0,,,,2.0
Burhanpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,5.0,4.0,,3.0,3.0,1.0,16.0
Burhanpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Burhanpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,5.0,4.0,,3.0,3.0,1.0,16.0
Burhanpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,1.0,,,,,1.0,3.0,,,5.0
Burhanpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Burhanpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,1.0,,,,,1.0,3.0,,,5.0
Burhanpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,3.0,3.0,,1.0,2.0,4.0,13.0
Burhanpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Burhanpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,3.0,3.0,,1.0,2.0,4.0,13.0
Burhanpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Burhanpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Burhanpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Burhanpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Burhanpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Burhanpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Burhanpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Burhanpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Burhanpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Burhanpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Burhanpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Burhanpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Burhanpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,1.0,1.0
Burhanpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,1.0,,,,,,,,,1.0
Burhanpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,1.0,,,,,,,,1.0,2.0
Burhanpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Burhanpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Burhanpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Burhanpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Burhanpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Burhanpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Burhanpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Burhanpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Burhanpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Burhanpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Burhanpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Burhanpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Burhanpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Burhanpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Burhanpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Burhanpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,1.0,,,,,,,,,,1.0
Burhanpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Burhanpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Burhanpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,1.0,,1.0
Burhanpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,1.0,,1.0
Burhanpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Burhanpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Burhanpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Burhanpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Burhanpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Burhanpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Burhanpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Burhanpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Chhatarpur,1.1,Total number of pregnant women Registered for ANC,TOTAL,2955.0,4211.0,4495.0,4813.0,4186.0,4076.0,3578.0,4554.0,3608.0,3807.0,4300.0,4483.0,49066.0
Chhatarpur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1239.0,1837.0,1847.0,1929.0,1778.0,1694.0,1731.0,2041.0,1655.0,1855.0,2238.0,2371.0,22215.0
Chhatarpur,1.2,Number of Pregnant women registered under JSY,TOTAL,2955.0,4211.0,4495.0,4813.0,4186.0,4076.0,3578.0,3976.0,3608.0,3267.0,4300.0,4483.0,47948.0
Chhatarpur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2388.0,2695.0,3056.0,3507.0,3461.0,3390.0,3293.0,3571.0,3077.0,3213.0,3266.0,3484.0,38401.0
Chhatarpur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2869.0,4034.0,4391.0,4703.0,4057.0,3881.0,3494.0,4066.0,3545.0,3186.0,4158.0,4351.0,46735.0
Chhatarpur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2479.0,3190.0,3412.0,3775.0,3849.0,3656.0,3451.0,3427.0,3398.0,2807.0,3030.0,3732.0,40206.0
Chhatarpur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3365.0,4515.0,4602.0,4829.0,4186.0,4075.0,3574.0,4553.0,3620.0,3267.0,4301.0,4526.0,49413.0
Chhatarpur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,143.0,147.0,213.0,215.0,158.0,106.0,112.0,114.0,100.0,108.0,186.0,118.0,1720.0
Chhatarpur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,6.0,8.0,8.0,3.0,8.0,6.0,26.0,12.0,6.0,5.0,8.0,99.0
Chhatarpur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,703.0,1804.0,1736.0,2217.0,1967.0,2206.0,1628.0,2072.0,1971.0,1781.0,2142.0,2138.0,22365.0
Chhatarpur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,27.0,56.0,63.0,69.0,63.0,94.0,63.0,60.0,65.0,57.0,121.0,104.0,842.0
Chhatarpur,1.8,Number of pregnancy test kits used at SC level,TOTAL,559.0,900.0,972.0,1031.0,810.0,803.0,587.0,765.0,702.0,687.0,880.0,1070.0,9766.0
Chhatarpur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,109.0,128.0,172.0,171.0,219.0,247.0,214.0,191.0,154.0,127.0,177.0,121.0,2030.0
Chhatarpur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,170.0,176.0,142.0,266.0,326.0,321.0,256.0,324.0,303.0,291.0,264.0,246.0,3085.0
Chhatarpur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,279.0,304.0,314.0,437.0,545.0,568.0,470.0,515.0,457.0,418.0,441.0,367.0,5115.0
Chhatarpur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,143.0,224.0,228.0,303.0,370.0,396.0,290.0,363.0,318.0,270.0,353.0,303.0,3561.0
Chhatarpur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,3.0,0.0,0.0,0.0,8.0,0.0,0.0,5.0,0.0,0.0,9.0,0.0,25.0
Chhatarpur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1660.0,2194.0,2758.0,2991.0,3555.0,3258.0,2946.0,3027.0,2675.0,2638.0,2397.0,2719.0,32818.0
Chhatarpur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,775.0,1002.0,1359.0,1366.0,1400.0,1481.0,1373.0,1404.0,1213.0,1140.0,1078.0,1199.0,14790.0
Chhatarpur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,736.0,1168.0,1823.0,2267.0,2669.0,2717.0,2180.0,2311.0,2331.0,2481.0,2137.0,2140.0,24960.0
Chhatarpur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,689.0,1274.0,1564.0,2213.0,2653.0,2244.0,1860.0,1589.0,2036.0,1988.0,1026.0,1558.0,20694.0
Chhatarpur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,43.0,78.0,69.0,269.0,112.0,51.0,65.0,62.0,69.0,58.0,74.0,83.0,1033.0
Chhatarpur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,294.0,316.0,,,,,328.0,408.0,,319.0,307.0,,1972.0
Chhatarpur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,,,,,0.0,0.0,,0.0,0.0,,0.0
Chhatarpur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,,,,,0.0,0.0,,0.0,0.0,,0.0
Chhatarpur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,,,,,0.0,0.0,,0.0,0.0,,0.0
Chhatarpur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,50.0,72.0,81.0,109.0,97.0,105.0,98.0,88.0,103.0,101.0,92.0,77.0,1073.0
Chhatarpur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhatarpur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,50.0,72.0,81.0,109.0,97.0,105.0,98.0,88.0,103.0,101.0,92.0,77.0,1073.0
Chhatarpur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,62.0,58.0,,,,,42.0,106.0,,52.0,53.0,,373.0
Chhatarpur,4.1.1.a,Number of male live births,TOTAL,1159.0,1496.0,1580.0,1742.0,2118.0,1953.0,1937.0,2002.0,1586.0,1770.0,1612.0,1600.0,20555.0
Chhatarpur,4.1.1.b,Number of female live births,TOTAL,1052.0,1260.0,1431.0,1631.0,1929.0,1841.0,1750.0,1888.0,1514.0,1563.0,1486.0,1450.0,18795.0
Chhatarpur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2211.0,2756.0,3011.0,3373.0,4047.0,3794.0,3687.0,3890.0,3100.0,3333.0,3098.0,3050.0,39350.0
Chhatarpur,4.1.2,Number of still births,TOTAL,31.0,68.0,72.0,67.0,69.0,47.0,73.0,78.0,36.0,57.0,60.0,44.0,702.0
Chhatarpur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,6.0,15.0,7.0,8.0,28.0,21.0,27.0,35.0,9.0,10.0,19.0,22.0,207.0
Chhatarpur,4.2.1,Number of Newborns weighed at birth,TOTAL,2186.0,2732.0,3006.0,3365.0,4000.0,3774.0,3655.0,3866.0,3058.0,3307.0,2968.0,3048.0,38965.0
Chhatarpur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,268.0,395.0,272.0,352.0,396.0,378.0,540.0,621.0,493.0,618.0,322.0,270.0,4925.0
Chhatarpur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2140.0,2711.0,2815.0,3341.0,4000.0,3772.0,3612.0,3801.0,3038.0,3275.0,2958.0,3020.0,38483.0
Chhatarpur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,27.0,54.0,103.0,90.0,40.0,65.0,58.0,42.0,74.0,43.0,48.0,31.0,675.0
Chhatarpur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,45.0,54.0,59.0,51.0,55.0,50.0,45.0,26.0,39.0,102.0,51.0,52.0,629.0
Chhatarpur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,145.0,166.0,168.0,205.0,262.0,205.0,146.0,189.0,176.0,170.0,175.0,156.0,2163.0
Chhatarpur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhatarpur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,217.0,274.0,330.0,346.0,357.0,320.0,249.0,257.0,289.0,315.0,274.0,239.0,3467.0
Chhatarpur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,44.0,51.0,,,,,47.0,30.0,,35.0,29.0,,236.0
Chhatarpur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,148.0,199.0,235.0,326.0,208.0,245.0,223.0,208.0,255.0,246.0,249.0,188.0,2730.0
Chhatarpur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,32.0,40.0,15.0,32.0,24.0,52.0,49.0,39.0,32.0,75.0,35.0,42.0,467.0
Chhatarpur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,157.0,159.0,164.0,231.0,148.0,199.0,169.0,207.0,186.0,217.0,187.0,180.0,2204.0
Chhatarpur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,130.0,148.0,101.0,0.0,228.0,162.0,142.0,116.0,135.0,152.0,143.0,100.0,1557.0
Chhatarpur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1948.0,2612.0,2778.0,3042.0,3737.0,3564.0,3474.0,3613.0,2847.0,3217.0,2871.0,2859.0,36562.0
Chhatarpur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1374.0,1654.0,1693.0,1784.0,2042.0,2253.0,2114.0,2191.0,2060.0,1880.0,1839.0,1602.0,22486.0
Chhatarpur,6.3,PNC maternal complications attended,TOTAL,19.0,23.0,122.0,22.0,31.0,35.0,30.0,31.0,33.0,34.0,30.0,40.0,450.0
Chhatarpur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,23.0,33.0,33.0,34.0,31.0,34.0,34.0,31.0,48.0,46.0,51.0,35.0,433.0
Chhatarpur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,23.0,33.0,33.0,34.0,31.0,34.0,34.0,31.0,48.0,46.0,51.0,35.0,433.0
Chhatarpur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,168.0,20.0,264.0,573.0,654.0,498.0,349.0,424.0,367.0,336.0,469.0,185.0,4307.0
Chhatarpur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,492.0,65.0,624.0,860.0,733.0,899.0,606.0,773.0,791.0,405.0,549.0,416.0,7213.0
Chhatarpur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,660.0,85.0,888.0,1433.0,1387.0,1397.0,955.0,1197.0,1158.0,741.0,1018.0,601.0,11520.0
Chhatarpur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,2.0,1.0,0.0,6.0
Chhatarpur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,2.0,0.0,0.0,0.0,3.0,0.0,1.0,4.0,8.0,3.0,12.0,2.0,35.0
Chhatarpur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,1.0,0.0,1.0,0.0,5.0,0.0,2.0,2.0,4.0,3.0,0.0,19.0
Chhatarpur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhatarpur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,1.0,0.0,1.0,3.0,5.0,1.0,8.0,11.0,9.0,16.0,2.0,60.0
Chhatarpur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,,,,,0.0,0.0,,,,,0.0
Chhatarpur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,11.0,5.0,4.0,2.0,9.0,18.0,57.0,1154.0,1115.0,439.0,287.0,15.0,3116.0
Chhatarpur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,5.0,3.0,0.0,8.0,45.0,7.0,33.0,1840.0,1314.0,545.0,1017.0,423.0,5240.0
Chhatarpur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,2.0,9.0,0.0,0.0,3.0,2.0,4.0,21.0,57.0,33.0,51.0,12.0,194.0
Chhatarpur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhatarpur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,18.0,17.0,4.0,10.0,57.0,27.0,94.0,3015.0,2486.0,1017.0,1355.0,450.0,8550.0
Chhatarpur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,,,,,0.0,0.0,,,,,0.0
Chhatarpur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,,,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0,0.0,4.0
Chhatarpur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhatarpur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0,0.0,4.0
Chhatarpur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,,,,,0.0,0.0,,,,,0.0
Chhatarpur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,58.0,44.0,104.0
Chhatarpur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,8.0,16.0,10.0,22.0,37.0,13.0,19.0,12.0,45.0,14.0,26.0,14.0,236.0
Chhatarpur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhatarpur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,10.0,16.0,10.0,22.0,37.0,13.0,19.0,12.0,45.0,14.0,84.0,58.0,340.0
Chhatarpur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,10.0,18.0,,,,,11.0,17.0,,,15.0,,71.0
Chhatarpur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,530.0,797.0,744.0,996.0,951.0,798.0,892.0,848.0,878.0,731.0,920.0,815.0,9900.0
Chhatarpur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,61.0,80.0,123.0,148.0,106.0,113.0,131.0,117.0,212.0,81.0,118.0,117.0,1407.0
Chhatarpur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,113.0,67.0,41.0,50.0,54.0,43.0,74.0,180.0,57.0,57.0,67.0,54.0,857.0
Chhatarpur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,242.0,30.0,102.0,181.0,94.0,67.0,31.0,86.0,200.0,171.0,93.0,140.0,1437.0
Chhatarpur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhatarpur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,946.0,974.0,1010.0,1375.0,1205.0,1021.0,1128.0,1231.0,1347.0,1040.0,1198.0,1126.0,13601.0
Chhatarpur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,240.0,40.0,144.0,208.0,226.0,118.0,114.0,198.0,211.0,236.0,223.0,214.0,2172.0
Chhatarpur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,4.0,1.0,,,,,0.0,0.0,,,2.0,,7.0
Chhatarpur,9.06,Number of IUCD removals,TOTAL,268.0,385.0,351.0,378.0,371.0,413.0,406.0,493.0,622.0,401.0,566.0,425.0,5079.0
Chhatarpur,9.07,Number of Oral Pills cycles distributed,TOTAL,5619.0,6397.0,5495.0,8777.0,9242.0,8023.0,8716.0,7493.0,8025.0,8881.0,9564.0,11058.0,97290.0
Chhatarpur,9.08,Number of Condom pieces distributed,TOTAL,34218.0,30080.0,27455.0,34988.0,38623.0,40696.0,44306.0,28956.0,53913.0,45755.0,54009.0,60630.0,493629.0
Chhatarpur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,10.0,63.0,29.0,12.0,36.0,48.0,12.0,23.0,7.0,240.0
Chhatarpur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,5.0,0.0,0.0,10.0
Chhatarpur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Chhatarpur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,2.0,1.0,1.0,1.0,0.0,1.0,1.0,2.0,1.0,0.0,4.0,14.0
Chhatarpur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,3.0,6.0,8.0,4.0,6.0,2.0,4.0,3.0,4.0,6.0,6.0,-1.0
Chhatarpur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2165.0,2644.0,3133.0,3448.0,4119.0,3800.0,3255.0,3115.0,2975.0,2847.0,3066.0,3522.0,38089.0
Chhatarpur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2450.0,2866.0,3077.0,3328.0,3529.0,3864.0,3861.0,2190.0,269.0,148.0,7.0,15.0,25604.0
Chhatarpur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2779.0,2851.0,2950.0,3226.0,3232.0,3383.0,3511.0,3643.0,1760.0,585.0,245.0,140.0,28305.0
Chhatarpur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2943.0,3222.0,2863.0,3181.0,3154.0,3244.0,3296.0,3473.0,3647.0,1736.0,636.0,341.0,31736.0
Chhatarpur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,5.0,0.0,1566.0,3308.0,2929.0,3394.0,3794.0,14996.0
Chhatarpur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1998.0,2629.0,3054.0,3898.0,11579.0
Chhatarpur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,1890.0,2789.0,3569.0,8257.0
Chhatarpur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1628.0,1932.0,2513.0,2712.0,3555.0,2911.0,2761.0,2256.0,2504.0,2514.0,2029.0,2693.0,30008.0
Chhatarpur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2444.0,2883.0,2992.0,3345.0,3505.0,3598.0,3833.0,2806.0,3415.0,2862.0,3351.0,3835.0,38869.0
Chhatarpur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2799.0,2856.0,2872.0,3226.0,3215.0,3183.0,3460.0,3043.0,3690.0,2909.0,3194.0,4049.0,38496.0
Chhatarpur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2908.0,3197.0,2796.0,3158.0,3125.0,3027.0,3265.0,2858.0,3563.0,3242.0,3252.0,3839.0,38230.0
Chhatarpur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1551.0,1888.0,2390.0,2716.0,3472.0,2874.0,2706.0,2362.0,2370.0,2401.0,1869.0,2528.0,29127.0
Chhatarpur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2450.0,2868.0,3077.0,3345.0,3532.0,3803.0,3861.0,2133.0,291.0,176.0,24.0,16.0,25576.0
Chhatarpur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2783.0,2857.0,2951.0,3241.0,3234.0,3392.0,3512.0,3617.0,1782.0,583.0,254.0,144.0,28350.0
Chhatarpur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2926.0,3203.0,2854.0,3228.0,3159.0,3260.0,3296.0,3430.0,3651.0,1747.0,659.0,340.0,31753.0
Chhatarpur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2226.0,3242.0,3397.0,3899.0,3624.0,3911.0,3443.0,3301.0,3067.0,2943.0,3400.0,3927.0,40380.0
Chhatarpur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1798.0,2735.0,2268.0,2742.0,2665.0,2742.0,2635.0,2766.0,2761.0,3140.0,3459.0,4054.0,33765.0
Chhatarpur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Chhatarpur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1196.0,1721.0,1824.0,2044.0,1931.0,2058.0,1814.0,1731.0,1633.0,1574.0,1842.0,2102.0,21470.0
Chhatarpur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1030.0,1521.0,1573.0,1856.0,1693.0,1849.0,1629.0,1570.0,1434.0,1369.0,1558.0,1825.0,18907.0
Chhatarpur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2226.0,3242.0,3397.0,3900.0,3624.0,3907.0,3443.0,3301.0,3067.0,2943.0,3400.0,3927.0,40377.0
Chhatarpur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2027.0,2630.0,2693.0,3119.0,3023.0,3033.0,2938.0,2882.0,3177.0,3232.0,3589.0,4115.0,36458.0
Chhatarpur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2047.0,2634.0,2693.0,3115.0,3011.0,2920.0,2918.0,2719.0,3129.0,3195.0,3502.0,4120.0,36003.0
Chhatarpur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,95.0,105.0,147.0,91.0,58.0,41.0,15.0,24.0,31.0,38.0,18.0,40.0,703.0
Chhatarpur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,80.0,90.0,131.0,83.0,50.0,32.0,12.0,23.0,22.0,39.0,19.0,39.0,620.0
Chhatarpur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,175.0,195.0,278.0,174.0,108.0,73.0,27.0,47.0,53.0,77.0,37.0,79.0,1323.0
Chhatarpur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1101.0,1553.0,1714.0,2433.0,2962.0,2346.0,2530.0,2409.0,2394.0,2761.0,2871.0,3166.0,28240.0
Chhatarpur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1506.0,1888.0,2066.0,2938.0,3091.0,3312.0,3052.0,3114.0,2757.0,3257.0,3191.0,3751.0,33923.0
Chhatarpur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1313.0,1944.0,1989.0,2574.0,3055.0,3101.0,2737.0,2935.0,2790.0,2728.0,3367.0,3302.0,31835.0
Chhatarpur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Chhatarpur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1580.0,1581.0,1568.0,1610.0,1625.0,1648.0,1628.0,1576.0,1635.0,1599.0,1656.0,1675.0,19381.0
Chhatarpur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1448.0,1496.0,1516.0,1546.0,1577.0,1606.0,1571.0,1538.0,1607.0,1534.0,1606.0,1639.0,18684.0
Chhatarpur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1220.0,1274.0,1290.0,1308.0,1311.0,1353.0,1339.0,1289.0,1381.0,1336.0,1323.0,1337.0,15761.0
Chhatarpur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2170.0,3180.0,3346.0,4364.0,3889.0,3877.0,3387.0,3315.0,3013.0,3686.0,3618.0,3894.0,41739.0
Chhatarpur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1116.0,1329.0,1392.0,12026.0,4916.0,1888.0,1743.0,1571.0,1550.0,14698.0,2903.0,1861.0,46993.0
Chhatarpur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,779.0,978.0,1046.0,13424.0,4302.0,1485.0,1361.0,1392.0,1140.0,15062.0,2413.0,1617.0,44999.0
Chhatarpur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Chhatarpur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,1.0,0.0,2.0,0.0,0.0,2.0,1.0,0.0,1.0,0.0,7.0
Chhatarpur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,16.0,6.0,6.0,26.0,2.0,6.0,8.0,3.0,1.0,3.0,6.0,2.0,85.0
Chhatarpur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,560.0,787.0,820.0,605.0,674.0,609.0,415.0,227.0,291.0,232.0,313.0,367.0,5900.0
Chhatarpur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,9.0,38.0,24.0,48.0,58.0,97.0,27.0,18.0,26.0,18.0,12.0,24.0,399.0
Chhatarpur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,101.0,95.0,85.0,83.0,49.0,86.0,146.0,115.0,87.0,66.0,205.0,255.0,1373.0
Chhatarpur,13.1,Number of Patients operated for cataract,TOTAL,0.0,222.0,406.0,420.0,445.0,804.0,666.0,1090.0,1020.0,757.0,761.0,828.0,7419.0
Chhatarpur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,219.0,398.0,413.0,437.0,786.0,654.0,1068.0,1001.0,740.0,752.0,815.0,7283.0
Chhatarpur,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,1145.0,51.0,130.0,0.0,0.0,0.0,0.0,1326.0
Chhatarpur,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1185.0,0.0,0.0,0.0,141.0,1326.0
Chhatarpur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,6.0,7.0,7.0,8.0,8.0,8.0,8.0,8.0,8.0,8.0,9.0,-1.0
Chhatarpur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,5.0,5.0,5.0,5.0,7.0,4.0,4.0,4.0,5.0,5.0,6.0,5.0,-1.0
Chhatarpur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1182.0,1236.0,1190.0,1228.0,1252.0,1256.0,1220.0,1222.0,1291.0,1237.0,1301.0,1293.0,-1.0
Chhatarpur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,11.0,11.0,11.0,11.0,11.0,11.0,11.0,11.0,11.0,11.0,11.0,11.0,-1.0
Chhatarpur,14.05,Number of RKS meetings held during the month,TOTAL,10.0,17.0,13.0,11.0,8.0,13.0,9.0,13.0,14.0,14.0,9.0,12.0,143.0
Chhatarpur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,13.0,12.0,13.0,12.0,10.0,11.0,11.0,12.0,13.0,13.0,13.0,14.0,-1.0
Chhatarpur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,21.0,14.0,10.0,7.0,40.0,12.0,9.0,6.0,5.0,4.0,5.0,9.0,142.0
Chhatarpur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,6.0,5.0,7.0,7.0,7.0,7.0,7.0,7.0,5.0,5.0,5.0,5.0,-1.0
Chhatarpur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,4.0,3.0,3.0,3.0,4.0,4.0,4.0,4.0,4.0,3.0,4.0,-1.0
Chhatarpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1057.0,1244.0,1416.0,1301.0,1264.0,1267.0,1134.0,933.0,912.0,762.0,990.0,1325.0,13605.0
Chhatarpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,900.0,1112.0,1300.0,1189.0,1052.0,1393.0,1075.0,1035.0,1119.0,1028.0,893.0,1266.0,13362.0
Chhatarpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,965.0,1153.0,1279.0,1195.0,1139.0,1180.0,1051.0,868.0,830.0,714.0,911.0,1211.0,12496.0
Chhatarpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2640.0,3212.0,3766.0,3928.0,4288.0,4155.0,3816.0,3650.0,3577.0,3028.0,3366.0,3387.0,42813.0
Chhatarpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2022.0,2397.0,2695.0,2496.0,2403.0,2447.0,2185.0,1801.0,1742.0,1476.0,1901.0,2536.0,26101.0
Chhatarpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3540.0,4324.0,5066.0,5117.0,5340.0,5548.0,4891.0,4685.0,4696.0,4056.0,4259.0,4653.0,56175.0
Chhatarpur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,26.0,0.0,26.0,49.0,38.0,44.0,45.0,50.0,41.0,39.0,44.0,45.0,447.0
Chhatarpur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,11.0,2.0,20.0,36.0,22.0,20.0,30.0,31.0,28.0,16.0,18.0,27.0,261.0
Chhatarpur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,37.0,2.0,46.0,85.0,60.0,64.0,75.0,81.0,69.0,55.0,62.0,72.0,708.0
Chhatarpur,14.11,In-Patient Head Count at midnight,TOTAL,8171.0,9272.0,9939.0,9647.0,10137.0,10298.0,9650.0,9981.0,9989.0,9539.0,9513.0,10088.0,116224.0
Chhatarpur,14.12.1,OPD attendance (All),TOTAL,55525.0,65959.0,67330.0,70356.0,77261.0,77295.0,67990.0,63064.0,59135.0,50817.0,76029.0,81482.0,812243.0
Chhatarpur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,152.0,189.0,268.0,226.0,189.0,220.0,252.0,246.0,228.0,221.0,254.0,251.0,2696.0
Chhatarpur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,82.0,105.0,108.0,102.0,116.0,138.0,74.0,90.0,109.0,88.0,178.0,139.0,1329.0
Chhatarpur,14.14.a,Number of patients given AYUSH treatment,TOTAL,1298.0,1298.0,1510.0,2257.0,2217.0,1578.0,1670.0,1899.0,2585.0,2348.0,2476.0,2679.0,23815.0
Chhatarpur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,789.0,601.0,729.0,473.0,573.0,917.0,664.0,830.0,858.0,759.0,714.0,924.0,8831.0
Chhatarpur,14.14.c,Number of Adolescents counselled,TOTAL,88.0,167.0,171.0,429.0,454.0,415.0,383.0,424.0,275.0,382.0,493.0,437.0,4118.0
Chhatarpur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3192.0,5841.0,6082.0,6024.0,6150.0,7207.0,5333.0,7543.0,6757.0,5170.0,5949.0,5781.0,71029.0
Chhatarpur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,62.0,246.0,245.0,141.0,258.0,286.0,227.0,245.0,191.0,122.0,169.0,137.0,2329.0
Chhatarpur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,216.0,73.0,235.0,212.0,238.0,263.0,280.0,196.0,137.0,169.0,232.0,182.0,2433.0
Chhatarpur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,0.0,2.0,1.0,0.0,3.0,0.0,0.0,0.0,1.0,2.0,1.0,12.0
Chhatarpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,183.0,152.0,252.0,334.0,346.0,337.0,424.0,541.0,243.0,264.0,379.0,244.0,3699.0
Chhatarpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,1.0,0.0,3.0
Chhatarpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,788.0,754.0,1136.0,1250.0,861.0,1143.0,650.0,1555.0,902.0,576.0,900.0,815.0,11330.0
Chhatarpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,3.0
Chhatarpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1187.0,979.0,1623.0,1796.0,1445.0,1743.0,1354.0,2292.0,1282.0,1009.0,1511.0,1241.0,17462.0
Chhatarpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,0.0,2.0,1.0,0.0,4.0,2.0,0.0,0.0,1.0,4.0,2.0,18.0
Chhatarpur,15.2,Number of Widal tests conducted,Number tested,93.0,642.0,696.0,488.0,465.0,1082.0,505.0,872.0,529.0,106.0,430.0,612.0,6520.0
Chhatarpur,15.3.a,Number of VDRL tests conducted on males,Number tested,164.0,18.0,188.0,175.0,178.0,211.0,217.0,134.0,134.0,127.0,199.0,144.0,1889.0
Chhatarpur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,141.0,56.0,136.0,118.0,125.0,118.0,376.0,329.0,282.0,138.0,119.0,88.0,2026.0
Chhatarpur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,589.0,364.0,1112.0,992.0,920.0,1061.0,621.0,1407.0,1126.0,595.0,1120.0,573.0,10480.0
Chhatarpur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,894.0,438.0,1436.0,1285.0,1223.0,1390.0,1214.0,1870.0,1542.0,860.0,1438.0,805.0,14395.0
Chhatarpur,15.4.1,Number of blood smears examined for Malaria,TOTAL,5686.0,6028.0,7666.0,7847.0,8614.0,10092.0,8409.0,6304.0,5541.0,3934.0,7539.0,6864.0,84524.0
Chhatarpur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,15.0,46.0,103.0,141.0,203.0,242.0,120.0,67.0,27.0,11.0,96.0,26.0,1097.0
Chhatarpur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,3.0,1.0,0.0,1.0,1.0,0.0,5.0,1.0,3.0,0.0,0.0,16.0
Chhatarpur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Chhatarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Chhatarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Chhatarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Chhatarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhatarpur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,2.0,1.0,,4.0,3.0,1.0,,2.0,3.0,3.0,20.0
Chhatarpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,2.0,1.0,6.0,2.0,6.0,2.0,3.0,7.0,5.0,2.0,2.0,38.0
Chhatarpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,1.0,2.0,1.0,1.0,2.0,4.0,2.0,1.0,,14.0
Chhatarpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,2.0,1.0,7.0,4.0,7.0,3.0,5.0,11.0,7.0,3.0,2.0,52.0
Chhatarpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,6.0,4.0,2.0,3.0,1.0,4.0,3.0,3.0,2.0,28.0
Chhatarpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chhatarpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,6.0,4.0,2.0,3.0,1.0,4.0,3.0,3.0,2.0,28.0
Chhatarpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,2.0,4.0,9.0,7.0,6.0,10.0,12.0,10.0,9.0,13.0,8.0,90.0
Chhatarpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,1.0,1.0,,,1.0,1.0,3.0,4.0,2.0,1.0,14.0
Chhatarpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,2.0,5.0,10.0,7.0,6.0,11.0,13.0,13.0,13.0,15.0,9.0,104.0
Chhatarpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,2.0,2.0,7.0,12.0,5.0,1.0,15.0,12.0,6.0,8.0,4.0,76.0
Chhatarpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,1.0,2.0,3.0,,3.0,,,1.0,,10.0
Chhatarpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,2.0,2.0,8.0,14.0,8.0,1.0,18.0,12.0,6.0,9.0,4.0,86.0
Chhatarpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,3.0,,1.0,4.0,2.0,2.0,3.0,1.0,5.0,21.0
Chhatarpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,1.0,1.0,,,1.0,2.0,,4.0,3.0,12.0
Chhatarpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,4.0,1.0,1.0,4.0,3.0,4.0,3.0,5.0,8.0,33.0
Chhatarpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,3.0,,,,,,,,,3.0
Chhatarpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Chhatarpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,3.0,,,,,,,,1.0,4.0
Chhatarpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,3.0,,,,,,2.0,,2.0,8.0
Chhatarpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,6.0,,,3.0,2.0,,2.0,1.0,,14.0
Chhatarpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,9.0,,,3.0,2.0,,4.0,1.0,2.0,22.0
Chhatarpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Chhatarpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chhatarpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Chhatarpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,2.0,1.0,7.0,2.0,1.0,3.0,1.0,5.0,11.0,4.0,6.0,44.0
Chhatarpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,4.0,,1.0,6.0,2.0,,1.0,3.0,4.0,2.0,2.0,1.0,26.0
Chhatarpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,5.0,2.0,2.0,13.0,4.0,1.0,4.0,4.0,9.0,13.0,6.0,7.0,70.0
Chhatarpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Chhatarpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Chhatarpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Chhatarpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Chhatarpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Chhatarpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,1.0,2.0,2.0,1.0,1.0,1.0,,3.0,1.0,,2.0,15.0
Chhatarpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,2.0,,1.0,1.0,,1.0,,1.0,6.0
Chhatarpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,1.0,2.0,2.0,3.0,1.0,2.0,1.0,3.0,2.0,,3.0,21.0
Chhatarpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Chhatarpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,,,1.0,,1.0,,2.0,1.0,3.0,2.0,11.0
Chhatarpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,,,1.0,,1.0,1.0,2.0,1.0,1.0,,1.0,9.0
Chhatarpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,,,1.0,1.0,1.0,2.0,2.0,3.0,2.0,3.0,3.0,20.0
Chhatarpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Chhatarpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Chhatarpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Chhatarpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Chhatarpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,1.0,2.0,,,1.0,1.0,,,,5.0
Chhatarpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,6.0,7.0,3.0,3.0,2.0,3.0,,2.0,1.0,1.0,28.0
Chhatarpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,2.0,1.0,,4.0,1.0,3.0,1.0,3.0,2.0,3.0,20.0
Chhatarpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,8.0,9.0,5.0,7.0,3.0,7.0,2.0,5.0,3.0,4.0,53.0
Chhatarpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Chhatarpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Chhatarpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Chhatarpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,2.0,,,,,,2.0
Chhatarpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Chhatarpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,7.0,,4.0,5.0,7.0,8.0,5.0,12.0,12.0,5.0,7.0,12.0,84.0
Chhatarpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,5.0,1.0,1.0,10.0,11.0,8.0,13.0,14.0,16.0,9.0,10.0,17.0,115.0
Chhatarpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,12.0,1.0,5.0,15.0,18.0,16.0,18.0,26.0,29.0,14.0,17.0,29.0,200.0
Chhatarpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Chhatarpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,,,1.0,1.0,1.0,,,1.0,,,,6.0
Chhatarpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,1.0,3.0,,1.0,2.0,,1.0,,1.0,,9.0
Chhatarpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,,1.0,4.0,1.0,2.0,2.0,,2.0,,1.0,,15.0
Chhatarpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Chhatarpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Chhatarpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Chhatarpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,1.0,,,,,,,1.0
Chhatarpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Chhatarpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,1.0,,,,,,,,,,,,1.0
Chhatarpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Chhatarpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,1.0,,,,,,,,,,,,1.0
Chhatarpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Chhatarpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Chhatarpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Chhatarpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Chhatarpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Chhatarpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,3.0,1.0,1.0,1.0,,,1.0,,,8.0
Chhatarpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Chhatarpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,3.0,1.0,1.0,1.0,,,1.0,,,8.0
Chhatarpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Chhatarpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Chhatarpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Chhatarpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Chhatarpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Chhatarpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,3.0,,1.0,1.0,4.0,2.0,,,,11.0
Chhatarpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Chhatarpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,3.0,,1.0,1.0,4.0,2.0,,,,11.0
Chhatarpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,2.0,1.0,1.0,1.0,1.0,2.0,3.0,3.0,,2.0,,16.0
Chhatarpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,9.0,5.0,14.0,13.0,4.0,9.0,7.0,10.0,10.0,9.0,12.0,105.0
Chhatarpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,5.0,2.0,3.0,1.0,3.0,9.0,2.0,2.0,1.0,4.0,33.0
Chhatarpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,11.0,11.0,17.0,17.0,6.0,14.0,19.0,15.0,12.0,12.0,16.0,154.0
Chhatarpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1.0,,,,,,,,,1.0,,,2.0
Chhatarpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,3.0,8.0,2.0,2.0,4.0,3.0,2.0,3.0,6.0,7.0,7.0,7.0,54.0
Chhatarpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,1.0,1.0,,,,,,2.0
Chhatarpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,8.0,2.0,2.0,4.0,4.0,3.0,3.0,6.0,8.0,7.0,7.0,58.0
Chhatarpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,,1.0,1.0,2.0,3.0,,,,,,8.0
Chhatarpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,1.0,1.0,1.0,2.0,4.0,2.0,,,,,12.0
Chhatarpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,1.0,,,1.0,,,2.0
Chhatarpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,2.0,1.0,2.0,2.0,4.0,8.0,2.0,,1.0,,,22.0
Chhatarpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Chhatarpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,,,2.0,3.0,6.0,3.0,2.0,,2.0,,6.0,26.0
Chhatarpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,,,4.0,1.0,1.0,5.0,6.0,4.0,,5.0,5.0,32.0
Chhatarpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,,,6.0,4.0,7.0,8.0,8.0,4.0,2.0,5.0,11.0,58.0
Chhatarpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Chhatarpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,1.0,3.0,1.0,2.0,,3.0,2.0,1.0,2.0,3.0,,20.0
Chhatarpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,3.0,2.0,2.0,1.0,,1.0,4.0,,4.0,4.0,,1.0,22.0
Chhatarpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,5.0,3.0,5.0,2.0,2.0,1.0,7.0,2.0,5.0,6.0,3.0,1.0,42.0
Chhatarpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,8.0,5.0,3.0,4.0,8.0,3.0,1.0,5.0,3.0,3.0,4.0,2.0,49.0
Chhatarpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,30.0,44.0,54.0,52.0,35.0,53.0,39.0,38.0,37.0,57.0,60.0,46.0,545.0
Chhatarpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,61.0,78.0,114.0,76.0,84.0,92.0,90.0,92.0,134.0,136.0,115.0,110.0,1182.0
Chhatarpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,99.0,127.0,171.0,132.0,127.0,148.0,130.0,135.0,174.0,196.0,179.0,158.0,1776.0
Chhindwada,1.1,Total number of pregnant women Registered for ANC,TOTAL,2833.0,3126.0,3368.0,3474.0,3286.0,3838.0,3455.0,3405.0,3603.0,3475.0,3606.0,3991.0,41460.0
Chhindwada,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2157.0,2348.0,2348.0,2420.0,2602.0,2837.0,2641.0,2788.0,2896.0,2765.0,2673.0,2907.0,31382.0
Chhindwada,1.2,Number of Pregnant women registered under JSY,TOTAL,2629.0,2790.0,3228.0,3297.0,3303.0,3807.0,3346.0,3292.0,3416.0,3367.0,3403.0,3781.0,39659.0
Chhindwada,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2612.0,2622.0,2681.0,2839.0,3003.0,2855.0,2860.0,2999.0,2976.0,2968.0,3063.0,3149.0,34627.0
Chhindwada,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1978.0,2055.0,2214.0,2315.0,2472.0,2706.0,2506.0,2482.0,2644.0,2769.0,2758.0,2734.0,29633.0
Chhindwada,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2044.0,2210.0,2370.0,2320.0,2304.0,2401.0,2629.0,2582.0,2751.0,2590.0,2664.0,2651.0,29516.0
Chhindwada,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2688.0,3130.0,3333.0,3019.0,3340.0,3854.0,3632.0,3517.0,3512.0,3645.0,3728.0,4179.0,41577.0
Chhindwada,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,92.0,125.0,164.0,151.0,108.0,204.0,219.0,228.0,289.0,163.0,175.0,219.0,2137.0
Chhindwada,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,6.0,0.0,24.0,0.0,0.0,0.0,0.0,0.0,4.0,2.0,36.0
Chhindwada,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1659.0,1831.0,2508.0,2272.0,2144.0,1983.0,1914.0,1955.0,2257.0,2096.0,1829.0,2169.0,24617.0
Chhindwada,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,14.0,17.0,19.0,14.0,9.0,22.0,14.0,15.0,19.0,19.0,13.0,20.0,195.0
Chhindwada,1.8,Number of pregnancy test kits used at SC level,TOTAL,944.0,983.0,1044.0,1165.0,1345.0,1213.0,1139.0,1254.0,1707.0,1938.0,1930.0,1870.0,16532.0
Chhindwada,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,16.0,16.0,13.0,16.0,1.0,7.0,2.0,2.0,5.0,0.0,1.0,0.0,79.0
Chhindwada,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,129.0,196.0,270.0,205.0,200.0,206.0,162.0,185.0,150.0,166.0,109.0,121.0,2099.0
Chhindwada,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,145.0,212.0,283.0,221.0,201.0,213.0,164.0,187.0,155.0,166.0,110.0,121.0,2178.0
Chhindwada,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,122.0,146.0,197.0,176.0,138.0,183.0,100.0,111.0,90.0,84.0,65.0,73.0,1485.0
Chhindwada,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,6.0,4.0,12.0,7.0,7.0,17.0,1.0,1.0,0.0,1.0,1.0,0.0,57.0
Chhindwada,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2384.0,2443.0,2705.0,2709.0,2762.0,2590.0,2282.0,2187.0,2468.0,2218.0,2289.0,2553.0,29590.0
Chhindwada,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1348.0,1394.0,1454.0,1312.0,166.0,283.0,192.0,221.0,255.0,239.0,282.0,206.0,7352.0
Chhindwada,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1638.0,1728.0,1897.0,1964.0,1995.0,1560.0,1594.0,1477.0,1567.0,1527.0,1636.0,1793.0,20376.0
Chhindwada,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1722.0,1565.0,1604.0,1740.0,1815.0,1369.0,1345.0,1379.0,1241.0,1234.0,1282.0,1427.0,17723.0
Chhindwada,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,19.0,9.0,16.0,0.0,45.0
Chhindwada,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,52.0,48.0,37.0,36.0,20.0,193.0
Chhindwada,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Chhindwada,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Chhindwada,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Chhindwada,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,9.0,16.0,11.0,14.0,18.0,8.0,10.0,1.0,1.0,0.0,0.0,0.0,88.0
Chhindwada,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,202.0,160.0,201.0,177.0,181.0,183.0,177.0,168.0,175.0,184.0,169.0,206.0,2183.0
Chhindwada,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhindwada,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,211.0,176.0,212.0,191.0,199.0,191.0,187.0,169.0,176.0,184.0,169.0,206.0,2271.0
Chhindwada,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,22.0,30.0,26.0,16.0,16.0,110.0
Chhindwada,4.1.1.a,Number of male live births,TOTAL,1261.0,1374.0,1458.0,1428.0,1549.0,1431.0,1307.0,1218.0,1396.0,1331.0,1155.0,1422.0,16330.0
Chhindwada,4.1.1.b,Number of female live births,TOTAL,1231.0,1256.0,1501.0,1456.0,1372.0,1389.0,1129.0,1191.0,1286.0,1086.0,1133.0,1259.0,15289.0
Chhindwada,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2492.0,2630.0,2959.0,2884.0,2921.0,2820.0,2436.0,2409.0,2682.0,2417.0,2288.0,2681.0,31619.0
Chhindwada,4.1.2,Number of still births,TOTAL,41.0,38.0,45.0,69.0,65.0,60.0,42.0,46.0,45.0,32.0,46.0,45.0,574.0
Chhindwada,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,25.0,27.0,48.0,27.0,29.0,40.0,41.0,43.0,51.0,58.0,37.0,42.0,468.0
Chhindwada,4.2.1,Number of Newborns weighed at birth,TOTAL,2347.0,2401.0,2814.0,2689.0,2865.0,2747.0,2385.0,2366.0,2601.0,2213.0,2221.0,2553.0,30202.0
Chhindwada,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,275.0,372.0,231.0,261.0,344.0,219.0,199.0,260.0,270.0,317.0,363.0,323.0,3434.0
Chhindwada,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2401.0,2414.0,2834.0,2732.0,2875.0,2727.0,2403.0,2374.0,2611.0,2213.0,2262.0,2625.0,30471.0
Chhindwada,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,7.0,9.0,16.0,10.0,13.0,9.0,9.0,5.0,10.0,8.0,2.0,98.0
Chhindwada,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,8.0,37.0,52.0,56.0,68.0,18.0,14.0,6.0,14.0,58.0,17.0,4.0,352.0
Chhindwada,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,225.0,216.0,230.0,225.0,1010.0,71.0,82.0,0.0,220.0,0.0,0.0,0.0,2279.0
Chhindwada,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhindwada,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,233.0,260.0,291.0,297.0,1088.0,102.0,105.0,15.0,239.0,68.0,25.0,6.0,2729.0
Chhindwada,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,20.0,28.0,12.0,14.0,,74.0
Chhindwada,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,268.0,326.0,379.0,351.0,343.0,253.0,249.0,252.0,385.0,433.0,557.0,353.0,4149.0
Chhindwada,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,48.0,70.0,59.0,87.0,63.0,50.0,46.0,16.0,78.0,123.0,223.0,45.0,908.0
Chhindwada,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,283.0,958.0,142.0,368.0,1087.0,922.0,913.0,825.0,319.0,748.0,887.0,1425.0,8877.0
Chhindwada,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,175.0,185.0,269.0,210.0,252.0,235.0,250.0,258.0,268.0,206.0,216.0,167.0,2691.0
Chhindwada,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1410.0,2130.0,1601.0,1857.0,2577.0,2591.0,2308.0,2133.0,2071.0,1329.0,1517.0,1489.0,23013.0
Chhindwada,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1030.0,1619.0,1416.0,1543.0,1780.0,1717.0,1697.0,1900.0,1574.0,1650.0,1662.0,2095.0,19683.0
Chhindwada,6.3,PNC maternal complications attended,TOTAL,21.0,4.0,5.0,11.0,5.0,9.0,5.0,9.0,3.0,12.0,8.0,9.0,101.0
Chhindwada,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,16.0,18.0,22.0,23.0,18.0,24.0,28.0,22.0,34.0,21.0,12.0,24.0,262.0
Chhindwada,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,6.0,0.0,9.0,14.0,9.0,7.0,7.0,23.0,11.0,7.0,10.0,15.0,118.0
Chhindwada,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,22.0,18.0,31.0,37.0,27.0,31.0,35.0,45.0,45.0,28.0,22.0,39.0,380.0
Chhindwada,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,43.0,12.0,11.0,7.0,2.0,75.0
Chhindwada,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,60.0,188.0,78.0,48.0,47.0,55.0,63.0,95.0,40.0,228.0,73.0,111.0,1086.0
Chhindwada,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,243.0,377.0,269.0,232.0,383.0,218.0,209.0,771.0,120.0,767.0,164.0,845.0,4598.0
Chhindwada,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,303.0,565.0,347.0,280.0,430.0,273.0,272.0,866.0,160.0,995.0,237.0,956.0,5684.0
Chhindwada,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,22.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19.0,41.0
Chhindwada,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,3.0,0.0,6.0,2.0,3.0,5.0,5.0,12.0,8.0,3.0,5.0,53.0
Chhindwada,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,1.0,0.0,1.0,57.0,4.0,1.0,11.0,13.0,9.0,8.0,5.0,111.0
Chhindwada,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,2.0,2.0,3.0,0.0,0.0,2.0,15.0,7.0,11.0,2.0,44.0
Chhindwada,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhindwada,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,4.0,2.0,9.0,62.0,7.0,6.0,18.0,40.0,24.0,22.0,12.0,208.0
Chhindwada,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Chhindwada,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,46.0,33.0,25.0,83.0,49.0,85.0,110.0,489.0,585.0,378.0,258.0,187.0,2328.0
Chhindwada,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,88.0,66.0,114.0,181.0,211.0,230.0,290.0,995.0,1558.0,948.0,768.0,693.0,6142.0
Chhindwada,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,72.0,77.0,68.0,117.0,88.0,93.0,76.0,166.0,615.0,395.0,437.0,232.0,2436.0
Chhindwada,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhindwada,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,206.0,176.0,207.0,381.0,348.0,408.0,476.0,1650.0,2758.0,1721.0,1463.0,1112.0,10906.0
Chhindwada,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,2.0,,,,4.0,6.0
Chhindwada,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,9.0,7.0,0.0,4.0,1.0,7.0,1.0,3.0,15.0,0.0,3.0,0.0,50.0
Chhindwada,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,3.0,7.0,5.0,5.0,23.0,16.0,14.0,12.0,26.0,43.0,13.0,0.0,167.0
Chhindwada,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,2.0,0.0,9.0,5.0,12.0,2.0,0.0,0.0,32.0,21.0,124.0,31.0,238.0
Chhindwada,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhindwada,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,14.0,14.0,14.0,14.0,36.0,25.0,15.0,15.0,73.0,64.0,140.0,31.0,455.0
Chhindwada,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Chhindwada,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0,0.0,0.0,0.0,4.0
Chhindwada,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,5.0,4.0,4.0,7.0,29.0,3.0,8.0,5.0,2.0,1.0,0.0,68.0
Chhindwada,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,2.0,4.0,0.0,0.0,18.0,0.0,14.0,0.0,38.0
Chhindwada,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhindwada,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,5.0,4.0,4.0,9.0,33.0,3.0,9.0,26.0,2.0,15.0,0.0,110.0
Chhindwada,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Chhindwada,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,152.0,166.0,212.0,197.0,141.0,173.0,181.0,255.0,247.0,251.0,279.0,210.0,2464.0
Chhindwada,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,25.0,29.0,24.0,15.0,11.0,13.0,8.0,5.0,23.0,19.0,18.0,17.0,207.0
Chhindwada,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,22.0,28.0,41.0,28.0,49.0,53.0,49.0,48.0,73.0,77.0,76.0,41.0,585.0
Chhindwada,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,463.0,238.0,257.0,240.0,243.0,283.0,196.0,166.0,195.0,398.0,549.0,745.0,3973.0
Chhindwada,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chhindwada,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,662.0,461.0,534.0,480.0,444.0,522.0,434.0,474.0,538.0,745.0,922.0,1013.0,7229.0
Chhindwada,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,27.0,20.0,69.0,63.0,68.0,92.0,64.0,89.0,98.0,130.0,160.0,99.0,979.0
Chhindwada,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Chhindwada,9.06,Number of IUCD removals,TOTAL,149.0,113.0,116.0,164.0,111.0,110.0,113.0,133.0,196.0,227.0,155.0,287.0,1874.0
Chhindwada,9.07,Number of Oral Pills cycles distributed,TOTAL,3147.0,3845.0,3793.0,3594.0,4715.0,4529.0,5263.0,6295.0,6602.0,5149.0,6248.0,6647.0,59827.0
Chhindwada,9.08,Number of Condom pieces distributed,TOTAL,11788.0,15190.0,16033.0,16510.0,22293.0,25608.0,23362.0,22768.0,27190.0,23844.0,25401.0,27395.0,257382.0
Chhindwada,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,7.0,0.0,0.0,0.0,14.0
Chhindwada,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,0.0,0.0,4.0
Chhindwada,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,4.0,5.0,3.0,3.0,0.0,16.0
Chhindwada,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,4.0
Chhindwada,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,2.0,2.0,0.0,0.0,0.0,1.0,4.0,3.0,1.0,0.0,13.0
Chhindwada,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,9.12,Number of Institutions having NSV trained doctors,TOTAL,29.0,26.0,25.0,26.0,26.0,27.0,23.0,22.0,25.0,25.0,25.0,25.0,-1.0
Chhindwada,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2524.0,2553.0,2871.0,2895.0,2941.0,2828.0,2536.0,2448.0,2357.0,2183.0,2277.0,2622.0,31035.0
Chhindwada,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2289.0,2788.0,2859.0,3044.0,2952.0,3342.0,3122.0,1224.0,474.0,139.0,157.0,72.0,22462.0
Chhindwada,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2447.0,2503.0,2924.0,3084.0,2794.0,3201.0,3159.0,3286.0,1319.0,313.0,280.0,102.0,25412.0
Chhindwada,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2520.0,2520.0,2545.0,3028.0,2822.0,2994.0,3029.0,3197.0,2984.0,1025.0,556.0,279.0,27499.0
Chhindwada,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1690.0,2315.0,2420.0,2413.0,2681.0,11519.0
Chhindwada,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1470.0,2315.0,2406.0,2695.0,8886.0
Chhindwada,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,40.0,0.0,0.0,2.0,0.0,58.0,1606.0,2208.0,2680.0,6594.0
Chhindwada,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2205.0,2174.0,2507.0,2312.0,2528.0,2285.0,2179.0,2090.0,2102.0,1907.0,2065.0,2309.0,26663.0
Chhindwada,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2286.0,2777.0,2857.0,3147.0,2948.0,3260.0,3113.0,2230.0,2002.0,2517.0,2493.0,2742.0,32372.0
Chhindwada,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2427.0,2524.0,2831.0,3096.0,2801.0,3146.0,3146.0,3172.0,2227.0,2486.0,2641.0,2815.0,33312.0
Chhindwada,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2527.0,2516.0,2549.0,3076.0,2831.0,2943.0,3035.0,2998.0,2834.0,2419.0,2665.0,2929.0,33322.0
Chhindwada,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1987.0,1908.0,2195.0,2048.0,2515.0,2230.0,2107.0,1954.0,1753.0,1548.0,1948.0,2096.0,24289.0
Chhindwada,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2290.0,2753.0,2868.0,3165.0,2946.0,3337.0,3121.0,1242.0,429.0,99.0,142.0,77.0,22469.0
Chhindwada,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2451.0,2525.0,2838.0,3093.0,2788.0,3191.0,3139.0,3273.0,1406.0,343.0,262.0,93.0,25402.0
Chhindwada,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2542.0,2517.0,2546.0,3036.0,2826.0,3000.0,3019.0,3162.0,2909.0,1043.0,535.0,245.0,27380.0
Chhindwada,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2466.0,2779.0,3016.0,3359.0,2659.0,2789.0,2573.0,2681.0,2519.0,2895.0,2477.0,3172.0,33385.0
Chhindwada,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,469.0,761.0,1043.0,1481.0,1498.0,1680.0,1788.0,1728.0,1801.0,2285.0,2015.0,2217.0,18766.0
Chhindwada,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1324.0,1440.0,1488.0,1631.0,1331.0,1419.0,1300.0,1345.0,1215.0,1431.0,1181.0,1616.0,16721.0
Chhindwada,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1110.0,1320.0,1398.0,1536.0,1198.0,1272.0,1302.0,1209.0,1145.0,1401.0,1169.0,1479.0,15539.0
Chhindwada,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2434.0,2760.0,2886.0,3167.0,2529.0,2691.0,2602.0,2554.0,2360.0,2832.0,2350.0,3095.0,32260.0
Chhindwada,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1882.0,2023.0,2319.0,2950.0,2421.0,2731.0,2673.0,2532.0,2851.0,3162.0,2653.0,2915.0,31112.0
Chhindwada,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1896.0,2022.0,2323.0,2943.0,2416.0,2719.0,2659.0,2549.0,2734.0,3175.0,2667.0,2901.0,31004.0
Chhindwada,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,501.0,381.0,425.0,472.0,372.0,495.0,412.0,460.0,460.0,543.0,473.0,573.0,5567.0
Chhindwada,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,389.0,378.0,394.0,431.0,340.0,480.0,420.0,404.0,404.0,550.0,498.0,543.0,5231.0
Chhindwada,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,890.0,759.0,819.0,903.0,712.0,975.0,832.0,864.0,864.0,1093.0,971.0,1116.0,10798.0
Chhindwada,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1059.0,1217.0,1540.0,2042.0,1896.0,1830.0,1754.0,1964.0,1890.0,2129.0,1818.0,1935.0,21074.0
Chhindwada,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1453.0,1622.0,1905.0,2568.0,3004.0,2664.0,2472.0,3119.0,3143.0,2769.0,2920.0,2961.0,30600.0
Chhindwada,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1526.0,1911.0,2010.0,2304.0,3097.0,2812.0,2624.0,3467.0,3065.0,2639.0,2762.0,3071.0,31288.0
Chhindwada,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,3.0
Chhindwada,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2230.0,2395.0,2349.0,2362.0,2363.0,2392.0,2343.0,2401.0,2397.0,2323.0,2308.0,2395.0,28258.0
Chhindwada,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2166.0,2336.0,2330.0,2330.0,2283.0,2359.0,2299.0,2365.0,2380.0,2294.0,2284.0,2374.0,27800.0
Chhindwada,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1836.0,1936.0,1924.0,1972.0,1907.0,1964.0,1916.0,2026.0,1995.0,1968.0,1984.0,2033.0,23461.0
Chhindwada,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Chhindwada,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2431.0,2766.0,3084.0,3757.0,2924.0,2900.0,2532.0,2713.0,2576.0,3880.0,2682.0,3092.0,35337.0
Chhindwada,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,653.0,783.0,1179.0,6958.0,4599.0,1268.0,841.0,936.0,1245.0,10050.0,3710.0,1059.0,33281.0
Chhindwada,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,427.0,603.0,878.0,6996.0,4190.0,794.0,638.0,663.0,918.0,10590.0,3329.0,837.0,30863.0
Chhindwada,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,4.0,2.0,9.0,4.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,2.0,25.0
Chhindwada,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,678.0,660.0,478.0,772.0,894.0,647.0,689.0,615.0,467.0,621.0,382.0,598.0,7501.0
Chhindwada,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,74.0,72.0,35.0,23.0,100.0,49.0,170.0,197.0,42.0,120.0,40.0,121.0,1043.0
Chhindwada,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,77.0,87.0,6.0,13.0,92.0,52.0,254.0,116.0,78.0,56.0,37.0,49.0,917.0
Chhindwada,13.1,Number of Patients operated for cataract,TOTAL,89.0,54.0,37.0,362.0,158.0,131.0,149.0,170.0,148.0,152.0,121.0,165.0,1736.0
Chhindwada,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,89.0,54.0,37.0,342.0,158.0,131.0,149.0,170.0,148.0,152.0,121.0,165.0,1716.0
Chhindwada,13.3,Number of School children detected with Refractive errors,TOTAL,89.0,0.0,0.0,25.0,39.0,106.0,263.0,188.0,100.0,4.0,0.0,75.0,889.0
Chhindwada,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,167.0,315.0,310.0,277.0,138.0,75.0,1282.0
Chhindwada,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,13.0,13.0,13.0,11.0,11.0,11.0,13.0,13.0,11.0,11.0,12.0,12.0,-1.0
Chhindwada,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,26.0,26.0,26.0,26.0,28.0,23.0,24.0,23.0,25.0,25.0,24.0,25.0,-1.0
Chhindwada,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1874.0,1942.0,1901.0,2084.0,1976.0,2005.0,1960.0,2048.0,2019.0,2063.0,2114.0,2044.0,-1.0
Chhindwada,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,14.0,14.0,14.0,14.0,16.0,13.0,15.0,15.0,15.0,15.0,16.0,16.0,-1.0
Chhindwada,14.05,Number of RKS meetings held during the month,TOTAL,17.0,14.0,14.0,12.0,14.0,11.0,18.0,15.0,13.0,14.0,16.0,15.0,173.0
Chhindwada,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,39.0,37.0,38.0,37.0,38.0,34.0,36.0,35.0,37.0,37.0,36.0,38.0,-1.0
Chhindwada,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,77.0,92.0,153.0,181.0,149.0,141.0,109.0,189.0,190.0,173.0,185.0,233.0,1872.0
Chhindwada,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,8.0,9.0,9.0,10.0,10.0,10.0,11.0,11.0,10.0,10.0,10.0,10.0,-1.0
Chhindwada,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,-1.0
Chhindwada,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,525.0,676.0,553.0,507.0,602.0,393.0,556.0,480.0,474.0,378.0,248.0,512.0,5904.0
Chhindwada,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2115.0,2662.0,2359.0,2134.0,2460.0,845.0,2954.0,2514.0,2201.0,1961.0,698.0,2222.0,25125.0
Chhindwada,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,591.0,750.0,644.0,595.0,796.0,555.0,663.0,579.0,431.0,412.0,321.0,694.0,7031.0
Chhindwada,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3371.0,4012.0,3731.0,3669.0,3967.0,2211.0,3948.0,4195.0,3617.0,3312.0,2361.0,3756.0,42150.0
Chhindwada,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1116.0,1426.0,1197.0,1102.0,1398.0,948.0,1219.0,1059.0,905.0,790.0,569.0,1206.0,12935.0
Chhindwada,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5486.0,6674.0,6090.0,5803.0,6427.0,3056.0,6902.0,6709.0,5818.0,5273.0,3059.0,5978.0,67275.0
Chhindwada,14.10.2.a,Number of death cases of Inpatient males,TOTAL,59.0,49.0,58.0,64.0,57.0,4.0,70.0,73.0,59.0,64.0,4.0,67.0,628.0
Chhindwada,14.10.2.b,Number of death cases of Inpatient females,TOTAL,50.0,61.0,74.0,53.0,49.0,3.0,63.0,63.0,50.0,54.0,0.0,61.0,581.0
Chhindwada,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,109.0,110.0,132.0,117.0,106.0,7.0,133.0,136.0,109.0,118.0,4.0,128.0,1209.0
Chhindwada,14.11,In-Patient Head Count at midnight,TOTAL,2020.0,2412.0,2240.0,2219.0,2979.0,2790.0,2308.0,2595.0,2322.0,1985.0,2420.0,2494.0,28784.0
Chhindwada,14.12.1,OPD attendance (All),TOTAL,84354.0,94130.0,100565.0,107984.0,120850.0,109832.0,117350.0,109608.0,97103.0,89077.0,83890.0,119718.0,1234461.0
Chhindwada,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,373.0,313.0,347.0,331.0,335.0,267.0,374.0,472.0,525.0,374.0,483.0,327.0,4521.0
Chhindwada,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,2.0,8.0,2.0,7.0,10.0,6.0,8.0,2.0,3.0,4.0,8.0,9.0,69.0
Chhindwada,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,553.0,694.0,594.0,705.0,634.0,759.0,595.0,632.0,579.0,735.0,838.0,952.0,8270.0
Chhindwada,14.14.a,Number of patients given AYUSH treatment,TOTAL,3355.0,3501.0,3655.0,3951.0,4150.0,4292.0,4302.0,3561.0,3566.0,3735.0,5269.0,4644.0,47981.0
Chhindwada,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,225.0,0.0,0.0,310.0,765.0,316.0,727.0,591.0,767.0,854.0,1022.0,5577.0
Chhindwada,14.14.c,Number of Adolescents counselled,TOTAL,464.0,624.0,362.0,372.0,374.0,402.0,695.0,306.0,361.0,667.0,476.0,426.0,5529.0
Chhindwada,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7458.0,7209.0,10630.0,10112.0,9793.0,8257.0,9696.0,8097.0,11404.0,8015.0,8134.0,9894.0,108699.0
Chhindwada,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,287.0,156.0,402.0,1000.0,820.0,237.0,258.0,312.0,240.0,203.0,241.0,190.0,4346.0
Chhindwada,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,163.0,201.0,163.0,213.0,197.0,206.0,445.0,390.0,381.0,325.0,441.0,442.0,3567.0
Chhindwada,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,5.0,4.0,8.0,10.0,2.0,5.0,5.0,8.0,47.0,3.0,6.0,103.0
Chhindwada,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,302.0,292.0,185.0,320.0,452.0,183.0,618.0,413.0,997.0,1020.0,859.0,800.0,6441.0
Chhindwada,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,6.0,0.0,2.0,7.0,1.0,2.0,4.0,1.0,238.0,2.0,15.0,279.0
Chhindwada,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,825.0,1480.0,758.0,1370.0,1021.0,827.0,1355.0,1587.0,1754.0,1173.0,843.0,1235.0,14228.0
Chhindwada,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,22.0,13.0,4.0,23.0,0.0,8.0,21.0,2.0,375.0,1.0,1.0,470.0
Chhindwada,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1290.0,1973.0,1106.0,1903.0,1670.0,1216.0,2418.0,2390.0,3132.0,2518.0,2143.0,2477.0,24236.0
Chhindwada,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,33.0,17.0,14.0,40.0,3.0,15.0,30.0,11.0,660.0,6.0,22.0,852.0
Chhindwada,15.2,Number of Widal tests conducted,Number tested,711.0,1015.0,1510.0,1345.0,1408.0,1330.0,1071.0,1183.0,681.0,281.0,513.0,3843.0,14891.0
Chhindwada,15.3.a,Number of VDRL tests conducted on males,Number tested,13.0,14.0,39.0,18.0,33.0,69.0,26.0,36.0,43.0,8.0,13.0,139.0,451.0
Chhindwada,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,86.0,210.0,195.0,251.0,341.0,62.0,174.0,419.0,264.0,59.0,187.0,311.0,2559.0
Chhindwada,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,150.0,913.0,1058.0,1511.0,1034.0,442.0,759.0,1012.0,1238.0,367.0,105.0,828.0,9417.0
Chhindwada,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,249.0,1137.0,1292.0,1780.0,1408.0,573.0,959.0,1467.0,1545.0,434.0,305.0,1278.0,12427.0
Chhindwada,15.4.1,Number of blood smears examined for Malaria,TOTAL,16830.0,13075.0,19074.0,20178.0,19827.0,23278.0,16204.0,21957.0,16825.0,7975.0,16365.0,13732.0,205320.0
Chhindwada,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,23.0,26.0,36.0,30.0,66.0,47.0,33.0,97.0,88.0,16.0,19.0,22.0,503.0
Chhindwada,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,64.0,51.0,78.0,46.0,182.0,192.0,120.0,732.0,735.0,102.0,71.0,57.0,2430.0
Chhindwada,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,2900.0,,2900.0
Chhindwada,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,1000.0,,1000.0
Chhindwada,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1900.0,0.0,1900.0
Chhindwada,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,400.0,,400.0
Chhindwada,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,1200.0,,1200.0
Chhindwada,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,950.0,,950.0
Chhindwada,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,650.0,0.0,650.0
Chhindwada,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,700.0,,700.0
Chhindwada,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,600.0,,600.0
Chhindwada,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,0.0,100.0
Chhindwada,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,730.0,,730.0
Chhindwada,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,2000.0,,2000.0
Chhindwada,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,1850.0,,1850.0
Chhindwada,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,880.0,0.0,880.0
Chhindwada,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chhindwada,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhindwada,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,1100.0,,1100.0
Chhindwada,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,1000.0,,1000.0
Chhindwada,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,900.0,,900.0
Chhindwada,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1200.0,0.0,1200.0
Chhindwada,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,900.0,,900.0
Chhindwada,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,1000.0,,1000.0
Chhindwada,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,1700.0,,1700.0
Chhindwada,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0,0.0,200.0
Chhindwada,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chhindwada,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhindwada,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,380.0,,380.0
Chhindwada,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chhindwada,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,380.0,0.0,380.0
Chhindwada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,2100.0,,2100.0
Chhindwada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,4200.0,,4200.0
Chhindwada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,2300.0,,2300.0
Chhindwada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0,0.0,4000.0
Chhindwada,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,25000.0,,25000.0
Chhindwada,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,20000.0,,20000.0
Chhindwada,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,5000.0
Chhindwada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,600.0,,600.0
Chhindwada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,24000.0,,24000.0
Chhindwada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,4600.0,,4600.0
Chhindwada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20000.0,0.0,20000.0
Chhindwada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chhindwada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chhindwada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,4000.0,,4000.0
Chhindwada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,6000.0,,6000.0
Chhindwada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,4000.0,,4000.0
Chhindwada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,0.0,6000.0
Chhindwada,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Chhindwada,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Chhindwada,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Chhindwada,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Chhindwada,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Chhindwada,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Chhindwada,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Chhindwada,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Chhindwada,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Chhindwada,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Chhindwada,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Chhindwada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Chhindwada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Chhindwada,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Chhindwada,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Chhindwada,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Chhindwada,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Chhindwada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Chhindwada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Chhindwada,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Chhindwada,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Chhindwada,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Chhindwada,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chhindwada,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,15000.0,,15000.0
Chhindwada,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,4500.0,,4500.0
Chhindwada,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10500.0,0.0,10500.0
Chhindwada,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,170000.0,,170000.0
Chhindwada,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,60000.0,,60000.0
Chhindwada,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,110000.0,0.0,110000.0
Chhindwada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,18000.0,,18000.0
Chhindwada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Chhindwada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Chhindwada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,7000.0,,7000.0
Chhindwada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11000.0,0.0,11000.0
Chhindwada,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,,,2.0,1.0,1.0,,,1.0,,1.0,7.0
Chhindwada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,1.0,,,,,1.0
Chhindwada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chhindwada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,1.0,,,,,1.0
Chhindwada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Chhindwada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chhindwada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Chhindwada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,6.0,4.0,9.0,1.0,2.0,2.0,5.0,5.0,5.0,2.0,2.0,2.0,45.0
Chhindwada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,1.0,,,,,,,,1.0
Chhindwada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,6.0,4.0,9.0,1.0,3.0,2.0,5.0,5.0,5.0,2.0,2.0,2.0,46.0
Chhindwada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,2.0,3.0,5.0,6.0,6.0,8.0,5.0,8.0,7.0,4.0,1.0,58.0
Chhindwada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,1.0,,1.0,,,,1.0,1.0,,,4.0
Chhindwada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,2.0,4.0,5.0,7.0,6.0,8.0,5.0,9.0,8.0,4.0,1.0,62.0
Chhindwada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,1.0,,2.0,,1.0,1.0,,3.0,,,,9.0
Chhindwada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,1.0,1.0,1.0,2.0,1.0,,1.0,,,,7.0
Chhindwada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,1.0,1.0,3.0,1.0,3.0,2.0,,4.0,,,,16.0
Chhindwada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Chhindwada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chhindwada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Chhindwada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,2.0,,1.0,1.0,,1.0,1.0,,,,6.0
Chhindwada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,1.0,,,,,1.0,4.0,2.0,,,,,8.0
Chhindwada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,2.0,,1.0,2.0,4.0,3.0,1.0,,,,14.0
Chhindwada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Chhindwada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chhindwada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Chhindwada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,2.0,11.0,4.0,14.0,9.0,15.0,16.0,,2.0,2.0,4.0,80.0
Chhindwada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,6.0,1.0,3.0,3.0,1.0,3.0,,,,2.0,20.0
Chhindwada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,3.0,17.0,5.0,17.0,12.0,16.0,19.0,,2.0,2.0,6.0,100.0
Chhindwada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Chhindwada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Chhindwada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Chhindwada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,,,,1.0,,,,,,,2.0
Chhindwada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Chhindwada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,1.0,3.0,,,1.0,1.0,,1.0,,,7.0
Chhindwada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,2.0,,,,1.0,,,,,,,3.0
Chhindwada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,2.0,1.0,3.0,,1.0,1.0,1.0,,1.0,,,10.0
Chhindwada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Chhindwada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,,,2.0,,,,,1.0,,,4.0
Chhindwada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,,,,,1.0,,,,,,,3.0
Chhindwada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,1.0,,,2.0,1.0,1.0,,,1.0,,,8.0
Chhindwada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Chhindwada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Chhindwada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Chhindwada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Chhindwada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,1.0,,,1.0,,2.0,1.0,1.0,,1.0,7.0
Chhindwada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,,3.0,1.0,1.0,,1.0,2.0,3.0,,1.0,,13.0
Chhindwada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,2.0,1.0,3.0,,,,2.0,3.0,1.0,,,12.0
Chhindwada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,2.0,5.0,4.0,1.0,1.0,1.0,6.0,7.0,2.0,1.0,1.0,32.0
Chhindwada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Chhindwada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Chhindwada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Chhindwada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Chhindwada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Chhindwada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,2.0,2.0,5.0,2.0,5.0,5.0,5.0,1.0,1.0,1.0,5.0,2.0,36.0
Chhindwada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2.0,6.0,3.0,2.0,5.0,2.0,,2.0,1.0,4.0,5.0,2.0,34.0
Chhindwada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,4.0,8.0,8.0,4.0,10.0,7.0,5.0,3.0,2.0,5.0,10.0,4.0,70.0
Chhindwada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Chhindwada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,,,1.0,,1.0,,,1.0,,,4.0
Chhindwada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,1.0,,,,1.0,,,1.0,,,3.0
Chhindwada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,1.0,,1.0,,2.0,,,2.0,1.0,,8.0
Chhindwada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Chhindwada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Chhindwada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Chhindwada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Chhindwada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Chhindwada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Chhindwada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Chhindwada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Chhindwada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Chhindwada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Chhindwada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Chhindwada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Chhindwada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Chhindwada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Chhindwada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Chhindwada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Chhindwada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Chhindwada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Chhindwada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Chhindwada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,1.0,,,,,,,,,1.0
Chhindwada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Chhindwada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,3.0,,1.0,,1.0,,1.0,1.0,,,3.0,1.0,11.0
Chhindwada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Chhindwada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,3.0,,1.0,,1.0,,1.0,1.0,,,3.0,1.0,11.0
Chhindwada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,2.0,2.0,1.0,1.0,1.0,,1.0,,2.0,,,10.0
Chhindwada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,4.0,7.0,6.0,6.0,9.0,11.0,11.0,4.0,5.0,5.0,4.0,74.0
Chhindwada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,,,1.0,2.0,1.0,1.0,1.0,1.0,1.0,,,10.0
Chhindwada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,6.0,9.0,8.0,9.0,11.0,12.0,13.0,5.0,8.0,5.0,4.0,94.0
Chhindwada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,1.0,1.0,,,,,,1.0,,,3.0
Chhindwada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,3.0,5.0,6.0,1.0,5.0,3.0,4.0,3.0,4.0,6.0,3.0,44.0
Chhindwada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,,1.0,,,,1.0,,1.0,2.0,,6.0
Chhindwada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,4.0,6.0,8.0,1.0,5.0,3.0,5.0,3.0,6.0,8.0,3.0,53.0
Chhindwada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Chhindwada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,2.0,1.0,2.0,,,1.0,,1.0,,,,7.0
Chhindwada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,,,1.0,,,,,,,2.0
Chhindwada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,2.0,2.0,2.0,,1.0,1.0,,1.0,,,,9.0
Chhindwada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,1.0,,1.0,,2.0
Chhindwada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,4.0,2.0,,,1.0,1.0,1.0,1.0,,2.0,,14.0
Chhindwada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,3.0,3.0,4.0,1.0,8.0,2.0,3.0,4.0,2.0,1.0,,1.0,32.0
Chhindwada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,5.0,7.0,6.0,1.0,8.0,3.0,4.0,5.0,4.0,1.0,3.0,1.0,48.0
Chhindwada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,1.0,,,1.0,,,2.0
Chhindwada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,1.0,3.0,1.0,4.0,1.0,5.0,2.0,3.0,1.0,2.0,,23.0
Chhindwada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,4.0,16.0,15.0,14.0,8.0,12.0,4.0,1.0,3.0,1.0,4.0,3.0,85.0
Chhindwada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,4.0,17.0,18.0,15.0,12.0,13.0,10.0,3.0,6.0,3.0,6.0,3.0,110.0
Chhindwada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,2.0,2.0,3.0,1.0,2.0,4.0,2.0,2.0,3.0,1.0,,23.0
Chhindwada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,19.0,20.0,20.0,15.0,27.0,27.0,19.0,26.0,19.0,27.0,25.0,24.0,268.0
Chhindwada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,37.0,52.0,70.0,44.0,86.0,104.0,85.0,130.0,89.0,93.0,51.0,75.0,916.0
Chhindwada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,57.0,74.0,92.0,62.0,114.0,133.0,108.0,158.0,110.0,123.0,77.0,99.0,1207.0
Damoh,1.1,Total number of pregnant women Registered for ANC,TOTAL,2456.0,3304.0,3771.0,3550.0,2811.0,3434.0,2975.0,3588.0,3343.0,2613.0,4157.0,4658.0,40660.0
Damoh,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1362.0,1862.0,2177.0,2078.0,1591.0,1828.0,1668.0,1772.0,1891.0,1779.0,2419.0,2715.0,23142.0
Damoh,1.2,Number of Pregnant women registered under JSY,TOTAL,2309.0,3120.0,3596.0,3365.0,2643.0,3237.0,2780.0,3203.0,2927.0,2454.0,3953.0,4394.0,37981.0
Damoh,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1886.0,2410.0,2819.0,2679.0,2505.0,2453.0,2244.0,2316.0,2368.0,2237.0,2694.0,3019.0,29630.0
Damoh,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1441.0,1933.0,2093.0,2006.0,1529.0,1791.0,1682.0,1855.0,1761.0,1655.0,2341.0,2362.0,22449.0
Damoh,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2087.0,2884.0,2727.0,2778.0,2619.0,2619.0,2345.0,2498.0,2357.0,1963.0,2607.0,3353.0,30837.0
Damoh,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2444.0,3264.0,4180.0,3862.0,3015.0,3724.0,3097.0,3672.0,3602.0,2821.0,4593.0,5187.0,43461.0
Damoh,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,132.0,316.0,264.0,170.0,154.0,106.0,109.0,142.0,196.0,230.0,216.0,235.0,2270.0
Damoh,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,23.0,34.0,45.0,23.0,44.0,33.0,46.0,56.0,6.0,33.0,68.0,43.0,454.0
Damoh,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,759.0,1148.0,1279.0,1454.0,1085.0,1302.0,1321.0,1511.0,1647.0,1192.0,1606.0,1713.0,16017.0
Damoh,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,32.0,72.0,63.0,71.0,36.0,15.0,17.0,18.0,41.0,40.0,43.0,69.0,517.0
Damoh,1.8,Number of pregnancy test kits used at SC level,TOTAL,432.0,827.0,1031.0,857.0,701.0,779.0,725.0,1121.0,1158.0,1023.0,1375.0,1883.0,11912.0
Damoh,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,60.0,128.0,98.0,106.0,131.0,143.0,164.0,119.0,220.0,167.0,132.0,139.0,1607.0
Damoh,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,168.0,190.0,161.0,227.0,258.0,162.0,154.0,187.0,79.0,67.0,57.0,66.0,1776.0
Damoh,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,228.0,318.0,259.0,333.0,389.0,305.0,318.0,306.0,299.0,234.0,189.0,205.0,3383.0
Damoh,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,157.0,246.0,193.0,197.0,226.0,183.0,183.0,200.0,276.0,206.0,175.0,158.0,2400.0
Damoh,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,21.0,18.0,24.0,32.0,40.0,2.0,1.0,0.0,25.0,4.0,10.0,13.0,190.0
Damoh,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,974.0,1224.0,1575.0,1813.0,2319.0,2227.0,1745.0,1863.0,1725.0,1791.0,1688.0,2046.0,20990.0
Damoh,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,134.0,128.0,161.0,432.0,412.0,333.0,469.0,665.0,434.0,264.0,168.0,305.0,3905.0
Damoh,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,964.0,1233.0,1548.0,1789.0,2164.0,1866.0,1648.0,1607.0,1489.0,2256.0,1447.0,1812.0,19823.0
Damoh,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,584.0,915.0,928.0,1047.0,1457.0,1666.0,1004.0,1154.0,1063.0,1272.0,1262.0,1300.0,13652.0
Damoh,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,53.0,63.0,62.0,80.0,79.0,63.0,70.0,45.0,48.0,86.0,65.0,52.0,766.0
Damoh,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,63.0,68.0,98.0,101.0,127.0,107.0,92.0,108.0,88.0,109.0,85.0,93.0,1139.0
Damoh,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Damoh,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,63.0,68.0,98.0,101.0,127.0,107.0,92.0,108.0,88.0,109.0,85.0,93.0,1139.0
Damoh,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,28.0,39.0,37.0,50.0,51.0,35.0,42.0,32.0,38.0,52.0,41.0,41.0,486.0
Damoh,4.1.1.a,Number of male live births,TOTAL,656.0,788.0,1011.0,1161.0,1436.0,1323.0,1058.0,1109.0,1047.0,1092.0,992.0,1158.0,12831.0
Damoh,4.1.1.b,Number of female live births,TOTAL,596.0,786.0,863.0,1026.0,1314.0,1248.0,1062.0,1070.0,1019.0,1003.0,930.0,1118.0,12035.0
Damoh,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1252.0,1574.0,1874.0,2187.0,2750.0,2571.0,2120.0,2179.0,2066.0,2095.0,1922.0,2276.0,24866.0
Damoh,4.1.2,Number of still births,TOTAL,11.0,23.0,22.0,29.0,29.0,26.0,23.0,30.0,23.0,15.0,15.0,24.0,270.0
Damoh,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,71.0,84.0,108.0,118.0,111.0,89.0,47.0,46.0,33.0,35.0,49.0,43.0,834.0
Damoh,4.2.1,Number of Newborns weighed at birth,TOTAL,1231.0,1567.0,1875.0,2166.0,2734.0,2551.0,2144.0,2173.0,2064.0,2100.0,1911.0,2262.0,24778.0
Damoh,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,110.0,137.0,214.0,235.0,286.0,314.0,229.0,278.0,227.0,274.0,218.0,221.0,2743.0
Damoh,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1220.0,1551.0,1860.0,2059.0,2701.0,2534.0,2114.0,2125.0,2004.0,2053.0,1877.0,2211.0,24309.0
Damoh,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,22.0,45.0,6.0,59.0,49.0,16.0,14.0,19.0,6.0,27.0,47.0,23.0,333.0
Damoh,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,38.0,64.0,90.0,86.0,99.0,75.0,99.0,77.0,109.0,92.0,70.0,71.0,970.0
Damoh,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,131.0,147.0,205.0,296.0,435.0,166.0,256.0,260.0,144.0,293.0,172.0,263.0,2768.0
Damoh,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Damoh,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,191.0,256.0,301.0,441.0,583.0,257.0,369.0,356.0,259.0,412.0,289.0,357.0,4071.0
Damoh,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,14.0,15.0,12.0,33.0,38.0,25.0,29.0,10.0,10.0,40.0,25.0,8.0,259.0
Damoh,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,231.0,345.0,529.0,688.0,636.0,378.0,414.0,687.0,613.0,626.0,695.0,414.0,6256.0
Damoh,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,30.0,105.0,99.0,80.0,107.0,113.0,88.0,109.0,78.0,93.0,80.0,56.0,1038.0
Damoh,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,622.0,680.0,879.0,1009.0,1098.0,1043.0,786.0,696.0,823.0,681.0,896.0,668.0,9881.0
Damoh,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,48.0,25.0,38.0,42.0,29.0,35.0,55.0,31.0,16.0,40.0,32.0,69.0,460.0
Damoh,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1037.0,1374.0,1672.0,1852.0,2367.0,1527.0,1471.0,1525.0,1344.0,1485.0,1328.0,1606.0,18588.0
Damoh,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,880.0,1338.0,1160.0,1147.0,1563.0,1790.0,1327.0,1247.0,1328.0,1246.0,1250.0,1667.0,15943.0
Damoh,6.3,PNC maternal complications attended,TOTAL,21.0,21.0,33.0,22.0,16.0,42.0,33.0,43.0,11.0,32.0,27.0,19.0,320.0
Damoh,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,25.0,35.0,42.0,43.0,55.0,26.0,19.0,28.0,45.0,43.0,40.0,52.0,453.0
Damoh,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,25.0,35.0,42.0,43.0,55.0,26.0,19.0,28.0,45.0,43.0,40.0,52.0,453.0
Damoh,7.2,Number of MTPs conducted at Private Facilities,TOTAL,18.0,17.0,13.0,30.0,9.0,18.0,11.0,13.0,13.0,23.0,18.0,11.0,194.0
Damoh,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,26.0,32.0,63.0,66.0,181.0,118.0,101.0,155.0,204.0,66.0,73.0,72.0,1157.0
Damoh,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,92.0,116.0,123.0,94.0,280.0,268.0,242.0,285.0,462.0,259.0,274.0,266.0,2761.0
Damoh,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,118.0,148.0,186.0,160.0,461.0,386.0,343.0,440.0,666.0,325.0,347.0,338.0,3918.0
Damoh,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,3.0,0.0,0.0,1.0,0.0,3.0,5.0,3.0,2.0,2.0,20.0
Damoh,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Damoh,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,1.0,3.0,0.0,0.0,1.0,0.0,3.0,5.0,3.0,2.0,2.0,20.0
Damoh,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,115.0,335.0,109.0,173.0,0.0,732.0
Damoh,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,17.0,16.0,0.0,49.0,1279.0,2049.0,980.0,857.0,154.0,5401.0
Damoh,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,375.0,390.0,138.0,259.0,29.0,1191.0
Damoh,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Damoh,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,17.0,16.0,0.0,49.0,1769.0,2774.0,1227.0,1289.0,183.0,7324.0
Damoh,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Damoh,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,6.0,2.0,2.0,5.0,6.0,8.0,5.0,5.0,5.0,4.0,3.0,5.0,56.0
Damoh,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,23.0,30.0,26.0,34.0,49.0,44.0,21.0,54.0,56.0,57.0,67.0,58.0,519.0
Damoh,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Damoh,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,23.0,30.0,26.0,34.0,49.0,44.0,21.0,54.0,56.0,57.0,67.0,58.0,519.0
Damoh,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,6.0,4.0,4.0,5.0,6.0,6.0,4.0,1.0,2.0,7.0,7.0,1.0,53.0
Damoh,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,586.0,1072.0,1122.0,954.0,964.0,1101.0,1037.0,1255.0,1079.0,1101.0,1023.0,772.0,12066.0
Damoh,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,3.0,6.0,7.0,13.0,10.0,12.0,13.0,12.0,27.0,14.0,29.0,32.0,178.0
Damoh,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,48.0,38.0,68.0,83.0,70.0,61.0,56.0,55.0,59.0,61.0,171.0,330.0,1100.0
Damoh,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,228.0,247.0,159.0,245.0,305.0,265.0,168.0,182.0,262.0,349.0,398.0,424.0,3232.0
Damoh,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Damoh,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,865.0,1363.0,1356.0,1295.0,1349.0,1439.0,1274.0,1504.0,1427.0,1525.0,1621.0,1558.0,16576.0
Damoh,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,183.0,211.0,136.0,232.0,251.0,219.0,126.0,201.0,340.0,450.0,626.0,843.0,3818.0
Damoh,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,3.0,3.0,6.0,6.0,6.0,3.0,0.0,0.0,3.0,4.0,0.0,34.0
Damoh,9.06,Number of IUCD removals,TOTAL,332.0,348.0,356.0,377.0,527.0,378.0,383.0,699.0,852.0,608.0,1150.0,585.0,6595.0
Damoh,9.07,Number of Oral Pills cycles distributed,TOTAL,5277.0,5165.0,5797.0,5648.0,6610.0,7664.0,8056.0,8732.0,7241.0,7027.0,7673.0,9938.0,84828.0
Damoh,9.08,Number of Condom pieces distributed,TOTAL,26043.0,29640.0,31028.0,30003.0,31218.0,35127.0,38503.0,35671.0,30013.0,28554.0,33508.0,44013.0,393321.0
Damoh,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,31.0,0.0,0.0,30.0,17.0,15.0,15.0,5.0,8.0,0.0,0.0,87.0,208.0
Damoh,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Damoh,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,9.12,Number of Institutions having NSV trained doctors,TOTAL,9.0,10.0,8.0,8.0,9.0,8.0,8.0,7.0,8.0,9.0,8.0,7.0,-1.0
Damoh,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1174.0,1533.0,1729.0,2077.0,2398.0,2750.0,2174.0,2326.0,2069.0,2086.0,2134.0,2205.0,24655.0
Damoh,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1496.0,1958.0,2030.0,1957.0,1933.0,2550.0,2740.0,1070.0,291.0,294.0,40.0,31.0,16390.0
Damoh,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1716.0,2113.0,1998.0,2151.0,1789.0,2086.0,2357.0,2763.0,1556.0,513.0,203.0,85.0,19330.0
Damoh,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1670.0,2249.0,2145.0,2205.0,1941.0,1913.0,1856.0,2327.0,2570.0,1300.0,622.0,297.0,21095.0
Damoh,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1527.0,2053.0,1844.0,2623.0,2697.0,10744.0
Damoh,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1062.0,1652.0,2400.0,2818.0,7932.0
Damoh,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,978.0,1953.0,2709.0,5647.0
Damoh,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,927.0,1242.0,1421.0,1869.0,2087.0,2267.0,1754.0,1693.0,1664.0,1908.0,1778.0,1825.0,20435.0
Damoh,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1525.0,2093.0,2028.0,1961.0,1927.0,2557.0,2682.0,1942.0,2146.0,2117.0,2504.0,2648.0,26130.0
Damoh,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1701.0,2116.0,2012.0,2161.0,1788.0,2085.0,2339.0,2444.0,2337.0,2070.0,2511.0,2886.0,26450.0
Damoh,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1656.0,2241.0,2139.0,2173.0,1920.0,1908.0,1844.0,2083.0,2451.0,2008.0,2410.0,2980.0,25813.0
Damoh,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,750.0,1074.0,1217.0,1634.0,1798.0,1998.0,1600.0,1678.0,1539.0,1736.0,1604.0,1623.0,18251.0
Damoh,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1466.0,1945.0,2019.0,1959.0,1935.0,2555.0,2696.0,1177.0,394.0,188.0,114.0,105.0,16553.0
Damoh,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1720.0,2104.0,1993.0,2157.0,1791.0,2089.0,2360.0,2777.0,1595.0,433.0,270.0,154.0,19443.0
Damoh,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1704.0,2253.0,2131.0,2196.0,1934.0,1915.0,1861.0,2311.0,2596.0,1226.0,668.0,335.0,21130.0
Damoh,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1584.0,2439.0,2601.0,2723.0,2217.0,2709.0,2331.0,2339.0,2174.0,1854.0,2266.0,2725.0,27962.0
Damoh,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,814.0,1163.0,1751.0,1698.0,1300.0,1492.0,1318.0,1608.0,2110.0,2123.0,2434.0,2874.0,20685.0
Damoh,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,808.0,1317.0,1348.0,1510.0,1155.0,1414.0,1144.0,1296.0,1131.0,1054.0,1254.0,1481.0,14912.0
Damoh,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,801.0,1196.0,1324.0,1346.0,1071.0,1314.0,1174.0,1139.0,1030.0,967.0,1122.0,1307.0,13791.0
Damoh,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1609.0,2513.0,2672.0,2856.0,2226.0,2728.0,2318.0,2435.0,2161.0,2021.0,2376.0,2788.0,28703.0
Damoh,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1681.0,2289.0,2396.0,2389.0,2080.0,2304.0,1987.0,2138.0,2531.0,2414.0,2750.0,3250.0,28209.0
Damoh,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1660.0,2282.0,2396.0,2381.0,2084.0,2205.0,1987.0,2034.0,2390.0,2426.0,2762.0,3267.0,27874.0
Damoh,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,33.0,0.0,0.0,0.0,44.0,17.0,14.0,0.0,0.0,0.0,108.0
Damoh,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,90.0,218.0,221.0,241.0,182.0,156.0,159.0,178.0,391.0,220.0,252.0,400.0,2708.0
Damoh,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,101.0,204.0,250.0,256.0,196.0,140.0,172.0,168.0,377.0,246.0,242.0,336.0,2688.0
Damoh,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,191.0,422.0,471.0,497.0,378.0,296.0,331.0,346.0,768.0,466.0,494.0,736.0,5396.0
Damoh,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1560.0,2076.0,2129.0,2428.0,2106.0,2128.0,1895.0,1967.0,2221.0,2345.0,2392.0,2574.0,25821.0
Damoh,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1713.0,2412.0,2561.0,2545.0,2471.0,2402.0,2138.0,2215.0,2390.0,2291.0,2272.0,2414.0,27824.0
Damoh,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1710.0,2502.0,2682.0,2638.0,2557.0,2522.0,2280.0,2321.0,2491.0,2440.0,2338.0,2331.0,28812.0
Damoh,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,1.0,5.0,3.0,0.0,0.0,0.0,11.0
Damoh,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,7.0,0.0,1.0,2.0,0.0,0.0,0.0,7.0,17.0
Damoh,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1154.0,1405.0,1392.0,1399.0,1371.0,1389.0,1360.0,1404.0,1436.0,1393.0,1421.0,1499.0,16623.0
Damoh,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1088.0,1414.0,1428.0,1421.0,1364.0,1386.0,1326.0,1399.0,1444.0,1404.0,1444.0,1565.0,16683.0
Damoh,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,876.0,1096.0,1093.0,1078.0,1082.0,1125.0,1094.0,1173.0,1190.0,1181.0,1179.0,1324.0,13491.0
Damoh,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1556.0,2526.0,2689.0,2982.0,2410.0,2752.0,2384.0,4008.0,2238.0,2314.0,2559.0,3020.0,31438.0
Damoh,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,469.0,486.0,431.0,6267.0,2416.0,704.0,632.0,641.0,661.0,7698.0,2234.0,865.0,23504.0
Damoh,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,298.0,293.0,250.0,6141.0,2323.0,525.0,453.0,584.0,476.0,7125.0,2255.0,844.0,21567.0
Damoh,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Damoh,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Damoh,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,1.0,1.0,0.0,0.0,0.0,1.0,2.0,0.0,1.0,13.0,0.0,1.0,20.0
Damoh,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,146.0,308.0,348.0,243.0,295.0,269.0,214.0,239.0,227.0,313.0,263.0,354.0,3219.0
Damoh,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,7.0,2.0,3.0,11.0,8.0,26.0,51.0,3.0,5.0,3.0,1.0,15.0,135.0
Damoh,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,3.0,3.0,5.0,21.0,28.0,31.0,22.0,35.0,28.0,23.0,36.0,21.0,256.0
Damoh,13.1,Number of Patients operated for cataract,TOTAL,137.0,55.0,22.0,86.0,63.0,212.0,234.0,437.0,518.0,265.0,503.0,247.0,2779.0
Damoh,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,135.0,53.0,20.0,81.0,59.0,208.0,231.0,425.0,504.0,263.0,492.0,239.0,2710.0
Damoh,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,115.0,202.0,306.0,260.0,728.0,636.0,330.0,101.0,119.0,2797.0
Damoh,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,60.0,154.0,241.0,195.0,227.0,280.0,215.0,68.0,28.0,1468.0
Damoh,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,5.0,4.0,4.0,4.0,3.0,4.0,4.0,5.0,4.0,5.0,4.0,-1.0
Damoh,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,4.0,5.0,4.0,4.0,3.0,4.0,4.0,4.0,4.0,5.0,2.0,7.0,-1.0
Damoh,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,909.0,1074.0,1117.0,1134.0,1096.0,1127.0,1089.0,1133.0,1144.0,1122.0,1139.0,1276.0,-1.0
Damoh,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,4.0,5.0,5.0,6.0,5.0,5.0,6.0,7.0,6.0,7.0,6.0,-1.0
Damoh,14.05,Number of RKS meetings held during the month,TOTAL,1.0,2.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,3.0,0.0,0.0,15.0
Damoh,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,12.0,13.0,12.0,12.0,10.0,12.0,12.0,13.0,13.0,12.0,12.0,16.0,-1.0
Damoh,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,10.0,8.0,20.0,20.0,37.0,39.0,42.0,32.0,9.0,22.0,53.0,36.0,328.0
Damoh,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,6.0,7.0,6.0,6.0,5.0,6.0,6.0,6.0,5.0,6.0,4.0,5.0,-1.0
Damoh,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,2343.0,1.0,1.0,1.0,1.0,0.0,1.0,0.0,2.0,-1.0
Damoh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,434.0,505.0,564.0,406.0,363.0,452.0,290.0,540.0,852.0,638.0,542.0,545.0,6131.0
Damoh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,821.0,1660.0,1578.0,1506.0,1423.0,1409.0,1569.0,1583.0,1551.0,1231.0,1561.0,1612.0,17504.0
Damoh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,275.0,566.0,514.0,355.0,485.0,459.0,282.0,835.0,975.0,509.0,576.0,407.0,6238.0
Damoh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1283.0,2156.0,2507.0,2310.0,2733.0,2511.0,2234.0,2382.0,2739.0,1443.0,2481.0,2273.0,27052.0
Damoh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,709.0,1071.0,1078.0,761.0,848.0,911.0,572.0,1375.0,1827.0,1147.0,1118.0,952.0,12369.0
Damoh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2104.0,3816.0,4085.0,3816.0,4156.0,3920.0,3803.0,3965.0,4290.0,2674.0,4042.0,3885.0,44556.0
Damoh,14.10.2.a,Number of death cases of Inpatient males,TOTAL,16.0,41.0,43.0,31.0,38.0,27.0,36.0,27.0,37.0,26.0,24.0,30.0,376.0
Damoh,14.10.2.b,Number of death cases of Inpatient females,TOTAL,16.0,29.0,25.0,24.0,35.0,19.0,23.0,20.0,23.0,22.0,20.0,25.0,281.0
Damoh,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,32.0,70.0,68.0,55.0,73.0,46.0,59.0,47.0,60.0,48.0,44.0,55.0,657.0
Damoh,14.11,In-Patient Head Count at midnight,TOTAL,7130.0,8292.0,7825.0,7746.0,8941.0,8616.0,6815.0,8220.0,8412.0,8284.0,8610.0,7921.0,96812.0
Damoh,14.12.1,OPD attendance (All),TOTAL,21334.0,36890.0,42732.0,41898.0,48313.0,53616.0,37671.0,43049.0,38031.0,29850.0,47127.0,45157.0,485668.0
Damoh,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,120.0,117.0,139.0,159.0,218.0,190.0,150.0,168.0,139.0,169.0,167.0,159.0,1895.0
Damoh,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,38.0,44.0,38.0,157.0,181.0,147.0,133.0,36.0,48.0,163.0,154.0,156.0,1295.0
Damoh,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,26.0,16.0,43.0,68.0,51.0,74.0,32.0,35.0,1694.0,367.0,191.0,49.0,2646.0
Damoh,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,1.0,371.0,407.0,293.0,1713.0,238.0,427.0,458.0,268.0,4176.0
Damoh,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,40.0,56.0,45.0,48.0,45.0,36.0,58.0,56.0,384.0
Damoh,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,143.0,176.0,186.0,216.0,202.0,257.0,242.0,246.0,1668.0
Damoh,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3487.0,4581.0,4922.0,4772.0,5789.0,6123.0,4868.0,3874.0,5563.0,5841.0,6042.0,6166.0,62028.0
Damoh,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,123.0,159.0,197.0,533.0,177.0,250.0,341.0,157.0,172.0,269.0,261.0,228.0,2867.0
Damoh,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,132.0,145.0,117.0,101.0,129.0,359.0,181.0,131.0,147.0,156.0,251.0,160.0,2009.0
Damoh,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,4.0,2.0,2.0,2.0,6.0,1.0,1.0,1.0,0.0,0.0,7.0,27.0
Damoh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,152.0,219.0,249.0,132.0,151.0,335.0,104.0,218.0,256.0,459.0,170.0,158.0,2603.0
Damoh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,3.0,0.0,0.0,1.0,4.0,1.0,0.0,0.0,0.0,0.0,0.0,9.0
Damoh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,537.0,853.0,1110.0,1402.0,1291.0,1438.0,754.0,1219.0,1123.0,928.0,1257.0,1278.0,13190.0
Damoh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,29.0,33.0
Damoh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,821.0,1217.0,1476.0,1635.0,1571.0,2132.0,1039.0,1568.0,1526.0,1543.0,1678.0,1596.0,17802.0
Damoh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,8.0,2.0,2.0,3.0,13.0,2.0,1.0,1.0,0.0,0.0,36.0,69.0
Damoh,15.2,Number of Widal tests conducted,Number tested,321.0,179.0,428.0,559.0,537.0,289.0,279.0,248.0,312.0,486.0,179.0,200.0,4017.0
Damoh,15.3.a,Number of VDRL tests conducted on males,Number tested,28.0,38.0,49.0,109.0,110.0,35.0,74.0,70.0,64.0,9.0,7.0,12.0,605.0
Damoh,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,50.0,78.0,99.0,231.0,53.0,238.0,131.0,266.0,156.0,52.0,117.0,105.0,1576.0
Damoh,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,382.0,526.0,808.0,562.0,693.0,713.0,438.0,827.0,368.0,117.0,652.0,642.0,6728.0
Damoh,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,460.0,642.0,956.0,902.0,856.0,986.0,643.0,1163.0,588.0,178.0,776.0,759.0,8909.0
Damoh,15.4.1,Number of blood smears examined for Malaria,TOTAL,8774.0,7619.0,13747.0,15323.0,12804.0,11961.0,8845.0,21824.0,20789.0,7067.0,16299.0,27398.0,172450.0
Damoh,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,15.0,19.0,30.0,41.0,50.0,77.0,68.0,153.0,56.0,11.0,31.0,56.0,607.0
Damoh,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,1.0,0.0,1.0,3.0,2.0,2.0,5.0,6.0,0.0,0.0,0.0,20.0
Damoh,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Damoh,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Damoh,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Damoh,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Damoh,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Damoh,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Damoh,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Damoh,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Damoh,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Damoh,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Damoh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Damoh,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Damoh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Damoh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Damoh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Damoh,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Damoh,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Damoh,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Damoh,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Damoh,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Damoh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Damoh,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Damoh,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Damoh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Damoh,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Damoh,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Damoh,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Damoh,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Damoh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Damoh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Damoh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Damoh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Damoh,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,4.0,1.0,,1.0,,7.0,,6.0,,3.0,,22.0
Damoh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,2.0,1.0,1.0,3.0,,,,,1.0,,1.0,9.0
Damoh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Damoh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,2.0,1.0,1.0,3.0,,,,,1.0,,1.0,9.0
Damoh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,2.0,,,,,,,2.0
Damoh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,,,,1.0
Damoh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,2.0,,,1.0,,,,3.0
Damoh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,2.0,1.0,2.0,4.0,8.0,5.0,2.0,4.0,4.0,3.0,2.0,38.0
Damoh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,,,,3.0,,1.0,1.0,,1.0,1.0,8.0
Damoh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,2.0,1.0,2.0,4.0,11.0,5.0,3.0,5.0,4.0,4.0,3.0,46.0
Damoh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,2.0,4.0,2.0,8.0,10.0,8.0,3.0,7.0,2.0,5.0,1.0,53.0
Damoh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,2.0,,3.0,3.0,3.0,1.0,1.0,1.0,,,,14.0
Damoh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,4.0,4.0,5.0,11.0,13.0,9.0,4.0,8.0,2.0,5.0,1.0,67.0
Damoh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,1.0,,1.0,,2.0,,,1.0,5.0
Damoh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,1.0,,,1.0
Damoh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,1.0,,1.0,,2.0,1.0,,1.0,6.0
Damoh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,1.0,1.0,1.0,,,,,,1.0,,,4.0
Damoh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,1.0,,,,,,,1.0,,,2.0
Damoh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,1.0,2.0,1.0,,,,,,2.0,,,6.0
Damoh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,2.0,,,,,,1.0,,,4.0
Damoh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,1.0,1.0,1.0,,,,,,1.0,4.0
Damoh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,3.0,1.0,1.0,,,,1.0,,1.0,8.0
Damoh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Damoh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Damoh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Damoh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,6.0,4.0,4.0,5.0,6.0,9.0,6.0,6.0,4.0,2.0,5.0,59.0
Damoh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,2.0,1.0,2.0,4.0,6.0,2.0,3.0,,1.0,2.0,23.0
Damoh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,6.0,6.0,5.0,7.0,10.0,15.0,8.0,9.0,4.0,3.0,7.0,82.0
Damoh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Damoh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,1.0,2.0,2.0,,1.0,,3.0,2.0,1.0,1.0,,1.0,14.0
Damoh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,2.0,2.0,,1.0,,,,,,,,6.0
Damoh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,2.0,4.0,4.0,,2.0,,3.0,2.0,1.0,1.0,,1.0,20.0
Damoh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Damoh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,,,,,3.0,1.0,2.0,1.0,2.0,1.0,11.0
Damoh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,1.0,,,1.0,,1.0,,,1.0,5.0
Damoh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,1.0,1.0,,,4.0,1.0,3.0,1.0,2.0,2.0,16.0
Damoh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Damoh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,5.0,1.0,1.0,4.0,5.0,1.0,2.0,2.0,4.0,4.0,3.0,33.0
Damoh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,,2.0,2.0,1.0,3.0,1.0,2.0,1.0,3.0,1.0,,17.0
Damoh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,5.0,3.0,3.0,5.0,8.0,3.0,4.0,3.0,7.0,5.0,3.0,51.0
Damoh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Damoh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Damoh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Damoh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Damoh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,3.0,,,,,1.0,4.0
Damoh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,3.0,4.0,2.0,3.0,3.0,,4.0,1.0,,,,21.0
Damoh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,3.0,3.0,3.0,1.0,1.0,2.0,,,1.0,3.0,18.0
Damoh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,3.0,7.0,5.0,6.0,4.0,4.0,6.0,1.0,,1.0,4.0,43.0
Damoh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Damoh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Damoh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Damoh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,2.0,,,,,,,,,2.0
Damoh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Damoh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,2.0,6.0,9.0,8.0,4.0,,5.0,2.0,5.0,11.0,8.0,7.0,67.0
Damoh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,4.0,2.0,3.0,8.0,6.0,6.0,4.0,4.0,7.0,7.0,6.0,8.0,65.0
Damoh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,6.0,8.0,12.0,16.0,10.0,6.0,9.0,6.0,12.0,18.0,15.0,15.0,133.0
Damoh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Damoh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Damoh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,1.0,,,1.0,,1.0,,,3.0
Damoh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,1.0,,1.0,1.0,,1.0,,,4.0
Damoh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Damoh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Damoh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Damoh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Damoh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Damoh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Damoh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Damoh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Damoh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Damoh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Damoh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Damoh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,1.0,,,,,1.0
Damoh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Damoh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Damoh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Damoh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,1.0,,,,,,,,,1.0
Damoh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Damoh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Damoh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Damoh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Damoh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Damoh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,,2.0,2.0,,2.0,,,,2.0,,9.0
Damoh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Damoh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,,2.0,2.0,,2.0,,,,2.0,,9.0
Damoh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,2.0,1.0,2.0,1.0,1.0,,,,,,1.0,,8.0
Damoh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,11.0,9.0,6.0,6.0,2.0,5.0,10.0,8.0,5.0,6.0,9.0,80.0
Damoh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,2.0,2.0,,1.0,,1.0,,,1.0,1.0,4.0,13.0
Damoh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,6.0,14.0,13.0,7.0,8.0,2.0,6.0,10.0,8.0,6.0,8.0,13.0,101.0
Damoh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,1.0,,,,,1.0,,,,,,2.0
Damoh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,5.0,9.0,11.0,16.0,7.0,4.0,7.0,9.0,9.0,3.0,5.0,2.0,87.0
Damoh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,,,,,1.0,1.0,,,1.0,,2.0,6.0
Damoh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,6.0,10.0,11.0,16.0,7.0,5.0,9.0,9.0,9.0,4.0,5.0,4.0,95.0
Damoh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,1.0,2.0,4.0,2.0,,,,,,,,10.0
Damoh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,2.0,4.0,4.0,10.0,6.0,5.0,3.0,,2.0,,,,36.0
Damoh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,2.0,1.0,,1.0,1.0,,,,5.0
Damoh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,3.0,5.0,6.0,14.0,10.0,6.0,3.0,1.0,3.0,,,,51.0
Damoh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,1.0,1.0,1.0,1.0,2.0,2.0,,,,9.0
Damoh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,13.0,8.0,9.0,9.0,6.0,7.0,9.0,16.0,2.0,9.0,5.0,94.0
Damoh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,6.0,9.0,2.0,2.0,15.0,6.0,12.0,8.0,10.0,10.0,4.0,9.0,93.0
Damoh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,7.0,22.0,11.0,12.0,25.0,13.0,20.0,19.0,28.0,12.0,13.0,14.0,196.0
Damoh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Damoh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,4.0,4.0,1.0,2.0,2.0,,,3.0,,3.0,2.0,21.0
Damoh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,2.0,,1.0,,2.0,,4.0,,6.0,2.0,1.0,4.0,22.0
Damoh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,2.0,4.0,5.0,1.0,4.0,2.0,4.0,,9.0,2.0,5.0,6.0,44.0
Damoh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,3.0,1.0,2.0,6.0,3.0,1.0,2.0,2.0,1.0,1.0,,22.0
Damoh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,16.0,19.0,24.0,16.0,19.0,19.0,28.0,27.0,23.0,30.0,22.0,24.0,267.0
Damoh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,38.0,51.0,53.0,56.0,57.0,54.0,68.0,63.0,59.0,57.0,45.0,46.0,647.0
Damoh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,54.0,73.0,78.0,74.0,82.0,76.0,97.0,92.0,84.0,88.0,68.0,70.0,936.0
Datia,1.1,Total number of pregnant women Registered for ANC,TOTAL,1312.0,1635.0,1695.0,1692.0,1532.0,1491.0,1176.0,1370.0,1187.0,1288.0,1639.0,1902.0,17919.0
Datia,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,849.0,992.0,1201.0,1128.0,1076.0,983.0,715.0,753.0,741.0,771.0,1043.0,1253.0,11505.0
Datia,1.2,Number of Pregnant women registered under JSY,TOTAL,1284.0,1340.0,1408.0,1442.0,1488.0,1473.0,1154.0,1293.0,1207.0,1190.0,1541.0,1864.0,16684.0
Datia,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,866.0,1107.0,1149.0,1189.0,1206.0,1187.0,1066.0,1105.0,1052.0,1070.0,1087.0,1155.0,13239.0
Datia,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1156.0,1454.0,1484.0,1594.0,1299.0,1296.0,1031.0,1145.0,1004.0,1054.0,1429.0,1713.0,15659.0
Datia,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,972.0,1202.0,1302.0,1347.0,1312.0,1284.0,1138.0,1050.0,1013.0,908.0,1000.0,1397.0,13925.0
Datia,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1057.0,1332.0,1452.0,1525.0,1250.0,1273.0,1607.0,1878.0,1128.0,1051.0,1329.0,2078.0,16960.0
Datia,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,72.0,96.0,120.0,194.0,212.0,128.0,94.0,98.0,105.0,112.0,97.0,75.0,1403.0
Datia,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,714.0,809.0,799.0,1.0,2.0,0.0,3.0,14.0,40.0,2382.0
Datia,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,542.0,806.0,857.0,845.0,742.0,721.0,670.0,615.0,782.0,539.0,773.0,844.0,8736.0
Datia,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,52.0,62.0,123.0,10.0,11.0,18.0,3.0,24.0,16.0,0.0,49.0,53.0,421.0
Datia,1.8,Number of pregnancy test kits used at SC level,TOTAL,1.0,259.0,540.0,815.0,700.0,500.0,416.0,476.0,453.0,432.0,522.0,505.0,5619.0
Datia,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,31.0,38.0,34.0,43.0,84.0,100.0,75.0,85.0,66.0,82.0,32.0,66.0,736.0
Datia,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,24.0,26.0,44.0,51.0,47.0,49.0,46.0,67.0,51.0,47.0,72.0,56.0,580.0
Datia,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,55.0,64.0,78.0,94.0,131.0,149.0,121.0,152.0,117.0,129.0,104.0,122.0,1316.0
Datia,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,35.0,33.0,43.0,73.0,76.0,79.0,79.0,74.0,47.0,70.0,55.0,66.0,730.0
Datia,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,8.0,1.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Datia,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,554.0,731.0,818.0,1074.0,1357.0,1212.0,1045.0,1074.0,1024.0,925.0,812.0,889.0,11515.0
Datia,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,19.0,15.0,94.0,127.0,291.0,60.0,104.0,142.0,221.0,508.0,29.0,29.0,1639.0
Datia,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,388.0,568.0,280.0,599.0,997.0,1041.0,669.0,1032.0,859.0,963.0,762.0,720.0,8878.0
Datia,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,218.0,340.0,257.0,305.0,596.0,763.0,653.0,522.0,778.0,568.0,439.0,568.0,6007.0
Datia,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Datia,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Datia,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Datia,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Datia,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,16.0,24.0,23.0,34.0,31.0,38.0,13.0,23.0,20.0,33.0,28.0,23.0,306.0
Datia,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Datia,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,16.0,24.0,23.0,34.0,31.0,38.0,13.0,23.0,20.0,33.0,28.0,23.0,306.0
Datia,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Datia,4.1.1.a,Number of male live births,TOTAL,310.0,430.0,487.0,644.0,807.0,723.0,596.0,640.0,587.0,562.0,477.0,522.0,6785.0
Datia,4.1.1.b,Number of female live births,TOTAL,295.0,363.0,404.0,512.0,668.0,660.0,568.0,568.0,560.0,491.0,438.0,490.0,6017.0
Datia,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,605.0,793.0,891.0,1156.0,1475.0,1383.0,1164.0,1208.0,1147.0,1053.0,915.0,1012.0,12802.0
Datia,4.1.2,Number of still births,TOTAL,13.0,6.0,12.0,22.0,22.0,25.0,18.0,10.0,10.0,12.0,5.0,12.0,167.0
Datia,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,25.0,13.0,17.0,40.0,34.0,10.0,10.0,27.0,12.0,29.0,15.0,19.0,251.0
Datia,4.2.1,Number of Newborns weighed at birth,TOTAL,603.0,785.0,835.0,1127.0,1393.0,1353.0,1147.0,1169.0,1105.0,1045.0,904.0,1010.0,12476.0
Datia,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,106.0,105.0,120.0,212.0,230.0,157.0,131.0,114.0,108.0,82.0,61.0,71.0,1497.0
Datia,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,579.0,761.0,859.0,1118.0,1341.0,1317.0,1110.0,1149.0,1061.0,1022.0,863.0,983.0,12163.0
Datia,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,11.0
Datia,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,12.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,13.0
Datia,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,90.0,90.0,66.0,164.0,103.0,204.0,151.0,93.0,72.0,39.0,84.0,94.0,1250.0
Datia,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Datia,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,90.0,90.0,86.0,164.0,103.0,204.0,152.0,93.0,72.0,39.0,84.0,97.0,1274.0
Datia,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Datia,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,90.0,90.0,57.0,153.0,85.0,204.0,137.0,93.0,51.0,28.0,73.0,86.0,1147.0
Datia,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,4.0,90.0,6.0,10.0,6.0,6.0,6.0,9.0,4.0,3.0,5.0,4.0,153.0
Datia,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,25.0,42.0,283.0,260.0,257.0,70.0,37.0,78.0,29.0,3.0,0.0,37.0,1121.0
Datia,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,36.0,46.0,61.0,67.0,76.0,67.0,49.0,56.0,52.0,24.0,45.0,71.0,650.0
Datia,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,518.0,698.0,751.0,1053.0,1250.0,1198.0,955.0,1000.0,1019.0,969.0,848.0,892.0,11151.0
Datia,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,115.0,340.0,282.0,617.0,611.0,702.0,511.0,562.0,490.0,335.0,315.0,454.0,5334.0
Datia,6.3,PNC maternal complications attended,TOTAL,16.0,25.0,173.0,43.0,84.0,38.0,3.0,33.0,354.0,26.0,28.0,26.0,849.0
Datia,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,5.0,13.0,0.0,25.0,18.0,15.0,7.0,8.0,19.0,22.0,10.0,8.0,150.0
Datia,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,4.0,5.0,4.0,17.0
Datia,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,6.0,13.0,1.0,25.0,18.0,15.0,7.0,8.0,21.0,26.0,15.0,12.0,167.0
Datia,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,85.0,85.0,48.0,77.0,112.0,111.0,166.0,63.0,75.0,71.0,51.0,44.0,988.0
Datia,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,235.0,269.0,253.0,286.0,279.0,390.0,350.0,374.0,466.0,429.0,585.0,484.0,4400.0
Datia,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,320.0,354.0,301.0,363.0,391.0,501.0,516.0,437.0,541.0,500.0,636.0,528.0,5388.0
Datia,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,1.0,4.0
Datia,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,3.0,0.0,1.0,0.0,7.0
Datia,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Datia,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,5.0,1.0,1.0,1.0,11.0
Datia,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Datia,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,4.0,0.0,134.0,199.0,127.0,133.0,19.0,616.0
Datia,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,1.0,1.0,0.0,0.0,0.0,10.0,5.0,402.0,448.0,224.0,297.0,63.0,1451.0
Datia,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,15.0,4.0,16.0,0.0,0.0,0.0,23.0,66.0,932.0,411.0,281.0,59.0,1807.0
Datia,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Datia,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,16.0,5.0,16.0,0.0,0.0,14.0,28.0,602.0,1579.0,762.0,711.0,141.0,3874.0
Datia,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Datia,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,4.0,0.0,11.0
Datia,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,4.0,3.0,2.0,0.0,7.0,7.0,4.0,0.0,0.0,55.0,40.0,14.0,136.0
Datia,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Datia,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,4.0,3.0,2.0,0.0,7.0,7.0,4.0,0.0,7.0,55.0,44.0,14.0,147.0
Datia,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Datia,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,3.0
Datia,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,6.0,6.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,12.0,8.0,35.0
Datia,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Datia,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,6.0,6.0,0.0,0.0,0.0,0.0,3.0,0.0,3.0,0.0,12.0,8.0,38.0
Datia,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Datia,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,190.0,187.0,289.0,302.0,223.0,238.0,205.0,204.0,205.0,176.0,172.0,169.0,2560.0
Datia,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,1.0,6.0,4.0,1.0,3.0,2.0,15.0,9.0,3.0,2.0,2.0,2.0,50.0
Datia,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,13.0,10.0,2.0,0.0,0.0,4.0,0.0,1.0,2.0,2.0,2.0,2.0,38.0
Datia,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,32.0,38.0,15.0,16.0,10.0,26.0,37.0,60.0,57.0,37.0,0.0,35.0,363.0
Datia,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Datia,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,236.0,241.0,310.0,319.0,236.0,270.0,257.0,274.0,267.0,217.0,176.0,208.0,3011.0
Datia,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,28.0,33.0,30.0,0.0,17.0,14.0,17.0,49.0,42.0,14.0,12.0,21.0,277.0
Datia,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Datia,9.06,Number of IUCD removals,TOTAL,114.0,197.0,149.0,150.0,215.0,296.0,244.0,154.0,209.0,187.0,173.0,116.0,2204.0
Datia,9.07,Number of Oral Pills cycles distributed,TOTAL,599.0,936.0,2023.0,1317.0,1576.0,1615.0,1748.0,2247.0,2264.0,1890.0,2005.0,1380.0,19600.0
Datia,9.08,Number of Condom pieces distributed,TOTAL,2080.0,3923.0,3268.0,2767.0,3270.0,3715.0,6050.0,5909.0,12528.0,5919.0,7483.0,5740.0,62652.0
Datia,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Datia,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,8.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,11.0
Datia,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,3.0
Datia,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Datia,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,9.12,Number of Institutions having NSV trained doctors,TOTAL,5.0,4.0,7.0,5.0,8.0,6.0,8.0,9.0,8.0,9.0,9.0,9.0,-1.0
Datia,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,618.0,746.0,824.0,1134.0,1171.0,1350.0,1063.0,1246.0,1099.0,974.0,955.0,975.0,12155.0
Datia,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,751.0,855.0,803.0,863.0,949.0,1208.0,1314.0,503.0,97.0,124.0,68.0,36.0,7571.0
Datia,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,832.0,909.0,801.0,919.0,812.0,970.0,1119.0,1290.0,439.0,191.0,114.0,51.0,8447.0
Datia,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,905.0,974.0,871.0,877.0,824.0,788.0,892.0,1065.0,1032.0,501.0,236.0,131.0,9096.0
Datia,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,426.0,984.0,916.0,1249.0,1356.0,4931.0
Datia,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,640.0,788.0,1002.0,1265.0,3702.0
Datia,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,382.0,864.0,1209.0,2455.0
Datia,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,491.0,698.0,692.0,1025.0,972.0,1204.0,960.0,965.0,887.0,859.0,667.0,703.0,10123.0
Datia,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,751.0,849.0,798.0,881.0,953.0,1208.0,1323.0,927.0,998.0,1201.0,1382.0,1414.0,12685.0
Datia,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,843.0,903.0,809.0,919.0,815.0,970.0,1123.0,1296.0,990.0,1007.0,1151.0,1345.0,12171.0
Datia,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,912.0,970.0,880.0,879.0,813.0,797.0,889.0,1067.0,1083.0,873.0,1040.0,1361.0,11564.0
Datia,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,245.0,259.0,325.0,359.0,721.0,785.0,702.0,808.0,761.0,718.0,519.0,523.0,6725.0
Datia,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,765.0,881.0,828.0,944.0,1062.0,1356.0,1310.0,546.0,189.0,32.0,48.0,28.0,7989.0
Datia,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,843.0,918.0,792.0,914.0,815.0,968.0,1131.0,1287.0,480.0,122.0,88.0,49.0,8407.0
Datia,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,912.0,967.0,876.0,882.0,825.0,791.0,886.0,1059.0,1091.0,519.0,197.0,94.0,9099.0
Datia,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,597.0,994.0,976.0,1248.0,1063.0,1000.0,1071.0,938.0,757.0,742.0,1141.0,1311.0,11838.0
Datia,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,460.0,760.0,742.0,856.0,684.0,705.0,550.0,670.0,674.0,812.0,892.0,1202.0,9007.0
Datia,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,35.0,0.0,0.0,35.0
Datia,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,281.0,496.0,431.0,642.0,511.0,507.0,515.0,381.0,350.0,340.0,431.0,378.0,5263.0
Datia,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,249.0,407.0,415.0,515.0,418.0,470.0,407.0,394.0,238.0,285.0,355.0,327.0,4480.0
Datia,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,530.0,903.0,846.0,1157.0,929.0,977.0,922.0,775.0,588.0,625.0,786.0,705.0,9743.0
Datia,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,578.0,839.0,851.0,971.0,735.0,817.0,637.0,685.0,694.0,894.0,972.0,868.0,9541.0
Datia,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,579.0,830.0,772.0,969.0,728.0,782.0,617.0,680.0,680.0,901.0,965.0,891.0,9394.0
Datia,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,4.0
Datia,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,108.0,232.0,181.0,265.0,173.0,185.0,128.0,145.0,149.0,154.0,217.0,304.0,2241.0
Datia,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,101.0,206.0,135.0,223.0,156.0,152.0,108.0,121.0,106.0,148.0,177.0,239.0,1872.0
Datia,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,209.0,438.0,316.0,488.0,329.0,337.0,236.0,266.0,255.0,302.0,394.0,543.0,4113.0
Datia,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,316.0,479.0,555.0,768.0,634.0,664.0,558.0,475.0,427.0,512.0,447.0,513.0,6348.0
Datia,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,501.0,680.0,701.0,807.0,772.0,767.0,856.0,788.0,734.0,734.0,767.0,790.0,8897.0
Datia,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,551.0,738.0,694.0,894.0,810.0,832.0,898.0,736.0,775.0,817.0,853.0,869.0,9467.0
Datia,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Datia,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,13.0,2.0,10.0,14.0,20.0,24.0,0.0,11.0,0.0,0.0,0.0,94.0
Datia,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,610.0,671.0,648.0,728.0,701.0,729.0,701.0,719.0,726.0,718.0,761.0,680.0,8392.0
Datia,10.4.2,Number of Immunisation sessions held during the month,TOTAL,605.0,654.0,646.0,726.0,694.0,721.0,699.0,722.0,720.0,702.0,741.0,676.0,8306.0
Datia,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,489.0,525.0,528.0,577.0,587.0,591.0,605.0,615.0,613.0,579.0,624.0,597.0,6930.0
Datia,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,589.0,975.0,957.0,1277.0,1216.0,1032.0,1023.0,977.0,783.0,987.0,927.0,1046.0,11789.0
Datia,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,312.0,500.0,495.0,1377.0,1513.0,483.0,466.0,448.0,414.0,3465.0,841.0,649.0,10963.0
Datia,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,256.0,200.0,258.0,1181.0,1288.0,287.0,286.0,267.0,210.0,2902.0,674.0,399.0,8208.0
Datia,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,11.0,3.0,5.0,25.0,0.0,0.0,6.0,0.0,0.0,6.0,2.0,0.0,58.0
Datia,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,237.0,323.0,407.0,826.0,971.0,823.0,801.0,511.0,532.0,522.0,427.0,607.0,6987.0
Datia,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,85.0,24.0,212.0,215.0,182.0,283.0,5.0,13.0,82.0,85.0,1.0,72.0,1259.0
Datia,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,3.0,0.0,0.0,14.0,96.0,57.0,5.0,102.0,280.0,160.0,198.0,0.0,915.0
Datia,13.1,Number of Patients operated for cataract,TOTAL,33.0,25.0,36.0,24.0,39.0,57.0,17.0,106.0,681.0,592.0,918.0,94.0,2622.0
Datia,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,33.0,24.0,36.0,24.0,39.0,57.0,17.0,106.0,650.0,591.0,753.0,94.0,2424.0
Datia,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,6.0,16.0,37.0,22.0,17.0,5.0,84.0,97.0,15.0,299.0
Datia,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,181.0,60.0,54.0,50.0,345.0
Datia,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,2.0,5.0,4.0,4.0,3.0,3.0,3.0,3.0,4.0,4.0,4.0,-1.0
Datia,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,7.0,7.0,6.0,6.0,8.0,6.0,8.0,8.0,8.0,8.0,8.0,8.0,-1.0
Datia,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,507.0,491.0,586.0,538.0,720.0,578.0,557.0,533.0,589.0,546.0,792.0,668.0,-1.0
Datia,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,3.0,4.0,5.0,2.0,3.0,3.0,3.0,3.0,4.0,4.0,-1.0
Datia,14.05,Number of RKS meetings held during the month,TOTAL,1.0,1.0,2.0,0.0,3.0,4.0,2.0,3.0,1.0,2.0,2.0,3.0,24.0
Datia,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,11.0,10.0,12.0,10.0,12.0,9.0,12.0,12.0,12.0,13.0,13.0,13.0,-1.0
Datia,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,38.0,39.0,25.0,52.0,150.0,44.0,58.0,69.0,116.0,0.0,0.0,0.0,591.0
Datia,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,2.0,4.0,4.0,4.0,4.0,3.0,3.0,3.0,4.0,3.0,4.0,-1.0
Datia,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Datia,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,361.0,688.0,628.0,692.0,833.0,712.0,706.0,504.0,343.0,300.0,480.0,596.0,6843.0
Datia,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1014.0,1773.0,1560.0,1770.0,1921.0,1234.0,1159.0,808.0,587.0,814.0,798.0,1098.0,14536.0
Datia,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,109.0,168.0,203.0,164.0,217.0,757.0,390.0,288.0,212.0,359.0,309.0,289.0,3465.0
Datia,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,872.0,1265.0,1175.0,1159.0,1724.0,1807.0,2082.0,1564.0,3134.0,1724.0,1453.0,1962.0,19921.0
Datia,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,470.0,856.0,831.0,856.0,1050.0,1469.0,1096.0,792.0,555.0,659.0,789.0,885.0,10308.0
Datia,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1886.0,3038.0,2735.0,2929.0,3645.0,3041.0,3241.0,2372.0,3721.0,2538.0,2251.0,3060.0,34457.0
Datia,14.10.2.a,Number of death cases of Inpatient males,TOTAL,10.0,11.0,14.0,16.0,15.0,11.0,12.0,10.0,14.0,15.0,11.0,11.0,150.0
Datia,14.10.2.b,Number of death cases of Inpatient females,TOTAL,4.0,7.0,9.0,8.0,7.0,12.0,7.0,6.0,3.0,5.0,4.0,7.0,79.0
Datia,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,14.0,18.0,23.0,24.0,22.0,23.0,19.0,16.0,17.0,20.0,15.0,18.0,229.0
Datia,14.11,In-Patient Head Count at midnight,TOTAL,2565.0,3915.0,3498.0,2921.0,3992.0,5943.0,2719.0,3221.0,3600.0,2698.0,3279.0,3418.0,41769.0
Datia,14.12.1,OPD attendance (All),TOTAL,30147.0,43000.0,43074.0,38499.0,56702.0,53089.0,51304.0,46424.0,42414.0,35240.0,53003.0,49994.0,542890.0
Datia,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,130.0,128.0,137.0,71.0,94.0,60.0,52.0,112.0,107.0,72.0,84.0,77.0,1124.0
Datia,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,34.0,31.0,42.0,39.0,23.0,0.0,33.0,28.0,23.0,253.0
Datia,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,215.0,130.0,149.0,124.0,146.0,140.0,93.0,117.0,328.0,184.0,42.0,133.0,1801.0
Datia,14.14.a,Number of patients given AYUSH treatment,TOTAL,2028.0,1653.0,2081.0,2299.0,2322.0,2234.0,1761.0,2152.0,2191.0,2429.0,2736.0,2978.0,26864.0
Datia,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,234.0,361.0,664.0,650.0,825.0,670.0,763.0,706.0,538.0,738.0,19.0,1177.0,7345.0
Datia,14.14.c,Number of Adolescents counselled,TOTAL,91.0,73.0,115.0,113.0,153.0,246.0,168.0,206.0,236.0,214.0,355.0,204.0,2174.0
Datia,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3324.0,3893.0,4419.0,4213.0,4191.0,3988.0,3567.0,4268.0,4837.0,3677.0,3814.0,4143.0,48334.0
Datia,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,52.0,73.0,145.0,131.0,157.0,160.0,101.0,100.0,93.0,56.0,84.0,75.0,1227.0
Datia,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,231.0,267.0,268.0,217.0,239.0,257.0,245.0,231.0,165.0,209.0,143.0,184.0,2656.0
Datia,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,19.0,24.0
Datia,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,273.0,294.0,305.0,237.0,318.0,309.0,235.0,303.0,510.0,292.0,332.0,204.0,3612.0
Datia,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,7.0,0.0,2.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,11.0
Datia,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,657.0,729.0,777.0,842.0,826.0,967.0,500.0,884.0,652.0,447.0,492.0,461.0,8234.0
Datia,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,13.0,0.0,0.0,0.0,1.0,0.0,4.0,0.0,0.0,0.0,0.0,19.0
Datia,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1161.0,1290.0,1350.0,1296.0,1383.0,1533.0,980.0,1418.0,1327.0,948.0,967.0,849.0,14502.0
Datia,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,20.0,0.0,2.0,1.0,1.0,2.0,5.0,1.0,1.0,0.0,19.0,54.0
Datia,15.2,Number of Widal tests conducted,Number tested,261.0,275.0,434.0,341.0,312.0,679.0,563.0,399.0,156.0,93.0,305.0,332.0,4150.0
Datia,15.3.a,Number of VDRL tests conducted on males,Number tested,4.0,19.0,361.0,65.0,103.0,25.0,20.0,18.0,39.0,17.0,40.0,13.0,724.0
Datia,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,2.0,10.0,1.0,0.0,1.0,20.0,7.0,38.0,60.0,32.0,29.0,15.0,215.0
Datia,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,12.0,31.0,11.0,15.0,97.0,146.0,48.0,96.0,62.0,0.0,14.0,89.0,621.0
Datia,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,18.0,60.0,373.0,80.0,201.0,191.0,75.0,152.0,161.0,49.0,83.0,117.0,1560.0
Datia,15.4.1,Number of blood smears examined for Malaria,TOTAL,4560.0,5030.0,9683.0,7895.0,7732.0,8239.0,96818.0,4870.0,4239.0,1361.0,2078.0,6125.0,158630.0
Datia,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,21.0,76.0,257.0,192.0,350.0,418.0,349.0,162.0,56.0,16.0,51.0,65.0,2013.0
Datia,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,5.0,4.0,34.0,4.0,14.0,17.0,37.0,10.0,3.0,4.0,4.0,9.0,145.0
Datia,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,14210.0,,24160.0,,19660.0,13210.0,,,,,,,71240.0
Datia,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,,0.0,,0.0,6000.0,,,,,,,16000.0
Datia,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,1036.0,,832.0,,967.0,864.0,,,,,,,3699.0
Datia,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,6910.0,,5550.0,,6450.0,5760.0,,,,,,,24670.0
Datia,16.1.1,Stock position of DPT vaccines,5. Total Stock,16264.0,0.0,17778.0,0.0,12243.0,12586.0,0.0,0.0,0.0,0.0,0.0,0.0,58871.0
Datia,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,,,,,,,,,,,,0.0
Datia,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,,,,,,,,,,,,0.0
Datia,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Datia,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,,,,,,,,,,,,0.0
Datia,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,2800.0,,15800.0,,10800.0,9200.0,,,,,,,38600.0
Datia,16.1.2,Stock position of OPV vaccines,2. Stocks Received,15000.0,,0.0,,10000.0,9000.0,,,,,,,34000.0
Datia,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,1020.0,,1605.0,,1740.0,1524.0,,,,,,,5889.0
Datia,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,6800.0,,10700.0,,11600.0,10160.0,,,,,,,39260.0
Datia,16.1.2,Stock position of OPV vaccines,5. Total Stock,9980.0,0.0,3495.0,0.0,7460.0,6516.0,0.0,0.0,0.0,0.0,0.0,0.0,27451.0
Datia,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,12540.0,,19430.0,,17020.0,10100.0,,,,,,,59090.0
Datia,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,,0.0,,0.0,6000.0,,,,,,,16000.0
Datia,16.1.3,Stock position of TT vaccines,3. Unusable Stock,1021.0,,744.0,,1038.0,975.0,,,,,,,3778.0
Datia,16.1.3,Stock position of TT vaccines,4. Stock Distributed,6810.0,,4960.0,,6920.0,6500.0,,,,,,,25190.0
Datia,16.1.3,Stock position of TT vaccines,5. Total Stock,14709.0,0.0,13726.0,0.0,9062.0,8625.0,0.0,0.0,0.0,0.0,0.0,0.0,46122.0
Datia,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,,4150.0,,,,,,,,,,4150.0
Datia,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,,0.0,,,,,,,,,,0.0
Datia,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,,165.0,,,,,,,,,,165.0
Datia,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,,1100.0,,,,,,,,,,1100.0
Datia,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,2885.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2885.0
Datia,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1720.0,,,,5600.0,9350.0,,,,,,,16670.0
Datia,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5000.0,,,,0.0,2500.0,,,,,,,7500.0
Datia,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,535.0,,,,337.0,99.0,,,,,,,971.0
Datia,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,3570.0,,,,2250.0,660.0,,,,,,,6480.0
Datia,16.1.5,Stock position of BCG vaccines,5. Total Stock,2615.0,0.0,0.0,0.0,3013.0,11091.0,0.0,0.0,0.0,0.0,0.0,0.0,16719.0
Datia,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4070.0,,8560.0,,8400.0,4680.0,,,,,,,25710.0
Datia,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3000.0,,0.0,,0.0,5000.0,,,,,,,8000.0
Datia,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,616.0,,421.0,,558.0,588.0,,,,,,,2183.0
Datia,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4110.0,,2810.0,,3720.0,3920.0,,,,,,,14560.0
Datia,16.1.6,Stock position of Measles vaccines,5. Total Stock,2344.0,0.0,5329.0,0.0,4122.0,5172.0,0.0,0.0,0.0,0.0,0.0,0.0,16967.0
Datia,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,,,,,,,,,,,,0.0
Datia,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,,,,,,,,,,,,0.0
Datia,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Datia,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,,,,,,,,,,,,0.0
Datia,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,6890.0,,11830.0,,6880.0,10660.0,,,,,,,36260.0
Datia,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,10200.0,,0.0,,10000.0,5000.0,,,,,,,25200.0
Datia,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,1022.0,,885.0,,933.0,822.0,,,,,,,3662.0
Datia,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,6860.0,,5900.0,,6220.0,5480.0,,,,,,,24460.0
Datia,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,9208.0,0.0,5045.0,0.0,9727.0,9358.0,0.0,0.0,0.0,0.0,0.0,0.0,33338.0
Datia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,10150.0,,3600.0,,,,,,,,,,13750.0
Datia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,,0.0,,,,,,,,,,0.0
Datia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,,0.0,,,,,,,,,,0.0
Datia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,,100.0,,,,,,,,,,100.0
Datia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,10150.0,0.0,3500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13650.0
Datia,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,95820.0,,8820.0,,,,,,,,,,104640.0
Datia,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,,0.0,,,,,,,,,,0.0
Datia,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,,0.0,,,,,,,,,,0.0
Datia,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,10500.0,,6600.0,,,,,,,,,,17100.0
Datia,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,85320.0,0.0,2220.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,87540.0
Datia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2415.0,,115.0,,,,,,,,,,2530.0
Datia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,0.0,,,,,,,,,,0.0
Datia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,0.0,,,,,,,,,,0.0
Datia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,500.0,,100.0,,,,,,,,,,600.0
Datia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1915.0,0.0,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1930.0
Datia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1600.0,,1600.0,,,,,,,,,,3200.0
Datia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,0.0,,,,,,,,,,0.0
Datia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,0.0,,,,,,,,,,0.0
Datia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,,0.0,,,,,,,,,,0.0
Datia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1600.0,0.0,1600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3200.0
Datia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,7300.0,,7300.0,,,,,,,,,,14600.0
Datia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,,0.0,,,,,,,,,,0.0
Datia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,,0.0,,,,,,,,,,0.0
Datia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,,0.0,,,,,,,,,,0.0
Datia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,7300.0,0.0,7300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14600.0
Datia,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,3500.0,,850.0,,,,,,,,,,4350.0
Datia,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,1600.0,,600.0,,,,,,,,,,2200.0
Datia,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,1900.0,0.0,250.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2150.0
Datia,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,1775.0,,675.0,,,,,,,,,,2450.0
Datia,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.02,Stock Position of Gloves,4. Stock Distributed,400.0,,,,,,,,,,,,400.0
Datia,16.3.02,Stock Position of Gloves,5. Total Stock,1375.0,0.0,675.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2050.0
Datia,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,,,,,,,,,,,,0.0
Datia,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,,,,,,,,,,,,0.0
Datia,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Datia,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,,,,,,,,,,,,0.0
Datia,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,400.0,,200.0,,,,,,,,,,600.0
Datia,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,,200.0,,,,,,,,,,200.0
Datia,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,400.0
Datia,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,150.0,,150.0,,,,,,,,,,300.0
Datia,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,150.0,0.0,150.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,300.0
Datia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,24.0,,9.0,,,,,,,,,,33.0
Datia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,,1.0,,,,,,,,,,1.0
Datia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,24.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,32.0
Datia,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,1150000.0,,596000.0,,,,,,,,,,1746000.0
Datia,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,380000.0,,40000.0,,,,,,,,,,420000.0
Datia,16.3.07,Stock Position of IFA Tablets,5. Total Stock,770000.0,0.0,556000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1326000.0
Datia,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,,,,,,,,,,,,0.0
Datia,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,,,,,,,,,,,,0.0
Datia,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Datia,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,,,,,,,,,,,,0.0
Datia,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Datia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,181000.0,,151000.0,,,,,,,,,,332000.0
Datia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,10000.0,,20000.0,,,,,,,,,,30000.0
Datia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,171000.0,0.0,131000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,302000.0
Datia,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,658.0,,1601.0,,,,,,,,,,2259.0
Datia,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,130.0,,1360.0,,,,,,,,,,1490.0
Datia,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,528.0,0.0,241.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,769.0
Datia,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,334400.0,,186925.0,,,,,,,,,,521325.0
Datia,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,,0.0,,,,,,,,,,0.0
Datia,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,19100.0,,36500.0,,,,,,,,,,55600.0
Datia,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,315300.0,0.0,150425.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,465725.0
Datia,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,9000.0,,2400.0,,5000.0,5000.0,,,,,,,21400.0
Datia,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,,0.0,,0.0,6600.0,,,,,,,6600.0
Datia,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,,0.0,,0.0,11600.0,,,,,,,11600.0
Datia,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,,1000.0,,0.0,0.0,,,,,,,1000.0
Datia,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,9000.0,0.0,1400.0,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15400.0
Datia,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,,170000.0,,13600.0,136000.0,,,,,,,319600.0
Datia,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,,0.0,,0.0,0.0,,,,,,,0.0
Datia,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,,0.0,,0.0,130000.0,,,,,,,130000.0
Datia,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,,64000.0,,0.0,6000.0,,,,,,,70000.0
Datia,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,106000.0,0.0,13600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,119600.0
Datia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,,2400.0,,5000.0,3500.0,,,,,,,10900.0
Datia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,9000.0,,0.0,,0.0,4000.0,,,,,,,13000.0
Datia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,,0.0,,0.0,7500.0,,,,,,,7500.0
Datia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,,1000.0,,0.0,0.0,,,,,,,1000.0
Datia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,9000.0,0.0,1400.0,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15400.0
Datia,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,4.0,1.0,5.0,4.0,1.0,2.0,1.0,2.0,1.0,1.0,2.0,26.0
Datia,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,1.0,,1.0,,,1.0,,,,3.0
Datia,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Datia,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,1.0,,1.0,,,1.0,,,,3.0
Datia,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,1.0,,,,,,1.0
Datia,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Datia,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,1.0,,,,,,1.0
Datia,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,,7.0,7.0,9.0,7.0,7.0,3.0,8.0,4.0,3.0,2.0,59.0
Datia,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Datia,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,,7.0,7.0,9.0,7.0,7.0,3.0,8.0,4.0,3.0,2.0,59.0
Datia,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,1.0,3.0,5.0,1.0,1.0,3.0,3.0,4.0,6.0,3.0,,31.0
Datia,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Datia,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,1.0,3.0,5.0,1.0,1.0,3.0,3.0,4.0,6.0,3.0,,31.0
Datia,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,,1.0,,,,1.0,3.0,,1.0,7.0
Datia,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,1.0,,,1.0
Datia,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,,1.0,,,,1.0,4.0,,1.0,8.0
Datia,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Datia,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
Datia,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,1.0,,,,,,,,1.0
Datia,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,2.0,1.0,1.0,1.0,1.0,1.0,,,,,,7.0
Datia,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,,,1.0,,,,,,,,2.0
Datia,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,3.0,1.0,1.0,2.0,1.0,1.0,,,,,,9.0
Datia,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Datia,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Datia,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Datia,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,3.0,4.0,2.0,3.0,4.0,1.0,6.0,3.0,5.0,2.0,34.0
Datia,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,2.0,2.0,,,3.0,,,1.0,,,8.0
Datia,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,1.0,5.0,6.0,2.0,3.0,7.0,1.0,6.0,4.0,5.0,2.0,42.0
Datia,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Datia,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,1.0,,2.0,,,3.0
Datia,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,5.0,,,,5.0
Datia,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,1.0,5.0,2.0,,,8.0
Datia,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Datia,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,3.0,1.0,1.0,3.0,2.0,3.0,1.0,1.0,,15.0
Datia,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,1.0,,,,1.0,1.0,,,3.0
Datia,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,3.0,2.0,1.0,3.0,2.0,4.0,2.0,1.0,,18.0
Datia,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Datia,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,2.0,,,2.0,,,1.0,,,1.0,,7.0
Datia,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,2.0,1.0,2.0,2.0,,2.0,,,1.0,10.0
Datia,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,2.0,,2.0,3.0,2.0,3.0,1.0,2.0,,1.0,1.0,18.0
Datia,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Datia,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Datia,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Datia,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,1.0,,,,,,,,,1.0
Datia,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Datia,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,2.0,1.0,,,,1.0,1.0,,,,,6.0
Datia,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,2.0,,1.0,,,,3.0
Datia,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,2.0,1.0,,,,3.0,1.0,1.0,,,,9.0
Datia,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Datia,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,,,1.0,,,,,,,2.0
Datia,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Datia,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,1.0,,,1.0,,,,,,,2.0
Datia,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Datia,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,2.0,1.0,2.0,2.0,1.0,3.0,2.0,7.0,,5.0,2.0,27.0
Datia,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2.0,2.0,2.0,2.0,1.0,2.0,2.0,,3.0,,5.0,4.0,25.0
Datia,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,2.0,4.0,3.0,4.0,3.0,3.0,5.0,2.0,10.0,,10.0,6.0,52.0
Datia,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Datia,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,2.0,1.0,,1.0,,1.0,,2.0,,7.0
Datia,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,1.0,,1.0,,,1.0,,,,3.0
Datia,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,3.0,1.0,1.0,1.0,,2.0,,3.0,,11.0
Datia,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Datia,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Datia,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Datia,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Datia,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Datia,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Datia,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Datia,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Datia,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Datia,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Datia,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Datia,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Datia,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Datia,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Datia,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Datia,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Datia,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Datia,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Datia,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Datia,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,1.0,,,,,,,,1.0
Datia,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Datia,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,1.0,,,,1.0,2.0,,,,4.0
Datia,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Datia,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,1.0,,,,1.0,2.0,,,,4.0
Datia,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,2.0,2.0,2.0,,,2.0,1.0,,,,,9.0
Datia,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,9.0,8.0,8.0,6.0,4.0,3.0,5.0,5.0,4.0,1.0,2.0,55.0
Datia,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,2.0,,1.0,,1.0,1.0,2.0,,1.0,3.0,12.0
Datia,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,11.0,12.0,10.0,7.0,4.0,6.0,7.0,7.0,4.0,2.0,5.0,76.0
Datia,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Datia,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,7.0,3.0,5.0,3.0,6.0,4.0,4.0,6.0,3.0,,1.0,44.0
Datia,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Datia,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,2.0,7.0,3.0,5.0,3.0,6.0,4.0,4.0,6.0,3.0,,1.0,44.0
Datia,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Datia,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,2.0,1.0,,,1.0,,,,4.0
Datia,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,2.0,,,,1.0,,2.0,1.0,,,,6.0
Datia,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,2.0,,,2.0,2.0,,2.0,2.0,,,,10.0
Datia,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Datia,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,2.0,,,2.0,1.0,1.0,,1.0,,,1.0,8.0
Datia,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,2.0,2.0,1.0,2.0,2.0,,,9.0
Datia,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,2.0,,,2.0,3.0,3.0,1.0,3.0,2.0,,1.0,17.0
Datia,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Datia,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,1.0,1.0,1.0,1.0,1.0,,5.0,1.0,2.0,3.0,,17.0
Datia,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,2.0,2.0,,2.0,,,2.0,1.0,1.0,1.0,,2.0,13.0
Datia,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,3.0,3.0,1.0,3.0,2.0,1.0,2.0,6.0,2.0,3.0,3.0,2.0,31.0
Datia,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,2.0,,1.0,1.0,2.0,2.0,,2.0,1.0,3.0,2.0,16.0
Datia,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,2.0,4.0,12.0,34.0,16.0,17.0,23.0,17.0,11.0,15.0,15.0,9.0,175.0
Datia,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,12.0,46.0,68.0,86.0,47.0,64.0,109.0,63.0,56.0,55.0,62.0,49.0,717.0
Datia,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,14.0,52.0,80.0,121.0,64.0,83.0,134.0,80.0,69.0,71.0,80.0,60.0,908.0
Dewas,1.1,Total number of pregnant women Registered for ANC,TOTAL,2117.0,2993.0,3578.0,3542.0,2704.0,3035.0,2636.0,2695.0,3051.0,2955.0,3157.0,3461.0,35924.0
Dewas,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1367.0,1667.0,2119.0,2201.0,1744.0,1909.0,1674.0,1708.0,1812.0,1867.0,1960.0,2142.0,22170.0
Dewas,1.2,Number of Pregnant women registered under JSY,TOTAL,2118.0,2981.0,3564.0,3536.0,2703.0,3028.0,2615.0,2671.0,3051.0,2947.0,3221.0,3410.0,35845.0
Dewas,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1667.0,2121.0,2384.0,2534.0,2587.0,2554.0,2299.0,2141.0,2381.0,2384.0,2388.0,2846.0,28286.0
Dewas,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1910.0,2654.0,3299.0,3239.0,2414.0,2817.0,2509.0,2488.0,2862.0,2752.0,2903.0,3091.0,32938.0
Dewas,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1909.0,2287.0,2657.0,3104.0,2734.0,2541.0,2511.0,2449.0,2504.0,2641.0,2640.0,3274.0,31251.0
Dewas,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1697.0,2896.0,3502.0,3422.0,2611.0,3047.0,2784.0,2669.0,3051.0,2920.0,3150.0,3408.0,35157.0
Dewas,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,186.0,246.0,229.0,177.0,92.0,133.0,180.0,259.0,183.0,107.0,189.0,226.0,2207.0
Dewas,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,3.0,12.0,4.0,33.0,7.0,4.0,4.0,3.0,10.0,6.0,8.0,96.0
Dewas,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,656.0,1119.0,1575.0,1580.0,1548.0,1625.0,1393.0,1485.0,1713.0,1537.0,1788.0,2028.0,18047.0
Dewas,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,67.0,96.0,65.0,79.0,120.0,110.0,119.0,70.0,86.0,70.0,67.0,97.0,1046.0
Dewas,1.8,Number of pregnancy test kits used at SC level,TOTAL,221.0,293.0,181.0,328.0,224.0,222.0,192.0,85.0,254.0,175.0,231.0,248.0,2654.0
Dewas,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,4.0,12.0,9.0,9.0,7.0,33.0,29.0,33.0,21.0,26.0,28.0,20.0,231.0
Dewas,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,36.0,56.0,84.0,86.0,75.0,61.0,64.0,54.0,62.0,52.0,18.0,27.0,675.0
Dewas,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,40.0,68.0,93.0,95.0,82.0,94.0,93.0,87.0,83.0,78.0,46.0,47.0,906.0
Dewas,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,12.0,29.0,55.0,54.0,71.0,53.0,45.0,52.0,77.0,70.0,36.0,42.0,596.0
Dewas,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,4.0,1.0,6.0,16.0
Dewas,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1219.0,1639.0,2013.0,2057.0,2263.0,2366.0,2064.0,2107.0,1950.0,1887.0,1726.0,2423.0,23714.0
Dewas,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,338.0,0.0,59.0,137.0,43.0,56.0,59.0,415.0,38.0,29.0,279.0,65.0,1518.0
Dewas,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,240.0,1030.0,1786.0,1790.0,2129.0,1937.0,1730.0,1856.0,1781.0,2177.0,1519.0,2804.0,20779.0
Dewas,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,126.0,425.0,1522.0,1283.0,1612.0,766.0,974.0,683.0,1306.0,1278.0,726.0,2881.0,13582.0
Dewas,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,145.0,271.0,288.0,153.0,217.0,143.0,271.0,184.0,307.0,189.0,157.0,257.0,2582.0
Dewas,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,,,0.0,0.0,0.0,,,,,,,0.0
Dewas,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,,,0.0,0.0,0.0,,,,,,,0.0
Dewas,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,,,0.0,,0.0,,,,,,,0.0
Dewas,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,75.0,0.0,0.0,0.0,0.0,75.0
Dewas,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,64.0,77.0,92.0,100.0,88.0,66.0,72.0,96.0,80.0,78.0,85.0,60.0,958.0
Dewas,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dewas,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,64.0,77.0,92.0,100.0,88.0,66.0,72.0,171.0,80.0,78.0,85.0,60.0,1033.0
Dewas,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,99.0,170.0,158.0,96.0,125.0,97.0,140.0,116.0,110.0,117.0,104.0,95.0,1427.0
Dewas,4.1.1.a,Number of male live births,TOTAL,704.0,1044.0,1230.0,1173.0,1325.0,1340.0,1279.0,1209.0,1181.0,1111.0,973.0,1391.0,13960.0
Dewas,4.1.1.b,Number of female live births,TOTAL,681.0,904.0,1125.0,1107.0,1214.0,1241.0,1121.0,1148.0,1131.0,1024.0,940.0,1300.0,12936.0
Dewas,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1385.0,1948.0,2355.0,2280.0,2539.0,2581.0,2400.0,2357.0,2312.0,2135.0,1913.0,2691.0,26896.0
Dewas,4.1.2,Number of still births,TOTAL,25.0,30.0,45.0,27.0,34.0,37.0,31.0,33.0,36.0,29.0,33.0,40.0,400.0
Dewas,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,36.0,9.0,52.0,79.0,45.0,49.0,30.0,51.0,69.0,47.0,37.0,78.0,582.0
Dewas,4.2.1,Number of Newborns weighed at birth,TOTAL,1313.0,1859.0,2259.0,2200.0,2372.0,2492.0,2238.0,2228.0,2218.0,2089.0,1876.0,2658.0,25802.0
Dewas,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,218.0,285.0,330.0,267.0,312.0,321.0,456.0,536.0,447.0,263.0,240.0,342.0,4017.0
Dewas,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1183.0,1756.0,2049.0,2074.0,2333.0,2437.0,2070.0,2121.0,2143.0,2007.0,1849.0,2607.0,24629.0
Dewas,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,8.0,21.0,10.0,13.0,11.0,19.0,38.0,30.0,10.0,24.0,30.0,214.0
Dewas,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,16.0,39.0,40.0,72.0,37.0,56.0,44.0,69.0,76.0,90.0,58.0,104.0,701.0
Dewas,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,124.0,175.0,198.0,153.0,151.0,110.0,118.0,96.0,102.0,113.0,146.0,238.0,1724.0
Dewas,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dewas,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,140.0,222.0,259.0,235.0,201.0,177.0,181.0,203.0,208.0,213.0,228.0,372.0,2639.0
Dewas,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,41.0,170.0,158.0,79.0,125.0,55.0,140.0,113.0,65.0,68.0,110.0,95.0,1219.0
Dewas,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1595.0,612.0,338.0,210.0,207.0,186.0,564.0,222.0,488.0,190.0,407.0,431.0,5450.0
Dewas,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,166.0,28.0,49.0,12.0,12.0,26.0,22.0,8.0,30.0,21.0,30.0,15.0,419.0
Dewas,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1239.0,317.0,245.0,182.0,209.0,224.0,228.0,237.0,228.0,206.0,238.0,225.0,3778.0
Dewas,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,55.0,85.0,98.0,88.0,64.0,68.0,70.0,60.0,52.0,44.0,57.0,57.0,798.0
Dewas,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1140.0,1734.0,1883.0,1929.0,2068.0,2156.0,2023.0,2265.0,1967.0,1946.0,1875.0,2413.0,23399.0
Dewas,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1001.0,1817.0,2139.0,1690.0,1982.0,1992.0,1883.0,1609.0,1402.0,1435.0,1850.0,2366.0,21166.0
Dewas,6.3,PNC maternal complications attended,TOTAL,8.0,18.0,33.0,35.0,46.0,35.0,33.0,32.0,29.0,21.0,55.0,21.0,366.0
Dewas,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,32.0,45.0,46.0,28.0,33.0,54.0,35.0,52.0,57.0,44.0,60.0,69.0,555.0
Dewas,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,4.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,1.0,0.0,0.0,8.0
Dewas,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,36.0,45.0,46.0,28.0,33.0,54.0,35.0,55.0,57.0,45.0,60.0,69.0,563.0
Dewas,7.2,Number of MTPs conducted at Private Facilities,TOTAL,29.0,31.0,20.0,17.0,23.0,22.0,18.0,8.0,9.0,20.0,25.0,15.0,237.0
Dewas,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,63.0,244.0,208.0,505.0,98.0,532.0,280.0,331.0,381.0,250.0,427.0,174.0,3493.0
Dewas,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,131.0,734.0,488.0,499.0,142.0,409.0,450.0,446.0,507.0,356.0,405.0,450.0,5017.0
Dewas,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,194.0,978.0,696.0,1004.0,240.0,941.0,730.0,777.0,888.0,606.0,832.0,624.0,8510.0
Dewas,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,3.0,1.0,3.0,0.0,0.0,9.0
Dewas,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,1.0,0.0,0.0,3.0,2.0,0.0,1.0,3.0,1.0,1.0,3.0,15.0
Dewas,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,7.0,4.0,2.0,4.0,5.0,0.0,6.0,0.0,4.0,3.0,10.0,45.0
Dewas,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dewas,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,8.0,4.0,2.0,7.0,7.0,2.0,10.0,4.0,8.0,4.0,13.0,69.0
Dewas,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dewas,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,2.0,32.0,61.0,55.0,46.0,44.0,41.0,204.0,38.0,106.0,19.0,22.0,670.0
Dewas,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,81.0,127.0,103.0,402.0,335.0,220.0,133.0,1022.0,811.0,881.0,644.0,118.0,4877.0
Dewas,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,7.0,24.0,28.0,21.0,28.0,27.0,7.0,56.0,67.0,62.0,39.0,14.0,380.0
Dewas,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dewas,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,90.0,183.0,192.0,478.0,409.0,291.0,181.0,1282.0,916.0,1049.0,702.0,154.0,5927.0
Dewas,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dewas,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,21.0,17.0,16.0,0.0,18.0,64.0,8.0,75.0,78.0,0.0,21.0,318.0
Dewas,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,1.0,40.0,22.0,37.0,24.0,6.0,4.0,67.0,151.0,61.0,22.0,19.0,454.0
Dewas,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,257.0,113.0,35.0,61.0,80.0,11.0,75.0,31.0,156.0,55.0,405.0,1279.0
Dewas,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dewas,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,1.0,318.0,152.0,88.0,85.0,104.0,79.0,150.0,257.0,295.0,77.0,445.0,2051.0
Dewas,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dewas,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Dewas,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,1.0,12.0,7.0,10.0,0.0,7.0,7.0,2.0,4.0,10.0,60.0
Dewas,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,36.0,40.0,70.0,43.0,48.0,16.0,40.0,0.0,54.0,40.0,61.0,448.0
Dewas,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dewas,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,36.0,41.0,82.0,50.0,58.0,16.0,47.0,9.0,56.0,44.0,71.0,510.0
Dewas,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dewas,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,252.0,327.0,365.0,356.0,435.0,455.0,415.0,438.0,415.0,432.0,420.0,394.0,4704.0
Dewas,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,45.0,46.0,43.0,64.0,52.0,52.0,25.0,60.0,66.0,47.0,42.0,73.0,615.0
Dewas,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,42.0,17.0,38.0,25.0,26.0,27.0,35.0,50.0,290.0,28.0,16.0,32.0,626.0
Dewas,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,124.0,77.0,124.0,117.0,62.0,80.0,75.0,69.0,46.0,24.0,40.0,838.0
Dewas,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dewas,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,339.0,514.0,523.0,569.0,630.0,596.0,555.0,623.0,840.0,553.0,502.0,539.0,6783.0
Dewas,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,17.0,118.0,56.0,138.0,124.0,140.0,61.0,165.0,195.0,101.0,67.0,112.0,1294.0
Dewas,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dewas,9.06,Number of IUCD removals,TOTAL,191.0,203.0,212.0,243.0,265.0,327.0,267.0,262.0,296.0,269.0,304.0,380.0,3219.0
Dewas,9.07,Number of Oral Pills cycles distributed,TOTAL,3786.0,4014.0,3903.0,4803.0,5033.0,6368.0,5687.0,5399.0,6243.0,5850.0,5375.0,6444.0,62905.0
Dewas,9.08,Number of Condom pieces distributed,TOTAL,45745.0,42796.0,45986.0,59854.0,63783.0,57142.0,62335.0,40551.0,132145.0,46107.0,61133.0,49521.0,707098.0
Dewas,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Dewas,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,4.0,2.0,0.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Dewas,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Dewas,9.12,Number of Institutions having NSV trained doctors,TOTAL,10.0,9.0,13.0,13.0,10.0,10.0,10.0,10.0,14.0,13.0,12.0,12.0,-1.0
Dewas,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1286.0,1979.0,2355.0,2443.0,2598.0,2762.0,2504.0,2452.0,2299.0,2334.0,2067.0,2717.0,27796.0
Dewas,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1664.0,2242.0,2594.0,2560.0,2416.0,2734.0,2664.0,1398.0,257.0,110.0,32.0,6.0,18677.0
Dewas,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1812.0,2240.0,2497.0,2818.0,2410.0,2578.0,2589.0,2613.0,1636.0,547.0,227.0,96.0,22063.0
Dewas,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2066.0,2289.0,2520.0,2589.0,2527.0,2593.0,2440.0,2480.0,2688.0,1370.0,469.0,263.0,24294.0
Dewas,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1409.0,2434.0,2501.0,2621.0,2954.0,11919.0
Dewas,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1207.0,2216.0,2578.0,3210.0,9211.0
Dewas,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1206.0,2212.0,3130.0,6548.0
Dewas,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1163.0,1748.0,2242.0,2323.0,2518.0,2657.0,2405.0,2328.0,2224.0,2134.0,1990.0,1619.0,25351.0
Dewas,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1671.0,2254.0,2584.0,2563.0,2401.0,2716.0,2662.0,2203.0,1667.0,1899.0,2033.0,2273.0,26926.0
Dewas,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1812.0,2245.0,2501.0,2819.0,2412.0,2589.0,2596.0,2610.0,2260.0,1985.0,2170.0,2677.0,28676.0
Dewas,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2056.0,2289.0,2505.0,2594.0,2524.0,2585.0,2435.0,2476.0,2670.0,1999.0,2111.0,2745.0,28989.0
Dewas,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,925.0,1415.0,1627.0,1707.0,1836.0,2061.0,1875.0,2255.0,1224.0,1203.0,1074.0,1621.0,18823.0
Dewas,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1690.0,2235.0,2587.0,2565.0,2450.0,2733.0,2643.0,1341.0,303.0,126.0,15.0,8.0,18696.0
Dewas,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1805.0,2231.0,2496.0,2817.0,2410.0,2582.0,2599.0,2592.0,1685.0,583.0,243.0,85.0,22128.0
Dewas,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2055.0,2276.0,2518.0,2597.0,2523.0,2592.0,2434.0,2497.0,2590.0,1450.0,507.0,239.0,24278.0
Dewas,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1771.0,2357.0,2793.0,3101.0,2459.0,2724.0,2393.0,2237.0,2296.0,2569.0,2398.0,2947.0,30045.0
Dewas,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,863.0,1157.0,1282.0,1496.0,1084.0,1256.0,1037.0,1442.0,1795.0,1997.0,1876.0,2323.0,17608.0
Dewas,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,834.0,1064.0,1324.0,1498.0,1147.0,1307.0,1141.0,1065.0,1137.0,1220.0,1146.0,1483.0,14366.0
Dewas,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,758.0,1052.0,1296.0,1345.0,1094.0,1219.0,1056.0,1002.0,1104.0,1162.0,1076.0,1318.0,13482.0
Dewas,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1592.0,2116.0,2620.0,2843.0,2241.0,2526.0,2197.0,2067.0,2241.0,2382.0,2222.0,2801.0,27848.0
Dewas,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1564.0,1949.0,2273.0,2534.0,1973.0,2056.0,1872.0,1892.0,2317.0,2609.0,2077.0,3036.0,26152.0
Dewas,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1563.0,1943.0,2267.0,2540.0,1980.0,2072.0,1888.0,1885.0,2306.0,2601.0,2077.0,3010.0,26132.0
Dewas,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,176.0,270.0,578.0,390.0,244.0,348.0,249.0,239.0,282.0,342.0,312.0,391.0,3821.0
Dewas,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,164.0,246.0,555.0,318.0,218.0,316.0,247.0,233.0,284.0,315.0,292.0,352.0,3540.0
Dewas,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,340.0,516.0,1133.0,708.0,462.0,664.0,496.0,472.0,566.0,657.0,604.0,743.0,7361.0
Dewas,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,0.0,13.0,0.0,115.0,132.0,107.0,155.0,373.0,299.0,404.0,402.0,384.0,2384.0
Dewas,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1067.0,1170.0,1464.0,1894.0,1721.0,1879.0,1741.0,1667.0,1709.0,1847.0,1955.0,1893.0,20007.0
Dewas,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,794.0,1156.0,1611.0,2319.0,1790.0,1926.0,1751.0,1769.0,1752.0,1966.0,2217.0,1846.0,20897.0
Dewas,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,8.0,8.0,0.0,0.0,0.0,12.0,3.0,6.0,14.0,51.0
Dewas,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,9.0,3.0,5.0,5.0,0.0,9.0,13.0,5.0,10.0,0.0,0.0,59.0
Dewas,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1279.0,1421.0,1464.0,1483.0,1463.0,1498.0,1482.0,1446.0,1473.0,1486.0,1463.0,1510.0,17468.0
Dewas,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1036.0,1417.0,1462.0,1511.0,1443.0,1486.0,1479.0,1451.0,1453.0,1478.0,1468.0,1513.0,17197.0
Dewas,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,773.0,1129.0,1146.0,1153.0,1124.0,1141.0,1135.0,1070.0,1118.0,1195.0,1121.0,1188.0,13293.0
Dewas,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1699.0,2138.0,2694.0,3549.0,2522.0,2667.0,2304.0,2069.0,2213.0,2592.0,2350.0,2929.0,29726.0
Dewas,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1147.0,898.0,1177.0,8422.0,3733.0,1155.0,1078.0,800.0,2133.0,13070.0,4627.0,1338.0,39578.0
Dewas,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,420.0,502.0,597.0,7852.0,4230.0,699.0,608.0,532.0,616.0,12773.0,3986.0,782.0,33597.0
Dewas,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,720.0,860.0,1008.0,706.0,1021.0,920.0,713.0,615.0,803.0,457.0,757.0,844.0,9424.0
Dewas,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,17.0,6.0,3.0,7.0,20.0,22.0,14.0,6.0,0.0,0.0,0.0,0.0,95.0
Dewas,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,28.0,52.0,43.0,55.0,62.0,98.0,128.0,374.0,368.0,50.0,161.0,137.0,1556.0
Dewas,13.1,Number of Patients operated for cataract,TOTAL,362.0,353.0,589.0,774.0,331.0,168.0,99.0,213.0,402.0,362.0,224.0,147.0,4024.0
Dewas,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,362.0,353.0,590.0,779.0,331.0,169.0,99.0,213.0,400.0,359.0,225.0,147.0,4027.0
Dewas,13.3,Number of School children detected with Refractive errors,TOTAL,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4325.0,0.0,0.0,4340.0
Dewas,13.4,Number of children provided free glasses,TOTAL,1.0,0.0,1.0,1.0,1.0,1.0,1.0,0.0,0.0,351.0,1.0,1.0,359.0
Dewas,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,6.0,6.0,6.0,6.0,6.0,6.0,5.0,5.0,6.0,6.0,5.0,-1.0
Dewas,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,9.0,8.0,9.0,10.0,10.0,11.0,10.0,9.0,10.0,11.0,12.0,12.0,-1.0
Dewas,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,876.0,1002.0,969.0,974.0,1034.0,984.0,996.0,928.0,930.0,934.0,973.0,1106.0,-1.0
Dewas,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,5.0,5.0,5.0,6.0,5.0,5.0,5.0,6.0,6.0,4.0,-1.0
Dewas,14.05,Number of RKS meetings held during the month,TOTAL,5.0,0.0,4.0,4.0,5.0,5.0,4.0,0.0,1.0,1.0,2.0,1.0,32.0
Dewas,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,10.0,9.0,11.0,11.0,10.0,10.0,10.0,14.0,15.0,15.0,15.0,14.0,-1.0
Dewas,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,45.0,64.0,129.0,0.0,0.0,14.0,0.0,43.0,0.0,75.0,76.0,52.0,498.0
Dewas,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,5.0,5.0,5.0,4.0,5.0,5.0,4.0,4.0,5.0,5.0,5.0,-1.0
Dewas,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Dewas,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,158.0,231.0,249.0,157.0,191.0,246.0,285.0,291.0,361.0,168.0,217.0,303.0,2857.0
Dewas,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1030.0,2026.0,1810.0,2139.0,2077.0,2075.0,1893.0,1614.0,1546.0,1135.0,1581.0,1983.0,20909.0
Dewas,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,132.0,197.0,239.0,144.0,168.0,248.0,266.0,274.0,589.0,207.0,246.0,320.0,3030.0
Dewas,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2292.0,3420.0,3890.0,4353.0,4035.0,4362.0,3883.0,4399.0,4950.0,3926.0,3938.0,5459.0,48907.0
Dewas,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,290.0,428.0,488.0,301.0,359.0,494.0,551.0,565.0,950.0,375.0,463.0,623.0,5887.0
Dewas,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3322.0,5446.0,5700.0,6492.0,6112.0,6437.0,5776.0,6013.0,6496.0,5061.0,5519.0,7442.0,69816.0
Dewas,14.10.2.a,Number of death cases of Inpatient males,TOTAL,6.0,29.0,18.0,13.0,11.0,12.0,14.0,22.0,10.0,29.0,25.0,39.0,228.0
Dewas,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,18.0,16.0,4.0,8.0,5.0,26.0,14.0,6.0,23.0,18.0,21.0,165.0
Dewas,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,12.0,47.0,34.0,17.0,19.0,17.0,40.0,36.0,16.0,52.0,43.0,60.0,393.0
Dewas,14.11,In-Patient Head Count at midnight,TOTAL,2827.0,810.0,4543.0,5009.0,4693.0,5721.0,4507.0,5498.0,6445.0,4676.0,5665.0,6458.0,56852.0
Dewas,14.12.1,OPD attendance (All),TOTAL,37170.0,51429.0,60318.0,62051.0,70755.0,76370.0,66165.0,61965.0,66473.0,50696.0,72584.0,86187.0,762163.0
Dewas,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,7.0,9.0,5.0,14.0,37.0,33.0,36.0,15.0,7.0,2.0,7.0,5.0,177.0
Dewas,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,81.0,138.0,201.0,428.0,405.0,234.0,141.0,571.0,706.0,491.0,544.0,169.0,4109.0
Dewas,14.14.a,Number of patients given AYUSH treatment,TOTAL,434.0,1216.0,1222.0,546.0,960.0,740.0,879.0,477.0,844.0,630.0,761.0,738.0,9447.0
Dewas,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,52.0,26.0,31.0,34.0,56.0,66.0,53.0,112.0,61.0,47.0,0.0,48.0,586.0
Dewas,14.14.c,Number of Adolescents counselled,TOTAL,0.0,41.0,43.0,21.0,0.0,0.0,0.0,10.0,285.0,0.0,0.0,0.0,400.0
Dewas,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5483.0,6289.0,6613.0,7833.0,6948.0,6711.0,6717.0,5959.0,5963.0,6488.0,6180.0,6681.0,77865.0
Dewas,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,155.0,153.0,224.0,270.0,267.0,244.0,276.0,209.0,244.0,257.0,234.0,254.0,2787.0
Dewas,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,347.0,281.0,278.0,513.0,277.0,559.0,382.0,343.0,376.0,382.0,428.0,245.0,4411.0
Dewas,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,1.0,1.0,2.0,2.0,6.0,1.0,4.0,1.0,3.0,2.0,3.0,27.0
Dewas,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,289.0,293.0,260.0,349.0,349.0,438.0,276.0,443.0,538.0,686.0,693.0,417.0,5031.0
Dewas,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,2.0,0.0,1.0,2.0,3.0,1.0,4.0,0.0,1.0,2.0,1.0,17.0
Dewas,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,579.0,955.0,950.0,1332.0,871.0,1257.0,943.0,1186.0,1266.0,1326.0,1216.0,1582.0,13463.0
Dewas,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,4.0,0.0,1.0,2.0,0.0,23.0,2.0,0.0,1.0,155.0,0.0,190.0
Dewas,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1215.0,1529.0,1488.0,2194.0,1497.0,2254.0,1601.0,1972.0,2180.0,2394.0,2337.0,2244.0,22905.0
Dewas,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,7.0,1.0,4.0,6.0,9.0,25.0,10.0,1.0,5.0,159.0,4.0,234.0
Dewas,15.2,Number of Widal tests conducted,Number tested,339.0,260.0,49.0,378.0,332.0,432.0,575.0,315.0,603.0,549.0,417.0,1097.0,5346.0
Dewas,15.3.a,Number of VDRL tests conducted on males,Number tested,128.0,156.0,141.0,304.0,201.0,437.0,252.0,260.0,191.0,232.0,303.0,155.0,2760.0
Dewas,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,215.0,219.0,169.0,239.0,325.0,213.0,191.0,297.0,251.0,435.0,211.0,282.0,3047.0
Dewas,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,473.0,465.0,590.0,510.0,441.0,615.0,280.0,477.0,424.0,399.0,409.0,476.0,5559.0
Dewas,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,816.0,840.0,900.0,1053.0,967.0,1265.0,723.0,1034.0,866.0,1066.0,923.0,913.0,11366.0
Dewas,15.4.1,Number of blood smears examined for Malaria,TOTAL,5514.0,9597.0,8963.0,7382.0,9590.0,10825.0,9314.0,12032.0,11897.0,7771.0,4948.0,9563.0,107396.0
Dewas,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2.0,6.0,9.0,11.0,6.0,11.0,11.0,8.0,9.0,4.0,3.0,6.0,86.0
Dewas,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,1.0,3.0,2.0,1.0,0.0,5.0,3.0,0.0,1.0,1.0,0.0,17.0
Dewas,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,8500.0,,,,,,,,,,,,8500.0
Dewas,16.1.1,Stock position of DPT vaccines,2. Stocks Received,15000.0,,,,,,,,,,,,15000.0
Dewas,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Dewas,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,13000.0,,,,,,,,,,,,13000.0
Dewas,16.1.1,Stock position of DPT vaccines,5. Total Stock,10500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10500.0
Dewas,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Dewas,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Dewas,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Dewas,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Dewas,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,17500.0,,,,,,,,,,,,17500.0
Dewas,16.1.2,Stock position of OPV vaccines,2. Stocks Received,15000.0,,,,,,,,,,,,15000.0
Dewas,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Dewas,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,21000.0,,,,,,,,,,,,21000.0
Dewas,16.1.2,Stock position of OPV vaccines,5. Total Stock,11500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11500.0
Dewas,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,6500.0,,,,,,,,,,,,6500.0
Dewas,16.1.3,Stock position of TT vaccines,2. Stocks Received,20000.0,,,,,,,,,,,,20000.0
Dewas,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Dewas,16.1.3,Stock position of TT vaccines,4. Stock Distributed,16500.0,,,,,,,,,,,,16500.0
Dewas,16.1.3,Stock position of TT vaccines,5. Total Stock,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0
Dewas,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Dewas,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Dewas,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dewas,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Dewas,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,6250.0,,,,,,,,,,,,6250.0
Dewas,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,,,,,,,,,,,,10000.0
Dewas,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Dewas,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,8000.0,,,,,,,,,,,,8000.0
Dewas,16.1.5,Stock position of BCG vaccines,5. Total Stock,8250.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8250.0
Dewas,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,8000.0,,,,,,,,,,,,8000.0
Dewas,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,,,,,,,,,,,,5000.0
Dewas,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Dewas,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,5000.0,,,,,,,,,,,,5000.0
Dewas,16.1.6,Stock position of Measles vaccines,5. Total Stock,8000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8000.0
Dewas,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Dewas,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Dewas,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dewas,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Dewas,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,3300.0,,,,,,,,,,,,3300.0
Dewas,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,20000.0,,,,,,,,,,,,20000.0
Dewas,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Dewas,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,18000.0,,,,,,,,,,,,18000.0
Dewas,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,5300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5300.0
Dewas,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1350.0,,,,,,,,,,,,1350.0
Dewas,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,,,,,,,,,,,,0.0
Dewas,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Dewas,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,900.0,,,,,,,,,,,,900.0
Dewas,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,450.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,450.0
Dewas,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,5320.0,,,,,,,,,,,,5320.0
Dewas,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,6000.0,,,,,,,,,,,,6000.0
Dewas,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Dewas,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,9000.0,,,,,,,,,,,,9000.0
Dewas,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,2320.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2320.0
Dewas,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,500.0,,,,,,,,,,,,500.0
Dewas,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,2000.0,,,,,,,,,,,,2000.0
Dewas,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Dewas,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,1500.0,,,,,,,,,,,,1500.0
Dewas,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0
Dewas,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Dewas,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Dewas,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Dewas,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Dewas,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Dewas,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Dewas,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Dewas,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Dewas,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Dewas,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Dewas,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Dewas,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Dewas,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Dewas,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Dewas,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Dewas,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Dewas,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Dewas,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Dewas,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Dewas,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Dewas,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Dewas,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Dewas,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Dewas,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Dewas,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Dewas,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Dewas,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Dewas,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Dewas,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Dewas,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Dewas,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Dewas,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Dewas,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Dewas,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Dewas,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Dewas,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Dewas,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Dewas,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Dewas,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Dewas,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Dewas,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Dewas,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Dewas,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Dewas,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Dewas,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Dewas,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Dewas,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Dewas,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Dewas,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Dewas,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Dewas,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Dewas,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Dewas,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dewas,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2400.0,,,,,,,,,,,,2400.0
Dewas,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6600.0,,,,,,,,,,,,6600.0
Dewas,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Dewas,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3500.0,,,,,,,,,,,,3500.0
Dewas,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,5500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5500.0
Dewas,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,88995.0,,,,,,,,,,,,88995.0
Dewas,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,,,,,,,,,,,,0.0
Dewas,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Dewas,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,,,,,,,,,,,,0.0
Dewas,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,88995.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,88995.0
Dewas,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2150.0,,,,,,,,,,,,2150.0
Dewas,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4000.0,,,,,,,,,,,,4000.0
Dewas,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Dewas,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2000.0,,,,,,,,,,,,2000.0
Dewas,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,4150.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4150.0
Dewas,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,5.0,,,,,1.0,,4.0,,4.0,14.0
Dewas,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,2.0,2.0,1.0,3.0,,,1.0,,1.0,2.0,2.0,15.0
Dewas,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,1.0,,,,2.0
Dewas,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,2.0,2.0,1.0,3.0,,,2.0,1.0,1.0,2.0,2.0,17.0
Dewas,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,1.0,2.0,,1.0,,1.0,1.0,,,1.0,2.0,9.0
Dewas,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dewas,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,1.0,2.0,,1.0,,1.0,1.0,,,1.0,2.0,9.0
Dewas,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,5.0,5.0,4.0,3.0,7.0,3.0,1.0,1.0,1.0,,8.0,38.0
Dewas,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,3.0,1.0,,1.0,,,,1.0,,,6.0
Dewas,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,5.0,8.0,5.0,3.0,8.0,3.0,1.0,1.0,2.0,,8.0,44.0
Dewas,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,3.0,7.0,6.0,10.0,6.0,6.0,5.0,9.0,10.0,4.0,4.0,72.0
Dewas,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,2.0,,,3.0,1.0,,5.0,4.0,1.0,2.0,1.0,4.0,23.0
Dewas,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,4.0,3.0,7.0,9.0,11.0,6.0,11.0,9.0,10.0,12.0,5.0,8.0,95.0
Dewas,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,2.0,1.0,3.0,2.0,,3.0,1.0,1.0,,4.0,18.0
Dewas,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,,,,,2.0,,,,1.0,4.0
Dewas,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,1.0,2.0,1.0,3.0,2.0,,5.0,1.0,1.0,,5.0,22.0
Dewas,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,1.0,,1.0
Dewas,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dewas,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,1.0,,1.0
Dewas,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,1.0,4.0,,,1.0,1.0,,,,,8.0
Dewas,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,2.0,,1.0,,1.0,1.0,,2.0,,,,7.0
Dewas,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,3.0,1.0,5.0,,1.0,2.0,1.0,2.0,,,,15.0
Dewas,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dewas,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dewas,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Dewas,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,3.0,8.0,3.0,4.0,4.0,5.0,7.0,4.0,11.0,3.0,6.0,60.0
Dewas,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,1.0,1.0,2.0,5.0,3.0,8.0,4.0,1.0,2.0,,28.0
Dewas,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,4.0,9.0,4.0,6.0,9.0,8.0,15.0,8.0,12.0,5.0,6.0,88.0
Dewas,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Dewas,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Dewas,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Dewas,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,1.0,,,,,,,,2.0
Dewas,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Dewas,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,,,1.0,,1.0,2.0,2.0,1.0,1.0,1.0,10.0
Dewas,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,,,,1.0,,,1.0,,,3.0
Dewas,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,1.0,,1.0,,2.0,2.0,2.0,2.0,1.0,1.0,13.0
Dewas,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Dewas,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,1.0,,2.0,,,,,,,,4.0
Dewas,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,,,,2.0,2.0,1.0,2.0,,5.0,,1.0,14.0
Dewas,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,,1.0,,4.0,2.0,1.0,2.0,,5.0,,1.0,18.0
Dewas,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Dewas,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Dewas,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Dewas,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,1.0,1.0
Dewas,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,,1.0,,,,1.0,1.0,,,,4.0
Dewas,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,3.0,3.0,,,1.0,,4.0,,,,1.0,1.0,13.0
Dewas,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,3.0,10.0,1.0,,,,,,,,,,14.0
Dewas,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,6.0,14.0,1.0,1.0,1.0,,4.0,1.0,1.0,,1.0,1.0,31.0
Dewas,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Dewas,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Dewas,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Dewas,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Dewas,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Dewas,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,4.0,2.0,3.0,3.0,2.0,2.0,5.0,4.0,2.0,,1.0,6.0,34.0
Dewas,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,3.0,5.0,6.0,2.0,2.0,10.0,6.0,5.0,6.0,2.0,3.0,51.0
Dewas,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,5.0,5.0,8.0,9.0,4.0,4.0,15.0,10.0,7.0,6.0,3.0,9.0,85.0
Dewas,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Dewas,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,1.0,,,1.0,,,,2.0
Dewas,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,,,1.0,1.0,,,,,,,,3.0
Dewas,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,,1.0,1.0,1.0,1.0,,,1.0,,,,6.0
Dewas,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Dewas,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,1.0,1.0
Dewas,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Dewas,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,1.0,1.0
Dewas,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Dewas,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Dewas,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Dewas,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Dewas,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Dewas,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Dewas,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Dewas,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,1.0,,,,,,,,,,1.0
Dewas,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Dewas,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,1.0,,,,,1.0,1.0,,,,3.0
Dewas,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Dewas,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,1.0,,,,,1.0,1.0,,,,3.0
Dewas,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Dewas,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Dewas,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Dewas,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Dewas,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Dewas,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,,1.0,,,,,4.0,2.0,3.0,1.0,3.0,15.0
Dewas,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Dewas,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,,1.0,,,,,4.0,2.0,3.0,1.0,3.0,15.0
Dewas,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Dewas,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,4.0,4.0,5.0,3.0,3.0,2.0,3.0,1.0,5.0,1.0,9.0,43.0
Dewas,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,1.0,,,,,1.0,,,2.0
Dewas,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,3.0,4.0,4.0,5.0,4.0,3.0,2.0,3.0,1.0,6.0,1.0,9.0,45.0
Dewas,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Dewas,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,2.0,1.0,1.0,1.0,1.0,3.0,3.0,2.0,1.0,2.0,3.0,24.0
Dewas,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Dewas,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,2.0,1.0,1.0,1.0,1.0,3.0,4.0,2.0,1.0,2.0,4.0,26.0
Dewas,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Dewas,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,2.0,,,,,,2.0
Dewas,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Dewas,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,1.0,,1.0,,2.0,,,,,,4.0
Dewas,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,1.0,,1.0,,,,,,2.0
Dewas,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,2.0,2.0,,2.0,2.0,1.0,,,1.0,,,10.0
Dewas,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,1.0,2.0,1.0,2.0,,,2.0,1.0,,9.0
Dewas,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,2.0,2.0,1.0,5.0,3.0,4.0,,,3.0,1.0,,21.0
Dewas,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Dewas,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,3.0,1.0,3.0,1.0,4.0,3.0,,,4.0,,19.0
Dewas,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,1.0,3.0,1.0,1.0,1.0,6.0,,,,8.0,2.0,23.0
Dewas,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,1.0,6.0,2.0,4.0,2.0,10.0,3.0,,,12.0,2.0,42.0
Dewas,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,1.0,4.0,1.0,2.0,,1.0,1.0,,,,,11.0
Dewas,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,4.0,9.0,19.0,11.0,8.0,11.0,14.0,15.0,7.0,12.0,6.0,25.0,141.0
Dewas,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,22.0,45.0,66.0,48.0,47.0,55.0,44.0,56.0,33.0,48.0,23.0,100.0,587.0
Dewas,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,27.0,55.0,89.0,60.0,57.0,66.0,59.0,72.0,40.0,60.0,29.0,125.0,739.0
Dhar,1.1,Total number of pregnant women Registered for ANC,TOTAL,3729.0,4648.0,6486.0,6520.0,5303.0,5103.0,4943.0,5023.0,5312.0,4904.0,5523.0,5918.0,63412.0
Dhar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1976.0,2379.0,3488.0,4069.0,3265.0,3102.0,2820.0,2868.0,3166.0,3189.0,3508.0,3608.0,37438.0
Dhar,1.2,Number of Pregnant women registered under JSY,TOTAL,3059.0,4459.0,5686.0,5801.0,4660.0,4785.0,4298.0,4568.0,5027.0,4594.0,5241.0,5648.0,57826.0
Dhar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2971.0,3690.0,4391.0,4560.0,4385.0,4511.0,3978.0,4046.0,4134.0,3899.0,4189.0,4367.0,49121.0
Dhar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1720.0,2261.0,3085.0,3259.0,2824.0,2833.0,2695.0,2734.0,2729.0,2688.0,3025.0,3122.0,32975.0
Dhar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2757.0,3296.0,4688.0,5296.0,4282.0,4062.0,3909.0,3751.0,4043.0,3683.0,4223.0,4710.0,48700.0
Dhar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3219.0,4536.0,6037.0,6126.0,5074.0,5117.0,4731.0,4911.0,5278.0,4982.0,5469.0,5758.0,61238.0
Dhar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,174.0,154.0,204.0,362.0,251.0,180.0,315.0,275.0,244.0,133.0,314.0,195.0,2801.0
Dhar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,11.0,10.0,5.0,2.0,1.0,3.0,11.0,3.0,2.0,2.0,16.0,3.0,69.0
Dhar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2365.0,2846.0,3608.0,4079.0,3273.0,3209.0,3199.0,3460.0,3331.0,3157.0,3548.0,3491.0,39566.0
Dhar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,77.0,42.0,152.0,110.0,63.0,36.0,60.0,105.0,88.0,81.0,80.0,164.0,1058.0
Dhar,1.8,Number of pregnancy test kits used at SC level,TOTAL,521.0,584.0,696.0,665.0,492.0,602.0,689.0,845.0,925.0,850.0,826.0,908.0,8603.0
Dhar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,122.0,186.0,328.0,490.0,496.0,469.0,349.0,185.0,177.0,199.0,143.0,227.0,3371.0
Dhar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,93.0,155.0,177.0,31.0,19.0,33.0,110.0,306.0,253.0,230.0,198.0,223.0,1828.0
Dhar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,215.0,341.0,505.0,521.0,515.0,502.0,459.0,491.0,430.0,429.0,341.0,450.0,5199.0
Dhar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,190.0,299.0,502.0,497.0,455.0,469.0,431.0,462.0,409.0,398.0,327.0,433.0,4872.0
Dhar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,2.0,3.0,5.0,0.0,11.0,9.0,22.0,10.0,8.0,0.0,2.0,0.0,72.0
Dhar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1624.0,2581.0,2703.0,2516.0,2646.0,2752.0,2607.0,2631.0,2525.0,2472.0,2596.0,3575.0,31228.0
Dhar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,661.0,1559.0,1033.0,145.0,388.0,397.0,530.0,434.0,417.0,361.0,305.0,505.0,6735.0
Dhar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1516.0,1923.0,2598.0,2526.0,2636.0,2677.0,2529.0,2606.0,2396.0,2427.0,2632.0,3342.0,29808.0
Dhar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1285.0,1536.0,2099.0,2105.0,2104.0,2383.0,2392.0,2184.0,2197.0,2129.0,2113.0,2960.0,25487.0
Dhar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,0.0,8.0
Dhar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,109.0,98.0,97.0,190.0,221.0,195.0,239.0,228.0,163.0,172.0,158.0,207.0,2077.0
Dhar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Dhar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Dhar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Dhar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,15.0,23.0,11.0,10.0,6.0,4.0,13.0,23.0,16.0,11.0,30.0,37.0,199.0
Dhar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,28.0,49.0,42.0,42.0,44.0,46.0,30.0,35.0,42.0,32.0,47.0,48.0,485.0
Dhar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,43.0,72.0,53.0,52.0,50.0,50.0,43.0,58.0,58.0,43.0,77.0,85.0,684.0
Dhar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,54.0,47.0,52.0,113.0,124.0,111.0,119.0,106.0,76.0,91.0,68.0,151.0,1112.0
Dhar,4.1.1.a,Number of male live births,TOTAL,1034.0,1548.0,1722.0,1670.0,1747.0,1827.0,1755.0,1691.0,1625.0,1609.0,1625.0,2231.0,20084.0
Dhar,4.1.1.b,Number of female live births,TOTAL,893.0,1432.0,1538.0,1522.0,1572.0,1566.0,1502.0,1610.0,1459.0,1417.0,1428.0,1966.0,17905.0
Dhar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1927.0,2980.0,3260.0,3192.0,3319.0,3393.0,3257.0,3301.0,3084.0,3026.0,3053.0,4197.0,37989.0
Dhar,4.1.2,Number of still births,TOTAL,28.0,46.0,50.0,44.0,67.0,66.0,54.0,59.0,36.0,55.0,53.0,48.0,606.0
Dhar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,49.0,137.0,116.0,156.0,126.0,133.0,123.0,141.0,144.0,177.0,172.0,142.0,1616.0
Dhar,4.2.1,Number of Newborns weighed at birth,TOTAL,1928.0,2962.0,3154.0,3177.0,3313.0,3385.0,3200.0,3254.0,3079.0,3004.0,3036.0,4141.0,37633.0
Dhar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,304.0,362.0,473.0,396.0,410.0,466.0,438.0,485.0,365.0,409.0,293.0,476.0,4877.0
Dhar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1700.0,2800.0,3028.0,3183.0,3273.0,3341.0,3209.0,3193.0,3039.0,2971.0,2996.0,4085.0,36818.0
Dhar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,5.0,2.0,3.0,234.0,74.0,63.0,38.0,52.0,91.0,98.0,82.0,111.0,853.0
Dhar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,57.0,78.0,111.0,645.0,357.0,483.0,268.0,241.0,353.0,189.0,311.0,618.0,3711.0
Dhar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,228.0,30.0,43.0,240.0,212.0,38.0,42.0,32.0,22.0,47.0,57.0,68.0,1059.0
Dhar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,290.0,110.0,157.0,1119.0,643.0,584.0,348.0,325.0,466.0,334.0,450.0,797.0,5623.0
Dhar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,31.0,52.0,56.0,50.0,61.0,52.0,67.0,56.0,57.0,482.0
Dhar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,271.0,81.0,114.0,956.0,624.0,488.0,329.0,316.0,438.0,359.0,395.0,697.0,5068.0
Dhar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,22.0,34.0,25.0,45.0,25.0,18.0,119.0,9.0,22.0,35.0,45.0,65.0,464.0
Dhar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,256.0,43.0,51.0,214.0,184.0,158.0,97.0,120.0,365.0,78.0,164.0,462.0,2192.0
Dhar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,25.0,31.0,47.0,77.0,62.0,77.0,72.0,64.0,50.0,77.0,68.0,68.0,718.0
Dhar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1659.0,2825.0,3002.0,2772.0,2726.0,2952.0,2702.0,2849.0,2848.0,2614.0,2748.0,3682.0,33379.0
Dhar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1261.0,1744.0,1952.0,2002.0,2046.0,2312.0,2320.0,2386.0,2202.0,2136.0,2119.0,2499.0,24979.0
Dhar,6.3,PNC maternal complications attended,TOTAL,2.0,28.0,27.0,70.0,83.0,14.0,120.0,65.0,4.0,43.0,43.0,3.0,502.0
Dhar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,70.0,136.0,123.0,148.0,100.0,117.0,104.0,92.0,138.0,146.0,129.0,159.0,1462.0
Dhar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,1.0,2.0,6.0,1.0,6.0,1.0,1.0,0.0,6.0,0.0,0.0,24.0
Dhar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,70.0,137.0,125.0,154.0,101.0,123.0,105.0,93.0,138.0,152.0,129.0,159.0,1486.0
Dhar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,62.0,0.0,57.0,70.0,88.0,74.0,0.0,85.0,52.0,47.0,61.0,76.0,672.0
Dhar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,37.0,92.0,105.0,110.0,163.0,81.0,167.0,155.0,239.0,208.0,243.0,169.0,1769.0
Dhar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,115.0,342.0,589.0,210.0,534.0,182.0,587.0,671.0,1062.0,670.0,694.0,189.0,5845.0
Dhar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,152.0,434.0,694.0,320.0,697.0,263.0,754.0,826.0,1301.0,878.0,937.0,358.0,7614.0
Dhar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21.0,0.0,0.0,0.0,21.0
Dhar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0
Dhar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,3.0,1.0,6.0,10.0,7.0,5.0,5.0,5.0,12.0,4.0,8.0,1.0,67.0
Dhar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,2.0
Dhar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,1.0,6.0,10.0,8.0,5.0,5.0,6.0,13.0,5.0,8.0,1.0,71.0
Dhar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Dhar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,36.0,68.0,120.0,243.0,142.0,157.0,88.0,237.0,272.0,294.0,195.0,200.0,2052.0
Dhar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,250.0,210.0,480.0,660.0,523.0,561.0,441.0,842.0,1418.0,1501.0,1686.0,966.0,9538.0
Dhar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,16.0,17.0,20.0,18.0,22.0,14.0,4.0,15.0,33.0,26.0,14.0,12.0,211.0
Dhar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,302.0,295.0,620.0,921.0,687.0,732.0,533.0,1094.0,1723.0,1821.0,1895.0,1178.0,11801.0
Dhar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,209.0,117.0,70.0,43.0,124.0,127.0,70.0,78.0,27.0,865.0
Dhar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,14.0,43.0,11.0,28.0,20.0,21.0,33.0,28.0,28.0,13.0,239.0
Dhar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,5.0,12.0,35.0,63.0,66.0,16.0,16.0,42.0,52.0,45.0,56.0,48.0,456.0
Dhar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,1.0,3.0,0.0,4.0,2.0,3.0,11.0,7.0,3.0,3.0,37.0
Dhar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,5.0,12.0,50.0,109.0,77.0,48.0,38.0,66.0,96.0,80.0,87.0,64.0,732.0
Dhar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,6.0,10.0,8.0,10.0,7.0,2.0,15.0,58.0
Dhar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,2.0,18.0,4.0,0.0,0.0,10.0,0.0,10.0,2.0,2.0,48.0
Dhar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,8.0,30.0,256.0,101.0,68.0,34.0,23.0,41.0,35.0,28.0,38.0,21.0,683.0
Dhar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,11.0,8.0,8.0,15.0,6.0,3.0,11.0,18.0,9.0,0.0,4.0,93.0
Dhar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,8.0,41.0,266.0,127.0,87.0,40.0,26.0,62.0,53.0,47.0,40.0,27.0,824.0
Dhar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,6.0,11.0,19.0,4.0,10.0,10.0,9.0,5.0,13.0,87.0
Dhar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,281.0,562.0,857.0,1255.0,947.0,909.0,889.0,752.0,940.0,911.0,831.0,829.0,9963.0
Dhar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,39.0,63.0,87.0,133.0,115.0,91.0,55.0,74.0,60.0,59.0,61.0,71.0,908.0
Dhar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,44.0,77.0,312.0,403.0,155.0,190.0,176.0,194.0,160.0,171.0,320.0,156.0,2358.0
Dhar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,74.0,89.0,13.0,55.0,94.0,63.0,65.0,65.0,30.0,59.0,116.0,62.0,785.0
Dhar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,438.0,791.0,1269.0,1846.0,1311.0,1253.0,1185.0,1085.0,1190.0,1200.0,1328.0,1118.0,14014.0
Dhar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,3.0,15.0,38.0,172.0,281.0,125.0,234.0,198.0,111.0,204.0,220.0,84.0,1685.0
Dhar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,7.0,17.0,3.0,1.0,1.0,2.0,,,2.0,33.0
Dhar,9.06,Number of IUCD removals,TOTAL,627.0,584.0,599.0,695.0,618.0,548.0,589.0,642.0,649.0,621.0,636.0,842.0,7650.0
Dhar,9.07,Number of Oral Pills cycles distributed,TOTAL,6368.0,7410.0,7212.0,8390.0,7904.0,8540.0,9109.0,9132.0,8561.0,8667.0,8120.0,7890.0,97303.0
Dhar,9.08,Number of Condom pieces distributed,TOTAL,35421.0,40859.0,34440.0,47564.0,44948.0,48071.0,48929.0,49722.0,49383.0,51026.0,50242.0,49838.0,550443.0
Dhar,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,201.0,3.0,0.0,8.0,3.0,0.0,34.0,5.0,8.0,6.0,5.0,5.0,278.0
Dhar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,11.0,0.0,0.0,0.0,12.0
Dhar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,7.0,6.0,13.0,0.0,0.0,0.0,27.0
Dhar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,2.0
Dhar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Dhar,9.12,Number of Institutions having NSV trained doctors,TOTAL,18.0,26.0,25.0,27.0,28.0,27.0,29.0,33.0,18.0,17.0,24.0,17.0,-1.0
Dhar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2240.0,2906.0,3408.0,3706.0,3411.0,3468.0,3226.0,3553.0,3207.0,3169.0,2986.0,4152.0,39432.0
Dhar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2736.0,3501.0,4277.0,4295.0,4026.0,4284.0,4185.0,2823.0,391.0,188.0,49.0,38.0,30793.0
Dhar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2800.0,3340.0,3810.0,4433.0,4041.0,4110.0,3880.0,3922.0,2638.0,740.0,221.0,125.0,34060.0
Dhar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2922.0,3497.0,3805.0,4201.0,4170.0,4461.0,3987.0,3949.0,4049.0,2116.0,665.0,264.0,38086.0
Dhar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1515.0,3456.0,3382.0,3783.0,4293.0,16429.0
Dhar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1439.0,3087.0,3593.0,4508.0,12628.0
Dhar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1438.0,3185.0,4376.0,9000.0
Dhar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1541.0,2326.0,2456.0,2696.0,2811.0,2848.0,2691.0,3033.0,2720.0,2729.0,2556.0,3621.0,32028.0
Dhar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2737.0,3495.0,4270.0,4305.0,4042.0,4198.0,4121.0,3570.0,3427.0,3605.0,3829.0,4382.0,45981.0
Dhar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2799.0,3334.0,3816.0,4441.0,4053.0,4050.0,3801.0,3774.0,3828.0,3745.0,3868.0,4705.0,46214.0
Dhar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2970.0,3583.0,3899.0,4209.0,4156.0,4366.0,3904.0,3859.0,3895.0,3412.0,3818.0,4803.0,46874.0
Dhar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1291.0,1946.0,2185.0,2555.0,2496.0,2654.0,2505.0,2726.0,2269.0,2476.0,2397.0,3234.0,28734.0
Dhar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2470.0,3171.0,3927.0,3947.0,3828.0,3968.0,3899.0,2724.0,421.0,220.0,67.0,71.0,28713.0
Dhar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2800.0,3343.0,3802.0,4430.0,4060.0,4107.0,3872.0,3905.0,2687.0,694.0,261.0,149.0,34110.0
Dhar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2935.0,3522.0,3824.0,4211.0,4161.0,4464.0,3972.0,3950.0,3999.0,2031.0,704.0,298.0,38071.0
Dhar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2708.0,3620.0,4393.0,4738.0,4086.0,4237.0,3823.0,3625.0,3435.0,3576.0,3903.0,5086.0,47230.0
Dhar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,830.0,1312.0,4200.0,3191.0,2301.0,2623.0,2411.0,2654.0,2622.0,2503.0,2673.0,3510.0,30830.0
Dhar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Dhar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1412.0,1901.0,2296.0,2473.0,2136.0,2226.0,2042.0,1902.0,1796.0,1849.0,2017.0,2695.0,24745.0
Dhar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1296.0,1721.0,2097.0,2261.0,1949.0,2059.0,1827.0,1721.0,1652.0,1720.0,1886.0,2391.0,22580.0
Dhar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2708.0,3622.0,4393.0,4734.0,4085.0,4285.0,3869.0,3623.0,3448.0,3569.0,3903.0,5086.0,47325.0
Dhar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2447.0,3052.0,3868.0,4316.0,3510.0,3711.0,3251.0,3606.0,3449.0,3522.0,3442.0,4393.0,42567.0
Dhar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2454.0,3052.0,3868.0,4316.0,3510.0,3711.0,3251.0,3606.0,3446.0,3522.0,3442.0,4393.0,42571.0
Dhar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,571.0,586.0,980.0,1365.0,1051.0,1065.0,896.0,975.0,1049.0,1064.0,995.0,1186.0,11783.0
Dhar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,505.0,563.0,884.0,1221.0,953.0,979.0,822.0,868.0,970.0,1000.0,895.0,1105.0,10765.0
Dhar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1076.0,1149.0,1864.0,2586.0,2004.0,2044.0,1718.0,1843.0,2019.0,2064.0,1890.0,2291.0,22548.0
Dhar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1272.0,1564.0,2074.0,3451.0,2908.0,2893.0,3023.0,2350.0,2494.0,3222.0,2641.0,4788.0,32680.0
Dhar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1539.0,1888.0,2332.0,3411.0,3610.0,3879.0,3665.0,2981.0,3006.0,2996.0,2712.0,5030.0,37049.0
Dhar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1412.0,1945.0,2490.0,3503.0,3536.0,3685.0,3887.0,2832.0,3388.0,2869.0,2670.0,4881.0,37098.0
Dhar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,7.0,0.0,1.0,0.0,0.0,9.0,0.0,0.0,0.0,1.0,18.0
Dhar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Dhar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2055.0,2335.0,2360.0,2397.0,2333.0,2294.0,2301.0,2312.0,2336.0,2267.0,2319.0,2534.0,27843.0
Dhar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1856.0,2285.0,2345.0,2389.0,2299.0,2267.0,2274.0,2290.0,2327.0,2254.0,2303.0,2528.0,27417.0
Dhar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1654.0,2049.0,2120.0,2126.0,2076.0,2078.0,2078.0,2079.0,2128.0,2082.0,2120.0,2343.0,24933.0
Dhar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,5.0
Dhar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2708.0,3622.0,4393.0,4723.0,4087.0,4237.0,3823.0,3623.0,3435.0,3571.0,3903.0,5078.0,47203.0
Dhar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,655.0,694.0,1264.0,18448.0,9323.0,971.0,904.0,974.0,995.0,20576.0,4325.0,611.0,59740.0
Dhar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,482.0,589.0,602.0,18249.0,9992.0,749.0,736.0,656.0,649.0,20104.0,3889.0,483.0,57180.0
Dhar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,16.0,0.0,0.0,12.0,0.0,0.0,1.0,3.0,0.0,0.0,0.0,32.0
Dhar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,250.0,479.0,328.0,509.0,535.0,471.0,888.0,807.0,731.0,785.0,865.0,932.0,7580.0
Dhar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,5.0,150.0,6.0,19.0,63.0,8.0,171.0,89.0,39.0,4.0,4.0,3.0,561.0
Dhar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,16.0,0.0,0.0,52.0,56.0,52.0,48.0,112.0,3.0,65.0,83.0,76.0,563.0
Dhar,13.1,Number of Patients operated for cataract,TOTAL,464.0,462.0,692.0,941.0,744.0,1085.0,662.0,2012.0,1289.0,1285.0,1009.0,1014.0,11659.0
Dhar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,459.0,442.0,693.0,939.0,742.0,1083.0,660.0,1858.0,1282.0,1276.0,1009.0,1014.0,11457.0
Dhar,13.3,Number of School children detected with Refractive errors,TOTAL,36.0,0.0,73.0,311.0,280.0,699.0,403.0,338.0,1344.0,660.0,373.0,228.0,4745.0
Dhar,13.4,Number of children provided free glasses,TOTAL,47.0,0.0,0.0,0.0,14.0,24.0,90.0,915.0,615.0,1030.0,240.0,231.0,3206.0
Dhar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,4.0,3.0,5.0,1.0,0.0,2.0,4.0,11.0,9.0,0.0,39.0
Dhar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,5.0
Dhar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,7.0,7.0,6.0,9.0,6.0,9.0,7.0,6.0,7.0,7.0,5.0,-1.0
Dhar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,15.0,20.0,23.0,20.0,25.0,22.0,30.0,26.0,22.0,17.0,24.0,20.0,-1.0
Dhar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1668.0,2125.0,2131.0,2095.0,1965.0,1996.0,1960.0,2256.0,2104.0,1988.0,2165.0,2045.0,-1.0
Dhar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,14.0,13.0,13.0,13.0,13.0,14.0,13.0,12.0,13.0,13.0,12.0,12.0,-1.0
Dhar,14.05,Number of RKS meetings held during the month,TOTAL,5.0,1.0,1.0,1.0,6.0,4.0,4.0,3.0,2.0,6.0,4.0,20.0,57.0
Dhar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,30.0,34.0,31.0,31.0,30.0,33.0,36.0,33.0,29.0,28.0,26.0,22.0,-1.0
Dhar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,138.0,146.0,150.0,171.0,108.0,85.0,108.0,78.0,97.0,100.0,119.0,173.0,1473.0
Dhar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,9.0,10.0,6.0,6.0,8.0,7.0,7.0,5.0,5.0,6.0,9.0,7.0,-1.0
Dhar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,3.0,4.0,4.0,3.0,54.0,3.0,3.0,4.0,4.0,5.0,4.0,-1.0
Dhar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,500.0,819.0,958.0,783.0,782.0,1181.0,1301.0,1068.0,784.0,648.0,881.0,900.0,10605.0
Dhar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1357.0,2320.0,2669.0,2145.0,2137.0,2315.0,3437.0,2372.0,2135.0,1513.0,1938.0,2408.0,26746.0
Dhar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,444.0,864.0,919.0,773.0,713.0,1098.0,1607.0,1137.0,889.0,836.0,989.0,1213.0,11482.0
Dhar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2740.0,4837.0,4897.0,4682.0,5071.0,5819.0,6732.0,5845.0,4957.0,4144.0,5257.0,6581.0,61562.0
Dhar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,944.0,1683.0,1877.0,1556.0,1495.0,2279.0,2908.0,2205.0,1673.0,1484.0,1870.0,2113.0,22087.0
Dhar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4097.0,7157.0,7566.0,6827.0,7208.0,8134.0,10169.0,8217.0,7092.0,5657.0,7195.0,8989.0,88308.0
Dhar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,6.0,11.0,8.0,5.0,14.0,12.0,10.0,15.0,14.0,7.0,6.0,5.0,113.0
Dhar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,10.0,7.0,7.0,7.0,4.0,4.0,5.0,10.0,2.0,5.0,5.0,72.0
Dhar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,12.0,21.0,15.0,12.0,21.0,16.0,14.0,20.0,24.0,9.0,11.0,10.0,185.0
Dhar,14.11,In-Patient Head Count at midnight,TOTAL,1313.0,1914.0,3516.0,5067.0,4962.0,5856.0,5102.0,3976.0,3102.0,3856.0,4303.0,5877.0,48844.0
Dhar,14.12.1,OPD attendance (All),TOTAL,62357.0,85009.0,97564.0,104550.0,105723.0,138685.0,121702.0,105161.0,88138.0,88703.0,109716.0,124714.0,1232022.0
Dhar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,2.0,51.0,74.0,56.0,19.0,19.0,20.0,35.0,17.0,27.0,36.0,356.0
Dhar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Dhar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,357.0,630.0,1140.0,1307.0,1156.0,1261.0,805.0,1097.0,1464.0,1637.0,784.0,535.0,12173.0
Dhar,14.14.a,Number of patients given AYUSH treatment,TOTAL,733.0,727.0,590.0,570.0,717.0,1399.0,1128.0,1849.0,1676.0,1854.0,2035.0,2506.0,15784.0
Dhar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhar,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,30.0,641.0,73.0,638.0,38.0,34.0,0.0,215.0,43.0,1712.0
Dhar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6641.0,10129.0,12280.0,16462.0,13682.0,15881.0,11615.0,12087.0,15552.0,14940.0,16598.0,15455.0,161322.0
Dhar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,210.0,332.0,459.0,593.0,557.0,627.0,423.0,446.0,547.0,512.0,615.0,530.0,5851.0
Dhar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,516.0,188.0,388.0,601.0,691.0,916.0,428.0,826.0,1065.0,803.0,704.0,768.0,7894.0
Dhar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,4.0,6.0,43.0,8.0,8.0,9.0,14.0,15.0,10.0,2.0,2.0,122.0
Dhar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,617.0,277.0,477.0,843.0,798.0,985.0,501.0,640.0,642.0,694.0,727.0,666.0,7867.0
Dhar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,2.0,3.0,16.0,7.0,6.0,1.0,3.0,12.0,7.0,1.0,1.0,61.0
Dhar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1328.0,1832.0,2604.0,2620.0,1695.0,2634.0,1399.0,2695.0,3150.0,2238.0,2104.0,1460.0,25759.0
Dhar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,82.0,92.0,152.0,104.0,99.0,39.0,14.0,31.0,34.0,0.0,647.0
Dhar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2461.0,2297.0,3469.0,4064.0,3184.0,4535.0,2328.0,4161.0,4857.0,3735.0,3535.0,2894.0,41520.0
Dhar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,6.0,91.0,151.0,167.0,118.0,109.0,56.0,41.0,48.0,37.0,3.0,830.0
Dhar,15.2,Number of Widal tests conducted,Number tested,1158.0,1566.0,1664.0,2037.0,2141.0,2607.0,2700.0,3373.0,2740.0,2054.0,3158.0,3622.0,28820.0
Dhar,15.3.a,Number of VDRL tests conducted on males,Number tested,52.0,15.0,40.0,390.0,386.0,549.0,551.0,709.0,647.0,459.0,453.0,430.0,4681.0
Dhar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,272.0,34.0,131.0,284.0,356.0,300.0,228.0,368.0,466.0,269.0,190.0,1541.0,4439.0
Dhar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,820.0,1022.0,1652.0,1959.0,1862.0,1605.0,993.0,1395.0,2485.0,2251.0,1992.0,1791.0,19827.0
Dhar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1144.0,1071.0,1823.0,2633.0,2604.0,2454.0,1772.0,2472.0,3598.0,2979.0,2635.0,3762.0,28947.0
Dhar,15.4.1,Number of blood smears examined for Malaria,TOTAL,16478.0,20791.0,24604.0,34493.0,36851.0,40346.0,37670.0,30525.0,27298.0,13386.0,21206.0,22998.0,326646.0
Dhar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,27.0,52.0,83.0,123.0,171.0,261.0,329.0,287.0,710.0,41.0,362.0,19.0,2465.0
Dhar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,20.0,9.0,6.0,13.0,45.0,153.0,295.0,447.0,298.0,85.0,13.0,10.0,1394.0
Dhar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,18500.0,21200.0,18100.0,25350.0,23850.0,28600.0,,13100.0,15400.0,8900.0,15900.0,188900.0
Dhar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,25000.0,25000.0,27000.0,20000.0,20000.0,0.0,,10000.0,10000.0,10000.0,0.0,147000.0
Dhar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Dhar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,22300.0,28100.0,19750.0,21500.0,15250.0,20300.0,,7700.0,16500.0,3000.0,6500.0,160900.0
Dhar,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,21200.0,18100.0,25350.0,23850.0,28600.0,8300.0,0.0,15400.0,8900.0,15900.0,9400.0,175000.0
Dhar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,0.0,,17000.0,7850.0,3450.0,9180.0,37480.0
Dhar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,0.0,33000.0,,0.0,5000.0,15000.0,20000.0,73000.0
Dhar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Dhar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,500.0,,9150.0,9400.0,9270.0,23670.0,51990.0
Dhar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,32500.0,0.0,7850.0,3450.0,9180.0,5510.0,58490.0
Dhar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,18860.0,21860.0,21360.0,350.0,340.0,12740.0,,940.0,8240.0,10040.0,1340.0,96070.0
Dhar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,35000.0,35000.0,5000.0,17000.0,32000.0,21500.0,,30000.0,10000.0,0.0,20000.0,205500.0
Dhar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Dhar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,32000.0,35500.0,26000.0,17010.0,19600.0,27540.0,,22700.0,8200.0,8700.0,10400.0,207650.0
Dhar,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,21860.0,21360.0,360.0,340.0,12740.0,6700.0,0.0,8240.0,10040.0,1340.0,10940.0,93920.0
Dhar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,20500.0,25500.0,20000.0,20150.0,15650.0,16450.0,,8480.0,14980.0,5980.0,2980.0,150670.0
Dhar,16.1.3,Stock position of TT vaccines,2. Stocks Received,,25000.0,20000.0,20000.0,15000.0,15000.0,5000.0,,15000.0,5000.0,0.0,10000.0,130000.0
Dhar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Dhar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,20000.0,25500.0,19850.0,19500.0,14200.0,15450.0,,8500.0,14000.0,3000.0,9200.0,149200.0
Dhar,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,25500.0,20000.0,20150.0,15650.0,16450.0,6000.0,0.0,14980.0,5980.0,2980.0,3780.0,131470.0
Dhar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0
Dhar,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0
Dhar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Dhar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0
Dhar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,16140.0,14240.0,11240.0,11270.0,10670.0,7170.0,,11770.0,7170.0,5970.0,4770.0,100410.0
Dhar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,10000.0,10000.0,10000.0,10000.0,5000.0,10000.0,,5000.0,5000.0,5000.0,3000.0,73000.0
Dhar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Dhar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,11900.0,13000.0,9970.0,10600.0,8480.0,8970.0,,9600.0,6200.0,6200.0,5800.0,90720.0
Dhar,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,14240.0,11240.0,11270.0,10670.0,7190.0,8200.0,0.0,7170.0,5970.0,4770.0,1970.0,82690.0
Dhar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,7650.0,1750.0,625.0,7125.0,350.0,1150.0,,125.0,2250.0,4750.0,2850.0,28625.0
Dhar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,5000.0,6000.0,12500.0,6000.0,4500.0,10500.0,,10000.0,10000.0,5000.0,5000.0,74500.0
Dhar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Dhar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,10900.0,7125.0,6000.0,12775.0,3700.0,8150.0,,7875.0,7500.0,6900.0,6450.0,77375.0
Dhar,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,1750.0,625.0,7125.0,350.0,1150.0,3500.0,0.0,2250.0,4750.0,2850.0,1400.0,25750.0
Dhar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Dhar,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,0.0,,,,,,,,0.0
Dhar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,0.0,0.0,,,,,,,0.0
Dhar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Dhar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,11990.0,15190.0,5290.0,9440.0,8340.0,10840.0,,240.0,3300.0,8800.0,,73430.0
Dhar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,20000.0,15000.0,25000.0,22000.0,20000.0,5000.0,,8000.0,10000.0,0.0,,125000.0
Dhar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,0.0,0.0,,,0.0,0.0,,0.0
Dhar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,16800.0,24900.0,20850.0,23100.0,17500.0,11440.0,,4940.0,4500.0,4700.0,,128730.0
Dhar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,15190.0,5290.0,9440.0,8340.0,10840.0,4400.0,0.0,3300.0,8800.0,4100.0,0.0,69700.0
Dhar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,2550.0,1900.0,1100.0,2950.0,1350.0,,3250.0,2500.0,2400.0,2050.0,20050.0
Dhar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,3000.0,1800.0,,3000.0,0.0,0.0,,0.0,0.0,0.0,0.0,7800.0
Dhar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Dhar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,450.0,2450.0,800.0,1150.0,1600.0,670.0,,750.0,100.0,350.0,1150.0,9470.0
Dhar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,2550.0,1900.0,1100.0,2950.0,1350.0,680.0,0.0,2500.0,2400.0,2050.0,900.0,18380.0
Dhar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,626.0,30000.0,101800.0,29710.0,91160.0,32640.0,,13120.0,11220.0,6620.0,6620.0,323516.0
Dhar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,60000.0,2016000.0,,102000.0,0.0,0.0,,30000.0,0.0,0.0,30000.0,2238000.0
Dhar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Dhar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,30000.0,1028000.0,72080.0,40560.0,58520.0,30040.0,,31900.0,4600.0,0.0,12120.0,1307820.0
Dhar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,30626.0,1018000.0,29720.0,91150.0,32640.0,2600.0,0.0,11220.0,6620.0,6620.0,24500.0,1253696.0
Dhar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,700.0,25950.0,7950.0,7050.0,2050.0,,1550.0,7400.0,11400.0,6800.0,70850.0
Dhar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,1200.0,30600.0,,6000.0,0.0,0.0,,10000.0,10000.0,0.0,10000.0,67800.0
Dhar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Dhar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,500.0,5350.0,18000.0,6900.0,5000.0,1750.0,,4150.0,6000.0,4600.0,6000.0,58250.0
Dhar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,700.0,25950.0,7950.0,7050.0,2050.0,300.0,0.0,7400.0,11400.0,6800.0,10800.0,80400.0
Dhar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,220.0,220.0,1120.0,820.0,3620.0,1170.0,,2270.0,870.0,770.0,120.0,11200.0
Dhar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,900.0,,4000.0,0.0,0.0,,0.0,0.0,0.0,0.0,4900.0
Dhar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Dhar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,300.0,1200.0,2450.0,470.0,,1400.0,100.0,650.0,120.0,6690.0
Dhar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,220.0,1120.0,820.0,3620.0,1170.0,700.0,0.0,870.0,770.0,120.0,0.0,9410.0
Dhar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,6825.0,6825.0,5825.0,5325.0,4525.0,3815.0,,1625.0,3200.0,6445.0,4845.0,49255.0
Dhar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,0.0,0.0,0.0,,4420.0,5000.0,0.0,0.0,9420.0
Dhar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Dhar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,1000.0,500.0,800.0,700.0,700.0,,2845.0,1755.0,1600.0,1700.0,11600.0
Dhar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,6825.0,5825.0,5325.0,4525.0,3825.0,3115.0,0.0,3200.0,6445.0,4845.0,3145.0,47075.0
Dhar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,11400.0,4000.0,1000.0,4000.0,2000.0,,1000.0,15000.0,10000.0,,48400.0
Dhar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,0.0,,0.0,0.0,0.0,,20000.0,0.0,0.0,,20000.0
Dhar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Dhar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,7400.0,3000.0,1000.0,2000.0,1000.0,,6000.0,5000.0,7000.0,,32400.0
Dhar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,4000.0,1000.0,0.0,2000.0,1000.0,0.0,15000.0,10000.0,3000.0,0.0,36000.0
Dhar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,3500.0,500.0,0.0,500.0,0.0,,8000.0,0.0,3300.0,,15800.0
Dhar,16.3.02,Stock Position of Gloves,2. Stocks Received,,,2000.0,,10000.0,0.0,12000.0,,0.0,4000.0,0.0,,28000.0
Dhar,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Dhar,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,5000.0,500.0,9500.0,500.0,4000.0,,8000.0,700.0,2300.0,,30500.0
Dhar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,500.0,0.0,500.0,0.0,8000.0,0.0,0.0,3300.0,1000.0,0.0,13300.0
Dhar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,0.0,,0.0,0.0,0.0,,0.0,145.0,145.0,,290.0
Dhar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,0.0,,0.0,0.0,0.0,,165.0,0.0,0.0,,165.0
Dhar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Dhar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,0.0,,0.0,0.0,0.0,,20.0,0.0,20.0,,40.0
Dhar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,145.0,145.0,125.0,0.0,415.0
Dhar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,9100.0,7100.0,3100.0,7100.0,4000.0,,3000.0,93000.0,92000.0,,218400.0
Dhar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,0.0,,0.0,0.0,0.0,,100000.0,0.0,0.0,,100000.0
Dhar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Dhar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,2000.0,4000.0,500.0,3000.0,1000.0,,10000.0,1000.0,87000.0,,108500.0
Dhar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,7100.0,3100.0,2600.0,4100.0,3000.0,0.0,93000.0,92000.0,5000.0,0.0,209900.0
Dhar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Dhar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Dhar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Dhar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Dhar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Dhar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Dhar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Dhar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Dhar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,3452100.0,2952100.0,2452100.0,2952100.0,2452100.0,,10000.0,250000.0,200000.0,,14720500.0
Dhar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,0.0,,0.0,0.0,0.0,,200000.0,0.0,0.0,,200000.0
Dhar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Dhar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,500000.0,500000.0,500000.0,500000.0,1000000.0,,50000.0,50000.0,100000.0,,3200000.0
Dhar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,2952100.0,2452100.0,1952100.0,2452100.0,1452100.0,0.0,160000.0,200000.0,100000.0,0.0,11720500.0
Dhar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,47790.0,,0.0,0.0,0.0,,0.0,0.0,17872.0,,65662.0
Dhar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,0.0,,0.0,0.0,0.0,,0.0,19872.0,10497.0,,30369.0
Dhar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Dhar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,47790.0,,0.0,0.0,0.0,,0.0,2000.0,21669.0,,71459.0
Dhar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17872.0,6700.0,0.0,24572.0
Dhar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,11600.0,9600.0,6600.0,9600.0,8600.0,,4600.0,8600.0,8000.0,,67200.0
Dhar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,0.0,,0.0,0.0,0.0,,5000.0,0.0,10000.0,,15000.0
Dhar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Dhar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,2000.0,3000.0,3000.0,1000.0,4000.0,,1000.0,600.0,5000.0,,19600.0
Dhar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,9600.0,6600.0,3600.0,8600.0,4600.0,0.0,8600.0,8000.0,13000.0,0.0,62600.0
Dhar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,6500.0,,0.0,6500.0,0.0,,0.0,3000.0,2500.0,,18500.0
Dhar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,0.0,,0.0,0.0,0.0,,5000.0,0.0,0.0,,5000.0
Dhar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Dhar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,6500.0,,0.0,6500.0,0.0,,2000.0,500.0,2000.0,,17500.0
Dhar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0,2500.0,500.0,0.0,6000.0
Dhar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,14000.0,105000.0,20000.0,105000.0,90600.0,,30000.0,25000.0,23000.0,,412600.0
Dhar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,200000.0,100000.0,190000.0,35600.0,0.0,,0.0,0.0,0.0,,525600.0
Dhar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Dhar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,109000.0,185000.0,90000.0,50000.0,10000.0,,5000.0,2000.0,8000.0,,459000.0
Dhar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,105000.0,20000.0,120000.0,90600.0,80600.0,0.0,25000.0,23000.0,15000.0,0.0,479200.0
Dhar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,2300.0,0.0,7000.0,8600.0,7900.0,12700.0,,5200.0,5800.0,1900.0,2800.0,54200.0
Dhar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,1000.0,13200.0,6600.0,6600.0,9900.0,3300.0,,3300.0,0.0,4000.0,6000.0,53900.0
Dhar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Dhar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,3300.0,6200.0,5000.0,7300.0,5100.0,12000.0,,2700.0,3900.0,3100.0,4900.0,53500.0
Dhar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,7000.0,8600.0,7900.0,12700.0,4000.0,0.0,5800.0,1900.0,2800.0,3900.0,54600.0
Dhar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,33450.0,250.0,12250.0,30850.0,33650.0,69450.0,,53850.0,33250.0,53250.0,77250.0,397500.0
Dhar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,24000.0,72000.0,48200.0,60000.0,110000.0,54000.0,,0.0,20000.0,30000.0,0.0,418200.0
Dhar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Dhar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,57200.0,60000.0,29600.0,57200.0,74200.0,71540.0,,20600.0,0.0,6000.0,23400.0,399740.0
Dhar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,250.0,12250.0,30850.0,33650.0,69450.0,51910.0,0.0,33250.0,53250.0,77250.0,53850.0,415960.0
Dhar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,3300.0,1800.0,2800.0,2800.0,1800.0,4400.0,,4900.0,5700.0,6300.0,8100.0,41900.0
Dhar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,2000.0,6000.0,4000.0,4000.0,6000.0,4000.0,,4000.0,4000.0,4000.0,4000.0,42000.0
Dhar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Dhar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,3500.0,5000.0,4000.0,5000.0,3400.0,4500.0,,3200.0,3400.0,2200.0,5200.0,39400.0
Dhar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,1800.0,2800.0,2800.0,1800.0,4400.0,3900.0,0.0,5700.0,6300.0,8100.0,6900.0,44500.0
Dhar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,1.0,,1.0,,,2.0
Dhar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,1.0,,1.0,1.0,,,,1.0,,1.0,5.0
Dhar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dhar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,1.0,,1.0,1.0,,,,1.0,,1.0,5.0
Dhar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,1.0,1.0,2.0
Dhar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dhar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,1.0,1.0,2.0
Dhar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,2.0,4.0,4.0,2.0,2.0,3.0,3.0,6.0,5.0,2.0,,35.0
Dhar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,3.0,1.0,5.0
Dhar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,2.0,4.0,4.0,2.0,2.0,3.0,3.0,6.0,6.0,5.0,1.0,40.0
Dhar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,11.0,5.0,9.0,4.0,8.0,10.0,6.0,6.0,7.0,11.0,4.0,4.0,85.0
Dhar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,1.0,,1.0,1.0,,,,3.0
Dhar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,11.0,5.0,9.0,4.0,8.0,11.0,6.0,7.0,8.0,11.0,4.0,4.0,88.0
Dhar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,5.0,5.0,3.0,3.0,7.0,2.0,3.0,10.0,4.0,9.0,,4.0,55.0
Dhar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,2.0,1.0,3.0,2.0,5.0,2.0,2.0,2.0,3.0,,1.0,1.0,24.0
Dhar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,7.0,6.0,6.0,5.0,12.0,4.0,5.0,12.0,7.0,9.0,1.0,5.0,79.0
Dhar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dhar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dhar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Dhar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,1.0,,1.0,,,,,1.0,,,4.0
Dhar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,,,,,,,,,,,1.0
Dhar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,1.0,1.0,,1.0,,,,,1.0,,,5.0
Dhar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dhar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dhar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Dhar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,5.0,4.0,2.0,4.0,4.0,6.0,5.0,5.0,3.0,5.0,5.0,6.0,54.0
Dhar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,4.0,4.0,4.0,5.0,3.0,4.0,3.0,4.0,4.0,4.0,40.0
Dhar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,6.0,4.0,6.0,8.0,8.0,11.0,8.0,9.0,6.0,9.0,9.0,10.0,94.0
Dhar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Dhar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,,,,,,,,,1.0,,2.0
Dhar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Dhar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,2.0,,,,,,,,,1.0,,3.0
Dhar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Dhar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,4.0,,,2.0,1.0,3.0,2.0,1.0,3.0,2.0,2.0,22.0
Dhar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,,,,1.0,,1.0,,2.0,,1.0,6.0
Dhar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,5.0,,,2.0,2.0,3.0,3.0,1.0,5.0,2.0,3.0,28.0
Dhar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Dhar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,2.0,,1.0,2.0,2.0,5.0,1.0,,6.0,19.0
Dhar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,5.0,4.0,5.0,3.0,8.0,14.0,14.0,15.0,13.0,7.0,9.0,9.0,106.0
Dhar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,5.0,4.0,5.0,5.0,8.0,15.0,16.0,17.0,18.0,8.0,9.0,15.0,125.0
Dhar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Dhar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Dhar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Dhar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Dhar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,1.0,,,2.0,2.0,,1.0,,,,7.0
Dhar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,2.0,1.0,1.0,3.0,2.0,3.0,,,,5.0,18.0
Dhar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,,,,2.0,2.0,1.0,,,1.0,6.0,13.0
Dhar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,1.0,3.0,1.0,1.0,7.0,6.0,4.0,1.0,,1.0,11.0,38.0
Dhar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Dhar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Dhar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Dhar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,1.0,,,,,1.0
Dhar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Dhar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,7.0,3.0,6.0,1.0,5.0,6.0,4.0,3.0,2.0,7.0,3.0,2.0,49.0
Dhar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2.0,3.0,7.0,,3.0,7.0,3.0,2.0,27.0,6.0,27.0,4.0,91.0
Dhar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,9.0,6.0,13.0,1.0,8.0,13.0,7.0,5.0,29.0,13.0,30.0,6.0,140.0
Dhar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Dhar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Dhar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,,,1.0,1.0,3.0,,1.0,,1.0,,,8.0
Dhar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,,,1.0,1.0,4.0,,1.0,,1.0,,,9.0
Dhar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Dhar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Dhar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Dhar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Dhar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Dhar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Dhar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Dhar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Dhar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Dhar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Dhar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Dhar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Dhar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Dhar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,1.0,,,,,1.0,1.0,1.0,,1.0,6.0
Dhar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Dhar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,1.0,,,,,1.0,1.0,1.0,,1.0,6.0
Dhar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Dhar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Dhar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Dhar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Dhar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Dhar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,3.0,3.0,2.0,1.0,3.0,1.0,3.0,3.0,,2.0,7.0,1.0,29.0
Dhar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Dhar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,3.0,3.0,2.0,1.0,3.0,1.0,3.0,3.0,,2.0,7.0,1.0,29.0
Dhar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,1.0,2.0,1.0,1.0,3.0,1.0,1.0,1.0,2.0,,1.0,15.0
Dhar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,5.0,6.0,8.0,4.0,2.0,9.0,11.0,8.0,5.0,9.0,3.0,11.0,81.0
Dhar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,3.0,1.0,2.0,1.0,,1.0,1.0,2.0,3.0,2.0,3.0,1.0,20.0
Dhar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,9.0,8.0,12.0,6.0,3.0,13.0,13.0,11.0,9.0,13.0,6.0,13.0,116.0
Dhar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,1.0,1.0,,1.0,,,,1.0,1.0,,,5.0
Dhar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,7.0,8.0,8.0,6.0,5.0,5.0,7.0,3.0,2.0,1.0,3.0,4.0,59.0
Dhar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,1.0,,2.0,1.0,1.0,1.0,,,1.0,,,8.0
Dhar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,8.0,10.0,9.0,8.0,7.0,6.0,8.0,3.0,3.0,3.0,3.0,4.0,72.0
Dhar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,1.0,1.0,,1.0,,1.0,,,,,5.0
Dhar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,1.0,,2.0,1.0,3.0,,1.0,1.0,,1.0,11.0
Dhar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Dhar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,2.0,2.0,1.0,2.0,2.0,3.0,1.0,1.0,1.0,,1.0,16.0
Dhar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,,,,,,2.0,,,,,,3.0
Dhar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,,1.0,2.0,2.0,3.0,2.0,2.0,1.0,1.0,1.0,1.0,17.0
Dhar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,3.0,4.0,1.0,2.0,4.0,10.0,7.0,12.0,4.0,4.0,4.0,4.0,59.0
Dhar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,5.0,4.0,2.0,4.0,6.0,13.0,11.0,14.0,5.0,5.0,5.0,5.0,79.0
Dhar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Dhar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,1.0,6.0,5.0,3.0,2.0,4.0,8.0,13.0,7.0,4.0,5.0,59.0
Dhar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,6.0,3.0,3.0,9.0,7.0,5.0,18.0,4.0,3.0,12.0,5.0,12.0,87.0
Dhar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,7.0,4.0,10.0,14.0,10.0,7.0,22.0,12.0,16.0,19.0,9.0,17.0,147.0
Dhar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,3.0,1.0,,,2.0,1.0,,7.0
Dhar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,3.0,1.0,2.0,1.0,7.0,1.0,,7.0,4.0,5.0,4.0,36.0
Dhar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,4.0,2.0,1.0,10.0,7.0,3.0,7.0,8.0,4.0,8.0,10.0,7.0,71.0
Dhar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,5.0,5.0,2.0,12.0,8.0,13.0,9.0,8.0,11.0,14.0,16.0,11.0,114.0
Dindori,1.1,Total number of pregnant women Registered for ANC,TOTAL,1397.0,1968.0,2233.0,1796.0,1856.0,2600.0,1801.0,1884.0,1755.0,1801.0,1624.0,1785.0,22500.0
Dindori,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1121.0,1621.0,1909.0,1612.0,1649.0,1952.0,1695.0,1749.0,1653.0,1682.0,1528.0,1655.0,19826.0
Dindori,1.2,Number of Pregnant women registered under JSY,TOTAL,1397.0,1968.0,2233.0,1800.0,1852.0,2600.0,1801.0,1916.0,1826.0,1801.0,1624.0,1785.0,22603.0
Dindori,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1570.0,1649.0,1815.0,1898.0,2144.0,2018.0,1887.0,1825.0,1816.0,1763.0,1657.0,1872.0,21914.0
Dindori,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1313.0,1812.0,1997.0,1657.0,1710.0,2400.0,1627.0,1698.0,1557.0,1560.0,1298.0,1441.0,20070.0
Dindori,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1435.0,1403.0,1836.0,2148.0,1734.0,2167.0,2028.0,1788.0,2036.0,1612.0,1815.0,1736.0,21738.0
Dindori,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1388.0,1995.0,2396.0,1934.0,1932.0,2503.0,1917.0,1911.0,1777.0,1810.0,1645.0,1776.0,22984.0
Dindori,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,25.0,83.0,144.0,100.0,108.0,69.0,70.0,121.0,156.0,126.0,89.0,63.0,1154.0
Dindori,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,40.0,11.0,26.0,2.0,2.0,0.0,3.0,3.0,2.0,2.0,4.0,95.0
Dindori,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,882.0,1393.0,1558.0,1664.0,1602.0,1599.0,1490.0,1727.0,1614.0,1676.0,1713.0,1807.0,18725.0
Dindori,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,78.0,303.0,364.0,262.0,127.0,137.0,177.0,142.0,962.0,342.0,400.0,400.0,3694.0
Dindori,1.8,Number of pregnancy test kits used at SC level,TOTAL,1106.0,1809.0,2554.0,2752.0,3121.0,3746.0,3270.0,3276.0,3061.0,3937.0,2942.0,3252.0,34826.0
Dindori,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,11.0,23.0,34.0,31.0,27.0,44.0,44.0,69.0,44.0,18.0,28.0,50.0,423.0
Dindori,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,123.0,132.0,115.0,62.0,45.0,59.0,22.0,17.0,34.0,26.0,17.0,22.0,674.0
Dindori,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,134.0,155.0,149.0,93.0,72.0,103.0,66.0,86.0,78.0,44.0,45.0,72.0,1097.0
Dindori,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,122.0,137.0,129.0,92.0,66.0,101.0,62.0,84.0,66.0,41.0,44.0,67.0,1011.0
Dindori,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,25.0,9.0,9.0,33.0,0.0,48.0,34.0,6.0,1.0,47.0,212.0
Dindori,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,724.0,904.0,1174.0,1208.0,1122.0,1006.0,1023.0,1012.0,1036.0,961.0,896.0,990.0,12056.0
Dindori,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,0.0,0.0,8.0,33.0,0.0,0.0,20.0,0.0,8.0,11.0,7.0,8.0,95.0
Dindori,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,390.0,728.0,1327.0,1076.0,934.0,975.0,896.0,841.0,914.0,1063.0,707.0,910.0,10761.0
Dindori,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,447.0,921.0,1297.0,1144.0,1000.0,907.0,942.0,1141.0,856.0,961.0,703.0,955.0,11274.0
Dindori,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,1.0,8.0,1.0,0.0,3.0,2.0,0.0,6.0,,0.0,,,21.0
Dindori,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Dindori,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Dindori,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Dindori,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Dindori,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Dindori,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Dindori,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,9.0,3.0,6.0,18.0,4.0,4.0,5.0,7.0,4.0,0.0,4.0,5.0,69.0
Dindori,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dindori,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,9.0,3.0,6.0,18.0,4.0,4.0,5.0,7.0,4.0,0.0,4.0,5.0,69.0
Dindori,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Dindori,4.1.1.a,Number of male live births,TOTAL,430.0,530.0,648.0,654.0,588.0,549.0,541.0,539.0,585.0,480.0,483.0,523.0,6550.0
Dindori,4.1.1.b,Number of female live births,TOTAL,422.0,518.0,653.0,613.0,577.0,542.0,522.0,527.0,514.0,496.0,435.0,528.0,6347.0
Dindori,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,852.0,1048.0,1301.0,1267.0,1165.0,1091.0,1063.0,1066.0,1099.0,976.0,918.0,1051.0,12897.0
Dindori,4.1.2,Number of still births,TOTAL,14.0,21.0,27.0,44.0,34.0,27.0,30.0,38.0,17.0,30.0,26.0,16.0,324.0
Dindori,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,28.0,44.0,48.0,75.0,123.0,140.0,118.0,145.0,150.0,138.0,135.0,128.0,1272.0
Dindori,4.2.1,Number of Newborns weighed at birth,TOTAL,851.0,1031.0,1305.0,1260.0,1163.0,1057.0,1063.0,1066.0,1085.0,975.0,917.0,1037.0,12810.0
Dindori,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,117.0,149.0,213.0,236.0,190.0,198.0,200.0,183.0,150.0,145.0,155.0,198.0,2134.0
Dindori,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,840.0,1006.0,1263.0,1239.0,1143.0,1066.0,1033.0,1060.0,1074.0,962.0,918.0,1019.0,12623.0
Dindori,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,2.0,3.0,9.0,7.0,5.0,0.0,0.0,9.0,1.0,2.0,2.0,11.0,51.0
Dindori,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,5.0,37.0,57.0,40.0,25.0,31.0,50.0,47.0,78.0,22.0,65.0,29.0,486.0
Dindori,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,42.0,43.0,38.0,29.0,35.0,16.0,31.0,36.0,27.0,32.0,28.0,38.0,395.0
Dindori,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dindori,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,49.0,83.0,104.0,76.0,65.0,47.0,81.0,92.0,106.0,56.0,95.0,78.0,932.0
Dindori,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Dindori,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,26.0,64.0,27.0,45.0,36.0,24.0,30.0,35.0,43.0,30.0,30.0,25.0,415.0
Dindori,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,13.0,26.0,28.0,21.0,11.0,6.0,13.0,16.0,21.0,9.0,18.0,22.0,204.0
Dindori,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,11.0,39.0,24.0,29.0,15.0,27.0,37.0,48.0,54.0,21.0,43.0,28.0,376.0
Dindori,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,9.0,3.0,4.0,12.0,11.0,3.0,11.0,6.0,6.0,5.0,5.0,10.0,85.0
Dindori,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,897.0,1214.0,1313.0,1271.0,1106.0,1056.0,1049.0,1018.0,1067.0,969.0,856.0,1020.0,12836.0
Dindori,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,533.0,786.0,799.0,630.0,971.0,1109.0,628.0,580.0,695.0,661.0,552.0,534.0,8478.0
Dindori,6.3,PNC maternal complications attended,TOTAL,8.0,26.0,49.0,14.0,4.0,17.0,0.0,4.0,14.0,2.0,9.0,6.0,153.0
Dindori,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,23.0,15.0,18.0,16.0,6.0,26.0,15.0,19.0,33.0,22.0,31.0,33.0,257.0
Dindori,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,4.0,0.0,5.0
Dindori,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,23.0,15.0,18.0,16.0,6.0,26.0,16.0,19.0,33.0,22.0,35.0,33.0,262.0
Dindori,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
Dindori,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,23.0,31.0,51.0,46.0,32.0,39.0,42.0,47.0,37.0,42.0,46.0,43.0,479.0
Dindori,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,32.0,38.0,56.0,61.0,53.0,56.0,66.0,56.0,54.0,59.0,43.0,44.0,618.0
Dindori,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,55.0,69.0,107.0,107.0,85.0,95.0,108.0,103.0,91.0,101.0,89.0,87.0,1097.0
Dindori,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
Dindori,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
Dindori,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,2.0,3.0,3.0,3.0,5.0,5.0,3.0,24.0
Dindori,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,0.0,,,0.0,0.0,,0.0
Dindori,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dindori,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,2.0,3.0,3.0,3.0,5.0,5.0,3.0,24.0
Dindori,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dindori,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,7.0,6.0,,,,,51.0,19.0,26.0,12.0,37.0,,158.0
Dindori,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,6.0,,46.0,75.0,47.0,198.0,221.0,692.0,730.0,757.0,557.0,215.0,3544.0
Dindori,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,6.0,,,,,25.0,16.0,118.0,301.0,137.0,152.0,33.0,788.0
Dindori,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dindori,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,19.0,6.0,46.0,75.0,47.0,223.0,288.0,829.0,1057.0,906.0,746.0,248.0,4490.0
Dindori,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dindori,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Dindori,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,0.0,,0.0
Dindori,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,0.0,,,0.0,0.0,,0.0
Dindori,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dindori,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,0.0,,,0.0,0.0,,0.0
Dindori,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dindori,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Dindori,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,0.0,,0.0
Dindori,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,1.0,2.0,1.0,4.0,,4.0,3.0,5.0,1.0,0.0,0.0,2.0,23.0
Dindori,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dindori,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,1.0,2.0,1.0,4.0,,4.0,3.0,5.0,1.0,0.0,0.0,2.0,23.0
Dindori,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dindori,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,362.0,537.0,746.0,811.0,731.0,668.0,737.0,610.0,591.0,595.0,605.0,738.0,7731.0
Dindori,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,2.0,,3.0,22.0,15.0,5.0,3.0,,2.0,26.0,21.0,43.0,142.0
Dindori,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,25.0,6.0,,75.0,41.0,48.0,52.0,61.0,233.0,91.0,632.0
Dindori,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,13.0,35.0,123.0,122.0,104.0,54.0,56.0,51.0,65.0,48.0,55.0,85.0,811.0
Dindori,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dindori,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,377.0,572.0,897.0,961.0,850.0,802.0,837.0,709.0,710.0,730.0,914.0,957.0,9316.0
Dindori,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,4.0,33.0,158.0,134.0,103.0,126.0,95.0,93.0,111.0,112.0,322.0,213.0,1504.0
Dindori,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dindori,9.06,Number of IUCD removals,TOTAL,160.0,82.0,128.0,221.0,163.0,219.0,224.0,288.0,513.0,473.0,409.0,465.0,3345.0
Dindori,9.07,Number of Oral Pills cycles distributed,TOTAL,1483.0,1868.0,3504.0,4001.0,4681.0,4151.0,3372.0,3745.0,3225.0,3557.0,3156.0,3381.0,40124.0
Dindori,9.08,Number of Condom pieces distributed,TOTAL,7299.0,10479.0,18663.0,24166.0,30742.0,28305.0,24518.0,18057.0,17428.0,22569.0,15200.0,17663.0,235089.0
Dindori,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dindori,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,2.0,5.0,13.0,32.0,6.0,3.0,0.0,6.0,8.0,9.0,8.0,92.0
Dindori,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,0.0,0.0,0.0,0.0,0.0
Dindori,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,3.0,5.0,3.0,1.0,,,,12.0
Dindori,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
Dindori,9.11.2.b,Number of failures following female sterilization,TOTAL,,,1.0,,,,,,1.0,0.0,0.0,0.0,2.0
Dindori,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
Dindori,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
Dindori,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,1.0,,,-1.0
Dindori,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,917.0,1072.0,1383.0,1284.0,1213.0,1141.0,1044.0,993.0,1138.0,993.0,947.0,993.0,13118.0
Dindori,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,916.0,1094.0,1408.0,1444.0,1503.0,1544.0,1614.0,44.0,0.0,0.0,0.0,0.0,9567.0
Dindori,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1053.0,989.0,1231.0,1496.0,1384.0,1561.0,1574.0,1616.0,56.0,6.0,0.0,0.0,10966.0
Dindori,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1182.0,1136.0,1139.0,1338.0,1461.0,1467.0,1608.0,1539.0,1585.0,59.0,9.0,1.0,12524.0
Dindori,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,1424.0,1235.0,1312.0,1420.0,1374.0,6765.0
Dindori,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,0.0,1272.0,1221.0,1370.0,1461.0,5324.0
Dindori,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,0.0,0.0,1273.0,1266.0,1407.0,3946.0
Dindori,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,788.0,963.0,1151.0,1113.0,1070.0,955.0,907.0,866.0,1009.0,924.0,899.0,911.0,11556.0
Dindori,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,917.0,1090.0,1383.0,1443.0,1502.0,1532.0,1618.0,1413.0,1213.0,1334.0,1377.0,1374.0,16196.0
Dindori,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1051.0,989.0,1231.0,1492.0,1386.0,1566.0,1569.0,1630.0,1317.0,1241.0,1356.0,1459.0,16287.0
Dindori,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1180.0,1146.0,1147.0,1330.0,1460.0,1464.0,1607.0,1539.0,1584.0,1322.0,1254.0,1415.0,16448.0
Dindori,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,661.0,915.0,1106.0,1072.0,1017.0,934.0,866.0,766.0,976.0,882.0,855.0,831.0,10881.0
Dindori,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,919.0,1092.0,1386.0,1445.0,1503.0,1546.0,1614.0,50.0,0.0,0.0,0.0,0.0,9555.0
Dindori,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1055.0,991.0,1223.0,1492.0,1382.0,1561.0,1575.0,1617.0,74.0,6.0,0.0,0.0,10976.0
Dindori,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1178.0,1140.0,1154.0,1334.0,1464.0,1463.0,1605.0,1541.0,1550.0,42.0,9.0,1.0,12481.0
Dindori,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1056.0,1167.0,1643.0,1750.0,1346.0,1421.0,1368.0,1224.0,1128.0,1333.0,1417.0,1722.0,16575.0
Dindori,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1366.0,1112.0,1327.0,1461.0,1157.0,1232.0,1231.0,1233.0,1168.0,1052.0,976.0,1417.0,14732.0
Dindori,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Dindori,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,541.0,618.0,841.0,904.0,674.0,734.0,697.0,624.0,576.0,674.0,729.0,885.0,8497.0
Dindori,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,514.0,549.0,804.0,834.0,672.0,687.0,671.0,600.0,549.0,659.0,688.0,807.0,8034.0
Dindori,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1055.0,1167.0,1645.0,1738.0,1346.0,1421.0,1368.0,1224.0,1125.0,1333.0,1417.0,1692.0,16531.0
Dindori,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1080.0,1168.0,1359.0,1437.0,1166.0,1253.0,1276.0,1325.0,1275.0,1301.0,1240.0,1514.0,15394.0
Dindori,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1081.0,1167.0,1357.0,1435.0,1165.0,1258.0,1267.0,1325.0,1277.0,1300.0,1240.0,1516.0,15388.0
Dindori,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,0.0,0.0,0.0,0.0,0.0
Dindori,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,231.0,257.0,253.0,291.0,238.0,229.0,250.0,243.0,289.0,245.0,271.0,296.0,3093.0
Dindori,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,224.0,232.0,258.0,238.0,230.0,228.0,240.0,240.0,270.0,234.0,215.0,304.0,2913.0
Dindori,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,455.0,489.0,511.0,529.0,468.0,457.0,490.0,483.0,559.0,479.0,486.0,600.0,6006.0
Dindori,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,300.0,214.0,249.0,358.0,370.0,425.0,468.0,533.0,443.0,587.0,577.0,544.0,5068.0
Dindori,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,635.0,791.0,1089.0,2483.0,1651.0,1247.0,1218.0,1259.0,1298.0,1221.0,1066.0,1178.0,15136.0
Dindori,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,669.0,795.0,1118.0,1916.0,1435.0,1161.0,1205.0,1101.0,1249.0,1299.0,1046.0,1301.0,14295.0
Dindori,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dindori,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Dindori,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Dindori,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,913.0,943.0,948.0,943.0,948.0,945.0,946.0,947.0,934.0,948.0,947.0,951.0,11313.0
Dindori,10.4.2,Number of Immunisation sessions held during the month,TOTAL,913.0,943.0,948.0,943.0,948.0,945.0,946.0,947.0,934.0,948.0,947.0,951.0,11313.0
Dindori,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,902.0,918.0,931.0,932.0,935.0,933.0,932.0,935.0,921.0,934.0,941.0,946.0,11160.0
Dindori,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
Dindori,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1039.0,1151.0,1582.0,1974.0,1389.0,1401.0,1349.0,1206.0,1196.0,1367.0,1425.0,1699.0,16778.0
Dindori,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,136.0,175.0,277.0,5410.0,2327.0,352.0,311.0,277.0,518.0,6427.0,727.0,333.0,17270.0
Dindori,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,128.0,160.0,189.0,5524.0,2102.0,186.0,294.0,233.0,393.0,6435.0,775.0,257.0,16676.0
Dindori,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Dindori,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Dindori,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Dindori,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Dindori,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Dindori,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,0.0,,,,,,,,0.0,,0.0
Dindori,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,314.0,498.0,558.0,486.0,947.0,539.0,341.0,259.0,228.0,327.0,338.0,297.0,5132.0
Dindori,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,8.0,8.0,18.0,20.0,47.0,25.0,25.0,16.0,14.0,1.0,1.0,4.0,187.0
Dindori,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,15.0,,26.0,15.0,10.0,,11.0,8.0,0.0,0.0,85.0
Dindori,13.1,Number of Patients operated for cataract,TOTAL,,,,,0.0,,0.0,0.0,0.0,49.0,122.0,62.0,233.0
Dindori,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,0.0,,0.0,0.0,0.0,49.0,122.0,62.0,233.0
Dindori,13.3,Number of School children detected with Refractive errors,TOTAL,12.0,65.0,,,157.0,266.0,2090.0,23.0,67.0,30.0,20.0,,2730.0
Dindori,13.4,Number of children provided free glasses,TOTAL,,5.0,,,0.0,113.0,131.0,,94.0,30.0,0.0,,373.0
Dindori,13.5,Number of eyes collected through eye donation,TOTAL,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0
Dindori,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,0.0,,,0.0,0.0,0.0,0.0,,0.0
Dindori,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,3.0,2.0,1.0,2.0,3.0,2.0,2.0,1.0,1.0,2.0,3.0,-1.0
Dindori,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,2.0,5.0,3.0,2.0,2.0,3.0,2.0,2.0,2.0,3.0,2.0,-1.0
Dindori,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,939.0,943.0,952.0,943.0,948.0,947.0,940.0,952.0,950.0,952.0,938.0,947.0,-1.0
Dindori,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,3.0,2.0,2.0,2.0,2.0,3.0,2.0,2.0,2.0,3.0,3.0,-1.0
Dindori,14.05,Number of RKS meetings held during the month,TOTAL,,1.0,0.0,2.0,5.0,10.0,7.0,2.0,5.0,4.0,4.0,3.0,43.0
Dindori,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,3.0,3.0,5.0,3.0,4.0,2.0,3.0,3.0,3.0,2.0,5.0,4.0,-1.0
Dindori,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,13.0,18.0,99.0,59.0,55.0,70.0,59.0,57.0,60.0,73.0,51.0,26.0,640.0
Dindori,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,,,1.0,,,1.0,1.0,,,2.0,1.0,-1.0
Dindori,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,0.0,0.0,0.0,,0.0,,0.0,0.0,-1.0
Dindori,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,244.0,303.0,324.0,356.0,336.0,404.0,473.0,196.0,244.0,306.0,130.0,365.0,3681.0
Dindori,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,555.0,904.0,1056.0,1556.0,793.0,991.0,620.0,663.0,402.0,691.0,737.0,1063.0,10031.0
Dindori,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,237.0,402.0,268.0,378.0,387.0,364.0,730.0,180.0,447.0,259.0,142.0,357.0,4151.0
Dindori,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1145.0,1832.0,2452.0,2171.0,2055.0,2002.0,1752.0,1369.0,1874.0,2027.0,2018.0,2463.0,23160.0
Dindori,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,481.0,705.0,592.0,734.0,723.0,768.0,1203.0,376.0,691.0,565.0,272.0,722.0,7832.0
Dindori,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1700.0,2736.0,3508.0,3727.0,2848.0,2993.0,2372.0,2032.0,2276.0,2718.0,2755.0,3526.0,33191.0
Dindori,14.10.2.a,Number of death cases of Inpatient males,TOTAL,10.0,6.0,9.0,15.0,14.0,15.0,18.0,8.0,8.0,6.0,8.0,9.0,126.0
Dindori,14.10.2.b,Number of death cases of Inpatient females,TOTAL,8.0,8.0,14.0,8.0,7.0,6.0,7.0,4.0,5.0,8.0,7.0,6.0,88.0
Dindori,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,18.0,14.0,23.0,23.0,21.0,21.0,25.0,12.0,13.0,14.0,15.0,15.0,214.0
Dindori,14.11,In-Patient Head Count at midnight,TOTAL,1674.0,2561.0,3720.0,3910.0,3085.0,4132.0,3642.0,1662.0,2085.0,1530.0,2031.0,2970.0,33002.0
Dindori,14.12.1,OPD attendance (All),TOTAL,25588.0,37175.0,44883.0,55652.0,52271.0,75692.0,54214.0,33677.0,36921.0,34726.0,36803.0,36348.0,523950.0
Dindori,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,9.0,3.0,9.0,22.0,1.0,7.0,5.0,10.0,11.0,2.0,12.0,6.0,97.0
Dindori,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,0.0,,,0.0,,0.0,0.0,0.0,0.0,0.0
Dindori,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,236.0,361.0,264.0,206.0,4.0,63.0,140.0,265.0,251.0,246.0,260.0,251.0,2547.0
Dindori,14.14.a,Number of patients given AYUSH treatment,TOTAL,658.0,497.0,751.0,586.0,1071.0,1400.0,939.0,1291.0,1420.0,1367.0,1053.0,1424.0,12457.0
Dindori,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,168.0,121.0,105.0,126.0,164.0,164.0,136.0,,0.0,0.0,984.0
Dindori,14.14.c,Number of Adolescents counselled,TOTAL,,,,3.0,25.0,61.0,48.0,,2.0,60.0,10.0,,209.0
Dindori,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5044.0,5674.0,7188.0,6760.0,5204.0,6514.0,5445.0,6731.0,7161.0,6699.0,7406.0,7384.0,77210.0
Dindori,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,177.0,345.0,347.0,299.0,307.0,358.0,370.0,762.0,484.0,379.0,430.0,318.0,4576.0
Dindori,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,160.0,225.0,144.0,206.0,142.0,142.0,187.0,122.0,140.0,240.0,33.0,185.0,1926.0
Dindori,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,8.0,2.0,1.0,0.0,,1.0,0.0,,0.0,0.0,0.0,12.0
Dindori,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,223.0,153.0,125.0,244.0,216.0,167.0,211.0,248.0,238.0,473.0,115.0,198.0,2611.0
Dindori,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,2.0,2.0,1.0,2.0,,0.0,0.0,,0.0,0.0,0.0,7.0
Dindori,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1146.0,983.0,1073.0,1080.0,814.0,1154.0,761.0,629.0,1123.0,633.0,926.0,558.0,10880.0
Dindori,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,2.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,7.0
Dindori,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1529.0,1361.0,1342.0,1530.0,1172.0,1463.0,1159.0,999.0,1501.0,1346.0,1074.0,941.0,15417.0
Dindori,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,12.0,5.0,2.0,3.0,0.0,1.0,2.0,0.0,0.0,0.0,0.0,26.0
Dindori,15.2,Number of Widal tests conducted,Number tested,117.0,628.0,801.0,751.0,396.0,896.0,678.0,303.0,230.0,230.0,280.0,441.0,5751.0
Dindori,15.3.a,Number of VDRL tests conducted on males,Number tested,11.0,42.0,59.0,23.0,10.0,27.0,26.0,37.0,25.0,18.0,17.0,25.0,320.0
Dindori,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,102.0,126.0,46.0,49.0,5.0,105.0,48.0,89.0,93.0,28.0,49.0,82.0,822.0
Dindori,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,358.0,391.0,104.0,17.0,48.0,242.0,264.0,339.0,328.0,29.0,148.0,251.0,2519.0
Dindori,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,471.0,559.0,209.0,89.0,63.0,374.0,338.0,465.0,446.0,75.0,214.0,358.0,3661.0
Dindori,15.4.1,Number of blood smears examined for Malaria,TOTAL,9899.0,10493.0,12397.0,15553.0,15231.0,20797.0,16321.0,11656.0,9436.0,4985.0,8945.0,8904.0,144617.0
Dindori,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,8.0,16.0,36.0,58.0,59.0,39.0,32.0,95.0,22.0,2.0,3.0,8.0,378.0
Dindori,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,18.0,31.0,201.0,533.0,1026.0,349.0,294.0,284.0,46.0,18.0,13.0,26.0,2839.0
Dindori,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,500.0,1700.0,1150.0,950.0,1600.0,2000.0,1350.0,1450.0,1000.0,500.0,,,12200.0
Dindori,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,0.0,1000.0,1500.0,1000.0,0.0,1000.0,,0.0,500.0,,,7000.0
Dindori,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,0.0
Dindori,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,800.0,550.0,1200.0,850.0,600.0,650.0,900.0,450.0,500.0,100.0,,,6600.0
Dindori,16.1.1,Stock position of DPT vaccines,5. Total Stock,1700.0,1150.0,950.0,1600.0,2000.0,1350.0,1450.0,1000.0,500.0,900.0,0.0,0.0,12600.0
Dindori,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,,,,,0.0,50.0,50.0,,,100.0
Dindori,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,,,,,750.0,0.0,900.0,,,1650.0
Dindori,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,,,,,,,0.0,,,0.0
Dindori,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,,,,,700.0,0.0,450.0,,,1150.0
Dindori,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0,50.0,500.0,0.0,0.0,600.0
Dindori,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,590.0,1450.0,900.0,800.0,350.0,650.0,650.0,550.0,900.0,1000.0,,,7840.0
Dindori,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1500.0,0.0,1000.0,500.0,1000.0,700.0,700.0,800.0,800.0,0.0,,,7000.0
Dindori,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Dindori,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,640.0,550.0,1100.0,800.0,700.0,700.0,800.0,450.0,700.0,225.0,,,6665.0
Dindori,16.1.2,Stock position of OPV vaccines,5. Total Stock,1450.0,900.0,800.0,500.0,650.0,650.0,550.0,900.0,1000.0,775.0,0.0,0.0,8175.0
Dindori,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,300.0,1550.0,950.0,900.0,1000.0,750.0,1100.0,1200.0,1700.0,900.0,,,10350.0
Dindori,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000.0,0.0,1000.0,1000.0,500.0,1000.0,1000.0,1000.0,0.0,500.0,,,8000.0
Dindori,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,0.0
Dindori,16.1.3,Stock position of TT vaccines,4. Stock Distributed,750.0,600.0,1050.0,900.0,750.0,650.0,900.0,500.0,800.0,500.0,,,7400.0
Dindori,16.1.3,Stock position of TT vaccines,5. Total Stock,1550.0,950.0,900.0,1000.0,750.0,1100.0,1200.0,1700.0,900.0,900.0,0.0,0.0,10950.0
Dindori,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Dindori,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Dindori,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Dindori,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Dindori,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dindori,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,250.0,1100.0,550.0,800.0,1150.0,1150.0,1100.0,900.0,850.0,650.0,,,8500.0
Dindori,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1500.0,0.0,1000.0,1000.0,500.0,500.0,500.0,500.0,500.0,500.0,,,6500.0
Dindori,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,0.0
Dindori,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,650.0,550.0,750.0,650.0,500.0,550.0,700.0,550.0,700.0,500.0,,,6100.0
Dindori,16.1.5,Stock position of BCG vaccines,5. Total Stock,1100.0,550.0,800.0,1150.0,1150.0,1100.0,900.0,850.0,650.0,650.0,0.0,0.0,8900.0
Dindori,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,450.0,1850.0,1100.0,1100.0,650.0,950.0,1100.0,1150.0,1200.0,1450.0,,,11000.0
Dindori,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3000.0,0.0,1000.0,500.0,1000.0,1000.0,1000.0,1000.0,1000.0,0.0,,,9500.0
Dindori,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,0.0
Dindori,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1600.0,750.0,1000.0,950.0,700.0,850.0,950.0,950.0,750.0,900.0,,,9400.0
Dindori,16.1.6,Stock position of Measles vaccines,5. Total Stock,1850.0,1100.0,1100.0,650.0,950.0,1100.0,1150.0,1200.0,1450.0,550.0,0.0,0.0,11100.0
Dindori,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Dindori,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Dindori,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Dindori,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Dindori,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dindori,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,500.0,1700.0,1000.0,1000.0,600.0,850.0,1300.0,1400.0,950.0,350.0,,,9650.0
Dindori,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,2000.0,0.0,1000.0,500.0,1000.0,1000.0,1000.0,0.0,0.0,500.0,,,7000.0
Dindori,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,,0.0
Dindori,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,800.0,700.0,1000.0,900.0,750.0,550.0,900.0,450.0,600.0,100.0,,,6750.0
Dindori,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1700.0,1000.0,1000.0,600.0,850.0,1300.0,1400.0,950.0,350.0,750.0,0.0,0.0,9900.0
Dindori,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1800.0,1200.0,,,3000.0
Dindori,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1800.0,0.0,0.0,,,1800.0
Dindori,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Dindori,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0,0.0,,,600.0
Dindori,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1800.0,1200.0,1200.0,0.0,0.0,4200.0
Dindori,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,60780.0,20460.0,0.0,0.0,0.0,17080.0,9580.0,4580.0,40160.0,10640.0,,,163280.0
Dindori,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,100800.0,30240.0,0.0,36000.0,0.0,0.0,,,167040.0
Dindori,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Dindori,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,40320.0,20460.0,0.0,0.0,83720.0,37740.0,5000.0,420.0,29520.0,0.0,,,217180.0
Dindori,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,20460.0,0.0,0.0,0.0,17080.0,9580.0,4580.0,40160.0,10640.0,10640.0,0.0,0.0,113140.0
Dindori,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,400.0,300.0,0.0,0.0,18600.0,4200.0,1600.0,1000.0,20800.0,7600.0,,,54500.0
Dindori,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,25200.0,0.0,6000.0,0.0,20000.0,0.0,0.0,,,51200.0
Dindori,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Dindori,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,100.0,300.0,0.0,6600.0,14400.0,8600.0,600.0,200.0,13200.0,2000.0,,,46000.0
Dindori,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,300.0,0.0,0.0,18600.0,4200.0,1600.0,1000.0,20800.0,7600.0,5600.0,0.0,0.0,59700.0
Dindori,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2800.0,2100.0,900.0,50.0,450.0,150.0,200.0,100.0,2100.0,400.0,,,9250.0
Dindori,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,900.0,0.0,2000.0,0.0,2000.0,0.0,0.0,,,4900.0
Dindori,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Dindori,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,700.0,1200.0,850.0,500.0,300.0,1950.0,100.0,0.0,1700.0,350.0,,,7650.0
Dindori,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,2100.0,900.0,50.0,450.0,150.0,200.0,100.0,2100.0,400.0,50.0,0.0,0.0,6500.0
Dindori,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,5000.0,5000.0,5000.0,5000.0,6967.0,5867.0,5867.0,5867.0,5867.0,5367.0,,,55802.0
Dindori,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,3067.0,0.0,0.0,0.0,0.0,0.0,0.0,,,3067.0
Dindori,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Dindori,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,1100.0,1100.0,0.0,0.0,0.0,500.0,500.0,,,3200.0
Dindori,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,5000.0,5000.0,5000.0,6967.0,5867.0,5867.0,5867.0,5867.0,5367.0,4867.0,0.0,0.0,55669.0
Dindori,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,600.0,300.0,0.0,0.0,0.0,1350.0,750.0,450.0,45.0,30.0,,,3525.0
Dindori,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,,,5000.0
Dindori,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Dindori,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,300.0,300.0,0.0,0.0,3650.0,600.0,300.0,405.0,15.0,0.0,,,5570.0
Dindori,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,300.0,0.0,0.0,0.0,1350.0,750.0,450.0,45.0,30.0,30.0,0.0,0.0,2955.0
Dindori,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,23500.0,8000.0,900.0,150.0,150.0,150.0,150.0,150.0,28650.0,,,61800.0
Dindori,16.3.02,Stock Position of Gloves,2. Stocks Received,30000.0,0.0,0.0,0.0,,0.0,0.0,0.0,40000.0,25000.0,,,95000.0
Dindori,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,0.0
Dindori,16.3.02,Stock Position of Gloves,4. Stock Distributed,6500.0,15500.0,7100.0,750.0,,0.0,0.0,0.0,11500.0,34350.0,,,75700.0
Dindori,16.3.02,Stock Position of Gloves,5. Total Stock,23500.0,8000.0,900.0,150.0,150.0,150.0,150.0,150.0,28650.0,19300.0,0.0,0.0,81100.0
Dindori,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,,,0.0
Dindori,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Dindori,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Dindori,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Dindori,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dindori,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,1200.0,600.0,400.0,100.0,100.0,400.0,200.0,100.0,100.0,20100.0,,,23300.0
Dindori,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,20000.0,0.0,,,22000.0
Dindori,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Dindori,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,600.0,200.0,300.0,0.0,1700.0,200.0,100.0,0.0,0.0,11000.0,,,14100.0
Dindori,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,600.0,400.0,100.0,100.0,400.0,200.0,100.0,100.0,20100.0,9100.0,0.0,0.0,31200.0
Dindori,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Dindori,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,,80.0,0.0,,,,,,80.0
Dindori,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Dindori,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,,80.0,0.0,,,,,,80.0
Dindori,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dindori,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Dindori,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Dindori,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Dindori,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Dindori,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dindori,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,34000.0,8000.0,8000.0,4000.0,0.0,0.0,418400.0,161000.0,61000.0,929600.0,,,1624000.0
Dindori,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,,500000.0,0.0,0.0,5000000.0,0.0,,,5500000.0
Dindori,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Dindori,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,26000.0,0.0,4000.0,4000.0,,81600.0,257400.0,100000.0,4131400.0,440500.0,,,5044900.0
Dindori,16.3.07,Stock Position of IFA Tablets,5. Total Stock,8000.0,8000.0,4000.0,0.0,0.0,418400.0,161000.0,61000.0,929600.0,489100.0,0.0,0.0,2079100.0
Dindori,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,26280.0,20160.0,19320.0,0.0,0.0,41072.0,39488.0,32328.0,30282.0,9650.0,,,218580.0
Dindori,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,50000.0,0.0,0.0,5000.0,0.0,0.0,,,55000.0
Dindori,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Dindori,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,6120.0,840.0,19320.0,0.0,8928.0,1584.0,7160.0,7046.0,20632.0,3432.0,,,75062.0
Dindori,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,20160.0,19320.0,0.0,0.0,41072.0,39488.0,32328.0,30282.0,9650.0,6218.0,0.0,0.0,198518.0
Dindori,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,42500.0,17000.0,52000.0,16800.0,200.0,150.0,100.0,50.0,50.0,50.0,,,128900.0
Dindori,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,47000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200000.0,,,247000.0
Dindori,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Dindori,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,25500.0,12000.0,35200.0,16600.0,50.0,50.0,50.0,0.0,0.0,107050.0,,,196500.0
Dindori,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,17000.0,52000.0,16800.0,200.0,150.0,100.0,50.0,50.0,50.0,93000.0,0.0,0.0,179400.0
Dindori,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,775.0,775.0,775.0,114.0,390.0,390.0,325.0,325.0,1700.0,331.0,,,5900.0
Dindori,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,114.0,400.0,0.0,0.0,0.0,1700.0,0.0,0.0,,,2214.0
Dindori,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Dindori,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,775.0,124.0,0.0,65.0,0.0,325.0,1369.0,250.0,,,2908.0
Dindori,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,775.0,775.0,114.0,390.0,390.0,325.0,325.0,1700.0,331.0,81.0,0.0,0.0,5206.0
Dindori,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,32500.0,6000.0,800.0,73000.0,400.0,200.0,221000.0,204400.0,174400.0,148400.0,,,861100.0
Dindori,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,75000.0,0.0,0.0,270000.0,0.0,0.0,0.0,0.0,,,345000.0
Dindori,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Dindori,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,26500.0,5200.0,2800.0,72600.0,200.0,49200.0,16600.0,30000.0,26000.0,25000.0,,,254100.0
Dindori,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,6000.0,800.0,73000.0,400.0,200.0,221000.0,204400.0,174400.0,148400.0,123400.0,0.0,0.0,952000.0
Dindori,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,24600.0,28500.0,35100.0,32000.0,48800.0,42800.0,37000.0,56800.0,53500.0,10600.0,,,369700.0
Dindori,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,9900.0,6600.0,0.0,19800.0,0.0,0.0,19800.0,0.0,0.0,0.0,,,56100.0
Dindori,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,0.0
Dindori,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,600.0,0.0,3100.0,3000.0,6000.0,5800.0,0.0,3300.0,42900.0,0.0,,,64700.0
Dindori,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,33900.0,35100.0,32000.0,48800.0,42800.0,37000.0,56800.0,53500.0,10600.0,10600.0,0.0,0.0,361100.0
Dindori,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,224400.0,206400.0,206400.0,206400.0,98000.0,58000.0,58000.0,118000.0,118000.0,118000.0,,,1411600.0
Dindori,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,90000.0,0.0,0.0,60000.0,0.0,0.0,0.0,,,150000.0
Dindori,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,0.0
Dindori,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,18000.0,0.0,0.0,206400.0,40000.0,0.0,0.0,0.0,0.0,0.0,,,264400.0
Dindori,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,206400.0,206400.0,206400.0,90000.0,58000.0,58000.0,118000.0,118000.0,118000.0,118000.0,0.0,0.0,1297200.0
Dindori,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,4100.0,6100.0,12100.0,6100.0,34100.0,28000.0,26000.0,42000.0,38000.0,36000.0,,,232500.0
Dindori,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4000.0,6000.0,0.0,30000.0,0.0,0.0,20000.0,,0.0,0.0,,,60000.0
Dindori,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,,0.0
Dindori,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2000.0,0.0,6000.0,0.0,6100.0,2000.0,4000.0,4000.0,2000.0,0.0,,,26100.0
Dindori,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,6100.0,12100.0,6100.0,36100.0,28000.0,26000.0,42000.0,38000.0,36000.0,36000.0,0.0,0.0,266400.0
Dindori,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,1.0,1.0,,1.0,1.0,,1.0,1.0,,1.0,8.0
Dindori,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Dindori,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dindori,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Dindori,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,1.0,,,,,,,1.0
Dindori,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,,,1.0
Dindori,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,1.0,,,,1.0,,,2.0
Dindori,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,3.0,4.0,6.0,7.0,11.0,11.0,4.0,9.0,3.0,8.0,4.0,72.0
Dindori,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,,,,,1.0
Dindori,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,3.0,4.0,6.0,7.0,11.0,11.0,5.0,9.0,3.0,8.0,4.0,73.0
Dindori,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,4.0,4.0,2.0,7.0,2.0,6.0,4.0,9.0,4.0,2.0,2.0,4.0,50.0
Dindori,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dindori,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,4.0,4.0,2.0,7.0,2.0,6.0,4.0,9.0,4.0,2.0,2.0,4.0,50.0
Dindori,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,2.0,1.0,,3.0,3.0,4.0,4.0,3.0,2.0,,2.0,24.0
Dindori,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,,,1.0,2.0,2.0,1.0,,,1.0,8.0
Dindori,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,3.0,1.0,,3.0,4.0,6.0,6.0,4.0,2.0,,3.0,32.0
Dindori,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,1.0,,,,,,,2.0,,,3.0
Dindori,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dindori,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,1.0,,,,,,,2.0,,,3.0
Dindori,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,1.0,,,,,,,1.0
Dindori,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dindori,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,1.0,,,,,,,1.0
Dindori,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dindori,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dindori,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Dindori,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,4.0,3.0,5.0,3.0,7.0,8.0,4.0,12.0,9.0,6.0,2.0,,63.0
Dindori,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,3.0,4.0,4.0,2.0,3.0,8.0,7.0,2.0,3.0,4.0,3.0,6.0,49.0
Dindori,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,7.0,7.0,9.0,5.0,10.0,16.0,11.0,14.0,12.0,10.0,5.0,6.0,112.0
Dindori,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Dindori,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,2.0,1.0,1.0,,,1.0,,,,,1.0,6.0
Dindori,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,1.0,,,2.0,1.0,1.0,,1.0,,,,6.0
Dindori,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,3.0,2.0,1.0,2.0,1.0,2.0,,1.0,,,1.0,13.0
Dindori,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Dindori,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,1.0,2.0,2.0,,2.0,,1.0,,,8.0
Dindori,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,2.0,,1.0,1.0,,,,,4.0
Dindori,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,1.0,4.0,2.0,1.0,3.0,,1.0,,,12.0
Dindori,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Dindori,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,2.0,,1.0,1.0,1.0,1.0,1.0,1.0,,,8.0
Dindori,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,1.0,2.0,1.0,2.0,3.0,1.0,,3.0,3.0,1.0,,17.0
Dindori,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,1.0,4.0,1.0,3.0,5.0,2.0,1.0,4.0,4.0,1.0,,26.0
Dindori,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Dindori,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Dindori,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Dindori,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Dindori,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,4.0,2.0,1.0,6.0,3.0,,,2.0,1.0,,19.0
Dindori,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,2.0,2.0,6.0,3.0,6.0,2.0,5.0,2.0,1.0,1.0,3.0,34.0
Dindori,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,3.0,3.0,,3.0,,1.0,,,,,,11.0
Dindori,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,5.0,9.0,8.0,7.0,12.0,6.0,5.0,2.0,3.0,2.0,3.0,64.0
Dindori,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Dindori,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Dindori,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Dindori,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,1.0,,,,,,1.0
Dindori,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Dindori,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,3.0,5.0,1.0,,1.0,1.0,2.0,2.0,3.0,1.0,,19.0
Dindori,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,,1.0,,2.0,12.0
Dindori,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,5.0,7.0,2.0,1.0,2.0,2.0,3.0,2.0,4.0,1.0,2.0,32.0
Dindori,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Dindori,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,1.0,3.0,3.0,,,7.0
Dindori,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,2.0,2.0,,,,,6.0,2.0,1.0,,,13.0
Dindori,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,2.0,2.0,,,,,7.0,5.0,4.0,,,20.0
Dindori,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Dindori,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Dindori,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Dindori,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Dindori,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Dindori,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,1.0,,,,,,,,,,,,1.0
Dindori,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Dindori,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,1.0,,,,,,,,,,,,1.0
Dindori,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Dindori,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,2.0,,,,1.0,,,,,,,3.0
Dindori,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Dindori,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,2.0,,,,1.0,,,,,,,3.0
Dindori,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Dindori,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Dindori,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Dindori,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,1.0,,,,,,,,,1.0
Dindori,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Dindori,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,1.0,,,,,,1.0,2.0
Dindori,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Dindori,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,1.0,,,,,,1.0,2.0
Dindori,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Dindori,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,1.0,,3.0,,3.0,,1.0,,,8.0
Dindori,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Dindori,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,1.0,,3.0,,3.0,,1.0,,,8.0
Dindori,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,2.0,,2.0,1.0,1.0,1.0,1.0,,,,1.0,,9.0
Dindori,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,5.0,6.0,8.0,5.0,8.0,9.0,6.0,9.0,3.0,6.0,7.0,14.0,86.0
Dindori,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,3.0,,6.0,1.0,4.0,1.0,3.0,,2.0,3.0,2.0,25.0
Dindori,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,7.0,9.0,10.0,12.0,10.0,14.0,8.0,12.0,3.0,8.0,11.0,16.0,120.0
Dindori,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Dindori,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,2.0,2.0,2.0,1.0,5.0,2.0,1.0,1.0,,3.0,2.0,21.0
Dindori,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,,,1.0,1.0,1.0,,1.0,,2.0,,7.0
Dindori,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,3.0,2.0,2.0,2.0,6.0,3.0,2.0,2.0,,5.0,2.0,29.0
Dindori,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,1.0,,,1.0,1.0,1.0,,,,,4.0
Dindori,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,2.0,4.0,3.0,1.0,2.0,2.0,2.0,,,,1.0,17.0
Dindori,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,1.0,,,2.0,,,,,,,4.0
Dindori,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,3.0,6.0,3.0,1.0,5.0,3.0,3.0,,,,1.0,25.0
Dindori,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,,,,,1.0,,1.0,,,,,3.0
Dindori,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,3.0,3.0,5.0,2.0,8.0,7.0,2.0,2.0,6.0,2.0,5.0,4.0,49.0
Dindori,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,5.0,3.0,7.0,6.0,8.0,19.0,14.0,13.0,13.0,9.0,7.0,10.0,114.0
Dindori,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,9.0,6.0,12.0,8.0,16.0,27.0,16.0,16.0,19.0,11.0,12.0,14.0,166.0
Dindori,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,1.0,,1.0,,1.0,1.0,,,1.0,1.0,6.0
Dindori,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,5.0,4.0,6.0,11.0,7.0,12.0,13.0,13.0,9.0,6.0,12.0,14.0,112.0
Dindori,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,19.0,9.0,15.0,16.0,15.0,28.0,27.0,28.0,23.0,13.0,20.0,28.0,241.0
Dindori,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,24.0,13.0,22.0,27.0,23.0,40.0,41.0,42.0,32.0,19.0,33.0,43.0,359.0
Dindori,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,3.0,4.0,1.0,2.0,5.0,2.0,7.0,3.0,2.0,2.0,3.0,35.0
Dindori,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,16.0,25.0,22.0,14.0,25.0,26.0,27.0,43.0,20.0,14.0,18.0,22.0,272.0
Dindori,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,19.0,42.0,41.0,29.0,25.0,64.0,44.0,67.0,50.0,38.0,36.0,38.0,493.0
Dindori,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,36.0,70.0,67.0,44.0,52.0,95.0,73.0,117.0,73.0,54.0,56.0,63.0,800.0
Guna,1.1,Total number of pregnant women Registered for ANC,TOTAL,2013.0,3113.0,3355.0,3425.0,2898.0,3185.0,3151.0,3195.0,3433.0,3250.0,3506.0,4350.0,38874.0
Guna,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1560.0,2436.0,2686.0,2591.0,2167.0,2417.0,2349.0,2861.0,2665.0,2647.0,2687.0,3351.0,30417.0
Guna,1.2,Number of Pregnant women registered under JSY,TOTAL,1655.0,2827.0,3107.0,3211.0,2664.0,2945.0,2956.0,3011.0,3192.0,3076.0,3181.0,3690.0,35515.0
Guna,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1821.0,2556.0,2712.0,2732.0,2679.0,2781.0,2768.0,2958.0,2907.0,2728.0,2637.0,3601.0,32880.0
Guna,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1759.0,2853.0,3008.0,3221.0,2666.0,2828.0,2854.0,2856.0,3149.0,2928.0,3102.0,3557.0,34781.0
Guna,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1728.0,2329.0,2495.0,2868.0,2516.0,2370.0,2595.0,2658.0,2720.0,2690.0,2888.0,3553.0,31410.0
Guna,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2054.0,2972.0,3289.0,3393.0,2822.0,3019.0,3121.0,3139.0,3376.0,3179.0,3302.0,4198.0,37864.0
Guna,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,71.0,103.0,112.0,79.0,77.0,132.0,70.0,65.0,93.0,72.0,63.0,189.0,1126.0
Guna,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,23.0,29.0,13.0,7.0,21.0,9.0,3.0,1.0,4.0,4.0,9.0,18.0,141.0
Guna,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,504.0,454.0,487.0,576.0,692.0,668.0,662.0,610.0,659.0,544.0,686.0,528.0,7070.0
Guna,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,15.0,40.0,64.0,23.0,21.0,36.0,13.0,11.0,13.0,12.0,11.0,8.0,267.0
Guna,1.8,Number of pregnancy test kits used at SC level,TOTAL,285.0,221.0,193.0,196.0,145.0,153.0,163.0,134.0,312.0,380.0,368.0,563.0,3113.0
Guna,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,2.0,44.0,66.0,70.0,46.0,59.0,56.0,121.0,102.0,104.0,73.0,102.0,845.0
Guna,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,66.0,57.0,62.0,100.0,100.0,171.0,120.0,63.0,49.0,52.0,81.0,84.0,1005.0
Guna,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,68.0,101.0,128.0,170.0,146.0,230.0,176.0,184.0,151.0,156.0,154.0,186.0,1850.0
Guna,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,56.0,86.0,80.0,109.0,118.0,188.0,125.0,150.0,118.0,114.0,87.0,132.0,1363.0
Guna,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,6.0,9.0,11.0,9.0,12.0,6.0,7.0,7.0,2.0,69.0
Guna,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1265.0,1722.0,2124.0,2134.0,2286.0,2315.0,2062.0,2278.0,2114.0,2034.0,1906.0,2308.0,24548.0
Guna,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,220.0,205.0,209.0,206.0,167.0,190.0,157.0,276.0,239.0,206.0,146.0,182.0,2403.0
Guna,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1065.0,1362.0,1530.0,1845.0,1787.0,1915.0,1850.0,2083.0,2032.0,1880.0,1602.0,2149.0,21100.0
Guna,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,574.0,888.0,994.0,1521.0,1156.0,1239.0,1257.0,1178.0,1298.0,1232.0,1025.0,1335.0,13697.0
Guna,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,118.0,125.0,127.0,181.0,136.0,143.0,164.0,159.0,188.0,179.0,160.0,183.0,1863.0
Guna,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,68.0,48.0,57.0,79.0,92.0,57.0,74.0,84.0,113.0,97.0,113.0,199.0,1081.0
Guna,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,0.0,0.0,,,,,,,,0.0
Guna,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,0.0,0.0,,,,,,,,0.0
Guna,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,0.0,0.0,,,,,,,,0.0
Guna,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,5.0
Guna,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,126.0,108.0,108.0,62.0,40.0,68.0,59.0,84.0,55.0,46.0,69.0,71.0,896.0
Guna,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Guna,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,126.0,108.0,109.0,63.0,40.0,69.0,59.0,84.0,57.0,46.0,69.0,71.0,901.0
Guna,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,35.0,20.0,33.0,26.0,41.0,24.0,49.0,21.0,63.0,57.0,77.0,84.0,530.0
Guna,4.1.1.a,Number of male live births,TOTAL,704.0,963.0,1117.0,1315.0,1328.0,1336.0,1166.0,1274.0,1248.0,1211.0,1095.0,1410.0,14167.0
Guna,4.1.1.b,Number of female live births,TOTAL,680.0,882.0,1156.0,1210.0,1170.0,1231.0,1140.0,1226.0,1096.0,1089.0,1043.0,1235.0,13158.0
Guna,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1384.0,1845.0,2273.0,2525.0,2498.0,2567.0,2306.0,2500.0,2344.0,2300.0,2138.0,2645.0,27325.0
Guna,4.1.2,Number of still births,TOTAL,23.0,30.0,33.0,49.0,37.0,38.0,12.0,47.0,36.0,16.0,35.0,48.0,404.0
Guna,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,34.0,38.0,12.0,16.0,26.0,27.0,11.0,24.0,12.0,24.0,16.0,24.0,264.0
Guna,4.2.1,Number of Newborns weighed at birth,TOTAL,1339.0,1744.0,2203.0,2422.0,2427.0,2453.0,2201.0,2438.0,2300.0,2224.0,2107.0,2528.0,26386.0
Guna,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,131.0,180.0,181.0,290.0,253.0,363.0,331.0,234.0,238.0,350.0,280.0,295.0,3126.0
Guna,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1172.0,1788.0,2103.0,2376.0,2315.0,2464.0,2125.0,2376.0,2170.0,2136.0,1979.0,2484.0,25488.0
Guna,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,14.0,10.0,14.0,24.0,15.0,23.0,21.0,21.0,18.0,23.0,13.0,40.0,236.0
Guna,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,1.0,4.0,33.0,0.0,29.0,58.0,16.0,15.0,92.0,53.0,44.0,48.0,393.0
Guna,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,126.0,138.0,137.0,81.0,135.0,12.0,79.0,109.0,57.0,46.0,80.0,106.0,1106.0
Guna,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Guna,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,141.0,152.0,184.0,105.0,179.0,93.0,116.0,145.0,167.0,122.0,137.0,194.0,1735.0
Guna,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,2.0,,4.0,2.0,32.0,4.0,2.0,1.0,1.0,2.0,2.0,2.0,54.0
Guna,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,172.0,172.0,181.0,142.0,129.0,195.0,122.0,234.0,164.0,144.0,166.0,188.0,2009.0
Guna,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,23.0,26.0,27.0,19.0,15.0,24.0,21.0,37.0,32.0,27.0,19.0,36.0,306.0
Guna,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,78.0,69.0,75.0,94.0,76.0,112.0,67.0,91.0,98.0,66.0,79.0,108.0,1013.0
Guna,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,54.0,43.0,49.0,35.0,35.0,33.0,19.0,109.0,103.0,57.0,95.0,108.0,740.0
Guna,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1261.0,1587.0,2162.0,2244.0,2279.0,2282.0,2153.0,2147.0,2070.0,2046.0,1854.0,2230.0,24315.0
Guna,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,515.0,523.0,440.0,577.0,902.0,996.0,1120.0,1383.0,1058.0,1072.0,560.0,593.0,9739.0
Guna,6.3,PNC maternal complications attended,TOTAL,13.0,6.0,42.0,13.0,61.0,49.0,16.0,15.0,25.0,23.0,33.0,18.0,314.0
Guna,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,28.0,35.0,22.0,24.0,12.0,22.0,15.0,31.0,19.0,18.0,20.0,139.0,385.0
Guna,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,2.0,5.0,2.0,1.0,4.0,3.0,2.0,0.0,0.0,0.0,2.0,7.0,28.0
Guna,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,30.0,40.0,24.0,25.0,16.0,25.0,17.0,31.0,19.0,18.0,22.0,146.0,413.0
Guna,7.2,Number of MTPs conducted at Private Facilities,TOTAL,16.0,10.0,6.0,5.0,4.0,1.0,7.0,10.0,5.0,7.0,14.0,10.0,95.0
Guna,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,328.0,124.0,213.0,139.0,291.0,182.0,151.0,42.0,19.0,10.0,22.0,112.0,1633.0
Guna,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,451.0,410.0,350.0,418.0,408.0,360.0,298.0,169.0,116.0,156.0,169.0,261.0,3566.0
Guna,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,779.0,534.0,563.0,557.0,699.0,542.0,449.0,211.0,135.0,166.0,191.0,373.0,5199.0
Guna,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,3.0
Guna,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,4.0,1.0,0.0,0.0,8.0
Guna,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
Guna,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Guna,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,0.0,0.0,0.0,1.0,1.0,0.0,2.0,4.0,1.0,0.0,0.0,10.0
Guna,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,,,0.0,0.0,,,,0.0,0.0,,,0.0
Guna,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,30.0,23.0,14.0,30.0,60.0,54.0,33.0,403.0,484.0,361.0,233.0,0.0,1725.0
Guna,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,42.0,43.0,44.0,131.0,52.0,48.0,50.0,401.0,795.0,601.0,353.0,74.0,2634.0
Guna,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,13.0,19.0,23.0,30.0,9.0,14.0,20.0,384.0,489.0,202.0,172.0,23.0,1398.0
Guna,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Guna,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,85.0,85.0,81.0,191.0,121.0,116.0,103.0,1188.0,1768.0,1164.0,758.0,97.0,5757.0
Guna,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,,,0.0,0.0,,,,0.0,0.0,,,0.0
Guna,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,4.0,0.0,3.0,13.0,10.0,13.0,6.0,14.0,150.0,127.0,41.0,35.0,416.0
Guna,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,2.0,8.0,5.0,3.0,6.0,0.0,2.0,2.0,2.0,5.0,4.0,39.0
Guna,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Guna,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,4.0,2.0,11.0,18.0,13.0,19.0,6.0,16.0,152.0,129.0,46.0,39.0,455.0
Guna,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,1.0,3.0,3.0,2.0,1.0,2.0,5.0,5.0,5.0,0.0,,,27.0
Guna,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,2.0,7.0,4.0,11.0,8.0,6.0,1.0,16.0,12.0,22.0,15.0,16.0,120.0
Guna,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,18.0,11.0,21.0,15.0,12.0,18.0,11.0,13.0,13.0,8.0,7.0,2.0,149.0
Guna,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Guna,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,20.0,18.0,25.0,26.0,20.0,24.0,12.0,29.0,25.0,30.0,22.0,18.0,269.0
Guna,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,6.0,8.0,6.0,4.0,3.0,5.0,7.0,6.0,4.0,6.0,6.0,4.0,65.0
Guna,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,236.0,253.0,263.0,252.0,226.0,181.0,169.0,232.0,276.0,199.0,221.0,187.0,2695.0
Guna,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,9.0,17.0,25.0,26.0,32.0,69.0,70.0,84.0,62.0,27.0,7.0,60.0,488.0
Guna,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,8.0,55.0,83.0,80.0,93.0,61.0,58.0,62.0,48.0,41.0,33.0,29.0,651.0
Guna,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,44.0,81.0,56.0,110.0,88.0,72.0,112.0,125.0,104.0,109.0,82.0,94.0,1077.0
Guna,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Guna,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,297.0,406.0,427.0,468.0,439.0,383.0,409.0,503.0,490.0,376.0,343.0,370.0,4911.0
Guna,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,50.0,97.0,98.0,105.0,85.0,206.0,269.0,226.0,185.0,127.0,86.0,348.0,1882.0
Guna,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,9.06,Number of IUCD removals,TOTAL,100.0,207.0,80.0,141.0,109.0,130.0,115.0,164.0,209.0,154.0,106.0,131.0,1646.0
Guna,9.07,Number of Oral Pills cycles distributed,TOTAL,4930.0,5227.0,5438.0,5677.0,6499.0,6031.0,6583.0,7069.0,7369.0,6944.0,6145.0,5860.0,73772.0
Guna,9.08,Number of Condom pieces distributed,TOTAL,15102.0,16596.0,13793.0,14585.0,13716.0,13731.0,14101.0,16463.0,15385.0,14743.0,15817.0,13758.0,177790.0
Guna,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,14.0,3.0,8.0,2.0,9.0,6.0,17.0,32.0,28.0,32.0,19.0,0.0,170.0
Guna,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,1.0,0.0,0.0,1.0,1.0,0.0,0.0,2.0,23.0,0.0,0.0,4.0,32.0
Guna,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,9.12,Number of Institutions having NSV trained doctors,TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,6.0,5.0,5.0,4.0,-1.0
Guna,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1307.0,1790.0,2205.0,2434.0,2383.0,2498.0,2220.0,2398.0,2201.0,2091.0,1972.0,2297.0,25796.0
Guna,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1583.0,2167.0,2354.0,2399.0,2193.0,2695.0,2750.0,1451.0,224.0,77.0,85.0,59.0,18037.0
Guna,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1620.0,2091.0,2218.0,2342.0,2162.0,2313.0,2399.0,2370.0,1717.0,342.0,138.0,129.0,19841.0
Guna,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1679.0,2204.0,2167.0,2281.0,2088.0,2349.0,2197.0,2387.0,2522.0,1390.0,472.0,295.0,22031.0
Guna,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1352.0,2295.0,2370.0,2410.0,3203.0,11630.0
Guna,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1227.0,1885.0,2221.0,3143.0,8476.0
Guna,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,965.0,1727.0,2953.0,5651.0
Guna,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1262.0,1752.0,2151.0,2332.0,2315.0,2428.0,2126.0,2295.0,2099.0,2027.0,1928.0,2260.0,24975.0
Guna,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1583.0,2167.0,2354.0,2399.0,2193.0,2695.0,2760.0,2432.0,2507.0,2465.0,2505.0,3157.0,29217.0
Guna,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1620.0,2091.0,2218.0,2342.0,2160.0,2313.0,2399.0,2356.0,2646.0,2238.0,2363.0,3150.0,27896.0
Guna,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1681.0,2206.0,2167.0,2281.0,2090.0,2349.0,2197.0,2380.0,2547.0,2229.0,2117.0,3078.0,27322.0
Guna,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1284.0,1744.0,2137.0,2352.0,2320.0,2422.0,2136.0,2262.0,2049.0,1954.0,1775.0,2233.0,24668.0
Guna,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1583.0,2167.0,2352.0,2399.0,2193.0,2695.0,2750.0,1577.0,501.0,60.0,54.0,70.0,18401.0
Guna,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1620.0,2103.0,2219.0,2342.0,2162.0,2313.0,2399.0,2592.0,1844.0,319.0,110.0,190.0,20213.0
Guna,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1679.0,2191.0,2168.0,2281.0,2088.0,2349.0,2197.0,2393.0,2470.0,1343.0,462.0,358.0,21979.0
Guna,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1418.0,1926.0,2291.0,2394.0,2214.0,2519.0,2399.0,2489.0,2348.0,2399.0,2243.0,2644.0,27284.0
Guna,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1187.0,1649.0,1833.0,2238.0,2529.0,1806.0,1761.0,1864.0,1990.0,1672.0,1960.0,2303.0,22792.0
Guna,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,722.0,1000.0,1198.0,1242.0,1086.0,1262.0,1166.0,1273.0,1087.0,1204.0,1102.0,1264.0,13606.0
Guna,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,682.0,931.0,1093.0,1153.0,1079.0,1185.0,1180.0,1234.0,1075.0,1150.0,1100.0,1165.0,13027.0
Guna,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1404.0,1931.0,2291.0,2395.0,2165.0,2447.0,2346.0,2507.0,2162.0,2354.0,2202.0,2429.0,26633.0
Guna,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1244.0,1643.0,1941.0,2261.0,1786.0,1816.0,1795.0,2094.0,1996.0,1728.0,1979.0,2513.0,22796.0
Guna,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1244.0,1643.0,1941.0,2261.0,1786.0,1816.0,1795.0,2091.0,1996.0,1726.0,1979.0,2513.0,22791.0
Guna,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,299.0,401.0,402.0,370.0,280.0,310.0,262.0,509.0,377.0,342.0,369.0,412.0,4333.0
Guna,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,272.0,375.0,390.0,364.0,319.0,351.0,294.0,562.0,387.0,325.0,371.0,400.0,4410.0
Guna,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,571.0,776.0,792.0,734.0,599.0,661.0,556.0,1071.0,764.0,667.0,740.0,812.0,8743.0
Guna,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,666.0,771.0,899.0,1130.0,818.0,933.0,918.0,947.0,1096.0,1415.0,1120.0,1475.0,12188.0
Guna,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1165.0,1568.0,1932.0,2246.0,1605.0,1845.0,1742.0,1706.0,1765.0,2054.0,1696.0,2123.0,21447.0
Guna,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1166.0,1621.0,2026.0,2368.0,1748.0,2034.0,1666.0,1804.0,1636.0,1951.0,2011.0,2240.0,22271.0
Guna,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
Guna,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,13.0,14.0,14.0,22.0,37.0,50.0,6.0,2.0,2.0,3.0,4.0,2.0,169.0
Guna,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1128.0,1356.0,1393.0,1424.0,1385.0,1359.0,1369.0,1401.0,1485.0,1442.0,1384.0,1580.0,16706.0
Guna,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1107.0,1348.0,1391.0,1426.0,1368.0,1380.0,1366.0,1405.0,1502.0,1438.0,1380.0,1575.0,16686.0
Guna,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,798.0,975.0,1043.0,1051.0,1022.0,1050.0,1000.0,1054.0,1099.0,1083.0,1035.0,1192.0,12402.0
Guna,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1442.0,1919.0,2289.0,2400.0,2210.0,2476.0,2391.0,2506.0,2345.0,2393.0,2237.0,2630.0,27238.0
Guna,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,557.0,945.0,962.0,4667.0,2108.0,1363.0,1227.0,1268.0,1197.0,6275.0,3271.0,1634.0,25474.0
Guna,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,413.0,747.0,830.0,7240.0,3204.0,710.0,838.0,1086.0,747.0,6473.0,3226.0,1087.0,26601.0
Guna,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Guna,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Guna,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,182.0,236.0,435.0,329.0,456.0,529.0,337.0,232.0,220.0,246.0,271.0,390.0,3863.0
Guna,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,10.0,10.0,4.0,2.0,4.0,3.0,5.0,7.0,113.0,6.0,5.0,2.0,171.0
Guna,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,12.0,32.0,42.0,36.0,59.0,55.0,68.0,59.0,46.0,41.0,96.0,91.0,637.0
Guna,13.1,Number of Patients operated for cataract,TOTAL,52.0,78.0,67.0,98.0,78.0,137.0,158.0,741.0,784.0,454.0,641.0,1240.0,4528.0
Guna,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,49.0,65.0,67.0,98.0,70.0,137.0,121.0,716.0,517.0,244.0,347.0,1240.0,3671.0
Guna,13.3,Number of School children detected with Refractive errors,TOTAL,29.0,28.0,30.0,59.0,100.0,157.0,76.0,888.0,532.0,96.0,143.0,60.0,2198.0
Guna,13.4,Number of children provided free glasses,TOTAL,15.0,22.0,2.0,8.0,29.0,9.0,30.0,918.0,144.0,63.0,142.0,129.0,1511.0
Guna,13.5,Number of eyes collected through eye donation,TOTAL,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Guna,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,2.0,2.0,2.0,2.0,2.0,2.0,4.0,3.0,3.0,2.0,3.0,-1.0
Guna,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,4.0,6.0,6.0,6.0,6.0,6.0,6.0,12.0,6.0,6.0,6.0,9.0,-1.0
Guna,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,742.0,948.0,1013.0,973.0,931.0,971.0,947.0,1038.0,1007.0,956.0,1035.0,1295.0,-1.0
Guna,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,1.0,3.0,2.0,2.0,3.0,3.0,3.0,5.0,4.0,3.0,4.0,4.0,-1.0
Guna,14.05,Number of RKS meetings held during the month,TOTAL,2.0,3.0,1.0,1.0,2.0,1.0,1.0,4.0,1.0,11.0,2.0,1.0,30.0
Guna,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,6.0,8.0,6.0,7.0,6.0,7.0,7.0,13.0,8.0,7.0,8.0,10.0,-1.0
Guna,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,288.0,327.0,347.0,517.0,395.0,307.0,325.0,691.0,396.0,419.0,505.0,611.0,5128.0
Guna,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,4.0,4.0,4.0,3.0,4.0,4.0,4.0,3.0,4.0,3.0,3.0,-1.0
Guna,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,6.0,1.0,1.0,1.0,1.0,-1.0
Guna,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,268.0,240.0,279.0,480.0,370.0,266.0,332.0,235.0,360.0,266.0,695.0,582.0,4373.0
Guna,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2051.0,2611.0,2366.0,1944.0,2299.0,2639.0,2013.0,2003.0,1902.0,1226.0,1712.0,2071.0,24837.0
Guna,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,331.0,336.0,310.0,653.0,393.0,334.0,303.0,193.0,278.0,236.0,407.0,526.0,4300.0
Guna,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2423.0,3326.0,3196.0,2898.0,3832.0,3321.0,3552.0,3824.0,3180.0,2677.0,3094.0,2654.0,37977.0
Guna,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,599.0,576.0,589.0,1133.0,763.0,600.0,635.0,428.0,638.0,502.0,1102.0,1108.0,8673.0
Guna,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4474.0,5937.0,5562.0,4842.0,6131.0,5960.0,5565.0,5827.0,5082.0,3903.0,4806.0,4725.0,62814.0
Guna,14.10.2.a,Number of death cases of Inpatient males,TOTAL,20.0,39.0,24.0,1.0,41.0,29.0,47.0,33.0,26.0,23.0,19.0,16.0,318.0
Guna,14.10.2.b,Number of death cases of Inpatient females,TOTAL,15.0,17.0,12.0,0.0,17.0,24.0,22.0,17.0,62.0,14.0,6.0,14.0,220.0
Guna,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,35.0,56.0,36.0,1.0,58.0,53.0,69.0,50.0,88.0,37.0,25.0,30.0,538.0
Guna,14.11,In-Patient Head Count at midnight,TOTAL,4558.0,4057.0,5050.0,6901.0,5742.0,7727.0,4316.0,4647.0,6107.0,5417.0,6561.0,6940.0,68023.0
Guna,14.12.1,OPD attendance (All),TOTAL,36854.0,43745.0,50237.0,50913.0,61820.0,69931.0,59435.0,58670.0,52622.0,49518.0,59205.0,63015.0,655965.0
Guna,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,285.0,301.0,316.0,242.0,340.0,351.0,307.0,428.0,253.0,302.0,270.0,236.0,3631.0
Guna,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,43.0,48.0,54.0,46.0,64.0,45.0,49.0,108.0,64.0,80.0,119.0,61.0,781.0
Guna,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,65.0,145.0,106.0,100.0,116.0,117.0,73.0,229.0,764.0,502.0,250.0,236.0,2703.0
Guna,14.14.a,Number of patients given AYUSH treatment,TOTAL,1156.0,2026.0,2053.0,3120.0,5581.0,1567.0,2273.0,2844.0,2242.0,2411.0,3316.0,944.0,29533.0
Guna,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,778.0,644.0,741.0,645.0,674.0,1013.0,723.0,689.0,699.0,1422.0,1422.0,966.0,10416.0
Guna,14.14.c,Number of Adolescents counselled,TOTAL,310.0,220.0,314.0,664.0,523.0,619.0,376.0,420.0,927.0,672.0,549.0,499.0,6093.0
Guna,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4182.0,5869.0,6453.0,6418.0,4874.0,8115.0,6649.0,7116.0,7619.0,6728.0,6241.0,7440.0,77704.0
Guna,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,143.0,157.0,205.0,251.0,238.0,181.0,119.0,157.0,164.0,136.0,462.0,103.0,2316.0
Guna,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,138.0,148.0,132.0,307.0,231.0,149.0,216.0,138.0,177.0,139.0,327.0,461.0,2563.0
Guna,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,283.0,187.0,203.0,286.0,221.0,185.0,215.0,533.0,198.0,209.0,162.0,329.0,3011.0
Guna,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,729.0,697.0,1032.0,953.0,1075.0,1025.0,1260.0,1004.0,1435.0,747.0,859.0,1323.0,12139.0
Guna,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1150.0,1032.0,1367.0,1546.0,1527.0,1359.0,1691.0,1675.0,1810.0,1095.0,1348.0,2113.0,17713.0
Guna,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,15.2,Number of Widal tests conducted,Number tested,902.0,1066.0,1072.0,1176.0,2076.0,3088.0,2821.0,1969.0,1316.0,818.0,876.0,2004.0,19184.0
Guna,15.3.a,Number of VDRL tests conducted on males,Number tested,57.0,71.0,122.0,76.0,59.0,54.0,372.0,95.0,135.0,82.0,115.0,117.0,1355.0
Guna,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,229.0,269.0,262.0,369.0,338.0,347.0,319.0,224.0,182.0,108.0,165.0,128.0,2940.0
Guna,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,318.0,518.0,702.0,902.0,814.0,1068.0,637.0,1421.0,606.0,867.0,462.0,812.0,9127.0
Guna,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,604.0,858.0,1086.0,1347.0,1211.0,1469.0,1328.0,1740.0,923.0,1057.0,742.0,1057.0,13422.0
Guna,15.4.1,Number of blood smears examined for Malaria,TOTAL,4146.0,8996.0,11924.0,16415.0,14011.0,19454.0,17248.0,12650.0,9535.0,8905.0,5565.0,9441.0,138290.0
Guna,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,76.0,26.0,92.0,190.0,132.0,186.0,323.0,99.0,46.0,51.0,11.0,650.0,1882.0
Guna,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,4.0,3.0,2.0,6.0,2.0,19.0,64.0,32.0,21.0,5.0,3.0,1.0,162.0
Guna,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Guna,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Guna,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Guna,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Guna,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Guna,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Guna,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Guna,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Guna,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Guna,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Guna,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Guna,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Guna,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Guna,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Guna,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Guna,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Guna,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Guna,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Guna,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Guna,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Guna,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Guna,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Guna,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Guna,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Guna,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Guna,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Guna,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Guna,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Guna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Guna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Guna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Guna,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Guna,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Guna,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Guna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Guna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Guna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Guna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Guna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Guna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Guna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Guna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Guna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Guna,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Guna,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Guna,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Guna,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Guna,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Guna,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Guna,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Guna,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Guna,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Guna,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Guna,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Guna,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Guna,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Guna,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Guna,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Guna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Guna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Guna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Guna,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Guna,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Guna,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Guna,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Guna,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Guna,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Guna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Guna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Guna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Guna,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Guna,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Guna,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Guna,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Guna,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Guna,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Guna,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Guna,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Guna,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Guna,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Guna,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Guna,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Guna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Guna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Guna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Guna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Guna,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,3.0,2.0,4.0,4.0,5.0,,2.0,6.0,8.0,4.0,3.0,5.0,46.0
Guna,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,2.0,6.0,5.0,6.0,1.0,1.0,1.0,5.0,,,1.0,29.0
Guna,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,3.0,4.0,2.0,6.0,3.0,1.0,3.0,2.0,1.0,1.0,2.0,5.0,33.0
Guna,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,4.0,6.0,8.0,11.0,9.0,2.0,4.0,3.0,6.0,1.0,2.0,6.0,62.0
Guna,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,1.0,2.0,4.0,4.0,,,1.0,,3.0,,,16.0
Guna,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,3.0,2.0,1.0,,1.0,,,1.0,,2.0,10.0
Guna,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,1.0,5.0,6.0,5.0,,1.0,1.0,,4.0,,2.0,26.0
Guna,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,5.0,4.0,6.0,8.0,9.0,5.0,9.0,9.0,10.0,16.0,15.0,10.0,106.0
Guna,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,3.0,6.0,,3.0,1.0,2.0,3.0,2.0,,2.0,1.0,2.0,25.0
Guna,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,8.0,10.0,6.0,11.0,10.0,7.0,12.0,11.0,10.0,18.0,16.0,12.0,131.0
Guna,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,6.0,3.0,4.0,4.0,5.0,,7.0,1.0,3.0,2.0,35.0
Guna,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,,4.0,,1.0,,,,,1.0,7.0
Guna,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,6.0,3.0,8.0,4.0,6.0,,7.0,1.0,3.0,3.0,42.0
Guna,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,1.0,,,,,2.0,,4.0,,7.0
Guna,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,1.0,1.0,,,,,,,2.0
Guna,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,1.0,1.0,1.0,,,2.0,,4.0,,9.0
Guna,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Guna,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Guna,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,1.0,,,,1.0
Guna,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,2.0,,1.0,,,,,,,1.0,5.0
Guna,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,1.0,,,1.0,1.0,,1.0,,4.0
Guna,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,1.0,2.0,,2.0,,,1.0,1.0,,1.0,1.0,9.0
Guna,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Guna,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Guna,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Guna,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,9.0,11.0,14.0,13.0,11.0,8.0,7.0,9.0,7.0,12.0,7.0,7.0,115.0
Guna,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,,,1.0,,,,,1.0,,4.0,7.0
Guna,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,9.0,12.0,14.0,13.0,12.0,8.0,7.0,9.0,7.0,13.0,7.0,11.0,122.0
Guna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Guna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Guna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Guna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Guna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Guna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Guna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Guna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,1.0,1.0
Guna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Guna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Guna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Guna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,1.0,1.0
Guna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Guna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Guna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Guna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Guna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Guna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Guna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Guna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Guna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Guna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Guna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Guna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Guna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Guna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,1.0,1.0,,,,,,,,,,2.0
Guna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Guna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,1.0,1.0,,,,,,,,,,2.0
Guna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Guna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Guna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Guna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Guna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Guna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,2.0,,,,,1.0,,,3.0
Guna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Guna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,2.0,,,,,1.0,,,3.0
Guna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Guna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Guna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Guna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Guna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Guna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,1.0,2.0,,,1.0,,,,,,1.0,6.0
Guna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Guna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,1.0,2.0,,,1.0,,,,,,1.0,6.0
Guna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Guna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,,,1.0,,1.0,2.0,,1.0,,,6.0
Guna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Guna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,,,1.0,,1.0,2.0,,1.0,,,6.0
Guna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Guna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,1.0,,,1.0,,,2.0
Guna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Guna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,1.0,,,1.0,,,2.0
Guna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Guna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,,1.0,2.0,1.0,,3.0,3.0,1.0,1.0,1.0,1.0,16.0
Guna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Guna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,,1.0,2.0,1.0,,3.0,3.0,1.0,1.0,1.0,1.0,16.0
Guna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Guna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,3.0,,1.0,1.0,,,,,,1.0,6.0
Guna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Guna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,3.0,,1.0,1.0,,,,,,3.0,8.0
Guna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Guna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,1.0,2.0,,,,,1.0,,,,,4.0
Guna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Guna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,1.0,2.0,,,,,1.0,,,,,4.0
Guna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Guna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Guna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Guna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Guna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Guna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Guna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Guna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,1.0,,1.0
Guna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Guna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Guna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Guna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Guna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,2.0,1.0,4.0,4.0,2.0,1.0,,1.0,1.0,1.0,,17.0
Guna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,7.0,11.0,13.0,13.0,6.0,8.0,9.0,,3.0,5.0,5.0,80.0
Guna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,12.0,6.0,13.0,16.0,3.0,1.0,5.0,,6.0,13.0,14.0,90.0
Guna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,1.0,21.0,18.0,30.0,33.0,11.0,10.0,14.0,1.0,10.0,19.0,19.0,187.0
Gwalior,1.1,Total number of pregnant women Registered for ANC,TOTAL,3285.0,5398.0,5221.0,4651.0,4354.0,4052.0,3343.0,4549.0,4551.0,3947.0,6004.0,5401.0,54756.0
Gwalior,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1815.0,2645.0,2756.0,2783.0,2755.0,1788.0,1351.0,1554.0,1599.0,1362.0,1709.0,2189.0,24306.0
Gwalior,1.2,Number of Pregnant women registered under JSY,TOTAL,2392.0,3947.0,4497.0,3835.0,4046.0,3607.0,3990.0,3071.0,2674.0,3129.0,3673.0,4756.0,43617.0
Gwalior,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2297.0,3563.0,3599.0,3190.0,3258.0,2980.0,2978.0,2899.0,2559.0,2694.0,2879.0,3546.0,36442.0
Gwalior,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2710.0,3955.0,3826.0,3832.0,3511.0,2937.0,2851.0,3421.0,2814.0,3186.0,3447.0,4050.0,40540.0
Gwalior,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2511.0,3511.0,3959.0,3803.0,3386.0,2970.0,3103.0,3231.0,2923.0,2889.0,3290.0,4080.0,39656.0
Gwalior,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3163.0,4683.0,4116.0,4953.0,5010.0,3971.0,4352.0,3483.0,8568.0,8102.0,5892.0,5837.0,62130.0
Gwalior,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,243.0,228.0,227.0,348.0,276.0,310.0,275.0,282.0,230.0,309.0,379.0,296.0,3403.0
Gwalior,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,20.0,12.0,22.0,30.0,22.0,9.0,8.0,12.0,6.0,28.0,12.0,14.0,195.0
Gwalior,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1807.0,3104.0,2739.0,2367.0,2780.0,2527.0,2170.0,2971.0,2816.0,2744.0,3277.0,3396.0,32698.0
Gwalior,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,66.0,137.0,165.0,283.0,206.0,132.0,63.0,100.0,149.0,146.0,101.0,206.0,1754.0
Gwalior,1.8,Number of pregnancy test kits used at SC level,TOTAL,269.0,224.0,246.0,308.0,494.0,418.0,227.0,336.0,403.0,486.0,675.0,769.0,4855.0
Gwalior,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,34.0,31.0,78.0,57.0,59.0,59.0,47.0,49.0,37.0,28.0,0.0,0.0,479.0
Gwalior,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,47.0,51.0,36.0,50.0,73.0,127.0,107.0,125.0,141.0,181.0,168.0,149.0,1255.0
Gwalior,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,81.0,82.0,114.0,107.0,132.0,186.0,154.0,174.0,178.0,209.0,168.0,149.0,1734.0
Gwalior,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,58.0,73.0,86.0,70.0,111.0,151.0,114.0,135.0,135.0,103.0,82.0,84.0,1202.0
Gwalior,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Gwalior,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1559.0,1882.0,2243.0,2351.0,2974.0,2933.0,2662.0,2644.0,2310.0,2474.0,2162.0,2304.0,28498.0
Gwalior,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,350.0,258.0,86.0,102.0,295.0,150.0,156.0,118.0,114.0,90.0,226.0,444.0,2389.0
Gwalior,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,589.0,1269.0,1840.0,1865.0,2355.0,2624.0,2430.0,2499.0,2135.0,2243.0,1999.0,2397.0,24245.0
Gwalior,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,150.0,477.0,1144.0,899.0,1039.0,1140.0,1093.0,1131.0,976.0,1274.0,1215.0,2094.0,12632.0
Gwalior,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,598.0,812.0,840.0,888.0,1047.0,697.0,852.0,800.0,704.0,668.0,705.0,545.0,9156.0
Gwalior,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Gwalior,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Gwalior,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Gwalior,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,227.0,269.0,261.0,265.0,343.0,332.0,309.0,281.0,261.0,323.0,277.0,251.0,3399.0
Gwalior,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gwalior,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,227.0,269.0,261.0,265.0,343.0,332.0,309.0,281.0,261.0,323.0,277.0,251.0,3399.0
Gwalior,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,300.0,447.0,452.0,498.0,559.0,360.0,453.0,440.0,409.0,346.0,387.0,307.0,4958.0
Gwalior,4.1.1.a,Number of male live births,TOTAL,1200.0,1476.0,1727.0,1727.0,2142.0,1962.0,1847.0,1847.0,1630.0,1742.0,1635.0,1583.0,20518.0
Gwalior,4.1.1.b,Number of female live births,TOTAL,1009.0,1255.0,1431.0,1550.0,1933.0,1790.0,1758.0,1704.0,1517.0,1558.0,1329.0,1388.0,18222.0
Gwalior,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2209.0,2731.0,3158.0,3277.0,4075.0,3752.0,3605.0,3551.0,3147.0,3300.0,2964.0,2971.0,38740.0
Gwalior,4.1.2,Number of still births,TOTAL,34.0,49.0,55.0,93.0,95.0,59.0,84.0,92.0,62.0,62.0,84.0,40.0,809.0
Gwalior,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,88.0,126.0,105.0,136.0,113.0,42.0,5.0,65.0,20.0,67.0,164.0,73.0,1004.0
Gwalior,4.2.1,Number of Newborns weighed at birth,TOTAL,2147.0,2513.0,2943.0,3118.0,3915.0,3404.0,2636.0,2648.0,2395.0,3019.0,2618.0,2748.0,34104.0
Gwalior,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,263.0,386.0,314.0,447.0,672.0,602.0,596.0,552.0,260.0,434.0,404.0,553.0,5483.0
Gwalior,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1537.0,2244.0,2840.0,3139.0,3710.0,3473.0,2483.0,2442.0,1806.0,2306.0,1885.0,2565.0,30430.0
Gwalior,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,3.0,9.0,0.0,0.0,0.0,78.0,21.0,0.0,0.0,0.0,111.0
Gwalior,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,27.0,25.0,39.0,91.0,55.0,53.0,60.0,58.0,28.0,37.0,23.0,32.0,528.0
Gwalior,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,105.0,484.0,537.0,327.0,293.0,356.0,208.0,318.0,201.0,253.0,286.0,308.0,3676.0
Gwalior,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gwalior,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,132.0,509.0,579.0,427.0,348.0,409.0,268.0,454.0,250.0,290.0,309.0,340.0,4315.0
Gwalior,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,44.0,35.0,66.0,,,,,,,,,,145.0
Gwalior,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,62.0,178.0,211.0,120.0,122.0,190.0,238.0,270.0,239.0,282.0,358.0,232.0,2502.0
Gwalior,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,6.0,8.0,35.0,5.0,18.0,10.0,14.0,10.0,12.0,36.0,42.0,53.0,249.0
Gwalior,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,152.0,96.0,135.0,56.0,59.0,84.0,37.0,74.0,77.0,96.0,222.0,37.0,1125.0
Gwalior,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,139.0,184.0,227.0,204.0,167.0,255.0,208.0,177.0,197.0,142.0,131.0,1.0,2032.0
Gwalior,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1509.0,1833.0,2221.0,2399.0,3055.0,2770.0,2002.0,2421.0,1873.0,3023.0,2057.0,1964.0,27127.0
Gwalior,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1243.0,1210.0,1484.0,1368.0,1815.0,1498.0,1363.0,1328.0,1078.0,1477.0,1502.0,1323.0,16689.0
Gwalior,6.3,PNC maternal complications attended,TOTAL,32.0,17.0,39.0,26.0,35.0,73.0,45.0,93.0,50.0,35.0,31.0,66.0,542.0
Gwalior,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,30.0,41.0,51.0,61.0,56.0,74.0,49.0,73.0,81.0,122.0,174.0,159.0,971.0
Gwalior,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,3.0,5.0,5.0,18.0
Gwalior,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,33.0,41.0,51.0,61.0,56.0,74.0,49.0,75.0,81.0,125.0,179.0,164.0,989.0
Gwalior,7.2,Number of MTPs conducted at Private Facilities,TOTAL,91.0,157.0,199.0,183.0,180.0,93.0,57.0,154.0,0.0,54.0,86.0,65.0,1319.0
Gwalior,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,166.0,286.0,258.0,156.0,182.0,320.0,483.0,243.0,215.0,118.0,121.0,38.0,2586.0
Gwalior,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,973.0,1346.0,766.0,421.0,518.0,799.0,1267.0,1031.0,1034.0,275.0,1159.0,577.0,10166.0
Gwalior,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1139.0,1632.0,1024.0,577.0,700.0,1119.0,1750.0,1274.0,1249.0,393.0,1280.0,615.0,12752.0
Gwalior,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,20.0,24.0,0.0,0.0,0.0,0.0,0.0,310.0,0.0,0.0,103.0,46.0,503.0
Gwalior,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,1.0,2.0,1.0,3.0,10.0
Gwalior,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,3.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,3.0,8.0,0.0,9.0,27.0
Gwalior,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,4.0,3.0,7.0,8.0,31.0,2.0,1.0,5.0,9.0,0.0,1.0,72.0
Gwalior,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gwalior,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,4.0,5.0,3.0,7.0,9.0,31.0,3.0,5.0,9.0,19.0,1.0,13.0,109.0
Gwalior,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,,0.0,0.0,0.0,4.0
Gwalior,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,21.0,9.0,16.0,18.0,56.0,28.0,9.0,416.0,572.0,284.0,419.0,198.0,2046.0
Gwalior,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,64.0,72.0,32.0,25.0,45.0,73.0,24.0,126.0,442.0,353.0,473.0,360.0,2089.0
Gwalior,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,25.0,19.0,18.0,17.0,15.0,15.0,10.0,266.0,539.0,329.0,363.0,181.0,1797.0
Gwalior,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gwalior,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,110.0,100.0,66.0,60.0,116.0,116.0,43.0,808.0,1553.0,966.0,1255.0,739.0,5932.0
Gwalior,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,17.0,30.0,64.0,47.0,39.0,21.0,54.0,89.0,,3.0,22.0,5.0,391.0
Gwalior,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,1.0,9.0,9.0,3.0,29.0,48.0,101.0
Gwalior,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,6.0,3.0,26.0,23.0,4.0,7.0,0.0,4.0,0.0,10.0,0.0,83.0
Gwalior,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gwalior,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,6.0,3.0,26.0,23.0,6.0,8.0,9.0,13.0,3.0,39.0,48.0,184.0
Gwalior,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,19.0,20.0,14.0,35.0,33.0,,,,,7.0,,0.0,128.0
Gwalior,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,6.0,18.0,11.0,13.0,11.0,19.0,8.0,16.0,14.0,12.0,5.0,71.0,204.0
Gwalior,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,24.0,21.0,17.0,2.0,6.0,31.0,33.0,17.0,44.0,12.0,14.0,2.0,223.0
Gwalior,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gwalior,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,30.0,39.0,28.0,15.0,17.0,50.0,41.0,33.0,58.0,24.0,19.0,73.0,427.0
Gwalior,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,6.0,22.0,,27.0,25.0,18.0,19.0,17.0,,17.0,7.0,7.0,165.0
Gwalior,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,227.0,322.0,389.0,438.0,421.0,452.0,413.0,289.0,245.0,196.0,241.0,195.0,3828.0
Gwalior,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,17.0,20.0,71.0,65.0,52.0,49.0,27.0,57.0,25.0,21.0,29.0,48.0,481.0
Gwalior,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,58.0,192.0,200.0,284.0,259.0,320.0,239.0,388.0,195.0,94.0,175.0,375.0,2779.0
Gwalior,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,146.0,177.0,203.0,98.0,160.0,236.0,201.0,220.0,15.0,220.0,196.0,251.0,2123.0
Gwalior,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gwalior,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,448.0,711.0,863.0,885.0,892.0,1057.0,880.0,954.0,480.0,531.0,641.0,869.0,9211.0
Gwalior,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,96.0,247.0,297.0,256.0,251.0,312.0,290.0,438.0,74.0,285.0,282.0,219.0,3047.0
Gwalior,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,26.0,47.0,31.0,53.0,54.0,6.0,6.0,31.0,,10.0,12.0,9.0,285.0
Gwalior,9.06,Number of IUCD removals,TOTAL,158.0,189.0,171.0,260.0,200.0,227.0,320.0,525.0,524.0,353.0,271.0,771.0,3969.0
Gwalior,9.07,Number of Oral Pills cycles distributed,TOTAL,3849.0,5428.0,5109.0,4385.0,3234.0,3755.0,4066.0,3787.0,6369.0,3932.0,4307.0,8223.0,56444.0
Gwalior,9.08,Number of Condom pieces distributed,TOTAL,12056.0,32812.0,43227.0,37370.0,16493.0,23950.0,17071.0,12847.0,30637.0,15499.0,40893.0,30516.0,313371.0
Gwalior,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,2.0,12.0,25.0,3.0,2.0,29.0,35.0,54.0,54.0,58.0,74.0,320.0,668.0
Gwalior,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,3.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Gwalior,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,5.0,2.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,10.0
Gwalior,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Gwalior,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,9.12,Number of Institutions having NSV trained doctors,TOTAL,5.0,5.0,5.0,5.0,4.0,5.0,3.0,3.0,3.0,4.0,4.0,4.0,-1.0
Gwalior,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2585.0,3184.0,3391.0,3384.0,3470.0,3895.0,3043.0,3781.0,2522.0,3220.0,3509.0,3310.0,39294.0
Gwalior,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2501.0,3041.0,3143.0,3124.0,2943.0,3668.0,3272.0,1644.0,699.0,424.0,499.0,109.0,25067.0
Gwalior,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2810.0,3102.0,3105.0,3113.0,2868.0,3200.0,2891.0,3261.0,1697.0,739.0,673.0,261.0,27720.0
Gwalior,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2830.0,3374.0,3246.0,3089.0,2792.0,3017.0,2596.0,2847.0,4242.0,1467.0,990.0,435.0,30925.0
Gwalior,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1883.0,2865.0,2491.0,3097.0,3659.0,13995.0
Gwalior,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1871.0,2546.0,3077.0,3695.0,11189.0
Gwalior,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,91.0,1546.0,2623.0,3492.0,7752.0
Gwalior,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2057.0,2460.0,2775.0,2798.0,2806.0,3340.0,3092.0,3246.0,1795.0,2850.0,2721.0,2711.0,32651.0
Gwalior,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2498.0,3039.0,3058.0,3060.0,2877.0,3700.0,3141.0,3316.0,2673.0,2655.0,3696.0,3585.0,37298.0
Gwalior,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2707.0,3124.0,3081.0,3102.0,2871.0,3232.0,2845.0,3518.0,2865.0,2648.0,3317.0,3840.0,37150.0
Gwalior,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2824.0,3241.0,3269.0,3094.0,2788.0,3156.0,2561.0,3056.0,2510.0,2365.0,3018.0,3691.0,35573.0
Gwalior,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1801.0,2043.0,2482.0,2198.0,2244.0,2678.0,2071.0,1827.0,1680.0,1763.0,1912.0,1449.0,24148.0
Gwalior,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2540.0,2941.0,3174.0,2998.0,2859.0,3628.0,3103.0,1871.0,651.0,665.0,471.0,512.0,25413.0
Gwalior,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2775.0,3068.0,3861.0,3043.0,2836.0,3203.0,2738.0,3381.0,1609.0,824.0,487.0,598.0,28423.0
Gwalior,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2840.0,3136.0,3241.0,3019.0,2735.0,3030.0,2479.0,3047.0,2748.0,1615.0,1075.0,866.0,29831.0
Gwalior,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2425.0,3214.0,3394.0,3626.0,3176.0,3182.0,2559.0,2854.0,2413.0,2374.0,2467.0,3353.0,35037.0
Gwalior,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1848.0,2195.0,1936.0,2095.0,1818.0,1920.0,1642.0,2094.0,1714.0,1696.0,1924.0,3398.0,24280.0
Gwalior,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1148.0,1662.0,1939.0,1842.0,1569.0,1717.0,1338.0,1388.0,1215.0,1297.0,1447.0,1847.0,18409.0
Gwalior,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1132.0,1498.0,1633.0,1570.0,1359.0,1424.0,1191.0,1171.0,1149.0,1103.0,1229.0,1620.0,16079.0
Gwalior,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2280.0,3160.0,3572.0,3412.0,2928.0,3141.0,2529.0,2559.0,2364.0,2400.0,2676.0,3467.0,34488.0
Gwalior,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2106.0,2699.0,2711.0,2695.0,2541.0,2402.0,2072.0,2605.0,2445.0,2509.0,2742.0,3848.0,31375.0
Gwalior,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2131.0,2674.0,2710.0,2673.0,2508.0,2394.0,2075.0,2601.0,2442.0,2458.0,2675.0,3988.0,31329.0
Gwalior,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,569.0,650.0,593.0,779.0,581.0,612.0,579.0,538.0,476.0,437.0,645.0,834.0,7293.0
Gwalior,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,525.0,576.0,546.0,713.0,533.0,515.0,530.0,501.0,401.0,380.0,573.0,769.0,6562.0
Gwalior,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1094.0,1226.0,1139.0,1492.0,1114.0,1127.0,1109.0,1039.0,877.0,817.0,1218.0,1603.0,13855.0
Gwalior,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1072.0,1430.0,1492.0,1571.0,1644.0,1165.0,1208.0,1240.0,1179.0,1520.0,1373.0,2028.0,16922.0
Gwalior,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1406.0,1827.0,1808.0,1767.0,2091.0,1507.0,1478.0,1463.0,1518.0,1643.0,1613.0,2500.0,20621.0
Gwalior,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1254.0,1922.0,1748.0,1865.0,2113.0,1559.0,1487.0,1596.0,1542.0,1640.0,1624.0,2368.0,20718.0
Gwalior,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,2.0,5.0,5.0,61.0,6.0,2.0,82.0
Gwalior,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,6.0,4.0,11.0,5.0,28.0
Gwalior,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1266.0,1259.0,1398.0,1279.0,1214.0,1134.0,1179.0,1049.0,1236.0,1191.0,1280.0,1242.0,14727.0
Gwalior,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1108.0,1215.0,1384.0,1253.0,1173.0,1095.0,1126.0,1054.0,1211.0,1190.0,1211.0,1209.0,14229.0
Gwalior,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,651.0,760.0,932.0,780.0,803.0,777.0,768.0,764.0,749.0,729.0,864.0,830.0,9407.0
Gwalior,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1739.0,2917.0,3112.0,3193.0,2697.0,2669.0,2407.0,2610.0,2315.0,3490.0,3246.0,3679.0,34074.0
Gwalior,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1131.0,2146.0,1618.0,4358.0,3803.0,1250.0,1139.0,1403.0,1936.0,5058.0,2710.0,2662.0,29214.0
Gwalior,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1330.0,925.0,933.0,3938.0,1262.0,868.0,719.0,1057.0,1167.0,5830.0,2239.0,1713.0,21981.0
Gwalior,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0,0.0,0.0,4.0
Gwalior,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,3.0
Gwalior,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,12.0,5.0,1.0,1.0,0.0,1.0,0.0,2.0,0.0,5.0,1.0,15.0,43.0
Gwalior,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,207.0,570.0,541.0,604.0,612.0,715.0,600.0,370.0,246.0,736.0,574.0,499.0,6274.0
Gwalior,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,35.0,53.0,99.0,74.0,100.0,274.0,238.0,166.0,3.0,63.0,57.0,29.0,1191.0
Gwalior,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,24.0,74.0,123.0,33.0,108.0,81.0,56.0,105.0,0.0,156.0,313.0,62.0,1135.0
Gwalior,13.1,Number of Patients operated for cataract,TOTAL,96.0,139.0,77.0,31.0,47.0,260.0,143.0,406.0,994.0,763.0,973.0,744.0,4673.0
Gwalior,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,95.0,134.0,76.0,31.0,46.0,260.0,140.0,406.0,616.0,779.0,932.0,102.0,3617.0
Gwalior,13.3,Number of School children detected with Refractive errors,TOTAL,99.0,0.0,0.0,443.0,253.0,589.0,1256.0,429.0,267.0,277.0,66.0,29.0,3708.0
Gwalior,13.4,Number of children provided free glasses,TOTAL,656.0,44.0,0.0,0.0,102.0,0.0,295.0,381.0,316.0,207.0,95.0,55.0,2151.0
Gwalior,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Gwalior,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,5.0,-1.0
Gwalior,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,1.0,-1.0
Gwalior,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,426.0,415.0,445.0,461.0,489.0,464.0,465.0,483.0,506.0,476.0,546.0,601.0,-1.0
Gwalior,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,-1.0
Gwalior,14.05,Number of RKS meetings held during the month,TOTAL,1.0,3.0,150.0,0.0,1.0,3.0,0.0,0.0,0.0,1.0,0.0,0.0,159.0
Gwalior,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,2.0,2.0,-1.0
Gwalior,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,0.0,0.0,0.0,83.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,83.0
Gwalior,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,1.0,-1.0
Gwalior,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,5.0,5.0,7.0,6.0,6.0,8.0,8.0,8.0,8.0,8.0,6.0,4.0,-1.0
Gwalior,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,30.0,44.0,96.0,72.0,89.0,22.0,11.0,708.0,579.0,471.0,430.0,28.0,2580.0
Gwalior,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,414.0,609.0,354.0,208.0,438.0,247.0,95.0,373.0,154.0,92.0,215.0,58.0,3257.0
Gwalior,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,37.0,367.0,65.0,45.0,126.0,36.0,93.0,510.0,430.0,327.0,306.0,29.0,2371.0
Gwalior,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1634.0,1893.0,1748.0,1994.0,2890.0,2594.0,2024.0,2242.0,2012.0,2097.0,2122.0,1965.0,25215.0
Gwalior,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,67.0,411.0,161.0,117.0,215.0,58.0,104.0,1218.0,1009.0,798.0,736.0,57.0,4951.0
Gwalior,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2048.0,2502.0,2102.0,2202.0,3328.0,2841.0,2119.0,2615.0,2166.0,2189.0,2337.0,2023.0,28472.0
Gwalior,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,94.0,94.0,94.0,76.0,3.0,361.0
Gwalior,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,61.0,50.0,58.0,41.0,4.0,214.0
Gwalior,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,155.0,144.0,152.0,117.0,7.0,575.0
Gwalior,14.11,In-Patient Head Count at midnight,TOTAL,1036.0,2113.0,2095.0,3062.0,6448.0,3826.0,16758.0,2807.0,3069.0,4023.0,10534.0,17173.0,72944.0
Gwalior,14.12.1,OPD attendance (All),TOTAL,41493.0,61464.0,64100.0,63643.0,80938.0,92730.0,77588.0,74398.0,64941.0,52297.0,77029.0,85699.0,836320.0
Gwalior,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,152.0,431.0,410.0,135.0,154.0,576.0,258.0,571.0,748.0,590.0,514.0,735.0,5274.0
Gwalior,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,1.0,20.0,28.0,1.0,0.0,92.0,45.0,32.0,51.0,33.0,1.0,0.0,304.0
Gwalior,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,108.0,217.0,200.0,200.0,1210.0,312.0,184.0,482.0,630.0,677.0,899.0,449.0,5568.0
Gwalior,14.14.a,Number of patients given AYUSH treatment,TOTAL,1407.0,4734.0,3345.0,3536.0,4245.0,4132.0,3517.0,3468.0,2648.0,2922.0,3283.0,1637.0,38874.0
Gwalior,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,156.0,0.0,157.0,102.0,173.0,107.0,275.0,230.0,172.0,128.0,124.0,1624.0
Gwalior,14.14.c,Number of Adolescents counselled,TOTAL,5.0,0.0,25.0,165.0,168.0,279.0,20.0,230.0,206.0,8.0,283.0,233.0,1622.0
Gwalior,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4371.0,6104.0,7310.0,7918.0,7739.0,9570.0,7829.0,9172.0,8809.0,7835.0,9600.0,6492.0,92749.0
Gwalior,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,219.0,294.0,242.0,316.0,214.0,255.0,162.0,230.0,211.0,192.0,129.0,134.0,2598.0
Gwalior,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,250.0,366.0,267.0,377.0,306.0,335.0,293.0,352.0,374.0,344.0,345.0,216.0,3825.0
Gwalior,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,4.0,5.0,2.0,0.0,1.0,1.0,1.0,3.0,1.0,1.0,0.0,21.0
Gwalior,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,292.0,361.0,311.0,260.0,420.0,411.0,368.0,509.0,347.0,386.0,443.0,210.0,4318.0
Gwalior,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,2.0,2.0,0.0,0.0,0.0,2.0,0.0,0.0,1.0,0.0,0.0,7.0
Gwalior,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1331.0,2157.0,2460.0,2439.0,2120.0,2095.0,1488.0,2233.0,2074.0,1454.0,1911.0,735.0,22497.0
Gwalior,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,2.0,4.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,399.0,407.0
Gwalior,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1873.0,2884.0,3038.0,3076.0,2846.0,2841.0,2149.0,3094.0,2795.0,2184.0,2699.0,1161.0,30640.0
Gwalior,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,8.0,11.0,2.0,0.0,1.0,5.0,1.0,3.0,2.0,1.0,399.0,435.0
Gwalior,15.2,Number of Widal tests conducted,Number tested,322.0,666.0,888.0,588.0,853.0,926.0,654.0,607.0,2807.0,259.0,854.0,679.0,10103.0
Gwalior,15.3.a,Number of VDRL tests conducted on males,Number tested,87.0,8.0,30.0,13.0,948.0,1191.0,32.0,70.0,86.0,251.0,50.0,6.0,2772.0
Gwalior,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,660.0,1405.0,1479.0,1567.0,1419.0,1796.0,1376.0,1624.0,1497.0,1296.0,1762.0,91.0,15972.0
Gwalior,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,190.0,1532.0,1711.0,1852.0,1486.0,2171.0,1106.0,1760.0,2269.0,1930.0,1397.0,299.0,17703.0
Gwalior,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,937.0,2945.0,3220.0,3432.0,3853.0,5158.0,2514.0,3454.0,3852.0,3477.0,3209.0,396.0,36447.0
Gwalior,15.4.1,Number of blood smears examined for Malaria,TOTAL,5114.0,8243.0,11313.0,11952.0,14660.0,18480.0,13477.0,13480.0,9002.0,6330.0,8827.0,17088.0,137966.0
Gwalior,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,25.0,37.0,167.0,141.0,152.0,510.0,358.0,105.0,51.0,19.0,20.0,417.0,2002.0
Gwalior,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,0.0,2.0,1.0,1.0,45.0,86.0,54.0,9.0,1.0,1.0,4.0,205.0
Gwalior,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,1330.0,,590.0,45.0,500.0,110.0,190.0,2765.0
Gwalior,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,0.0,,500.0,1400.0,0.0,800.0,800.0,3500.0
Gwalior,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,770.0,,1045.0,945.0,390.0,720.0,410.0,4280.0
Gwalior,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,560.0,0.0,45.0,500.0,110.0,190.0,580.0,1985.0
Gwalior,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,0.0,,1325.0,1090.0,1570.0,220.0,672.0,4877.0
Gwalior,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,0.0,,0.0,500.0,0.0,1500.0,1450.0,3450.0
Gwalior,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,0.0,,235.0,20.0,1350.0,1048.0,792.0,3445.0
Gwalior,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1090.0,1570.0,220.0,672.0,1330.0,4882.0
Gwalior,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,506.0,,0.0,149.0,25084.0,204.0,140.0,26083.0
Gwalior,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,0.0,,1149.0,26140.0,0.0,24625.0,500.0,52414.0
Gwalior,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,450.0,,1000.0,1205.0,24880.0,24689.0,291.0,52515.0
Gwalior,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,56.0,0.0,149.0,25084.0,204.0,140.0,349.0,25982.0
Gwalior,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,1275.0,,575.0,445.0,1095.0,1005.0,1055.0,5450.0
Gwalior,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,0.0,,1000.0,2000.0,500.0,1000.0,1500.0,6000.0
Gwalior,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,695.0,,1130.0,1350.0,590.0,950.0,1360.0,6075.0
Gwalior,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,580.0,0.0,445.0,1095.0,1005.0,1055.0,1195.0,5375.0
Gwalior,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,932.0,,292.0,142.0,512.0,132.0,532.0,2542.0
Gwalior,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,0.0,,600.0,1300.0,0.0,1000.0,1000.0,3900.0
Gwalior,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,545.0,,750.0,930.0,380.0,600.0,730.0,3935.0
Gwalior,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,387.0,0.0,142.0,512.0,132.0,532.0,802.0,2507.0
Gwalior,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,1655.0,,605.0,850.0,1632.0,1032.0,1482.0,7256.0
Gwalior,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,0.0,,1150.0,1000.0,0.0,1600.0,0.0,3750.0
Gwalior,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,200.0,,905.0,218.0,600.0,1150.0,930.0,4003.0
Gwalior,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,1455.0,0.0,850.0,1632.0,1032.0,1482.0,552.0,7003.0
Gwalior,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,1250.0,,25.0,0.0,487.0,242.0,692.0,2696.0
Gwalior,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,0.0,,600.0,1400.0,0.0,800.0,200.0,3000.0
Gwalior,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,945.0,,625.0,913.0,245.0,350.0,285.0,3363.0
Gwalior,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,305.0,0.0,0.0,487.0,242.0,692.0,607.0,2333.0
Gwalior,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,3750.0,,3100.0,0.0,0.0,0.0,0.0,6850.0
Gwalior,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,0.0,,0.0,0.0,0.0,0.0,4800.0,4800.0
Gwalior,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,3100.0,,3100.0,0.0,0.0,0.0,4800.0,11000.0
Gwalior,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,650.0,0.0,0.0,0.0,0.0,0.0,0.0,650.0
Gwalior,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,48500.0,,8660.0,8660.0,8660.0,8660.0,20660.0,103800.0
Gwalior,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,0.0,,0.0,0.0,0.0,18000.0,18000.0,36000.0
Gwalior,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,48500.0,,0.0,0.0,0.0,6000.0,24000.0,78500.0
Gwalior,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8660.0,8660.0,8660.0,20660.0,14660.0,61300.0
Gwalior,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,5800.0,,1400.0,8700.0,8700.0,8700.0,13700.0,47000.0
Gwalior,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,29000.0,0.0,0.0,9000.0,37000.0,75000.0
Gwalior,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,21700.0,0.0,0.0,4000.0,30500.0,56200.0
Gwalior,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,5800.0,0.0,8700.0,8700.0,8700.0,13700.0,20200.0,65800.0
Gwalior,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,3700.0,,0.0,0.0,0.0,0.0,5000.0,8700.0
Gwalior,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,0.0,,0.0,0.0,0.0,6000.0,3000.0,9000.0
Gwalior,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,3700.0,,0.0,0.0,0.0,1000.0,6100.0,10800.0
Gwalior,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,1900.0,6900.0
Gwalior,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,3000.0,,2600.0,600.0,100.0,4500.0,4000.0,14800.0
Gwalior,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,0.0,,0.0,0.0,9422.0,0.0,0.0,9422.0
Gwalior,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,400.0,,2000.0,500.0,5022.0,500.0,2000.0,10422.0
Gwalior,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,2600.0,0.0,600.0,100.0,4500.0,4000.0,2000.0,13800.0
Gwalior,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,6400.0,,3400.0,3350.0,8800.0,8150.0,7150.0,37250.0
Gwalior,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,0.0,,0.0,10000.0,0.0,0.0,0.0,10000.0
Gwalior,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,1800.0,,50.0,4550.0,650.0,1000.0,3300.0,11350.0
Gwalior,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,4600.0,0.0,3350.0,8800.0,8150.0,7150.0,3850.0,35900.0
Gwalior,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,2200.0,,300.0,5300.0,700.0,500.0,500.0,9500.0
Gwalior,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,0.0,,5000.0,0.0,0.0,0.0,20000.0,25000.0
Gwalior,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,1500.0,,0.0,4600.0,200.0,500.0,5900.0,12700.0
Gwalior,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,700.0,0.0,5300.0,700.0,500.0,0.0,14600.0,21800.0
Gwalior,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,1700.0,,1000.0,1000.0,500.0,18800.0,10900.0,33900.0
Gwalior,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,0.0,,0.0,0.0,20000.0,0.0,0.0,20000.0
Gwalior,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,700.0,,0.0,500.0,1700.0,7900.0,7000.0,17800.0
Gwalior,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,1000.0,0.0,1000.0,500.0,18800.0,10900.0,3900.0,36100.0
Gwalior,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,260000.0,,40000.0,269800.0,700000.0,190000.0,130000.0,1589800.0
Gwalior,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,0.0,,250000.0,5000000.0,0.0,0.0,0.0,5250000.0
Gwalior,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,202000.0,,20200.0,4569800.0,510000.0,60000.0,70000.0,5432000.0
Gwalior,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,58000.0,0.0,269800.0,700000.0,190000.0,130000.0,60000.0,1407800.0
Gwalior,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,0.0,,0.0,27985.0,144.0,144.0,5000.0,33273.0
Gwalior,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,0.0,,100000.0,0.0,0.0,5000.0,45000.0,150000.0
Gwalior,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,0.0,,72015.0,0.0,0.0,0.0,0.0,72015.0
Gwalior,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,0.0,,27985.0,27841.0,0.0,144.0,11551.0,67521.0
Gwalior,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,144.0,144.0,5000.0,38449.0,43737.0
Gwalior,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,10150.0,,8440.0,,201510.0,,,220100.0
Gwalior,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,2000.0,,500000.0,,200000.0,,,702000.0
Gwalior,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,0.0,,0.0,,0.0,,,0.0
Gwalior,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,2750.0,,104200.0,,70500.0,,,177450.0
Gwalior,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,9400.0,0.0,404240.0,0.0,331010.0,0.0,0.0,744650.0
Gwalior,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,2850.0,,750.0,750.0,1971.0,600.0,550.0,7471.0
Gwalior,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,0.0,,0.0,4500.0,0.0,0.0,10000.0,14500.0
Gwalior,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,450.0,,0.0,3279.0,1371.0,50.0,300.0,5450.0
Gwalior,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,2400.0,0.0,750.0,1971.0,600.0,550.0,10250.0,16521.0
Gwalior,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,5500.0,,96000.0,53980.0,16000.0,1540.0,340.0,173360.0
Gwalior,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,0.0,,0.0,70000.0,0.0,0.0,50000.0,120000.0
Gwalior,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gwalior,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,1550.0,,42020.0,107980.0,14460.0,1200.0,0.0,167210.0
Gwalior,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,3950.0,0.0,53980.0,16000.0,1540.0,340.0,50340.0,126150.0
Gwalior,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,14700.0,,8100.0,4900.0,22100.0,,15900.0,65700.0
Gwalior,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,0.0,,0.0,19800.0,0.0,,0.0,19800.0
Gwalior,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,,0.0,0.0
Gwalior,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,1200.0,,3200.0,2600.0,1200.0,,6000.0,14200.0
Gwalior,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,13500.0,0.0,4900.0,22100.0,20900.0,0.0,9900.0,71300.0
Gwalior,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,149600.0,,118600.0,42600.0,31800.0,,301800.0,644400.0
Gwalior,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,0.0,,0.0,0.0,0.0,,0.0,0.0
Gwalior,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,,0.0,0.0
Gwalior,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,5000.0,,76000.0,10800.0,20000.0,,188000.0,299800.0
Gwalior,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,144600.0,0.0,42600.0,31800.0,11800.0,0.0,113800.0,344600.0
Gwalior,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,9250.0,,5250.0,1750.0,10450.0,,16350.0,43050.0
Gwalior,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,0.0,,0.0,10000.0,0.0,,0.0,10000.0
Gwalior,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,0.0,,0.0,0.0,0.0,,0.0,0.0
Gwalior,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,1000.0,,3500.0,1300.0,500.0,,3400.0,9700.0
Gwalior,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,8250.0,0.0,1750.0,10450.0,9950.0,0.0,12950.0,43350.0
Gwalior,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,3.0,1.0,2.0,,,,2.0,8.0
Gwalior,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,1.0,2.0,,,,,,1.0,1.0,1.0,,6.0
Gwalior,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
Gwalior,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,2.0,2.0,,,,,,1.0,1.0,1.0,,7.0
Gwalior,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,1.0,,,1.0,,,,1.0,1.0,,1.0,5.0
Gwalior,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gwalior,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,1.0,,,1.0,,,,1.0,1.0,,1.0,5.0
Gwalior,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,5.0,3.0,5.0,5.0,2.0,2.0,3.0,6.0,2.0,1.0,35.0
Gwalior,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,2.0,,2.0,,1.0,1.0,2.0,,,,9.0
Gwalior,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,1.0,7.0,3.0,7.0,5.0,3.0,3.0,5.0,6.0,2.0,1.0,44.0
Gwalior,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,6.0,5.0,6.0,5.0,4.0,3.0,4.0,1.0,12.0,3.0,3.0,54.0
Gwalior,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,,,3.0,1.0,,3.0,,1.0,,9.0
Gwalior,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,6.0,5.0,6.0,5.0,7.0,4.0,4.0,4.0,12.0,4.0,3.0,63.0
Gwalior,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,1.0,1.0,,2.0
Gwalior,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,1.0,,,,,1.0,,2.0
Gwalior,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,1.0,,,,1.0,2.0,,4.0
Gwalior,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gwalior,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gwalior,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Gwalior,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,1.0,,1.0,,1.0,1.0,,,,,5.0
Gwalior,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,1.0,,,,,,1.0,,,,,,2.0
Gwalior,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,1.0,1.0,,1.0,,2.0,1.0,,,,,7.0
Gwalior,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gwalior,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gwalior,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Gwalior,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,1.0,3.0,3.0,4.0,2.0,1.0,3.0,2.0,4.0,2.0,6.0,32.0
Gwalior,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,1.0,5.0,1.0,4.0,3.0,3.0,,1.0,1.0,2.0,1.0,24.0
Gwalior,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,2.0,8.0,4.0,8.0,5.0,4.0,3.0,3.0,5.0,4.0,7.0,56.0
Gwalior,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Gwalior,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Gwalior,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Gwalior,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Gwalior,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Gwalior,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,1.0,,,1.0,1.0,1.0,2.0,3.0,1.0,1.0,2.0,14.0
Gwalior,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,1.0,,1.0,,,,,,3.0,5.0
Gwalior,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,1.0,,1.0,1.0,2.0,1.0,2.0,3.0,1.0,1.0,5.0,19.0
Gwalior,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Gwalior,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,2.0,,,,,,,2.0
Gwalior,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,2.0,,,,,2.0
Gwalior,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,2.0,,2.0,,,,,4.0
Gwalior,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Gwalior,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Gwalior,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Gwalior,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Gwalior,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Gwalior,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,1.0,,,1.0,,,,2.0,4.0
Gwalior,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,1.0,,,,,2.0,,,,,3.0
Gwalior,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,1.0,,1.0,,,3.0,,,,2.0,7.0
Gwalior,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Gwalior,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Gwalior,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Gwalior,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,1.0,,1.0
Gwalior,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Gwalior,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,1.0,2.0,2.0,5.0,,2.0,,3.0,15.0
Gwalior,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,1.0,2.0,,3.0,,2.0,2.0,1.0,,4.0,,16.0
Gwalior,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,1.0,2.0,,5.0,2.0,4.0,7.0,1.0,2.0,4.0,3.0,32.0
Gwalior,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Gwalior,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,1.0,1.0,,2.0
Gwalior,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,,,,,,,,,1.0,2.0
Gwalior,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,,,,,,,,1.0,1.0,1.0,4.0
Gwalior,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Gwalior,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Gwalior,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Gwalior,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Gwalior,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Gwalior,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Gwalior,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Gwalior,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Gwalior,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Gwalior,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Gwalior,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Gwalior,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Gwalior,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Gwalior,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Gwalior,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Gwalior,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Gwalior,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Gwalior,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Gwalior,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Gwalior,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,1.0,,,,,1.0
Gwalior,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Gwalior,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,6.0,8.0,6.0,7.0,4.0,7.0,4.0,1.0,2.0,,1.0,4.0,50.0
Gwalior,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Gwalior,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,6.0,8.0,6.0,7.0,4.0,7.0,4.0,1.0,2.0,,1.0,4.0,50.0
Gwalior,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,,3.0,,,1.0,,,,,1.0,,6.0
Gwalior,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,7.0,6.0,4.0,2.0,9.0,2.0,1.0,5.0,6.0,10.0,4.0,6.0,62.0
Gwalior,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,2.0,4.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,,17.0
Gwalior,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,8.0,8.0,11.0,4.0,10.0,4.0,2.0,6.0,7.0,12.0,7.0,6.0,85.0
Gwalior,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Gwalior,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,,3.0,3.0,2.0,3.0,1.0,5.0,1.0,2.0,1.0,2.0,25.0
Gwalior,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Gwalior,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,2.0,,3.0,3.0,2.0,3.0,1.0,6.0,1.0,2.0,1.0,2.0,26.0
Gwalior,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Gwalior,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,1.0,3.0,,,1.0,,,1.0,,7.0
Gwalior,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,1.0,,,,,1.0,2.0
Gwalior,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,1.0,1.0,3.0,,1.0,1.0,,,1.0,1.0,9.0
Gwalior,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Gwalior,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,1.0,2.0,1.0,,,,,,1.0,5.0
Gwalior,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Gwalior,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,1.0,2.0,1.0,,,,,,2.0,6.0
Gwalior,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,1.0,,,1.0,,,,,,,2.0
Gwalior,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,4.0,1.0,1.0,,,1.0,1.0,,2.0,2.0,2.0,15.0
Gwalior,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,8.0,1.0,3.0,,2.0,,1.0,1.0,,2.0,1.0,2.0,21.0
Gwalior,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,9.0,5.0,5.0,1.0,2.0,1.0,2.0,2.0,,4.0,3.0,4.0,38.0
Gwalior,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,1.0,1.0,2.0,1.0,,,,5.0
Gwalior,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,8.0,3.0,5.0,6.0,5.0,5.0,8.0,7.0,4.0,2.0,3.0,57.0
Gwalior,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,19.0,29.0,46.0,30.0,21.0,30.0,30.0,26.0,28.0,25.0,28.0,39.0,351.0
Gwalior,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,20.0,37.0,49.0,35.0,27.0,36.0,36.0,36.0,36.0,29.0,30.0,42.0,413.0
Harda,1.1,Total number of pregnant women Registered for ANC,TOTAL,750.0,977.0,1175.0,1136.0,1055.0,1184.0,950.0,1167.0,1058.0,890.0,1132.0,1056.0,12530.0
Harda,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,390.0,455.0,590.0,614.0,510.0,637.0,535.0,717.0,680.0,537.0,666.0,642.0,6973.0
Harda,1.2,Number of Pregnant women registered under JSY,TOTAL,747.0,978.0,1182.0,1136.0,1055.0,1184.0,950.0,1167.0,1058.0,890.0,1132.0,1052.0,12531.0
Harda,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,551.0,719.0,767.0,924.0,829.0,745.0,790.0,934.0,733.0,809.0,859.0,851.0,9511.0
Harda,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,499.0,651.0,754.0,742.0,599.0,789.0,593.0,946.0,711.0,579.0,689.0,712.0,8264.0
Harda,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,662.0,764.0,899.0,1023.0,913.0,856.0,868.0,1129.0,920.0,859.0,924.0,953.0,10770.0
Harda,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,728.0,954.0,1145.0,1090.0,843.0,1012.0,922.0,1073.0,963.0,890.0,1023.0,968.0,11611.0
Harda,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,89.0,233.0,277.0,196.0,159.0,184.0,155.0,190.0,219.0,171.0,214.0,180.0,2267.0
Harda,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,35.0,52.0,8.0,3.0,4.0,3.0,2.0,3.0,22.0,4.0,20.0,77.0,233.0
Harda,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,520.0,334.0,657.0,583.0,435.0,455.0,675.0,614.0,595.0,409.0,591.0,559.0,6427.0
Harda,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,31.0,34.0,9.0,22.0,21.0,3.0,15.0,18.0,16.0,63.0,18.0,8.0,258.0
Harda,1.8,Number of pregnancy test kits used at SC level,TOTAL,447.0,486.0,577.0,624.0,545.0,652.0,544.0,746.0,621.0,516.0,603.0,512.0,6873.0
Harda,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,6.0,30.0,55.0,38.0,58.0,62.0,86.0,58.0,67.0,54.0,78.0,592.0
Harda,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,84.0,111.0,132.0,97.0,133.0,132.0,118.0,119.0,93.0,66.0,68.0,89.0,1242.0
Harda,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,84.0,117.0,162.0,152.0,171.0,190.0,180.0,205.0,151.0,133.0,122.0,167.0,1834.0
Harda,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,71.0,89.0,143.0,131.0,163.0,173.0,177.0,187.0,139.0,131.0,122.0,158.0,1684.0
Harda,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,2.0,14.0,6.0,3.0,0.0,0.0,1.0,0.0,0.0,25.0,22.0,73.0
Harda,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,479.0,557.0,646.0,648.0,716.0,691.0,687.0,675.0,620.0,547.0,600.0,792.0,7658.0
Harda,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,5.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0,24.0
Harda,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,479.0,557.0,556.0,616.0,593.0,630.0,507.0,549.0,573.0,465.0,554.0,726.0,6805.0
Harda,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,356.0,213.0,433.0,205.0,220.0,153.0,194.0,212.0,490.0,422.0,353.0,660.0,3911.0
Harda,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,6.0,3.0,4.0,37.0,68.0,54.0,37.0,39.0,45.0,53.0,36.0,54.0,436.0
Harda,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,82.0,65.0,93.0,89.0,78.0,101.0,98.0,109.0,82.0,64.0,64.0,88.0,1013.0
Harda,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Harda,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Harda,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Harda,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,0.0,,,,,,,,0.0
Harda,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,47.0,47.0,79.0,84.0,96.0,67.0,74.0,61.0,60.0,47.0,71.0,70.0,803.0
Harda,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Harda,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,47.0,47.0,79.0,84.0,96.0,67.0,74.0,61.0,60.0,47.0,71.0,70.0,803.0
Harda,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,58.0,44.0,55.0,58.0,57.0,65.0,71.0,69.0,76.0,61.0,53.0,67.0,734.0
Harda,4.1.1.a,Number of male live births,TOTAL,338.0,387.0,443.0,481.0,491.0,459.0,473.0,466.0,443.0,369.0,426.0,521.0,5297.0
Harda,4.1.1.b,Number of female live births,TOTAL,302.0,344.0,453.0,402.0,467.0,515.0,482.0,506.0,401.0,355.0,348.0,507.0,5082.0
Harda,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,640.0,731.0,896.0,883.0,958.0,974.0,955.0,972.0,844.0,724.0,774.0,1028.0,10379.0
Harda,4.1.2,Number of still births,TOTAL,5.0,8.0,5.0,6.0,7.0,8.0,10.0,17.0,9.0,20.0,13.0,19.0,127.0
Harda,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,126.0,136.0,113.0,105.0,122.0,127.0,125.0,170.0,154.0,116.0,164.0,162.0,1620.0
Harda,4.2.1,Number of Newborns weighed at birth,TOTAL,640.0,731.0,898.0,882.0,958.0,974.0,955.0,972.0,844.0,724.0,752.0,1028.0,10358.0
Harda,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,75.0,228.0,229.0,138.0,116.0,157.0,109.0,128.0,120.0,94.0,121.0,132.0,1647.0
Harda,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,640.0,731.0,882.0,882.0,958.0,974.0,955.0,972.0,844.0,724.0,752.0,1028.0,10342.0
Harda,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,4.0,15.0,8.0,13.0,10.0,6.0,7.0,7.0,8.0,6.0,84.0
Harda,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,25.0,,2.0,32.0,28.0,23.0,27.0,12.0,31.0,31.0,33.0,36.0,280.0
Harda,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,160.0,100.0,187.0,200.0,163.0,161.0,141.0,128.0,140.0,105.0,113.0,114.0,1712.0
Harda,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Harda,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,185.0,100.0,193.0,247.0,199.0,197.0,178.0,146.0,178.0,143.0,154.0,156.0,2076.0
Harda,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Harda,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,164.0,100.0,86.0,243.0,134.0,161.0,168.0,142.0,172.0,137.0,152.0,152.0,1811.0
Harda,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,39.0,10.0,23.0,28.0,25.0,27.0,14.0,13.0,25.0,22.0,2.0,28.0,256.0
Harda,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,160.0,100.0,193.0,202.0,191.0,156.0,148.0,146.0,164.0,139.0,151.0,153.0,1903.0
Harda,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,23.0,42.0,28.0,31.0,33.0,49.0,38.0,36.0,39.0,0.0,18.0,21.0,358.0
Harda,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,536.0,547.0,766.0,564.0,666.0,862.0,828.0,870.0,764.0,651.0,711.0,851.0,8616.0
Harda,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,480.0,606.0,704.0,687.0,797.0,811.0,744.0,776.0,715.0,639.0,660.0,736.0,8355.0
Harda,6.3,PNC maternal complications attended,TOTAL,140.0,46.0,20.0,15.0,26.0,12.0,10.0,2.0,40.0,20.0,16.0,29.0,376.0
Harda,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,14.0,20.0,13.0,16.0,13.0,14.0,22.0,36.0,46.0,29.0,30.0,26.0,279.0
Harda,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,2.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,2.0,9.0
Harda,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,16.0,21.0,13.0,16.0,13.0,15.0,22.0,37.0,46.0,30.0,31.0,28.0,288.0
Harda,7.2,Number of MTPs conducted at Private Facilities,TOTAL,98.0,98.0,80.0,70.0,69.0,75.0,80.0,83.0,88.0,68.0,86.0,95.0,990.0
Harda,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,88.0,167.0,71.0,155.0,188.0,366.0,119.0,202.0,286.0,83.0,90.0,100.0,1915.0
Harda,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,398.0,533.0,378.0,642.0,601.0,681.0,543.0,632.0,475.0,431.0,608.0,477.0,6399.0
Harda,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,486.0,700.0,449.0,797.0,789.0,1047.0,662.0,834.0,761.0,514.0,698.0,577.0,8314.0
Harda,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,0.0,1.0,3.0,1.0,0.0,0.0,7.0,2.0,1.0,6.0,0.0,22.0
Harda,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,1.0,0.0,0.0,0.0,1.0,4.0,0.0,0.0,1.0,7.0
Harda,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Harda,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,0.0,1.0,4.0,1.0,0.0,0.0,8.0,6.0,1.0,6.0,1.0,29.0
Harda,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Harda,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,5.0,2.0,9.0,48.0,72.0,52.0,38.0,588.0,627.0,306.0,276.0,57.0,2080.0
Harda,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,5.0,6.0,2.0,11.0,2.0,2.0,1.0,11.0,14.0,8.0,14.0,11.0,87.0
Harda,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Harda,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,10.0,8.0,11.0,59.0,74.0,54.0,39.0,599.0,641.0,314.0,290.0,68.0,2167.0
Harda,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Harda,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,1.0,0.0,0.0,,,,,2.0,1.0,7.0,1.0,,12.0
Harda,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,18.0,17.0,13.0,28.0,17.0,20.0,15.0,24.0,27.0,18.0,25.0,19.0,241.0
Harda,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Harda,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,19.0,17.0,13.0,28.0,17.0,20.0,15.0,26.0,28.0,25.0,26.0,19.0,253.0
Harda,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,3.0,14.0,6.0,11.0,6.0,21.0,10.0,5.0,19.0,9.0,13.0,8.0,125.0
Harda,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,0.0,0.0,0.0,,,,,6.0,6.0,0.0,,12.0
Harda,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,14.0,14.0,13.0,36.0,15.0,10.0,12.0,13.0,13.0,13.0,19.0,12.0,184.0
Harda,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Harda,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,14.0,14.0,13.0,36.0,15.0,10.0,12.0,13.0,19.0,19.0,19.0,12.0,196.0
Harda,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Harda,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,147.0,233.0,272.0,395.0,309.0,267.0,166.0,170.0,134.0,129.0,136.0,125.0,2483.0
Harda,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,10.0,10.0,18.0,19.0,13.0,18.0,6.0,5.0,4.0,4.0,4.0,4.0,115.0
Harda,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,12.0,13.0,11.0,34.0,37.0,27.0,24.0,12.0,19.0,16.0,17.0,11.0,233.0
Harda,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,11.0,14.0,42.0,25.0,10.0,11.0,13.0,12.0,13.0,16.0,16.0,12.0,195.0
Harda,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Harda,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,180.0,270.0,343.0,473.0,369.0,323.0,209.0,199.0,170.0,165.0,173.0,152.0,3026.0
Harda,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,3.0,13.0,40.0,10.0,7.0,11.0,13.0,10.0,4.0,6.0,13.0,16.0,146.0
Harda,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Harda,9.06,Number of IUCD removals,TOTAL,223.0,188.0,154.0,173.0,149.0,179.0,115.0,149.0,308.0,126.0,130.0,188.0,2082.0
Harda,9.07,Number of Oral Pills cycles distributed,TOTAL,1687.0,1104.0,1861.0,3734.0,3448.0,3299.0,3308.0,3578.0,6843.0,3477.0,3713.0,3660.0,39712.0
Harda,9.08,Number of Condom pieces distributed,TOTAL,23382.0,29488.0,27432.0,31441.0,28304.0,30914.0,32712.0,42926.0,37679.0,41348.0,42806.0,42528.0,410960.0
Harda,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,9.12,Number of Institutions having NSV trained doctors,TOTAL,3.0,3.0,2.0,1.0,1.0,2.0,1.0,1.0,2.0,1.0,2.0,1.0,-1.0
Harda,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,705.0,783.0,910.0,854.0,977.0,930.0,886.0,887.0,842.0,778.0,776.0,916.0,10244.0
Harda,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,673.0,819.0,953.0,830.0,865.0,905.0,954.0,348.0,8.0,3.0,19.0,13.0,6390.0
Harda,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,859.0,779.0,818.0,921.0,778.0,879.0,874.0,1045.0,455.0,124.0,214.0,25.0,7771.0
Harda,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,900.0,876.0,838.0,860.0,855.0,849.0,869.0,991.0,875.0,474.0,212.0,76.0,8675.0
Harda,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,18.0,711.0,922.0,879.0,876.0,982.0,4388.0
Harda,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19.0,403.0,762.0,862.0,1017.0,3063.0
Harda,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,337.0,575.0,882.0,1794.0
Harda,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,443.0,519.0,615.0,619.0,723.0,708.0,650.0,667.0,645.0,526.0,589.0,649.0,7353.0
Harda,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,672.0,819.0,948.0,830.0,865.0,905.0,954.0,365.0,8.0,174.0,333.0,409.0,7282.0
Harda,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,859.0,779.0,824.0,921.0,778.0,879.0,874.0,1045.0,455.0,294.0,497.0,435.0,8640.0
Harda,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,900.0,876.0,846.0,860.0,855.0,914.0,869.0,991.0,875.0,563.0,431.0,368.0,9348.0
Harda,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,443.0,519.0,467.0,489.0,506.0,629.0,510.0,452.0,481.0,379.0,432.0,408.0,5715.0
Harda,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,672.0,819.0,935.0,830.0,865.0,905.0,954.0,365.0,3.0,3.0,19.0,13.0,6383.0
Harda,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,859.0,779.0,815.0,921.0,778.0,879.0,874.0,1045.0,455.0,124.0,215.0,25.0,7769.0
Harda,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,900.0,876.0,845.0,860.0,855.0,849.0,869.0,991.0,875.0,471.0,221.0,76.0,8688.0
Harda,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,764.0,938.0,929.0,978.0,910.0,1000.0,792.0,764.0,646.0,737.0,718.0,1002.0,10178.0
Harda,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,173.0,260.0,316.0,326.0,518.0,713.0,604.0,896.0,823.0,782.0,898.0,856.0,7165.0
Harda,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,406.0,500.0,506.0,500.0,473.0,514.0,428.0,412.0,321.0,399.0,371.0,516.0,5346.0
Harda,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,358.0,433.0,423.0,476.0,437.0,486.0,364.0,349.0,325.0,338.0,347.0,486.0,4822.0
Harda,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,764.0,933.0,929.0,976.0,910.0,1000.0,792.0,761.0,646.0,737.0,718.0,1002.0,10168.0
Harda,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,632.0,724.0,749.0,891.0,653.0,827.0,695.0,933.0,935.0,831.0,952.0,1131.0,9953.0
Harda,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,632.0,724.0,745.0,891.0,653.0,827.0,695.0,933.0,935.0,831.0,952.0,1131.0,9949.0
Harda,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,125.0,117.0,184.0,153.0,244.0,282.0,239.0,332.0,267.0,270.0,303.0,369.0,2885.0
Harda,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,126.0,126.0,184.0,183.0,277.0,272.0,189.0,306.0,263.0,227.0,264.0,357.0,2774.0
Harda,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,251.0,243.0,368.0,336.0,521.0,554.0,428.0,638.0,530.0,497.0,567.0,726.0,5659.0
Harda,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,391.0,586.0,685.0,710.0,797.0,1559.0,1034.0,1314.0,1052.0,646.0,795.0,730.0,10299.0
Harda,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,335.0,524.0,624.0,803.0,1009.0,2014.0,1247.0,1320.0,1031.0,783.0,1014.0,987.0,11691.0
Harda,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,506.0,601.0,680.0,769.0,920.0,1954.0,1455.0,1219.0,1416.0,1006.0,923.0,637.0,12086.0
Harda,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Harda,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,11.0,14.0,6.0,17.0,19.0,16.0,13.0,3.0,5.0,4.0,3.0,9.0,120.0
Harda,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,485.0,533.0,556.0,545.0,527.0,526.0,535.0,535.0,560.0,592.0,616.0,649.0,6659.0
Harda,10.4.2,Number of Immunisation sessions held during the month,TOTAL,432.0,503.0,556.0,524.0,499.0,509.0,480.0,518.0,538.0,569.0,590.0,631.0,6349.0
Harda,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,357.0,396.0,445.0,416.0,402.0,426.0,414.0,436.0,448.0,460.0,502.0,517.0,5219.0
Harda,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,783.0,941.0,929.0,1248.0,927.0,1002.0,792.0,765.0,651.0,1054.0,774.0,1019.0,10885.0
Harda,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,39.0,79.0,224.0,1618.0,804.0,196.0,188.0,188.0,166.0,1967.0,532.0,140.0,6141.0
Harda,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,4.0,68.0,74.0,1416.0,674.0,92.0,75.0,133.0,65.0,1650.0,443.0,25.0,4719.0
Harda,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,356.0,463.0,451.0,371.0,516.0,471.0,538.0,282.0,287.0,274.0,303.0,480.0,4792.0
Harda,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,13.1,Number of Patients operated for cataract,TOTAL,8.0,0.0,,25.0,31.0,49.0,70.0,86.0,188.0,63.0,100.0,79.0,699.0
Harda,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,6.0,0.0,,23.0,29.0,42.0,66.0,79.0,183.0,62.0,99.0,75.0,664.0
Harda,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,,0.0,28.0,82.0,307.0,13.0,19.0,7.0,15.0,0.0,471.0
Harda,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,417.0,0.0,0.0,39.0,456.0
Harda,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,3.0,3.0,3.0,1.0,2.0,2.0,3.0,2.0,3.0,2.0,3.0,-1.0
Harda,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2.0,2.0,2.0,2.0,,,,,2.0,2.0,2.0,2.0,-1.0
Harda,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,329.0,358.0,407.0,377.0,362.0,374.0,342.0,375.0,397.0,391.0,411.0,419.0,-1.0
Harda,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,3.0,4.0,3.0,2.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Harda,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,4.0
Harda,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1.0,2.0,3.0,2.0,2.0,1.0,3.0,3.0,2.0,3.0,3.0,3.0,-1.0
Harda,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,0.0,3.0,14.0,0.0,10.0,0.0,20.0,8.0,14.0,12.0,10.0,6.0,97.0
Harda,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Harda,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Harda,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,365.0,620.0,638.0,485.0,637.0,661.0,516.0,475.0,477.0,308.0,423.0,470.0,6075.0
Harda,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,802.0,865.0,767.0,622.0,490.0,650.0,710.0,496.0,843.0,498.0,597.0,510.0,7850.0
Harda,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,370.0,1203.0,1262.0,1058.0,1198.0,1314.0,491.0,1157.0,1281.0,325.0,1123.0,1017.0,11799.0
Harda,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1826.0,1236.0,1517.0,1224.0,998.0,1207.0,1629.0,1350.0,1680.0,1495.0,859.0,995.0,16016.0
Harda,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,735.0,1823.0,1900.0,1543.0,1835.0,1975.0,1007.0,1632.0,1758.0,633.0,1546.0,1487.0,17874.0
Harda,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2628.0,2101.0,2284.0,1846.0,1488.0,1857.0,2339.0,1846.0,2523.0,1993.0,1456.0,1505.0,23866.0
Harda,14.10.2.a,Number of death cases of Inpatient males,TOTAL,11.0,19.0,16.0,0.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,57.0
Harda,14.10.2.b,Number of death cases of Inpatient females,TOTAL,10.0,6.0,14.0,0.0,16.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,46.0
Harda,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,21.0,25.0,30.0,0.0,27.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,103.0
Harda,14.11,In-Patient Head Count at midnight,TOTAL,973.0,3031.0,3195.0,3121.0,2603.0,2819.0,2771.0,2936.0,3051.0,3060.0,3134.0,3410.0,34104.0
Harda,14.12.1,OPD attendance (All),TOTAL,22621.0,22934.0,25726.0,24753.0,31829.0,40462.0,27602.0,29072.0,26661.0,24667.0,40702.0,33908.0,350937.0
Harda,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,16.0,71.0,105.0,123.0,111.0,0.0,86.0,102.0,96.0,86.0,70.0,103.0,969.0
Harda,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,8.0,0.0,8.0,10.0,3.0,0.0,8.0,12.0,12.0,11.0,8.0,10.0,90.0
Harda,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4.0,6.0,11.0,9.0,9.0,0.0,12.0,12.0,9.0,17.0,14.0,15.0,118.0
Harda,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,543.0,613.0,714.0,693.0,656.0,0.0,715.0,760.0,768.0,726.0,698.0,796.0,7682.0
Harda,14.14.c,Number of Adolescents counselled,TOTAL,70.0,120.0,115.0,87.0,119.0,0.0,713.0,167.0,195.0,119.0,209.0,180.0,2094.0
Harda,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1034.0,795.0,1556.0,1089.0,992.0,1143.0,1004.0,1584.0,1494.0,1137.0,1149.0,1011.0,13988.0
Harda,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,68.0,69.0,65.0,64.0,42.0,46.0,42.0,46.0,39.0,86.0,32.0,17.0,616.0
Harda,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,145.0,151.0,183.0,248.0,274.0,214.0,236.0,90.0,130.0,141.0,175.0,208.0,2195.0
Harda,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0,2.0,8.0
Harda,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,206.0,132.0,243.0,341.0,371.0,320.0,230.0,321.0,626.0,424.0,423.0,288.0,3925.0
Harda,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,2.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,5.0
Harda,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,852.0,690.0,943.0,780.0,783.0,909.0,666.0,655.0,649.0,735.0,579.0,580.0,8821.0
Harda,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Harda,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1203.0,973.0,1369.0,1369.0,1428.0,1443.0,1132.0,1066.0,1405.0,1300.0,1177.0,1076.0,14941.0
Harda,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,3.0,1.0,1.0,0.0,2.0,0.0,1.0,0.0,1.0,2.0,2.0,14.0
Harda,15.2,Number of Widal tests conducted,Number tested,30.0,36.0,36.0,52.0,36.0,144.0,125.0,83.0,55.0,47.0,28.0,26.0,698.0
Harda,15.3.a,Number of VDRL tests conducted on males,Number tested,146.0,14.0,21.0,337.0,42.0,425.0,67.0,57.0,57.0,54.0,56.0,509.0,1785.0
Harda,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,80.0,3.0,4.0,7.0,53.0,53.0,82.0,93.0,86.0,86.0,85.0,110.0,742.0
Harda,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,199.0,380.0,354.0,436.0,395.0,253.0,344.0,697.0,537.0,461.0,570.0,346.0,4972.0
Harda,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,425.0,397.0,379.0,780.0,490.0,731.0,493.0,847.0,680.0,601.0,711.0,965.0,7499.0
Harda,15.4.1,Number of blood smears examined for Malaria,TOTAL,4481.0,2025.0,3914.0,3166.0,3081.0,4292.0,3900.0,3970.0,4222.0,2840.0,3892.0,3564.0,43347.0
Harda,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,11.0,0.0,5.0,16.0,11.0,16.0,20.0,12.0,0.0,1.0,0.0,3.0,95.0
Harda,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,0.0,1.0,1.0,3.0,13.0,38.0,20.0,2.0,6.0,0.0,0.0,86.0
Harda,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,5000.0,0.0,2500.0,0.0,4000.0,7000.0,7000.0,5000.0,7000.0,,4500.0,5250.0,47250.0
Harda,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,5000.0,0.0,7000.0,5000.0,7000.0,6000.0,6000.0,3000.0,,2000.0,2000.0,43000.0
Harda,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Harda,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,5000.0,2500.0,2500.0,1500.0,2000.0,7000.0,8000.0,4000.0,4000.0,,1250.0,3750.0,41500.0
Harda,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,2500.0,0.0,5500.0,7000.0,7000.0,5000.0,7000.0,6000.0,0.0,5250.0,3500.0,48750.0
Harda,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,,,,,,1900.0,4500.0,,5000.0,750.0,12150.0
Harda,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,3000.0,,,,5000.0,8000.0
Harda,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Harda,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,,,,,,,400.0,,,4250.0,600.0,5250.0
Harda,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4500.0,4500.0,0.0,750.0,5150.0,14900.0
Harda,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,43000.0,33000.0,26500.0,21000.0,21500.0,17000.0,14500.0,9000.0,15500.0,,14500.0,9500.0,225000.0
Harda,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,2000.0,,3000.0,3000.0,7000.0,8000.0,10000.0,,,96500.0,5000.0,134500.0
Harda,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Harda,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,10000.0,8500.0,5500.0,6000.0,7500.0,9500.0,13500.0,3500.0,8000.0,,101500.0,1500.0,175000.0
Harda,16.1.2,Stock position of OPV vaccines,5. Total Stock,33000.0,26500.0,21000.0,18000.0,17000.0,14500.0,9000.0,15500.0,7500.0,0.0,9500.0,13000.0,184500.0
Harda,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,13500.0,9500.0,11000.0,5000.0,5500.0,8500.0,5000.0,3500.0,6000.0,,5000.0,6500.0,79000.0
Harda,16.1.3,Stock position of TT vaccines,2. Stocks Received,,5000.0,,,5000.0,5000.0,6000.0,6000.0,,,5000.0,2000.0,34000.0
Harda,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Harda,16.1.3,Stock position of TT vaccines,4. Stock Distributed,4000.0,3500.0,5000.0,500.0,2000.0,8500.0,7500.0,3500.0,4000.0,,3500.0,3500.0,45500.0
Harda,16.1.3,Stock position of TT vaccines,5. Total Stock,9500.0,11000.0,6000.0,4500.0,8500.0,5000.0,3500.0,6000.0,2000.0,0.0,6500.0,5000.0,67500.0
Harda,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Harda,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Harda,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Harda,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Harda,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,5500.0,1500.0,5000.0,1500.0,4500.0,8500.0,6500.0,7000.0,5500.0,,5500.0,3250.0,54250.0
Harda,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,5000.0,,5000.0,5000.0,3000.0,2000.0,2000.0,,,,3000.0,25000.0
Harda,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Harda,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,4000.0,1500.0,3500.0,1500.0,1000.0,5000.0,1500.0,3500.0,2000.0,,2250.0,2250.0,28000.0
Harda,16.1.5,Stock position of BCG vaccines,5. Total Stock,1500.0,5000.0,1500.0,5000.0,8500.0,6500.0,7000.0,5500.0,3500.0,0.0,3250.0,4000.0,51250.0
Harda,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,10250.0,6250.0,8250.0,6250.0,10250.0,11500.0,7500.0,9500.0,10000.0,,9500.0,9750.0,99000.0
Harda,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,5000.0,,5000.0,5000.0,,5000.0,2000.0,,,2500.0,10000.0,34500.0
Harda,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Harda,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4000.0,3000.0,2000.0,750.0,3750.0,4000.0,3000.0,1500.0,3250.0,,2250.0,3750.0,31250.0
Harda,16.1.6,Stock position of Measles vaccines,5. Total Stock,6250.0,8250.0,6250.0,10500.0,11500.0,7500.0,9500.0,10000.0,6750.0,0.0,9750.0,16000.0,102250.0
Harda,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Harda,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Harda,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Harda,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Harda,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,12500.0,7500.0,7000.0,2500.0,6000.0,9000.0,7000.0,4500.0,4500.0,,4500.0,5500.0,70500.0
Harda,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,5000.0,,5000.0,5000.0,5000.0,2500.0,2500.0,,,2000.0,,27000.0
Harda,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Harda,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,5000.0,5500.0,4500.0,1500.0,2000.0,7000.0,5000.0,2500.0,,,1000.0,,34000.0
Harda,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,7500.0,7000.0,2500.0,6000.0,9000.0,7000.0,4500.0,4500.0,4500.0,0.0,5500.0,5500.0,63500.0
Harda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,300.0,300.0,1800.0,1200.0,1200.0,1000.0,200.0,200.0,200.0,,1900.0,1700.0,10000.0
Harda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,1800.0,,,,,,,,,,3000.0,4800.0
Harda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Harda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,300.0,600.0,,200.0,800.0,0.0,,200.0,,200.0,600.0,2900.0
Harda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,300.0,1800.0,1200.0,1200.0,1000.0,200.0,200.0,200.0,0.0,0.0,1700.0,4100.0,11900.0
Harda,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,174540.0,84060.0,126060.0,90780.0,140700.0,155340.0,165420.0,115020.0,104940.0,,58380.0,4380.0,1219620.0
Harda,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,60000.0,,,60000.0,50400.0,25200.0,,,,,30000.0,225600.0
Harda,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Harda,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,90480.0,18000.0,35280.0,15120.0,45360.0,40320.0,75600.0,10080.0,45360.0,,54000.0,6000.0,435600.0
Harda,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,84060.0,126060.0,90780.0,75660.0,155340.0,165420.0,115020.0,104940.0,59580.0,0.0,4380.0,28380.0,1009620.0
Harda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,24000.0,24200.0,25600.0,34000.0,28700.0,26700.0,,22700.0,19100.0,205000.0
Harda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,30000.0,5000.0,10000.0,10000.0,5000.0,,,,,40000.0,100000.0
Harda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Harda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,6000.0,4800.0,8600.0,1600.0,10300.0,2000.0,6500.0,,3600.0,1000.0,44400.0
Harda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,24000.0,24200.0,25600.0,34000.0,28700.0,26700.0,20200.0,0.0,19100.0,58100.0,260600.0
Harda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1060.0,1060.0,1060.0,1340.0,2560.0,1800.0,520.0,2520.0,2520.0,,1460.0,1460.0,17360.0
Harda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,1500.0,,,,,,,,,9150.0,10650.0
Harda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Harda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,,,760.0,1280.0,,,1060.0,,,,3100.0
Harda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1060.0,1060.0,2560.0,1340.0,1800.0,520.0,520.0,2520.0,1460.0,0.0,1460.0,10610.0,24910.0
Harda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,4600.0,4600.0,4600.0,4600.0,4600.0,4400.0,3900.0,4400.0,3400.0,,2400.0,2400.0,43900.0
Harda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Harda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Harda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,500.0,200.0,,0.0,1000.0,900.0,,,,2600.0
Harda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,4600.0,4600.0,4600.0,4100.0,4400.0,4400.0,3900.0,3400.0,2500.0,0.0,2400.0,2400.0,41300.0
Harda,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Harda,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Harda,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Harda,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Harda,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Harda,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Harda,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Harda,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Harda,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Harda,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Harda,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Harda,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Harda,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Harda,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Harda,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Harda,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Harda,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Harda,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Harda,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Harda,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Harda,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Harda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Harda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Harda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Harda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Harda,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Harda,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Harda,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Harda,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Harda,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Harda,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Harda,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Harda,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Harda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Harda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Harda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Harda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,1189.0,1189.0,339.0,339.0,539.0,339.0,,,39.0,,3973.0
Harda,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,0.0,,,,,,0.0
Harda,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Harda,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,650.0,,,0.0,,,,,,650.0
Harda,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,1189.0,539.0,339.0,339.0,539.0,339.0,0.0,0.0,39.0,0.0,3323.0
Harda,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Harda,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Harda,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Harda,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Harda,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Harda,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,8100.0,3800.0,2600.0,2800.0,5100.0,6900.0,9700.0,7700.0,9000.0,,10000.0,8000.0,73700.0
Harda,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,0.0,,3000.0,3300.0,3300.0,1500.0,3300.0,,,,,14400.0
Harda,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Harda,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,4300.0,1200.0,0.0,1200.0,1500.0,500.0,3500.0,2000.0,1500.0,,2000.0,1000.0,18700.0
Harda,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3800.0,2600.0,2600.0,4600.0,6900.0,9700.0,7700.0,9000.0,7500.0,0.0,8000.0,7000.0,69400.0
Harda,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,40400.0,29800.0,43100.0,42500.0,35300.0,44500.0,46500.0,48100.0,33700.0,,32900.0,32900.0,429700.0
Harda,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,24000.0,,,24000.0,24000.0,10000.0,,,,,200000.0,282000.0
Harda,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Harda,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,10600.0,10700.0,600.0,7200.0,14800.0,22000.0,10400.0,14400.0,14400.0,,,26700.0,131800.0
Harda,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,29800.0,43100.0,42500.0,35300.0,44500.0,46500.0,46100.0,33700.0,19300.0,0.0,32900.0,206200.0,579900.0
Harda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,4500.0,3500.0,3500.0,2500.0,2000.0,600.0,600.0,0.0,4000.0,,3100.0,2000.0,26300.0
Harda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,0.0,,,,,,4000.0,,,,4000.0,8000.0
Harda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Harda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1000.0,0.0,1000.0,500.0,1400.0,600.0,,0.0,500.0,,1100.0,,6100.0
Harda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,3500.0,3500.0,2500.0,2000.0,600.0,0.0,600.0,4000.0,3500.0,0.0,2000.0,6000.0,28200.0
Harda,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,,,2.0,,,,1.0,2.0,2.0,,,8.0
Harda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,4.0,1.0,3.0,4.0,2.0,,3.0,2.0,1.0,,4.0,2.0,26.0
Harda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,2.0,,,,,,,1.0,1.0,,,4.0
Harda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,4.0,3.0,3.0,4.0,2.0,,3.0,2.0,2.0,1.0,4.0,2.0,30.0
Harda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,3.0,,,2.0,,,,1.0,,,1.0,9.0
Harda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Harda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,3.0,,,2.0,,,,1.0,,,1.0,9.0
Harda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,3.0,3.0,,1.0,5.0,13.0,10.0,8.0,9.0,6.0,3.0,61.0
Harda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,1.0,,,,1.0,,,4.0,1.0,2.0,10.0
Harda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,4.0,4.0,,1.0,5.0,14.0,10.0,8.0,13.0,7.0,5.0,71.0
Harda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,6.0,6.0,4.0,8.0,7.0,2.0,1.0,5.0,5.0,9.0,6.0,8.0,67.0
Harda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,1.0,2.0,4.0
Harda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,6.0,6.0,4.0,8.0,7.0,2.0,1.0,5.0,5.0,10.0,7.0,10.0,71.0
Harda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,1.0,2.0,,,1.0,1.0,1.0,1.0,,1.0,9.0
Harda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,2.0,,,,,,2.0
Harda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,1.0,2.0,,,3.0,1.0,1.0,1.0,,1.0,11.0
Harda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,1.0,,1.0
Harda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,1.0,,,1.0,,,,,2.0
Harda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,1.0,,,1.0,,,1.0,,3.0
Harda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,2.0,1.0,,,,1.0,4.0
Harda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,,,,1.0,2.0,,,,,,4.0
Harda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,1.0,,,,1.0,4.0,1.0,,,,1.0,8.0
Harda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Harda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Harda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Harda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,,1.0,5.0,,3.0,4.0,4.0,4.0,4.0,,2.0,29.0
Harda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,1.0,1.0,3.0,3.0,5.0,2.0,3.0,2.0,,1.0,22.0
Harda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,1.0,2.0,6.0,3.0,6.0,9.0,6.0,7.0,6.0,,3.0,51.0
Harda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Harda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Harda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Harda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,1.0,,,,,1.0
Harda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Harda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,1.0,,1.0,,2.0
Harda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,2.0,,,,2.0
Harda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,3.0,1.0,1.0,,5.0
Harda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Harda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,1.0,,,1.0,,,2.0
Harda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Harda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,1.0,,1.0,1.0,,,3.0
Harda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Harda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Harda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Harda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Harda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Harda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,2.0,1.0,,1.0,2.0,2.0,1.0,,3.0,3.0,,15.0
Harda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,1.0,2.0,3.0,2.0,2.0,1.0,,2.0,2.0,2.0,,18.0
Harda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,3.0,3.0,3.0,3.0,4.0,3.0,1.0,2.0,5.0,5.0,,33.0
Harda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Harda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Harda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Harda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Harda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Harda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,2.0,5.0,2.0,3.0,3.0,1.0,4.0,3.0,8.0,6.0,4.0,44.0
Harda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,8.0,9.0,7.0,14.0,10.0,6.0,6.0,6.0,9.0,7.0,7.0,11.0,100.0
Harda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,11.0,11.0,12.0,16.0,13.0,9.0,7.0,10.0,12.0,15.0,13.0,16.0,145.0
Harda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Harda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Harda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,1.0,,1.0,,1.0,3.0
Harda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,1.0,1.0,1.0,,1.0,4.0
Harda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Harda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Harda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Harda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Harda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Harda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Harda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Harda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Harda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Harda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,,1.0,,,,,,1.0,,,,3.0
Harda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Harda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,,1.0,,,,,,1.0,,,,3.0
Harda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Harda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Harda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Harda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,1.0,,,,,,,,1.0
Harda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Harda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Harda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Harda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Harda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Harda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,,,,,,2.0,2.0,1.0,,1.0,,7.0
Harda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Harda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,,,,,,2.0,2.0,1.0,,1.0,,7.0
Harda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,1.0,,,1.0,,,2.0
Harda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,5.0,12.0,6.0,3.0,1.0,2.0,3.0,9.0,5.0,8.0,2.0,6.0,62.0
Harda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,1.0,,1.0,1.0,2.0,1.0,2.0,1.0,3.0,1.0,2.0,15.0
Harda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,5.0,13.0,6.0,4.0,2.0,4.0,5.0,11.0,6.0,12.0,3.0,8.0,79.0
Harda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Harda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,2.0,1.0,1.0,,1.0,,1.0,4.0,4.0,2.0,4.0,20.0
Harda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Harda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,2.0,1.0,1.0,,2.0,,1.0,4.0,4.0,2.0,4.0,21.0
Harda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,2.0,,1.0,,,,,3.0
Harda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,,,2.0,,1.0,,,,,4.0
Harda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Harda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,1.0,,,5.0,,2.0,,,,,8.0
Harda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Harda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,,3.0,3.0,1.0,2.0,2.0,3.0,4.0,2.0,3.0,5.0,29.0
Harda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,1.0,11.0,1.0,2.0,8.0,9.0,4.0,5.0,5.0,2.0,3.0,51.0
Harda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,1.0,14.0,4.0,3.0,10.0,11.0,7.0,9.0,8.0,5.0,8.0,81.0
Harda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Harda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,5.0,1.0,2.0,4.0,8.0,7.0,8.0,9.0,6.0,6.0,6.0,63.0
Harda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,11.0,15.0,7.0,10.0,14.0,11.0,11.0,8.0,7.0,19.0,7.0,10.0,130.0
Harda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,12.0,20.0,8.0,12.0,18.0,19.0,18.0,16.0,16.0,25.0,13.0,16.0,193.0
Harda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Harda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,3.0,6.0,1.0,5.0,2.0,2.0,6.0,4.0,1.0,5.0,8.0,4.0,47.0
Harda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,24.0,23.0,22.0,21.0,21.0,39.0,22.0,34.0,35.0,40.0,27.0,37.0,345.0
Harda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,27.0,29.0,23.0,27.0,23.0,41.0,28.0,38.0,36.0,45.0,35.0,41.0,393.0
Hoshangabad,1.1,Total number of pregnant women Registered for ANC,TOTAL,1429.0,1845.0,2658.0,2592.0,1951.0,2358.0,2196.0,2333.0,2224.0,2171.0,2455.0,2393.0,26605.0
Hoshangabad,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,928.0,1150.0,1341.0,1571.0,1186.0,1419.0,1431.0,1401.0,1310.0,1238.0,1606.0,1448.0,16029.0
Hoshangabad,1.2,Number of Pregnant women registered under JSY,TOTAL,1429.0,1845.0,2316.0,2338.0,1779.0,2145.0,1881.0,2023.0,2014.0,1877.0,2230.0,2393.0,24270.0
Hoshangabad,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1188.0,1347.0,1901.0,1802.0,1843.0,1861.0,1743.0,1947.0,1909.0,1883.0,2230.0,2134.0,21788.0
Hoshangabad,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1167.0,1472.0,1910.0,2151.0,1610.0,1862.0,1816.0,1850.0,1786.0,1563.0,2020.0,1842.0,21049.0
Hoshangabad,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1080.0,1527.0,1966.0,2257.0,1997.0,2054.0,1776.0,2118.0,2063.0,1766.0,2226.0,2111.0,22941.0
Hoshangabad,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1517.0,2147.0,2826.0,2731.0,2110.0,2581.0,2382.0,2443.0,2474.0,2231.0,2675.0,2464.0,28581.0
Hoshangabad,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,81.0,243.0,159.0,206.0,157.0,130.0,122.0,145.0,139.0,112.0,148.0,116.0,1758.0
Hoshangabad,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,2.0,16.0,7.0,29.0,15.0,4.0,2.0,3.0,3.0,8.0,3.0,93.0
Hoshangabad,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,700.0,1143.0,1419.0,1283.0,1071.0,1364.0,1113.0,1507.0,1684.0,1304.0,1600.0,1466.0,15654.0
Hoshangabad,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,19.0,49.0,91.0,91.0,87.0,92.0,149.0,59.0,82.0,43.0,84.0,35.0,881.0
Hoshangabad,1.8,Number of pregnancy test kits used at SC level,TOTAL,303.0,426.0,478.0,583.0,430.0,468.0,521.0,572.0,651.0,585.0,597.0,592.0,6206.0
Hoshangabad,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,1.0,2.0,7.0,7.0,12.0,14.0,39.0,25.0,19.0,22.0,10.0,14.0,172.0
Hoshangabad,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,49.0,57.0,62.0,79.0,91.0,53.0,62.0,67.0,71.0,71.0,59.0,62.0,783.0
Hoshangabad,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,50.0,59.0,69.0,86.0,103.0,67.0,101.0,92.0,90.0,93.0,69.0,76.0,955.0
Hoshangabad,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,40.0,49.0,65.0,83.0,94.0,63.0,101.0,88.0,88.0,86.0,66.0,66.0,889.0
Hoshangabad,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,5.0,4.0,8.0,1.0,6.0,7.0,1.0,18.0,5.0,0.0,55.0
Hoshangabad,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1005.0,1280.0,1413.0,1444.0,1491.0,1669.0,1456.0,1652.0,1438.0,1573.0,1408.0,1634.0,17463.0
Hoshangabad,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,72.0,116.0,537.0,2.0,15.0,15.0,10.0,36.0,15.0,21.0,16.0,15.0,870.0
Hoshangabad,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,897.0,1161.0,1413.0,1386.0,1446.0,1610.0,1398.0,1535.0,1437.0,1573.0,1406.0,1634.0,16896.0
Hoshangabad,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,695.0,977.0,739.0,647.0,777.0,910.0,776.0,989.0,925.0,986.0,872.0,1129.0,10422.0
Hoshangabad,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,136.0,77.0,437.0,101.0,265.0,303.0,142.0,127.0,51.0,101.0,181.0,141.0,2062.0
Hoshangabad,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,315.0,270.0,319.0,394.0,320.0,260.0,432.0,460.0,460.0,275.0,612.0,933.0,5050.0
Hoshangabad,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Hoshangabad,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,1.0,1.0,0.0,1.0,0.0,1.0,0.0,2.0,10.0,20.0,11.0,12.0,59.0
Hoshangabad,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,150.0,156.0,216.0,201.0,198.0,217.0,196.0,218.0,196.0,185.0,197.0,199.0,2329.0
Hoshangabad,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hoshangabad,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,151.0,157.0,216.0,202.0,198.0,218.0,196.0,220.0,206.0,205.0,208.0,211.0,2388.0
Hoshangabad,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,170.0,135.0,158.0,128.0,125.0,151.0,272.0,211.0,211.0,128.0,341.0,488.0,2518.0
Hoshangabad,4.1.1.a,Number of male live births,TOTAL,732.0,834.0,944.0,1052.0,999.0,1035.0,1019.0,1143.0,1032.0,999.0,1067.0,1325.0,12181.0
Hoshangabad,4.1.1.b,Number of female live births,TOTAL,618.0,756.0,841.0,850.0,910.0,938.0,948.0,1039.0,935.0,923.0,1002.0,1304.0,11064.0
Hoshangabad,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1350.0,1590.0,1785.0,1902.0,1909.0,1973.0,1967.0,2182.0,1967.0,1922.0,2069.0,2629.0,23245.0
Hoshangabad,4.1.2,Number of still births,TOTAL,29.0,30.0,27.0,33.0,21.0,38.0,34.0,35.0,35.0,37.0,31.0,25.0,375.0
Hoshangabad,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,40.0,39.0,135.0,99.0,78.0,79.0,63.0,76.0,78.0,87.0,73.0,119.0,966.0
Hoshangabad,4.2.1,Number of Newborns weighed at birth,TOTAL,1271.0,1581.0,1763.0,1821.0,1896.0,1970.0,1967.0,2175.0,1951.0,1912.0,2073.0,2606.0,22986.0
Hoshangabad,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,144.0,256.0,288.0,483.0,263.0,242.0,232.0,231.0,267.0,213.0,186.0,553.0,3358.0
Hoshangabad,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1259.0,1403.0,1616.0,1864.0,1880.0,1968.0,1934.0,2159.0,1948.0,1908.0,2073.0,2603.0,22615.0
Hoshangabad,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,9.0,8.0,1.0,0.0,2.0,2.0,4.0,4.0,7.0,4.0,3.0,1.0,45.0
Hoshangabad,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,37.0,23.0,25.0,31.0,34.0,26.0,110.0,51.0,67.0,79.0,106.0,83.0,672.0
Hoshangabad,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,48.0,111.0,130.0,111.0,93.0,327.0,220.0,368.0,202.0,160.0,224.0,275.0,2269.0
Hoshangabad,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hoshangabad,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,94.0,142.0,156.0,142.0,129.0,355.0,334.0,423.0,276.0,243.0,333.0,359.0,2986.0
Hoshangabad,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,7.0,3.0,163.0,125.0,120.0,159.0,272.0,310.0,310.0,205.0,218.0,128.0,2020.0
Hoshangabad,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,123.0,237.0,267.0,158.0,224.0,209.0,521.0,722.0,564.0,414.0,518.0,570.0,4527.0
Hoshangabad,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,13.0,11.0,55.0,86.0,96.0,47.0,267.0,459.0,408.0,241.0,260.0,44.0,1987.0
Hoshangabad,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,182.0,98.0,171.0,320.0,480.0,200.0,372.0,721.0,267.0,429.0,409.0,429.0,4078.0
Hoshangabad,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,54.0,12.0,97.0,78.0,56.0,64.0,71.0,66.0,40.0,22.0,28.0,88.0,676.0
Hoshangabad,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1349.0,1471.0,1775.0,1831.0,1903.0,1975.0,1954.0,2108.0,1965.0,1772.0,1951.0,2542.0,22596.0
Hoshangabad,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,752.0,748.0,902.0,910.0,1062.0,1082.0,1340.0,1013.0,960.0,938.0,1028.0,1165.0,11900.0
Hoshangabad,6.3,PNC maternal complications attended,TOTAL,9.0,17.0,14.0,33.0,54.0,21.0,35.0,43.0,51.0,65.0,108.0,23.0,473.0
Hoshangabad,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,12.0,51.0,47.0,54.0,50.0,28.0,34.0,45.0,56.0,50.0,45.0,74.0,546.0
Hoshangabad,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,21.0,5.0,5.0,6.0,1.0,3.0,5.0,4.0,0.0,4.0,54.0
Hoshangabad,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,12.0,51.0,68.0,59.0,55.0,34.0,35.0,48.0,61.0,54.0,45.0,78.0,600.0
Hoshangabad,7.2,Number of MTPs conducted at Private Facilities,TOTAL,26.0,35.0,85.0,35.0,31.0,22.0,7.0,14.0,14.0,18.0,43.0,218.0,548.0
Hoshangabad,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,104.0,205.0,282.0,329.0,235.0,326.0,237.0,373.0,408.0,225.0,287.0,286.0,3297.0
Hoshangabad,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,262.0,405.0,480.0,587.0,625.0,732.0,459.0,128.0,553.0,581.0,563.0,716.0,6091.0
Hoshangabad,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,366.0,610.0,762.0,916.0,860.0,1058.0,696.0,501.0,961.0,806.0,850.0,1002.0,9388.0
Hoshangabad,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,383.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,190.0,574.0
Hoshangabad,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,5.0,5.0,9.0,14.0,34.0
Hoshangabad,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,2.0,0.0,0.0,3.0,1.0,1.0,4.0,2.0,1.0,1.0,0.0,17.0
Hoshangabad,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hoshangabad,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,2.0,0.0,0.0,3.0,1.0,1.0,5.0,7.0,6.0,10.0,14.0,51.0
Hoshangabad,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,5.0,0.0,0.0,0.0,0.0,2.0,0.0,8.0,7.0,1.0,0.0,0.0,23.0
Hoshangabad,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,4.0,3.0,0.0,0.0,0.0,0.0,0.0,13.0,0.0,0.0,0.0,0.0,20.0
Hoshangabad,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,1.0,5.0,0.0,39.0,24.0,18.0,18.0,326.0,1080.0,646.0,573.0,117.0,2847.0
Hoshangabad,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,2.0,0.0,0.0,6.0,0.0,8.0,3.0,44.0,48.0,75.0,78.0,79.0,343.0
Hoshangabad,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hoshangabad,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,7.0,8.0,0.0,45.0,24.0,26.0,21.0,383.0,1128.0,721.0,651.0,196.0,3210.0
Hoshangabad,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,17.0,10.0,12.0,0.0,53.0,19.0,0.0,43.0,30.0,0.0,35.0,108.0,327.0
Hoshangabad,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Hoshangabad,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,7.0,13.0,6.0,12.0,39.0
Hoshangabad,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,7.0,0.0,30.0,14.0,18.0,16.0,7.0,41.0,23.0,47.0,46.0,43.0,292.0
Hoshangabad,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hoshangabad,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,7.0,0.0,30.0,14.0,21.0,16.0,7.0,41.0,30.0,60.0,52.0,55.0,333.0
Hoshangabad,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,25.0,13.0,22.0,9.0,26.0,0.0,0.0,5.0,5.0,3.0,108.0
Hoshangabad,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Hoshangabad,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0,4.0
Hoshangabad,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,9.0,22.0,16.0,9.0,4.0,26.0,54.0,47.0,77.0,6.0,4.0,4.0,278.0
Hoshangabad,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hoshangabad,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,9.0,22.0,16.0,9.0,16.0,26.0,54.0,47.0,77.0,6.0,5.0,7.0,294.0
Hoshangabad,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,3.0,11.0,6.0,3.0,28.0,24.0,24.0,2.0,1.0,0.0,102.0
Hoshangabad,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,206.0,287.0,379.0,441.0,418.0,396.0,401.0,485.0,452.0,454.0,445.0,452.0,4816.0
Hoshangabad,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,25.0,19.0,40.0,34.0,50.0,4.0,18.0,30.0,36.0,39.0,49.0,11.0,355.0
Hoshangabad,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,46.0,20.0,49.0,41.0,33.0,38.0,97.0,56.0,59.0,58.0,86.0,100.0,683.0
Hoshangabad,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,82.0,98.0,134.0,56.0,62.0,65.0,56.0,47.0,45.0,29.0,42.0,606.0,1322.0
Hoshangabad,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hoshangabad,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,359.0,424.0,602.0,572.0,563.0,503.0,572.0,618.0,592.0,580.0,622.0,1169.0,7176.0
Hoshangabad,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,66.0,54.0,100.0,118.0,806.0,80.0,134.0,97.0,65.0,93.0,146.0,768.0,2527.0
Hoshangabad,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,11.0,9.0,10.0,2.0,18.0,3.0,3.0,0.0,11.0,15.0,82.0
Hoshangabad,9.06,Number of IUCD removals,TOTAL,149.0,133.0,200.0,187.0,146.0,787.0,174.0,268.0,303.0,222.0,238.0,250.0,3057.0
Hoshangabad,9.07,Number of Oral Pills cycles distributed,TOTAL,8343.0,8972.0,8456.0,11351.0,9518.0,16862.0,9581.0,9900.0,10126.0,9982.0,9563.0,9998.0,122652.0
Hoshangabad,9.08,Number of Condom pieces distributed,TOTAL,80356.0,102083.0,92959.0,102240.0,101289.0,98638.0,101574.0,105409.0,106722.0,109085.0,107114.0,105754.0,1213223.0
Hoshangabad,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,,0.0,,,,,,,0.0
Hoshangabad,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,11.0,394.0,1.0,35.0,2.0,16.0,97.0,16.0,22.0,33.0,36.0,30.0,693.0
Hoshangabad,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,1.0,1.0,0.0,0.0,0.0,1.0,5.0
Hoshangabad,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,9.12,Number of Institutions having NSV trained doctors,TOTAL,10.0,9.0,9.0,7.0,7.0,6.0,7.0,3.0,5.0,5.0,4.0,8.0,-1.0
Hoshangabad,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1288.0,1490.0,1832.0,1757.0,1973.0,1962.0,1922.0,2025.0,1844.0,1911.0,1941.0,2894.0,22839.0
Hoshangabad,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1175.0,1525.0,1785.0,1751.0,1727.0,1868.0,1860.0,877.0,41.0,30.0,23.0,261.0,12923.0
Hoshangabad,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1269.0,1507.0,1735.0,1779.0,1599.0,1751.0,1672.0,1840.0,768.0,168.0,63.0,199.0,14350.0
Hoshangabad,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1411.0,1559.0,1711.0,1778.0,1768.0,1789.0,1656.0,1828.0,1914.0,616.0,222.0,440.0,16692.0
Hoshangabad,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1189.0,1804.0,1891.0,1916.0,2182.0,8982.0
Hoshangabad,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1146.0,1583.0,1955.0,2331.0,7015.0
Hoshangabad,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1096.0,1612.0,2492.0,5200.0
Hoshangabad,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1002.0,1287.0,1670.0,1688.0,1837.0,1810.0,1674.0,1877.0,1600.0,1581.0,1808.0,1766.0,19600.0
Hoshangabad,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1176.0,1525.0,1830.0,1766.0,1740.0,1866.0,1826.0,1823.0,1893.0,2103.0,1923.0,2221.0,21692.0
Hoshangabad,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1262.0,1507.0,1732.0,1776.0,1620.0,1743.0,1677.0,1826.0,1864.0,1724.0,2019.0,2376.0,21126.0
Hoshangabad,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1417.0,1559.0,1710.0,1773.0,1776.0,1799.0,1626.0,1824.0,1915.0,1694.0,1815.0,2596.0,21504.0
Hoshangabad,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,891.0,753.0,957.0,953.0,1318.0,1002.0,1268.0,1197.0,1248.0,1080.0,1065.0,1200.0,12932.0
Hoshangabad,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1171.0,1525.0,1895.0,1954.0,1712.0,1964.0,1738.0,950.0,153.0,212.0,222.0,182.0,13678.0
Hoshangabad,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1277.0,1507.0,1731.0,1781.0,1603.0,1729.0,1569.0,1868.0,846.0,150.0,66.0,194.0,14321.0
Hoshangabad,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1410.0,1559.0,1714.0,1778.0,1766.0,1725.0,1635.0,1836.0,1930.0,695.0,205.0,160.0,16413.0
Hoshangabad,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1090.0,1744.0,2069.0,2110.0,1852.0,2089.0,1862.0,1923.0,1816.0,1716.0,1874.0,2364.0,22509.0
Hoshangabad,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,867.0,1096.0,1179.0,1352.0,1364.0,1293.0,1267.0,1464.0,1421.0,1458.0,1650.0,2334.0,16745.0
Hoshangabad,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,0.0,0.0
Hoshangabad,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,523.0,726.0,921.0,911.0,808.0,879.0,809.0,877.0,883.0,807.0,888.0,1142.0,10174.0
Hoshangabad,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,446.0,680.0,853.0,822.0,749.0,798.0,742.0,809.0,748.0,731.0,846.0,1066.0,9290.0
Hoshangabad,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,969.0,1406.0,1774.0,1733.0,1557.0,1677.0,1551.0,1686.0,1631.0,1538.0,1734.0,2208.0,19464.0
Hoshangabad,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1204.0,1366.0,1688.0,1936.0,1586.0,1725.0,1505.0,1752.0,1725.0,1795.0,1784.0,2522.0,20588.0
Hoshangabad,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1207.0,1314.0,1684.0,1938.0,1588.0,1724.0,1520.0,1731.0,1724.0,1798.0,1790.0,2528.0,20546.0
Hoshangabad,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Hoshangabad,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,170.0,214.0,261.0,309.0,229.0,231.0,297.0,352.0,345.0,355.0,371.0,434.0,3568.0
Hoshangabad,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,167.0,209.0,227.0,276.0,209.0,223.0,254.0,298.0,315.0,312.0,350.0,416.0,3256.0
Hoshangabad,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,337.0,423.0,488.0,585.0,438.0,454.0,551.0,650.0,660.0,667.0,721.0,850.0,6824.0
Hoshangabad,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,337.0,545.0,694.0,928.0,845.0,1144.0,1063.0,1238.0,1066.0,1060.0,948.0,987.0,10855.0
Hoshangabad,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,598.0,897.0,1100.0,1563.0,1505.0,1953.0,1715.0,2191.0,1807.0,1610.0,1589.0,1409.0,17937.0
Hoshangabad,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,707.0,941.0,1268.0,1723.0,1687.0,1895.0,1730.0,2420.0,1913.0,1749.0,1790.0,1559.0,19382.0
Hoshangabad,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Hoshangabad,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,4.0,0.0,6.0,1.0,0.0,0.0,0.0,0.0,11.0
Hoshangabad,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1069.0,1349.0,1378.0,1386.0,1333.0,1344.0,1359.0,1375.0,1375.0,1348.0,1324.0,1473.0,16113.0
Hoshangabad,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1012.0,1313.0,1338.0,1351.0,1315.0,1295.0,1302.0,1330.0,1344.0,1299.0,1302.0,1454.0,15655.0
Hoshangabad,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,935.0,1099.0,1170.0,1076.0,1091.0,1075.0,1045.0,1100.0,1133.0,1106.0,1090.0,1222.0,13142.0
Hoshangabad,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1100.0,1692.0,2016.0,2362.0,1884.0,2013.0,1761.0,1881.0,1763.0,1739.0,1844.0,2424.0,22479.0
Hoshangabad,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,581.0,625.0,813.0,14474.0,6377.0,987.0,711.0,833.0,2700.0,15187.0,3098.0,1098.0,47484.0
Hoshangabad,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,357.0,440.0,600.0,10764.0,7544.0,989.0,330.0,527.0,2015.0,14867.0,2714.0,468.0,41615.0
Hoshangabad,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,13.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,23.0
Hoshangabad,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,427.0,448.0,469.0,449.0,456.0,503.0,371.0,450.0,618.0,492.0,487.0,461.0,5631.0
Hoshangabad,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,19.0,23.0,10.0,24.0,27.0,84.0,411.0,47.0,81.0,65.0,5.0,0.0,796.0
Hoshangabad,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,129.0,105.0,132.0,136.0,177.0,209.0,194.0,223.0,97.0,212.0,230.0,278.0,2122.0
Hoshangabad,13.1,Number of Patients operated for cataract,TOTAL,148.0,33.0,35.0,32.0,29.0,358.0,273.0,434.0,1312.0,358.0,593.0,605.0,4210.0
Hoshangabad,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,148.0,33.0,35.0,32.0,29.0,320.0,273.0,432.0,944.0,358.0,587.0,593.0,3784.0
Hoshangabad,13.3,Number of School children detected with Refractive errors,TOTAL,45.0,10.0,2.0,1036.0,55.0,116.0,80.0,660.0,235.0,95.0,41.0,47.0,2422.0
Hoshangabad,13.4,Number of children provided free glasses,TOTAL,25.0,10.0,0.0,0.0,0.0,0.0,42.0,360.0,257.0,307.0,28.0,0.0,1029.0
Hoshangabad,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,212.0,0.0,0.0,0.0,212.0
Hoshangabad,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,51.0,0.0,0.0,0.0,51.0
Hoshangabad,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,5.0,5.0,4.0,4.0,4.0,5.0,7.0,7.0,8.0,8.0,8.0,-1.0
Hoshangabad,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,6.0,7.0,7.0,7.0,8.0,7.0,8.0,8.0,11.0,10.0,10.0,11.0,-1.0
Hoshangabad,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,836.0,1028.0,1051.0,1008.0,1026.0,1057.0,1005.0,992.0,1007.0,1010.0,988.0,1133.0,-1.0
Hoshangabad,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,10.0,10.0,8.0,8.0,7.0,7.0,9.0,9.0,8.0,8.0,9.0,8.0,-1.0
Hoshangabad,14.05,Number of RKS meetings held during the month,TOTAL,9.0,8.0,12.0,6.0,3.0,7.0,4.0,4.0,4.0,5.0,4.0,1.0,67.0
Hoshangabad,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,14.0,12.0,14.0,11.0,14.0,11.0,12.0,11.0,11.0,11.0,11.0,15.0,-1.0
Hoshangabad,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,17.0,37.0,52.0,32.0,17.0,61.0,27.0,25.0,34.0,49.0,45.0,39.0,435.0
Hoshangabad,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,7.0,6.0,5.0,5.0,6.0,5.0,6.0,7.0,6.0,7.0,7.0,7.0,-1.0
Hoshangabad,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,2.0,2.0,2.0,1.0,2.0,2.0,2.0,1.0,2.0,2.0,-1.0
Hoshangabad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,696.0,885.0,834.0,702.0,1115.0,990.0,330.0,634.0,727.0,863.0,811.0,1176.0,9763.0
Hoshangabad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2441.0,3697.0,3147.0,2823.0,2023.0,2984.0,25605.0,1897.0,1990.0,2334.0,2495.0,2539.0,53975.0
Hoshangabad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,540.0,927.0,864.0,800.0,781.0,1044.0,271.0,773.0,734.0,815.0,1011.0,886.0,9446.0
Hoshangabad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2739.0,3442.0,4276.0,3589.0,2822.0,3823.0,28200.0,3189.0,3581.0,3571.0,3005.0,3613.0,65850.0
Hoshangabad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1236.0,1812.0,1698.0,1502.0,1896.0,2034.0,601.0,1407.0,1461.0,1678.0,1822.0,2062.0,19209.0
Hoshangabad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5180.0,7139.0,7423.0,6412.0,4845.0,6807.0,53805.0,5086.0,5571.0,5905.0,5500.0,6152.0,119825.0
Hoshangabad,14.10.2.a,Number of death cases of Inpatient males,TOTAL,22.0,13.0,26.0,16.0,34.0,25.0,9.0,16.0,7.0,11.0,6.0,10.0,195.0
Hoshangabad,14.10.2.b,Number of death cases of Inpatient females,TOTAL,14.0,8.0,22.0,17.0,19.0,25.0,4.0,6.0,8.0,3.0,3.0,2.0,131.0
Hoshangabad,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,36.0,21.0,48.0,33.0,53.0,50.0,13.0,22.0,15.0,14.0,9.0,12.0,326.0
Hoshangabad,14.11,In-Patient Head Count at midnight,TOTAL,1139.0,1133.0,1405.0,1533.0,1380.0,1335.0,1295.0,4312.0,1374.0,1212.0,1275.0,4602.0,21995.0
Hoshangabad,14.12.1,OPD attendance (All),TOTAL,48748.0,61583.0,68521.0,70681.0,69482.0,98568.0,299217.0,74873.0,67342.0,62381.0,79469.0,81577.0,1082442.0
Hoshangabad,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,163.0,229.0,288.0,112.0,87.0,305.0,60.0,71.0,181.0,232.0,272.0,169.0,2169.0
Hoshangabad,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,3.0,26.0,1.0,45.0,3.0,0.0,2.0,0.0,11.0,14.0,137.0,7.0,249.0
Hoshangabad,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,171.0,368.0,421.0,361.0,452.0,331.0,183.0,567.0,1123.0,908.0,803.0,377.0,6065.0
Hoshangabad,14.14.a,Number of patients given AYUSH treatment,TOTAL,839.0,2385.0,1870.0,2593.0,2628.0,4562.0,4229.0,4127.0,2889.0,3364.0,4265.0,4224.0,37975.0
Hoshangabad,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,331.0,340.0,333.0,563.0,540.0,529.0,113.0,237.0,145.0,247.0,111.0,113.0,3602.0
Hoshangabad,14.14.c,Number of Adolescents counselled,TOTAL,341.0,352.0,264.0,54.0,94.0,88.0,58.0,143.0,189.0,145.0,230.0,158.0,2116.0
Hoshangabad,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4814.0,6365.0,8794.0,8114.0,8028.0,9459.0,5510.0,9556.0,9245.0,6313.0,11192.0,12988.0,100378.0
Hoshangabad,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,202.0,249.0,238.0,259.0,326.0,374.0,286.0,381.0,331.0,119.0,142.0,396.0,3303.0
Hoshangabad,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,131.0,156.0,725.0,337.0,371.0,263.0,494.0,175.0,413.0,223.0,613.0,1513.0,5414.0
Hoshangabad,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,111.0,3.0,18.0,2.0,2.0,0.0,1.0,2.0,2.0,1.0,4.0,146.0
Hoshangabad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,167.0,207.0,541.0,252.0,426.0,260.0,206.0,242.0,745.0,341.0,655.0,838.0,4880.0
Hoshangabad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,65.0,1.0,382.0,61.0,80.0,0.0,0.0,1.0,0.0,2.0,1.0,594.0
Hoshangabad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,824.0,1160.0,1894.0,1831.0,1448.0,2408.0,1037.0,1648.0,1950.0,1801.0,1672.0,1827.0,19500.0
Hoshangabad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,353.0,0.0,613.0,29.0,2.0,0.0,0.0,1.0,0.0,0.0,1.0,999.0
Hoshangabad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1122.0,1523.0,3160.0,2420.0,2245.0,2931.0,1737.0,2065.0,3108.0,2365.0,2940.0,4178.0,29794.0
Hoshangabad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,529.0,4.0,1013.0,92.0,84.0,0.0,1.0,4.0,2.0,3.0,6.0,1739.0
Hoshangabad,15.2,Number of Widal tests conducted,Number tested,266.0,225.0,409.0,873.0,826.0,322.0,1158.0,805.0,863.0,704.0,826.0,1650.0,8927.0
Hoshangabad,15.3.a,Number of VDRL tests conducted on males,Number tested,35.0,50.0,202.0,133.0,145.0,354.0,170.0,279.0,312.0,230.0,236.0,606.0,2752.0
Hoshangabad,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,114.0,50.0,70.0,610.0,391.0,455.0,83.0,105.0,394.0,378.0,226.0,167.0,3043.0
Hoshangabad,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,115.0,278.0,489.0,317.0,725.0,841.0,480.0,867.0,825.0,567.0,1322.0,2892.0,9718.0
Hoshangabad,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,264.0,378.0,761.0,1060.0,1261.0,1650.0,733.0,1251.0,1531.0,1175.0,1784.0,3665.0,15513.0
Hoshangabad,15.4.1,Number of blood smears examined for Malaria,TOTAL,7143.0,8862.0,13731.0,14691.0,19281.0,28864.0,30286.0,24336.0,15108.0,6889.0,12818.0,15386.0,197395.0
Hoshangabad,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,473.0,36.0,1074.0,79.0,120.0,300.0,215.0,188.0,63.0,12.0,12.0,49.0,2621.0
Hoshangabad,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,411.0,19.0,31.0,45.0,59.0,193.0,362.0,272.0,109.0,12.0,19.0,33.0,1565.0
Hoshangabad,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,18000.0,23500.0,12500.0,17000.0,26500.0,23500.0,12500.0,15000.0,12000.0,10000.0,10000.0,15000.0,195500.0
Hoshangabad,16.1.1,Stock position of DPT vaccines,2. Stocks Received,15000.0,0.0,20000.0,15000.0,10000.0,0.0,15000.0,0.0,0.0,5000.0,5000.0,0.0,85000.0
Hoshangabad,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,9500.0,11000.0,15500.0,5500.0,13000.0,11000.0,12500.0,3000.0,2000.0,5000.0,0.0,9500.0,97500.0
Hoshangabad,16.1.1,Stock position of DPT vaccines,5. Total Stock,23500.0,12500.0,17000.0,26500.0,23500.0,12500.0,15000.0,12000.0,10000.0,10000.0,15000.0,5500.0,183000.0
Hoshangabad,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3470.0,5370.0,4300.0,13660.0,17130.0,43930.0
Hoshangabad,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,9500.0,5000.0,0.0,20000.0,5000.0,0.0,39500.0
Hoshangabad,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,6030.0,3100.0,1070.0,10640.0,1530.0,14050.0,36420.0
Hoshangabad,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,3470.0,5370.0,4300.0,13660.0,17130.0,3080.0,47010.0
Hoshangabad,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,30000.0,38500.0,19000.0,28500.0,34000.0,35500.0,14000.0,30500.0,20500.0,13500.0,26000.0,38000.0,328000.0
Hoshangabad,16.1.2,Stock position of OPV vaccines,2. Stocks Received,20000.0,0.0,30000.0,30000.0,20000.0,0.0,30000.0,10000.0,0.0,250000.0,20000.0,0.0,410000.0
Hoshangabad,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,11500.0,19500.0,20500.0,24500.0,18500.0,21500.0,13500.0,20000.0,7000.0,237500.0,8000.0,24500.0,426500.0
Hoshangabad,16.1.2,Stock position of OPV vaccines,5. Total Stock,38500.0,19000.0,28500.0,34000.0,35500.0,14000.0,30500.0,20500.0,13500.0,26000.0,38000.0,13500.0,311500.0
Hoshangabad,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,13000.0,24500.0,14000.0,19000.0,28000.0,31000.0,18400.0,13700.0,16500.0,12000.0,25300.0,25300.0,240700.0
Hoshangabad,16.1.3,Stock position of TT vaccines,2. Stocks Received,20000.0,0.0,20000.0,15000.0,15000.0,0.0,15000.0,10000.0,0.0,25000.0,0.0,0.0,120000.0
Hoshangabad,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.1.3,Stock position of TT vaccines,4. Stock Distributed,8500.0,10500.0,15000.0,6000.0,12000.0,12600.0,19700.0,7200.0,4500.0,11700.0,0.0,13800.0,121500.0
Hoshangabad,16.1.3,Stock position of TT vaccines,5. Total Stock,24500.0,14000.0,19000.0,28000.0,31000.0,18400.0,13700.0,16500.0,12000.0,25300.0,25300.0,11500.0,239200.0
Hoshangabad,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,9500.0,24000.0,18500.0,19500.0,23000.0,26000.0,19500.0,15800.0,15800.0,13300.0,17700.0,17000.0,219600.0
Hoshangabad,16.1.5,Stock position of BCG vaccines,2. Stocks Received,20000.0,0.0,10000.0,10000.0,10000.0,0.0,10000.0,5000.0,0.0,10000.0,0.0,0.0,75000.0
Hoshangabad,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,5500.0,5500.0,9000.0,6000.0,7000.0,6500.0,13700.0,5000.0,2500.0,5600.0,700.0,12500.0,79500.0
Hoshangabad,16.1.5,Stock position of BCG vaccines,5. Total Stock,24000.0,18500.0,19500.0,23500.0,26000.0,19500.0,15800.0,15800.0,13300.0,17700.0,17000.0,4500.0,215100.0
Hoshangabad,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,9500.0,18000.0,9500.0,9750.0,15750.0,11805.0,6205.0,7780.0,7000.0,4650.0,2650.0,7250.0,109840.0
Hoshangabad,16.1.6,Stock position of Measles vaccines,2. Stocks Received,15000.0,0.0,10000.0,10000.0,2805.0,0.0,10000.0,5000.0,0.0,5000.0,5000.0,0.0,62805.0
Hoshangabad,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,6500.0,8500.0,9750.0,4000.0,6750.0,5600.0,8425.0,5780.0,2350.0,7000.0,400.0,6250.0,71305.0
Hoshangabad,16.1.6,Stock position of Measles vaccines,5. Total Stock,18000.0,9500.0,9750.0,15750.0,11805.0,6205.0,7780.0,7000.0,4650.0,2650.0,7250.0,1000.0,101340.0
Hoshangabad,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,17500.0,27000.0,15000.0,14500.0,28000.0,26500.0,14500.0,11500.0,8500.0,6800.0,4300.0,14300.0,188400.0
Hoshangabad,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,20000.0,0.0,15000.0,20000.0,10000.0,0.0,10000.0,0.0,0.0,5000.0,10000.0,0.0,90000.0
Hoshangabad,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,10500.0,12000.0,15500.0,6500.0,11500.0,12000.0,13000.0,3000.0,1700.0,7500.0,0.0,8000.0,101200.0
Hoshangabad,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,27000.0,15000.0,14500.0,28000.0,26500.0,14500.0,11500.0,8500.0,6800.0,4300.0,14300.0,6300.0,177200.0
Hoshangabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,900.0,900.0,700.0,300.0,2400.0,1200.0,1200.0,600.0,1600.0,1300.0,2300.0,2300.0,15700.0
Hoshangabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,2400.0,0.0,0.0,0.0,1200.0,0.0,1200.0,0.0,3000.0,7800.0
Hoshangabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,200.0,400.0,300.0,1200.0,0.0,600.0,200.0,300.0,200.0,0.0,4200.0,7600.0
Hoshangabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,900.0,700.0,300.0,2400.0,1200.0,1200.0,600.0,1600.0,1300.0,2300.0,2300.0,1100.0,15900.0
Hoshangabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,220000.0,162000.0,144000.0,114000.0,42000.0,62000.0,52000.0,76000.0,28000.0,28000.0,16000.0,10000.0,954000.0
Hoshangabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,60000.0,200000.0,60000.0,0.0,0.0,30000.0,0.0,37065.0,387065.0
Hoshangabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,58000.0,18000.0,30000.0,72000.0,40000.0,210000.0,36000.0,48000.0,0.0,42000.0,6000.0,42000.0,602000.0
Hoshangabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,162000.0,144000.0,114000.0,42000.0,62000.0,52000.0,76000.0,28000.0,28000.0,16000.0,10000.0,5065.0,739065.0
Hoshangabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,369.0,169.0,169.0,21169.0,3169.0,6769.0,9969.0,19769.0,7569.0,7569.0,8569.0,6969.0,92228.0
Hoshangabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,27000.0,0.0,6000.0,20000.0,30000.0,0.0,0.0,10000.0,0.0,40000.0,133000.0
Hoshangabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,200.0,0.0,6000.0,18000.0,2400.0,16800.0,20200.0,12200.0,0.0,9000.0,1600.0,36000.0,122400.0
Hoshangabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,169.0,169.0,21169.0,3169.0,6769.0,9969.0,19769.0,7569.0,7569.0,8569.0,6969.0,10969.0,102828.0
Hoshangabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,620.0,620.0,620.0,2120.0,2120.0,0.0,1000.0,2900.0,2700.0,2700.0,1700.0,1700.0,18800.0
Hoshangabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,1500.0,0.0,0.0,10000.0,10000.0,0.0,0.0,5000.0,0.0,10221.0,36721.0
Hoshangabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,2120.0,9000.0,8100.0,200.0,0.0,6000.0,0.0,9600.0,35020.0
Hoshangabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,620.0,620.0,2120.0,2120.0,0.0,1000.0,2900.0,2700.0,2700.0,1700.0,1700.0,2321.0,20501.0
Hoshangabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,2670.0,2670.0,2670.0,2670.0,2670.0,2670.0,2670.0,2170.0,5000.0,4300.0,7000.0,7000.0,44160.0
Hoshangabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,5000.0,0.0,4915.0,0.0,0.0,9915.0
Hoshangabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,500.0,2170.0,700.0,2215.0,0.0,0.0,5585.0
Hoshangabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,2670.0,2670.0,2670.0,2670.0,2670.0,2670.0,2170.0,5000.0,4300.0,7000.0,7000.0,7000.0,48490.0
Hoshangabad,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,7100.0,7100.0,4750.0,3750.0,750.0,450.0,250.0,150.0,150.0,45.0,45.0,0.0,24540.0
Hoshangabad,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,45000.0,45000.0
Hoshangabad,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,2350.0,1000.0,3000.0,300.0,200.0,100.0,0.0,105.0,0.0,45.0,13600.0,20700.0
Hoshangabad,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,7100.0,4750.0,3750.0,750.0,450.0,250.0,150.0,150.0,45.0,45.0,0.0,31400.0,48840.0
Hoshangabad,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,5000.0,5000.0,5000.0,4000.0,4000.0,4000.0,7475.0,6275.0,4375.0,28500.0,73625.0
Hoshangabad,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,8000.0,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,0.0,55000.0,0.0,68000.0
Hoshangabad,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,1000.0,0.0,0.0,1525.0,1200.0,1900.0,30875.0,700.0,37200.0
Hoshangabad,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,8000.0,5000.0,5000.0,4000.0,4000.0,4000.0,7475.0,6275.0,4375.0,28500.0,27800.0,104425.0
Hoshangabad,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,21000.0,20000.0,14300.0,14200.0,13200.0,11800.0,10300.0,10200.0,9800.0,98000.0,980.0,10080.0,233860.0
Hoshangabad,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,10000.0
Hoshangabad,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,1000.0,5700.0,100.0,1000.0,1400.0,1500.0,100.0,400.0,0.0,0.0,900.0,80.0,12180.0
Hoshangabad,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,20000.0,14300.0,14200.0,13200.0,11800.0,10300.0,10200.0,9800.0,9800.0,98000.0,10080.0,10000.0,231680.0
Hoshangabad,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,600.0,1600.0
Hoshangabad,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,400.0,0.0,400.0
Hoshangabad,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0,600.0,1200.0
Hoshangabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,60.0,60.0,54.0,54.0,54.0,18.0,18.0,18.0,10.0,8.0,6.0,4.0,364.0
Hoshangabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,6.0,0.0,0.0,36.0,0.0,0.0,8.0,2.0,2.0,2.0,0.0,56.0
Hoshangabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,60.0,54.0,54.0,54.0,18.0,18.0,18.0,10.0,8.0,6.0,4.0,4.0,308.0
Hoshangabad,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1468500.0,1392900.0,2861400.0
Hoshangabad,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,75600.0,75600.0,151200.0
Hoshangabad,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1392900.0,1317300.0,2710200.0
Hoshangabad,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,7100.0,4560.0,4200.0,1200.0,7140.0,39212.0,37628.0,37484.0,37196.0,24380.0,19628.0,18764.0,238492.0
Hoshangabad,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,50000.0,50000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100000.0
Hoshangabad,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,2540.0,360.0,3000.0,44060.0,17928.0,1584.0,144.0,288.0,12816.0,4752.0,864.0,576.0,88912.0
Hoshangabad,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,4560.0,4200.0,1200.0,7140.0,39212.0,37628.0,37484.0,37196.0,24380.0,19628.0,18764.0,18188.0,249580.0
Hoshangabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,9766.0,9766.0,9766.0,6301.0,4601.0,4501.0,4101.0,4029.0,3129.0,3000.0,2250.0,2050.0,63260.0
Hoshangabad,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,3465.0,1700.0,100.0,400.0,72.0,900.0,129.0,750.0,200.0,0.0,7716.0
Hoshangabad,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,9766.0,9766.0,6301.0,4601.0,4501.0,4101.0,4029.0,3129.0,3000.0,2250.0,2050.0,2050.0,55544.0
Hoshangabad,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,160740.0,120740.0,190320.0,172500.0,142600.0,108450.0,73450.0,0.0,145000.0,138000.0,108000.0,64480.0,1424280.0
Hoshangabad,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,100000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100000.0
Hoshangabad,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,30420.0,17820.0,29900.0,34150.0,35000.0,6000.0,0.0,7000.0,30000.0,43520.0,12000.0,245810.0
Hoshangabad,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,160740.0,190320.0,172500.0,142600.0,108450.0,73450.0,67450.0,0.0,138000.0,108000.0,64480.0,52480.0,1278470.0
Hoshangabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,18300.0,16600.0,14700.0,18600.0,17100.0,15100.0,11500.0,12700.0,11200.0,11000.0,12900.0,11000.0,170700.0
Hoshangabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,6600.0,0.0,3300.0,0.0,6600.0,0.0,0.0,3300.0,0.0,0.0,19800.0
Hoshangabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1700.0,1900.0,2700.0,1500.0,5300.0,3600.0,5400.0,1500.0,200.0,1400.0,1900.0,3000.0,30100.0
Hoshangabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,16600.0,14700.0,18600.0,17100.0,15100.0,11500.0,12700.0,11200.0,11000.0,12900.0,11000.0,8000.0,160400.0
Hoshangabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,65400.0,51000.0,38000.0,31400.0,40200.0,35800.0,15800.0,34600.0,34600.0,34600.0,30600.0,30600.0,442600.0
Hoshangabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,20000.0,30000.0,20000.0,0.0,312000.0,0.0,0.0,0.0,0.0,200000.0,582000.0
Hoshangabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,14400.0,13000.0,26600.0,21200.0,24400.0,20000.0,293200.0,0.0,0.0,4000.0,0.0,184400.0,601200.0
Hoshangabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,51000.0,38000.0,31400.0,40200.0,35800.0,15800.0,34600.0,34600.0,34600.0,30600.0,30600.0,46200.0,423400.0
Hoshangabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,7400.0,10200.0,9700.0,11500.0,9500.0,8000.0,5000.0,5500.0,4000.0,4000.0,8000.0,8000.0,90800.0
Hoshangabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4000.0,0.0,4000.0,0.0,2000.0,0.0,4000.0,0.0,0.0,4000.0,0.0,0.0,18000.0
Hoshangabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshangabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1200.0,500.0,2200.0,2000.0,3500.0,3000.0,3500.0,1500.0,0.0,0.0,0.0,2000.0,19400.0
Hoshangabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,10200.0,9700.0,11500.0,9500.0,8000.0,5000.0,5500.0,4000.0,4000.0,8000.0,8000.0,6000.0,89400.0
Hoshangabad,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,3.0,1.0,1.0,2.0,1.0,2.0,3.0,3.0,3.0,2.0,1.0,,22.0
Hoshangabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,2.0,1.0,1.0,,1.0,1.0,,3.0,,,9.0
Hoshangabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Hoshangabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,2.0,1.0,1.0,,1.0,1.0,,3.0,,,9.0
Hoshangabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,1.0,,,1.0,,,,2.0
Hoshangabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Hoshangabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,1.0,,,1.0,,,,2.0
Hoshangabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,1.0,3.0,4.0,3.0,3.0,1.0,10.0,7.0,4.0,3.0,,39.0
Hoshangabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,1.0,,1.0
Hoshangabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,1.0,3.0,4.0,3.0,3.0,1.0,10.0,7.0,4.0,4.0,,40.0
Hoshangabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,9.0,10.0,16.0,3.0,6.0,5.0,9.0,11.0,14.0,14.0,5.0,2.0,104.0
Hoshangabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,,1.0,,1.0,,,,,,,3.0
Hoshangabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,9.0,11.0,16.0,4.0,6.0,6.0,9.0,11.0,14.0,14.0,5.0,2.0,107.0
Hoshangabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,1.0,3.0,1.0,,1.0,,1.0,,4.0,,3.0,15.0
Hoshangabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,2.0,,,,,1.0,,,1.0,,,4.0
Hoshangabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,3.0,3.0,1.0,,1.0,1.0,1.0,,5.0,,3.0,19.0
Hoshangabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,2.0,,,,,,,,,,2.0
Hoshangabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,1.0,,,,,,,,,,1.0
Hoshangabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,3.0,,,,,,,,,,3.0
Hoshangabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,3.0,,1.0,1.0,1.0,,,1.0,,8.0
Hoshangabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,3.0,1.0,1.0,,2.0,,,,,7.0
Hoshangabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,6.0,1.0,2.0,1.0,3.0,,,1.0,,15.0
Hoshangabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Hoshangabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Hoshangabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Hoshangabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,4.0,3.0,12.0,7.0,4.0,8.0,8.0,7.0,3.0,5.0,7.0,4.0,72.0
Hoshangabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,2.0,7.0,4.0,7.0,2.0,5.0,4.0,4.0,3.0,2.0,1.0,42.0
Hoshangabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,5.0,5.0,19.0,11.0,11.0,10.0,13.0,11.0,7.0,8.0,9.0,5.0,114.0
Hoshangabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Hoshangabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,1.0,,,,,,,,,,,,1.0
Hoshangabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Hoshangabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,,1.0,,,1.0,,,,,,3.0
Hoshangabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Hoshangabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,2.0,1.0,,1.0,2.0,1.0,1.0,,,3.0,12.0
Hoshangabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,2.0,1.0,,3.0,,1.0,,,,7.0
Hoshangabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,2.0,3.0,1.0,1.0,5.0,1.0,2.0,,,3.0,19.0
Hoshangabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,1.0,1.0,2.0
Hoshangabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,4.0,,1.0,,1.0,,4.0,,2.0,1.0,2.0,15.0
Hoshangabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,1.0,1.0,1.0,,,1.0,1.0,,2.0,1.0,2.0,10.0
Hoshangabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,5.0,1.0,2.0,,1.0,1.0,5.0,,4.0,3.0,5.0,27.0
Hoshangabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Hoshangabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,1.0,,,,,,1.0,,,,,2.0
Hoshangabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Hoshangabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,1.0,,,,,,1.0,,,,,2.0
Hoshangabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,,2.0,,2.0,5.0,,,,,,10.0
Hoshangabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,5.0,6.0,1.0,3.0,5.0,1.0,,1.0,1.0,,1.0,,24.0
Hoshangabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,3.0,16.0,25.0,2.0,2.0,5.0,2.0,,1.0,2.0,1.0,,59.0
Hoshangabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,9.0,22.0,26.0,7.0,7.0,8.0,7.0,1.0,2.0,2.0,2.0,,93.0
Hoshangabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Hoshangabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Hoshangabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Hoshangabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Hoshangabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Hoshangabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,8.0,14.0,13.0,8.0,10.0,5.0,7.0,7.0,9.0,5.0,7.0,8.0,101.0
Hoshangabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,7.0,6.0,14.0,7.0,7.0,5.0,12.0,7.0,5.0,10.0,7.0,14.0,101.0
Hoshangabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,15.0,20.0,27.0,15.0,17.0,10.0,19.0,14.0,14.0,16.0,14.0,22.0,203.0
Hoshangabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Hoshangabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,1.0,,,,,,1.0,,2.0,4.0
Hoshangabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,2.0,,,2.0,1.0,1.0,3.0,,,,10.0
Hoshangabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,2.0,1.0,,2.0,1.0,1.0,3.0,1.0,,2.0,14.0
Hoshangabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Hoshangabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Hoshangabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Hoshangabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Hoshangabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Hoshangabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Hoshangabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Hoshangabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Hoshangabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Hoshangabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,,,,,1.0,,,,,,1.0,3.0
Hoshangabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Hoshangabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,,,,,1.0,,,,,,1.0,3.0
Hoshangabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Hoshangabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,1.0,,,1.0
Hoshangabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Hoshangabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,1.0,,,1.0
Hoshangabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Hoshangabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Hoshangabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Hoshangabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,1.0,,,,,1.0
Hoshangabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Hoshangabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,2.0,1.0,1.0,2.0,,2.0,4.0,1.0,1.0,2.0,,18.0
Hoshangabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Hoshangabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,2.0,1.0,1.0,2.0,,2.0,4.0,1.0,1.0,2.0,,18.0
Hoshangabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,2.0,,,,,2.0,1.0,1.0,2.0,,,2.0,10.0
Hoshangabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,10.0,8.0,18.0,21.0,13.0,9.0,11.0,18.0,7.0,6.0,4.0,13.0,138.0
Hoshangabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,2.0,,3.0,2.0,1.0,1.0,,3.0,2.0,2.0,1.0,18.0
Hoshangabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,13.0,10.0,18.0,24.0,15.0,12.0,13.0,19.0,12.0,8.0,6.0,16.0,166.0
Hoshangabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Hoshangabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,2.0,3.0,10.0,1.0,1.0,3.0,2.0,2.0,2.0,1.0,5.0,33.0
Hoshangabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,2.0,,,,,,,,,,2.0
Hoshangabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,2.0,5.0,10.0,1.0,1.0,3.0,2.0,2.0,2.0,1.0,5.0,35.0
Hoshangabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,1.0,,,,1.0,,,,,,2.0
Hoshangabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,2.0,3.0,4.0,1.0,2.0,2.0,,,1.0,,16.0
Hoshangabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Hoshangabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,2.0,3.0,3.0,4.0,1.0,3.0,2.0,,,1.0,,19.0
Hoshangabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,1.0,,,,,,1.0,,,3.0
Hoshangabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,3.0,2.0,2.0,3.0,1.0,2.0,6.0,1.0,2.0,1.0,3.0,26.0
Hoshangabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,2.0,1.0,1.0,1.0,3.0,1.0,2.0,3.0,1.0,2.0,1.0,18.0
Hoshangabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,5.0,4.0,4.0,4.0,4.0,3.0,8.0,4.0,4.0,3.0,4.0,47.0
Hoshangabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Hoshangabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,4.0,2.0,3.0,3.0,6.0,12.0,6.0,7.0,4.0,5.0,2.0,56.0
Hoshangabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,6.0,10.0,10.0,14.0,4.0,10.0,11.0,10.0,7.0,10.0,6.0,4.0,102.0
Hoshangabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,9.0,14.0,12.0,17.0,7.0,16.0,23.0,16.0,14.0,14.0,11.0,6.0,159.0
Hoshangabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,2.0,1.0,1.0,2.0,3.0,3.0,2.0,2.0,1.0,1.0,2.0,21.0
Hoshangabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,6.0,8.0,7.0,7.0,13.0,13.0,18.0,12.0,10.0,19.0,10.0,15.0,138.0
Hoshangabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,27.0,33.0,58.0,37.0,50.0,50.0,46.0,58.0,57.0,63.0,40.0,56.0,575.0
Hoshangabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,34.0,43.0,66.0,45.0,65.0,66.0,67.0,72.0,69.0,83.0,51.0,73.0,734.0
Indore,1.1,Total number of pregnant women Registered for ANC,TOTAL,2778.0,7769.0,7781.0,8946.0,6222.0,6447.0,6240.0,6738.0,8039.0,6445.0,5922.0,6440.0,79767.0
Indore,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1529.0,3621.0,3882.0,3841.0,3169.0,3561.0,3227.0,3251.0,3523.0,3197.0,3057.0,3421.0,39279.0
Indore,1.2,Number of Pregnant women registered under JSY,TOTAL,2470.0,6272.0,6599.0,8508.0,5480.0,5745.0,5835.0,6249.0,6894.0,5437.0,5932.0,6690.0,72111.0
Indore,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2374.0,5657.0,5635.0,6707.0,4720.0,4920.0,4519.0,4924.0,6498.0,4345.0,4646.0,5660.0,60605.0
Indore,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1955.0,6009.0,6004.0,7146.0,4757.0,5091.0,4526.0,4852.0,6106.0,4178.0,4899.0,5271.0,60794.0
Indore,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1887.0,4051.0,4139.0,7466.0,4956.0,4568.0,4274.0,4646.0,4761.0,3954.0,4731.0,5193.0,54626.0
Indore,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2880.0,23599.0,7258.0,8686.0,5881.0,5956.0,5719.0,6351.0,7701.0,5554.0,5940.0,6311.0,91836.0
Indore,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,110.0,95.0,186.0,140.0,117.0,57.0,75.0,48.0,122.0,238.0,143.0,66.0,1397.0
Indore,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,4.0,3.0,2.0,7.0,8.0,8.0,10.0,10.0,8.0,10.0,5.0,77.0
Indore,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,809.0,3200.0,2669.0,2918.0,1958.0,1800.0,1573.0,2072.0,2017.0,1931.0,2386.0,2145.0,25478.0
Indore,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,62.0,74.0,120.0,85.0,92.0,54.0,70.0,114.0,97.0,38.0,23.0,35.0,864.0
Indore,1.8,Number of pregnancy test kits used at SC level,TOTAL,242.0,242.0,457.0,427.0,359.0,528.0,281.0,446.0,489.0,453.0,531.0,547.0,5002.0
Indore,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,8.0,2.0,31.0,16.0,8.0,14.0,8.0,9.0,7.0,9.0,5.0,6.0,123.0
Indore,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,6.0,0.0,2.0,1.0,0.0,1.0,0.0,4.0,1.0,6.0,0.0,21.0
Indore,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,8.0,8.0,31.0,18.0,9.0,14.0,9.0,9.0,11.0,10.0,11.0,6.0,144.0
Indore,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1.0,5.0,31.0,16.0,8.0,12.0,8.0,8.0,7.0,3.0,7.0,3.0,109.0
Indore,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Indore,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1920.0,2552.0,2604.0,2905.0,3037.0,3173.0,3115.0,2875.0,2783.0,2790.0,2707.0,2755.0,33216.0
Indore,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,211.0,344.0,245.0,298.0,228.0,241.0,262.0,171.0,249.0,246.0,241.0,236.0,2972.0
Indore,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1782.0,2324.0,2445.0,2736.0,2852.0,2914.0,2928.0,2828.0,2727.0,2760.0,2777.0,2731.0,31804.0
Indore,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,401.0,1015.0,871.0,1110.0,1274.0,1273.0,763.0,1118.0,965.0,775.0,835.0,971.0,11371.0
Indore,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,100.0,162.0,151.0,216.0,145.0,271.0,246.0,231.0,189.0,184.0,73.0,97.0,2065.0
Indore,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1682.0,1726.0,1451.0,1709.0,2203.0,2652.0,2869.0,2597.0,2385.0,2433.0,2009.0,2426.0,26142.0
Indore,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Indore,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Indore,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Indore,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,9.0,18.0,4.0,26.0,26.0,26.0,26.0,19.0,21.0,7.0,22.0,204.0
Indore,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,355.0,387.0,422.0,429.0,456.0,472.0,413.0,412.0,405.0,405.0,414.0,420.0,4990.0
Indore,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Indore,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,355.0,396.0,440.0,433.0,482.0,498.0,439.0,438.0,424.0,426.0,421.0,442.0,5194.0
Indore,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,492.0,398.0,321.0,375.0,280.0,426.0,545.0,587.0,228.0,303.0,392.0,590.0,4937.0
Indore,4.1.1.a,Number of male live births,TOTAL,1785.0,2262.0,2068.0,2360.0,2717.0,3037.0,3112.0,2841.0,2725.0,2754.0,2426.0,2708.0,30795.0
Indore,4.1.1.b,Number of female live births,TOTAL,1803.0,2035.0,1954.0,2230.0,2481.0,2769.0,2850.0,2621.0,2415.0,2459.0,2269.0,2451.0,28337.0
Indore,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3588.0,4297.0,4022.0,4590.0,5198.0,5806.0,5962.0,5462.0,5140.0,5213.0,4695.0,5159.0,59132.0
Indore,4.1.2,Number of still births,TOTAL,22.0,64.0,67.0,45.0,52.0,36.0,36.0,25.0,52.0,46.0,33.0,32.0,510.0
Indore,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,72.0,158.0,162.0,113.0,166.0,99.0,115.0,97.0,106.0,108.0,91.0,61.0,1348.0
Indore,4.2.1,Number of Newborns weighed at birth,TOTAL,3588.0,4278.0,4022.0,4587.0,5194.0,5805.0,5960.0,5106.0,5144.0,5196.0,4675.0,5159.0,58714.0
Indore,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,365.0,711.0,702.0,759.0,589.0,732.0,715.0,809.0,853.0,908.0,692.0,709.0,8544.0
Indore,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2737.0,4209.0,3709.0,3843.0,4775.0,5043.0,5201.0,4190.0,4853.0,4588.0,3952.0,4365.0,51465.0
Indore,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,11.0,9.0,12.0,17.0,17.0,17.0,9.0,33.0,15.0,11.0,13.0,164.0
Indore,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,5.0,6.0,7.0,15.0,35.0,69.0,39.0,41.0,69.0,35.0,93.0,43.0,457.0
Indore,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,125.0,269.0,356.0,409.0,419.0,467.0,408.0,413.0,474.0,376.0,517.0,391.0,4624.0
Indore,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Indore,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,130.0,286.0,372.0,436.0,471.0,553.0,464.0,463.0,576.0,426.0,621.0,447.0,5245.0
Indore,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Indore,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,43.0,119.0,166.0,219.0,205.0,237.0,187.0,157.0,223.0,215.0,298.0,213.0,2282.0
Indore,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,23.0,51.0,56.0,60.0,51.0,50.0,40.0,56.0,108.0,31.0,3.0,53.0,582.0
Indore,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,100.0,191.0,251.0,360.0,303.0,365.0,341.0,327.0,368.0,274.0,498.0,271.0,3649.0
Indore,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,4.0,11.0,23.0,27.0,25.0,12.0,28.0,30.0,36.0,30.0,18.0,21.0,265.0
Indore,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,3580.0,4101.0,3824.0,4524.0,5163.0,5744.0,5937.0,5353.0,5078.0,5176.0,4628.0,5138.0,58246.0
Indore,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2293.0,3006.0,2869.0,3691.0,4030.0,4616.0,4698.0,4478.0,4304.0,3554.0,2575.0,2322.0,42436.0
Indore,6.3,PNC maternal complications attended,TOTAL,16.0,31.0,22.0,29.0,19.0,16.0,61.0,7.0,16.0,10.0,7.0,13.0,247.0
Indore,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,66.0,133.0,142.0,164.0,147.0,121.0,124.0,137.0,104.0,139.0,117.0,84.0,1478.0
Indore,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,5.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Indore,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,66.0,138.0,142.0,164.0,147.0,122.0,124.0,137.0,104.0,139.0,117.0,84.0,1484.0
Indore,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,58.0,50.0,2.0,41.0,0.0,1.0,0.0,40.0,0.0,0.0,0.0,192.0
Indore,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,189.0,450.0,437.0,643.0,299.0,321.0,282.0,231.0,284.0,256.0,227.0,234.0,3853.0
Indore,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,607.0,560.0,1009.0,1059.0,865.0,1120.0,960.0,1012.0,842.0,912.0,438.0,746.0,10130.0
Indore,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,796.0,1010.0,1446.0,1702.0,1164.0,1441.0,1242.0,1243.0,1126.0,1168.0,665.0,980.0,13983.0
Indore,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,19.0,12.0,6.0,37.0,15.0,16.0,0.0,17.0,9.0,18.0,0.0,0.0,149.0
Indore,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,2.0,3.0,7.0,2.0,3.0,0.0,0.0,1.0,0.0,4.0,5.0,27.0
Indore,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,3.0,5.0,11.0,4.0,12.0,6.0,5.0,10.0,6.0,14.0,10.0,11.0,97.0
Indore,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,9.0,9.0,10.0,6.0,10.0,8.0,11.0,19.0,15.0,10.0,5.0,11.0,123.0
Indore,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Indore,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,12.0,16.0,24.0,17.0,24.0,17.0,16.0,29.0,22.0,24.0,19.0,27.0,247.0
Indore,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,0.0,,6.0,12.0,1.0,0.0,21.0
Indore,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,76.0,137.0,156.0,238.0,100.0,72.0,32.0,174.0,156.0,55.0,104.0,93.0,1393.0
Indore,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,57.0,111.0,187.0,311.0,218.0,238.0,115.0,441.0,514.0,318.0,380.0,208.0,3098.0
Indore,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,105.0,178.0,150.0,179.0,144.0,177.0,122.0,222.0,279.0,342.0,268.0,175.0,2341.0
Indore,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Indore,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,238.0,426.0,493.0,728.0,462.0,487.0,269.0,837.0,949.0,715.0,752.0,476.0,6832.0
Indore,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,23.0,86.0,117.0,141.0,123.0,32.0,64.0,74.0,277.0,134.0,17.0,22.0,1110.0
Indore,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,1.0,74.0,15.0,7.0,0.0,85.0,85.0,97.0,85.0,0.0,1.0,2.0,452.0
Indore,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,51.0,47.0,70.0,83.0,62.0,79.0,35.0,95.0,119.0,84.0,80.0,59.0,864.0
Indore,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,31.0,108.0,186.0,193.0,186.0,23.0,224.0,141.0,191.0,198.0,116.0,202.0,1799.0
Indore,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Indore,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,83.0,229.0,271.0,283.0,248.0,187.0,344.0,333.0,395.0,282.0,197.0,263.0,3115.0
Indore,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,123.0,530.0,999.0,952.0,809.0,775.0,870.0,486.0,550.0,712.0,757.0,1129.0,8692.0
Indore,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,2.0,0.0,17.0,12.0,0.0,5.0,0.0,0.0,0.0,0.0,2.0,60.0,98.0
Indore,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,8.0,6.0,17.0,29.0,18.0,32.0,17.0,47.0,37.0,48.0,40.0,38.0,337.0
Indore,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,58.0,53.0,41.0,89.0,51.0,117.0,47.0,97.0,105.0,72.0,75.0,89.0,894.0
Indore,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Indore,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,68.0,59.0,75.0,130.0,69.0,154.0,64.0,144.0,142.0,120.0,117.0,187.0,1329.0
Indore,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,40.0,40.0,0.0,81.0,0.0,28.0,254.0,102.0,0.0,,14.0,559.0
Indore,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,298.0,267.0,354.0,365.0,352.0,403.0,332.0,365.0,313.0,280.0,240.0,235.0,3804.0
Indore,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,148.0,626.0,539.0,636.0,618.0,663.0,668.0,698.0,651.0,471.0,602.0,610.0,6930.0
Indore,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,124.0,133.0,94.0,99.0,87.0,148.0,133.0,161.0,65.0,90.0,115.0,163.0,1412.0
Indore,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,122.0,463.0,214.0,265.0,203.0,203.0,222.0,315.0,194.0,194.0,305.0,153.0,2853.0
Indore,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Indore,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,692.0,1489.0,1201.0,1365.0,1260.0,1417.0,1355.0,1539.0,1223.0,1035.0,1262.0,1161.0,14999.0
Indore,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,39.0,68.0,35.0,69.0,74.0,98.0,84.0,239.0,94.0,78.0,257.0,48.0,1183.0
Indore,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,697.0,385.0,0.0,414.0,0.0,108.0,197.0,0.0,,,,1801.0
Indore,9.06,Number of IUCD removals,TOTAL,827.0,1111.0,430.0,2538.0,2148.0,691.0,413.0,591.0,481.0,514.0,598.0,478.0,10820.0
Indore,9.07,Number of Oral Pills cycles distributed,TOTAL,9674.0,21325.0,15324.0,22273.0,20171.0,18946.0,15714.0,17239.0,16705.0,14748.0,18321.0,18483.0,208923.0
Indore,9.08,Number of Condom pieces distributed,TOTAL,29437.0,54950.0,71248.0,88997.0,84006.0,80892.0,90728.0,83480.0,82290.0,55509.0,59755.0,66588.0,847880.0
Indore,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,20.0,0.0,3.0,0.0,0.0,14.0,60.0,0.0,97.0
Indore,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,11.0,56.0,27.0,73.0,85.0,72.0,75.0,61.0,107.0,76.0,53.0,53.0,749.0
Indore,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Indore,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,19.0,0.0,0.0,2.0,1.0,1.0,0.0,0.0,0.0,10.0,0.0,0.0,33.0
Indore,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Indore,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,9.12,Number of Institutions having NSV trained doctors,TOTAL,33.0,31.0,35.0,27.0,28.0,30.0,25.0,27.0,27.0,27.0,31.0,29.0,-1.0
Indore,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1729.0,4954.0,5878.0,6369.0,4837.0,5056.0,4728.0,4759.0,5630.0,3916.0,4265.0,4291.0,56412.0
Indore,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2130.0,4763.0,4835.0,5935.0,5113.0,5386.0,5072.0,4069.0,841.0,350.0,314.0,94.0,38902.0
Indore,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2017.0,4546.0,4495.0,5903.0,4982.0,5303.0,4854.0,5483.0,3699.0,2100.0,851.0,234.0,44467.0
Indore,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2162.0,4673.0,4788.0,5936.0,5020.0,5229.0,4731.0,5463.0,4941.0,2852.0,1898.0,766.0,48459.0
Indore,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1824.0,3115.0,3465.0,3952.0,4670.0,17026.0
Indore,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1377.0,2687.0,3779.0,4531.0,12374.0
Indore,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,43.0,1592.0,3567.0,4324.0,9526.0
Indore,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1212.0,3110.0,2839.0,2467.0,1824.0,1928.0,1922.0,1832.0,2264.0,1755.0,1917.0,1962.0,25032.0
Indore,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2120.0,4786.0,4813.0,6037.0,5230.0,5349.0,5006.0,4571.0,3772.0,3715.0,3806.0,4317.0,53522.0
Indore,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2012.0,4564.0,4331.0,5953.0,8218.0,5233.0,4794.0,5505.0,5020.0,3823.0,3859.0,4424.0,57736.0
Indore,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2139.0,4656.0,4661.0,8917.0,5050.0,5188.0,4674.0,5468.0,5301.0,3635.0,4122.0,4345.0,58156.0
Indore,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,704.0,1892.0,1527.0,1453.0,1210.0,1343.0,1121.0,1448.0,1712.0,1509.0,1801.0,1517.0,17237.0
Indore,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1948.0,4133.0,4314.0,5498.0,4757.0,4916.0,4667.0,4043.0,1801.0,476.0,530.0,135.0,37218.0
Indore,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1932.0,4324.0,4556.0,5787.0,4982.0,5261.0,4853.0,5521.0,3830.0,2089.0,1007.0,250.0,44392.0
Indore,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2170.0,4489.0,4439.0,5436.0,5040.0,5165.0,4658.0,5493.0,5150.0,3847.0,2025.0,718.0,48630.0
Indore,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3108.0,4374.0,4767.0,6091.0,4849.0,5117.0,4563.0,4572.0,4629.0,3955.0,4629.0,5047.0,55701.0
Indore,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,258.0,545.0,752.0,1332.0,1013.0,1673.0,1614.0,1650.0,1665.0,1695.0,2134.0,2329.0,16660.0
Indore,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,5.0,0.0,7.0
Indore,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1628.0,2351.0,2437.0,3139.0,2457.0,2641.0,2343.0,2368.0,2345.0,1899.0,2461.0,2784.0,28853.0
Indore,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1555.0,2151.0,2173.0,2914.0,2266.0,2470.0,2078.0,2056.0,2114.0,1793.0,2108.0,2628.0,26306.0
Indore,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3183.0,4502.0,4610.0,6053.0,4723.0,5111.0,4421.0,4424.0,4459.0,3692.0,4569.0,5412.0,55159.0
Indore,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1619.0,3909.0,4041.0,4871.0,3854.0,3809.0,3965.0,3809.0,3836.0,3514.0,4524.0,4770.0,46521.0
Indore,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1616.0,3879.0,4028.0,4897.0,3855.0,3750.0,3924.0,3801.0,3821.0,3504.0,4520.0,4770.0,46365.0
Indore,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,0.0,12.0
Indore,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,330.0,553.0,790.0,1098.0,846.0,1013.0,752.0,848.0,796.0,696.0,918.0,1148.0,9788.0
Indore,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,285.0,551.0,759.0,1066.0,822.0,926.0,723.0,832.0,772.0,658.0,918.0,1141.0,9453.0
Indore,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,615.0,1104.0,1549.0,2164.0,1668.0,1939.0,1475.0,1680.0,1568.0,1354.0,1836.0,2289.0,19241.0
Indore,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1131.0,2881.0,2913.0,4278.0,3350.0,4008.0,3765.0,3918.0,4064.0,3469.0,3857.0,4035.0,41669.0
Indore,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1128.0,2941.0,2986.0,4323.0,3927.0,4621.0,3929.0,3956.0,3839.0,3100.0,3439.0,3836.0,42025.0
Indore,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1200.0,2819.0,2648.0,4817.0,3963.0,4731.0,3874.0,4005.0,3822.0,3145.0,3656.0,3821.0,42501.0
Indore,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,0.0,1.0,0.0,0.0,4.0,3.0,11.0
Indore,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,1.0,0.0,0.0,4.0
Indore,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,808.0,1300.0,1403.0,1495.0,1501.0,1536.0,1473.0,1417.0,1512.0,1383.0,1472.0,1503.0,16803.0
Indore,10.4.2,Number of Immunisation sessions held during the month,TOTAL,714.0,1260.0,1380.0,1467.0,1440.0,1503.0,1339.0,1372.0,1462.0,1345.0,1454.0,1484.0,16220.0
Indore,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,454.0,727.0,714.0,1097.0,737.0,747.0,658.0,675.0,725.0,639.0,665.0,725.0,8563.0
Indore,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Indore,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1801.0,4022.0,4535.0,6259.0,5138.0,5495.0,4590.0,4286.0,4134.0,3810.0,4620.0,5440.0,54130.0
Indore,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1424.0,2958.0,3585.0,11656.0,6159.0,3692.0,3679.0,3650.0,3593.0,19328.0,5605.0,3816.0,69145.0
Indore,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1648.0,3935.0,2803.0,11671.0,7451.0,3690.0,3942.0,3796.0,3596.0,18195.0,8395.0,4923.0,74045.0
Indore,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,9.0,2.0,8.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23.0
Indore,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,220.0,415.0,468.0,309.0,522.0,460.0,362.0,346.0,341.0,278.0,231.0,335.0,4287.0
Indore,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,298.0,362.0,483.0,250.0,124.0,64.0,107.0,82.0,86.0,94.0,51.0,7.0,2008.0
Indore,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,9.0,19.0,21.0,19.0,6.0,7.0,8.0,7.0,15.0,6.0,21.0,6.0,144.0
Indore,13.1,Number of Patients operated for cataract,TOTAL,49.0,80.0,171.0,171.0,110.0,193.0,168.0,237.0,204.0,386.0,143.0,203.0,2115.0
Indore,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,49.0,80.0,127.0,166.0,110.0,193.0,171.0,237.0,179.0,386.0,143.0,203.0,2044.0
Indore,13.3,Number of School children detected with Refractive errors,TOTAL,65.0,32.0,175.0,175.0,283.0,268.0,558.0,274.0,232.0,211.0,92.0,65.0,2430.0
Indore,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,150.0,91.0,407.0,266.0,212.0,201.0,78.0,65.0,1470.0
Indore,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,9.0,6.0,6.0,4.0,5.0,4.0,5.0,5.0,4.0,4.0,6.0,6.0,-1.0
Indore,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,16.0,13.0,15.0,15.0,11.0,15.0,15.0,13.0,16.0,13.0,13.0,15.0,-1.0
Indore,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,422.0,559.0,584.0,570.0,559.0,581.0,568.0,579.0,569.0,947.0,548.0,571.0,-1.0
Indore,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,7.0,6.0,5.0,9.0,8.0,10.0,8.0,7.0,6.0,7.0,6.0,-1.0
Indore,14.05,Number of RKS meetings held during the month,TOTAL,4.0,7.0,6.0,7.0,9.0,9.0,13.0,13.0,10.0,9.0,11.0,11.0,109.0
Indore,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,21.0,17.0,17.0,13.0,14.0,16.0,17.0,16.0,17.0,13.0,15.0,16.0,-1.0
Indore,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,122.0,245.0,237.0,204.0,235.0,333.0,274.0,93.0,82.0,103.0,109.0,6.0,2043.0
Indore,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,2.0,4.0,2.0,4.0,3.0,3.0,3.0,4.0,4.0,4.0,4.0,-1.0
Indore,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,-1.0
Indore,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,50.0,121.0,138.0,144.0,173.0,141.0,165.0,121.0,104.0,87.0,147.0,126.0,1517.0
Indore,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,293.0,583.0,848.0,665.0,708.0,1041.0,1463.0,694.0,2139.0,363.0,477.0,739.0,10013.0
Indore,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,63.0,118.0,152.0,145.0,218.0,121.0,145.0,97.0,99.0,76.0,322.0,120.0,1676.0
Indore,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1840.0,2601.0,4050.0,3602.0,3266.0,3738.0,2790.0,3139.0,3359.0,2588.0,2473.0,2522.0,35968.0
Indore,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,113.0,239.0,290.0,289.0,391.0,262.0,310.0,218.0,203.0,163.0,469.0,246.0,3193.0
Indore,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2133.0,3184.0,4898.0,4267.0,3974.0,4779.0,4253.0,3833.0,5498.0,2951.0,2950.0,3261.0,45981.0
Indore,14.10.2.a,Number of death cases of Inpatient males,TOTAL,2.0,4.0,0.0,1.0,1.0,72.0,1.0,36.0,2.0,2.0,2.0,4.0,127.0
Indore,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,3.0,0.0,1.0,9.0,3.0,0.0,2.0,1.0,0.0,0.0,0.0,20.0
Indore,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,3.0,7.0,0.0,2.0,10.0,75.0,1.0,38.0,3.0,2.0,2.0,4.0,147.0
Indore,14.11,In-Patient Head Count at midnight,TOTAL,1395.0,2447.0,2894.0,2650.0,2560.0,3090.0,2806.0,2581.0,2701.0,2342.0,2545.0,2706.0,30717.0
Indore,14.12.1,OPD attendance (All),TOTAL,46204.0,74209.0,85754.0,86437.0,79237.0,95064.0,95058.0,94897.0,89129.0,79784.0,133751.0,132674.0,1092198.0
Indore,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,139.0,298.0,171.0,178.0,213.0,226.0,179.0,253.0,229.0,255.0,208.0,241.0,2590.0
Indore,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,7.0,65.0,30.0,44.0,134.0,52.0,31.0,34.0,42.0,32.0,3.0,0.0,474.0
Indore,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,396.0,222.0,186.0,352.0,163.0,192.0,165.0,242.0,370.0,253.0,510.0,242.0,3293.0
Indore,14.14.a,Number of patients given AYUSH treatment,TOTAL,3555.0,6649.0,6948.0,12049.0,7682.0,10777.0,9832.0,16946.0,15054.0,14557.0,37243.0,38528.0,179820.0
Indore,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,618.0,909.0,395.0,1239.0,1402.0,1707.0,1164.0,1260.0,1451.0,1383.0,1518.0,1925.0,14971.0
Indore,14.14.c,Number of Adolescents counselled,TOTAL,0.0,190.0,0.0,199.0,165.0,112.0,254.0,484.0,64.0,65.0,153.0,79.0,1765.0
Indore,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4318.0,5115.0,9234.0,9814.0,8585.0,8311.0,7670.0,9441.0,7645.0,7623.0,9244.0,11003.0,98003.0
Indore,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,81.0,124.0,226.0,147.0,284.0,139.0,126.0,241.0,205.0,136.0,143.0,183.0,2035.0
Indore,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,285.0,967.0,713.0,847.0,1001.0,1040.0,843.0,700.0,851.0,803.0,686.0,817.0,9553.0
Indore,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,4.0,3.0,3.0,7.0,2.0,8.0,4.0,7.0,1.0,10.0,3.0,53.0
Indore,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,209.0,467.0,733.0,992.0,623.0,359.0,1145.0,500.0,981.0,664.0,1173.0,438.0,8284.0
Indore,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,1.0,1.0,2.0,3.0,1.0,3.0,1.0,1.0,0.0,2.0,0.0,16.0
Indore,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,932.0,1471.0,2378.0,2601.0,2097.0,3405.0,2399.0,2582.0,2652.0,2898.0,2323.0,2575.0,28313.0
Indore,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,78.0,3.0,1.0,1.0,9.0,2.0,4.0,2.0,2.0,67.0,24.0,194.0
Indore,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1426.0,2905.0,3824.0,4440.0,3721.0,4804.0,4387.0,3782.0,4484.0,4365.0,4182.0,3830.0,46150.0
Indore,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,83.0,7.0,6.0,11.0,12.0,13.0,9.0,10.0,3.0,79.0,27.0,263.0
Indore,15.2,Number of Widal tests conducted,Number tested,201.0,417.0,459.0,624.0,541.0,582.0,556.0,633.0,371.0,422.0,602.0,445.0,5853.0
Indore,15.3.a,Number of VDRL tests conducted on males,Number tested,93.0,136.0,312.0,176.0,582.0,759.0,424.0,199.0,678.0,583.0,375.0,739.0,5056.0
Indore,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,154.0,390.0,326.0,527.0,184.0,329.0,441.0,73.0,154.0,159.0,618.0,233.0,3588.0
Indore,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,541.0,709.0,1076.0,1390.0,1234.0,1456.0,992.0,960.0,973.0,855.0,1100.0,1146.0,12432.0
Indore,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,788.0,1235.0,1714.0,2093.0,2000.0,2544.0,1857.0,1232.0,1805.0,1597.0,2093.0,2118.0,21076.0
Indore,15.4.1,Number of blood smears examined for Malaria,TOTAL,5628.0,8128.0,11725.0,8681.0,9720.0,9889.0,9484.0,8711.0,7454.0,5867.0,6585.0,7614.0,99486.0
Indore,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,11.0,9.0,15.0,7.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,44.0
Indore,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,8.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,27.0
Indore,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Indore,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Indore,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Indore,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Indore,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Indore,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Indore,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Indore,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Indore,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Indore,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Indore,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Indore,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Indore,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Indore,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Indore,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Indore,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Indore,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Indore,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Indore,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Indore,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Indore,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Indore,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Indore,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Indore,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Indore,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Indore,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Indore,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Indore,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Indore,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Indore,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Indore,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Indore,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Indore,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Indore,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Indore,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Indore,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Indore,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Indore,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Indore,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Indore,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Indore,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Indore,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Indore,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Indore,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Indore,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Indore,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Indore,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Indore,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Indore,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Indore,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Indore,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Indore,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Indore,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,10700.0,10100.0,9300.0,,,,,,,,30100.0
Indore,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,0.0,,,,,,,,0.0
Indore,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,10100.0,9300.0,9300.0,,,,,,,,28700.0
Indore,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,600.0,800.0,0.0,,,,,,,,1400.0
Indore,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,50.0,3200.0,500.0,,,,,,,,3750.0
Indore,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,5000.0,0.0,10000.0,,,,,,,,15000.0
Indore,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,3300.0,500.0,6700.0,,,,,,,,10500.0
Indore,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,1750.0,2700.0,3800.0,,,,,,,,8250.0
Indore,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,5250.0,12000.0,2000.0,,,,,,,,19250.0
Indore,16.3.02,Stock Position of Gloves,2. Stocks Received,,,10000.0,0.0,0.0,,,,,,,,10000.0
Indore,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,9000.0,2000.0,1000.0,,,,,,,,12000.0
Indore,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,6250.0,10000.0,1000.0,,,,,,,,17250.0
Indore,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,0.0,,,,,,,,,,0.0
Indore,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,0.0,,,,,,,,,,0.0
Indore,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,0.0,,,,,,,,,,0.0
Indore,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,0.0,,,,,,,,,,0.0
Indore,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,343100.0,281000.0,250700.0,,,,,,,,874800.0
Indore,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,0.0,0.0,0.0,,,,,,,,0.0
Indore,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,281500.0,250700.0,188100.0,,,,,,,,720300.0
Indore,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,61600.0,30300.0,62600.0,,,,,,,,154500.0
Indore,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,0.0,,,,,,,,,,0.0
Indore,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,0.0,,,,,,,,,,0.0
Indore,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,0.0,,,,,,,,,,0.0
Indore,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,0.0,,,,,,,,,,0.0
Indore,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,43.0,43.0,43.0,,,,,,,,129.0
Indore,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,0.0,0.0,0.0,,,,,,,,0.0
Indore,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,43.0,43.0,40.0,,,,,,,,126.0
Indore,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,0.0,0.0,3.0,,,,,,,,3.0
Indore,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,1576000.0,1776000.0,476000.0,,,,,,,,3828000.0
Indore,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,0.0,0.0,0.0,,,,,,,,0.0
Indore,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,1576000.0,676000.0,20000.0,,,,,,,,2272000.0
Indore,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,0.0,1100000.0,456000.0,,,,,,,,1556000.0
Indore,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,11500.0,11340.0,6540.0,,,,,,,,29380.0
Indore,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,0.0,0.0,51500.0,,,,,,,,51500.0
Indore,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,11340.0,6540.0,57080.0,,,,,,,,74960.0
Indore,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,160.0,4800.0,960.0,,,,,,,,5920.0
Indore,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,6000.0,5000.0,4100.0,,,,,,,,15100.0
Indore,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,0.0,0.0,0.0,,,,,,,,0.0
Indore,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,5000.0,3200.0,3900.0,,,,,,,,12100.0
Indore,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,1000.0,1800.0,200.0,,,,,,,,3000.0
Indore,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,0.0,0.0,1000.0,,,,,,,,1000.0
Indore,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,0.0,1000.0,0.0,,,,,,,,1000.0
Indore,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,0.0,1000.0,500.0,,,,,,,,1500.0
Indore,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,0.0,0.0,500.0,,,,,,,,500.0
Indore,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,30000.0,10000.0,7000.0,,,,,,,,47000.0
Indore,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,0.0,50000.0,59000.0,,,,,,,,109000.0
Indore,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,10000.0,7000.0,5000.0,,,,,,,,22000.0
Indore,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,20000.0,53000.0,61000.0,,,,,,,,134000.0
Indore,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Indore,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Indore,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Indore,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Indore,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Indore,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Indore,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Indore,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Indore,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,58800.0,33800.0,11000.0,,,,,,,,103600.0
Indore,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,0.0,0.0,0.0,,,,,,,,0.0
Indore,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,45800.0,11000.0,4000.0,,,,,,,,60800.0
Indore,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,13000.0,22800.0,7000.0,,,,,,,,42800.0
Indore,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Indore,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Indore,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,1.0,,,,,,,,,,,1.0
Indore,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Indore,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,1.0,,,,,,,,,,,1.0
Indore,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Indore,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Indore,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Indore,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,,,,,,,,,,,,2.0
Indore,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Indore,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,,,,,,,,,,,,2.0
Indore,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,,,,,,,,,,,1.0,3.0
Indore,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,,,,,,,,,,1.0
Indore,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,,,,,,,,,,,1.0,4.0
Indore,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Indore,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Indore,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Indore,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Indore,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Indore,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Indore,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Indore,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Indore,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Indore,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Indore,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Indore,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Indore,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,,,,,,,,,,,,1.0
Indore,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Indore,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,,,,,,,,,,,,1.0
Indore,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Indore,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Indore,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Indore,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Indore,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Indore,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Indore,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Indore,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Indore,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Indore,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Indore,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Indore,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Indore,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Indore,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Indore,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Indore,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Indore,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Indore,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Indore,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Indore,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Indore,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Indore,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Indore,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Indore,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Indore,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Indore,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Indore,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Indore,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Indore,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Indore,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Indore,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Indore,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Indore,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Indore,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Indore,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Indore,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Indore,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Indore,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Indore,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Indore,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,3.0,,,,,2.0,,,,,,,5.0
Indore,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Indore,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,3.0,,,,,2.0,,,,,,,5.0
Indore,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Indore,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Indore,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Indore,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Indore,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Indore,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Indore,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Indore,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Indore,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Indore,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Indore,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Indore,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Indore,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Indore,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Indore,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Indore,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Indore,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Indore,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Indore,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Jabalpur,1.1,Total number of pregnant women Registered for ANC,TOTAL,4111.0,4648.0,4496.0,5188.0,3952.0,4470.0,3571.0,3915.0,3937.0,3704.0,5413.0,5688.0,53093.0
Jabalpur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1813.0,2553.0,2367.0,2792.0,2164.0,2342.0,2030.0,2046.0,2087.0,1967.0,2374.0,2999.0,27534.0
Jabalpur,1.2,Number of Pregnant women registered under JSY,TOTAL,3693.0,4247.0,4342.0,4812.0,3719.0,4374.0,4091.0,3630.0,3819.0,2937.0,4465.0,4443.0,48572.0
Jabalpur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3062.0,3339.0,3403.0,3618.0,4748.0,4427.0,4340.0,5707.0,3995.0,3390.0,3654.0,4564.0,48247.0
Jabalpur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2141.0,3035.0,2903.0,3212.0,2942.0,2809.0,2564.0,2484.0,2441.0,2582.0,4158.0,4276.0,35547.0
Jabalpur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1997.0,3134.0,3246.0,3767.0,3256.0,2980.0,2565.0,2605.0,2609.0,2211.0,2515.0,4524.0,35409.0
Jabalpur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3587.0,3949.0,4210.0,4594.0,3922.0,4523.0,3449.0,3954.0,3420.0,3311.0,4952.0,13358.0,57229.0
Jabalpur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,169.0,174.0,314.0,243.0,237.0,436.0,279.0,263.0,358.0,164.0,345.0,373.0,3355.0
Jabalpur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,30.0,14.0,30.0,24.0,53.0,62.0,61.0,65.0,120.0,31.0,33.0,96.0,619.0
Jabalpur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,3783.0,4229.0,4781.0,4801.0,4689.0,2230.0,4555.0,4976.0,4729.0,3806.0,4740.0,4309.0,51628.0
Jabalpur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,82.0,113.0,155.0,163.0,130.0,163.0,132.0,152.0,102.0,107.0,118.0,154.0,1571.0
Jabalpur,1.8,Number of pregnancy test kits used at SC level,TOTAL,205.0,216.0,252.0,236.0,298.0,323.0,283.0,338.0,349.0,350.0,456.0,557.0,3863.0
Jabalpur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,28.0,37.0,57.0,37.0,78.0,98.0,66.0,62.0,44.0,63.0,69.0,54.0,693.0
Jabalpur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,68.0,94.0,106.0,102.0,134.0,141.0,123.0,136.0,112.0,61.0,74.0,71.0,1222.0
Jabalpur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,96.0,131.0,163.0,139.0,212.0,239.0,189.0,198.0,156.0,124.0,143.0,125.0,1915.0
Jabalpur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,70.0,107.0,86.0,75.0,122.0,156.0,135.0,124.0,100.0,84.0,136.0,91.0,1286.0
Jabalpur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,2.0,2.0,1.0,0.0,4.0,2.0,0.0,11.0,4.0,2.0,28.0
Jabalpur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1930.0,1884.0,2204.0,2519.0,3167.0,3451.0,2980.0,2693.0,2374.0,2327.0,2173.0,2520.0,30222.0
Jabalpur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,107.0,38.0,30.0,54.0,39.0,35.0,54.0,112.0,27.0,23.0,58.0,195.0,772.0
Jabalpur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1855.0,1611.0,1811.0,2025.0,3013.0,3250.0,2671.0,2420.0,2222.0,1980.0,2076.0,2604.0,27538.0
Jabalpur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1300.0,1525.0,1380.0,1689.0,2161.0,2478.0,2214.0,1572.0,1416.0,2087.0,1913.0,1905.0,21640.0
Jabalpur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,18.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,7.0,31.0
Jabalpur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,307.0,523.0,446.0,521.0,759.0,949.0,583.0,679.0,532.0,427.0,452.0,612.0,6790.0
Jabalpur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0
Jabalpur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,2.0,1.0,6.0
Jabalpur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,296.0,414.0,358.0,470.0,512.0,382.0,422.0,414.0,318.0,358.0,365.0,305.0,4614.0
Jabalpur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jabalpur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,296.0,423.0,358.0,471.0,512.0,382.0,422.0,415.0,318.0,359.0,367.0,306.0,4629.0
Jabalpur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,63.0,100.0,118.0,122.0,185.0,186.0,142.0,182.0,95.0,145.0,75.0,90.0,1503.0
Jabalpur,4.1.1.a,Number of male live births,TOTAL,1202.0,1283.0,1488.0,1654.0,2159.0,2324.0,1975.0,1791.0,1529.0,1415.0,1437.0,1678.0,19935.0
Jabalpur,4.1.1.b,Number of female live births,TOTAL,1135.0,1265.0,1291.0,1489.0,1962.0,2290.0,1768.0,1760.0,1517.0,1426.0,1290.0,1577.0,18770.0
Jabalpur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2337.0,2548.0,2779.0,3143.0,4121.0,4614.0,3743.0,3551.0,3046.0,2841.0,2727.0,3255.0,38705.0
Jabalpur,4.1.2,Number of still births,TOTAL,28.0,26.0,46.0,44.0,26.0,34.0,23.0,20.0,22.0,45.0,52.0,42.0,408.0
Jabalpur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,49.0,44.0,27.0,58.0,22.0,26.0,22.0,50.0,34.0,54.0,57.0,52.0,495.0
Jabalpur,4.2.1,Number of Newborns weighed at birth,TOTAL,2293.0,2500.0,2730.0,3103.0,4073.0,4538.0,3422.0,3137.0,3005.0,2824.0,2693.0,3193.0,37511.0
Jabalpur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,422.0,292.0,351.0,774.0,652.0,730.0,1070.0,682.0,499.0,388.0,455.0,629.0,6944.0
Jabalpur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2272.0,2439.0,2664.0,2814.0,4053.0,4529.0,3548.0,3140.0,3021.0,2831.0,2705.0,3205.0,37221.0
Jabalpur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,12.0,26.0,55.0,45.0,23.0,21.0,8.0,1.0,43.0,5.0,58.0,5.0,302.0
Jabalpur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,31.0,19.0,38.0,31.0,2.0,51.0,8.0,23.0,11.0,11.0,69.0,26.0,320.0
Jabalpur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,380.0,530.0,600.0,683.0,788.0,850.0,810.0,540.0,527.0,609.0,607.0,778.0,7702.0
Jabalpur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jabalpur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,423.0,575.0,693.0,759.0,813.0,922.0,826.0,564.0,581.0,625.0,734.0,809.0,8324.0
Jabalpur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,63.0,100.0,118.0,122.0,185.0,186.0,142.0,182.0,95.0,0.0,74.0,90.0,1357.0
Jabalpur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,328.0,253.0,349.0,370.0,455.0,650.0,623.0,582.0,492.0,473.0,482.0,473.0,5530.0
Jabalpur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,36.0,13.0,42.0,25.0,56.0,69.0,70.0,64.0,67.0,52.0,52.0,245.0,791.0
Jabalpur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,435.0,448.0,523.0,579.0,829.0,1027.0,952.0,833.0,621.0,697.0,643.0,869.0,8456.0
Jabalpur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,236.0,323.0,427.0,411.0,422.0,464.0,493.0,100.0,390.0,422.0,356.0,460.0,4504.0
Jabalpur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2200.0,2419.0,2650.0,3069.0,4013.0,4584.0,3677.0,3492.0,2968.0,2828.0,2684.0,3222.0,37806.0
Jabalpur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,638.0,1895.0,1615.0,1128.0,3922.0,4401.0,3705.0,3577.0,3149.0,2954.0,2876.0,3239.0,33099.0
Jabalpur,6.3,PNC maternal complications attended,TOTAL,24.0,52.0,434.0,53.0,300.0,49.0,43.0,57.0,27.0,23.0,66.0,25.0,1153.0
Jabalpur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,73.0,95.0,78.0,77.0,73.0,75.0,105.0,75.0,45.0,50.0,87.0,47.0,880.0
Jabalpur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,5.0,3.0,11.0,11.0,4.0,12.0,2.0,5.0,19.0,22.0,12.0,10.0,116.0
Jabalpur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,78.0,98.0,89.0,88.0,77.0,87.0,107.0,80.0,64.0,72.0,99.0,57.0,996.0
Jabalpur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,42.0,78.0,45.0,96.0,91.0,71.0,74.0,84.0,98.0,65.0,16.0,17.0,777.0
Jabalpur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,243.0,424.0,241.0,648.0,466.0,270.0,365.0,170.0,163.0,199.0,204.0,215.0,3608.0
Jabalpur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,203.0,519.0,390.0,508.0,698.0,771.0,702.0,652.0,904.0,791.0,716.0,826.0,7680.0
Jabalpur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,446.0,943.0,631.0,1156.0,1164.0,1041.0,1067.0,822.0,1067.0,990.0,920.0,1041.0,11288.0
Jabalpur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,2.0,4.0,3.0,3.0,3.0,3.0,8.0,1.0,2.0,1.0,3.0,4.0,37.0
Jabalpur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,1.0,1.0,3.0,3.0,0.0,2.0,12.0
Jabalpur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,5.0,4.0,6.0,4.0,3.0,12.0,7.0,1.0,8.0,19.0,0.0,52.0,121.0
Jabalpur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jabalpur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,7.0,8.0,9.0,9.0,6.0,15.0,16.0,3.0,13.0,23.0,3.0,58.0,170.0
Jabalpur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,,,3.0
Jabalpur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,17.0,21.0,19.0,45.0,20.0,15.0,98.0,952.0,906.0,617.0,635.0,228.0,3573.0
Jabalpur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,15.0,33.0,17.0,69.0,41.0,46.0,131.0,902.0,1244.0,878.0,627.0,303.0,4306.0
Jabalpur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,83.0,48.0,127.0,91.0,25.0,109.0,116.0,80.0,274.0,197.0,30.0,1505.0,2685.0
Jabalpur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jabalpur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,115.0,102.0,163.0,205.0,86.0,170.0,345.0,1934.0,2424.0,1692.0,1292.0,2036.0,10564.0
Jabalpur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,8.0,41.0,78.0,37.0,63.0,50.0,20.0,78.0,46.0,108.0,50.0,103.0,682.0
Jabalpur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Jabalpur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Jabalpur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,62.0,21.0,18.0,80.0,126.0,78.0,69.0,19.0,26.0,110.0,21.0,0.0,630.0
Jabalpur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jabalpur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,62.0,21.0,18.0,81.0,126.0,78.0,69.0,19.0,26.0,111.0,21.0,0.0,632.0
Jabalpur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,62.0,39.0,65.0,20.0,40.0,65.0,92.0,0.0,35.0,,,418.0
Jabalpur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,5.0,14.0,1.0,4.0,16.0,9.0,13.0,0.0,9.0,0.0,9.0,4.0,84.0
Jabalpur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,2.0
Jabalpur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,120.0,110.0,149.0,167.0,170.0,139.0,167.0,193.0,151.0,71.0,158.0,105.0,1700.0
Jabalpur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jabalpur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,125.0,124.0,150.0,171.0,186.0,148.0,180.0,194.0,160.0,71.0,168.0,109.0,1786.0
Jabalpur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,93.0,85.0,40.0,72.0,88.0,50.0,63.0,68.0,59.0,37.0,16.0,0.0,671.0
Jabalpur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,426.0,405.0,463.0,443.0,500.0,553.0,497.0,476.0,661.0,821.0,739.0,736.0,6720.0
Jabalpur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,32.0,51.0,22.0,48.0,59.0,38.0,70.0,82.0,68.0,47.0,75.0,92.0,684.0
Jabalpur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,25.0,59.0,74.0,86.0,118.0,130.0,46.0,43.0,42.0,61.0,40.0,48.0,772.0
Jabalpur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,706.0,636.0,748.0,608.0,777.0,811.0,857.0,889.0,876.0,666.0,824.0,931.0,9329.0
Jabalpur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jabalpur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1189.0,1151.0,1307.0,1185.0,1454.0,1532.0,1470.0,1490.0,1647.0,1595.0,1678.0,1807.0,17505.0
Jabalpur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,118.0,589.0,540.0,477.0,744.0,847.0,827.0,454.0,282.0,477.0,472.0,1015.0,6842.0
Jabalpur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,4.0,7.0,20.0
Jabalpur,9.06,Number of IUCD removals,TOTAL,301.0,215.0,197.0,222.0,348.0,262.0,380.0,270.0,295.0,261.0,298.0,315.0,3364.0
Jabalpur,9.07,Number of Oral Pills cycles distributed,TOTAL,3663.0,3363.0,3223.0,3199.0,4125.0,4347.0,4088.0,3404.0,11266.0,4875.0,4904.0,5345.0,55802.0
Jabalpur,9.08,Number of Condom pieces distributed,TOTAL,45427.0,41489.0,44227.0,54766.0,67087.0,40661.0,46130.0,33310.0,38899.0,43660.0,46927.0,30476.0,533059.0
Jabalpur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,3.0,17.0,4.0,5.0,1.0,81.0,1.0,6.0,3.0,16.0,71.0,59.0,267.0
Jabalpur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Jabalpur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,7.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,5.0,0.0,14.0
Jabalpur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,4.0
Jabalpur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,9.12,Number of Institutions having NSV trained doctors,TOTAL,18.0,19.0,16.0,17.0,17.0,16.0,15.0,15.0,15.0,15.0,13.0,11.0,-1.0
Jabalpur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2038.0,2490.0,2596.0,2860.0,3864.0,4165.0,3400.0,3596.0,2873.0,2580.0,2776.0,3008.0,36246.0
Jabalpur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2266.0,2613.0,2653.0,2777.0,2700.0,3277.0,3416.0,1454.0,533.0,146.0,89.0,437.0,22361.0
Jabalpur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2293.0,2644.0,2545.0,3081.0,2605.0,3096.0,3181.0,3293.0,1896.0,824.0,425.0,474.0,26357.0
Jabalpur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2493.0,2707.0,2705.0,3085.0,3059.0,3091.0,2527.0,2777.0,3210.0,1970.0,949.0,951.0,29524.0
Jabalpur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,68.0,0.0,0.0,0.0,0.0,0.0,2131.0,3050.0,2886.0,2933.0,3556.0,14624.0
Jabalpur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,64.0,0.0,0.0,0.0,0.0,0.0,0.0,1769.0,2445.0,2957.0,3635.0,10870.0
Jabalpur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,60.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,1316.0,2533.0,3545.0,7458.0
Jabalpur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1833.0,2128.0,2238.0,2578.0,3491.0,3725.0,3425.0,3152.0,2569.0,2396.0,2612.0,2873.0,33020.0
Jabalpur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2258.0,2646.0,2655.0,2727.0,2666.0,3292.0,3317.0,3024.0,3248.0,2651.0,2874.0,3576.0,34934.0
Jabalpur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2287.0,2699.0,2551.0,3090.0,2578.0,3092.0,3131.0,3276.0,3209.0,2917.0,3059.0,3669.0,35558.0
Jabalpur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2506.0,2721.0,2711.0,3073.0,3022.0,3089.0,2769.0,2738.0,3187.0,3043.0,3115.0,3628.0,35602.0
Jabalpur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1728.0,1914.0,1924.0,2280.0,3379.0,3482.0,2790.0,2903.0,2453.0,2229.0,2423.0,2516.0,30021.0
Jabalpur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2201.0,2608.0,2645.0,2754.0,2694.0,3295.0,3292.0,1757.0,588.0,220.0,398.0,355.0,22807.0
Jabalpur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2278.0,2636.0,2535.0,3072.0,2608.0,3086.0,3168.0,3296.0,1946.0,914.0,732.0,710.0,26981.0
Jabalpur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2459.0,2701.0,2694.0,3087.0,3053.0,3096.0,2832.0,2741.0,3218.0,1924.0,1248.0,1130.0,30183.0
Jabalpur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2149.0,2608.0,3122.0,3708.0,3212.0,3359.0,2969.0,3053.0,2937.0,2575.0,2960.0,3575.0,36227.0
Jabalpur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1526.0,2088.0,2064.0,3330.0,2448.0,2456.0,2166.0,2482.0,2545.0,2540.0,3150.0,3621.0,30416.0
Jabalpur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,51.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,51.0
Jabalpur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1098.0,1362.0,1578.0,1892.0,1708.0,1745.0,1501.0,1576.0,1492.0,1341.0,1529.0,1805.0,18627.0
Jabalpur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,967.0,1195.0,1411.0,1686.0,1515.0,1535.0,1403.0,1405.0,1333.0,1256.0,1394.0,1608.0,16708.0
Jabalpur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2065.0,2557.0,2989.0,3578.0,3223.0,3280.0,2904.0,2981.0,2825.0,2597.0,2923.0,3413.0,35335.0
Jabalpur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2133.0,2438.0,2542.0,3058.0,2612.0,2735.0,2274.0,2452.0,2844.0,2797.0,3192.0,3542.0,32619.0
Jabalpur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2125.0,2419.0,2555.0,3041.0,2578.0,2739.0,2248.0,2441.0,2828.0,2811.0,3198.0,3782.0,32765.0
Jabalpur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,478.0,635.0,640.0,928.0,759.0,790.0,658.0,628.0,396.0,583.0,824.0,854.0,8173.0
Jabalpur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,394.0,588.0,579.0,826.0,706.0,699.0,594.0,513.0,370.0,546.0,767.0,826.0,7408.0
Jabalpur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,872.0,1223.0,1219.0,1754.0,1465.0,1489.0,1252.0,1141.0,766.0,1129.0,1591.0,1680.0,15581.0
Jabalpur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1341.0,1690.0,1848.0,2278.0,2182.0,2496.0,1944.0,2176.0,2033.0,2485.0,2370.0,2816.0,25659.0
Jabalpur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1442.0,1684.0,1955.0,2304.0,2339.0,2417.0,2064.0,2313.0,2104.0,2652.0,2608.0,2927.0,26809.0
Jabalpur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1645.0,1956.0,2199.0,2688.0,2374.0,2742.0,2446.0,2677.0,2286.0,2743.0,2741.0,3412.0,29909.0
Jabalpur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,3.0,3.0,2.0,11.0
Jabalpur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,7.0,0.0,2.0,5.0,3.0,3.0,0.0,15.0,26.0,26.0,3.0,1.0,91.0
Jabalpur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1665.0,1963.0,1942.0,1979.0,1950.0,1929.0,1906.0,1968.0,1967.0,1912.0,1937.0,2033.0,23151.0
Jabalpur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1476.0,1880.0,1915.0,1908.0,1849.0,1910.0,1802.0,1899.0,1938.0,1755.0,1859.0,1991.0,22182.0
Jabalpur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1090.0,1361.0,1395.0,1439.0,1384.0,1419.0,1311.0,1528.0,1518.0,1478.0,1462.0,1574.0,16959.0
Jabalpur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1975.0,2464.0,3078.0,3661.0,3328.0,3153.0,2689.0,2990.0,2880.0,2763.0,3306.0,3481.0,35768.0
Jabalpur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,827.0,1050.0,1197.0,9698.0,5140.0,1908.0,1240.0,1171.0,1342.0,8562.0,11351.0,1387.0,44873.0
Jabalpur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,614.0,926.0,1027.0,9876.0,4526.0,2396.0,967.0,977.0,1193.0,7752.0,10907.0,1073.0,42234.0
Jabalpur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Jabalpur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0,0.0,16.0,3.0,32.0
Jabalpur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,203.0,380.0,380.0,446.0,439.0,678.0,710.0,432.0,180.0,287.0,543.0,623.0,5301.0
Jabalpur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,1.0,9.0,0.0,5.0,10.0,0.0,2.0,1.0,5.0,0.0,140.0,5.0,178.0
Jabalpur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,1.0,2.0,0.0,5.0,1.0,4.0,2.0,5.0,6.0,1.0,0.0,1.0,28.0
Jabalpur,13.1,Number of Patients operated for cataract,TOTAL,146.0,338.0,246.0,198.0,186.0,195.0,263.0,580.0,320.0,51.0,165.0,210.0,2898.0
Jabalpur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,142.0,338.0,246.0,198.0,186.0,195.0,193.0,570.0,312.0,51.0,35.0,210.0,2676.0
Jabalpur,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,22.0,644.0,207.0,323.0,104.0,56.0,0.0,89.0,1445.0
Jabalpur,13.4,Number of children provided free glasses,TOTAL,9.0,17.0,0.0,0.0,0.0,9.0,167.0,237.0,204.0,140.0,27.0,77.0,887.0
Jabalpur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,7.0,7.0,7.0,8.0,6.0,8.0,7.0,7.0,9.0,6.0,7.0,-1.0
Jabalpur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,11.0,12.0,10.0,10.0,10.0,10.0,11.0,11.0,10.0,11.0,12.0,10.0,-1.0
Jabalpur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1365.0,1645.0,1694.0,1695.0,1664.0,1714.0,1632.0,1679.0,1772.0,1593.0,1677.0,1847.0,-1.0
Jabalpur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,9.0,8.0,8.0,8.0,8.0,8.0,9.0,8.0,8.0,10.0,8.0,10.0,-1.0
Jabalpur,14.05,Number of RKS meetings held during the month,TOTAL,5.0,4.0,5.0,4.0,4.0,5.0,5.0,4.0,2.0,3.0,4.0,4.0,49.0
Jabalpur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,19.0,18.0,17.0,20.0,20.0,20.0,22.0,21.0,21.0,24.0,21.0,19.0,-1.0
Jabalpur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,713.0,666.0,894.0,971.0,1247.0,1414.0,1428.0,1525.0,1035.0,762.0,920.0,1148.0,12723.0
Jabalpur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,7.0,6.0,6.0,6.0,5.0,4.0,5.0,5.0,5.0,7.0,6.0,7.0,-1.0
Jabalpur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,9.0,9.0,9.0,8.0,8.0,8.0,12.0,10.0,2.0,2.0,7.0,3.0,-1.0
Jabalpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,214.0,352.0,238.0,300.0,285.0,325.0,357.0,264.0,279.0,233.0,237.0,304.0,3388.0
Jabalpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,995.0,1556.0,1469.0,1326.0,1571.0,2415.0,2219.0,2055.0,1540.0,1900.0,1928.0,1782.0,20756.0
Jabalpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,257.0,490.0,242.0,329.0,360.0,372.0,343.0,327.0,250.0,256.0,262.0,332.0,3820.0
Jabalpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2346.0,2785.0,2759.0,3597.0,4085.0,4332.0,3578.0,3574.0,2812.0,3428.0,3181.0,3492.0,39969.0
Jabalpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,471.0,842.0,480.0,629.0,645.0,697.0,700.0,591.0,529.0,489.0,499.0,636.0,7208.0
Jabalpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3341.0,4341.0,4228.0,4923.0,5656.0,6747.0,5797.0,5629.0,4352.0,5328.0,5109.0,5274.0,60725.0
Jabalpur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,12.0,10.0,10.0,19.0,18.0,18.0,13.0,0.0,19.0,1.0,1.0,2.0,123.0
Jabalpur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,12.0,12.0,10.0,22.0,19.0,20.0,6.0,0.0,15.0,1.0,0.0,1.0,118.0
Jabalpur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,24.0,22.0,20.0,41.0,37.0,38.0,19.0,0.0,34.0,2.0,1.0,3.0,241.0
Jabalpur,14.11,In-Patient Head Count at midnight,TOTAL,4532.0,5193.0,4991.0,5416.0,7062.0,7696.0,7083.0,7602.0,5136.0,5872.0,6840.0,7002.0,74425.0
Jabalpur,14.12.1,OPD attendance (All),TOTAL,42315.0,55078.0,58072.0,68281.0,66557.0,77442.0,71531.0,75900.0,61772.0,61633.0,79356.0,76227.0,794164.0
Jabalpur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,308.0,396.0,307.0,335.0,392.0,469.0,270.0,294.0,183.0,976.0,251.0,328.0,4509.0
Jabalpur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,1.0,0.0,0.0,0.0,0.0,49.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0
Jabalpur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,183.0,221.0,268.0,339.0,477.0,442.0,110.0,613.0,461.0,422.0,360.0,526.0,4422.0
Jabalpur,14.14.a,Number of patients given AYUSH treatment,TOTAL,3623.0,2821.0,4004.0,3927.0,3529.0,3557.0,4078.0,6995.0,5667.0,6528.0,7631.0,6515.0,58875.0
Jabalpur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,822.0,803.0,920.0,895.0,748.0,648.0,660.0,45.0,30.0,299.0,164.0,60.0,6094.0
Jabalpur,14.14.c,Number of Adolescents counselled,TOTAL,482.0,533.0,459.0,751.0,904.0,656.0,743.0,429.0,264.0,230.0,284.0,299.0,6034.0
Jabalpur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7030.0,9109.0,9428.0,11292.0,10225.0,10710.0,8298.0,9710.0,9484.0,8284.0,9208.0,9000.0,111778.0
Jabalpur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,244.0,387.0,635.0,898.0,420.0,522.0,224.0,252.0,206.0,260.0,184.0,247.0,4479.0
Jabalpur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,168.0,277.0,321.0,289.0,271.0,467.0,363.0,638.0,534.0,460.0,511.0,419.0,4718.0
Jabalpur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,3.0,0.0,3.0,2.0,8.0,5.0,4.0,1.0,0.0,0.0,89.0,116.0
Jabalpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,117.0,173.0,336.0,177.0,240.0,623.0,509.0,770.0,687.0,530.0,423.0,374.0,4959.0
Jabalpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,0.0,1.0,0.0,0.0,4.0,4.0,10.0,2.0,0.0,1.0,63.0,86.0
Jabalpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1684.0,2029.0,2360.0,2293.0,1930.0,3908.0,2794.0,3813.0,2447.0,2921.0,3033.0,2056.0,31268.0
Jabalpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,1.0,0.0,6.0,2.0,4.0,0.0,9.0,6.0,1.0,1.0,220.0,251.0
Jabalpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1969.0,2479.0,3017.0,2759.0,2441.0,4998.0,3666.0,5221.0,3668.0,3911.0,3967.0,2849.0,40945.0
Jabalpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,4.0,1.0,9.0,4.0,16.0,9.0,23.0,9.0,1.0,2.0,372.0,453.0
Jabalpur,15.2,Number of Widal tests conducted,Number tested,222.0,369.0,318.0,256.0,394.0,1141.0,747.0,1188.0,497.0,606.0,764.0,933.0,7435.0
Jabalpur,15.3.a,Number of VDRL tests conducted on males,Number tested,54.0,14.0,126.0,239.0,34.0,17.0,83.0,5.0,790.0,63.0,51.0,74.0,1550.0
Jabalpur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,71.0,266.0,317.0,432.0,4.0,430.0,216.0,5.0,614.0,357.0,233.0,330.0,3275.0
Jabalpur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,210.0,255.0,276.0,513.0,417.0,881.0,554.0,343.0,480.0,573.0,658.0,562.0,5722.0
Jabalpur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,335.0,535.0,719.0,1184.0,455.0,1328.0,853.0,353.0,1884.0,993.0,942.0,966.0,10547.0
Jabalpur,15.4.1,Number of blood smears examined for Malaria,TOTAL,18677.0,19566.0,20568.0,22273.0,20937.0,21153.0,22517.0,16660.0,14656.0,10652.0,15609.0,15632.0,218900.0
Jabalpur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,15.0,10.0,15.0,26.0,16.0,37.0,41.0,36.0,14.0,4.0,3.0,6.0,223.0
Jabalpur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,1.0,1.0,1.0,5.0,13.0,15.0,14.0,9.0,6.0,0.0,5.0,72.0
Jabalpur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1155.0,880.0,910.0,415.0,415.0,1220.0,2200.0,1725.0,490.0,2855.0,2155.0,,14420.0
Jabalpur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1500.0,1500.0,1500.0,3500.0,3500.0,2000.0,1000.0,,3200.0,,,,17700.0
Jabalpur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1775.0,1470.0,1995.0,1570.0,1570.0,1020.0,1475.0,1235.0,835.0,700.0,420.0,,14065.0
Jabalpur,16.1.1,Stock position of DPT vaccines,5. Total Stock,880.0,910.0,415.0,2345.0,2345.0,2200.0,1725.0,490.0,2855.0,2155.0,1735.0,0.0,18055.0
Jabalpur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0,465.0,1805.0,980.0,,3850.0
Jabalpur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,,,,,,1900.0,,1800.0,,1000.0,,4700.0
Jabalpur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,,,,,,1300.0,135.0,460.0,825.0,995.0,,3715.0
Jabalpur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,600.0,465.0,1805.0,980.0,985.0,0.0,4835.0
Jabalpur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1780.0,1010.0,865.0,170.0,170.0,510.0,15.0,700.0,125.0,540.0,290.0,,6175.0
Jabalpur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1000.0,1000.0,1000.0,1800.0,1800.0,1000.0,1700.0,300.0,1800.0,225.0,800.0,,12425.0
Jabalpur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1770.0,1145.0,1695.0,1360.0,1360.0,1495.0,1015.0,875.0,1385.0,475.0,465.0,,13040.0
Jabalpur,16.1.2,Stock position of OPV vaccines,5. Total Stock,1010.0,865.0,170.0,610.0,610.0,15.0,700.0,125.0,540.0,290.0,625.0,0.0,5560.0
Jabalpur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1590.0,1025.0,1175.0,1440.0,1440.0,920.0,950.0,1200.0,1740.0,2055.0,2055.0,,15590.0
Jabalpur,16.1.3,Stock position of TT vaccines,2. Stocks Received,1000.0,1500.0,1500.0,2000.0,2000.0,1000.0,1500.0,1400.0,2000.0,,,,13900.0
Jabalpur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1565.0,1350.0,1235.0,1570.0,1570.0,970.0,1250.0,860.0,1685.0,,495.0,,12550.0
Jabalpur,16.1.3,Stock position of TT vaccines,5. Total Stock,1025.0,1175.0,1440.0,1870.0,1870.0,950.0,1200.0,1740.0,2055.0,2055.0,1560.0,0.0,16940.0
Jabalpur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Jabalpur,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,,,,,,,,,,,,0.0
Jabalpur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,,,,,,,,,,,,0.0
Jabalpur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,870.0,1105.0,1255.0,1270.0,1270.0,720.0,1010.0,1420.0,832.0,1107.0,1487.0,,12346.0
Jabalpur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000.0,1000.0,700.0,1000.0,1000.0,1000.0,1000.0,,1000.0,1000.0,,,8700.0
Jabalpur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,765.0,850.0,685.0,920.0,920.0,710.0,590.0,588.0,725.0,620.0,875.0,,8248.0
Jabalpur,16.1.5,Stock position of BCG vaccines,5. Total Stock,1105.0,1255.0,1270.0,1350.0,1350.0,1010.0,1420.0,832.0,1107.0,1487.0,612.0,0.0,12798.0
Jabalpur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,887.0,585.0,650.0,315.0,315.0,1825.0,425.0,0.0,1270.0,1510.0,1000.0,,8782.0
Jabalpur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1000.0,1500.0,1500.0,3000.0,3000.0,,1000.0,1500.0,2000.0,1000.0,1000.0,,16500.0
Jabalpur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1302.0,1435.0,1835.0,2170.0,2170.0,1400.0,1425.0,230.0,1760.0,1510.0,1270.0,,16507.0
Jabalpur,16.1.6,Stock position of Measles vaccines,5. Total Stock,585.0,650.0,315.0,1145.0,1145.0,425.0,0.0,1270.0,1510.0,1000.0,730.0,0.0,8775.0
Jabalpur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Jabalpur,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,,,,,,,,,,,,0.0
Jabalpur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,,,,,,,,,,,,0.0
Jabalpur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1265.0,930.0,1180.0,515.0,515.0,1815.0,725.0,925.0,990.0,1055.0,1705.0,,11620.0
Jabalpur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1500.0,1500.0,1000.0,2000.0,2000.0,,1500.0,1000.0,1000.0,1000.0,,,12500.0
Jabalpur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1835.0,1250.0,1665.0,1500.0,1500.0,1090.0,1300.0,935.0,935.0,350.0,440.0,,12800.0
Jabalpur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,930.0,1180.0,515.0,1015.0,1015.0,725.0,925.0,990.0,1055.0,1705.0,1265.0,0.0,11320.0
Jabalpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,3450.0,2750.0,1750.0,0.0,0.0,150.0,500.0,3600.0,1700.0,850.0,2850.0,,17600.0
Jabalpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,,,1300.0,1300.0,3600.0,3600.0,,1800.0,2400.0,3000.0,,17000.0
Jabalpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,700.0,1000.0,1750.0,850.0,850.0,3250.0,500.0,1900.0,2650.0,400.0,800.0,,14650.0
Jabalpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2750.0,1750.0,0.0,450.0,450.0,500.0,3600.0,1700.0,850.0,2850.0,5050.0,0.0,19950.0
Jabalpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,95750.0,50400.0,0.0,0.0,0.0,97880.0,27740.0,35020.0,20.0,940.0,0.0,,307750.0
Jabalpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,,,20160.0,20160.0,30240.0,45360.0,,48000.0,,54000.0,,217920.0
Jabalpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,45350.0,50400.0,,4280.0,4280.0,100380.0,38080.0,35000.0,47080.0,940.0,29000.0,,354790.0
Jabalpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,50400.0,0.0,0.0,15880.0,15880.0,27740.0,35020.0,20.0,940.0,0.0,25000.0,0.0,170880.0
Jabalpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,11890.0,4190.0,4890.0,4090.0,14090.0,25890.0,,65040.0
Jabalpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,30000.0,30000.0,6600.0,4000.0,,30000.0,20000.0,30000.0,,150600.0
Jabalpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Jabalpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,9310.0,9310.0,14300.0,3300.0,800.0,20000.0,8200.0,8000.0,,73220.0
Jabalpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,20690.0,20690.0,4190.0,4890.0,4090.0,14090.0,25890.0,47890.0,0.0,142420.0
Jabalpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,900.0,200.0,200.0,440.0,440.0,850.0,2150.0,2150.0,1350.0,800.0,6750.0,,16230.0
Jabalpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,600.0,,,2000.0,,,3000.0,6000.0,,,11600.0
Jabalpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,700.0,0.0,360.0,440.0,440.0,700.0,,800.0,3550.0,50.0,550.0,,7590.0
Jabalpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,200.0,200.0,440.0,0.0,0.0,2150.0,2150.0,1350.0,800.0,6750.0,6200.0,0.0,20240.0
Jabalpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,3350.0,3350.0,7600.0,12500.0,12500.0,19100.0,17900.0,17900.0,14700.0,12400.0,11400.0,,132700.0
Jabalpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,4550.0,5000.0,,,,,,0.0,,5000.0,,14550.0
Jabalpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,300.0,100.0,,,1200.0,,3200.0,2300.0,1000.0,2000.0,,10100.0
Jabalpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,3350.0,7600.0,12500.0,12500.0,12500.0,17900.0,17900.0,14700.0,12400.0,11400.0,14400.0,0.0,137150.0
Jabalpur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,2250.0,990.0,,3240.0
Jabalpur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,10000.0,,,,10000.0
Jabalpur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Jabalpur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,7750.0,1260.0,710.0,,9720.0
Jabalpur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2250.0,990.0,280.0,0.0,3520.0
Jabalpur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Jabalpur,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Jabalpur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Jabalpur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Jabalpur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Jabalpur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Jabalpur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Jabalpur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Jabalpur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,88900.0,80400.0,78400.0,74400.0,74400.0,58900.0,46600.0,28000.0,21000.0,18000.0,14900.0,,583900.0
Jabalpur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,,,,,,,,,,,,0.0
Jabalpur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,8500.0,2000.0,4000.0,10000.0,10000.0,12300.0,18600.0,7000.0,3000.0,3100.0,1000.0,,79500.0
Jabalpur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,80400.0,78400.0,74400.0,64400.0,64400.0,46600.0,28000.0,21000.0,18000.0,14900.0,13900.0,0.0,504400.0
Jabalpur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,18500.0,15975.0,,34475.0
Jabalpur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,19300.0,,,,19300.0
Jabalpur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Jabalpur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,800.0,2525.0,5300.0,,8625.0
Jabalpur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18500.0,15975.0,10675.0,0.0,45150.0
Jabalpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,19.0,18.0,18.0,16.0,16.0,9.0,9.0,9.0,9.0,75.0,39.0,,237.0
Jabalpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,,,,,,,,84.0,16.0,,,100.0
Jabalpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,1.0,,2.0,7.0,7.0,,,,18.0,52.0,6.0,,93.0
Jabalpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,18.0,18.0,16.0,9.0,9.0,9.0,9.0,9.0,75.0,39.0,33.0,0.0,244.0
Jabalpur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,884000.0,622000.0,83000.0,18000.0,18000.0,2900.0,500000.0,31800.0,0.0,251700.0,2919300.0,,5330700.0
Jabalpur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,,,,,500000.0,,,4000000.0,3000000.0,,,7500000.0
Jabalpur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,262000.0,539000.0,65000.0,13100.0,13100.0,2900.0,468200.0,31800.0,3748300.0,332400.0,300000.0,,5775800.0
Jabalpur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,622000.0,83000.0,18000.0,4900.0,4900.0,500000.0,31800.0,0.0,251700.0,2919300.0,2619300.0,0.0,7054900.0
Jabalpur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,0.0,50.0,40.0,40.0,13694.0,490.0,490.0,346.0,32.0,32.0,,15214.0
Jabalpur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,100.0,,,100000.0,,,,,,,,100100.0
Jabalpur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Jabalpur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,50.0,10.0,40.0,86346.0,13204.0,,144.0,314.0,,10.0,,100118.0
Jabalpur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,50.0,40.0,0.0,13694.0,490.0,490.0,346.0,32.0,32.0,22.0,0.0,15196.0
Jabalpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Jabalpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Jabalpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Jabalpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Jabalpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jabalpur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,102.0,102.0,52.0,20.0,20.0,5.0,2.0,2.0,2.0,152.0,2.0,,461.0
Jabalpur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,,,,,,,,5000.0,,900.0,,5900.0
Jabalpur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,50.0,32.0,15.0,15.0,3.0,,,4850.0,150.0,240.0,,5355.0
Jabalpur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,102.0,52.0,20.0,5.0,5.0,2.0,2.0,2.0,152.0,2.0,662.0,0.0,1006.0
Jabalpur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,100.0,0.0,196000.0,128000.0,128000.0,151995.0,219995.0,201995.0,190995.0,154995.0,141875.0,,1513950.0
Jabalpur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,300000.0,,,,90000.0,,,,,,,390000.0
Jabalpur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,100.0,104000.0,68000.0,33005.0,33005.0,22000.0,18000.0,11000.0,36000.0,13120.0,39000.0,,377230.0
Jabalpur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,196000.0,128000.0,94995.0,94995.0,219995.0,201995.0,190995.0,154995.0,141875.0,102875.0,0.0,1526720.0
Jabalpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4700.0,10800.0,4800.0,8500.0,8500.0,18400.0,12800.0,26600.0,22200.0,0.0,0.0,,117300.0
Jabalpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,13200.0,,6600.0,19800.0,19800.0,,19800.0,,,,,,79200.0
Jabalpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,7100.0,6000.0,2900.0,8900.0,8900.0,5600.0,6000.0,4400.0,22200.0,,0.0,,72000.0
Jabalpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,10800.0,4800.0,8500.0,19400.0,19400.0,12800.0,26600.0,22200.0,0.0,0.0,0.0,0.0,124500.0
Jabalpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,248600.0,203000.0,379600.0,331600.0,331600.0,383600.0,347600.0,564600.0,534600.0,490600.0,468100.0,,4283500.0
Jabalpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,212000.0,,100000.0,100000.0,,252000.0,,,,,,664000.0
Jabalpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,45600.0,35400.0,48000.0,34000.0,34000.0,36000.0,35000.0,30000.0,44000.0,22500.0,32000.0,,396500.0
Jabalpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,203000.0,379600.0,331600.0,397600.0,397600.0,347600.0,564600.0,534600.0,490600.0,468100.0,436100.0,0.0,4551000.0
Jabalpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,8100.0,9200.0,7800.0,6600.0,24700.0,46100.0,46100.0,45000.0,41400.0,38200.0,37200.0,,310400.0
Jabalpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,8000.0,,,20000.0,22000.0,,0.0,,,,,,50000.0
Jabalpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,,,,,,,,,,,,0.0
Jabalpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,6900.0,1400.0,1200.0,1900.0,600.0,,1100.0,,3200.0,1000.0,2500.0,,19800.0
Jabalpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,9200.0,7800.0,6600.0,24700.0,46100.0,46100.0,45000.0,45000.0,38200.0,37200.0,34700.0,0.0,340600.0
Jabalpur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,2.0,,3.0,2.0,3.0,1.0,,,,11.0
Jabalpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,3.0,,2.0,3.0,6.0,8.0,10.0,7.0,3.0,4.0,6.0,8.0,60.0
Jabalpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,2.0,1.0,,,,2.0,,1.0,,,,1.0,7.0
Jabalpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,5.0,1.0,2.0,3.0,6.0,10.0,10.0,8.0,3.0,4.0,6.0,9.0,67.0
Jabalpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,3.0,6.0,4.0,6.0,8.0,7.0,6.0,5.0,2.0,6.0,5.0,4.0,62.0
Jabalpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,1.0,2.0,,,1.0,,,,,,1.0,5.0
Jabalpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,3.0,7.0,6.0,6.0,8.0,8.0,6.0,5.0,2.0,6.0,5.0,5.0,67.0
Jabalpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,6.0,5.0,14.0,12.0,24.0,16.0,22.0,17.0,11.0,10.0,6.0,5.0,148.0
Jabalpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,3.0,3.0,1.0,2.0,,,1.0,,,,11.0
Jabalpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,7.0,5.0,17.0,15.0,25.0,18.0,22.0,17.0,12.0,10.0,6.0,5.0,159.0
Jabalpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,7.0,5.0,1.0,13.0,19.0,15.0,26.0,9.0,9.0,11.0,12.0,128.0
Jabalpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,1.0,,,,1.0,1.0,1.0,1.0,3.0,8.0
Jabalpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,7.0,5.0,2.0,13.0,19.0,15.0,27.0,10.0,10.0,12.0,15.0,136.0
Jabalpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,1.0,1.0,,1.0,,1.0,1.0,1.0,,,7.0
Jabalpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,2.0,,1.0,,,,,3.0
Jabalpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,1.0,1.0,,3.0,,2.0,1.0,1.0,,,10.0
Jabalpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Jabalpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jabalpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,1.0,,,,,,1.0
Jabalpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,1.0,3.0,1.0,2.0,2.0,2.0,,,11.0
Jabalpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,1.0,2.0,2.0,3.0,,1.0,,1.0,,,10.0
Jabalpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,2.0,3.0,6.0,1.0,3.0,2.0,3.0,,,21.0
Jabalpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jabalpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jabalpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Jabalpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,8.0,3.0,8.0,9.0,7.0,6.0,4.0,5.0,3.0,7.0,4.0,66.0
Jabalpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,1.0,5.0,4.0,5.0,9.0,5.0,5.0,3.0,2.0,2.0,1.0,43.0
Jabalpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,9.0,8.0,12.0,14.0,16.0,11.0,9.0,8.0,5.0,9.0,5.0,109.0
Jabalpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Jabalpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Jabalpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Jabalpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,1.0,,,,,,,,1.0
Jabalpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Jabalpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,1.0,,3.0,,4.0,1.0,9.0,1.0,2.0,,2.0,24.0
Jabalpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,1.0,2.0,,,1.0,,,1.0,5.0
Jabalpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,1.0,,3.0,1.0,6.0,1.0,10.0,2.0,2.0,,3.0,30.0
Jabalpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Jabalpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,2.0,1.0,,1.0,,3.0,5.0,2.0,,3.0,4.0,21.0
Jabalpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,2.0,2.0,2.0,4.0,,,10.0,7.0,6.0,5.0,7.0,46.0
Jabalpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,4.0,3.0,2.0,5.0,,3.0,15.0,9.0,6.0,8.0,11.0,67.0
Jabalpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Jabalpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Jabalpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Jabalpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Jabalpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,2.0,,,,2.0
Jabalpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,1.0,1.0,,,,2.0,1.0,1.0,,1.0,8.0
Jabalpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,1.0,2.0,,2.0,,,,5.0
Jabalpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,1.0,1.0,,1.0,2.0,2.0,5.0,1.0,,1.0,15.0
Jabalpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Jabalpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Jabalpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Jabalpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Jabalpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Jabalpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,4.0,14.0,10.0,9.0,13.0,20.0,1.0,12.0,8.0,9.0,8.0,13.0,121.0
Jabalpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,8.0,10.0,12.0,5.0,8.0,11.0,10.0,11.0,11.0,6.0,8.0,10.0,110.0
Jabalpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,12.0,24.0,22.0,14.0,21.0,31.0,11.0,23.0,19.0,15.0,16.0,24.0,232.0
Jabalpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Jabalpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,2.0,,,,2.0,,,1.0,1.0,1.0,1.0,8.0
Jabalpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,2.0,,,,,1.0,2.0,,,3.0,,,8.0
Jabalpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,2.0,,,,3.0,2.0,,1.0,4.0,1.0,1.0,16.0
Jabalpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Jabalpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Jabalpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Jabalpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Jabalpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Jabalpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Jabalpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Jabalpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Jabalpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Jabalpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,,,,2.0,2.0,,,,,1.0,2.0,8.0
Jabalpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Jabalpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,,,,2.0,2.0,,,,,1.0,2.0,8.0
Jabalpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Jabalpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,,,2.0,,,,,,3.0
Jabalpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Jabalpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,1.0,,,2.0,,,,,,3.0
Jabalpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Jabalpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,3.0,,,,,3.0
Jabalpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Jabalpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,3.0,,,,,3.0
Jabalpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Jabalpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,2.0,1.0,3.0,4.0,,,,4.0,14.0
Jabalpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Jabalpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,2.0,1.0,3.0,4.0,,,,4.0,14.0
Jabalpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,2.0,4.0,1.0,1.0,,,2.0,2.0,,,,12.0
Jabalpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,5.0,14.0,12.0,15.0,5.0,17.0,6.0,12.0,11.0,12.0,10.0,11.0,130.0
Jabalpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,4.0,4.0,3.0,,1.0,2.0,1.0,3.0,,2.0,2.0,22.0
Jabalpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,5.0,20.0,20.0,19.0,6.0,18.0,8.0,15.0,16.0,12.0,12.0,13.0,164.0
Jabalpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,1.0,,,1.0,2.0,,,,,4.0
Jabalpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,8.0,8.0,13.0,13.0,9.0,12.0,6.0,10.0,8.0,5.0,5.0,11.0,108.0
Jabalpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,2.0,,1.0,3.0,,,,,,,6.0
Jabalpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,8.0,8.0,15.0,14.0,10.0,15.0,7.0,12.0,8.0,5.0,5.0,11.0,118.0
Jabalpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,1.0,2.0,,3.0,,,1.0,,,,8.0
Jabalpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,2.0,2.0,5.0,3.0,,1.0,1.0,1.0,,,15.0
Jabalpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,1.0,,,1.0,,,,2.0
Jabalpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,3.0,4.0,5.0,7.0,,1.0,3.0,1.0,,,25.0
Jabalpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,1.0,,,1.0,,1.0,1.0,,,,,4.0
Jabalpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,3.0,7.0,9.0,7.0,2.0,6.0,7.0,8.0,3.0,5.0,7.0,64.0
Jabalpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,7.0,9.0,7.0,5.0,1.0,11.0,8.0,12.0,6.0,3.0,6.0,77.0
Jabalpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,2.0,11.0,16.0,16.0,13.0,3.0,18.0,16.0,20.0,9.0,8.0,13.0,145.0
Jabalpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,1.0,,,1.0,1.0,,,,,,4.0
Jabalpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,6.0,12.0,8.0,9.0,9.0,15.0,11.0,14.0,10.0,7.0,8.0,14.0,123.0
Jabalpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,14.0,28.0,21.0,21.0,23.0,23.0,18.0,31.0,29.0,12.0,21.0,27.0,268.0
Jabalpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,20.0,41.0,30.0,30.0,32.0,39.0,30.0,45.0,39.0,19.0,29.0,41.0,395.0
Jabalpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,3.0,,1.0,3.0,2.0,1.0,2.0,,,2.0,2.0,16.0
Jabalpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,8.0,11.0,13.0,18.0,23.0,24.0,24.0,18.0,19.0,17.0,23.0,30.0,228.0
Jabalpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,17.0,49.0,70.0,57.0,83.0,95.0,69.0,83.0,80.0,66.0,67.0,67.0,803.0
Jabalpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,25.0,63.0,83.0,76.0,109.0,121.0,94.0,103.0,99.0,83.0,92.0,99.0,1047.0
Jhabua,1.1,Total number of pregnant women Registered for ANC,TOTAL,2225.0,2921.0,3238.0,3676.0,3002.0,2929.0,2748.0,3254.0,3002.0,2824.0,3098.0,3942.0,36859.0
Jhabua,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,700.0,851.0,1192.0,1453.0,1496.0,1324.0,1361.0,1615.0,1557.0,1501.0,1363.0,1712.0,16125.0
Jhabua,1.2,Number of Pregnant women registered under JSY,TOTAL,2147.0,2821.0,3123.0,3528.0,2934.0,2848.0,2670.0,3203.0,2945.0,2764.0,3036.0,3861.0,35880.0
Jhabua,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1539.0,1897.0,1925.0,2443.0,2190.0,2332.0,2108.0,2348.0,2376.0,2327.0,2288.0,2594.0,26367.0
Jhabua,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,970.0,1150.0,1206.0,1325.0,1164.0,1192.0,1113.0,1329.0,1248.0,1043.0,1263.0,1550.0,14553.0
Jhabua,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1562.0,1985.0,2271.0,2600.0,2148.0,2111.0,1991.0,2169.0,2238.0,1963.0,2109.0,2804.0,25951.0
Jhabua,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2177.0,2715.0,3153.0,3647.0,2936.0,2871.0,2706.0,3250.0,2955.0,2704.0,3010.0,3825.0,35949.0
Jhabua,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,52.0,34.0,59.0,63.0,39.0,35.0,71.0,66.0,55.0,146.0,78.0,56.0,754.0
Jhabua,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,17.0,18.0,17.0,25.0,11.0,12.0,9.0,4.0,10.0,26.0,10.0,12.0,171.0
Jhabua,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1384.0,1578.0,2242.0,2269.0,2409.0,2467.0,2302.0,3046.0,2681.0,1459.0,1820.0,1654.0,25311.0
Jhabua,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,20.0,26.0,53.0,22.0,27.0,15.0,15.0,50.0,197.0,50.0,45.0,92.0,612.0
Jhabua,1.8,Number of pregnancy test kits used at SC level,TOTAL,599.0,641.0,944.0,1113.0,1184.0,967.0,934.0,1098.0,1137.0,991.0,1019.0,1221.0,11848.0
Jhabua,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,147.0,263.0,336.0,339.0,381.0,373.0,279.0,382.0,401.0,326.0,276.0,343.0,3846.0
Jhabua,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,147.0,263.0,336.0,339.0,381.0,373.0,279.0,382.0,401.0,326.0,276.0,343.0,3846.0
Jhabua,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,87.0,186.0,218.0,253.0,310.0,301.0,192.0,297.0,316.0,305.0,258.0,314.0,3037.0
Jhabua,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,1.0,1.0,41.0,64.0,87.0,37.0,204.0,33.0,151.0,0.0,32.0,652.0
Jhabua,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1328.0,2352.0,2398.0,2149.0,2255.0,2181.0,2172.0,2268.0,2011.0,2055.0,2018.0,2857.0,26044.0
Jhabua,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,319.0,715.0,524.0,581.0,553.0,349.0,610.0,476.0,296.0,268.0,435.0,480.0,5606.0
Jhabua,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,302.0,695.0,1729.0,1943.0,1709.0,2433.0,1699.0,2682.0,2056.0,1595.0,2676.0,1727.0,21246.0
Jhabua,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,179.0,371.0,1456.0,1060.0,1045.0,1099.0,1042.0,1453.0,1358.0,988.0,1907.0,2008.0,13966.0
Jhabua,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,98.0,112.0,123.0,102.0,110.0,109.0,123.0,129.0,107.0,92.0,114.0,131.0,1350.0
Jhabua,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Jhabua,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Jhabua,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Jhabua,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,13.0,17.0,14.0,15.0,26.0,17.0,10.0,15.0,18.0,14.0,12.0,18.0,189.0
Jhabua,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,15.0,3.0,9.0,6.0,5.0,8.0,2.0,,,2.0,3.0,2.0,55.0
Jhabua,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jhabua,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,28.0,20.0,23.0,21.0,31.0,25.0,12.0,15.0,18.0,16.0,15.0,20.0,244.0
Jhabua,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,13.0,19.0,16.0,16.0,19.0,9.0,34.0,13.0,14.0,15.0,11.0,27.0,206.0
Jhabua,4.1.1.a,Number of male live births,TOTAL,798.0,1357.0,1432.0,1331.0,1397.0,1387.0,1304.0,1414.0,1314.0,1237.0,1222.0,1713.0,15906.0
Jhabua,4.1.1.b,Number of female live births,TOTAL,753.0,1342.0,1397.0,1252.0,1291.0,1224.0,1237.0,1317.0,1209.0,1205.0,1160.0,1581.0,14968.0
Jhabua,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1551.0,2699.0,2829.0,2583.0,2688.0,2611.0,2541.0,2731.0,2523.0,2442.0,2382.0,3294.0,30874.0
Jhabua,4.1.2,Number of still births,TOTAL,23.0,30.0,39.0,46.0,68.0,59.0,43.0,68.0,43.0,51.0,40.0,51.0,561.0
Jhabua,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,61.0,84.0,81.0,97.0,107.0,96.0,91.0,93.0,52.0,82.0,64.0,89.0,997.0
Jhabua,4.2.1,Number of Newborns weighed at birth,TOTAL,1478.0,2594.0,2688.0,2474.0,2561.0,2450.0,2424.0,2646.0,2436.0,2371.0,2324.0,3205.0,29651.0
Jhabua,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,246.0,443.0,481.0,416.0,485.0,546.0,383.0,538.0,467.0,458.0,428.0,495.0,5386.0
Jhabua,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1536.0,2683.0,2801.0,2560.0,2647.0,2546.0,2481.0,2714.0,2480.0,2383.0,2318.0,3197.0,30346.0
Jhabua,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,3.0,0.0,4.0,4.0,17.0,28.0,11.0,18.0,33.0,26.0,15.0,12.0,171.0
Jhabua,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,57.0,335.0,277.0,182.0,193.0,148.0,136.0,137.0,270.0,158.0,188.0,249.0,2330.0
Jhabua,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,131.0,84.0,79.0,71.0,68.0,61.0,71.0,,23.0,16.0,42.0,42.0,688.0
Jhabua,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jhabua,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,191.0,419.0,360.0,257.0,278.0,237.0,218.0,155.0,326.0,200.0,245.0,303.0,3189.0
Jhabua,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,14.0,23.0,53.0,56.0,20.0,4.0,39.0,27.0,42.0,33.0,26.0,65.0,402.0
Jhabua,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,107.0,268.0,202.0,168.0,170.0,138.0,129.0,127.0,258.0,150.0,152.0,207.0,2076.0
Jhabua,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,17.0,18.0,17.0,25.0,29.0,12.0,9.0,4.0,10.0,26.0,10.0,15.0,192.0
Jhabua,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,59.0,144.0,194.0,90.0,68.0,61.0,76.0,51.0,91.0,53.0,80.0,116.0,1083.0
Jhabua,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,22.0,12.0,0.0,30.0,31.0,30.0,45.0,0.0,23.0,4.0,29.0,30.0,256.0
Jhabua,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1191.0,2028.0,2186.0,2090.0,2284.0,2055.0,2121.0,2191.0,2127.0,2150.0,2080.0,2799.0,25302.0
Jhabua,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,723.0,1184.0,1314.0,1360.0,1025.0,1236.0,866.0,1142.0,1042.0,1108.0,1363.0,1684.0,14047.0
Jhabua,6.3,PNC maternal complications attended,TOTAL,10.0,15.0,16.0,17.0,40.0,97.0,28.0,65.0,83.0,29.0,63.0,59.0,522.0
Jhabua,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,34.0,48.0,53.0,67.0,60.0,67.0,49.0,57.0,49.0,53.0,86.0,84.0,707.0
Jhabua,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,5.0,3.0,0.0,0.0,0.0,0.0,2.0,3.0,2.0,0.0,0.0,0.0,15.0
Jhabua,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,39.0,51.0,53.0,67.0,60.0,67.0,51.0,60.0,51.0,53.0,86.0,84.0,722.0
Jhabua,7.2,Number of MTPs conducted at Private Facilities,TOTAL,7.0,8.0,11.0,9.0,7.0,0.0,6.0,0.0,0.0,15.0,9.0,12.0,84.0
Jhabua,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,137.0,152.0,201.0,314.0,270.0,213.0,349.0,186.0,300.0,291.0,251.0,314.0,2978.0
Jhabua,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,152.0,361.0,566.0,513.0,319.0,464.0,939.0,493.0,431.0,423.0,410.0,422.0,5493.0
Jhabua,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,289.0,513.0,767.0,827.0,589.0,677.0,1288.0,679.0,731.0,714.0,661.0,736.0,8471.0
Jhabua,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Jhabua,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,1.0,0.0,1.0,0.0,2.0,0.0,3.0,1.0,0.0,1.0,3.0,12.0
Jhabua,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,,,1.0,,,,2.0,0.0,1.0,1.0,6.0
Jhabua,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jhabua,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,2.0,0.0,1.0,1.0,2.0,0.0,3.0,3.0,0.0,2.0,4.0,18.0
Jhabua,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Jhabua,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,8.0,26.0,298.0,773.0,478.0,556.0,288.0,671.0,1066.0,1266.0,647.0,515.0,6592.0
Jhabua,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,,,3.0,1.0,5.0,1.0,8.0,4.0,9.0,11.0,0.0,42.0
Jhabua,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jhabua,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,8.0,26.0,298.0,776.0,479.0,561.0,289.0,679.0,1070.0,1275.0,658.0,515.0,6634.0
Jhabua,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,3.0,2.0,1.0,2.0,2.0,,,,2.0,3.0,,15.0
Jhabua,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,5.0,5.0,6.0,4.0,0.0,0.0,2.0,7.0,11.0,6.0,2.0,10.0,58.0
Jhabua,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,,,,,,,,0.0,0.0,,0.0,0.0
Jhabua,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jhabua,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,5.0,5.0,6.0,4.0,0.0,0.0,2.0,7.0,11.0,6.0,2.0,10.0,58.0
Jhabua,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Jhabua,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,2.0,10.0,63.0,0.0,1.0,2.0,1.0,32.0,32.0,143.0
Jhabua,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,6.0,,1.0,8.0,2.0,4.0,1.0,6.0,1.0,3.0,3.0,4.0,39.0
Jhabua,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jhabua,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,6.0,0.0,1.0,10.0,12.0,67.0,1.0,7.0,3.0,4.0,35.0,36.0,182.0
Jhabua,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,2.0,3.0,,,,,2.0,,,,,,7.0
Jhabua,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,289.0,370.0,419.0,568.0,766.0,672.0,708.0,788.0,727.0,655.0,664.0,541.0,7167.0
Jhabua,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,5.0,7.0,14.0,21.0,8.0,14.0,8.0,7.0,8.0,14.0,8.0,14.0,128.0
Jhabua,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,16.0,18.0,31.0,13.0,35.0,15.0,28.0,22.0,27.0,71.0,45.0,85.0,406.0
Jhabua,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,98.0,34.0,21.0,20.0,19.0,6.0,6.0,14.0,5.0,7.0,4.0,23.0,257.0
Jhabua,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jhabua,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,408.0,429.0,485.0,622.0,828.0,707.0,750.0,831.0,767.0,747.0,721.0,663.0,7958.0
Jhabua,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,89.0,31.0,15.0,14.0,25.0,8.0,15.0,55.0,48.0,60.0,36.0,85.0,481.0
Jhabua,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,2.0,3.0,2.0,2.0,,,,,4.0,,,13.0
Jhabua,9.06,Number of IUCD removals,TOTAL,182.0,204.0,225.0,177.0,211.0,290.0,208.0,313.0,319.0,351.0,328.0,359.0,3167.0
Jhabua,9.07,Number of Oral Pills cycles distributed,TOTAL,4132.0,4551.0,4530.0,5956.0,6822.0,6545.0,6716.0,7039.0,6174.0,6381.0,6145.0,5573.0,70564.0
Jhabua,9.08,Number of Condom pieces distributed,TOTAL,25227.0,30717.0,23046.0,31663.0,31912.0,24980.0,24056.0,25147.0,22317.0,23619.0,23195.0,21678.0,307557.0
Jhabua,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,5.0,17.0,21.0,48.0,70.0,40.0,13.0,34.0,19.0,76.0,15.0,10.0,368.0
Jhabua,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,5.0,12.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,4.0,22.0
Jhabua,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,9.11.2.b,Number of failures following female sterilization,TOTAL,5.0,4.0,0.0,1.0,2.0,1.0,1.0,0.0,3.0,5.0,1.0,4.0,27.0
Jhabua,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,9.12,Number of Institutions having NSV trained doctors,TOTAL,,1.0,2.0,1.0,1.0,,,6.0,3.0,2.0,2.0,2.0,-1.0
Jhabua,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1675.0,2497.0,3132.0,2971.0,2892.0,2830.0,2737.0,3081.0,2852.0,2460.0,2609.0,3743.0,33479.0
Jhabua,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1669.0,2121.0,2585.0,2969.0,2571.0,2569.0,2388.0,1179.0,89.0,4.0,10.0,9.0,18163.0
Jhabua,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1724.0,1936.0,2079.0,2616.0,2534.0,2571.0,2435.0,2534.0,1418.0,536.0,211.0,141.0,20735.0
Jhabua,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1777.0,1893.0,2101.0,2389.0,2295.0,2532.0,2380.0,2561.0,2410.0,1518.0,674.0,428.0,22958.0
Jhabua,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1373.0,1992.0,2358.0,2440.0,3122.0,11285.0
Jhabua,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,947.0,1859.0,2102.0,2665.0,7573.0
Jhabua,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,952.0,1576.0,2385.0,4913.0
Jhabua,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1192.0,1865.0,2297.0,1902.0,2099.0,2135.0,2062.0,2244.0,2030.0,2023.0,2001.0,2797.0,24647.0
Jhabua,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1668.0,2102.0,2575.0,2964.0,2552.0,2409.0,2175.0,2234.0,2134.0,2255.0,2447.0,3056.0,28571.0
Jhabua,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1716.0,1942.0,2089.0,2632.0,2530.0,2424.0,2150.0,2521.0,2282.0,2255.0,2270.0,2755.0,27566.0
Jhabua,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1758.0,1883.0,2092.0,2390.0,2316.0,2376.0,2118.0,2574.0,2470.0,2298.0,2154.0,2732.0,27161.0
Jhabua,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1160.0,1586.0,2153.0,1759.0,1916.0,2051.0,1962.0,2082.0,1675.0,1740.0,1741.0,2698.0,22523.0
Jhabua,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1657.0,2095.0,2563.0,2964.0,2549.0,2550.0,2380.0,1163.0,74.0,6.0,6.0,10.0,18017.0
Jhabua,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1702.0,1942.0,2079.0,2620.0,2529.0,2547.0,2432.0,2500.0,1428.0,558.0,209.0,137.0,20683.0
Jhabua,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1747.0,1879.0,2088.0,2390.0,2301.0,2513.0,2373.0,2537.0,2357.0,1496.0,644.0,405.0,22730.0
Jhabua,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1713.0,2344.0,2477.0,2465.0,2293.0,2296.0,2184.0,2621.0,2018.0,2078.0,1955.0,2556.0,27000.0
Jhabua,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1239.0,2109.0,3517.0,2124.0,1614.0,1748.0,1675.0,1786.0,1964.0,2021.0,2011.0,2550.0,24358.0
Jhabua,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,833.0,1086.0,1172.0,1148.0,1104.0,1031.0,1029.0,1196.0,1010.0,1037.0,1005.0,1303.0,12954.0
Jhabua,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,708.0,1036.0,1073.0,1047.0,1001.0,1034.0,1003.0,1153.0,940.0,953.0,918.0,1201.0,12067.0
Jhabua,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1541.0,2122.0,2245.0,2195.0,2105.0,2065.0,2032.0,2349.0,1950.0,1990.0,1923.0,2504.0,25021.0
Jhabua,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1404.0,2256.0,1941.0,2204.0,1884.0,1830.0,1832.0,2040.0,2059.0,2230.0,2187.0,2624.0,24491.0
Jhabua,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1404.0,2260.0,1942.0,2198.0,1884.0,1759.0,1691.0,2039.0,2047.0,2214.0,2187.0,2623.0,24248.0
Jhabua,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,89.0,112.0,126.0,128.0,95.0,116.0,79.0,131.0,72.0,111.0,116.0,171.0,1346.0
Jhabua,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,74.0,110.0,106.0,142.0,91.0,112.0,65.0,126.0,64.0,98.0,128.0,162.0,1278.0
Jhabua,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,163.0,222.0,232.0,270.0,186.0,228.0,144.0,257.0,136.0,209.0,244.0,333.0,2624.0
Jhabua,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1062.0,1503.0,1621.0,1948.0,1676.0,1549.0,1572.0,1594.0,1792.0,2205.0,1978.0,2222.0,20722.0
Jhabua,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1242.0,1451.0,1688.0,1980.0,1786.0,1872.0,1841.0,1758.0,1869.0,1994.0,2000.0,2178.0,21659.0
Jhabua,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1277.0,1493.0,1737.0,2247.0,1942.0,1842.0,1855.0,1757.0,1956.0,2150.0,1982.0,2138.0,22376.0
Jhabua,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,3.0,0.0,1.0,2.0,5.0,10.0,4.0,2.0,3.0,4.0,34.0
Jhabua,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,23.0,21.0,10.0,14.0,25.0,3.0,22.0,3.0,21.0,15.0,6.0,31.0,194.0
Jhabua,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,918.0,1083.0,1116.0,1180.0,1097.0,1093.0,1105.0,1152.0,1222.0,1227.0,1218.0,1458.0,13869.0
Jhabua,10.4.2,Number of Immunisation sessions held during the month,TOTAL,815.0,1041.0,1103.0,1180.0,1068.0,1084.0,1092.0,1147.0,1216.0,1215.0,1211.0,1450.0,13622.0
Jhabua,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,723.0,923.0,980.0,1074.0,987.0,991.0,993.0,1005.0,1067.0,1060.0,1020.0,1249.0,12072.0
Jhabua,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1713.0,2339.0,2477.0,2465.0,2293.0,2296.0,2184.0,2621.0,2011.0,2214.0,2157.0,2797.0,27567.0
Jhabua,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,0.0,201.0,24228.0,2602.0,0.0,0.0,0.0,0.0,25349.0,6805.0,0.0,59185.0
Jhabua,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,64.0,23839.0,2325.0,0.0,0.0,0.0,0.0,27625.0,8059.0,0.0,61912.0
Jhabua,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0
Jhabua,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,1.0,2.0,8.0
Jhabua,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,23.0,333.0,74.0,0.0,0.0,1.0,1.0,0.0,0.0,2.0,16.0,17.0,467.0
Jhabua,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,445.0,559.0,610.0,486.0,760.0,872.0,629.0,762.0,597.0,828.0,779.0,707.0,8034.0
Jhabua,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,34.0,143.0,352.0,95.0,117.0,188.0,462.0,1198.0,625.0,254.0,215.0,105.0,3788.0
Jhabua,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,18.0,16.0,9.0,16.0,50.0,108.0,94.0,20.0,32.0,12.0,16.0,137.0,528.0
Jhabua,13.1,Number of Patients operated for cataract,TOTAL,126.0,82.0,135.0,185.0,267.0,224.0,250.0,325.0,325.0,160.0,185.0,126.0,2390.0
Jhabua,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,126.0,82.0,135.0,185.0,267.0,224.0,250.0,325.0,325.0,160.0,185.0,126.0,2390.0
Jhabua,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,475.0,0.0,218.0,204.0,897.0
Jhabua,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,475.0,475.0,0.0,218.0,204.0,1372.0
Jhabua,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,4.0,0.0,3.0,2.0,13.0
Jhabua,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Jhabua,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,2.0,,,,5.0,3.0,1.0,,3.0,-1.0
Jhabua,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,701.0,914.0,1197.0,1050.0,997.0,1017.0,982.0,953.0,925.0,998.0,976.0,1099.0,-1.0
Jhabua,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,8.0,8.0,8.0,8.0,8.0,8.0,7.0,7.0,8.0,8.0,8.0,-1.0
Jhabua,14.05,Number of RKS meetings held during the month,TOTAL,3.0,3.0,1.0,2.0,1.0,1.0,2.0,7.0,6.0,3.0,3.0,4.0,36.0
Jhabua,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,16.0,16.0,15.0,15.0,17.0,14.0,17.0,14.0,12.0,15.0,13.0,14.0,-1.0
Jhabua,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,258.0,502.0,984.0,720.0,1261.0,1880.0,1608.0,1518.0,1207.0,1333.0,1663.0,1528.0,14462.0
Jhabua,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,-1.0
Jhabua,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0,2.0,-1.0
Jhabua,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,522.0,697.0,665.0,621.0,777.0,1232.0,825.0,983.0,815.0,449.0,691.0,1136.0,9413.0
Jhabua,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,960.0,1728.0,1417.0,1340.0,1509.0,2003.0,1803.0,2540.0,1939.0,1232.0,1477.0,2031.0,19979.0
Jhabua,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,472.0,707.0,647.0,543.0,764.0,1161.0,833.0,914.0,789.0,421.0,655.0,1108.0,9014.0
Jhabua,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2251.0,3472.0,3668.0,3265.0,3822.0,4009.0,3714.0,4206.0,4201.0,3145.0,3878.0,5094.0,44725.0
Jhabua,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,994.0,1404.0,1312.0,1164.0,1541.0,2393.0,1658.0,1897.0,1604.0,870.0,1346.0,2244.0,18427.0
Jhabua,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3211.0,5200.0,5085.0,4605.0,5331.0,6012.0,5517.0,6746.0,6140.0,4377.0,5355.0,7125.0,64704.0
Jhabua,14.10.2.a,Number of death cases of Inpatient males,TOTAL,14.0,2.0,2.0,4.0,6.0,13.0,3.0,8.0,18.0,15.0,18.0,29.0,132.0
Jhabua,14.10.2.b,Number of death cases of Inpatient females,TOTAL,14.0,1.0,2.0,5.0,1.0,17.0,7.0,3.0,15.0,8.0,10.0,17.0,100.0
Jhabua,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,28.0,3.0,4.0,9.0,7.0,30.0,10.0,11.0,33.0,23.0,28.0,46.0,232.0
Jhabua,14.11,In-Patient Head Count at midnight,TOTAL,3704.0,4554.0,4334.0,4051.0,5738.0,5441.0,4059.0,6178.0,6236.0,5023.0,5845.0,7339.0,62502.0
Jhabua,14.12.1,OPD attendance (All),TOTAL,37000.0,57282.0,63979.0,66058.0,77304.0,105562.0,88005.0,85978.0,72657.0,61344.0,61360.0,76330.0,852859.0
Jhabua,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,57.0,43.0,31.0,28.0,78.0,39.0,29.0,50.0,83.0,65.0,46.0,54.0,603.0
Jhabua,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,2.0,0.0,17.0,17.0,21.0,17.0,17.0,9.0,15.0,13.0,2.0,3.0,133.0
Jhabua,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,48.0,23.0,35.0,229.0,840.0,164.0,361.0,311.0,363.0,694.0,123.0,266.0,3457.0
Jhabua,14.14.a,Number of patients given AYUSH treatment,TOTAL,1027.0,1154.0,751.0,735.0,1361.0,1488.0,893.0,973.0,1317.0,1504.0,1394.0,1304.0,13901.0
Jhabua,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,78.0,0.0,0.0,0.0,14.0,50.0,0.0,0.0,68.0,72.0,59.0,66.0,407.0
Jhabua,14.14.c,Number of Adolescents counselled,TOTAL,179.0,0.0,11.0,15.0,376.0,0.0,12.0,20.0,164.0,173.0,200.0,178.0,1328.0
Jhabua,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6651.0,6783.0,7771.0,8203.0,11739.0,12601.0,11509.0,14320.0,11270.0,10569.0,10876.0,10708.0,123000.0
Jhabua,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,407.0,379.0,363.0,260.0,1549.0,1383.0,1379.0,459.0,573.0,559.0,605.0,532.0,8448.0
Jhabua,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,139.0,164.0,191.0,218.0,168.0,288.0,582.0,181.0,186.0,136.0,150.0,129.0,2532.0
Jhabua,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3.0,2.0,5.0,2.0,4.0,4.0,2.0,2.0,3.0,0.0,4.0,0.0,31.0
Jhabua,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,656.0,787.0,716.0,469.0,740.0,793.0,389.0,295.0,370.0,303.0,287.0,260.0,6065.0
Jhabua,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,3.0,0.0,5.0,2.0,1.0,2.0,0.0,0.0,0.0,0.0,14.0
Jhabua,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1239.0,1775.0,1946.0,1869.0,1422.0,1536.0,1572.0,2469.0,2161.0,1952.0,2157.0,2007.0,22105.0
Jhabua,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,1.0,0.0,2.0,3.0,0.0,0.0,1.0,0.0,1.0,0.0,8.0
Jhabua,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2034.0,2726.0,2853.0,2556.0,2330.0,2617.0,2543.0,2945.0,2717.0,2391.0,2594.0,2396.0,30702.0
Jhabua,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,3.0,9.0,2.0,11.0,9.0,3.0,4.0,4.0,0.0,5.0,0.0,53.0
Jhabua,15.2,Number of Widal tests conducted,Number tested,432.0,475.0,839.0,962.0,1127.0,1480.0,783.0,1215.0,463.0,328.0,482.0,533.0,9119.0
Jhabua,15.3.a,Number of VDRL tests conducted on males,Number tested,156.0,44.0,19.0,19.0,78.0,333.0,309.0,69.0,148.0,44.0,100.0,81.0,1400.0
Jhabua,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,601.0,642.0,525.0,414.0,605.0,751.0,824.0,1413.0,487.0,232.0,427.0,211.0,7132.0
Jhabua,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,689.0,907.0,1150.0,1190.0,1473.0,1497.0,1316.0,1294.0,1093.0,1256.0,1782.0,1879.0,15526.0
Jhabua,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1446.0,1593.0,1694.0,1623.0,2156.0,2581.0,2449.0,2776.0,1728.0,1532.0,2309.0,2171.0,24058.0
Jhabua,15.4.1,Number of blood smears examined for Malaria,TOTAL,8809.0,9427.0,10793.0,13233.0,16220.0,23872.0,25729.0,32005.0,24448.0,11790.0,13949.0,13386.0,203661.0
Jhabua,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,185.0,237.0,224.0,308.0,283.0,599.0,991.0,1524.0,980.0,452.0,76.0,112.0,5971.0
Jhabua,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,137.0,140.0,184.0,132.0,175.0,535.0,1091.0,2063.0,1199.0,519.0,121.0,93.0,6389.0
Jhabua,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,26000.0,26500.0,16500.0,10500.0,12000.0,12000.0,10000.0,0.0,22500.0,6000.0,1500.0,11000.0,154500.0
Jhabua,16.1.1,Stock position of DPT vaccines,2. Stocks Received,20000.0,5000.0,15000.0,20000.0,5000.0,5000.0,5000.0,40000.0,0.0,0.0,10000.0,,125000.0
Jhabua,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,0.0,,,,,,,,,0.0
Jhabua,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,19500.0,15000.0,21000.0,18500.0,5000.0,7000.0,15000.0,17500.0,16500.0,4500.0,500.0,5000.0,145000.0
Jhabua,16.1.1,Stock position of DPT vaccines,5. Total Stock,26500.0,16500.0,10500.0,12000.0,12000.0,10000.0,0.0,22500.0,6000.0,1500.0,11000.0,6000.0,134500.0
Jhabua,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,2500.0,500.0,1000.0,0.0,6000.0,10000.0
Jhabua,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,9000.0,3000.0,6000.0,10000.0,10000.0,,38000.0
Jhabua,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,6500.0,5000.0,5500.0,11000.0,4000.0,6000.0,38000.0
Jhabua,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,2500.0,500.0,1000.0,0.0,6000.0,0.0,10000.0
Jhabua,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,24500.0,22500.0,12500.0,11500.0,4500.0,4000.0,0.0,3000.0,12500.0,1500.0,2000.0,89280.0,187780.0
Jhabua,16.1.2,Stock position of OPV vaccines,2. Stocks Received,15000.0,15000.0,25000.0,5000.0,2000.0,10000.0,20000.0,35500.0,231000.0,20000.0,251280.0,,629780.0
Jhabua,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,0.0,,,,,,,,,0.0
Jhabua,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,17000.0,25000.0,26000.0,12000.0,2500.0,14000.0,17000.0,26000.0,242000.0,19500.0,164000.0,74280.0,639280.0
Jhabua,16.1.2,Stock position of OPV vaccines,5. Total Stock,22500.0,12500.0,11500.0,4500.0,4000.0,0.0,3000.0,12500.0,1500.0,2000.0,89280.0,15000.0,178280.0
Jhabua,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,5500.0,19500.0,17000.0,17000.0,16000.0,21000.0,13000.0,7000.0,23000.0,8500.0,1000.0,8000.0,156500.0
Jhabua,16.1.3,Stock position of TT vaccines,2. Stocks Received,35000.0,10000.0,12500.0,10000.0,5000.0,3000.0,3000.0,30000.0,0.0,0.0,10000.0,,118500.0
Jhabua,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,0.0,,,,,,,,,0.0
Jhabua,16.1.3,Stock position of TT vaccines,4. Stock Distributed,21000.0,12500.0,12500.0,11000.0,,11000.0,9000.0,14000.0,14500.0,7500.0,3000.0,1500.0,117500.0
Jhabua,16.1.3,Stock position of TT vaccines,5. Total Stock,19500.0,17000.0,17000.0,16000.0,21000.0,13000.0,7000.0,23000.0,8500.0,1000.0,8000.0,6500.0,157500.0
Jhabua,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Jhabua,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Jhabua,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Jhabua,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2000.0,2000.0,6000.0,500.0,2000.0,10500.0,13000.0,7000.0,13500.0,3000.0,0.0,7000.0,66500.0
Jhabua,16.1.5,Stock position of BCG vaccines,2. Stocks Received,20000.0,10000.0,5000.0,10000.0,10000.0,5000.0,5000.0,20000.0,0.0,5000.0,10000.0,,100000.0
Jhabua,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,0.0,,,,,,,,,0.0
Jhabua,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,20000.0,6000.0,10500.0,8500.0,1500.0,2500.0,11000.0,13500.0,10500.0,8000.0,3000.0,3000.0,98000.0
Jhabua,16.1.5,Stock position of BCG vaccines,5. Total Stock,2000.0,6000.0,500.0,2000.0,10500.0,13000.0,7000.0,13500.0,3000.0,0.0,7000.0,4000.0,68500.0
Jhabua,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,6000.0,7000.0,12000.0,10000.0,3000.0,6500.0,4250.0,750.0,2500.0,4500.0,750.0,5250.0,62500.0
Jhabua,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,130000.0,,0.0,5000.0,0.0,2500.0,7000.0,10000.0,,10000.0,,174500.0
Jhabua,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,0.0,,0.0,,,,,,,0.0
Jhabua,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,9000.0,125000.0,2000.0,7000.0,1500.0,2250.0,6000.0,5250.0,8000.0,3750.0,5500.0,5250.0,180500.0
Jhabua,16.1.6,Stock position of Measles vaccines,5. Total Stock,7000.0,12000.0,10000.0,3000.0,6500.0,4250.0,750.0,2500.0,4500.0,750.0,5250.0,0.0,56500.0
Jhabua,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Jhabua,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Jhabua,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Jhabua,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,11500.0,22000.0,16500.0,2000.0,,,13000.0,500.0,22500.0,3000.0,,5000.0,96000.0
Jhabua,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,20000.0,10000.0,4500.0,14000.0,,23500.0,5000.0,40000.0,0.0,2000.0,5000.0,,124000.0
Jhabua,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,0.0,,,,,,,,,0.0
Jhabua,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,9500.0,15500.0,19000.0,12500.0,,10500.0,17500.0,18000.0,19500.0,5000.0,0.0,1500.0,128500.0
Jhabua,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,22000.0,16500.0,2000.0,3500.0,0.0,13000.0,500.0,22500.0,3000.0,0.0,5000.0,3500.0,91500.0
Jhabua,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1200.0,900.0,900.0,,1900.0,1150.0,1050.0,700.0,700.0,700.0,700.0,300.0,10200.0
Jhabua,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,3000.0,,,,,,,,,,3000.0
Jhabua,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,300.0,,2700.0,,750.0,100.0,350.0,,,,400.0,300.0,4900.0
Jhabua,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,900.0,900.0,1200.0,0.0,1150.0,1050.0,700.0,700.0,700.0,700.0,300.0,0.0,8300.0
Jhabua,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,22680.0,11040.0,11040.0,,47020.0,15000.0,9980.0,2500.0,2500.0,2500.0,2500.0,2500.0,129260.0
Jhabua,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,176400.0,,,,,,,,,,176400.0
Jhabua,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,11640.0,,184920.0,,32020.0,5020.0,7480.0,,,,,,241080.0
Jhabua,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,11040.0,11040.0,2520.0,0.0,15000.0,9980.0,2500.0,2500.0,2500.0,2500.0,2500.0,2500.0,64580.0
Jhabua,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,200.0,,,,1200.0,1000.0,700.0,600.0,600.0,600.0,600.0,600.0,6100.0
Jhabua,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Jhabua,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,200.0,,,,200.0,300.0,100.0,,,,,600.0,1400.0
Jhabua,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,1000.0,700.0,600.0,600.0,600.0,600.0,600.0,0.0,4700.0
Jhabua,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,300.0,,,,,700.0,600.0,400.0,400.0,400.0,400.0,,3200.0
Jhabua,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,900.0,,,,,,,,900.0
Jhabua,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,300.0,,,,200.0,100.0,200.0,,,,400.0,,1200.0
Jhabua,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,700.0,600.0,400.0,400.0,400.0,400.0,0.0,0.0,2900.0
Jhabua,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,3600.0,3600.0,3600.0,,3000.0,2000.0,1500.0,900.0,4800.0,2600.0,1700.0,1700.0,29000.0
Jhabua,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,5000.0,,,,,5000.0
Jhabua,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,100.0,,1000.0,500.0,600.0,1100.0,2200.0,900.0,,500.0,6900.0
Jhabua,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,3600.0,3600.0,3500.0,0.0,2000.0,1500.0,900.0,4800.0,2600.0,1700.0,1700.0,1200.0,27100.0
Jhabua,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,4550.0,3550.0,600.0,,1000.0,1000.0,550.0,50.0,1460.0,18360.0,18360.0,12285.0,61765.0
Jhabua,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,5000.0,30000.0,,,,35000.0
Jhabua,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,1000.0,2950.0,200.0,,,450.0,500.0,3590.0,13100.0,,6075.0,,27865.0
Jhabua,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,3550.0,600.0,400.0,0.0,1000.0,550.0,50.0,1460.0,18360.0,18360.0,12285.0,12285.0,68900.0
Jhabua,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,250.0,8400.0,44000.0,,10400.0,6900.0,2400.0,2400.0,500.0,500.0,500.0,500.0,76750.0
Jhabua,16.3.02,Stock Position of Gloves,2. Stocks Received,16400.0,50000.0,,,,,,,,,,,66400.0
Jhabua,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.3.02,Stock Position of Gloves,4. Stock Distributed,8250.0,14400.0,28600.0,,3500.0,4500.0,,1900.0,,,,,61150.0
Jhabua,16.3.02,Stock Position of Gloves,5. Total Stock,8400.0,44000.0,15400.0,0.0,6900.0,2400.0,2400.0,500.0,500.0,500.0,500.0,500.0,82000.0
Jhabua,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,0.0,,,,,0.0
Jhabua,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,19.0,19.0
Jhabua,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Jhabua,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19.0,19.0
Jhabua,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,10900.0,10900.0,7900.0,,10900.0,4400.0,2100.0,200.0,100.0,100.0,29100.0,29100.0,105700.0
Jhabua,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,30000.0,,,30000.0
Jhabua,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,3000.0,,,6500.0,2300.0,1900.0,100.0,,1000.0,,15000.0,29800.0
Jhabua,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,10900.0,7900.0,7900.0,0.0,4400.0,2100.0,200.0,100.0,100.0,29100.0,29100.0,14100.0,105900.0
Jhabua,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Jhabua,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,200.0,,,,,,,,,,200.0
Jhabua,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,200.0,,,,,,,,,,200.0
Jhabua,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,10.0,,,,,,,,,,,,10.0
Jhabua,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Jhabua,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,10.0,,,,,,,,,,,,10.0
Jhabua,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jhabua,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,222000.0,222000.0,82000.0,,32000.0,32000.0,12000.0,12000.0,12000.0,2890200.0,150200.0,150200.0,3816600.0
Jhabua,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,5700000.0,,,,5700000.0
Jhabua,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,140000.0,60000.0,,,20000.0,,,2821800.0,2740000.0,,,5781800.0
Jhabua,16.3.07,Stock Position of IFA Tablets,5. Total Stock,222000.0,82000.0,22000.0,0.0,32000.0,12000.0,12000.0,12000.0,2890200.0,150200.0,150200.0,150200.0,3734800.0
Jhabua,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,2054.0,2054.0
Jhabua,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,2054.0,,2054.0
Jhabua,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Jhabua,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2054.0,2054.0,4108.0
Jhabua,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,15700.0,6000.0,5400.0,,6900.0,17700.0,32700.0,22200.0,20000.0,19900.0,16300.0,,162800.0
Jhabua,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,15000.0,20000.0,,,,,,500000.0,535000.0
Jhabua,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,9700.0,600.0,5400.0,,4200.0,5000.0,10500.0,2200.0,100.0,3600.0,16300.0,300000.0,357600.0
Jhabua,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,6000.0,5400.0,0.0,0.0,17700.0,32700.0,22200.0,20000.0,19900.0,16300.0,0.0,200000.0,340200.0
Jhabua,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,160.0,160.0,60.0,,98.0,48.0,48.0,7.0,3007.0,751.0,631.0,631.0,5601.0
Jhabua,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,200.0,1741.0,,,,,3000.0,,,,,4941.0
Jhabua,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,300.0,1641.0,,50.0,,41.0,,2256.0,120.0,,613.0,5021.0
Jhabua,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,160.0,60.0,160.0,0.0,48.0,48.0,7.0,3007.0,751.0,631.0,631.0,18.0,5521.0
Jhabua,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,5300.0,8500.0,3875.0,,410.0,2210.0,51210.0,46010.0,37010.0,33810.0,33810.0,23810.0,245955.0
Jhabua,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,50000.0,,100000.0,,100000.0,100000.0,,,,,,,350000.0
Jhabua,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Jhabua,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,46800.0,4625.0,58840.0,,98200.0,51000.0,5200.0,9000.0,3200.0,0.0,10000.0,3600.0,290465.0
Jhabua,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,8500.0,3875.0,45035.0,0.0,2210.0,51210.0,46010.0,37010.0,33810.0,33810.0,23810.0,20210.0,305490.0
Jhabua,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,5000.0,8400.0,5700.0,7000.0,9600.0,14000.0,17800.0,14600.0,10400.0,5600.0,2800.0,700.0,101600.0
Jhabua,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6600.0,3300.0,6600.0,6600.0,6600.0,6600.0,3300.0,5800.0,0.0,2000.0,,700.0,48100.0
Jhabua,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,0.0,,,,,,,,,0.0
Jhabua,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3200.0,6000.0,5300.0,4600.0,2200.0,2800.0,6500.0,10000.0,4800.0,4800.0,2100.0,,52300.0
Jhabua,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,8400.0,5700.0,7000.0,9000.0,14000.0,17800.0,14600.0,10400.0,5600.0,2800.0,700.0,1400.0,97400.0
Jhabua,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,0.0,,4800.0,2400.0,7200.0,10800.0,10800.0,10800.0,10800.0,10800.0,4800.0,73200.0
Jhabua,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,120000.0,36000.0,24000.0,24000.0,40000.0,40000.0,30000.0,0.0,10000.0,20000.0,,344000.0
Jhabua,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,0.0,,,,,,,,,0.0
Jhabua,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,120000.0,31200.0,26400.0,19200.0,36400.0,40000.0,30000.0,0.0,0.0,26000.0,2000.0,331200.0
Jhabua,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,4800.0,2400.0,7200.0,10800.0,10800.0,10800.0,10800.0,20800.0,4800.0,2800.0,86000.0
Jhabua,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,5400.0,6900.0,8600.0,5100.0,3800.0,4500.0,3700.0,900.0,5900.0,3200.0,8700.0,7400.0,64100.0
Jhabua,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2000.0,22000.0,2000.0,2000.0,2000.0,2000.0,2000.0,10000.0,0.0,10000.0,2000.0,,56000.0
Jhabua,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,0.0,,,,,,,,,0.0
Jhabua,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,500.0,20300.0,5500.0,3300.0,1300.0,2800.0,4800.0,5000.0,2700.0,4500.0,3300.0,2600.0,56600.0
Jhabua,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,6900.0,8600.0,5100.0,3800.0,4500.0,3700.0,900.0,5900.0,3200.0,8700.0,7400.0,4800.0,63500.0
Jhabua,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,,,,,,1.0,,,,1.0,,3.0
Jhabua,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,1.0,,,,,,,,,,,1.0
Jhabua,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jhabua,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,1.0,,,,,,,,,,,1.0
Jhabua,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,5.0,1.0,3.0,,1.0,1.0,2.0,,1.0,14.0
Jhabua,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jhabua,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,5.0,1.0,3.0,,1.0,1.0,2.0,,1.0,14.0
Jhabua,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,4.0,3.0,5.0,5.0,5.0,12.0,7.0,5.0,2.0,8.0,2.0,11.0,69.0
Jhabua,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jhabua,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,4.0,3.0,5.0,5.0,5.0,12.0,7.0,5.0,2.0,8.0,2.0,11.0,69.0
Jhabua,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,3.0,4.0,1.0,2.0,7.0,4.0,7.0,8.0,7.0,5.0,4.0,55.0
Jhabua,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,,,,,1.0,,,,,2.0
Jhabua,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,4.0,3.0,4.0,1.0,2.0,7.0,4.0,8.0,8.0,7.0,5.0,4.0,57.0
Jhabua,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,2.0,5.0,1.0,,4.0,7.0,5.0,4.0,,,3.0,32.0
Jhabua,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,2.0,2.0,1.0,1.0,,6.0,5.0,3.0,6.0,7.0,,2.0,35.0
Jhabua,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,3.0,4.0,6.0,2.0,,10.0,12.0,8.0,10.0,7.0,,5.0,67.0
Jhabua,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,1.0,,,1.0
Jhabua,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,1.0,,,,1.0,,,2.0
Jhabua,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,1.0,,,,2.0,,,3.0
Jhabua,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,3.0,5.0,1.0,,1.0,2.0,1.0,1.0,2.0,,2.0,18.0
Jhabua,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,2.0,1.0,,,1.0,1.0,2.0,6.0,6.0,1.0,,2.0,22.0
Jhabua,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,2.0,4.0,5.0,1.0,1.0,2.0,4.0,7.0,7.0,3.0,,4.0,40.0
Jhabua,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jhabua,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,2.0,,,,,,,,,,,2.0
Jhabua,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,2.0,,,,,,,,,,,2.0
Jhabua,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,9.0,5.0,10.0,5.0,8.0,9.0,5.0,14.0,17.0,8.0,7.0,5.0,102.0
Jhabua,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,11.0,11.0,10.0,7.0,17.0,20.0,27.0,16.0,21.0,11.0,18.0,171.0
Jhabua,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,11.0,16.0,21.0,15.0,15.0,26.0,25.0,41.0,33.0,29.0,18.0,23.0,273.0
Jhabua,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Jhabua,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Jhabua,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Jhabua,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,1.0,,,,,,1.0
Jhabua,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Jhabua,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,1.0,,3.0,1.0,,,1.0,,2.0,3.0,12.0
Jhabua,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,1.0,,,,,1.0,2.0,,1.0,,6.0
Jhabua,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,2.0,2.0,1.0,3.0,1.0,,1.0,3.0,,3.0,3.0,19.0
Jhabua,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Jhabua,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,,1.0,,1.0,,,,,1.0,4.0
Jhabua,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,2.0,1.0,2.0,,1.0,,,,,1.0,7.0
Jhabua,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,3.0,1.0,3.0,,2.0,,,,,2.0,11.0
Jhabua,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Jhabua,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Jhabua,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Jhabua,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Jhabua,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,3.0,,5.0,1.0,5.0,2.0,2.0,2.0,,3.0,23.0
Jhabua,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,2.0,4.0,1.0,6.0,3.0,4.0,,2.0,2.0,1.0,4.0,29.0
Jhabua,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,3.0,1.0,2.0,,,1.0,,,,,,8.0
Jhabua,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,5.0,8.0,3.0,11.0,4.0,10.0,2.0,4.0,4.0,1.0,7.0,60.0
Jhabua,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Jhabua,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,1.0,1.0,,,,1.0,1.0,,,5.0
Jhabua,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Jhabua,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,1.0,1.0,1.0,,,,2.0,1.0,,,6.0
Jhabua,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Jhabua,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,1.0,1.0,1.0,2.0,1.0,,3.0,1.0,2.0,,6.0,18.0
Jhabua,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,2.0,,,2.0,,3.0,1.0,,1.0,3.0,1.0,14.0
Jhabua,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,3.0,1.0,1.0,4.0,1.0,3.0,4.0,1.0,3.0,3.0,7.0,32.0
Jhabua,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Jhabua,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Jhabua,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Jhabua,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,2.0,,,,,,,,,,,2.0
Jhabua,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Jhabua,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Jhabua,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Jhabua,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Jhabua,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Jhabua,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Jhabua,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Jhabua,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Jhabua,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Jhabua,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,1.0,,,,1.0,2.0
Jhabua,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Jhabua,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,1.0,,,,1.0,2.0
Jhabua,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Jhabua,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,1.0,1.0,,,,,,,2.0
Jhabua,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Jhabua,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,1.0,1.0,,,,,,,2.0
Jhabua,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Jhabua,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,1.0,,,,1.0,,,,,1.0,,3.0
Jhabua,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Jhabua,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,1.0,,,,1.0,,,,,1.0,,3.0
Jhabua,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Jhabua,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,3.0,1.0,,1.0,,1.0,,4.0,4.0,2.0,4.0,22.0
Jhabua,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Jhabua,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,3.0,1.0,,1.0,,1.0,,4.0,4.0,2.0,4.0,22.0
Jhabua,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,2.0,2.0,3.0,2.0,3.0,1.0,2.0,1.0,1.0,2.0,3.0,6.0,28.0
Jhabua,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,12.0,12.0,14.0,9.0,10.0,6.0,10.0,7.0,8.0,6.0,8.0,17.0,119.0
Jhabua,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,2.0,3.0,7.0,,1.0,2.0,1.0,1.0,1.0,2.0,20.0
Jhabua,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,14.0,14.0,19.0,14.0,20.0,7.0,13.0,10.0,10.0,9.0,12.0,25.0,167.0
Jhabua,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,1.0,,,1.0,1.0,,3.0
Jhabua,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,8.0,5.0,3.0,6.0,4.0,7.0,4.0,4.0,3.0,2.0,9.0,56.0
Jhabua,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,1.0,1.0,,1.0,,3.0
Jhabua,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,8.0,5.0,3.0,6.0,4.0,8.0,5.0,5.0,4.0,4.0,9.0,62.0
Jhabua,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,1.0,,3.0,,,,,,,,4.0
Jhabua,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,,2.0,3.0,2.0,3.0,2.0,,2.0,,,3.0,18.0
Jhabua,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,2.0,,,1.0,,1.0,,1.0,,,,,5.0
Jhabua,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,3.0,,3.0,4.0,5.0,4.0,2.0,1.0,2.0,,,3.0,27.0
Jhabua,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Jhabua,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,3.0,,1.0,1.0,1.0,3.0,,,,,2.0,13.0
Jhabua,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,3.0,2.0,2.0,1.0,4.0,,,,,,,13.0
Jhabua,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,6.0,2.0,3.0,2.0,5.0,3.0,,,,,2.0,26.0
Jhabua,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,1.0,2.0,,,,,,3.0
Jhabua,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,6.0,7.0,1.0,7.0,13.0,7.0,5.0,3.0,1.0,1.0,1.0,,52.0
Jhabua,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,9.0,20.0,7.0,8.0,14.0,9.0,10.0,2.0,7.0,,3.0,4.0,93.0
Jhabua,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,15.0,27.0,8.0,15.0,27.0,17.0,17.0,5.0,8.0,1.0,4.0,4.0,148.0
Jhabua,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,2.0,5.0,5.0,3.0,3.0,,6.0,5.0,,1.0,,31.0
Jhabua,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,9.0,24.0,17.0,17.0,9.0,23.0,17.0,13.0,12.0,15.0,14.0,40.0,210.0
Jhabua,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,33.0,63.0,39.0,42.0,35.0,58.0,55.0,39.0,35.0,41.0,30.0,101.0,571.0
Jhabua,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,43.0,89.0,61.0,64.0,47.0,84.0,72.0,58.0,52.0,56.0,45.0,141.0,812.0
Katni,1.1,Total number of pregnant women Registered for ANC,TOTAL,2566.0,2711.0,3013.0,3022.0,2066.0,2698.0,2391.0,2452.0,2285.0,1984.0,2805.0,3570.0,31563.0
Katni,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1476.0,1422.0,1749.0,1701.0,1307.0,1547.0,1446.0,1401.0,1245.0,1255.0,1632.0,2199.0,18380.0
Katni,1.2,Number of Pregnant women registered under JSY,TOTAL,2566.0,2691.0,3013.0,2873.0,1937.0,2698.0,2155.0,2073.0,1917.0,1933.0,2435.0,3285.0,29576.0
Katni,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1659.0,1921.0,2476.0,2740.0,2338.0,2516.0,2116.0,2256.0,2096.0,1747.0,2078.0,2653.0,26596.0
Katni,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1784.0,1861.0,2412.0,2208.0,1472.0,1959.0,1767.0,1757.0,1719.0,1494.0,2041.0,2561.0,23035.0
Katni,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2043.0,1971.0,2444.0,2657.0,2035.0,2063.0,2022.0,1984.0,2136.0,1540.0,1893.0,2613.0,25401.0
Katni,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1987.0,2442.0,2689.0,3046.0,2625.0,2628.0,2242.0,2556.0,2568.0,1978.0,2753.0,3491.0,31005.0
Katni,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,101.0,199.0,133.0,174.0,162.0,177.0,192.0,124.0,125.0,93.0,114.0,71.0,1665.0
Katni,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,4.0,7.0,8.0,7.0,18.0,5.0,12.0,5.0,12.0,5.0,5.0,13.0,101.0
Katni,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,758.0,900.0,1053.0,1340.0,1017.0,1202.0,3229.0,1301.0,1092.0,813.0,1144.0,1476.0,15325.0
Katni,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,4.0,9.0,38.0,42.0,59.0,62.0,136.0,56.0,39.0,31.0,69.0,67.0,612.0
Katni,1.8,Number of pregnancy test kits used at SC level,TOTAL,1110.0,737.0,633.0,701.0,536.0,594.0,606.0,582.0,513.0,522.0,612.0,1010.0,8156.0
Katni,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,7.0,12.0,20.0,11.0,11.0,70.0,7.0,45.0,23.0,13.0,16.0,37.0,272.0
Katni,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,149.0,136.0,131.0,139.0,240.0,241.0,241.0,215.0,176.0,178.0,143.0,174.0,2163.0
Katni,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,156.0,148.0,151.0,150.0,251.0,311.0,248.0,260.0,199.0,191.0,159.0,211.0,2435.0
Katni,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,97.0,92.0,90.0,94.0,194.0,234.0,172.0,204.0,135.0,149.0,116.0,140.0,1717.0
Katni,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,15.0,2.0,8.0,0.0,7.0,7.0,126.0,39.0,48.0,228.0,82.0,15.0,577.0
Katni,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,966.0,1124.0,1177.0,1461.0,2210.0,2372.0,1903.0,1652.0,1525.0,1509.0,1496.0,1785.0,19180.0
Katni,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,75.0,70.0,154.0,47.0,123.0,121.0,50.0,54.0,73.0,50.0,65.0,76.0,958.0
Katni,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,568.0,735.0,1172.0,1203.0,1594.0,1830.0,1628.0,1293.0,1102.0,1758.0,1335.0,1997.0,16215.0
Katni,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,347.0,623.0,815.0,806.0,1171.0,1177.0,1028.0,469.0,756.0,2759.0,1316.0,1646.0,12913.0
Katni,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,202.0,144.0,265.0,218.0,225.0,250.0,246.0,180.0,177.0,151.0,282.0,181.0,2521.0
Katni,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Katni,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Katni,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Katni,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,19.0,16.0,4.0,35.0,44.0,49.0,44.0,40.0,42.0,51.0,50.0,61.0,455.0
Katni,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Katni,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,19.0,16.0,4.0,35.0,44.0,49.0,44.0,40.0,42.0,51.0,50.0,61.0,455.0
Katni,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,126.0,99.0,164.0,142.0,114.0,163.0,176.0,108.0,106.0,87.0,183.0,112.0,1580.0
Katni,4.1.1.a,Number of male live births,TOTAL,652.0,677.0,819.0,938.0,1311.0,1447.0,1227.0,1083.0,989.0,954.0,940.0,1092.0,12129.0
Katni,4.1.1.b,Number of female live births,TOTAL,650.0,717.0,745.0,859.0,1314.0,1436.0,1131.0,985.0,881.0,863.0,963.0,1044.0,11588.0
Katni,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1302.0,1394.0,1564.0,1797.0,2625.0,2883.0,2358.0,2068.0,1870.0,1817.0,1903.0,2136.0,23717.0
Katni,4.1.2,Number of still births,TOTAL,22.0,22.0,35.0,34.0,64.0,58.0,48.0,29.0,38.0,36.0,37.0,42.0,465.0
Katni,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,21.0,22.0,48.0,43.0,72.0,54.0,44.0,77.0,48.0,56.0,72.0,73.0,630.0
Katni,4.2.1,Number of Newborns weighed at birth,TOTAL,1261.0,1396.0,1560.0,1779.0,2608.0,2874.0,2300.0,2035.0,1850.0,1807.0,1892.0,2118.0,23480.0
Katni,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,81.0,88.0,95.0,126.0,180.0,225.0,265.0,211.0,209.0,170.0,397.0,186.0,2233.0
Katni,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1130.0,1286.0,1383.0,1611.0,2578.0,2563.0,2127.0,1812.0,1675.0,1673.0,1666.0,1933.0,21437.0
Katni,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,1.0,2.0,1.0,1.0,4.0,11.0,8.0,3.0,0.0,0.0,0.0,12.0,43.0
Katni,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,4.0,0.0,8.0,17.0
Katni,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,32.0,24.0,36.0,40.0,169.0,127.0,113.0,108.0,80.0,27.0,55.0,72.0,883.0
Katni,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Katni,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,34.0,26.0,37.0,41.0,173.0,142.0,121.0,111.0,80.0,31.0,55.0,92.0,943.0
Katni,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,126.0,99.0,164.0,164.0,114.0,163.0,176.0,0.0,106.0,87.0,183.0,112.0,1494.0
Katni,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,125.0,136.0,208.0,228.0,283.0,362.0,302.0,215.0,219.0,133.0,238.0,187.0,2636.0
Katni,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,4.0,6.0,7.0,24.0,14.0,6.0,10.0,12.0,11.0,5.0,8.0,15.0,122.0
Katni,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,337.0,131.0,161.0,227.0,157.0,324.0,294.0,204.0,574.0,112.0,220.0,177.0,2918.0
Katni,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,14.0,22.0,14.0,52.0,49.0,33.0,16.0,33.0,34.0,9.0,50.0,29.0,355.0
Katni,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1163.0,1191.0,1522.0,1636.0,2773.0,2667.0,2307.0,1914.0,1771.0,1641.0,1865.0,2007.0,22457.0
Katni,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,877.0,1043.0,1027.0,1105.0,1560.0,1755.0,1341.0,1390.0,1326.0,1211.0,1304.0,1546.0,15485.0
Katni,6.3,PNC maternal complications attended,TOTAL,15.0,3.0,16.0,15.0,60.0,57.0,42.0,34.0,29.0,26.0,26.0,18.0,341.0
Katni,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,11.0,21.0,10.0,21.0,37.0,21.0,11.0,19.0,36.0,25.0,48.0,29.0,289.0
Katni,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,8.0,0.0,1.0,11.0
Katni,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,11.0,21.0,10.0,22.0,37.0,21.0,11.0,19.0,37.0,33.0,48.0,30.0,300.0
Katni,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,1.0,0.0,1.0,6.0,0.0,0.0,0.0,6.0,4.0,3.0,231.0,252.0
Katni,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,404.0,117.0,633.0,125.0,929.0,977.0,761.0,636.0,154.0,591.0,600.0,276.0,6203.0
Katni,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,568.0,396.0,1087.0,469.0,1288.0,1638.0,1089.0,1229.0,489.0,1049.0,1170.0,1115.0,11587.0
Katni,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,972.0,513.0,1720.0,594.0,2217.0,2615.0,1850.0,1865.0,643.0,1640.0,1770.0,1391.0,17790.0
Katni,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,183.0,17.0,0.0,389.0,15.0,0.0,0.0,49.0,0.0,0.0,4.0,0.0,657.0
Katni,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,1.0,5.0,1.0,2.0,2.0,3.0,1.0,5.0,1.0,3.0,3.0,28.0
Katni,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,2.0,4.0,2.0,0.0,1.0,6.0,16.0
Katni,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,3.0,3.0,1.0,2.0,1.0,6.0,15.0,13.0,3.0,48.0
Katni,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Katni,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,1.0,6.0,4.0,5.0,3.0,7.0,6.0,13.0,16.0,17.0,12.0,92.0
Katni,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,,0.0,0.0,0.0,2.0
Katni,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,5.0,2.0,10.0,20.0,25.0,13.0,15.0,78.0,342.0,166.0,414.0,56.0,1146.0
Katni,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,1.0,0.0,0.0,0.0,1.0,41.0,350.0,886.0,365.0,932.0,462.0,3038.0
Katni,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,7.0,5.0,2.0,10.0,3.0,4.0,1.0,12.0,565.0,163.0,87.0,98.0,957.0
Katni,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Katni,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,12.0,8.0,12.0,30.0,28.0,18.0,57.0,440.0,1793.0,694.0,1433.0,616.0,5141.0
Katni,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Katni,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,4.0,12.0,6.0,15.0,9.0,11.0,13.0,53.0,33.0,14.0,43.0,33.0,246.0
Katni,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,13.0,0.0,0.0,0.0,0.0,0.0,16.0,29.0
Katni,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,0.0,1.0,5.0,1.0,4.0,0.0,3.0,11.0,97.0,123.0
Katni,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Katni,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,4.0,12.0,7.0,15.0,10.0,29.0,14.0,57.0,33.0,17.0,54.0,146.0,398.0
Katni,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,15.0,15.0,16.0,14.0,12.0,10.0,21.0,9.0,13.0,0.0,0.0,20.0,145.0
Katni,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,3.0,0.0,0.0,6.0
Katni,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Katni,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,3.0,0.0,0.0,6.0
Katni,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,15.0,15.0,16.0,14.0,12.0,10.0,21.0,9.0,13.0,3.0,17.0,3.0,148.0
Katni,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,502.0,482.0,653.0,627.0,775.0,668.0,641.0,582.0,714.0,619.0,622.0,649.0,7534.0
Katni,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,66.0,18.0,32.0,47.0,35.0,33.0,45.0,35.0,54.0,30.0,25.0,109.0,529.0
Katni,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,19.0,44.0,22.0,10.0,33.0,10.0,11.0,20.0,39.0,27.0,21.0,46.0,302.0
Katni,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,112.0,212.0,118.0,417.0,322.0,253.0,68.0,127.0,44.0,275.0,259.0,283.0,2490.0
Katni,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Katni,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,699.0,756.0,825.0,1101.0,1165.0,964.0,765.0,764.0,851.0,951.0,927.0,1087.0,10855.0
Katni,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,175.0,223.0,166.0,495.0,496.0,196.0,212.0,269.0,189.0,401.0,442.0,630.0,3894.0
Katni,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,4.0,4.0,3.0,1.0,6.0,,0.0,0.0,0.0,18.0
Katni,9.06,Number of IUCD removals,TOTAL,180.0,210.0,195.0,173.0,244.0,241.0,218.0,282.0,422.0,363.0,327.0,336.0,3191.0
Katni,9.07,Number of Oral Pills cycles distributed,TOTAL,4537.0,3954.0,4356.0,4386.0,5193.0,5559.0,5971.0,6474.0,5850.0,6198.0,5899.0,5910.0,64287.0
Katni,9.08,Number of Condom pieces distributed,TOTAL,35568.0,38063.0,28350.0,25051.0,24469.0,36959.0,43044.0,42564.0,35513.0,39722.0,41311.0,41477.0,432091.0
Katni,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,7.0,6.0,3.0,0.0,3.0,11.0,0.0,7.0,13.0,504.0,10.0,9.0,573.0
Katni,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,9.12,Number of Institutions having NSV trained doctors,TOTAL,7.0,11.0,13.0,13.0,13.0,13.0,14.0,14.0,16.0,10.0,14.0,17.0,-1.0
Katni,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1369.0,1488.0,1538.0,1804.0,2509.0,2921.0,2380.0,2184.0,1807.0,1748.0,1706.0,2109.0,23563.0
Katni,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1616.0,1500.0,1797.0,1674.0,1444.0,1780.0,2256.0,1320.0,122.0,8.0,2.0,14.0,13533.0
Katni,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1796.0,1604.0,1695.0,2004.0,1463.0,1542.0,1673.0,2250.0,1326.0,330.0,141.0,75.0,15899.0
Katni,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1979.0,1858.0,1893.0,1985.0,1655.0,1536.0,1518.0,1739.0,2104.0,1197.0,545.0,318.0,18327.0
Katni,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1242.0,2324.0,1857.0,1955.0,2278.0,9656.0
Katni,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1047.0,1699.0,1997.0,2294.0,7037.0
Katni,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,815.0,1574.0,2309.0,4698.0
Katni,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1053.0,1228.0,1261.0,1482.0,2099.0,1686.0,1739.0,1746.0,1591.0,1533.0,1489.0,1758.0,18665.0
Katni,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1618.0,1501.0,1805.0,1674.0,1444.0,1830.0,2368.0,2334.0,2150.0,1704.0,1955.0,2233.0,22616.0
Katni,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1795.0,1606.0,1686.0,2004.0,1459.0,1547.0,1672.0,2238.0,2227.0,1945.0,2099.0,2284.0,22562.0
Katni,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1959.0,1845.0,1885.0,1957.0,1658.0,1522.0,1518.0,1739.0,2090.0,1962.0,2064.0,2558.0,22757.0
Katni,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,945.0,1043.0,1049.0,1285.0,1958.0,2188.0,1726.0,1533.0,1462.0,1410.0,1377.0,1589.0,17565.0
Katni,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1592.0,1502.0,1806.0,1765.0,1498.0,1795.0,2251.0,1328.0,63.0,8.0,5.0,8.0,13621.0
Katni,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1778.0,1599.0,1682.0,2003.0,1473.0,1546.0,1660.0,2256.0,1323.0,339.0,144.0,52.0,15855.0
Katni,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1967.0,1864.0,1880.0,1967.0,1663.0,1513.0,1516.0,1738.0,2104.0,1194.0,552.0,316.0,18274.0
Katni,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1365.0,1531.0,2543.0,2921.0,2193.0,2195.0,1975.0,1946.0,1708.0,1483.0,1698.0,1894.0,23452.0
Katni,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1223.0,923.0,1208.0,1472.0,1157.0,1206.0,1306.0,1441.0,1512.0,1747.0,2045.0,3256.0,18496.0
Katni,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,697.0,807.0,1292.0,1467.0,1151.0,1067.0,1043.0,973.0,859.0,742.0,834.0,938.0,11870.0
Katni,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,688.0,701.0,1115.0,1292.0,996.0,975.0,970.0,919.0,803.0,672.0,774.0,886.0,10791.0
Katni,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1385.0,1508.0,2407.0,2759.0,2147.0,2042.0,2013.0,1892.0,1662.0,1414.0,1608.0,1824.0,22661.0
Katni,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1766.0,1471.0,1771.0,2076.0,1442.0,1443.0,1466.0,1581.0,1608.0,1881.0,2109.0,2763.0,21377.0
Katni,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1775.0,1461.0,1769.0,2074.0,1441.0,1444.0,1470.0,1574.0,1624.0,1884.0,2111.0,2672.0,21299.0
Katni,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,61.0,39.0,64.0,74.0,55.0,79.0,80.0,68.0,72.0,93.0,120.0,163.0,968.0
Katni,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,56.0,45.0,56.0,71.0,51.0,64.0,85.0,74.0,65.0,90.0,106.0,150.0,913.0
Katni,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,117.0,84.0,120.0,145.0,106.0,143.0,165.0,142.0,137.0,183.0,226.0,313.0,1881.0
Katni,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,954.0,1097.0,1103.0,1584.0,1244.0,1129.0,1037.0,1129.0,1002.0,1293.0,1183.0,1499.0,14254.0
Katni,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,865.0,953.0,1004.0,1238.0,1139.0,1065.0,1035.0,1049.0,969.0,950.0,996.0,1205.0,12468.0
Katni,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,928.0,943.0,1136.0,1256.0,1187.0,1129.0,1034.0,1108.0,970.0,999.0,1044.0,1251.0,12985.0
Katni,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1090.0,1131.0,1243.0,1166.0,1160.0,1175.0,1142.0,1162.0,1166.0,1157.0,1157.0,1201.0,13950.0
Katni,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1013.0,1097.0,1252.0,1177.0,1128.0,1162.0,1105.0,1139.0,1149.0,1068.0,1136.0,1226.0,13652.0
Katni,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,865.0,923.0,1059.0,1014.0,961.0,959.0,941.0,972.0,970.0,934.0,984.0,1055.0,11637.0
Katni,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1347.0,1518.0,2503.0,2913.0,2349.0,2159.0,1969.0,1943.0,1693.0,1907.0,1703.0,1844.0,23848.0
Katni,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,375.0,39.0,79.0,5176.0,980.0,450.0,42.0,31.0,99.0,8590.0,190.0,85.0,16136.0
Katni,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,313.0,0.0,27.0,4972.0,1070.0,301.0,39.0,48.0,125.0,8505.0,220.0,67.0,15687.0
Katni,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,13.0,0.0,0.0,14.0,0.0,1.0,28.0
Katni,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,126.0,243.0,269.0,446.0,508.0,354.0,177.0,248.0,132.0,478.0,429.0,526.0,3936.0
Katni,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,19.0,6.0,5.0,15.0,22.0,21.0,11.0,2.0,0.0,37.0,8.0,7.0,153.0
Katni,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,19.0,65.0,25.0,9.0,14.0,109.0,24.0,58.0,24.0,32.0,50.0,217.0,646.0
Katni,13.1,Number of Patients operated for cataract,TOTAL,4.0,9.0,3.0,5.0,6.0,22.0,13.0,61.0,266.0,311.0,53.0,39.0,792.0
Katni,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,4.0,9.0,3.0,5.0,6.0,22.0,9.0,55.0,176.0,236.0,53.0,39.0,617.0
Katni,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,24.0,0.0,502.0,239.0,55.0,128.0,6.0,3476.0,0.0,4430.0
Katni,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,24.0,0.0,32.0,42.0,145.0,137.0,70.0,334.0,0.0,784.0
Katni,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,5.0,5.0,6.0,6.0,6.0,7.0,6.0,4.0,5.0,5.0,6.0,-1.0
Katni,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,10.0,12.0,12.0,13.0,10.0,13.0,13.0,9.0,12.0,9.0,13.0,13.0,-1.0
Katni,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,884.0,986.0,1085.0,1108.0,1023.0,1024.0,1025.0,1163.0,1169.0,951.0,1043.0,1119.0,-1.0
Katni,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,7.0,7.0,7.0,6.0,6.0,7.0,6.0,5.0,4.0,5.0,7.0,-1.0
Katni,14.05,Number of RKS meetings held during the month,TOTAL,1.0,5.0,1.0,1.0,2.0,2.0,2.0,2.0,3.0,1.0,2.0,1.0,23.0
Katni,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,13.0,13.0,13.0,11.0,10.0,16.0,14.0,12.0,14.0,11.0,14.0,18.0,-1.0
Katni,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,28.0,22.0,32.0,33.0,42.0,141.0,60.0,140.0,160.0,141.0,159.0,170.0,1128.0
Katni,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,5.0,4.0,4.0,4.0,4.0,4.0,4.0,3.0,4.0,4.0,4.0,-1.0
Katni,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,3.0,3.0,3.0,4.0,3.0,3.0,3.0,3.0,3.0,3.0,4.0,-1.0
Katni,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,164.0,277.0,361.0,434.0,491.0,729.0,423.0,450.0,431.0,291.0,271.0,421.0,4743.0
Katni,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,628.0,787.0,1063.0,961.0,1004.0,1071.0,1462.0,924.0,870.0,702.0,721.0,1146.0,11339.0
Katni,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,150.0,184.0,265.0,368.0,618.0,820.0,281.0,385.0,204.0,283.0,267.0,344.0,4169.0
Katni,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1519.0,1740.0,2510.0,2488.0,2879.0,2948.0,2729.0,2450.0,2513.0,2494.0,2888.0,3155.0,30313.0
Katni,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,314.0,461.0,626.0,802.0,1109.0,1549.0,704.0,835.0,635.0,574.0,538.0,765.0,8912.0
Katni,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2147.0,2527.0,3573.0,3449.0,3883.0,4019.0,4191.0,3374.0,3383.0,3196.0,3609.0,4301.0,41652.0
Katni,14.10.2.a,Number of death cases of Inpatient males,TOTAL,13.0,26.0,34.0,40.0,36.0,47.0,27.0,35.0,29.0,31.0,98.0,42.0,458.0
Katni,14.10.2.b,Number of death cases of Inpatient females,TOTAL,14.0,31.0,28.0,32.0,55.0,38.0,27.0,33.0,20.0,23.0,28.0,18.0,347.0
Katni,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,27.0,57.0,62.0,72.0,91.0,85.0,54.0,68.0,49.0,54.0,126.0,60.0,805.0
Katni,14.11,In-Patient Head Count at midnight,TOTAL,976.0,1142.0,891.0,691.0,1098.0,8131.0,7534.0,6750.0,6519.0,6355.0,6850.0,8331.0,55268.0
Katni,14.12.1,OPD attendance (All),TOTAL,30032.0,39423.0,49000.0,50943.0,61843.0,74271.0,59248.0,60352.0,51328.0,44576.0,52581.0,75056.0,648653.0
Katni,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,30.0,34.0,16.0,46.0,54.0,67.0,57.0,58.0,59.0,27.0,84.0,79.0,611.0
Katni,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Katni,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,89.0,73.0,91.0,210.0,135.0,116.0,138.0,126.0,22.0,238.0,198.0,346.0,1782.0
Katni,14.14.a,Number of patients given AYUSH treatment,TOTAL,1023.0,712.0,1049.0,774.0,833.0,494.0,638.0,316.0,687.0,643.0,1072.0,885.0,9126.0
Katni,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,7.0,46.0,47.0,52.0,39.0,72.0,47.0,49.0,51.0,24.0,44.0,0.0,478.0
Katni,14.14.c,Number of Adolescents counselled,TOTAL,51.0,53.0,45.0,47.0,63.0,43.0,59.0,45.0,69.0,69.0,68.0,158.0,770.0
Katni,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3335.0,3911.0,4780.0,5701.0,4987.0,4925.0,5169.0,5836.0,7811.0,6287.0,6148.0,7044.0,65934.0
Katni,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,110.0,136.0,152.0,159.0,183.0,200.0,216.0,372.0,251.0,185.0,224.0,246.0,2434.0
Katni,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,138.0,190.0,153.0,260.0,337.0,285.0,236.0,329.0,213.0,136.0,325.0,300.0,2902.0
Katni,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,36.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,41.0
Katni,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,151.0,157.0,201.0,322.0,439.0,411.0,210.0,288.0,325.0,440.0,568.0,436.0,3948.0
Katni,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,69.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,73.0
Katni,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,569.0,684.0,658.0,1280.0,1000.0,1264.0,936.0,1040.0,831.0,844.0,1075.0,1174.0,11355.0
Katni,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,178.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,12.0,193.0
Katni,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,858.0,1031.0,1012.0,1862.0,1776.0,1960.0,1382.0,1657.0,1369.0,1420.0,1968.0,1910.0,18205.0
Katni,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,283.0,0.0,1.0,2.0,2.0,0.0,0.0,0.0,1.0,1.0,16.0,307.0
Katni,15.2,Number of Widal tests conducted,Number tested,242.0,264.0,233.0,381.0,593.0,820.0,1370.0,820.0,674.0,288.0,458.0,443.0,6586.0
Katni,15.3.a,Number of VDRL tests conducted on males,Number tested,94.0,12.0,190.0,125.0,115.0,120.0,103.0,94.0,111.0,297.0,96.0,152.0,1509.0
Katni,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,87.0,58.0,205.0,225.0,253.0,210.0,131.0,126.0,121.0,144.0,107.0,160.0,1827.0
Katni,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,185.0,462.0,203.0,785.0,783.0,510.0,496.0,475.0,570.0,382.0,316.0,548.0,5715.0
Katni,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,366.0,532.0,598.0,1135.0,1151.0,840.0,730.0,695.0,802.0,823.0,519.0,860.0,9051.0
Katni,15.4.1,Number of blood smears examined for Malaria,TOTAL,6427.0,8131.0,7120.0,12690.0,10625.0,10640.0,11248.0,8774.0,9241.0,4993.0,9594.0,12435.0,111918.0
Katni,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,20.0,22.0,17.0,65.0,122.0,126.0,59.0,6.0,30.0,13.0,22.0,30.0,532.0
Katni,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,6.0,4.0,1.0,25.0,17.0,20.0,2.0,6.0,10.0,6.0,75.0,2.0,174.0
Katni,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,850.0,1200.0,2050.0
Katni,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,500.0,0.0,500.0
Katni,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,1150.0,0.0,1150.0
Katni,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,200.0,650.0,850.0
Katni,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,550.0,550.0
Katni,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,600.0,750.0,1350.0
Katni,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,1000.0,900.0,1900.0
Katni,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,650.0,0.0,650.0
Katni,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,950.0,750.0,1700.0
Katni,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,900.0,900.0
Katni,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,350.0,265.0,615.0
Katni,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,500.0,1100.0,1600.0
Katni,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,190.0,0.0,190.0
Katni,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,660.0,500.0,1160.0
Katni,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,865.0,865.0
Katni,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,900.0,850.0,1750.0
Katni,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,500.0,500.0,1000.0
Katni,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,750.0,0.0,750.0
Katni,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,650.0,800.0,1450.0
Katni,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,550.0,550.0
Katni,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,0.0,0.0,0.0
Katni,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,0.0,0.0,0.0
Katni,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,0.0,0.0,0.0
Katni,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,350.0,700.0,1050.0
Katni,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,950.0,1000.0,1950.0
Katni,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,600.0,0.0,600.0
Katni,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,700.0,750.0,1450.0
Katni,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,950.0,950.0
Katni,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,150.0,200.0,350.0
Katni,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,1000.0,1200.0,2200.0
Katni,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,200.0,0.0,200.0
Katni,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,950.0,1000.0,1950.0
Katni,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,400.0,400.0
Katni,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,0.0,0.0,0.0
Katni,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,0.0,0.0,0.0
Katni,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,0.0,0.0,0.0
Katni,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,500.0,850.0,1350.0
Katni,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,500.0,0.0,500.0
Katni,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,850.0,0.0,850.0
Katni,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,150.0,350.0,500.0
Katni,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0,500.0
Katni,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,0.0,1400.0,1400.0
Katni,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,2400.0,0.0,2400.0
Katni,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,1000.0,500.0,1500.0
Katni,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1400.0,900.0,2300.0
Katni,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,6500.0,0.0,6500.0
Katni,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,24000.0,24000.0,48000.0
Katni,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,30500.0,18500.0,49000.0
Katni,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5500.0,5500.0
Katni,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,9000.0,28000.0,37000.0
Katni,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,41000.0,0.0,41000.0
Katni,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,22000.0,5000.0,27000.0
Katni,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28000.0,23000.0,51000.0
Katni,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,800.0,5700.0,6500.0
Katni,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,7000.0,0.0,7000.0
Katni,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,3000.0,500.0,3500.0
Katni,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4800.0,5200.0,10000.0
Katni,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,13872.0,18288.0,32160.0
Katni,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,4915.0,0.0,4915.0
Katni,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,500.0,0.0,500.0
Katni,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18287.0,18288.0,36575.0
Katni,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,14390.0,14390.0,28780.0
Katni,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,0.0,2000.0,2000.0
Katni,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14390.0,12390.0,26780.0
Katni,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,16425.0,16425.0,32850.0
Katni,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,0.0,5000.0,5000.0
Katni,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16425.0,11425.0,27850.0
Katni,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Katni,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,20000.0,0.0,20000.0
Katni,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,0.0,,0.0
Katni,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Katni,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,0.0,,0.0
Katni,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20000.0,0.0,20000.0
Katni,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,0.0,20000.0,20000.0
Katni,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,0.0,10000.0,10000.0
Katni,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,10000.0
Katni,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,13.0,13.0,26.0
Katni,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0,13.0,26.0
Katni,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,1677000.0,1127000.0,2804000.0
Katni,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,550000.0,200000.0,750000.0
Katni,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1127000.0,927000.0,2054000.0
Katni,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,50400.0,44400.0,94800.0
Katni,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,6000.0,35000.0,41000.0
Katni,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,44400.0,9400.0,53800.0
Katni,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,472000.0,56400.0,528400.0
Katni,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,0.0,26000.0,26000.0
Katni,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,472000.0,30400.0,502400.0
Katni,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,500.0,500.0,1000.0
Katni,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0,500.0,1000.0
Katni,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,77000.0,67000.0,144000.0
Katni,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,10000.0,20000.0,30000.0
Katni,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,67000.0,47000.0,114000.0
Katni,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,19900.0,19900.0,39800.0
Katni,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,0.0,0.0,0.0
Katni,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,18900.0,0.0,18900.0
Katni,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,1000.0,6000.0,7000.0
Katni,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13900.0,13900.0
Katni,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,253400.0,253400.0,506800.0
Katni,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,0.0,0.0,0.0
Katni,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,0.0,24000.0,24000.0
Katni,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,253400.0,229400.0,482800.0
Katni,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,20900.0,20900.0,41800.0
Katni,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,0.0,0.0,0.0
Katni,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Katni,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,0.0,6100.0,6100.0
Katni,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20900.0,14800.0,35700.0
Katni,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,4.0,4.0,4.0,3.0,2.0,1.0,1.0,,1.0,,20.0
Katni,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,2.0,2.0,3.0,5.0,3.0,2.0,1.0,4.0,2.0,3.0,1.0,1.0,29.0
Katni,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,,,,,1.0
Katni,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,2.0,2.0,3.0,5.0,3.0,2.0,1.0,5.0,2.0,3.0,1.0,1.0,30.0
Katni,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,1.0,3.0,7.0,3.0,5.0,3.0,7.0,6.0,6.0,6.0,3.0,52.0
Katni,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,2.0,,2.0
Katni,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,1.0,3.0,7.0,3.0,5.0,3.0,7.0,6.0,6.0,8.0,3.0,54.0
Katni,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,6.0,10.0,10.0,13.0,6.0,16.0,19.0,2.0,6.0,6.0,4.0,99.0
Katni,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,1.0,,,,1.0,,1.0,,3.0
Katni,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,6.0,10.0,10.0,14.0,6.0,16.0,19.0,3.0,6.0,7.0,4.0,102.0
Katni,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,5.0,6.0,5.0,5.0,4.0,9.0,10.0,7.0,8.0,9.0,6.0,75.0
Katni,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,,1.0,,2.0
Katni,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,5.0,6.0,5.0,5.0,4.0,9.0,10.0,8.0,8.0,10.0,6.0,77.0
Katni,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,1.0,,2.0,2.0,2.0,,1.0,1.0,3.0,13.0
Katni,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,2.0,1.0,1.0,,1.0,3.0,1.0,,2.0,1.0,12.0
Katni,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,3.0,2.0,1.0,2.0,3.0,5.0,1.0,1.0,3.0,4.0,25.0
Katni,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,1.0,,1.0,,,,,,,,2.0
Katni,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,1.0,,,,,,1.0,,2.0
Katni,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,1.0,,2.0,,,,,,1.0,,4.0
Katni,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,2.0,1.0,3.0,1.0,2.0,,,2.0,,,1.0,2.0,14.0
Katni,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,5.0,1.0,7.0,5.0,2.0,3.0,2.0,1.0,1.0,,,27.0
Katni,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,2.0,6.0,4.0,8.0,7.0,2.0,3.0,4.0,1.0,1.0,1.0,2.0,41.0
Katni,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Katni,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Katni,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Katni,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,2.0,7.0,5.0,9.0,4.0,10.0,8.0,9.0,9.0,3.0,3.0,69.0
Katni,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,3.0,4.0,1.0,4.0,6.0,5.0,10.0,7.0,1.0,1.0,2.0,5.0,49.0
Katni,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,6.0,8.0,9.0,15.0,9.0,20.0,15.0,10.0,10.0,5.0,8.0,118.0
Katni,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Katni,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Katni,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,1.0,1.0,,,,,,,1.0,3.0
Katni,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,2.0,2.0,,,,,,,1.0,5.0
Katni,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,3.0,1.0,,,,1.0,1.0,,,,,6.0
Katni,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,8.0,5.0,7.0,6.0,3.0,6.0,1.0,4.0,7.0,2.0,6.0,57.0
Katni,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,2.0,1.0,1.0,2.0,,,,3.0,2.0,1.0,3.0,15.0
Katni,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,13.0,7.0,8.0,8.0,3.0,7.0,2.0,7.0,9.0,3.0,9.0,78.0
Katni,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,1.0,1.0,,1.0,,,1.0,1.0,5.0
Katni,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,4.0,4.0,7.0,1.0,2.0,7.0,4.0,4.0,3.0,2.0,5.0,5.0,48.0
Katni,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,4.0,2.0,7.0,2.0,3.0,3.0,5.0,5.0,4.0,2.0,2.0,41.0
Katni,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,6.0,8.0,9.0,8.0,5.0,11.0,7.0,10.0,8.0,6.0,8.0,8.0,94.0
Katni,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Katni,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Katni,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Katni,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,1.0,,,,,,,1.0
Katni,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,2.0,1.0,,1.0,3.0,2.0,,,,,,9.0
Katni,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,4.0,7.0,4.0,8.0,4.0,9.0,16.0,10.0,4.0,7.0,4.0,8.0,85.0
Katni,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,5.0,3.0,4.0,4.0,2.0,11.0,1.0,9.0,4.0,3.0,6.0,1.0,53.0
Katni,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,9.0,12.0,9.0,12.0,7.0,23.0,19.0,19.0,8.0,10.0,10.0,9.0,147.0
Katni,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Katni,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Katni,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Katni,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,1.0,1.0,,,,2.0
Katni,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Katni,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,6.0,7.0,5.0,6.0,5.0,9.0,9.0,5.0,9.0,4.0,7.0,11.0,83.0
Katni,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,4.0,6.0,6.0,8.0,8.0,10.0,8.0,13.0,11.0,12.0,3.0,5.0,94.0
Katni,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,10.0,13.0,11.0,14.0,13.0,19.0,17.0,18.0,20.0,16.0,10.0,16.0,177.0
Katni,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Katni,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,3.0,3.0,5.0,5.0,4.0,2.0,2.0,4.0,2.0,1.0,8.0,4.0,43.0
Katni,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,5.0,3.0,10.0,5.0,8.0,3.0,2.0,3.0,3.0,8.0,9.0,11.0,70.0
Katni,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,8.0,6.0,16.0,10.0,12.0,5.0,4.0,7.0,5.0,9.0,17.0,15.0,114.0
Katni,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Katni,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Katni,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Katni,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Katni,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Katni,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,1.0,,,1.0,1.0,1.0,,,,4.0
Katni,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Katni,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,1.0,,,1.0,1.0,1.0,,,,4.0
Katni,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Katni,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,,,3.0,1.0,1.0,,1.0,,,,7.0
Katni,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Katni,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,,,3.0,1.0,1.0,,1.0,,,,7.0
Katni,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Katni,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,1.0,,3.0,,1.0,1.0,3.0,,,,,10.0
Katni,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Katni,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,1.0,,3.0,,1.0,1.0,3.0,,,,,10.0
Katni,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Katni,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Katni,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Katni,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,1.0,,,,,,,,1.0
Katni,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Katni,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,2.0,1.0,1.0,,,1.0,,,,,,5.0
Katni,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Katni,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,2.0,1.0,1.0,,,1.0,,,,,,5.0
Katni,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,3.0,3.0,,,3.0,1.0,2.0,,2.0,,,1.0,15.0
Katni,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,13.0,7.0,17.0,18.0,14.0,18.0,16.0,15.0,14.0,11.0,15.0,8.0,166.0
Katni,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,5.0,6.0,2.0,2.0,4.0,1.0,1.0,5.0,3.0,2.0,4.0,6.0,41.0
Katni,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,21.0,16.0,19.0,20.0,21.0,20.0,19.0,20.0,19.0,13.0,19.0,15.0,222.0
Katni,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,1.0,,1.0,,,,,,,,,2.0
Katni,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,9.0,11.0,10.0,7.0,3.0,11.0,3.0,4.0,5.0,8.0,7.0,80.0
Katni,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,2.0,,,1.0,1.0,,,,,1.0,,5.0
Katni,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,2.0,12.0,11.0,11.0,8.0,4.0,11.0,3.0,4.0,5.0,9.0,7.0,87.0
Katni,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,2.0,,3.0,,,,,,5.0
Katni,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,,4.0,10.0,9.0,7.0,1.0,4.0,2.0,,,,38.0
Katni,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,,2.0,2.0,2.0,,1.0,,,,,8.0
Katni,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,1.0,4.0,12.0,13.0,9.0,4.0,5.0,2.0,,,,51.0
Katni,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,1.0,1.0,,2.0,,,1.0,,1.0,,,7.0
Katni,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,4.0,9.0,11.0,11.0,20.0,7.0,20.0,8.0,14.0,14.0,7.0,9.0,134.0
Katni,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,16.0,13.0,15.0,13.0,13.0,29.0,22.0,26.0,19.0,17.0,13.0,12.0,208.0
Katni,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,21.0,23.0,27.0,24.0,35.0,36.0,42.0,35.0,33.0,32.0,20.0,21.0,349.0
Katni,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,2.0,3.0,1.0,1.0,,,,1.0,,,9.0
Katni,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,3.0,8.0,6.0,2.0,6.0,14.0,13.0,9.0,6.0,5.0,6.0,9.0,87.0
Katni,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,14.0,9.0,25.0,21.0,17.0,27.0,37.0,42.0,21.0,23.0,31.0,40.0,307.0
Katni,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,17.0,18.0,33.0,26.0,24.0,42.0,50.0,51.0,27.0,29.0,37.0,49.0,403.0
Katni,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,3.0,,4.0,5.0,1.0,2.0,4.0,,,1.0,21.0
Katni,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,8.0,8.0,22.0,21.0,24.0,43.0,32.0,33.0,18.0,15.0,16.0,20.0,260.0
Katni,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,23.0,39.0,42.0,51.0,61.0,87.0,73.0,56.0,49.0,54.0,33.0,48.0,616.0
Katni,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,31.0,48.0,67.0,72.0,89.0,135.0,106.0,91.0,71.0,69.0,49.0,69.0,897.0
Khandwa,1.1,Total number of pregnant women Registered for ANC,TOTAL,2338.0,2531.0,2938.0,2986.0,3004.0,3272.0,2723.0,2782.0,2608.0,2878.0,2839.0,2844.0,33743.0
Khandwa,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1855.0,2173.0,2351.0,2286.0,2697.0,3174.0,2211.0,2224.0,2155.0,2278.0,2322.0,2401.0,28127.0
Khandwa,1.2,Number of Pregnant women registered under JSY,TOTAL,2062.0,2117.0,2738.0,2746.0,2667.0,2962.0,2437.0,2827.0,2446.0,2672.0,2711.0,2742.0,31127.0
Khandwa,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2167.0,2281.0,2382.0,2421.0,2865.0,2923.0,3200.0,2943.0,2556.0,2543.0,2562.0,2627.0,31470.0
Khandwa,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2184.0,2402.0,2777.0,2808.0,2769.0,3132.0,2705.0,2667.0,2513.0,2795.0,2789.0,2839.0,32380.0
Khandwa,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2239.0,2294.0,2455.0,2535.0,2753.0,3038.0,2993.0,2643.0,2473.0,2424.0,6929.0,2952.0,35728.0
Khandwa,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2579.0,2651.0,2947.0,3081.0,3310.0,3368.0,2654.0,3504.0,2589.0,2712.0,2733.0,2850.0,34978.0
Khandwa,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,358.0,449.0,283.0,277.0,238.0,363.0,229.0,602.0,85.0,169.0,137.0,228.0,3418.0
Khandwa,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,7.0,9.0,22.0,29.0,28.0,23.0,9.0,13.0,28.0,10.0,6.0,186.0
Khandwa,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2386.0,3164.0,3255.0,3491.0,3608.0,3745.0,3311.0,3272.0,1771.0,2762.0,1972.0,2571.0,35308.0
Khandwa,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,472.0,422.0,543.0,454.0,603.0,730.0,675.0,329.0,698.0,815.0,521.0,592.0,6854.0
Khandwa,1.8,Number of pregnancy test kits used at SC level,TOTAL,539.0,525.0,656.0,1332.0,1437.0,1620.0,1403.0,1586.0,1636.0,1644.0,1714.0,1636.0,15728.0
Khandwa,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,82.0,113.0,79.0,88.0,208.0,198.0,183.0,157.0,167.0,140.0,125.0,126.0,1666.0
Khandwa,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,96.0,117.0,130.0,161.0,150.0,125.0,87.0,72.0,58.0,40.0,60.0,76.0,1172.0
Khandwa,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,178.0,230.0,209.0,249.0,358.0,323.0,270.0,229.0,225.0,180.0,185.0,202.0,2838.0
Khandwa,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,165.0,196.0,191.0,229.0,311.0,271.0,225.0,206.0,215.0,175.0,172.0,192.0,2548.0
Khandwa,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,13.0,0.0,10.0,3.0,0.0,0.0,2.0,1.0,0.0,3.0,32.0
Khandwa,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1683.0,1710.0,1681.0,1828.0,1942.0,1880.0,1793.0,1751.0,1702.0,1606.0,1555.0,1821.0,20952.0
Khandwa,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,574.0,574.0,373.0,908.0,895.0,941.0,906.0,717.0,543.0,412.0,543.0,722.0,8108.0
Khandwa,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,824.0,1347.0,1404.0,1720.0,2037.0,2175.0,1730.0,1764.0,1604.0,1739.0,1644.0,1294.0,19282.0
Khandwa,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,861.0,1138.0,1659.0,1661.0,1297.0,2422.0,1787.0,1939.0,990.0,1961.0,1845.0,2111.0,19671.0
Khandwa,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Khandwa,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,144.0,135.0,162.0,157.0,137.0,155.0,147.0,133.0,133.0,114.0,133.0,148.0,1698.0
Khandwa,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,,,,,,,,,,,0.0
Khandwa,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,,,,,,,,,,,0.0
Khandwa,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,,,,,,,,,,,0.0
Khandwa,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,186.0,192.0,162.0,166.0,160.0,152.0,183.0,157.0,158.0,169.0,168.0,202.0,2055.0
Khandwa,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khandwa,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,186.0,192.0,162.0,166.0,160.0,152.0,183.0,157.0,158.0,169.0,168.0,202.0,2055.0
Khandwa,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,81.0,35.0,105.0,103.0,73.0,97.0,99.0,90.0,90.0,73.0,97.0,97.0,1040.0
Khandwa,4.1.1.a,Number of male live births,TOTAL,1012.0,1034.0,1078.0,1149.0,1218.0,1244.0,1147.0,1074.0,1074.0,960.0,955.0,1109.0,13054.0
Khandwa,4.1.1.b,Number of female live births,TOTAL,949.0,994.0,944.0,1041.0,1187.0,1076.0,1050.0,1005.0,973.0,931.0,904.0,1041.0,12095.0
Khandwa,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1961.0,2028.0,2022.0,2190.0,2405.0,2320.0,2197.0,2079.0,2047.0,1891.0,1859.0,2150.0,25149.0
Khandwa,4.1.2,Number of still births,TOTAL,31.0,40.0,36.0,41.0,39.0,45.0,30.0,47.0,34.0,43.0,22.0,32.0,440.0
Khandwa,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,62.0,70.0,47.0,58.0,47.0,117.0,112.0,41.0,77.0,111.0,665.0,63.0,1470.0
Khandwa,4.2.1,Number of Newborns weighed at birth,TOTAL,1873.0,1956.0,1977.0,2152.0,2344.0,2227.0,2089.0,1994.0,2026.0,1874.0,1849.0,2142.0,24503.0
Khandwa,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,184.0,161.0,223.0,326.0,377.0,343.0,355.0,296.0,360.0,323.0,395.0,233.0,3576.0
Khandwa,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1818.0,1894.0,1891.0,2047.0,2259.0,2111.0,1963.0,1975.0,2025.0,1802.0,1779.0,2009.0,23573.0
Khandwa,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,30.0,71.0,56.0,69.0,62.0,170.0,305.0,176.0,121.0,113.0,1173.0
Khandwa,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,26.0,0.0,95.0,148.0,151.0,172.0,173.0,174.0,179.0,157.0,102.0,104.0,1481.0
Khandwa,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,11.0,117.0,63.0,0.0,68.0,,52.0,97.0,408.0
Khandwa,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khandwa,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,26.0,0.0,125.0,219.0,218.0,358.0,298.0,344.0,552.0,333.0,275.0,314.0,3062.0
Khandwa,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,20.0,3.0,2.0,183.0,30.0,0.0,11.0,,0.0,15.0,38.0,10.0,312.0
Khandwa,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,42.0,46.0,188.0,206.0,209.0,1385.0,1504.0,1459.0,1271.0,1262.0,1292.0,1455.0,10319.0
Khandwa,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,5.0,3.0,41.0,22.0,54.0,276.0,58.0,49.0,4015.0,2618.0,2522.0,1031.0,10694.0
Khandwa,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,44.0,28.0,206.0,226.0,190.0,1313.0,1032.0,325.0,770.0,1457.0,1269.0,1096.0,7956.0
Khandwa,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,188.0,248.0,220.0,247.0,287.0,283.0,224.0,217.0,210.0,198.0,179.0,161.0,2662.0
Khandwa,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1404.0,1411.0,1436.0,1533.0,2055.0,2093.0,1987.0,1785.0,1776.0,1678.0,1631.0,1595.0,20384.0
Khandwa,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1326.0,1499.0,1522.0,1534.0,1997.0,1287.0,1139.0,1147.0,1441.0,1493.0,1155.0,1014.0,16554.0
Khandwa,6.3,PNC maternal complications attended,TOTAL,1.0,1.0,20.0,58.0,29.0,72.0,42.0,78.0,21.0,42.0,34.0,47.0,445.0
Khandwa,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,29.0,35.0,39.0,56.0,51.0,63.0,38.0,27.0,44.0,62.0,56.0,64.0,564.0
Khandwa,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,18.0,19.0,35.0,11.0,1.0,9.0,15.0,12.0,12.0,12.0,12.0,14.0,170.0
Khandwa,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,47.0,54.0,74.0,67.0,52.0,72.0,53.0,39.0,56.0,74.0,68.0,78.0,734.0
Khandwa,7.2,Number of MTPs conducted at Private Facilities,TOTAL,35.0,93.0,37.0,41.0,39.0,17.0,16.0,22.0,20.0,91.0,47.0,56.0,514.0
Khandwa,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,64.0,51.0,56.0,62.0,108.0,56.0,408.0,52.0,111.0,277.0,106.0,85.0,1436.0
Khandwa,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,336.0,330.0,260.0,387.0,455.0,684.0,268.0,388.0,591.0,92.0,491.0,426.0,4708.0
Khandwa,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,400.0,381.0,316.0,449.0,563.0,740.0,676.0,440.0,702.0,369.0,597.0,511.0,6144.0
Khandwa,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,8.0,10.0,2.0,2.0,2.0,0.0,6.0,0.0,30.0
Khandwa,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,1.0,0.0,1.0,1.0,1.0,2.0,7.0,4.0,8.0,13.0,4.0,43.0
Khandwa,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,5.0,1.0,0.0,2.0,2.0,1.0,3.0,5.0,5.0,3.0,5.0,32.0
Khandwa,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khandwa,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,6.0,1.0,1.0,11.0,13.0,5.0,12.0,11.0,13.0,22.0,9.0,105.0
Khandwa,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,13.0,0.0,0.0,264.0,170.0,200.0,105.0,643.0,411.0,344.0,281.0,109.0,2540.0
Khandwa,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,5.0,14.0,96.0,162.0,233.0,312.0,171.0,724.0,627.0,379.0,517.0,138.0,3378.0
Khandwa,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,12.0,6.0,32.0,34.0,24.0,38.0,25.0,53.0,52.0,13.0,34.0,5.0,328.0
Khandwa,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khandwa,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,30.0,20.0,128.0,460.0,427.0,550.0,301.0,1420.0,1090.0,736.0,832.0,252.0,6246.0
Khandwa,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,1.0,22.0,1.0,0.0,0.0,0.0,0.0,0.0,24.0
Khandwa,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,8.0,1.0,2.0,4.0,5.0,9.0,3.0,9.0,0.0,0.0,19.0,60.0
Khandwa,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,3.0,6.0,1.0,1.0,8.0,5.0,8.0,19.0,4.0,19.0,3.0,77.0
Khandwa,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,5.0,41.0,33.0,23.0,27.0,25.0,4.0,13.0,14.0,6.0,10.0,40.0,241.0
Khandwa,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khandwa,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,5.0,52.0,40.0,26.0,32.0,38.0,18.0,24.0,42.0,10.0,29.0,62.0,378.0
Khandwa,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,20.0,4.0,0.0,0.0,,32.0,51.0,47.0,29.0,34.0,2.0,16.0,235.0
Khandwa,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,5.0,3.0,5.0,0.0,3.0,2.0,0.0,3.0,7.0,0.0,0.0,15.0,43.0
Khandwa,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,1.0,2.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Khandwa,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,15.0,22.0,22.0,0.0,38.0,24.0,24.0,24.0,0.0,29.0,,18.0,216.0
Khandwa,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khandwa,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,20.0,25.0,28.0,2.0,41.0,27.0,24.0,27.0,7.0,29.0,0.0,33.0,263.0
Khandwa,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,22.0,30.0,17.0,22.0,,2.0,28.0,13.0,17.0,8.0,20.0,24.0,203.0
Khandwa,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,196.0,209.0,276.0,348.0,267.0,300.0,413.0,404.0,1162.0,490.0,514.0,430.0,5009.0
Khandwa,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,1.0,1.0,6.0,0.0,8.0,5.0,5.0,4.0,88.0,102.0,8.0,11.0,239.0
Khandwa,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,1.0,3.0,5.0,11.0,15.0,20.0,33.0,24.0,58.0,20.0,130.0,2.0,322.0
Khandwa,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,83.0,75.0,46.0,49.0,39.0,60.0,30.0,42.0,18.0,289.0,18.0,174.0,923.0
Khandwa,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khandwa,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,281.0,288.0,333.0,408.0,329.0,385.0,481.0,474.0,1326.0,901.0,670.0,617.0,6493.0
Khandwa,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,72.0,65.0,16.0,39.0,33.0,63.0,41.0,79.0,119.0,300.0,344.0,67.0,1238.0
Khandwa,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,23.0,14.0,16.0,17.0,29.0,0.0,5.0,1.0,4.0,2.0,1.0,8.0,120.0
Khandwa,9.06,Number of IUCD removals,TOTAL,129.0,159.0,198.0,197.0,163.0,124.0,186.0,147.0,123.0,231.0,216.0,176.0,2049.0
Khandwa,9.07,Number of Oral Pills cycles distributed,TOTAL,7028.0,5274.0,5065.0,5780.0,6278.0,6432.0,6848.0,4337.0,3125.0,4287.0,6690.0,6924.0,68068.0
Khandwa,9.08,Number of Condom pieces distributed,TOTAL,16081.0,13201.0,12790.0,15569.0,15394.0,15760.0,18466.0,4699.0,3388.0,5010.0,8626.0,11484.0,140468.0
Khandwa,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,7.0
Khandwa,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,17.0,9.0,39.0,56.0,20.0,95.0,58.0,24.0,54.0,29.0,5.0,406.0
Khandwa,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,3.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14.0
Khandwa,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,2.0
Khandwa,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,9.12,Number of Institutions having NSV trained doctors,TOTAL,3.0,3.0,2.0,3.0,3.0,3.0,5.0,4.0,4.0,4.0,2.0,2.0,-1.0
Khandwa,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1855.0,1932.0,2174.0,1899.0,2139.0,2121.0,2056.0,2009.0,1996.0,1822.0,8321.0,2109.0,30433.0
Khandwa,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1823.0,2072.0,2224.0,2257.0,2344.0,2655.0,2657.0,659.0,508.0,348.0,587.0,379.0,18513.0
Khandwa,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1773.0,1912.0,2072.0,2126.0,2161.0,2516.0,2631.0,2660.0,775.0,437.0,435.0,381.0,19879.0
Khandwa,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1877.0,1801.0,1937.0,2064.0,2037.0,2557.0,2429.0,2688.0,2482.0,764.0,5247.0,346.0,26229.0
Khandwa,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,21.0,1795.0,2190.0,2492.0,2257.0,2360.0,11115.0
Khandwa,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1486.0,2270.0,2310.0,2403.0,8469.0
Khandwa,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,1979.0,2089.0,2380.0,6456.0
Khandwa,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1649.0,1679.0,1829.0,1628.0,1866.0,1936.0,1855.0,1850.0,1823.0,1741.0,1666.0,1983.0,21505.0
Khandwa,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1823.0,2059.0,2216.0,2257.0,2342.0,2655.0,2644.0,2456.0,2191.0,2204.0,2380.0,2389.0,27616.0
Khandwa,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1773.0,1913.0,2075.0,2126.0,2162.0,2511.0,2624.0,2662.0,2233.0,2064.0,2301.0,2428.0,26872.0
Khandwa,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1877.0,1802.0,1944.0,2059.0,2318.0,2557.0,2421.0,2668.0,2483.0,2181.0,2120.0,2395.0,26825.0
Khandwa,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1582.0,1675.0,1773.0,1629.0,1647.0,1928.0,1845.0,1801.0,1753.0,1603.0,1502.0,1897.0,20635.0
Khandwa,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1826.0,2064.0,2241.0,2257.0,2255.0,2717.0,2657.0,664.0,508.0,372.0,598.0,378.0,18537.0
Khandwa,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1772.0,1911.0,2075.0,2126.0,2132.0,2515.0,2631.0,2648.0,789.0,432.0,417.0,379.0,19827.0
Khandwa,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1866.0,1805.0,1950.0,2060.0,2092.0,2556.0,2429.0,2654.0,2451.0,755.0,460.0,342.0,21420.0
Khandwa,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1907.0,2046.0,2129.0,2077.0,1842.0,2723.0,2390.0,2262.0,1998.0,2173.0,6960.0,2805.0,31312.0
Khandwa,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,669.0,793.0,931.0,1095.0,1361.0,1518.0,1573.0,2388.0,2056.0,2231.0,2088.0,2412.0,19115.0
Khandwa,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,935.0,1003.0,879.0,818.0,918.0,1347.0,1190.0,1138.0,991.0,1091.0,1206.0,1568.0,13084.0
Khandwa,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,813.0,942.0,837.0,780.0,894.0,1306.0,1137.0,1102.0,930.0,1016.0,1172.0,1517.0,12446.0
Khandwa,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1748.0,1945.0,1716.0,1598.0,1812.0,2653.0,2327.0,2240.0,1921.0,2107.0,2378.0,3085.0,25530.0
Khandwa,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1675.0,1621.0,2024.0,2056.0,2020.0,2353.0,2104.0,2450.0,2378.0,2266.0,2142.0,2458.0,25547.0
Khandwa,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1674.0,1613.0,2024.0,2056.0,2020.0,2353.0,2104.0,2451.0,2378.0,2266.0,2142.0,2458.0,25539.0
Khandwa,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,221.0,417.0,338.0,316.0,364.0,669.0,601.0,396.0,686.0,563.0,653.0,725.0,5949.0
Khandwa,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,204.0,395.0,296.0,298.0,295.0,624.0,566.0,374.0,698.0,568.0,600.0,712.0,5630.0
Khandwa,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,425.0,812.0,634.0,614.0,659.0,1293.0,1167.0,770.0,1384.0,1131.0,1253.0,1437.0,11579.0
Khandwa,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1402.0,1515.0,1679.0,2039.0,1654.0,2312.0,2071.0,1618.0,2101.0,2344.0,2494.0,2674.0,23903.0
Khandwa,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1232.0,1437.0,1544.0,2005.0,1928.0,2305.0,2065.0,1612.0,2637.0,2185.0,2442.0,2423.0,23815.0
Khandwa,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1266.0,1440.0,1584.0,1955.0,1929.0,2039.0,1980.0,1774.0,2355.0,2513.0,2535.0,2456.0,23826.0
Khandwa,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,1.0,1.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Khandwa,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,45.0,42.0,57.0,66.0,34.0,0.0,0.0,0.0,0.0,244.0
Khandwa,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1021.0,1043.0,1050.0,1030.0,1018.0,1028.0,1025.0,1030.0,1030.0,1047.0,1033.0,1037.0,12392.0
Khandwa,10.4.2,Number of Immunisation sessions held during the month,TOTAL,967.0,1025.0,1035.0,1004.0,993.0,1009.0,1016.0,1025.0,1027.0,1026.0,1013.0,1041.0,12181.0
Khandwa,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,897.0,936.0,922.0,924.0,913.0,926.0,929.0,942.0,939.0,944.0,940.0,977.0,11189.0
Khandwa,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,6.0,0.0,0.0,0.0,10.0
Khandwa,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1877.0,2031.0,2128.0,2379.0,2141.0,2694.0,2353.0,2200.0,1960.0,2539.0,2390.0,2777.0,27469.0
Khandwa,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,216.0,247.0,582.0,4752.0,1479.0,565.0,681.0,620.0,1714.0,11002.0,947.0,663.0,23468.0
Khandwa,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,165.0,181.0,424.0,5248.0,1494.0,576.0,633.0,529.0,1292.0,10116.0,769.0,372.0,21799.0
Khandwa,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Khandwa,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,1.0,4.0,8.0,2.0,15.0,0.0,1.0,0.0,5.0,0.0,0.0,36.0
Khandwa,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,140.0,162.0,185.0,728.0,595.0,882.0,277.0,285.0,230.0,165.0,161.0,212.0,4022.0
Khandwa,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,4.0,12.0,111.0,41.0,40.0,50.0,45.0,55.0,15.0,32.0,14.0,13.0,432.0
Khandwa,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,6.0,6.0,31.0,177.0,282.0,871.0,134.0,91.0,155.0,104.0,72.0,60.0,1989.0
Khandwa,13.1,Number of Patients operated for cataract,TOTAL,21.0,128.0,57.0,143.0,198.0,339.0,222.0,368.0,306.0,334.0,398.0,398.0,2912.0
Khandwa,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,51.0,122.0,113.0,147.0,267.0,443.0,292.0,461.0,424.0,334.0,466.0,334.0,3454.0
Khandwa,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,2970.0,495.0,208.0,190.0,10.0,210.0,0.0,4083.0
Khandwa,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,569.0,34.0,196.0,148.0,0.0,93.0,0.0,1040.0
Khandwa,13.5,Number of eyes collected through eye donation,TOTAL,2.0,0.0,2.0,0.0,3.0,3.0,2.0,0.0,0.0,0.0,1.0,1.0,14.0
Khandwa,13.6,Number of eyes utilised for corneal transplant,TOTAL,2.0,0.0,2.0,0.0,3.0,3.0,2.0,0.0,0.0,0.0,1.0,1.0,14.0
Khandwa,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,5.0,3.0,3.0,3.0,3.0,4.0,3.0,4.0,4.0,1.0,2.0,-1.0
Khandwa,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,1.0,2.0,,,,12.0,4.0,4.0,2.0,1.0,4.0,-1.0
Khandwa,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,714.0,749.0,791.0,740.0,764.0,753.0,704.0,699.0,713.0,730.0,736.0,752.0,-1.0
Khandwa,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,6.0,5.0,5.0,6.0,6.0,7.0,6.0,7.0,6.0,5.0,5.0,-1.0
Khandwa,14.05,Number of RKS meetings held during the month,TOTAL,2.0,3.0,5.0,3.0,6.0,8.0,8.0,7.0,8.0,77.0,6.0,6.0,139.0
Khandwa,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,8.0,9.0,6.0,5.0,6.0,4.0,17.0,11.0,10.0,6.0,5.0,5.0,-1.0
Khandwa,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,34.0,74.0,16.0,27.0,102.0,84.0,69.0,113.0,111.0,65.0,56.0,16.0,767.0
Khandwa,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,4.0,2.0,3.0,3.0,3.0,4.0,3.0,3.0,2.0,1.0,1.0,-1.0
Khandwa,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,5.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Khandwa,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,538.0,488.0,1319.0,384.0,822.0,749.0,13831.0,364.0,5015.0,109.0,902.0,481.0,25002.0
Khandwa,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,981.0,1437.0,1774.0,1199.0,1177.0,2097.0,658.0,630.0,1816.0,1510.0,636.0,1174.0,15089.0
Khandwa,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,337.0,785.0,1105.0,426.0,1361.0,1636.0,13580.0,2078.0,446.0,141.0,1503.0,191.0,23589.0
Khandwa,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1511.0,1426.0,2151.0,2185.0,2608.0,3025.0,1506.0,1719.0,3190.0,1368.0,1258.0,1734.0,23681.0
Khandwa,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,875.0,1273.0,2424.0,810.0,2183.0,2385.0,27411.0,2442.0,5461.0,250.0,2405.0,672.0,48591.0
Khandwa,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2492.0,2863.0,3925.0,3384.0,3785.0,5122.0,2164.0,2349.0,5006.0,2878.0,1894.0,2908.0,38770.0
Khandwa,14.10.2.a,Number of death cases of Inpatient males,TOTAL,15.0,14.0,36.0,38.0,31.0,35.0,53.0,2.0,45.0,55.0,41.0,41.0,406.0
Khandwa,14.10.2.b,Number of death cases of Inpatient females,TOTAL,11.0,14.0,34.0,31.0,16.0,30.0,20.0,2.0,26.0,35.0,40.0,23.0,282.0
Khandwa,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,26.0,28.0,70.0,69.0,47.0,65.0,73.0,4.0,71.0,90.0,81.0,64.0,688.0
Khandwa,14.11,In-Patient Head Count at midnight,TOTAL,625.0,626.0,648.0,569.0,781.0,865.0,606.0,684.0,821.0,662.0,438.0,553.0,7878.0
Khandwa,14.12.1,OPD attendance (All),TOTAL,46683.0,50352.0,53245.0,53140.0,66568.0,89223.0,62999.0,63703.0,65938.0,59610.0,66396.0,70394.0,748251.0
Khandwa,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,113.0,168.0,3.0,63.0,47.0,46.0,35.0,27.0,34.0,169.0,45.0,35.0,785.0
Khandwa,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,28.0,73.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,101.0
Khandwa,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,158.0,163.0,17.0,133.0,220.0,240.0,136.0,319.0,285.0,273.0,303.0,117.0,2364.0
Khandwa,14.14.a,Number of patients given AYUSH treatment,TOTAL,769.0,764.0,781.0,2130.0,2616.0,8379.0,805.0,1366.0,2497.0,941.0,1779.0,2383.0,25210.0
Khandwa,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,761.0,0.0,0.0,0.0,1076.0,1035.0,1064.0,915.0,1088.0,987.0,896.0,849.0,8671.0
Khandwa,14.14.c,Number of Adolescents counselled,TOTAL,4.0,6.0,5.0,7.0,115.0,22.0,15.0,26.0,205.0,8.0,10.0,8.0,431.0
Khandwa,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5893.0,5742.0,8407.0,8034.0,9048.0,9264.0,9529.0,10025.0,9576.0,28784.0,26239.0,27010.0,157551.0
Khandwa,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,555.0,543.0,665.0,626.0,757.0,918.0,942.0,925.0,968.0,1057.0,692.0,792.0,9440.0
Khandwa,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,87.0,101.0,174.0,97.0,286.0,181.0,270.0,198.0,95.0,150.0,173.0,195.0,2007.0
Khandwa,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,5.0,6.0,4.0,4.0,2.0,3.0,4.0,3.0,42.0,1.0,27.0,1.0,102.0
Khandwa,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,134.0,104.0,204.0,147.0,273.0,184.0,434.0,144.0,349.0,250.0,301.0,224.0,2748.0
Khandwa,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,4.0,2.0,1.0,2.0,1.0,1.0,42.0,40.0,0.0,37.0,1.0,132.0
Khandwa,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,757.0,850.0,1566.0,1045.0,1307.0,1325.0,752.0,957.0,918.0,714.0,596.0,609.0,11396.0
Khandwa,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,2.0,1.0,36.0,0.0,0.0,217.0,207.0,0.0,82.0,0.0,546.0
Khandwa,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,978.0,1055.0,1944.0,1289.0,1866.0,1690.0,1456.0,1299.0,1362.0,1114.0,1070.0,1028.0,16151.0
Khandwa,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,6.0,11.0,8.0,6.0,40.0,4.0,5.0,262.0,289.0,1.0,146.0,2.0,780.0
Khandwa,15.2,Number of Widal tests conducted,Number tested,289.0,286.0,439.0,478.0,564.0,297.0,599.0,649.0,256.0,848.0,246.0,541.0,5492.0
Khandwa,15.3.a,Number of VDRL tests conducted on males,Number tested,19.0,21.0,12.0,28.0,36.0,55.0,33.0,45.0,446.0,503.0,523.0,402.0,2123.0
Khandwa,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,22.0,40.0,38.0,40.0,49.0,97.0,48.0,70.0,167.0,80.0,53.0,25.0,729.0
Khandwa,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,291.0,620.0,777.0,902.0,625.0,701.0,370.0,805.0,988.0,1034.0,585.0,553.0,8251.0
Khandwa,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,332.0,681.0,827.0,970.0,710.0,853.0,451.0,920.0,1601.0,1617.0,1161.0,980.0,11103.0
Khandwa,15.4.1,Number of blood smears examined for Malaria,TOTAL,9749.0,10271.0,13217.0,12450.0,12702.0,16045.0,14087.0,10728.0,9435.0,5604.0,9346.0,10073.0,133707.0
Khandwa,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,40.0,31.0,56.0,97.0,97.0,110.0,112.0,87.0,45.0,30.0,40.0,18.0,763.0
Khandwa,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,12.0,4.0,2.0,21.0,29.0,94.0,76.0,102.0,112.0,26.0,14.0,10.0,502.0
Khandwa,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Khandwa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Khandwa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Khandwa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Khandwa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khandwa,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,1.0,,1.0,,,,,1.0,,3.0
Khandwa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,6.0,6.0,6.0,2.0,,2.0,2.0,8.0,,,,,32.0
Khandwa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Khandwa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,6.0,6.0,6.0,2.0,,2.0,2.0,8.0,,,,,32.0
Khandwa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,1.0,,,,,,2.0,3.0
Khandwa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Khandwa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,1.0,,,,,,2.0,3.0
Khandwa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,4.0,8.0,9.0,10.0,4.0,9.0,4.0,11.0,4.0,11.0,3.0,1.0,78.0
Khandwa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,3.0,,,4.0
Khandwa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,4.0,8.0,9.0,10.0,4.0,9.0,4.0,11.0,5.0,14.0,3.0,1.0,82.0
Khandwa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,5.0,15.0,11.0,20.0,12.0,10.0,18.0,14.0,3.0,4.0,4.0,17.0,133.0
Khandwa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,,,1.0,,,1.0,1.0,,1.0,2.0,7.0
Khandwa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,5.0,16.0,11.0,20.0,13.0,10.0,18.0,15.0,4.0,4.0,5.0,19.0,140.0
Khandwa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,1.0,,2.0,,1.0,,,,1.0,6.0
Khandwa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,1.0,,,,1.0,,,2.0
Khandwa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,1.0,,3.0,,1.0,,1.0,,1.0,8.0
Khandwa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,2.0,,,,,,,,2.0
Khandwa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Khandwa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,2.0,,,,,,,,2.0
Khandwa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,1.0,1.0
Khandwa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Khandwa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,1.0,1.0
Khandwa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Khandwa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Khandwa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Khandwa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,1.0,1.0,3.0,3.0,8.0,6.0,1.0,6.0,4.0,5.0,,39.0
Khandwa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,1.0,3.0,5.0,3.0,3.0,3.0,3.0,3.0,2.0,2.0,29.0
Khandwa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,2.0,2.0,6.0,8.0,11.0,9.0,4.0,9.0,7.0,7.0,2.0,68.0
Khandwa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Khandwa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Khandwa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Khandwa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Khandwa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Khandwa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,1.0,,,,,,1.0,,1.0,,3.0
Khandwa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,3.0,1.0,,2.0,1.0,,,,1.0,8.0
Khandwa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,1.0,3.0,1.0,,2.0,1.0,1.0,,1.0,1.0,12.0
Khandwa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,2.0,,,,,,,,,2.0
Khandwa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,5.0,,,,2.0,,1.0,,,8.0
Khandwa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,13.0,,,,,,,,,13.0
Khandwa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,20.0,,,,2.0,,1.0,,,23.0
Khandwa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Khandwa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Khandwa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Khandwa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,1.0,,,,,,,,,,,1.0
Khandwa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Khandwa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,,1.0,,,5.0,3.0,6.0,7.0,4.0,27.0
Khandwa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,,,8.0,11.0,16.0,20.0,14.0,28.0,33.0,27.0,158.0
Khandwa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,1.0,,9.0,11.0,16.0,25.0,17.0,34.0,40.0,31.0,185.0
Khandwa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Khandwa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Khandwa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Khandwa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,1.0,,,,,,1.0,2.0
Khandwa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Khandwa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,2.0,,3.0,4.0,4.0,5.0,3.0,6.0,4.0,5.0,5.0,42.0
Khandwa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,3.0,3.0,,4.0,1.0,1.0,2.0,4.0,4.0,5.0,5.0,33.0
Khandwa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,2.0,5.0,3.0,3.0,8.0,5.0,6.0,5.0,10.0,8.0,10.0,10.0,75.0
Khandwa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Khandwa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Khandwa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Khandwa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Khandwa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Khandwa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Khandwa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Khandwa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Khandwa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Khandwa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Khandwa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Khandwa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,1.0,,,,,,,,,,1.0
Khandwa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Khandwa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,1.0,1.0,,,1.0,,,,,,,4.0
Khandwa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Khandwa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,1.0,1.0,,,1.0,,,,,,,4.0
Khandwa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Khandwa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,,,1.0,,1.0,,,,3.0
Khandwa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Khandwa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,1.0,,,1.0,,1.0,,,,3.0
Khandwa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Khandwa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Khandwa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Khandwa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Khandwa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Khandwa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,2.0,1.0,2.0,2.0,3.0,1.0,,1.0,,,12.0
Khandwa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Khandwa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,2.0,1.0,2.0,2.0,3.0,1.0,,1.0,,,12.0
Khandwa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,,,,,,,,,,1.0,,2.0
Khandwa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,1.0,5.0,4.0,4.0,11.0,9.0,10.0,2.0,6.0,3.0,5.0,61.0
Khandwa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,1.0,,,3.0,3.0,4.0,1.0,1.0,,,13.0
Khandwa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,1.0,6.0,4.0,4.0,14.0,12.0,14.0,3.0,7.0,4.0,5.0,76.0
Khandwa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,1.0,,,1.0,2.0
Khandwa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,3.0,2.0,2.0,2.0,,1.0,3.0,,,2.0,2.0,18.0
Khandwa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Khandwa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,3.0,2.0,2.0,2.0,,1.0,4.0,1.0,,2.0,3.0,21.0
Khandwa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Khandwa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,,2.0,1.0,1.0,,,,,,5.0
Khandwa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,1.0,2.0,,,,,,1.0,4.0
Khandwa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,1.0,,3.0,3.0,1.0,,,,,1.0,9.0
Khandwa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Khandwa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,1.0,,,2.0,,,3.0
Khandwa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Khandwa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,1.0,,,,,1.0,,,2.0,,,4.0
Khandwa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Khandwa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Khandwa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,1.0,1.0,,,,,,,2.0,,4.0
Khandwa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,1.0,2.0,,,,,,,2.0,,5.0
Khandwa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,2.0,,,3.0,3.0,6.0,1.0,2.0,1.0,2.0,21.0
Khandwa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,3.0,14.0,33.0,30.0,35.0,39.0,35.0,34.0,5.0,16.0,14.0,30.0,288.0
Khandwa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,2.0,11.0,43.0,37.0,47.0,40.0,44.0,44.0,24.0,46.0,29.0,48.0,415.0
Khandwa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,5.0,26.0,78.0,67.0,82.0,82.0,82.0,84.0,30.0,64.0,44.0,80.0,724.0
Khargone,1.1,Total number of pregnant women Registered for ANC,TOTAL,3047.0,3652.0,4233.0,4055.0,3307.0,4266.0,3307.0,3726.0,3608.0,3856.0,3633.0,3759.0,44449.0
Khargone,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1686.0,1990.0,2492.0,2403.0,2074.0,2598.0,2129.0,2405.0,2340.0,2404.0,2256.0,2266.0,27043.0
Khargone,1.2,Number of Pregnant women registered under JSY,TOTAL,3046.0,3611.0,4222.0,4042.0,3286.0,4247.0,3288.0,3651.0,3567.0,3802.0,3610.0,3746.0,44118.0
Khargone,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2720.0,3044.0,3477.0,3645.0,3472.0,3711.0,3293.0,3551.0,3383.0,3405.0,3409.0,3713.0,40823.0
Khargone,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1894.0,2976.0,3599.0,3616.0,2971.0,3603.0,2874.0,3294.0,3458.0,3251.0,3403.0,3470.0,38409.0
Khargone,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2379.0,2431.0,3139.0,3591.0,2990.0,3331.0,3036.0,3101.0,3094.0,3129.0,3172.0,3354.0,36747.0
Khargone,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3064.0,3490.0,4190.0,4019.0,3338.0,4104.0,3351.0,3602.0,3603.0,3784.0,3601.0,3862.0,44008.0
Khargone,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,133.0,108.0,159.0,171.0,115.0,115.0,57.0,135.0,157.0,156.0,193.0,153.0,1652.0
Khargone,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,5.0,3.0,9.0,6.0,11.0,3.0,5.0,6.0,7.0,2.0,2.0,2.0,61.0
Khargone,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1782.0,2630.0,2298.0,2990.0,2485.0,2234.0,1997.0,2325.0,2427.0,2345.0,2297.0,2227.0,28037.0
Khargone,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,19.0,57.0,51.0,59.0,38.0,47.0,34.0,47.0,61.0,30.0,95.0,30.0,568.0
Khargone,1.8,Number of pregnancy test kits used at SC level,TOTAL,170.0,263.0,217.0,185.0,158.0,108.0,115.0,609.0,424.0,513.0,542.0,514.0,3818.0
Khargone,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,18.0,24.0,37.0,61.0,157.0,180.0,176.0,255.0,263.0,349.0,280.0,285.0,2085.0
Khargone,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,340.0,451.0,473.0,427.0,259.0,278.0,228.0,223.0,149.0,165.0,117.0,144.0,3254.0
Khargone,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,358.0,475.0,510.0,488.0,416.0,458.0,404.0,478.0,412.0,514.0,397.0,429.0,5339.0
Khargone,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,143.0,330.0,471.0,358.0,397.0,388.0,364.0,349.0,296.0,452.0,305.0,378.0,4231.0
Khargone,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,3.0,0.0,7.0,1.0,2.0,1.0,15.0
Khargone,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2022.0,2353.0,2597.0,2413.0,2635.0,2730.0,2428.0,2285.0,2349.0,2267.0,2343.0,3127.0,29549.0
Khargone,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,132.0,426.0,391.0,284.0,72.0,238.0,69.0,494.0,694.0,337.0,241.0,261.0,3639.0
Khargone,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1395.0,2196.0,1442.0,2266.0,1996.0,1577.0,1762.0,1687.0,1583.0,1596.0,1733.0,2128.0,21361.0
Khargone,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1278.0,2046.0,2594.0,2231.0,2215.0,2395.0,2134.0,1812.0,1717.0,1945.0,1749.0,2938.0,25054.0
Khargone,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,801.0,0.0,0.0,737.0,0.0,89.0,0.0,0.0,0.0,1.0,1628.0
Khargone,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,90.0,124.0,129.0,119.0,82.0,160.0,109.0,154.0,146.0,107.0,118.0,100.0,1438.0
Khargone,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,151.0,213.0,243.0,180.0,200.0,206.0,143.0,197.0,191.0,158.0,186.0,361.0,2429.0
Khargone,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khargone,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,151.0,213.0,243.0,180.0,200.0,206.0,143.0,197.0,191.0,158.0,186.0,361.0,2429.0
Khargone,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,16.0,92.0,60.0,88.0,62.0,134.0,84.0,115.0,111.0,73.0,78.0,65.0,978.0
Khargone,4.1.1.a,Number of male live births,TOTAL,1210.0,1574.0,1694.0,1512.0,1552.0,1652.0,1472.0,1536.0,1533.0,1496.0,1410.0,1848.0,18489.0
Khargone,4.1.1.b,Number of female live births,TOTAL,1216.0,1339.0,1479.0,1464.0,1524.0,1637.0,1425.0,1350.0,1319.0,1332.0,1396.0,1737.0,17218.0
Khargone,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2426.0,2913.0,3173.0,2976.0,3076.0,3289.0,2897.0,2886.0,2852.0,2828.0,2806.0,3585.0,35707.0
Khargone,4.1.2,Number of still births,TOTAL,46.0,57.0,70.0,52.0,69.0,69.0,57.0,53.0,62.0,73.0,55.0,80.0,743.0
Khargone,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,84.0,69.0,80.0,93.0,71.0,95.0,91.0,77.0,79.0,86.0,91.0,87.0,1003.0
Khargone,4.2.1,Number of Newborns weighed at birth,TOTAL,2308.0,2878.0,3120.0,2898.0,3039.0,3241.0,2880.0,2861.0,2848.0,2829.0,2807.0,3580.0,35289.0
Khargone,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,660.0,337.0,394.0,341.0,335.0,350.0,303.0,385.0,435.0,354.0,344.0,488.0,4726.0
Khargone,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2378.0,2868.0,3112.0,2939.0,3064.0,3255.0,2856.0,2853.0,2802.0,2802.0,2767.0,2646.0,34342.0
Khargone,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,7.0,41.0,32.0,37.0,17.0,24.0,38.0,48.0,30.0,40.0,36.0,44.0,394.0
Khargone,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,20.0,63.0,83.0,86.0,45.0,171.0,287.0,103.0,55.0,69.0,65.0,96.0,1143.0
Khargone,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,155.0,374.0,168.0,182.0,202.0,204.0,145.0,119.0,462.0,160.0,173.0,374.0,2718.0
Khargone,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khargone,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,182.0,478.0,283.0,305.0,264.0,399.0,470.0,270.0,547.0,269.0,274.0,514.0,4255.0
Khargone,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,16.0,32.0,25.0,1.0,13.0,7.0,0.0,0.0,0.0,0.0,34.0,15.0,143.0
Khargone,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,168.0,438.0,445.0,275.0,303.0,393.0,312.0,327.0,272.0,224.0,313.0,346.0,3816.0
Khargone,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,152.0,59.0,36.0,36.0,35.0,26.0,26.0,58.0,22.0,34.0,28.0,25.0,537.0
Khargone,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,327.0,319.0,796.0,256.0,238.0,623.0,579.0,560.0,661.0,561.0,510.0,767.0,6197.0
Khargone,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,55.0,139.0,94.0,77.0,76.0,100.0,51.0,90.0,88.0,68.0,86.0,97.0,1021.0
Khargone,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2187.0,2533.0,2755.0,2684.0,2779.0,2882.0,2474.0,2442.0,2344.0,2366.0,2496.0,3036.0,30978.0
Khargone,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1583.0,1853.0,2198.0,2343.0,2334.0,2490.0,2353.0,2312.0,2286.0,2613.0,2370.0,2874.0,27609.0
Khargone,6.3,PNC maternal complications attended,TOTAL,15.0,77.0,26.0,15.0,283.0,53.0,152.0,146.0,446.0,65.0,217.0,273.0,1768.0
Khargone,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,28.0,18.0,33.0,37.0,33.0,26.0,31.0,34.0,34.0,55.0,41.0,44.0,414.0
Khargone,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,4.0,0.0,12.0,12.0,1.0,0.0,0.0,1.0,2.0,5.0,37.0
Khargone,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,28.0,18.0,37.0,37.0,45.0,38.0,32.0,34.0,34.0,56.0,43.0,49.0,451.0
Khargone,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,12.0,19.0,20.0,11.0,18.0,0.0,17.0,14.0,0.0,14.0,8.0,133.0
Khargone,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,24.0,36.0,42.0,31.0,52.0,75.0,61.0,80.0,61.0,46.0,115.0,96.0,719.0
Khargone,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,326.0,277.0,358.0,338.0,364.0,457.0,518.0,1114.0,440.0,264.0,752.0,920.0,6128.0
Khargone,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,350.0,313.0,400.0,369.0,416.0,532.0,579.0,1194.0,501.0,310.0,867.0,1016.0,6847.0
Khargone,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,63.0,79.0,0.0,0.0,0.0,0.0,68.0,72.0,40.0,54.0,49.0,425.0
Khargone,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,1.0,0.0,2.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0,7.0
Khargone,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,0.0,1.0,0.0,4.0,0.0,0.0,0.0,0.0,3.0,1.0,0.0,10.0
Khargone,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,5.0,5.0,7.0,5.0,8.0,3.0,7.0,8.0,1.0,6.0,7.0,63.0
Khargone,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khargone,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,6.0,6.0,9.0,9.0,8.0,5.0,7.0,8.0,4.0,7.0,9.0,80.0
Khargone,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,10.0,36.0,66.0,201.0,147.0,140.0,80.0,339.0,395.0,159.0,422.0,151.0,2146.0
Khargone,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,142.0,80.0,327.0,472.0,602.0,716.0,317.0,558.0,763.0,633.0,986.0,401.0,5997.0
Khargone,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,34.0,63.0,125.0,210.0,150.0,205.0,95.0,147.0,210.0,176.0,284.0,95.0,1794.0
Khargone,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khargone,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,186.0,179.0,518.0,883.0,899.0,1061.0,492.0,1044.0,1368.0,968.0,1692.0,647.0,9937.0
Khargone,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,5.0,3.0,6.0,4.0,21.0
Khargone,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,1.0,2.0,13.0,0.0,11.0,11.0,40.0
Khargone,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,44.0,24.0,40.0,80.0,40.0,44.0,92.0,108.0,100.0,69.0,118.0,69.0,828.0
Khargone,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khargone,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,44.0,24.0,40.0,80.0,42.0,44.0,94.0,112.0,118.0,72.0,135.0,84.0,889.0
Khargone,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,5.0,8.0,14.0,12.0,3.0,12.0,24.0,13.0,11.0,9.0,8.0,8.0,127.0
Khargone,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,12.0,4.0,4.0,24.0
Khargone,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,3.0,0.0,1.0,7.0,13.0
Khargone,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,31.0,55.0,51.0,61.0,59.0,91.0,64.0,87.0,79.0,59.0,59.0,74.0,770.0
Khargone,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khargone,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,31.0,55.0,51.0,63.0,59.0,91.0,64.0,87.0,86.0,71.0,64.0,85.0,807.0
Khargone,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,7.0,10.0,5.0,0.0,0.0,4.0,1.0,0.0,0.0,27.0
Khargone,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,482.0,480.0,475.0,524.0,472.0,510.0,521.0,480.0,420.0,443.0,458.0,398.0,5663.0
Khargone,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,5.0,13.0,4.0,7.0,12.0,15.0,92.0,80.0,5.0,4.0,1.0,19.0,257.0
Khargone,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,25.0,27.0,64.0,25.0,22.0,5.0,4.0,20.0,31.0,23.0,22.0,8.0,276.0
Khargone,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,229.0,186.0,301.0,301.0,268.0,223.0,183.0,186.0,93.0,124.0,144.0,190.0,2428.0
Khargone,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khargone,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,741.0,706.0,844.0,857.0,774.0,753.0,800.0,766.0,549.0,594.0,625.0,615.0,8624.0
Khargone,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,220.0,142.0,263.0,284.0,256.0,204.0,131.0,180.0,112.0,120.0,152.0,181.0,2245.0
Khargone,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,1.0,0.0,0.0,0.0,0.0,4.0,3.0,0.0,15.0,0.0,3.0,4.0,30.0
Khargone,9.06,Number of IUCD removals,TOTAL,205.0,206.0,205.0,198.0,229.0,217.0,203.0,277.0,248.0,273.0,192.0,202.0,2655.0
Khargone,9.07,Number of Oral Pills cycles distributed,TOTAL,5422.0,6032.0,6263.0,7510.0,7516.0,7940.0,8075.0,7489.0,7034.0,8223.0,9364.0,9393.0,90261.0
Khargone,9.08,Number of Condom pieces distributed,TOTAL,37111.0,39651.0,40931.0,46245.0,50535.0,53900.0,44850.0,41343.0,42919.0,44774.0,48919.0,51528.0,542706.0
Khargone,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,2.0,2.0,4.0,2.0,1.0,2.0,37.0,16.0,26.0,9.0,15.0,116.0
Khargone,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,1.0,0.0,8.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,12.0
Khargone,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Khargone,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,2.0,2.0,1.0,0.0,3.0,2.0,2.0,0.0,4.0,1.0,0.0,17.0
Khargone,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Khargone,9.12,Number of Institutions having NSV trained doctors,TOTAL,14.0,10.0,24.0,14.0,15.0,16.0,12.0,15.0,24.0,16.0,13.0,10.0,-1.0
Khargone,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2483.0,2857.0,3097.0,3091.0,3112.0,3196.0,2816.0,2653.0,2773.0,2957.0,2814.0,3594.0,35443.0
Khargone,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2703.0,3026.0,3403.0,3444.0,3038.0,3293.0,3167.0,1029.0,155.0,56.0,3.0,7.0,23324.0
Khargone,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2640.0,2882.0,3150.0,3489.0,3031.0,3155.0,2967.0,3366.0,1236.0,300.0,112.0,20.0,26348.0
Khargone,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2696.0,2909.0,3077.0,3467.0,2965.0,3289.0,2975.0,3134.0,3169.0,1186.0,260.0,47.0,29174.0
Khargone,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2401.0,3032.0,2841.0,3018.0,3244.0,14536.0
Khargone,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,2130.0,2634.0,2860.0,3232.0,10862.0
Khargone,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1935.0,2591.0,3265.0,7792.0
Khargone,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1917.0,2255.0,2460.0,2489.0,2726.0,2646.0,2442.0,2301.0,2296.0,2405.0,2367.0,2972.0,29276.0
Khargone,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2707.0,3016.0,3387.0,3434.0,2723.0,2179.0,2988.0,2513.0,2959.0,2987.0,3143.0,3303.0,35339.0
Khargone,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2648.0,2877.0,3162.0,3489.0,2709.0,2091.0,2716.0,2699.0,2940.0,2974.0,3086.0,3287.0,34678.0
Khargone,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2697.0,2893.0,3104.0,3469.0,2641.0,2158.0,2672.0,2459.0,3107.0,2994.0,3084.0,3372.0,34650.0
Khargone,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1794.0,1389.0,2286.0,2333.0,2541.0,2523.0,2352.0,2309.0,2204.0,2258.0,2192.0,3017.0,27198.0
Khargone,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2764.0,3763.0,3399.0,3456.0,3056.0,3177.0,3024.0,1011.0,256.0,56.0,12.0,0.0,23974.0
Khargone,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2647.0,2906.0,3161.0,3481.0,3033.0,3151.0,2976.0,3382.0,1270.0,307.0,134.0,14.0,26462.0
Khargone,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2706.0,2935.0,3059.0,3481.0,2960.0,3302.0,2949.0,3124.0,3108.0,1247.0,304.0,48.0,29223.0
Khargone,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2583.0,2931.0,3849.0,3416.0,2804.0,3249.0,2843.0,2982.0,2977.0,2778.0,3045.0,3451.0,36908.0
Khargone,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1688.0,2316.0,3129.0,3074.0,2326.0,2698.0,2472.0,2756.0,2830.0,2586.0,2794.0,2965.0,31634.0
Khargone,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1188.0,1300.0,1462.0,1632.0,1386.0,1567.0,1364.0,1311.0,1375.0,1168.0,1475.0,1604.0,16832.0
Khargone,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1060.0,1261.0,1363.0,1522.0,1300.0,1425.0,1267.0,1196.0,1262.0,1097.0,1291.0,1412.0,15456.0
Khargone,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2248.0,2561.0,2825.0,3154.0,2686.0,2992.0,2631.0,2507.0,2637.0,2265.0,2766.0,3016.0,32288.0
Khargone,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2367.0,2744.0,2945.0,3248.0,2499.0,2994.0,2675.0,2990.0,2966.0,2799.0,3013.0,3100.0,34340.0
Khargone,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2365.0,2742.0,2953.0,3250.0,2394.0,1902.0,2390.0,2411.0,3027.0,2765.0,3025.0,3098.0,32322.0
Khargone,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,215.0,248.0,309.0,293.0,231.0,429.0,292.0,317.0,346.0,370.0,398.0,320.0,3768.0
Khargone,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,209.0,242.0,308.0,295.0,243.0,361.0,286.0,264.0,345.0,398.0,423.0,308.0,3682.0
Khargone,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,424.0,490.0,617.0,588.0,474.0,790.0,578.0,581.0,691.0,768.0,821.0,628.0,7450.0
Khargone,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,2153.0,2507.0,2793.0,3163.0,2681.0,2863.0,2479.0,2738.0,2610.0,2913.0,2757.0,2955.0,32612.0
Khargone,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2174.0,2480.0,2683.0,2917.0,2587.0,2836.0,2544.0,2639.0,2445.0,2543.0,2523.0,2694.0,31065.0
Khargone,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2113.0,2361.0,2673.0,2968.0,2622.0,2950.0,2496.0,2541.0,2429.0,2669.0,2583.0,2727.0,31132.0
Khargone,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,1.0,0.0,0.0,0.0,9.0,10.0,17.0,32.0,26.0,16.0,112.0
Khargone,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,42.0,10.0,17.0,17.0,5.0,2.0,6.0,18.0,41.0,145.0,115.0,65.0,483.0
Khargone,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1513.0,1525.0,1562.0,1667.0,1588.0,1603.0,1556.0,1628.0,1623.0,1614.0,1612.0,1674.0,19165.0
Khargone,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1424.0,1454.0,1498.0,1591.0,1523.0,1556.0,1493.0,1616.0,1597.0,1585.0,1579.0,1665.0,18581.0
Khargone,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1268.0,1301.0,1331.0,1406.0,1364.0,1402.0,1288.0,1447.0,1450.0,1403.0,1417.0,1519.0,16596.0
Khargone,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2573.0,2880.0,3045.0,3681.0,2807.0,3206.0,2723.0,2875.0,2899.0,5008.0,3101.0,3332.0,38130.0
Khargone,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,113.0,140.0,253.0,22298.0,2103.0,239.0,263.0,298.0,1277.0,25337.0,1444.0,345.0,54110.0
Khargone,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,82.0,116.0,142.0,23879.0,2026.0,139.0,147.0,186.0,1111.0,26583.0,1392.0,160.0,55963.0
Khargone,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Khargone,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,1.0,0.0,0.0,0.0,2.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,6.0
Khargone,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,15.0,17.0,2.0,7.0,7.0,3.0,2.0,24.0,3.0,8.0,6.0,4.0,98.0
Khargone,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,455.0,527.0,403.0,533.0,607.0,799.0,498.0,532.0,526.0,510.0,487.0,543.0,6420.0
Khargone,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,76.0,28.0,26.0,9.0,41.0,49.0,28.0,70.0,88.0,26.0,74.0,78.0,593.0
Khargone,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,26.0,270.0,121.0,7.0,10.0,269.0,19.0,92.0,119.0,18.0,15.0,25.0,991.0
Khargone,13.1,Number of Patients operated for cataract,TOTAL,40.0,79.0,130.0,198.0,121.0,388.0,286.0,324.0,203.0,193.0,192.0,277.0,2431.0
Khargone,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,40.0,79.0,130.0,198.0,121.0,388.0,286.0,324.0,201.0,193.0,192.0,277.0,2429.0
Khargone,13.3,Number of School children detected with Refractive errors,TOTAL,4.0,0.0,0.0,12.0,21.0,863.0,142.0,138.0,69.0,45.0,15.0,8.0,1317.0
Khargone,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,5.0,200.0,0.0,352.0,69.0,52.0,139.0,0.0,817.0
Khargone,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,10.0,7.0,8.0,6.0,9.0,7.0,7.0,7.0,4.0,5.0,6.0,5.0,-1.0
Khargone,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,12.0,18.0,21.0,12.0,17.0,16.0,22.0,11.0,12.0,13.0,11.0,8.0,-1.0
Khargone,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1121.0,1118.0,1217.0,1267.0,1227.0,1271.0,1249.0,1240.0,1225.0,1229.0,1262.0,1335.0,-1.0
Khargone,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,8.0,8.0,7.0,9.0,5.0,6.0,9.0,2.0,5.0,6.0,7.0,-1.0
Khargone,14.05,Number of RKS meetings held during the month,TOTAL,4.0,5.0,2.0,5.0,14.0,5.0,4.0,8.0,12.0,10.0,8.0,10.0,87.0
Khargone,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,19.0,24.0,30.0,19.0,24.0,24.0,22.0,21.0,22.0,26.0,20.0,16.0,-1.0
Khargone,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,31.0,24.0,22.0,68.0,27.0,28.0,25.0,39.0,25.0,97.0,83.0,28.0,497.0
Khargone,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,6.0,4.0,7.0,6.0,8.0,8.0,6.0,7.0,5.0,7.0,7.0,5.0,-1.0
Khargone,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,2.0,2.0,0.0,1.0,1.0,2.0,2.0,2.0,2.0,3.0,-1.0
Khargone,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,929.0,1396.0,1267.0,980.0,915.0,1202.0,1026.0,811.0,853.0,476.0,1040.0,772.0,11667.0
Khargone,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1974.0,2080.0,2437.0,2609.0,2375.0,2809.0,2373.0,2152.0,2185.0,1702.0,2442.0,2603.0,27741.0
Khargone,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,770.0,1800.0,1477.0,831.0,792.0,1142.0,819.0,1058.0,890.0,528.0,1194.0,878.0,12179.0
Khargone,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,5513.0,5373.0,6191.0,6866.0,6243.0,6383.0,5986.0,5202.0,6083.0,3357.0,6048.0,5721.0,68966.0
Khargone,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1699.0,3196.0,2744.0,1811.0,1707.0,2344.0,1845.0,1869.0,1743.0,1004.0,2234.0,1650.0,23846.0
Khargone,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,7487.0,7453.0,8628.0,9475.0,8618.0,9192.0,8359.0,7354.0,8268.0,5059.0,8490.0,8324.0,96707.0
Khargone,14.10.2.a,Number of death cases of Inpatient males,TOTAL,39.0,32.0,37.0,40.0,48.0,40.0,42.0,52.0,44.0,28.0,49.0,36.0,487.0
Khargone,14.10.2.b,Number of death cases of Inpatient females,TOTAL,25.0,34.0,21.0,18.0,26.0,35.0,31.0,270.0,25.0,17.0,31.0,29.0,562.0
Khargone,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,64.0,66.0,58.0,58.0,74.0,75.0,73.0,322.0,69.0,45.0,80.0,65.0,1049.0
Khargone,14.11,In-Patient Head Count at midnight,TOTAL,3011.0,3604.0,4230.0,3705.0,5063.0,4667.0,4656.0,3671.0,3632.0,2810.0,3725.0,6434.0,49208.0
Khargone,14.12.1,OPD attendance (All),TOTAL,73128.0,87547.0,98579.0,104671.0,108240.0,162611.0,124080.0,111169.0,105861.0,72684.0,115927.0,117036.0,1281533.0
Khargone,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,527.0,526.0,644.0,605.0,535.0,656.0,490.0,567.0,576.0,213.0,463.0,384.0,6186.0
Khargone,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,265.0,301.0,4.0,176.0,0.0,277.0,5.0,1.0,4.0,4.0,1037.0
Khargone,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,445.0,402.0,194.0,205.0,541.0,377.0,458.0,1158.0,622.0,278.0,430.0,453.0,5563.0
Khargone,14.14.a,Number of patients given AYUSH treatment,TOTAL,1135.0,2608.0,2670.0,2180.0,1244.0,4179.0,1615.0,2180.0,2909.0,2099.0,1545.0,1528.0,25892.0
Khargone,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,449.0,610.0,459.0,490.0,856.0,900.0,364.0,846.0,519.0,942.0,645.0,773.0,7853.0
Khargone,14.14.c,Number of Adolescents counselled,TOTAL,5.0,242.0,0.0,384.0,229.0,18.0,638.0,752.0,817.0,748.0,961.0,783.0,5577.0
Khargone,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7624.0,9447.0,11669.0,11274.0,11435.0,13727.0,10214.0,11668.0,11991.0,9611.0,11602.0,10997.0,131259.0
Khargone,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,257.0,332.0,324.0,351.0,501.0,488.0,310.0,415.0,1159.0,194.0,389.0,400.0,5120.0
Khargone,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,181.0,213.0,220.0,196.0,421.0,457.0,266.0,474.0,407.0,243.0,359.0,633.0,4070.0
Khargone,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,6.0,3.0,9.0,4.0,3.0,3.0,1.0,4.0,2.0,2.0,0.0,0.0,37.0
Khargone,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,186.0,228.0,525.0,426.0,567.0,719.0,338.0,706.0,435.0,394.0,427.0,323.0,5274.0
Khargone,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,59.0,2.0,1.0,4.0,2.0,1.0,1.0,1.0,1.0,2.0,0.0,0.0,74.0
Khargone,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1598.0,2445.0,3052.0,2744.0,2573.0,3489.0,2148.0,2627.0,2944.0,2836.0,3009.0,2937.0,32402.0
Khargone,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,1.0,1.0,0.0,6.0
Khargone,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1965.0,2886.0,3797.0,3366.0,3561.0,4665.0,2752.0,3807.0,3786.0,3473.0,3795.0,3893.0,41746.0
Khargone,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,65.0,6.0,11.0,8.0,5.0,6.0,2.0,5.0,3.0,5.0,1.0,0.0,117.0
Khargone,15.2,Number of Widal tests conducted,Number tested,577.0,810.0,1054.0,883.0,1099.0,1133.0,1009.0,1245.0,1651.0,714.0,710.0,1099.0,11984.0
Khargone,15.3.a,Number of VDRL tests conducted on males,Number tested,57.0,9.0,52.0,175.0,24.0,191.0,28.0,52.0,137.0,7.0,55.0,38.0,825.0
Khargone,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,23.0,6.0,27.0,21.0,48.0,34.0,9.0,38.0,263.0,47.0,58.0,53.0,627.0
Khargone,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,999.0,1564.0,2143.0,2122.0,1515.0,2196.0,1460.0,1377.0,1875.0,1450.0,1999.0,1367.0,20067.0
Khargone,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1079.0,1579.0,2222.0,2318.0,1587.0,2421.0,1497.0,1467.0,2275.0,1504.0,2112.0,1458.0,21519.0
Khargone,15.4.1,Number of blood smears examined for Malaria,TOTAL,17486.0,18663.0,20024.0,20050.0,22188.0,28555.0,25794.0,22311.0,18605.0,11989.0,18831.0,19671.0,244167.0
Khargone,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,65.0,89.0,143.0,144.0,148.0,234.0,174.0,176.0,102.0,50.0,22.0,34.0,1381.0
Khargone,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,23.0,10.0,7.0,9.0,39.0,157.0,152.0,258.0,196.0,74.0,24.0,34.0,983.0
Khargone,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,4500.0,,,,,,,2500.0,,,,,7000.0
Khargone,16.1.1,Stock position of DPT vaccines,2. Stocks Received,20000.0,,,,,,,20000.0,,,,,40000.0
Khargone,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,17500.0,,,,,17500.0
Khargone,16.1.1,Stock position of DPT vaccines,5. Total Stock,24500.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,29500.0
Khargone,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,0.0,,,,,0.0
Khargone,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,29500.0,,,,,29500.0
Khargone,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,15500.0,,,,,15500.0
Khargone,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14000.0,0.0,0.0,0.0,0.0,14000.0
Khargone,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,8000.0,,,,,,,500.0,,,,,8500.0
Khargone,16.1.2,Stock position of OPV vaccines,2. Stocks Received,20000.0,,,,,,,20000.0,,,,,40000.0
Khargone,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,25000.0,,,,,25000.0
Khargone,16.1.2,Stock position of OPV vaccines,5. Total Stock,28000.0,0.0,0.0,0.0,0.0,0.0,0.0,-4500.0,0.0,0.0,0.0,0.0,23500.0
Khargone,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,45000.0,,,,,,,1500.0,,,,,46500.0
Khargone,16.1.3,Stock position of TT vaccines,2. Stocks Received,15000.0,,,,,,,15000.0,,,,,30000.0
Khargone,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,15000.0,,,,,15000.0
Khargone,16.1.3,Stock position of TT vaccines,5. Total Stock,60000.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0,0.0,0.0,0.0,0.0,61500.0
Khargone,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khargone,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Khargone,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khargone,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1500.0,,,,,,,500.0,,,,,2000.0
Khargone,16.1.5,Stock position of BCG vaccines,2. Stocks Received,15000.0,,,,,,,5000.0,,,,,20000.0
Khargone,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,0.0,,,,,0.0
Khargone,16.1.5,Stock position of BCG vaccines,5. Total Stock,16500.0,0.0,0.0,0.0,0.0,0.0,0.0,5500.0,0.0,0.0,0.0,0.0,22000.0
Khargone,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2500.0,,,,,,,7000.0,,,,,9500.0
Khargone,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,,,,,,,0.0,,,,,10000.0
Khargone,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,1000.0,,,,,1000.0
Khargone,16.1.6,Stock position of Measles vaccines,5. Total Stock,12500.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,0.0,0.0,0.0,0.0,18500.0
Khargone,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khargone,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Khargone,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khargone,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,500.0,,,,,,,2500.0,,,,,3000.0
Khargone,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,20000.0,,,,,,,20000.0,,,,,40000.0
Khargone,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,16500.0,,,,,16500.0
Khargone,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,20500.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,0.0,0.0,0.0,0.0,26500.0
Khargone,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khargone,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khargone,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khargone,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khargone,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khargone,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khargone,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khargone,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khargone,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khargone,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khargone,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khargone,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khargone,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,1600.0,10800.0,,10000.0,4600.0,,4300.0,,,,31300.0
Khargone,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,9400.0,,,,,,,,,,9400.0
Khargone,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,200.0,100.0,,5400.0,,,2300.0,,,,8000.0
Khargone,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,10800.0,10700.0,0.0,4600.0,4600.0,0.0,2000.0,0.0,0.0,0.0,32700.0
Khargone,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,12570.0,8970.0,,1870.0,70.0,,9697.0,,,,33177.0
Khargone,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,9600.0,,,,,,9600.0
Khargone,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,3629.0,,,,3629.0
Khargone,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,3600.0,3300.0,,1800.0,6263.0,,,,,,14963.0
Khargone,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,8970.0,5670.0,0.0,70.0,3407.0,0.0,6068.0,0.0,0.0,0.0,24185.0
Khargone,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,250.0,100.0,,,,,,,,,350.0
Khargone,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,15000.0,,,,15000.0
Khargone,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,1325.0,,,,1325.0
Khargone,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,150.0,,,,,,,,,,150.0
Khargone,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,100.0,100.0,0.0,0.0,0.0,0.0,13675.0,0.0,0.0,0.0,13875.0
Khargone,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Khargone,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Khargone,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Khargone,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,28300.0,24700.0,,13300.0,7000.0,,48900.0,,,,122200.0
Khargone,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Khargone,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,6700.0,,,,6700.0
Khargone,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,3600.0,3600.0,,6300.0,6500.0,,,,,,20000.0
Khargone,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,24700.0,21100.0,0.0,7000.0,500.0,0.0,42200.0,0.0,0.0,0.0,95500.0
Khargone,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,500.0,500.0,,450.0,450.0,,,,,,1900.0
Khargone,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Khargone,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,50.0,,,,,,,,,50.0
Khargone,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,500.0,450.0,0.0,450.0,450.0,0.0,0.0,0.0,0.0,0.0,1850.0
Khargone,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Khargone,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Khargone,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Khargone,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,686000.0,596000.0,,237000.0,782000.0,,134300.0,,,,2435300.0
Khargone,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,720000.0,,,5000000.0,,,,5720000.0
Khargone,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,1485500.0,,,,1485500.0
Khargone,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,90000.0,208000.0,,175000.0,432500.0,,,,,,905500.0
Khargone,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,596000.0,388000.0,0.0,782000.0,349500.0,0.0,3648800.0,0.0,0.0,0.0,5764300.0
Khargone,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,760.0,400.0,,400.0,20000.0,,19100.0,,,,40660.0
Khargone,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Khargone,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,400.0,,,,400.0
Khargone,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,360.0,,,400.0,,,,,,,760.0
Khargone,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,400.0,400.0,0.0,0.0,20000.0,0.0,18700.0,0.0,0.0,0.0,39500.0
Khargone,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,5990.0,3110.0,,,,,,,,,9100.0
Khargone,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Khargone,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,2880.0,3110.0,,,,,,,,,5990.0
Khargone,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,3110.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3110.0
Khargone,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,680.0,2171.0,,1671.0,1471.0,,1446.0,,,,7439.0
Khargone,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,2891.0,,,,,,5000.0,,,,7891.0
Khargone,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,1275.0,,,,1275.0
Khargone,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,1400.0,300.0,,200.0,25.0,,,,,,1925.0
Khargone,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,2171.0,1871.0,0.0,1471.0,1446.0,0.0,5171.0,0.0,0.0,0.0,12130.0
Khargone,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,9651.0,8651.0,,8150.0,151.0,,269951.0,,,,296554.0
Khargone,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,30000.0,,,,,,30000.0
Khargone,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,6401.0,,,,6401.0
Khargone,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,1000.0,501.0,,7999.0,21000.0,,,,,,30500.0
Khargone,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,8651.0,8150.0,0.0,151.0,9151.0,0.0,263550.0,0.0,0.0,0.0,289653.0
Khargone,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Khargone,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Khargone,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Khargone,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Khargone,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Khargone,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Khargone,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Khargone,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khargone,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,24350.0,,,253000.0,199100.0,,83500.0,,,,559950.0
Khargone,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,300000.0,,,,,,,,,300000.0
Khargone,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,44560.0,,,,44560.0
Khargone,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,24350.0,5000.0,,53900.0,75100.0,,,,,,158350.0
Khargone,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,295000.0,0.0,199100.0,124000.0,0.0,38940.0,0.0,0.0,0.0,657040.0
Khargone,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,1.0,,2.0,,3.0,,,1.0,2.0,3.0,1.0,15.0
Khargone,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,2.0,,,,,,2.0
Khargone,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Khargone,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,2.0,,,,,,2.0
Khargone,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,2.0,1.0,,,2.0,1.0,,1.0,,,,7.0
Khargone,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Khargone,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,2.0,1.0,,,2.0,1.0,,1.0,,,,7.0
Khargone,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,5.0,9.0,13.0,3.0,5.0,16.0,11.0,6.0,17.0,11.0,11.0,4.0,111.0
Khargone,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,1.0,,2.0,,1.0,3.0,,,,7.0
Khargone,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,5.0,9.0,13.0,4.0,5.0,18.0,11.0,7.0,20.0,11.0,11.0,4.0,118.0
Khargone,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,10.0,17.0,7.0,7.0,15.0,26.0,11.0,18.0,8.0,6.0,9.0,136.0
Khargone,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,1.0,,1.0,5.0,3.0,1.0,1.0,12.0
Khargone,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,10.0,17.0,7.0,7.0,16.0,26.0,12.0,23.0,11.0,7.0,10.0,148.0
Khargone,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,,3.0,5.0,2.0,4.0,3.0,3.0,1.0,1.0,23.0
Khargone,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,2.0,,,5.0,,,3.0,,,,10.0
Khargone,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,3.0,,3.0,10.0,2.0,4.0,6.0,3.0,1.0,1.0,33.0
Khargone,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Khargone,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Khargone,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Khargone,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,1.0,,,,,,,,,,2.0
Khargone,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,3.0,,,,,,1.0,,,,,4.0
Khargone,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,4.0,1.0,,,,,1.0,,,,,6.0
Khargone,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Khargone,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Khargone,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Khargone,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,2.0,5.0,3.0,2.0,6.0,5.0,6.0,15.0,10.0,5.0,6.0,68.0
Khargone,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,2.0,4.0,,2.0,5.0,4.0,3.0,11.0,,1.0,4.0,37.0
Khargone,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,4.0,4.0,9.0,3.0,4.0,11.0,9.0,9.0,26.0,10.0,6.0,10.0,105.0
Khargone,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Khargone,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,1.0,1.0,1.0,1.0,,,,,4.0
Khargone,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,1.0,,,,,,1.0,1.0,1.0,,4.0
Khargone,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,1.0,,1.0,1.0,2.0,1.0,1.0,1.0,1.0,,9.0
Khargone,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Khargone,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,2.0,,2.0,1.0,6.0,,1.0,5.0,2.0,3.0,2.0,24.0
Khargone,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,2.0,1.0,,2.0,,2.0,2.0,,,,10.0
Khargone,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,3.0,2.0,3.0,1.0,8.0,,3.0,7.0,2.0,4.0,2.0,35.0
Khargone,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,1.0,1.0,,,,,,,,2.0
Khargone,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,2.0,1.0,6.0,1.0,3.0,,13.0
Khargone,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,4.0,3.0,,9.0,6.0,4.0,8.0,5.0,2.0,3.0,44.0
Khargone,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,4.0,4.0,1.0,9.0,8.0,5.0,14.0,6.0,5.0,3.0,59.0
Khargone,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Khargone,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,1.0,,,,,1.0,1.0,,,,,3.0
Khargone,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Khargone,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,1.0,,,,,1.0,1.0,1.0,1.0,,,5.0
Khargone,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,,,,3.0,2.0,,1.0,1.0,,1.0,9.0
Khargone,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,1.0,,1.0,3.0,4.0,1.0,1.0,2.0,4.0,4.0,22.0
Khargone,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,,1.0,,3.0,3.0,1.0,3.0,2.0,2.0,1.0,17.0
Khargone,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,2.0,1.0,1.0,1.0,9.0,9.0,2.0,5.0,5.0,6.0,6.0,48.0
Khargone,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Khargone,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Khargone,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Khargone,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Khargone,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,1.0,,2.0,1.0,1.0,,,5.0
Khargone,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,2.0,2.0,7.0,5.0,9.0,16.0,5.0,8.0,12.0,12.0,10.0,9.0,97.0
Khargone,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,9.0,6.0,8.0,3.0,3.0,16.0,20.0,9.0,22.0,13.0,10.0,14.0,133.0
Khargone,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,11.0,8.0,15.0,8.0,12.0,33.0,25.0,19.0,35.0,26.0,20.0,23.0,235.0
Khargone,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,1.0,,1.0,,1.0,,,1.0,1.0,,,5.0
Khargone,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,1.0,3.0,4.0,1.0,2.0,,4.0,2.0,2.0,2.0,21.0
Khargone,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,1.0,1.0,3.0,2.0,1.0,3.0,1.0,1.0,1.0,,1.0,16.0
Khargone,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,2.0,2.0,7.0,6.0,3.0,5.0,1.0,6.0,4.0,2.0,3.0,42.0
Khargone,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Khargone,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Khargone,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Khargone,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Khargone,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Khargone,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Khargone,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Khargone,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Khargone,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Khargone,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,,,,2.0,,,,,1.0,,4.0
Khargone,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Khargone,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,,,,2.0,,,,,1.0,,4.0
Khargone,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Khargone,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,2.0,1.0,,1.0,,,,,4.0
Khargone,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Khargone,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,2.0,1.0,,1.0,,,,,4.0
Khargone,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Khargone,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Khargone,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Khargone,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Khargone,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Khargone,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,,1.0,,5.0,2.0,1.0,3.0,1.0,2.0,4.0,20.0
Khargone,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Khargone,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,,1.0,,5.0,2.0,1.0,3.0,1.0,2.0,4.0,20.0
Khargone,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,1.0,1.0,2.0,4.0,1.0,6.0,1.0,5.0,,4.0,5.0,31.0
Khargone,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,8.0,14.0,18.0,15.0,9.0,31.0,20.0,23.0,16.0,22.0,16.0,21.0,213.0
Khargone,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,4.0,2.0,3.0,4.0,4.0,5.0,3.0,3.0,3.0,3.0,7.0,42.0
Khargone,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,10.0,19.0,21.0,20.0,17.0,36.0,31.0,27.0,24.0,25.0,23.0,33.0,286.0
Khargone,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,1.0,1.0,1.0,,2.0,,,,1.0,6.0
Khargone,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,3.0,12.0,8.0,11.0,15.0,31.0,17.0,20.0,20.0,12.0,6.0,21.0,176.0
Khargone,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,,1.0,,2.0,,1.0,1.0,,1.0,,7.0
Khargone,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,3.0,13.0,8.0,13.0,16.0,34.0,17.0,23.0,21.0,12.0,7.0,22.0,189.0
Khargone,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,1.0,2.0,1.0,2.0,1.0,,,,,,7.0
Khargone,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,,,1.0,1.0,4.0,3.0,2.0,,1.0,,,13.0
Khargone,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,2.0,,1.0,1.0,,,,,,4.0
Khargone,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,,1.0,5.0,2.0,7.0,5.0,2.0,,1.0,,,24.0
Khargone,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,1.0,1.0,,,1.0,1.0,1.0,1.0,1.0,7.0
Khargone,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,4.0,5.0,7.0,9.0,22.0,3.0,7.0,12.0,8.0,8.0,9.0,96.0
Khargone,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,2.0,2.0,8.0,7.0,5.0,5.0,9.0,6.0,10.0,3.0,5.0,63.0
Khargone,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,6.0,7.0,16.0,17.0,27.0,8.0,17.0,19.0,19.0,12.0,15.0,166.0
Khargone,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,2.0,,,2.0,1.0,1.0,,,,,6.0
Khargone,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,4.0,6.0,11.0,11.0,12.0,13.0,15.0,13.0,14.0,14.0,13.0,8.0,134.0
Khargone,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,5.0,16.0,24.0,16.0,39.0,42.0,32.0,39.0,26.0,23.0,24.0,31.0,317.0
Khargone,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,9.0,22.0,37.0,27.0,51.0,57.0,48.0,53.0,40.0,37.0,37.0,39.0,457.0
Khargone,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,3.0,9.0,4.0,4.0,,6.0,2.0,4.0,4.0,1.0,1.0,2.0,40.0
Khargone,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,27.0,25.0,40.0,25.0,19.0,30.0,37.0,38.0,23.0,39.0,30.0,49.0,382.0
Khargone,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,75.0,106.0,114.0,66.0,66.0,116.0,123.0,110.0,109.0,129.0,97.0,94.0,1205.0
Khargone,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,105.0,140.0,158.0,95.0,85.0,152.0,162.0,152.0,136.0,169.0,128.0,145.0,1627.0
Mandla,1.1,Total number of pregnant women Registered for ANC,TOTAL,1323.0,1490.0,2187.0,2290.0,1567.0,1767.0,1482.0,1540.0,1697.0,2028.0,1688.0,2021.0,21080.0
Mandla,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1102.0,1199.0,1681.0,1756.0,1273.0,1476.0,1217.0,1270.0,1525.0,1732.0,1464.0,1664.0,17359.0
Mandla,1.2,Number of Pregnant women registered under JSY,TOTAL,1200.0,1410.0,2111.0,2203.0,1530.0,1736.0,1452.0,1520.0,1668.0,1958.0,1576.0,1966.0,20330.0
Mandla,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1226.0,1384.0,1739.0,1757.0,1413.0,1526.0,1360.0,1490.0,1628.0,1791.0,1574.0,1741.0,18629.0
Mandla,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,728.0,818.0,1104.0,1185.0,937.0,1089.0,906.0,895.0,914.0,1113.0,961.0,1146.0,11796.0
Mandla,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1033.0,1225.0,1644.0,1813.0,1292.0,1393.0,1237.0,1373.0,1404.0,1680.0,1537.0,1649.0,17280.0
Mandla,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1322.0,1486.0,2180.0,2288.0,1573.0,1787.0,1521.0,1565.0,1764.0,2145.0,1706.0,2025.0,21362.0
Mandla,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,42.0,64.0,95.0,58.0,36.0,28.0,38.0,8.0,78.0,54.0,29.0,79.0,609.0
Mandla,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,5.0,4.0,3.0,8.0,3.0,3.0,2.0,0.0,3.0,2.0,3.0,2.0,38.0
Mandla,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,564.0,674.0,797.0,806.0,591.0,571.0,534.0,677.0,905.0,908.0,847.0,701.0,8575.0
Mandla,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,9.0,32.0,7.0,5.0,6.0,11.0,18.0,3.0,5.0,9.0,13.0,6.0,124.0
Mandla,1.8,Number of pregnancy test kits used at SC level,TOTAL,408.0,479.0,1037.0,859.0,840.0,925.0,907.0,1200.0,1258.0,1813.0,1558.0,1796.0,13080.0
Mandla,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,147.0,285.0,198.0,198.0,251.0,211.0,217.0,181.0,194.0,222.0,173.0,209.0,2486.0
Mandla,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,147.0,285.0,198.0,198.0,251.0,211.0,217.0,181.0,194.0,222.0,173.0,209.0,2486.0
Mandla,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,123.0,265.0,155.0,147.0,196.0,184.0,191.0,167.0,181.0,206.0,164.0,166.0,2145.0
Mandla,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,2.0,1.0,0.0,8.0,12.0,4.0,23.0,24.0,74.0
Mandla,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1048.0,1128.0,1207.0,1350.0,1382.0,1247.0,1216.0,1063.0,1048.0,929.0,946.0,1095.0,13659.0
Mandla,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,98.0,144.0,47.0,30.0,24.0,13.0,40.0,11.0,16.0,21.0,42.0,105.0,591.0
Mandla,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,762.0,920.0,1049.0,1103.0,1133.0,1075.0,1004.0,897.0,1029.0,920.0,739.0,1008.0,11639.0
Mandla,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,796.0,674.0,735.0,656.0,946.0,1102.0,1003.0,783.0,959.0,649.0,850.0,941.0,10094.0
Mandla,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,86.0,71.0,93.0,84.0,76.0,76.0,73.0,65.0,58.0,70.0,67.0,80.0,899.0
Mandla,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,11.0,9.0,14.0,4.0,6.0,11.0,4.0,59.0
Mandla,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,16.0,7.0,24.0,22.0,13.0,14.0,9.0,21.0,29.0,12.0,14.0,16.0,197.0
Mandla,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandla,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,16.0,7.0,24.0,22.0,13.0,25.0,18.0,35.0,33.0,18.0,25.0,20.0,256.0
Mandla,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,59.0,37.0,52.0,40.0,35.0,33.0,40.0,28.0,36.0,39.0,47.0,55.0,501.0
Mandla,4.1.1.a,Number of male live births,TOTAL,650.0,721.0,759.0,830.0,865.0,748.0,754.0,654.0,637.0,632.0,599.0,706.0,8555.0
Mandla,4.1.1.b,Number of female live births,TOTAL,606.0,733.0,713.0,761.0,818.0,743.0,729.0,631.0,635.0,568.0,560.0,668.0,8165.0
Mandla,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1256.0,1454.0,1472.0,1591.0,1683.0,1491.0,1483.0,1285.0,1272.0,1200.0,1159.0,1374.0,16720.0
Mandla,4.1.2,Number of still births,TOTAL,28.0,30.0,22.0,42.0,28.0,33.0,27.0,31.0,30.0,30.0,32.0,26.0,359.0
Mandla,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,29.0,30.0,42.0,50.0,31.0,41.0,42.0,52.0,56.0,56.0,72.0,51.0,552.0
Mandla,4.2.1,Number of Newborns weighed at birth,TOTAL,1248.0,1408.0,1447.0,1579.0,1663.0,1469.0,1468.0,1241.0,1210.0,1110.0,1135.0,1341.0,16319.0
Mandla,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,233.0,173.0,173.0,370.0,155.0,125.0,357.0,156.0,119.0,101.0,184.0,144.0,2290.0
Mandla,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1253.0,1417.0,1460.0,1578.0,1666.0,1469.0,1463.0,1256.0,1242.0,1181.0,904.0,1362.0,16251.0
Mandla,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,3.0,11.0,4.0,6.0,8.0,2.0,4.0,15.0,13.0,3.0,29.0,15.0,113.0
Mandla,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,8.0,11.0,11.0,20.0,22.0,35.0,39.0,61.0,49.0,56.0,54.0,8.0,374.0
Mandla,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,96.0,146.0,24.0,22.0,43.0,35.0,152.0,33.0,65.0,30.0,19.0,36.0,701.0
Mandla,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandla,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,107.0,168.0,39.0,48.0,73.0,72.0,195.0,109.0,127.0,89.0,102.0,59.0,1188.0
Mandla,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,51.0,18.0,40.0,23.0,28.0,22.0,33.0,25.0,38.0,46.0,53.0,55.0,432.0
Mandla,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,161.0,76.0,67.0,66.0,81.0,86.0,71.0,91.0,129.0,92.0,113.0,52.0,1085.0
Mandla,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,16.0,9.0,27.0,3.0,3.0,9.0,10.0,12.0,29.0,30.0,36.0,38.0,222.0
Mandla,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,41.0,9.0,103.0,49.0,135.0,33.0,30.0,68.0,172.0,67.0,331.0,124.0,1162.0
Mandla,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,30.0,54.0,49.0,9.0,51.0,22.0,10.0,15.0,8.0,10.0,9.0,9.0,276.0
Mandla,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1103.0,1225.0,1309.0,1362.0,1513.0,1185.0,1317.0,1071.0,1081.0,1027.0,783.0,970.0,13946.0
Mandla,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,434.0,536.0,476.0,558.0,539.0,432.0,400.0,450.0,362.0,321.0,317.0,447.0,5272.0
Mandla,6.3,PNC maternal complications attended,TOTAL,17.0,7.0,24.0,22.0,0.0,0.0,0.0,1.0,0.0,1.0,3.0,0.0,75.0
Mandla,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,21.0,16.0,19.0,23.0,14.0,1.0,15.0,17.0,13.0,25.0,21.0,2.0,187.0
Mandla,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,21.0,16.0,19.0,23.0,14.0,1.0,15.0,17.0,13.0,25.0,21.0,2.0,187.0
Mandla,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,24.0,2.0,11.0,18.0,14.0,19.0,19.0,18.0,42.0,41.0,22.0,35.0,265.0
Mandla,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,43.0,25.0,19.0,69.0,50.0,65.0,76.0,92.0,123.0,126.0,111.0,88.0,887.0
Mandla,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,67.0,27.0,30.0,87.0,64.0,84.0,95.0,110.0,165.0,167.0,133.0,123.0,1152.0
Mandla,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23.0,0.0,23.0
Mandla,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,3.0
Mandla,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,1.0,1.0,1.0,4.0,12.0,1.0,8.0,7.0,6.0,31.0,10.0,83.0
Mandla,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandla,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,1.0,1.0,1.0,4.0,12.0,1.0,11.0,7.0,6.0,31.0,10.0,86.0
Mandla,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,,0.0,,0.0,,0.0,0.0,0.0,,0.0
Mandla,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,1.0,80.0,66.0,330.0,212.0,1215.0,1141.0,729.0,567.0,146.0,4487.0
Mandla,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,12.0,10.0,1.0,0.0,2.0,3.0,1.0,41.0,135.0,159.0,103.0,6.0,473.0
Mandla,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandla,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,12.0,10.0,2.0,80.0,68.0,333.0,213.0,1256.0,1276.0,888.0,670.0,152.0,4960.0
Mandla,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,,,,0.0,,0.0,0.0,0.0,,0.0
Mandla,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,1.0,9.0,0.0,2.0,11.0,2.0,,0.0,25.0
Mandla,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandla,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,1.0,9.0,0.0,2.0,11.0,2.0,0.0,0.0,25.0
Mandla,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,,,,0.0,,6.0,4.0,0.0,,10.0
Mandla,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,21.0,36.0,21.0,0.0,22.0,28.0,18.0,2.0,4.0,6.0,3.0,6.0,167.0
Mandla,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,2.0,4.0,3.0,0.0,3.0,1.0,1.0,14.0,0.0,4.0,27.0,6.0,65.0
Mandla,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandla,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,23.0,40.0,24.0,0.0,25.0,29.0,19.0,16.0,4.0,10.0,30.0,12.0,232.0
Mandla,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,1.0,5.0,1.0,2.0,,1.0,1.0,,0.0,0.0,0.0,,11.0
Mandla,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,31.0,53.0,51.0,40.0,124.0,87.0,78.0,138.0,86.0,61.0,33.0,19.0,801.0
Mandla,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,4.0,11.0,16.0,10.0,31.0,19.0,3.0,4.0,8.0,6.0,28.0,21.0,161.0
Mandla,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,62.0,18.0,36.0,57.0,70.0,70.0,60.0,68.0,47.0,52.0,62.0,68.0,670.0
Mandla,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,157.0,155.0,171.0,197.0,172.0,229.0,192.0,203.0,,14.0,,158.0,1648.0
Mandla,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandla,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,254.0,237.0,274.0,304.0,397.0,405.0,333.0,413.0,141.0,133.0,123.0,266.0,3280.0
Mandla,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,158.0,150.0,144.0,182.0,172.0,257.0,217.0,248.0,65.0,79.0,80.0,257.0,2009.0
Mandla,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,,,3.0,0.0,,0.0,0.0,0.0,,3.0
Mandla,9.06,Number of IUCD removals,TOTAL,90.0,22.0,130.0,17.0,37.0,26.0,47.0,128.0,122.0,65.0,86.0,163.0,933.0
Mandla,9.07,Number of Oral Pills cycles distributed,TOTAL,2142.0,2347.0,3011.0,2519.0,2655.0,3358.0,3639.0,3738.0,4148.0,3795.0,3671.0,3756.0,38779.0
Mandla,9.08,Number of Condom pieces distributed,TOTAL,4494.0,6085.0,7161.0,11248.0,9908.0,10510.0,9182.0,9883.0,10883.0,12131.0,13014.0,13005.0,117504.0
Mandla,9.09,Number of Centchroman (weekly) pills given,TOTAL,4.0,0.0,34.0,7.0,12.0,3.0,0.0,0.0,0.0,5.0,0.0,0.0,65.0
Mandla,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,2.0,26.0,8.0,27.0,31.0,11.0,53.0,92.0,95.0,113.0,80.0,122.0,660.0
Mandla,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,6.0
Mandla,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,23.0,14.0,0.0,0.0,0.0,0.0,37.0
Mandla,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,9.12,Number of Institutions having NSV trained doctors,TOTAL,14.0,6.0,8.0,6.0,5.0,9.0,8.0,10.0,2.0,9.0,11.0,4.0,-1.0
Mandla,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1054.0,1421.0,1527.0,1708.0,1803.0,1708.0,1515.0,1342.0,1294.0,1261.0,1171.0,1413.0,17217.0
Mandla,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,927.0,1130.0,1418.0,1468.0,1464.0,1729.0,1725.0,675.0,155.0,113.0,36.0,50.0,10890.0
Mandla,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1030.0,1105.0,1220.0,1453.0,1322.0,1513.0,1592.0,1750.0,791.0,296.0,87.0,48.0,12207.0
Mandla,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1185.0,1222.0,1274.0,1296.0,1384.0,1360.0,1398.0,1670.0,1687.0,875.0,223.0,140.0,13714.0
Mandla,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,892.0,1351.0,1313.0,1236.0,1432.0,6224.0
Mandla,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,806.0,1208.0,1304.0,1413.0,4731.0
Mandla,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,710.0,1202.0,1540.0,3459.0
Mandla,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,822.0,989.0,1011.0,1169.0,1330.0,1233.0,1079.0,997.0,979.0,848.0,757.0,1045.0,12259.0
Mandla,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,795.0,1133.0,1307.0,1410.0,1543.0,1734.0,1688.0,1251.0,1235.0,1236.0,1321.0,1355.0,16008.0
Mandla,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,881.0,1105.0,1226.0,1300.0,1396.0,1569.0,1596.0,1727.0,1297.0,1295.0,1414.0,1532.0,16338.0
Mandla,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1055.0,1182.0,1216.0,1211.0,1370.0,1398.0,1449.0,1688.0,1478.0,1365.0,1493.0,1700.0,16605.0
Mandla,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,561.0,875.0,892.0,1043.0,866.0,1177.0,1086.0,949.0,818.0,815.0,542.0,725.0,10349.0
Mandla,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,882.0,1039.0,1347.0,1487.0,1440.0,1701.0,1603.0,662.0,181.0,130.0,73.0,76.0,10621.0
Mandla,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1000.0,1057.0,1156.0,1417.0,1324.0,1514.0,1561.0,1724.0,838.0,309.0,114.0,69.0,12083.0
Mandla,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1139.0,1158.0,1190.0,1317.0,1365.0,1316.0,1417.0,1669.0,1703.0,856.0,307.0,178.0,13615.0
Mandla,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,777.0,994.0,1713.0,2112.0,1483.0,1753.0,1449.0,1276.0,1387.0,1274.0,1348.0,1777.0,17343.0
Mandla,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,167.0,68.0,370.0,551.0,847.0,1440.0,1797.0,1430.0,1695.0,1441.0,1308.0,1453.0,12567.0
Mandla,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,16.0,0.0,0.0,0.0,18.0
Mandla,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,315.0,467.0,787.0,999.0,759.0,912.0,712.0,600.0,620.0,567.0,649.0,835.0,8222.0
Mandla,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,293.0,451.0,751.0,928.0,734.0,893.0,671.0,604.0,622.0,558.0,580.0,757.0,7842.0
Mandla,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,608.0,918.0,1538.0,1927.0,1493.0,1805.0,1383.0,1204.0,1242.0,1125.0,1229.0,1592.0,16064.0
Mandla,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,909.0,1113.0,1366.0,1511.0,1276.0,1334.0,1463.0,1350.0,1700.0,1783.0,1559.0,1734.0,17098.0
Mandla,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,789.0,1030.0,1217.0,1476.0,1314.0,1331.0,1432.0,1357.0,1583.0,1760.0,1591.0,1769.0,16649.0
Mandla,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,116.0,137.0,192.0,264.0,276.0,438.0,319.0,361.0,213.0,286.0,275.0,297.0,3174.0
Mandla,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,102.0,131.0,160.0,212.0,269.0,397.0,303.0,327.0,252.0,312.0,228.0,312.0,3005.0
Mandla,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,218.0,268.0,352.0,476.0,545.0,835.0,622.0,688.0,465.0,598.0,503.0,609.0,6179.0
Mandla,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,453.0,578.0,855.0,1338.0,1240.0,1490.0,1227.0,1133.0,1267.0,1075.0,1042.0,1118.0,12816.0
Mandla,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,505.0,594.0,908.0,1647.0,2075.0,2817.0,2213.0,2428.0,2176.0,1717.0,1434.0,1347.0,19861.0
Mandla,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,496.0,640.0,965.0,1676.0,1999.0,2566.0,1703.0,2312.0,1973.0,1660.0,1661.0,1336.0,18987.0
Mandla,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,3.0,1.0,0.0,3.0,0.0,0.0,8.0
Mandla,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1199.0,1288.0,1343.0,1309.0,1285.0,1307.0,1197.0,1306.0,1331.0,1366.0,1429.0,1431.0,15791.0
Mandla,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1153.0,1267.0,1316.0,1307.0,1285.0,1302.0,1296.0,1282.0,1326.0,1362.0,1419.0,1441.0,15756.0
Mandla,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1035.0,1162.0,1212.0,1215.0,1224.0,1237.0,1218.0,1170.0,1221.0,1277.0,1297.0,1280.0,14548.0
Mandla,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,665.0,866.0,1488.0,2531.0,1950.0,1705.0,1333.0,1255.0,1286.0,1725.0,1419.0,1738.0,17961.0
Mandla,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,112.0,138.0,277.0,9161.0,3832.0,475.0,296.0,188.0,769.0,8958.0,4357.0,470.0,29033.0
Mandla,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,29.0,137.0,237.0,8430.0,3847.0,211.0,238.0,80.0,455.0,8907.0,2560.0,158.0,25289.0
Mandla,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,3.0,0.0,18.0,0.0,0.0,0.0,3.0,2.0,0.0,0.0,26.0
Mandla,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,302.0,498.0,358.0,582.0,631.0,355.0,280.0,256.0,303.0,279.0,271.0,572.0,4687.0
Mandla,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,46.0,55.0,4.0,32.0,109.0,37.0,29.0,140.0,69.0,46.0,8.0,23.0,598.0
Mandla,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,2.0,4.0,1.0,1.0,5.0,5.0,9.0,3.0,5.0,0.0,0.0,1.0,36.0
Mandla,13.1,Number of Patients operated for cataract,TOTAL,18.0,3.0,75.0,61.0,79.0,91.0,241.0,136.0,311.0,324.0,124.0,374.0,1837.0
Mandla,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,4.0,2.0,74.0,452.0,72.0,84.0,234.0,34.0,281.0,324.0,345.0,374.0,2280.0
Mandla,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,781.0,388.0,263.0,1118.0,723.0,178.0,27.0,56.0,5.0,3539.0
Mandla,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,263.0,1259.0,1156.0,416.0,224.0,51.0,0.0,3369.0
Mandla,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,5.0,2.0,3.0,3.0,1.0,5.0,4.0,5.0,5.0,3.0,3.0,-1.0
Mandla,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,4.0,4.0,2.0,2.0,1.0,3.0,7.0,6.0,13.0,11.0,12.0,-1.0
Mandla,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1021.0,1050.0,1131.0,1103.0,1161.0,1241.0,1186.0,1178.0,1174.0,1200.0,1222.0,1113.0,-1.0
Mandla,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,8.0,6.0,6.0,8.0,6.0,6.0,8.0,6.0,7.0,7.0,7.0,-1.0
Mandla,14.05,Number of RKS meetings held during the month,TOTAL,4.0,6.0,5.0,7.0,7.0,8.0,7.0,8.0,8.0,6.0,5.0,8.0,79.0
Mandla,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,18.0,14.0,12.0,12.0,17.0,18.0,20.0,19.0,19.0,24.0,21.0,20.0,-1.0
Mandla,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,101.0,130.0,126.0,100.0,120.0,135.0,101.0,126.0,65.0,103.0,66.0,241.0,1414.0
Mandla,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,5.0,3.0,3.0,5.0,2.0,5.0,3.0,4.0,6.0,4.0,3.0,-1.0
Mandla,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Mandla,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,441.0,471.0,409.0,302.0,1279.0,295.0,256.0,262.0,132.0,248.0,1983.0,315.0,6393.0
Mandla,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1617.0,1876.0,1517.0,1546.0,1466.0,9605.0,1950.0,1236.0,330.0,838.0,4430.0,1257.0,27668.0
Mandla,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,513.0,552.0,466.0,300.0,1620.0,280.0,321.0,435.0,150.0,263.0,1918.0,340.0,7158.0
Mandla,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2078.0,3030.0,2465.0,2868.0,2358.0,10309.0,2732.0,1903.0,640.0,1561.0,6072.0,2122.0,38138.0
Mandla,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,954.0,1023.0,875.0,602.0,2899.0,575.0,577.0,697.0,282.0,511.0,3901.0,655.0,13551.0
Mandla,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3695.0,4906.0,3982.0,4414.0,3824.0,19914.0,4682.0,3139.0,970.0,2399.0,10502.0,3379.0,65806.0
Mandla,14.10.2.a,Number of death cases of Inpatient males,TOTAL,24.0,14.0,26.0,26.0,32.0,4.0,24.0,19.0,9.0,6.0,42.0,60.0,286.0
Mandla,14.10.2.b,Number of death cases of Inpatient females,TOTAL,13.0,6.0,14.0,20.0,18.0,8.0,16.0,19.0,4.0,4.0,17.0,16.0,155.0
Mandla,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,37.0,20.0,40.0,46.0,50.0,12.0,40.0,38.0,13.0,10.0,59.0,76.0,441.0
Mandla,14.11,In-Patient Head Count at midnight,TOTAL,1362.0,3735.0,3252.0,3618.0,3656.0,3620.0,2472.0,2464.0,1921.0,1500.0,1971.0,2461.0,32032.0
Mandla,14.12.1,OPD attendance (All),TOTAL,49106.0,54313.0,60367.0,62723.0,69166.0,92395.0,65351.0,59471.0,39778.0,47959.0,57849.0,53679.0,712157.0
Mandla,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,101.0,76.0,87.0,93.0,87.0,95.0,60.0,55.0,0.0,2349.0,146.0,72.0,3221.0
Mandla,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,307.0,325.0,397.0,361.0,248.0,388.0,264.0,334.0,195.0,323.0,286.0,293.0,3721.0
Mandla,14.14.a,Number of patients given AYUSH treatment,TOTAL,1688.0,2356.0,1984.0,2534.0,1881.0,2648.0,2985.0,2299.0,2242.0,1821.0,2174.0,2735.0,27347.0
Mandla,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,381.0,329.0,351.0,314.0,256.0,351.0,73.0,70.0,50.0,96.0,56.0,92.0,2419.0
Mandla,14.14.c,Number of Adolescents counselled,TOTAL,15.0,75.0,100.0,148.0,163.0,241.0,177.0,176.0,22.0,211.0,295.0,230.0,1853.0
Mandla,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4368.0,5557.0,6654.0,7130.0,6195.0,6253.0,5982.0,5960.0,5403.0,4941.0,8091.0,4785.0,71319.0
Mandla,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,74.0,34.0,195.0,273.0,212.0,294.0,105.0,210.0,196.0,87.0,196.0,162.0,2038.0
Mandla,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,90.0,92.0,145.0,147.0,152.0,213.0,250.0,269.0,170.0,140.0,95.0,57.0,1820.0
Mandla,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,1.0,1.0,2.0,9.0,0.0,0.0,0.0,1.0,1.0,0.0,7.0,22.0
Mandla,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,147.0,67.0,279.0,79.0,128.0,268.0,216.0,163.0,247.0,149.0,208.0,18.0,1969.0
Mandla,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,1.0,0.0,0.0,2.0,0.0,0.0,1.0,0.0,1.0,1.0,25.0,33.0
Mandla,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,544.0,555.0,695.0,974.0,957.0,1180.0,967.0,1118.0,1115.0,759.0,645.0,482.0,9991.0
Mandla,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,27.0,29.0
Mandla,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,781.0,714.0,1119.0,1200.0,1237.0,1661.0,1433.0,1550.0,1532.0,1048.0,948.0,557.0,13780.0
Mandla,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,3.0,1.0,2.0,12.0,0.0,0.0,1.0,1.0,2.0,1.0,59.0,84.0
Mandla,15.2,Number of Widal tests conducted,Number tested,514.0,1231.0,1179.0,1604.0,1219.0,1955.0,1610.0,1356.0,580.0,615.0,528.0,1054.0,13445.0
Mandla,15.3.a,Number of VDRL tests conducted on males,Number tested,83.0,259.0,278.0,392.0,332.0,340.0,85.0,355.0,117.0,87.0,73.0,237.0,2638.0
Mandla,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,94.0,186.0,155.0,65.0,16.0,80.0,231.0,64.0,101.0,102.0,74.0,36.0,1204.0
Mandla,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,188.0,109.0,299.0,313.0,256.0,415.0,345.0,547.0,687.0,522.0,325.0,272.0,4278.0
Mandla,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,365.0,554.0,732.0,770.0,604.0,835.0,661.0,966.0,905.0,711.0,472.0,545.0,8120.0
Mandla,15.4.1,Number of blood smears examined for Malaria,TOTAL,12706.0,13631.0,17861.0,20452.0,21236.0,31520.0,27573.0,19705.0,14646.0,9716.0,13520.0,12302.0,214868.0
Mandla,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,12.0,18.0,48.0,46.0,51.0,60.0,89.0,154.0,48.0,16.0,33.0,7.0,582.0
Mandla,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,25.0,16.0,26.0,119.0,145.0,165.0,493.0,1143.0,370.0,34.0,24.0,11.0,2571.0
Mandla,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,585.0,1910.0,1435.0,1285.0,2380.0,3905.0,3005.0,2180.0,1710.0,2063.0,2560.0,2960.0,25978.0
Mandla,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,1000.0,0.0,2000.0,2000.0,0.0,0.0,0.0,1000.0,1000.0,1000.0,0.0,10000.0
Mandla,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,525.0,1475.0,150.0,905.0,475.0,900.0,825.0,587.0,637.0,503.0,600.0,650.0,8232.0
Mandla,16.1.1,Stock position of DPT vaccines,5. Total Stock,2060.0,1435.0,1285.0,2380.0,3905.0,3005.0,2180.0,1593.0,2073.0,2560.0,2960.0,2310.0,27746.0
Mandla,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,100.0,7.0,315.0,65.0,587.0
Mandla,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,950.0,0.0,0.0,1000.0,500.0,1400.0,3850.0
Mandla,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,850.0,85.0,93.0,692.0,750.0,810.0,3280.0
Mandla,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,100.0,15.0,7.0,315.0,65.0,655.0,1157.0
Mandla,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,0.0,175.0,525.0,310.0,390.0,800.0,285.0,25.0,5.0,106.0,195.0,380.0,3196.0
Mandla,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1000.0,600.0,700.0,1200.0,900.0,400.0,500.0,300.0,400.0,800.0,800.0,1100.0,8700.0
Mandla,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,825.0,250.0,915.0,1120.0,490.0,915.0,760.0,279.0,299.0,711.0,615.0,1074.0,8253.0
Mandla,16.1.2,Stock position of OPV vaccines,5. Total Stock,175.0,525.0,310.0,390.0,800.0,285.0,25.0,46.0,106.0,195.0,380.0,406.0,3643.0
Mandla,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,590.0,1440.0,1965.0,1390.0,2465.0,2345.0,1020.0,820.0,170.0,135.0,435.0,290.0,13065.0
Mandla,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000.0,1000.0,700.0,2000.0,1000.0,0.0,1000.0,0.0,500.0,1000.0,1000.0,1000.0,11200.0
Mandla,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1150.0,475.0,1275.0,925.0,1120.0,1325.0,1200.0,812.0,535.0,700.0,1145.0,1035.0,11697.0
Mandla,16.1.3,Stock position of TT vaccines,5. Total Stock,1440.0,1965.0,1390.0,2465.0,2345.0,1020.0,820.0,8.0,135.0,435.0,290.0,255.0,12568.0
Mandla,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,0.0,275.0,995.0,445.0,1285.0,1585.0,860.0,665.0,390.0,230.0,265.0,495.0,7490.0
Mandla,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000.0,1000.0,800.0,1500.0,900.0,0.0,600.0,0.0,500.0,800.0,1000.0,500.0,8600.0
Mandla,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,725.0,280.0,1350.0,660.0,600.0,725.0,795.0,541.0,660.0,765.0,770.0,905.0,8776.0
Mandla,16.1.5,Stock position of BCG vaccines,5. Total Stock,275.0,995.0,445.0,1285.0,1585.0,860.0,665.0,124.0,230.0,265.0,495.0,90.0,7314.0
Mandla,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0.0,1350.0,1860.0,585.0,1320.0,1505.0,420.0,505.0,455.0,130.0,20.0,13.0,8163.0
Mandla,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2000.0,1000.0,500.0,2000.0,1000.0,0.0,1000.0,1000.0,500.0,1000.0,1000.0,1500.0,12500.0
Mandla,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,650.0,490.0,1779.0,1265.0,815.0,1085.0,915.0,1050.0,825.0,1110.0,1007.0,1288.0,12279.0
Mandla,16.1.6,Stock position of Measles vaccines,5. Total Stock,1350.0,1860.0,581.0,1320.0,1505.0,420.0,505.0,455.0,130.0,20.0,13.0,225.0,8384.0
Mandla,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,205.0,1180.0,630.0,1155.0,855.0,1170.0,370.0,485.0,75.0,20.0,530.0,620.0,7295.0
Mandla,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,2000.0,1000.0,800.0,600.0,1000.0,0.0,1000.0,0.0,500.0,1000.0,500.0,500.0,8900.0
Mandla,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,850.0,1550.0,275.0,900.0,685.0,800.0,885.0,410.0,555.0,490.0,410.0,613.0,8423.0
Mandla,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1355.0,630.0,1155.0,855.0,1170.0,370.0,485.0,75.0,20.0,530.0,620.0,507.0,7772.0
Mandla,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,8250.0,11000.0,8000.0,7350.0,3850.0,1850.0,8600.0,8600.0,8300.0,9300.0,11000.0,,86100.0
Mandla,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,3600.0,0.0,0.0,1600.0,0.0,6850.0,0.0,0.0,3000.0,2000.0,2000.0,,19050.0
Mandla,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,850.0,3000.0,650.0,5100.0,2000.0,100.0,0.0,300.0,2000.0,300.0,1150.0,,15450.0
Mandla,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,11000.0,8000.0,7350.0,3850.0,1850.0,8600.0,8600.0,8300.0,9300.0,11000.0,11850.0,0.0,89700.0
Mandla,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,74970.0,69930.0,4410.0,4410.0,4410.0,139650.0,118450.0,117270.0,102150.0,77150.0,32150.0,,744950.0
Mandla,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,141120.0,30240.0,0.0,0.0,0.0,0.0,0.0,,171360.0
Mandla,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,5040.0,65520.0,0.0,0.0,5880.0,51440.0,1180.0,15120.0,25000.0,45000.0,7650.0,,221830.0
Mandla,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,69930.0,4410.0,4410.0,4410.0,139650.0,118450.0,117270.0,102150.0,77150.0,32150.0,24500.0,0.0,694480.0
Mandla,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,400.0,400.0,400.0,400.0,16100.0,12400.0,8700.0,8700.0,8700.0,18100.0,17700.0,,92000.0
Mandla,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,24000.0,1200.0,6000.0,0.0,0.0,10000.0,0.0,0.0,,41200.0
Mandla,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,8300.0,4900.0,9700.0,0.0,0.0,600.0,400.0,700.0,,24600.0
Mandla,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,400.0,400.0,400.0,16100.0,12400.0,8700.0,8700.0,8700.0,18100.0,17700.0,17000.0,0.0,108600.0
Mandla,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2100.0,3000.0,3000.0,3000.0,2400.0,1500.0,1300.0,1000.0,800.0,5800.0,5200.0,,29100.0
Mandla,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,900.0,0.0,0.0,2400.0,600.0,0.0,0.0,0.0,5000.0,0.0,0.0,,8900.0
Mandla,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,3000.0,1500.0,200.0,300.0,200.0,0.0,600.0,610.0,,6410.0
Mandla,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,3000.0,3000.0,3000.0,2400.0,1500.0,1300.0,1000.0,800.0,5800.0,5200.0,4590.0,0.0,31590.0
Mandla,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,6600.0,9800.0,9800.0,9800.0,7800.0,12465.0,11965.0,16965.0,21965.0,21465.0,21165.0,,149790.0
Mandla,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,3200.0,0.0,0.0,0.0,5165.0,0.0,5000.0,5000.0,0.0,0.0,0.0,,18365.0
Mandla,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,2000.0,500.0,500.0,0.0,0.0,500.0,300.0,65.0,,3865.0
Mandla,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,9800.0,9800.0,9800.0,7800.0,12465.0,11965.0,16965.0,21965.0,21465.0,21165.0,21100.0,0.0,164290.0
Mandla,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,3000.0,3500.0,3000.0,1500.0,900.0,900.0,900.0,900.0,900.0,900.0,2000.0,,18400.0
Mandla,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2000.0
Mandla,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,1500.0,500.0,1500.0,600.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,,5100.0
Mandla,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,3500.0,3000.0,1500.0,900.0,900.0,900.0,900.0,900.0,900.0,900.0,1000.0,0.0,15300.0
Mandla,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,8500.0,5000.0,2000.0,1500.0,500.0,0.0,0.0,0.0,0.0,0.0,47500.0,,65000.0
Mandla,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.02,Stock Position of Gloves,4. Stock Distributed,3500.0,3000.0,500.0,1000.0,,,0.0,0.0,,0.0,5000.0,,13000.0
Mandla,16.3.02,Stock Position of Gloves,5. Total Stock,5000.0,2000.0,1500.0,500.0,500.0,0.0,0.0,0.0,0.0,0.0,42500.0,0.0,52000.0
Mandla,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,3400.0,1900.0,1400.0,1000.0,700.0,700.0,700.0,700.0,700.0,700.0,0.0,,11900.0
Mandla,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,1500.0,500.0,400.0,300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2700.0
Mandla,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,1900.0,1400.0,1000.0,700.0,700.0,700.0,700.0,700.0,700.0,700.0,0.0,0.0,9200.0
Mandla,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,594500.0,200000.0,130000.0,90000.0,60000.0,60000.0,60000.0,60000.0,60000.0,60000.0,1225000.0,,2599500.0
Mandla,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,394500.0,70000.0,40000.0,30000.0,0.0,0.0,0.0,0.0,0.0,0.0,900000.0,,1434500.0
Mandla,16.3.07,Stock Position of IFA Tablets,5. Total Stock,200000.0,130000.0,90000.0,60000.0,60000.0,60000.0,60000.0,60000.0,60000.0,60000.0,325000.0,0.0,1165000.0
Mandla,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,1416.0,1416.0,1000.0,500.0,500.0,500.0,500.0,500.0,500.0,500.0,17500.0,,24832.0
Mandla,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,416.0,500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,,5916.0
Mandla,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,1416.0,1000.0,500.0,500.0,500.0,500.0,500.0,500.0,500.0,500.0,12500.0,0.0,18916.0
Mandla,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,30490.0,29640.0,23640.0,18640.0,12640.0,12640.0,12640.0,12640.0,12640.0,12640.0,6440.0,,184690.0
Mandla,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,850.0,6000.0,5000.0,6000.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0,,19350.0
Mandla,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,29640.0,23640.0,18640.0,12640.0,12640.0,12640.0,12640.0,12640.0,12640.0,12640.0,4940.0,0.0,165340.0
Mandla,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,190.0,140.0,100.0,60.0,60.0,60.0,60.0,60.0,60.0,60.0,40.0,,890.0
Mandla,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,50.0,40.0,40.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,40.0,,170.0
Mandla,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,140.0,100.0,60.0,60.0,60.0,60.0,60.0,60.0,60.0,60.0,0.0,0.0,720.0
Mandla,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,457720.0,332720.0,287720.0,222720.0,172720.0,172720.0,172720.0,172720.0,172720.0,172720.0,112720.0,,2449920.0
Mandla,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Mandla,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,125000.0,45000.0,65000.0,50000.0,0.0,0.0,0.0,0.0,0.0,0.0,15000.0,,300000.0
Mandla,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,332720.0,287720.0,222720.0,172720.0,172720.0,172720.0,172720.0,172720.0,172720.0,172720.0,97720.0,0.0,2149920.0
Mandla,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,11600.0,8200.0,4200.0,2200.0,16000.0,11600.0,6800.0,5700.0,4200.0,3100.0,1300.0,1300.0,76200.0
Mandla,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,19800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3300.0,23100.0
Mandla,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3400.0,4000.0,2000.0,6000.0,4400.0,4800.0,1100.0,1500.0,1100.0,1800.0,700.0,4600.0,35400.0
Mandla,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,8200.0,4200.0,2200.0,16000.0,11600.0,6800.0,5700.0,4200.0,3100.0,1300.0,600.0,0.0,63900.0
Mandla,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,336000.0,306000.0,306000.0,223000.0,207000.0,289000.0,209000.0,159000.0,88000.0,88000.0,84000.0,84000.0,2379000.0
Mandla,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,80000.0,50000.0,158000.0,0.0,0.0,0.0,0.0,0.0,0.0,80000.0,368000.0
Mandla,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,30000.0,0.0,163000.0,66000.0,76000.0,80000.0,50000.0,71000.0,0.0,4000.0,0.0,55740.0,595740.0
Mandla,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,306000.0,306000.0,223000.0,207000.0,289000.0,209000.0,159000.0,88000.0,88000.0,84000.0,84000.0,108260.0,2151260.0
Mandla,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2900.0,1400.0,1400.0,400.0,15200.0,11200.0,7000.0,6400.0,8900.0,12700.0,10500.0,8900.0,86900.0
Mandla,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,20000.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,30000.0
Mandla,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandla,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1500.0,0.0,1000.0,5200.0,4000.0,4200.0,600.0,2500.0,6200.0,2200.0,1600.0,2500.0,31500.0
Mandla,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1400.0,1400.0,400.0,15200.0,11200.0,7000.0,6400.0,3900.0,12700.0,10500.0,8900.0,6400.0,85400.0
Mandla,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,1.0,,,,,1.0,1.0,,3.0
Mandla,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Mandla,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mandla,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Mandla,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,1.0,,,1.0
Mandla,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mandla,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,1.0,,,1.0
Mandla,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,2.0,1.0,1.0,1.0,4.0,,,,,2.0,2.0,14.0
Mandla,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mandla,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,2.0,1.0,1.0,1.0,4.0,,,,,2.0,2.0,14.0
Mandla,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,1.0,,3.0,4.0,1.0,2.0,2.0,2.0,,2.0,2.0,19.0
Mandla,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mandla,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,1.0,,3.0,4.0,1.0,2.0,2.0,2.0,,2.0,2.0,19.0
Mandla,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,2.0,3.0,,1.0,2.0,1.0,9.0
Mandla,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,1.0,,1.0,,,2.0
Mandla,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,2.0,4.0,,2.0,2.0,1.0,11.0
Mandla,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,2.0,,2.0
Mandla,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mandla,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,2.0,,2.0
Mandla,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Mandla,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,1.0,,,,,2.0,,,,,3.0
Mandla,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,,,,1.0,2.0,,,,,4.0
Mandla,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mandla,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mandla,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Mandla,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,2.0,,1.0,,3.0,1.0,1.0,2.0,1.0,2.0,14.0
Mandla,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,1.0,3.0,,4.0,,1.0,5.0,,2.0,1.0,,18.0
Mandla,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,2.0,5.0,,5.0,,4.0,6.0,1.0,4.0,2.0,2.0,32.0
Mandla,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Mandla,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Mandla,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,1.0,,,,1.0,,,2.0
Mandla,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,1.0,1.0,,,1.0,,,3.0
Mandla,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Mandla,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,2.0,1.0,2.0,2.0,,,,1.0,,1.0,10.0
Mandla,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Mandla,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,2.0,1.0,2.0,2.0,,,,1.0,,1.0,10.0
Mandla,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Mandla,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,,,,,,1.0,1.0,,,,3.0
Mandla,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,1.0,,,1.0,,1.0,,2.0,,3.0,4.0,12.0
Mandla,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,2.0,,,1.0,,1.0,1.0,3.0,,3.0,4.0,15.0
Mandla,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Mandla,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Mandla,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Mandla,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Mandla,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Mandla,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,1.0,1.0,,1.0,5.0,,,8.0
Mandla,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,1.0,,,,1.0,3.0,,2.0,,,8.0
Mandla,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,1.0,,,1.0,2.0,3.0,1.0,7.0,,,16.0
Mandla,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Mandla,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Mandla,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Mandla,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Mandla,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Mandla,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,,2.0,3.0,3.0,2.0,1.0,2.0,,2.0,,3.0,21.0
Mandla,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,2.0,6.0,3.0,3.0,2.0,3.0,1.0,,1.0,,,22.0
Mandla,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,4.0,2.0,9.0,6.0,6.0,4.0,4.0,3.0,,3.0,,3.0,44.0
Mandla,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Mandla,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,2.0,1.0,,3.0,1.0,,1.0,8.0
Mandla,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,4.0,1.0,3.0,1.0,3.0,2.0,11.0,8.0,6.0,40.0
Mandla,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,,4.0,1.0,5.0,2.0,3.0,5.0,12.0,8.0,7.0,48.0
Mandla,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Mandla,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Mandla,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Mandla,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Mandla,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Mandla,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Mandla,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Mandla,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,1.0,,,,,,,1.0
Mandla,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Mandla,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Mandla,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Mandla,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,1.0,,,,,,,,1.0
Mandla,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Mandla,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Mandla,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Mandla,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Mandla,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Mandla,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Mandla,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Mandla,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Mandla,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Mandla,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,1.0,,,,,1.0,,1.0,,3.0
Mandla,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Mandla,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,1.0,,,,,1.0,,1.0,,3.0
Mandla,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Mandla,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,3.0,4.0,2.0,2.0,4.0,1.0,,2.0,4.0,5.0,3.0,32.0
Mandla,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,1.0,2.0,,2.0,,5.0
Mandla,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,3.0,4.0,3.0,2.0,4.0,1.0,1.0,4.0,4.0,7.0,3.0,38.0
Mandla,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Mandla,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,3.0,2.0,4.0,1.0,,1.0,,,,,3.0,15.0
Mandla,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,2.0,1.0,2.0,1.0,,3.0,,9.0
Mandla,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,3.0,2.0,4.0,1.0,2.0,2.0,2.0,1.0,,3.0,3.0,24.0
Mandla,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Mandla,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,4.0,1.0,2.0,1.0,1.0,,2.0,,,11.0
Mandla,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,1.0,,,,1.0,,,,,2.0
Mandla,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,5.0,1.0,2.0,1.0,3.0,,2.0,,,14.0
Mandla,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Mandla,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,1.0,2.0,4.0,,1.0,,,2.0,2.0,,13.0
Mandla,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,1.0,1.0,4.0,3.0,2.0,1.0,,,,1.0,13.0
Mandla,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,1.0,2.0,3.0,8.0,3.0,3.0,1.0,,2.0,2.0,1.0,26.0
Mandla,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,2.0,1.0,,1.0,,1.0,,,5.0
Mandla,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,6.0,8.0,7.0,7.0,8.0,3.0,13.0,4.0,8.0,4.0,5.0,7.0,80.0
Mandla,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,5.0,16.0,17.0,20.0,12.0,16.0,9.0,8.0,8.0,5.0,11.0,15.0,142.0
Mandla,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,11.0,24.0,24.0,27.0,22.0,20.0,22.0,13.0,16.0,10.0,16.0,22.0,227.0
Mandla,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,1.0,,1.0,1.0,1.0,1.0,5.0
Mandla,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,3.0,1.0,2.0,2.0,3.0,4.0,3.0,7.0,4.0,5.0,10.0,45.0
Mandla,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,13.0,5.0,11.0,9.0,24.0,23.0,31.0,16.0,24.0,21.0,22.0,20.0,219.0
Mandla,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,14.0,8.0,12.0,11.0,26.0,26.0,36.0,19.0,32.0,26.0,28.0,31.0,269.0
Mandsaur,1.1,Total number of pregnant women Registered for ANC,TOTAL,1775.0,2227.0,2637.0,2796.0,2127.0,2598.0,1798.0,2309.0,2369.0,2085.0,2479.0,3012.0,28212.0
Mandsaur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1071.0,1415.0,1637.0,1850.0,1398.0,1676.0,1293.0,1498.0,1639.0,1605.0,1747.0,2070.0,18899.0
Mandsaur,1.2,Number of Pregnant women registered under JSY,TOTAL,1775.0,2222.0,2634.0,2796.0,2127.0,2598.0,1791.0,2295.0,2369.0,2085.0,2479.0,3000.0,28171.0
Mandsaur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1393.0,1682.0,2031.0,2066.0,1854.0,1986.0,1793.0,1890.0,1966.0,1907.0,1984.0,2524.0,23076.0
Mandsaur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1684.0,2098.0,2502.0,2640.0,2003.0,2478.0,1708.0,2219.0,2284.0,2004.0,2406.0,2936.0,26962.0
Mandsaur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1448.0,1743.0,2190.0,2296.0,2027.0,2078.0,1932.0,1992.0,1991.0,2028.0,2148.0,2762.0,24635.0
Mandsaur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1764.0,2244.0,2633.0,2795.0,2147.0,2571.0,1791.0,2373.0,2415.0,2085.0,2519.0,3061.0,28398.0
Mandsaur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,95.0,158.0,62.0,109.0,125.0,70.0,89.0,55.0,9.0,10.0,14.0,56.0,852.0
Mandsaur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,5.0,5.0,5.0,3.0,5.0,2.0,2.0,2.0,0.0,8.0,4.0,3.0,44.0
Mandsaur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,796.0,1109.0,1383.0,1367.0,1160.0,1308.0,1061.0,1135.0,1415.0,1244.0,1512.0,1458.0,14948.0
Mandsaur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,47.0,22.0,38.0,31.0,18.0,31.0,18.0,23.0,16.0,16.0,16.0,22.0,298.0
Mandsaur,1.8,Number of pregnancy test kits used at SC level,TOTAL,412.0,357.0,483.0,551.0,370.0,435.0,362.0,390.0,646.0,646.0,682.0,825.0,6159.0
Mandsaur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Mandsaur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,30.0,34.0,56.0,65.0,58.0,76.0,51.0,73.0,54.0,42.0,58.0,54.0,651.0
Mandsaur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,33.0,34.0,56.0,65.0,58.0,76.0,51.0,73.0,54.0,42.0,58.0,54.0,654.0
Mandsaur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,20.0,24.0,35.0,57.0,38.0,55.0,34.0,55.0,44.0,32.0,40.0,41.0,475.0
Mandsaur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,3.0,0.0,0.0,4.0,3.0,5.0,1.0,6.0,5.0,2.0,2.0,4.0,35.0
Mandsaur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1079.0,1474.0,1893.0,1852.0,1812.0,2099.0,1880.0,1972.0,1765.0,1706.0,1903.0,2315.0,21750.0
Mandsaur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,301.0,397.0,13.0,53.0,1.0,29.0,6.0,147.0,149.0,126.0,123.0,80.0,1425.0
Mandsaur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1079.0,1474.0,1889.0,1852.0,1809.0,2099.0,1880.0,1972.0,1765.0,1876.0,1903.0,2332.0,21930.0
Mandsaur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,743.0,1032.0,1271.0,1294.0,1327.0,1507.0,1335.0,1460.0,1282.0,1282.0,1230.0,1360.0,15123.0
Mandsaur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,87.0,75.0,71.0,88.0,77.0,101.0,84.0,73.0,80.0,76.0,812.0
Mandsaur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,0.0,0.0,0.0,,,,,,,,0.0
Mandsaur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,0.0,0.0,0.0,,,,,,,,0.0
Mandsaur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,0.0,0.0,0.0,,,,,,,,0.0
Mandsaur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,106.0,155.0,185.0,213.0,185.0,176.0,187.0,170.0,142.0,159.0,205.0,208.0,2091.0
Mandsaur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandsaur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,106.0,155.0,185.0,213.0,185.0,176.0,187.0,170.0,142.0,159.0,205.0,208.0,2091.0
Mandsaur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,52.0,42.0,42.0,61.0,50.0,62.0,58.0,44.0,49.0,49.0,509.0
Mandsaur,4.1.1.a,Number of male live births,TOTAL,562.0,793.0,1091.0,1023.0,999.0,1165.0,1024.0,1095.0,948.0,1028.0,1038.0,1254.0,12020.0
Mandsaur,4.1.1.b,Number of female live births,TOTAL,526.0,681.0,912.0,946.0,898.0,1061.0,952.0,1011.0,916.0,937.0,962.0,1165.0,10967.0
Mandsaur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1088.0,1474.0,2003.0,1969.0,1897.0,2226.0,1976.0,2106.0,1864.0,1965.0,2000.0,2419.0,22987.0
Mandsaur,4.1.2,Number of still births,TOTAL,28.0,39.0,43.0,33.0,53.0,44.0,43.0,49.0,50.0,45.0,51.0,51.0,529.0
Mandsaur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,11.0,16.0,26.0,21.0,22.0,10.0,20.0,9.0,8.0,13.0,10.0,18.0,184.0
Mandsaur,4.2.1,Number of Newborns weighed at birth,TOTAL,1090.0,1464.0,1997.0,1947.0,1879.0,2203.0,1956.0,2061.0,1861.0,1944.0,1975.0,2404.0,22781.0
Mandsaur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,179.0,284.0,281.0,304.0,328.0,399.0,364.0,329.0,453.0,362.0,369.0,637.0,4289.0
Mandsaur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1068.0,1447.0,1886.0,1957.0,1879.0,2211.0,1950.0,1962.0,1759.0,1867.0,1879.0,2320.0,22185.0
Mandsaur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,27.0,0.0,0.0,0.0,36.0
Mandsaur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,22.0,33.0,36.0,44.0,46.0,18.0,35.0,29.0,39.0,12.0,20.0,0.0,334.0
Mandsaur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,106.0,147.0,191.0,214.0,180.0,170.0,192.0,202.0,157.0,169.0,216.0,215.0,2159.0
Mandsaur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandsaur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,129.0,181.0,228.0,260.0,227.0,189.0,228.0,232.0,223.0,181.0,236.0,215.0,2529.0
Mandsaur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,0.0,,,,,,,,,,0.0
Mandsaur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,111.0,155.0,180.0,224.0,187.0,180.0,73.0,197.0,192.0,179.0,216.0,211.0,2105.0
Mandsaur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,23.0,43.0,29.0,25.0,25.0,26.0,14.0,16.0,15.0,15.0,7.0,6.0,244.0
Mandsaur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,111.0,158.0,208.0,225.0,204.0,160.0,71.0,198.0,179.0,183.0,146.0,197.0,2040.0
Mandsaur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,126.0,177.0,164.0,175.0,424.0,153.0,98.0,151.0,147.0,167.0,157.0,175.0,2114.0
Mandsaur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1091.0,1443.0,1715.0,1867.0,1637.0,1980.0,1909.0,1883.0,1689.0,1792.0,1891.0,2332.0,21229.0
Mandsaur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,926.0,1192.0,1460.0,1476.0,1423.0,1817.0,1081.0,1257.0,1665.0,1533.0,1663.0,1758.0,17251.0
Mandsaur,6.3,PNC maternal complications attended,TOTAL,1.0,3.0,2.0,4.0,1.0,6.0,8.0,12.0,2.0,1.0,12.0,4.0,56.0
Mandsaur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,25.0,42.0,47.0,37.0,39.0,43.0,23.0,29.0,27.0,26.0,49.0,81.0,468.0
Mandsaur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1.0,0.0,0.0,3.0
Mandsaur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,25.0,42.0,47.0,37.0,39.0,43.0,25.0,29.0,27.0,27.0,49.0,81.0,471.0
Mandsaur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,13.0,4.0,13.0,7.0,0.0,6.0,22.0,19.0,84.0
Mandsaur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,76.0,78.0,92.0,81.0,80.0,99.0,94.0,78.0,85.0,71.0,82.0,94.0,1010.0
Mandsaur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,416.0,443.0,527.0,688.0,702.0,569.0,718.0,630.0,630.0,640.0,655.0,867.0,7485.0
Mandsaur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,492.0,521.0,619.0,769.0,782.0,668.0,812.0,708.0,715.0,711.0,737.0,961.0,8495.0
Mandsaur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18.0,18.0
Mandsaur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,5.0,1.0,0.0,3.0,3.0,0.0,0.0,2.0,1.0,0.0,4.0,20.0
Mandsaur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,0.0,1.0,2.0,0.0,3.0,0.0,0.0,9.0,2.0,2.0,5.0,25.0
Mandsaur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,1.0,4.0,1.0,3.0,0.0,2.0,4.0,3.0,8.0,6.0,33.0
Mandsaur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandsaur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,6.0,3.0,6.0,4.0,9.0,0.0,2.0,15.0,6.0,10.0,15.0,78.0
Mandsaur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mandsaur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,36.0,48.0,77.0,27.0,48.0,0.0,41.0,70.0,67.0,35.0,32.0,481.0
Mandsaur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,10.0,0.0,21.0,7.0,0.0,0.0,12.0,40.0,0.0,90.0
Mandsaur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,2.0,2.0,2.0,44.0,21.0,0.0,0.0,84.0,47.0,11.0,36.0,13.0,262.0
Mandsaur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandsaur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,2.0,38.0,50.0,131.0,48.0,69.0,7.0,125.0,117.0,90.0,111.0,45.0,833.0
Mandsaur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mandsaur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,28.0,38.0,13.0,27.0,14.0,30.0,11.0,19.0,59.0,45.0,77.0,19.0,380.0
Mandsaur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,62.0,38.0,28.0,76.0,106.0,154.0,59.0,192.0,306.0,204.0,223.0,115.0,1563.0
Mandsaur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,221.0,76.0,109.0,165.0,94.0,177.0,39.0,133.0,182.0,180.0,258.0,105.0,1739.0
Mandsaur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandsaur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,311.0,152.0,150.0,268.0,214.0,361.0,109.0,344.0,547.0,429.0,558.0,239.0,3682.0
Mandsaur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mandsaur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,6.0,21.0,13.0,22.0,11.0,18.0,2.0,5.0,16.0,15.0,16.0,11.0,156.0
Mandsaur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,9.0,12.0,23.0,34.0,34.0,44.0,11.0,37.0,27.0,39.0,56.0,45.0,371.0
Mandsaur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,177.0,73.0,145.0,195.0,132.0,144.0,121.0,8.0,127.0,116.0,106.0,169.0,1513.0
Mandsaur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandsaur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,192.0,106.0,181.0,251.0,177.0,206.0,134.0,50.0,170.0,170.0,178.0,225.0,2040.0
Mandsaur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mandsaur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,211.0,268.0,365.0,346.0,361.0,356.0,355.0,334.0,344.0,307.0,295.0,358.0,3900.0
Mandsaur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,25.0,87.0,102.0,31.0,30.0,26.0,26.0,46.0,41.0,30.0,25.0,43.0,512.0
Mandsaur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,11.0,8.0,11.0,13.0,12.0,22.0,104.0,73.0,34.0,73.0,22.0,32.0,415.0
Mandsaur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,147.0,176.0,139.0,134.0,75.0,100.0,75.0,52.0,18.0,22.0,29.0,219.0,1186.0
Mandsaur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandsaur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,394.0,539.0,617.0,524.0,478.0,504.0,560.0,505.0,437.0,432.0,371.0,652.0,6013.0
Mandsaur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,35.0,117.0,109.0,85.0,66.0,79.0,173.0,101.0,34.0,175.0,287.0,111.0,1372.0
Mandsaur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mandsaur,9.06,Number of IUCD removals,TOTAL,134.0,196.0,168.0,182.0,176.0,268.0,179.0,314.0,189.0,243.0,196.0,253.0,2498.0
Mandsaur,9.07,Number of Oral Pills cycles distributed,TOTAL,5278.0,5519.0,6449.0,6887.0,8324.0,7603.0,7771.0,8186.0,7828.0,7905.0,8189.0,9352.0,89291.0
Mandsaur,9.08,Number of Condom pieces distributed,TOTAL,37976.0,34819.0,47511.0,51660.0,46204.0,48052.0,54983.0,45485.0,45811.0,47515.0,44324.0,40413.0,544753.0
Mandsaur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,138.0,68.0,51.0,41.0,31.0,75.0,35.0,93.0,180.0,108.0,96.0,173.0,1089.0
Mandsaur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Mandsaur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,0.0,3.0,7.0
Mandsaur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,9.12,Number of Institutions having NSV trained doctors,TOTAL,12.0,12.0,12.0,12.0,12.0,12.0,12.0,13.0,17.0,18.0,13.0,12.0,-1.0
Mandsaur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1127.0,1484.0,1927.0,1838.0,1815.0,2091.0,1860.0,2001.0,1759.0,1873.0,1907.0,2368.0,22050.0
Mandsaur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1274.0,1627.0,1866.0,1975.0,2005.0,2110.0,1851.0,925.0,51.0,29.0,2.0,0.0,13715.0
Mandsaur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1239.0,1631.0,1909.0,1964.0,1763.0,2056.0,1802.0,1982.0,790.0,206.0,55.0,14.0,15411.0
Mandsaur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1327.0,1651.0,1970.0,2063.0,1850.0,1938.0,1846.0,1989.0,1967.0,808.0,183.0,97.0,17689.0
Mandsaur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1483.0,1844.0,1862.0,1904.0,2500.0,9593.0
Mandsaur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1373.0,1685.0,1909.0,2406.0,7373.0
Mandsaur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,1194.0,1755.0,2379.0,5334.0
Mandsaur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1101.0,1472.0,1911.0,1816.0,2042.0,2078.0,1847.0,1969.0,1752.0,1879.0,1878.0,2343.0,22088.0
Mandsaur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1271.0,1637.0,1864.0,1975.0,1951.0,2110.0,1846.0,2143.0,1890.0,1891.0,1905.0,2504.0,22987.0
Mandsaur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1239.0,1631.0,1911.0,1974.0,1778.0,2056.0,1795.0,1993.0,2159.0,1879.0,1960.0,2422.0,22797.0
Mandsaur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1334.0,1651.0,1971.0,2063.0,1639.0,1938.0,1832.0,1999.0,1971.0,1965.0,1934.0,2468.0,22765.0
Mandsaur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1038.0,1412.0,1825.0,1760.0,1748.0,2026.0,1816.0,1882.0,1691.0,1783.0,1810.0,1550.0,20341.0
Mandsaur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1267.0,1625.0,1857.0,1963.0,2005.0,2110.0,1847.0,935.0,75.0,46.0,2.0,0.0,13732.0
Mandsaur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1238.0,1625.0,1911.0,1977.0,1763.0,2056.0,1791.0,1981.0,830.0,298.0,55.0,14.0,15539.0
Mandsaur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1334.0,1654.0,1972.0,2052.0,1853.0,1938.0,1850.0,1998.0,1960.0,797.0,188.0,96.0,17692.0
Mandsaur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1204.0,1677.0,2151.0,2318.0,1922.0,2133.0,1661.0,1926.0,1867.0,1808.0,1783.0,2454.0,22904.0
Mandsaur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,691.0,911.0,953.0,1262.0,1011.0,1023.0,892.0,1340.0,1642.0,1543.0,1702.0,1650.0,14620.0
Mandsaur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,585.0,838.0,2016.0,1132.0,997.0,1058.0,845.0,961.0,991.0,922.0,943.0,1300.0,12588.0
Mandsaur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,523.0,738.0,1694.0,1017.0,887.0,966.0,736.0,887.0,876.0,807.0,834.0,1145.0,11110.0
Mandsaur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1108.0,1576.0,3710.0,2149.0,1884.0,2024.0,1581.0,1848.0,1867.0,1729.0,1777.0,2445.0,23698.0
Mandsaur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1033.0,1332.0,1691.0,2065.0,1556.0,1642.0,1297.0,1588.0,1659.0,1934.0,1779.0,2238.0,19814.0
Mandsaur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1033.0,1331.0,1691.0,2052.0,1554.0,1644.0,1279.0,1537.0,1660.0,1939.0,1779.0,2237.0,19736.0
Mandsaur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,112.0,186.0,915.0,264.0,168.0,223.0,197.0,273.0,434.0,374.0,388.0,485.0,4019.0
Mandsaur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,99.0,159.0,819.0,237.0,139.0,199.0,166.0,233.0,375.0,321.0,353.0,375.0,3475.0
Mandsaur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,211.0,345.0,1734.0,501.0,307.0,422.0,363.0,506.0,809.0,695.0,741.0,860.0,7494.0
Mandsaur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,611.0,950.0,1274.0,2232.0,2025.0,2289.0,1674.0,1786.0,1897.0,2444.0,1836.0,2310.0,21328.0
Mandsaur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,775.0,1168.0,1553.0,2377.0,2269.0,2780.0,2367.0,2651.0,2710.0,2474.0,1847.0,2208.0,25179.0
Mandsaur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,634.0,1192.0,1370.0,2556.0,2095.0,2666.0,2308.0,2701.0,2663.0,2616.0,1899.0,2229.0,24929.0
Mandsaur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,3.0
Mandsaur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1036.0,1174.0,1249.0,1249.0,1247.0,1219.0,1197.0,1209.0,1242.0,1214.0,1259.0,1408.0,14703.0
Mandsaur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,972.0,1156.0,1238.0,1238.0,1239.0,1216.0,1184.0,1202.0,1241.0,1199.0,1257.0,1409.0,14551.0
Mandsaur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,843.0,971.0,1057.0,1039.0,1036.0,1044.0,1019.0,1039.0,1096.0,1027.0,1080.0,1172.0,12423.0
Mandsaur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1200.0,1684.0,2151.0,2328.0,1922.0,2133.0,1661.0,1925.0,1867.0,1923.0,1757.0,2498.0,23049.0
Mandsaur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,411.0,657.0,703.0,13024.0,4227.0,743.0,441.0,667.0,726.0,15641.0,1766.0,1053.0,40059.0
Mandsaur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,287.0,396.0,587.0,18864.0,7225.0,2495.0,326.0,431.0,511.0,17998.0,2777.0,890.0,52787.0
Mandsaur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,11.0,12.0
Mandsaur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,489.0,571.0,587.0,578.0,629.0,670.0,492.0,656.0,648.0,402.0,521.0,644.0,6887.0
Mandsaur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,1.0,4.0,8.0,4.0,2.0,9.0,1.0,0.0,1.0,30.0
Mandsaur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,51.0,89.0,68.0,54.0,56.0,116.0,157.0,104.0,70.0,72.0,131.0,194.0,1162.0
Mandsaur,13.1,Number of Patients operated for cataract,TOTAL,1166.0,39.0,68.0,75.0,62.0,94.0,43.0,110.0,168.0,154.0,112.0,141.0,2232.0
Mandsaur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,2.0,38.0,58.0,70.0,60.0,90.0,43.0,86.0,168.0,148.0,108.0,132.0,1003.0
Mandsaur,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,135.0,15.0,174.0,71.0,19.0,49.0,86.0,549.0
Mandsaur,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,20.0,15.0,169.0,65.0,17.0,35.0,85.0,406.0
Mandsaur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,7.0,6.0,6.0,7.0,7.0,7.0,7.0,7.0,8.0,8.0,8.0,-1.0
Mandsaur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,12.0,9.0,8.0,9.0,12.0,9.0,14.0,12.0,15.0,11.0,10.0,12.0,-1.0
Mandsaur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,709.0,899.0,916.0,1004.0,993.0,963.0,930.0,922.0,955.0,877.0,963.0,1066.0,-1.0
Mandsaur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,7.0,8.0,8.0,8.0,8.0,8.0,8.0,7.0,7.0,7.0,7.0,-1.0
Mandsaur,14.05,Number of RKS meetings held during the month,TOTAL,9.0,6.0,4.0,7.0,4.0,4.0,5.0,4.0,5.0,5.0,8.0,4.0,65.0
Mandsaur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,14.0,11.0,11.0,12.0,13.0,13.0,14.0,14.0,13.0,12.0,11.0,12.0,-1.0
Mandsaur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,118.0,281.0,346.0,285.0,240.0,379.0,254.0,353.0,416.0,406.0,491.0,753.0,4322.0
Mandsaur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,5.0,6.0,6.0,5.0,5.0,4.0,5.0,5.0,5.0,5.0,5.0,-1.0
Mandsaur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Mandsaur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,544.0,711.0,641.0,904.0,787.0,932.0,888.0,776.0,760.0,782.0,778.0,1098.0,9601.0
Mandsaur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,798.0,943.0,864.0,1373.0,1463.0,1579.0,1503.0,1287.0,1323.0,958.0,1448.0,1543.0,15082.0
Mandsaur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,300.0,479.0,539.0,319.0,434.0,463.0,229.0,394.0,365.0,367.0,400.0,917.0,5206.0
Mandsaur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1979.0,2778.0,3412.0,3434.0,3158.0,3835.0,3248.0,3493.0,3434.0,3591.0,3816.0,4274.0,40452.0
Mandsaur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,844.0,1190.0,1180.0,1223.0,1221.0,1395.0,1117.0,1170.0,1125.0,1149.0,1178.0,2015.0,14807.0
Mandsaur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2777.0,3721.0,4276.0,4807.0,4621.0,5414.0,4751.0,4780.0,4757.0,4549.0,5264.0,5817.0,55534.0
Mandsaur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,23.0,35.0,51.0,30.0,36.0,50.0,41.0,40.0,47.0,39.0,20.0,37.0,449.0
Mandsaur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,12.0,26.0,23.0,11.0,22.0,29.0,25.0,19.0,20.0,19.0,17.0,24.0,247.0
Mandsaur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,35.0,61.0,74.0,41.0,58.0,79.0,66.0,59.0,67.0,58.0,37.0,61.0,696.0
Mandsaur,14.11,In-Patient Head Count at midnight,TOTAL,8285.0,1613.0,1679.0,14705.0,12094.0,15849.0,15320.0,11800.0,12306.0,12661.0,12912.0,15037.0,134261.0
Mandsaur,14.12.1,OPD attendance (All),TOTAL,40394.0,56702.0,66110.0,67224.0,67137.0,93017.0,72982.0,68298.0,65390.0,58871.0,75125.0,95898.0,827148.0
Mandsaur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,30.0,104.0,249.0,334.0,282.0,253.0,252.0,64.0,193.0,194.0,234.0,243.0,2432.0
Mandsaur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,314.0,517.0,463.0,635.0,389.0,524.0,367.0,598.0,668.0,559.0,656.0,451.0,6141.0
Mandsaur,14.14.a,Number of patients given AYUSH treatment,TOTAL,1339.0,768.0,700.0,782.0,770.0,1673.0,687.0,1343.0,2104.0,1622.0,2212.0,2037.0,16037.0
Mandsaur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,862.0,1394.0,1247.0,1374.0,1312.0,1599.0,1077.0,1417.0,1544.0,1337.0,1396.0,1157.0,15716.0
Mandsaur,14.14.c,Number of Adolescents counselled,TOTAL,134.0,171.0,746.0,338.0,258.0,503.0,362.0,481.0,635.0,1009.0,574.0,720.0,5931.0
Mandsaur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6343.0,7907.0,10663.0,9200.0,7517.0,11100.0,9553.0,8875.0,9313.0,8204.0,10014.0,11192.0,109881.0
Mandsaur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,725.0,1109.0,1510.0,1285.0,1093.0,1231.0,1085.0,1099.0,1431.0,1188.0,1199.0,1193.0,14148.0
Mandsaur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,341.0,532.0,546.0,646.0,648.0,620.0,541.0,446.0,396.0,398.0,372.0,521.0,6007.0
Mandsaur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,7.0,12.0,13.0,11.0,11.0,14.0,8.0,9.0,10.0,4.0,21.0,5.0,125.0
Mandsaur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,230.0,553.0,505.0,484.0,490.0,446.0,557.0,481.0,363.0,460.0,322.0,370.0,5261.0
Mandsaur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,4.0,3.0,18.0,12.0,8.0,14.0,5.0,5.0,4.0,0.0,53.0,3.0,129.0
Mandsaur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1662.0,1827.0,2199.0,1910.0,1599.0,1876.0,1322.0,1770.0,1533.0,1453.0,1073.0,1270.0,19494.0
Mandsaur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,5.0,16.0,2.0,1.0,2.0,1.0,0.0,0.0,0.0,26.0,2.0,55.0
Mandsaur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2233.0,2912.0,3250.0,3040.0,2737.0,2942.0,2420.0,2697.0,2292.0,2311.0,1767.0,2161.0,30762.0
Mandsaur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,11.0,20.0,47.0,25.0,20.0,30.0,14.0,14.0,14.0,4.0,100.0,10.0,309.0
Mandsaur,15.2,Number of Widal tests conducted,Number tested,803.0,884.0,1252.0,923.0,840.0,1554.0,1325.0,1553.0,1124.0,750.0,1393.0,1513.0,13914.0
Mandsaur,15.3.a,Number of VDRL tests conducted on males,Number tested,58.0,335.0,214.0,357.0,850.0,1008.0,784.0,814.0,1112.0,983.0,1096.0,691.0,8302.0
Mandsaur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,207.0,727.0,965.0,1125.0,146.0,234.0,176.0,225.0,200.0,223.0,210.0,197.0,4635.0
Mandsaur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,903.0,864.0,999.0,898.0,675.0,744.0,517.0,761.0,702.0,675.0,815.0,838.0,9391.0
Mandsaur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1168.0,1926.0,2178.0,2380.0,1671.0,1986.0,1477.0,1800.0,2014.0,1881.0,2121.0,1726.0,22328.0
Mandsaur,15.4.1,Number of blood smears examined for Malaria,TOTAL,4649.0,9564.0,7983.0,7522.0,8694.0,11104.0,13966.0,9153.0,11828.0,5311.0,8216.0,11764.0,109754.0
Mandsaur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,10.0,13.0,22.0,31.0,19.0,35.0,35.0,25.0,10.0,5.0,7.0,6.0,218.0
Mandsaur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,1.0,5.0,2.0,2.0,16.0,22.0,15.0,7.0,1.0,0.0,2.0,74.0
Mandsaur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,24950.0,,,,,,,,24950.0
Mandsaur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,20000.0,,,,,,,,20000.0
Mandsaur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,11450.0,,,,,,,,11450.0
Mandsaur,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,33500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,33500.0
Mandsaur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Mandsaur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,0.0,,,,,,,,0.0
Mandsaur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,33640.0,,,,,,,,33640.0
Mandsaur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,20000.0,,,,,,,,20000.0
Mandsaur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,23500.0,,,,,,,,23500.0
Mandsaur,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,30140.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30140.0
Mandsaur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,14460.0,,,,,,,,14460.0
Mandsaur,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,10000.0,,,,,,,,10000.0
Mandsaur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,11950.0,,,,,,,,11950.0
Mandsaur,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,12510.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12510.0
Mandsaur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Mandsaur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,0.0,,,,,,,,0.0
Mandsaur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,7820.0,,,,,,,,7820.0
Mandsaur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,3000.0,,,,,,,,3000.0
Mandsaur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,5800.0,,,,,,,,5800.0
Mandsaur,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,5020.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5020.0
Mandsaur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,7000.0,,,,,,,,7000.0
Mandsaur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,3000.0,,,,,,,,3000.0
Mandsaur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,5425.0,,,,,,,,5425.0
Mandsaur,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,4575.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4575.0
Mandsaur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Mandsaur,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,0.0,,,,,,,,0.0
Mandsaur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,7490.0,,,,,,,,7490.0
Mandsaur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,3000.0,,,,,,,,3000.0
Mandsaur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,9150.0,,,,,,,,9150.0
Mandsaur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,1340.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1340.0
Mandsaur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,1200.0,,,,,,,,1200.0
Mandsaur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,3000.0,,,,,,,,3000.0
Mandsaur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,4200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4200.0
Mandsaur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Mandsaur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,55440.0,,,,,,,,55440.0
Mandsaur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,55440.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,55440.0
Mandsaur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,13200.0,,,,,,,,13200.0
Mandsaur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,4800.0,,,,,,,,4800.0
Mandsaur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,18000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18000.0
Mandsaur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,1100.0,,,,,,,,1100.0
Mandsaur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,0.0,,,,,,,,0.0
Mandsaur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,1100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1100.0
Mandsaur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Mandsaur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,0.0,,,,,,,,0.0
Mandsaur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandsaur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,6000.0,,,,,,,,6000.0
Mandsaur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,3300.0,,,,,,,,3300.0
Mandsaur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,9300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9300.0
Mandsaur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,54000.0,,,,,,,,54000.0
Mandsaur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,72000.0,,,,,,,,72000.0
Mandsaur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,126000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,126000.0
Mandsaur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,6900.0,,,,,,,,6900.0
Mandsaur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,2000.0,,,,,,,,2000.0
Mandsaur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Mandsaur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Mandsaur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,8900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8900.0
Mandsaur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,2.0,4.0,4.0,1.0,,1.0,1.0,,,,13.0
Mandsaur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,1.0,,4.0,1.0,2.0,2.0,2.0,1.0,2.0,15.0
Mandsaur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,1.0,,,,,,,,,1.0
Mandsaur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,2.0,,4.0,1.0,2.0,2.0,2.0,1.0,2.0,16.0
Mandsaur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,4.0,3.0,,1.0,6.0,,6.0,2.0,6.0,3.0,4.0,35.0
Mandsaur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mandsaur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,4.0,3.0,,1.0,6.0,,6.0,2.0,6.0,3.0,4.0,35.0
Mandsaur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,1.0,1.0,,2.0,,,2.0,,2.0,3.0,2.0,13.0
Mandsaur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mandsaur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,1.0,1.0,,2.0,,,2.0,,2.0,3.0,2.0,13.0
Mandsaur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,8.0,6.0,13.0,6.0,8.0,12.0,4.0,12.0,16.0,6.0,8.0,13.0,112.0
Mandsaur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,2.0,,1.0,,,,,1.0,1.0,,6.0
Mandsaur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,8.0,7.0,15.0,6.0,9.0,12.0,4.0,12.0,16.0,7.0,9.0,13.0,118.0
Mandsaur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,,,,,1.0,,3.0,2.0,2.0,,9.0
Mandsaur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mandsaur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,,,,,1.0,,3.0,2.0,2.0,,9.0
Mandsaur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mandsaur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,1.0,,,,1.0
Mandsaur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,1.0,,,,1.0
Mandsaur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,1.0,1.0,2.0,1.0,1.0,1.0,,7.0
Mandsaur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,1.0,,1.0
Mandsaur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,1.0,1.0,2.0,1.0,1.0,2.0,,8.0
Mandsaur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mandsaur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mandsaur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Mandsaur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,2.0,1.0,2.0,4.0,6.0,6.0,5.0,4.0,4.0,6.0,4.0,46.0
Mandsaur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,1.0,,2.0,5.0,1.0,,2.0,,2.0,13.0
Mandsaur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,2.0,1.0,3.0,4.0,8.0,11.0,6.0,4.0,6.0,6.0,6.0,59.0
Mandsaur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Mandsaur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Mandsaur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Mandsaur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Mandsaur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,1.0,,,,,,,,1.0,,2.0
Mandsaur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,2.0,,2.0,1.0,2.0,2.0,2.0,3.0,5.0,,20.0
Mandsaur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,4.0,,8.0,1.0,4.0,4.0,5.0,5.0,3.0,34.0
Mandsaur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,3.0,4.0,2.0,9.0,3.0,6.0,6.0,8.0,11.0,3.0,56.0
Mandsaur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,1.0,,1.0,,,,,2.0
Mandsaur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,2.0,,2.0,2.0,1.0,1.0,5.0,1.0,2.0,1.0,1.0,19.0
Mandsaur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,2.0,1.0,,,1.0,5.0,1.0,4.0,2.0,1.0,1.0,19.0
Mandsaur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,4.0,1.0,2.0,2.0,3.0,6.0,7.0,5.0,4.0,2.0,2.0,40.0
Mandsaur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Mandsaur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Mandsaur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Mandsaur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,1.0,,,,,,,1.0
Mandsaur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,1.0,,,,2.0,,,,3.0
Mandsaur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,2.0,,1.0,,1.0,,,1.0,3.0,1.0,10.0
Mandsaur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,3.0,,,,3.0,,,,,,6.0
Mandsaur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,5.0,,2.0,,4.0,,2.0,1.0,3.0,1.0,19.0
Mandsaur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Mandsaur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Mandsaur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Mandsaur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,2.0,,,,,,,2.0
Mandsaur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,1.0,,,1.0,,,2.0
Mandsaur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,2.0,3.0,5.0,6.0,2.0,6.0,20.0,18.0,20.0,19.0,18.0,22.0,141.0
Mandsaur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,1.0,6.0,6.0,5.0,8.0,21.0,15.0,44.0,18.0,18.0,20.0,162.0
Mandsaur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,2.0,4.0,11.0,12.0,7.0,14.0,42.0,33.0,64.0,38.0,36.0,42.0,305.0
Mandsaur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,1.0,,1.0,,,1.0,3.0
Mandsaur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,3.0,,,,,,4.0,2.0,1.0,1.0,1.0,13.0
Mandsaur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,,,2.0,,1.0,1.0,,,1.0,6.0
Mandsaur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,4.0,,,,2.0,1.0,5.0,4.0,1.0,1.0,3.0,22.0
Mandsaur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Mandsaur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Mandsaur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Mandsaur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Mandsaur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Mandsaur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Mandsaur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Mandsaur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,1.0,,,,,1.0
Mandsaur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Mandsaur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Mandsaur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Mandsaur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Mandsaur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Mandsaur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,,1.0,1.0,,,,,1.0,,1.0,5.0
Mandsaur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Mandsaur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,,1.0,1.0,,,,,1.0,,1.0,5.0
Mandsaur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Mandsaur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,1.0,,,,,,,,,,,1.0
Mandsaur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Mandsaur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,1.0,,,,,,,,,,,1.0
Mandsaur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Mandsaur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,2.0,,1.0,1.0,,3.0,3.0,1.0,,2.0,14.0
Mandsaur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Mandsaur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,2.0,,1.0,1.0,,3.0,3.0,1.0,,2.0,14.0
Mandsaur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,,,,4.0,6.0,,3.0,1.0,2.0,,17.0
Mandsaur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,13.0,4.0,13.0,11.0,16.0,14.0,16.0,9.0,16.0,8.0,16.0,137.0
Mandsaur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,1.0,2.0,3.0,5.0,3.0,9.0,2.0,6.0,2.0,2.0,36.0
Mandsaur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,14.0,5.0,15.0,14.0,25.0,23.0,25.0,14.0,23.0,12.0,18.0,190.0
Mandsaur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Mandsaur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,1.0,3.0,4.0,1.0,8.0,2.0,2.0,6.0,2.0,8.0,4.0,43.0
Mandsaur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,1.0,,,1.0,,,2.0
Mandsaur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,2.0,1.0,3.0,4.0,1.0,8.0,3.0,2.0,7.0,3.0,8.0,4.0,46.0
Mandsaur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,1.0,,1.0,1.0,2.0,1.0,,,1.0,7.0
Mandsaur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,2.0,4.0,3.0,1.0,,,,1.0,1.0,13.0
Mandsaur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,1.0,,2.0,,2.0,,,5.0
Mandsaur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,1.0,3.0,4.0,5.0,2.0,4.0,1.0,2.0,1.0,2.0,25.0
Mandsaur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Mandsaur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,2.0,,4.0,,,1.0,3.0,1.0,,2.0,,13.0
Mandsaur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,,2.0,,,,3.0,2.0,2.0,1.0,1.0,2.0,14.0
Mandsaur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,2.0,2.0,4.0,,,4.0,5.0,3.0,1.0,3.0,2.0,27.0
Mandsaur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,2.0,1.0,,,1.0,4.0
Mandsaur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,1.0,3.0,1.0,2.0,6.0,1.0,2.0,2.0,6.0,3.0,5.0,32.0
Mandsaur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,1.0,2.0,9.0,1.0,8.0,2.0,4.0,1.0,3.0,,4.0,35.0
Mandsaur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,2.0,5.0,10.0,3.0,14.0,3.0,8.0,4.0,9.0,3.0,10.0,71.0
Mandsaur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,1.0,4.0,1.0,1.0,,2.0,3.0,12.0
Mandsaur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,2.0,8.0,14.0,9.0,9.0,12.0,16.0,8.0,16.0,11.0,19.0,28.0,152.0
Mandsaur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,28.0,57.0,106.0,75.0,83.0,138.0,159.0,125.0,122.0,149.0,154.0,167.0,1363.0
Mandsaur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,30.0,65.0,120.0,84.0,92.0,151.0,179.0,134.0,139.0,160.0,175.0,198.0,1527.0
Morena,1.1,Total number of pregnant women Registered for ANC,TOTAL,5196.0,4864.0,4529.0,4499.0,4079.0,4228.0,3224.0,4047.0,5072.0,4123.0,5295.0,5247.0,54403.0
Morena,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2532.0,2716.0,2476.0,2583.0,2840.0,2529.0,1935.0,2572.0,2599.0,3435.0,3505.0,3119.0,32841.0
Morena,1.2,Number of Pregnant women registered under JSY,TOTAL,3767.0,4266.0,3663.0,4097.0,3242.0,3623.0,3128.0,3505.0,2710.0,4296.0,3735.0,4531.0,44563.0
Morena,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3206.0,3749.0,5469.0,4039.0,4206.0,3418.0,2947.0,3576.0,3400.0,3381.0,3694.0,3921.0,45006.0
Morena,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3707.0,4072.0,3971.0,3842.0,3277.0,3491.0,2731.0,3077.0,2869.0,3278.0,4034.0,4276.0,42625.0
Morena,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3662.0,4616.0,4452.0,4694.0,4149.0,3883.0,3494.0,3577.0,3499.0,3371.0,3717.0,4391.0,47505.0
Morena,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4282.0,4398.0,4662.0,5560.0,4414.0,4295.0,3256.0,3859.0,4458.0,4383.0,4695.0,4778.0,53040.0
Morena,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,335.0,324.0,373.0,158.0,388.0,100.0,70.0,157.0,465.0,451.0,435.0,358.0,3614.0
Morena,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,5.0,9.0,9.0,29.0,11.0,8.0,2.0,5.0,24.0,18.0,17.0,16.0,153.0
Morena,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2083.0,3382.0,3597.0,3705.0,3735.0,3033.0,2742.0,3234.0,3474.0,2428.0,3065.0,3293.0,37771.0
Morena,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,143.0,109.0,102.0,128.0,128.0,87.0,65.0,242.0,155.0,195.0,202.0,137.0,1693.0
Morena,1.8,Number of pregnancy test kits used at SC level,TOTAL,361.0,147.0,144.0,175.0,143.0,169.0,199.0,267.0,332.0,451.0,485.0,871.0,3744.0
Morena,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,22.0,12.0,5.0,5.0,11.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,59.0
Morena,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,48.0,87.0,75.0,105.0,150.0,201.0,144.0,180.0,152.0,137.0,140.0,113.0,1532.0
Morena,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,70.0,99.0,80.0,110.0,161.0,201.0,145.0,181.0,152.0,139.0,140.0,113.0,1591.0
Morena,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,37.0,48.0,51.0,59.0,96.0,105.0,67.0,115.0,79.0,66.0,58.0,57.0,838.0
Morena,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,6.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,12.0
Morena,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1781.0,2221.0,2593.0,3420.0,4327.0,4041.0,3545.0,3287.0,3133.0,3026.0,2457.0,2258.0,36089.0
Morena,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,446.0,505.0,656.0,1263.0,1463.0,1636.0,1425.0,1374.0,1324.0,571.0,875.0,1317.0,12855.0
Morena,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1059.0,1370.0,1676.0,3177.0,3767.0,3342.0,2440.0,2532.0,1245.0,1457.0,1867.0,2791.0,26723.0
Morena,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,425.0,528.0,1818.0,2585.0,1754.0,1545.0,1484.0,2246.0,965.0,1151.0,1036.0,5669.0,21206.0
Morena,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,71.0,43.0,115.0,157.0,220.0,109.0,92.0,99.0,141.0,101.0,73.0,478.0,1699.0
Morena,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,173.0,222.0,296.0,141.0,300.0,,0.0,362.0,410.0,357.0,426.0,365.0,3052.0
Morena,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,,,,,0.0,0.0,0.0,,,,,0.0
Morena,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,,,,,0.0,0.0,0.0,,,,,0.0
Morena,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,,,,,0.0,0.0,0.0,,,,,0.0
Morena,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,20.0,11.0,20.0,17.0,7.0,9.0,17.0,25.0,30.0,28.0,15.0,22.0,221.0
Morena,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Morena,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,20.0,11.0,20.0,17.0,7.0,9.0,17.0,25.0,30.0,28.0,15.0,22.0,221.0
Morena,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,53.0,75.0,72.0,36.0,103.0,,,116.0,146.0,169.0,178.0,140.0,1088.0
Morena,4.1.1.a,Number of male live births,TOTAL,1056.0,1339.0,1587.0,1944.0,2494.0,2173.0,1942.0,1956.0,1885.0,1744.0,1588.0,1405.0,21113.0
Morena,4.1.1.b,Number of female live births,TOTAL,943.0,1151.0,1352.0,1672.0,2245.0,2022.0,1697.0,1809.0,1758.0,1750.0,1403.0,1294.0,19096.0
Morena,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1999.0,2490.0,2939.0,3616.0,4739.0,4195.0,3639.0,3765.0,3643.0,3494.0,2991.0,2699.0,40209.0
Morena,4.1.2,Number of still births,TOTAL,40.0,68.0,68.0,73.0,87.0,62.0,66.0,55.0,72.0,90.0,61.0,57.0,799.0
Morena,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,95.0,86.0,101.0,91.0,70.0,63.0,36.0,72.0,144.0,122.0,173.0,115.0,1168.0
Morena,4.2.1,Number of Newborns weighed at birth,TOTAL,1795.0,2382.0,2916.0,3440.0,4616.0,4122.0,3488.0,3717.0,3569.0,3399.0,2912.0,2638.0,38994.0
Morena,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,197.0,350.0,430.0,478.0,410.0,500.0,546.0,484.0,545.0,762.0,432.0,680.0,5814.0
Morena,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1902.0,2365.0,2769.0,3491.0,4613.0,4130.0,3467.0,3654.0,3462.0,3335.0,2807.0,2548.0,38543.0
Morena,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,21.0,20.0,17.0,39.0,18.0,33.0,26.0,25.0,29.0,85.0,15.0,13.0,341.0
Morena,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,29.0,106.0,172.0,91.0,65.0,103.0,33.0,51.0,39.0,86.0,65.0,26.0,866.0
Morena,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,95.0,105.0,119.0,262.0,244.0,224.0,139.0,194.0,239.0,204.0,193.0,210.0,2228.0
Morena,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Morena,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,145.0,231.0,308.0,392.0,327.0,360.0,198.0,270.0,307.0,375.0,273.0,249.0,3435.0
Morena,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,2.0,33.0,40.0,38.0,83.0,,,107.0,137.0,191.0,262.0,114.0,1007.0
Morena,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,117.0,134.0,230.0,335.0,321.0,261.0,166.0,220.0,238.0,356.0,337.0,242.0,2957.0
Morena,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,16.0,31.0,16.0,64.0,37.0,39.0,12.0,26.0,62.0,138.0,61.0,63.0,565.0
Morena,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,26.0,47.0,123.0,96.0,142.0,39.0,109.0,72.0,40.0,161.0,186.0,121.0,1162.0
Morena,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,11.0,20.0,18.0,34.0,38.0,18.0,19.0,19.0,33.0,103.0,59.0,57.0,429.0
Morena,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2500.0,1665.0,1705.0,2755.0,3320.0,2867.0,2412.0,2882.0,2899.0,2834.0,2567.0,2089.0,30495.0
Morena,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1213.0,1300.0,1436.0,1291.0,2336.0,1858.0,1523.0,1619.0,1606.0,1643.0,1793.0,1845.0,19463.0
Morena,6.3,PNC maternal complications attended,TOTAL,15.0,27.0,20.0,37.0,14.0,11.0,92.0,39.0,39.0,75.0,24.0,30.0,423.0
Morena,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,48.0,52.0,33.0,56.0,37.0,40.0,25.0,47.0,62.0,54.0,32.0,38.0,524.0
Morena,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,48.0,52.0,33.0,56.0,37.0,40.0,25.0,47.0,62.0,54.0,32.0,38.0,524.0
Morena,7.2,Number of MTPs conducted at Private Facilities,TOTAL,48.0,33.0,59.0,24.0,15.0,0.0,0.0,15.0,35.0,12.0,49.0,20.0,310.0
Morena,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,19.0,12.0,12.0,12.0,19.0,22.0,68.0,12.0,18.0,27.0,14.0,9.0,244.0
Morena,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,110.0,166.0,157.0,149.0,154.0,167.0,175.0,178.0,154.0,168.0,57.0,26.0,1661.0
Morena,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,129.0,178.0,169.0,161.0,173.0,189.0,243.0,190.0,172.0,195.0,71.0,35.0,1905.0
Morena,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Morena,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,2.0,2.0,2.0,6.0,15.0
Morena,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,0.0,1.0,4.0,4.0,3.0,1.0,1.0,2.0,0.0,0.0,2.0,19.0
Morena,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Morena,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,0.0,2.0,4.0,4.0,3.0,1.0,3.0,4.0,2.0,2.0,8.0,34.0
Morena,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,,,,,,,,,0.0,,,0.0
Morena,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,18.0,0.0,0.0,0.0,0.0,20.0
Morena,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,40.0,7.0,7.0,21.0,18.0,108.0,11.0,1315.0,1982.0,1905.0,791.0,1132.0,7337.0
Morena,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,11.0,4.0,2.0,4.0,9.0,4.0,5.0,59.0,91.0,53.0,91.0,14.0,347.0
Morena,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Morena,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,53.0,11.0,9.0,25.0,27.0,112.0,16.0,1392.0,2073.0,1958.0,882.0,1146.0,7704.0
Morena,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,12.0,9.0,9.0,,,,,7.0,8.0,10.0,7.0,1.0,63.0
Morena,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Morena,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,6.0,0.0,4.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,11.0
Morena,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Morena,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,7.0,0.0,4.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,13.0
Morena,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,,5.0,,,,,,3.0,1.0,3.0,4.0,16.0
Morena,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,6.0,2.0,0.0,1.0,2.0,5.0,11.0,11.0,3.0,4.0,45.0
Morena,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,4.0,2.0,0.0,2.0,4.0,7.0,4.0,1.0,1.0,25.0
Morena,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Morena,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,6.0,6.0,2.0,1.0,4.0,9.0,18.0,15.0,4.0,5.0,70.0
Morena,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,2.0,5.0,8.0,7.0,10.0,,,17.0,12.0,12.0,9.0,8.0,90.0
Morena,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,440.0,482.0,537.0,595.0,582.0,495.0,523.0,473.0,452.0,346.0,357.0,346.0,5628.0
Morena,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,7.0,22.0,24.0,12.0,8.0,9.0,41.0,11.0,12.0,10.0,13.0,16.0,185.0
Morena,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,11.0,17.0,22.0,15.0,20.0,12.0,13.0,48.0,21.0,24.0,11.0,16.0,230.0
Morena,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,20.0,20.0,13.0,9.0,9.0,378.0,12.0,38.0,21.0,4.0,33.0,25.0,582.0
Morena,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Morena,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,478.0,541.0,596.0,631.0,619.0,894.0,589.0,570.0,506.0,384.0,414.0,403.0,6625.0
Morena,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,6.0,8.0,14.0,1.0,6.0,372.0,6.0,26.0,17.0,90.0,34.0,32.0,612.0
Morena,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,15.0,7.0,6.0,8.0,4.0,,,7.0,9.0,3.0,13.0,12.0,84.0
Morena,9.06,Number of IUCD removals,TOTAL,252.0,248.0,159.0,251.0,530.0,339.0,200.0,417.0,257.0,209.0,178.0,194.0,3234.0
Morena,9.07,Number of Oral Pills cycles distributed,TOTAL,6340.0,5534.0,5187.0,6309.0,7091.0,6410.0,6174.0,6204.0,6519.0,6545.0,6793.0,6426.0,75532.0
Morena,9.08,Number of Condom pieces distributed,TOTAL,22242.0,28959.0,34804.0,30077.0,28187.0,27743.0,27636.0,24656.0,25025.0,28335.0,26322.0,20658.0,324644.0
Morena,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,96.0,63.0,99.0,76.0,66.0,106.0,92.0,100.0,84.0,90.0,92.0,104.0,1068.0
Morena,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,0.0,10.0
Morena,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,9.11.2.b,Number of failures following female sterilization,TOTAL,2.0,2.0,3.0,5.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0
Morena,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,9.12,Number of Institutions having NSV trained doctors,TOTAL,21.0,21.0,19.0,22.0,21.0,24.0,19.0,19.0,18.0,17.0,14.0,17.0,-1.0
Morena,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2063.0,2652.0,2801.0,3578.0,5019.0,4530.0,3862.0,4068.0,3514.0,3572.0,2888.0,2720.0,41267.0
Morena,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2801.0,2763.0,2805.0,2875.0,2983.0,4114.0,7350.0,703.0,70.0,101.0,17.0,24.0,26606.0
Morena,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3185.0,3083.0,2909.0,2923.0,2712.0,3037.0,3587.0,4217.0,1695.0,623.0,249.0,178.0,28398.0
Morena,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3342.0,3432.0,3225.0,3073.0,2724.0,2822.0,2860.0,3596.0,3812.0,1882.0,811.0,457.0,32036.0
Morena,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4012.0,4303.0,3951.0,3674.0,3786.0,19726.0
Morena,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2811.0,3554.0,3661.0,3764.0,13790.0
Morena,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0,2262.0,3030.0,3851.0,9193.0
Morena,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1894.0,2471.0,2662.0,3437.0,4763.0,4289.0,3669.0,3764.0,3204.0,3332.0,2661.0,2517.0,38663.0
Morena,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2800.0,2763.0,2808.0,2870.0,2974.0,4113.0,4449.0,4410.0,4393.0,4105.0,3734.0,3804.0,43223.0
Morena,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3184.0,3038.0,2916.0,2922.0,2713.0,3026.0,3576.0,4114.0,4105.0,4172.0,3914.0,3890.0,41570.0
Morena,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3345.0,3405.0,3226.0,3090.0,2729.0,2842.0,2897.0,3551.0,3828.0,3930.0,3827.0,4148.0,40818.0
Morena,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1604.0,2115.0,2262.0,2979.0,4435.0,3685.0,3104.0,3141.0,2649.0,2764.0,2264.0,2001.0,33003.0
Morena,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2811.0,2783.0,2802.0,2847.0,2979.0,4108.0,4431.0,650.0,69.0,89.0,17.0,39.0,23625.0
Morena,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,3204.0,3070.0,2915.0,2925.0,2711.0,3025.0,3562.0,4193.0,1687.0,641.0,250.0,193.0,28376.0
Morena,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3346.0,3394.0,3240.0,3089.0,2775.0,2818.0,2892.0,3567.0,3822.0,1880.0,814.0,448.0,32085.0
Morena,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2841.0,3371.0,4256.0,3920.0,3583.0,4133.0,3637.0,3398.0,2935.0,2816.0,2458.0,3380.0,40728.0
Morena,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2367.0,2615.0,3699.0,2488.0,2006.0,2109.0,2245.0,2350.0,2411.0,3063.0,3121.0,6822.0,35296.0
Morena,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1432.0,1768.0,2976.0,1797.0,1846.0,2068.0,1856.0,1749.0,1560.0,1511.0,1294.0,1560.0,21417.0
Morena,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1236.0,1455.0,2434.0,1661.0,1550.0,1808.0,1595.0,1462.0,1247.0,1250.0,1105.0,1326.0,18129.0
Morena,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2668.0,3223.0,5410.0,3458.0,3396.0,3876.0,3451.0,3211.0,2807.0,2761.0,2399.0,2886.0,39546.0
Morena,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2936.0,2904.0,3034.0,2896.0,2391.0,2608.0,2598.0,2964.0,3001.0,3608.0,3492.0,4595.0,37027.0
Morena,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2926.0,2897.0,3033.0,2900.0,2379.0,2603.0,2608.0,2936.0,2992.0,3598.0,3482.0,4599.0,36953.0
Morena,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,403.0,358.0,338.0,355.0,382.0,413.0,371.0,380.0,498.0,559.0,546.0,690.0,5293.0
Morena,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,316.0,318.0,332.0,321.0,307.0,369.0,317.0,307.0,447.0,486.0,429.0,596.0,4545.0
Morena,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,719.0,676.0,670.0,676.0,689.0,782.0,688.0,687.0,945.0,1045.0,975.0,1286.0,9838.0
Morena,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1258.0,1382.0,1534.0,1808.0,1558.0,1433.0,1305.0,1367.0,1453.0,1868.0,1504.0,1906.0,18376.0
Morena,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1690.0,1880.0,1833.0,1927.0,1872.0,1931.0,2009.0,2070.0,1996.0,1910.0,1788.0,2077.0,22983.0
Morena,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1795.0,2014.0,2138.0,2356.0,1988.0,2170.0,2130.0,2272.0,2297.0,2248.0,1982.0,2189.0,25579.0
Morena,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,1.0,1.0,0.0,0.0,1.0,2.0,5.0,4.0,2.0,1.0,1.0,20.0
Morena,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,6.0,0.0,14.0,0.0,4.0,0.0,0.0,8.0,8.0,0.0,9.0,6.0,55.0
Morena,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1538.0,1521.0,1576.0,1570.0,1545.0,1554.0,1559.0,1614.0,1633.0,1625.0,1626.0,1614.0,18975.0
Morena,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1534.0,1508.0,1552.0,1565.0,1539.0,1549.0,1546.0,1599.0,1620.0,1616.0,1607.0,1613.0,18848.0
Morena,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1144.0,1172.0,1153.0,1152.0,1321.0,1168.0,1213.0,1273.0,1287.0,1286.0,1283.0,1306.0,14758.0
Morena,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2858.0,3349.0,4181.0,3890.0,3519.0,4049.0,3532.0,3355.0,2856.0,2743.0,2363.0,3323.0,40018.0
Morena,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,959.0,974.0,1193.0,3387.0,790.0,836.0,867.0,1126.0,1499.0,6016.0,1410.0,1508.0,20565.0
Morena,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,429.0,583.0,605.0,2813.0,601.0,398.0,521.0,600.0,1182.0,5878.0,744.0,749.0,15103.0
Morena,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,3.0,24.0,11.0,0.0,0.0,7.0,16.0,0.0,22.0,0.0,0.0,20.0,103.0
Morena,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,693.0,746.0,714.0,798.0,1021.0,830.0,639.0,761.0,468.0,535.0,590.0,747.0,8542.0
Morena,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,40.0,11.0,96.0,12.0,12.0,26.0,79.0,16.0,26.0,0.0,12.0,3.0,333.0
Morena,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,42.0,17.0,30.0,30.0,48.0,31.0,8.0,89.0,24.0,79.0,88.0,104.0,590.0
Morena,13.1,Number of Patients operated for cataract,TOTAL,33.0,174.0,119.0,316.0,264.0,231.0,327.0,318.0,1179.0,20.0,159.0,73.0,3213.0
Morena,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,33.0,173.0,118.0,316.0,264.0,231.0,327.0,318.0,1179.0,20.0,159.0,73.0,3211.0
Morena,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,243.0,165.0,317.0,180.0,235.0,8.0,75.0,179.0,1402.0
Morena,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,214.0,493.0,482.0,171.0,17.0,53.0,74.0,1504.0
Morena,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,8.0,7.0,7.0,7.0,7.0,7.0,6.0,5.0,6.0,6.0,6.0,6.0,-1.0
Morena,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,13.0,10.0,11.0,11.0,11.0,12.0,11.0,13.0,8.0,8.0,11.0,11.0,-1.0
Morena,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1174.0,1128.0,1150.0,1198.0,1189.0,1214.0,1242.0,1233.0,1242.0,1207.0,1259.0,1285.0,-1.0
Morena,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,9.0,8.0,8.0,8.0,8.0,8.0,7.0,6.0,7.0,7.0,7.0,7.0,-1.0
Morena,14.05,Number of RKS meetings held during the month,TOTAL,1.0,2.0,2.0,1.0,2.0,2.0,3.0,2.0,1.0,1.0,1.0,1.0,19.0
Morena,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,21.0,21.0,22.0,22.0,22.0,23.0,21.0,22.0,18.0,19.0,19.0,21.0,-1.0
Morena,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,114.0,64.0,18.0,103.0,178.0,168.0,268.0,193.0,123.0,136.0,145.0,181.0,1691.0
Morena,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,6.0,6.0,6.0,6.0,6.0,5.0,4.0,5.0,5.0,5.0,6.0,-1.0
Morena,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,3.0,2.0,3.0,2.0,6.0,2.0,2.0,2.0,2.0,5.0,5.0,-1.0
Morena,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,796.0,1081.0,178.0,892.0,1195.0,1065.0,946.0,829.0,785.0,696.0,829.0,799.0,10091.0
Morena,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,887.0,1862.0,575.0,973.0,1419.0,732.0,1053.0,1132.0,915.0,728.0,887.0,762.0,11925.0
Morena,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1004.0,1415.0,200.0,1358.0,1344.0,1009.0,1178.0,1211.0,1120.0,1016.0,1147.0,1120.0,13122.0
Morena,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1667.0,3112.0,1551.0,2395.0,2901.0,3109.0,2444.0,2719.0,2419.0,2268.0,2632.0,1908.0,29125.0
Morena,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1800.0,2496.0,378.0,2250.0,2539.0,2074.0,2124.0,2040.0,1905.0,1712.0,1976.0,1919.0,23213.0
Morena,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2554.0,4974.0,2126.0,3368.0,4320.0,3841.0,3497.0,3851.0,3334.0,2996.0,3519.0,2670.0,41050.0
Morena,14.10.2.a,Number of death cases of Inpatient males,TOTAL,8.0,9.0,20.0,8.0,5.0,8.0,17.0,12.0,8.0,14.0,16.0,17.0,142.0
Morena,14.10.2.b,Number of death cases of Inpatient females,TOTAL,9.0,10.0,11.0,13.0,3.0,3.0,10.0,9.0,5.0,5.0,10.0,11.0,99.0
Morena,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,17.0,19.0,31.0,21.0,8.0,11.0,27.0,21.0,13.0,19.0,26.0,28.0,241.0
Morena,14.11,In-Patient Head Count at midnight,TOTAL,531.0,924.0,650.0,736.0,1005.0,1086.0,1100.0,1002.0,753.0,893.0,610.0,612.0,9902.0
Morena,14.12.1,OPD attendance (All),TOTAL,48290.0,83191.0,77805.0,82980.0,86837.0,101227.0,76367.0,73431.0,62803.0,51779.0,95218.0,85083.0,925011.0
Morena,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,28.0,62.0,54.0,25.0,103.0,64.0,20.0,66.0,54.0,87.0,56.0,25.0,644.0
Morena,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,5.0,39.0,31.0,0.0,51.0,0.0,0.0,37.0,27.0,47.0,29.0,15.0,281.0
Morena,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,8.0,22.0,17.0,10.0,373.0,248.0,321.0,93.0,47.0,92.0,62.0,103.0,1396.0
Morena,14.14.a,Number of patients given AYUSH treatment,TOTAL,849.0,622.0,806.0,1493.0,1075.0,1398.0,464.0,647.0,677.0,1004.0,785.0,1097.0,10917.0
Morena,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,14.14.c,Number of Adolescents counselled,TOTAL,28.0,0.0,10.0,0.0,0.0,0.0,70.0,0.0,14.0,0.0,37.0,0.0,159.0
Morena,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7799.0,9748.0,9537.0,9792.0,10196.0,10550.0,8131.0,11137.0,10294.0,7498.0,9724.0,7268.0,111674.0
Morena,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,182.0,312.0,330.0,270.0,300.0,415.0,263.0,338.0,321.0,261.0,217.0,268.0,3477.0
Morena,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,130.0,127.0,20.0,153.0,138.0,92.0,64.0,179.0,148.0,109.0,112.0,133.0,1405.0
Morena,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,11.0,0.0,3.0,2.0,5.0,1.0,3.0,4.0,0.0,3.0,2.0,36.0
Morena,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,75.0,133.0,49.0,145.0,109.0,102.0,60.0,275.0,181.0,211.0,92.0,125.0,1557.0
Morena,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,4.0,0.0,2.0,3.0,1.0,1.0,3.0,2.0,0.0,2.0,1.0,20.0
Morena,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,889.0,941.0,590.0,971.0,1076.0,705.0,599.0,757.0,678.0,610.0,374.0,934.0,9124.0
Morena,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,71.0,0.0,0.0,0.0,3.0,32.0,0.0,0.0,0.0,38.0,1.0,145.0
Morena,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1094.0,1201.0,659.0,1269.0,1323.0,899.0,723.0,1211.0,1007.0,930.0,578.0,1192.0,12086.0
Morena,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,86.0,0.0,5.0,5.0,9.0,34.0,6.0,6.0,0.0,43.0,4.0,201.0
Morena,15.2,Number of Widal tests conducted,Number tested,806.0,1033.0,1116.0,887.0,1188.0,1386.0,1041.0,998.0,674.0,333.0,911.0,1258.0,11631.0
Morena,15.3.a,Number of VDRL tests conducted on males,Number tested,56.0,30.0,25.0,28.0,28.0,11.0,83.0,26.0,105.0,61.0,38.0,133.0,624.0
Morena,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,37.0,208.0,81.0,75.0,88.0,7.0,85.0,106.0,127.0,134.0,40.0,111.0,1099.0
Morena,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,143.0,382.0,416.0,337.0,576.0,579.0,692.0,572.0,245.0,224.0,161.0,218.0,4545.0
Morena,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,236.0,620.0,522.0,440.0,692.0,597.0,860.0,704.0,477.0,419.0,239.0,462.0,6268.0
Morena,15.4.1,Number of blood smears examined for Malaria,TOTAL,11965.0,16575.0,17340.0,15106.0,16274.0,20509.0,16467.0,15601.0,11611.0,5816.0,11330.0,12353.0,170947.0
Morena,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,75.0,109.0,235.0,279.0,226.0,601.0,337.0,161.0,75.0,13.0,17.0,51.0,2179.0
Morena,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,9.0,17.0,12.0,8.0,19.0,130.0,221.0,102.0,52.0,1.0,14.0,4.0,589.0
Morena,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3000.0,,,,13500.0,,,,,,9500.0,,26000.0
Morena,16.1.1,Stock position of DPT vaccines,2. Stocks Received,20000.0,,,,0.0,,,,,,10000.0,,30000.0
Morena,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,7500.0,,,,10500.0,,,,,,9500.0,,27500.0
Morena,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,15500.0,,,,3000.0,,,,,,10000.0,,28500.0
Morena,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,0.0,,,,,,8000.0,,8000.0
Morena,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,0.0,,,,,,20000.0,,20000.0
Morena,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,0.0,,,,,,13000.0,,13000.0
Morena,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,0.0,,,,,,15000.0,,15000.0
Morena,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,2000.0,,,,18000.0,,,,,,10000.0,,30000.0
Morena,16.1.2,Stock position of OPV vaccines,2. Stocks Received,25000.0,,,,0.0,,,,,,30000.0,,55000.0
Morena,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,500.0,,,,6000.0,,,,,,14000.0,,20500.0
Morena,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,26500.0,,,,12000.0,,,,,,26000.0,,64500.0
Morena,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1000.0,,,,15500.0,,,,,,15500.0,,32000.0
Morena,16.1.3,Stock position of TT vaccines,2. Stocks Received,20000.0,,,,0.0,,,,,,10000.0,,30000.0
Morena,16.1.3,Stock position of TT vaccines,3. Unusable Stock,1000.0,,,,14500.0,,,,,,12500.0,,28000.0
Morena,16.1.3,Stock position of TT vaccines,4. Stock Distributed,20000.0,,,,1000.0,,,,,,13000.0,,34000.0
Morena,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,0.0,,,,,,,,0.0
Morena,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,0.0,,,,,,,,0.0
Morena,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Morena,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,0.0,,,,,,,,0.0
Morena,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,4500.0,,,,6000.0,,,,,,6000.0,,16500.0
Morena,16.1.5,Stock position of BCG vaccines,2. Stocks Received,8000.0,,,,0.0,,,,,,16000.0,,24000.0
Morena,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,5500.0,,,,2000.0,,,,,,6000.0,,13500.0
Morena,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,7000.0,,,,4000.0,,,,,,16000.0,,27000.0
Morena,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3250.0,,,,14750.0,,,,,,2250.0,,20250.0
Morena,16.1.6,Stock position of Measles vaccines,2. Stocks Received,7000.0,,,,0.0,,,,,,10000.0,,17000.0
Morena,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,2750.0,,,,12750.0,,,,,,250.0,,15750.0
Morena,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,7500.0,,,,2000.0,,,,,,12000.0,,21500.0
Morena,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,0.0,,,,,,0.0,,0.0
Morena,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,0.0,,,,,,0.0,,0.0
Morena,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,0.0,,,,,,0.0,,0.0
Morena,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,0.0,,,,,,0.0,,0.0
Morena,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1500.0,,,,16000.0,,,,,,12000.0,,29500.0
Morena,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,20000.0,,,,0.0,,,,,,5000.0,,25000.0
Morena,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,4600.0,,,,10000.0,,,,,,10000.0,,24600.0
Morena,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,16900.0,,,,6000.0,,,,,,7000.0,,29900.0
Morena,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1200.0,,,,1500.0,,,,,,50.0,,2750.0
Morena,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,0.0,,,,,,3000.0,,3000.0
Morena,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,1200.0,,,,50.0,,,,,,1350.0,,2600.0
Morena,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,,,,1450.0,,,,,,1700.0,,3150.0
Morena,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,15120.0,,,,100800.0,,,,,,0.0,,115920.0
Morena,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,75600.0,,,,0.0,,,,,,18000.0,,93600.0
Morena,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,10080.0,,,,5040.0,,,,,,2000.0,,17120.0
Morena,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,80640.0,,,,95760.0,,,,,,16000.0,,192400.0
Morena,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,600.0,,,,,,100.0,,700.0
Morena,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,0.0,,,,,,29000.0,,29000.0
Morena,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,100.0,,,,,,14000.0,,14100.0
Morena,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,500.0,,,,,,15100.0,,15600.0
Morena,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,0.0,,,,,,50.0,,50.0
Morena,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,0.0,,,,,,6000.0,,6000.0
Morena,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,,,,,50.0,,50.0
Morena,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,0.0,,,,,,6000.0,,6000.0
Morena,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,0.0,,0.0
Morena,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,0.0,,0.0
Morena,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Morena,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,0.0,,0.0
Morena,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Morena,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Morena,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Morena,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Morena,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Morena,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Morena,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Morena,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Morena,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Morena,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Morena,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Morena,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Morena,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Morena,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Morena,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Morena,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Morena,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Morena,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Morena,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Morena,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Morena,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Morena,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Morena,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Morena,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Morena,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Morena,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Morena,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Morena,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Morena,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Morena,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Morena,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Morena,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Morena,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Morena,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Morena,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Morena,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Morena,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,100.0,,,,10.0,,,,,,600.0,,710.0
Morena,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,2000.0,,,,,,0.0,,2000.0
Morena,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,90.0,,,,128.0,,,,,,600.0,,818.0
Morena,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,10.0,,,,1882.0,,,,,,0.0,,1892.0
Morena,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Morena,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Morena,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Morena,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Morena,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3000.0,,,,8300.0,,,,,,100.0,,11400.0
Morena,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,12000.0,,,,0.0,,,,,,6600.0,,18600.0
Morena,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,7400.0,,,,3300.0,,,,,,6700.0,,17400.0
Morena,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,7600.0,,,,5000.0,,,,,,0.0,,12600.0
Morena,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,6000.0,,,,38000.0,,,,,,0.0,,44000.0
Morena,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,290000.0,,,,0.0,,,,,,0.0,,290000.0
Morena,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,116000.0,,,,18000.0,,,,,,0.0,,134000.0
Morena,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,180000.0,,,,20000.0,,,,,,0.0,,200000.0
Morena,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,900.0,,,,5300.0,,,,,,500.0,,6700.0
Morena,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,6000.0,,,,0.0,,,,,,4000.0,,10000.0
Morena,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,3300.0,,,,300.0,,,,,,4500.0,,8100.0
Morena,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3600.0,,,,5000.0,,,,,,0.0,,8600.0
Morena,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Morena,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,1.0,,2.0,1.0,,1.0,1.0,39.0,,,45.0
Morena,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,2.0,3.0,1.0,2.0,,,5.0,,,13.0
Morena,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Morena,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,2.0,3.0,1.0,2.0,,,5.0,,,13.0
Morena,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,,,10.0,3.0,9.0,2.0,2.0,2.0,6.0,2.0,4.0,41.0
Morena,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,1.0,,1.0
Morena,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,,,10.0,3.0,9.0,2.0,2.0,2.0,6.0,3.0,4.0,42.0
Morena,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,2.0,6.0,2.0,2.0,3.0,5.0,4.0,3.0,53.0,1.0,,81.0
Morena,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,2.0,1.0,,3.0
Morena,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,2.0,6.0,2.0,2.0,3.0,5.0,4.0,3.0,55.0,2.0,,84.0
Morena,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,2.0,,2.0,3.0,11.0,10.0,5.0,10.0,193.0,13.0,6.0,256.0
Morena,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,3.0,,,3.0
Morena,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,2.0,,2.0,3.0,11.0,10.0,5.0,10.0,196.0,13.0,6.0,259.0
Morena,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,1.0,,,,12.0,,2.0,15.0
Morena,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,1.0,,,1.0
Morena,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,1.0,,,,13.0,,2.0,16.0
Morena,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,5.0,,,5.0
Morena,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,2.0,,,2.0
Morena,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,7.0,,,7.0
Morena,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,,,,1.0,,13.0,1.0,,16.0
Morena,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,1.0,1.0,9.0,,,11.0
Morena,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,,,,,2.0,1.0,22.0,1.0,,27.0
Morena,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,1.0,,,,,,,,,,,1.0
Morena,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Morena,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,1.0,,,,,,,,,,,1.0
Morena,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,5.0,6.0,3.0,2.0,10.0,2.0,3.0,3.0,183.0,12.0,6.0,238.0
Morena,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,1.0,5.0,2.0,4.0,7.0,4.0,,95.0,3.0,4.0,125.0
Morena,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,5.0,7.0,8.0,4.0,14.0,9.0,7.0,3.0,278.0,15.0,10.0,363.0
Morena,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Morena,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Morena,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Morena,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Morena,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Morena,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,2.0,,1.0,1.0,1.0,1.0,1.0,2.0,3.0,1.0,13.0
Morena,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,,,,,,1.0,,,,2.0,4.0
Morena,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,2.0,,1.0,1.0,1.0,2.0,1.0,2.0,3.0,3.0,17.0
Morena,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Morena,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,2.0,1.0,1.0,2.0,,,6.0
Morena,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,1.0,,,,,2.0,,,,,3.0
Morena,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,1.0,,,,2.0,3.0,1.0,2.0,,,9.0
Morena,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Morena,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Morena,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Morena,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Morena,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Morena,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Morena,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Morena,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,1.0,,,1.0
Morena,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Morena,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Morena,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Morena,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,1.0,,,,,,,,,,1.0
Morena,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Morena,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,1.0,,,,,,,,,,,2.0
Morena,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,1.0,,,2.0,,,,,,,,3.0
Morena,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,2.0,,,2.0,,,,,,,,5.0
Morena,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,2.0,,,,,,,,,2.0
Morena,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,1.0,,,,1.0,,1.0,,,3.0
Morena,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Morena,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,3.0,,,,1.0,,1.0,,,5.0
Morena,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Morena,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,1.0,,,,,,,,1.0,,,2.0
Morena,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Morena,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,1.0,,,,,,,,1.0,,,2.0
Morena,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Morena,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Morena,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Morena,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Morena,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Morena,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Morena,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Morena,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,1.0,,,,,,,,,1.0
Morena,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Morena,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,1.0,,1.0,,1.0,,,6.0,,,10.0
Morena,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Morena,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,1.0,,1.0,,1.0,,,6.0,,,10.0
Morena,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Morena,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,1.0,,,,1.0,,,2.0
Morena,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Morena,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,1.0,,,,1.0,,,2.0
Morena,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Morena,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,,,,,1.0,,,18.0,3.0,1.0,24.0
Morena,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Morena,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,,,,,1.0,,,18.0,3.0,1.0,24.0
Morena,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,2.0,,,,,,1.0,,,,,,3.0
Morena,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,4.0,3.0,1.0,5.0,5.0,5.0,4.0,2.0,,1.0,1.0,1.0,32.0
Morena,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Morena,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,6.0,3.0,1.0,5.0,5.0,5.0,6.0,2.0,,1.0,1.0,1.0,36.0
Morena,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Morena,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,3.0,2.0,,2.0,1.0,2.0,1.0,2.0,,2.0,,15.0
Morena,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Morena,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,3.0,2.0,,2.0,1.0,2.0,1.0,2.0,,2.0,,15.0
Morena,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Morena,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Morena,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Morena,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,1.0,,,,,1.0,,,2.0
Morena,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Morena,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,2.0,,,1.0,,,,,,,3.0
Morena,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Morena,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,2.0,,,1.0,1.0,,,,,,4.0
Morena,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Morena,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,1.0,3.0,,,,1.0,,1.0,,,7.0
Morena,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,2.0,,,,,1.0,,1.0,1.0,,5.0
Morena,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,,3.0,3.0,,,,2.0,,2.0,1.0,,12.0
Morena,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,3.0,1.0,1.0,3.0,1.0,,,,,9.0
Morena,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,2.0,3.0,3.0,1.0,5.0,9.0,11.0,2.0,5.0,1.0,10.0,6.0,58.0
Morena,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,2.0,15.0,10.0,9.0,6.0,25.0,20.0,4.0,5.0,4.0,20.0,10.0,130.0
Morena,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,4.0,18.0,13.0,13.0,12.0,35.0,34.0,7.0,10.0,5.0,30.0,16.0,197.0
Narsinghpur,1.1,Total number of pregnant women Registered for ANC,TOTAL,1733.0,1961.0,2147.0,2289.0,1622.0,1852.0,1867.0,1776.0,1982.0,2078.0,2248.0,2182.0,23737.0
Narsinghpur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,887.0,1062.0,1375.0,1466.0,1097.0,1244.0,1219.0,1222.0,1427.0,1438.0,1546.0,1482.0,15465.0
Narsinghpur,1.2,Number of Pregnant women registered under JSY,TOTAL,1723.0,1963.0,2147.0,2287.0,1622.0,1847.0,1861.0,1776.0,1982.0,2078.0,2248.0,2182.0,23716.0
Narsinghpur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1382.0,1728.0,1777.0,1901.0,1636.0,1884.0,1552.0,1804.0,1965.0,2134.0,1914.0,2149.0,21826.0
Narsinghpur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1241.0,1359.0,1397.0,1549.0,1121.0,1259.0,1342.0,1296.0,1401.0,1418.0,1555.0,1516.0,16454.0
Narsinghpur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1401.0,1703.0,1855.0,1930.0,1611.0,1572.0,1523.0,1566.0,1589.0,1626.0,1768.0,2103.0,20247.0
Narsinghpur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1814.0,1995.0,2210.0,2321.0,1656.0,1918.0,1869.0,1769.0,2026.0,2221.0,2228.0,2298.0,24325.0
Narsinghpur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,73.0,100.0,80.0,66.0,105.0,68.0,39.0,32.0,30.0,33.0,45.0,161.0,832.0
Narsinghpur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,2.0,0.0,0.0,0.0,8.0
Narsinghpur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,318.0,586.0,655.0,630.0,559.0,688.0,819.0,794.0,855.0,735.0,933.0,992.0,8564.0
Narsinghpur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,14.0,2.0,8.0,2.0,23.0,19.0,21.0,22.0,60.0,9.0,13.0,80.0,273.0
Narsinghpur,1.8,Number of pregnancy test kits used at SC level,TOTAL,1079.0,1329.0,1540.0,1547.0,1221.0,1200.0,1292.0,1236.0,1256.0,1272.0,1723.0,1635.0,16330.0
Narsinghpur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,32.0,36.0,74.0,55.0,68.0,66.0,70.0,59.0,50.0,45.0,48.0,71.0,674.0
Narsinghpur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,37.0,48.0,74.0,84.0,111.0,110.0,90.0,49.0,65.0,68.0,41.0,29.0,806.0
Narsinghpur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,69.0,84.0,148.0,139.0,179.0,176.0,160.0,108.0,115.0,113.0,89.0,100.0,1480.0
Narsinghpur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,60.0,61.0,126.0,129.0,158.0,141.0,141.0,108.0,107.0,106.0,88.0,92.0,1317.0
Narsinghpur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,7.0,17.0,3.0,3.0,1.0,5.0,3.0,0.0,31.0,70.0
Narsinghpur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,935.0,972.0,1278.0,1390.0,1561.0,1482.0,1399.0,1338.0,1165.0,1140.0,1055.0,1100.0,14815.0
Narsinghpur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,175.0,28.0,12.0,15.0,18.0,18.0,44.0,16.0,10.0,12.0,11.0,39.0,398.0
Narsinghpur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,594.0,761.0,1144.0,1044.0,1291.0,1511.0,957.0,1256.0,957.0,1068.0,1050.0,899.0,12532.0
Narsinghpur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,463.0,582.0,763.0,1066.0,1204.0,1227.0,737.0,1004.0,672.0,992.0,893.0,749.0,10352.0
Narsinghpur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,169.0,185.0,217.0,240.0,242.0,242.0,232.0,217.0,208.0,231.0,177.0,166.0,2526.0
Narsinghpur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Narsinghpur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Narsinghpur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Narsinghpur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,99.0,105.0,136.0,126.0,127.0,106.0,199.0,144.0,90.0,100.0,87.0,98.0,1417.0
Narsinghpur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narsinghpur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,99.0,105.0,136.0,126.0,127.0,106.0,199.0,144.0,90.0,100.0,87.0,98.0,1417.0
Narsinghpur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,97.0,109.0,121.0,130.0,134.0,129.0,132.0,129.0,116.0,132.0,106.0,102.0,1437.0
Narsinghpur,4.1.1.a,Number of male live births,TOTAL,591.0,646.0,833.0,937.0,1007.0,981.0,931.0,860.0,784.0,751.0,680.0,746.0,9747.0
Narsinghpur,4.1.1.b,Number of female live births,TOTAL,560.0,580.0,809.0,835.0,961.0,912.0,853.0,800.0,697.0,725.0,634.0,610.0,8976.0
Narsinghpur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1151.0,1226.0,1642.0,1772.0,1968.0,1893.0,1784.0,1660.0,1481.0,1476.0,1314.0,1356.0,18723.0
Narsinghpur,4.1.2,Number of still births,TOTAL,23.0,26.0,13.0,13.0,22.0,13.0,18.0,14.0,17.0,18.0,18.0,12.0,207.0
Narsinghpur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,19.0,30.0,32.0,18.0,24.0,34.0,38.0,16.0,50.0,46.0,22.0,19.0,348.0
Narsinghpur,4.2.1,Number of Newborns weighed at birth,TOTAL,1135.0,1224.0,1642.0,1751.0,1963.0,1892.0,1781.0,1660.0,1481.0,1471.0,1299.0,1354.0,18653.0
Narsinghpur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,151.0,97.0,118.0,125.0,94.0,109.0,68.0,158.0,107.0,74.0,78.0,139.0,1318.0
Narsinghpur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1134.0,1224.0,1641.0,1751.0,1963.0,1889.0,1777.0,1659.0,1442.0,1471.0,1148.0,1354.0,18453.0
Narsinghpur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,2.0,2.0,1.0,4.0,0.0,1.0,4.0,0.0,0.0,0.0,0.0,1.0,15.0
Narsinghpur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,8.0,55.0,10.0,5.0,4.0,5.0,2.0,19.0,30.0,38.0,33.0,209.0
Narsinghpur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,99.0,93.0,136.0,100.0,111.0,90.0,109.0,97.0,80.0,0.0,67.0,98.0,1080.0
Narsinghpur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narsinghpur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,101.0,103.0,192.0,114.0,116.0,95.0,118.0,99.0,99.0,30.0,105.0,132.0,1304.0
Narsinghpur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Narsinghpur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,305.0,303.0,348.0,388.0,422.0,320.0,383.0,357.0,309.0,327.0,319.0,396.0,4177.0
Narsinghpur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,112.0,115.0,150.0,122.0,128.0,148.0,187.0,170.0,142.0,116.0,59.0,45.0,1494.0
Narsinghpur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,239.0,319.0,355.0,366.0,399.0,317.0,391.0,351.0,294.0,272.0,268.0,497.0,4068.0
Narsinghpur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,33.0,37.0,44.0,48.0,54.0,51.0,0.0,13.0,17.0,28.0,11.0,22.0,358.0
Narsinghpur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1018.0,1022.0,1149.0,1176.0,1590.0,1464.0,1325.0,1318.0,1211.0,1190.0,1134.0,1027.0,14624.0
Narsinghpur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,502.0,739.0,933.0,1053.0,1188.0,1258.0,1178.0,917.0,932.0,894.0,808.0,897.0,11299.0
Narsinghpur,6.3,PNC maternal complications attended,TOTAL,5.0,7.0,12.0,15.0,23.0,21.0,3.0,1.0,0.0,7.0,8.0,3.0,105.0
Narsinghpur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,12.0,16.0,16.0,5.0,7.0,16.0,22.0,8.0,16.0,57.0,11.0,20.0,206.0
Narsinghpur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,7.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,13.0
Narsinghpur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,12.0,16.0,23.0,5.0,7.0,16.0,28.0,8.0,16.0,57.0,11.0,20.0,219.0
Narsinghpur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Narsinghpur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,312.0,113.0,301.0,290.0,348.0,310.0,139.0,157.0,165.0,316.0,119.0,167.0,2737.0
Narsinghpur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,171.0,373.0,176.0,120.0,185.0,190.0,389.0,423.0,219.0,333.0,401.0,463.0,3443.0
Narsinghpur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,483.0,486.0,477.0,410.0,533.0,500.0,528.0,580.0,384.0,649.0,520.0,630.0,6180.0
Narsinghpur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,67.0,83.0,150.0,87.0,116.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,503.0
Narsinghpur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,3.0,0.0,0.0,0.0,4.0
Narsinghpur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,1.0,0.0,1.0,1.0,4.0,6.0,1.0,16.0
Narsinghpur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,0.0,1.0,3.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0,27.0,36.0
Narsinghpur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narsinghpur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,0.0,1.0,5.0,0.0,3.0,1.0,1.0,4.0,4.0,8.0,28.0,56.0
Narsinghpur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,1.0,,1.0
Narsinghpur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,4.0,0.0,2.0,24.0,0.0,7.0,157.0,985.0,1036.0,657.0,407.0,263.0,3542.0
Narsinghpur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,25.0,8.0,14.0,93.0,807.0,885.0,395.0,303.0,107.0,2637.0
Narsinghpur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,3.0,0.0,2.0,8.0,1.0,2.0,2.0,11.0,31.0,26.0,17.0,10.0,113.0
Narsinghpur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narsinghpur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,7.0,0.0,4.0,57.0,9.0,23.0,252.0,1803.0,1952.0,1078.0,727.0,380.0,6292.0
Narsinghpur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,0.0,,,,,,,0.0
Narsinghpur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,3.0,0.0,0.0,8.0,3.0,1.0,4.0,4.0,1.0,6.0,1.0,31.0
Narsinghpur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,15.0,31.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,46.0
Narsinghpur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narsinghpur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,15.0,34.0,0.0,0.0,8.0,3.0,1.0,4.0,4.0,1.0,6.0,1.0,77.0
Narsinghpur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Narsinghpur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,3.0,11.0,6.0,9.0,3.0,13.0,16.0,27.0,18.0,0.0,11.0,117.0
Narsinghpur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,25.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0,50.0,42.0,40.0,72.0,258.0
Narsinghpur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narsinghpur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,25.0,3.0,11.0,6.0,9.0,3.0,13.0,45.0,77.0,60.0,40.0,83.0,375.0
Narsinghpur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,2.0,70.0,7.0,94.0,92.0,21.0,8.0,294.0
Narsinghpur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,208.0,261.0,318.0,438.0,326.0,327.0,280.0,347.0,307.0,326.0,255.0,253.0,3646.0
Narsinghpur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,74.0,64.0,61.0,73.0,71.0,93.0,66.0,46.0,61.0,61.0,66.0,53.0,789.0
Narsinghpur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,138.0,133.0,107.0,122.0,129.0,131.0,133.0,119.0,97.0,123.0,83.0,104.0,1419.0
Narsinghpur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,120.0,164.0,104.0,106.0,115.0,16.0,60.0,116.0,53.0,169.0,197.0,135.0,1355.0
Narsinghpur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narsinghpur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,540.0,622.0,590.0,739.0,641.0,567.0,539.0,628.0,518.0,679.0,601.0,545.0,7209.0
Narsinghpur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,267.0,166.0,248.0,176.0,254.0,194.0,203.0,234.0,166.0,192.0,147.0,209.0,2456.0
Narsinghpur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Narsinghpur,9.06,Number of IUCD removals,TOTAL,164.0,163.0,164.0,214.0,115.0,130.0,138.0,239.0,246.0,194.0,271.0,261.0,2299.0
Narsinghpur,9.07,Number of Oral Pills cycles distributed,TOTAL,2582.0,2713.0,2977.0,3453.0,3662.0,4140.0,4137.0,3844.0,4188.0,4235.0,3826.0,4322.0,44079.0
Narsinghpur,9.08,Number of Condom pieces distributed,TOTAL,20618.0,21960.0,29569.0,22341.0,23087.0,26300.0,30266.0,28401.0,30309.0,31192.0,33405.0,29390.0,326838.0
Narsinghpur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,5.0,0.0,37.0,42.0,9.0,3.0,3.0,9.0,6.0,6.0,120.0
Narsinghpur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,6.0
Narsinghpur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,3.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,5.0
Narsinghpur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,2.0,2.0,0.0,1.0,0.0,0.0,0.0,6.0
Narsinghpur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,9.12,Number of Institutions having NSV trained doctors,TOTAL,6.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,3.0,3.0,-1.0
Narsinghpur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1135.0,1213.0,1617.0,1770.0,1939.0,1429.0,1763.0,1647.0,1453.0,1430.0,1301.0,1326.0,18023.0
Narsinghpur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1211.0,1351.0,1607.0,1532.0,1504.0,1826.0,2033.0,955.0,352.0,247.0,106.0,0.0,12724.0
Narsinghpur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1310.0,1339.0,1491.0,1604.0,1259.0,1568.0,1753.0,1865.0,897.0,415.0,155.0,84.0,13740.0
Narsinghpur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1453.0,1433.0,1518.0,1606.0,1407.0,1399.0,1602.0,1591.0,1700.0,870.0,391.0,189.0,15159.0
Narsinghpur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,896.0,1621.0,1515.0,1467.0,1915.0,7414.0
Narsinghpur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,45.0,823.0,1143.0,1554.0,1888.0,5453.0
Narsinghpur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,51.0,0.0,705.0,1288.0,2004.0,4048.0
Narsinghpur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1089.0,1160.0,1524.0,1670.0,1826.0,1303.0,1668.0,1581.0,1382.0,1354.0,1237.0,1223.0,17017.0
Narsinghpur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1211.0,1351.0,1607.0,1532.0,1418.0,1828.0,2027.0,1651.0,1705.0,1626.0,1577.0,2004.0,19537.0
Narsinghpur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1310.0,1339.0,1491.0,1604.0,1259.0,1568.0,1759.0,1841.0,1737.0,1940.0,1707.0,1935.0,19490.0
Narsinghpur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1453.0,1433.0,1518.0,1606.0,1299.0,1399.0,1608.0,1583.0,1678.0,1592.0,1667.0,2094.0,18930.0
Narsinghpur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1032.0,1140.0,1508.0,1651.0,1809.0,1280.0,1644.0,1753.0,1338.0,1354.0,1214.0,1216.0,16939.0
Narsinghpur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1171.0,1351.0,1606.0,1532.0,1504.0,1786.0,2033.0,1026.0,579.0,250.0,218.0,150.0,13206.0
Narsinghpur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1311.0,1339.0,1491.0,1604.0,1259.0,1568.0,1769.0,1868.0,884.0,415.0,264.0,225.0,13997.0
Narsinghpur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1461.0,1433.0,1518.0,1606.0,1299.0,1399.0,1608.0,1543.0,1596.0,849.0,429.0,320.0,15061.0
Narsinghpur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1309.0,1522.0,1427.0,2439.0,1946.0,1921.0,1737.0,1413.0,1473.0,1512.0,1756.0,2146.0,20601.0
Narsinghpur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,926.0,1366.0,1524.0,1798.0,1280.0,1215.0,1381.0,1420.0,1493.0,1367.0,1518.0,2082.0,17370.0
Narsinghpur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,677.0,775.0,743.0,1270.0,978.0,979.0,915.0,773.0,763.0,719.0,930.0,1007.0,10529.0
Narsinghpur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,634.0,738.0,672.0,1170.0,832.0,955.0,841.0,688.0,710.0,702.0,831.0,876.0,9649.0
Narsinghpur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1311.0,1513.0,1415.0,2440.0,1810.0,1934.0,1756.0,1461.0,1473.0,1421.0,1761.0,1883.0,20178.0
Narsinghpur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1272.0,1462.0,1545.0,1821.0,1280.0,1291.0,1366.0,1378.0,1557.0,1597.0,1732.0,2245.0,18546.0
Narsinghpur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1266.0,1463.0,1547.0,1821.0,1280.0,1298.0,1369.0,1424.0,1557.0,1467.0,1768.0,2245.0,18505.0
Narsinghpur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,218.0,199.0,170.0,447.0,238.0,289.0,270.0,252.0,242.0,264.0,380.0,312.0,3281.0
Narsinghpur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,205.0,207.0,145.0,389.0,198.0,241.0,246.0,220.0,221.0,233.0,365.0,290.0,2960.0
Narsinghpur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,423.0,406.0,315.0,836.0,436.0,530.0,516.0,472.0,463.0,497.0,745.0,602.0,6241.0
Narsinghpur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,930.0,1091.0,1393.0,1816.0,1358.0,1190.0,1315.0,1281.0,1425.0,1731.0,1526.0,1697.0,16753.0
Narsinghpur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,825.0,999.0,1448.0,1465.0,1309.0,1210.0,1284.0,1274.0,1321.0,1483.0,1459.0,1702.0,15779.0
Narsinghpur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,891.0,1053.0,1472.0,1689.0,1331.0,1389.0,1326.0,1279.0,1341.0,1518.0,1560.0,1792.0,16641.0
Narsinghpur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Narsinghpur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,6.0
Narsinghpur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1146.0,1156.0,1142.0,1151.0,1116.0,1111.0,1152.0,1139.0,1145.0,1144.0,1126.0,1181.0,13709.0
Narsinghpur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1146.0,1156.0,1141.0,1151.0,1116.0,1111.0,1152.0,1139.0,1145.0,1144.0,1125.0,1181.0,13707.0
Narsinghpur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1098.0,1110.0,1100.0,1110.0,1099.0,1090.0,1098.0,1088.0,1095.0,1099.0,1075.0,1102.0,13164.0
Narsinghpur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1288.0,1514.0,1415.0,2445.0,1899.0,2016.0,1741.0,1432.0,1449.0,1452.0,1750.0,2019.0,20420.0
Narsinghpur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,984.0,854.0,888.0,4191.0,1585.0,1379.0,1160.0,1456.0,2088.0,5370.0,1256.0,867.0,22078.0
Narsinghpur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,468.0,448.0,583.0,2395.0,752.0,590.0,610.0,669.0,1005.0,12250.0,348.0,285.0,20403.0
Narsinghpur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,557.0,741.0,619.0,740.0,702.0,494.0,384.0,427.0,367.0,327.0,281.0,752.0,6391.0
Narsinghpur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,5.0,2.0,11.0,13.0,13.0,8.0,11.0,102.0,0.0,165.0
Narsinghpur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,16.0,0.0,84.0,0.0,27.0,26.0,25.0,0.0,0.0,178.0
Narsinghpur,13.1,Number of Patients operated for cataract,TOTAL,37.0,67.0,498.0,396.0,422.0,579.0,117.0,148.0,144.0,136.0,110.0,148.0,2802.0
Narsinghpur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,37.0,61.0,55.0,50.0,89.0,83.0,106.0,137.0,133.0,124.0,101.0,138.0,1114.0
Narsinghpur,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,83.0,953.0,515.0,719.0,39.0,39.0,41.0,0.0,2389.0
Narsinghpur,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,770.0,564.0,611.0,39.0,39.0,41.0,0.0,2064.0
Narsinghpur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Narsinghpur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,7.0,6.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,5.0,-1.0
Narsinghpur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,8.0,9.0,8.0,8.0,7.0,7.0,6.0,5.0,5.0,6.0,6.0,7.0,-1.0
Narsinghpur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,772.0,894.0,845.0,864.0,878.0,870.0,836.0,879.0,876.0,872.0,897.0,912.0,-1.0
Narsinghpur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,7.0,6.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,-1.0
Narsinghpur,14.05,Number of RKS meetings held during the month,TOTAL,1.0,2.0,2.0,2.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,11.0
Narsinghpur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,12.0,13.0,12.0,13.0,11.0,11.0,9.0,10.0,9.0,9.0,13.0,11.0,-1.0
Narsinghpur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,129.0,563.0,283.0,924.0,837.0,191.0,184.0,190.0,203.0,170.0,232.0,157.0,4063.0
Narsinghpur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,6.0,6.0,5.0,6.0,5.0,6.0,6.0,6.0,6.0,6.0,6.0,5.0,-1.0
Narsinghpur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,6.0,2.0,4.0,4.0,4.0,4.0,4.0,4.0,3.0,3.0,2.0,-1.0
Narsinghpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,365.0,367.0,401.0,696.0,847.0,376.0,428.0,489.0,308.0,329.0,346.0,648.0,5600.0
Narsinghpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1771.0,1620.0,1626.0,1603.0,2620.0,1286.0,1696.0,1349.0,1168.0,1175.0,671.0,1179.0,17764.0
Narsinghpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,524.0,334.0,276.0,375.0,509.0,583.0,411.0,467.0,285.0,302.0,280.0,695.0,5041.0
Narsinghpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1989.0,1573.0,1871.0,2221.0,3685.0,1687.0,2456.0,1734.0,2441.0,2204.0,1338.0,1557.0,24756.0
Narsinghpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,889.0,701.0,677.0,1071.0,1356.0,959.0,839.0,956.0,593.0,631.0,626.0,1343.0,10641.0
Narsinghpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3760.0,3193.0,3497.0,3824.0,6305.0,2973.0,4152.0,3083.0,3609.0,3379.0,2009.0,2736.0,42520.0
Narsinghpur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,12.0,16.0,6.0,7.0,12.0,21.0,19.0,16.0,14.0,13.0,15.0,2.0,153.0
Narsinghpur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,15.0,13.0,3.0,12.0,18.0,9.0,13.0,10.0,10.0,7.0,5.0,0.0,115.0
Narsinghpur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,27.0,29.0,9.0,19.0,30.0,30.0,32.0,26.0,24.0,20.0,20.0,2.0,268.0
Narsinghpur,14.11,In-Patient Head Count at midnight,TOTAL,2855.0,1842.0,2334.0,2460.0,2810.0,2894.0,2374.0,2215.0,2040.0,1788.0,1183.0,3269.0,28064.0
Narsinghpur,14.12.1,OPD attendance (All),TOTAL,46264.0,44132.0,40486.0,55478.0,55891.0,76246.0,68678.0,62158.0,58004.0,57486.0,54210.0,55417.0,674450.0
Narsinghpur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,66.0,63.0,9.0,97.0,63.0,90.0,51.0,67.0,74.0,14.0,130.0,15.0,739.0
Narsinghpur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28.0,0.0,0.0,4.0,33.0
Narsinghpur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,157.0,116.0,110.0,379.0,320.0,289.0,96.0,374.0,192.0,302.0,76.0,90.0,2501.0
Narsinghpur,14.14.a,Number of patients given AYUSH treatment,TOTAL,1.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,56.0
Narsinghpur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,58.0,302.0,65.0,47.0,70.0,83.0,87.0,89.0,57.0,190.0,175.0,265.0,1488.0
Narsinghpur,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,223.0,223.0
Narsinghpur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2520.0,3524.0,2985.0,3720.0,2550.0,2855.0,3538.0,5365.0,4059.0,4162.0,4304.0,4565.0,44147.0
Narsinghpur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,19.0,42.0,62.0,97.0,45.0,57.0,54.0,73.0,92.0,90.0,166.0,440.0,1237.0
Narsinghpur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,125.0,231.0,78.0,581.0,362.0,71.0,100.0,150.0,62.0,152.0,160.0,151.0,2223.0
Narsinghpur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,1.0,0.0,2.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,7.0
Narsinghpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,887.0,601.0,99.0,268.0,291.0,178.0,139.0,340.0,278.0,326.0,217.0,237.0,3861.0
Narsinghpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,5.0
Narsinghpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,839.0,645.0,830.0,1595.0,777.0,715.0,595.0,818.0,860.0,730.0,477.0,484.0,9365.0
Narsinghpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,5.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,7.0
Narsinghpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1851.0,1477.0,1007.0,2444.0,1430.0,964.0,834.0,1308.0,1200.0,1208.0,854.0,872.0,15449.0
Narsinghpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,6.0,2.0,0.0,4.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,4.0,19.0
Narsinghpur,15.2,Number of Widal tests conducted,Number tested,307.0,262.0,121.0,174.0,252.0,673.0,1176.0,566.0,712.0,259.0,341.0,392.0,5235.0
Narsinghpur,15.3.a,Number of VDRL tests conducted on males,Number tested,118.0,83.0,10.0,66.0,9.0,32.0,270.0,287.0,120.0,171.0,73.0,85.0,1324.0
Narsinghpur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,242.0,166.0,4.0,8.0,15.0,66.0,346.0,260.0,599.0,97.0,118.0,40.0,1961.0
Narsinghpur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,401.0,116.0,69.0,107.0,86.0,27.0,68.0,106.0,446.0,414.0,432.0,335.0,2607.0
Narsinghpur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,761.0,365.0,83.0,181.0,110.0,125.0,684.0,653.0,1165.0,682.0,623.0,460.0,5892.0
Narsinghpur,15.4.1,Number of blood smears examined for Malaria,TOTAL,7930.0,5111.0,7420.0,10464.0,10697.0,16660.0,12643.0,10282.0,8472.0,4953.0,5325.0,8123.0,108080.0
Narsinghpur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,8.0,19.0,17.0,63.0,100.0,160.0,120.0,128.0,99.0,68.0,13.0,54.0,849.0
Narsinghpur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,9.0,12.0,7.0,33.0,78.0,94.0,80.0,60.0,51.0,94.0,10.0,49.0,577.0
Narsinghpur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2750.0,2850.0,2550.0,2700.0,2495.0,2850.0,2550.0,2150.0,3450.0,2850.0,2100.0,1950.0,31245.0
Narsinghpur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,1000.0,1000.0,1000.0,0.0,0.0,1000.0,2000.0,0.0,0.0,0.0,0.0,8000.0
Narsinghpur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1900.0,1300.0,850.0,1205.0,350.0,300.0,1400.0,700.0,600.0,750.0,150.0,350.0,9855.0
Narsinghpur,16.1.1,Stock position of DPT vaccines,5. Total Stock,2850.0,2550.0,2700.0,2495.0,2145.0,2550.0,2150.0,3450.0,2850.0,2100.0,1950.0,1600.0,29390.0
Narsinghpur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,778.0,269.0,1137.0,562.0,212.0,2958.0
Narsinghpur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,1050.0,,900.0,0.0,0.0,900.0,2850.0
Narsinghpur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,272.0,510.0,32.0,575.0,350.0,250.0,1989.0
Narsinghpur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,778.0,268.0,1137.0,562.0,212.0,862.0,3819.0
Narsinghpur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,585.0,850.0,325.0,675.0,1400.0,400.0,650.0,675.0,800.0,11694.0,713.0,411.0,19178.0
Narsinghpur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1000.0,700.0,1000.0,700.0,0.0,800.0,1000.0,1000.0,11344.0,0.0,10450.0,700.0,28694.0
Narsinghpur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,735.0,1225.0,650.0,975.0,1000.0,550.0,975.0,875.0,450.0,10981.0,10752.0,253.0,29421.0
Narsinghpur,16.1.2,Stock position of OPV vaccines,5. Total Stock,850.0,325.0,675.0,400.0,400.0,650.0,675.0,800.0,11694.0,713.0,411.0,858.0,18451.0
Narsinghpur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2050.0,2350.0,2750.0,2650.0,2450.0,1500.0,650.0,1600.0,1950.0,2250.0,1500.0,1100.0,22800.0
Narsinghpur,16.1.3,Stock position of TT vaccines,2. Stocks Received,1000.0,2000.0,500.0,1000.0,0.0,0.0,2000.0,1000.0,1000.0,0.0,0.0,1000.0,9500.0
Narsinghpur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,700.0,1600.0,600.0,1200.0,950.0,850.0,1050.0,650.0,700.0,750.0,400.0,700.0,10150.0
Narsinghpur,16.1.3,Stock position of TT vaccines,5. Total Stock,2350.0,2750.0,2650.0,2450.0,1500.0,650.0,1600.0,1950.0,2250.0,1500.0,1100.0,1400.0,22150.0
Narsinghpur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
Narsinghpur,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
Narsinghpur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Narsinghpur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0
Narsinghpur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,550.0,950.0,1000.0,1550.0,2150.0,1250.0,1700.0,1900.0,1700.0,2400.0,2000.0,1600.0,18750.0
Narsinghpur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000.0,1000.0,1000.0,800.0,0.0,800.0,1000.0,500.0,1000.0,0.0,0.0,1000.0,8100.0
Narsinghpur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,600.0,950.0,450.0,1005.0,900.0,350.0,800.0,700.0,300.0,400.0,400.0,600.0,7455.0
Narsinghpur,16.1.5,Stock position of BCG vaccines,5. Total Stock,950.0,1000.0,1550.0,1345.0,1250.0,1700.0,1900.0,1700.0,2400.0,2000.0,1600.0,2000.0,19395.0
Narsinghpur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,400.0,1600.0,2150.0,1750.0,2200.0,1250.0,800.0,500.0,1750.0,2300.0,1500.0,500.0,16700.0
Narsinghpur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2000.0,2000.0,0.0,2000.0,0.0,0.0,1000.0,2000.0,1500.0,0.0,0.0,1000.0,11500.0
Narsinghpur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,800.0,1450.0,400.0,1555.0,950.0,450.0,1300.0,750.0,950.0,800.0,1000.0,1050.0,11455.0
Narsinghpur,16.1.6,Stock position of Measles vaccines,5. Total Stock,1600.0,2150.0,1750.0,2195.0,1250.0,800.0,500.0,1750.0,2300.0,1500.0,500.0,450.0,16745.0
Narsinghpur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Narsinghpur,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Narsinghpur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Narsinghpur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Narsinghpur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1000.0,2050.0,1650.0,1850.0,2500.0,1500.0,1200.0,1150.0,1750.0,2150.0,1600.0,1350.0,19750.0
Narsinghpur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,2000.0,1000.0,1000.0,1000.0,0.0,800.0,1000.0,1000.0,1000.0,0.0,0.0,0.0,8800.0
Narsinghpur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,950.0,1400.0,800.0,1355.0,950.0,1100.0,1050.0,400.0,600.0,550.0,250.0,350.0,9755.0
Narsinghpur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2050.0,1650.0,1850.0,1495.0,1550.0,1200.0,1150.0,1750.0,2150.0,1600.0,1350.0,1000.0,18795.0
Narsinghpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,4900.0,4600.0,2300.0,3300.0,3300.0,2700.0,1800.0,5400.0,2400.0,2500.0,2000.0,2800.0,38000.0
Narsinghpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,600.0,0.0,3600.0,,1200.0,0.0,2400.0,3600.0,11400.0
Narsinghpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,300.0,2300.0,200.0,0.0,1200.0,900.0,0.0,3000.0,1100.0,500.0,1600.0,600.0,11700.0
Narsinghpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,4600.0,2300.0,2100.0,3300.0,2700.0,1800.0,5400.0,2400.0,2500.0,2000.0,2800.0,5800.0,37700.0
Narsinghpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,125600.0,60320.0,14920.0,4840.0,4840.0,81640.0,8550.0,8550.0,550.0,48550.0,550.0,18550.0,377460.0
Narsinghpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,100800.0,0.0,0.0,,48000.0,0.0,24000.0,24000.0,196800.0
Narsinghpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,65280.0,45400.0,10080.0,0.0,32000.0,73090.0,0.0,,0.0,48000.0,6000.0,18000.0,297850.0
Narsinghpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,60320.0,14920.0,4840.0,4840.0,73640.0,8550.0,8550.0,8550.0,48550.0,550.0,18550.0,24550.0,276410.0
Narsinghpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,200.0,200.0,200.0,30100.0,18900.0,12900.0,2500.0,7500.0,1900.0,21200.0,18200.0,32400.0,146200.0
Narsinghpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,1800.0,0.0,5000.0,,20000.0,0.0,18000.0,21000.0,65800.0
Narsinghpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,100.0,0.0,7800.0,10400.0,2500.0,5600.0,700.0,3000.0,3800.0,21600.0,55500.0
Narsinghpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,200.0,200.0,100.0,30100.0,12900.0,2500.0,5000.0,1900.0,21200.0,18200.0,32400.0,31800.0,156500.0
Narsinghpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,4430.0,3530.0,2930.0,2030.0,2030.0,3510.0,860.0,1860.0,1510.0,4460.0,4460.0,10760.0,42370.0
Narsinghpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,1500.0,0.0,1000.0,,3000.0,0.0,6500.0,1800.0,13800.0
Narsinghpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,900.0,0.0,900.0,0.0,20.0,2650.0,200.0,350.0,50.0,0.0,200.0,1500.0,6770.0
Narsinghpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,3530.0,3530.0,2030.0,2030.0,3510.0,860.0,1660.0,1510.0,4460.0,4460.0,10760.0,11060.0,49400.0
Narsinghpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,23950.0,23950.0,23950.0,26440.0,0.0,24940.0,24940.0,23840.0,21340.0,20440.0,19640.0,23305.0,256735.0
Narsinghpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,4465.0,0.0,4465.0
Narsinghpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,500.0,0.0,0.0,0.0,1000.0,2500.0,900.0,800.0,800.0,0.0,6500.0
Narsinghpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,23950.0,23950.0,23450.0,26440.0,0.0,24940.0,23940.0,21340.0,20440.0,19640.0,23305.0,23305.0,254700.0
Narsinghpur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,5750.0,4950.0,350.0,2350.0,2250.0,3250.0,,,,,825.0,95.0,19820.0
Narsinghpur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,2000.0,0.0,,,,,0.0,0.0,2000.0
Narsinghpur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0
Narsinghpur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,800.0,4600.0,0.0,100.0,1000.0,2950.0,,,,,730.0,60.0,10240.0
Narsinghpur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,4950.0,350.0,350.0,2250.0,3250.0,300.0,0.0,0.0,0.0,0.0,95.0,35.0,11580.0
Narsinghpur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,13300.0,11300.0,4300.0,0.0,29300.0,,,,,,,58200.0
Narsinghpur,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Narsinghpur,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Narsinghpur,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,2000.0,7000.0,0.0,0.0,5050.0,,,,,,,14050.0
Narsinghpur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,11300.0,4300.0,4300.0,0.0,24250.0,0.0,0.0,0.0,0.0,0.0,0.0,44150.0
Narsinghpur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Narsinghpur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Narsinghpur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Narsinghpur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Narsinghpur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,71495.0,62400.0,60100.0,58400.0,54400.0,54300.0,39800.0,39800.0,25100.0,22100.0,22100.0,21900.0,531895.0
Narsinghpur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,9095.0,2300.0,1700.0,4000.0,100.0,14500.0,12700.0,14700.0,3000.0,0.0,200.0,700.0,62995.0
Narsinghpur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,62400.0,60100.0,58400.0,54400.0,54300.0,39800.0,27100.0,25100.0,22100.0,22100.0,21900.0,21200.0,468900.0
Narsinghpur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Narsinghpur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Narsinghpur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Narsinghpur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Narsinghpur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Narsinghpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Narsinghpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Narsinghpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Narsinghpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,1800000.0,1720000.0,1399000.0,744000.0,644000.0,504000.0,120000.0,,1668000.0,3290000.0,2129400.0,1929400.0,15947800.0
Narsinghpur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3000000.0,0.0,0.0,0.0,3000000.0
Narsinghpur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,321000.0,655000.0,100000.0,140000.0,384000.0,105000.0,,1378000.0,1160600.0,200000.0,375000.0,4818600.0
Narsinghpur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,1800000.0,1399000.0,744000.0,644000.0,504000.0,120000.0,15000.0,0.0,3290000.0,2129400.0,1929400.0,1554400.0,14129200.0
Narsinghpur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,20234.0,16494.0,104808.0,96564.0,1924.0,1184.0,284.0,,164.0,572.0,72626.0,22456.0,337310.0
Narsinghpur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1080.0,89872.0,19872.0,0.0,110824.0
Narsinghpur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,3940.0,4686.0,8244.0,94640.0,740.0,900.0,120.0,,672.0,17818.0,70042.0,11400.0,213202.0
Narsinghpur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,16294.0,11808.0,96564.0,1924.0,1184.0,284.0,164.0,0.0,572.0,72626.0,22456.0,11056.0,234932.0
Narsinghpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,2850.0,,1750.0,1750.0,850.0,750.0,7950.0
Narsinghpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,900.0,,0.0,900.0,100.0,450.0,2350.0
Narsinghpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,1950.0,0.0,1750.0,850.0,750.0,300.0,5600.0
Narsinghpur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,9500.0,9100.0,8600.0,4800.0,2300.0,1800.0,800.0,,800.0,75.0,2675.0,2450.0,42900.0
Narsinghpur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,2600.0,0.0,0.0,2600.0
Narsinghpur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,400.0,500.0,3800.0,2500.0,500.0,1000.0,0.0,,725.0,0.0,225.0,0.0,9650.0
Narsinghpur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,9100.0,8600.0,4800.0,2300.0,1800.0,800.0,800.0,0.0,75.0,2675.0,2450.0,2450.0,35850.0
Narsinghpur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,83000.0,128000.0,27350.0,1050.0,10500.0,55500.0,37500.0,,21500.0,15500.0,9500.0,2500.0,391900.0
Narsinghpur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,150000.0,0.0,0.0,,0.0,0.0,0.0,0.0,150000.0
Narsinghpur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Narsinghpur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,5000.0,100650.0,16850.0,0.0,95550.0,18000.0,6000.0,,6000.0,6000.0,7000.0,0.0,261050.0
Narsinghpur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,78000.0,27350.0,10500.0,1050.0,64950.0,37500.0,31500.0,0.0,15500.0,9500.0,2500.0,2500.0,280850.0
Narsinghpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,9000.0,14900.0,8600.0,5600.0,5600.0,5600.0,5600.0,22100.0,22100.0,132000.0,132000.0,13200.0,376300.0
Narsinghpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,9900.0,0.0,0.0,0.0,0.0,0.0,19800.0,,0.0,0.0,0.0,,29700.0
Narsinghpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Narsinghpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3000.0,6300.0,3000.0,0.0,0.0,0.0,3300.0,,8900.0,0.0,0.0,,24500.0
Narsinghpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,15900.0,8600.0,5600.0,5600.0,5600.0,5600.0,22100.0,22100.0,13200.0,132000.0,132000.0,13200.0,381500.0
Narsinghpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,48000.0,102000.0,102000.0,102000.0,102000.0,102000.0,102000.0,334000.0,334000.0,306000.0,306000.0,306000.0,2246000.0
Narsinghpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,54000.0,0.0,0.0,0.0,0.0,0.0,25000.0,,0.0,0.0,0.0,,79000.0
Narsinghpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Narsinghpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,18000.0,,28000.0,0.0,0.0,,46000.0
Narsinghpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,102000.0,102000.0,102000.0,102000.0,102000.0,102000.0,109000.0,334000.0,306000.0,306000.0,306000.0,306000.0,2279000.0
Narsinghpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,5600.0,15900.0,8100.0,8100.0,8100.0,81000.0,8100.0,28100.0,28100.0,24100.0,24100.0,24100.0,263400.0
Narsinghpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,6000.0,0.0,0.0,0.0,0.0,0.0,30100.0,,0.0,0.0,0.0,,36100.0
Narsinghpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Narsinghpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1000.0,7800.0,0.0,0.0,0.0,0.0,2000.0,,4000.0,0.0,0.0,,14800.0
Narsinghpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,10600.0,8100.0,8100.0,8100.0,8100.0,81000.0,36200.0,28100.0,24100.0,24100.0,24100.0,24100.0,284700.0
Narsinghpur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,4.0,5.0,7.0,,1.0,1.0,1.0,,1.0,1.0,1.0,23.0
Narsinghpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,1.0,,1.0,,,,,,,1.0,3.0
Narsinghpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Narsinghpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,1.0,,1.0,,,,,,,1.0,3.0
Narsinghpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,1.0,,,1.0,,,2.0
Narsinghpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Narsinghpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,1.0,,,1.0,,,2.0
Narsinghpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,7.0,4.0,4.0,7.0,6.0,4.0,2.0,4.0,6.0,3.0,4.0,1.0,52.0
Narsinghpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,2.0,1.0,,,2.0,,1.0,,,1.0,,7.0
Narsinghpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,7.0,6.0,5.0,7.0,6.0,6.0,2.0,5.0,6.0,3.0,5.0,1.0,59.0
Narsinghpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,6.0,1.0,2.0,4.0,1.0,3.0,3.0,1.0,6.0,4.0,6.0,38.0
Narsinghpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,1.0,,,,,,,,,2.0
Narsinghpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,6.0,1.0,3.0,4.0,1.0,3.0,3.0,1.0,6.0,4.0,6.0,40.0
Narsinghpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,2.0,,,,,,1.0,,,,,3.0
Narsinghpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,1.0,1.0,,,,,2.0
Narsinghpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,2.0,,,,,1.0,2.0,,,,,5.0
Narsinghpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,1.0,,,1.0,,,,,2.0
Narsinghpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Narsinghpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,1.0,,,1.0,,,,,2.0
Narsinghpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,3.0,,1.0,,,,,,5.0
Narsinghpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,3.0,,1.0,,,,,,,4.0
Narsinghpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,3.0,3.0,1.0,1.0,,,,,,9.0
Narsinghpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Narsinghpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Narsinghpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Narsinghpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,2.0,9.0,2.0,10.0,2.0,,6.0,3.0,,,,36.0
Narsinghpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,1.0,5.0,3.0,,3.0,1.0,3.0,1.0,1.0,2.0,21.0
Narsinghpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,2.0,10.0,7.0,13.0,2.0,3.0,7.0,6.0,1.0,1.0,2.0,57.0
Narsinghpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Narsinghpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,1.0,1.0,,,,,,2.0
Narsinghpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Narsinghpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,1.0,2.0,,,,,,3.0
Narsinghpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Narsinghpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,3.0,,3.0,,,1.0,1.0,2.0,,2.0,1.0,13.0
Narsinghpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,2.0,,,,,,2.0,2.0,1.0,2.0,,9.0
Narsinghpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,5.0,,3.0,,,1.0,3.0,4.0,1.0,4.0,1.0,22.0
Narsinghpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Narsinghpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,1.0,,1.0,,,,,,,,3.0
Narsinghpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Narsinghpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,,1.0,,1.0,,,,,,,,3.0
Narsinghpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Narsinghpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Narsinghpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Narsinghpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Narsinghpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,2.0,,,,,2.0
Narsinghpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,,4.0,3.0,1.0,,,,,1.0,1.0,11.0
Narsinghpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,2.0,,2.0,,1.0,,,1.0,,,1.0,7.0
Narsinghpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,3.0,,6.0,3.0,2.0,,2.0,1.0,,1.0,2.0,20.0
Narsinghpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Narsinghpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Narsinghpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Narsinghpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Narsinghpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Narsinghpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,2.0,4.0,6.0,3.0,3.0,1.0,5.0,4.0,2.0,2.0,10.0,43.0
Narsinghpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2.0,4.0,3.0,3.0,,2.0,2.0,3.0,2.0,2.0,2.0,6.0,31.0
Narsinghpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,4.0,6.0,7.0,9.0,3.0,5.0,3.0,8.0,6.0,4.0,4.0,16.0,75.0
Narsinghpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Narsinghpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,,1.0,1.0,1.0,,,,,,1.0,,5.0
Narsinghpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Narsinghpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,,1.0,1.0,1.0,,,,,,2.0,,6.0
Narsinghpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Narsinghpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Narsinghpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Narsinghpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Narsinghpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Narsinghpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Narsinghpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Narsinghpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,1.0,,,,,,1.0
Narsinghpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Narsinghpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,1.0,,,,,,,,1.0,,3.0
Narsinghpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Narsinghpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,1.0,,,,,,,,1.0,,3.0
Narsinghpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Narsinghpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Narsinghpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Narsinghpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Narsinghpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Narsinghpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Narsinghpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Narsinghpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Narsinghpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Narsinghpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,3.0,2.0,,,1.0,,,1.0,1.0,1.0,,9.0
Narsinghpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Narsinghpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,3.0,2.0,,,1.0,,,1.0,1.0,1.0,,9.0
Narsinghpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,2.0,2.0,1.0,1.0,2.0,,2.0,,1.0,,12.0
Narsinghpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,4.0,7.0,12.0,6.0,4.0,4.0,9.0,4.0,7.0,3.0,3.0,7.0,70.0
Narsinghpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,3.0,2.0,2.0,1.0,,,1.0,,,,2.0,11.0
Narsinghpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,11.0,16.0,10.0,6.0,5.0,11.0,5.0,9.0,3.0,4.0,9.0,93.0
Narsinghpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Narsinghpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,5.0,4.0,1.0,1.0,2.0,6.0,2.0,,2.0,1.0,3.0,31.0
Narsinghpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,1.0,,,,,,,,1.0,,2.0
Narsinghpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,5.0,5.0,1.0,1.0,2.0,6.0,2.0,,2.0,2.0,3.0,33.0
Narsinghpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Narsinghpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,2.0,1.0,1.0,1.0,,,,,,,,6.0
Narsinghpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Narsinghpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,2.0,1.0,1.0,1.0,,,,,,,,6.0
Narsinghpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Narsinghpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Narsinghpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,2.0,,,,,1.0,,,1.0,,1.0,5.0
Narsinghpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,2.0,,,,,2.0,,,1.0,,2.0,7.0
Narsinghpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Narsinghpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,3.0,,2.0,,3.0,1.0,,,,1.0,,,10.0
Narsinghpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,3.0,,,,1.0,1.0,,1.0,3.0,,1.0,10.0
Narsinghpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,3.0,3.0,2.0,,3.0,2.0,1.0,,1.0,4.0,,1.0,20.0
Narsinghpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,1.0,2.0,2.0,2.0,,,,1.0,3.0,,,13.0
Narsinghpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,8.0,14.0,8.0,9.0,18.0,11.0,9.0,11.0,8.0,8.0,4.0,14.0,122.0
Narsinghpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,34.0,56.0,50.0,52.0,27.0,29.0,27.0,27.0,40.0,23.0,24.0,34.0,423.0
Narsinghpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,44.0,71.0,60.0,63.0,47.0,40.0,36.0,38.0,49.0,34.0,28.0,48.0,558.0
Neemuch,1.1,Total number of pregnant women Registered for ANC,TOTAL,1066.0,1300.0,1434.0,1441.0,1202.0,1710.0,1364.0,1269.0,1281.0,1306.0,1382.0,1531.0,16286.0
Neemuch,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,563.0,670.0,876.0,919.0,759.0,1084.0,824.0,779.0,743.0,850.0,820.0,969.0,9856.0
Neemuch,1.2,Number of Pregnant women registered under JSY,TOTAL,1066.0,1300.0,1434.0,1441.0,1202.0,1710.0,1364.0,1269.0,1281.0,1192.0,1382.0,1531.0,16172.0
Neemuch,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,872.0,1053.0,1032.0,1096.0,961.0,1162.0,809.0,1096.0,1004.0,1080.0,1054.0,1221.0,12440.0
Neemuch,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,965.0,1280.0,1409.0,1441.0,1199.0,1620.0,1293.0,1252.0,1281.0,1276.0,1289.0,1465.0,15770.0
Neemuch,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,927.0,1165.0,1222.0,1295.0,1316.0,1211.0,1201.0,1034.0,1141.0,1158.0,1087.0,1371.0,14128.0
Neemuch,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1066.0,1300.0,1434.0,1441.0,1109.0,1612.0,907.0,1252.0,1268.0,1242.0,1364.0,1531.0,15526.0
Neemuch,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,82.0,103.0,47.0,61.0,42.0,45.0,61.0,77.0,73.0,112.0,40.0,73.0,816.0
Neemuch,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,32.0,0.0,17.0,0.0,0.0,50.0
Neemuch,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,516.0,438.0,636.0,750.0,626.0,674.0,542.0,710.0,752.0,652.0,638.0,790.0,7724.0
Neemuch,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,45.0,8.0,17.0,22.0,84.0,40.0,52.0,82.0,66.0,125.0,133.0,2.0,676.0
Neemuch,1.8,Number of pregnancy test kits used at SC level,TOTAL,78.0,345.0,891.0,598.0,417.0,501.0,327.0,418.0,399.0,385.0,401.0,403.0,5163.0
Neemuch,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,3.0,17.0,22.0,14.0,23.0,25.0,30.0,22.0,30.0,17.0,16.0,13.0,232.0
Neemuch,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,33.0,32.0,46.0,41.0,37.0,41.0,20.0,26.0,20.0,30.0,25.0,31.0,382.0
Neemuch,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,36.0,49.0,68.0,55.0,60.0,66.0,50.0,48.0,50.0,47.0,41.0,44.0,614.0
Neemuch,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,34.0,46.0,59.0,55.0,57.0,66.0,44.0,47.0,48.0,45.0,37.0,41.0,579.0
Neemuch,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,3.0,2.0,0.0,2.0,0.0,0.0,0.0,1.0,8.0
Neemuch,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,851.0,878.0,1123.0,992.0,1094.0,1063.0,954.0,1017.0,1010.0,972.0,860.0,988.0,11802.0
Neemuch,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,12.0,11.0,25.0,42.0,106.0,22.0,15.0,19.0,22.0,27.0,9.0,6.0,316.0
Neemuch,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,465.0,479.0,694.0,847.0,1043.0,1017.0,950.0,944.0,909.0,975.0,705.0,669.0,9697.0
Neemuch,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,240.0,306.0,518.0,624.0,320.0,260.0,284.0,265.0,290.0,337.0,439.0,574.0,4457.0
Neemuch,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,55.0,,,55.0
Neemuch,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,0.0,,,0.0
Neemuch,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,0.0,,,0.0
Neemuch,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,0.0,,,0.0
Neemuch,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,64.0,65.0,75.0,66.0,116.0,74.0,64.0,62.0,76.0,91.0,63.0,65.0,881.0
Neemuch,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Neemuch,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,64.0,65.0,75.0,66.0,116.0,74.0,64.0,62.0,76.0,91.0,63.0,65.0,881.0
Neemuch,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,6.0,,,6.0
Neemuch,4.1.1.a,Number of male live births,TOTAL,455.0,477.0,628.0,527.0,581.0,568.0,547.0,569.0,538.0,525.0,466.0,539.0,6420.0
Neemuch,4.1.1.b,Number of female live births,TOTAL,412.0,432.0,548.0,504.0,549.0,531.0,459.0,485.0,500.0,545.0,420.0,476.0,5861.0
Neemuch,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,867.0,909.0,1176.0,1031.0,1130.0,1099.0,1006.0,1054.0,1038.0,1070.0,886.0,1015.0,12281.0
Neemuch,4.1.2,Number of still births,TOTAL,26.0,18.0,15.0,25.0,30.0,33.0,2.0,26.0,29.0,23.0,15.0,19.0,261.0
Neemuch,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,5.0,10.0,1.0,3.0,16.0,1.0,5.0,2.0,0.0,8.0,2.0,4.0,57.0
Neemuch,4.2.1,Number of Newborns weighed at birth,TOTAL,844.0,893.0,1139.0,1025.0,1116.0,1077.0,995.0,1030.0,1009.0,1011.0,867.0,988.0,11994.0
Neemuch,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,186.0,152.0,120.0,174.0,226.0,195.0,230.0,96.0,103.0,185.0,44.0,188.0,1899.0
Neemuch,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,865.0,852.0,1066.0,971.0,1031.0,1029.0,819.0,1054.0,950.0,863.0,886.0,1001.0,11387.0
Neemuch,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,9.0,5.0,5.0,5.0,0.0,0.0,0.0,0.0,24.0
Neemuch,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,34.0,8.0,8.0,10.0,5.0,6.0,10.0,47.0,21.0,20.0,169.0
Neemuch,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,80.0,65.0,87.0,183.0,208.0,97.0,101.0,239.0,225.0,142.0,114.0,90.0,1631.0
Neemuch,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Neemuch,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,80.0,65.0,121.0,191.0,225.0,112.0,111.0,250.0,235.0,189.0,135.0,110.0,1824.0
Neemuch,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,1.0,,,1.0
Neemuch,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,80.0,65.0,121.0,191.0,216.0,139.0,134.0,275.0,261.0,190.0,121.0,127.0,1920.0
Neemuch,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,70.0,57.0,75.0,183.0,206.0,87.0,89.0,10.0,4.0,15.0,5.0,15.0,816.0
Neemuch,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,80.0,65.0,115.0,191.0,221.0,144.0,98.0,285.0,256.0,248.0,73.0,30.0,1806.0
Neemuch,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,197.0,0.0,0.0,0.0,113.0,96.0,0.0,0.0,406.0
Neemuch,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,874.0,927.0,1189.0,1046.0,1148.0,1109.0,577.0,1070.0,1061.0,996.0,890.0,963.0,11850.0
Neemuch,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,469.0,536.0,762.0,793.0,1206.0,839.0,684.0,794.0,832.0,826.0,853.0,928.0,9522.0
Neemuch,6.3,PNC maternal complications attended,TOTAL,120.0,165.0,215.0,83.0,206.0,113.0,5.0,10.0,235.0,124.0,107.0,97.0,1480.0
Neemuch,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,11.0,18.0,20.0,11.0,17.0,15.0,10.0,12.0,12.0,8.0,32.0,13.0,179.0
Neemuch,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0
Neemuch,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,11.0,18.0,20.0,11.0,18.0,15.0,10.0,12.0,12.0,8.0,33.0,13.0,181.0
Neemuch,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,6.0
Neemuch,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,34.0,65.0,29.0,24.0,22.0,20.0,4.0,18.0,55.0,77.0,48.0,30.0,426.0
Neemuch,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,163.0,194.0,251.0,234.0,285.0,177.0,21.0,166.0,165.0,145.0,126.0,141.0,2068.0
Neemuch,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,197.0,259.0,280.0,258.0,307.0,197.0,25.0,184.0,220.0,222.0,174.0,171.0,2494.0
Neemuch,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,2.0,1.0,1.0,4.0,5.0,5.0,28.0,18.0,6.0,9.0,22.0,1.0,102.0
Neemuch,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,6.0,3.0,0.0,3.0,0.0,7.0,5.0,1.0,0.0,3.0,28.0
Neemuch,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,5.0,1.0,7.0,2.0,0.0,0.0,1.0,2.0,3.0,5.0,0.0,28.0
Neemuch,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Neemuch,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,4.0,6.0,8.0,14.0,7.0,8.0,28.0,26.0,13.0,13.0,27.0,4.0,158.0
Neemuch,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,0.0,,,0.0
Neemuch,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,38.0,18.0,40.0,37.0,23.0,28.0,48.0,48.0,29.0,23.0,57.0,2.0,391.0
Neemuch,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,4.0,39.0,35.0,13.0,13.0,0.0,54.0,154.0,168.0,118.0,41.0,639.0
Neemuch,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,3.0,2.0,2.0,2.0,1.0,0.0,20.0,55.0,43.0,39.0,0.0,167.0
Neemuch,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Neemuch,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,38.0,25.0,81.0,74.0,38.0,42.0,48.0,122.0,238.0,234.0,214.0,43.0,1197.0
Neemuch,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,0.0,,,0.0
Neemuch,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,73.0,55.0,62.0,48.0,62.0,46.0,64.0,65.0,140.0,132.0,28.0,775.0
Neemuch,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,29.0,30.0,45.0,24.0,26.0,29.0,14.0,51.0,0.0,3.0,0.0,127.0,378.0
Neemuch,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,10.0,24.0,31.0,29.0,15.0,28.0,9.0,31.0,20.0,40.0,31.0,19.0,287.0
Neemuch,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Neemuch,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,39.0,127.0,131.0,115.0,89.0,119.0,69.0,146.0,85.0,183.0,163.0,174.0,1440.0
Neemuch,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,1.0,,,1.0
Neemuch,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,2.0,0.0,2.0,2.0,1.0,1.0,0.0,1.0,3.0,7.0,15.0,34.0
Neemuch,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,18.0,28.0,40.0,28.0,22.0,29.0,27.0,16.0,0.0,36.0,10.0,0.0,254.0
Neemuch,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,4.0,18.0,11.0,10.0,12.0,8.0,7.0,13.0,16.0,26.0,11.0,10.0,146.0
Neemuch,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Neemuch,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,22.0,48.0,51.0,40.0,36.0,38.0,35.0,29.0,17.0,65.0,28.0,25.0,434.0
Neemuch,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,0.0,,,0.0
Neemuch,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,190.0,248.0,254.0,283.0,274.0,324.0,252.0,274.0,254.0,229.0,326.0,264.0,3172.0
Neemuch,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,5.0,5.0,8.0,5.0,6.0,8.0,9.0,10.0,7.0,10.0,23.0,14.0,110.0
Neemuch,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,5.0,9.0,18.0,15.0,5.0,2.0,4.0,2.0,0.0,9.0,10.0,2.0,81.0
Neemuch,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,27.0,46.0,39.0,62.0,75.0,57.0,62.0,62.0,59.0,19.0,57.0,69.0,634.0
Neemuch,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Neemuch,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,227.0,308.0,319.0,365.0,360.0,391.0,327.0,348.0,320.0,267.0,416.0,349.0,3997.0
Neemuch,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,53.0,24.0,27.0,11.0,14.0,24.0,47.0,44.0,11.0,4.0,23.0,13.0,295.0
Neemuch,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,0.0,,,0.0
Neemuch,9.06,Number of IUCD removals,TOTAL,250.0,231.0,176.0,218.0,306.0,224.0,182.0,315.0,252.0,188.0,315.0,211.0,2868.0
Neemuch,9.07,Number of Oral Pills cycles distributed,TOTAL,3979.0,5115.0,4874.0,4684.0,4268.0,4269.0,5118.0,5483.0,4610.0,4271.0,4483.0,4309.0,55463.0
Neemuch,9.08,Number of Condom pieces distributed,TOTAL,13183.0,14872.0,14598.0,14129.0,13082.0,13805.0,15836.0,15040.0,13107.0,11855.0,12114.0,12689.0,164310.0
Neemuch,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,2.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Neemuch,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,1.0,4.0,2.0,3.0,6.0,2.0,6.0,3.0,5.0,4.0,36.0
Neemuch,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0
Neemuch,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,4.0
Neemuch,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,2.0,1.0,1.0,2.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,-1.0
Neemuch,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,866.0,1006.0,1160.0,1065.0,1207.0,1229.0,1126.0,1139.0,1223.0,1108.0,1069.0,1213.0,13411.0
Neemuch,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,882.0,1019.0,1064.0,1114.0,1138.0,1209.0,1096.0,681.0,218.0,270.0,144.0,29.0,8864.0
Neemuch,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,926.0,1005.0,1105.0,1109.0,1119.0,1224.0,1131.0,1205.0,594.0,355.0,185.0,30.0,9988.0
Neemuch,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1010.0,1125.0,1051.0,1187.0,1190.0,1153.0,1094.0,1146.0,1134.0,620.0,217.0,65.0,10992.0
Neemuch,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,668.0,851.0,983.0,1108.0,1333.0,4943.0
Neemuch,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,477.0,859.0,1114.0,1240.0,3691.0
Neemuch,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,545.0,1014.0,1284.0,2846.0
Neemuch,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,816.0,959.0,1113.0,1065.0,1086.0,1166.0,1092.0,1090.0,1135.0,1080.0,985.0,1103.0,12690.0
Neemuch,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,870.0,1019.0,1064.0,1114.0,1138.0,1209.0,1093.0,1005.0,832.0,864.0,784.0,1353.0,12345.0
Neemuch,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,927.0,1005.0,1105.0,1108.0,1117.0,1224.0,1131.0,1202.0,983.0,869.0,850.0,1306.0,12827.0
Neemuch,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1012.0,1124.0,1051.0,1190.0,1190.0,1153.0,1099.0,1156.0,1162.0,966.0,831.0,1321.0,13255.0
Neemuch,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,847.0,932.0,1087.0,1050.0,1057.0,1130.0,1072.0,1076.0,770.0,839.0,769.0,511.0,11140.0
Neemuch,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,869.0,1011.0,1062.0,1114.0,1121.0,1209.0,1095.0,676.0,215.0,225.0,207.0,25.0,8829.0
Neemuch,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,931.0,1005.0,1102.0,1108.0,1118.0,1214.0,1141.0,1209.0,584.0,269.0,229.0,28.0,9938.0
Neemuch,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1002.0,1126.0,1046.0,1190.0,1196.0,1153.0,1097.0,1148.0,1145.0,569.0,292.0,273.0,11237.0
Neemuch,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,876.0,1069.0,1209.0,1373.0,1075.0,1160.0,933.0,982.0,1057.0,1055.0,1106.0,1390.0,13285.0
Neemuch,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,436.0,757.0,796.0,1033.0,816.0,788.0,557.0,798.0,928.0,974.0,923.0,1112.0,9918.0
Neemuch,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,12.0,0.0,2.0,23.0,0.0,10.0,47.0
Neemuch,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,416.0,529.0,580.0,731.0,583.0,577.0,463.0,469.0,540.0,523.0,409.0,571.0,6391.0
Neemuch,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,387.0,492.0,512.0,636.0,483.0,500.0,383.0,441.0,459.0,461.0,389.0,495.0,5638.0
Neemuch,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,803.0,1021.0,1092.0,1367.0,1066.0,1077.0,846.0,910.0,999.0,984.0,798.0,1066.0,12029.0
Neemuch,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,618.0,846.0,994.0,1172.0,865.0,800.0,720.0,794.0,905.0,1041.0,959.0,1166.0,10880.0
Neemuch,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,603.0,839.0,988.0,1161.0,866.0,792.0,719.0,791.0,903.0,1053.0,946.0,1168.0,10829.0
Neemuch,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,31.0,31.0
Neemuch,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,132.0,139.0,165.0,363.0,311.0,250.0,239.0,275.0,353.0,430.0,379.0,457.0,3493.0
Neemuch,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,118.0,126.0,146.0,336.0,281.0,248.0,238.0,276.0,346.0,381.0,342.0,443.0,3281.0
Neemuch,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,250.0,265.0,311.0,699.0,592.0,498.0,477.0,551.0,699.0,811.0,721.0,900.0,6774.0
Neemuch,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,283.0,302.0,489.0,822.0,482.0,442.0,420.0,465.0,396.0,722.0,551.0,926.0,6300.0
Neemuch,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,429.0,635.0,766.0,1209.0,883.0,804.0,762.0,773.0,787.0,897.0,735.0,1222.0,9902.0
Neemuch,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,437.0,572.0,840.0,1328.0,890.0,808.0,710.0,679.0,717.0,839.0,732.0,1242.0,9794.0
Neemuch,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,1.0,1.0,0.0,0.0,7.0
Neemuch,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,3.0,0.0,5.0
Neemuch,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,563.0,703.0,736.0,724.0,692.0,713.0,667.0,743.0,762.0,745.0,726.0,837.0,8611.0
Neemuch,10.4.2,Number of Immunisation sessions held during the month,TOTAL,514.0,671.0,725.0,722.0,683.0,705.0,644.0,722.0,749.0,740.0,719.0,834.0,8428.0
Neemuch,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,434.0,572.0,581.0,611.0,574.0,573.0,543.0,568.0,577.0,589.0,566.0,686.0,6874.0
Neemuch,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,860.0,1007.0,1294.0,1876.0,1072.0,1172.0,937.0,1015.0,1051.0,1640.0,1116.0,1400.0,14440.0
Neemuch,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,202.0,337.0,386.0,3832.0,295.0,311.0,249.0,271.0,343.0,5901.0,369.0,352.0,12848.0
Neemuch,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,151.0,174.0,182.0,4014.0,392.0,160.0,139.0,128.0,234.0,7752.0,613.0,150.0,14089.0
Neemuch,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,4.0,1.0,7.0,1.0,2.0,1.0,18.0
Neemuch,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,117.0,141.0,138.0,146.0,210.0,155.0,151.0,151.0,46.0,84.0,199.0,272.0,1810.0
Neemuch,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,1.0,0.0,0.0,0.0,0.0,10.0,28.0,20.0,0.0,0.0,0.0,8.0,67.0
Neemuch,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,8.0,12.0,2.0,11.0,11.0,10.0,12.0,9.0,11.0,20.0,18.0,6.0,130.0
Neemuch,13.1,Number of Patients operated for cataract,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1866.0,0.0,0.0,0.0,0.0,1868.0
Neemuch,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1866.0,0.0,0.0,0.0,0.0,1866.0
Neemuch,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,0.0,38.0,0.0,0.0,0.0,0.0,43.0
Neemuch,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,38.0,0.0,0.0,0.0,40.0
Neemuch,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,3.0,2.0,2.0,2.0,3.0,1.0,2.0,1.0,2.0,1.0,-1.0
Neemuch,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,4.0,4.0,5.0,4.0,4.0,4.0,4.0,4.0,5.0,5.0,4.0,5.0,-1.0
Neemuch,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,448.0,535.0,599.0,625.0,609.0,566.0,539.0,615.0,559.0,645.0,570.0,648.0,-1.0
Neemuch,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,4.0,5.0,4.0,4.0,4.0,5.0,4.0,4.0,4.0,5.0,3.0,-1.0
Neemuch,14.05,Number of RKS meetings held during the month,TOTAL,0.0,1.0,1.0,1.0,1.0,1.0,3.0,2.0,2.0,1.0,2.0,1.0,16.0
Neemuch,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,4.0,4.0,5.0,4.0,4.0,4.0,4.0,3.0,5.0,4.0,3.0,4.0,-1.0
Neemuch,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,0.0,0.0,3.0,21.0,19.0,18.0,0.0,0.0,15.0,5.0,6.0,0.0,87.0
Neemuch,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,2.0,3.0,2.0,3.0,2.0,-1.0
Neemuch,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,2.0,2.0,3.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Neemuch,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,237.0,200.0,124.0,100.0,90.0,70.0,76.0,163.0,46.0,93.0,26.0,228.0,1453.0
Neemuch,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,816.0,803.0,635.0,398.0,442.0,556.0,411.0,644.0,453.0,377.0,94.0,473.0,6102.0
Neemuch,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,191.0,239.0,325.0,158.0,74.0,55.0,55.0,139.0,49.0,79.0,30.0,170.0,1564.0
Neemuch,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1025.0,1437.0,1507.0,1251.0,730.0,1200.0,544.0,1807.0,1570.0,1149.0,662.0,1389.0,14271.0
Neemuch,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,428.0,439.0,449.0,258.0,164.0,125.0,131.0,302.0,95.0,172.0,56.0,398.0,3017.0
Neemuch,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1841.0,2240.0,2142.0,1649.0,1172.0,1756.0,955.0,2451.0,2023.0,1526.0,756.0,1862.0,20373.0
Neemuch,14.10.2.a,Number of death cases of Inpatient males,TOTAL,1.0,1.0,1.0,1.0,0.0,0.0,0.0,11.0,12.0,9.0,6.0,13.0,55.0
Neemuch,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,1.0,2.0,0.0,0.0,0.0,0.0,4.0,5.0,2.0,3.0,4.0,22.0
Neemuch,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,2.0,2.0,3.0,1.0,0.0,0.0,0.0,15.0,17.0,11.0,9.0,17.0,77.0
Neemuch,14.11,In-Patient Head Count at midnight,TOTAL,475.0,857.0,5604.0,1321.0,970.0,971.0,4865.0,974.0,956.0,1579.0,847.0,5661.0,25080.0
Neemuch,14.12.1,OPD attendance (All),TOTAL,24563.0,29496.0,27767.0,31000.0,33968.0,41618.0,31064.0,35990.0,33302.0,27405.0,37403.0,43445.0,397021.0
Neemuch,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,97.0,161.0,191.0,108.0,61.0,54.0,29.0,71.0,70.0,95.0,2.0,49.0,988.0
Neemuch,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,120.0,27.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,147.0
Neemuch,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,29.0,34.0,7.0,112.0,46.0,69.0,34.0,221.0,196.0,250.0,47.0,86.0,1131.0
Neemuch,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,111.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,111.0
Neemuch,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,198.0,10.0,0.0,0.0,21.0,24.0,162.0,189.0,203.0,0.0,211.0,1018.0
Neemuch,14.14.c,Number of Adolescents counselled,TOTAL,6.0,0.0,0.0,0.0,0.0,0.0,0.0,428.0,0.0,251.0,0.0,0.0,685.0
Neemuch,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1750.0,3617.0,4399.0,4043.0,4256.0,3458.0,1532.0,3793.0,4466.0,3154.0,3449.0,3656.0,41573.0
Neemuch,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,68.0,95.0,135.0,186.0,142.0,165.0,125.0,168.0,128.0,149.0,162.0,153.0,1676.0
Neemuch,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,339.0,470.0,333.0,243.0,388.0,462.0,320.0,465.0,528.0,300.0,387.0,374.0,4609.0
Neemuch,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3.0,5.0,0.0,2.0,35.0,2.0,1.0,4.0,0.0,0.0,3.0,3.0,58.0
Neemuch,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,328.0,346.0,1063.0,478.0,301.0,553.0,322.0,511.0,442.0,354.0,404.0,329.0,5431.0
Neemuch,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,36.0,0.0,0.0,6.0,0.0,3.0,0.0,3.0,48.0
Neemuch,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,741.0,946.0,738.0,1248.0,785.0,958.0,567.0,1193.0,1190.0,853.0,874.0,774.0,10867.0
Neemuch,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,3.0,1.0,1.0,1.0,2.0,38.0,1.0,2.0,0.0,0.0,14.0,0.0,63.0
Neemuch,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1408.0,1762.0,2134.0,1969.0,1474.0,1973.0,1209.0,2169.0,2160.0,1507.0,1665.0,1477.0,20907.0
Neemuch,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,6.0,6.0,1.0,3.0,73.0,40.0,2.0,12.0,0.0,3.0,17.0,6.0,169.0
Neemuch,15.2,Number of Widal tests conducted,Number tested,299.0,378.0,559.0,273.0,413.0,615.0,153.0,481.0,296.0,231.0,364.0,421.0,4483.0
Neemuch,15.3.a,Number of VDRL tests conducted on males,Number tested,39.0,103.0,77.0,95.0,17.0,17.0,117.0,81.0,15.0,13.0,29.0,25.0,628.0
Neemuch,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,26.0,90.0,654.0,514.0,26.0,33.0,50.0,42.0,109.0,133.0,223.0,118.0,2018.0
Neemuch,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,56.0,82.0,152.0,85.0,512.0,567.0,172.0,592.0,832.0,582.0,217.0,256.0,4105.0
Neemuch,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,121.0,275.0,883.0,694.0,555.0,617.0,339.0,715.0,956.0,728.0,469.0,399.0,6751.0
Neemuch,15.4.1,Number of blood smears examined for Malaria,TOTAL,3006.0,3262.0,1562.0,1238.0,1718.0,4213.0,3352.0,1817.0,1829.0,1159.0,1490.0,1629.0,26275.0
Neemuch,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,3.0,7.0,4.0,4.0,2.0,8.0,5.0,9.0,3.0,2.0,1.0,0.0,48.0
Neemuch,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,1.0,0.0,1.0,0.0,1.0,3.0,3.0,3.0,0.0,0.0,2.0,14.0
Neemuch,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,10000.0,,2500.0,10000.0,17500.0,,16000.0,30000.0,18500.0,14000.0,11000.0,11000.0,140500.0
Neemuch,16.1.1,Stock position of DPT vaccines,2. Stocks Received,15000.0,,15000.0,10000.0,0.0,,20000.0,0.0,0.0,0.0,0.0,0.0,60000.0
Neemuch,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,11000.0,,7500.0,2500.0,2500.0,,6000.0,11500.0,4500.0,500.0,0.0,2000.0,48000.0
Neemuch,16.1.1,Stock position of DPT vaccines,5. Total Stock,14000.0,0.0,10000.0,17500.0,15000.0,0.0,30000.0,18500.0,14000.0,13500.0,11000.0,9000.0,152500.0
Neemuch,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,,0.0,0.0,0.0,,0.0,2550.0,2550.0,5550.0,4250.0,9500.0,24400.0
Neemuch,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,,0.0,0.0,0.0,,0.0,0.0,3000.0,0.0,10000.0,0.0,13000.0
Neemuch,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,4750.0,3600.0,8350.0
Neemuch,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2550.0,5550.0,5550.0,9500.0,5900.0,29050.0
Neemuch,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,18000.0,,22500.0,41500.0,31000.0,,21000.0,14000.0,8000.0,14500.0,9000.0,8000.0,187500.0
Neemuch,16.1.2,Stock position of OPV vaccines,2. Stocks Received,20000.0,,25000.0,0.0,0.0,,10000.0,10000.0,15000.0,0.0,0.0,0.0,80000.0
Neemuch,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,9000.0,,6000.0,10500.0,12000.0,,17000.0,16000.0,8500.0,3500.0,1000.0,2000.0,85500.0
Neemuch,16.1.2,Stock position of OPV vaccines,5. Total Stock,29000.0,0.0,41500.0,31000.0,19000.0,0.0,14000.0,8000.0,14500.0,11000.0,8000.0,6000.0,182000.0
Neemuch,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,13500.0,,7500.0,11000.0,18000.0,,12500.0,8500.0,13500.0,10000.0,6000.0,14000.0,114500.0
Neemuch,16.1.3,Stock position of TT vaccines,2. Stocks Received,5000.0,,10000.0,10000.0,0.0,,7000.0,10000.0,0.0,0.0,10000.0,0.0,52000.0
Neemuch,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.1.3,Stock position of TT vaccines,4. Stock Distributed,14500.0,,6500.0,2500.0,7000.0,,11000.0,5000.0,3500.0,2000.0,2000.0,6000.0,60000.0
Neemuch,16.1.3,Stock position of TT vaccines,5. Total Stock,4000.0,0.0,11000.0,18500.0,11000.0,0.0,8500.0,13500.0,10000.0,8000.0,14000.0,8000.0,106500.0
Neemuch,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,8000.0,,4000.0,9000.0,6000.0,,5500.0,11500.0,17000.0,14000.0,11000.0,8000.0,94000.0
Neemuch,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,,10000.0,0.0,0.0,,10000.0,10000.0,0.0,0.0,0.0,0.0,40000.0
Neemuch,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,6000.0,,5000.0,3000.0,1000.0,,4000.0,4500.0,3000.0,0.0,3000.0,1000.0,30500.0
Neemuch,16.1.5,Stock position of BCG vaccines,5. Total Stock,12000.0,0.0,9000.0,6000.0,5000.0,0.0,11500.0,17000.0,14000.0,14000.0,8000.0,7000.0,103500.0
Neemuch,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,8000.0,,1500.0,8000.0,6000.0,,2500.0,1250.0,1500.0,8000.0,5000.0,10000.0,51750.0
Neemuch,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,,10000.0,0.0,0.0,,5000.0,5000.0,10000.0,0.0,5000.0,0.0,40000.0
Neemuch,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3250.0,,3500.0,2000.0,3500.0,,6250.0,4750.0,3500.0,750.0,1750.0,6500.0,35750.0
Neemuch,16.1.6,Stock position of Measles vaccines,5. Total Stock,9750.0,0.0,8000.0,6000.0,2500.0,0.0,1250.0,1500.0,8000.0,7250.0,8250.0,3500.0,56000.0
Neemuch,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,5000.0,,4500.0,15000.0,10500.0,,6500.0,16000.0,18000.0,13000.0,11000.0,10000.0,109500.0
Neemuch,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,20000.0,,20000.0,0.0,0.0,,20000.0,10000.0,0.0,0.0,0.0,0.0,70000.0
Neemuch,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,12500.0,,9500.0,4500.0,4500.0,,10500.0,8000.0,5000.0,0.0,1000.0,2000.0,57500.0
Neemuch,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,12500.0,0.0,15000.0,10500.0,6000.0,0.0,16000.0,18000.0,13000.0,13000.0,10000.0,8000.0,122000.0
Neemuch,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,0.0,,,,0.0,,,,0.0
Neemuch,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,5375.0,,2800.0,2050.0,750.0,,3150.0,9375.0,9375.0,8195.0,6995.0,6395.0,54460.0
Neemuch,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,,0.0,0.0,5000.0,,10000.0,0.0,0.0,0.0,0.0,5000.0,20000.0
Neemuch,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,675.0,,750.0,1300.0,2600.0,,1605.0,0.0,1180.0,1200.0,600.0,4050.0,13960.0
Neemuch,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,4700.0,0.0,2050.0,750.0,3150.0,0.0,11545.0,9375.0,8195.0,6995.0,6395.0,7345.0,60500.0
Neemuch,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,4000.0,,11000.0,17500.0,13000.0,,4800.0,3700.0,3200.0,2700.0,100.0,175.0,60175.0
Neemuch,16.3.02,Stock Position of Gloves,2. Stocks Received,40000.0,,6500.0,0.0,0.0,,0.0,0.0,0.0,0.0,500.0,0.0,47000.0
Neemuch,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.02,Stock Position of Gloves,4. Stock Distributed,27500.0,,0.0,4500.0,8200.0,,200.0,500.0,500.0,2600.0,425.0,0.0,44425.0
Neemuch,16.3.02,Stock Position of Gloves,5. Total Stock,16500.0,0.0,17500.0,13000.0,4800.0,0.0,4600.0,3200.0,2700.0,100.0,175.0,175.0,62750.0
Neemuch,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,633.0,,488.0,488.0,473.0,,472.0,422.0,420.0,420.0,412.0,152.0,4380.0
Neemuch,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,145.0,,0.0,15.0,1.0,,45.0,2.0,0.0,8.0,260.0,100.0,576.0
Neemuch,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,488.0,0.0,488.0,473.0,472.0,0.0,427.0,420.0,420.0,412.0,152.0,52.0,3804.0
Neemuch,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,2000.0,,2000.0,475.0,475.0,,475.0,475.0,475.0,475.0,275.0,0.0,7125.0
Neemuch,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,,1575.0,0.0,0.0,,0.0,0.0,0.0,200.0,275.0,0.0,2050.0
Neemuch,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,2000.0,0.0,425.0,475.0,475.0,0.0,475.0,475.0,475.0,275.0,0.0,0.0,5075.0
Neemuch,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,235.0,,130.0,80.0,80.0,,80.0,80.0,80.0,80.0,80.0,80.0,1005.0
Neemuch,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,,50.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,50.0
Neemuch,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,235.0,0.0,80.0,80.0,80.0,0.0,80.0,80.0,80.0,80.0,80.0,80.0,955.0
Neemuch,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,136.0,,0.0,0.0,0.0,,5.0,5.0,2960.0,43914.0,42294.0,42294.0,131608.0
Neemuch,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,,0.0,0.0,5.0,,0.0,5200.0,43800.0,0.0,0.0,0.0,49005.0
Neemuch,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,,0.0,0.0,0.0,,0.0,2245.0,2846.0,1620.0,0.0,5500.0,12211.0
Neemuch,16.3.07,Stock Position of IFA Tablets,5. Total Stock,136.0,0.0,0.0,0.0,5.0,0.0,5.0,2960.0,43914.0,42294.0,42294.0,36794.0,168402.0
Neemuch,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,7240.0,,40.0,40.0,40.0,,40.0,4708.0,4704.0,4704.0,3552.0,2688.0,27756.0
Neemuch,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,,0.0,0.0,0.0,,68500.0,0.0,0.0,0.0,0.0,0.0,68500.0
Neemuch,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,3160.0,,0.0,0.0,0.0,,57064.0,4.0,0.0,1152.0,864.0,0.0,62244.0
Neemuch,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,4080.0,0.0,40.0,40.0,40.0,0.0,11476.0,4704.0,4704.0,3552.0,2688.0,2688.0,34012.0
Neemuch,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,4225.0,,3900.0,3900.0,8595.0,,5200.0,2700.0,1000.0,200.0,10.0,10.0,29740.0
Neemuch,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,,0.0,4695.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,4695.0
Neemuch,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,225.0,,0.0,0.0,3395.0,,1500.0,0.0,800.0,190.0,0.0,0.0,6110.0
Neemuch,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,4000.0,0.0,3900.0,8595.0,5200.0,0.0,3700.0,2700.0,200.0,10.0,10.0,10.0,28325.0
Neemuch,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,10.0,,0.0,0.0,2000.0,,1700.0,1600.0,1550.0,390.0,290.0,10.0,7550.0
Neemuch,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,2000.0,,0.0,0.0,0.0,,0.0,0.0,100.0,0.0,0.0,0.0,2100.0
Neemuch,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,10.0,,0.0,0.0,0.0,,100.0,50.0,1260.0,100.0,0.0,0.0,1520.0
Neemuch,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,2000.0,0.0,0.0,0.0,2000.0,0.0,1600.0,1550.0,390.0,290.0,290.0,10.0,8130.0
Neemuch,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,6300.0,,33500.0,9500.0,5500.0,,800.0,25000.0,19000.0,15920.0,13990.0,2990.0,132500.0
Neemuch,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,,0.0,20000.0,0.0,,97000.0,0.0,0.0,0.0,0.0,0.0,117000.0
Neemuch,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,3300.0,,24000.0,24000.0,4700.0,,20800.0,6000.0,3080.0,200.0,11000.0,1990.0,99070.0
Neemuch,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,3000.0,0.0,9500.0,5500.0,800.0,0.0,77000.0,19000.0,15920.0,15720.0,2990.0,1000.0,150430.0
Neemuch,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,6000.0,,3500.0,6800.0,6800.0,,3300.0,9000.0,80000.0,8000.0,7000.0,6000.0,136400.0
Neemuch,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6600.0,,6800.0,3300.0,0.0,,6000.0,6600.0,0.0,0.0,0.0,0.0,29300.0
Neemuch,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2000.0,,3500.0,3300.0,3500.0,,900.0,7600.0,0.0,0.0,1000.0,3000.0,24800.0
Neemuch,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,10600.0,0.0,6800.0,6800.0,3300.0,0.0,8400.0,8000.0,80000.0,8000.0,6000.0,3000.0,140900.0
Neemuch,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,50000.0,,62500.0,10000.0,100000.0,,70000.0,130000.0,10000.0,100000.0,60000.0,110000.0,702500.0
Neemuch,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,,100000.0,0.0,0.0,,0.0,0.0,0.0,0.0,50000.0,0.0,150000.0
Neemuch,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,6500.0,,62500.0,0.0,30000.0,,20000.0,30000.0,0.0,0.0,0.0,0.0,149000.0
Neemuch,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,43500.0,0.0,100000.0,10000.0,70000.0,0.0,50000.0,100000.0,10000.0,100000.0,110000.0,110000.0,703500.0
Neemuch,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,6000.0,,13300.0,94000.0,6000.0,,4000.0,10000.0,10000.0,10000.0,6000.0,6000.0,165300.0
Neemuch,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2000.0,,6000.0,50000.0,0.0,,6000.0,6000.0,0.0,0.0,0.0,0.0,70000.0
Neemuch,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Neemuch,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,,4500.0,10000.0,2000.0,,10000.0,6000.0,0.0,0.0,0.0,1000.0,33500.0
Neemuch,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,8000.0,0.0,14800.0,134000.0,4000.0,0.0,0.0,10000.0,10000.0,10000.0,6000.0,5000.0,201800.0
Neemuch,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,1.0,,1.0,,,,,,,,2.0
Neemuch,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,7.0,1.0,1.0,,,,1.0,1.0,,3.0,14.0
Neemuch,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,,,,1.0
Neemuch,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,7.0,1.0,1.0,,,,2.0,1.0,,3.0,15.0
Neemuch,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,7.0,6.0,6.0,,,,,,,,,19.0
Neemuch,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Neemuch,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,7.0,6.0,6.0,,,,,,,,,19.0
Neemuch,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,4.0,5.0,9.0,2.0,6.0,3.0,2.0,7.0,4.0,2.0,3.0,3.0,50.0
Neemuch,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,1.0,1.0,,,,,,,,,2.0
Neemuch,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,4.0,5.0,10.0,3.0,6.0,3.0,2.0,7.0,4.0,2.0,3.0,3.0,52.0
Neemuch,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,11.0,16.0,10.0,28.0,2.0,,10.0,5.0,17.0,14.0,12.0,126.0
Neemuch,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,1.0,,,,,,,1.0,,,2.0
Neemuch,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,11.0,17.0,10.0,28.0,2.0,,10.0,5.0,18.0,14.0,12.0,128.0
Neemuch,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,2.0,,,,1.0,2.0,,,,,5.0
Neemuch,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,,,,,,1.0,,,,,,2.0
Neemuch,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,2.0,,,,2.0,2.0,,,,,7.0
Neemuch,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Neemuch,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Neemuch,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,1.0,,,,1.0
Neemuch,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,1.0,,1.0,,,,1.0,,2.0,2.0,8.0
Neemuch,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,1.0,1.0,1.0,1.0,,1.0,,,,5.0
Neemuch,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,1.0,1.0,1.0,2.0,1.0,1.0,,2.0,,2.0,2.0,13.0
Neemuch,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Neemuch,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Neemuch,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Neemuch,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,1.0,3.0,,1.0,,,,,2.0,,2.0,12.0
Neemuch,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,1.0,2.0,2.0,1.0,6.0
Neemuch,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,1.0,3.0,,1.0,,,,1.0,4.0,2.0,3.0,18.0
Neemuch,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Neemuch,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Neemuch,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Neemuch,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,1.0,,,,1.0
Neemuch,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Neemuch,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,1.0,2.0,2.0,,2.0,,,1.0,3.0,11.0
Neemuch,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,,,,,,1.0,,,1.0,1.0,4.0
Neemuch,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,,1.0,2.0,2.0,,3.0,,,2.0,4.0,15.0
Neemuch,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Neemuch,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,,,1.0,,,2.0,1.0,,1.0,1.0,7.0
Neemuch,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,,,1.0,2.0,,1.0,,1.0,4.0,2.0,4.0,16.0
Neemuch,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,,,1.0,3.0,,1.0,2.0,2.0,4.0,3.0,5.0,23.0
Neemuch,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Neemuch,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Neemuch,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Neemuch,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Neemuch,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,2.0,,,,,1.0,,3.0
Neemuch,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,2.0,1.0,,,1.0,,2.0,3.0,9.0
Neemuch,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,2.0,,,,1.0,1.0,,,4.0
Neemuch,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,4.0,3.0,,,2.0,1.0,3.0,3.0,16.0
Neemuch,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Neemuch,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,1.0,,1.0,,,2.0
Neemuch,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Neemuch,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,1.0,,1.0,,,2.0
Neemuch,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Neemuch,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,1.0,,1.0,2.0,,3.0,2.0,8.0,3.0,2.0,5.0,27.0
Neemuch,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2.0,1.0,,1.0,4.0,3.0,3.0,3.0,1.0,,2.0,2.0,22.0
Neemuch,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,2.0,2.0,,2.0,6.0,3.0,6.0,5.0,10.0,3.0,4.0,7.0,50.0
Neemuch,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Neemuch,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Neemuch,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Neemuch,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,1.0,,,,,1.0
Neemuch,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Neemuch,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Neemuch,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Neemuch,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,1.0,,,,,1.0
Neemuch,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Neemuch,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Neemuch,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Neemuch,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Neemuch,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Neemuch,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Neemuch,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Neemuch,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Neemuch,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Neemuch,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,2.0,,,,,1.0,,,2.0,,,5.0
Neemuch,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Neemuch,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,2.0,,,,,1.0,,,2.0,,,5.0
Neemuch,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Neemuch,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,1.0,,1.0,,,,,,,,,,2.0
Neemuch,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Neemuch,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,1.0,,1.0,,,,,,,,,,2.0
Neemuch,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Neemuch,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,2.0,,,2.0,1.0,,,1.0,2.0,1.0,1.0,10.0
Neemuch,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Neemuch,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,2.0,,,2.0,1.0,,,1.0,2.0,1.0,1.0,10.0
Neemuch,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,,,,1.0,1.0,,,,,1.0,4.0
Neemuch,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,1.0,,3.0,5.0,2.0,2.0,3.0,3.0,4.0,5.0,3.0,32.0
Neemuch,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,1.0,,1.0,,1.0,,1.0,,2.0,,,6.0
Neemuch,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,3.0,,4.0,5.0,4.0,3.0,4.0,3.0,6.0,5.0,4.0,42.0
Neemuch,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,1.0,1.0,,,,,,,2.0
Neemuch,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,2.0,,,1.0,2.0,1.0,,3.0,9.0
Neemuch,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Neemuch,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,3.0,1.0,,1.0,2.0,1.0,,3.0,11.0
Neemuch,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Neemuch,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,1.0,2.0,1.0,,1.0,,,,1.0,7.0
Neemuch,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Neemuch,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,1.0,1.0,2.0,1.0,1.0,1.0,,,,1.0,8.0
Neemuch,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Neemuch,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,1.0,,,2.0,,3.0
Neemuch,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,1.0,1.0,,,1.0,,2.0,5.0
Neemuch,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,1.0,1.0,1.0,,1.0,2.0,2.0,8.0
Neemuch,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Neemuch,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,1.0,,,1.0,3.0,4.0,1.0,,3.0,3.0,17.0
Neemuch,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,2.0,1.0,5.0,1.0,3.0,1.0,1.0,,1.0,15.0
Neemuch,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,,1.0,2.0,1.0,6.0,4.0,7.0,2.0,1.0,4.0,4.0,33.0
Neemuch,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,1.0,,1.0,,2.0,2.0,2.0,,1.0,,10.0
Neemuch,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,1.0,1.0,3.0,6.0,7.0,7.0,10.0,10.0,2.0,9.0,12.0,68.0
Neemuch,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,16.0,16.0,6.0,18.0,36.0,49.0,51.0,44.0,51.0,29.0,33.0,68.0,417.0
Neemuch,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,17.0,17.0,8.0,21.0,43.0,56.0,60.0,56.0,63.0,31.0,43.0,80.0,495.0
Panna,1.1,Total number of pregnant women Registered for ANC,TOTAL,1956.0,2577.0,3654.0,3600.0,2574.0,2971.0,2693.0,2501.0,2706.0,2392.0,3132.0,3480.0,34236.0
Panna,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1746.0,2281.0,3199.0,3420.0,2234.0,2764.0,2491.0,2025.0,2304.0,2090.0,2600.0,3032.0,30186.0
Panna,1.2,Number of Pregnant women registered under JSY,TOTAL,1956.0,2577.0,3654.0,3600.0,2574.0,2971.0,2693.0,2501.0,2706.0,2392.0,3132.0,3480.0,34236.0
Panna,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1370.0,1946.0,2258.0,2468.0,2316.0,2383.0,2224.0,2226.0,2256.0,2032.0,2405.0,2741.0,26625.0
Panna,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1700.0,2562.0,3451.0,3489.0,2439.0,2811.0,2485.0,2266.0,2614.0,2250.0,3073.0,3384.0,32524.0
Panna,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1325.0,1689.0,2121.0,2410.0,2153.0,2027.0,1935.0,1793.0,2015.0,1693.0,1966.0,2077.0,23204.0
Panna,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1370.0,2577.0,3547.0,3609.0,2574.0,2971.0,2693.0,2501.0,2706.0,2392.0,3132.0,3480.0,33552.0
Panna,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,121.0,90.0,137.0,111.0,67.0,76.0,124.0,80.0,75.0,95.0,85.0,87.0,1148.0
Panna,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,6.0,15.0,4.0,15.0,12.0,62.0,55.0,11.0,5.0,48.0,13.0,7.0,253.0
Panna,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,328.0,459.0,569.0,518.0,478.0,645.0,490.0,1002.0,786.0,919.0,895.0,1052.0,8141.0
Panna,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,9.0,20.0,34.0,65.0,25.0,27.0,69.0,87.0,63.0,66.0,45.0,37.0,547.0
Panna,1.8,Number of pregnancy test kits used at SC level,TOTAL,879.0,1546.0,2111.0,2229.0,1614.0,1657.0,1635.0,1541.0,1518.0,1578.0,2131.0,2283.0,20722.0
Panna,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,82.0,93.0,91.0,127.0,128.0,211.0,143.0,130.0,85.0,146.0,123.0,167.0,1526.0
Panna,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,34.0,26.0,29.0,47.0,84.0,69.0,50.0,85.0,106.0,138.0,105.0,42.0,815.0
Panna,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,116.0,119.0,120.0,174.0,212.0,280.0,193.0,215.0,191.0,284.0,228.0,209.0,2341.0
Panna,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,84.0,108.0,113.0,165.0,168.0,231.0,161.0,155.0,164.0,255.0,175.0,191.0,1970.0
Panna,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,2.0,1.0,1.0,0.0,3.0,0.0,5.0,28.0,8.0,48.0
Panna,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,961.0,1158.0,1334.0,1569.0,2021.0,1998.0,1617.0,1562.0,1400.0,1395.0,1323.0,1559.0,17897.0
Panna,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,143.0,113.0,194.0,162.0,243.0,194.0,268.0,194.0,125.0,72.0,87.0,111.0,1906.0
Panna,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,463.0,865.0,974.0,1757.0,1414.0,1756.0,1457.0,1418.0,1927.0,1208.0,1021.0,1818.0,16078.0
Panna,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,349.0,567.0,555.0,1728.0,941.0,1175.0,1338.0,1254.0,1609.0,1026.0,949.0,940.0,12431.0
Panna,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,38.0,41.0,42.0,101.0,26.0,46.0,51.0,31.0,181.0,35.0,32.0,140.0,764.0
Panna,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Panna,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Panna,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Panna,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Panna,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,19.0,24.0,40.0,43.0,49.0,35.0,40.0,40.0,31.0,52.0,57.0,53.0,483.0
Panna,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Panna,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,19.0,24.0,40.0,43.0,49.0,35.0,40.0,40.0,31.0,52.0,57.0,53.0,483.0
Panna,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Panna,4.1.1.a,Number of male live births,TOTAL,570.0,664.0,768.0,899.0,1136.0,1208.0,929.0,932.0,832.0,825.0,819.0,916.0,10498.0
Panna,4.1.1.b,Number of female live births,TOTAL,496.0,590.0,666.0,805.0,1053.0,1045.0,843.0,833.0,741.0,823.0,721.0,834.0,9450.0
Panna,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1066.0,1254.0,1434.0,1704.0,2189.0,2253.0,1772.0,1765.0,1573.0,1648.0,1540.0,1750.0,19948.0
Panna,4.1.2,Number of still births,TOTAL,14.0,32.0,22.0,40.0,57.0,38.0,44.0,30.0,32.0,41.0,21.0,26.0,397.0
Panna,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,22.0,40.0,22.0,32.0,31.0,31.0,33.0,30.0,26.0,38.0,37.0,35.0,377.0
Panna,4.2.1,Number of Newborns weighed at birth,TOTAL,1032.0,1230.0,1419.0,1682.0,2139.0,2199.0,1715.0,1693.0,1496.0,1541.0,1457.0,1708.0,19311.0
Panna,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,189.0,215.0,240.0,319.0,397.0,299.0,288.0,302.0,207.0,262.0,206.0,250.0,3174.0
Panna,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1002.0,1189.0,1381.0,1653.0,2170.0,2201.0,1725.0,1632.0,1449.0,1575.0,1417.0,1637.0,19031.0
Panna,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,11.0,10.0,0.0,0.0,0.0,2.0,2.0,0.0,16.0,7.0,22.0,28.0,98.0
Panna,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,17.0,26.0,20.0,15.0,29.0,30.0,69.0,54.0,96.0,117.0,61.0,69.0,603.0
Panna,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,146.0,42.0,51.0,46.0,66.0,61.0,61.0,49.0,75.0,80.0,81.0,81.0,839.0
Panna,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Panna,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,174.0,78.0,71.0,61.0,95.0,93.0,132.0,103.0,187.0,204.0,164.0,178.0,1540.0
Panna,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Panna,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,171.0,78.0,71.0,61.0,95.0,93.0,131.0,103.0,164.0,202.0,159.0,149.0,1477.0
Panna,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,8.0,12.0,35.0,29.0,10.0,6.0,14.0,11.0,6.0,8.0,14.0,6.0,159.0
Panna,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,167.0,78.0,70.0,14.0,32.0,82.0,92.0,103.0,113.0,189.0,157.0,172.0,1269.0
Panna,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,28.0,40.0,35.0,45.0,27.0,42.0,52.0,17.0,14.0,23.0,13.0,19.0,355.0
Panna,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1045.0,1259.0,1433.0,1727.0,2198.0,2237.0,1766.0,1737.0,1524.0,1596.0,1522.0,1754.0,19798.0
Panna,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,446.0,509.0,760.0,1066.0,1165.0,1122.0,944.0,945.0,829.0,1015.0,996.0,999.0,10796.0
Panna,6.3,PNC maternal complications attended,TOTAL,13.0,12.0,2.0,6.0,8.0,8.0,1.0,22.0,7.0,16.0,6.0,21.0,122.0
Panna,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,32.0,30.0,36.0,36.0,28.0,31.0,17.0,34.0,48.0,29.0,24.0,29.0,374.0
Panna,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,32.0,30.0,36.0,36.0,28.0,31.0,17.0,34.0,48.0,29.0,24.0,29.0,374.0
Panna,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,119.0,122.0,116.0,131.0,153.0,117.0,73.0,148.0,194.0,323.0,205.0,252.0,1953.0
Panna,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,171.0,151.0,131.0,169.0,225.0,166.0,144.0,227.0,278.0,441.0,182.0,336.0,2621.0
Panna,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,290.0,273.0,247.0,300.0,378.0,283.0,217.0,375.0,472.0,764.0,387.0,588.0,4574.0
Panna,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,2.0
Panna,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,1.0,0.0,3.0,6.0,3.0,0.0,1.0,15.0
Panna,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,4.0
Panna,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Panna,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,0.0,1.0,0.0,1.0,1.0,1.0,3.0,7.0,4.0,0.0,2.0,21.0
Panna,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Panna,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,9.0,1.0,10.0,4.0,253.0,403.0,165.0,49.0,11.0,905.0
Panna,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,1.0,1.0,10.0,22.0,4.0,13.0,57.0,630.0,1338.0,803.0,429.0,93.0,3401.0
Panna,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,1.0,4.0,5.0,8.0,4.0,0.0,12.0,13.0,46.0,92.0,99.0,164.0,448.0
Panna,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Panna,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,2.0,5.0,15.0,39.0,9.0,23.0,73.0,896.0,1787.0,1060.0,577.0,268.0,4754.0
Panna,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Panna,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Panna,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Panna,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,2.0,7.0,6.0,5.0,5.0,3.0,4.0,1.0,7.0,0.0,16.0,17.0,73.0
Panna,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Panna,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2.0,7.0,6.0,5.0,5.0,3.0,4.0,1.0,7.0,0.0,16.0,17.0,73.0
Panna,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Panna,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,268.0,441.0,530.0,462.0,357.0,436.0,393.0,308.0,290.0,479.0,434.0,444.0,4842.0
Panna,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,42.0,15.0,15.0,75.0,4.0,6.0,52.0,60.0,35.0,37.0,22.0,29.0,392.0
Panna,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,38.0,62.0,78.0,285.0,42.0,14.0,49.0,125.0,435.0,497.0,229.0,289.0,2143.0
Panna,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,199.0,183.0,186.0,162.0,196.0,238.0,164.0,155.0,162.0,164.0,125.0,123.0,2057.0
Panna,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Panna,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,547.0,701.0,809.0,984.0,599.0,694.0,658.0,648.0,922.0,1177.0,810.0,885.0,9434.0
Panna,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,186.0,156.0,189.0,392.0,377.0,421.0,251.0,238.0,466.0,711.0,623.0,775.0,4785.0
Panna,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Panna,9.06,Number of IUCD removals,TOTAL,194.0,150.0,190.0,190.0,178.0,195.0,206.0,318.0,198.0,214.0,241.0,327.0,2601.0
Panna,9.07,Number of Oral Pills cycles distributed,TOTAL,2027.0,2818.0,3196.0,2869.0,2177.0,2294.0,3436.0,4313.0,3469.0,3650.0,3336.0,4092.0,37677.0
Panna,9.08,Number of Condom pieces distributed,TOTAL,20310.0,23610.0,26630.0,29594.0,29330.0,29730.0,32800.0,38470.0,43460.0,43760.0,52740.0,49480.0,419914.0
Panna,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,57.0,78.0,100.0,85.0,82.0,66.0,61.0,118.0,150.0,126.0,252.0,80.0,1255.0
Panna,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,6.0,5.0,0.0,0.0,2.0,0.0,13.0
Panna,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Panna,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,9.12,Number of Institutions having NSV trained doctors,TOTAL,11.0,9.0,9.0,10.0,10.0,10.0,10.0,10.0,11.0,12.0,12.0,12.0,-1.0
Panna,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1114.0,1308.0,1468.0,1840.0,2203.0,2271.0,1893.0,1758.0,1559.0,1633.0,1562.0,1743.0,20352.0
Panna,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1221.0,1620.0,1897.0,1932.0,1857.0,1914.0,2201.0,788.0,0.0,0.0,0.0,1.0,13431.0
Panna,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1344.0,1589.0,1801.0,1908.0,1762.0,1806.0,1850.0,1953.0,944.0,435.0,71.0,19.0,15482.0
Panna,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1385.0,1639.0,1855.0,1975.0,1781.0,1764.0,1830.0,1715.0,1848.0,917.0,342.0,296.0,17347.0
Panna,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1458.0,1856.0,1803.0,2022.0,2027.0,9166.0
Panna,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1326.0,1679.0,1862.0,2001.0,6868.0
Panna,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1134.0,1690.0,1931.0,4755.0
Panna,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,864.0,1075.0,1228.0,1401.0,1742.0,1879.0,1476.0,1477.0,1344.0,1309.0,1255.0,1454.0,16504.0
Panna,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1221.0,1620.0,1897.0,1932.0,1857.0,1914.0,2201.0,1592.0,1747.0,1803.0,2022.0,2028.0,21834.0
Panna,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1344.0,1589.0,1807.0,1908.0,1762.0,1806.0,1839.0,1953.0,2315.0,2114.0,1933.0,2020.0,22390.0
Panna,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1385.0,1649.0,1849.0,1975.0,1781.0,1764.0,1841.0,1715.0,1848.0,2051.0,2032.0,2227.0,22117.0
Panna,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,864.0,1075.0,1228.0,1401.0,1742.0,1879.0,1476.0,1475.0,1344.0,1077.0,1255.0,1454.0,16270.0
Panna,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1221.0,1620.0,1971.0,1932.0,1857.0,1914.0,2201.0,776.0,0.0,0.0,0.0,1.0,13493.0
Panna,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1344.0,1589.0,1810.0,1908.0,1762.0,1806.0,1839.0,1953.0,944.0,435.0,71.0,19.0,15480.0
Panna,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1385.0,1649.0,1846.0,1959.0,1781.0,1764.0,1841.0,1715.0,1848.0,917.0,342.0,296.0,17343.0
Panna,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1209.0,1797.0,2357.0,2252.0,2014.0,1988.0,1870.0,1740.0,1716.0,1886.0,1762.0,1869.0,22460.0
Panna,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,626.0,1121.0,1805.0,1536.0,1479.0,1456.0,1405.0,1338.0,1484.0,1768.0,1677.0,2004.0,17699.0
Panna,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,644.0,974.0,1250.0,1169.0,1066.0,1046.0,966.0,933.0,914.0,1001.0,929.0,995.0,11887.0
Panna,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,565.0,823.0,1107.0,1083.0,948.0,942.0,904.0,807.0,802.0,885.0,833.0,874.0,10573.0
Panna,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1209.0,1797.0,2357.0,2252.0,2014.0,1988.0,1870.0,1740.0,1716.0,1886.0,1762.0,1869.0,22460.0
Panna,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1019.0,1513.0,1786.0,1698.0,1562.0,1507.0,1429.0,1416.0,1511.0,1768.0,1677.0,2004.0,18890.0
Panna,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1019.0,1513.0,1786.0,1698.0,1562.0,1507.0,1429.0,1416.0,1511.0,1768.0,1677.0,2004.0,18890.0
Panna,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,541.0,779.0,944.0,899.0,810.0,776.0,762.0,738.0,801.0,932.0,886.0,1067.0,9935.0
Panna,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,478.0,734.0,842.0,799.0,752.0,731.0,665.0,678.0,710.0,836.0,791.0,937.0,8953.0
Panna,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1019.0,1513.0,1786.0,1698.0,1562.0,1507.0,1427.0,1416.0,1511.0,1768.0,1677.0,2004.0,18888.0
Panna,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,38.0,43.0,57.0,34.0,33.0,205.0
Panna,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,723.0,1135.0,1413.0,1657.0,1299.0,1485.0,1384.0,1072.0,1192.0,1317.0,1318.0,1254.0,15249.0
Panna,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,762.0,1150.0,1336.0,1583.0,1301.0,1645.0,1351.0,1175.0,1240.0,1307.0,1265.0,1183.0,15298.0
Panna,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,8.0,8.0,9.0,7.0,4.0,3.0,4.0,3.0,23.0,12.0,3.0,2.0,86.0
Panna,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,26.0,8.0,24.0,12.0,13.0,19.0,12.0,10.0,52.0,83.0,42.0,58.0,359.0
Panna,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1133.0,1155.0,1164.0,1168.0,1172.0,1172.0,1177.0,1190.0,1218.0,1206.0,1225.0,1269.0,14249.0
Panna,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1038.0,1112.0,1141.0,1146.0,1154.0,1153.0,1160.0,1177.0,1213.0,1178.0,1209.0,1252.0,13933.0
Panna,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,878.0,960.0,982.0,1012.0,1003.0,1015.0,1020.0,1049.0,1083.0,1055.0,1082.0,1146.0,12285.0
Panna,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1209.0,1797.0,2357.0,2252.0,2014.0,1977.0,1872.0,1740.0,1716.0,1886.0,1762.0,1869.0,22451.0
Panna,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,505.0,701.0,1518.0,4837.0,1860.0,1104.0,1070.0,1130.0,987.0,5452.0,1684.0,1389.0,22237.0
Panna,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,332.0,397.0,1599.0,4013.0,1189.0,596.0,790.0,450.0,465.0,4177.0,1023.0,609.0,15640.0
Panna,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,5.0,2.0,0.0,15.0,2.0,3.0,11.0,25.0,63.0
Panna,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,101.0,302.0,254.0,312.0,209.0,243.0,133.0,165.0,227.0,181.0,256.0,246.0,2629.0
Panna,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,24.0,24.0,38.0,39.0,38.0,49.0,71.0,23.0,28.0,16.0,59.0,101.0,510.0
Panna,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,12.0,16.0,12.0,15.0,9.0,7.0,21.0,12.0,23.0,2.0,17.0,27.0,173.0
Panna,13.1,Number of Patients operated for cataract,TOTAL,18.0,4.0,3.0,1.0,1.0,5.0,5.0,7.0,3.0,1.0,0.0,0.0,48.0
Panna,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,18.0,4.0,3.0,1.0,0.0,1.0,1.0,7.0,3.0,1.0,0.0,0.0,39.0
Panna,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,17.0,33.0,12.0,12.0,135.0,79.0,24.0,24.0,0.0,336.0
Panna,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,12.0,0.0,9.0,9.0,0.0,0.0,0.0,70.0,15.0,115.0
Panna,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,-1.0
Panna,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,8.0,7.0,8.0,8.0,8.0,8.0,8.0,10.0,10.0,10.0,10.0,10.0,-1.0
Panna,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,867.0,916.0,913.0,976.0,975.0,927.0,972.0,925.0,1141.0,1014.0,1052.0,1118.0,-1.0
Panna,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,-1.0
Panna,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Panna,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,14.0,12.0,13.0,14.0,14.0,14.0,14.0,13.0,13.0,13.0,13.0,13.0,-1.0
Panna,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0,9.0
Panna,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,4.0,4.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Panna,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,-1.0
Panna,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,685.0,623.0,722.0,631.0,720.0,722.0,632.0,441.0,402.0,385.0,617.0,554.0,7134.0
Panna,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,813.0,1192.0,1119.0,1271.0,1276.0,1409.0,1351.0,1348.0,958.0,1059.0,1121.0,1747.0,14664.0
Panna,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,917.0,656.0,751.0,625.0,778.0,775.0,664.0,404.0,436.0,404.0,519.0,630.0,7559.0
Panna,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1581.0,2182.0,2272.0,2250.0,2618.0,2565.0,2358.0,2264.0,2425.0,2218.0,2540.0,2242.0,27515.0
Panna,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1602.0,1279.0,1473.0,1256.0,1498.0,1497.0,1296.0,845.0,838.0,789.0,1136.0,1184.0,14693.0
Panna,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2394.0,3374.0,3391.0,3521.0,3894.0,3974.0,3709.0,3612.0,3383.0,3277.0,3661.0,3989.0,42179.0
Panna,14.10.2.a,Number of death cases of Inpatient males,TOTAL,21.0,22.0,41.0,24.0,25.0,28.0,18.0,25.0,24.0,12.0,11.0,13.0,264.0
Panna,14.10.2.b,Number of death cases of Inpatient females,TOTAL,14.0,19.0,22.0,13.0,11.0,23.0,11.0,12.0,10.0,6.0,4.0,7.0,152.0
Panna,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,35.0,41.0,63.0,37.0,36.0,51.0,29.0,37.0,34.0,18.0,15.0,20.0,416.0
Panna,14.11,In-Patient Head Count at midnight,TOTAL,1487.0,1685.0,2378.0,2695.0,2574.0,2655.0,2970.0,2778.0,3163.0,2939.0,2947.0,2790.0,31061.0
Panna,14.12.1,OPD attendance (All),TOTAL,29418.0,29307.0,36922.0,39776.0,45735.0,47210.0,40190.0,33302.0,30682.0,29015.0,41633.0,41713.0,444903.0
Panna,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,31.0,47.0,62.0,73.0,68.0,70.0,69.0,64.0,32.0,96.0,108.0,77.0,797.0
Panna,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,1.0,2.0,4.0,2.0,1.0,5.0,6.0,0.0,8.0,8.0,5.0,4.0,46.0
Panna,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,68.0,85.0,68.0,87.0,89.0,84.0,82.0,72.0,81.0,62.0,81.0,90.0,949.0
Panna,14.14.a,Number of patients given AYUSH treatment,TOTAL,889.0,1653.0,1748.0,1858.0,1523.0,1112.0,854.0,1011.0,1583.0,1388.0,1130.0,917.0,15666.0
Panna,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,59.0,41.0,59.0,56.0,26.0,19.0,23.0,64.0,64.0,64.0,26.0,35.0,536.0
Panna,14.14.c,Number of Adolescents counselled,TOTAL,126.0,150.0,37.0,192.0,185.0,185.0,215.0,250.0,265.0,239.0,205.0,221.0,2270.0
Panna,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1985.0,3376.0,3414.0,4029.0,2526.0,2992.0,2500.0,3850.0,4211.0,4269.0,4480.0,4663.0,42295.0
Panna,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,55.0,124.0,112.0,161.0,167.0,147.0,116.0,203.0,178.0,185.0,138.0,299.0,1885.0
Panna,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,342.0,302.0,399.0,370.0,388.0,311.0,245.0,335.0,228.0,217.0,240.0,299.0,3676.0
Panna,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0
Panna,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,370.0,407.0,522.0,432.0,851.0,465.0,378.0,377.0,355.0,209.0,307.0,341.0,5014.0
Panna,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,669.0,903.0,913.0,870.0,839.0,1011.0,750.0,981.0,1169.0,1289.0,1243.0,1106.0,11743.0
Panna,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1381.0,1612.0,1834.0,1672.0,2078.0,1787.0,1373.0,1693.0,1752.0,1715.0,1790.0,1746.0,20433.0
Panna,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0
Panna,15.2,Number of Widal tests conducted,Number tested,313.0,340.0,309.0,261.0,303.0,308.0,313.0,317.0,113.0,92.0,254.0,391.0,3314.0
Panna,15.3.a,Number of VDRL tests conducted on males,Number tested,59.0,51.0,60.0,66.0,77.0,59.0,79.0,98.0,137.0,213.0,165.0,232.0,1296.0
Panna,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,79.0,95.0,90.0,93.0,130.0,91.0,86.0,114.0,171.0,218.0,192.0,260.0,1619.0
Panna,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,16.0,5.0,3.0,232.0,0.0,4.0,5.0,0.0,203.0,182.0,0.0,6.0,656.0
Panna,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,154.0,151.0,153.0,391.0,207.0,154.0,170.0,212.0,511.0,613.0,357.0,498.0,3571.0
Panna,15.4.1,Number of blood smears examined for Malaria,TOTAL,2738.0,4323.0,4311.0,5645.0,4457.0,3760.0,4269.0,3453.0,3930.0,2060.0,4782.0,5623.0,49351.0
Panna,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,65.0,159.0,75.0,100.0,83.0,72.0,76.0,82.0,43.0,24.0,52.0,31.0,862.0
Panna,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,20.0,35.0,13.0,13.0,14.0,7.0,28.0,17.0,11.0,6.0,11.0,13.0,188.0
Panna,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,14500.0,14500.0
Panna,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,0.0,0.0
Panna,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Panna,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,4500.0,4500.0
Panna,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,10000.0
Panna,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,1500.0,1500.0
Panna,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,10000.0,10000.0
Panna,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Panna,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,5500.0,5500.0
Panna,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,6000.0
Panna,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,2000.0,2000.0
Panna,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,0.0,0.0
Panna,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Panna,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,0.0,0.0
Panna,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,2000.0
Panna,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,6000.0,6000.0
Panna,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,15000.0,15000.0
Panna,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Panna,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,9000.0,9000.0
Panna,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12000.0,12000.0
Panna,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,0.0,0.0
Panna,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,0.0,0.0
Panna,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Panna,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,0.0,0.0
Panna,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,2750.0,2750.0
Panna,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,5000.0,5000.0
Panna,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Panna,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,6000.0,6000.0
Panna,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1750.0,1750.0
Panna,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,5875.0,5875.0
Panna,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,5000.0,5000.0
Panna,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Panna,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,6250.0,6250.0
Panna,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4625.0,4625.0
Panna,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Panna,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Panna,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Panna,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Panna,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,15200.0,15200.0
Panna,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,0.0,0.0
Panna,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Panna,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,6250.0,6250.0
Panna,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8950.0,8950.0
Panna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,10200.0,10200.0
Panna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,0.0,0.0
Panna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Panna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,200.0,200.0
Panna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,10000.0
Panna,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,96240.0,96240.0
Panna,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,0.0,0.0
Panna,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Panna,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,10000.0,10000.0
Panna,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,86240.0,86240.0
Panna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,59300.0,59300.0
Panna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,0.0,0.0
Panna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Panna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,15000.0,15000.0
Panna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,44300.0,44300.0
Panna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,3475.0,3475.0
Panna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,0.0,0.0
Panna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Panna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,475.0,475.0
Panna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0,3000.0
Panna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,18600.0,18600.0
Panna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,0.0,0.0
Panna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Panna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,0.0,0.0
Panna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18600.0,18600.0
Panna,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,9315.0,9315.0
Panna,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,0.0,0.0
Panna,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Panna,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,8115.0,8115.0
Panna,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1200.0,1200.0
Panna,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,20970.0,20970.0
Panna,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,0.0,0.0
Panna,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Panna,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,19945.0,19945.0
Panna,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1025.0,1025.0
Panna,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,0.0,0.0
Panna,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,16.0,16.0
Panna,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Panna,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,0.0,0.0
Panna,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0,16.0
Panna,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,196800.0,196800.0
Panna,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,0.0,0.0
Panna,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Panna,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,80345.0,80345.0
Panna,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,116455.0,116455.0
Panna,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,2057.0,2057.0
Panna,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,0.0,0.0
Panna,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Panna,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,600.0,600.0
Panna,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1457.0,1457.0
Panna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Panna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Panna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Panna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Panna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,1742004.0,1742004.0
Panna,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,0.0,0.0
Panna,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Panna,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,715640.0,715640.0
Panna,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1026364.0,1026364.0
Panna,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,45280.0,45280.0
Panna,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,0.0,0.0
Panna,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Panna,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,5000.0,5000.0
Panna,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,40280.0,40280.0
Panna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,1135.0,1135.0
Panna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,0.0,0.0
Panna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Panna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,0.0,0.0
Panna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1135.0,1135.0
Panna,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,155.0,155.0
Panna,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,0.0,0.0
Panna,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Panna,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,0.0,0.0
Panna,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,155.0,155.0
Panna,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,265533.0,265533.0
Panna,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,0.0,0.0
Panna,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Panna,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,0.0,0.0
Panna,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,265533.0,265533.0
Panna,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,1600.0,1600.0
Panna,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,3300.0,3300.0
Panna,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Panna,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,4600.0,4600.0
Panna,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,300.0,300.0
Panna,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,56400.0,56400.0
Panna,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,100000.0,100000.0
Panna,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Panna,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,34000.0,34000.0
Panna,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,122400.0,122400.0
Panna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,400.0,400.0
Panna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,4000.0,4000.0
Panna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Panna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,4400.0,4400.0
Panna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Panna,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,2.0,,,3.0,,1.0,1.0,,2.0,4.0,2.0,15.0
Panna,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,8.0,4.0,3.0,4.0,4.0,5.0,,3.0,2.0,1.0,34.0
Panna,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,2.0,1.0,4.0,,1.0,,,1.0,,9.0
Panna,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,8.0,6.0,4.0,8.0,4.0,6.0,,3.0,3.0,1.0,43.0
Panna,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,7.0,7.0,7.0,3.0,7.0,5.0,5.0,,,2.0,,2.0,45.0
Panna,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,1.0,1.0,,,1.0,1.0,,,,,,1.0,5.0
Panna,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,8.0,8.0,7.0,3.0,8.0,6.0,5.0,,,2.0,,3.0,50.0
Panna,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,4.0,5.0,9.0,4.0,8.0,8.0,4.0,5.0,7.0,1.0,2.0,3.0,60.0
Panna,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,1.0,,,,2.0,,,,3.0
Panna,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,4.0,5.0,9.0,4.0,9.0,8.0,4.0,5.0,9.0,1.0,2.0,3.0,63.0
Panna,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,6.0,10.0,8.0,3.0,7.0,3.0,7.0,11.0,14.0,6.0,7.0,3.0,85.0
Panna,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,,,1.0
Panna,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,6.0,10.0,8.0,3.0,7.0,3.0,8.0,11.0,14.0,6.0,7.0,3.0,86.0
Panna,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,3.0,2.0,1.0,,1.0,1.0,1.0,,3.0,3.0,3.0,1.0,19.0
Panna,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,1.0,,,,,1.0,3.0,2.0,2.0,,9.0
Panna,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,3.0,2.0,2.0,,1.0,1.0,1.0,1.0,6.0,5.0,5.0,1.0,28.0
Panna,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,1.0,,,,,,,,,,,,1.0
Panna,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,1.0,,,,,1.0,,,,,2.0
Panna,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,1.0,,1.0,,,,,1.0,,,,,3.0
Panna,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,4.0,1.0,2.0,2.0,,,,,,9.0
Panna,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,1.0,1.0,,1.0,1.0,1.0,,,2.0,,7.0
Panna,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,5.0,1.0,3.0,3.0,1.0,,,2.0,,16.0
Panna,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Panna,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Panna,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Panna,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,4.0,5.0,6.0,2.0,4.0,10.0,10.0,7.0,7.0,6.0,5.0,66.0
Panna,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,3.0,4.0,6.0,8.0,4.0,4.0,7.0,2.0,5.0,2.0,4.0,6.0,55.0
Panna,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,8.0,11.0,14.0,6.0,8.0,17.0,12.0,12.0,9.0,10.0,11.0,121.0
Panna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Panna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Panna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,1.0,,,,,2.0,,,,1.0,4.0
Panna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,1.0,,,,,2.0,,,,1.0,4.0
Panna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Panna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,3.0,4.0,1.0,2.0,2.0,12.0
Panna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,2.0,1.0,2.0,1.0,6.0
Panna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,3.0,6.0,2.0,4.0,3.0,18.0
Panna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Panna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,3.0,1.0,,3.0,,2.0,1.0,,,,10.0
Panna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,1.0,,1.0,,,1.0,1.0,1.0,,,5.0
Panna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,4.0,1.0,1.0,3.0,,3.0,2.0,1.0,,,15.0
Panna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Panna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Panna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Panna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Panna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Panna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,2.0,2.0,5.0,2.0,3.0,5.0,3.0,3.0,,3.0,3.0,3.0,34.0
Panna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,3.0,3.0,3.0,3.0,1.0,6.0,,1.0,,1.0,4.0,3.0,28.0
Panna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,5.0,5.0,8.0,5.0,4.0,11.0,3.0,4.0,,4.0,7.0,6.0,62.0
Panna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Panna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Panna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Panna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Panna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Panna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,3.0,7.0,1.0,,2.0,1.0,5.0,,1.0,,2.0,25.0
Panna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,5.0,4.0,6.0,4.0,3.0,2.0,2.0,1.0,1.0,4.0,3.0,3.0,38.0
Panna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,8.0,7.0,13.0,5.0,3.0,4.0,3.0,6.0,1.0,5.0,3.0,5.0,63.0
Panna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Panna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,1.0,,,,1.0,,,,,,2.0
Panna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,1.0,1.0,,1.0,,2.0,,,,,,6.0
Panna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,1.0,2.0,,1.0,,3.0,,,,,,8.0
Panna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Panna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Panna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Panna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Panna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Panna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Panna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Panna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Panna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Panna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Panna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Panna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Panna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Panna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,1.0,,,,,2.0,1.0,,,,4.0
Panna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Panna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,1.0,,,,,2.0,1.0,,,,4.0
Panna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Panna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,1.0,1.0,,,,,,,,2.0
Panna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Panna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,1.0,1.0,,,,,,,,2.0
Panna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Panna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,1.0,,2.0,1.0,1.0,2.0,1.0,1.0,,,10.0
Panna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Panna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,1.0,,2.0,1.0,1.0,2.0,1.0,1.0,,,10.0
Panna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Panna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,1.0,1.0,,1.0,1.0,,1.0,6.0,5.0,3.0,2.0,23.0
Panna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,1.0,,,,2.0,,,,,,,5.0
Panna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,2.0,1.0,,1.0,3.0,,1.0,6.0,5.0,3.0,3.0,29.0
Panna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Panna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,1.0,2.0,2.0,,4.0,2.0,4.0,3.0,3.0,2.0,7.0,34.0
Panna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,1.0,,,,,1.0,,,,1.0,3.0
Panna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,1.0,3.0,2.0,,4.0,2.0,5.0,3.0,3.0,3.0,8.0,38.0
Panna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Panna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,1.0,,1.0,1.0,4.0,1.0,1.0,,,,1.0,11.0
Panna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Panna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,1.0,,1.0,1.0,5.0,1.0,1.0,,,,1.0,12.0
Panna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Panna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,1.0,,,,,2.0,1.0,,,1.0,6.0
Panna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,1.0,5.0,2.0,2.0,3.0,13.0
Panna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,1.0,1.0,,,,,3.0,6.0,2.0,2.0,4.0,19.0
Panna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Panna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,5.0,1.0,,,,3.0,6.0,1.0,,1.0,17.0
Panna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,2.0,2.0,2.0,1.0,,,4.0,3.0,3.0,2.0,3.0,22.0
Panna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,2.0,7.0,3.0,1.0,,,7.0,9.0,4.0,2.0,4.0,39.0
Panna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,,,,,,,1.0,1.0,1.0,,4.0
Panna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,8.0,7.0,10.0,4.0,5.0,3.0,10.0,6.0,13.0,15.0,17.0,21.0,119.0
Panna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,11.0,7.0,21.0,14.0,8.0,10.0,12.0,18.0,38.0,37.0,33.0,29.0,238.0
Panna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,20.0,14.0,31.0,18.0,13.0,13.0,22.0,24.0,52.0,53.0,51.0,50.0,361.0
Raisen,1.1,Total number of pregnant women Registered for ANC,TOTAL,2676.0,2572.0,2978.0,3179.0,2809.0,2888.0,2662.0,2958.0,2819.0,2870.0,2959.0,2939.0,34309.0
Raisen,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2012.0,1910.0,2208.0,2271.0,2088.0,2267.0,2056.0,2207.0,2133.0,2088.0,2282.0,2419.0,25941.0
Raisen,1.2,Number of Pregnant women registered under JSY,TOTAL,2568.0,2502.0,2886.0,3301.0,2619.0,2830.0,2550.0,2958.0,2758.0,2844.0,2941.0,2955.0,33712.0
Raisen,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2244.0,2200.0,2642.0,2750.0,2456.0,2591.0,2367.0,2572.0,2563.0,2602.0,2549.0,3077.0,30613.0
Raisen,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1890.0,1796.0,1986.0,2110.0,1872.0,2141.0,1983.0,2080.0,1969.0,2020.0,2118.0,2071.0,24036.0
Raisen,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2132.0,2073.0,2353.0,2519.0,2496.0,2226.0,2252.0,2149.0,2257.0,2301.0,2373.0,2537.0,27668.0
Raisen,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2926.0,2474.0,3103.0,3309.0,2774.0,2852.0,2662.0,2943.0,2901.0,3045.0,3022.0,3158.0,35169.0
Raisen,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,590.0,107.0,45.0,200.0,189.0,191.0,166.0,82.0,113.0,274.0,132.0,178.0,2267.0
Raisen,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,36.0,26.0,14.0,17.0,45.0,25.0,18.0,12.0,19.0,26.0,23.0,7.0,268.0
Raisen,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1626.0,1415.0,1727.0,1608.0,1426.0,1731.0,1591.0,1756.0,1762.0,2092.0,2190.0,1896.0,20820.0
Raisen,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,117.0,64.0,128.0,94.0,65.0,122.0,56.0,70.0,116.0,74.0,58.0,11.0,975.0
Raisen,1.8,Number of pregnancy test kits used at SC level,TOTAL,641.0,1000.0,1269.0,1282.0,1172.0,1430.0,1250.0,1656.0,1342.0,1464.0,1734.0,1884.0,16124.0
Raisen,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,12.0,9.0,4.0,0.0,0.0,3.0,16.0,4.0,14.0,10.0,23.0,3.0,98.0
Raisen,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,161.0,181.0,244.0,256.0,391.0,323.0,302.0,388.0,283.0,288.0,252.0,238.0,3307.0
Raisen,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,173.0,190.0,248.0,256.0,391.0,326.0,318.0,392.0,297.0,298.0,275.0,241.0,3405.0
Raisen,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,113.0,110.0,178.0,150.0,223.0,147.0,157.0,244.0,246.0,197.0,230.0,209.0,2204.0
Raisen,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,19.0,4.0,7.0,1.0,0.0,2.0,1.0,5.0,21.0,15.0,75.0
Raisen,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1287.0,1326.0,1504.0,1519.0,1650.0,1519.0,1543.0,1565.0,1493.0,1398.0,1363.0,1570.0,17737.0
Raisen,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,130.0,116.0,125.0,111.0,235.0,159.0,453.0,164.0,111.0,159.0,158.0,172.0,2093.0
Raisen,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1100.0,1103.0,1285.0,1340.0,1539.0,1249.0,1256.0,1331.0,1358.0,1435.0,1162.0,1536.0,15694.0
Raisen,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,585.0,682.0,937.0,936.0,1144.0,889.0,1003.0,981.0,850.0,1032.0,919.0,1049.0,11007.0
Raisen,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,70.0,58.0,29.0,41.0,43.0,26.0,20.0,34.0,42.0,185.0,73.0,82.0,703.0
Raisen,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Raisen,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Raisen,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Raisen,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Raisen,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,2.0,2.0,1.0,4.0,5.0,1.0,2.0,2.0,3.0,11.0,33.0
Raisen,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,52.0,43.0,47.0,21.0,0.0,0.0,28.0,38.0,42.0,46.0,45.0,55.0,417.0
Raisen,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raisen,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,52.0,43.0,49.0,23.0,1.0,4.0,33.0,39.0,44.0,48.0,48.0,66.0,450.0
Raisen,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Raisen,4.1.1.a,Number of male live births,TOTAL,747.0,821.0,885.0,936.0,1054.0,966.0,943.0,1039.0,932.0,893.0,820.0,871.0,10907.0
Raisen,4.1.1.b,Number of female live births,TOTAL,696.0,690.0,873.0,823.0,967.0,862.0,902.0,934.0,837.0,867.0,795.0,845.0,10091.0
Raisen,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1443.0,1511.0,1758.0,1759.0,2021.0,1828.0,1845.0,1973.0,1769.0,1760.0,1615.0,1716.0,20998.0
Raisen,4.1.2,Number of still births,TOTAL,26.0,24.0,34.0,33.0,38.0,18.0,23.0,34.0,29.0,28.0,30.0,15.0,332.0
Raisen,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,62.0,41.0,81.0,48.0,65.0,59.0,73.0,51.0,55.0,83.0,63.0,67.0,748.0
Raisen,4.2.1,Number of Newborns weighed at birth,TOTAL,1356.0,1506.0,1740.0,1699.0,2003.0,1821.0,1844.0,1962.0,1760.0,1720.0,1595.0,1719.0,20725.0
Raisen,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,169.0,155.0,179.0,166.0,190.0,251.0,183.0,242.0,214.0,245.0,137.0,190.0,2321.0
Raisen,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1389.0,1509.0,1678.0,1724.0,1829.0,1780.0,1799.0,1840.0,1731.0,1686.0,1585.0,1684.0,20234.0
Raisen,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,8.0,9.0,9.0,9.0,19.0,25.0,6.0,47.0,23.0,31.0,10.0,72.0,268.0
Raisen,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,37.0,41.0,66.0,76.0,58.0,107.0,73.0,96.0,44.0,70.0,80.0,73.0,821.0
Raisen,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,80.0,85.0,127.0,111.0,133.0,101.0,122.0,72.0,48.0,98.0,89.0,161.0,1227.0
Raisen,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raisen,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,125.0,135.0,202.0,196.0,210.0,233.0,201.0,215.0,115.0,199.0,179.0,306.0,2316.0
Raisen,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Raisen,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,171.0,184.0,184.0,506.0,487.0,451.0,429.0,150.0,219.0,228.0,86.0,151.0,3246.0
Raisen,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,15.0,30.0,17.0,23.0,38.0,65.0,18.0,21.0,38.0,8.0,29.0,30.0,332.0
Raisen,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,739.0,603.0,629.0,606.0,663.0,678.0,647.0,692.0,370.0,186.0,77.0,99.0,5989.0
Raisen,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,32.0,41.0,59.0,104.0,21.0,56.0,0.0,100.0,17.0,48.0,36.0,33.0,547.0
Raisen,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1235.0,1381.0,1589.0,1554.0,1713.0,1603.0,1609.0,1609.0,1563.0,1550.0,1407.0,1572.0,18385.0
Raisen,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,323.0,430.0,541.0,664.0,614.0,631.0,574.0,892.0,488.0,651.0,683.0,584.0,7075.0
Raisen,6.3,PNC maternal complications attended,TOTAL,44.0,89.0,107.0,98.0,114.0,96.0,111.0,61.0,78.0,93.0,75.0,109.0,1075.0
Raisen,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,59.0,39.0,51.0,36.0,30.0,67.0,51.0,55.0,90.0,68.0,52.0,73.0,671.0
Raisen,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,3.0,7.0,2.0,0.0,1.0,0.0,0.0,1.0,0.0,14.0
Raisen,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,59.0,39.0,51.0,39.0,37.0,69.0,51.0,56.0,90.0,68.0,53.0,73.0,685.0
Raisen,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Raisen,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,141.0,188.0,286.0,335.0,152.0,275.0,169.0,405.0,284.0,390.0,145.0,126.0,2896.0
Raisen,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,296.0,873.0,575.0,597.0,539.0,542.0,731.0,781.0,1049.0,639.0,489.0,329.0,7440.0
Raisen,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,437.0,1061.0,861.0,932.0,691.0,817.0,900.0,1186.0,1333.0,1029.0,634.0,455.0,10336.0
Raisen,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,38.0,0.0,38.0
Raisen,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,1.0,2.0,0.0,0.0,2.0,1.0,4.0,8.0,4.0,3.0,2.0,28.0
Raisen,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,2.0,1.0,7.0
Raisen,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raisen,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,1.0,2.0,0.0,0.0,2.0,1.0,4.0,10.0,6.0,5.0,3.0,35.0
Raisen,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Raisen,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,23.0,18.0,0.0,0.0,0.0,265.0,424.0,133.0,53.0,58.0,974.0
Raisen,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,25.0,1.0,20.0,71.0,20.0,20.0,29.0,974.0,1219.0,588.0,610.0,103.0,3680.0
Raisen,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,3.0,0.0,0.0,26.0,10.0,0.0,3.0,207.0,217.0,124.0,76.0,12.0,678.0
Raisen,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raisen,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,28.0,1.0,43.0,115.0,30.0,20.0,32.0,1446.0,1860.0,845.0,739.0,173.0,5332.0
Raisen,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Raisen,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,10.0,10.0,25.0,6.0,61.0
Raisen,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,10.0,2.0,3.0,1.0,21.0
Raisen,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raisen,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,14.0,20.0,12.0,28.0,7.0,82.0
Raisen,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Raisen,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,5.0,6.0,4.0,6.0,1.0,15.0,37.0
Raisen,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,10.0,12.0,12.0,4.0,0.0,0.0,11.0,8.0,14.0,21.0,21.0,12.0,125.0
Raisen,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raisen,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,10.0,12.0,12.0,4.0,0.0,0.0,16.0,14.0,18.0,27.0,22.0,27.0,162.0
Raisen,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Raisen,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,274.0,364.0,377.0,376.0,386.0,392.0,317.0,324.0,278.0,247.0,304.0,277.0,3916.0
Raisen,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,58.0,138.0,186.0,99.0,172.0,179.0,150.0,129.0,84.0,73.0,47.0,62.0,1377.0
Raisen,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,88.0,120.0,300.0,265.0,144.0,222.0,122.0,167.0,145.0,136.0,243.0,223.0,2175.0
Raisen,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,149.0,228.0,73.0,247.0,187.0,165.0,155.0,159.0,159.0,133.0,185.0,224.0,2064.0
Raisen,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raisen,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,569.0,850.0,936.0,987.0,889.0,958.0,744.0,779.0,666.0,589.0,779.0,786.0,9532.0
Raisen,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,206.0,355.0,497.0,443.0,450.0,499.0,382.0,403.0,397.0,371.0,474.0,509.0,4986.0
Raisen,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Raisen,9.06,Number of IUCD removals,TOTAL,409.0,191.0,298.0,182.0,154.0,324.0,205.0,240.0,267.0,138.0,180.0,305.0,2893.0
Raisen,9.07,Number of Oral Pills cycles distributed,TOTAL,8184.0,8210.0,10662.0,10757.0,9165.0,8869.0,8417.0,9169.0,10167.0,10546.0,10021.0,9454.0,113621.0
Raisen,9.08,Number of Condom pieces distributed,TOTAL,20231.0,24046.0,47318.0,29455.0,26146.0,30740.0,29313.0,28610.0,27968.0,27295.0,32905.0,47085.0,371112.0
Raisen,9.09,Number of Centchroman (weekly) pills given,TOTAL,97.0,7.0,97.0,81.0,0.0,137.0,16.0,13.0,4.0,3.0,1.0,7.0,463.0
Raisen,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,106.0,124.0,100.0,100.0,119.0,183.0,135.0,178.0,57.0,104.0,140.0,80.0,1426.0
Raisen,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,7.0,0.0,0.0,0.0,0.0,2.0,0.0,1.0,0.0,2.0,1.0,1.0,14.0
Raisen,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Raisen,9.11.2.b,Number of failures following female sterilization,TOTAL,6.0,2.0,0.0,4.0,0.0,3.0,0.0,2.0,0.0,3.0,2.0,2.0,24.0
Raisen,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,9.12,Number of Institutions having NSV trained doctors,TOTAL,8.0,4.0,3.0,6.0,6.0,7.0,4.0,6.0,4.0,8.0,5.0,6.0,-1.0
Raisen,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1551.0,1525.0,1746.0,1712.0,1927.0,1848.0,1772.0,1936.0,1811.0,1749.0,1655.0,1825.0,21057.0
Raisen,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1917.0,2016.0,2210.0,2282.0,2298.0,2516.0,2685.0,526.0,378.0,56.0,0.0,279.0,17163.0
Raisen,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2180.0,2007.0,2219.0,2440.0,2176.0,2298.0,2389.0,2628.0,879.0,263.0,134.0,357.0,19970.0
Raisen,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2332.0,2243.0,2340.0,2391.0,2238.0,2237.0,2300.0,2538.0,2586.0,779.0,398.0,246.0,22628.0
Raisen,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,30.0,2010.0,2085.0,2371.0,2460.0,2401.0,11358.0
Raisen,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1632.0,2071.0,2439.0,2444.0,8587.0
Raisen,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23.0,1403.0,1788.0,2462.0,5676.0
Raisen,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1404.0,1429.0,1625.0,1579.0,1808.0,1712.0,1628.0,1619.0,1642.0,1590.0,1521.0,1631.0,19188.0
Raisen,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1917.0,2009.0,2213.0,2281.0,2306.0,2511.0,2664.0,1686.0,2342.0,2328.0,2436.0,2317.0,27010.0
Raisen,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2181.0,2015.0,2212.0,2428.0,2171.0,2297.0,2427.0,2623.0,2333.0,2237.0,2452.0,2417.0,27793.0
Raisen,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2323.0,2250.0,2340.0,2386.0,2238.0,2235.0,2306.0,2543.0,2610.0,2165.0,2108.0,2558.0,28062.0
Raisen,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1265.0,1284.0,1429.0,1325.0,1461.0,1434.0,1409.0,1251.0,1585.0,1337.0,1058.0,1482.0,16320.0
Raisen,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1675.0,1761.0,1956.0,1984.0,2066.0,2308.0,2301.0,530.0,893.0,99.0,287.0,100.0,15960.0
Raisen,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2197.0,2016.0,2217.0,2434.0,2209.0,2304.0,2400.0,2624.0,1142.0,461.0,339.0,154.0,20497.0
Raisen,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2362.0,2287.0,2370.0,2399.0,2285.0,2298.0,2365.0,2547.0,2522.0,979.0,424.0,292.0,23130.0
Raisen,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2226.0,2240.0,2682.0,2667.0,2514.0,2817.0,2483.0,2382.0,2341.0,2327.0,2332.0,2463.0,29474.0
Raisen,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1122.0,1078.0,1587.0,1559.0,1315.0,1423.0,1356.0,1567.0,2127.0,2091.0,2006.0,2644.0,19875.0
Raisen,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,5.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,7.0
Raisen,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1061.0,1075.0,1216.0,1799.0,1123.0,1353.0,1310.0,1126.0,1183.0,1134.0,1176.0,1211.0,14767.0
Raisen,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,975.0,970.0,1118.0,1580.0,1046.0,1284.0,1155.0,1004.0,1027.0,1034.0,1016.0,1096.0,13305.0
Raisen,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2036.0,2045.0,2334.0,3379.0,2169.0,2637.0,2465.0,2130.0,2210.0,2168.0,2192.0,2307.0,28072.0
Raisen,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1790.0,1678.0,2024.0,2053.0,1745.0,1893.0,1811.0,2098.0,2194.0,2422.0,2309.0,2474.0,24491.0
Raisen,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1789.0,1673.0,2016.0,2013.0,1743.0,1892.0,1815.0,2115.0,2172.0,2421.0,2300.0,2449.0,24398.0
Raisen,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,49.0,0.0,0.0,0.0,53.0,29.0,0.0,9.0,0.0,6.0,0.0,5.0,151.0
Raisen,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,308.0,264.0,362.0,312.0,343.0,374.0,284.0,426.0,546.0,530.0,480.0,419.0,4648.0
Raisen,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,262.0,250.0,330.0,285.0,276.0,336.0,262.0,404.0,478.0,481.0,420.0,386.0,4170.0
Raisen,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,570.0,514.0,692.0,597.0,619.0,710.0,546.0,830.0,1024.0,1011.0,900.0,805.0,8818.0
Raisen,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,611.0,591.0,780.0,876.0,849.0,806.0,773.0,794.0,773.0,939.0,940.0,932.0,9664.0
Raisen,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1219.0,1314.0,1416.0,1728.0,1738.0,1835.0,1643.0,1573.0,1616.0,1627.0,1519.0,1504.0,18732.0
Raisen,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1140.0,1206.0,1466.0,1709.0,1641.0,1957.0,1643.0,1579.0,1596.0,1617.0,1522.0,1617.0,18693.0
Raisen,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,5.0,2.0,0.0,1.0,2.0,1.0,2.0,3.0,3.0,2.0,0.0,23.0
Raisen,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,7.0,10.0,9.0,13.0,10.0,11.0,19.0,11.0,16.0,4.0,0.0,112.0
Raisen,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1277.0,1328.0,1452.0,1342.0,1355.0,1315.0,1365.0,1337.0,1392.0,1390.0,1409.0,1472.0,16434.0
Raisen,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1251.0,1272.0,1430.0,1343.0,1327.0,1287.0,1336.0,1318.0,1381.0,1372.0,1351.0,1461.0,16129.0
Raisen,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,973.0,984.0,1108.0,1031.0,1000.0,1007.0,983.0,991.0,1061.0,1109.0,1065.0,1262.0,12574.0
Raisen,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2212.0,2273.0,2782.0,3238.0,2567.0,2766.0,2287.0,2219.0,2299.0,2663.0,2240.0,2426.0,29972.0
Raisen,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,848.0,1002.0,1549.0,10703.0,4318.0,848.0,964.0,1026.0,3507.0,13676.0,1239.0,1034.0,40714.0
Raisen,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,465.0,435.0,1113.0,10929.0,3663.0,607.0,755.0,674.0,3219.0,14803.0,1162.0,724.0,38549.0
Raisen,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,10.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Raisen,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,4.0,0.0,5.0,2.0,15.0
Raisen,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,385.0,458.0,469.0,467.0,467.0,437.0,337.0,222.0,375.0,201.0,207.0,269.0,4294.0
Raisen,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,177.0,29.0,7.0,29.0,23.0,75.0,60.0,10.0,99.0,75.0,17.0,347.0,948.0
Raisen,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,50.0,26.0,22.0,38.0,81.0,111.0,105.0,40.0,66.0,91.0,88.0,78.0,796.0
Raisen,13.1,Number of Patients operated for cataract,TOTAL,210.0,175.0,118.0,401.0,338.0,507.0,776.0,701.0,962.0,799.0,866.0,320.0,6173.0
Raisen,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,216.0,212.0,134.0,399.0,336.0,549.0,794.0,733.0,956.0,861.0,866.0,308.0,6364.0
Raisen,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,2.0,4.0,443.0,118.0,10.0,42.0,112.0,47.0,10.0,21.0,17.0,826.0
Raisen,13.4,Number of children provided free glasses,TOTAL,2.0,1.0,1.0,265.0,5.0,2.0,190.0,184.0,25.0,36.0,23.0,23.0,757.0
Raisen,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,6.0,6.0,6.0,5.0,6.0,7.0,5.0,7.0,6.0,6.0,7.0,-1.0
Raisen,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,9.0,7.0,9.0,9.0,9.0,7.0,11.0,11.0,12.0,12.0,11.0,13.0,-1.0
Raisen,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1042.0,1140.0,1184.0,1158.0,1149.0,1093.0,1157.0,1114.0,1148.0,1129.0,1148.0,1249.0,-1.0
Raisen,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,6.0,7.0,7.0,6.0,6.0,7.0,7.0,8.0,7.0,8.0,9.0,-1.0
Raisen,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,5.0,8.0,16.0
Raisen,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,12.0,11.0,11.0,11.0,12.0,12.0,12.0,12.0,12.0,12.0,13.0,17.0,-1.0
Raisen,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,73.0,29.0,342.0,260.0,21.0,47.0,124.0,106.0,121.0,66.0,357.0,375.0,1921.0
Raisen,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,4.0,3.0,5.0,4.0,4.0,3.0,3.0,4.0,2.0,4.0,5.0,-1.0
Raisen,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,6.0,7.0,6.0,7.0,0.0,3.0,4.0,1.0,3.0,5.0,8.0,3.0,-1.0
Raisen,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,413.0,406.0,457.0,281.0,340.0,570.0,465.0,624.0,427.0,176.0,185.0,217.0,4561.0
Raisen,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1536.0,2018.0,2003.0,1182.0,1476.0,2205.0,1639.0,1884.0,1140.0,1393.0,2252.0,939.0,19667.0
Raisen,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,345.0,405.0,419.0,249.0,387.0,437.0,480.0,345.0,565.0,142.0,146.0,263.0,4183.0
Raisen,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2400.0,2877.0,2994.0,2608.0,3089.0,2929.0,2624.0,2507.0,3176.0,2456.0,2633.0,1960.0,32253.0
Raisen,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,758.0,811.0,876.0,530.0,727.0,1007.0,945.0,969.0,992.0,318.0,331.0,480.0,8744.0
Raisen,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3936.0,4895.0,4997.0,3790.0,4565.0,5134.0,4263.0,4391.0,4316.0,3849.0,4885.0,2899.0,51920.0
Raisen,14.10.2.a,Number of death cases of Inpatient males,TOTAL,7.0,6.0,5.0,3.0,8.0,7.0,3.0,7.0,5.0,1.0,4.0,5.0,61.0
Raisen,14.10.2.b,Number of death cases of Inpatient females,TOTAL,3.0,2.0,8.0,1.0,5.0,4.0,3.0,4.0,1.0,2.0,1.0,2.0,36.0
Raisen,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,10.0,8.0,13.0,4.0,13.0,11.0,6.0,11.0,6.0,3.0,5.0,7.0,97.0
Raisen,14.11,In-Patient Head Count at midnight,TOTAL,3416.0,4084.0,4104.0,4068.0,4477.0,5318.0,3806.0,4275.0,4136.0,3623.0,4087.0,2719.0,48113.0
Raisen,14.12.1,OPD attendance (All),TOTAL,61812.0,80132.0,74623.0,76834.0,95374.0,121607.0,80256.0,87711.0,76732.0,73640.0,104079.0,75862.0,1008662.0
Raisen,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,68.0,43.0,61.0,23.0,0.0,3.0,28.0,57.0,58.0,65.0,72.0,55.0,533.0
Raisen,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,3.0,1.0,1.0,0.0,0.0,0.0,3.0,3.0,3.0,6.0,20.0,3.0,43.0
Raisen,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,62.0,31.0,66.0,122.0,10.0,13.0,53.0,293.0,848.0,186.0,428.0,159.0,2271.0
Raisen,14.14.a,Number of patients given AYUSH treatment,TOTAL,2963.0,2331.0,2468.0,3532.0,2282.0,4980.0,2379.0,5454.0,2684.0,2933.0,3450.0,3924.0,39380.0
Raisen,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,51.0,150.0,145.0,181.0,109.0,151.0,131.0,130.0,98.0,81.0,172.0,106.0,1505.0
Raisen,14.14.c,Number of Adolescents counselled,TOTAL,126.0,48.0,89.0,216.0,6.0,0.0,0.0,69.0,124.0,0.0,1.0,0.0,679.0
Raisen,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7483.0,7742.0,6612.0,7044.0,8566.0,8123.0,8327.0,7992.0,8255.0,7260.0,7787.0,8680.0,93871.0
Raisen,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,262.0,182.0,116.0,156.0,193.0,158.0,103.0,225.0,213.0,200.0,190.0,205.0,2203.0
Raisen,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,408.0,303.0,427.0,442.0,287.0,543.0,337.0,518.0,324.0,489.0,446.0,356.0,4880.0
Raisen,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,6.0,0.0,2.0,1.0,2.0,1.0,1.0,3.0,2.0,2.0,0.0,21.0
Raisen,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,375.0,387.0,513.0,592.0,582.0,437.0,365.0,680.0,500.0,408.0,597.0,453.0,5889.0
Raisen,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,6.0
Raisen,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1738.0,1508.0,1774.0,1279.0,1772.0,1563.0,1408.0,1801.0,1531.0,1314.0,1303.0,1422.0,18413.0
Raisen,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,33.0,31.0,29.0,32.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,127.0
Raisen,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2521.0,2198.0,2714.0,2313.0,2641.0,2543.0,2110.0,2999.0,2355.0,2211.0,2346.0,2231.0,29182.0
Raisen,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,34.0,38.0,30.0,34.0,3.0,2.0,2.0,2.0,4.0,3.0,2.0,0.0,154.0
Raisen,15.2,Number of Widal tests conducted,Number tested,938.0,871.0,967.0,941.0,1836.0,1360.0,1279.0,1584.0,1259.0,1163.0,993.0,2158.0,15349.0
Raisen,15.3.a,Number of VDRL tests conducted on males,Number tested,239.0,404.0,337.0,745.0,159.0,330.0,297.0,486.0,151.0,269.0,509.0,163.0,4089.0
Raisen,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,3357.0,280.0,426.0,351.0,307.0,243.0,276.0,317.0,237.0,286.0,300.0,323.0,6703.0
Raisen,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1619.0,1124.0,1400.0,942.0,1653.0,1150.0,895.0,1243.0,860.0,966.0,1144.0,1023.0,14019.0
Raisen,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,5215.0,1808.0,2163.0,2038.0,2119.0,1723.0,1468.0,2046.0,1248.0,1521.0,1953.0,1509.0,24811.0
Raisen,15.4.1,Number of blood smears examined for Malaria,TOTAL,12142.0,11115.0,13283.0,13485.0,14317.0,53068.0,16923.0,13848.0,9430.0,7624.0,11340.0,13318.0,189893.0
Raisen,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,34.0,42.0,53.0,72.0,95.0,204.0,96.0,49.0,26.0,8.0,27.0,41.0,747.0
Raisen,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,2.0,4.0,0.0,20.0,23.0,17.0,17.0,12.0,2.0,0.0,0.0,99.0
Raisen,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,11000.0,13000.0,9000.0,12000.0,5000.0,8000.0,8000.0,,,,,,66000.0
Raisen,16.1.1,Stock position of DPT vaccines,2. Stocks Received,15000.0,15000.0,15000.0,15000.0,15000.0,15000.0,,,,,,,90000.0
Raisen,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,13000.0,9000.0,6000.0,10000.0,8000.0,12000.0,5000.0,,,,,,63000.0
Raisen,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,13000.0,19000.0,18000.0,17000.0,12000.0,11000.0,3000.0,,,,,,93000.0
Raisen,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Raisen,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,12500.0,,,,,,12500.0
Raisen,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,,,,,,2000.0
Raisen,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,10500.0,,,,,,10500.0
Raisen,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,11000.0,11000.0,23000.0,12000.0,6000.0,16000.0,16000.0,,,,,,95000.0
Raisen,16.1.2,Stock position of OPV vaccines,2. Stocks Received,30000.0,30000.0,20000.0,30000.0,30000.0,20000.0,15000.0,,,,,,175000.0
Raisen,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,11000.0,23000.0,13000.0,14000.0,16000.0,14000.0,5000.0,,,,,,96000.0
Raisen,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,30000.0,18000.0,30000.0,28000.0,20000.0,22000.0,26000.0,,,,,,174000.0
Raisen,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,5500.0,1000.0,13000.0,13000.0,4000.0,8000.0,8000.0,,,,,,52500.0
Raisen,16.1.3,Stock position of TT vaccines,2. Stocks Received,20000.0,20000.0,15000.0,15000.0,15000.0,12000.0,,,,,,,97000.0
Raisen,16.1.3,Stock position of TT vaccines,3. Unusable Stock,1000.0,13000.0,13000.0,0.0,8000.0,12000.0,3000.0,,,,,,50000.0
Raisen,16.1.3,Stock position of TT vaccines,4. Stock Distributed,24500.0,8000.0,15000.0,0.0,11000.0,8000.0,5000.0,,,,,,71500.0
Raisen,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,28000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28000.0
Raisen,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Raisen,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Raisen,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Raisen,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Raisen,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,11000.0,11000.0,10000.0,12000.0,6000.0,6000.0,6000.0,,,,,,62000.0
Raisen,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,0.0,,,,,,60000.0
Raisen,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,11000.0,10000.0,9000.0,8000.0,6000.0,7000.0,4000.0,,,,,,55000.0
Raisen,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,10000.0,11000.0,11000.0,14000.0,10000.0,9000.0,2000.0,,,,,,67000.0
Raisen,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4500.0,4500.0,6000.0,3800.0,5000.0,7000.0,7000.0,,,,,,37800.0
Raisen,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,10000.0,5000.0,10000.0,10000.0,5000.0,5000.0,,,,,,50000.0
Raisen,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,4500.0,6000.0,6000.0,4800.0,7000.0,6000.0,2000.0,,,,,,36300.0
Raisen,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,5000.0,8500.0,5000.0,9000.0,8000.0,6000.0,10000.0,,,,,,51500.0
Raisen,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Raisen,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Raisen,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Raisen,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Raisen,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,8000.0,10000.0,11000.0,13000.0,13000.0,7000.0,13000.0,,,,,,75000.0
Raisen,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,20000.0,20000.0,15000.0,15000.0,12000.0,12000.0,,,,,,,94000.0
Raisen,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,10000.0,11000.0,8000.0,8000.0,5000.0,13000.0,5000.0,,,,,,60000.0
Raisen,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,18000.0,19000.0,18000.0,20000.0,20000.0,6000.0,8000.0,,,,,,109000.0
Raisen,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,3600.0,2200.0,2000.0,2100.0,,,,,,,,,9900.0
Raisen,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,1200.0,,,,,,,,,1200.0
Raisen,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,2200.0,2000.0,1200.0,1300.0,,,,,,,,,6700.0
Raisen,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,1400.0,200.0,800.0,2000.0,,,,,,,,,4400.0
Raisen,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,66000.0,16000.0,26000.0,22000.0,6000.0,12000.0,12000.0,,,,,,160000.0
Raisen,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,18000.0,30000.0,36000.0,36000.0,60000.0,,,,,,,180000.0
Raisen,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,16000.0,26000.0,26000.0,36000.0,12000.0,12000.0,6000.0,,,,,,134000.0
Raisen,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,50000.0,8000.0,30000.0,22000.0,30000.0,6000.0,6000.0,,,,,,152000.0
Raisen,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,54000.0,0.0,0.0,0.0,0.0,0.0,0.0,54000.0
Raisen,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2200.0,1800.0,1200.0,800.0,1000.0,1000.0,800.0,,,,,,8800.0
Raisen,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,20000.0,5000.0,5000.0,10000.0,,,,,,,40000.0
Raisen,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,1800.0,1200.0,7000.0,0.0,1000.0,800.0,800.0,,,,,,12600.0
Raisen,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,400.0,600.0,14200.0,0.0,5000.0,10200.0,,,,,,,30400.0
Raisen,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,5800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5800.0
Raisen,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,600.0,,100.0,100.0,,,,,,800.0
Raisen,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,600.0,900.0,0.0,,,,,,,,,1500.0
Raisen,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,300.0,,0.0,100.0,,,,,,400.0
Raisen,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,300.0,,,,,,,,,300.0
Raisen,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,600.0,900.0,0.0,0.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,1600.0
Raisen,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,7000.0,7000.0,0.0,0.0,,,,,,,,,14000.0
Raisen,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Raisen,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,7000.0,0.0,0.0,0.0,,,,,,,,,7000.0
Raisen,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Raisen,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,7000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7000.0
Raisen,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,14900.0,14800.0,12000.0,14800.0,,,,,,,,,56500.0
Raisen,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,10000.0,,,,,,,,,10000.0
Raisen,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,14800.0,12000.0,6000.0,16300.0,,,,,,,,,49100.0
Raisen,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,100.0,2800.0,6000.0,8500.0,,,,,,,,,17400.0
Raisen,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,3000.0,500.0,0.0,0.0,,,,,,,,,3500.0
Raisen,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Raisen,16.3.02,Stock Position of Gloves,3. Unusable Stock,500.0,0.0,0.0,0.0,,,,,,,,,500.0
Raisen,16.3.02,Stock Position of Gloves,4. Stock Distributed,2500.0,500.0,0.0,0.0,,,,,,,,,3000.0
Raisen,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Raisen,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Raisen,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Raisen,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Raisen,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,47555.0,46695.0,40000.0,46595.0,,,,,,,,,180845.0
Raisen,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Raisen,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,46695.0,40000.0,30800.0,37395.0,,,,,,,,,154890.0
Raisen,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,860.0,6695.0,9200.0,9200.0,,,,,,,,,25955.0
Raisen,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Raisen,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Raisen,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Raisen,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Raisen,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Raisen,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Raisen,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Raisen,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Raisen,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,24000.0,0.0,0.0,243000.0,,,,,,,,,267000.0
Raisen,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,400000.0,5000000.0,,,,,,,,,5400000.0
Raisen,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,200000.0,4500000.0,,,,,,,,,4700000.0
Raisen,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,24000.0,0.0,200000.0,743000.0,,,,,,,,,967000.0
Raisen,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,42080.0,26680.0,20000.0,3680.0,,,,,,,,,92440.0
Raisen,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Raisen,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,26680.0,20000.0,0.0,0.0,,,,,,,,,46680.0
Raisen,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,15400.0,6680.0,20000.0,3680.0,,,,,,,,,45760.0
Raisen,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,8060.0,5120.0,3000.0,9520.0,,,,,,,,,25700.0
Raisen,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,5000.0,0.0,,,,,,,,,5000.0
Raisen,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,5120.0,3000.0,5000.0,4330.0,,,,,,,,,17450.0
Raisen,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,2940.0,2120.0,3000.0,5190.0,,,,,,,,,13250.0
Raisen,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,4084.0,4084.0,1584.0,192.0,,,,,,,,,9944.0
Raisen,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Raisen,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,1584.0,84.0,0.0,,,,,,,,,1668.0
Raisen,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,2500.0,1500.0,0.0,,,,,,,,,4000.0
Raisen,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,4084.0,0.0,0.0,192.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4276.0
Raisen,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,52100.0,104600.0,54600.0,25000.0,,,,,,,,,236300.0
Raisen,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,100000.0,0.0,100000.0,,,,,,,,,200000.0
Raisen,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,4600.0,150000.0,35000.0,5700.0,,,,,,,,,195300.0
Raisen,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,47500.0,54600.0,19600.0,119300.0,,,,,,,,,241000.0
Raisen,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,16500.0,4000.0,1700.0,3000.0,800.0,600.0,2000.0,,,,,,28600.0
Raisen,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,3300.0,6600.0,3300.0,3300.0,3300.0,3300.0,,,,,,,23100.0
Raisen,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,4000.0,1700.0,1500.0,4300.0,600.0,2000.0,1000.0,,,,,,15100.0
Raisen,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,15800.0,8900.0,3500.0,2000.0,3500.0,1900.0,1000.0,,,,,,36600.0
Raisen,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,21000.0,28000.0,1500.0,80000.0,80000.0,80000.0,80000.0,,,,,,370500.0
Raisen,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,12000.0,12000.0,292000.0,0.0,0.0,,,,,,,,316000.0
Raisen,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,28000.0,15000.0,150000.0,70000.0,0.0,,80000.0,,,,,,343000.0
Raisen,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,5000.0,25000.0,143500.0,10000.0,0.0,,,,,,,,183500.0
Raisen,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,80000.0,80000.0,0.0,0.0,0.0,0.0,0.0,0.0,160000.0
Raisen,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,21000.0,4000.0,2000.0,3200.0,1500.0,1500.0,1500.0,,,,,,34700.0
Raisen,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2000.0,4000.0,2000.0,0.0,,,,,,,,,8000.0
Raisen,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,4000.0,4000.0,1500.0,1200.0,1500.0,1500.0,1500.0,,,,,,15200.0
Raisen,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,19000.0,4000.0,2500.0,2000.0,,,,,,,,,27500.0
Raisen,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raisen,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,1.0,,1.0,2.0,,,,,,1.0,6.0
Raisen,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,1.0,,,1.0,,,1.0,,3.0
Raisen,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Raisen,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,1.0,,,1.0,,,1.0,,3.0
Raisen,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,1.0,,,,,,1.0,1.0,,1.0,4.0
Raisen,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Raisen,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,1.0,,,,,,1.0,1.0,,1.0,4.0
Raisen,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,1.0,2.0,3.0,8.0,1.0,7.0,3.0,8.0,4.0,3.0,41.0
Raisen,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Raisen,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,,1.0,2.0,3.0,8.0,1.0,7.0,3.0,8.0,4.0,3.0,41.0
Raisen,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,1.0,10.0,3.0,5.0,12.0,5.0,7.0,6.0,7.0,2.0,6.0,65.0
Raisen,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,1.0,,1.0
Raisen,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,1.0,10.0,3.0,5.0,12.0,5.0,7.0,6.0,7.0,3.0,6.0,66.0
Raisen,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,,1.0,,1.0,,2.0,1.0,,1.0,2.0,9.0
Raisen,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,2.0,,,,2.0
Raisen,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,,1.0,,1.0,,2.0,3.0,,1.0,2.0,11.0
Raisen,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,1.0,1.0
Raisen,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Raisen,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,1.0,1.0
Raisen,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,1.0,,2.0,1.0,4.0
Raisen,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Raisen,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,1.0,,2.0,2.0,5.0
Raisen,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Raisen,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Raisen,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Raisen,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,8.0,,2.0,4.0,8.0,5.0,5.0,4.0,4.0,4.0,44.0
Raisen,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,2.0,,4.0,3.0,2.0,,3.0,3.0,1.0,1.0,20.0
Raisen,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,,10.0,,6.0,7.0,10.0,5.0,8.0,7.0,5.0,5.0,64.0
Raisen,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Raisen,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Raisen,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Raisen,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Raisen,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Raisen,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,3.0,,1.0,2.0,,,2.0,1.0,,3.0,1.0,,13.0
Raisen,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,2.0,2.0
Raisen,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,3.0,,1.0,2.0,,,2.0,1.0,,3.0,1.0,2.0,15.0
Raisen,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Raisen,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,3.0,,,1.0,1.0,,,5.0
Raisen,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,1.0,,,,,2.0,3.0
Raisen,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,3.0,1.0,,1.0,1.0,,2.0,8.0
Raisen,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Raisen,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Raisen,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Raisen,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Raisen,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,1.0,,1.0,1.0,,1.0,,1.0,,5.0
Raisen,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,2.0,4.0,10.0,5.0,5.0,8.0,16.0,8.0,9.0,4.0,10.0,5.0,86.0
Raisen,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,11.0,15.0,30.0,20.0,18.0,47.0,31.0,20.0,19.0,30.0,20.0,11.0,272.0
Raisen,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,13.0,19.0,40.0,26.0,23.0,56.0,48.0,28.0,29.0,34.0,31.0,16.0,363.0
Raisen,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Raisen,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Raisen,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Raisen,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Raisen,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Raisen,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,1.0,4.0,2.0,2.0,12.0,1.0,6.0,4.0,1.0,5.0,5.0,46.0
Raisen,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,5.0,3.0,4.0,,5.0,3.0,6.0,9.0,2.0,3.0,6.0,47.0
Raisen,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,4.0,6.0,7.0,6.0,2.0,17.0,4.0,12.0,13.0,3.0,8.0,11.0,93.0
Raisen,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Raisen,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,1.0,,,,,,,1.0,2.0
Raisen,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Raisen,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,1.0,,,,,,1.0,1.0,3.0
Raisen,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Raisen,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Raisen,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Raisen,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Raisen,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Raisen,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Raisen,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Raisen,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Raisen,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Raisen,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,,,,,,1.0,,,,,2.0
Raisen,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Raisen,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,,,,,,1.0,,,,,2.0
Raisen,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Raisen,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,1.0,1.0,1.0,,,1.0,4.0
Raisen,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Raisen,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,1.0,1.0,1.0,,,1.0,4.0
Raisen,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Raisen,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Raisen,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Raisen,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,1.0,,,,,1.0
Raisen,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Raisen,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,1.0,,,1.0,2.0,,,2.0,1.0,1.0,1.0,10.0
Raisen,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Raisen,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,1.0,,,1.0,2.0,,,2.0,1.0,1.0,1.0,10.0
Raisen,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,,,,,,,1.0,5.0,,,,7.0
Raisen,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,5.0,6.0,2.0,6.0,6.0,3.0,3.0,7.0,2.0,9.0,7.0,8.0,64.0
Raisen,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,3.0,,2.0,,2.0,,2.0,1.0,2.0,2.0,1.0,,15.0
Raisen,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,9.0,6.0,4.0,6.0,8.0,3.0,5.0,9.0,9.0,11.0,8.0,8.0,86.0
Raisen,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,1.0,,,,,,1.0,,,,,2.0
Raisen,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,,6.0,,,1.0,,1.0,2.0,3.0,1.0,,16.0
Raisen,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Raisen,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,2.0,1.0,6.0,,,1.0,,2.0,2.0,3.0,1.0,1.0,19.0
Raisen,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Raisen,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,3.0,2.0,1.0,2.0,1.0,,,,9.0
Raisen,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,,1.0,1.0,,,,,,,,3.0
Raisen,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,,1.0,4.0,2.0,2.0,2.0,1.0,,,,13.0
Raisen,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Raisen,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,1.0,1.0,1.0,,,1.0,1.0,,,,,6.0
Raisen,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,1.0,6.0,4.0,4.0,4.0,17.0,,,1.0,4.0,,43.0
Raisen,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,2.0,7.0,5.0,4.0,4.0,18.0,1.0,,1.0,4.0,,49.0
Raisen,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Raisen,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,1.0,1.0,,1.0,1.0,,,,,2.0,2.0,9.0
Raisen,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,4.0,4.0,1.0,,1.0,2.0,3.0,5.0,4.0,2.0,2.0,2.0,30.0
Raisen,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,5.0,5.0,2.0,,2.0,3.0,3.0,5.0,4.0,2.0,4.0,4.0,39.0
Raisen,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,3.0,2.0,2.0,2.0,1.0,1.0,,,,1.0,1.0,14.0
Raisen,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,8.0,9.0,19.0,17.0,19.0,21.0,9.0,18.0,18.0,12.0,3.0,12.0,165.0
Raisen,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,22.0,25.0,38.0,12.0,35.0,39.0,33.0,37.0,56.0,34.0,33.0,34.0,398.0
Raisen,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,31.0,37.0,59.0,31.0,56.0,61.0,43.0,55.0,74.0,46.0,37.0,47.0,577.0
Rajgarh,1.1,Total number of pregnant women Registered for ANC,TOTAL,3100.0,2981.0,3667.0,3484.0,2595.0,3161.0,2334.0,3107.0,3031.0,2787.0,3417.0,3130.0,36794.0
Rajgarh,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1980.0,1871.0,2286.0,2214.0,1652.0,2016.0,1476.0,1901.0,1862.0,1767.0,2080.0,1945.0,23050.0
Rajgarh,1.2,Number of Pregnant women registered under JSY,TOTAL,3100.0,2981.0,3667.0,3484.0,2595.0,3161.0,2334.0,3107.0,3031.0,2787.0,3417.0,3130.0,36794.0
Rajgarh,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2331.0,2392.0,2646.0,2633.0,2484.0,2826.0,2156.0,2517.0,2288.0,2408.0,2480.0,2572.0,29733.0
Rajgarh,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2326.0,2177.0,2676.0,2544.0,1910.0,2381.0,1731.0,2301.0,2332.0,2067.0,2475.0,2159.0,27079.0
Rajgarh,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2552.0,2636.0,2982.0,3327.0,2544.0,2663.0,2363.0,2392.0,2605.0,2503.0,2775.0,3076.0,32418.0
Rajgarh,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3006.0,2981.0,3633.0,3544.0,2677.0,3178.0,2437.0,3131.0,3071.0,2803.0,3409.0,2858.0,36728.0
Rajgarh,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,235.0,118.0,316.0,421.0,467.0,257.0,223.0,247.0,347.0,338.0,435.0,275.0,3679.0
Rajgarh,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,3.0,16.0,11.0,2.0,6.0,5.0,9.0,3.0,7.0,10.0,2.0,74.0
Rajgarh,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,998.0,1330.0,1457.0,1608.0,1387.0,1632.0,1445.0,1926.0,1659.0,1402.0,1751.0,1883.0,18478.0
Rajgarh,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,69.0,40.0,61.0,35.0,38.0,86.0,35.0,64.0,80.0,78.0,38.0,39.0,663.0
Rajgarh,1.8,Number of pregnancy test kits used at SC level,TOTAL,201.0,155.0,189.0,172.0,284.0,433.0,450.0,573.0,1056.0,935.0,974.0,1112.0,6534.0
Rajgarh,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,37.0,29.0,24.0,44.0,18.0,40.0,23.0,27.0,20.0,21.0,41.0,41.0,365.0
Rajgarh,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,115.0,80.0,125.0,116.0,134.0,156.0,111.0,172.0,153.0,123.0,124.0,82.0,1491.0
Rajgarh,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,152.0,109.0,149.0,160.0,152.0,196.0,134.0,199.0,173.0,144.0,165.0,123.0,1856.0
Rajgarh,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,63.0,64.0,86.0,100.0,102.0,134.0,94.0,128.0,146.0,80.0,118.0,101.0,1216.0
Rajgarh,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,3.0,4.0,11.0,7.0,29.0
Rajgarh,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1411.0,1722.0,1997.0,1985.0,2292.0,2228.0,2020.0,2329.0,1945.0,1851.0,1737.0,1825.0,23342.0
Rajgarh,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,99.0,20.0,46.0,74.0,113.0,90.0,49.0,116.0,121.0,143.0,133.0,114.0,1118.0
Rajgarh,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,801.0,1256.0,1317.0,1501.0,1691.0,2153.0,1583.0,1729.0,1531.0,2058.0,1578.0,1641.0,18839.0
Rajgarh,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,247.0,706.0,692.0,748.0,1036.0,1098.0,1045.0,1022.0,938.0,1086.0,802.0,838.0,10258.0
Rajgarh,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Rajgarh,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,42.0,51.0,70.0,69.0,79.0,48.0,51.0,52.0,40.0,43.0,43.0,41.0,629.0
Rajgarh,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,32.0,36.0,43.0,29.0,19.0,33.0,18.0,35.0,19.0,27.0,23.0,38.0,352.0
Rajgarh,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajgarh,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,32.0,36.0,43.0,29.0,19.0,33.0,18.0,35.0,19.0,27.0,23.0,38.0,352.0
Rajgarh,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,12.0,15.0,21.0,16.0,29.0,13.0,19.0,16.0,13.0,10.0,23.0,19.0,206.0
Rajgarh,4.1.1.a,Number of male live births,TOTAL,823.0,998.0,1112.0,1121.0,1284.0,1275.0,1086.0,1292.0,1072.0,1004.0,975.0,1013.0,13055.0
Rajgarh,4.1.1.b,Number of female live births,TOTAL,764.0,853.0,1069.0,1057.0,1154.0,1163.0,1081.0,1258.0,1043.0,996.0,950.0,954.0,12342.0
Rajgarh,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1587.0,1851.0,2181.0,2178.0,2438.0,2438.0,2167.0,2550.0,2115.0,2000.0,1925.0,1967.0,25397.0
Rajgarh,4.1.2,Number of still births,TOTAL,27.0,45.0,50.0,49.0,54.0,48.0,50.0,43.0,49.0,50.0,25.0,32.0,522.0
Rajgarh,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,34.0,36.0,69.0,64.0,36.0,59.0,56.0,78.0,64.0,33.0,73.0,49.0,651.0
Rajgarh,4.2.1,Number of Newborns weighed at birth,TOTAL,1476.0,1776.0,2115.0,2091.0,2395.0,2390.0,2122.0,2439.0,2046.0,1956.0,1870.0,1910.0,24586.0
Rajgarh,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,161.0,232.0,327.0,316.0,490.0,418.0,502.0,415.0,357.0,347.0,281.0,379.0,4225.0
Rajgarh,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1444.0,1725.0,2050.0,2023.0,2355.0,2324.0,2049.0,2409.0,2001.0,1804.0,1806.0,1834.0,23824.0
Rajgarh,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,11.0,14.0,18.0,17.0,23.0,19.0,8.0,4.0,8.0,5.0,17.0,13.0,157.0
Rajgarh,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,14.0,14.0,7.0,45.0,64.0,111.0,49.0,51.0,14.0,20.0,106.0,104.0,599.0
Rajgarh,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,287.0,311.0,202.0,178.0,181.0,406.0,322.0,320.0,286.0,177.0,394.0,323.0,3387.0
Rajgarh,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajgarh,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,312.0,339.0,227.0,240.0,268.0,536.0,379.0,375.0,308.0,202.0,517.0,440.0,4143.0
Rajgarh,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Rajgarh,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,177.0,276.0,276.0,240.0,279.0,376.0,167.0,246.0,205.0,232.0,302.0,296.0,3072.0
Rajgarh,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,20.0,18.0,23.0,25.0,14.0,37.0,19.0,32.0,15.0,31.0,21.0,61.0,316.0
Rajgarh,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,135.0,177.0,204.0,179.0,170.0,209.0,140.0,145.0,168.0,460.0,157.0,199.0,2343.0
Rajgarh,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,121.0,85.0,141.0,112.0,122.0,179.0,93.0,121.0,44.0,116.0,108.0,31.0,1273.0
Rajgarh,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1364.0,1557.0,2016.0,1992.0,2294.0,2249.0,1958.0,2305.0,1830.0,1715.0,1624.0,1670.0,22574.0
Rajgarh,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,544.0,889.0,1133.0,890.0,709.0,918.0,859.0,821.0,704.0,798.0,911.0,970.0,10146.0
Rajgarh,6.3,PNC maternal complications attended,TOTAL,26.0,43.0,25.0,34.0,30.0,58.0,37.0,52.0,51.0,4.0,35.0,43.0,438.0
Rajgarh,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,46.0,33.0,46.0,34.0,35.0,36.0,30.0,58.0,28.0,29.0,49.0,48.0,472.0
Rajgarh,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,5.0,0.0,0.0,0.0,0.0,6.0
Rajgarh,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,46.0,33.0,46.0,34.0,35.0,36.0,31.0,63.0,28.0,29.0,49.0,48.0,478.0
Rajgarh,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Rajgarh,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,169.0,152.0,157.0,213.0,203.0,245.0,173.0,207.0,254.0,202.0,155.0,249.0,2379.0
Rajgarh,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,377.0,302.0,312.0,453.0,280.0,437.0,337.0,377.0,383.0,394.0,275.0,427.0,4354.0
Rajgarh,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,546.0,454.0,469.0,666.0,483.0,682.0,510.0,584.0,637.0,596.0,430.0,676.0,6733.0
Rajgarh,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,4.0
Rajgarh,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,2.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0,0.0,0.0,7.0
Rajgarh,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,2.0,2.0,10.0
Rajgarh,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajgarh,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,1.0,1.0,0.0,0.0,4.0,0.0,0.0,2.0,5.0,3.0,2.0,21.0
Rajgarh,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,2.0,0.0,4.0,12.0,10.0,6.0,0.0,192.0,474.0,233.0,136.0,14.0,1083.0
Rajgarh,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,61.0,3.0,1.0,47.0,40.0,41.0,21.0,405.0,959.0,724.0,312.0,104.0,2718.0
Rajgarh,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,7.0,7.0,5.0,25.0,19.0,7.0,6.0,90.0,181.0,462.0,97.0,21.0,927.0
Rajgarh,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajgarh,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,70.0,10.0,10.0,84.0,69.0,54.0,27.0,687.0,1614.0,1419.0,545.0,139.0,4728.0
Rajgarh,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,4.0,0.0,16.0,11.0,1.0,116.0,0.0,0.0,0.0,4.0,152.0
Rajgarh,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,22.0,15.0,18.0,23.0,33.0,27.0,17.0,49.0,148.0,93.0,75.0,50.0,570.0
Rajgarh,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajgarh,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,22.0,15.0,22.0,23.0,49.0,38.0,18.0,165.0,148.0,93.0,75.0,54.0,722.0
Rajgarh,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Rajgarh,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0,0.0,1.0,2.0,9.0
Rajgarh,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,14.0,18.0,18.0,13.0,19.0,16.0,12.0,31.0,28.0,33.0,27.0,29.0,258.0
Rajgarh,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajgarh,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,14.0,18.0,18.0,13.0,19.0,16.0,12.0,34.0,31.0,34.0,28.0,31.0,268.0
Rajgarh,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Rajgarh,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,117.0,141.0,162.0,239.0,162.0,196.0,185.0,214.0,244.0,196.0,274.0,194.0,2324.0
Rajgarh,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,12.0,36.0,22.0,22.0,19.0,25.0,30.0,25.0,32.0,59.0,62.0,118.0,462.0
Rajgarh,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,24.0,8.0,14.0,13.0,17.0,41.0,55.0,27.0,39.0,56.0,49.0,147.0,490.0
Rajgarh,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,53.0,71.0,87.0,53.0,64.0,93.0,59.0,62.0,84.0,384.0,353.0,230.0,1593.0
Rajgarh,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajgarh,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,206.0,256.0,285.0,327.0,262.0,355.0,329.0,328.0,399.0,695.0,738.0,689.0,4869.0
Rajgarh,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,41.0,10.0,14.0,50.0,33.0,55.0,29.0,75.0,63.0,355.0,324.0,243.0,1292.0
Rajgarh,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Rajgarh,9.06,Number of IUCD removals,TOTAL,142.0,86.0,94.0,88.0,203.0,114.0,93.0,171.0,212.0,327.0,200.0,200.0,1930.0
Rajgarh,9.07,Number of Oral Pills cycles distributed,TOTAL,9428.0,7811.0,9362.0,10552.0,10398.0,10762.0,9936.0,11065.0,10935.0,15583.0,16395.0,15344.0,137571.0
Rajgarh,9.08,Number of Condom pieces distributed,TOTAL,53495.0,44557.0,64129.0,62311.0,68815.0,65764.0,65452.0,85928.0,75236.0,106353.0,134143.0,117539.0,943722.0
Rajgarh,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,25.0,9.0,31.0,9.0,47.0,48.0,57.0,28.0,18.0,16.0,23.0,25.0,336.0
Rajgarh,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,1.0,0.0,3.0,1.0,0.0,0.0,13.0,2.0,7.0,1.0,0.0,28.0
Rajgarh,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,7.0,0.0,0.0,0.0,2.0,1.0,7.0,1.0,0.0,18.0
Rajgarh,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,9.12,Number of Institutions having NSV trained doctors,TOTAL,8.0,8.0,7.0,7.0,8.0,8.0,8.0,9.0,9.0,9.0,8.0,12.0,-1.0
Rajgarh,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1634.0,1756.0,2115.0,2101.0,2415.0,2405.0,2089.0,2493.0,2028.0,1950.0,1812.0,1937.0,24735.0
Rajgarh,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2351.0,2254.0,2589.0,2601.0,2400.0,2740.0,2444.0,1299.0,610.0,355.0,327.0,343.0,20313.0
Rajgarh,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2724.0,2226.0,2502.0,2716.0,2449.0,2497.0,2505.0,2667.0,1388.0,604.0,374.0,436.0,23088.0
Rajgarh,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2833.0,2553.0,2550.0,2631.0,2463.0,2692.0,2380.0,2530.0,2527.0,1204.0,587.0,475.0,25425.0
Rajgarh,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1556.0,2308.0,2512.0,2293.0,2520.0,11189.0
Rajgarh,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25.0,1439.0,2284.0,2295.0,2473.0,8516.0
Rajgarh,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,224.0,1519.0,1973.0,2415.0,6131.0
Rajgarh,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1476.0,1667.0,1935.0,1977.0,2259.0,2248.0,1965.0,2012.0,1884.0,1795.0,1705.0,1769.0,22692.0
Rajgarh,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2351.0,2254.0,2563.0,2597.0,2387.0,2742.0,2444.0,2476.0,2573.0,2496.0,2657.0,2824.0,30364.0
Rajgarh,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2721.0,2226.0,2478.0,2717.0,2436.0,2500.0,2505.0,2670.0,2544.0,2504.0,2670.0,2850.0,30821.0
Rajgarh,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2825.0,2544.0,2523.0,2618.0,2450.0,2689.0,2380.0,2522.0,2562.0,2369.0,2566.0,2841.0,30889.0
Rajgarh,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1409.0,1563.0,1861.0,1989.0,2129.0,2247.0,1962.0,1932.0,1859.0,1705.0,1494.0,1762.0,21912.0
Rajgarh,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2351.0,2253.0,2573.0,2593.0,2396.0,2740.0,2444.0,1281.0,521.0,290.0,82.0,105.0,19629.0
Rajgarh,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2724.0,2226.0,2504.0,2717.0,2451.0,2497.0,2505.0,2655.0,1326.0,476.0,141.0,111.0,22333.0
Rajgarh,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2835.0,2554.0,2551.0,2626.0,2463.0,2691.0,2380.0,2527.0,2395.0,1129.0,347.0,177.0,24675.0
Rajgarh,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2325.0,2360.0,3101.0,3082.0,2684.0,2916.0,2350.0,2485.0,2431.0,2426.0,2308.0,2908.0,31376.0
Rajgarh,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1030.0,1268.0,1697.0,2095.0,1616.0,1546.0,1218.0,1696.0,1928.0,1823.0,2039.0,3228.0,21184.0
Rajgarh,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1218.0,1183.0,1504.0,1564.0,1322.0,1540.0,1219.0,1276.0,1267.0,1201.0,1203.0,1396.0,15893.0
Rajgarh,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1071.0,1068.0,1336.0,1437.0,1232.0,1450.0,1087.0,1208.0,1133.0,1103.0,1053.0,1315.0,14493.0
Rajgarh,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2289.0,2251.0,2840.0,3001.0,2554.0,2990.0,2306.0,2484.0,2400.0,2304.0,2256.0,2711.0,30386.0
Rajgarh,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2234.0,1962.0,2401.0,2725.0,2086.0,2325.0,1997.0,2246.0,2303.0,2291.0,2308.0,2760.0,27638.0
Rajgarh,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2234.0,1962.0,2401.0,2725.0,2086.0,2325.0,1997.0,2241.0,2303.0,2289.0,2308.0,2757.0,27628.0
Rajgarh,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,239.0,142.0,159.0,180.0,132.0,228.0,205.0,363.0,420.0,296.0,180.0,817.0,3361.0
Rajgarh,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,236.0,139.0,157.0,164.0,139.0,241.0,197.0,359.0,402.0,284.0,174.0,656.0,3148.0
Rajgarh,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,475.0,281.0,316.0,344.0,271.0,469.0,402.0,722.0,822.0,580.0,354.0,1473.0,6509.0
Rajgarh,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,965.0,999.0,1365.0,1604.0,1386.0,1411.0,1236.0,1153.0,1227.0,1358.0,1231.0,1602.0,15537.0
Rajgarh,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1525.0,1505.0,1795.0,2339.0,1948.0,1925.0,1678.0,1705.0,1807.0,1897.0,1909.0,2174.0,22207.0
Rajgarh,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1757.0,1689.0,1955.0,2613.0,2064.0,2299.0,1909.0,1910.0,1917.0,2204.0,2066.0,2207.0,24590.0
Rajgarh,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,2.0,2.0,1.0,1.0,6.0,0.0,2.0,2.0,16.0
Rajgarh,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,26.0,13.0,22.0,17.0,21.0,14.0,16.0,25.0,31.0,25.0,52.0,52.0,314.0
Rajgarh,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1707.0,1609.0,1638.0,1707.0,1636.0,1660.0,1624.0,1634.0,1682.0,1690.0,1721.0,1738.0,20046.0
Rajgarh,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1700.0,1562.0,1608.0,1694.0,1594.0,1640.0,1581.0,1617.0,1673.0,1667.0,1711.0,1734.0,19781.0
Rajgarh,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1218.0,1161.0,1170.0,1213.0,1188.0,1235.0,1117.0,1239.0,1229.0,1223.0,1295.0,1285.0,14573.0
Rajgarh,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2330.0,2328.0,3124.0,3352.0,3022.0,2845.0,2289.0,2477.0,2422.0,3417.0,2345.0,2834.0,32785.0
Rajgarh,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,523.0,440.0,1258.0,13841.0,5611.0,528.0,486.0,501.0,1713.0,18462.0,1608.0,723.0,45694.0
Rajgarh,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,586.0,590.0,1326.0,13289.0,5549.0,622.0,549.0,574.0,2038.0,18623.0,2181.0,637.0,46564.0
Rajgarh,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,273.0,340.0,382.0,320.0,469.0,396.0,252.0,254.0,322.0,290.0,430.0,521.0,4249.0
Rajgarh,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,1.0,5.0,5.0,35.0,4.0,5.0,9.0,2.0,37.0,0.0,3.0,106.0
Rajgarh,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,59.0,19.0,27.0,37.0,49.0,65.0,21.0,107.0,67.0,58.0,74.0,92.0,675.0
Rajgarh,13.1,Number of Patients operated for cataract,TOTAL,203.0,150.0,71.0,254.0,138.0,115.0,123.0,316.0,380.0,419.0,674.0,578.0,3421.0
Rajgarh,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,200.0,150.0,70.0,254.0,143.0,187.0,189.0,316.0,379.0,455.0,649.0,635.0,3627.0
Rajgarh,13.3,Number of School children detected with Refractive errors,TOTAL,53.0,64.0,87.0,1279.0,177.0,210.0,103.0,216.0,232.0,1224.0,97.0,136.0,3878.0
Rajgarh,13.4,Number of children provided free glasses,TOTAL,0.0,51.0,51.0,0.0,0.0,0.0,0.0,186.0,141.0,148.0,68.0,85.0,730.0
Rajgarh,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,20.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Rajgarh,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,4.0,2.0,1.0,2.0,2.0,2.0,2.0,3.0,3.0,2.0,3.0,-1.0
Rajgarh,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,8.0,8.0,7.0,7.0,8.0,9.0,9.0,8.0,8.0,8.0,5.0,7.0,-1.0
Rajgarh,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1527.0,1634.0,1730.0,1693.0,1571.0,1625.0,1576.0,1578.0,1627.0,1619.0,1676.0,1822.0,-1.0
Rajgarh,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,8.0,6.0,5.0,6.0,7.0,6.0,6.0,6.0,6.0,6.0,6.0,-1.0
Rajgarh,14.05,Number of RKS meetings held during the month,TOTAL,4.0,3.0,3.0,4.0,3.0,4.0,6.0,4.0,4.0,4.0,4.0,4.0,47.0
Rajgarh,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,17.0,17.0,16.0,15.0,16.0,16.0,16.0,15.0,14.0,14.0,12.0,15.0,-1.0
Rajgarh,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,24.0,30.0,37.0,34.0,40.0,82.0,40.0,102.0,22.0,30.0,23.0,15.0,479.0
Rajgarh,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,5.0,4.0,3.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
Rajgarh,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,-1.0
Rajgarh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,270.0,350.0,441.0,508.0,387.0,392.0,405.0,336.0,293.0,296.0,270.0,288.0,4236.0
Rajgarh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1513.0,4091.0,2060.0,1665.0,1752.0,2515.0,2172.0,1866.0,1569.0,1255.0,1718.0,1627.0,23803.0
Rajgarh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,275.0,567.0,572.0,372.0,320.0,483.0,444.0,427.0,289.0,184.0,282.0,258.0,4473.0
Rajgarh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2988.0,3671.0,4060.0,3363.0,3531.0,4361.0,3401.0,4143.0,4586.0,3696.0,4253.0,4028.0,46081.0
Rajgarh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,545.0,917.0,1013.0,880.0,707.0,875.0,849.0,763.0,582.0,480.0,552.0,546.0,8709.0
Rajgarh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4501.0,7762.0,6120.0,5028.0,5283.0,6876.0,5573.0,6009.0,6155.0,4951.0,5971.0,5655.0,69884.0
Rajgarh,14.10.2.a,Number of death cases of Inpatient males,TOTAL,14.0,37.0,30.0,21.0,19.0,26.0,16.0,23.0,9.0,10.0,22.0,12.0,239.0
Rajgarh,14.10.2.b,Number of death cases of Inpatient females,TOTAL,11.0,10.0,20.0,18.0,9.0,16.0,6.0,19.0,10.0,14.0,0.0,15.0,148.0
Rajgarh,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,25.0,47.0,50.0,39.0,28.0,42.0,22.0,42.0,19.0,24.0,22.0,27.0,387.0
Rajgarh,14.11,In-Patient Head Count at midnight,TOTAL,6723.0,8421.0,12516.0,8634.0,9219.0,10522.0,11695.0,9207.0,9814.0,8593.0,9196.0,9875.0,114415.0
Rajgarh,14.12.1,OPD attendance (All),TOTAL,53350.0,61870.0,68223.0,72361.0,74973.0,103232.0,69547.0,75315.0,67712.0,61082.0,88339.0,81214.0,877218.0
Rajgarh,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,38.0,77.0,55.0,41.0,25.0,46.0,31.0,45.0,24.0,47.0,44.0,77.0,550.0
Rajgarh,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,25.0,31.0,30.0,3.0,3.0,3.0,2.0,3.0,1.0,12.0,15.0,1.0,129.0
Rajgarh,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,160.0,204.0,240.0,257.0,283.0,338.0,195.0,318.0,726.0,500.0,549.0,365.0,4135.0
Rajgarh,14.14.a,Number of patients given AYUSH treatment,TOTAL,3691.0,4926.0,4913.0,5429.0,5573.0,8002.0,6454.0,8189.0,7934.0,7119.0,8096.0,7370.0,77696.0
Rajgarh,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,38.0,40.0,45.0,39.0,43.0,38.0,42.0,35.0,36.0,90.0,48.0,44.0,538.0
Rajgarh,14.14.c,Number of Adolescents counselled,TOTAL,109.0,135.0,149.0,13.0,0.0,0.0,4.0,97.0,49.0,79.0,123.0,272.0,1030.0
Rajgarh,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5670.0,5412.0,6448.0,8339.0,7132.0,9776.0,7765.0,8697.0,8376.0,6986.0,9608.0,9883.0,94092.0
Rajgarh,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,167.0,129.0,137.0,170.0,151.0,195.0,182.0,173.0,128.0,112.0,123.0,144.0,1811.0
Rajgarh,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,102.0,153.0,161.0,169.0,135.0,244.0,105.0,122.0,169.0,127.0,166.0,196.0,1849.0
Rajgarh,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,35.0,2.0,3.0,1.0,2.0,2.0,0.0,2.0,0.0,0.0,2.0,0.0,49.0
Rajgarh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,122.0,171.0,226.0,171.0,163.0,168.0,208.0,268.0,155.0,124.0,327.0,244.0,2347.0
Rajgarh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,0.0,2.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,3.0,0.0,10.0
Rajgarh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,691.0,869.0,814.0,874.0,808.0,1236.0,1434.0,847.0,939.0,711.0,803.0,991.0,11017.0
Rajgarh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,2.0,1.0,0.0,6.0,20.0,15.0,14.0,0.0,49.0,28.0,23.0,158.0
Rajgarh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,915.0,1193.0,1201.0,1214.0,1106.0,1648.0,1747.0,1237.0,1263.0,962.0,1296.0,1431.0,15213.0
Rajgarh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,36.0,4.0,6.0,1.0,9.0,22.0,16.0,16.0,1.0,50.0,33.0,23.0,217.0
Rajgarh,15.2,Number of Widal tests conducted,Number tested,759.0,1172.0,1292.0,1361.0,1320.0,1807.0,2347.0,1227.0,839.0,829.0,873.0,1439.0,15265.0
Rajgarh,15.3.a,Number of VDRL tests conducted on males,Number tested,113.0,137.0,70.0,83.0,43.0,137.0,118.0,63.0,80.0,110.0,272.0,198.0,1424.0
Rajgarh,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,141.0,214.0,165.0,141.0,144.0,99.0,196.0,199.0,80.0,132.0,241.0,199.0,1951.0
Rajgarh,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,403.0,350.0,565.0,588.0,399.0,597.0,329.0,236.0,393.0,412.0,573.0,896.0,5741.0
Rajgarh,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,657.0,701.0,800.0,812.0,586.0,833.0,643.0,498.0,553.0,654.0,1086.0,1293.0,9116.0
Rajgarh,15.4.1,Number of blood smears examined for Malaria,TOTAL,7903.0,11535.0,10494.0,13380.0,15621.0,30789.0,14161.0,12632.0,10837.0,4289.0,9180.0,11140.0,151961.0
Rajgarh,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,20.0,52.0,75.0,56.0,50.0,118.0,139.0,70.0,16.0,6.0,419.0,26.0,1047.0
Rajgarh,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,4.0,5.0,3.0,0.0,2.0,2.0,3.0,3.0,0.0,0.0,0.0,7.0,29.0
Rajgarh,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3150.0,2850.0,2500.0,2300.0,3000.0,2750.0,,,,1600.0,1400.0,,19550.0
Rajgarh,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,1000.0,1000.0,2000.0,1000.0,1000.0,,,,0.0,500.0,,16500.0
Rajgarh,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
Rajgarh,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1300.0,1350.0,1200.0,1300.0,1250.0,900.0,,,,200.0,250.0,,7750.0
Rajgarh,16.1.1,Stock position of DPT vaccines,5. Total Stock,11850.0,2500.0,2300.0,3000.0,2750.0,2850.0,0.0,0.0,0.0,1400.0,1650.0,0.0,28300.0
Rajgarh,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,0.0,0.0,,,,1600.0,1450.0,,3050.0
Rajgarh,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,0.0,0.0,,,,0.0,500.0,,500.0
Rajgarh,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,0.0,0.0,,,,0.0,0.0,,0.0
Rajgarh,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,0.0,0.0,,,,150.0,650.0,,800.0
Rajgarh,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1450.0,1300.0,0.0,2750.0
Rajgarh,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1575.0,1500.0,1500.0,1550.0,1700.0,1625.0,,,,2050.0,1125.0,,12625.0
Rajgarh,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1000.0,1000.0,1000.0,1500.0,1000.0,1000.0,,,,14000.0,15500.0,,36000.0
Rajgarh,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
Rajgarh,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1075.0,1000.0,950.0,1350.0,1075.0,900.0,,,,14925.0,16125.0,,37400.0
Rajgarh,16.1.2,Stock position of OPV vaccines,5. Total Stock,1500.0,1500.0,1550.0,1700.0,1625.0,1725.0,0.0,0.0,0.0,1125.0,500.0,0.0,11225.0
Rajgarh,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2800.0,2600.0,3100.0,3200.0,2300.0,2550.0,,,,1500.0,1100.0,,19150.0
Rajgarh,16.1.3,Stock position of TT vaccines,2. Stocks Received,1000.0,2000.0,1000.0,1000.0,1000.0,1000.0,,,,0.0,1000.0,,8000.0
Rajgarh,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
Rajgarh,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1200.0,1450.0,900.0,1300.0,1350.0,900.0,,,,400.0,550.0,,8050.0
Rajgarh,16.1.3,Stock position of TT vaccines,5. Total Stock,2600.0,3150.0,3200.0,2900.0,1950.0,2650.0,0.0,0.0,0.0,1100.0,1550.0,0.0,19100.0
Rajgarh,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,,,,0.0,0.0,,,,0.0,,,0.0
Rajgarh,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,,,,0.0,0.0,,,,0.0,,,0.0
Rajgarh,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,,,,0.0,0.0,,,,0.0,,,0.0
Rajgarh,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,,,,0.0,0.0,,,,0.0,,,0.0
Rajgarh,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1300.0,1900.0,1400.0,900.0,1200.0,1750.0,,,,1050.0,800.0,,10300.0
Rajgarh,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000.0,0.0,0.0,1000.0,1000.0,0.0,,,,0.0,1000.0,,4000.0
Rajgarh,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
Rajgarh,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,400.0,500.0,500.0,700.0,450.0,300.0,,,,250.0,350.0,,3450.0
Rajgarh,16.1.5,Stock position of BCG vaccines,5. Total Stock,1900.0,1400.0,900.0,1200.0,1750.0,1450.0,0.0,0.0,0.0,800.0,1450.0,0.0,10850.0
Rajgarh,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1950.0,2000.0,2400.0,1950.0,1450.0,2150.0,,,,1800.0,1200.0,,14900.0
Rajgarh,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1000.0,2000.0,1000.0,1000.0,2000.0,0.0,,,,0.0,1000.0,,8000.0
Rajgarh,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
Rajgarh,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,950.0,1600.0,1450.0,1500.0,1300.0,1250.0,,,,600.0,1400.0,,10050.0
Rajgarh,16.1.6,Stock position of Measles vaccines,5. Total Stock,2000.0,2400.0,1950.0,1450.0,2150.0,900.0,0.0,0.0,0.0,1200.0,800.0,0.0,12850.0
Rajgarh,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,,,,0.0,0.0,,,,0.0,,,0.0
Rajgarh,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,,,,0.0,0.0,,,,0.0,,,0.0
Rajgarh,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,,,,0.0,0.0,,,,0.0,,,0.0
Rajgarh,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,,,,0.0,0.0,,,,0.0,,,0.0
Rajgarh,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2400.0,3150.0,2750.0,2500.0,3250.0,3000.0,,,,2100.0,1950.0,,21100.0
Rajgarh,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,2000.0,1000.0,1000.0,2000.0,1000.0,1000.0,,,,0.0,0.0,,8000.0
Rajgarh,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
Rajgarh,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1250.0,1400.0,1250.0,1250.0,1250.0,900.0,,,,150.0,250.0,,7700.0
Rajgarh,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3150.0,2750.0,2500.0,3250.0,3000.0,3100.0,0.0,0.0,0.0,1950.0,1700.0,0.0,21400.0
Rajgarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1200.0,2400.0,1800.0,1800.0,2400.0,1200.0,,,,3600.0,3600.0,,18000.0
Rajgarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,2400.0,2400.0,0.0,3600.0,0.0,3600.0,,,,0.0,0.0,,12000.0
Rajgarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
Rajgarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,1200.0,3000.0,0.0,3000.0,1200.0,1200.0,,,,0.0,1200.0,,10800.0
Rajgarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2400.0,1800.0,1800.0,2400.0,1200.0,3600.0,0.0,0.0,0.0,3600.0,2400.0,0.0,19200.0
Rajgarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,27960.0,93360.0,36840.0,24000.0,126000.0,36000.0,,,,11000.0,5000.0,,360160.0
Rajgarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,90000.0,60000.0,90000.0,240000.0,0.0,180000.0,,,,0.0,0.0,,660000.0
Rajgarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
Rajgarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,24600.0,116520.0,102840.0,138000.0,50000.0,55000.0,,,,6000.0,5000.0,,497960.0
Rajgarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,93360.0,36840.0,24000.0,126000.0,76000.0,161000.0,0.0,0.0,0.0,5000.0,0.0,0.0,522200.0
Rajgarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,600.0,600.0,600.0,6000.0,8200.0,1800.0,,,,36400.0,36400.0,,90600.0
Rajgarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,30000.0,5000.0,0.0,20000.0,,,,0.0,0.0,,55000.0
Rajgarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
Rajgarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,24600.0,2800.0,6400.0,4300.0,,,,0.0,18400.0,,56500.0
Rajgarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,600.0,600.0,6000.0,8200.0,1800.0,17500.0,0.0,0.0,0.0,36400.0,18000.0,0.0,89100.0
Rajgarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,500.0,3500.0,2400.0,300.0,600.0,600.0,,,,5700.0,5700.0,,19300.0
Rajgarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,3000.0,0.0,0.0,1500.0,0.0,3000.0,,,,0.0,0.0,,7500.0
Rajgarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
Rajgarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,1100.0,2100.0,1200.0,0.0,600.0,,,,0.0,3700.0,,8700.0
Rajgarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,3500.0,2400.0,300.0,600.0,600.0,3000.0,0.0,0.0,0.0,5700.0,2000.0,0.0,18100.0
Rajgarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Rajgarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Rajgarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rajgarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Rajgarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Rajgarh,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Rajgarh,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Rajgarh,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Rajgarh,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Rajgarh,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Rajgarh,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Rajgarh,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Rajgarh,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Rajgarh,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Rajgarh,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Rajgarh,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Rajgarh,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Rajgarh,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Rajgarh,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Rajgarh,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Rajgarh,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Rajgarh,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Rajgarh,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Rajgarh,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Rajgarh,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Rajgarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Rajgarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Rajgarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Rajgarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Rajgarh,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Rajgarh,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Rajgarh,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Rajgarh,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Rajgarh,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Rajgarh,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Rajgarh,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Rajgarh,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Rajgarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Rajgarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Rajgarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Rajgarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,500.0,,,,,0.0,,,,,,,500.0
Rajgarh,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,,,,,0.0,,,,,,,0.0
Rajgarh,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,,,,,0.0,,,,,,,0.0
Rajgarh,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,,,,,0.0,,,,,,,0.0
Rajgarh,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0
Rajgarh,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Rajgarh,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Rajgarh,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Rajgarh,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Rajgarh,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajgarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,7100.0,4200.0,3900.0,4200.0,4200.0,8200.0,,,,5700.0,4500.0,,42000.0
Rajgarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,3300.0,3300.0,3300.0,6600.0,3300.0,,,,0.0,3300.0,,23100.0
Rajgarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
Rajgarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2900.0,3600.0,3000.0,3300.0,2600.0,2700.0,,,,1200.0,3400.0,,22700.0
Rajgarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,4200.0,3900.0,4200.0,4200.0,8200.0,8800.0,0.0,0.0,0.0,4500.0,4400.0,0.0,42400.0
Rajgarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,28000.0,31600.0,17600.0,46000.0,18000.0,40000.0,,,,162000.0,158000.0,,501200.0
Rajgarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,24000.0,12000.0,42000.0,10000.0,40000.0,316000.0,,,,0.0,0.0,,444000.0
Rajgarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
Rajgarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,20400.0,26000.0,13600.0,36000.0,18000.0,40000.0,,,,4000.0,34000.0,,192000.0
Rajgarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,31600.0,17600.0,46000.0,20000.0,40000.0,316000.0,0.0,0.0,0.0,158000.0,124000.0,0.0,753200.0
Rajgarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,5500.0,3300.0,2800.0,2800.0,2400.0,5000.0,,,,3700.0,3100.0,,28600.0
Rajgarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,2000.0,2000.0,2000.0,4000.0,0.0,,,,0.0,2000.0,,12000.0
Rajgarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
Rajgarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2200.0,2500.0,2000.0,2400.0,1400.0,1500.0,,,,600.0,2700.0,,15300.0
Rajgarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,3300.0,2800.0,2800.0,2400.0,5000.0,3500.0,0.0,0.0,0.0,3100.0,2400.0,0.0,25300.0
Rajgarh,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,,1.0,2.0,,,,13.0,4.0,6.0,5.0,8.0,41.0
Rajgarh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,2.0,1.0,6.0,1.0,2.0,,,2.0,4.0,1.0,,2.0,21.0
Rajgarh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,1.0,1.0,,,,,,,,,3.0
Rajgarh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,2.0,2.0,7.0,2.0,2.0,,,2.0,4.0,1.0,,2.0,24.0
Rajgarh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,1.0,2.0,,,,,1.0,,1.0,2.0,1.0,9.0
Rajgarh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rajgarh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,1.0,2.0,,,,,1.0,,1.0,2.0,1.0,9.0
Rajgarh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,8.0,10.0,1.0,6.0,14.0,9.0,5.0,6.0,4.0,9.0,5.0,79.0
Rajgarh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,1.0,,,,,,,,,,1.0
Rajgarh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,8.0,11.0,1.0,6.0,14.0,9.0,5.0,6.0,4.0,9.0,5.0,80.0
Rajgarh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,8.0,6.0,10.0,38.0,5.0,11.0,6.0,8.0,7.0,7.0,12.0,7.0,125.0
Rajgarh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,2.0,,1.0,,,,,,,,3.0
Rajgarh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,8.0,6.0,12.0,38.0,6.0,11.0,6.0,8.0,7.0,7.0,12.0,7.0,128.0
Rajgarh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,3.0,6.0,,3.0,6.0,3.0,6.0,2.0,5.0,5.0,4.0,44.0
Rajgarh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,1.0,2.0,1.0,,,1.0,1.0,6.0
Rajgarh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,3.0,6.0,,3.0,7.0,5.0,7.0,2.0,5.0,6.0,5.0,50.0
Rajgarh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,1.0,,,,1.0,1.0,,3.0
Rajgarh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,1.0,,,,,,,1.0
Rajgarh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,2.0,,,,1.0,1.0,,4.0
Rajgarh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,2.0,,,5.0,1.0,4.0,,,2.0,,15.0
Rajgarh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,1.0,,1.0,,1.0,4.0,1.0,1.0,,1.0,,1.0,11.0
Rajgarh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,2.0,,3.0,,1.0,9.0,2.0,5.0,,1.0,2.0,1.0,26.0
Rajgarh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Rajgarh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rajgarh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Rajgarh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,,5.0,4.0,4.0,1.0,4.0,3.0,4.0,8.0,5.0,2.0,43.0
Rajgarh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,1.0,5.0,5.0,2.0,10.0,4.0,5.0,5.0,2.0,4.0,1.0,45.0
Rajgarh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,4.0,1.0,10.0,9.0,6.0,11.0,8.0,8.0,9.0,10.0,9.0,3.0,88.0
Rajgarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Rajgarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,1.0,,,1.0,,,,,,,2.0
Rajgarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,1.0,1.0,,2.0,,,,,,4.0
Rajgarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,1.0,1.0,1.0,1.0,2.0,,,,,,6.0
Rajgarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Rajgarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,5.0,,4.0,4.0,1.0,3.0,3.0,2.0,2.0,1.0,2.0,,27.0
Rajgarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,3.0,,1.0,,4.0,2.0,,,,,11.0
Rajgarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,5.0,1.0,7.0,4.0,2.0,3.0,7.0,4.0,2.0,1.0,2.0,1.0,39.0
Rajgarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Rajgarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,3.0,3.0,2.0,,,1.0,5.0,4.0,3.0,4.0,1.0,5.0,31.0
Rajgarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,4.0,4.0,5.0,11.0,7.0,13.0,13.0,10.0,10.0,16.0,13.0,17.0,123.0
Rajgarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,7.0,7.0,7.0,11.0,7.0,14.0,18.0,14.0,13.0,20.0,14.0,22.0,154.0
Rajgarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Rajgarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,1.0,,,1.0,,,,,,,1.0,,3.0
Rajgarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Rajgarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,,,1.0,,,,,,,1.0,,3.0
Rajgarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,2.0,,1.0,,,,3.0
Rajgarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,2.0,1.0,1.0,3.0,3.0,10.0,2.0,1.0,3.0,,27.0
Rajgarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,2.0,3.0,1.0,4.0,5.0,10.0,6.0,9.0,4.0,6.0,2.0,53.0
Rajgarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,3.0,5.0,2.0,5.0,8.0,15.0,16.0,12.0,5.0,9.0,2.0,83.0
Rajgarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Rajgarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Rajgarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Rajgarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Rajgarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Rajgarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,5.0,10.0,9.0,6.0,8.0,13.0,5.0,8.0,4.0,11.0,12.0,4.0,95.0
Rajgarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,7.0,17.0,18.0,18.0,15.0,19.0,13.0,18.0,10.0,16.0,20.0,17.0,188.0
Rajgarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,12.0,27.0,27.0,24.0,23.0,32.0,18.0,26.0,14.0,27.0,32.0,21.0,283.0
Rajgarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Rajgarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,1.0,1.0,2.0,2.0,1.0,3.0,2.0,,1.0,,13.0
Rajgarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,,2.0,1.0,1.0,7.0,5.0,6.0,10.0,7.0,8.0,4.0,52.0
Rajgarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,,3.0,2.0,3.0,10.0,6.0,9.0,12.0,7.0,9.0,4.0,66.0
Rajgarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Rajgarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Rajgarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Rajgarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Rajgarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Rajgarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Rajgarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Rajgarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Rajgarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Rajgarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,1.0,,,1.0,,1.0,,,2.0,,5.0
Rajgarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Rajgarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,1.0,,,1.0,,1.0,,,2.0,,5.0
Rajgarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Rajgarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,2.0,1.0,,1.0,,1.0,,5.0
Rajgarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Rajgarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,2.0,1.0,,1.0,,1.0,,5.0
Rajgarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Rajgarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,1.0,,,,,1.0,2.0
Rajgarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Rajgarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,1.0,,,,,1.0,2.0
Rajgarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Rajgarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,2.0,,1.0,,3.0,2.0,3.0,3.0,1.0,,15.0
Rajgarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Rajgarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,2.0,,1.0,,3.0,2.0,3.0,3.0,1.0,,15.0
Rajgarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,8.0,5.0,1.0,2.0,,1.0,,1.0,1.0,,2.0,5.0,26.0
Rajgarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,10.0,14.0,8.0,20.0,9.0,12.0,4.0,16.0,8.0,18.0,11.0,17.0,147.0
Rajgarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,3.0,3.0,4.0,3.0,4.0,8.0,6.0,5.0,2.0,9.0,3.0,52.0
Rajgarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,20.0,22.0,12.0,26.0,12.0,17.0,12.0,23.0,14.0,20.0,22.0,25.0,225.0
Rajgarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1.0,,,,1.0,,,,,,,,2.0
Rajgarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,9.0,5.0,4.0,11.0,2.0,3.0,4.0,3.0,6.0,5.0,6.0,62.0
Rajgarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,1.0,1.0,1.0,2.0,,,1.0,3.0,,,9.0
Rajgarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,5.0,9.0,6.0,5.0,13.0,4.0,3.0,4.0,4.0,9.0,5.0,6.0,73.0
Rajgarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,1.0,2.0,,,,,,,,,4.0
Rajgarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,2.0,1.0,1.0,4.0,2.0,2.0,,2.0,3.0,,,,17.0
Rajgarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,,2.0,1.0,,,1.0,,,,5.0
Rajgarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,2.0,3.0,6.0,4.0,3.0,,2.0,4.0,,,,26.0
Rajgarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,1.0,,1.0,,2.0,,,,,5.0
Rajgarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,4.0,2.0,11.0,6.0,4.0,8.0,8.0,5.0,3.0,6.0,6.0,6.0,69.0
Rajgarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,9.0,13.0,12.0,13.0,28.0,15.0,12.0,20.0,12.0,12.0,7.0,12.0,165.0
Rajgarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,13.0,15.0,24.0,20.0,32.0,24.0,20.0,27.0,15.0,18.0,13.0,18.0,239.0
Rajgarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,1.0,,,,1.0,2.0,,,1.0,,6.0
Rajgarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,7.0,3.0,4.0,8.0,4.0,2.0,5.0,6.0,2.0,7.0,5.0,7.0,60.0
Rajgarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,5.0,10.0,22.0,14.0,15.0,16.0,24.0,13.0,24.0,24.0,27.0,20.0,214.0
Rajgarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,12.0,14.0,27.0,22.0,19.0,18.0,30.0,21.0,26.0,31.0,33.0,27.0,280.0
Rajgarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,5.0,3.0,6.0,1.0,1.0,2.0,3.0,1.0,,,3.0,4.0,29.0
Rajgarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,17.0,37.0,44.0,24.0,28.0,38.0,21.0,21.0,24.0,31.0,21.0,28.0,334.0
Rajgarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,75.0,125.0,191.0,120.0,118.0,167.0,135.0,140.0,113.0,116.0,143.0,111.0,1554.0
Rajgarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,97.0,165.0,241.0,145.0,147.0,207.0,159.0,162.0,137.0,147.0,167.0,143.0,1917.0
Ratlam,1.1,Total number of pregnant women Registered for ANC,TOTAL,2423.0,2934.0,3317.0,3621.0,2852.0,2966.0,2628.0,3133.0,3262.0,3010.0,4122.0,4185.0,38453.0
Ratlam,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1361.0,1483.0,1664.0,1845.0,1518.0,1734.0,1445.0,1701.0,2116.0,2035.0,2363.0,2687.0,21952.0
Ratlam,1.2,Number of Pregnant women registered under JSY,TOTAL,2423.0,2929.0,3297.0,3591.0,2845.0,2966.0,2625.0,3130.0,3249.0,3010.0,3054.0,3169.0,36288.0
Ratlam,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1671.0,2037.0,2341.0,2760.0,2462.0,2480.0,2280.0,2602.0,2746.0,2736.0,3137.0,3194.0,30446.0
Ratlam,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1933.0,2289.0,2623.0,2750.0,2297.0,2327.0,2022.0,2465.0,2547.0,2387.0,2550.0,2747.0,28937.0
Ratlam,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2018.0,2109.0,2714.0,3000.0,2614.0,2526.0,2475.0,2463.0,2762.0,2572.0,2843.0,2912.0,31008.0
Ratlam,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2060.0,2856.0,3425.0,3467.0,2808.0,2673.0,2236.0,2817.0,3106.0,2900.0,3746.0,3889.0,35983.0
Ratlam,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,61.0,81.0,679.0,623.0,706.0,111.0,71.0,152.0,291.0,64.0,211.0,303.0,3353.0
Ratlam,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,10.0,23.0,4.0,13.0,10.0,14.0,4.0,9.0,10.0,7.0,30.0,36.0,170.0
Ratlam,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,774.0,1021.0,1180.0,1377.0,1167.0,1462.0,1087.0,1690.0,1688.0,1427.0,1570.0,1663.0,16106.0
Ratlam,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,52.0,65.0,128.0,54.0,65.0,108.0,74.0,63.0,66.0,31.0,66.0,51.0,823.0
Ratlam,1.8,Number of pregnancy test kits used at SC level,TOTAL,398.0,393.0,275.0,302.0,477.0,408.0,202.0,156.0,270.0,307.0,368.0,364.0,3920.0
Ratlam,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,18.0,25.0,24.0,34.0,21.0,44.0,10.0,14.0,31.0,26.0,37.0,39.0,323.0
Ratlam,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,64.0,67.0,80.0,74.0,87.0,124.0,106.0,108.0,104.0,106.0,66.0,76.0,1062.0
Ratlam,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,82.0,92.0,104.0,108.0,108.0,168.0,116.0,122.0,135.0,132.0,103.0,115.0,1385.0
Ratlam,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,61.0,62.0,58.0,83.0,85.0,121.0,92.0,104.0,123.0,105.0,83.0,75.0,1052.0
Ratlam,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,2.0,0.0,1.0,7.0,3.0,5.0,5.0,9.0,5.0,7.0,11.0,56.0
Ratlam,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1349.0,1939.0,2122.0,2024.0,2286.0,2391.0,2296.0,2393.0,2189.0,2331.0,2174.0,2561.0,26055.0
Ratlam,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,17.0,30.0,23.0,22.0,0.0,10.0,131.0,39.0,46.0,33.0,50.0,340.0,741.0
Ratlam,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1487.0,1467.0,1651.0,1694.0,1993.0,2036.0,1875.0,1905.0,2097.0,2003.0,1742.0,1900.0,21850.0
Ratlam,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,606.0,661.0,808.0,880.0,1006.0,1148.0,1004.0,1030.0,1231.0,1157.0,1041.0,1167.0,11739.0
Ratlam,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,110.0,0.0,110.0
Ratlam,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,187.0,193.0,380.0
Ratlam,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,0.0,0.0,0.0
Ratlam,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,0.0,0.0,0.0
Ratlam,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,0.0,0.0,0.0
Ratlam,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,1.0,4.0,4.0,4.0,6.0,4.0,10.0,13.0,5.0,51.0
Ratlam,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,64.0,111.0,102.0,92.0,100.0,116.0,96.0,113.0,95.0,86.0,97.0,101.0,1173.0
Ratlam,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ratlam,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,64.0,111.0,102.0,93.0,104.0,120.0,100.0,119.0,99.0,96.0,110.0,106.0,1224.0
Ratlam,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,97.0,88.0,185.0
Ratlam,4.1.1.a,Number of male live births,TOTAL,767.0,1028.0,1131.0,1078.0,1261.0,1295.0,1275.0,1261.0,1211.0,1253.0,1305.0,1496.0,14361.0
Ratlam,4.1.1.b,Number of female live births,TOTAL,650.0,991.0,1083.0,1045.0,1110.0,1246.0,1115.0,1224.0,1092.0,1181.0,1137.0,1387.0,13261.0
Ratlam,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1417.0,2019.0,2214.0,2123.0,2371.0,2541.0,2390.0,2485.0,2303.0,2434.0,2442.0,2883.0,27622.0
Ratlam,4.1.2,Number of still births,TOTAL,20.0,23.0,22.0,22.0,40.0,31.0,33.0,37.0,27.0,33.0,36.0,28.0,352.0
Ratlam,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,18.0,89.0,61.0,65.0,49.0,52.0,40.0,45.0,69.0,37.0,51.0,56.0,632.0
Ratlam,4.2.1,Number of Newborns weighed at birth,TOTAL,1399.0,1948.0,2101.0,1990.0,2270.0,2370.0,2358.0,2468.0,2167.0,2285.0,2305.0,2770.0,26431.0
Ratlam,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,182.0,280.0,299.0,292.0,298.0,446.0,395.0,443.0,343.0,377.0,320.0,296.0,3971.0
Ratlam,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1393.0,1878.0,2160.0,2072.0,2242.0,2407.0,2262.0,2385.0,2191.0,2275.0,2318.0,2583.0,26166.0
Ratlam,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,34.0,11.0,14.0,5.0,11.0,8.0,32.0,7.0,4.0,29.0,11.0,166.0
Ratlam,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,16.0,17.0,24.0,26.0,22.0,27.0,22.0,12.0,13.0,21.0,39.0,24.0,263.0
Ratlam,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,78.0,134.0,115.0,111.0,126.0,158.0,126.0,199.0,235.0,179.0,199.0,214.0,1874.0
Ratlam,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ratlam,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,94.0,185.0,150.0,151.0,153.0,196.0,156.0,243.0,255.0,204.0,267.0,249.0,2303.0
Ratlam,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,9.0,48.0,57.0
Ratlam,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,80.0,152.0,135.0,134.0,135.0,175.0,149.0,193.0,161.0,131.0,268.0,268.0,1981.0
Ratlam,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,26.0,31.0,11.0,28.0,8.0,14.0,4.0,10.0,27.0,35.0,39.0,25.0,258.0
Ratlam,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,70.0,44.0,653.0,143.0,121.0,151.0,32.0,51.0,86.0,715.0,223.0,247.0,2536.0
Ratlam,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,10.0,41.0,30.0,30.0,36.0,65.0,75.0,45.0,22.0,195.0,125.0,29.0,703.0
Ratlam,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1465.0,1796.0,1955.0,1923.0,2188.0,2357.0,1803.0,2047.0,2263.0,2392.0,2313.0,2797.0,25299.0
Ratlam,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1139.0,1630.0,1018.0,1163.0,1403.0,1316.0,1351.0,1378.0,1242.0,1432.0,1440.0,1856.0,16368.0
Ratlam,6.3,PNC maternal complications attended,TOTAL,12.0,24.0,27.0,27.0,32.0,28.0,22.0,32.0,57.0,36.0,26.0,36.0,359.0
Ratlam,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,25.0,37.0,38.0,51.0,45.0,48.0,36.0,36.0,52.0,47.0,38.0,22.0,475.0
Ratlam,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,9.0,17.0,6.0,7.0,4.0,6.0,6.0,3.0,5.0,7.0,8.0,78.0
Ratlam,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,25.0,46.0,55.0,57.0,52.0,52.0,42.0,42.0,55.0,52.0,45.0,30.0,553.0
Ratlam,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,26.0,24.0,50.0
Ratlam,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,154.0,141.0,157.0,202.0,148.0,106.0,217.0,216.0,170.0,187.0,366.0,296.0,2360.0
Ratlam,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,517.0,547.0,573.0,750.0,597.0,511.0,676.0,685.0,796.0,804.0,878.0,823.0,8157.0
Ratlam,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,671.0,688.0,730.0,952.0,745.0,617.0,893.0,901.0,966.0,991.0,1244.0,1119.0,10517.0
Ratlam,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,6.0,8.0,2.0,0.0,0.0,0.0,0.0,0.0,16.0
Ratlam,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,4.0
Ratlam,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,2.0,1.0,1.0,2.0,1.0,0.0,4.0,1.0,12.0
Ratlam,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,3.0,4.0,1.0,3.0,2.0,3.0,6.0,2.0,5.0,6.0,35.0
Ratlam,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ratlam,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,3.0,4.0,4.0,5.0,3.0,5.0,9.0,2.0,9.0,7.0,51.0
Ratlam,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,0.0,0.0,0.0
Ratlam,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,18.0,39.0,45.0,69.0,67.0,53.0,36.0,89.0,166.0,98.0,127.0,63.0,870.0
Ratlam,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,32.0,30.0,51.0,70.0,48.0,69.0,11.0,231.0,296.0,268.0,188.0,64.0,1358.0
Ratlam,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,71.0,148.0,170.0,232.0,107.0,160.0,54.0,249.0,119.0,48.0,106.0,113.0,1577.0
Ratlam,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ratlam,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,121.0,217.0,266.0,371.0,222.0,282.0,101.0,569.0,581.0,414.0,421.0,240.0,3805.0
Ratlam,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,1.0,2.0,3.0
Ratlam,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,14.0,24.0,167.0,174.0,17.0,23.0,7.0,65.0,259.0,231.0,168.0,62.0,1211.0
Ratlam,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,20.0,71.0,157.0,192.0,70.0,56.0,22.0,136.0,284.0,252.0,198.0,79.0,1537.0
Ratlam,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,28.0,44.0,40.0,77.0,55.0,56.0,12.0,144.0,148.0,127.0,50.0,190.0,971.0
Ratlam,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ratlam,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,62.0,139.0,364.0,443.0,142.0,135.0,41.0,345.0,691.0,610.0,416.0,331.0,3719.0
Ratlam,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,3.0,0.0,3.0
Ratlam,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,4.0,8.0,12.0,13.0,7.0,7.0,2.0,1.0,6.0,3.0,35.0,13.0,111.0
Ratlam,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,1.0,9.0,4.0,4.0,4.0,1.0,0.0,5.0,21.0,13.0,27.0,31.0,120.0
Ratlam,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,11.0,32.0,33.0,44.0,48.0,40.0,26.0,56.0,51.0,36.0,38.0,41.0,456.0
Ratlam,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ratlam,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,16.0,49.0,49.0,61.0,59.0,48.0,28.0,62.0,78.0,52.0,100.0,85.0,687.0
Ratlam,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,1.0,1.0,2.0
Ratlam,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,300.0,451.0,486.0,535.0,493.0,494.0,452.0,439.0,554.0,582.0,568.0,592.0,5946.0
Ratlam,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,2.0,7.0,7.0,5.0,7.0,1.0,0.0,0.0,6.0,4.0,17.0,15.0,71.0
Ratlam,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,2.0,7.0,32.0,10.0,9.0,26.0,10.0,36.0,14.0,15.0,62.0,7.0,230.0
Ratlam,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,148.0,128.0,169.0,181.0,214.0,435.0,190.0,217.0,316.0,184.0,236.0,217.0,2635.0
Ratlam,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ratlam,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,452.0,593.0,694.0,731.0,723.0,956.0,652.0,692.0,890.0,785.0,883.0,831.0,8882.0
Ratlam,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,21.0,18.0,12.0,29.0,139.0,275.0,259.0,163.0,32.0,131.0,104.0,29.0,1212.0
Ratlam,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,19.0,6.0,25.0
Ratlam,9.06,Number of IUCD removals,TOTAL,279.0,306.0,293.0,260.0,259.0,303.0,299.0,287.0,340.0,260.0,394.0,383.0,3663.0
Ratlam,9.07,Number of Oral Pills cycles distributed,TOTAL,2465.0,2629.0,2302.0,3472.0,3608.0,3641.0,3721.0,4029.0,4541.0,3807.0,3452.0,3982.0,41649.0
Ratlam,9.08,Number of Condom pieces distributed,TOTAL,9457.0,11500.0,12080.0,13035.0,15118.0,13753.0,11008.0,12234.0,13520.0,15502.0,15444.0,15726.0,158377.0
Ratlam,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,5.0,25.0,43.0,30.0,22.0,29.0,32.0,40.0,27.0,142.0,96.0,53.0,544.0
Ratlam,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Ratlam,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,1.0,8.0
Ratlam,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,8.0
Ratlam,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,9.12,Number of Institutions having NSV trained doctors,TOTAL,3.0,5.0,7.0,6.0,7.0,7.0,8.0,7.0,5.0,5.0,7.0,6.0,-1.0
Ratlam,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1411.0,1909.0,2255.0,2106.0,2405.0,2651.0,2548.0,2425.0,2331.0,2435.0,2389.0,2689.0,27554.0
Ratlam,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1821.0,2297.0,2501.0,2540.0,2374.0,2652.0,2354.0,1162.0,240.0,84.0,80.0,41.0,18146.0
Ratlam,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1965.0,2152.0,2441.0,2720.0,2278.0,2547.0,2341.0,2487.0,1565.0,413.0,214.0,106.0,21229.0
Ratlam,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2067.0,2194.0,2339.0,2701.0,2373.0,2486.0,2310.0,2390.0,2387.0,1386.0,443.0,252.0,23328.0
Ratlam,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1730.0,2226.0,2352.0,2424.0,3217.0,11949.0
Ratlam,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,1306.0,2042.0,2389.0,2721.0,8461.0
Ratlam,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,1.0,1214.0,2106.0,2752.0,6078.0
Ratlam,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1360.0,1863.0,2169.0,2022.0,2342.0,2535.0,2458.0,2370.0,2232.0,2344.0,2331.0,2633.0,26659.0
Ratlam,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1791.0,2303.0,2501.0,2540.0,2374.0,2652.0,2354.0,2081.0,1575.0,2016.0,1883.0,2276.0,26346.0
Ratlam,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1926.0,2153.0,2441.0,2720.0,2278.0,2547.0,2343.0,2487.0,2460.0,2104.0,1997.0,2240.0,27696.0
Ratlam,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2016.0,2194.0,2339.0,2701.0,2373.0,2486.0,2310.0,2393.0,2379.0,2352.0,1968.0,2345.0,27856.0
Ratlam,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1165.0,1314.0,1919.0,1720.0,2057.0,2283.0,2223.0,2165.0,2062.0,2320.0,2025.0,2484.0,23737.0
Ratlam,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1821.0,2541.0,2501.0,2687.0,2374.0,2724.0,2354.0,922.0,240.0,72.0,66.0,24.0,18326.0
Ratlam,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1970.0,2150.0,2441.0,2720.0,2281.0,2542.0,2343.0,2487.0,1436.0,382.0,182.0,84.0,21018.0
Ratlam,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2069.0,2194.0,2339.0,2701.0,2370.0,2491.0,2310.0,2393.0,2387.0,1396.0,422.0,254.0,23326.0
Ratlam,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1914.0,2307.0,2702.0,3167.0,2427.0,2670.0,2296.0,2334.0,2401.0,2396.0,2251.0,2715.0,29580.0
Ratlam,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1449.0,2177.0,2395.0,2835.0,1929.0,2272.0,2004.0,2071.0,2268.0,2626.0,2120.0,2748.0,26894.0
Ratlam,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,882.0,1223.0,1430.0,1605.0,1244.0,1354.0,1189.0,1154.0,1233.0,1230.0,1183.0,1383.0,15110.0
Ratlam,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,801.0,1061.0,1201.0,1493.0,1124.0,1285.0,1049.0,1073.0,1128.0,1127.0,1065.0,1264.0,13671.0
Ratlam,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1683.0,2284.0,2631.0,3098.0,2368.0,2639.0,2238.0,2227.0,2361.0,2357.0,2248.0,2647.0,28781.0
Ratlam,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1678.0,2056.0,2371.0,2906.0,1969.0,2278.0,1988.0,2060.0,2268.0,2631.0,2139.0,2763.0,27107.0
Ratlam,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1646.0,2030.0,2368.0,2906.0,1966.0,2269.0,1989.0,2062.0,2268.0,2631.0,2142.0,2744.0,27021.0
Ratlam,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,323.0,409.0,394.0,503.0,398.0,459.0,410.0,370.0,412.0,462.0,415.0,545.0,5100.0
Ratlam,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,322.0,389.0,386.0,478.0,350.0,436.0,363.0,343.0,406.0,416.0,425.0,505.0,4819.0
Ratlam,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,645.0,798.0,780.0,981.0,748.0,895.0,773.0,713.0,818.0,878.0,840.0,1050.0,9919.0
Ratlam,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,664.0,1143.0,1237.0,2751.0,1410.0,2564.0,1470.0,1148.0,1315.0,2640.0,1599.0,1673.0,19614.0
Ratlam,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,737.0,1089.0,1235.0,2664.0,1601.0,3437.0,1907.0,1279.0,1314.0,2097.0,1837.0,1801.0,20998.0
Ratlam,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,708.0,1100.0,1283.0,2683.0,1629.0,2500.0,1822.0,1472.0,1343.0,2260.0,1673.0,1777.0,20250.0
Ratlam,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,1.0,4.0
Ratlam,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,1.0,6.0,0.0,1.0,1.0,0.0,0.0,8.0,0.0,1.0,18.0
Ratlam,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1324.0,1299.0,1267.0,1300.0,1311.0,1312.0,1281.0,1336.0,1297.0,1303.0,1314.0,1340.0,15684.0
Ratlam,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1272.0,1305.0,1282.0,1259.0,1310.0,1311.0,1267.0,1315.0,1278.0,1292.0,1291.0,1337.0,15519.0
Ratlam,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,936.0,935.0,886.0,955.0,966.0,981.0,941.0,1097.0,1072.0,1132.0,1089.0,1158.0,12148.0
Ratlam,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1770.0,2285.0,2619.0,3359.0,2445.0,2616.0,2236.0,2281.0,2382.0,3035.0,2208.0,2697.0,29933.0
Ratlam,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,367.0,480.0,486.0,11127.0,4248.0,1847.0,507.0,443.0,492.0,14562.0,2771.0,783.0,38113.0
Ratlam,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,10.0,4.0,0.0,10819.0,3534.0,1059.0,0.0,0.0,150.0,15112.0,1800.0,211.0,32699.0
Ratlam,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Ratlam,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,3.0,6.0,0.0,0.0,0.0,18.0,0.0,3.0,1.0,7.0,0.0,2.0,40.0
Ratlam,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,230.0,324.0,406.0,276.0,417.0,577.0,270.0,377.0,339.0,229.0,351.0,217.0,4013.0
Ratlam,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,48.0,44.0,13.0,34.0,41.0,90.0,103.0,116.0,164.0,74.0,42.0,133.0,902.0
Ratlam,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,96.0,99.0,66.0,58.0,75.0,339.0,179.0,138.0,90.0,94.0,272.0,186.0,1692.0
Ratlam,13.1,Number of Patients operated for cataract,TOTAL,388.0,260.0,517.0,385.0,397.0,2.0,303.0,688.0,675.0,792.0,927.0,1000.0,6334.0
Ratlam,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,388.0,260.0,517.0,385.0,397.0,2.0,303.0,662.0,672.0,792.0,927.0,1000.0,6305.0
Ratlam,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,21.0,27.0,1548.0,2097.0,15.0,21.0,35.0,3764.0
Ratlam,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1276.0,1511.0,35.0,4.0,0.0,2826.0
Ratlam,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Ratlam,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Ratlam,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,5.0,5.0,5.0,6.0,6.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Ratlam,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,4.0,3.0,6.0,6.0,6.0,6.0,7.0,6.0,7.0,7.0,6.0,4.0,-1.0
Ratlam,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,987.0,995.0,992.0,998.0,1008.0,952.0,933.0,998.0,1017.0,1011.0,1019.0,1021.0,-1.0
Ratlam,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,6.0,6.0,5.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,-1.0
Ratlam,14.05,Number of RKS meetings held during the month,TOTAL,2.0,2.0,3.0,1.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,2.0,30.0
Ratlam,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,9.0,8.0,10.0,7.0,9.0,9.0,11.0,11.0,11.0,13.0,12.0,9.0,-1.0
Ratlam,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,302.0,354.0,606.0,385.0,496.0,258.0,345.0,457.0,423.0,481.0,490.0,234.0,4831.0
Ratlam,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,6.0,6.0,4.0,4.0,3.0,3.0,3.0,4.0,4.0,4.0,4.0,4.0,-1.0
Ratlam,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,1.0,1.0,1.0,1.0,-1.0
Ratlam,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,567.0,755.0,982.0,770.0,828.0,1265.0,948.0,985.0,909.0,549.0,770.0,1031.0,10359.0
Ratlam,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1956.0,3052.0,3416.0,2641.0,2663.0,3613.0,2992.0,3204.0,2973.0,2384.0,2869.0,3475.0,35238.0
Ratlam,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,402.0,865.0,723.0,571.0,584.0,1119.0,896.0,660.0,639.0,437.0,617.0,681.0,8194.0
Ratlam,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3401.0,5686.0,5605.0,5937.0,5529.0,6389.0,5020.0,6508.0,5418.0,4804.0,5653.0,5982.0,65932.0
Ratlam,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,969.0,1620.0,1705.0,1341.0,1412.0,2384.0,1844.0,1645.0,1548.0,986.0,1387.0,1712.0,18553.0
Ratlam,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5357.0,8738.0,9021.0,8578.0,8192.0,10002.0,8012.0,9712.0,8391.0,7188.0,8522.0,9457.0,101170.0
Ratlam,14.10.2.a,Number of death cases of Inpatient males,TOTAL,54.0,58.0,67.0,53.0,87.0,63.0,71.0,85.0,71.0,39.0,56.0,57.0,761.0
Ratlam,14.10.2.b,Number of death cases of Inpatient females,TOTAL,52.0,55.0,75.0,38.0,57.0,40.0,48.0,54.0,55.0,59.0,73.0,66.0,672.0
Ratlam,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,106.0,113.0,142.0,91.0,144.0,103.0,119.0,139.0,126.0,98.0,129.0,123.0,1433.0
Ratlam,14.11,In-Patient Head Count at midnight,TOTAL,5529.0,9713.0,11369.0,9515.0,8752.0,11050.0,8848.0,10887.0,10452.0,7848.0,9137.0,11763.0,114863.0
Ratlam,14.12.1,OPD attendance (All),TOTAL,45715.0,74043.0,76066.0,82123.0,82818.0,113681.0,86000.0,94724.0,92643.0,72559.0,108318.0,118264.0,1046954.0
Ratlam,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,108.0,226.0,261.0,174.0,175.0,194.0,169.0,167.0,167.0,180.0,115.0,46.0,1982.0
Ratlam,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,9.0,4.0,12.0,85.0,1.0,7.0,3.0,7.0,4.0,5.0,3.0,0.0,140.0
Ratlam,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,159.0,350.0,550.0,306.0,244.0,244.0,246.0,418.0,717.0,754.0,355.0,489.0,4832.0
Ratlam,14.14.a,Number of patients given AYUSH treatment,TOTAL,1.0,1.0,1.0,1.0,2.0,3.0,2.0,1.0,1.0,1.0,1.0,1.0,16.0
Ratlam,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,230.0,370.0,390.0,290.0,220.0,360.0,280.0,340.0,260.0,291.0,242.0,520.0,3793.0
Ratlam,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6901.0,9640.0,10167.0,10039.0,8833.0,10037.0,8970.0,10546.0,10389.0,8595.0,6683.0,5722.0,106522.0
Ratlam,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,531.0,488.0,797.0,360.0,376.0,290.0,310.0,526.0,485.0,1680.0,223.0,169.0,6235.0
Ratlam,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,328.0,338.0,323.0,339.0,238.0,272.0,256.0,301.0,290.0,275.0,336.0,135.0,3431.0
Ratlam,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,7.0,6.0,12.0,16.0,8.0,7.0,11.0,10.0,5.0,1.0,14.0,0.0,97.0
Ratlam,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,555.0,1358.0,458.0,328.0,295.0,435.0,257.0,470.0,464.0,382.0,454.0,172.0,5628.0
Ratlam,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,5.0,0.0,3.0,9.0,2.0,5.0,5.0,5.0,0.0,0.0,6.0,1.0,41.0
Ratlam,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1936.0,1503.0,2239.0,2522.0,2267.0,1853.0,1691.0,2435.0,2437.0,1741.0,1842.0,1154.0,23620.0
Ratlam,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,4.0,3.0,4.0,2.0,1.0,1.0,0.0,3.0,0.0,1.0,0.0,20.0
Ratlam,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2819.0,3199.0,3020.0,3189.0,2800.0,2560.0,2204.0,3206.0,3191.0,2398.0,2632.0,1461.0,32679.0
Ratlam,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,13.0,10.0,18.0,29.0,12.0,13.0,17.0,15.0,8.0,1.0,21.0,1.0,158.0
Ratlam,15.2,Number of Widal tests conducted,Number tested,236.0,324.0,338.0,378.0,554.0,922.0,554.0,477.0,393.0,266.0,557.0,560.0,5559.0
Ratlam,15.3.a,Number of VDRL tests conducted on males,Number tested,111.0,80.0,84.0,59.0,46.0,95.0,111.0,94.0,122.0,1.0,213.0,40.0,1056.0
Ratlam,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,408.0,311.0,195.0,253.0,291.0,599.0,569.0,898.0,258.0,63.0,796.0,284.0,4925.0
Ratlam,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,411.0,364.0,449.0,802.0,665.0,789.0,1125.0,1280.0,1175.0,660.0,1370.0,890.0,9980.0
Ratlam,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,930.0,755.0,728.0,1114.0,1002.0,1483.0,1805.0,2272.0,1555.0,724.0,2379.0,1214.0,15961.0
Ratlam,15.4.1,Number of blood smears examined for Malaria,TOTAL,10373.0,13419.0,15042.0,16183.0,17864.0,15699.0,23427.0,18967.0,15782.0,9610.0,21286.0,10119.0,187771.0
Ratlam,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,27.0,70.0,38.0,120.0,169.0,191.0,199.0,259.0,296.0,138.0,85.0,21.0,1613.0
Ratlam,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,6.0,4.0,2.0,12.0,16.0,55.0,49.0,41.0,18.0,26.0,12.0,242.0
Ratlam,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,10300.0,2300.0,10800.0,6800.0,3800.0,9300.0,,,30100.0,14600.0,,,88000.0
Ratlam,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,40000.0,15000.0,0.0,20000.0,20000.0,,,0.0,0.0,,,95000.0
Ratlam,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,2300.0,10800.0,6800.0,3800.0,9300.0,18300.0,,,14600.0,6900.0,,,72800.0
Ratlam,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,8000.0,31500.0,19000.0,3000.0,14500.0,11000.0,,,15500.0,7700.0,,,110200.0
Ratlam,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,16700.0,5900.0,,,22600.0
Ratlam,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,0.0,0.0,,,0.0
Ratlam,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,5900.0,3200.0,,,9100.0
Ratlam,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,10800.0,2700.0,,,13500.0
Ratlam,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,5500.0,17500.0,16500.0,17500.0,4500.0,24500.0,,,30000.0,304000.0,,,420000.0
Ratlam,16.1.2,Stock position of OPV vaccines,2. Stocks Received,25000.0,40000.0,25000.0,0.0,50000.0,20000.0,,,296000.0,30000.0,,,486000.0
Ratlam,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,17500.0,16500.0,17500.0,4500.0,24500.0,19500.0,,,304000.0,20500.0,,,424500.0
Ratlam,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,13000.0,41000.0,24000.0,13000.0,30000.0,25000.0,,,22000.0,313500.0,,,481500.0
Ratlam,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1300.0,10300.0,10800.0,8800.0,5800.0,18800.0,,,12600.0,100.0,,,68500.0
Ratlam,16.1.3,Stock position of TT vaccines,2. Stocks Received,15000.0,30000.0,15000.0,0.0,25000.0,0.0,,,0.0,20000.0,,,105000.0
Ratlam,16.1.3,Stock position of TT vaccines,3. Unusable Stock,10300.0,10800.0,8800.0,5800.0,18800.0,9300.0,,,100.0,13600.0,,,77500.0
Ratlam,16.1.3,Stock position of TT vaccines,4. Stock Distributed,6000.0,29500.0,17000.0,3000.0,12000.0,9500.0,,,12500.0,6500.0,,,96000.0
Ratlam,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,,0.0
Ratlam,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,,0.0
Ratlam,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,,0.0
Ratlam,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,,0.0
Ratlam,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,9250.0,2250.0,12750.0,16250.0,14750.0,23750.0,,,4750.0,250.0,,,84000.0
Ratlam,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,30000.0,10000.0,0.0,20000.0,0.0,,,0.0,10000.0,,,70000.0
Ratlam,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,2250.0,12750.0,16250.0,14750.0,23750.0,16250.0,,,250.0,3950.0,,,90200.0
Ratlam,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,7000.0,19500.0,6500.0,1500.0,11000.0,7500.0,,,4500.0,6300.0,,,63800.0
Ratlam,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,5300.0,1300.0,7550.0,7800.0,5300.0,8800.0,,,2300.0,4800.0,,,43150.0
Ratlam,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,30000.0,5000.0,0.0,12000.0,0.0,,,10000.0,5000.0,,,62000.0
Ratlam,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,1300.0,7550.0,7800.0,5300.0,8800.0,4300.0,,,4800.0,3800.0,,,43650.0
Ratlam,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4000.0,23750.0,4750.0,2500.0,8500.0,4500.0,,,7500.0,6000.0,,,61500.0
Ratlam,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,,0.0
Ratlam,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,,0.0
Ratlam,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,,0.0
Ratlam,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,,0.0
Ratlam,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1500.0,10500.0,9500.0,8600.0,5600.0,19500.0,,,13000.0,22000.0,,,90200.0
Ratlam,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,15000.0,30000.0,15000.0,0.0,28000.0,0.0,,,20000.0,0.0,,,108000.0
Ratlam,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,10500.0,9500.0,8600.0,5600.0,19500.0,6000.0,,,22000.0,15300.0,,,97000.0
Ratlam,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,6000.0,31000.0,15900.0,3000.0,14100.0,13500.0,,,11000.0,6700.0,,,101200.0
Ratlam,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,5950.0,8250.0,8190.0,6550.0,6500.0,9500.0,5300.0,4400.0,4400.0,3800.0,3800.0,3600.0,70240.0
Ratlam,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,2400.0,2640.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8040.0
Ratlam,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,8250.0,8190.0,6550.0,6500.0,9500.0,5300.0,4400.0,4400.0,3800.0,3800.0,3600.0,3600.0,67890.0
Ratlam,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,100.0,2700.0,1640.0,50.0,0.0,4200.0,900.0,0.0,600.0,0.0,200.0,0.0,10390.0
Ratlam,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,35440.0,31940.0,58340.0,34760.0,31760.0,157260.0,86700.0,66460.0,111820.0,66460.0,38760.0,38760.0,758460.0
Ratlam,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,50400.0,0.0,0.0,126000.0,0.0,0.0,50400.0,0.0,0.0,0.0,0.0,226800.0
Ratlam,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,31940.0,58340.0,34760.0,31760.0,157260.0,86700.0,66460.0,111820.0,66460.0,38760.0,38760.0,19220.0,742240.0
Ratlam,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,3500.0,24000.0,23580.0,3000.0,500.0,70560.0,20240.0,5040.0,45360.0,27700.0,0.0,19540.0,243020.0
Ratlam,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,100.0,100.0,100.0,100.0,14400.0,19200.0,10200.0,7800.0,37800.0,31500.0,31000.0,31000.0,183300.0
Ratlam,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,30000.0,4800.0,0.0,0.0,42000.0,0.0,0.0,0.0,0.0,76800.0
Ratlam,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,100.0,100.0,100.0,14400.0,19200.0,10200.0,7800.0,37800.0,31500.0,31000.0,31000.0,30000.0,213200.0
Ratlam,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,15700.0,0.0,9000.0,2400.0,12000.0,6300.0,500.0,0.0,1000.0,46900.0
Ratlam,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,4160.0,3960.0,1860.0,1750.0,2990.0,2640.0,540.0,540.0,7130.0,5630.0,5270.0,5270.0,41740.0
Ratlam,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,300.0,0.0,1800.0,0.0,0.0,0.0,8840.0,0.0,0.0,0.0,0.0,10940.0
Ratlam,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,3960.0,1860.0,1750.0,2990.0,2640.0,540.0,540.0,7130.0,5630.0,5270.0,5270.0,5270.0,42850.0
Ratlam,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,200.0,2400.0,110.0,560.0,350.0,2100.0,0.0,2250.0,1500.0,360.0,0.0,0.0,9830.0
Ratlam,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1900.0,1900.0,6118.0,5518.0,5518.0,5518.0,4818.0,4218.0,4018.0,3618.0,2818.0,2318.0,48280.0
Ratlam,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,4418.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4418.0
Ratlam,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,1900.0,6118.0,5518.0,5518.0,5518.0,4818.0,4218.0,4018.0,3618.0,2818.0,2318.0,2018.0,48398.0
Ratlam,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,200.0,600.0,0.0,0.0,700.0,600.0,200.0,400.0,800.0,500.0,300.0,4300.0
Ratlam,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,48000.0,43200.0,38550.0,37950.0,34850.0,33650.0,29750.0,26700.0,24350.0,21150.0,18850.0,15750.0,372750.0
Ratlam,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20000.0,20000.0
Ratlam,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,43200.0,38550.0,37950.0,34850.0,33650.0,29750.0,26700.0,24350.0,21150.0,18850.0,15750.0,28250.0,353000.0
Ratlam,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,4800.0,4650.0,600.0,3100.0,1200.0,3900.0,3050.0,2350.0,3200.0,2300.0,3100.0,7500.0,39750.0
Ratlam,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,18750.0,14850.0,36600.0,28900.0,7050.0,5000.0,35900.0,33850.0,26950.0,61600.0,50775.0,46975.0,367200.0
Ratlam,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,25000.0,0.0,0.0,0.0,35000.0,0.0,0.0,40000.0,0.0,0.0,5000.0,105000.0
Ratlam,16.3.02,Stock Position of Gloves,3. Unusable Stock,14850.0,36600.0,28900.0,7050.0,5000.0,35900.0,33850.0,26950.0,61600.0,50775.0,46975.0,51375.0,399825.0
Ratlam,16.3.02,Stock Position of Gloves,4. Stock Distributed,3900.0,3250.0,7700.0,21850.0,2050.0,4100.0,2050.0,6900.0,5350.0,10825.0,3800.0,600.0,72375.0
Ratlam,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,12.0
Ratlam,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,12.0
Ratlam,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,21450.0,20450.0,18950.0,15750.0,12550.0,12150.0,6450.0,4950.0,12850.0,10350.0,9350.0,6850.0,152100.0
Ratlam,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,10000.0
Ratlam,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,20450.0,18950.0,15750.0,12550.0,12150.0,6450.0,4950.0,12850.0,10350.0,9350.0,6850.0,5850.0,136500.0
Ratlam,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,1000.0,1500.0,3200.0,3200.0,400.0,5700.0,1500.0,2100.0,2500.0,1000.0,2500.0,1000.0,25600.0
Ratlam,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,25.0,775.0,775.0,775.0,775.0,775.0,775.0,725.0,675.0,675.0,9350.0,575.0,16675.0
Ratlam,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0
Ratlam,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,775.0,775.0,775.0,775.0,775.0,775.0,725.0,675.0,675.0,575.0,6850.0,575.0,14725.0
Ratlam,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,250.0,0.0,0.0,0.0,0.0,0.0,50.0,50.0,0.0,100.0,2500.0,0.0,2950.0
Ratlam,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,10.0
Ratlam,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,10.0
Ratlam,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,1565000.0,1405000.0,1243000.0,988000.0,663000.0,538000.0,2251000.0,728000.0,603000.0,5094000.0,1782000.0,1706500.0,18566500.0
Ratlam,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,2000000.0,0.0,0.0,5000000.0,0.0,0.0,0.0,7000000.0
Ratlam,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,1405000.0,1243000.0,988000.0,663000.0,538000.0,2251000.0,728000.0,603000.0,5094000.0,1782000.0,1706500.0,1696000.0,18697500.0
Ratlam,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,160000.0,162000.0,255000.0,325000.0,125000.0,287000.0,1523000.0,125000.0,509000.0,3312000.0,75500.0,10500.0,6869000.0
Ratlam,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,15520.0,13400.0,8510.0,340.0,290.0,73110.0,17718.0,13681.0,13393.0,4321.0,9906.0,2531.0,172720.0
Ratlam,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,100000.0,0.0,0.0,0.0,0.0,9936.0,0.0,0.0,109936.0
Ratlam,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,13400.0,8510.0,340.0,290.0,73110.0,17718.0,13681.0,13393.0,4321.0,9906.0,2531.0,2381.0,159581.0
Ratlam,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,2120.0,4890.0,8170.0,50.0,27180.0,55392.0,4037.0,288.0,9072.0,4351.0,7375.0,150.0,123075.0
Ratlam,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,809300.0,464300.0,157300.0,335300.0,332300.0,327300.0,321300.0,273300.0,553300.0,387300.0,361300.0,353300.0,4675600.0
Ratlam,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,200000.0,0.0,0.0,0.0,0.0,300000.0,0.0,0.0,0.0,600000.0,1100000.0
Ratlam,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,464300.0,157300.0,335300.0,332300.0,327300.0,321300.0,273300.0,553300.0,387300.0,361300.0,353300.0,915200.0,4781500.0
Ratlam,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,345000.0,307000.0,22000.0,3000.0,5000.0,6000.0,48000.0,20000.0,166000.0,26000.0,8000.0,38100.0,994100.0
Ratlam,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,1350.0,1140.0,1020.0,170.0,135.0,125.0,100.0,90.0,90.0,1135.0,1135.0,1105.0,7595.0
Ratlam,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,2500.0,0.0,0.0,0.0,0.0,0.0,3400.0,0.0,0.0,0.0,5900.0
Ratlam,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,1140.0,1020.0,170.0,135.0,125.0,100.0,90.0,90.0,1135.0,1135.0,1105.0,1080.0,7325.0
Ratlam,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,210.0,120.0,3350.0,35.0,10.0,25.0,10.0,0.0,2355.0,0.0,30.0,25.0,6170.0
Ratlam,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,104100.0,71975.0,34525.0,20900.0,41000.0,24900.0,122900.0,114000.0,108750.0,70750.0,62750.0,39450.0,816000.0
Ratlam,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,150000.0,0.0,150000.0,0.0,0.0,0.0,0.0,0.0,100000.0,400000.0
Ratlam,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,71975.0,34525.0,20900.0,41000.0,24900.0,122900.0,114000.0,108750.0,70750.0,62750.0,39450.0,139450.0,851350.0
Ratlam,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,32125.0,37450.0,13625.0,129900.0,16100.0,52000.0,8900.0,5250.0,38000.0,8000.0,23300.0,0.0,364650.0
Ratlam,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1700.0,3600.0,5800.0,3400.0,2800.0,5100.0,,,3100.0,6100.0,,,31600.0
Ratlam,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,4000.0,10500.0,3300.0,0.0,6600.0,0.0,,,6600.0,0.0,,,31000.0
Ratlam,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,3600.0,5800.0,3400.0,2800.0,5100.0,700.0,,,6100.0,800.0,,,28300.0
Ratlam,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2100.0,8300.0,5700.0,600.0,4300.0,4400.0,,,3600.0,5300.0,,,34300.0
Ratlam,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,50400.0,46400.0,21400.0,21400.0,17400.0,49400.0,,,19400.0,9400.0,,,235200.0
Ratlam,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,105000.0,50000.0,0.0,50000.0,0.0,,,0.0,100000.0,,,305000.0
Ratlam,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,46400.0,21400.0,21400.0,17400.0,49400.0,41400.0,,,9400.0,33400.0,,,240200.0
Ratlam,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,4000.0,130000.0,50000.0,4000.0,18000.0,8000.0,,,10000.0,76000.0,,,300000.0
Ratlam,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,200.0,1200.0,3600.0,4200.0,3200.0,4500.0,,,800.0,2200.0,,,19900.0
Ratlam,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2000.0,8000.0,4000.0,0.0,4000.0,0.0,,,4000.0,4000.0,,,26000.0
Ratlam,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,1200.0,3600.0,4200.0,3200.0,4000.0,900.0,,,2200.0,2000.0,,,21300.0
Ratlam,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1000.0,5600.0,3400.0,1000.0,3200.0,3600.0,,,2600.0,4200.0,,,24600.0
Ratlam,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ratlam,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,,,,,,,,3.0,,,,4.0
Ratlam,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,2.0,1.0,3.0,1.0,,,3.0,1.0,,,1.0,13.0
Ratlam,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,,3.0,,,,,,,,,4.0
Ratlam,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,3.0,1.0,6.0,1.0,,,3.0,1.0,,,1.0,17.0
Ratlam,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,5.0,4.0,2.0,1.0,11.0,3.0,,4.0,,,,,30.0
Ratlam,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,1.0,,,,,,,,1.0
Ratlam,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,5.0,4.0,2.0,1.0,12.0,3.0,,4.0,,,,,31.0
Ratlam,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,9.0,10.0,16.0,10.0,13.0,6.0,6.0,12.0,9.0,2.0,3.0,,96.0
Ratlam,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,2.0,1.0,,4.0,,1.0,,,,,,8.0
Ratlam,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,9.0,12.0,17.0,10.0,17.0,6.0,7.0,12.0,9.0,2.0,3.0,,104.0
Ratlam,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,25.0,16.0,13.0,12.0,10.0,3.0,5.0,21.0,20.0,11.0,1.0,,137.0
Ratlam,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,2.0,,,,,,,,,,,3.0
Ratlam,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,26.0,18.0,13.0,12.0,10.0,3.0,5.0,21.0,20.0,11.0,1.0,,140.0
Ratlam,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,1.0,2.0,,1.0,1.0,1.0,2.0,2.0,,1.0,,12.0
Ratlam,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,1.0,,,2.0,,,,,,,3.0
Ratlam,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,1.0,3.0,,1.0,3.0,1.0,2.0,2.0,,1.0,,15.0
Ratlam,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ratlam,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ratlam,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Ratlam,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Ratlam,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
Ratlam,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,1.0,,,,1.0,,,,2.0
Ratlam,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ratlam,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ratlam,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Ratlam,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,5.0,8.0,11.0,9.0,6.0,4.0,5.0,10.0,5.0,,2.0,,65.0
Ratlam,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,3.0,5.0,11.0,6.0,2.0,2.0,7.0,13.0,,,,50.0
Ratlam,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,6.0,11.0,16.0,20.0,12.0,6.0,7.0,17.0,18.0,,2.0,,115.0
Ratlam,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Ratlam,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Ratlam,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Ratlam,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,,,,,,,,,1.0
Ratlam,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Ratlam,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,3.0,8.0,5.0,2.0,6.0,3.0,4.0,3.0,3.0,4.0,1.0,1.0,43.0
Ratlam,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,1.0,3.0,2.0,2.0,2.0,3.0,2.0,4.0,2.0,1.0,,24.0
Ratlam,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,5.0,9.0,8.0,4.0,8.0,5.0,7.0,5.0,7.0,6.0,2.0,1.0,67.0
Ratlam,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Ratlam,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,2.0,2.0,,1.0,,1.0,,2.0,,,1.0,2.0,11.0
Ratlam,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,8.0,13.0,7.0,5.0,3.0,9.0,8.0,10.0,6.0,2.0,3.0,11.0,85.0
Ratlam,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,10.0,15.0,7.0,6.0,3.0,10.0,8.0,12.0,6.0,2.0,4.0,13.0,96.0
Ratlam,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Ratlam,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Ratlam,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Ratlam,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Ratlam,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Ratlam,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,4.0,14.0,10.0,11.0,9.0,,,9.0,8.0,,,3.0,68.0
Ratlam,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,7.0,10.0,5.0,11.0,6.0,,,5.0,6.0,1.0,,1.0,52.0
Ratlam,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,11.0,25.0,15.0,22.0,15.0,,,14.0,14.0,1.0,,4.0,121.0
Ratlam,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Ratlam,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,,1.0,,2.0,,,1.0,,,5.0
Ratlam,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Ratlam,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,1.0,,1.0,,2.0,,,1.0,,,5.0
Ratlam,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,2.0,1.0,,,,3.0
Ratlam,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,17.0,14.0,15.0,23.0,11.0,9.0,3.0,17.0,27.0,1.0,3.0,9.0,149.0
Ratlam,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,14.0,18.0,23.0,23.0,17.0,6.0,9.0,33.0,22.0,5.0,7.0,6.0,183.0
Ratlam,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,31.0,32.0,38.0,46.0,28.0,15.0,12.0,52.0,50.0,6.0,10.0,15.0,335.0
Ratlam,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Ratlam,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,2.0,,3.0,,2.0,3.0,,3.0,2.0,,1.0,17.0
Ratlam,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,2.0,6.0,5.0,6.0,5.0,3.0,8.0,2.0,4.0,7.0,3.0,1.0,52.0
Ratlam,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,3.0,8.0,5.0,9.0,6.0,5.0,11.0,2.0,7.0,9.0,3.0,2.0,70.0
Ratlam,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Ratlam,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Ratlam,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Ratlam,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Ratlam,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Ratlam,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Ratlam,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Ratlam,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Ratlam,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Ratlam,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Ratlam,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Ratlam,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Ratlam,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Ratlam,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,1.0,1.0
Ratlam,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Ratlam,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,1.0,1.0
Ratlam,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Ratlam,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Ratlam,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Ratlam,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Ratlam,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Ratlam,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,,2.0,1.0,,,,,,1.0,,2.0,8.0
Ratlam,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Ratlam,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,,2.0,1.0,,,,,,1.0,,2.0,8.0
Ratlam,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,2.0,1.0,3.0,1.0,1.0,2.0,,,,,,10.0
Ratlam,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,9.0,14.0,12.0,10.0,12.0,6.0,5.0,5.0,4.0,7.0,6.0,4.0,94.0
Ratlam,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,4.0,2.0,3.0,,,3.0,7.0,,,,,21.0
Ratlam,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,11.0,20.0,15.0,16.0,13.0,7.0,10.0,12.0,4.0,7.0,6.0,4.0,125.0
Ratlam,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Ratlam,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,9.0,9.0,19.0,8.0,1.0,,13.0,6.0,,,,65.0
Ratlam,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,1.0,,1.0,,,,1.0,,3.0
Ratlam,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,9.0,9.0,19.0,10.0,1.0,1.0,13.0,6.0,,1.0,,69.0
Ratlam,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,1.0,2.0,,,,1.0,,,,,,5.0
Ratlam,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,1.0,3.0,4.0,3.0,1.0,,2.0,2.0,,,,17.0
Ratlam,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,,,1.0,,,,,,,2.0
Ratlam,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,2.0,6.0,4.0,3.0,2.0,1.0,2.0,2.0,,,,24.0
Ratlam,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,2.0,,,,,,,,1.0,,,3.0
Ratlam,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,3.0,2.0,3.0,6.0,3.0,4.0,1.0,4.0,3.0,2.0,2.0,3.0,36.0
Ratlam,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,3.0,8.0,3.0,,8.0,4.0,2.0,5.0,8.0,4.0,,,45.0
Ratlam,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,6.0,12.0,6.0,6.0,11.0,8.0,3.0,9.0,11.0,7.0,2.0,3.0,84.0
Ratlam,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Ratlam,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,3.0,3.0,1.0,1.0,2.0,4.0,4.0,3.0,,3.0,3.0,2.0,29.0
Ratlam,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,6.0,6.0,5.0,3.0,5.0,8.0,4.0,10.0,3.0,2.0,4.0,2.0,58.0
Ratlam,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,9.0,9.0,6.0,4.0,7.0,13.0,8.0,13.0,3.0,5.0,7.0,4.0,88.0
Ratlam,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,1.0,1.0,2.0,1.0,4.0,2.0,1.0,1.0,1.0,2.0,17.0
Ratlam,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,8.0,11.0,11.0,11.0,13.0,16.0,13.0,13.0,8.0,9.0,7.0,5.0,125.0
Ratlam,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,29.0,25.0,46.0,42.0,24.0,48.0,60.0,38.0,45.0,38.0,33.0,27.0,455.0
Ratlam,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,38.0,36.0,58.0,54.0,39.0,65.0,77.0,53.0,54.0,48.0,41.0,34.0,597.0
Rewa,1.1,Total number of pregnant women Registered for ANC,TOTAL,5231.0,6170.0,6744.0,7572.0,6499.0,7041.0,5632.0,6064.0,4862.0,5769.0,7244.0,7522.0,76350.0
Rewa,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2636.0,3174.0,3953.0,4597.0,3827.0,3912.0,3032.0,3268.0,2909.0,3064.0,3816.0,4187.0,42375.0
Rewa,1.2,Number of Pregnant women registered under JSY,TOTAL,4397.0,5414.0,6470.0,6966.0,6182.0,6447.0,5310.0,5516.0,4093.0,4687.0,6737.0,6750.0,68969.0
Rewa,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3073.0,3706.0,4484.0,4943.0,4602.0,4775.0,4213.0,4199.0,4766.0,3875.0,5113.0,5049.0,52798.0
Rewa,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3428.0,4274.0,4833.0,5542.0,4452.0,4484.0,4021.0,3999.0,3405.0,3885.0,4788.0,5185.0,52296.0
Rewa,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3474.0,4111.0,4955.0,5491.0,5202.0,5010.0,4520.0,3975.0,3903.0,4198.0,4754.0,5385.0,54978.0
Rewa,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4431.0,5530.0,6421.0,6858.0,5934.0,6532.0,5522.0,5942.0,6492.0,7935.0,12593.0,7945.0,82135.0
Rewa,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,233.0,307.0,315.0,198.0,349.0,311.0,438.0,334.0,588.0,348.0,397.0,397.0,4215.0
Rewa,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,5.0,5.0,4.0,1.0,1.0,3.0,27.0,173.0,201.0,60.0,5.0,488.0
Rewa,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1987.0,2208.0,2785.0,3361.0,2773.0,2899.0,2824.0,2655.0,2058.0,2180.0,2908.0,2974.0,31612.0
Rewa,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,109.0,154.0,172.0,99.0,70.0,113.0,99.0,153.0,120.0,48.0,129.0,106.0,1372.0
Rewa,1.8,Number of pregnancy test kits used at SC level,TOTAL,712.0,806.0,1393.0,1470.0,1266.0,1181.0,1212.0,1129.0,765.0,928.0,1470.0,1823.0,14155.0
Rewa,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,50.0,52.0,33.0,47.0,39.0,28.0,47.0,44.0,100.0,69.0,19.0,47.0,575.0
Rewa,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,139.0,167.0,175.0,173.0,205.0,376.0,343.0,442.0,303.0,297.0,243.0,338.0,3201.0
Rewa,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,189.0,219.0,208.0,220.0,244.0,404.0,390.0,486.0,403.0,366.0,262.0,385.0,3776.0
Rewa,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,145.0,227.0,167.0,128.0,173.0,231.0,267.0,265.0,156.0,194.0,130.0,247.0,2330.0
Rewa,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,27.0,62.0,4.0,7.0,20.0,9.0,15.0,15.0,20.0,54.0,13.0,43.0,289.0
Rewa,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2370.0,2450.0,2690.0,3001.0,4092.0,4410.0,4187.0,3339.0,1967.0,3157.0,3049.0,2992.0,37704.0
Rewa,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,195.0,176.0,189.0,18.0,610.0,585.0,296.0,880.0,571.0,328.0,433.0,151.0,4432.0
Rewa,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2042.0,2109.0,2599.0,2907.0,3300.0,3531.0,3086.0,2244.0,2766.0,2685.0,2594.0,2895.0,32758.0
Rewa,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1549.0,1748.0,2001.0,2218.0,2488.0,3003.0,2622.0,2015.0,2268.0,2257.0,2300.0,2090.0,26559.0
Rewa,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,8.0,0.0,0.0,0.0,1.0,0.0,1.0,13.0,95.0,0.0,0.0,118.0
Rewa,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,6.0,7.0,13.0
Rewa,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,0.0,0.0,0.0
Rewa,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,0.0,0.0,0.0
Rewa,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,0.0,0.0,0.0
Rewa,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,84.0,80.0,87.0,85.0,83.0,121.0,116.0,103.0,2.0,98.0,99.0,128.0,1086.0
Rewa,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rewa,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,84.0,80.0,87.0,85.0,83.0,121.0,116.0,103.0,2.0,98.0,99.0,128.0,1086.0
Rewa,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,0.0,0.0,0.0
Rewa,4.1.1.a,Number of male live births,TOTAL,1402.0,1470.0,1654.0,1830.0,2428.0,2728.0,2439.0,2213.0,1581.0,1976.0,1917.0,1873.0,23511.0
Rewa,4.1.1.b,Number of female live births,TOTAL,1266.0,1277.0,1428.0,1584.0,2142.0,2573.0,2299.0,1924.0,1350.0,1732.0,1757.0,1735.0,21067.0
Rewa,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2668.0,2747.0,3082.0,3414.0,4570.0,5301.0,4738.0,4137.0,2931.0,3708.0,3674.0,3608.0,44578.0
Rewa,4.1.2,Number of still births,TOTAL,37.0,219.0,54.0,52.0,56.0,84.0,77.0,75.0,39.0,56.0,55.0,44.0,848.0
Rewa,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,60.0,53.0,49.0,66.0,69.0,79.0,50.0,42.0,24.0,37.0,44.0,340.0,913.0
Rewa,4.2.1,Number of Newborns weighed at birth,TOTAL,2453.0,2544.0,2893.0,3252.0,4260.0,4665.0,4474.0,3724.0,2417.0,3432.0,3217.0,3286.0,40617.0
Rewa,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,162.0,156.0,213.0,229.0,286.0,340.0,281.0,269.0,215.0,285.0,181.0,199.0,2816.0
Rewa,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2568.0,2617.0,2970.0,3310.0,4273.0,4847.0,4552.0,3748.0,2400.0,3444.0,3235.0,3304.0,41268.0
Rewa,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,17.0,6.0,11.0,12.0,22.0,21.0,43.0,49.0,24.0,30.0,47.0,25.0,307.0
Rewa,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,42.0,145.0,68.0,73.0,52.0,141.0,251.0,248.0,189.0,219.0,477.0,448.0,2353.0
Rewa,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,84.0,80.0,87.0,85.0,97.0,145.0,116.0,103.0,,98.0,151.0,132.0,1178.0
Rewa,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rewa,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,143.0,231.0,166.0,170.0,171.0,307.0,410.0,400.0,213.0,347.0,675.0,605.0,3838.0
Rewa,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,0.0,0.0,0.0
Rewa,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,129.0,222.0,233.0,168.0,240.0,279.0,658.0,256.0,144.0,454.0,609.0,748.0,4140.0
Rewa,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,87.0,80.0,87.0,85.0,97.0,145.0,120.0,111.0,24.0,82.0,117.0,134.0,1169.0
Rewa,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,96.0,187.0,184.0,92.0,181.0,226.0,357.0,224.0,114.0,252.0,258.0,212.0,2383.0
Rewa,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,24.0,0.0,0.0,0.0,0.0,0.0,0.0,24.0
Rewa,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2515.0,2537.0,2923.0,3319.0,4080.0,4574.0,4392.0,3639.0,2172.0,3124.0,3096.0,3080.0,39451.0
Rewa,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1691.0,1919.0,2098.0,2433.0,2818.0,3146.0,3286.0,2465.0,1642.0,2151.0,2342.0,2103.0,28094.0
Rewa,6.3,PNC maternal complications attended,TOTAL,84.0,81.0,87.0,83.0,99.0,145.0,128.0,110.0,8.0,124.0,95.0,120.0,1164.0
Rewa,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,48.0,51.0,46.0,60.0,67.0,45.0,47.0,26.0,6.0,12.0,34.0,40.0,482.0
Rewa,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Rewa,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,48.0,51.0,46.0,60.0,67.0,45.0,47.0,26.0,8.0,12.0,34.0,40.0,484.0
Rewa,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,317.0,480.0,275.0,848.0,1075.0,1180.0,875.0,712.0,516.0,404.0,442.0,496.0,7620.0
Rewa,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,634.0,886.0,706.0,1222.0,1757.0,1819.0,1611.0,1227.0,873.0,972.0,1146.0,971.0,13824.0
Rewa,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,951.0,1366.0,981.0,2070.0,2832.0,2999.0,2486.0,1939.0,1389.0,1376.0,1588.0,1467.0,21444.0
Rewa,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,353.0,6.0,0.0,0.0,0.0,0.0,359.0
Rewa,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,26.0,11.0,4.0,2.0,47.0
Rewa,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,5.0,1.0,0.0,4.0,9.0,2.0,10.0,31.0,53.0,44.0,27.0,16.0,202.0
Rewa,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,2.0,9.0,4.0,5.0,2.0,1.0,6.0,6.0,7.0,6.0,7.0,56.0
Rewa,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rewa,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,6.0,3.0,9.0,8.0,14.0,4.0,11.0,41.0,85.0,62.0,37.0,25.0,305.0
Rewa,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,0.0,0.0,0.0
Rewa,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,1.0,1.0,1.0,0.0,0.0,64.0,278.0,697.0,450.0,235.0,20.0,1747.0
Rewa,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,39.0,5.0,4.0,68.0,37.0,55.0,170.0,835.0,1398.0,1269.0,701.0,146.0,4727.0
Rewa,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,15.0,7.0,14.0,6.0,4.0,11.0,23.0,42.0,72.0,58.0,1.0,26.0,279.0
Rewa,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rewa,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,54.0,13.0,19.0,75.0,41.0,66.0,257.0,1155.0,2167.0,1777.0,937.0,192.0,6753.0
Rewa,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,0.0,0.0,0.0
Rewa,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,20.0,0.0,4.0,0.0,0.0,0.0,1.0,60.0,1.0,87.0
Rewa,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rewa,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,1.0,20.0,0.0,4.0,0.0,0.0,0.0,1.0,60.0,1.0,87.0
Rewa,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,0.0,0.0,0.0
Rewa,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0,0.0,0.0,6.0
Rewa,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,5.0,7.0,1.0,2.0,2.0,4.0,10.0,9.0,0.0,9.0,6.0,7.0,62.0
Rewa,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rewa,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,5.0,7.0,1.0,2.0,2.0,4.0,10.0,9.0,3.0,12.0,6.0,7.0,68.0
Rewa,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,0.0,0.0,0.0
Rewa,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,823.0,970.0,1074.0,1171.0,1083.0,1080.0,1011.0,1149.0,1015.0,1211.0,1113.0,1009.0,12709.0
Rewa,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,31.0,32.0,55.0,75.0,73.0,72.0,72.0,53.0,49.0,48.0,68.0,91.0,719.0
Rewa,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,80.0,239.0,343.0,444.0,330.0,438.0,439.0,269.0,236.0,336.0,678.0,393.0,4225.0
Rewa,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,69.0,120.0,61.0,164.0,114.0,37.0,39.0,53.0,23.0,62.0,70.0,63.0,875.0
Rewa,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rewa,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1003.0,1361.0,1533.0,1854.0,1600.0,1627.0,1561.0,1524.0,1323.0,1657.0,1929.0,1556.0,18528.0
Rewa,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,47.0,87.0,125.0,253.0,347.0,297.0,312.0,141.0,197.0,194.0,344.0,313.0,2657.0
Rewa,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,0.0,0.0,0.0
Rewa,9.06,Number of IUCD removals,TOTAL,768.0,784.0,596.0,563.0,558.0,683.0,609.0,708.0,794.0,616.0,659.0,655.0,7993.0
Rewa,9.07,Number of Oral Pills cycles distributed,TOTAL,5711.0,4955.0,4706.0,5405.0,5564.0,9204.0,9267.0,7712.0,10908.0,8329.0,8843.0,9160.0,89764.0
Rewa,9.08,Number of Condom pieces distributed,TOTAL,22403.0,33634.0,23378.0,29518.0,36955.0,36928.0,25286.0,24398.0,73519.0,33262.0,36029.0,34743.0,410053.0
Rewa,9.09,Number of Centchroman (weekly) pills given,TOTAL,72.0,281.0,89.0,192.0,0.0,13.0,1.0,73.0,359.0,133.0,100.0,10.0,1323.0
Rewa,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,16.0,27.0,27.0,13.0,0.0,11.0,27.0,8.0,220.0,17.0,33.0,48.0,447.0
Rewa,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,1.0,7.0,7.0,0.0,2.0,0.0,18.0
Rewa,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,1.0,0.0,6.0,1.0,0.0,0.0,1.0,29.0,34.0,20.0,16.0,19.0,127.0
Rewa,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Rewa,9.11.2.b,Number of failures following female sterilization,TOTAL,4.0,0.0,1.0,0.0,3.0,1.0,0.0,0.0,7.0,0.0,0.0,1.0,17.0
Rewa,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Rewa,9.12,Number of Institutions having NSV trained doctors,TOTAL,18.0,18.0,16.0,18.0,14.0,14.0,14.0,16.0,12.0,13.0,16.0,16.0,-1.0
Rewa,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2876.0,3124.0,3480.0,3661.0,4778.0,5210.0,4640.0,3739.0,3506.0,3733.0,3643.0,3740.0,46130.0
Rewa,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3710.0,4274.0,4586.0,4821.0,4177.0,4453.0,5201.0,2044.0,417.0,963.0,175.0,83.0,34904.0
Rewa,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3781.0,4520.0,4760.0,4995.0,4202.0,4179.0,4399.0,4430.0,2353.0,1953.0,918.0,915.0,41405.0
Rewa,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3648.0,4457.0,4856.0,4864.0,4339.0,4153.0,4293.0,4076.0,3855.0,3741.0,1572.0,1292.0,45146.0
Rewa,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,11.0,0.0,0.0,0.0,0.0,0.0,0.0,3225.0,3961.0,4699.0,5159.0,5382.0,22437.0
Rewa,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,2888.0,4320.0,4812.0,5341.0,17371.0
Rewa,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,87.0,2359.0,4053.0,5669.0,12169.0
Rewa,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2456.0,2494.0,2686.0,2906.0,3393.0,4129.0,3230.0,2002.0,2887.0,3016.0,2706.0,2570.0,34475.0
Rewa,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3517.0,4234.0,4593.0,4726.0,3112.0,3925.0,4004.0,3076.0,4616.0,5299.0,3715.0,5188.0,50005.0
Rewa,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3489.0,4379.0,4685.0,4899.0,3223.0,3573.0,3402.0,2272.0,3544.0,5442.0,3935.0,4960.0,47803.0
Rewa,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3363.0,4448.0,4818.0,4765.0,3324.0,3548.0,3335.0,2163.0,3004.0,4664.0,3600.0,5396.0,46428.0
Rewa,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2304.0,2187.0,2285.0,2578.0,2691.0,2786.0,3806.0,2316.0,1967.0,2877.0,2399.0,2253.0,30449.0
Rewa,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,3424.0,3725.0,4293.0,4118.0,3809.0,4019.0,4897.0,1945.0,646.0,880.0,262.0,235.0,32253.0
Rewa,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,3882.0,4568.0,4567.0,4603.0,4076.0,4136.0,4615.0,3988.0,2563.0,1958.0,869.0,1334.0,41159.0
Rewa,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3805.0,4543.0,4798.0,4492.0,4239.0,4143.0,4360.0,4009.0,4041.0,3471.0,1646.0,2144.0,45691.0
Rewa,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3331.0,4584.0,5004.0,5828.0,5147.0,4893.0,5372.0,3139.0,3860.0,4747.0,4612.0,5461.0,55978.0
Rewa,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,482.0,733.0,785.0,2630.0,1461.0,1628.0,2099.0,1313.0,1714.0,2363.0,1788.0,2121.0,19117.0
Rewa,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,18.0,0.0,0.0,0.0,13.0,127.0,8.0,245.0,88.0,11.0,510.0
Rewa,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1546.0,2042.0,2185.0,2423.0,2157.0,2327.0,2568.0,1712.0,1795.0,2084.0,2223.0,2552.0,25614.0
Rewa,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1296.0,1796.0,1933.0,2182.0,1906.0,2044.0,2273.0,1434.0,1595.0,1829.0,2008.0,2337.0,22633.0
Rewa,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2842.0,3838.0,4118.0,4605.0,4063.0,4371.0,4841.0,3146.0,3390.0,3913.0,4231.0,4889.0,48247.0
Rewa,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2638.0,3112.0,4302.0,4537.0,3408.0,3723.0,3825.0,3386.0,3075.0,4720.0,4112.0,4722.0,45560.0
Rewa,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2474.0,3268.0,4099.0,4473.0,2478.0,3166.0,2687.0,1909.0,2576.0,4639.0,3082.0,4306.0,39157.0
Rewa,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,112.0,110.0,142.0,0.0,10.0,0.0,13.0,5.0,10.0,14.0,22.0,31.0,469.0
Rewa,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,941.0,1183.0,1260.0,1441.0,887.0,1155.0,952.0,870.0,700.0,703.0,661.0,943.0,11696.0
Rewa,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,824.0,1076.0,1126.0,1302.0,749.0,1003.0,829.0,730.0,604.0,593.0,605.0,838.0,10279.0
Rewa,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1765.0,2259.0,2386.0,2743.0,1636.0,2158.0,1781.0,1600.0,1304.0,1296.0,1266.0,1781.0,21975.0
Rewa,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1246.0,1799.0,1619.0,1896.0,1623.0,1901.0,2091.0,1848.0,1739.0,3147.0,2429.0,2636.0,23974.0
Rewa,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2392.0,3043.0,3055.0,3667.0,3663.0,3921.0,3841.0,3580.0,3212.0,3650.0,3453.0,3664.0,41141.0
Rewa,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2421.0,2812.0,3024.0,3623.0,3789.0,3986.0,3736.0,3250.0,3052.0,3278.0,2971.0,3346.0,39288.0
Rewa,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,194.0,22.0,0.0,0.0,222.0
Rewa,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,4.0,10.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,16.0
Rewa,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2519.0,2678.0,2638.0,2534.0,2635.0,2654.0,2716.0,2665.0,2256.0,2662.0,2696.0,2724.0,31377.0
Rewa,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2251.0,2509.0,2570.0,2460.0,2439.0,2563.0,2517.0,2538.0,2057.0,2490.0,2554.0,2574.0,29522.0
Rewa,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1907.0,2267.0,2300.0,2236.0,2132.0,2237.0,2191.0,1989.0,1989.0,2210.0,2301.0,2113.0,25872.0
Rewa,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Rewa,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2838.0,3742.0,4385.0,8331.0,4912.0,4057.0,4283.0,2975.0,4449.0,6630.0,4824.0,5127.0,56553.0
Rewa,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,703.0,1106.0,1753.0,26615.0,2320.0,1552.0,1324.0,1610.0,2063.0,23500.0,2898.0,2005.0,67449.0
Rewa,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,452.0,648.0,858.0,20040.0,1826.0,920.0,1257.0,858.0,1423.0,22686.0,2820.0,681.0,54469.0
Rewa,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,3.0
Rewa,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,3.0
Rewa,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,7.0,0.0,0.0,10.0,15.0,0.0,23.0,60.0,48.0,0.0,40.0,205.0
Rewa,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,262.0,289.0,275.0,252.0,275.0,261.0,277.0,276.0,240.0,137.0,147.0,208.0,2899.0
Rewa,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,186.0,445.0,313.0,104.0,212.0,359.0,347.0,294.0,422.0,131.0,168.0,212.0,3193.0
Rewa,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,47.0,10.0,21.0,0.0,0.0,0.0,2.0,0.0,0.0,91.0,0.0,7.0,178.0
Rewa,13.1,Number of Patients operated for cataract,TOTAL,60.0,52.0,49.0,56.0,62.0,185.0,105.0,253.0,267.0,307.0,359.0,306.0,2061.0
Rewa,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,50.0,48.0,49.0,52.0,41.0,173.0,165.0,253.0,257.0,304.0,403.0,305.0,2100.0
Rewa,13.3,Number of School children detected with Refractive errors,TOTAL,34.0,3.0,0.0,48.0,139.0,307.0,214.0,223.0,276.0,572.0,647.0,363.0,2826.0
Rewa,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,38.0,444.0,99.0,461.0,649.0,383.0,2074.0
Rewa,13.5,Number of eyes collected through eye donation,TOTAL,28.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28.0
Rewa,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,9.0,9.0,11.0,11.0,11.0,11.0,11.0,10.0,8.0,9.0,9.0,10.0,-1.0
Rewa,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,15.0,15.0,15.0,15.0,14.0,14.0,12.0,15.0,11.0,10.0,13.0,13.0,-1.0
Rewa,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1431.0,1502.0,1549.0,1573.0,1552.0,1576.0,1623.0,1614.0,1539.0,1480.0,1662.0,1634.0,-1.0
Rewa,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,9.0,9.0,12.0,12.0,10.0,10.0,10.0,9.0,5.0,7.0,7.0,8.0,-1.0
Rewa,14.05,Number of RKS meetings held during the month,TOTAL,2.0,1.0,1.0,3.0,5.0,5.0,6.0,7.0,6.0,8.0,9.0,8.0,61.0
Rewa,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,22.0,23.0,25.0,23.0,25.0,25.0,21.0,24.0,18.0,20.0,21.0,22.0,-1.0
Rewa,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,645.0,494.0,756.0,847.0,750.0,296.0,215.0,275.0,20.0,92.0,140.0,130.0,4660.0
Rewa,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,5.0,8.0,7.0,7.0,7.0,7.0,8.0,5.0,8.0,6.0,7.0,-1.0
Rewa,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,6.0,3.0,5.0,5.0,5.0,5.0,5.0,5.0,3.0,2.0,3.0,2.0,-1.0
Rewa,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,760.0,456.0,624.0,838.0,690.0,740.0,562.0,470.0,560.0,490.0,615.0,565.0,7370.0
Rewa,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1851.0,2121.0,2361.0,2743.0,2664.0,2334.0,2216.0,1486.0,916.0,1277.0,1770.0,1807.0,23546.0
Rewa,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,740.0,457.0,645.0,924.0,708.0,898.0,744.0,532.0,658.0,623.0,834.0,449.0,8212.0
Rewa,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3160.0,4020.0,4060.0,5568.0,4742.0,6010.0,4643.0,4300.0,3032.0,3869.0,4084.0,3944.0,51432.0
Rewa,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1500.0,913.0,1269.0,1762.0,1398.0,1638.0,1306.0,1002.0,1218.0,1113.0,1449.0,1014.0,15582.0
Rewa,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5011.0,6141.0,6421.0,8311.0,7406.0,8344.0,6859.0,5786.0,3948.0,5146.0,5854.0,5751.0,74978.0
Rewa,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,12.0,3.0,4.0,3.0,1.0,1.0,6.0,1.0,0.0,0.0,31.0
Rewa,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,8.0,3.0,6.0,4.0,1.0,1.0,4.0,1.0,1.0,0.0,29.0
Rewa,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,20.0,6.0,10.0,7.0,2.0,2.0,10.0,2.0,1.0,0.0,60.0
Rewa,14.11,In-Patient Head Count at midnight,TOTAL,895.0,1855.0,1562.0,1114.0,2571.0,2112.0,1281.0,1152.0,978.0,1085.0,1450.0,2036.0,18091.0
Rewa,14.12.1,OPD attendance (All),TOTAL,72945.0,66938.0,74309.0,93260.0,108898.0,118374.0,94531.0,77751.0,70455.0,54928.0,77538.0,84358.0,994285.0
Rewa,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,17.0,0.0,0.0,9.0,67.0,3842.0,26.0,5.0,65.0,8.0,4039.0
Rewa,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,62.0,8.0,73.0
Rewa,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,276.0,316.0,395.0,538.0,370.0,391.0,569.0,495.0,644.0,434.0,841.0,670.0,5939.0
Rewa,14.14.a,Number of patients given AYUSH treatment,TOTAL,1254.0,2081.0,1915.0,2861.0,2800.0,2735.0,2659.0,5113.0,2930.0,2791.0,2529.0,2156.0,31824.0
Rewa,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,14.14.c,Number of Adolescents counselled,TOTAL,0.0,15.0,35.0,210.0,145.0,123.0,125.0,160.0,0.0,0.0,10.0,0.0,823.0
Rewa,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5334.0,5676.0,7186.0,9402.0,8116.0,9031.0,8033.0,7856.0,6641.0,6819.0,8164.0,7748.0,90006.0
Rewa,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,97.0,155.0,212.0,181.0,160.0,153.0,157.0,295.0,132.0,168.0,155.0,174.0,2039.0
Rewa,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1067.0,918.0,1056.0,960.0,1156.0,1282.0,1069.0,1227.0,642.0,988.0,955.0,904.0,12224.0
Rewa,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,8.0,3.0,6.0,12.0,5.0,9.0,9.0,7.0,1.0,33.0,18.0,1.0,112.0
Rewa,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1060.0,1276.0,1219.0,1122.0,1232.0,1646.0,1241.0,1766.0,1091.0,1220.0,1184.0,821.0,14878.0
Rewa,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,6.0,0.0,10.0,8.0,10.0,131.0,6.0,4.0,0.0,24.0,15.0,0.0,214.0
Rewa,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2501.0,2660.0,3060.0,3386.0,3157.0,3894.0,2864.0,2780.0,2108.0,2213.0,2662.0,2241.0,33526.0
Rewa,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,5.0,0.0,0.0,55.0,58.0,38.0,2.0,1.0,1.0,97.0,16.0,0.0,273.0
Rewa,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,4628.0,4854.0,5335.0,5468.0,5545.0,6822.0,5174.0,5773.0,3841.0,4421.0,4801.0,3966.0,60628.0
Rewa,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,19.0,3.0,16.0,75.0,73.0,178.0,17.0,12.0,2.0,154.0,49.0,1.0,599.0
Rewa,15.2,Number of Widal tests conducted,Number tested,578.0,659.0,688.0,804.0,696.0,877.0,897.0,685.0,643.0,462.0,684.0,364.0,8037.0
Rewa,15.3.a,Number of VDRL tests conducted on males,Number tested,78.0,20.0,84.0,177.0,155.0,211.0,186.0,128.0,155.0,126.0,191.0,155.0,1666.0
Rewa,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,243.0,22.0,105.0,90.0,52.0,60.0,80.0,101.0,559.0,129.0,259.0,81.0,1781.0
Rewa,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,121.0,344.0,255.0,218.0,187.0,148.0,199.0,188.0,455.0,250.0,270.0,312.0,2947.0
Rewa,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,442.0,386.0,444.0,485.0,394.0,419.0,465.0,417.0,1169.0,505.0,720.0,548.0,6394.0
Rewa,15.4.1,Number of blood smears examined for Malaria,TOTAL,15005.0,12549.0,19768.0,24731.0,27219.0,26160.0,21019.0,17096.0,15555.0,5774.0,20783.0,13906.0,219565.0
Rewa,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,96.0,59.0,109.0,164.0,125.0,268.0,205.0,92.0,3762.0,23.0,36.0,53.0,4992.0
Rewa,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,19.0,6.0,9.0,14.0,10.0,18.0,26.0,9.0,1.0,1.0,1.0,2.0,116.0
Rewa,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Rewa,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Rewa,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Rewa,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Rewa,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Rewa,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Rewa,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Rewa,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Rewa,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Rewa,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Rewa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Rewa,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Rewa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Rewa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Rewa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Rewa,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Rewa,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Rewa,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Rewa,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Rewa,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Rewa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Rewa,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Rewa,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Rewa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Rewa,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Rewa,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Rewa,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Rewa,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Rewa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Rewa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Rewa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Rewa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rewa,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,3.0,1.0,,,1.0,,5.0
Rewa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Rewa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rewa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Rewa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Rewa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rewa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Rewa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,4.0,,1.0,2.0,,,,7.0
Rewa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rewa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,4.0,,1.0,2.0,,,,7.0
Rewa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,1.0,2.0,3.0,,1.0,,,7.0
Rewa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rewa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,1.0,2.0,3.0,,1.0,,,7.0
Rewa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,1.0,,1.0,2.0,,4.0
Rewa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,1.0,,,,1.0,,,2.0
Rewa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,1.0,,1.0,,2.0,2.0,,6.0
Rewa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Rewa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rewa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Rewa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,3.0,3.0,2.0,,,,,8.0
Rewa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,1.0,1.0,1.0,,,,,3.0
Rewa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,4.0,4.0,3.0,,,,,11.0
Rewa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Rewa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rewa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Rewa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,2.0,3.0,,,1.0,1.0,1.0,8.0
Rewa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,2.0,2.0,,,,,,4.0
Rewa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,4.0,5.0,,,1.0,1.0,1.0,12.0
Rewa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Rewa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Rewa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Rewa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Rewa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Rewa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Rewa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Rewa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,1.0,,,,1.0
Rewa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Rewa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Rewa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Rewa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Rewa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Rewa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Rewa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Rewa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Rewa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Rewa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,4.0,,,1.0,3.0,8.0
Rewa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,6.0,7.0,,,4.0,17.0
Rewa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,10.0,7.0,,1.0,7.0,25.0
Rewa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Rewa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Rewa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Rewa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Rewa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Rewa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,1.0,,,1.0,,1.0,3.0
Rewa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,1.0,1.0,1.0,,2.0,1.0,6.0
Rewa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,2.0,1.0,1.0,1.0,2.0,2.0,9.0
Rewa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Rewa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Rewa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Rewa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Rewa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Rewa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Rewa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Rewa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Rewa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Rewa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Rewa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Rewa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Rewa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Rewa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Rewa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Rewa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Rewa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Rewa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Rewa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Rewa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,1.0,,,,,,,1.0
Rewa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Rewa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Rewa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Rewa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Rewa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Rewa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,1.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,,10.0
Rewa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Rewa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,1.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,,10.0
Rewa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,3.0,,,,,,3.0
Rewa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,2.0,4.0,,2.0,,,,8.0
Rewa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,2.0,1.0,,,,3.0
Rewa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,2.0,7.0,2.0,3.0,,,,14.0
Rewa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Rewa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,3.0,1.0,1.0,,,1.0,6.0
Rewa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Rewa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,3.0,2.0,1.0,,,1.0,7.0
Rewa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Rewa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Rewa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Rewa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,1.0,,,,,1.0
Rewa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Rewa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Rewa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Rewa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Rewa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Rewa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Rewa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Rewa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Rewa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Rewa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,9.0,3.0,4.0,1.0,,,17.0
Rewa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,9.0,5.0,6.0,2.0,5.0,1.0,28.0
Rewa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,18.0,8.0,11.0,3.0,5.0,1.0,46.0
Sagar,1.1,Total number of pregnant women Registered for ANC,TOTAL,3830.0,4849.0,4914.0,6261.0,4502.0,5249.0,4638.0,4936.0,4673.0,4647.0,6092.0,6336.0,60927.0
Sagar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1983.0,2648.0,2593.0,3092.0,2190.0,2488.0,2292.0,2448.0,2614.0,2495.0,3050.0,3458.0,31351.0
Sagar,1.2,Number of Pregnant women registered under JSY,TOTAL,3783.0,4579.0,4637.0,5569.0,4248.0,4830.0,4388.0,4773.0,4518.0,4414.0,5573.0,5870.0,57182.0
Sagar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3003.0,3572.0,3479.0,4129.0,3522.0,3955.0,3694.0,3959.0,4048.0,3677.0,4079.0,4880.0,45997.0
Sagar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2886.0,3771.0,3828.0,4328.0,3311.0,3891.0,3463.0,3570.0,3327.0,3576.0,4368.0,4658.0,44977.0
Sagar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3088.0,3666.0,3954.0,4681.0,3881.0,4293.0,3919.0,4128.0,3831.0,3732.0,4603.0,5719.0,49495.0
Sagar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3873.0,4675.0,4982.0,6119.0,4441.0,5090.0,4371.0,4686.0,4625.0,4522.0,5847.0,6228.0,59459.0
Sagar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,362.0,379.0,460.0,496.0,363.0,309.0,402.0,365.0,438.0,414.0,352.0,332.0,4672.0
Sagar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,6.0,11.0,15.0,29.0,17.0,20.0,15.0,9.0,11.0,14.0,9.0,10.0,166.0
Sagar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1142.0,1441.0,2105.0,2289.0,1409.0,1809.0,1623.0,2149.0,2428.0,2039.0,2273.0,2480.0,23187.0
Sagar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,103.0,135.0,126.0,99.0,81.0,77.0,98.0,97.0,84.0,71.0,99.0,63.0,1133.0
Sagar,1.8,Number of pregnancy test kits used at SC level,TOTAL,346.0,546.0,521.0,694.0,644.0,825.0,840.0,1054.0,1017.0,1070.0,1198.0,1590.0,10345.0
Sagar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,56.0,64.0,80.0,136.0,109.0,129.0,93.0,106.0,132.0,159.0,94.0,134.0,1292.0
Sagar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,197.0,266.0,290.0,325.0,403.0,446.0,385.0,459.0,390.0,353.0,324.0,319.0,4157.0
Sagar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,253.0,330.0,370.0,461.0,512.0,575.0,478.0,565.0,522.0,512.0,418.0,453.0,5449.0
Sagar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,161.0,206.0,209.0,274.0,324.0,349.0,315.0,397.0,331.0,336.0,322.0,350.0,3574.0
Sagar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,33.0,37.0,4.0,4.0,0.0,1.0,0.0,3.0,3.0,14.0,24.0,2.0,125.0
Sagar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1955.0,1936.0,2653.0,3121.0,3561.0,3474.0,2933.0,3271.0,2982.0,2960.0,2556.0,2577.0,33979.0
Sagar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,303.0,287.0,796.0,1183.0,1178.0,1202.0,1157.0,841.0,372.0,665.0,610.0,489.0,9083.0
Sagar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1469.0,1171.0,2420.0,2539.0,3190.0,3538.0,2713.0,2943.0,3381.0,2559.0,2733.0,2231.0,30887.0
Sagar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,765.0,826.0,1144.0,1488.0,1927.0,1796.0,2030.0,1824.0,1878.0,1900.0,1871.0,1169.0,18618.0
Sagar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,28.0,31.0,64.0,46.0,26.0,26.0,111.0,36.0,54.0,55.0,64.0,32.0,573.0
Sagar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,312.0,311.0,26.0,649.0
Sagar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Sagar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,0.0,,,0.0
Sagar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,0.0,,,0.0
Sagar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,1.0,1.0,2.0,5.0,4.0,3.0,1.0,2.0,3.0,2.0,2.0,26.0
Sagar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,123.0,136.0,115.0,143.0,138.0,150.0,124.0,140.0,142.0,123.0,107.0,79.0,1520.0
Sagar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sagar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,123.0,137.0,116.0,145.0,143.0,154.0,127.0,141.0,144.0,126.0,109.0,81.0,1546.0
Sagar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,98.0,74.0,17.0,189.0
Sagar,4.1.1.a,Number of male live births,TOTAL,1139.0,1124.0,1582.0,1815.0,2097.0,2016.0,1767.0,1953.0,1759.0,1967.0,1708.0,1561.0,20488.0
Sagar,4.1.1.b,Number of female live births,TOTAL,1041.0,1090.0,1388.0,1725.0,1934.0,1972.0,1590.0,1820.0,1691.0,1774.0,1572.0,1458.0,19055.0
Sagar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2180.0,2214.0,2970.0,3540.0,4031.0,3988.0,3357.0,3773.0,3450.0,3741.0,3280.0,3019.0,39543.0
Sagar,4.1.2,Number of still births,TOTAL,34.0,66.0,68.0,60.0,63.0,73.0,73.0,70.0,54.0,52.0,51.0,42.0,706.0
Sagar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,50.0,90.0,76.0,76.0,75.0,85.0,59.0,96.0,81.0,94.0,116.0,109.0,1007.0
Sagar,4.2.1,Number of Newborns weighed at birth,TOTAL,2144.0,2086.0,2933.0,3487.0,3970.0,3898.0,3260.0,3673.0,3309.0,3508.0,3088.0,2940.0,38296.0
Sagar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,143.0,228.0,223.0,258.0,350.0,272.0,286.0,289.0,228.0,179.0,213.0,164.0,2833.0
Sagar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2144.0,2168.0,2942.0,3521.0,3990.0,3965.0,3315.0,3671.0,3434.0,3621.0,3255.0,2986.0,39012.0
Sagar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,2.0,0.0,40.0,72.0,13.0,11.0,28.0,31.0,32.0,34.0,35.0,26.0,324.0
Sagar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,49.0,47.0,45.0,69.0,100.0,406.0,294.0,59.0,63.0,73.0,64.0,53.0,1322.0
Sagar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,155.0,92.0,135.0,142.0,110.0,122.0,108.0,118.0,116.0,102.0,86.0,73.0,1359.0
Sagar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sagar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,206.0,139.0,220.0,283.0,223.0,539.0,430.0,208.0,211.0,209.0,185.0,152.0,3005.0
Sagar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,98.0,83.0,12.0,193.0
Sagar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,70.0,110.0,117.0,164.0,176.0,183.0,138.0,141.0,119.0,175.0,216.0,221.0,1830.0
Sagar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,50.0,105.0,114.0,152.0,60.0,49.0,20.0,19.0,25.0,41.0,34.0,44.0,713.0
Sagar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,77.0,81.0,94.0,113.0,462.0,485.0,355.0,277.0,93.0,432.0,524.0,492.0,3485.0
Sagar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,141.0,74.0,126.0,129.0,89.0,104.0,101.0,113.0,113.0,110.0,95.0,70.0,1265.0
Sagar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1851.0,1923.0,2695.0,2869.0,3695.0,3583.0,3095.0,3321.0,2934.0,3146.0,2676.0,2475.0,34263.0
Sagar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1161.0,1122.0,1566.0,1741.0,1961.0,2083.0,1908.0,2002.0,1726.0,1855.0,1645.0,1590.0,20360.0
Sagar,6.3,PNC maternal complications attended,TOTAL,31.0,92.0,22.0,15.0,16.0,22.0,10.0,12.0,9.0,17.0,11.0,11.0,268.0
Sagar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,27.0,42.0,35.0,67.0,36.0,47.0,54.0,46.0,51.0,76.0,70.0,74.0,625.0
Sagar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,1.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,7.0
Sagar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,27.0,43.0,38.0,67.0,36.0,47.0,54.0,46.0,51.0,76.0,73.0,74.0,632.0
Sagar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,87.0,149.0,0.0,236.0
Sagar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,189.0,246.0,338.0,404.0,196.0,369.0,291.0,312.0,488.0,340.0,500.0,368.0,4041.0
Sagar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,266.0,413.0,518.0,489.0,525.0,622.0,458.0,512.0,806.0,635.0,997.0,693.0,6934.0
Sagar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,455.0,659.0,856.0,893.0,721.0,991.0,749.0,824.0,1294.0,975.0,1497.0,1061.0,10975.0
Sagar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,8.0,6.0,5.0,4.0,3.0,4.0,5.0,0.0,6.0,5.0,133.0,179.0
Sagar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,10.0,0.0,12.0
Sagar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,5.0,0.0,2.0,0.0,0.0,1.0,3.0,4.0,0.0,15.0
Sagar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,3.0,2.0,6.0,3.0,9.0,2.0,9.0,20.0,27.0,19.0,14.0,114.0
Sagar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sagar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,3.0,2.0,11.0,3.0,11.0,2.0,9.0,21.0,32.0,33.0,14.0,141.0
Sagar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,0.0,0.0,0.0,0.0
Sagar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,4.0,0.0,0.0,0.0,0.0,0.0,414.0,704.0,494.0,114.0,5.0,1735.0
Sagar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,2.0,2.0,42.0,21.0,5.0,16.0,2377.0,3067.0,1241.0,943.0,58.0,7774.0
Sagar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,3.0,1.0,1.0,3.0,11.0,13.0,5.0,209.0,516.0,187.0,111.0,55.0,1115.0
Sagar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sagar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,3.0,7.0,3.0,45.0,32.0,18.0,21.0,3000.0,4287.0,1922.0,1168.0,118.0,10624.0
Sagar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,365.0,424.0,8.0,0.0,0.0,797.0
Sagar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,2.0,0.0,2.0,1.0,2.0,0.0,0.0,2.0,6.0,3.0,3.0,21.0
Sagar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,6.0,7.0,5.0,8.0,5.0,8.0,5.0,1.0,0.0,3.0,29.0,12.0,89.0
Sagar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sagar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,6.0,9.0,5.0,10.0,6.0,10.0,5.0,1.0,2.0,9.0,32.0,15.0,110.0
Sagar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,0.0,0.0,0.0,0.0
Sagar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,1.0,1.0,3.0,1.0,0.0,0.0,1.0,1.0,4.0,39.0,3.0,54.0
Sagar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,17.0,18.0,10.0,26.0,30.0,22.0,20.0,75.0,54.0,70.0,56.0,60.0,458.0
Sagar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sagar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,17.0,19.0,11.0,29.0,31.0,22.0,20.0,76.0,55.0,74.0,95.0,63.0,512.0
Sagar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,11.0,10.0,6.0,27.0
Sagar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,391.0,578.0,581.0,567.0,595.0,547.0,521.0,688.0,694.0,649.0,798.0,831.0,7440.0
Sagar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,9.0,4.0,4.0,8.0,7.0,2.0,9.0,8.0,14.0,21.0,57.0,47.0,190.0
Sagar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,83.0,51.0,70.0,113.0,63.0,67.0,37.0,101.0,59.0,51.0,71.0,86.0,852.0
Sagar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,151.0,211.0,273.0,216.0,279.0,633.0,316.0,156.0,152.0,240.0,201.0,260.0,3088.0
Sagar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sagar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,634.0,844.0,928.0,904.0,944.0,1249.0,883.0,953.0,919.0,961.0,1127.0,1224.0,11570.0
Sagar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,201.0,234.0,304.0,245.0,401.0,693.0,356.0,295.0,256.0,358.0,300.0,444.0,4087.0
Sagar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,0.0,,0.0,0.0
Sagar,9.06,Number of IUCD removals,TOTAL,294.0,300.0,302.0,300.0,238.0,280.0,277.0,636.0,678.0,577.0,618.0,684.0,5184.0
Sagar,9.07,Number of Oral Pills cycles distributed,TOTAL,2568.0,3023.0,3969.0,3082.0,3606.0,3917.0,6028.0,7439.0,8008.0,8258.0,9154.0,12240.0,71292.0
Sagar,9.08,Number of Condom pieces distributed,TOTAL,23074.0,42383.0,50227.0,64898.0,52252.0,55777.0,64381.0,56531.0,60004.0,68521.0,91238.0,95084.0,724370.0
Sagar,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,167.0,0.0,0.0,0.0,0.0,25.0,56.0,0.0,95.0,0.0,343.0
Sagar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,1087.0,16.0,23.0,31.0,14.0,188.0,90.0,91.0,99.0,113.0,106.0,190.0,2048.0
Sagar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Sagar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,2.0,0.0,1.0,0.0,45.0,711.0,43.0,32.0,0.0,834.0
Sagar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,4.0,6.0,6.0,8.0,0.0,1.0,26.0
Sagar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,9.12,Number of Institutions having NSV trained doctors,TOTAL,9.0,11.0,7.0,7.0,8.0,9.0,11.0,11.0,11.0,9.0,11.0,11.0,-1.0
Sagar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2515.0,2591.0,2972.0,4452.0,4375.0,4540.0,3980.0,4346.0,4003.0,3741.0,3551.0,4200.0,45266.0
Sagar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2814.0,3192.0,3189.0,3692.0,3062.0,4250.0,4330.0,1662.0,237.0,294.0,49.0,34.0,26805.0
Sagar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3377.0,3418.0,3221.0,3952.0,3064.0,3525.0,3825.0,4428.0,2460.0,1212.0,547.0,313.0,33342.0
Sagar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3644.0,3802.0,3459.0,4055.0,3285.0,3722.0,3433.0,4048.0,4224.0,2535.0,1325.0,821.0,38353.0
Sagar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,12.0,0.0,0.0,0.0,0.0,2980.0,3938.0,3818.0,4633.0,5113.0,20494.0
Sagar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,2349.0,3089.0,4364.0,5160.0,14966.0
Sagar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,55.0,1832.0,3428.0,5095.0,10412.0
Sagar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2062.0,2039.0,2501.0,3747.0,3890.0,3605.0,2990.0,2904.0,2984.0,3139.0,2810.0,2951.0,35622.0
Sagar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2836.0,3195.0,3133.0,3650.0,2941.0,3914.0,3975.0,2151.0,3235.0,2901.0,4418.0,5055.0,41404.0
Sagar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3385.0,3409.0,3177.0,3906.0,2973.0,3216.0,3519.0,2595.0,3532.0,3082.0,4490.0,5974.0,43258.0
Sagar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3533.0,3780.0,3415.0,4000.0,3165.0,3424.0,3232.0,2365.0,3504.0,2993.0,4187.0,5747.0,43345.0
Sagar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1619.0,1532.0,2074.0,3173.0,3295.0,2930.0,2374.0,2801.0,2450.0,2457.0,2257.0,2140.0,29102.0
Sagar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2644.0,3172.0,3028.0,4066.0,2872.0,4137.0,4404.0,1734.0,588.0,406.0,208.0,59.0,27318.0
Sagar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,3231.0,3345.0,3214.0,3759.0,2894.0,3497.0,3819.0,4398.0,2461.0,1285.0,693.0,351.0,32947.0
Sagar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3472.0,3726.0,3439.0,3785.0,3107.0,3686.0,3421.0,4042.0,4043.0,2469.0,1586.0,925.0,37701.0
Sagar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2643.0,3265.0,4002.0,4929.0,3747.0,4582.0,4032.0,3752.0,3535.0,3267.0,3763.0,4557.0,46074.0
Sagar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1382.0,1673.0,2153.0,2351.0,1566.0,2443.0,2317.0,2456.0,2551.0,2679.0,2953.0,4184.0,28708.0
Sagar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0,5.0,20.0,0.0,0.0,41.0
Sagar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1302.0,1619.0,1983.0,2450.0,1827.0,2162.0,2046.0,1866.0,1776.0,1618.0,1823.0,2446.0,22918.0
Sagar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1189.0,1435.0,1787.0,2240.0,1605.0,2106.0,1918.0,1687.0,1623.0,1535.0,1755.0,2231.0,21111.0
Sagar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2491.0,3054.0,3770.0,4690.0,3432.0,4268.0,3964.0,3553.0,3399.0,3153.0,3578.0,4677.0,44029.0
Sagar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2494.0,3067.0,3197.0,3982.0,2933.0,3269.0,3094.0,3218.0,3266.0,3624.0,3928.0,5079.0,41151.0
Sagar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2491.0,3068.0,3198.0,3970.0,2901.0,3172.0,2964.0,2244.0,2940.0,3364.0,3894.0,5077.0,39283.0
Sagar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,66.0,113.0,33.0,21.0,233.0
Sagar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,475.0,764.0,752.0,989.0,758.0,770.0,731.0,811.0,778.0,757.0,895.0,1293.0,9773.0
Sagar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,436.0,714.0,750.0,946.0,722.0,748.0,676.0,765.0,792.0,700.0,785.0,1171.0,9205.0
Sagar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,911.0,1478.0,1502.0,1935.0,1480.0,1518.0,1407.0,1576.0,1570.0,1457.0,1680.0,2464.0,18978.0
Sagar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1220.0,1687.0,1728.0,2226.0,1975.0,2591.0,2237.0,2920.0,2494.0,2789.0,3159.0,3550.0,28576.0
Sagar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2111.0,2739.0,2686.0,3153.0,3227.0,4830.0,3610.0,3203.0,2823.0,2868.0,3330.0,3842.0,38422.0
Sagar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2092.0,2849.0,2841.0,3282.0,3298.0,4266.0,3605.0,3212.0,2929.0,2971.0,3408.0,3804.0,38557.0
Sagar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,2.0,0.0,7.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,11.0
Sagar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,3.0,2.0,6.0,3.0,4.0,5.0,4.0,6.0,7.0,5.0,9.0,55.0
Sagar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1986.0,2104.0,2109.0,2084.0,1984.0,1927.0,2077.0,2112.0,2153.0,2099.0,2108.0,2187.0,24930.0
Sagar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1813.0,2025.0,2056.0,2094.0,1874.0,1894.0,1974.0,2069.0,2129.0,2225.0,2089.0,2177.0,24419.0
Sagar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1401.0,1512.0,1517.0,1568.0,1397.0,1439.0,1525.0,1612.0,1761.0,2025.0,1786.0,1884.0,19427.0
Sagar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2441.0,3272.0,4033.0,5454.0,3561.0,4383.0,3977.0,3643.0,3592.0,5105.0,3986.0,4662.0,48109.0
Sagar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,642.0,894.0,1105.0,9384.0,7841.0,2055.0,994.0,1016.0,1290.0,15524.0,8541.0,1960.0,51246.0
Sagar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,189.0,509.0,417.0,7428.0,2802.0,1899.0,481.0,339.0,532.0,15608.0,5753.0,1821.0,37778.0
Sagar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,4.0
Sagar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,1.0,0.0,1.0,2.0,0.0,0.0,1.0,2.0,0.0,0.0,2.0,9.0
Sagar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,2.0,48.0,15.0,41.0,28.0,1.0,6.0,8.0,19.0,56.0,23.0,249.0
Sagar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,567.0,794.0,615.0,556.0,721.0,468.0,418.0,348.0,335.0,338.0,476.0,488.0,6124.0
Sagar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,48.0,79.0,339.0,144.0,454.0,215.0,139.0,131.0,19.0,63.0,139.0,26.0,1796.0
Sagar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,212.0,162.0,156.0,128.0,238.0,250.0,376.0,206.0,173.0,133.0,247.0,308.0,2589.0
Sagar,13.1,Number of Patients operated for cataract,TOTAL,33.0,62.0,419.0,248.0,113.0,140.0,249.0,685.0,940.0,911.0,979.0,266.0,5045.0
Sagar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,33.0,62.0,419.0,248.0,178.0,139.0,249.0,685.0,938.0,910.0,977.0,264.0,5102.0
Sagar,13.3,Number of School children detected with Refractive errors,TOTAL,4.0,0.0,0.0,62.0,167.0,338.0,308.0,1247.0,129.0,64.0,105.0,69.0,2493.0
Sagar,13.4,Number of children provided free glasses,TOTAL,4.0,0.0,0.0,0.0,0.0,27.0,166.0,4007.0,436.0,125.0,102.0,75.0,4942.0
Sagar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Sagar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,6.0,7.0,6.0,7.0,6.0,7.0,6.0,8.0,8.0,8.0,6.0,-1.0
Sagar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,7.0,7.0,8.0,5.0,4.0,8.0,9.0,10.0,10.0,9.0,7.0,9.0,-1.0
Sagar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1207.0,1349.0,1426.0,1594.0,1257.0,1300.0,1349.0,1400.0,1479.0,1408.0,1389.0,1523.0,-1.0
Sagar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,9.0,8.0,9.0,9.0,9.0,7.0,8.0,8.0,9.0,9.0,9.0,9.0,-1.0
Sagar,14.05,Number of RKS meetings held during the month,TOTAL,4.0,6.0,4.0,5.0,5.0,5.0,2.0,3.0,3.0,2.0,2.0,3.0,44.0
Sagar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,12.0,12.0,12.0,12.0,12.0,16.0,17.0,17.0,18.0,16.0,16.0,17.0,-1.0
Sagar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,47.0,68.0,76.0,32.0,26.0,69.0,66.0,77.0,73.0,73.0,231.0,236.0,1074.0
Sagar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,3.0,2.0,2.0,2.0,2.0,4.0,3.0,4.0,4.0,4.0,3.0,-1.0
Sagar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,8.0,4.0,4.0,3.0,4.0,3.0,3.0,3.0,3.0,4.0,5.0,-1.0
Sagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,459.0,511.0,552.0,422.0,513.0,527.0,602.0,431.0,330.0,454.0,428.0,371.0,5600.0
Sagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,722.0,886.0,1429.0,1109.0,846.0,1006.0,1090.0,894.0,841.0,710.0,612.0,638.0,10783.0
Sagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,346.0,548.0,474.0,492.0,545.0,499.0,533.0,438.0,293.0,374.0,439.0,410.0,5391.0
Sagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2472.0,2629.0,2921.0,3637.0,3918.0,4021.0,3511.0,4166.0,3730.0,3522.0,3307.0,3272.0,41106.0
Sagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,805.0,1059.0,1026.0,914.0,1058.0,1026.0,1135.0,869.0,623.0,828.0,867.0,781.0,10991.0
Sagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3194.0,3515.0,4350.0,4746.0,4764.0,5027.0,4601.0,5060.0,4571.0,4232.0,3919.0,3910.0,51889.0
Sagar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,6.0,11.0,19.0,10.0,20.0,14.0,14.0,19.0,10.0,10.0,7.0,5.0,145.0
Sagar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,11.0,21.0,15.0,22.0,13.0,14.0,16.0,16.0,12.0,12.0,9.0,167.0
Sagar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,12.0,22.0,40.0,25.0,42.0,27.0,28.0,35.0,26.0,22.0,19.0,14.0,312.0
Sagar,14.11,In-Patient Head Count at midnight,TOTAL,1412.0,1531.0,1613.0,1967.0,2505.0,2061.0,2615.0,2566.0,2218.0,1802.0,2112.0,2197.0,24599.0
Sagar,14.12.1,OPD attendance (All),TOTAL,55822.0,65626.0,69593.0,87255.0,92647.0,119838.0,95797.0,87954.0,78694.0,70812.0,92273.0,87191.0,1003502.0
Sagar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,77.0,101.0,4635.0,95.0,98.0,85.0,56.0,129.0,44.0,797.0,83.0,100.0,6300.0
Sagar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,1.0,0.0,2.0,0.0,4.0,3.0,1.0,2.0,3.0,15.0,17.0,48.0
Sagar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,249.0,254.0,238.0,329.0,312.0,591.0,490.0,782.0,536.0,657.0,443.0,199.0,5080.0
Sagar,14.14.a,Number of patients given AYUSH treatment,TOTAL,714.0,521.0,467.0,1111.0,718.0,782.0,2339.0,1763.0,2744.0,2371.0,1790.0,1542.0,16862.0
Sagar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,189.0,190.0,180.0,118.0,111.0,118.0,188.0,122.0,21.0,128.0,289.0,123.0,1777.0
Sagar,14.14.c,Number of Adolescents counselled,TOTAL,41.0,109.0,106.0,118.0,93.0,74.0,63.0,61.0,60.0,70.0,77.0,76.0,948.0
Sagar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6629.0,7785.0,8466.0,9736.0,7932.0,10538.0,9653.0,10061.0,9649.0,8609.0,9837.0,10331.0,109226.0
Sagar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,366.0,442.0,379.0,508.0,288.0,378.0,336.0,346.0,303.0,274.0,378.0,876.0,4874.0
Sagar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,496.0,319.0,464.0,843.0,578.0,555.0,333.0,480.0,521.0,483.0,584.0,439.0,6095.0
Sagar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,5.0,4.0,5.0,3.0,5.0,3.0,6.0,4.0,1.0,3.0,1.0,4.0,44.0
Sagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,264.0,273.0,213.0,278.0,271.0,477.0,184.0,377.0,313.0,190.0,395.0,351.0,3586.0
Sagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,6.0,0.0,1.0,1.0,1.0,2.0,2.0,1.0,0.0,1.0,1.0,2.0,18.0
Sagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1351.0,1695.0,1848.0,1861.0,1540.0,2173.0,1587.0,1977.0,1795.0,1026.0,1374.0,967.0,19194.0
Sagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,311.0,3.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,317.0
Sagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2111.0,2287.0,2525.0,2982.0,2389.0,3205.0,2104.0,2834.0,2629.0,1699.0,2353.0,1757.0,28875.0
Sagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,11.0,4.0,317.0,7.0,6.0,5.0,9.0,6.0,1.0,5.0,2.0,6.0,379.0
Sagar,15.2,Number of Widal tests conducted,Number tested,857.0,772.0,1029.0,1296.0,1857.0,3281.0,2250.0,1425.0,786.0,585.0,1048.0,1400.0,16586.0
Sagar,15.3.a,Number of VDRL tests conducted on males,Number tested,218.0,171.0,130.0,111.0,115.0,118.0,86.0,128.0,81.0,127.0,110.0,208.0,1603.0
Sagar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,319.0,331.0,447.0,465.0,336.0,471.0,285.0,392.0,230.0,242.0,301.0,248.0,4067.0
Sagar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,735.0,581.0,850.0,816.0,897.0,898.0,812.0,899.0,763.0,584.0,932.0,687.0,9454.0
Sagar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1272.0,1083.0,1427.0,1392.0,1348.0,1487.0,1183.0,1419.0,1074.0,953.0,1343.0,1143.0,15124.0
Sagar,15.4.1,Number of blood smears examined for Malaria,TOTAL,7625.0,7449.0,9356.0,13257.0,14627.0,12743.0,11508.0,9268.0,7069.0,8444.0,8883.0,12305.0,122534.0
Sagar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,34.0,41.0,73.0,93.0,349.0,397.0,127.0,97.0,58.0,45.0,26.0,22.0,1362.0
Sagar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,1.0,2.0,14.0,16.0,23.0,17.0,21.0,11.0,4.0,5.0,1.0,117.0
Sagar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,43000.0,33000.0,,76000.0
Sagar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,0.0,0.0,,0.0
Sagar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,0.0,0.0,,0.0
Sagar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,10000.0,14500.0,,24500.0
Sagar,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,33000.0,18500.0,0.0,51500.0
Sagar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,15500.0,26500.0,,42000.0
Sagar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,0.0,10000.0,,10000.0
Sagar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,0.0,0.0,,0.0
Sagar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,8000.0,11500.0,,19500.0
Sagar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7500.0,25000.0,0.0,32500.0
Sagar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,900.0,0.0,,900.0
Sagar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,2000.0,513000.0,,515000.0
Sagar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,0.0,0.0,,0.0
Sagar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,900.0,508000.0,,508900.0
Sagar,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,5000.0,0.0,7000.0
Sagar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,10500.0,4000.0,,14500.0
Sagar,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,2500.0,15000.0,,17500.0
Sagar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,0.0,500.0,,500.0
Sagar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,9000.0,17000.0,,26000.0
Sagar,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0,1500.0,0.0,5500.0
Sagar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sagar,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Sagar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sagar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sagar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,10800.0,14800.0,,25600.0
Sagar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,10000.0,0.0,,10000.0
Sagar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,0.0,500.0,,500.0
Sagar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,6000.0,9800.0,,15800.0
Sagar,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14800.0,4500.0,0.0,19300.0
Sagar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,9400.0,5900.0,,15300.0
Sagar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,5000.0,5000.0,,10000.0
Sagar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,0.0,0.0,,0.0
Sagar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,8500.0,10500.0,,19000.0
Sagar,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5900.0,400.0,0.0,6300.0
Sagar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sagar,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Sagar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sagar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sagar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,14500.0,11000.0,,25500.0
Sagar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,0.0,10000.0,,10000.0
Sagar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,0.0,0.0,,0.0
Sagar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,8500.0,12500.0,,21000.0
Sagar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,8500.0,0.0,14500.0
Sagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,2250.0,1250.0,,3500.0
Sagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,0.0,0.0,,0.0
Sagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,0.0,0.0,,0.0
Sagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,1000.0,0.0,,1000.0
Sagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1250.0,1250.0,0.0,2500.0
Sagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,152510.0,207890.0,,360400.0
Sagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,100800.0,0.0,,100800.0
Sagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,0.0,0.0,,0.0
Sagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,45360.0,95760.0,,141120.0
Sagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,207950.0,112130.0,0.0,320080.0
Sagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,23000.0,17000.0,,40000.0
Sagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,0.0,0.0,,0.0
Sagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,0.0,0.0,,0.0
Sagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,6000.0,13000.0,,19000.0
Sagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17000.0,4000.0,0.0,21000.0
Sagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,0.0,13500.0,,13500.0
Sagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,19500.0,0.0,,19500.0
Sagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,0.0,0.0,,0.0
Sagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,6000.0,11000.0,,17000.0
Sagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13500.0,2500.0,0.0,16000.0
Sagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Sagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Sagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Sagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Sagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Sagar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Sagar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Sagar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Sagar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Sagar,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Sagar,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Sagar,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Sagar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Sagar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Sagar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Sagar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Sagar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Sagar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Sagar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Sagar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Sagar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Sagar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Sagar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Sagar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Sagar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Sagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Sagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Sagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Sagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Sagar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Sagar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Sagar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Sagar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Sagar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Sagar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Sagar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Sagar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Sagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Sagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Sagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Sagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Sagar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Sagar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Sagar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Sagar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Sagar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Sagar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Sagar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Sagar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,1300.0,6500.0,,7800.0
Sagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,6000.0,0.0,,6000.0
Sagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,0.0,0.0,,0.0
Sagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,800.0,5200.0,,6000.0
Sagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6500.0,1300.0,0.0,7800.0
Sagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,656000.0,534800.0,,1190800.0
Sagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,0.0,0.0,,0.0
Sagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,0.0,10000.0,,10000.0
Sagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,121200.0,62000.0,,183200.0
Sagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,534800.0,462800.0,0.0,997600.0
Sagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,1000.0,4300.0,,5300.0
Sagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,4000.0,0.0,,4000.0
Sagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,0.0,0.0,,0.0
Sagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,700.0,2700.0,,3400.0
Sagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4300.0,1600.0,0.0,5900.0
Sagar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,4.0,2.0,3.0,7.0,1.0,10.0,4.0,3.0,2.0,3.0,39.0
Sagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,1.0,,,,,1.0,,,,1.0,1.0,4.0
Sagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,1.0,1.0
Sagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,1.0,,,,,1.0,,,,1.0,2.0,5.0
Sagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,1.0,,1.0
Sagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,1.0,,1.0
Sagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,2.0,3.0,1.0,2.0,4.0,4.0,9.0,8.0,8.0,5.0,8.0,54.0
Sagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,1.0,,,,,,,1.0,,2.0
Sagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,2.0,3.0,2.0,2.0,4.0,4.0,9.0,8.0,8.0,6.0,8.0,56.0
Sagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,2.0,5.0,,5.0,6.0,14.0,10.0,18.0,12.0,4.0,9.0,88.0
Sagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,1.0,3.0,5.0
Sagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,3.0,5.0,,5.0,6.0,14.0,10.0,18.0,12.0,5.0,12.0,93.0
Sagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,,,,,1.0,,,,,,2.0
Sagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,,,,,1.0,,,,,,2.0
Sagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,1.0,,,,,,,,,,,1.0
Sagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
Sagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,1.0,,,1.0,,,,,,,,2.0
Sagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,2.0,,2.0,1.0,,,5.0
Sagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,1.0,,,,2.0,1.0,2.0,1.0,,7.0
Sagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,1.0,,,2.0,2.0,3.0,3.0,1.0,,12.0
Sagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Sagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,2.0,2.0,2.0,4.0,6.0,3.0,6.0,7.0,7.0,5.0,9.0,55.0
Sagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,4.0,2.0,3.0,,3.0,2.0,7.0,2.0,5.0,6.0,5.0,39.0
Sagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,6.0,4.0,5.0,4.0,9.0,5.0,13.0,9.0,12.0,11.0,14.0,94.0
Sagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Sagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Sagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Sagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Sagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Sagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,2.0,2.0,1.0,2.0,1.0,,2.0,2.0,12.0
Sagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Sagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,1.0,,2.0,2.0,1.0,2.0,1.0,,2.0,2.0,13.0
Sagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Sagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,,,,,,,,,,,1.0
Sagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,1.0,,2.0,,,,,1.0,4.0
Sagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,,,,1.0,,2.0,,,,,1.0,5.0
Sagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Sagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Sagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Sagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,1.0,,,,,,,,,1.0
Sagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,2.0,,,,,,,,2.0
Sagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Sagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Sagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,1.0,3.0,,,,,,,,4.0
Sagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Sagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Sagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Sagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Sagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Sagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,1.0,3.0,5.0,6.0,6.0,3.0,1.0,5.0,1.0,1.0,32.0
Sagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,1.0,2.0,5.0,1.0,2.0,2.0,5.0,2.0,1.0,3.0,3.0,27.0
Sagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,1.0,3.0,8.0,6.0,8.0,8.0,8.0,3.0,6.0,4.0,4.0,59.0
Sagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Sagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,2.0,,,,1.0,1.0,,,1.0,1.0,1.0,7.0
Sagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,,,,,,1.0,1.0,2.0,,1.0,1.0,7.0
Sagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,2.0,,,,1.0,2.0,1.0,2.0,1.0,2.0,2.0,14.0
Sagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Sagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Sagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Sagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Sagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Sagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Sagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Sagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Sagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Sagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Sagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Sagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,1.0,,,,,,,1.0
Sagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Sagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Sagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Sagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Sagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Sagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Sagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Sagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Sagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Sagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,1.0,2.0,,,2.0,,,,5.0
Sagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Sagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,1.0,2.0,,,2.0,,,,5.0
Sagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,2.0,,1.0,3.0,1.0,,1.0,,,,,,8.0
Sagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,2.0,2.0,9.0,2.0,4.0,9.0,2.0,3.0,3.0,1.0,5.0,44.0
Sagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,1.0,1.0,1.0,2.0,,,,2.0,7.0
Sagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,2.0,3.0,12.0,4.0,5.0,11.0,4.0,3.0,3.0,1.0,7.0,59.0
Sagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Sagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,3.0,5.0,2.0,3.0,5.0,2.0,4.0,2.0,1.0,1.0,2.0,30.0
Sagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,1.0,,2.0,,1.0,1.0,5.0
Sagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,3.0,5.0,2.0,3.0,5.0,3.0,4.0,4.0,2.0,2.0,3.0,36.0
Sagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,2.0,,1.0,2.0,,,,,5.0
Sagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,,1.0,1.0,4.0,1.0,,,,,,8.0
Sagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Sagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,,1.0,3.0,5.0,2.0,2.0,,,,,14.0
Sagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,1.0,,1.0,,,,,,2.0
Sagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,1.0,2.0,,1.0,5.0,1.0,1.0,2.0,,,3.0,17.0
Sagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,1.0,3.0,,1.0,2.0,4.0,2.0,5.0,1.0,4.0,,23.0
Sagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,2.0,5.0,,3.0,7.0,6.0,3.0,7.0,1.0,4.0,3.0,42.0
Sagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Sagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,1.0,,2.0,1.0,,,,,,,1.0,5.0
Sagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,3.0,3.0,1.0,10.0,1.0,5.0,,,1.0,3.0,,,27.0
Sagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,3.0,4.0,1.0,12.0,2.0,5.0,,,1.0,3.0,,1.0,32.0
Sagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,2.0,,2.0,2.0,1.0,2.0,2.0,1.0,,,1.0,14.0
Sagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,10.0,7.0,1.0,10.0,5.0,8.0,13.0,9.0,16.0,5.0,2.0,87.0
Sagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,19.0,13.0,20.0,19.0,39.0,22.0,13.0,40.0,32.0,31.0,34.0,21.0,303.0
Sagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,21.0,25.0,27.0,22.0,51.0,28.0,23.0,55.0,42.0,47.0,39.0,24.0,404.0
Satna,1.1,Total number of pregnant women Registered for ANC,TOTAL,4530.0,4786.0,5859.0,6619.0,5041.0,5576.0,4730.0,4309.0,4187.0,4635.0,5237.0,5612.0,61121.0
Satna,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2271.0,2374.0,2812.0,3156.0,2532.0,2841.0,2506.0,2469.0,2488.0,2962.0,3217.0,3171.0,32799.0
Satna,1.2,Number of Pregnant women registered under JSY,TOTAL,4422.0,4660.0,5687.0,6482.0,4969.0,5446.0,4411.0,4271.0,4125.0,4548.0,4903.0,5049.0,58973.0
Satna,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4788.0,4021.0,4761.0,5438.0,5603.0,5455.0,4922.0,4418.0,4454.0,4079.0,4160.0,4506.0,56605.0
Satna,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4121.0,3960.0,4922.0,5809.0,4423.0,4753.0,4135.0,3863.0,3478.0,3833.0,4330.0,4757.0,52384.0
Satna,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4077.0,3557.0,4510.0,5189.0,5093.0,4527.0,4557.0,4202.0,3613.0,3539.0,3860.0,4609.0,51333.0
Satna,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4557.0,4708.0,6169.0,6337.0,4774.0,5168.0,4803.0,4362.0,4142.0,4556.0,5130.0,5380.0,60086.0
Satna,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,168.0,209.0,374.0,169.0,232.0,218.0,160.0,175.0,187.0,176.0,124.0,276.0,2468.0
Satna,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,5.0,7.0,12.0,8.0,4.0,8.0,10.0,9.0,8.0,5.0,6.0,7.0,89.0
Satna,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1471.0,1634.0,1988.0,2187.0,2386.0,2387.0,2093.0,2319.0,2136.0,1735.0,2024.0,2154.0,24514.0
Satna,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,35.0,63.0,65.0,34.0,69.0,86.0,103.0,334.0,52.0,30.0,17.0,21.0,909.0
Satna,1.8,Number of pregnancy test kits used at SC level,TOTAL,608.0,705.0,882.0,572.0,903.0,1166.0,1026.0,819.0,920.0,1106.0,1632.0,1468.0,11807.0
Satna,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,34.0,82.0,61.0,102.0,124.0,61.0,96.0,120.0,115.0,86.0,75.0,77.0,1033.0
Satna,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,235.0,209.0,315.0,340.0,535.0,716.0,471.0,391.0,341.0,342.0,236.0,254.0,4385.0
Satna,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,269.0,291.0,376.0,442.0,659.0,777.0,567.0,511.0,456.0,428.0,311.0,331.0,5418.0
Satna,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,147.0,195.0,231.0,265.0,393.0,374.0,342.0,366.0,274.0,259.0,217.0,193.0,3256.0
Satna,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,6.0,0.0,35.0,4.0,6.0,4.0,9.0,1.0,5.0,8.0,2.0,14.0,94.0
Satna,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1836.0,1681.0,1975.0,2457.0,3635.0,3725.0,3065.0,2856.0,2680.0,2696.0,2388.0,2378.0,31372.0
Satna,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,307.0,168.0,171.0,192.0,236.0,153.0,112.0,165.0,193.0,76.0,192.0,78.0,2043.0
Satna,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1147.0,1393.0,1606.0,2020.0,2726.0,3154.0,2610.0,2674.0,2500.0,2625.0,2350.0,2177.0,26982.0
Satna,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,552.0,802.0,934.0,1469.0,1852.0,1999.0,1868.0,1683.0,1543.0,1684.0,1577.0,1543.0,17506.0
Satna,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,6.0,6.0,0.0,41.0,55.0,0.0,10.0,25.0,2.0,0.0,2.0,147.0
Satna,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,131.0,159.0,166.0,150.0,280.0,241.0,239.0,156.0,163.0,84.0,83.0,96.0,1948.0
Satna,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,114.0,89.0,84.0,103.0,126.0,123.0,119.0,148.0,144.0,194.0,181.0,198.0,1623.0
Satna,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Satna,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,114.0,89.0,84.0,103.0,126.0,123.0,119.0,148.0,144.0,194.0,181.0,198.0,1623.0
Satna,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,59.0,57.0,39.0,51.0,62.0,89.0,109.0,78.0,74.0,52.0,38.0,63.0,771.0
Satna,4.1.1.a,Number of male live births,TOTAL,1134.0,1115.0,1319.0,1615.0,2327.0,2412.0,1989.0,1745.0,1655.0,1663.0,1433.0,1432.0,19839.0
Satna,4.1.1.b,Number of female live births,TOTAL,1067.0,960.0,1176.0,1389.0,2188.0,2245.0,1828.0,1737.0,1589.0,1511.0,1314.0,1342.0,18346.0
Satna,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2201.0,2075.0,2495.0,3004.0,4515.0,4657.0,3817.0,3482.0,3244.0,3174.0,2747.0,2774.0,38185.0
Satna,4.1.2,Number of still births,TOTAL,45.0,72.0,64.0,83.0,66.0,109.0,80.0,61.0,59.0,45.0,52.0,50.0,786.0
Satna,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,238.0,210.0,336.0,316.0,332.0,324.0,278.0,268.0,314.0,315.0,293.0,349.0,3573.0
Satna,4.2.1,Number of Newborns weighed at birth,TOTAL,2064.0,1972.0,2343.0,2810.0,4092.0,4322.0,3538.0,3321.0,3103.0,3023.0,2576.0,2616.0,35780.0
Satna,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,304.0,298.0,350.0,424.0,688.0,829.0,590.0,670.0,596.0,459.0,497.0,299.0,6004.0
Satna,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2047.0,1902.0,2240.0,2683.0,4058.0,4298.0,3491.0,3334.0,3049.0,2829.0,2603.0,2545.0,35079.0
Satna,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,21.0,29.0,60.0,64.0,90.0,24.0,29.0,63.0,67.0,57.0,30.0,31.0,565.0
Satna,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,95.0,117.0,65.0,60.0,70.0,104.0,119.0,82.0,55.0,56.0,64.0,51.0,938.0
Satna,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,94.0,144.0,141.0,182.0,227.0,264.0,173.0,151.0,168.0,147.0,110.0,130.0,1931.0
Satna,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Satna,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,210.0,290.0,266.0,306.0,387.0,392.0,321.0,296.0,290.0,260.0,204.0,212.0,3434.0
Satna,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,36.0,18.0,28.0,70.0,73.0,90.0,50.0,60.0,21.0,0.0,0.0,8.0,454.0
Satna,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,203.0,260.0,232.0,329.0,389.0,348.0,363.0,325.0,240.0,238.0,168.0,200.0,3295.0
Satna,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,21.0,49.0,31.0,63.0,222.0,177.0,84.0,54.0,55.0,49.0,34.0,37.0,876.0
Satna,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,96.0,169.0,225.0,316.0,234.0,238.0,251.0,265.0,232.0,181.0,175.0,180.0,2562.0
Satna,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,26.0,52.0,55.0,41.0,127.0,131.0,33.0,36.0,27.0,24.0,38.0,69.0,659.0
Satna,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1886.0,1764.0,2131.0,2568.0,3913.0,4038.0,3487.0,3175.0,2857.0,2858.0,2535.0,2318.0,33530.0
Satna,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1207.0,1034.0,1379.0,1422.0,1885.0,2114.0,1688.0,1978.0,2083.0,2116.0,1857.0,1705.0,20468.0
Satna,6.3,PNC maternal complications attended,TOTAL,22.0,42.0,55.0,107.0,115.0,195.0,256.0,212.0,102.0,60.0,45.0,41.0,1252.0
Satna,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,100.0,110.0,137.0,119.0,105.0,92.0,108.0,94.0,117.0,130.0,164.0,152.0,1428.0
Satna,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,8.0,5.0,15.0,12.0,19.0,13.0,13.0,11.0,33.0,43.0,5.0,4.0,181.0
Satna,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,108.0,115.0,152.0,131.0,124.0,105.0,121.0,105.0,150.0,173.0,169.0,156.0,1609.0
Satna,7.2,Number of MTPs conducted at Private Facilities,TOTAL,5.0,7.0,22.0,4.0,20.0,15.0,13.0,7.0,12.0,5.0,5.0,20.0,135.0
Satna,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,182.0,307.0,326.0,323.0,418.0,411.0,585.0,141.0,340.0,296.0,853.0,928.0,5110.0
Satna,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,471.0,424.0,366.0,499.0,348.0,330.0,736.0,374.0,600.0,381.0,1028.0,1276.0,6833.0
Satna,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,653.0,731.0,692.0,822.0,766.0,741.0,1321.0,515.0,940.0,677.0,1881.0,2204.0,11943.0
Satna,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,0.0,21.0
Satna,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,21.0,28.0,21.0,13.0,11.0,1.0,95.0
Satna,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,2.0,14.0,8.0,13.0,21.0,57.0,131.0,52.0,15.0,9.0,322.0
Satna,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,2.0,3.0,3.0,1.0,9.0,6.0,24.0,64.0,28.0,16.0,13.0,171.0
Satna,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Satna,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,2.0,5.0,17.0,9.0,22.0,48.0,109.0,216.0,93.0,42.0,23.0,588.0
Satna,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,,0.0
Satna,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,3.0,18.0,198.0,828.0,735.0,300.0,169.0,7.0,2258.0
Satna,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,12.0,9.0,20.0,85.0,52.0,95.0,549.0,1136.0,1212.0,527.0,311.0,100.0,4108.0
Satna,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,16.0,10.0,10.0,24.0,11.0,37.0,98.0,490.0,589.0,293.0,189.0,47.0,1814.0
Satna,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Satna,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,28.0,19.0,30.0,109.0,66.0,150.0,845.0,2454.0,2536.0,1120.0,669.0,154.0,8180.0
Satna,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0
Satna,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,7.0,12.0,11.0,11.0,10.0,10.0,9.0,19.0,16.0,7.0,11.0,24.0,147.0
Satna,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Satna,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,7.0,12.0,11.0,11.0,10.0,10.0,9.0,19.0,16.0,7.0,11.0,24.0,147.0
Satna,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0
Satna,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Satna,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,13.0,30.0,12.0,13.0,17.0,22.0,20.0,54.0,71.0,60.0,43.0,81.0,436.0
Satna,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Satna,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,13.0,30.0,12.0,13.0,17.0,22.0,20.0,55.0,71.0,60.0,43.0,81.0,437.0
Satna,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,3.0,3.0
Satna,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,344.0,372.0,329.0,592.0,548.0,473.0,486.0,490.0,532.0,548.0,496.0,381.0,5591.0
Satna,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,13.0,3.0,16.0,25.0,26.0,27.0,16.0,21.0,83.0,65.0,121.0,150.0,566.0
Satna,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,120.0,80.0,86.0,63.0,101.0,36.0,47.0,68.0,58.0,159.0,271.0,128.0,1217.0
Satna,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,228.0,160.0,290.0,214.0,129.0,442.0,355.0,374.0,422.0,581.0,399.0,547.0,4141.0
Satna,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Satna,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,705.0,615.0,721.0,894.0,804.0,978.0,904.0,953.0,1095.0,1353.0,1287.0,1206.0,11515.0
Satna,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,256.0,190.0,368.0,246.0,191.0,448.0,399.0,471.0,505.0,539.0,674.0,715.0,5002.0
Satna,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,11.0,3.0,0.0,,2.0,,,0.0,0.0,4.0,0.0,2.0,22.0
Satna,9.06,Number of IUCD removals,TOTAL,390.0,343.0,226.0,328.0,319.0,394.0,406.0,459.0,931.0,439.0,701.0,411.0,5347.0
Satna,9.07,Number of Oral Pills cycles distributed,TOTAL,1692.0,1747.0,1113.0,1039.0,1720.0,3317.0,4101.0,5319.0,5408.0,5495.0,5211.0,5513.0,41675.0
Satna,9.08,Number of Condom pieces distributed,TOTAL,9053.0,8142.0,4198.0,8304.0,4649.0,13197.0,10938.0,15442.0,21316.0,25798.0,22238.0,19864.0,163139.0
Satna,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,29.0,31.0,33.0,16.0,23.0,12.0,20.0,38.0,53.0,57.0,192.0,33.0,537.0
Satna,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,1.0,1.0,0.0,0.0,0.0,1.0,2.0,9.0,8.0,11.0,3.0,0.0,36.0
Satna,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,3.0,7.0,1.0,1.0,8.0,15.0,36.0,18.0,9.0,19.0,2.0,119.0
Satna,9.11.2.a,Number of failures following male sterilization,TOTAL,2.0,2.0,1.0,1.0,0.0,0.0,0.0,1.0,4.0,0.0,0.0,0.0,11.0
Satna,9.11.2.b,Number of failures following female sterilization,TOTAL,8.0,6.0,4.0,5.0,4.0,13.0,5.0,7.0,4.0,8.0,5.0,5.0,74.0
Satna,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,9.12,Number of Institutions having NSV trained doctors,TOTAL,14.0,16.0,22.0,26.0,21.0,23.0,17.0,23.0,23.0,29.0,20.0,27.0,-1.0
Satna,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2166.0,2269.0,2602.0,3013.0,4061.0,4589.0,3802.0,3445.0,3128.0,3180.0,2843.0,2943.0,38041.0
Satna,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3197.0,3138.0,3552.0,3618.0,3699.0,4230.0,4522.0,1259.0,434.0,390.0,113.0,191.0,28343.0
Satna,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3656.0,3159.0,3543.0,3817.0,3599.0,3698.0,3792.0,4480.0,1855.0,775.0,484.0,368.0,33226.0
Satna,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3652.0,3476.0,3560.0,3853.0,3682.0,3691.0,3433.0,3784.0,4270.0,1784.0,1108.0,650.0,36943.0
Satna,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,22.0,3038.0,3480.0,3368.0,3911.0,3825.0,17644.0
Satna,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2468.0,3111.0,3659.0,3852.0,13090.0
Satna,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2182.0,3280.0,3619.0,9081.0
Satna,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1699.0,1821.0,2103.0,2380.0,3516.0,3839.0,3031.0,2215.0,2330.0,2540.0,2357.0,2513.0,30344.0
Satna,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2999.0,3034.0,3469.0,3616.0,3085.0,3799.0,3862.0,1802.0,3370.0,3823.0,3805.0,3938.0,40602.0
Satna,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3391.0,3087.0,3514.0,3727.0,3021.0,3332.0,3246.0,1911.0,3272.0,3826.0,3848.0,4042.0,40217.0
Satna,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3375.0,3430.0,3568.0,3746.0,3112.0,3395.0,2948.0,1692.0,3428.0,3569.0,3916.0,4036.0,40215.0
Satna,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1667.0,1711.0,1941.0,2283.0,3397.0,3772.0,2592.0,2472.0,2468.0,2252.0,2061.0,2195.0,28811.0
Satna,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2883.0,2792.0,3038.0,3049.0,3382.0,3934.0,4702.0,1317.0,389.0,275.0,179.0,166.0,26106.0
Satna,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,3632.0,3052.0,3192.0,3374.0,3589.0,3794.0,3816.0,4462.0,1915.0,720.0,522.0,316.0,32384.0
Satna,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3649.0,3367.0,3240.0,3392.0,3720.0,3718.0,3527.0,3831.0,4231.0,1761.0,1170.0,591.0,36197.0
Satna,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2947.0,3462.0,4322.0,4980.0,4156.0,4504.0,3941.0,3168.0,3308.0,3094.0,3967.0,3593.0,45442.0
Satna,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2215.0,2250.0,2673.0,3097.0,2635.0,2549.0,2548.0,2383.0,2601.0,3136.0,3565.0,3505.0,33157.0
Satna,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1488.0,1665.0,2111.0,2443.0,2071.0,2242.0,1982.0,1618.0,1642.0,1468.0,2002.0,1779.0,22511.0
Satna,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1331.0,1541.0,1871.0,2192.0,1843.0,1990.0,1731.0,1403.0,1444.0,1368.0,1764.0,1602.0,20080.0
Satna,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2819.0,3206.0,3982.0,4635.0,3914.0,4232.0,3713.0,3021.0,3086.0,2836.0,3766.0,3381.0,42591.0
Satna,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2994.0,2818.0,3284.0,3757.0,3110.0,3061.0,2993.0,2884.0,3168.0,3687.0,3764.0,3876.0,39396.0
Satna,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2824.0,2768.0,3249.0,3639.0,2706.0,2763.0,2475.0,1347.0,2674.0,3431.0,3559.0,3768.0,35203.0
Satna,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,425.0,261.0,285.0,422.0,369.0,521.0,433.0,385.0,434.0,437.0,434.0,584.0,4990.0
Satna,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,386.0,235.0,279.0,365.0,334.0,452.0,355.0,337.0,377.0,405.0,422.0,521.0,4468.0
Satna,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,811.0,496.0,564.0,787.0,703.0,973.0,788.0,722.0,811.0,842.0,856.0,1105.0,9458.0
Satna,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1771.0,1871.0,2068.0,2976.0,2583.0,2447.0,2363.0,2213.0,2571.0,2927.0,2784.0,2925.0,29499.0
Satna,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2084.0,2131.0,2534.0,3283.0,2965.0,2935.0,2597.0,2650.0,2840.0,2589.0,2876.0,2935.0,32419.0
Satna,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2132.0,2034.0,2769.0,3090.0,3092.0,3140.0,2778.0,2905.0,2978.0,2611.0,2905.0,3165.0,33599.0
Satna,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,9.0,10.0,2.0,2.0,1.0,1.0,0.0,5.0,1.0,0.0,2.0,33.0
Satna,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,0.0,5.0,1.0,4.0,5.0,5.0,4.0,1.0,4.0,8.0,20.0,59.0
Satna,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1792.0,1805.0,1876.0,1823.0,1812.0,1833.0,1819.0,1845.0,1894.0,1876.0,1843.0,1848.0,22066.0
Satna,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1722.0,1706.0,1825.0,1790.0,1770.0,1795.0,1756.0,1806.0,1851.0,1812.0,1802.0,1801.0,21436.0
Satna,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1559.0,1489.0,1522.0,1586.0,1580.0,1622.0,1509.0,1634.0,1648.0,1598.0,1626.0,1601.0,18974.0
Satna,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2719.0,3230.0,4062.0,5478.0,4322.0,4309.0,3670.0,2916.0,3180.0,6455.0,3647.0,3278.0,47266.0
Satna,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1451.0,1530.0,1890.0,19317.0,8850.0,1589.0,1451.0,1467.0,2364.0,24476.0,3955.0,1778.0,70118.0
Satna,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,677.0,673.0,1309.0,19821.0,7566.0,948.0,814.0,774.0,1713.0,23555.0,2701.0,876.0,61427.0
Satna,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,1.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,4.0
Satna,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,10.0,17.0,19.0,20.0,5.0,6.0,0.0,3.0,11.0,3.0,0.0,0.0,94.0
Satna,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,600.0,828.0,947.0,1290.0,1472.0,963.0,877.0,645.0,554.0,496.0,707.0,838.0,10217.0
Satna,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,79.0,108.0,223.0,435.0,269.0,226.0,151.0,61.0,61.0,70.0,129.0,133.0,1945.0
Satna,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,23.0,45.0,48.0,52.0,34.0,56.0,95.0,24.0,189.0,92.0,142.0,122.0,922.0
Satna,13.1,Number of Patients operated for cataract,TOTAL,47.0,13.0,28.0,56.0,88.0,138.0,137.0,305.0,255.0,339.0,176.0,120.0,1702.0
Satna,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,29.0,13.0,28.0,56.0,88.0,129.0,100.0,327.0,212.0,284.0,139.0,53.0,1458.0
Satna,13.3,Number of School children detected with Refractive errors,TOTAL,76.0,94.0,27.0,143.0,368.0,1894.0,605.0,1295.0,1184.0,675.0,872.0,319.0,7552.0
Satna,13.4,Number of children provided free glasses,TOTAL,55.0,75.0,12.0,42.0,209.0,486.0,9.0,867.0,1128.0,401.0,1208.0,392.0,4884.0
Satna,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,6.0,7.0,7.0,6.0,5.0,7.0,7.0,8.0,8.0,5.0,8.0,-1.0
Satna,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,14.0,11.0,17.0,20.0,14.0,14.0,11.0,15.0,14.0,20.0,10.0,17.0,-1.0
Satna,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1472.0,1389.0,1561.0,1538.0,1418.0,1462.0,1416.0,1484.0,1439.0,1383.0,1497.0,1499.0,-1.0
Satna,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,12.0,12.0,12.0,11.0,10.0,12.0,12.0,12.0,12.0,12.0,11.0,11.0,-1.0
Satna,14.05,Number of RKS meetings held during the month,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,4.0,1.0,1.0,1.0,1.0,15.0
Satna,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,21.0,26.0,31.0,33.0,25.0,24.0,25.0,28.0,24.0,30.0,20.0,29.0,-1.0
Satna,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,140.0,623.0,430.0,407.0,360.0,556.0,592.0,424.0,706.0,628.0,648.0,537.0,6051.0
Satna,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,9.0,8.0,6.0,8.0,9.0,8.0,6.0,7.0,7.0,9.0,5.0,5.0,-1.0
Satna,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,2.0,0.0,4.0,1.0,3.0,2.0,0.0,25.0,1.0,0.0,-1.0
Satna,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,635.0,836.0,912.0,1208.0,1089.0,1637.0,951.0,625.0,426.0,410.0,705.0,616.0,10050.0
Satna,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1539.0,2267.0,2622.0,2347.0,2872.0,4169.0,3719.0,2177.0,1611.0,1676.0,1945.0,1994.0,28938.0
Satna,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,568.0,936.0,1082.0,982.0,1391.0,927.0,801.0,632.0,453.0,366.0,592.0,590.0,9320.0
Satna,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2798.0,3659.0,4177.0,4901.0,3782.0,4508.0,4498.0,5336.0,3720.0,4422.0,4887.0,4873.0,51561.0
Satna,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1203.0,1772.0,1994.0,2190.0,2480.0,2564.0,1752.0,1257.0,879.0,776.0,1297.0,1206.0,19370.0
Satna,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4337.0,5926.0,6799.0,7248.0,6654.0,8677.0,8217.0,7513.0,5331.0,6098.0,6832.0,6867.0,80499.0
Satna,14.10.2.a,Number of death cases of Inpatient males,TOTAL,93.0,81.0,110.0,67.0,72.0,76.0,97.0,71.0,40.0,81.0,58.0,73.0,919.0
Satna,14.10.2.b,Number of death cases of Inpatient females,TOTAL,48.0,80.0,70.0,73.0,67.0,58.0,66.0,64.0,37.0,29.0,40.0,65.0,697.0
Satna,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,141.0,161.0,180.0,140.0,139.0,134.0,163.0,135.0,77.0,110.0,98.0,138.0,1616.0
Satna,14.11,In-Patient Head Count at midnight,TOTAL,9718.0,10098.0,12009.0,10151.0,9287.0,10217.0,19938.0,24907.0,19369.0,17666.0,18828.0,17663.0,179851.0
Satna,14.12.1,OPD attendance (All),TOTAL,80464.0,84057.0,102919.0,120374.0,119997.0,136470.0,97757.0,103307.0,83991.0,80547.0,119978.0,104839.0,1234700.0
Satna,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,643.0,739.0,641.0,518.0,532.0,425.0,525.0,539.0,446.0,421.0,3296.0,536.0,9261.0
Satna,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,6.0,10.0,8.0,8.0,25.0,20.0,32.0,32.0,88.0,18.0,37.0,10.0,294.0
Satna,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2129.0,2249.0,2352.0,2015.0,2418.0,2726.0,1707.0,1609.0,2152.0,1353.0,1685.0,1477.0,23872.0
Satna,14.14.a,Number of patients given AYUSH treatment,TOTAL,1989.0,4111.0,4843.0,2903.0,2513.0,7442.0,5905.0,5120.0,4364.0,3747.0,2882.0,2805.0,48624.0
Satna,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,940.0,2042.0,1391.0,1795.0,1892.0,1870.0,1742.0,1708.0,960.0,1249.0,1402.0,1469.0,18460.0
Satna,14.14.c,Number of Adolescents counselled,TOTAL,321.0,274.0,375.0,420.0,1415.0,404.0,322.0,496.0,305.0,271.0,474.0,384.0,5461.0
Satna,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,8279.0,9269.0,9761.0,10646.0,9229.0,12132.0,10542.0,11654.0,9964.0,9341.0,9177.0,9578.0,119572.0
Satna,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,175.0,174.0,283.0,216.0,261.0,424.0,441.0,362.0,308.0,208.0,158.0,147.0,3157.0
Satna,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,440.0,668.0,389.0,350.0,487.0,468.0,425.0,444.0,581.0,421.0,320.0,385.0,5378.0
Satna,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,2.0,7.0,2.0,4.0,4.0,2.0,4.0,8.0,3.0,3.0,3.0,43.0
Satna,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,606.0,661.0,504.0,391.0,377.0,352.0,411.0,363.0,480.0,436.0,434.0,468.0,5483.0
Satna,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,4.0,0.0,2.0,1.0,0.0,1.0,3.0,7.0,1.0,4.0,3.0,28.0
Satna,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,813.0,1043.0,1464.0,1369.0,970.0,1239.0,926.0,1085.0,1143.0,740.0,976.0,891.0,12659.0
Satna,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,1.0,24.0,12.0,42.0
Satna,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1859.0,2372.0,2357.0,2110.0,1834.0,2059.0,1762.0,1892.0,2204.0,1597.0,1730.0,1744.0,23520.0
Satna,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,4.0,6.0,7.0,5.0,6.0,5.0,3.0,8.0,15.0,5.0,31.0,18.0,113.0
Satna,15.2,Number of Widal tests conducted,Number tested,449.0,1069.0,855.0,1100.0,877.0,1965.0,800.0,1232.0,1056.0,1023.0,1117.0,1295.0,12838.0
Satna,15.3.a,Number of VDRL tests conducted on males,Number tested,292.0,309.0,316.0,229.0,586.0,460.0,366.0,397.0,362.0,329.0,296.0,242.0,4184.0
Satna,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,383.0,381.0,299.0,347.0,244.0,370.0,458.0,441.0,606.0,394.0,398.0,375.0,4696.0
Satna,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,547.0,811.0,1112.0,785.0,693.0,862.0,660.0,641.0,752.0,962.0,924.0,890.0,9639.0
Satna,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1222.0,1501.0,1727.0,1361.0,1523.0,1692.0,1484.0,1479.0,1720.0,1685.0,1618.0,1507.0,18519.0
Satna,15.4.1,Number of blood smears examined for Malaria,TOTAL,6972.0,6031.0,6108.0,9488.0,10920.0,10910.0,11849.0,11847.0,8549.0,5788.0,5505.0,6867.0,100834.0
Satna,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,46.0,75.0,103.0,180.0,138.0,225.0,265.0,128.0,56.0,28.0,37.0,27.0,1308.0
Satna,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,19.0,1.0,20.0,22.0,18.0,32.0,51.0,49.0,32.0,6.0,11.0,12.0,273.0
Satna,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,5500.0,,26000.0,,,,8000.0,6250.0,,,9750.0,55500.0
Satna,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,25000.0,,10000.0,,,,15000.0,5000.0,,,10000.0,65000.0
Satna,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,0.0,,0.0,,,,0.0,0.0,,,0.0,0.0
Satna,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,25000.0,,24500.0,,,,16750.0,10750.0,,,9250.0,86250.0
Satna,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,5500.0,0.0,11500.0,0.0,0.0,0.0,6250.0,500.0,0.0,0.0,10500.0,34250.0
Satna,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,0.0,,0.0,,,,0.0,4540.0,,,1540.0,6080.0
Satna,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,0.0,,0.0,,,,12790.0,0.0,,,10000.0,22790.0
Satna,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,0.0,,0.0,,,,0.0,0.0,,,0.0,0.0
Satna,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,0.0,,0.0,,,,8250.0,4500.0,,,11040.0,23790.0
Satna,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4540.0,40.0,0.0,0.0,500.0,5080.0
Satna,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,6000.0,,9800.0,,,,0.0,8500.0,,,0.0,24300.0
Satna,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,20000.0,,21300.0,,,,20000.0,32000.0,,,0.0,93300.0
Satna,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,0.0,,0.0,,,,0.0,0.0,,,0.0,0.0
Satna,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,23000.0,,29500.0,,,,11500.0,39000.0,,,0.0,103000.0
Satna,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,3000.0,0.0,1600.0,0.0,0.0,0.0,8500.0,1500.0,0.0,0.0,0.0,14600.0
Satna,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,3000.0,,1500.0,,,,0.0,8500.0,,,4250.0,17250.0
Satna,16.1.3,Stock position of TT vaccines,2. Stocks Received,,25000.0,,20000.0,,,,26000.0,20000.0,,,20000.0,111000.0
Satna,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,0.0,,0.0,,,,0.0,0.0,,,0.0,0.0
Satna,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,21500.0,,11500.0,,,,17500.0,27500.0,,,18000.0,96000.0
Satna,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,6500.0,0.0,10000.0,0.0,0.0,0.0,8500.0,1000.0,0.0,0.0,6250.0,32250.0
Satna,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,0.0,,0.0,,,,0.0,0.0,,,0.0,0.0
Satna,16.1.4,Stock position of DT vaccines,2. Stocks Received,,0.0,,0.0,,,,0.0,0.0,,,0.0,0.0
Satna,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,0.0,,0.0,,,,0.0,0.0,,,0.0,0.0
Satna,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,0.0,,0.0,,,,0.0,0.0,,,0.0,0.0
Satna,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,4500.0,,1000.0,,,,11000.0,9500.0,,,1000.0,27000.0
Satna,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,15000.0,,17000.0,,,,10000.0,10000.0,,,10000.0,62000.0
Satna,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,0.0,,0.0,,,,0.0,0.0,,,0.0,0.0
Satna,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,15000.0,,12500.0,,,,11500.0,16000.0,,,6750.0,61750.0
Satna,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,4500.0,0.0,5500.0,0.0,0.0,0.0,9500.0,3500.0,0.0,0.0,4250.0,27250.0
Satna,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,2875.0,,0.0,,,,0.0,1750.0,,,5250.0,9875.0
Satna,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,10000.0,,11000.0,,,,10000.0,7500.0,,,10000.0,48500.0
Satna,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,0.0,,0.0,,,,0.0,0.0,,,0.0,0.0
Satna,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,11250.0,,10250.0,,,,8250.0,9250.0,,,11250.0,50250.0
Satna,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,1625.0,0.0,750.0,0.0,0.0,0.0,1750.0,0.0,0.0,0.0,4000.0,8125.0
Satna,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,0.0,,0.0,,,,0.0,0.0,,,0.0,0.0
Satna,16.1.7,Stock position of JE vaccines,2. Stocks Received,,0.0,,0.0,,,,0.0,0.0,,,0.0,0.0
Satna,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,0.0,,0.0,,,,0.0,0.0,,,0.0,0.0
Satna,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,0.0,,0.0,,,,0.0,0.0,,,0.0,0.0
Satna,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,3000.0,,0.0,,,,0.0,6000.0,,,2250.0,11250.0
Satna,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,10000.0,,30000.0,,,,20000.0,20000.0,,,10000.0,90000.0
Satna,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,0.0,,0.0,,,,0.0,0.0,,,0.0,0.0
Satna,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,11000.0,,27250.0,,,,14000.0,23000.0,,,9000.0,84250.0
Satna,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,2000.0,0.0,2750.0,0.0,0.0,0.0,6000.0,3000.0,0.0,0.0,3250.0,17000.0
Satna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Satna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Satna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Satna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Satna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Satna,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Satna,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Satna,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Satna,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Satna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Satna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Satna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Satna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Satna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Satna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Satna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Satna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Satna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Satna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Satna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Satna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Satna,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Satna,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Satna,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Satna,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Satna,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Satna,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Satna,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Satna,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Satna,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Satna,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Satna,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Satna,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Satna,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Satna,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Satna,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Satna,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Satna,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Satna,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Satna,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Satna,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Satna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Satna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Satna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Satna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Satna,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Satna,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Satna,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Satna,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Satna,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Satna,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Satna,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Satna,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Satna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Satna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Satna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Satna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Satna,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Satna,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Satna,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Satna,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Satna,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Satna,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Satna,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Satna,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Satna,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,10300.0,,4500.0,,,,0.0,0.0,,,0.0,14800.0
Satna,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,5000.0,,6600.0,,,,0.0,3300.0,,,300.0,15200.0
Satna,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,0.0,,0.0,,,,0.0,0.0,,,0.0,0.0
Satna,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,8900.0,,7200.0,,,,0.0,2800.0,,,300.0,19200.0
Satna,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,6400.0,0.0,3900.0,0.0,0.0,0.0,0.0,500.0,0.0,0.0,0.0,10800.0
Satna,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,33200.0,,241200.0,,,,121800.0,89800.0,,,79800.0,565800.0
Satna,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,20000.0,,0.0,,,,40000.0,70000.0,,,0.0,130000.0
Satna,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,0.0,,0.0,,,,0.0,0.0,,,0.0,0.0
Satna,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,22000.0,,60000.0,,,,72000.0,60000.0,,,12400.0,226400.0
Satna,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,31200.0,0.0,181200.0,0.0,0.0,0.0,89800.0,99800.0,0.0,0.0,67400.0,469400.0
Satna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,0.0,,0.0,,,,0.0,1000.0,,,1800.0,2800.0
Satna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,0.0,,2000.0,,,,2000.0,6000.0,,,1000.0,11000.0
Satna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,0.0,,0.0,,,,0.0,0.0,,,0.0,0.0
Satna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,0.0,,2000.0,,,,400.0,5100.0,,,1104.0,8604.0
Satna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1600.0,1900.0,0.0,0.0,1696.0,5196.0
Satna,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,3.0,6.0,2.0,4.0,2.0,2.0,,2.0,,1.0,1.0,1.0,24.0
Satna,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,1.0,1.0,1.0,3.0,1.0,2.0,2.0,1.0,2.0,1.0,,16.0
Satna,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,1.0,,1.0,1.0,,4.0
Satna,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,2.0,1.0,1.0,3.0,1.0,2.0,3.0,1.0,3.0,2.0,,20.0
Satna,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,3.0,6.0,6.0,,1.0,3.0,4.0,3.0,,,1.0,2.0,29.0
Satna,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,1.0,,,,,,1.0,2.0
Satna,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,3.0,6.0,6.0,,1.0,4.0,4.0,3.0,,,1.0,3.0,31.0
Satna,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,7.0,11.0,14.0,7.0,15.0,25.0,18.0,17.0,6.0,9.0,8.0,7.0,144.0
Satna,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,1.0,,,,1.0,1.0,,,,,4.0
Satna,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,8.0,11.0,15.0,7.0,15.0,25.0,19.0,18.0,6.0,9.0,8.0,7.0,148.0
Satna,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,16.0,12.0,14.0,23.0,17.0,30.0,15.0,16.0,14.0,19.0,20.0,12.0,208.0
Satna,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,1.0,,,,,,,,,,2.0
Satna,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,17.0,12.0,15.0,23.0,17.0,30.0,15.0,16.0,14.0,19.0,20.0,12.0,210.0
Satna,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,2.0,3.0,2.0,1.0,1.0,2.0,5.0,6.0,3.0,2.0,4.0,3.0,34.0
Satna,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,,,,,3.0,2.0,,2.0,2.0,1.0,,11.0
Satna,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,3.0,3.0,2.0,1.0,1.0,5.0,7.0,6.0,5.0,4.0,5.0,3.0,45.0
Satna,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,1.0,1.0,,,,,,,2.0
Satna,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,1.0,1.0,1.0,,,,,,,3.0
Satna,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,1.0,2.0,2.0,,,,,,,5.0
Satna,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,1.0,4.0,6.0,6.0,2.0,6.0,3.0,2.0,1.0,4.0,1.0,37.0
Satna,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,4.0,6.0,4.0,6.0,10.0,4.0,2.0,1.0,2.0,2.0,41.0
Satna,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,1.0,8.0,12.0,10.0,8.0,16.0,7.0,4.0,2.0,6.0,3.0,78.0
Satna,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Satna,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Satna,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Satna,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,7.0,10.0,13.0,8.0,15.0,18.0,11.0,17.0,15.0,17.0,20.0,13.0,164.0
Satna,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,5.0,3.0,8.0,3.0,12.0,22.0,11.0,11.0,4.0,8.0,6.0,3.0,96.0
Satna,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,12.0,13.0,21.0,11.0,27.0,40.0,22.0,28.0,19.0,25.0,26.0,16.0,260.0
Satna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,2.0,,,,,,,,,,2.0
Satna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,,1.0,1.0,1.0,,,,,,,4.0
Satna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Satna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,2.0,1.0,1.0,1.0,,,,,,,6.0
Satna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,1.0,,,,,,,1.0,,,,2.0
Satna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,3.0,7.0,1.0,2.0,8.0,4.0,,2.0,3.0,,1.0,33.0
Satna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,1.0,2.0,2.0,2.0,,2.0,1.0,1.0,2.0,2.0,2.0,18.0
Satna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,3.0,5.0,9.0,3.0,4.0,8.0,6.0,1.0,4.0,5.0,2.0,3.0,53.0
Satna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Satna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,2.0,1.0,,1.0,1.0,1.0,1.0,1.0,1.0,,2.0,,11.0
Satna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,2.0,3.0,4.0,1.0,2.0,4.0,5.0,,1.0,,,23.0
Satna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,3.0,3.0,3.0,5.0,2.0,3.0,5.0,6.0,1.0,1.0,2.0,,34.0
Satna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Satna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,2.0,,,,,,,2.0
Satna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Satna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,3.0,,,,,,,3.0
Satna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,1.0,,1.0,,,,,,1.0,,3.0
Satna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,6.0,6.0,3.0,2.0,15.0,9.0,6.0,7.0,6.0,6.0,4.0,70.0
Satna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,6.0,13.0,,2.0,11.0,14.0,24.0,9.0,6.0,6.0,12.0,104.0
Satna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,12.0,20.0,3.0,5.0,26.0,23.0,30.0,16.0,12.0,13.0,16.0,177.0
Satna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Satna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Satna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Satna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Satna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Satna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,2.0,3.0,2.0,4.0,6.0,5.0,3.0,3.0,1.0,3.0,5.0,6.0,43.0
Satna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,6.0,6.0,10.0,3.0,1.0,5.0,7.0,5.0,5.0,11.0,3.0,9.0,71.0
Satna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,8.0,9.0,12.0,7.0,7.0,10.0,10.0,8.0,6.0,14.0,8.0,16.0,115.0
Satna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Satna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,1.0,,,,4.0,8.0,3.0,1.0,3.0,1.0,,23.0
Satna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,2.0,1.0,1.0,1.0,3.0,1.0,3.0,2.0,,6.0,1.0,3.0,24.0
Satna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,4.0,3.0,1.0,1.0,3.0,5.0,11.0,5.0,1.0,9.0,2.0,3.0,48.0
Satna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Satna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Satna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Satna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Satna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Satna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Satna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Satna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,1.0,,,,,1.0
Satna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Satna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,,,,1.0,,1.0,,,,,3.0
Satna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Satna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,,,,1.0,,1.0,,,,,3.0
Satna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Satna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,2.0,1.0,,,2.0,,2.0,,,,,7.0
Satna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Satna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,2.0,1.0,,,2.0,,2.0,,,,,7.0
Satna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Satna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Satna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Satna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,1.0,,,,,1.0
Satna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Satna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,4.0,1.0,1.0,2.0,,5.0,,5.0,,,,5.0,23.0
Satna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Satna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,4.0,1.0,1.0,2.0,,5.0,,5.0,,,,5.0,23.0
Satna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,4.0,4.0,,2.0,4.0,1.0,4.0,,,,,,19.0
Satna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,10.0,8.0,8.0,12.0,7.0,5.0,16.0,4.0,3.0,4.0,5.0,5.0,87.0
Satna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,4.0,,5.0,1.0,4.0,4.0,3.0,1.0,,,1.0,24.0
Satna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,15.0,16.0,8.0,19.0,12.0,10.0,24.0,7.0,4.0,4.0,5.0,6.0,130.0
Satna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Satna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,4.0,9.0,6.0,8.0,7.0,11.0,5.0,6.0,5.0,8.0,7.0,80.0
Satna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,1.0,,,,,,,,,,1.0,3.0
Satna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,5.0,5.0,9.0,6.0,8.0,7.0,11.0,6.0,6.0,5.0,8.0,8.0,84.0
Satna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,,,1.0,2.0,1.0,,,,,,,5.0
Satna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,,2.0,,3.0,4.0,,,1.0,,,11.0
Satna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,,2.0,,1.0,,,,,1.0,,5.0
Satna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,2.0,,5.0,2.0,5.0,4.0,,,1.0,1.0,,21.0
Satna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Satna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,3.0,1.0,4.0,1.0,4.0,2.0,3.0,4.0,,2.0,,26.0
Satna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,3.0,3.0,2.0,2.0,5.0,5.0,,1.0,1.0,2.0,1.0,27.0
Satna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,4.0,6.0,5.0,6.0,3.0,9.0,7.0,3.0,5.0,1.0,4.0,1.0,54.0
Satna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,1.0,2.0,,,,,,1.0,,,4.0
Satna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,5.0,5.0,8.0,6.0,4.0,11.0,19.0,11.0,6.0,6.0,6.0,5.0,92.0
Satna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,8.0,2.0,2.0,4.0,7.0,9.0,12.0,12.0,15.0,8.0,9.0,6.0,94.0
Satna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,13.0,7.0,11.0,12.0,11.0,20.0,31.0,23.0,21.0,15.0,15.0,11.0,190.0
Satna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,5.0,2.0,1.0,2.0,2.0,6.0,7.0,5.0,3.0,,,,33.0
Satna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,8.0,20.0,15.0,19.0,18.0,29.0,38.0,27.0,19.0,20.0,25.0,23.0,261.0
Satna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,31.0,39.0,52.0,58.0,35.0,82.0,81.0,66.0,50.0,69.0,61.0,59.0,683.0
Satna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,44.0,61.0,68.0,79.0,55.0,117.0,126.0,98.0,72.0,89.0,86.0,82.0,977.0
Sehore,1.1,Total number of pregnant women Registered for ANC,TOTAL,2447.0,2519.0,3244.0,3417.0,2757.0,3164.0,2817.0,3309.0,3263.0,3135.0,2906.0,3957.0,36935.0
Sehore,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1778.0,1901.0,2112.0,2599.0,2129.0,2528.0,2251.0,2744.0,2483.0,1969.0,2206.0,2792.0,27492.0
Sehore,1.2,Number of Pregnant women registered under JSY,TOTAL,2447.0,2519.0,3244.0,3417.0,2748.0,3164.0,2817.0,3304.0,3157.0,3064.0,2846.0,3579.0,36306.0
Sehore,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2248.0,2294.0,2552.0,2689.0,2639.0,2548.0,2223.0,2432.0,2562.0,1976.0,2499.0,3033.0,29695.0
Sehore,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2447.0,2450.0,3188.0,3417.0,2743.0,3164.0,2804.0,3188.0,3146.0,2600.0,2707.0,3026.0,34880.0
Sehore,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2306.0,2243.0,2621.0,2950.0,2590.0,2442.0,2387.0,2614.0,2619.0,2486.0,2505.0,2982.0,30745.0
Sehore,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2447.0,2407.0,3181.0,3417.0,2746.0,3164.0,3069.0,3591.0,3405.0,3040.0,3043.0,4073.0,37583.0
Sehore,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,96.0,173.0,99.0,146.0,87.0,361.0,68.0,94.0,126.0,155.0,174.0,73.0,1652.0
Sehore,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,2.0,1.0,2.0,5.0,13.0
Sehore,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,981.0,938.0,1637.0,1477.0,1326.0,1665.0,1043.0,1242.0,2128.0,1846.0,1802.0,1655.0,17740.0
Sehore,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,68.0,81.0,42.0,69.0,209.0,250.0,120.0,26.0,131.0,57.0,54.0,92.0,1199.0
Sehore,1.8,Number of pregnancy test kits used at SC level,TOTAL,49.0,37.0,52.0,77.0,124.0,92.0,63.0,110.0,112.0,146.0,117.0,141.0,1120.0
Sehore,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,15.0,42.0,0.0,28.0,30.0,100.0,74.0,40.0,36.0,53.0,36.0,36.0,490.0
Sehore,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,24.0,34.0,90.0,42.0,16.0,7.0,0.0,51.0,45.0,51.0,44.0,64.0,468.0
Sehore,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,39.0,76.0,90.0,70.0,46.0,107.0,74.0,91.0,81.0,104.0,80.0,100.0,958.0
Sehore,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,26.0,54.0,68.0,46.0,29.0,99.0,73.0,39.0,36.0,67.0,44.0,26.0,607.0
Sehore,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,40.0,0.0,45.0
Sehore,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1462.0,1516.0,1820.0,1858.0,2036.0,1949.0,1833.0,2012.0,1823.0,1655.0,1514.0,1732.0,21210.0
Sehore,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,163.0,106.0,4.0,14.0,96.0,192.0,235.0,318.0,369.0,254.0,325.0,321.0,2397.0
Sehore,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1243.0,1217.0,1600.0,1831.0,1974.0,1834.0,1691.0,1901.0,1753.0,1748.0,1529.0,1759.0,20080.0
Sehore,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,816.0,1118.0,802.0,1145.0,1485.0,1466.0,1311.0,1449.0,1160.0,1586.0,1024.0,1141.0,14503.0
Sehore,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0,0.0,17.0
Sehore,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,151.0,20.0,160.0,169.0,191.0,123.0,164.0,93.0,135.0,133.0,122.0,152.0,1613.0
Sehore,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,0.0,0.0,,,,,,,,,0.0
Sehore,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,0.0,0.0,,,,,,,,,0.0
Sehore,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,0.0,,,,,,,,,0.0
Sehore,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,98.0,81.0,90.0,129.0,118.0,91.0,114.0,104.0,102.0,77.0,99.0,88.0,1191.0
Sehore,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sehore,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,98.0,81.0,90.0,129.0,118.0,91.0,114.0,104.0,102.0,77.0,99.0,88.0,1191.0
Sehore,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,,45.0,54.0,70.0,43.0,67.0,33.0,50.0,58.0,30.0,48.0,498.0
Sehore,4.1.1.a,Number of male live births,TOTAL,838.0,803.0,1069.0,1079.0,1182.0,1078.0,1061.0,1109.0,1032.0,970.0,856.0,1053.0,12130.0
Sehore,4.1.1.b,Number of female live births,TOTAL,797.0,774.0,951.0,990.0,1061.0,1080.0,986.0,1055.0,1004.0,902.0,840.0,905.0,11345.0
Sehore,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1635.0,1577.0,2020.0,2069.0,2243.0,2158.0,2047.0,2164.0,2036.0,1872.0,1696.0,1958.0,23475.0
Sehore,4.1.2,Number of still births,TOTAL,18.0,35.0,51.0,28.0,30.0,21.0,24.0,32.0,25.0,28.0,20.0,26.0,338.0
Sehore,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,70.0,68.0,81.0,75.0,73.0,94.0,95.0,107.0,157.0,76.0,103.0,78.0,1077.0
Sehore,4.2.1,Number of Newborns weighed at birth,TOTAL,1450.0,1515.0,1834.0,1865.0,2013.0,1929.0,1818.0,2023.0,1827.0,1648.0,1494.0,1732.0,21148.0
Sehore,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,181.0,165.0,256.0,287.0,270.0,296.0,320.0,339.0,313.0,326.0,310.0,280.0,3343.0
Sehore,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1339.0,1421.0,1725.0,1743.0,1903.0,1809.0,1696.0,1918.0,1748.0,1537.0,1452.0,1597.0,19888.0
Sehore,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,6.0,7.0,0.0,5.0,0.0,0.0,14.0,12.0,1.0,4.0,9.0,11.0,69.0
Sehore,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,3.0,143.0,121.0,105.0,97.0,64.0,50.0,49.0,96.0,49.0,76.0,85.0,938.0
Sehore,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,98.0,81.0,117.0,129.0,29.0,107.0,114.0,104.0,23.0,77.0,82.0,114.0,1075.0
Sehore,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sehore,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,107.0,231.0,238.0,239.0,126.0,171.0,178.0,165.0,120.0,130.0,167.0,210.0,2082.0
Sehore,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Sehore,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,68.0,121.0,301.0,239.0,126.0,171.0,85.0,61.0,59.0,64.0,53.0,109.0,1457.0
Sehore,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,30.0,34.0,163.0,191.0,63.0,171.0,8.0,25.0,24.0,17.0,62.0,54.0,842.0
Sehore,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,70.0,278.0,301.0,237.0,116.0,171.0,51.0,64.0,59.0,59.0,51.0,225.0,1682.0
Sehore,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,13.0,43.0,90.0,104.0,32.0,171.0,84.0,35.0,23.0,77.0,82.0,121.0,875.0
Sehore,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1451.0,1534.0,1856.0,1872.0,1951.0,1922.0,1763.0,1777.0,1645.0,1641.0,1536.0,1667.0,20615.0
Sehore,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,684.0,1013.0,864.0,881.0,502.0,426.0,374.0,1102.0,944.0,1193.0,1091.0,1132.0,10206.0
Sehore,6.3,PNC maternal complications attended,TOTAL,4.0,5.0,97.0,134.0,47.0,116.0,115.0,112.0,95.0,88.0,95.0,118.0,1026.0
Sehore,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,76.0,81.0,80.0,59.0,52.0,66.0,63.0,88.0,114.0,70.0,115.0,101.0,965.0
Sehore,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,36.0,25.0,0.0,65.0
Sehore,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,76.0,81.0,80.0,59.0,56.0,66.0,63.0,88.0,114.0,106.0,140.0,101.0,1030.0
Sehore,7.2,Number of MTPs conducted at Private Facilities,TOTAL,33.0,0.0,15.0,29.0,16.0,22.0,28.0,15.0,26.0,23.0,21.0,24.0,252.0
Sehore,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,43.0,36.0,40.0,36.0,48.0,68.0,45.0,48.0,89.0,71.0,44.0,57.0,625.0
Sehore,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,222.0,321.0,281.0,433.0,449.0,404.0,344.0,490.0,325.0,379.0,328.0,248.0,4224.0
Sehore,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,265.0,357.0,321.0,469.0,497.0,472.0,389.0,538.0,414.0,450.0,372.0,305.0,4849.0
Sehore,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,107.0,126.0,4.0,0.0,4.0,0.0,4.0,71.0,58.0,0.0,0.0,0.0,374.0
Sehore,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,11.0,13.0,5.0,19.0,36.0,18.0,6.0,19.0,31.0,24.0,46.0,7.0,235.0
Sehore,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,0.0,2.0,2.0,1.0,0.0,0.0,3.0,0.0,2.0,6.0,5.0,22.0
Sehore,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sehore,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,12.0,13.0,7.0,21.0,37.0,18.0,6.0,22.0,31.0,26.0,52.0,12.0,257.0
Sehore,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sehore,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,57.0,39.0,38.0,208.0,167.0,147.0,27.0,770.0,1051.0,750.0,778.0,163.0,4195.0
Sehore,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,1.0,4.0
Sehore,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sehore,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,57.0,39.0,38.0,208.0,167.0,147.0,27.0,770.0,1051.0,751.0,780.0,164.0,4199.0
Sehore,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sehore,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,89.0,60.0,130.0,165.0,109.0,144.0,62.0,250.0,392.0,191.0,245.0,79.0,1916.0
Sehore,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,33.0,9.0,29.0,12.0,13.0,7.0,10.0,46.0,43.0,34.0,31.0,41.0,308.0
Sehore,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sehore,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,122.0,69.0,159.0,177.0,122.0,151.0,72.0,296.0,435.0,225.0,276.0,120.0,2224.0
Sehore,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sehore,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,4.0,11.0,2.0,8.0,15.0,7.0,4.0,39.0,76.0,35.0,7.0,40.0,248.0
Sehore,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,23.0,13.0,27.0,20.0,21.0,14.0,27.0,26.0,25.0,33.0,0.0,229.0
Sehore,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sehore,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,4.0,34.0,15.0,35.0,35.0,28.0,18.0,66.0,102.0,60.0,40.0,40.0,477.0
Sehore,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sehore,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,598.0,640.0,760.0,772.0,637.0,732.0,821.0,773.0,596.0,876.0,875.0,888.0,8968.0
Sehore,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,78.0,86.0,61.0,62.0,57.0,71.0,76.0,55.0,80.0,60.0,81.0,85.0,852.0
Sehore,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,431.0,94.0,177.0,169.0,230.0,180.0,149.0,77.0,149.0,58.0,98.0,41.0,1853.0
Sehore,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,83.0,148.0,73.0,143.0,133.0,183.0,88.0,119.0,183.0,127.0,183.0,113.0,1576.0
Sehore,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sehore,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1190.0,968.0,1071.0,1146.0,1057.0,1166.0,1134.0,1024.0,1008.0,1121.0,1237.0,1127.0,13249.0
Sehore,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,34.0,30.0,75.0,54.0,45.0,41.0,116.0,79.0,120.0,77.0,67.0,78.0,816.0
Sehore,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sehore,9.06,Number of IUCD removals,TOTAL,1223.0,957.0,1207.0,921.0,1043.0,594.0,964.0,661.0,720.0,592.0,673.0,880.0,10435.0
Sehore,9.07,Number of Oral Pills cycles distributed,TOTAL,12389.0,12134.0,11170.0,11903.0,15606.0,14623.0,14257.0,16093.0,15325.0,15859.0,18278.0,17091.0,174728.0
Sehore,9.08,Number of Condom pieces distributed,TOTAL,13723.0,20722.0,22861.0,15919.0,20942.0,14094.0,16574.0,16948.0,22261.0,19589.0,19998.0,21686.0,225317.0
Sehore,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,8.0
Sehore,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,23.0,33.0
Sehore,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,2.0,0.0,0.0,1.0,3.0,0.0,0.0,1.0,0.0,0.0,0.0,7.0
Sehore,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,9.11.2.b,Number of failures following female sterilization,TOTAL,2.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,5.0
Sehore,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,9.12,Number of Institutions having NSV trained doctors,TOTAL,6.0,2.0,2.0,2.0,2.0,1.0,1.0,4.0,5.0,6.0,4.0,3.0,-1.0
Sehore,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1483.0,1557.0,1860.0,1902.0,2024.0,1953.0,1987.0,2238.0,2102.0,2061.0,1817.0,1920.0,22904.0
Sehore,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2280.0,2128.0,2498.0,2700.0,2497.0,2866.0,2743.0,1589.0,524.0,90.0,814.0,0.0,20729.0
Sehore,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2399.0,2262.0,2392.0,2672.0,2493.0,2788.0,2736.0,2843.0,1838.0,439.0,914.0,1242.0,25018.0
Sehore,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2591.0,2454.0,2577.0,2808.0,2652.0,2883.0,2624.0,2755.0,2870.0,1540.0,1128.0,1326.0,28208.0
Sehore,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1571.0,2497.0,2528.0,2511.0,2851.0,11958.0
Sehore,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1314.0,2140.0,2308.0,2970.0,8732.0
Sehore,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1186.0,1957.0,2705.0,5848.0
Sehore,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1483.0,1557.0,1860.0,1902.0,2024.0,1953.0,1833.0,2016.0,1791.0,1790.0,1535.0,1730.0,21474.0
Sehore,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2261.0,2128.0,2498.0,2700.0,2500.0,2871.0,2743.0,2050.0,1922.0,1465.0,2097.0,2873.0,28108.0
Sehore,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2413.0,2262.0,2392.0,2672.0,2493.0,2788.0,2736.0,2841.0,2244.0,1628.0,2023.0,3017.0,29509.0
Sehore,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2558.0,2454.0,2577.0,2807.0,2652.0,2874.0,2624.0,2756.0,2854.0,1891.0,2112.0,2933.0,31092.0
Sehore,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1474.0,1537.0,1838.0,1881.0,2009.0,1928.0,1810.0,1879.0,1720.0,1769.0,1476.0,962.0,20283.0
Sehore,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1967.0,2128.0,2498.0,2700.0,2501.0,2866.0,2737.0,1510.0,789.0,136.0,811.0,8.0,20651.0
Sehore,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2401.0,2262.0,2382.0,2668.0,2493.0,2788.0,2736.0,2794.0,1821.0,466.0,929.0,1243.0,24983.0
Sehore,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2569.0,2454.0,2577.0,2837.0,2652.0,2883.0,2624.0,2709.0,2809.0,1489.0,1151.0,1268.0,28022.0
Sehore,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1637.0,2126.0,2592.0,3476.0,2846.0,3090.0,2913.0,2579.0,2615.0,2763.0,2556.0,3190.0,32383.0
Sehore,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,187.0,675.0,868.0,1909.0,1715.0,1423.0,1542.0,1237.0,1676.0,1287.0,1769.0,2116.0,16404.0
Sehore,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,807.0,1110.0,1352.0,1725.0,1371.0,1540.0,1482.0,1324.0,1338.0,1376.0,1314.0,1664.0,16403.0
Sehore,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,779.0,1026.0,1206.0,1608.0,1241.0,1452.0,1431.0,1249.0,1251.0,1319.0,1205.0,1542.0,15309.0
Sehore,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1586.0,2136.0,2558.0,3333.0,2612.0,2992.0,2913.0,2573.0,2589.0,2695.0,2519.0,3206.0,31712.0
Sehore,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1809.0,1932.0,2167.0,2547.0,2086.0,2280.0,2146.0,2182.0,2397.0,2593.0,2558.0,3003.0,27700.0
Sehore,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1798.0,1926.0,2167.0,2547.0,2084.0,2280.0,2146.0,2182.0,2396.0,2593.0,2551.0,3007.0,27677.0
Sehore,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,581.0,770.0,632.0,875.0,1142.0,647.0,771.0,569.0,780.0,787.0,855.0,794.0,9203.0
Sehore,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,563.0,734.0,562.0,829.0,1004.0,597.0,771.0,520.0,784.0,684.0,799.0,799.0,8646.0
Sehore,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1144.0,1504.0,1194.0,1704.0,2146.0,1244.0,1542.0,1089.0,1564.0,1471.0,1654.0,1593.0,17849.0
Sehore,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1019.0,1074.0,1240.0,1622.0,1535.0,1879.0,1582.0,1413.0,1895.0,1638.0,1493.0,1841.0,18231.0
Sehore,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1151.0,1149.0,1480.0,1678.0,1805.0,2550.0,2094.0,1884.0,2205.0,1693.0,1755.0,1829.0,21273.0
Sehore,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1094.0,1055.0,1448.0,1836.0,1785.0,2735.0,1999.0,1662.0,2190.0,1915.0,1766.0,1850.0,21335.0
Sehore,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
Sehore,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1427.0,1430.0,1430.0,1449.0,1428.0,1424.0,1436.0,1429.0,1449.0,1460.0,1509.0,1427.0,17298.0
Sehore,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1402.0,1413.0,1413.0,1449.0,1419.0,1409.0,1423.0,1423.0,1446.0,1466.0,1499.0,1425.0,17187.0
Sehore,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1302.0,1104.0,1138.0,1345.0,1269.0,1190.0,1283.0,1203.0,1312.0,1239.0,1291.0,1245.0,14921.0
Sehore,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1907.0,1843.0,2681.0,3836.0,2858.0,3085.0,2844.0,2319.0,2552.0,3500.0,2590.0,3210.0,33225.0
Sehore,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,903.0,792.0,644.0,13585.0,4248.0,1247.0,707.0,277.0,354.0,10998.0,1928.0,373.0,36056.0
Sehore,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,2249.0,544.0,501.0,10063.0,3747.0,971.0,636.0,353.0,311.0,12067.0,1859.0,502.0,33803.0
Sehore,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0
Sehore,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,355.0,536.0,534.0,173.0,519.0,467.0,415.0,410.0,424.0,395.0,386.0,690.0,5304.0
Sehore,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,6.0,26.0,0.0,27.0,0.0,4.0,1.0,18.0,0.0,0.0,35.0,0.0,117.0
Sehore,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,249.0,344.0,286.0,249.0,264.0,489.0,655.0,551.0,309.0,293.0,435.0,321.0,4445.0
Sehore,13.1,Number of Patients operated for cataract,TOTAL,120.0,303.0,490.0,261.0,379.0,715.0,148.0,678.0,457.0,629.0,1329.0,473.0,5982.0
Sehore,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,54.0,303.0,490.0,261.0,379.0,715.0,148.0,678.0,457.0,629.0,1329.0,473.0,5916.0
Sehore,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,119.0,489.0,210.0,629.0,1329.0,473.0,3249.0
Sehore,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,152.0,30.0,153.0,79.0,0.0,414.0
Sehore,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Sehore,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,8.0,8.0,8.0,7.0,6.0,7.0,6.0,7.0,6.0,7.0,7.0,7.0,-1.0
Sehore,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,5.0,5.0,6.0,6.0,7.0,6.0,7.0,6.0,6.0,6.0,5.0,6.0,-1.0
Sehore,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,601.0,747.0,713.0,758.0,764.0,615.0,669.0,769.0,724.0,697.0,766.0,872.0,-1.0
Sehore,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,9.0,9.0,8.0,9.0,8.0,8.0,8.0,8.0,8.0,9.0,9.0,-1.0
Sehore,14.05,Number of RKS meetings held during the month,TOTAL,10.0,57.0,5.0,8.0,8.0,7.0,9.0,8.0,8.0,8.0,6.0,6.0,140.0
Sehore,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,11.0,11.0,11.0,11.0,11.0,10.0,12.0,11.0,11.0,11.0,11.0,11.0,-1.0
Sehore,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,15.0,119.0,419.0,63.0,187.0,490.0,107.0,175.0,57.0,17.0,47.0,28.0,1724.0
Sehore,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,2.0,2.0,3.0,2.0,2.0,1.0,-1.0
Sehore,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Sehore,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,940.0,507.0,1320.0,728.0,725.0,523.0,652.0,475.0,830.0,282.0,398.0,347.0,7727.0
Sehore,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1488.0,2230.0,4236.0,2570.0,2653.0,3995.0,3695.0,3227.0,5351.0,1538.0,1856.0,2611.0,35450.0
Sehore,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1383.0,775.0,1336.0,1022.0,1283.0,623.0,842.0,699.0,1035.0,489.0,629.0,443.0,10559.0
Sehore,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2524.0,3633.0,4003.0,4166.0,3713.0,5280.0,4946.0,5121.0,9774.0,2441.0,3114.0,4688.0,53403.0
Sehore,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2323.0,1282.0,2656.0,1750.0,2008.0,1146.0,1494.0,1174.0,1865.0,771.0,1027.0,790.0,18286.0
Sehore,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4012.0,5863.0,8239.0,6736.0,6366.0,9275.0,8641.0,8348.0,15125.0,3979.0,4970.0,7299.0,88853.0
Sehore,14.10.2.a,Number of death cases of Inpatient males,TOTAL,7.0,8.0,3.0,0.0,2.0,2.0,2.0,0.0,0.0,3.0,1.0,3.0,31.0
Sehore,14.10.2.b,Number of death cases of Inpatient females,TOTAL,3.0,1.0,4.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,1.0,2.0,14.0
Sehore,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,10.0,9.0,7.0,0.0,3.0,2.0,2.0,0.0,0.0,5.0,2.0,5.0,45.0
Sehore,14.11,In-Patient Head Count at midnight,TOTAL,3201.0,8298.0,5544.0,4631.0,4434.0,4914.0,3449.0,3717.0,7373.0,3513.0,2723.0,4327.0,56124.0
Sehore,14.12.1,OPD attendance (All),TOTAL,55603.0,75596.0,66562.0,67872.0,71676.0,113857.0,79702.0,81505.0,83219.0,64224.0,92922.0,93096.0,945834.0
Sehore,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,96.0,8.0,113.0,183.0,148.0,99.0,159.0,103.0,84.0,45.0,97.0,67.0,1202.0
Sehore,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,38.0,0.0,40.0,57.0,21.0,91.0,0.0,8.0,84.0,0.0,5.0,3.0,347.0
Sehore,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,25.0,54.0,0.0,129.0,81.0,80.0,77.0,137.0,314.0,90.0,135.0,93.0,1215.0
Sehore,14.14.a,Number of patients given AYUSH treatment,TOTAL,2068.0,2002.0,2566.0,1526.0,2254.0,1081.0,1354.0,4651.0,2875.0,2589.0,2422.0,4431.0,29819.0
Sehore,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1350.0,762.0,1491.0,1503.0,1279.0,996.0,1277.0,1711.0,1845.0,1257.0,1734.0,1994.0,17199.0
Sehore,14.14.c,Number of Adolescents counselled,TOTAL,220.0,1.0,878.0,1411.0,959.0,944.0,938.0,1050.0,515.0,475.0,429.0,349.0,8169.0
Sehore,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5706.0,7392.0,7763.0,7641.0,7244.0,8285.0,4747.0,4943.0,8750.0,28684.0,7889.0,8069.0,107113.0
Sehore,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,105.0,206.0,135.0,227.0,159.0,369.0,192.0,83.0,372.0,216.0,271.0,291.0,2626.0
Sehore,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,314.0,363.0,267.0,240.0,195.0,208.0,234.0,229.0,227.0,174.0,228.0,196.0,2875.0
Sehore,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,1.0,0.0,1.0,1.0,0.0,4.0,1.0,4.0,1.0,0.0,1.0,15.0
Sehore,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,319.0,492.0,443.0,239.0,353.0,260.0,293.0,333.0,483.0,254.0,210.0,211.0,3890.0
Sehore,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,18.0,0.0,0.0,1.0,1.0,0.0,0.0,2.0,2.0,1.0,0.0,2.0,27.0
Sehore,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1618.0,1911.0,2122.0,1959.0,1327.0,2023.0,1063.0,1881.0,1919.0,1659.0,1184.0,952.0,19618.0
Sehore,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,156.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,160.0
Sehore,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2251.0,2766.0,2832.0,2438.0,1875.0,2491.0,1590.0,2443.0,2629.0,2087.0,1622.0,1359.0,26383.0
Sehore,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,175.0,2.0,1.0,3.0,2.0,0.0,5.0,3.0,6.0,2.0,0.0,3.0,202.0
Sehore,15.2,Number of Widal tests conducted,Number tested,274.0,383.0,480.0,531.0,646.0,415.0,630.0,637.0,2349.0,155.0,114.0,320.0,6934.0
Sehore,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,1.0,1.0,9.0,12.0,41.0,28.0,174.0,7.0,70.0,188.0,2.0,533.0
Sehore,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,21.0,0.0,0.0,1.0,28.0,374.0,277.0,144.0,94.0,336.0,29.0,1304.0
Sehore,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,318.0,312.0,308.0,492.0,211.0,702.0,599.0,883.0,481.0,627.0,622.0,361.0,5916.0
Sehore,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,318.0,334.0,309.0,501.0,224.0,771.0,1001.0,1334.0,632.0,791.0,1146.0,392.0,7753.0
Sehore,15.4.1,Number of blood smears examined for Malaria,TOTAL,9740.0,9349.0,10905.0,12750.0,14737.0,17435.0,17799.0,15582.0,12368.0,7316.0,8206.0,8522.0,144709.0
Sehore,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,21.0,32.0,26.0,28.0,43.0,81.0,61.0,38.0,26.0,10.0,3.0,3.0,372.0
Sehore,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,3.0,5.0,1.0,1.0,8.0,18.0,29.0,11.0,6.0,5.0,2.0,3.0,92.0
Sehore,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,0.0,1050.0,1300.0,1200.0,1585.0,1835.0,1035.0,435.0,1675.0,925.0,1625.0,1475.0,14140.0
Sehore,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1500.0,1000.0,2000.0,1500.0,1500.0,1000.0,1000.0,1500.0,500.0,1000.0,0.0,0.0,12500.0
Sehore,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,800.0,750.0,2100.0,1115.0,1250.0,1800.0,1600.0,260.0,1250.0,300.0,150.0,300.0,11675.0
Sehore,16.1.1,Stock position of DPT vaccines,5. Total Stock,700.0,1300.0,1200.0,1585.0,1835.0,1035.0,435.0,1675.0,925.0,1625.0,1475.0,1175.0,14965.0
Sehore,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,,0.0,0.0,,0.0,0.0,0.0,100.0,110.0,1200.0,1700.0,3110.0
Sehore,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,,0.0,0.0,,0.0,0.0,1250.0,1150.0,1500.0,1000.0,0.0,4900.0
Sehore,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,,0.0,0.0,,0.0,0.0,1150.0,1140.0,410.0,500.0,650.0,3850.0
Sehore,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,110.0,1200.0,1700.0,1050.0,4160.0
Sehore,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,235.0,1475.0,1375.0,450.0,725.0,1375.0,1050.0,425.0,1100.0,525.0,600.0,0.0,9335.0
Sehore,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1500.0,1000.0,1500.0,1500.0,0.0,1500.0,1000.0,1000.0,1000.0,500.0,0.0,1000.0,11500.0
Sehore,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,775.0,1100.0,2425.0,1225.0,600.0,1825.0,1625.0,325.0,1575.0,425.0,600.0,150.0,12650.0
Sehore,16.1.2,Stock position of OPV vaccines,5. Total Stock,960.0,1375.0,450.0,725.0,125.0,1050.0,425.0,1100.0,525.0,600.0,0.0,850.0,8185.0
Sehore,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,650.0,1750.0,2025.0,1325.0,1525.0,2175.0,1325.0,675.0,1275.0,975.0,1475.0,1975.0,17150.0
Sehore,16.1.3,Stock position of TT vaccines,2. Stocks Received,1500.0,1500.0,1500.0,1500.0,1500.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,0.0,13500.0
Sehore,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.1.3,Stock position of TT vaccines,4. Stock Distributed,800.0,1225.0,2200.0,1300.0,850.0,1850.0,1650.0,400.0,1300.0,500.0,500.0,775.0,13350.0
Sehore,16.1.3,Stock position of TT vaccines,5. Total Stock,1350.0,2025.0,1325.0,1525.0,2175.0,1325.0,675.0,1275.0,975.0,1475.0,1975.0,1200.0,17300.0
Sehore,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,,0.0,0.0,,0.0,,0.0,,,0.0,0.0,0.0
Sehore,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,,0.0,0.0,,0.0,,0.0,,,0.0,0.0,0.0
Sehore,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,,0.0,0.0,,0.0,,0.0,,,0.0,0.0,0.0
Sehore,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,,0.0,0.0,,0.0,,0.0,,,0.0,0.0,0.0
Sehore,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,675.0,1425.0,1550.0,1300.0,1150.0,1300.0,1150.0,300.0,1150.0,100.0,750.0,1450.0,12300.0
Sehore,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000.0,1000.0,1000.0,500.0,1000.0,1000.0,0.0,1000.0,0.0,1000.0,1000.0,0.0,8500.0
Sehore,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,400.0,875.0,1250.0,650.0,850.0,1150.0,850.0,150.0,1050.0,350.0,300.0,500.0,8375.0
Sehore,16.1.5,Stock position of BCG vaccines,5. Total Stock,1275.0,1550.0,1300.0,1150.0,1300.0,1150.0,300.0,1150.0,100.0,750.0,1450.0,950.0,12425.0
Sehore,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,500.0,1050.0,0.0,600.0,1150.0,1300.0,50.0,350.0,850.0,800.0,350.0,750.0,7750.0
Sehore,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1000.0,1000.0,2000.0,2000.0,1000.0,0.0,2000.0,1000.0,2000.0,500.0,1000.0,1000.0,14500.0
Sehore,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,850.0,1100.0,1400.0,1450.0,850.0,1250.0,1700.0,500.0,2050.0,950.0,600.0,1550.0,14250.0
Sehore,16.1.6,Stock position of Measles vaccines,5. Total Stock,650.0,950.0,600.0,1150.0,1300.0,50.0,350.0,850.0,800.0,350.0,750.0,200.0,8000.0
Sehore,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,,0.0,0.0,,0.0,,,,,0.0,0.0,0.0
Sehore,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,,0.0,0.0,,0.0,,,,,0.0,0.0,0.0
Sehore,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,,0.0,0.0,,0.0,,,,,0.0,0.0,0.0
Sehore,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,,0.0,0.0,,0.0,,,,,0.0,0.0,0.0
Sehore,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,150.0,1150.0,1250.0,464.0,1214.0,1864.0,1064.0,564.0,1264.0,614.0,1414.0,1364.0,12376.0
Sehore,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1500.0,1550.0,1500.0,2000.0,1500.0,1000.0,1000.0,1000.0,500.0,1000.0,0.0,0.0,12550.0
Sehore,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,900.0,1400.0,2286.0,1250.0,850.0,1800.0,1500.0,300.0,1150.0,200.0,50.0,100.0,11786.0
Sehore,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,750.0,1300.0,464.0,1214.0,1864.0,1064.0,564.0,1264.0,614.0,1414.0,1364.0,1264.0,13140.0
Sehore,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1.0,1.0,1.0,1.0,131460.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,131471.0
Sehore,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,131460.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,131460.0
Sehore,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1.0,1.0,1.0,1.0,0.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,11.0
Sehore,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,88360.0,88360.0,68200.0,37960.0,97960.0,206500.0,90580.0,90580.0,135940.0,191260.0,120080.0,108080.0,1323860.0
Sehore,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,60000.0,60000.0,0.0,60000.0,240000.0,0.0,0.0,50400.0,120000.0,0.0,0.0,0.0,590400.0
Sehore,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,60000.0,80160.0,30240.0,0.0,206500.0,115920.0,0.0,5040.0,64680.0,71180.0,12000.0,6000.0,651720.0
Sehore,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,88360.0,68200.0,37960.0,97960.0,131460.0,90580.0,90580.0,135940.0,191260.0,120080.0,108080.0,102080.0,1262540.0
Sehore,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,5400.0,15400.0,6200.0,10200.0,33200.0,20200.0,14200.0,3200.0,2572.0,110572.0
Sehore,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,10000.0,0.0,10000.0,57000.0,0.0,0.0,0.0,0.0,30000.0,107000.0
Sehore,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,9200.0,6000.0,34000.0,13000.0,6000.0,11000.0,628.0,2572.0,82400.0
Sehore,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,15400.0,6200.0,10200.0,33200.0,20200.0,14200.0,3200.0,2572.0,30000.0,135172.0
Sehore,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,14220.0,14220.0,14220.0,13620.0,13620.0,11520.0,642.0,42.0,3442.0,3442.0,1382.0,1082.0,91452.0
Sehore,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0,0.0,0.0,0.0,10200.0,14200.0
Sehore,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,900.0,0.0,2100.0,10878.0,600.0,600.0,0.0,2060.0,300.0,0.0,17438.0
Sehore,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,14220.0,14220.0,13320.0,13620.0,11520.0,642.0,42.0,3442.0,3442.0,1382.0,1082.0,11282.0,88214.0
Sehore,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,4900.0,4900.0,0.0,4700.0,4700.0,3300.0,3300.0,3300.0,2300.0,1700.0,1200.0,800.0,35100.0
Sehore,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,200.0,0.0,0.0,1400.0,0.0,0.0,1000.0,600.0,500.0,400.0,0.0,4100.0
Sehore,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,4900.0,4700.0,0.0,4700.0,3300.0,3300.0,3300.0,2300.0,1700.0,1200.0,800.0,800.0,31000.0
Sehore,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,48150.0,48150.0,40950.0,36450.0,34450.0,31150.0,300500.0,293745.0,15575.0,849120.0
Sehore,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,3600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,13600.0
Sehore,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,3100.0,0.0,0.0,2400.0,7200.0,4500.0,2000.0,3300.0,1100.0,6755.0,288170.0,0.0,318525.0
Sehore,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,500.0,0.0,0.0,45750.0,40950.0,36450.0,34450.0,31150.0,30050.0,293745.0,15575.0,15575.0,544195.0
Sehore,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,41600.0,84490.0,74690.0,75040.0,72740.0,63140.0,63425.0,54925.0,43975.0,49375.0,40375.0,38700.0,702475.0
Sehore,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,10000.0,10000.0,0.0,0.0,10000.0,0.0,0.0,10000.0,0.0,0.0,0.0,40000.0
Sehore,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,9800.0,9650.0,2300.0,9600.0,9715.0,8500.0,10950.0,4600.0,9000.0,1675.0,14000.0,89790.0
Sehore,16.3.02,Stock Position of Gloves,5. Total Stock,41600.0,84690.0,75040.0,72740.0,63140.0,63425.0,54925.0,43975.0,49375.0,40375.0,38700.0,24700.0,652685.0
Sehore,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,11200.0,11200.0,10200.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,32600.0
Sehore,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,1000.0,10200.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11200.0
Sehore,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,11200.0,10200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21400.0
Sehore,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,1047300.0,1047300.0,1054300.0,799000.0,455300.0,912800.0,5964000.0,5964000.0,4823800.0,4787800.0,4715800.0,4595800.0,36167200.0
Sehore,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,999900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,999900.0
Sehore,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,255300.0,343700.0,549400.0,342200.0,0.0,1140200.0,36000.0,72000.0,120000.0,1812000.0,4670800.0
Sehore,16.3.07,Stock Position of IFA Tablets,5. Total Stock,1047300.0,1047300.0,799000.0,455300.0,905800.0,570600.0,5964000.0,4823800.0,4787800.0,4715800.0,4595800.0,2783800.0,32496300.0
Sehore,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,3480.0,0.0,0.0,960.0,6232.0,6232.0,27520.0,25210.0,20600.0,7934.0,9023.0,4991.0,112182.0
Sehore,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,50832.0,0.0,24168.0,0.0,0.0,0.0,10453.0,0.0,0.0,85453.0
Sehore,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Sehore,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,120.0,0.0,0.0,0.0,0.0,2880.0,2310.0,4610.0,12666.0,9364.0,4032.0,144.0,36126.0
Sehore,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,3360.0,0.0,0.0,51792.0,6232.0,27520.0,25210.0,20600.0,7934.0,9023.0,4991.0,4847.0,161509.0
Sehore,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,718.0,218.0,0.0,100.0,0.0,0.0,0.0,0.0,67.0,1451.0,767.0,767.0,4088.0
Sehore,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,2500.0,0.0,0.0,0.0,0.0,68.0,5000.0,0.0,0.0,0.0,7568.0
Sehore,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,500.0,200.0,2400.0,100.0,0.0,0.0,0.0,1.0,3616.0,684.0,0.0,50.0,7551.0
Sehore,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,218.0,18.0,100.0,0.0,0.0,0.0,0.0,67.0,1451.0,767.0,767.0,717.0,4105.0
Sehore,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,25775.0,18775.0,0.0,77475.0,77475.0,24975.0,1493976.0,0.0,224671.0,207546.0,142546.0,107541.0,2400755.0
Sehore,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,100000.0,1500000.0,150000.0,224671.0,0.0,0.0,0.0,0.0,1974671.0
Sehore,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,7000.0,10100.0,0.0,29250.0,152500.0,31000.0,10000.0,0.0,17125.0,65000.0,35005.0,56000.0,412980.0
Sehore,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,18775.0,8675.0,0.0,48225.0,24975.0,1493975.0,1633976.0,224671.0,207546.0,142546.0,107541.0,51541.0,3962446.0
Sehore,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,12000.0,16000.0,21000.0,20000.0,23800.0,25100.0,19100.0,12300.0,7700.0,5300.0,9300.0,3300.0,174900.0
Sehore,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6600.0,6600.0,0.0,6600.0,3300.0,0.0,0.0,0.0,6600.0,6600.0,0.0,6000.0,42300.0
Sehore,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2600.0,3200.0,1000.0,2800.0,2000.0,6000.0,6800.0,4600.0,9000.0,2600.0,6000.0,3000.0,49600.0
Sehore,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,16000.0,19400.0,20000.0,23800.0,25100.0,19100.0,12300.0,7700.0,5300.0,9300.0,3300.0,6300.0,167600.0
Sehore,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,7600.0,7600.0,2800.0,0.0,30600.0,30600.0,22800.0,19400.0,11000.0,121000.0,45000.0,45000.0,343400.0
Sehore,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,33000.0,0.0,0.0,0.0,0.0,110000.0,0.0,0.0,150000.0,293000.0
Sehore,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,4800.0,2800.0,2400.0,0.0,7800.0,3400.0,8400.0,0.0,76000.0,0.0,143000.0,248600.0
Sehore,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,7600.0,2800.0,0.0,30600.0,30600.0,22800.0,19400.0,11000.0,121000.0,45000.0,45000.0,52000.0,387800.0
Sehore,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,10000.0,12000.0,12000.0,12000.0,12000.0,12000.0,12000.0,12000.0,6000.0,4000.0,4000.0,4000.0,112000.0
Sehore,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0
Sehore,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sehore,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,2000.0,0.0,0.0,0.0,10000.0
Sehore,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,12000.0,12000.0,12000.0,12000.0,12000.0,12000.0,12000.0,6000.0,4000.0,4000.0,4000.0,4000.0,106000.0
Sehore,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,5.0,2.0,1.0,7.0,3.0,,,1.0,2.0,1.0,,,22.0
Sehore,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sehore,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sehore,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Sehore,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,1.0,1.0,,2.0
Sehore,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sehore,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,1.0,1.0,,2.0
Sehore,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,4.0,4.0,2.0,2.0,3.0,1.0,2.0,6.0,6.0,5.0,4.0,8.0,47.0
Sehore,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,4.0,5.0,2.0,4.0,1.0,,,,,,,,16.0
Sehore,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,8.0,9.0,4.0,6.0,4.0,1.0,2.0,6.0,6.0,5.0,4.0,8.0,63.0
Sehore,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,4.0,3.0,1.0,3.0,2.0,2.0,4.0,13.0,10.0,7.0,12.0,5.0,66.0
Sehore,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,9.0,,3.0,,,,,,,,13.0
Sehore,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,5.0,3.0,10.0,3.0,5.0,2.0,4.0,13.0,10.0,7.0,12.0,5.0,79.0
Sehore,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,3.0,2.0,4.0,3.0,3.0,1.0,3.0,10.0,7.0,3.0,,1.0,40.0
Sehore,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,3.0,2.0,1.0,2.0,1.0,1.0,,,1.0,2.0,14.0
Sehore,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,3.0,3.0,7.0,5.0,4.0,3.0,4.0,11.0,7.0,3.0,1.0,3.0,54.0
Sehore,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,1.0,,,,,1.0
Sehore,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sehore,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,1.0,,,,,1.0
Sehore,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,2.0,3.0,1.0,1.0,,,,,,,8.0
Sehore,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,1.0,1.0,2.0,2.0,,,,,,,,1.0,7.0
Sehore,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,2.0,4.0,5.0,1.0,1.0,,,,,,1.0,15.0
Sehore,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sehore,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sehore,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Sehore,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,3.0,1.0,2.0,1.0,1.0,2.0,3.0,4.0,6.0,2.0,4.0,30.0
Sehore,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,1.0,5.0,4.0,3.0,3.0,2.0,1.0,2.0,4.0,5.0,,32.0
Sehore,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,4.0,6.0,6.0,4.0,4.0,4.0,4.0,6.0,10.0,7.0,4.0,62.0
Sehore,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Sehore,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Sehore,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Sehore,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Sehore,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Sehore,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Sehore,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,1.0,,,,1.0,2.0
Sehore,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,2.0,,,,1.0,3.0
Sehore,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Sehore,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,1.0,,1.0,,,1.0,,2.0,1.0,1.0,8.0
Sehore,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,2.0,,,1.0,6.0,6.0,3.0,2.0,2.0,22.0
Sehore,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,1.0,1.0,2.0,1.0,,1.0,7.0,6.0,5.0,3.0,3.0,30.0
Sehore,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Sehore,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Sehore,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Sehore,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Sehore,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,1.0,1.0,1.0,,,3.0
Sehore,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,1.0,1.0,,,,,2.0,1.0,2.0,8.0
Sehore,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,,,,1.0,4.0,5.0,17.0,5.0,,,33.0
Sehore,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,1.0,1.0,1.0,1.0,4.0,6.0,18.0,8.0,1.0,2.0,44.0
Sehore,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Sehore,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Sehore,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Sehore,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Sehore,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Sehore,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,1.0,5.0,4.0,5.0,2.0,2.0,2.0,5.0,1.0,,2.0,29.0
Sehore,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,2.0,4.0,1.0,1.0,3.0,2.0,5.0,4.0,4.0,3.0,3.0,33.0
Sehore,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,3.0,9.0,5.0,6.0,5.0,4.0,7.0,9.0,5.0,3.0,5.0,62.0
Sehore,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,1.0,,,1.0,2.0
Sehore,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,1.0,,2.0,1.0,,4.0
Sehore,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,2.0,3.0,4.0,,9.0
Sehore,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,1.0,3.0,5.0,5.0,1.0,15.0
Sehore,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Sehore,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Sehore,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Sehore,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Sehore,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Sehore,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Sehore,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Sehore,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Sehore,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Sehore,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Sehore,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Sehore,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Sehore,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Sehore,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,1.0,1.0,,,,,2.0,,,,4.0
Sehore,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Sehore,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,1.0,1.0,,,,,2.0,,,,4.0
Sehore,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Sehore,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Sehore,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Sehore,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Sehore,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Sehore,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,5.0,1.0,1.0,,2.0,3.0,2.0,4.0,18.0
Sehore,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Sehore,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,5.0,1.0,1.0,,2.0,3.0,2.0,4.0,18.0
Sehore,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,3.0,,2.0,,,3.0,,,,1.0,1.0,10.0
Sehore,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,4.0,2.0,3.0,5.0,13.0,7.0,3.0,1.0,2.0,4.0,4.0,49.0
Sehore,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,2.0,,1.0,3.0,2.0,,1.0,1.0,,,1.0,11.0
Sehore,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,9.0,2.0,6.0,8.0,15.0,10.0,4.0,2.0,2.0,5.0,6.0,70.0
Sehore,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Sehore,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,1.0,,1.0,3.0,,3.0,3.0,3.0,2.0,1.0,2.0,20.0
Sehore,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,1.0,,,,,1.0,1.0,,,,4.0
Sehore,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,2.0,1.0,1.0,3.0,,3.0,4.0,5.0,2.0,1.0,2.0,25.0
Sehore,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Sehore,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,,1.0,1.0,5.0,2.0,,1.0,,1.0,12.0
Sehore,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,,,,1.0,,,,,,,2.0
Sehore,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,1.0,,1.0,2.0,5.0,2.0,,1.0,,1.0,14.0
Sehore,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,1.0,,,,,,,,,2.0
Sehore,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,1.0,1.0,5.0,2.0,6.0,3.0,5.0,,2.0,3.0,2.0,32.0
Sehore,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,3.0,7.0,27.0,13.0,5.0,12.0,19.0,10.0,19.0,15.0,10.0,7.0,147.0
Sehore,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,5.0,8.0,29.0,19.0,7.0,18.0,22.0,15.0,19.0,17.0,13.0,9.0,181.0
Sehore,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,1.0,,2.0,2.0,,,,,,5.0
Sehore,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,,,4.0,2.0,5.0,6.0,4.0,2.0,4.0,8.0,36.0
Sehore,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,10.0,10.0,11.0,3.0,21.0,22.0,25.0,11.0,14.0,16.0,12.0,13.0,168.0
Sehore,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,11.0,10.0,11.0,4.0,25.0,26.0,32.0,17.0,18.0,18.0,16.0,21.0,209.0
Sehore,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,1.0,,1.0,,1.0,3.0,1.0,,,1.0,3.0,13.0
Sehore,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,6.0,8.0,1.0,4.0,3.0,4.0,4.0,5.0,3.0,3.0,2.0,8.0,51.0
Sehore,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,23.0,27.0,27.0,16.0,23.0,45.0,44.0,43.0,27.0,37.0,52.0,59.0,423.0
Sehore,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,31.0,36.0,28.0,21.0,26.0,50.0,51.0,49.0,30.0,40.0,55.0,70.0,487.0
Seoni,1.1,Total number of pregnant women Registered for ANC,TOTAL,1902.0,2193.0,2713.0,2475.0,2071.0,2515.0,2191.0,2441.0,2357.0,2789.0,2702.0,3133.0,29482.0
Seoni,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1175.0,1371.0,1804.0,1709.0,1422.0,1661.0,1545.0,1656.0,1674.0,1957.0,1914.0,2207.0,20095.0
Seoni,1.2,Number of Pregnant women registered under JSY,TOTAL,1861.0,2160.0,2699.0,2466.0,2068.0,2464.0,2186.0,2395.0,2333.0,2682.0,2648.0,3074.0,29036.0
Seoni,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1549.0,1886.0,2145.0,2014.0,1844.0,1901.0,1642.0,1726.0,1672.0,1914.0,1992.0,2135.0,22420.0
Seoni,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1719.0,1917.0,2339.0,2201.0,1795.0,2240.0,2040.0,2151.0,2140.0,2372.0,2276.0,2657.0,25847.0
Seoni,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1822.0,1984.0,2229.0,2175.0,1751.0,1899.0,1861.0,1989.0,2051.0,2146.0,2341.0,2606.0,24854.0
Seoni,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1848.0,2105.0,2611.0,2478.0,2038.0,2163.0,2013.0,2241.0,2079.0,2613.0,2587.0,3054.0,27830.0
Seoni,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,155.0,145.0,174.0,214.0,171.0,180.0,171.0,169.0,187.0,204.0,177.0,240.0,2187.0
Seoni,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,8.0,5.0,7.0,8.0,7.0,3.0,5.0,7.0,12.0,9.0,3.0,4.0,78.0
Seoni,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1137.0,1306.0,1707.0,1944.0,1553.0,1648.0,1446.0,1728.0,1971.0,1928.0,2144.0,2768.0,21280.0
Seoni,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,51.0,51.0,46.0,56.0,91.0,44.0,52.0,118.0,80.0,78.0,66.0,74.0,807.0
Seoni,1.8,Number of pregnancy test kits used at SC level,TOTAL,895.0,1129.0,1715.0,1483.0,1291.0,1395.0,1233.0,1371.0,1431.0,1671.0,1782.0,2036.0,17432.0
Seoni,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,9.0,39.0,60.0,70.0,67.0,89.0,66.0,59.0,37.0,48.0,20.0,34.0,598.0
Seoni,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,43.0,56.0,62.0,70.0,117.0,63.0,62.0,55.0,59.0,54.0,33.0,41.0,715.0
Seoni,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,52.0,95.0,122.0,140.0,184.0,152.0,128.0,114.0,96.0,102.0,53.0,75.0,1313.0
Seoni,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,44.0,83.0,116.0,116.0,163.0,139.0,114.0,101.0,88.0,88.0,52.0,71.0,1175.0
Seoni,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,1.0,6.0,1.0,9.0,7.0,4.0,3.0,4.0,24.0,0.0,24.0,83.0
Seoni,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1307.0,1875.0,2100.0,1999.0,2113.0,2098.0,1803.0,1584.0,1429.0,1304.0,1376.0,1643.0,20631.0
Seoni,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,171.0,203.0,155.0,237.0,116.0,115.0,110.0,104.0,146.0,60.0,57.0,95.0,1569.0
Seoni,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,359.0,1268.0,1411.0,1709.0,1557.0,1794.0,1519.0,1591.0,1410.0,1543.0,1192.0,1864.0,17217.0
Seoni,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,21.0,869.0,1491.0,1607.0,1471.0,1552.0,1521.0,1268.0,1588.0,1273.0,1060.0,944.0,14665.0
Seoni,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,27.0,116.0,169.0,122.0,111.0,174.0,93.0,90.0,70.0,106.0,25.0,66.0,1169.0
Seoni,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,91.0,95.0,115.0,120.0,105.0,113.0,122.0,114.0,103.0,104.0,108.0,136.0,1326.0
Seoni,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Seoni,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Seoni,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Seoni,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,65.0,70.0,93.0,89.0,6.0,10.0,6.0,12.0,9.0,11.0,14.0,21.0,406.0
Seoni,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,146.0,174.0,163.0,124.0,140.0,154.0,151.0,161.0,137.0,107.0,143.0,178.0,1778.0
Seoni,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Seoni,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,211.0,244.0,256.0,213.0,146.0,164.0,157.0,173.0,146.0,118.0,157.0,199.0,2184.0
Seoni,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,64.0,66.0,88.0,83.0,57.0,79.0,75.0,87.0,82.0,85.0,88.0,100.0,954.0
Seoni,4.1.1.a,Number of male live births,TOTAL,685.0,1006.0,1131.0,1077.0,1211.0,1167.0,1044.0,918.0,800.0,764.0,746.0,961.0,11510.0
Seoni,4.1.1.b,Number of female live births,TOTAL,647.0,938.0,1057.0,1031.0,1157.0,1160.0,986.0,870.0,802.0,723.0,780.0,874.0,11025.0
Seoni,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1332.0,1944.0,2188.0,2108.0,2368.0,2327.0,2030.0,1788.0,1602.0,1487.0,1526.0,1835.0,22535.0
Seoni,4.1.2,Number of still births,TOTAL,35.0,39.0,49.0,46.0,50.0,49.0,34.0,32.0,39.0,35.0,20.0,30.0,458.0
Seoni,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,99.0,105.0,116.0,211.0,191.0,188.0,196.0,183.0,192.0,206.0,199.0,260.0,2146.0
Seoni,4.2.1,Number of Newborns weighed at birth,TOTAL,1332.0,1943.0,2188.0,2108.0,2366.0,2324.0,2021.0,1782.0,1601.0,1487.0,1525.0,1834.0,22511.0
Seoni,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,259.0,335.0,329.0,356.0,400.0,410.0,327.0,280.0,257.0,286.0,263.0,288.0,3790.0
Seoni,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1250.0,1857.0,2084.0,2012.0,2283.0,2212.0,1943.0,1694.0,1526.0,1416.0,1456.0,1752.0,21485.0
Seoni,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,5.0,5.0,12.0,11.0,25.0,4.0,15.0,17.0,16.0,18.0,4.0,7.0,139.0
Seoni,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,53.0,67.0,124.0,173.0,81.0,120.0,111.0,136.0,94.0,137.0,125.0,116.0,1337.0
Seoni,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,118.0,174.0,163.0,124.0,143.0,149.0,165.0,139.0,70.0,90.0,73.0,64.0,1472.0
Seoni,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Seoni,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,176.0,246.0,299.0,308.0,249.0,273.0,291.0,292.0,180.0,245.0,202.0,187.0,2948.0
Seoni,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,10.0,4.0,61.0,70.0,47.0,61.0,67.0,55.0,53.0,53.0,59.0,74.0,614.0
Seoni,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,158.0,191.0,246.0,274.0,258.0,298.0,317.0,275.0,214.0,237.0,249.0,243.0,2960.0
Seoni,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,59.0,51.0,101.0,81.0,102.0,66.0,71.0,77.0,67.0,89.0,39.0,89.0,892.0
Seoni,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,121.0,116.0,128.0,164.0,156.0,182.0,187.0,208.0,139.0,148.0,187.0,192.0,1928.0
Seoni,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,72.0,81.0,77.0,40.0,40.0,50.0,91.0,90.0,50.0,61.0,60.0,50.0,762.0
Seoni,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1184.0,1508.0,2076.0,1793.0,1956.0,2218.0,1974.0,1543.0,1586.0,1453.0,1478.0,1784.0,20553.0
Seoni,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,812.0,1272.0,1569.0,1450.0,1430.0,1459.0,1274.0,1397.0,1189.0,1103.0,1176.0,1479.0,15610.0
Seoni,6.3,PNC maternal complications attended,TOTAL,62.0,78.0,103.0,102.0,95.0,78.0,76.0,58.0,50.0,68.0,71.0,56.0,897.0
Seoni,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,32.0,31.0,35.0,27.0,9.0,3.0,8.0,14.0,29.0,14.0,15.0,26.0,243.0
Seoni,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,5.0
Seoni,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,32.0,32.0,36.0,27.0,9.0,3.0,8.0,14.0,30.0,16.0,15.0,26.0,248.0
Seoni,7.2,Number of MTPs conducted at Private Facilities,TOTAL,7.0,8.0,11.0,11.0,12.0,18.0,7.0,9.0,4.0,9.0,13.0,7.0,116.0
Seoni,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,116.0,102.0,150.0,254.0,311.0,180.0,190.0,170.0,257.0,251.0,192.0,322.0,2495.0
Seoni,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,375.0,438.0,655.0,852.0,961.0,818.0,922.0,806.0,697.0,974.0,871.0,828.0,9197.0
Seoni,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,491.0,540.0,805.0,1106.0,1272.0,998.0,1112.0,976.0,954.0,1225.0,1063.0,1150.0,11692.0
Seoni,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,2.0,2.0,1.0,4.0,1.0,10.0,9.0,10.0,2.0,2.0,0.0,0.0,43.0
Seoni,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,1.0,0.0,1.0,1.0,0.0,1.0,1.0,1.0,1.0,0.0,1.0,9.0
Seoni,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Seoni,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,3.0,1.0,5.0,2.0,10.0,10.0,11.0,3.0,3.0,0.0,1.0,52.0
Seoni,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,48.0,0.0,40.0,69.0,38.0,30.0,22.0,247.0
Seoni,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,14.0,37.0,32.0,81.0,104.0,593.0,320.0,1145.0,2044.0,818.0,696.0,267.0,6151.0
Seoni,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,4.0,7.0,6.0,10.0,5.0,5.0,3.0,17.0,23.0,22.0,12.0,18.0,132.0
Seoni,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Seoni,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,18.0,44.0,38.0,91.0,109.0,646.0,323.0,1202.0,2136.0,878.0,738.0,307.0,6530.0
Seoni,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,1.0,3.0,1.0,2.0,3.0,3.0,0.0,0.0,0.0,0.0,13.0
Seoni,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,11.0,3.0,0.0,11.0,1.0,5.0,0.0,0.0,1.0,0.0,0.0,0.0,32.0
Seoni,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,26.0,48.0,3.0,4.0,6.0,7.0,5.0,4.0,6.0,8.0,11.0,7.0,135.0
Seoni,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Seoni,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,37.0,51.0,3.0,15.0,7.0,12.0,5.0,4.0,7.0,8.0,11.0,7.0,167.0
Seoni,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,11.0,2.0,0.0,9.0,8.0,18.0,1.0,0.0,0.0,6.0,7.0,2.0,64.0
Seoni,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,1.0,18.0,22.0,1.0,0.0,24.0,11.0,13.0,3.0,2.0,1.0,1.0,97.0
Seoni,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,25.0,44.0,48.0,37.0,34.0,45.0,38.0,42.0,43.0,33.0,41.0,34.0,464.0
Seoni,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Seoni,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,26.0,62.0,70.0,38.0,34.0,69.0,49.0,55.0,46.0,35.0,42.0,35.0,561.0
Seoni,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,16.0,21.0,,,,14.0,20.0,15.0,15.0,4.0,5.0,110.0
Seoni,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,226.0,399.0,562.0,757.0,613.0,617.0,492.0,580.0,576.0,551.0,547.0,493.0,6413.0
Seoni,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,7.0,10.0,6.0,13.0,5.0,12.0,5.0,4.0,5.0,8.0,3.0,6.0,84.0
Seoni,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,26.0,69.0,61.0,68.0,61.0,134.0,179.0,231.0,188.0,201.0,235.0,242.0,1695.0
Seoni,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,168.0,122.0,110.0,144.0,98.0,111.0,98.0,110.0,105.0,116.0,131.0,129.0,1442.0
Seoni,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Seoni,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,427.0,600.0,739.0,982.0,777.0,874.0,774.0,925.0,874.0,876.0,916.0,870.0,9634.0
Seoni,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,190.0,269.0,155.0,86.0,97.0,244.0,263.0,329.0,273.0,313.0,337.0,371.0,2927.0
Seoni,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,1.0,1.0,4.0,11.0,2.0,5.0,2.0,6.0,4.0,4.0,2.0,5.0,47.0
Seoni,9.06,Number of IUCD removals,TOTAL,400.0,357.0,395.0,413.0,375.0,386.0,337.0,479.0,528.0,410.0,400.0,470.0,4950.0
Seoni,9.07,Number of Oral Pills cycles distributed,TOTAL,2350.0,2566.0,2353.0,3859.0,7074.0,5778.0,3302.0,4770.0,3828.0,3772.0,4051.0,5839.0,49542.0
Seoni,9.08,Number of Condom pieces distributed,TOTAL,14914.0,17528.0,10274.0,6924.0,11018.0,29250.0,17409.0,9008.0,9200.0,9300.0,10299.0,11138.0,156262.0
Seoni,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,21.0,37.0,37.0,0.0,0.0,0.0,26.0,0.0,0.0,0.0,121.0
Seoni,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Seoni,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Seoni,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,9.12,Number of Institutions having NSV trained doctors,TOTAL,8.0,8.0,5.0,3.0,11.0,6.0,7.0,9.0,8.0,17.0,6.0,6.0,-1.0
Seoni,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1202.0,1830.0,2072.0,2054.0,2268.0,2316.0,1976.0,1715.0,1555.0,1469.0,1516.0,1774.0,21747.0
Seoni,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1358.0,1579.0,1913.0,2019.0,1826.0,2444.0,2438.0,362.0,76.0,69.0,9.0,34.0,14127.0
Seoni,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1328.0,1493.0,1857.0,1987.0,1603.0,2109.0,2142.0,2260.0,892.0,395.0,173.0,95.0,16334.0
Seoni,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1535.0,1545.0,1739.0,1940.0,1603.0,1863.0,1901.0,2036.0,2163.0,1176.0,570.0,292.0,18363.0
Seoni,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,40.0,1948.0,2020.0,1803.0,1753.0,1891.0,9455.0
Seoni,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,1355.0,1658.0,2047.0,2060.0,7124.0
Seoni,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,60.0,931.0,1630.0,2224.0,4846.0
Seoni,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1167.0,1733.0,1949.0,1895.0,2090.0,2121.0,1735.0,1519.0,1141.0,1269.0,1338.0,1645.0,19602.0
Seoni,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1328.0,1570.0,1885.0,2019.0,1813.0,2334.0,2244.0,1773.0,1465.0,1737.0,1691.0,1817.0,21676.0
Seoni,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1327.0,1485.0,1835.0,1985.0,1584.0,2111.0,2069.0,2246.0,1495.0,1822.0,2103.0,2116.0,22178.0
Seoni,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1603.0,1535.0,1730.0,1950.0,1604.0,1872.0,1856.0,2057.0,1701.0,1848.0,1997.0,2382.0,22135.0
Seoni,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1136.0,1720.0,1897.0,1828.0,2017.0,2025.0,1707.0,1500.0,1319.0,1228.0,1265.0,1542.0,19184.0
Seoni,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1307.0,1587.0,1892.0,2017.0,1824.0,2345.0,2311.0,368.0,94.0,83.0,41.0,54.0,13923.0
Seoni,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1305.0,1496.0,1830.0,1991.0,1595.0,2097.0,2130.0,2226.0,897.0,407.0,186.0,116.0,16276.0
Seoni,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1490.0,1577.0,1750.0,1940.0,1609.0,1881.0,1886.0,2033.0,2143.0,1171.0,579.0,304.0,18363.0
Seoni,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1037.0,1630.0,2235.0,2951.0,1975.0,2083.0,1744.0,1593.0,1538.0,1814.0,1851.0,2561.0,23012.0
Seoni,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,600.0,1049.0,1336.0,1813.0,1308.0,1277.0,1192.0,1352.0,1451.0,1707.0,1902.0,2799.0,17786.0
Seoni,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,530.0,857.0,1142.0,1484.0,1018.0,1087.0,913.0,829.0,755.0,948.0,974.0,1286.0,11823.0
Seoni,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,507.0,760.0,1091.0,1467.0,951.0,990.0,828.0,743.0,766.0,859.0,871.0,1259.0,11092.0
Seoni,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1037.0,1617.0,2233.0,2951.0,1969.0,2077.0,1741.0,1572.0,1521.0,1807.0,1845.0,2545.0,22915.0
Seoni,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1403.0,1583.0,1808.0,1998.0,1449.0,1653.0,1624.0,1782.0,1962.0,2223.0,1926.0,2777.0,22188.0
Seoni,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1400.0,1574.0,1804.0,2004.0,1436.0,1635.0,1600.0,1775.0,1643.0,2200.0,1933.0,2771.0,21775.0
Seoni,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,18.0,43.0,33.0,36.0,10.0,12.0,9.0,17.0,5.0,13.0,5.0,7.0,208.0
Seoni,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,13.0,30.0,32.0,31.0,10.0,18.0,7.0,16.0,2.0,15.0,6.0,7.0,187.0
Seoni,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,31.0,73.0,65.0,67.0,20.0,30.0,16.0,33.0,7.0,28.0,11.0,14.0,395.0
Seoni,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,558.0,761.0,877.0,1619.0,968.0,1082.0,1018.0,920.0,1106.0,1340.0,1277.0,1534.0,13060.0
Seoni,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,692.0,835.0,1053.0,1908.0,1438.0,1556.0,1339.0,1279.0,1340.0,1518.0,1396.0,1509.0,15863.0
Seoni,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,736.0,916.0,1191.0,2484.0,1524.0,1570.0,1331.0,1351.0,1404.0,1808.0,1524.0,1660.0,17499.0
Seoni,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,6.0,12.0,9.0,11.0,5.0,7.0,11.0,0.0,0.0,0.0,0.0,0.0,61.0
Seoni,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1410.0,1434.0,1518.0,1577.0,1513.0,1532.0,1521.0,1529.0,1516.0,1556.0,1553.0,1595.0,18254.0
Seoni,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1278.0,1331.0,1478.0,1545.0,1427.0,1470.0,1422.0,1467.0,1484.0,1499.0,1519.0,1569.0,17489.0
Seoni,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1227.0,1273.0,1418.0,1496.0,1369.0,1413.0,1368.0,1417.0,1427.0,1446.0,1440.0,1455.0,16749.0
Seoni,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1051.0,1629.0,2217.0,2996.0,1975.0,2074.0,1740.0,1561.0,1499.0,1806.0,1836.0,2557.0,22941.0
Seoni,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,4.0,0.0,9.0,1.0,0.0,2.0,4.0,14.0,1.0,0.0,5.0,0.0,40.0
Seoni,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1.0,0.0,10.0,6.0,1.0,0.0,0.0,0.0,1.0,0.0,4.0,0.0,23.0
Seoni,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,8.0,2.0,0.0,2.0,0.0,2.0,10.0,14.0,3.0,16.0,20.0,77.0
Seoni,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,384.0,620.0,506.0,693.0,726.0,483.0,447.0,620.0,529.0,543.0,915.0,1148.0,7614.0
Seoni,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,12.0,6.0,12.0,17.0,64.0,56.0,49.0,165.0,86.0,90.0,26.0,26.0,609.0
Seoni,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,47.0,36.0,32.0,24.0,58.0,210.0,172.0,50.0,32.0,19.0,57.0,80.0,817.0
Seoni,13.1,Number of Patients operated for cataract,TOTAL,85.0,38.0,51.0,54.0,42.0,82.0,124.0,118.0,77.0,127.0,143.0,152.0,1093.0
Seoni,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,85.0,38.0,51.0,54.0,42.0,82.0,124.0,118.0,77.0,127.0,143.0,152.0,1093.0
Seoni,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,387.0,628.0,864.0,291.0,142.0,319.0,0.0,2631.0
Seoni,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,250.0,494.0,2.0,566.0,603.0,90.0,242.0,2247.0
Seoni,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,5.0,5.0,4.0,4.0,4.0,4.0,5.0,5.0,6.0,6.0,4.0,-1.0
Seoni,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,1.0,1.0,1.0,,1.0,1.0,1.0,5.0,2.0,1.0,-1.0
Seoni,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1224.0,1307.0,1448.0,1546.0,1429.0,1468.0,1415.0,1484.0,1462.0,1431.0,1416.0,1533.0,-1.0
Seoni,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,6.0,7.0,6.0,7.0,8.0,7.0,7.0,7.0,7.0,7.0,5.0,-1.0
Seoni,14.05,Number of RKS meetings held during the month,TOTAL,5.0,4.0,1.0,2.0,1.0,1.0,3.0,2.0,2.0,2.0,2.0,0.0,25.0
Seoni,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,6.0,5.0,5.0,5.0,5.0,4.0,5.0,7.0,4.0,7.0,6.0,4.0,-1.0
Seoni,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,7.0,6.0,6.0,7.0,7.0,9.0,9.0,111.0,11.0,11.0,8.0,12.0,204.0
Seoni,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,4.0,2.0,1.0,-1.0
Seoni,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Seoni,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,624.0,853.0,901.0,798.0,896.0,1126.0,917.0,852.0,651.0,708.0,691.0,763.0,9780.0
Seoni,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1326.0,2653.0,1887.0,1579.0,1643.0,1764.0,1551.0,1567.0,1276.0,1079.0,1343.0,1393.0,19061.0
Seoni,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,470.0,643.0,822.0,613.0,759.0,871.0,762.0,642.0,588.0,613.0,688.0,804.0,8275.0
Seoni,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2781.0,2879.0,3955.0,4052.0,4248.0,4341.0,3568.0,3518.0,4218.0,3430.0,3335.0,3731.0,44056.0
Seoni,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1094.0,1496.0,1723.0,1411.0,1655.0,1997.0,1679.0,1494.0,1239.0,1321.0,1379.0,1567.0,18055.0
Seoni,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4107.0,5532.0,5842.0,5631.0,5891.0,6105.0,5119.0,5085.0,5494.0,4509.0,4678.0,5124.0,63117.0
Seoni,14.10.2.a,Number of death cases of Inpatient males,TOTAL,44.0,4.0,52.0,41.0,42.0,43.0,66.0,41.0,51.0,37.0,6.0,46.0,473.0
Seoni,14.10.2.b,Number of death cases of Inpatient females,TOTAL,21.0,3.0,45.0,32.0,24.0,35.0,28.0,31.0,29.0,32.0,4.0,24.0,308.0
Seoni,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,65.0,7.0,97.0,73.0,66.0,78.0,94.0,72.0,80.0,69.0,10.0,70.0,781.0
Seoni,14.11,In-Patient Head Count at midnight,TOTAL,10775.0,14489.0,14922.0,15334.0,15219.0,16459.0,14793.0,14174.0,13211.0,11590.0,11854.0,13809.0,166629.0
Seoni,14.12.1,OPD attendance (All),TOTAL,42833.0,41392.0,66693.0,72625.0,79836.0,109626.0,77393.0,79920.0,70182.0,66138.0,79034.0,93535.0,879207.0
Seoni,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,230.0,261.0,262.0,242.0,232.0,262.0,245.0,275.0,232.0,215.0,266.0,267.0,2989.0
Seoni,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,1.0,2.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Seoni,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,204.0,221.0,203.0,340.0,281.0,667.0,311.0,1351.0,2414.0,1207.0,984.0,593.0,8776.0
Seoni,14.14.a,Number of patients given AYUSH treatment,TOTAL,1009.0,1132.0,1104.0,1229.0,1055.0,1446.0,1323.0,1623.0,1533.0,1324.0,1614.0,1132.0,15524.0
Seoni,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3249.0,4138.0,5137.0,5181.0,4438.0,5611.0,4493.0,4770.0,4736.0,3827.0,4821.0,5089.0,55490.0
Seoni,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,128.0,206.0,213.0,214.0,182.0,198.0,177.0,215.0,101.0,153.0,140.0,146.0,2073.0
Seoni,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,223.0,218.0,229.0,337.0,292.0,364.0,147.0,125.0,283.0,117.0,155.0,129.0,2619.0
Seoni,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,7.0,11.0,7.0,11.0,5.0,7.0,2.0,5.0,6.0,4.0,9.0,1.0,75.0
Seoni,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,214.0,234.0,250.0,309.0,407.0,610.0,156.0,127.0,379.0,119.0,183.0,159.0,3147.0
Seoni,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,4.0,11.0,6.0,6.0,2.0,8.0,6.0,6.0,7.0,2.0,3.0,2.0,63.0
Seoni,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1282.0,1663.0,2333.0,1875.0,1475.0,2160.0,1456.0,1721.0,1715.0,1987.0,1795.0,1511.0,20973.0
Seoni,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,2.0,2.0,2.0,0.0,1.0,0.0,1.0,4.0,0.0,1.0,0.0,13.0
Seoni,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1719.0,2115.0,2812.0,2521.0,2174.0,3134.0,1759.0,1973.0,2377.0,2223.0,2133.0,1799.0,26739.0
Seoni,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,11.0,24.0,15.0,19.0,7.0,16.0,8.0,12.0,17.0,6.0,13.0,3.0,151.0
Seoni,15.2,Number of Widal tests conducted,Number tested,939.0,1266.0,1259.0,1361.0,1642.0,2369.0,1930.0,1953.0,1105.0,971.0,1410.0,1363.0,17568.0
Seoni,15.3.a,Number of VDRL tests conducted on males,Number tested,97.0,89.0,199.0,81.0,88.0,109.0,280.0,169.0,106.0,63.0,131.0,201.0,1613.0
Seoni,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,95.0,134.0,209.0,192.0,103.0,151.0,165.0,113.0,119.0,112.0,151.0,150.0,1694.0
Seoni,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,382.0,351.0,398.0,304.0,333.0,1664.0,562.0,1109.0,888.0,920.0,981.0,621.0,8513.0
Seoni,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,574.0,574.0,806.0,577.0,524.0,1924.0,1007.0,1391.0,1113.0,1095.0,1263.0,972.0,11820.0
Seoni,15.4.1,Number of blood smears examined for Malaria,TOTAL,6392.0,13902.0,17013.0,18780.0,17406.0,25423.0,21073.0,19905.0,17478.0,13318.0,11071.0,14119.0,195880.0
Seoni,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,13.0,38.0,53.0,49.0,65.0,104.0,104.0,133.0,75.0,37.0,39.0,57.0,767.0
Seoni,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,3.0,22.0,42.0,26.0,81.0,120.0,172.0,356.0,186.0,53.0,13.0,18.0,1092.0
Seoni,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1900.0,2200.0,1600.0,1400.0,4050.0,3300.0,1400.0,1450.0,2500.0,1950.0,1650.0,1900.0,25300.0
Seoni,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1000.0,1000.0,1000.0,4000.0,0.0,0.0,1000.0,2000.0,0.0,0.0,1000.0,0.0,11000.0
Seoni,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,700.0,1600.0,1200.0,1350.0,750.0,1900.0,950.0,950.0,550.0,300.0,750.0,250.0,11250.0
Seoni,16.1.1,Stock position of DPT vaccines,5. Total Stock,2200.0,1600.0,1400.0,4050.0,3300.0,1400.0,1450.0,2500.0,1950.0,1650.0,1900.0,1650.0,25050.0
Seoni,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,250.0,150.0,50.0,950.0,950.0,2350.0
Seoni,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,0.0,0.0,1000.0,1000.0,1000.0,3000.0
Seoni,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,100.0,100.0,100.0,1000.0,650.0,1950.0
Seoni,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,150.0,50.0,950.0,950.0,1300.0,3400.0
Seoni,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,800.0,1300.0,900.0,1100.0,1100.0,800.0,250.0,200.0,75.0,475.0,225.0,825.0,8050.0
Seoni,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1200.0,1000.0,1000.0,500.0,700.0,400.0,725.0,300.0,1000.0,0.0,1000.0,800.0,8625.0
Seoni,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,700.0,1400.0,800.0,500.0,1000.0,950.0,775.0,425.0,600.0,250.0,400.0,0.0,7800.0
Seoni,16.1.2,Stock position of OPV vaccines,5. Total Stock,1300.0,900.0,1100.0,1100.0,800.0,250.0,200.0,75.0,475.0,225.0,825.0,1625.0,8875.0
Seoni,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2600.0,2700.0,1350.0,1400.0,2800.0,2850.0,1500.0,1500.0,2100.0,1500.0,1900.0,1400.0,23600.0
Seoni,16.1.3,Stock position of TT vaccines,2. Stocks Received,1000.0,1000.0,1000.0,2000.0,1000.0,0.0,1000.0,1400.0,0.0,1000.0,1000.0,1000.0,11400.0
Seoni,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.1.3,Stock position of TT vaccines,4. Stock Distributed,900.0,2350.0,950.0,600.0,950.0,1350.0,1000.0,800.0,600.0,600.0,1500.0,1000.0,12600.0
Seoni,16.1.3,Stock position of TT vaccines,5. Total Stock,2700.0,1350.0,1400.0,2800.0,2850.0,1500.0,1500.0,2100.0,1500.0,1900.0,1400.0,1400.0,22400.0
Seoni,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Seoni,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Seoni,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Seoni,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1150.0,1800.0,1200.0,1800.0,2300.0,1700.0,900.0,550.0,1250.0,950.0,750.0,950.0,15300.0
Seoni,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000.0,1000.0,1000.0,1000.0,0.0,0.0,0.0,1000.0,0.0,0.0,1000.0,1000.0,7000.0
Seoni,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,350.0,1600.0,400.0,500.0,600.0,800.0,350.0,300.0,300.0,200.0,800.0,350.0,6550.0
Seoni,16.1.5,Stock position of BCG vaccines,5. Total Stock,1800.0,1200.0,1800.0,2300.0,1700.0,900.0,550.0,1250.0,950.0,750.0,950.0,1600.0,15750.0
Seoni,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,400.0,1450.0,300.0,1400.0,2250.0,1200.0,950.0,1000.0,950.0,650.0,850.0,400.0,11800.0
Seoni,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2000.0,0.0,2000.0,2000.0,0.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,2000.0,14000.0
Seoni,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,950.0,1150.0,900.0,1150.0,1050.0,1250.0,950.0,1050.0,1300.0,800.0,1450.0,950.0,12950.0
Seoni,16.1.6,Stock position of Measles vaccines,5. Total Stock,1450.0,300.0,1400.0,2250.0,1200.0,950.0,1000.0,950.0,650.0,850.0,400.0,1450.0,12850.0
Seoni,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Seoni,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Seoni,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Seoni,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1350.0,2000.0,700.0,1500.0,3200.0,3350.0,2000.0,2000.0,2300.0,1800.0,1600.0,2000.0,23800.0
Seoni,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000.0,1000.0,1900.0,3000.0,1000.0,0.0,1000.0,1000.0,0.0,0.0,1000.0,1000.0,11900.0
Seoni,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,350.0,2300.0,1100.0,1300.0,850.0,1350.0,1000.0,700.0,500.0,200.0,600.0,0.0,10250.0
Seoni,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2000.0,700.0,1500.0,3200.0,3350.0,2000.0,2000.0,2300.0,1800.0,1600.0,2000.0,3000.0,25450.0
Seoni,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,900.0,700.0,600.0,0.0,800.0,1200.0,600.0,2600.0,2000.0,1200.0,1200.0,1800.0,13600.0
Seoni,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,3600.0,0.0,0.0,1200.0,600.0,0.0,3600.0,0.0,0.0,0.0,3000.0,0.0,12000.0
Seoni,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,3800.0,100.0,600.0,400.0,200.0,600.0,1600.0,600.0,800.0,0.0,2400.0,1000.0,12100.0
Seoni,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,700.0,600.0,0.0,800.0,1200.0,600.0,2600.0,2000.0,1200.0,1200.0,1800.0,800.0,13500.0
Seoni,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,45360.0,25440.0,7320.0,7320.0,7320.0,17420.0,0.0,,,,0.0,16000.0,126180.0
Seoni,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,50400.0,0.0,0.0,0.0,100800.0,0.0,0.0,,,,24000.0,0.0,175200.0
Seoni,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,70320.0,18120.0,0.0,0.0,90700.0,17420.0,0.0,,,,8000.0,7000.0,211560.0
Seoni,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,25440.0,7320.0,7320.0,7320.0,17420.0,0.0,0.0,0.0,0.0,0.0,16000.0,9000.0,89820.0
Seoni,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,100.0,100.0,100.0,100.0,12100.0,1900.0,100.0,2900.0,400.0,200.0,200.0,14800.0,33000.0
Seoni,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,30000.0,2400.0,0.0,5000.0,0.0,0.0,0.0,24000.0,0.0,61400.0
Seoni,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,18000.0,12600.0,1800.0,2200.0,2500.0,200.0,0.0,9400.0,8400.0,55100.0
Seoni,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,100.0,100.0,100.0,12100.0,1900.0,100.0,2900.0,400.0,200.0,200.0,14800.0,6400.0,39300.0
Seoni,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,900.0,300.0,300.0,300.0,300.0,300.0,250.0,1000.0,950.0,950.0,700.0,4050.0,10300.0
Seoni,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,1200.0,0.0,0.0,900.0,600.0,0.0,2000.0,0.0,0.0,0.0,6000.0,0.0,10700.0
Seoni,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,1800.0,0.0,0.0,900.0,600.0,50.0,1250.0,50.0,0.0,250.0,2650.0,2750.0,10300.0
Seoni,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,300.0,300.0,300.0,300.0,300.0,250.0,1000.0,950.0,950.0,700.0,4050.0,1300.0,10700.0
Seoni,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,10350.0,10350.0,10350.0,10350.0,10350.0,10350.0,10350.0,10350.0,8350.0,5350.0,5350.0,10265.0,112115.0
Seoni,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4915.0,0.0,4915.0
Seoni,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,3000.0,0.0,0.0,0.0,5000.0
Seoni,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,10350.0,10350.0,10350.0,10350.0,10350.0,10350.0,10350.0,8350.0,5350.0,5350.0,10265.0,10265.0,112030.0
Seoni,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,11050.0,9050.0,6850.0,3240.0,1040.0,240.0,6110.0,2410.0,510.0,60.0,60.0,60.0,40680.0
Seoni,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,11000.0,0.0,0.0,0.0,0.0,0.0,10000.0,21000.0
Seoni,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,2000.0,2200.0,3610.0,2200.0,800.0,5130.0,3700.0,1900.0,450.0,0.0,0.0,5950.0,27940.0
Seoni,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,9050.0,6850.0,3240.0,1040.0,240.0,6110.0,2410.0,510.0,60.0,60.0,60.0,4110.0,33740.0
Seoni,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,7275.0,7275.0,3625.0,10000.0,10000.0,1500.0,14390.0,14390.0,27715.0,21040.0,12150.0,8150.0,137510.0
Seoni,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,10000.0,0.0,0.0,49140.0,0.0,20000.0,0.0,0.0,0.0,0.0,79140.0
Seoni,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,3650.0,3625.0,0.0,8500.0,36250.0,0.0,6675.0,6675.0,8890.0,4000.0,4650.0,82915.0
Seoni,16.3.02,Stock Position of Gloves,5. Total Stock,7275.0,3625.0,10000.0,10000.0,1500.0,14390.0,14390.0,27715.0,21040.0,12150.0,8150.0,3500.0,133735.0
Seoni,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Seoni,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Seoni,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Seoni,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,1100.0,400.0,,,,,,,10000.0,2300.0,1000.0,900.0,15700.0
Seoni,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,,,,,,,0.0,0.0,0.0,0.0,0.0
Seoni,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,700.0,400.0,,,,,,,7700.0,1300.0,100.0,100.0,10300.0
Seoni,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2300.0,1000.0,900.0,800.0,5400.0
Seoni,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Seoni,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Seoni,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Seoni,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Seoni,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Seoni,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Seoni,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Seoni,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,842730.0,622730.0,275730.0,105730.0,730.0,730.0,730.0,730.0,730.0,2250360.0,1650000.0,1450730.0,7201660.0
Seoni,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6500000.0,0.0,0.0,0.0,6500000.0
Seoni,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,220000.0,347000.0,170000.0,105000.0,0.0,0.0,0.0,0.0,4250370.0,600360.0,199270.0,400000.0,6292000.0
Seoni,16.3.07,Stock Position of IFA Tablets,5. Total Stock,622730.0,275730.0,105730.0,730.0,730.0,730.0,730.0,730.0,2250360.0,1650000.0,1450730.0,1050730.0,7409660.0
Seoni,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,110.0,110.0,110.0,110.0,110.0,7156.0,6192.0,6192.0,5892.0,,2212.0,294.0,28488.0
Seoni,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,50000.0,0.0,0.0,0.0,0.0,,0.0,0.0,50000.0
Seoni,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,42954.0,964.0,0.0,300.0,3680.0,,1918.0,0.0,49816.0
Seoni,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,110.0,110.0,110.0,110.0,7156.0,6192.0,6192.0,5892.0,2212.0,0.0,294.0,294.0,28672.0
Seoni,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,10100.0,30100.0,14100.0,8350.0,8350.0,6150.0,3250.0,550.0,550.0,550.0,550.0,0.0,82600.0
Seoni,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,20000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20000.0
Seoni,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,16000.0,5750.0,0.0,2200.0,2900.0,2700.0,0.0,0.0,0.0,550.0,0.0,30100.0
Seoni,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,30100.0,14100.0,8350.0,8350.0,6150.0,3250.0,550.0,550.0,550.0,550.0,0.0,0.0,72500.0
Seoni,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,900.0,800.0,790.0,0.0,0.0,,,,5900.0,3400.0,2210.0,2210.0,16210.0
Seoni,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0,0.0
Seoni,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,100.0,10.0,790.0,0.0,0.0,,,,2500.0,1190.0,0.0,170.0,4760.0
Seoni,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,800.0,790.0,0.0,0.0,0.0,0.0,0.0,0.0,3400.0,2210.0,2210.0,2040.0,11450.0
Seoni,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,208570.0,139570.0,63270.0,48270.0,94270.0,26270.0,6470.0,85470.0,275970.0,274370.0,271570.0,200070.0,1694140.0
Seoni,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,150000.0,0.0,0.0,100000.0,200000.0,0.0,0.0,0.0,0.0,450000.0
Seoni,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,69000.0,76300.0,15000.0,104000.0,68000.0,19800.0,21000.0,9500.0,1600.0,2800.0,71500.0,18600.0,477100.0
Seoni,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,139570.0,63270.0,48270.0,94270.0,26270.0,6470.0,85470.0,275970.0,274370.0,271570.0,200070.0,181470.0,1667040.0
Seoni,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1500.0,1500.0,3000.0,4200.0,13700.0,10700.0,8700.0,,23800.0,23300.0,23300.0,23300.0,137000.0
Seoni,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,4000.0,4000.0,19800.0,0.0,0.0,19800.0,,0.0,0.0,0.0,0.0,47600.0
Seoni,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,2500.0,2800.0,10300.0,3000.0,2000.0,28000.0,,500.0,0.0,0.0,2000.0,51100.0
Seoni,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1500.0,3000.0,4200.0,13700.0,10700.0,8700.0,500.0,0.0,23300.0,23300.0,23300.0,21300.0,133500.0
Seoni,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,110000.0,110000.0,110000.0,85000.0,382800.0,358800.0,334600.0,592600.0,498600.0,402600.0,400600.0,396600.0,3782200.0
Seoni,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,400000.0,0.0,0.0,270000.0,0.0,0.0,0.0,0.0,0.0,670000.0
Seoni,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,25000.0,102200.0,24000.0,24200.0,12000.0,94000.0,96000.0,2000.0,4000.0,10000.0,393400.0
Seoni,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,110000.0,110000.0,85000.0,382800.0,358800.0,334600.0,592600.0,498600.0,402600.0,400600.0,396600.0,386600.0,4058800.0
Seoni,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,5000.0,5000.0,24000.0,24000.0,23500.0,47000.0,43000.0,41000.0,4100.0,37000.0,253600.0
Seoni,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,5000.0,5000.0,20000.0,0.0,0.0,24000.0,0.0,0.0,0.0,65800.0,0.0,119800.0
Seoni,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Seoni,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,5000.0,1000.0,0.0,500.0,500.0,4000.0,2000.0,36900.0,32900.0,0.0,82800.0
Seoni,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,5000.0,5000.0,24000.0,24000.0,23500.0,47000.0,43000.0,41000.0,4100.0,37000.0,37000.0,290600.0
Seoni,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,2.0,,9.0,4.0,4.0,4.0,1.0,,1.0,1.0,26.0
Seoni,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,1.0,3.0,2.0,2.0,5.0,2.0,1.0,1.0,1.0,3.0,1.0,22.0
Seoni,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,1.0,,,1.0,,,2.0,,1.0,,6.0
Seoni,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,2.0,4.0,2.0,2.0,6.0,2.0,1.0,3.0,1.0,4.0,1.0,28.0
Seoni,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,3.0,5.0,4.0,9.0,3.0,7.0,6.0,,4.0,2.0,5.0,5.0,53.0
Seoni,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,1.0,1.0,,1.0,1.0,,,,,1.0,,5.0
Seoni,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,3.0,6.0,5.0,9.0,4.0,8.0,6.0,,4.0,2.0,6.0,5.0,58.0
Seoni,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,7.0,6.0,15.0,7.0,13.0,7.0,7.0,15.0,2.0,2.0,5.0,3.0,89.0
Seoni,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,3.0,1.0,1.0,5.0,1.0,,2.0,2.0,3.0,3.0,22.0
Seoni,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,8.0,6.0,18.0,8.0,14.0,12.0,8.0,15.0,4.0,4.0,8.0,6.0,111.0
Seoni,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,6.0,11.0,7.0,8.0,3.0,9.0,7.0,8.0,9.0,7.0,12.0,89.0
Seoni,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,2.0,,4.0,3.0,3.0,3.0,4.0,4.0,2.0,2.0,28.0
Seoni,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,7.0,13.0,7.0,12.0,6.0,12.0,10.0,12.0,13.0,9.0,14.0,117.0
Seoni,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,3.0,5.0,8.0,1.0,3.0,5.0,6.0,3.0,2.0,6.0,6.0,2.0,50.0
Seoni,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,1.0,,,1.0,2.0,,2.0,,2.0,2.0,10.0
Seoni,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,3.0,5.0,9.0,1.0,3.0,6.0,8.0,3.0,4.0,6.0,8.0,4.0,60.0
Seoni,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,1.0,,1.0,,,,,,1.0,,1.0,4.0
Seoni,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,1.0,,1.0,,,,,1.0,3.0
Seoni,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,1.0,,1.0,1.0,,1.0,,,1.0,,2.0,7.0
Seoni,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,2.0,5.0,,1.0,,4.0,,1.0,,,3.0,17.0
Seoni,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,,,2.0,3.0,3.0,,1.0,,2.0,,12.0
Seoni,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,3.0,5.0,,3.0,3.0,7.0,,2.0,,2.0,3.0,29.0
Seoni,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Seoni,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Seoni,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Seoni,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,5.0,6.0,9.0,9.0,12.0,9.0,12.0,7.0,6.0,9.0,15.0,101.0
Seoni,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,6.0,8.0,7.0,2.0,9.0,15.0,11.0,4.0,9.0,3.0,5.0,7.0,86.0
Seoni,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,8.0,13.0,13.0,11.0,18.0,27.0,20.0,16.0,16.0,9.0,14.0,22.0,187.0
Seoni,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Seoni,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,1.0,,1.0,,,,,1.0,,,2.0,2.0,7.0
Seoni,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,,2.0,,1.0,,,1.0,,1.0,,,6.0
Seoni,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,2.0,,3.0,,1.0,,,2.0,,1.0,2.0,2.0,13.0
Seoni,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Seoni,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,3.0,6.0,2.0,6.0,7.0,6.0,5.0,6.0,11.0,4.0,1.0,58.0
Seoni,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,,,2.0,,2.0,1.0,,1.0,2.0,2.0,11.0
Seoni,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,4.0,6.0,2.0,9.0,7.0,8.0,6.0,6.0,12.0,6.0,3.0,70.0
Seoni,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Seoni,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,3.0,,,,5.0,3.0,3.0,1.0,3.0,3.0,21.0
Seoni,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,,3.0,,2.0,1.0,2.0,3.0,4.0,4.0,2.0,3.0,26.0
Seoni,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,,6.0,,2.0,1.0,7.0,6.0,7.0,5.0,5.0,7.0,48.0
Seoni,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Seoni,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,1.0,1.0,,,,2.0
Seoni,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Seoni,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,1.0,1.0,1.0,,,,3.0
Seoni,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,1.0,1.0,,,,,,1.0,3.0
Seoni,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,3.0,2.0,5.0,4.0,7.0,5.0,7.0,3.0,1.0,1.0,3.0,12.0,53.0
Seoni,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,2.0,3.0,,1.0,5.0,8.0,1.0,2.0,,4.0,9.0,13.0,48.0
Seoni,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,5.0,5.0,5.0,5.0,13.0,14.0,8.0,5.0,1.0,5.0,12.0,26.0,104.0
Seoni,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Seoni,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,1.0,1.0,1.0,1.0,,1.0,,,2.0,,,1.0,8.0
Seoni,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Seoni,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,1.0,1.0,1.0,2.0,,1.0,,,2.0,,,1.0,9.0
Seoni,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,1.0,,,,,,,,,2.0
Seoni,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,11.0,17.0,16.0,18.0,20.0,23.0,21.0,16.0,12.0,15.0,26.0,22.0,217.0
Seoni,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,20.0,22.0,23.0,20.0,24.0,25.0,24.0,22.0,23.0,34.0,16.0,25.0,278.0
Seoni,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,31.0,39.0,40.0,39.0,44.0,48.0,45.0,38.0,35.0,49.0,42.0,47.0,497.0
Seoni,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,2.0,2.0
Seoni,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,1.0,2.0,4.0,,2.0,4.0,6.0,2.0,5.0,,3.0,31.0
Seoni,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,3.0,5.0,4.0,4.0,3.0,6.0,6.0,12.0,11.0,8.0,23.0,2.0,87.0
Seoni,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,5.0,6.0,6.0,8.0,3.0,8.0,10.0,18.0,13.0,13.0,23.0,7.0,120.0
Seoni,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Seoni,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Seoni,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Seoni,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Seoni,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Seoni,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,1.0,,,1.0
Seoni,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Seoni,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,1.0,,,1.0
Seoni,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Seoni,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,1.0,1.0,,,,,,1.0,1.0,,4.0
Seoni,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Seoni,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,1.0,1.0,,,,,,1.0,1.0,,4.0
Seoni,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Seoni,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,1.0,,,,1.0,2.0,1.0,,,,6.0
Seoni,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Seoni,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,1.0,,,,1.0,2.0,1.0,,,,6.0
Seoni,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Seoni,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Seoni,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Seoni,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,1.0,,,,,1.0
Seoni,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Seoni,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,2.0,2.0,2.0,1.0,2.0,,2.0,2.0,2.0,,,16.0
Seoni,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Seoni,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,2.0,2.0,2.0,1.0,2.0,,2.0,2.0,2.0,,,16.0
Seoni,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,1.0,2.0,6.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,3.0,22.0
Seoni,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,12.0,21.0,22.0,19.0,16.0,19.0,20.0,26.0,19.0,19.0,13.0,21.0,227.0
Seoni,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,4.0,3.0,1.0,3.0,2.0,2.0,4.0,4.0,5.0,5.0,1.0,3.0,37.0
Seoni,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,17.0,25.0,25.0,28.0,20.0,22.0,25.0,32.0,25.0,25.0,15.0,27.0,286.0
Seoni,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Seoni,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,6.0,5.0,5.0,9.0,5.0,8.0,7.0,9.0,1.0,7.0,2.0,9.0,73.0
Seoni,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,1.0,,,1.0,,1.0,,1.0,4.0,8.0
Seoni,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,6.0,5.0,5.0,10.0,5.0,8.0,8.0,9.0,2.0,7.0,3.0,14.0,82.0
Seoni,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,2.0,3.0,3.0,1.0,2.0,,,,,,12.0
Seoni,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,2.0,2.0,6.0,2.0,6.0,1.0,1.0,1.0,1.0,,,22.0
Seoni,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Seoni,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,3.0,4.0,9.0,6.0,7.0,3.0,1.0,1.0,1.0,,,35.0
Seoni,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,2.0,,,,2.0,1.0,1.0,1.0,,,,,7.0
Seoni,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,12.0,9.0,14.0,8.0,14.0,13.0,15.0,14.0,20.0,10.0,9.0,9.0,147.0
Seoni,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,14.0,20.0,41.0,4.0,23.0,30.0,17.0,34.0,10.0,7.0,21.0,22.0,243.0
Seoni,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,28.0,29.0,55.0,12.0,39.0,44.0,33.0,49.0,30.0,17.0,30.0,31.0,397.0
Seoni,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,,,1.0,1.0,1.0,,2.0,4.0,,,3.0,13.0
Seoni,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,9.0,19.0,23.0,20.0,13.0,15.0,23.0,32.0,15.0,16.0,15.0,26.0,226.0
Seoni,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,12.0,15.0,31.0,20.0,28.0,28.0,18.0,61.0,56.0,26.0,28.0,32.0,355.0
Seoni,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,22.0,34.0,54.0,41.0,42.0,44.0,41.0,95.0,75.0,42.0,43.0,61.0,594.0
Seoni,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,2.0,2.0,5.0,4.0,7.0,3.0,2.0,4.0,3.0,2.0,2.0,38.0
Seoni,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,23.0,40.0,56.0,39.0,51.0,73.0,71.0,68.0,48.0,37.0,38.0,34.0,578.0
Seoni,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,64.0,109.0,200.0,131.0,211.0,200.0,206.0,193.0,176.0,234.0,146.0,183.0,2053.0
Seoni,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,89.0,151.0,258.0,175.0,266.0,280.0,280.0,263.0,228.0,274.0,186.0,219.0,2669.0
Shahdol,1.1,Total number of pregnant women Registered for ANC,TOTAL,2138.0,2047.0,2460.0,2840.0,1906.0,2158.0,1999.0,2168.0,2121.0,2431.0,2336.0,2531.0,27135.0
Shahdol,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1224.0,1095.0,1357.0,1630.0,1054.0,1285.0,1226.0,1399.0,1339.0,1627.0,1779.0,1876.0,16891.0
Shahdol,1.2,Number of Pregnant women registered under JSY,TOTAL,2137.0,2043.0,2460.0,2840.0,1906.0,2158.0,1999.0,2168.0,2121.0,2258.0,2295.0,2352.0,26737.0
Shahdol,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1861.0,1782.0,1863.0,1909.0,1810.0,2036.0,1745.0,1823.0,1794.0,1923.0,1894.0,2441.0,22881.0
Shahdol,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1586.0,1529.0,1787.0,2101.0,1394.0,1514.0,1675.0,1629.0,1562.0,1698.0,1902.0,2057.0,20434.0
Shahdol,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1528.0,1647.0,1796.0,1839.0,1780.0,1365.0,1532.0,1542.0,1581.0,1541.0,1885.0,2100.0,20136.0
Shahdol,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1888.0,2048.0,2206.0,2619.0,1792.0,1996.0,1947.0,2229.0,2030.0,2131.0,2350.0,2537.0,25773.0
Shahdol,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,49.0,44.0,87.0,113.0,55.0,30.0,83.0,68.0,58.0,37.0,43.0,29.0,696.0
Shahdol,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,3.0,15.0,28.0,13.0,6.0,12.0,8.0,13.0,13.0,8.0,5.0,127.0
Shahdol,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1117.0,968.0,1749.0,2166.0,1625.0,1827.0,1581.0,1852.0,2005.0,2123.0,1940.0,1997.0,20950.0
Shahdol,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,61.0,69.0,101.0,204.0,120.0,146.0,70.0,190.0,50.0,92.0,103.0,52.0,1258.0
Shahdol,1.8,Number of pregnancy test kits used at SC level,TOTAL,525.0,818.0,1155.0,1813.0,1261.0,1440.0,1414.0,1464.0,1384.0,1629.0,1510.0,1591.0,16004.0
Shahdol,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,208.0,147.0,213.0,208.0,249.0,293.0,226.0,206.0,140.0,152.0,120.0,133.0,2295.0
Shahdol,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,50.0,45.0,13.0,81.0,39.0,23.0,44.0,26.0,38.0,28.0,37.0,27.0,451.0
Shahdol,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,258.0,192.0,226.0,289.0,288.0,316.0,270.0,232.0,178.0,180.0,157.0,160.0,2746.0
Shahdol,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,210.0,155.0,220.0,270.0,277.0,311.0,262.0,215.0,176.0,163.0,142.0,136.0,2537.0
Shahdol,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,6.0,6.0,18.0,5.0,17.0,20.0,11.0,14.0,15.0,13.0,12.0,137.0
Shahdol,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1521.0,1341.0,1541.0,1783.0,1893.0,1754.0,1651.0,1499.0,1468.0,1480.0,1332.0,1388.0,18651.0
Shahdol,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,8.0,9.0,10.0,37.0,11.0,21.0,42.0,12.0,12.0,11.0,21.0,24.0,218.0
Shahdol,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,730.0,825.0,1405.0,1415.0,1468.0,1406.0,1246.0,1256.0,1223.0,1108.0,1203.0,1433.0,14718.0
Shahdol,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,180.0,737.0,720.0,1161.0,1453.0,1059.0,1155.0,1026.0,1324.0,732.0,1401.0,1132.0,12080.0
Shahdol,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,52.0,69.0,51.0,172.0
Shahdol,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Shahdol,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Shahdol,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Shahdol,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,2.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Shahdol,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,184.0,183.0,166.0,208.0,212.0,190.0,203.0,181.0,203.0,207.0,148.0,191.0,2276.0
Shahdol,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shahdol,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,184.0,183.0,166.0,208.0,214.0,193.0,203.0,181.0,203.0,207.0,148.0,191.0,2281.0
Shahdol,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,51.0,57.0,40.0,148.0
Shahdol,4.1.1.a,Number of male live births,TOTAL,920.0,749.0,897.0,1047.0,1127.0,1046.0,977.0,875.0,858.0,861.0,801.0,788.0,10946.0
Shahdol,4.1.1.b,Number of female live births,TOTAL,831.0,741.0,854.0,977.0,997.0,988.0,904.0,835.0,768.0,828.0,723.0,772.0,10218.0
Shahdol,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1751.0,1490.0,1751.0,2024.0,2124.0,2034.0,1881.0,1710.0,1626.0,1689.0,1524.0,1560.0,21164.0
Shahdol,4.1.2,Number of still births,TOTAL,39.0,52.0,50.0,66.0,76.0,53.0,62.0,40.0,46.0,49.0,49.0,60.0,642.0
Shahdol,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,18.0,20.0,69.0,50.0,47.0,61.0,48.0,102.0,90.0,107.0,90.0,53.0,755.0
Shahdol,4.2.1,Number of Newborns weighed at birth,TOTAL,1681.0,1457.0,1739.0,2023.0,2062.0,1991.0,1750.0,1626.0,1618.0,1633.0,1514.0,1557.0,20651.0
Shahdol,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,162.0,207.0,249.0,270.0,298.0,233.0,284.0,222.0,199.0,215.0,180.0,201.0,2720.0
Shahdol,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1728.0,1431.0,1714.0,1938.0,2043.0,1949.0,1808.0,1635.0,1566.0,1622.0,1433.0,1508.0,20375.0
Shahdol,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,12.0,36.0,67.0,62.0,50.0,49.0,69.0,55.0,37.0,57.0,144.0,88.0,726.0
Shahdol,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,2.0,37.0,83.0,110.0,126.0,98.0,76.0,54.0,29.0,39.0,232.0,74.0,960.0
Shahdol,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,183.0,208.0,195.0,218.0,245.0,226.0,210.0,190.0,208.0,224.0,206.0,205.0,2518.0
Shahdol,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shahdol,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,197.0,281.0,345.0,390.0,421.0,373.0,355.0,299.0,274.0,320.0,582.0,367.0,4204.0
Shahdol,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,35.0,48.0,83.0
Shahdol,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,192.0,259.0,567.0,382.0,445.0,367.0,338.0,301.0,281.0,356.0,404.0,401.0,4293.0
Shahdol,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,5.0,34.0,38.0,40.0,21.0,21.0,26.0,16.0,12.0,20.0,28.0,19.0,280.0
Shahdol,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,179.0,191.0,276.0,395.0,424.0,301.0,259.0,222.0,217.0,343.0,279.0,308.0,3394.0
Shahdol,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,181.0,192.0,167.0,202.0,142.0,200.0,109.0,180.0,146.0,82.0,68.0,112.0,1781.0
Shahdol,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1461.0,1186.0,1479.0,1887.0,1942.0,1927.0,1780.0,1618.0,1540.0,1580.0,1468.0,1459.0,19327.0
Shahdol,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,542.0,874.0,1022.0,1050.0,919.0,871.0,883.0,1096.0,1039.0,991.0,1010.0,955.0,11252.0
Shahdol,6.3,PNC maternal complications attended,TOTAL,31.0,48.0,104.0,111.0,58.0,75.0,49.0,37.0,57.0,57.0,16.0,71.0,714.0
Shahdol,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,15.0,12.0,11.0,21.0,9.0,26.0,9.0,17.0,21.0,10.0,31.0,19.0,201.0
Shahdol,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,1.0,0.0,5.0
Shahdol,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,15.0,13.0,11.0,21.0,9.0,26.0,9.0,17.0,23.0,11.0,32.0,19.0,206.0
Shahdol,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,167.0,181.0,218.0,807.0,305.0,369.0,303.0,402.0,373.0,612.0,523.0,654.0,4914.0
Shahdol,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,449.0,365.0,461.0,1125.0,624.0,792.0,682.0,443.0,721.0,811.0,1246.0,1380.0,9099.0
Shahdol,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,616.0,546.0,679.0,1932.0,929.0,1161.0,985.0,845.0,1094.0,1423.0,1769.0,2034.0,14013.0
Shahdol,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,1.0,5.0,8.0,0.0,22.0
Shahdol,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,2.0,2.0,7.0,4.0,17.0,11.0,38.0,43.0,54.0,37.0,57.0,272.0
Shahdol,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,1.0,2.0,3.0,1.0,,1.0,8.0,11.0,19.0,10.0,2.0,58.0
Shahdol,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shahdol,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,3.0,4.0,10.0,5.0,17.0,12.0,54.0,55.0,78.0,55.0,59.0,352.0
Shahdol,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Shahdol,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,3.0,225.0,23.0,149.0,120.0,3.0,526.0
Shahdol,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,9.0,9.0,3.0,66.0,12.0,75.0,21.0,364.0,882.0,605.0,332.0,133.0,2511.0
Shahdol,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,2.0,3.0,,1.0,2.0,2.0,5.0,24.0,307.0,176.0,57.0,13.0,592.0
Shahdol,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shahdol,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,11.0,12.0,3.0,70.0,14.0,77.0,29.0,613.0,1212.0,930.0,509.0,149.0,3629.0
Shahdol,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Shahdol,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0
Shahdol,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,1.0,19.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Shahdol,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,58.0,80.0,68.0,,,,,,,2.0,,208.0
Shahdol,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shahdol,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,58.0,80.0,68.0,1.0,19.0,1.0,1.0,0.0,0.0,2.0,0.0,230.0
Shahdol,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Shahdol,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,6.0
Shahdol,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Shahdol,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,50.0,58.0,,,71.0,66.0,57.0,82.0,84.0,70.0,76.0,45.0,659.0
Shahdol,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shahdol,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,50.0,58.0,0.0,0.0,71.0,66.0,57.0,82.0,84.0,70.0,76.0,51.0,665.0
Shahdol,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Shahdol,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,141.0,79.0,338.0,301.0,275.0,308.0,345.0,274.0,225.0,250.0,342.0,203.0,3081.0
Shahdol,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,23.0,3.0,29.0,23.0,11.0,49.0,29.0,30.0,36.0,80.0,313.0
Shahdol,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,7.0,18.0,23.0,19.0,25.0,37.0,42.0,84.0,97.0,54.0,71.0,477.0
Shahdol,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,289.0,216.0,290.0,401.0,473.0,373.0,304.0,302.0,263.0,307.0,274.0,285.0,3777.0
Shahdol,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shahdol,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,430.0,302.0,669.0,728.0,796.0,729.0,697.0,667.0,601.0,684.0,706.0,639.0,7648.0
Shahdol,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,6.0,0.0,273.0,408.0,348.0,324.0,341.0,335.0,342.0,453.0,398.0,407.0,3635.0
Shahdol,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Shahdol,9.06,Number of IUCD removals,TOTAL,174.0,55.0,255.0,232.0,234.0,198.0,229.0,198.0,241.0,129.0,143.0,132.0,2220.0
Shahdol,9.07,Number of Oral Pills cycles distributed,TOTAL,1245.0,1651.0,1715.0,1776.0,1907.0,1749.0,2108.0,2154.0,2356.0,1836.0,2089.0,2081.0,22667.0
Shahdol,9.08,Number of Condom pieces distributed,TOTAL,9974.0,5463.0,11535.0,9654.0,10192.0,12762.0,12115.0,10529.0,13061.0,11369.0,11513.0,11215.0,129382.0
Shahdol,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0,0.0,0.0,0.0,20.0
Shahdol,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,4.0,27.0,52.0,72.0,8.0,13.0,0.0,11.0,0.0,3.0,2.0,0.0,192.0
Shahdol,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,12.0,0.0,16.0
Shahdol,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,8.0
Shahdol,9.11.2.a,Number of failures following male sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Shahdol,9.11.2.b,Number of failures following female sterilization,TOTAL,5.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Shahdol,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,9.12,Number of Institutions having NSV trained doctors,TOTAL,5.0,5.0,3.0,2.0,4.0,3.0,3.0,2.0,3.0,4.0,3.0,3.0,-1.0
Shahdol,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1544.0,1522.0,1675.0,1978.0,2095.0,1943.0,1859.0,1663.0,1613.0,1593.0,1545.0,1514.0,20544.0
Shahdol,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1525.0,1572.0,1689.0,1860.0,1755.0,1968.0,2030.0,558.0,78.0,82.0,106.0,14.0,13237.0
Shahdol,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1692.0,1423.0,1660.0,1806.0,1785.0,1777.0,1899.0,2198.0,282.0,85.0,89.0,8.0,14704.0
Shahdol,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1812.0,1664.0,1619.0,1781.0,1669.0,1713.0,1733.0,1875.0,1844.0,322.0,127.0,9.0,16168.0
Shahdol,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1422.0,1685.0,1576.0,1523.0,1583.0,7789.0
Shahdol,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1444.0,1579.0,1590.0,1530.0,6143.0
Shahdol,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1324.0,1485.0,1512.0,4321.0
Shahdol,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1336.0,1276.0,1412.0,1775.0,1867.0,1712.0,1633.0,1488.0,1447.0,1451.0,1425.0,1409.0,18231.0
Shahdol,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1530.0,1566.0,1694.0,1860.0,1749.0,1933.0,2024.0,1494.0,1659.0,1597.0,1599.0,1597.0,20302.0
Shahdol,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1689.0,1434.0,1662.0,1806.0,1778.0,1750.0,1894.0,1907.0,1607.0,1616.0,1650.0,1538.0,20331.0
Shahdol,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1819.0,1674.0,1619.0,1781.0,1658.0,1685.0,1730.0,1781.0,1773.0,1522.0,1548.0,1519.0,20109.0
Shahdol,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1336.0,1276.0,1406.0,1753.0,1867.0,1698.0,1637.0,1481.0,1447.0,1405.0,1417.0,1406.0,18129.0
Shahdol,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1508.0,1563.0,1696.0,1870.0,1755.0,1968.0,2030.0,566.0,137.0,129.0,112.0,14.0,13348.0
Shahdol,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1671.0,1427.0,1662.0,1806.0,1785.0,1777.0,1899.0,1994.0,319.0,95.0,94.0,8.0,14537.0
Shahdol,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1788.0,1675.0,1619.0,1781.0,1669.0,1713.0,1729.0,1874.0,1824.0,312.0,123.0,9.0,16116.0
Shahdol,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1577.0,1636.0,1647.0,2333.0,1819.0,1800.0,1796.0,1659.0,1492.0,1555.0,1587.0,1633.0,20534.0
Shahdol,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,797.0,988.0,1256.0,1641.0,1275.0,1275.0,1274.0,1402.0,1425.0,1722.0,1843.0,1894.0,16792.0
Shahdol,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,812.0,859.0,851.0,1160.0,947.0,940.0,932.0,888.0,788.0,803.0,814.0,850.0,10644.0
Shahdol,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,747.0,733.0,732.0,1099.0,862.0,862.0,858.0,744.0,673.0,743.0,729.0,771.0,9553.0
Shahdol,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1559.0,1592.0,1583.0,2259.0,1809.0,1802.0,1790.0,1632.0,1461.0,1546.0,1543.0,1621.0,20197.0
Shahdol,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1429.0,1344.0,1451.0,1701.0,1447.0,1357.0,1338.0,1476.0,1518.0,1746.0,1900.0,1894.0,18601.0
Shahdol,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1416.0,1337.0,1441.0,1686.0,1446.0,1335.0,1329.0,1448.0,1513.0,1745.0,1895.0,1894.0,18485.0
Shahdol,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,127.0,81.0,160.0,244.0,279.0,285.0,301.0,191.0,212.0,295.0,286.0,353.0,2814.0
Shahdol,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,133.0,89.0,101.0,175.0,248.0,232.0,275.0,146.0,173.0,257.0,240.0,282.0,2351.0
Shahdol,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,260.0,170.0,261.0,419.0,527.0,517.0,576.0,337.0,385.0,552.0,526.0,635.0,5165.0
Shahdol,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,878.0,964.0,976.0,1232.0,1230.0,1237.0,977.0,1005.0,1126.0,1339.0,1307.0,1281.0,13552.0
Shahdol,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1235.0,1221.0,1380.0,1714.0,1635.0,1644.0,1511.0,1503.0,1574.0,1595.0,1402.0,1464.0,17878.0
Shahdol,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1130.0,1150.0,1365.0,1625.0,1479.0,1578.0,1512.0,1475.0,1483.0,1555.0,1420.0,1574.0,17346.0
Shahdol,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,1.0,0.0,2.0,2.0,2.0,0.0,2.0,10.0,0.0,16.0,35.0
Shahdol,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,0.0,2.0,20.0,13.0,12.0,5.0,0.0,4.0,6.0,0.0,5.0,69.0
Shahdol,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1087.0,1096.0,1122.0,1166.0,1159.0,1163.0,1151.0,1169.0,1183.0,1174.0,1192.0,1174.0,13836.0
Shahdol,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1072.0,1079.0,1115.0,1161.0,1149.0,1150.0,1139.0,1161.0,1179.0,1166.0,1182.0,1169.0,13722.0
Shahdol,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,929.0,906.0,931.0,950.0,965.0,977.0,941.0,973.0,934.0,973.0,978.0,967.0,11424.0
Shahdol,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1125.0,1399.0,1373.0,2501.0,1617.0,1697.0,1680.0,1535.0,1451.0,1721.0,1556.0,1646.0,19301.0
Shahdol,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,395.0,282.0,380.0,5120.0,765.0,454.0,483.0,507.0,528.0,4997.0,1741.0,863.0,16515.0
Shahdol,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,173.0,116.0,248.0,4042.0,621.0,405.0,368.0,310.0,447.0,5426.0,813.0,341.0,13310.0
Shahdol,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,6.0
Shahdol,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,508.0,717.0,840.0,810.0,861.0,1010.0,671.0,889.0,784.0,865.0,815.0,1255.0,10025.0
Shahdol,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,7.0,9.0,48.0,22.0,67.0,85.0,43.0,55.0,67.0,17.0,18.0,18.0,456.0
Shahdol,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,237.0,29.0,194.0,172.0,185.0,194.0,57.0,68.0,160.0,21.0,78.0,41.0,1436.0
Shahdol,13.1,Number of Patients operated for cataract,TOTAL,76.0,114.0,56.0,102.0,60.0,93.0,193.0,633.0,515.0,322.0,474.0,244.0,2882.0
Shahdol,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,76.0,114.0,56.0,102.0,59.0,93.0,193.0,632.0,515.0,319.0,474.0,241.0,2874.0
Shahdol,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,134.0,185.0,172.0,162.0,1594.0,103.0,260.0,560.0,580.0,3750.0
Shahdol,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,280.0,0.0,538.0,101.0,258.0,447.0,268.0,1892.0
Shahdol,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
Shahdol,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
Shahdol,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,2.0,2.0,3.0,3.0,3.0,3.0,2.0,2.0,2.0,2.0,-1.0
Shahdol,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,5.0,6.0,2.0,1.0,1.0,5.0,1.0,1.0,2.0,,,4.0,-1.0
Shahdol,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,749.0,758.0,775.0,749.0,757.0,813.0,780.0,719.0,808.0,782.0,859.0,790.0,-1.0
Shahdol,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,4.0,6.0,5.0,5.0,5.0,5.0,4.0,4.0,4.0,4.0,-1.0
Shahdol,14.05,Number of RKS meetings held during the month,TOTAL,1.0,1.0,14.0,12.0,15.0,15.0,16.0,15.0,14.0,13.0,13.0,13.0,142.0
Shahdol,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,8.0,9.0,6.0,10.0,10.0,10.0,10.0,10.0,7.0,7.0,6.0,6.0,-1.0
Shahdol,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,19.0,25.0,192.0,2.0,3.0,3.0,39.0,33.0,14.0,3.0,17.0,7.0,357.0
Shahdol,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,1.0,2.0,3.0,3.0,3.0,3.0,2.0,2.0,1.0,2.0,-1.0
Shahdol,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Shahdol,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,587.0,595.0,639.0,763.0,924.0,833.0,687.0,634.0,521.0,354.0,378.0,386.0,7301.0
Shahdol,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1290.0,1495.0,1439.0,1379.0,1342.0,1990.0,1495.0,1074.0,901.0,1009.0,1078.0,1080.0,15572.0
Shahdol,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,800.0,908.0,973.0,1112.0,1364.0,1214.0,1051.0,930.0,796.0,409.0,312.0,348.0,10217.0
Shahdol,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2553.0,2623.0,2666.0,2886.0,3114.0,3053.0,2681.0,2570.0,2406.0,2412.0,2187.0,2749.0,31900.0
Shahdol,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1387.0,1503.0,1612.0,1875.0,2288.0,2047.0,1738.0,1564.0,1317.0,763.0,690.0,734.0,17518.0
Shahdol,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3843.0,4118.0,4105.0,4265.0,4456.0,5043.0,4176.0,3644.0,3307.0,3421.0,3265.0,3829.0,47472.0
Shahdol,14.10.2.a,Number of death cases of Inpatient males,TOTAL,44.0,43.0,61.0,47.0,65.0,64.0,68.0,47.0,168.0,44.0,53.0,27.0,731.0
Shahdol,14.10.2.b,Number of death cases of Inpatient females,TOTAL,35.0,28.0,53.0,38.0,65.0,48.0,90.0,36.0,33.0,30.0,28.0,38.0,522.0
Shahdol,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,79.0,71.0,114.0,85.0,130.0,112.0,158.0,83.0,201.0,74.0,81.0,65.0,1253.0
Shahdol,14.11,In-Patient Head Count at midnight,TOTAL,190.0,344.0,350.0,540.0,574.0,516.0,249.0,298.0,314.0,187.0,222.0,242.0,4026.0
Shahdol,14.12.1,OPD attendance (All),TOTAL,38527.0,44001.0,45232.0,55456.0,57125.0,69286.0,53367.0,48088.0,43979.0,40314.0,49166.0,53162.0,597703.0
Shahdol,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,26.0,27.0,35.0,49.0,30.0,35.0,237.0,20.0,309.0,308.0,19.0,46.0,1141.0
Shahdol,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,6.0,7.0,3.0,3.0,1.0,2.0,4.0,1.0,4.0,66.0,4.0,3.0,104.0
Shahdol,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,134.0,124.0,138.0,114.0,104.0,105.0,118.0,103.0,84.0,123.0,153.0,145.0,1445.0
Shahdol,14.14.a,Number of patients given AYUSH treatment,TOTAL,1236.0,1431.0,3317.0,5611.0,5691.0,5092.0,5717.0,6681.0,7074.0,6381.0,6870.0,15467.0,70568.0
Shahdol,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,431.0,509.0,507.0,525.0,430.0,460.0,405.0,439.0,460.0,442.0,327.0,373.0,5308.0
Shahdol,14.14.c,Number of Adolescents counselled,TOTAL,56.0,60.0,140.0,60.0,73.0,680.0,767.0,829.0,799.0,1022.0,1250.0,842.0,6578.0
Shahdol,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5292.0,5439.0,6102.0,6800.0,6676.0,7848.0,5733.0,5651.0,5573.0,5726.0,6242.0,6368.0,73450.0
Shahdol,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,257.0,322.0,393.0,364.0,316.0,367.0,351.0,392.0,341.0,416.0,448.0,410.0,4377.0
Shahdol,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,63.0,118.0,33.0,29.0,36.0,106.0,42.0,52.0,39.0,79.0,100.0,101.0,798.0
Shahdol,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,6.0,0.0,4.0,2.0,0.0,2.0,1.0,2.0,1.0,1.0,0.0,0.0,19.0
Shahdol,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,41.0,57.0,59.0,48.0,47.0,81.0,37.0,30.0,146.0,59.0,90.0,100.0,795.0
Shahdol,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,2.0,3.0,0.0,2.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,11.0
Shahdol,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,751.0,953.0,536.0,713.0,717.0,827.0,969.0,1020.0,756.0,874.0,926.0,837.0,9879.0
Shahdol,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,29.0,1.0,1.0,72.0,0.0,0.0,0.0,0.0,7.0,0.0,32.0,143.0
Shahdol,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,855.0,1128.0,628.0,790.0,800.0,1014.0,1048.0,1102.0,941.0,1012.0,1116.0,1038.0,11472.0
Shahdol,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,9.0,31.0,8.0,3.0,74.0,3.0,2.0,2.0,1.0,8.0,0.0,32.0,173.0
Shahdol,15.2,Number of Widal tests conducted,Number tested,106.0,91.0,117.0,223.0,271.0,470.0,385.0,273.0,129.0,167.0,271.0,280.0,2783.0
Shahdol,15.3.a,Number of VDRL tests conducted on males,Number tested,1.0,21.0,29.0,17.0,24.0,48.0,2.0,1.0,17.0,20.0,8.0,32.0,220.0
Shahdol,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,2.0,5.0,4.0,0.0,15.0,2.0,1.0,28.0,3.0,50.0,28.0,45.0,183.0
Shahdol,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,104.0,179.0,154.0,115.0,142.0,27.0,154.0,168.0,182.0,82.0,94.0,86.0,1487.0
Shahdol,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,107.0,205.0,187.0,132.0,181.0,77.0,157.0,197.0,202.0,152.0,130.0,163.0,1890.0
Shahdol,15.4.1,Number of blood smears examined for Malaria,TOTAL,9637.0,7629.0,8599.0,10973.0,14029.0,15183.0,13786.0,9706.0,5813.0,3777.0,5085.0,5490.0,109707.0
Shahdol,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,98.0,17.0,33.0,57.0,62.0,98.0,173.0,41.0,185.0,6.0,74.0,22.0,866.0
Shahdol,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,3.0,13.0,23.0,32.0,126.0,129.0,139.0,207.0,68.0,17.0,41.0,16.0,814.0
Shahdol,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Shahdol,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Shahdol,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Shahdol,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Shahdol,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shahdol,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Shahdol,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Shahdol,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Shahdol,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Shahdol,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Shahdol,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Shahdol,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Shahdol,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,1.0,1.0,1.0,,,4.0,6.0,2.0,1.0,3.0,1.0,20.0
Shahdol,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Shahdol,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,1.0,1.0,1.0,,,4.0,6.0,2.0,1.0,3.0,1.0,20.0
Shahdol,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,13.0,5.0,3.0,8.0,5.0,6.0,4.0,1.0,6.0,4.0,3.0,61.0
Shahdol,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Shahdol,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,13.0,5.0,3.0,8.0,5.0,6.0,4.0,1.0,6.0,4.0,3.0,61.0
Shahdol,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,1.0,5.0,7.0,6.0,3.0,,22.0
Shahdol,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Shahdol,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,1.0,5.0,7.0,6.0,3.0,,22.0
Shahdol,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,2.0,1.0,,,,,,,,3.0
Shahdol,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,1.0,,,,,,,,,,,1.0
Shahdol,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,1.0,,2.0,1.0,,,,,,,,4.0
Shahdol,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,,2.0,1.0,2.0,1.0,3.0,,,2.0,,12.0
Shahdol,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,3.0,2.0,3.0,,,1.0,,,,9.0
Shahdol,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,1.0,,5.0,3.0,5.0,1.0,3.0,1.0,,2.0,,21.0
Shahdol,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Shahdol,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Shahdol,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Shahdol,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,4.0,4.0,1.0,1.0,6.0,1.0,6.0,7.0,7.0,8.0,4.0,,49.0
Shahdol,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,2.0,1.0,2.0,,1.0,4.0,1.0,2.0,1.0,3.0,1.0,20.0
Shahdol,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,6.0,6.0,2.0,3.0,6.0,2.0,10.0,8.0,9.0,9.0,7.0,1.0,69.0
Shahdol,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Shahdol,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Shahdol,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Shahdol,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,1.0,,,,,,1.0
Shahdol,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Shahdol,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,,,,,1.0,,1.0,,,,3.0
Shahdol,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Shahdol,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,1.0,,,,1.0,,1.0,,,,4.0
Shahdol,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Shahdol,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,3.0,,,,3.0
Shahdol,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Shahdol,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,1.0,3.0,,,,4.0
Shahdol,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Shahdol,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Shahdol,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Shahdol,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Shahdol,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,,,1.0,,,,,,,,2.0
Shahdol,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,1.0,1.0,2.0,1.0,3.0,1.0,3.0,,,12.0
Shahdol,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,2.0,3.0,2.0,3.0,,7.0,1.0,,18.0
Shahdol,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,,,1.0,4.0,5.0,3.0,6.0,1.0,10.0,1.0,,32.0
Shahdol,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Shahdol,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Shahdol,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Shahdol,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Shahdol,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Shahdol,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,1.0,,,1.0,2.0,,,,,,,4.0
Shahdol,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,1.0,2.0,,2.0,1.0,,6.0
Shahdol,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,1.0,,,1.0,2.0,1.0,2.0,,2.0,1.0,,10.0
Shahdol,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Shahdol,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Shahdol,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,2.0,,,1.0,,,,,,4.0
Shahdol,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,2.0,,2.0,,,1.0,,,,,,5.0
Shahdol,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Shahdol,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Shahdol,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Shahdol,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Shahdol,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Shahdol,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Shahdol,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Shahdol,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Shahdol,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Shahdol,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Shahdol,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Shahdol,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Shahdol,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Shahdol,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Shahdol,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Shahdol,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Shahdol,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Shahdol,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,1.0,,2.0,1.0,,,,,,,,4.0
Shahdol,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Shahdol,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,1.0,,2.0,1.0,,,,,,,,4.0
Shahdol,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Shahdol,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,6.0,3.0,3.0,2.0,4.0,2.0,1.0,,,21.0
Shahdol,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Shahdol,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,6.0,3.0,3.0,2.0,4.0,2.0,1.0,,,21.0
Shahdol,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,,,,,1.0,,,,,,2.0
Shahdol,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,2.0,,,,,1.0,,,1.0,,,6.0
Shahdol,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,1.0,1.0,,,,,2.0
Shahdol,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,3.0,,,,,3.0,1.0,,1.0,,,10.0
Shahdol,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Shahdol,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,2.0,1.0,,1.0,,,1.0,2.0,1.0,,,8.0
Shahdol,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,1.0,,1.0,1.0,,,,3.0
Shahdol,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,2.0,1.0,,1.0,1.0,,2.0,3.0,1.0,,,11.0
Shahdol,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Shahdol,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Shahdol,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Shahdol,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Shahdol,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Shahdol,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,1.0,2.0,1.0,3.0,1.0,,1.0,,,,9.0
Shahdol,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,3.0,3.0,1.0,7.0,2.0,1.0,,,,17.0
Shahdol,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,1.0,5.0,4.0,5.0,8.0,2.0,2.0,,,,27.0
Shahdol,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Shahdol,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,1.0,1.0,,,,,1.0,1.0,,,,5.0
Shahdol,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,2.0,11.0,2.0,3.0,,,,2.0,7.0,,,,27.0
Shahdol,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,3.0,12.0,3.0,3.0,,,,3.0,8.0,,,,32.0
Shahdol,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,1.0,1.0,2.0,1.0,2.0,2.0,,,,,9.0
Shahdol,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,7.0,3.0,4.0,2.0,6.0,9.0,8.0,7.0,4.0,2.0,4.0,1.0,57.0
Shahdol,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,6.0,3.0,3.0,6.0,9.0,9.0,13.0,7.0,3.0,1.0,,3.0,63.0
Shahdol,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,13.0,6.0,8.0,9.0,17.0,19.0,23.0,16.0,7.0,3.0,4.0,4.0,129.0
Shajapur,1.1,Total number of pregnant women Registered for ANC,TOTAL,1387.0,1764.0,2119.0,1887.0,1394.0,1666.0,1285.0,1643.0,1636.0,1502.0,1780.0,1741.0,19804.0
Shajapur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,892.0,1219.0,1440.0,1277.0,1042.0,1123.0,872.0,1132.0,1160.0,1087.0,1289.0,1328.0,13861.0
Shajapur,1.2,Number of Pregnant women registered under JSY,TOTAL,1387.0,1764.0,2119.0,1883.0,1389.0,1658.0,1275.0,1649.0,1636.0,1502.0,1764.0,1775.0,19801.0
Shajapur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1127.0,1208.0,1560.0,1771.0,1501.0,1572.0,1292.0,1516.0,1382.0,1365.0,1441.0,1592.0,17327.0
Shajapur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1369.0,1730.0,2113.0,1882.0,1380.0,1669.0,1281.0,1614.0,1614.0,1453.0,1742.0,1742.0,19589.0
Shajapur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1268.0,1433.0,1764.0,1864.0,1554.0,1473.0,1321.0,1419.0,1499.0,1311.0,1468.0,1749.0,18123.0
Shajapur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1340.0,1947.0,2130.0,1883.0,1420.0,1665.0,1264.0,1608.0,1665.0,1442.0,1824.0,1786.0,19974.0
Shajapur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,64.0,90.0,119.0,106.0,101.0,126.0,120.0,169.0,129.0,79.0,86.0,86.0,1275.0
Shajapur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,4.0,5.0,2.0,7.0,41.0,53.0,27.0,24.0,16.0,13.0,28.0,20.0,240.0
Shajapur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,392.0,599.0,710.0,721.0,425.0,544.0,461.0,735.0,723.0,637.0,598.0,684.0,7229.0
Shajapur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,14.0,20.0,40.0,39.0,22.0,21.0,15.0,31.0,30.0,21.0,22.0,48.0,323.0
Shajapur,1.8,Number of pregnancy test kits used at SC level,TOTAL,292.0,355.0,623.0,499.0,346.0,472.0,432.0,440.0,698.0,624.0,843.0,888.0,6512.0
Shajapur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,0.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,0.0,3.0,7.0
Shajapur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,6.0,21.0,36.0,33.0,35.0,37.0,39.0,33.0,18.0,36.0,22.0,41.0,357.0
Shajapur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,6.0,21.0,36.0,33.0,36.0,38.0,39.0,35.0,18.0,36.0,22.0,44.0,364.0
Shajapur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,0.0,20.0,32.0,25.0,30.0,33.0,38.0,18.0,11.0,8.0,14.0,34.0,263.0
Shajapur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,12.0,13.0
Shajapur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,762.0,972.0,1201.0,1249.0,1371.0,1521.0,1351.0,1506.0,1283.0,1223.0,1172.0,1446.0,15057.0
Shajapur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,84.0,78.0,49.0,30.0,138.0,103.0,23.0,15.0,22.0,27.0,40.0,80.0,689.0
Shajapur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,294.0,778.0,1118.0,1203.0,1282.0,1351.0,993.0,1358.0,1196.0,1229.0,938.0,1494.0,13234.0
Shajapur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,254.0,422.0,750.0,686.0,804.0,758.0,899.0,636.0,723.0,813.0,609.0,754.0,8108.0
Shajapur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,77.0,117.0,118.0,127.0,138.0,114.0,110.0,96.0,80.0,101.0,102.0,105.0,1285.0
Shajapur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,0.0,,0.0
Shajapur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,0.0,,0.0
Shajapur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Shajapur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,25.0,19.0,13.0,12.0,17.0,41.0,55.0,54.0,33.0,71.0,68.0,46.0,454.0
Shajapur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shajapur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,25.0,19.0,13.0,12.0,17.0,41.0,55.0,54.0,33.0,71.0,68.0,46.0,454.0
Shajapur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,37.0,53.0,59.0,48.0,59.0,46.0,44.0,41.0,26.0,42.0,36.0,45.0,536.0
Shajapur,4.1.1.a,Number of male live births,TOTAL,442.0,574.0,701.0,720.0,826.0,849.0,771.0,849.0,688.0,678.0,649.0,839.0,8586.0
Shajapur,4.1.1.b,Number of female live births,TOTAL,395.0,525.0,651.0,674.0,708.0,816.0,710.0,785.0,682.0,672.0,641.0,732.0,7991.0
Shajapur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,837.0,1099.0,1352.0,1394.0,1534.0,1665.0,1481.0,1634.0,1370.0,1350.0,1290.0,1571.0,16577.0
Shajapur,4.1.2,Number of still births,TOTAL,10.0,18.0,10.0,25.0,17.0,13.0,23.0,21.0,12.0,18.0,15.0,15.0,197.0
Shajapur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,35.0,32.0,27.0,36.0,27.0,35.0,8.0,17.0,26.0,40.0,27.0,50.0,360.0
Shajapur,4.2.1,Number of Newborns weighed at birth,TOTAL,835.0,1096.0,1342.0,1391.0,1527.0,1649.0,1477.0,1615.0,1365.0,1247.0,1233.0,1504.0,16281.0
Shajapur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,89.0,91.0,139.0,193.0,186.0,190.0,185.0,217.0,219.0,194.0,107.0,113.0,1923.0
Shajapur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,825.0,1053.0,1342.0,1381.0,1500.0,1647.0,1471.0,1614.0,1365.0,1296.0,1246.0,1471.0,16211.0
Shajapur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,3.0,0.0,0.0,3.0,6.0,8.0,12.0,5.0,37.0
Shajapur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,20.0,43.0,15.0,2.0,8.0,5.0,2.0,4.0,24.0,5.0,128.0
Shajapur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,38.0,50.0,33.0,146.0,146.0,152.0,73.0,125.0,142.0,52.0,60.0,64.0,1081.0
Shajapur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shajapur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,38.0,50.0,53.0,189.0,164.0,154.0,81.0,133.0,150.0,64.0,96.0,74.0,1246.0
Shajapur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Shajapur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,38.0,50.0,46.0,189.0,161.0,154.0,81.0,130.0,154.0,63.0,96.0,74.0,1236.0
Shajapur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,8.0,12.0,8.0,14.0,16.0,53.0,30.0,22.0,32.0,19.0,21.0,22.0,257.0
Shajapur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,125.0,135.0,172.0,21.0,56.0,162.0,150.0,143.0,100.0,115.0,206.0,106.0,1491.0
Shajapur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,15.0,12.0,2.0,109.0,107.0,60.0,41.0,73.0,99.0,12.0,10.0,40.0,580.0
Shajapur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,621.0,939.0,1120.0,1243.0,1335.0,1517.0,1263.0,1404.0,1152.0,1119.0,1084.0,1369.0,14166.0
Shajapur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,336.0,303.0,555.0,519.0,517.0,573.0,507.0,619.0,498.0,636.0,662.0,655.0,6380.0
Shajapur,6.3,PNC maternal complications attended,TOTAL,0.0,14.0,8.0,12.0,17.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,51.0
Shajapur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,14.0,17.0,8.0,2.0,1.0,1.0,0.0,23.0,6.0,1.0,6.0,4.0,83.0
Shajapur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,1.0,12.0
Shajapur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,14.0,19.0,8.0,2.0,1.0,1.0,0.0,23.0,6.0,1.0,15.0,5.0,95.0
Shajapur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,41.0,84.0,49.0,103.0,93.0,136.0,111.0,100.0,90.0,163.0,111.0,106.0,1187.0
Shajapur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,408.0,268.0,224.0,178.0,327.0,530.0,280.0,431.0,413.0,314.0,433.0,377.0,4183.0
Shajapur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,449.0,352.0,273.0,281.0,420.0,666.0,391.0,531.0,503.0,477.0,544.0,483.0,5370.0
Shajapur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,1.0,0.0,3.0,9.0,2.0,3.0,1.0,4.0,1.0,7.0,2.0,34.0
Shajapur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,4.0,0.0,4.0,6.0,4.0,3.0,0.0,2.0,9.0,3.0,8.0,6.0,49.0
Shajapur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,2.0,3.0,2.0,7.0,4.0,2.0,3.0,6.0,5.0,5.0,6.0,46.0
Shajapur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shajapur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,6.0,3.0,7.0,11.0,20.0,9.0,5.0,6.0,19.0,9.0,20.0,14.0,129.0
Shajapur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Shajapur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,12.0,2.0,14.0,95.0,112.0,24.0,22.0,128.0,201.0,101.0,113.0,33.0,857.0
Shajapur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,15.0,2.0,10.0,56.0,44.0,35.0,0.0,83.0,155.0,112.0,152.0,590.0,1254.0
Shajapur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,31.0,11.0,21.0,70.0,71.0,69.0,95.0,59.0,169.0,150.0,82.0,32.0,860.0
Shajapur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shajapur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,58.0,15.0,45.0,221.0,227.0,128.0,117.0,270.0,525.0,363.0,347.0,655.0,2971.0
Shajapur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Shajapur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,4.0,1.0,0.0,5.0,1.0,0.0,1.0,0.0,4.0,0.0,0.0,1.0,17.0
Shajapur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,2.0,0.0,4.0,2.0,6.0,1.0,0.0,7.0,8.0,3.0,3.0,3.0,39.0
Shajapur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,25.0,17.0,39.0,38.0,46.0,39.0,29.0,105.0,180.0,63.0,70.0,7.0,658.0
Shajapur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shajapur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,31.0,18.0,43.0,45.0,53.0,40.0,30.0,112.0,192.0,66.0,73.0,11.0,714.0
Shajapur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Shajapur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,2.0
Shajapur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,18.0,6.0,21.0,18.0,37.0,40.0,11.0,32.0,34.0,25.0,28.0,32.0,302.0
Shajapur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shajapur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,18.0,6.0,21.0,18.0,37.0,40.0,11.0,32.0,35.0,25.0,28.0,33.0,304.0
Shajapur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Shajapur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,86.0,172.0,202.0,149.0,133.0,142.0,81.0,88.0,54.0,32.0,63.0,57.0,1259.0
Shajapur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,1.0,2.0,3.0,1.0,0.0,0.0,0.0,8.0
Shajapur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,23.0,39.0,107.0,48.0,67.0,65.0,40.0,33.0,190.0,254.0,302.0,331.0,1499.0
Shajapur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shajapur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,109.0,211.0,309.0,198.0,200.0,208.0,123.0,124.0,245.0,286.0,365.0,388.0,2766.0
Shajapur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,3.0,3.0,68.0,19.0,46.0,37.0,4.0,12.0,167.0,239.0,284.0,306.0,1188.0
Shajapur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Shajapur,9.06,Number of IUCD removals,TOTAL,64.0,104.0,94.0,89.0,80.0,120.0,96.0,94.0,104.0,97.0,80.0,145.0,1167.0
Shajapur,9.07,Number of Oral Pills cycles distributed,TOTAL,975.0,1103.0,1474.0,2539.0,3374.0,2768.0,2122.0,2940.0,3332.0,3079.0,2700.0,3835.0,30241.0
Shajapur,9.08,Number of Condom pieces distributed,TOTAL,11450.0,11481.0,16832.0,16318.0,17447.0,25656.0,17522.0,23657.0,32372.0,21474.0,20718.0,12529.0,227456.0
Shajapur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,29.0,78.0,40.0,18.0,2.0,16.0,40.0,31.0,24.0,117.0,395.0
Shajapur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Shajapur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0
Shajapur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,3.0,1.0,2.0,0.0,0.0,0.0,3.0,0.0,1.0,3.0,14.0
Shajapur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,9.12,Number of Institutions having NSV trained doctors,TOTAL,6.0,6.0,5.0,5.0,5.0,6.0,6.0,6.0,6.0,5.0,1.0,7.0,-1.0
Shajapur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,816.0,1085.0,1399.0,1400.0,1514.0,1665.0,1459.0,1689.0,1373.0,1273.0,1191.0,1552.0,16416.0
Shajapur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1035.0,1383.0,1473.0,1326.0,1417.0,1617.0,1507.0,252.0,26.0,16.0,2.0,8.0,10062.0
Shajapur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1087.0,1303.0,1523.0,1553.0,1262.0,1438.0,1386.0,1687.0,394.0,157.0,35.0,11.0,11836.0
Shajapur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1282.0,1448.0,1546.0,1656.0,1400.0,1363.0,1218.0,1596.0,1497.0,573.0,169.0,72.0,13820.0
Shajapur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1495.0,1498.0,1549.0,1501.0,1568.0,7611.0
Shajapur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1189.0,1340.0,1581.0,1652.0,5762.0
Shajapur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,49.0,915.0,1392.0,1766.0,4122.0
Shajapur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,741.0,996.0,1251.0,1278.0,1385.0,1527.0,1313.0,1481.0,1271.0,1175.0,1105.0,1429.0,14952.0
Shajapur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1035.0,1383.0,1462.0,1326.0,1305.0,1632.0,1507.0,1595.0,1497.0,1583.0,1478.0,1562.0,17365.0
Shajapur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1095.0,1303.0,1517.0,1553.0,1260.0,1437.0,1388.0,1705.0,1586.0,1497.0,1587.0,1658.0,17586.0
Shajapur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1298.0,1451.0,1555.0,1656.0,1395.0,1364.0,1216.0,1607.0,1584.0,1483.0,1512.0,1833.0,17954.0
Shajapur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,590.0,731.0,937.0,1218.0,1344.0,1258.0,1017.0,1309.0,1132.0,1032.0,1017.0,1259.0,12844.0
Shajapur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1034.0,1374.0,1462.0,1326.0,1305.0,1636.0,1489.0,555.0,9.0,16.0,43.0,27.0,10276.0
Shajapur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1094.0,1290.0,1517.0,1530.0,1261.0,1438.0,1391.0,1691.0,572.0,171.0,72.0,29.0,12056.0
Shajapur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1290.0,1429.0,1554.0,1657.0,1397.0,1363.0,1220.0,1584.0,1524.0,552.0,176.0,85.0,13831.0
Shajapur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1039.0,1434.0,1800.0,1962.0,1529.0,1749.0,1289.0,1480.0,1433.0,1292.0,1404.0,1668.0,18079.0
Shajapur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,966.0,1138.0,1628.0,1747.0,1100.0,1246.0,949.0,1182.0,1433.0,1338.0,1439.0,1667.0,15833.0
Shajapur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,475.0,702.0,897.0,944.0,772.0,843.0,629.0,739.0,664.0,566.0,606.0,758.0,8595.0
Shajapur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,457.0,625.0,808.0,948.0,709.0,816.0,531.0,703.0,618.0,503.0,542.0,691.0,7951.0
Shajapur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,932.0,1327.0,1705.0,1892.0,1481.0,1659.0,1160.0,1442.0,1282.0,1069.0,1148.0,1449.0,16546.0
Shajapur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1027.0,1122.0,1516.0,1720.0,1137.0,1354.0,1001.0,1311.0,1299.0,1404.0,1497.0,1701.0,16089.0
Shajapur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1027.0,1121.0,1515.0,1721.0,1138.0,1348.0,995.0,1310.0,1288.0,1403.0,1497.0,1701.0,16064.0
Shajapur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,37.0,36.0,61.0,92.0,50.0,48.0,32.0,29.0,3.0,23.0,10.0,40.0,461.0
Shajapur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,31.0,38.0,55.0,89.0,42.0,43.0,38.0,34.0,10.0,17.0,19.0,27.0,443.0
Shajapur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,68.0,74.0,116.0,181.0,92.0,91.0,70.0,63.0,13.0,40.0,29.0,67.0,904.0
Shajapur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,76.0,142.0,203.0,1015.0,380.0,485.0,168.0,308.0,590.0,796.0,612.0,899.0,5674.0
Shajapur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,463.0,600.0,740.0,1485.0,887.0,1063.0,726.0,909.0,881.0,1150.0,1022.0,1155.0,11081.0
Shajapur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,527.0,753.0,805.0,1530.0,902.0,1528.0,883.0,1042.0,1001.0,1383.0,1049.0,1304.0,12707.0
Shajapur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,4.0,1.0,1.0,1.0,0.0,0.0,7.0
Shajapur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,699.0,721.0,727.0,727.0,726.0,731.0,729.0,736.0,731.0,739.0,743.0,750.0,8759.0
Shajapur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,692.0,717.0,723.0,726.0,726.0,730.0,727.0,735.0,730.0,738.0,739.0,753.0,8736.0
Shajapur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,530.0,553.0,559.0,557.0,545.0,553.0,533.0,546.0,533.0,549.0,541.0,566.0,6565.0
Shajapur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1047.0,1386.0,1805.0,1943.0,1552.0,1733.0,1266.0,1467.0,1393.0,1351.0,1336.0,1674.0,17953.0
Shajapur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,404.0,541.0,987.0,6681.0,451.0,648.0,405.0,439.0,723.0,6065.0,494.0,622.0,18460.0
Shajapur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,192.0,299.0,502.0,9248.0,162.0,160.0,165.0,213.0,373.0,7210.0,200.0,159.0,18883.0
Shajapur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,157.0,419.0,435.0,260.0,241.0,329.0,193.0,203.0,184.0,199.0,299.0,237.0,3156.0
Shajapur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,1.0,1.0,1.0,0.0,1.0,0.0,2.0,2.0,1.0,0.0,0.0,0.0,9.0
Shajapur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,95.0,66.0,48.0,24.0,71.0,209.0,169.0,111.0,80.0,74.0,221.0,113.0,1281.0
Shajapur,13.1,Number of Patients operated for cataract,TOTAL,234.0,118.0,237.0,114.0,168.0,186.0,56.0,292.0,477.0,65.0,234.0,168.0,2349.0
Shajapur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,234.0,118.0,237.0,114.0,166.0,186.0,56.0,292.0,477.0,65.0,234.0,168.0,2347.0
Shajapur,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,18.0,75.0,189.0,166.0,252.0,10.0,10.0,69.0,35.0,824.0
Shajapur,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,48.0,211.0,5.0,5.0,69.0,56.0,394.0
Shajapur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0
Shajapur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Shajapur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,5.0,4.0,5.0,5.0,4.0,4.0,5.0,6.0,6.0,6.0,5.0,6.0,-1.0
Shajapur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,553.0,497.0,486.0,487.0,515.0,559.0,536.0,545.0,507.0,570.0,560.0,635.0,-1.0
Shajapur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,6.0,6.0,6.0,6.0,5.0,5.0,5.0,5.0,6.0,6.0,6.0,-1.0
Shajapur,14.05,Number of RKS meetings held during the month,TOTAL,4.0,5.0,5.0,6.0,5.0,5.0,8.0,8.0,8.0,8.0,7.0,8.0,77.0
Shajapur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,8.0,5.0,8.0,-1.0
Shajapur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,9.0,9.0,11.0,6.0,28.0,23.0,35.0,25.0,18.0,33.0,26.0,30.0,253.0
Shajapur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,3.0,2.0,3.0,2.0,3.0,3.0,3.0,3.0,3.0,2.0,3.0,-1.0
Shajapur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Shajapur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,453.0,590.0,882.0,415.0,430.0,1012.0,591.0,428.0,396.0,427.0,466.0,426.0,6516.0
Shajapur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,767.0,941.0,1102.0,1031.0,1002.0,2090.0,1103.0,596.0,834.0,813.0,924.0,1009.0,12212.0
Shajapur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,412.0,464.0,739.0,295.0,310.0,658.0,366.0,760.0,263.0,260.0,329.0,350.0,5206.0
Shajapur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1889.0,2338.0,2720.0,2784.0,2304.0,1618.0,2537.0,3416.0,2816.0,2702.0,2730.0,2225.0,30079.0
Shajapur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,865.0,1054.0,1621.0,710.0,740.0,1670.0,957.0,1188.0,659.0,687.0,795.0,776.0,11722.0
Shajapur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2656.0,3279.0,3822.0,3815.0,3306.0,3708.0,3640.0,4012.0,3650.0,3515.0,3654.0,3234.0,42291.0
Shajapur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,9.0,12.0,13.0,8.0,18.0,0.0,24.0,11.0,19.0,12.0,21.0,21.0,168.0
Shajapur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,11.0,7.0,17.0,10.0,12.0,2.0,14.0,13.0,11.0,13.0,3.0,9.0,122.0
Shajapur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,20.0,19.0,30.0,18.0,30.0,2.0,38.0,24.0,30.0,25.0,24.0,30.0,290.0
Shajapur,14.11,In-Patient Head Count at midnight,TOTAL,5031.0,5756.0,6001.0,6135.0,5179.0,8031.0,7431.0,9416.0,7382.0,7151.0,8065.0,7405.0,82983.0
Shajapur,14.12.1,OPD attendance (All),TOTAL,47222.0,41644.0,50656.0,47488.0,44728.0,71475.0,49121.0,51358.0,48791.0,44998.0,64473.0,63968.0,625922.0
Shajapur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,38.0,29.0,21.0,22.0,33.0,55.0,63.0,70.0,57.0,85.0,87.0,55.0,615.0
Shajapur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,34.0,56.0,36.0,27.0,76.0,81.0,47.0,52.0,97.0,211.0,121.0,114.0,952.0
Shajapur,14.14.a,Number of patients given AYUSH treatment,TOTAL,1109.0,1332.0,1345.0,1059.0,1358.0,2170.0,1495.0,1576.0,1425.0,1351.0,1640.0,885.0,16745.0
Shajapur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,514.0,1102.0,386.0,666.0,1098.0,824.0,764.0,860.0,924.0,931.0,860.0,834.0,9763.0
Shajapur,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,79.0,82.0,130.0,106.0,124.0,236.0,212.0,242.0,260.0,1471.0
Shajapur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2825.0,3722.0,5670.0,5062.0,4754.0,4689.0,4571.0,4636.0,5806.0,4306.0,4777.0,3684.0,54502.0
Shajapur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,293.0,346.0,456.0,356.0,356.0,345.0,376.0,431.0,418.0,445.0,407.0,498.0,4727.0
Shajapur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,62.0,40.0,72.0,83.0,62.0,69.0,52.0,121.0,156.0,124.0,87.0,84.0,1012.0
Shajapur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,1.0,2.0,2.0,0.0,0.0,0.0,1.0,2.0,3.0,1.0,0.0,14.0
Shajapur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,78.0,46.0,101.0,123.0,215.0,172.0,108.0,100.0,240.0,70.0,128.0,134.0,1515.0
Shajapur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,3.0,0.0,1.0,0.0,0.0,1.0,2.0,0.0,1.0,0.0,8.0
Shajapur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,999.0,943.0,1448.0,1046.0,1414.0,1235.0,855.0,769.0,1081.0,588.0,1046.0,805.0,12229.0
Shajapur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,6.0
Shajapur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1139.0,1029.0,1621.0,1252.0,1691.0,1476.0,1015.0,990.0,1477.0,782.0,1261.0,1023.0,14756.0
Shajapur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,2.0,6.0,3.0,1.0,0.0,0.0,2.0,5.0,3.0,2.0,1.0,28.0
Shajapur,15.2,Number of Widal tests conducted,Number tested,205.0,198.0,280.0,183.0,263.0,343.0,439.0,225.0,240.0,128.0,290.0,256.0,3050.0
Shajapur,15.3.a,Number of VDRL tests conducted on males,Number tested,13.0,13.0,104.0,76.0,13.0,80.0,45.0,143.0,36.0,36.0,41.0,54.0,654.0
Shajapur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,8.0,13.0,18.0,11.0,60.0,12.0,25.0,49.0,32.0,39.0,77.0,30.0,374.0
Shajapur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,660.0,1070.0,976.0,667.0,909.0,1005.0,782.0,981.0,931.0,747.0,977.0,841.0,10546.0
Shajapur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,681.0,1096.0,1098.0,754.0,982.0,1097.0,852.0,1173.0,999.0,822.0,1095.0,925.0,11574.0
Shajapur,15.4.1,Number of blood smears examined for Malaria,TOTAL,7405.0,9200.0,8397.0,9061.0,9725.0,10162.0,10830.0,10574.0,9749.0,7306.0,8086.0,8557.0,109052.0
Shajapur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,3.0,2.0,9.0,5.0,8.0,11.0,7.0,5.0,0.0,1.0,1.0,0.0,52.0
Shajapur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,1.0,1.0,0.0,6.0,0.0,2.0,0.0,3.0,0.0,0.0,0.0,14.0
Shajapur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Shajapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Shajapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Shajapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Shajapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shajapur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,,1.0,,,,,,,1.0,,3.0
Shajapur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,1.0,,1.0,1.0,2.0,2.0,,2.0,2.0,,11.0
Shajapur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Shajapur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,1.0,,1.0,1.0,2.0,2.0,,2.0,2.0,,11.0
Shajapur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,4.0,1.0,,,,3.0,,,,8.0
Shajapur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Shajapur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,4.0,1.0,,,,3.0,,,,8.0
Shajapur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,4.0,4.0,6.0,6.0,13.0,7.0,2.0,2.0,2.0,7.0,4.0,2.0,59.0
Shajapur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Shajapur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,4.0,4.0,6.0,6.0,13.0,7.0,2.0,2.0,2.0,7.0,4.0,2.0,59.0
Shajapur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,7.0,28.0,14.0,15.0,19.0,13.0,21.0,20.0,12.0,13.0,3.0,168.0
Shajapur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Shajapur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,7.0,28.0,14.0,15.0,19.0,13.0,21.0,20.0,12.0,13.0,3.0,168.0
Shajapur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,3.0,2.0,,2.0,1.0,,1.0,3.0,,1.0,1.0,15.0
Shajapur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,1.0,,,,1.0,1.0,,,,4.0
Shajapur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,4.0,2.0,1.0,2.0,1.0,,2.0,4.0,,1.0,1.0,19.0
Shajapur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Shajapur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Shajapur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Shajapur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,,1.0,,,,,,,1.0,1.0,4.0
Shajapur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,1.0,,,1.0,,2.0,4.0
Shajapur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,,1.0,,,1.0,,,1.0,1.0,3.0,8.0
Shajapur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Shajapur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Shajapur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Shajapur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,8.0,8.0,3.0,5.0,5.0,10.0,1.0,4.0,2.0,1.0,1.0,50.0
Shajapur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,7.0,7.0,2.0,2.0,2.0,2.0,3.0,,,3.0,2.0,30.0
Shajapur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,15.0,15.0,5.0,7.0,7.0,12.0,4.0,4.0,2.0,4.0,3.0,80.0
Shajapur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Shajapur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,,1.0,,,,,,,1.0,,3.0
Shajapur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Shajapur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,2.0,,1.0,,,,,,,1.0,,4.0
Shajapur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Shajapur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,2.0,3.0,1.0,1.0,2.0,,1.0,4.0,,,,15.0
Shajapur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,,,,,1.0,1.0,1.0,1.0,,1.0,,7.0
Shajapur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,3.0,2.0,3.0,1.0,1.0,3.0,1.0,2.0,5.0,,1.0,,22.0
Shajapur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Shajapur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,,1.0,,,2.0,1.0,,,,,5.0
Shajapur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,4.0,1.0,,,,,3.0,9.0,2.0,1.0,,2.0,22.0
Shajapur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,4.0,2.0,,1.0,,,5.0,10.0,2.0,1.0,,2.0,27.0
Shajapur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Shajapur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Shajapur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Shajapur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Shajapur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Shajapur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,1.0,1.0,,2.0
Shajapur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,1.0,1.0,,,,,,2.0,3.0,1.0,8.0
Shajapur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,1.0,1.0,,,,,,3.0,4.0,1.0,10.0
Shajapur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Shajapur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,1.0,1.0,2.0
Shajapur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Shajapur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,1.0,1.0,2.0
Shajapur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,1.0,,,1.0,,,,2.0
Shajapur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,2.0,9.0,6.0,6.0,10.0,11.0,7.0,3.0,16.0,5.0,4.0,80.0
Shajapur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,9.0,13.0,13.0,11.0,15.0,13.0,13.0,12.0,5.0,17.0,11.0,23.0,155.0
Shajapur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,10.0,15.0,22.0,17.0,21.0,24.0,24.0,19.0,9.0,33.0,16.0,27.0,237.0
Shajapur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Shajapur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,,,1.0,,,,1.0,,,1.0,4.0
Shajapur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,3.0,1.0,3.0,2.0,,2.0,2.0,1.0,1.0,2.0,,1.0,18.0
Shajapur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,3.0,2.0,3.0,2.0,1.0,2.0,2.0,1.0,2.0,2.0,,2.0,22.0
Shajapur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Shajapur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Shajapur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Shajapur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Shajapur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Shajapur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,1.0,,,,,1.0,,,,,,,2.0
Shajapur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Shajapur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,1.0,,,,,1.0,,,,,,,2.0
Shajapur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Shajapur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Shajapur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Shajapur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Shajapur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Shajapur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,,,2.0,1.0,,2.0,,,2.0,8.0
Shajapur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Shajapur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,,,2.0,1.0,,2.0,,,2.0,8.0
Shajapur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Shajapur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Shajapur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Shajapur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Shajapur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Shajapur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Shajapur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Shajapur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,1.0,,,,,1.0
Shajapur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,1.0,2.0,3.0,,5.0,,,1.0,1.0,,,14.0
Shajapur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,14.0,14.0,16.0,14.0,9.0,10.0,14.0,5.0,11.0,7.0,4.0,15.0,133.0
Shajapur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,3.0,5.0,1.0,2.0,,6.0,2.0,1.0,,4.0,3.0,29.0
Shajapur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,17.0,18.0,23.0,18.0,11.0,15.0,20.0,7.0,13.0,8.0,8.0,18.0,176.0
Shajapur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Shajapur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,2.0,2.0,4.0,1.0,1.0,4.0,5.0,1.0,,,,21.0
Shajapur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Shajapur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,2.0,2.0,4.0,1.0,1.0,4.0,5.0,1.0,,,,21.0
Shajapur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,1.0,,,1.0,1.0,,,,,,3.0
Shajapur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,1.0,,2.0,2.0,,1.0,,1.0,,7.0
Shajapur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,3.0,,,,,,1.0,,4.0
Shajapur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,1.0,1.0,3.0,3.0,3.0,,1.0,,2.0,,14.0
Shajapur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Shajapur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,,,,,1.0,1.0,1.0,,,1.0,,6.0
Shajapur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,1.0,3.0,,,,1.0,,,,2.0,,7.0
Shajapur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,2.0,1.0,3.0,,,1.0,2.0,1.0,,,3.0,,13.0
Shajapur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Shajapur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,1.0,,3.0,1.0,2.0,,,1.0,1.0,1.0,1.0,11.0
Shajapur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,5.0,3.0,,4.0,5.0,,3.0,1.0,1.0,2.0,5.0,,29.0
Shajapur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,5.0,4.0,,7.0,6.0,3.0,3.0,1.0,2.0,3.0,6.0,1.0,41.0
Shajapur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,,1.0,,11.0
Shajapur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,10.0,14.0,23.0,21.0,17.0,11.0,29.0,11.0,14.0,12.0,15.0,16.0,193.0
Shajapur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,27.0,77.0,89.0,47.0,78.0,75.0,90.0,61.0,68.0,69.0,52.0,57.0,790.0
Shajapur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,37.0,92.0,114.0,70.0,96.0,87.0,120.0,73.0,83.0,81.0,68.0,73.0,994.0
Sheopur,1.1,Total number of pregnant women Registered for ANC,TOTAL,1443.0,1722.0,2271.0,2247.0,1719.0,1824.0,1516.0,1587.0,1663.0,1602.0,1790.0,2027.0,21411.0
Sheopur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,934.0,1242.0,1243.0,1479.0,1033.0,1173.0,952.0,1070.0,1234.0,1128.0,1364.0,1316.0,14168.0
Sheopur,1.2,Number of Pregnant women registered under JSY,TOTAL,1443.0,1722.0,2271.0,2246.0,1719.0,1813.0,1516.0,1581.0,1661.0,1602.0,1790.0,2027.0,21391.0
Sheopur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1149.0,1216.0,1541.0,1439.0,1232.0,1324.0,1146.0,1308.0,1373.0,1395.0,1451.0,1498.0,16072.0
Sheopur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1138.0,1421.0,1722.0,1761.0,1265.0,1361.0,1188.0,1242.0,1400.0,1177.0,1504.0,1612.0,16791.0
Sheopur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1192.0,1193.0,1457.0,1626.0,1430.0,1338.0,1270.0,1175.0,1244.0,1207.0,1211.0,1634.0,15977.0
Sheopur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1444.0,1729.0,2227.0,2258.0,1717.0,1823.0,1511.0,1583.0,1663.0,1602.0,1790.0,2027.0,21374.0
Sheopur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,63.0,151.0,176.0,105.0,36.0,84.0,120.0,111.0,77.0,89.0,77.0,173.0,1262.0
Sheopur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,2.0,6.0,3.0,3.0,0.0,1.0,2.0,0.0,4.0,2.0,3.0,26.0
Sheopur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1095.0,1017.0,1751.0,1524.0,1208.0,1155.0,783.0,705.0,1291.0,1346.0,1471.0,1458.0,14804.0
Sheopur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,62.0,73.0,82.0,99.0,106.0,89.0,66.0,75.0,56.0,46.0,29.0,52.0,835.0
Sheopur,1.8,Number of pregnancy test kits used at SC level,TOTAL,234.0,755.0,947.0,867.0,744.0,779.0,471.0,899.0,906.0,835.0,1012.0,1087.0,9536.0
Sheopur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,1.0,0.0,1.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,9.0
Sheopur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,122.0,176.0,223.0,239.0,271.0,387.0,305.0,298.0,298.0,271.0,249.0,309.0,3148.0
Sheopur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,122.0,177.0,223.0,240.0,271.0,387.0,305.0,305.0,298.0,271.0,249.0,309.0,3157.0
Sheopur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,110.0,170.0,153.0,209.0,232.0,296.0,259.0,255.0,270.0,245.0,216.0,230.0,2645.0
Sheopur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,12.0,26.0,24.0,35.0,65.0,85.0,45.0,30.0,39.0,23.0,44.0,193.0,621.0
Sheopur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,522.0,784.0,912.0,1030.0,1228.0,1269.0,1157.0,1102.0,970.0,1007.0,947.0,1029.0,11957.0
Sheopur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,62.0,97.0,170.0,262.0,243.0,221.0,235.0,198.0,129.0,174.0,140.0,179.0,2110.0
Sheopur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,439.0,882.0,775.0,1024.0,1348.0,941.0,1122.0,1097.0,965.0,985.0,897.0,1034.0,11509.0
Sheopur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,130.0,212.0,296.0,483.0,650.0,723.0,491.0,567.0,713.0,413.0,543.0,735.0,5956.0
Sheopur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,8.0,27.0,20.0,33.0,23.0,12.0,40.0,15.0,14.0,23.0,215.0
Sheopur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Sheopur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Sheopur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Sheopur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Sheopur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,23.0,26.0,30.0,38.0,48.0,54.0,46.0,45.0,48.0,37.0,32.0,46.0,473.0
Sheopur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheopur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,23.0,26.0,30.0,38.0,48.0,54.0,46.0,45.0,48.0,37.0,32.0,46.0,473.0
Sheopur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Sheopur,4.1.1.a,Number of male live births,TOTAL,352.0,508.0,577.0,649.0,792.0,819.0,735.0,727.0,651.0,675.0,593.0,667.0,7745.0
Sheopur,4.1.1.b,Number of female live births,TOTAL,283.0,444.0,538.0,602.0,686.0,810.0,713.0,663.0,609.0,590.0,590.0,652.0,7180.0
Sheopur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,635.0,952.0,1115.0,1251.0,1478.0,1629.0,1448.0,1390.0,1260.0,1265.0,1183.0,1319.0,14925.0
Sheopur,4.1.2,Number of still births,TOTAL,10.0,15.0,24.0,22.0,30.0,28.0,24.0,24.0,15.0,15.0,19.0,22.0,248.0
Sheopur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,33.0,38.0,39.0,37.0,21.0,20.0,17.0,35.0,31.0,38.0,42.0,40.0,391.0
Sheopur,4.2.1,Number of Newborns weighed at birth,TOTAL,623.0,945.0,1089.0,1240.0,1472.0,1621.0,1444.0,1373.0,1252.0,1265.0,1176.0,1319.0,14819.0
Sheopur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,174.0,290.0,402.0,300.0,461.0,411.0,401.0,334.0,211.0,234.0,221.0,317.0,3756.0
Sheopur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,611.0,937.0,1090.0,1233.0,1458.0,1619.0,1402.0,1346.0,1206.0,1264.0,1179.0,1319.0,14664.0
Sheopur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,5.0,14.0,50.0,26.0,40.0,51.0,38.0,38.0,21.0,5.0,18.0,14.0,320.0
Sheopur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,1.0,21.0,12.0,5.0,14.0,2.0,2.0,3.0,7.0,26.0,6.0,17.0,116.0
Sheopur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,172.0,283.0,184.0,125.0,338.0,335.0,309.0,286.0,274.0,187.0,157.0,174.0,2824.0
Sheopur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheopur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,178.0,318.0,246.0,156.0,392.0,388.0,349.0,327.0,302.0,218.0,181.0,205.0,3260.0
Sheopur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Sheopur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,181.0,302.0,208.0,137.0,360.0,386.0,344.0,307.0,287.0,214.0,161.0,195.0,3082.0
Sheopur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,3.0,2.0,7.0,3.0,6.0,2.0,2.0,4.0,2.0,3.0,3.0,3.0,40.0
Sheopur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,47.0,109.0,113.0,115.0,114.0,348.0,324.0,98.0,189.0,180.0,173.0,137.0,1947.0
Sheopur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,39.0,33.0,30.0,43.0,48.0,71.0,49.0,42.0,25.0,30.0,30.0,34.0,474.0
Sheopur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,552.0,808.0,1015.0,1081.0,1324.0,1493.0,1313.0,1283.0,967.0,1124.0,1129.0,1082.0,13171.0
Sheopur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,264.0,278.0,244.0,276.0,352.0,722.0,475.0,446.0,426.0,268.0,352.0,673.0,4776.0
Sheopur,6.3,PNC maternal complications attended,TOTAL,18.0,2.0,31.0,0.0,0.0,11.0,10.0,10.0,2.0,0.0,4.0,3.0,91.0
Sheopur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,2.0,1.0,1.0,4.0,3.0,4.0,1.0,3.0,3.0,8.0,8.0,6.0,44.0
Sheopur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Sheopur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,3.0,1.0,1.0,4.0,3.0,4.0,1.0,3.0,3.0,8.0,8.0,6.0,45.0
Sheopur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,43.0,11.0,21.0,21.0,30.0,57.0,21.0,19.0,36.0,34.0,46.0,37.0,376.0
Sheopur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,207.0,258.0,297.0,349.0,300.0,300.0,236.0,295.0,276.0,290.0,250.0,302.0,3360.0
Sheopur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,250.0,269.0,318.0,370.0,330.0,357.0,257.0,314.0,312.0,324.0,296.0,339.0,3736.0
Sheopur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,2.0,1.0,0.0,9.0,15.0
Sheopur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,6.0
Sheopur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheopur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,2.0,0.0,2.0,0.0,5.0,2.0,1.0,0.0,9.0,21.0
Sheopur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sheopur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,1.0,0.0,0.0,10.0,10.0,4.0,0.0,412.0,521.0,107.0,97.0,0.0,1162.0
Sheopur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,8.0,3.0,14.0,23.0,31.0,94.0,5.0,1042.0,904.0,358.0,281.0,24.0,2787.0
Sheopur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,6.0,3.0,2.0,0.0,0.0,2.0,4.0,5.0,19.0,17.0,21.0,11.0,90.0
Sheopur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheopur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,15.0,6.0,16.0,33.0,41.0,100.0,9.0,1459.0,1444.0,482.0,399.0,35.0,4039.0
Sheopur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sheopur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,1.0,0.0,2.0,0.0,1.0,0.0,4.0,0.0,68.0,24.0,100.0
Sheopur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,6.0,0.0,2.0,2.0,0.0,0.0,0.0,5.0,0.0,15.0
Sheopur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheopur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,1.0,6.0,2.0,2.0,3.0,0.0,4.0,0.0,73.0,24.0,115.0
Sheopur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sheopur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,2.0,1.0,0.0,1.0,4.0,2.0,0.0,3.0,3.0,8.0,2.0,1.0,27.0
Sheopur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,6.0,8.0,8.0,6.0,3.0,2.0,2.0,3.0,6.0,3.0,0.0,2.0,49.0
Sheopur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheopur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,8.0,9.0,8.0,7.0,7.0,4.0,2.0,6.0,9.0,11.0,2.0,3.0,76.0
Sheopur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sheopur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,77.0,92.0,76.0,99.0,118.0,91.0,71.0,86.0,149.0,279.0,305.0,102.0,1545.0
Sheopur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,4.0,0.0,2.0,2.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,10.0
Sheopur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,2.0,3.0,7.0,2.0,0.0,3.0,2.0,8.0,0.0,12.0,10.0,12.0,61.0
Sheopur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,88.0,136.0,118.0,62.0,52.0,7.0,7.0,2.0,59.0,9.0,12.0,25.0,577.0
Sheopur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sheopur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,167.0,235.0,201.0,165.0,172.0,101.0,80.0,97.0,209.0,300.0,327.0,139.0,2193.0
Sheopur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,81.0,132.0,117.0,59.0,48.0,6.0,6.0,7.0,69.0,15.0,17.0,24.0,581.0
Sheopur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sheopur,9.06,Number of IUCD removals,TOTAL,74.0,48.0,42.0,70.0,50.0,42.0,69.0,90.0,80.0,61.0,72.0,146.0,844.0
Sheopur,9.07,Number of Oral Pills cycles distributed,TOTAL,2470.0,2994.0,3028.0,2518.0,3027.0,2974.0,3789.0,4045.0,4060.0,3665.0,4042.0,4205.0,40817.0
Sheopur,9.08,Number of Condom pieces distributed,TOTAL,6893.0,8281.0,10976.0,8604.0,10619.0,10131.0,10900.0,11987.0,10703.0,11537.0,11589.0,12140.0,124360.0
Sheopur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,21.0,38.0,34.0,31.0,22.0,23.0,0.0,20.0,13.0,30.0,24.0,26.0,282.0
Sheopur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0,14.0
Sheopur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,9.12,Number of Institutions having NSV trained doctors,TOTAL,6.0,2.0,3.0,3.0,,2.0,3.0,4.0,3.0,2.0,2.0,3.0,-1.0
Sheopur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,652.0,911.0,1095.0,1248.0,1227.0,1484.0,1393.0,1469.0,1326.0,1260.0,1027.0,1241.0,14333.0
Sheopur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,998.0,1118.0,1243.0,1303.0,1237.0,1436.0,1510.0,650.0,82.0,0.0,0.0,20.0,9597.0
Sheopur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1006.0,1234.0,1220.0,1371.0,1141.0,1336.0,1274.0,1416.0,874.0,302.0,134.0,85.0,11393.0
Sheopur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1084.0,1248.0,1369.0,1430.0,1183.0,1270.0,1197.0,1248.0,1354.0,934.0,448.0,266.0,13031.0
Sheopur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,962.0,1365.0,1427.0,1407.0,1575.0,6736.0
Sheopur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,609.0,1145.0,1301.0,1569.0,4624.0
Sheopur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,537.0,916.0,1439.0,2901.0
Sheopur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,446.0,611.0,622.0,765.0,903.0,902.0,839.0,931.0,776.0,840.0,631.0,845.0,9111.0
Sheopur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1005.0,1115.0,1237.0,1284.0,1243.0,1461.0,1117.0,1447.0,1449.0,1488.0,1383.0,1596.0,15825.0
Sheopur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1001.0,1234.0,1211.0,1359.0,1141.0,1344.0,889.0,1406.0,1412.0,1396.0,1404.0,1618.0,15415.0
Sheopur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1093.0,1248.0,1340.0,1401.0,1180.0,1266.0,884.0,1253.0,1318.0,1326.0,1314.0,1631.0,15254.0
Sheopur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,383.0,542.0,553.0,705.0,719.0,674.0,695.0,749.0,638.0,675.0,536.0,768.0,7637.0
Sheopur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,968.0,1124.0,1240.0,1293.0,1308.0,1541.0,1611.0,620.0,186.0,132.0,0.0,14.0,10037.0
Sheopur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,990.0,1242.0,1214.0,1381.0,1139.0,1342.0,1266.0,1386.0,863.0,381.0,135.0,69.0,11408.0
Sheopur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1075.0,1252.0,1358.0,1433.0,1181.0,1258.0,1211.0,1222.0,1294.0,924.0,433.0,272.0,12913.0
Sheopur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,843.0,1076.0,1324.0,1573.0,1258.0,1373.0,1273.0,1177.0,1228.0,1112.0,997.0,1369.0,14603.0
Sheopur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,632.0,744.0,936.0,996.0,756.0,829.0,875.0,861.0,1034.0,1020.0,1001.0,1273.0,10957.0
Sheopur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,393.0,537.0,636.0,737.0,643.0,670.0,636.0,570.0,638.0,573.0,502.0,685.0,7220.0
Sheopur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,378.0,489.0,535.0,646.0,541.0,612.0,551.0,529.0,516.0,426.0,451.0,577.0,6251.0
Sheopur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,771.0,1026.0,1171.0,1383.0,1184.0,1282.0,1187.0,1099.0,1154.0,999.0,953.0,1262.0,13471.0
Sheopur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,802.0,1003.0,1123.0,1301.0,998.0,1036.0,963.0,1040.0,1266.0,1258.0,1209.0,1479.0,13478.0
Sheopur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,795.0,1009.0,1143.0,1282.0,1008.0,1043.0,742.0,1076.0,1269.0,1258.0,1206.0,1469.0,13300.0
Sheopur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,106.0,153.0,228.0,241.0,211.0,209.0,192.0,207.0,251.0,286.0,261.0,210.0,2555.0
Sheopur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,117.0,128.0,198.0,199.0,223.0,158.0,151.0,171.0,239.0,260.0,248.0,238.0,2330.0
Sheopur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,223.0,281.0,426.0,440.0,434.0,367.0,343.0,378.0,490.0,546.0,509.0,448.0,4885.0
Sheopur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,520.0,702.0,848.0,1064.0,757.0,801.0,870.0,756.0,718.0,913.0,751.0,1019.0,9719.0
Sheopur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,558.0,761.0,865.0,911.0,816.0,825.0,879.0,817.0,757.0,805.0,785.0,937.0,9716.0
Sheopur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,678.0,834.0,906.0,993.0,850.0,883.0,897.0,835.0,780.0,932.0,806.0,972.0,10366.0
Sheopur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Sheopur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,3.0,3.0,3.0,2.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,12.0
Sheopur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,546.0,620.0,713.0,676.0,638.0,637.0,633.0,652.0,664.0,677.0,662.0,759.0,7877.0
Sheopur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,482.0,581.0,675.0,649.0,597.0,611.0,606.0,625.0,653.0,661.0,633.0,749.0,7522.0
Sheopur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,380.0,454.0,526.0,537.0,459.0,497.0,482.0,502.0,505.0,537.0,521.0,620.0,6020.0
Sheopur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,808.0,1045.0,1314.0,1753.0,1193.0,1322.0,1226.0,1195.0,1175.0,1390.0,1019.0,1387.0,14827.0
Sheopur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,135.0,155.0,227.0,4136.0,3036.0,303.0,176.0,288.0,280.0,5726.0,1256.0,431.0,16149.0
Sheopur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,112.0,90.0,104.0,4348.0,3091.0,111.0,72.0,111.0,148.0,6420.0,982.0,274.0,15863.0
Sheopur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,0.0,5.0
Sheopur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,5.0,0.0,6.0,28.0,6.0,0.0,0.0,1.0,15.0,0.0,0.0,0.0,61.0
Sheopur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,580.0,975.0,810.0,733.0,787.0,829.0,671.0,444.0,359.0,449.0,383.0,459.0,7479.0
Sheopur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,111.0,204.0,238.0,246.0,276.0,687.0,1125.0,419.0,126.0,119.0,113.0,175.0,3839.0
Sheopur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,92.0,107.0,92.0,48.0,51.0,90.0,92.0,148.0,142.0,120.0,122.0,148.0,1252.0
Sheopur,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,77.0,201.0,0.0,111.0,37.0,426.0
Sheopur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,77.0,201.0,0.0,111.0,37.0,426.0
Sheopur,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,98.0,15.0,287.0,0.0,0.0,0.0,400.0
Sheopur,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,113.0,287.0,0.0,0.0,0.0,400.0
Sheopur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,3.0,3.0,2.0,3.0,3.0,3.0,2.0,2.0,2.0,2.0,3.0,-1.0
Sheopur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,7.0,2.0,5.0,3.0,6.0,3.0,1.0,3.0,1.0,1.0,1.0,,-1.0
Sheopur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,384.0,430.0,485.0,510.0,391.0,460.0,438.0,488.0,465.0,461.0,545.0,632.0,-1.0
Sheopur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,4.0,3.0,3.0,3.0,4.0,3.0,3.0,4.0,4.0,4.0,4.0,-1.0
Sheopur,14.05,Number of RKS meetings held during the month,TOTAL,3.0,2.0,3.0,2.0,2.0,2.0,2.0,1.0,0.0,0.0,0.0,2.0,19.0
Sheopur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,10.0,9.0,8.0,7.0,6.0,6.0,6.0,6.0,5.0,5.0,5.0,4.0,-1.0
Sheopur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,33.0,1.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,37.0
Sheopur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,1.0,1.0,1.0,1.0,-1.0
Sheopur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,-1.0
Sheopur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,462.0,718.0,928.0,811.0,810.0,787.0,1016.0,474.0,429.0,414.0,569.0,708.0,8126.0
Sheopur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,616.0,1128.0,1298.0,1007.0,831.0,987.0,985.0,771.0,582.0,621.0,687.0,960.0,10473.0
Sheopur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,302.0,523.0,649.0,523.0,543.0,989.0,585.0,521.0,317.0,229.0,375.0,439.0,5995.0
Sheopur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,984.0,1471.0,1897.0,1592.0,1777.0,1998.0,1933.0,1643.0,1481.0,1430.0,1388.0,1359.0,18953.0
Sheopur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,764.0,1241.0,1577.0,1334.0,1353.0,1776.0,1601.0,995.0,746.0,643.0,944.0,1147.0,14121.0
Sheopur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1600.0,2599.0,3195.0,2599.0,2608.0,2985.0,2918.0,2414.0,2063.0,2051.0,2075.0,2319.0,29426.0
Sheopur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,8.0,6.0,10.0,5.0,9.0,9.0,11.0,11.0,8.0,8.0,4.0,10.0,99.0
Sheopur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,6.0,6.0,6.0,7.0,17.0,11.0,15.0,8.0,3.0,3.0,4.0,92.0
Sheopur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,14.0,12.0,16.0,11.0,16.0,26.0,22.0,26.0,16.0,11.0,7.0,14.0,191.0
Sheopur,14.11,In-Patient Head Count at midnight,TOTAL,880.0,963.0,1628.0,1388.0,1763.0,1804.0,1848.0,1530.0,1217.0,1022.0,1189.0,1282.0,16514.0
Sheopur,14.12.1,OPD attendance (All),TOTAL,24294.0,35756.0,36520.0,36448.0,44137.0,54811.0,55791.0,40450.0,36815.0,29139.0,39829.0,44969.0,478959.0
Sheopur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,25.0,26.0,30.0,48.0,50.0,54.0,52.0,50.0,55.0,45.0,33.0,45.0,513.0
Sheopur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,5.0,0.0,0.0,1.0,1.0,2.0,0.0,0.0,5.0,1.0,2.0,17.0
Sheopur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,108.0,127.0,79.0,59.0,101.0,108.0,52.0,595.0,969.0,356.0,335.0,94.0,2983.0
Sheopur,14.14.a,Number of patients given AYUSH treatment,TOTAL,181.0,172.0,475.0,420.0,327.0,635.0,729.0,563.0,468.0,290.0,374.0,607.0,5241.0
Sheopur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,180.0,148.0,185.0,154.0,170.0,180.0,158.0,172.0,190.0,159.0,148.0,158.0,2002.0
Sheopur,14.14.c,Number of Adolescents counselled,TOTAL,99.0,103.0,230.0,187.0,223.0,335.0,191.0,236.0,216.0,210.0,838.0,217.0,3085.0
Sheopur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2688.0,3493.0,3678.0,3946.0,3812.0,4400.0,3882.0,3573.0,2972.0,2865.0,3682.0,3932.0,42923.0
Sheopur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,92.0,188.0,115.0,156.0,161.0,197.0,176.0,165.0,96.0,98.0,88.0,109.0,1641.0
Sheopur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,145.0,105.0,98.0,90.0,107.0,113.0,79.0,77.0,134.0,101.0,132.0,99.0,1280.0
Sheopur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Sheopur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,234.0,283.0,226.0,235.0,243.0,252.0,190.0,287.0,267.0,274.0,229.0,270.0,2990.0
Sheopur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Sheopur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,303.0,381.0,503.0,476.0,501.0,539.0,308.0,349.0,325.0,293.0,312.0,274.0,4564.0
Sheopur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,5.0
Sheopur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,682.0,769.0,827.0,801.0,851.0,904.0,577.0,713.0,726.0,668.0,673.0,643.0,8834.0
Sheopur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,1.0,2.0,0.0,3.0,5.0,0.0,0.0,0.0,0.0,0.0,11.0
Sheopur,15.2,Number of Widal tests conducted,Number tested,970.0,1208.0,1150.0,1269.0,1508.0,1956.0,2033.0,1747.0,1144.0,879.0,188.0,1154.0,15206.0
Sheopur,15.3.a,Number of VDRL tests conducted on males,Number tested,3.0,14.0,23.0,37.0,69.0,117.0,24.0,57.0,196.0,4.0,240.0,16.0,800.0
Sheopur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,11.0,18.0,26.0,59.0,17.0,20.0,49.0,153.0,0.0,4.0,11.0,368.0
Sheopur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,25.0,77.0,147.0,116.0,67.0,86.0,194.0,8.0,227.0,263.0,250.0,358.0,1818.0
Sheopur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,28.0,102.0,188.0,179.0,195.0,220.0,238.0,114.0,576.0,267.0,494.0,385.0,2986.0
Sheopur,15.4.1,Number of blood smears examined for Malaria,TOTAL,4252.0,10107.0,8199.0,10213.0,8552.0,16575.0,27741.0,17452.0,8055.0,4416.0,6305.0,6500.0,128367.0
Sheopur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,49.0,153.0,202.0,296.0,347.0,1077.0,1649.0,458.0,142.0,25.0,42.0,42.0,4482.0
Sheopur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,11.0,5.0,12.0,11.0,108.0,727.0,256.0,112.0,14.0,6.0,5.0,1269.0
Sheopur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1000.0,200.0,9500.0,3500.0,1000.0,2000.0,3200.0,3000.0,1100.0,1100.0,0.0,1200.0,26800.0
Sheopur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,8000.0,18000.0,0.0,6000.0,8000.0,8000.0,7000.0,3000.0,3000.0,2000.0,4000.0,2000.0,69000.0
Sheopur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,8800.0,8700.0,6000.0,8500.0,7000.0,6800.0,7200.0,4900.0,3000.0,3100.0,2800.0,1550.0,68350.0
Sheopur,16.1.1,Stock position of DPT vaccines,5. Total Stock,200.0,9500.0,3500.0,1000.0,2000.0,3200.0,3000.0,1100.0,1100.0,0.0,1200.0,1650.0,27450.0
Sheopur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8400.0,7480.0,4000.0,8870.0,1900.0,30650.0
Sheopur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,12000.0,0.0,0.0,8000.0,0.0,8000.0,28000.0
Sheopur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,3600.0,920.0,3480.0,3130.0,6970.0,1700.0,19800.0
Sheopur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,8400.0,7480.0,4000.0,8870.0,1900.0,8200.0,38850.0
Sheopur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,3000.0,400.0,3300.0,1500.0,1000.0,200.0,0.0,1000.0,0.0,152200.0,3000.0,6000.0,171600.0
Sheopur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,10000.0,18000.0,5000.0,15000.0,9000.0,8500.0,8000.0,8500.0,161000.0,4000.0,153500.0,2760.0,403260.0
Sheopur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,12600.0,15100.0,6800.0,15500.0,9800.0,8700.0,7000.0,9500.0,8800.0,153200.0,150500.0,3860.0,401360.0
Sheopur,16.1.2,Stock position of OPV vaccines,5. Total Stock,400.0,3300.0,1500.0,1000.0,200.0,0.0,1000.0,0.0,152200.0,3000.0,6000.0,4900.0,173500.0
Sheopur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2500.0,2000.0,6500.0,3000.0,1000.0,2000.0,3200.0,3500.0,1200.0,4100.0,3500.0,1650.0,34150.0
Sheopur,16.1.3,Stock position of TT vaccines,2. Stocks Received,7000.0,13000.0,0.0,5000.0,8000.0,7500.0,7000.0,3000.0,7000.0,5000.0,5000.0,5000.0,72500.0
Sheopur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,7500.0,8500.0,3500.0,7000.0,7000.0,6300.0,6700.0,5300.0,4100.0,5600.0,6850.0,2550.0,70900.0
Sheopur,16.1.3,Stock position of TT vaccines,5. Total Stock,2000.0,6500.0,3000.0,1000.0,2000.0,3200.0,3500.0,1200.0,4100.0,3500.0,1650.0,4100.0,35750.0
Sheopur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1800.0,650.0,4250.0,3500.0,0.0,500.0,1000.0,250.0,0.0,1000.0,290.0,250.0,13490.0
Sheopur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,3000.0,7500.0,0.0,0.0,3000.0,3000.0,3000.0,3000.0,3000.0,3000.0,3000.0,3000.0,34500.0
Sheopur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,4150.0,3900.0,750.0,3500.0,2500.0,2500.0,3750.0,3250.0,2000.0,3710.0,3040.0,2750.0,35800.0
Sheopur,16.1.5,Stock position of BCG vaccines,5. Total Stock,650.0,4250.0,3500.0,0.0,500.0,1000.0,250.0,0.0,1000.0,290.0,250.0,500.0,12190.0
Sheopur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,750.0,2250.0,3750.0,2000.0,1750.0,2000.0,3350.0,2700.0,3000.0,1500.0,1500.0,3350.0,27900.0
Sheopur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,7000.0,6000.0,0.0,5000.0,5000.0,5000.0,3000.0,3000.0,2000.0,3000.0,5000.0,4000.0,48000.0
Sheopur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,5500.0,4500.0,1750.0,5250.0,4750.0,3650.0,3650.0,2700.0,3500.0,3000.0,3150.0,3300.0,44700.0
Sheopur,16.1.6,Stock position of Measles vaccines,5. Total Stock,2250.0,3750.0,2000.0,1750.0,2000.0,3350.0,2700.0,3000.0,1500.0,1500.0,3350.0,4050.0,31200.0
Sheopur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1000.0,1100.0,4800.0,600.0,1000.0,2000.0,3700.0,4800.0,3700.0,4200.0,2900.0,4200.0,34000.0
Sheopur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,8000.0,15000.0,0.0,8300.0,8000.0,8000.0,7200.0,3000.0,3000.0,2000.0,5000.0,0.0,67500.0
Sheopur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,7900.0,11300.0,4200.0,7900.0,7000.0,6300.0,6100.0,4100.0,2500.0,3300.0,3700.0,1000.0,65300.0
Sheopur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1100.0,4800.0,600.0,1000.0,2000.0,3700.0,4800.0,3700.0,4200.0,2900.0,4200.0,3200.0,36200.0
Sheopur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,3650.0,3500.0,2300.0,2300.0,3150.0,2550.0,1950.0,1950.0,1950.0,1950.0,1950.0,1950.0,29150.0
Sheopur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,1200.0,1200.0,3600.0,0.0,0.0,0.0,0.0,0.0,3000.0,9000.0
Sheopur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,150.0,1200.0,0.0,350.0,1800.0,4200.0,0.0,0.0,0.0,0.0,0.0,1800.0,9500.0
Sheopur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,3500.0,2300.0,2300.0,3150.0,2550.0,1950.0,1950.0,1950.0,1950.0,1950.0,1950.0,3150.0,28650.0
Sheopur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,39480.0,30000.0,20000.0,10280.0,0.0,15120.0,10080.0,5040.0,0.0,0.0,0.0,0.0,130000.0
Sheopur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,50400.0,0.0,0.0,75600.0,30240.0,0.0,0.0,0.0,0.0,12000.0,12000.0,180240.0
Sheopur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,9480.0,60400.0,9720.0,10280.0,60480.0,35280.0,5040.0,5040.0,0.0,0.0,12000.0,12000.0,219720.0
Sheopur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,30000.0,20000.0,10280.0,0.0,15120.0,10080.0,5040.0,0.0,0.0,0.0,0.0,0.0,90520.0
Sheopur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,1200.0,1200.0,200.0,200.0,7700.0,7600.0,2500.0,3000.0,23600.0
Sheopur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,9000.0,3000.0,3600.0,0.0,20000.0,0.0,0.0,6000.0,10000.0,51600.0
Sheopur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,7800.0,3000.0,4600.0,0.0,12500.0,100.0,5100.0,5500.0,9500.0,48100.0
Sheopur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,1200.0,1200.0,200.0,200.0,7700.0,7600.0,2500.0,3000.0,3500.0,27100.0
Sheopur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,1000.0
Sheopur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,4000.0,2000.0,9000.0
Sheopur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,3000.0,2000.0,8000.0
Sheopur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,1000.0,2000.0
Sheopur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,500.0,500.0,500.0,500.0,10000.0
Sheopur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0,0.0,0.0,0.0,0.0,500.0
Sheopur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,500.0,500.0,500.0,500.0,500.0,9500.0
Sheopur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,4450.0,4000.0,3000.0,2000.0,2000.0,4500.0,300.0,200.0,200.0,300.0,300.0,150.0,21400.0
Sheopur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,5000.0,0.0,0.0,0.0,300.0,0.0,0.0,1000.0,6300.0
Sheopur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,450.0,1000.0,1000.0,0.0,2500.0,4200.0,100.0,0.0,200.0,0.0,150.0,650.0,10250.0
Sheopur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,4000.0,3000.0,2000.0,2000.0,4500.0,300.0,200.0,200.0,300.0,300.0,150.0,500.0,17450.0
Sheopur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,32000.0,20000.0,12000.0,10000.0,3000.0,500.0,12000.0,10000.0,3000.0,14300.0,10000.0,119000.0,245800.0
Sheopur,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,5000.0,25000.0,0.0,0.0,20000.0,0.0,139000.0,0.0,189000.0
Sheopur,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.3.02,Stock Position of Gloves,4. Stock Distributed,12000.0,8000.0,2000.0,7000.0,7500.0,13500.0,2000.0,7000.0,8700.0,4300.0,30000.0,29000.0,131000.0
Sheopur,16.3.02,Stock Position of Gloves,5. Total Stock,20000.0,12000.0,10000.0,3000.0,500.0,12000.0,10000.0,3000.0,14300.0,10000.0,119000.0,90000.0,303800.0
Sheopur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,10000.0,9500.0,9000.0,9000.0,12000.0,10000.0,9500.0,9000.0,7600.0,7200.0,6500.0,14000.0,113300.0
Sheopur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,20000.0
Sheopur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,500.0,500.0,0.0,7000.0,2000.0,500.0,500.0,1400.0,400.0,700.0,2500.0,1000.0,17000.0
Sheopur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,9500.0,9000.0,9000.0,12000.0,10000.0,9500.0,9000.0,7600.0,7200.0,6500.0,14000.0,13000.0,116300.0
Sheopur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,102.0,448.0,392.0,642.0,742.0,723.0,711.0,646.0,967.0,967.0,848.0,1010.0,8198.0
Sheopur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,500.0,0.0,400.0,150.0,95.0,75.0,0.0,500.0,0.0,0.0,1000.0,,2720.0
Sheopur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,15.0,6.0,10.0,5.0,5.0,7.0,10.0,10.0,0.0,10.0,0.0,,78.0
Sheopur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,139.0,50.0,140.0,45.0,109.0,80.0,55.0,169.0,0.0,109.0,838.0,,1734.0
Sheopur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,448.0,392.0,642.0,742.0,723.0,711.0,646.0,967.0,967.0,848.0,1010.0,1010.0,9106.0
Sheopur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Sheopur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Sheopur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Sheopur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,20000.0,0.0,0.0,0.0,0.0,0.0,247000.0,147000.0,478000.0,152270.0,1400000.0,2400000.0,4844270.0
Sheopur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,,0.0,1000000.0,0.0,800000.0,1550000.0,1550000.0,2000000.0,2000000.0,8900000.0
Sheopur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,20000.0,0.0,0.0,,0.0,753000.0,100000.0,469000.0,505300.0,302270.0,1000000.0,1500000.0,4649570.0
Sheopur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,247000.0,147000.0,478000.0,1522700.0,1400000.0,2400000.0,2900000.0,9094700.0
Sheopur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,4000.0,28000.0,4000.0,0.0,0.0,16000.0,10805.0,9000.0,5655.0,55.0,4000.0,1.0,81516.0
Sheopur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,25000.0,0.0,0.0,0.0,20000.0,0.0,0.0,0.0,13000.0,16600.0,0.0,1000.0,75600.0
Sheopur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,1000.0,24000.0,4000.0,0.0,4000.0,5195.0,1805.0,3345.0,18600.0,12655.0,3999.0,500.0,79099.0
Sheopur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,28000.0,4000.0,0.0,0.0,16000.0,10805.0,9000.0,5655.0,55.0,4000.0,1.0,501.0,78017.0
Sheopur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,4000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0,4600.0
Sheopur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,600.0,200.0,800.0
Sheopur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,4000.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,700.0,4700.0
Sheopur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0,100.0,700.0
Sheopur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,70.0,70.0,70.0,70.0,800.0,1500.0,300.0,300.0,15.0,300.0,200.0,800.0,4495.0
Sheopur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,0.0,0.0,2008.0,1000.0,0.0,0.0,0.0,1000.0,0.0,600.0,0.0,4608.0
Sheopur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,0.0,0.0,1278.0,300.0,1200.0,0.0,285.0,715.0,100.0,0.0,50.0,3928.0
Sheopur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,70.0,70.0,70.0,800.0,1500.0,300.0,300.0,15.0,300.0,200.0,800.0,750.0,5175.0
Sheopur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,69000.0,69000.0,25000.0,100000.0,1000.0,5000.0,50000.0,50000.0,55000.0,55000.0,45000.0,25000.0,549000.0
Sheopur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,100000.0,0.0,9000.0,95000.0,0.0,20000.0,0.0,0.0,0.0,0.0,224000.0
Sheopur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,44000.0,25000.0,99000.0,5000.0,50000.0,0.0,15000.0,0.0,10000.0,20000.0,2000.0,270000.0
Sheopur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,69000.0,25000.0,100000.0,1000.0,5000.0,50000.0,50000.0,55000.0,55000.0,45000.0,25000.0,23000.0,503000.0
Sheopur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,150.0,3600.0,4800.0,1400.0,0.0,6000.0,1500.0,4200.0,2700.0,0.0,9300.0,5000.0,38650.0
Sheopur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6000.0,6600.0,0.0,0.0,9900.0,0.0,3300.0,3300.0,0.0,9900.0,0.0,0.0,39000.0
Sheopur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2550.0,5400.0,3400.0,1400.0,3900.0,4500.0,600.0,4800.0,2700.0,600.0,4300.0,1500.0,35650.0
Sheopur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3600.0,4800.0,1400.0,0.0,6000.0,1500.0,4200.0,2700.0,0.0,9300.0,5000.0,3500.0,42000.0
Sheopur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,149000.0,116000.0,300000.0,292000.0,230000.0,220000.0,204000.0,250000.0,438500.0,310000.0,300000.0,180000.0,2989500.0
Sheopur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,200000.0,0.0,0.0,0.0,0.0,62000.0,200000.0,0.0,0.0,0.0,100000.0,562000.0
Sheopur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,33000.0,16000.0,8000.0,62000.0,10000.0,16000.0,16000.0,11500.0,128500.0,10000.0,120000.0,2000.0,433000.0
Sheopur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,116000.0,300000.0,292000.0,230000.0,220000.0,204000.0,250000.0,438500.0,310000.0,300000.0,180000.0,278000.0,3118500.0
Sheopur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,1800.0,4500.0,2400.0,400.0,3000.0,1500.0,2300.0,1200.0,0.0,3400.0,2000.0,22500.0
Sheopur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4000.0,4000.0,0.0,0.0,6000.0,0.0,2000.0,2000.0,0.0,4000.0,0.0,0.0,22000.0
Sheopur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sheopur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2200.0,1300.0,2100.0,2000.0,3400.0,1500.0,1200.0,3100.0,1200.0,600.0,1400.0,200.0,20200.0
Sheopur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1800.0,4500.0,2400.0,400.0,3000.0,1500.0,2300.0,1200.0,0.0,3400.0,2000.0,1800.0,24300.0
Sheopur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,2.0,3.0,1.0,3.0,3.0,,3.0,,2.0,,,17.0
Sheopur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,,3.0,4.0,2.0,3.0,,1.0,1.0,1.0,2.0,1.0,19.0
Sheopur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,1.0,1.0
Sheopur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,,3.0,4.0,2.0,3.0,,1.0,1.0,1.0,2.0,2.0,20.0
Sheopur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,5.0,6.0,8.0,3.0,2.0,3.0,,4.0,1.0,,2.0,35.0
Sheopur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sheopur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,5.0,6.0,8.0,3.0,2.0,3.0,,4.0,1.0,,2.0,35.0
Sheopur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,2.0,3.0,1.0,7.0,8.0,5.0,4.0,7.0,6.0,3.0,4.0,51.0
Sheopur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,1.0,1.0,,,,,,,,2.0
Sheopur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,2.0,3.0,2.0,8.0,8.0,5.0,4.0,7.0,6.0,3.0,4.0,53.0
Sheopur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,,3.0,2.0,9.0,1.0,7.0,6.0,5.0,12.0,8.0,4.0,60.0
Sheopur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,1.0,,,,1.0,,,,,,2.0
Sheopur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,,4.0,2.0,9.0,1.0,8.0,6.0,5.0,12.0,8.0,4.0,62.0
Sheopur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,1.0,1.0,1.0,,2.0,1.0,3.0,3.0,1.0,5.0,4.0,23.0
Sheopur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,1.0,1.0,1.0,2.0,,4.0,2.0,,,,11.0
Sheopur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,1.0,2.0,2.0,1.0,4.0,1.0,7.0,5.0,1.0,5.0,4.0,34.0
Sheopur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sheopur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sheopur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Sheopur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,2.0,,1.0,2.0,3.0,,1.0,1.0,3.0,,13.0
Sheopur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,1.0,1.0,2.0,1.0,5.0,2.0,,,1.0,1.0,15.0
Sheopur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,1.0,3.0,1.0,3.0,3.0,8.0,2.0,1.0,1.0,4.0,1.0,28.0
Sheopur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sheopur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sheopur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Sheopur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,4.0,5.0,7.0,6.0,8.0,12.0,13.0,10.0,3.0,6.0,13.0,5.0,92.0
Sheopur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,2.0,20.0,7.0,2.0,8.0,31.0,26.0,12.0,7.0,5.0,3.0,124.0
Sheopur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,5.0,7.0,27.0,13.0,10.0,20.0,44.0,36.0,15.0,13.0,18.0,8.0,216.0
Sheopur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Sheopur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,2.0,2.0,,,1.0,,,,,5.0
Sheopur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Sheopur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,2.0,2.0,,1.0,1.0,,,,,6.0
Sheopur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Sheopur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,2.0,3.0,4.0,4.0,1.0,2.0,1.0,2.0,3.0,2.0,2.0,28.0
Sheopur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,,2.0,2.0,,,,,1.0,2.0,1.0,9.0
Sheopur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,3.0,3.0,7.0,6.0,1.0,2.0,1.0,2.0,4.0,4.0,3.0,38.0
Sheopur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Sheopur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,1.0,,,1.0,1.0,,,1.0,1.0,6.0
Sheopur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,4.0,1.0,1.0,,,2.0,2.0,,,,,11.0
Sheopur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,4.0,2.0,2.0,,,4.0,3.0,,,1.0,1.0,18.0
Sheopur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,1.0,,1.0,,,,,,,2.0
Sheopur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,2.0,3.0,1.0,,,,,,6.0
Sheopur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Sheopur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,,,1.0,2.0,4.0,1.0,,,,,,9.0
Sheopur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,2.0,,,1.0,,,1.0,4.0
Sheopur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,2.0,3.0,4.0,,1.0,3.0,2.0,2.0,3.0,3.0,,3.0,26.0
Sheopur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,2.0,,1.0,2.0,1.0,,4.0,2.0,1.0,1.0,15.0
Sheopur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,3.0,3.0,6.0,,2.0,7.0,3.0,2.0,8.0,5.0,1.0,5.0,45.0
Sheopur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Sheopur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Sheopur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Sheopur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Sheopur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Sheopur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,1.0,,3.0,,2.0,1.0,3.0,,,3.0,13.0
Sheopur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,1.0,,,,,,1.0,2.0,,1.0,4.0,10.0
Sheopur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,1.0,1.0,,4.0,,2.0,2.0,5.0,,1.0,7.0,24.0
Sheopur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,1.0,1.0,,,,,2.0
Sheopur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,1.0,,,,1.0,,2.0,1.0,1.0,,,8.0
Sheopur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,2.0,,,1.0,,1.0,,4.0,5.0,,1.0,,14.0
Sheopur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,4.0,1.0,,1.0,,2.0,1.0,7.0,6.0,1.0,1.0,,24.0
Sheopur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Sheopur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Sheopur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Sheopur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Sheopur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Sheopur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Sheopur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Sheopur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Sheopur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Sheopur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Sheopur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Sheopur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,1.0,,,,,,,,,1.0
Sheopur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Sheopur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,1.0,,1.0,1.0,2.0,,,,,,,6.0
Sheopur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Sheopur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,1.0,,1.0,1.0,2.0,,,,,,,6.0
Sheopur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Sheopur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Sheopur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Sheopur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Sheopur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Sheopur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,2.0,2.0,3.0,4.0,4.0,2.0,5.0,2.0,1.0,2.0,3.0,30.0
Sheopur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Sheopur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,2.0,2.0,3.0,4.0,4.0,2.0,5.0,2.0,1.0,2.0,3.0,30.0
Sheopur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Sheopur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,2.0,3.0,1.0,2.0,2.0,3.0,2.0,1.0,2.0,1.0,4.0,24.0
Sheopur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,1.0,1.0,1.0,3.0
Sheopur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,2.0,3.0,1.0,2.0,2.0,3.0,3.0,1.0,3.0,2.0,5.0,28.0
Sheopur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Sheopur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,1.0,2.0,,,1.0,1.0,1.0,1.0,2.0,1.0,2.0,12.0
Sheopur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Sheopur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,1.0,2.0,,,1.0,1.0,1.0,1.0,2.0,1.0,3.0,13.0
Sheopur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,,2.0,1.0,1.0,1.0,,,,,,6.0
Sheopur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Sheopur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Sheopur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,,2.0,2.0,1.0,1.0,,,,,,7.0
Sheopur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Sheopur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,3.0,,,,,,,,4.0,1.0,,,8.0
Sheopur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,1.0,,,,7.0,1.0,,1.0,10.0
Sheopur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,,,,1.0,,,,11.0,2.0,,1.0,18.0
Sheopur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Sheopur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,,,,,,1.0,3.0,1.0,1.0,2.0,9.0
Sheopur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1.0,,,,2.0,,,,,1.0,,,4.0
Sheopur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,2.0,,,,2.0,,,1.0,3.0,2.0,1.0,2.0,13.0
Sheopur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,1.0,,,2.0,3.0,5.0,7.0,1.0,1.0,,2.0,23.0
Sheopur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,5.0,10.0,10.0,6.0,7.0,6.0,5.0,2.0,1.0,9.0,2.0,9.0,72.0
Sheopur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,8.0,4.0,7.0,1.0,11.0,,,15.0,12.0,14.0,17.0,11.0,100.0
Sheopur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,14.0,15.0,17.0,7.0,20.0,9.0,10.0,24.0,14.0,24.0,19.0,22.0,195.0
Shivpuri,1.1,Total number of pregnant women Registered for ANC,TOTAL,3524.0,4599.0,5328.0,5591.0,4468.0,4967.0,4000.0,4056.0,4228.0,3880.0,5377.0,5348.0,55366.0
Shivpuri,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2042.0,2861.0,3278.0,3356.0,2751.0,2913.0,2358.0,2462.0,2457.0,2575.0,3460.0,3216.0,33729.0
Shivpuri,1.2,Number of Pregnant women registered under JSY,TOTAL,3404.0,4444.0,5069.0,5390.0,4342.0,4850.0,3951.0,3808.0,3888.0,3728.0,4972.0,5053.0,52899.0
Shivpuri,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2918.0,3441.0,4129.0,4380.0,3914.0,4086.0,3661.0,3663.0,3638.0,3550.0,4120.0,4500.0,46000.0
Shivpuri,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3089.0,3919.0,4447.0,4788.0,3718.0,4196.0,3285.0,3269.0,3627.0,3278.0,4537.0,4567.0,46720.0
Shivpuri,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2878.0,3182.0,3631.0,4100.0,3647.0,3632.0,3202.0,3132.0,3264.0,2916.0,3850.0,4716.0,42150.0
Shivpuri,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3405.0,4316.0,5196.0,5100.0,4179.0,4407.0,3947.0,3707.0,4036.0,3719.0,5001.0,5298.0,52311.0
Shivpuri,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,275.0,390.0,334.0,598.0,481.0,508.0,438.0,556.0,571.0,661.0,1046.0,944.0,6802.0
Shivpuri,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,4.0,4.0,3.0,5.0,3.0,7.0,3.0,2.0,4.0,6.0,8.0,9.0,58.0
Shivpuri,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1567.0,1218.0,2169.0,2151.0,1866.0,1773.0,1709.0,2363.0,2036.0,1866.0,2225.0,2256.0,23199.0
Shivpuri,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,40.0,97.0,128.0,141.0,146.0,196.0,96.0,159.0,104.0,135.0,114.0,148.0,1504.0
Shivpuri,1.8,Number of pregnancy test kits used at SC level,TOTAL,144.0,168.0,212.0,224.0,103.0,153.0,134.0,257.0,304.0,392.0,437.0,548.0,3076.0
Shivpuri,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,26.0,0.0,0.0,0.0,0.0,18.0,12.0,13.0,1.0,2.0,6.0,44.0,122.0
Shivpuri,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,260.0,292.0,338.0,389.0,449.0,436.0,370.0,537.0,535.0,555.0,550.0,471.0,5182.0
Shivpuri,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,286.0,292.0,338.0,389.0,449.0,454.0,382.0,550.0,536.0,557.0,556.0,515.0,5304.0
Shivpuri,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,226.0,230.0,233.0,310.0,411.0,362.0,318.0,308.0,207.0,460.0,294.0,321.0,3680.0
Shivpuri,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,3.0,0.0,1.0,0.0,0.0,0.0,2.0,5.0,0.0,0.0,0.0,0.0,11.0
Shivpuri,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1939.0,2133.0,2510.0,2869.0,3443.0,3140.0,2736.0,2740.0,2704.0,2511.0,2426.0,2709.0,31860.0
Shivpuri,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,434.0,29.0,51.0,121.0,537.0,149.0,71.0,490.0,363.0,123.0,109.0,132.0,2609.0
Shivpuri,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1708.0,2113.0,2230.0,2699.0,3108.0,2789.0,2430.0,2575.0,2467.0,2404.0,1989.0,1981.0,28493.0
Shivpuri,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1256.0,1402.0,1600.0,1870.0,2125.0,1845.0,1508.0,1645.0,1636.0,1667.0,1660.0,1504.0,19718.0
Shivpuri,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,30.0,25.0,31.0,35.0,30.0,21.0,20.0,35.0,27.0,32.0,34.0,10.0,330.0
Shivpuri,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Shivpuri,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Shivpuri,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Shivpuri,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,4.0,8.0,2.0,1.0,0.0,0.0,16.0
Shivpuri,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,72.0,122.0,117.0,114.0,136.0,114.0,116.0,105.0,114.0,116.0,122.0,146.0,1394.0
Shivpuri,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shivpuri,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,73.0,122.0,117.0,114.0,136.0,114.0,120.0,113.0,116.0,117.0,122.0,146.0,1410.0
Shivpuri,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,11.0,6.0,12.0,13.0,9.0,4.0,7.0,10.0,8.0,11.0,8.0,2.0,101.0
Shivpuri,4.1.1.a,Number of male live births,TOTAL,1144.0,1266.0,1504.0,1707.0,2089.0,1786.0,1664.0,1690.0,1647.0,1560.0,1569.0,1671.0,19297.0
Shivpuri,4.1.1.b,Number of female live births,TOTAL,1058.0,1131.0,1322.0,1544.0,1792.0,1759.0,1435.0,1589.0,1576.0,1510.0,1413.0,1533.0,17662.0
Shivpuri,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2202.0,2397.0,2826.0,3251.0,3881.0,3545.0,3099.0,3279.0,3223.0,3070.0,2982.0,3204.0,36959.0
Shivpuri,4.1.2,Number of still births,TOTAL,56.0,56.0,55.0,52.0,41.0,72.0,40.0,53.0,47.0,32.0,34.0,34.0,572.0
Shivpuri,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,43.0,72.0,64.0,61.0,105.0,58.0,102.0,125.0,129.0,108.0,137.0,148.0,1152.0
Shivpuri,4.2.1,Number of Newborns weighed at birth,TOTAL,2138.0,2240.0,2717.0,3156.0,3676.0,3491.0,3026.0,3122.0,3074.0,3028.0,2882.0,3085.0,35635.0
Shivpuri,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,261.0,311.0,350.0,399.0,592.0,476.0,493.0,510.0,575.0,373.0,549.0,793.0,5682.0
Shivpuri,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2126.0,2330.0,2717.0,3161.0,3665.0,3474.0,3032.0,3153.0,3113.0,3003.0,2868.0,3051.0,35693.0
Shivpuri,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,7.0,2.0,0.0,1.0,7.0,9.0,4.0,3.0,20.0,14.0,80.0,4.0,151.0
Shivpuri,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,24.0,26.0,40.0,43.0,61.0,35.0,34.0,38.0,50.0,64.0,51.0,30.0,496.0
Shivpuri,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,4.0,12.0,7.0,7.0,8.0,18.0,5.0,9.0,114.0,246.0,170.0,17.0,617.0
Shivpuri,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shivpuri,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,35.0,40.0,47.0,51.0,76.0,62.0,43.0,50.0,184.0,324.0,301.0,51.0,1264.0
Shivpuri,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,10.0,12.0,8.0,10.0,9.0,13.0,5.0,6.0,3.0,5.0,3.0,13.0,97.0
Shivpuri,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,44.0,36.0,23.0,97.0,411.0,66.0,23.0,29.0,163.0,314.0,254.0,38.0,1498.0
Shivpuri,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,14.0,20.0,14.0,88.0,28.0,24.0,17.0,12.0,8.0,73.0,40.0,35.0,373.0
Shivpuri,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,17.0,31.0,19.0,23.0,339.0,34.0,21.0,36.0,120.0,133.0,192.0,36.0,1001.0
Shivpuri,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,7.0,16.0,10.0,13.0,10.0,18.0,10.0,12.0,22.0,79.0,74.0,19.0,290.0
Shivpuri,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2040.0,2224.0,2573.0,2895.0,3575.0,3334.0,2924.0,2825.0,2355.0,2404.0,2325.0,2668.0,32142.0
Shivpuri,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1461.0,1880.0,1972.0,2116.0,2363.0,2283.0,1996.0,1801.0,1730.0,1910.0,1771.0,1936.0,23219.0
Shivpuri,6.3,PNC maternal complications attended,TOTAL,21.0,16.0,17.0,10.0,13.0,31.0,33.0,107.0,22.0,78.0,47.0,150.0,545.0
Shivpuri,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,54.0,79.0,52.0,62.0,64.0,49.0,61.0,80.0,78.0,64.0,74.0,83.0,800.0
Shivpuri,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,4.0,0.0,0.0,0.0,0.0,0.0,2.0,3.0,1.0,0.0,1.0,3.0,14.0
Shivpuri,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,58.0,79.0,52.0,62.0,64.0,49.0,63.0,83.0,79.0,64.0,75.0,86.0,814.0
Shivpuri,7.2,Number of MTPs conducted at Private Facilities,TOTAL,5.0,5.0,0.0,2.0,3.0,3.0,3.0,2.0,5.0,4.0,3.0,2.0,37.0
Shivpuri,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,70.0,50.0,72.0,178.0,260.0,626.0,303.0,149.0,206.0,143.0,184.0,170.0,2411.0
Shivpuri,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,339.0,476.0,442.0,517.0,629.0,1119.0,1047.0,598.0,952.0,614.0,805.0,561.0,8099.0
Shivpuri,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,409.0,526.0,514.0,695.0,889.0,1745.0,1350.0,747.0,1158.0,757.0,989.0,731.0,10510.0
Shivpuri,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,5.0,2.0,0.0,8.0
Shivpuri,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,0.0,2.0,3.0,0.0,0.0,0.0,2.0,7.0,9.0,0.0,0.0,25.0
Shivpuri,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shivpuri,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,0.0,2.0,3.0,0.0,0.0,0.0,2.0,8.0,14.0,2.0,0.0,33.0
Shivpuri,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Shivpuri,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,178.0,382.0,286.0,156.0,31.0,1033.0
Shivpuri,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,8.0,14.0,4.0,9.0,10.0,13.0,11.0,565.0,1948.0,2316.0,519.0,395.0,5812.0
Shivpuri,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,7.0,55.0,2.0,3.0,4.0,7.0,3.0,50.0,109.0,231.0,142.0,17.0,630.0
Shivpuri,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shivpuri,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,15.0,69.0,6.0,12.0,14.0,20.0,14.0,793.0,2439.0,2833.0,817.0,443.0,7475.0
Shivpuri,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,2.0,1.0,4.0,,2.0,1.0,1.0,1.0,1.0,,,,13.0
Shivpuri,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,2.0,2.0,2.0,4.0,5.0,4.0,2.0,25.0,8.0,14.0,2.0,70.0
Shivpuri,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shivpuri,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,2.0,2.0,2.0,4.0,5.0,4.0,2.0,25.0,8.0,14.0,2.0,70.0
Shivpuri,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Shivpuri,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,2.0,12.0
Shivpuri,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,14.0,12.0,11.0,23.0,29.0,16.0,26.0,18.0,23.0,25.0,19.0,23.0,239.0
Shivpuri,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shivpuri,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,14.0,12.0,11.0,23.0,29.0,16.0,26.0,18.0,23.0,35.0,19.0,25.0,251.0
Shivpuri,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,3.0,2.0,,5.0
Shivpuri,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,146.0,206.0,209.0,260.0,296.0,298.0,291.0,256.0,291.0,262.0,302.0,269.0,3086.0
Shivpuri,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,20.0,12.0,12.0,9.0,13.0,4.0,4.0,4.0,4.0,8.0,9.0,13.0,112.0
Shivpuri,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,31.0,49.0,41.0,30.0,31.0,35.0,63.0,59.0,39.0,39.0,98.0,37.0,552.0
Shivpuri,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,34.0,91.0,32.0,48.0,58.0,20.0,25.0,38.0,55.0,46.0,73.0,143.0,663.0
Shivpuri,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shivpuri,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,231.0,358.0,294.0,347.0,398.0,357.0,383.0,357.0,389.0,355.0,482.0,462.0,4413.0
Shivpuri,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,2.0,0.0,2.0,19.0,11.0,15.0,23.0,24.0,83.0,76.0,140.0,395.0
Shivpuri,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,6.0,9.0,8.0,8.0,4.0,7.0,8.0,5.0,8.0,15.0,10.0,8.0,96.0
Shivpuri,9.06,Number of IUCD removals,TOTAL,168.0,148.0,175.0,207.0,162.0,162.0,164.0,232.0,153.0,218.0,239.0,215.0,2243.0
Shivpuri,9.07,Number of Oral Pills cycles distributed,TOTAL,5370.0,6293.0,6528.0,6833.0,7625.0,8195.0,8156.0,8325.0,7972.0,8417.0,9517.0,9462.0,92693.0
Shivpuri,9.08,Number of Condom pieces distributed,TOTAL,39387.0,41803.0,48032.0,51475.0,54655.0,53453.0,61002.0,41383.0,35317.0,36722.0,36302.0,36632.0,536163.0
Shivpuri,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,146.0,38.0,33.0,21.0,28.0,28.0,45.0,61.0,93.0,137.0,132.0,172.0,934.0
Shivpuri,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Shivpuri,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,6.0,1.0,0.0,0.0,2.0,0.0,0.0,1.0,0.0,0.0,0.0,10.0
Shivpuri,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,9.12,Number of Institutions having NSV trained doctors,TOTAL,10.0,9.0,11.0,11.0,10.0,11.0,11.0,8.0,8.0,8.0,10.0,10.0,-1.0
Shivpuri,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2072.0,2332.0,2844.0,3019.0,3719.0,3510.0,2848.0,3167.0,3168.0,2842.0,2774.0,3016.0,35311.0
Shivpuri,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2636.0,3196.0,3476.0,3444.0,3319.0,3604.0,3676.0,1369.0,1109.0,332.0,243.0,128.0,26532.0
Shivpuri,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2711.0,3050.0,3242.0,3433.0,3161.0,3194.0,3435.0,3490.0,2169.0,1382.0,862.0,413.0,30542.0
Shivpuri,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2880.0,3159.0,3195.0,3413.0,3077.0,3092.0,3199.0,3379.0,3405.0,2259.0,1676.0,826.0,33560.0
Shivpuri,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1896.0,1950.0,2670.0,3132.0,3667.0,13315.0
Shivpuri,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1008.0,1914.0,2606.0,3679.0,9207.0
Shivpuri,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,747.0,2011.0,3473.0,6231.0
Shivpuri,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1989.0,2270.0,2510.0,2785.0,3451.0,3257.0,2570.0,2692.0,2862.0,2638.0,2603.0,2803.0,32430.0
Shivpuri,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2615.0,3164.0,3448.0,3342.0,3297.0,3542.0,3682.0,2448.0,2599.0,2466.0,3093.0,3770.0,37466.0
Shivpuri,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2700.0,3015.0,3243.0,3346.0,3104.0,3181.0,3449.0,3462.0,2916.0,2793.0,3091.0,3961.0,38261.0
Shivpuri,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2895.0,3138.0,3195.0,3355.0,3074.0,3046.0,3230.0,3285.0,3422.0,2609.0,3136.0,4103.0,38488.0
Shivpuri,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1491.0,1699.0,1917.0,2049.0,2781.0,2821.0,2184.0,2074.0,2137.0,2145.0,2084.0,1624.0,25006.0
Shivpuri,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1899.0,2335.0,2721.0,2766.0,2517.0,2695.0,2963.0,1051.0,819.0,555.0,415.0,339.0,21075.0
Shivpuri,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2662.0,3118.0,3297.0,3499.0,3113.0,5471.0,3392.0,3416.0,2312.0,1857.0,1359.0,1250.0,34746.0
Shivpuri,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2883.0,3169.0,3274.0,3384.0,3066.0,3137.0,3230.0,3384.0,3469.0,2441.0,2234.0,1885.0,35556.0
Shivpuri,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2753.0,3487.0,3856.0,4235.0,3546.0,3806.0,3463.0,3129.0,3131.0,3065.0,3827.0,4369.0,42667.0
Shivpuri,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1040.0,1700.0,1857.0,2011.0,1767.0,2159.0,2218.0,1781.0,1912.0,1907.0,2422.0,3380.0,24154.0
Shivpuri,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1400.0,1762.0,1906.0,1951.0,1722.0,1816.0,1819.0,1548.0,1559.0,1426.0,1966.0,2226.0,21101.0
Shivpuri,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1210.0,1543.0,1639.0,1752.0,1561.0,1582.0,1576.0,1368.0,1311.0,1253.0,1740.0,1875.0,18410.0
Shivpuri,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2610.0,3305.0,3545.0,3703.0,3283.0,3398.0,3395.0,2916.0,2870.0,2679.0,3706.0,4101.0,39511.0
Shivpuri,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2102.0,2695.0,3231.0,3488.0,2855.0,2947.0,2897.0,2682.0,2944.0,3049.0,3345.0,4428.0,36663.0
Shivpuri,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2100.0,2674.0,3225.0,3449.0,2853.0,2910.0,2813.0,2632.0,2896.0,3052.0,3372.0,4451.0,36427.0
Shivpuri,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,729.0,922.0,1042.0,1132.0,1054.0,1114.0,1031.0,861.0,983.0,1014.0,1231.0,1590.0,12703.0
Shivpuri,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,664.0,802.0,979.0,1084.0,1033.0,997.0,944.0,777.0,870.0,881.0,1035.0,1319.0,11385.0
Shivpuri,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1393.0,1724.0,2021.0,2216.0,2087.0,2111.0,1975.0,1638.0,1853.0,1895.0,2266.0,2909.0,24088.0
Shivpuri,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1035.0,1394.0,1554.0,1903.0,1517.0,1530.0,1477.0,1441.0,1461.0,1838.0,2268.0,2250.0,19668.0
Shivpuri,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1851.0,2295.0,2578.0,2770.0,2583.0,2509.0,2315.0,2109.0,2376.0,2561.0,2867.0,3191.0,30005.0
Shivpuri,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1848.0,2284.0,2579.0,2855.0,2594.0,2429.0,2341.0,2106.0,2289.0,2422.0,2791.0,3054.0,29592.0
Shivpuri,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,1.0,0.0,4.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,8.0
Shivpuri,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,5.0,10.0,0.0,11.0,0.0,6.0,7.0,11.0,4.0,0.0,0.0,0.0,54.0
Shivpuri,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1743.0,1837.0,1861.0,1905.0,1876.0,1916.0,1860.0,1853.0,1865.0,1875.0,1925.0,2014.0,22530.0
Shivpuri,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1583.0,1759.0,1785.0,1869.0,1818.0,1875.0,1805.0,1773.0,1818.0,1729.0,1820.0,1951.0,21585.0
Shivpuri,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1330.0,1458.0,1454.0,1553.0,1539.0,1539.0,1484.0,1463.0,1482.0,1419.0,1542.0,1602.0,17865.0
Shivpuri,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2495.0,3287.0,3643.0,4794.0,3634.0,3946.0,3312.0,3079.0,3123.0,3587.0,3392.0,4498.0,42790.0
Shivpuri,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1922.0,2305.0,3096.0,9640.0,4837.0,3588.0,2930.0,2975.0,3242.0,12853.0,7917.0,4548.0,59853.0
Shivpuri,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1676.0,2114.0,2429.0,12609.0,4761.0,4220.0,2427.0,2520.0,4253.0,15366.0,6830.0,3577.0,62782.0
Shivpuri,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Shivpuri,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,8.0,9.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,28.0
Shivpuri,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,892.0,1454.0,1187.0,1314.0,1362.0,1515.0,863.0,985.0,620.0,581.0,663.0,745.0,12181.0
Shivpuri,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,243.0,155.0,175.0,108.0,93.0,117.0,91.0,136.0,99.0,40.0,32.0,256.0,1545.0
Shivpuri,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,141.0,134.0,49.0,121.0,173.0,594.0,216.0,184.0,340.0,179.0,345.0,646.0,3122.0
Shivpuri,13.1,Number of Patients operated for cataract,TOTAL,33.0,51.0,23.0,79.0,70.0,166.0,94.0,339.0,298.0,213.0,247.0,253.0,1866.0
Shivpuri,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,33.0,51.0,23.0,79.0,74.0,166.0,94.0,339.0,298.0,213.0,238.0,253.0,1861.0
Shivpuri,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,42.0,82.0,116.0,328.0,528.0,1708.0,426.0,72.0,5.0,3307.0
Shivpuri,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,23.0,18.0,112.0,304.0,481.0,233.0,186.0,80.0,31.0,1468.0
Shivpuri,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,6.0,5.0,6.0,6.0,7.0,-1.0
Shivpuri,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,5.0,6.0,6.0,6.0,5.0,7.0,5.0,6.0,5.0,5.0,6.0,6.0,-1.0
Shivpuri,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1057.0,1038.0,1129.0,1140.0,1093.0,1118.0,1128.0,1163.0,1164.0,1091.0,1162.0,1284.0,-1.0
Shivpuri,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,6.0,6.0,6.0,5.0,6.0,6.0,5.0,5.0,5.0,6.0,8.0,-1.0
Shivpuri,14.05,Number of RKS meetings held during the month,TOTAL,2.0,11.0,3.0,3.0,3.0,2.0,4.0,2.0,2.0,2.0,2.0,6.0,42.0
Shivpuri,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,12.0,10.0,12.0,12.0,11.0,13.0,11.0,11.0,12.0,12.0,16.0,18.0,-1.0
Shivpuri,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,6.0,79.0,75.0,1.0,0.0,47.0,23.0,475.0,503.0,548.0,567.0,646.0,2970.0
Shivpuri,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,3.0,3.0,4.0,-1.0
Shivpuri,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,5.0,5.0,6.0,6.0,-1.0
Shivpuri,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1022.0,1425.0,1409.0,1220.0,1237.0,1455.0,1116.0,755.0,708.0,553.0,813.0,1415.0,13128.0
Shivpuri,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1514.0,2393.0,2042.0,2147.0,1982.0,2408.0,2121.0,1692.0,1310.0,1454.0,1481.0,1880.0,22424.0
Shivpuri,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,550.0,933.0,1013.0,924.0,737.0,1068.0,625.0,421.0,390.0,343.0,471.0,848.0,8323.0
Shivpuri,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2684.0,3808.0,3732.0,3586.0,3824.0,3908.0,3572.0,3008.0,2854.0,2365.0,2446.0,3327.0,39114.0
Shivpuri,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1572.0,2358.0,2422.0,2144.0,1974.0,2523.0,1741.0,1176.0,1098.0,896.0,1284.0,2263.0,21451.0
Shivpuri,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4198.0,6201.0,5774.0,5733.0,5806.0,6316.0,5693.0,4700.0,4164.0,3819.0,3927.0,5207.0,61538.0
Shivpuri,14.10.2.a,Number of death cases of Inpatient males,TOTAL,19.0,31.0,39.0,37.0,32.0,50.0,48.0,29.0,23.0,38.0,35.0,38.0,419.0
Shivpuri,14.10.2.b,Number of death cases of Inpatient females,TOTAL,22.0,21.0,30.0,23.0,22.0,27.0,28.0,20.0,6.0,29.0,38.0,27.0,293.0
Shivpuri,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,41.0,52.0,69.0,60.0,54.0,77.0,76.0,49.0,29.0,67.0,73.0,65.0,712.0
Shivpuri,14.11,In-Patient Head Count at midnight,TOTAL,3220.0,4148.0,4360.0,4477.0,5419.0,5876.0,5323.0,5052.0,3895.0,3493.0,23569.0,5503.0,74335.0
Shivpuri,14.12.1,OPD attendance (All),TOTAL,49909.0,73434.0,81229.0,84942.0,100875.0,123782.0,88336.0,75280.0,64953.0,72509.0,81337.0,112121.0,1008707.0
Shivpuri,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,31.0,37.0,62.0,54.0,32.0,49.0,39.0,62.0,46.0,24.0,35.0,71.0,542.0
Shivpuri,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,65.0,109.0,111.0,135.0,105.0,152.0,134.0,202.0,824.0,243.0,303.0,158.0,2541.0
Shivpuri,14.14.a,Number of patients given AYUSH treatment,TOTAL,868.0,1313.0,697.0,1419.0,1513.0,1125.0,2759.0,1313.0,1880.0,2531.0,3774.0,3528.0,22720.0
Shivpuri,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1112.0,1102.0,1327.0,1230.0,1235.0,1039.0,1436.0,938.0,1192.0,982.0,896.0,1112.0,13601.0
Shivpuri,14.14.c,Number of Adolescents counselled,TOTAL,139.0,210.0,102.0,158.0,148.0,127.0,187.0,191.0,170.0,147.0,301.0,22.0,1902.0
Shivpuri,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5579.0,7510.0,7872.0,10509.0,9963.0,11673.0,10781.0,9510.0,8679.0,7486.0,8588.0,10337.0,108487.0
Shivpuri,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,403.0,379.0,345.0,412.0,470.0,500.0,473.0,414.0,300.0,305.0,355.0,373.0,4729.0
Shivpuri,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,164.0,266.0,234.0,240.0,284.0,268.0,173.0,262.0,199.0,150.0,192.0,191.0,2623.0
Shivpuri,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,5.0,8.0,1.0,2.0,5.0,3.0,3.0,12.0,8.0,4.0,7.0,59.0
Shivpuri,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,311.0,353.0,390.0,386.0,524.0,413.0,487.0,577.0,354.0,488.0,252.0,246.0,4781.0
Shivpuri,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,2.0,2.0,2.0,1.0,2.0,2.0,1.0,5.0,3.0,2.0,5.0,29.0
Shivpuri,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,439.0,864.0,471.0,1042.0,698.0,813.0,612.0,799.0,856.0,788.0,780.0,539.0,8701.0
Shivpuri,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,1.0,1.0,0.0,23.0,5.0,1.0,1.0,1.0,33.0
Shivpuri,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,914.0,1483.0,1095.0,1668.0,1506.0,1494.0,1272.0,1638.0,1409.0,1426.0,1224.0,976.0,16105.0
Shivpuri,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,7.0,10.0,3.0,4.0,8.0,5.0,27.0,22.0,12.0,7.0,13.0,121.0
Shivpuri,15.2,Number of Widal tests conducted,Number tested,183.0,567.0,218.0,841.0,442.0,599.0,562.0,761.0,263.0,229.0,298.0,330.0,5293.0
Shivpuri,15.3.a,Number of VDRL tests conducted on males,Number tested,41.0,32.0,69.0,89.0,88.0,58.0,37.0,64.0,93.0,56.0,76.0,131.0,834.0
Shivpuri,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,123.0,170.0,123.0,161.0,158.0,188.0,140.0,182.0,184.0,99.0,115.0,239.0,1882.0
Shivpuri,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,319.0,725.0,373.0,745.0,568.0,568.0,570.0,569.0,632.0,343.0,415.0,552.0,6379.0
Shivpuri,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,483.0,927.0,565.0,995.0,814.0,814.0,747.0,815.0,909.0,498.0,606.0,922.0,9095.0
Shivpuri,15.4.1,Number of blood smears examined for Malaria,TOTAL,8586.0,10290.0,11452.0,18819.0,22486.0,28850.0,20005.0,13821.0,9881.0,6973.0,10025.0,14569.0,175757.0
Shivpuri,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,56.0,132.0,178.0,728.0,598.0,989.0,684.0,219.0,152.0,43.0,34.0,42.0,3855.0
Shivpuri,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,5.0,18.0,5.0,11.0,13.0,77.0,184.0,82.0,25.0,7.0,5.0,6.0,438.0
Shivpuri,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,10000.0,3000.0,3000.0,13500.0,21000.0,24000.0,10500.0,12500.0,8500.0,2000.0,2500.0,4500.0,115000.0
Shivpuri,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,30000.0,30000.0,30000.0,20000.0,5000.0,10000.0,5000.0,5000.0,8000.0,10000.0,10000.0,173000.0
Shivpuri,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Shivpuri,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,17000.0,30000.0,19500.0,22500.0,17000.0,18500.0,8000.0,9000.0,11500.0,7500.0,8000.0,5500.0,174000.0
Shivpuri,16.1.1,Stock position of DPT vaccines,5. Total Stock,3000.0,3000.0,13500.0,21000.0,24000.0,10500.0,12500.0,8500.0,2000.0,2500.0,4500.0,9000.0,114000.0
Shivpuri,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,19000.0,18500.0,17000.0,7500.0,5000.0,67000.0
Shivpuri,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,0.0,,,5000.0,9000.0,14000.0
Shivpuri,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,0.0,,,0.0,0.0,0.0
Shivpuri,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,500.0,1500.0,9500.0,7500.0,10900.0,29900.0
Shivpuri,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18500.0,17000.0,7500.0,5000.0,3100.0,51100.0
Shivpuri,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1000.0,2500.0,2500.0,5500.0,2000.0,17000.0,3000.0,2000.0,500.0,2000.0,0.0,25000.0,63000.0
Shivpuri,16.1.2,Stock position of OPV vaccines,2. Stocks Received,25000.0,30000.0,35000.0,35000.0,44000.0,13500.0,23000.0,20000.0,30000.0,5000.0,25000.0,6700.0,292200.0
Shivpuri,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Shivpuri,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,23500.0,30000.0,32000.0,38500.0,29000.0,27500.0,24000.0,21500.0,28500.0,7000.0,0.0,13000.0,274500.0
Shivpuri,16.1.2,Stock position of OPV vaccines,5. Total Stock,2500.0,2500.0,5500.0,2000.0,17000.0,3000.0,2000.0,500.0,2000.0,0.0,25000.0,18700.0,80700.0
Shivpuri,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1500.0,4500.0,5000.0,12500.0,15500.0,21500.0,10000.0,10500.0,11500.0,500.0,0.0,6500.0,99500.0
Shivpuri,16.1.3,Stock position of TT vaccines,2. Stocks Received,30000.0,30000.0,30000.0,25000.0,25000.0,5000.0,10000.0,10000.0,5000.0,10000.0,20000.0,10000.0,210000.0
Shivpuri,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Shivpuri,16.1.3,Stock position of TT vaccines,4. Stock Distributed,27000.0,29500.0,22500.0,22000.0,19000.0,16500.0,9500.0,9000.0,16000.0,10500.0,13500.0,12000.0,207000.0
Shivpuri,16.1.3,Stock position of TT vaccines,5. Total Stock,4500.0,5000.0,12500.0,15500.0,21500.0,10000.0,10500.0,11500.0,500.0,0.0,6500.0,4500.0,102500.0
Shivpuri,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Shivpuri,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Shivpuri,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Shivpuri,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Shivpuri,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,6000.0,5500.0,5500.0,5000.0,0.0,2500.0,3000.0,3000.0,4000.0,6500.0,3500.0,5500.0,50000.0
Shivpuri,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,10000.0,7000.0,7000.0,10000.0,10000.0,10000.0,10000.0,10000.0,5000.0,10000.0,5000.0,104000.0
Shivpuri,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Shivpuri,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,10500.0,10000.0,7500.0,12000.0,7500.0,9500.0,10000.0,9000.0,7500.0,8000.0,8000.0,7000.0,106500.0
Shivpuri,16.1.5,Stock position of BCG vaccines,5. Total Stock,5500.0,5500.0,5000.0,0.0,2500.0,3000.0,3000.0,4000.0,6500.0,3500.0,5500.0,3500.0,47500.0
Shivpuri,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,5750.0,5750.0,1750.0,1250.0,3000.0,13250.0,12250.0,10500.0,8750.0,3500.0,2000.0,5250.0,73000.0
Shivpuri,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,10000.0,5000.0,15000.0,20000.0,10000.0,5000.0,5000.0,2000.0,5000.0,10000.0,10000.0,107000.0
Shivpuri,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Shivpuri,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,10000.0,14000.0,5500.0,13250.0,9750.0,11000.0,6750.0,6750.0,7250.0,6500.0,6760.0,7500.0,105010.0
Shivpuri,16.1.6,Stock position of Measles vaccines,5. Total Stock,5750.0,1750.0,1250.0,3000.0,13250.0,12250.0,10500.0,8750.0,3500.0,2000.0,5240.0,7750.0,74990.0
Shivpuri,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Shivpuri,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Shivpuri,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Shivpuri,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Shivpuri,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,5000.0,9500.0,5100.0,2200.0,5200.0,11200.0,5700.0,20400.0,9000.0,1800.0,1800.0,3300.0,80200.0
Shivpuri,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,20000.0,19800.0,12000.0,25000.0,25000.0,15000.0,30000.0,0.0,6000.0,10000.0,10000.0,10000.0,182800.0
Shivpuri,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Shivpuri,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,15500.0,24200.0,14900.0,22000.0,19000.0,20500.0,15300.0,11400.0,13200.0,10000.0,8500.0,6600.0,181100.0
Shivpuri,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,9500.0,5100.0,2200.0,5200.0,11200.0,5700.0,20400.0,9000.0,1800.0,1800.0,3300.0,6700.0,81900.0
Shivpuri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,100.0,100.0,100.0,50.0,600.0,300.0,1200.0,250.0,250.0,200.0,200.0,200.0,3550.0
Shivpuri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,0.0,3000.0,0.0,4200.0,0.0,0.0,,0.0,0.0,4200.0,11400.0
Shivpuri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Shivpuri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,100.0,50.0,2450.0,300.0,3300.0,950.0,,,0.0,0.0,200.0,7350.0
Shivpuri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,100.0,0.0,50.0,600.0,300.0,1200.0,250.0,250.0,250.0,200.0,200.0,4200.0,7600.0
Shivpuri,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,440.0,20600.0,20600.0,5480.0,71000.0,25640.0,20600.0,5480.0,5480.0,5000.0,5000.0,11000.0,196320.0
Shivpuri,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,75600.0,,0.0,126000.0,0.0,35280.0,0.0,,,0.0,18000.0,36000.0,290880.0
Shivpuri,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Shivpuri,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,55440.0,20600.0,15120.0,60480.0,45360.0,40320.0,15120.0,,480.0,0.0,12000.0,12000.0,276920.0
Shivpuri,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,20600.0,0.0,5480.0,71000.0,25640.0,20600.0,5480.0,5480.0,5000.0,5000.0,11000.0,35000.0,210280.0
Shivpuri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,100.0,100.0,100.0,100.0,1900.0,0.0,0.0,3000.0,3000.0,2800.0,2800.0,3800.0,17700.0
Shivpuri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,0.0,18000.0,0.0,4200.0,30000.0,,,,9000.0,47000.0,108200.0
Shivpuri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Shivpuri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,100.0,0.0,16200.0,1900.0,4200.0,27000.0,,200.0,,8000.0,14800.0,72400.0
Shivpuri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,100.0,0.0,100.0,1900.0,0.0,0.0,3000.0,3000.0,2800.0,2800.0,3800.0,36000.0,53500.0
Shivpuri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,620.0,620.0,620.0,620.0,20.0,20.0,20.0,20.0,20.0,20.0,20.0,20.0,2640.0
Shivpuri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,0.0,1800.0,0.0,5000.0,0.0,,,0.0,6000.0,0.0,12800.0
Shivpuri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Shivpuri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,620.0,0.0,2400.0,0.0,5000.0,0.0,,,0.0,6000.0,0.0,14020.0
Shivpuri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,620.0,0.0,620.0,20.0,20.0,20.0,20.0,20.0,20.0,20.0,20.0,20.0,1420.0
Shivpuri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1300.0,1300.0,1300.0,1300.0,1300.0,1300.0,1300.0,1300.0,1300.0,1950.0,550.0,550.0,14750.0
Shivpuri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,,6150.0,0.0,0.0,0.0,6150.0
Shivpuri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Shivpuri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,1300.0,0.0,0.0,0.0,0.0,0.0,,5500.0,1400.0,0.0,0.0,8200.0
Shivpuri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,1300.0,0.0,1300.0,1300.0,1300.0,1300.0,1300.0,1300.0,1950.0,550.0,550.0,550.0,12700.0
Shivpuri,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,6650.0,5350.0,1650.0,950.0,250.0,250.0,250.0,6825.0,1225.0,1225.0,1225.0,25.0,25875.0
Shivpuri,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,0.0,0.0,0.0,0.0,9600.0,0.0,0.0,0.0,0.0,20000.0,29600.0
Shivpuri,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,1300.0,3700.0,700.0,700.0,0.0,0.0,3025.0,5600.0,0.0,0.0,1200.0,6600.0,22825.0
Shivpuri,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,5350.0,1650.0,950.0,250.0,250.0,250.0,6825.0,1225.0,1225.0,1225.0,25.0,13425.0,32650.0
Shivpuri,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,20000.0,10950.0,4000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1975.0,19575.0,8075.0,2875.0,72450.0
Shivpuri,16.3.02,Stock Position of Gloves,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,4175.0,30000.0,0.0,0.0,0.0,34175.0
Shivpuri,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.3.02,Stock Position of Gloves,4. Stock Distributed,9050.0,6950.0,3000.0,0.0,0.0,0.0,0.0,3200.0,12400.0,11500.0,5200.0,2000.0,53300.0
Shivpuri,16.3.02,Stock Position of Gloves,5. Total Stock,10950.0,4000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1975.0,19575.0,8075.0,2875.0,875.0,53325.0
Shivpuri,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,72735.0,71735.0,62735.0,78735.0,78235.0,76235.0,68635.0,68635.0,65635.0,65635.0,64635.0,52135.0,825720.0
Shivpuri,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,20000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20000.0,40000.0
Shivpuri,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,1000.0,9000.0,4000.0,500.0,2000.0,7600.0,0.0,3000.0,1000.0,0.0,12500.0,5500.0,46100.0
Shivpuri,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,71735.0,62735.0,78735.0,78235.0,76235.0,68635.0,68635.0,65635.0,64635.0,65635.0,52135.0,66635.0,819620.0
Shivpuri,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,7000.0,7000.0,5000.0,5000.0,5000.0,5000.0,250.0,50.0,50.0,50.0,50.0,50.0,34500.0
Shivpuri,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,2000.0,0.0,0.0,0.0,4750.0,200.0,0.0,0.0,0.0,0.0,0.0,6950.0
Shivpuri,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,7000.0,5000.0,5000.0,5000.0,5000.0,250.0,50.0,50.0,50.0,50.0,50.0,50.0,27550.0
Shivpuri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,24.0
Shivpuri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,24.0
Shivpuri,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,63000.0,63000.0,13000.0,13000.0,13000.0,13000.0,13000.0,1000.0,1000.0,1000.0,780000.0,1465800.0,2439800.0
Shivpuri,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,0.0,0.0,5100000.0,900400.0,96000.0,6096400.0
Shivpuri,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,50000.0,,,,,12000.0,0.0,0.0,4321000.0,214600.0,20000.0,4617600.0
Shivpuri,16.3.07,Stock Position of IFA Tablets,5. Total Stock,63000.0,13000.0,13000.0,13000.0,13000.0,13000.0,1000.0,1000.0,1000.0,780000.0,1465800.0,1541800.0,3918600.0
Shivpuri,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,14436.0,12336.0,8604.0,5620.0,26068.0,15554.0,7778.0,4608.0,0.0,0.0,35564.0,93214.0,223782.0
Shivpuri,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,70000.0,90000.0,20000.0,0.0,0.0,0.0,0.0,162652.0,76000.0,0.0,418652.0
Shivpuri,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,2100.0,3732.0,72984.0,69552.0,30514.0,7776.0,3170.0,4608.0,0.0,127088.0,18350.0,27025.0,366899.0
Shivpuri,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,12336.0,8604.0,5620.0,26068.0,15554.0,7778.0,4608.0,0.0,0.0,35564.0,93214.0,66189.0,275535.0
Shivpuri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,155165.0,125565.0,25100.0,22165.0,18665.0,17868.0,1168.0,1100.0,1100.0,1100.0,1100.0,1100.0,371196.0
Shivpuri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,420000.0,,0.0,0.0,0.0,0.0,0.0,420000.0
Shivpuri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,29600.0,100435.0,2935.0,3500.0,797.0,437700.0,68.0,0.0,0.0,0.0,0.0,0.0,575035.0
Shivpuri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,125565.0,25130.0,22165.0,18665.0,17868.0,168.0,1100.0,1100.0,1100.0,1100.0,1100.0,1100.0,216161.0
Shivpuri,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,3822.0,3712.0,3112.0,1072.0,572.0,402.0,402.0,402.0,302.0,162.0,162.0,112.0,14234.0
Shivpuri,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,0.0,4000.0,0.0,0.0,0.0,4000.0
Shivpuri,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,110.0,600.0,2040.0,500.0,170.0,0.0,0.0,100.0,4140.0,0.0,50.0,0.0,7710.0
Shivpuri,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,3712.0,3112.0,1072.0,572.0,402.0,402.0,402.0,302.0,162.0,162.0,112.0,112.0,10524.0
Shivpuri,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,3240.0,3240.0,3240.0,14000.0,15000.0,15000.0,42100.0,19200.0,0.0,0.0,32800.0,23650.0,171470.0
Shivpuri,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,50000.0,210000.0,0.0,100000.0,0.0,20000.0,0.0,100000.0,0.0,100000.0,580000.0
Shivpuri,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Shivpuri,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,39240.0,209000.0,0.0,72900.0,22900.0,39200.0,0.0,67200.0,9150.0,12700.0,472290.0
Shivpuri,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,3240.0,3240.0,14000.0,15000.0,15000.0,42100.0,19200.0,0.0,0.0,32800.0,23650.0,110950.0,279180.0
Shivpuri,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2200.0,5200.0,200.0,5200.0,1400.0,9900.0,3300.0,6200.0,1600.0,200.0,2300.0,900.0,38600.0
Shivpuri,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,12000.0,,9900.0,0.0,16500.0,9900.0,9900.0,,6600.0,6600.0,6600.0,6600.0,84600.0
Shivpuri,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Shivpuri,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,9000.0,5000.0,4900.0,3800.0,8000.0,16500.0,7000.0,4600.0,8000.0,4500.0,8000.0,2000.0,81300.0
Shivpuri,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,5200.0,200.0,5200.0,1400.0,9900.0,3300.0,6200.0,1600.0,200.0,2300.0,900.0,5500.0,41900.0
Shivpuri,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,38200.0,198200.0,38200.0,38200.0,38200.0,0.0,0.0,6000.0,4000.0,14000.0,14000.0,14000.0,403000.0
Shivpuri,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,280000.0,,0.0,0.0,0.0,0.0,10000.0,,84000.0,,0.0,0.0,374000.0
Shivpuri,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Shivpuri,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,120000.0,160000.0,0.0,0.0,38200.0,0.0,4000.0,2000.0,74000.0,,0.0,2000.0,400200.0
Shivpuri,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,198200.0,38200.0,38200.0,38200.0,0.0,0.0,6000.0,4000.0,14000.0,14000.0,14000.0,12000.0,376800.0
Shivpuri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,200.0,1700.0,0.0,1700.0,400.0,2600.0,0.0,1000.0,0.0,1500.0,2000.0,1500.0,12600.0
Shivpuri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,6000.0,,4000.0,0.0,10000.0,4000.0,6000.0,,6000.0,4000.0,4000.0,4000.0,48000.0
Shivpuri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Shivpuri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,4500.0,1700.0,2300.0,1300.0,7800.0,6600.0,5000.0,1000.0,4500.0,3500.0,4500.0,900.0,43600.0
Shivpuri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1700.0,0.0,1700.0,400.0,2600.0,0.0,1000.0,0.0,1500.0,2000.0,1500.0,4600.0,17000.0
Shivpuri,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,1.0,9.0,13.0,14.0,14.0,2.0,1.0,,9.0,6.0,9.0,79.0
Shivpuri,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,3.0,,2.0,2.0,1.0,2.0,2.0,1.0,1.0,3.0,,17.0
Shivpuri,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,1.0,,,,1.0,,,,,,2.0
Shivpuri,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,3.0,1.0,2.0,2.0,1.0,3.0,2.0,1.0,1.0,3.0,,19.0
Shivpuri,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,1.0,2.0,3.0,4.0,,3.0,2.0,1.0,6.0,1.0,3.0,26.0
Shivpuri,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,1.0,,1.0,,,3.0
Shivpuri,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,1.0,2.0,3.0,4.0,,4.0,3.0,1.0,7.0,1.0,3.0,29.0
Shivpuri,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,5.0,2.0,3.0,4.0,5.0,14.0,8.0,6.0,5.0,7.0,12.0,73.0
Shivpuri,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,1.0,1.0,,,2.0,5.0
Shivpuri,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,6.0,2.0,3.0,4.0,5.0,14.0,9.0,7.0,5.0,7.0,14.0,78.0
Shivpuri,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,3.0,5.0,1.0,2.0,3.0,4.0,5.0,11.0,11.0,9.0,5.0,60.0
Shivpuri,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,,4.0,5.0
Shivpuri,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,3.0,5.0,1.0,2.0,3.0,4.0,5.0,11.0,12.0,9.0,9.0,65.0
Shivpuri,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,2.0,1.0,1.0,4.0,1.0,1.0,5.0,1.0,1.0,1.0,6.0,1.0,25.0
Shivpuri,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,2.0,1.0,2.0,,1.0,2.0,2.0,3.0,,1.0,1.0,15.0
Shivpuri,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,2.0,3.0,2.0,6.0,1.0,2.0,7.0,3.0,4.0,1.0,7.0,2.0,40.0
Shivpuri,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,1.0,,,1.0,1.0,,,,,,,,3.0
Shivpuri,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Shivpuri,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,1.0,,,1.0,1.0,,,,,,,,3.0
Shivpuri,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,1.0,1.0,,,,2.0
Shivpuri,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,1.0,1.0,1.0,1.0,,,,,,,,,4.0
Shivpuri,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,1.0,1.0,1.0,,,,1.0,1.0,,,,6.0
Shivpuri,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Shivpuri,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Shivpuri,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Shivpuri,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,3.0,1.0,2.0,4.0,2.0,2.0,6.0,4.0,4.0,3.0,26.0,58.0
Shivpuri,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,1.0,1.0,3.0,4.0,3.0,5.0,7.0,4.0,2.0,3.0,19.0,54.0
Shivpuri,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,4.0,2.0,5.0,8.0,5.0,7.0,13.0,8.0,6.0,6.0,45.0,112.0
Shivpuri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,1.0,,,2.0,,,,,,,,3.0
Shivpuri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Shivpuri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,2.0,1.0,,,,,,,,,3.0
Shivpuri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,2.0,2.0,2.0,,,,,,,,7.0
Shivpuri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Shivpuri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,8.0,6.0,6.0,12.0,1.0,6.0,1.0,7.0,6.0,4.0,6.0,8.0,71.0
Shivpuri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,4.0,5.0,2.0,3.0,2.0,2.0,1.0,2.0,1.0,3.0,1.0,28.0
Shivpuri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,10.0,10.0,11.0,14.0,4.0,8.0,3.0,8.0,8.0,5.0,9.0,9.0,99.0
Shivpuri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,1.0,,,1.0,,4.0,,1.0,1.0,,1.0,9.0
Shivpuri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,5.0,14.0,8.0,10.0,12.0,11.0,11.0,9.0,5.0,14.0,15.0,22.0,136.0
Shivpuri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,9.0,37.0,37.0,31.0,23.0,32.0,28.0,30.0,22.0,38.0,34.0,51.0,372.0
Shivpuri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,14.0,52.0,45.0,41.0,36.0,43.0,43.0,39.0,28.0,53.0,49.0,74.0,517.0
Shivpuri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Shivpuri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Shivpuri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Shivpuri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Shivpuri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,1.0,,1.0,,,,,1.0,,,3.0
Shivpuri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,3.0,,1.0,,1.0,,2.0,2.0,1.0,,,2.0,12.0
Shivpuri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,1.0,,,3.0,,,,1.0,1.0,,6.0
Shivpuri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,3.0,,3.0,,2.0,3.0,2.0,2.0,1.0,2.0,1.0,2.0,21.0
Shivpuri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Shivpuri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Shivpuri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Shivpuri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,1.0,1.0
Shivpuri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Shivpuri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,5.0,1.0,1.0,4.0,2.0,,,4.0,4.0,2.0,4.0,7.0,34.0
Shivpuri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,8.0,7.0,10.0,1.0,3.0,9.0,3.0,5.0,2.0,2.0,8.0,4.0,62.0
Shivpuri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,13.0,8.0,11.0,5.0,6.0,9.0,3.0,9.0,6.0,4.0,12.0,11.0,97.0
Shivpuri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,1.0,,,,1.0,,,1.0,,3.0
Shivpuri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,1.0,4.0,,1.0,,3.0,,,1.0,,10.0
Shivpuri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,2.0,2.0,2.0,1.0,1.0,,3.0,,1.0,2.0,,14.0
Shivpuri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,2.0,3.0,7.0,1.0,2.0,,7.0,,1.0,4.0,,27.0
Shivpuri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Shivpuri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,2.0,,,2.0
Shivpuri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Shivpuri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,2.0,,,2.0
Shivpuri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Shivpuri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,1.0,1.0,2.0
Shivpuri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Shivpuri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,1.0,1.0,2.0
Shivpuri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Shivpuri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,1.0,1.0,,,,1.0,,3.0
Shivpuri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Shivpuri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,1.0,1.0,,,,1.0,,3.0
Shivpuri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Shivpuri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,1.0,,1.0,2.0
Shivpuri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Shivpuri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,1.0,,1.0,2.0
Shivpuri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Shivpuri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Shivpuri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Shivpuri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Shivpuri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Shivpuri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,,3.0,1.0,,,,,2.0,2.0,1.0,6.0,16.0
Shivpuri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Shivpuri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,,3.0,1.0,,,,,2.0,2.0,1.0,6.0,16.0
Shivpuri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,1.0,,,,2.0,,,2.0,,,6.0
Shivpuri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,4.0,1.0,5.0,5.0,4.0,7.0,7.0,3.0,5.0,9.0,3.0,9.0,62.0
Shivpuri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,3.0,1.0,,1.0,2.0,1.0,2.0,1.0,1.0,1.0,,13.0
Shivpuri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,5.0,7.0,5.0,5.0,9.0,10.0,5.0,6.0,12.0,4.0,9.0,81.0
Shivpuri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Shivpuri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,1.0,10.0,3.0,2.0,2.0,3.0,,1.0,3.0,7.0,1.0,33.0
Shivpuri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Shivpuri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,1.0,10.0,3.0,2.0,2.0,3.0,,1.0,3.0,7.0,1.0,34.0
Shivpuri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,1.0,,1.0,,,,,,1.0,,3.0
Shivpuri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,1.0,6.0,6.0,2.0,1.0,,,,1.0,,18.0
Shivpuri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,1.0,1.0,,,,,,2.0
Shivpuri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,2.0,6.0,7.0,3.0,2.0,,,,2.0,,23.0
Shivpuri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Shivpuri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,3.0,6.0,3.0,2.0,3.0,1.0,1.0,1.0,,3.0,3.0,4.0,30.0
Shivpuri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,4.0,5.0,6.0,7.0,7.0,5.0,5.0,3.0,9.0,5.0,2.0,2.0,60.0
Shivpuri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,7.0,11.0,9.0,9.0,10.0,6.0,6.0,4.0,9.0,8.0,5.0,6.0,90.0
Shivpuri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Shivpuri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,5.0,2.0,2.0,2.0,1.0,1.0,1.0,,,,5.0,20.0
Shivpuri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,1.0,5.0,3.0,4.0,3.0,4.0,2.0,3.0,3.0,3.0,2.0,33.0
Shivpuri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,6.0,7.0,5.0,6.0,4.0,5.0,3.0,3.0,3.0,3.0,7.0,53.0
Shivpuri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,2.0,,,2.0,2.0,,,,1.0,1.0,8.0
Shivpuri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,5.0,7.0,,2.0,3.0,7.0,7.0,8.0,11.0,4.0,9.0,64.0
Shivpuri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,4.0,5.0,,,,2.0,8.0,12.0,19.0,5.0,1.0,57.0
Shivpuri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,2.0,9.0,14.0,,2.0,5.0,11.0,15.0,20.0,30.0,10.0,11.0,129.0
Sidhi,1.1,Total number of pregnant women Registered for ANC,TOTAL,3291.0,3157.0,3854.0,4378.0,3427.0,3666.0,3225.0,3292.0,3279.0,3154.0,3723.0,3671.0,42117.0
Sidhi,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1738.0,1873.0,2497.0,2253.0,1698.0,1816.0,1618.0,1846.0,2096.0,2068.0,2356.0,2420.0,24279.0
Sidhi,1.2,Number of Pregnant women registered under JSY,TOTAL,3062.0,2664.0,3502.0,4002.0,2950.0,3439.0,2612.0,2680.0,2629.0,2687.0,3308.0,3226.0,36761.0
Sidhi,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2095.0,2412.0,2573.0,2936.0,2670.0,2806.0,2492.0,2450.0,2543.0,2439.0,2696.0,2996.0,31108.0
Sidhi,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2792.0,2497.0,2928.0,3181.0,2425.0,2662.0,2434.0,2628.0,2387.0,2334.0,2591.0,2603.0,31462.0
Sidhi,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2301.0,2501.0,2192.0,2719.0,3010.0,2565.0,2715.0,2754.0,2615.0,2199.0,2513.0,2680.0,30764.0
Sidhi,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3034.0,2811.0,3339.0,3675.0,2812.0,3836.0,3562.0,4070.0,3223.0,3431.0,3590.0,3570.0,40953.0
Sidhi,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,157.0,254.0,257.0,284.0,204.0,253.0,377.0,363.0,261.0,320.0,359.0,353.0,3442.0
Sidhi,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,5.0,10.0,4.0,1.0,1.0,5.0,2.0,3.0,2.0,2.0,2.0,40.0
Sidhi,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1567.0,1406.0,1593.0,1917.0,2142.0,2686.0,2207.0,2436.0,2263.0,2386.0,2526.0,2179.0,25308.0
Sidhi,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,77.0,109.0,178.0,146.0,160.0,134.0,70.0,109.0,127.0,45.0,88.0,57.0,1300.0
Sidhi,1.8,Number of pregnancy test kits used at SC level,TOTAL,1033.0,802.0,1011.0,1172.0,1124.0,1043.0,1069.0,981.0,1140.0,1084.0,1322.0,1328.0,13109.0
Sidhi,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,342.0,306.0,402.0,285.0,350.0,197.0,151.0,72.0,63.0,184.0,89.0,62.0,2503.0
Sidhi,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,443.0,420.0,314.0,290.0,378.0,629.0,471.0,497.0,407.0,443.0,432.0,381.0,5105.0
Sidhi,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,785.0,726.0,716.0,575.0,728.0,826.0,622.0,569.0,470.0,627.0,521.0,443.0,7608.0
Sidhi,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,667.0,492.0,696.0,429.0,412.0,429.0,429.0,444.0,434.0,569.0,436.0,376.0,5813.0
Sidhi,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,14.0,28.0,22.0,2.0,2.0,0.0,8.0,23.0,80.0,2.0,97.0,125.0,403.0
Sidhi,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1543.0,1362.0,1464.0,2270.0,2268.0,1986.0,1711.0,1500.0,1415.0,1634.0,1539.0,1482.0,20174.0
Sidhi,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,396.0,352.0,64.0,117.0,573.0,102.0,89.0,44.0,32.0,60.0,179.0,119.0,2127.0
Sidhi,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1769.0,1470.0,1670.0,1581.0,1387.0,1405.0,1346.0,1173.0,788.0,860.0,1176.0,743.0,15368.0
Sidhi,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1452.0,1110.0,1103.0,1188.0,1121.0,1209.0,1180.0,993.0,730.0,779.0,997.0,711.0,12573.0
Sidhi,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0,6.0
Sidhi,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,32.0,38.0,47.0,42.0,54.0,,71.0,36.0,37.0,50.0,33.0,31.0,471.0
Sidhi,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Sidhi,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Sidhi,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Sidhi,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,50.0,38.0,21.0,41.0,42.0,45.0,29.0,23.0,32.0,42.0,33.0,27.0,423.0
Sidhi,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sidhi,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,50.0,38.0,21.0,41.0,42.0,45.0,29.0,23.0,32.0,42.0,33.0,27.0,423.0
Sidhi,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,20.0,20.0,24.0,17.0,25.0,,41.0,18.0,18.0,25.0,18.0,17.0,243.0
Sidhi,4.1.1.a,Number of male live births,TOTAL,1218.0,1129.0,1175.0,1498.0,1535.0,1361.0,1231.0,1072.0,975.0,1237.0,1081.0,1052.0,14564.0
Sidhi,4.1.1.b,Number of female live births,TOTAL,1115.0,969.0,1014.0,1371.0,1470.0,1419.0,1183.0,1003.0,933.0,1051.0,1000.0,893.0,13421.0
Sidhi,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2333.0,2098.0,2189.0,2869.0,3005.0,2780.0,2414.0,2075.0,1908.0,2288.0,2081.0,1945.0,27985.0
Sidhi,4.1.2,Number of still births,TOTAL,40.0,38.0,47.0,34.0,73.0,55.0,48.0,49.0,44.0,52.0,39.0,35.0,554.0
Sidhi,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,144.0,117.0,60.0,50.0,114.0,119.0,49.0,59.0,90.0,87.0,164.0,120.0,1173.0
Sidhi,4.2.1,Number of Newborns weighed at birth,TOTAL,2128.0,2012.0,2017.0,2459.0,2680.0,2564.0,2282.0,1902.0,1733.0,2082.0,1915.0,1871.0,25645.0
Sidhi,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,350.0,289.0,274.0,382.0,514.0,667.0,451.0,394.0,302.0,370.0,311.0,354.0,4658.0
Sidhi,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2273.0,2030.0,2138.0,2809.0,2869.0,2684.0,2232.0,1876.0,1884.0,2251.0,2051.0,1900.0,26997.0
Sidhi,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,95.0,46.0,63.0,68.0,99.0,28.0,28.0,26.0,89.0,154.0,223.0,83.0,1002.0
Sidhi,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,49.0,37.0,154.0,81.0,89.0,80.0,90.0,50.0,127.0,107.0,110.0,97.0,1071.0
Sidhi,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,240.0,200.0,150.0,139.0,131.0,84.0,118.0,80.0,118.0,195.0,145.0,174.0,1774.0
Sidhi,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sidhi,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,384.0,283.0,367.0,288.0,319.0,192.0,236.0,156.0,334.0,456.0,478.0,354.0,3847.0
Sidhi,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,3.0,,1.0,25.0,,65.0,2.0,2.0,1.0,,,99.0
Sidhi,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,272.0,254.0,358.0,270.0,344.0,192.0,223.0,158.0,323.0,448.0,477.0,350.0,3669.0
Sidhi,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,25.0,21.0,11.0,17.0,20.0,21.0,29.0,20.0,20.0,48.0,123.0,67.0,422.0
Sidhi,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,79.0,63.0,56.0,91.0,86.0,74.0,83.0,18.0,70.0,115.0,190.0,79.0,1004.0
Sidhi,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,67.0,65.0,57.0,74.0,97.0,79.0,40.0,62.0,71.0,69.0,1.0,155.0,837.0
Sidhi,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1943.0,1647.0,1996.0,2132.0,1907.0,2477.0,1967.0,1779.0,1601.0,2101.0,1917.0,1771.0,23238.0
Sidhi,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,980.0,1028.0,1235.0,1416.0,1150.0,1514.0,1360.0,1161.0,1136.0,1280.0,1177.0,1843.0,15280.0
Sidhi,6.3,PNC maternal complications attended,TOTAL,10.0,6.0,15.0,18.0,3.0,26.0,25.0,30.0,3.0,3.0,10.0,0.0,149.0
Sidhi,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,111.0,88.0,55.0,68.0,64.0,75.0,30.0,29.0,49.0,61.0,97.0,71.0,798.0
Sidhi,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,11.0,4.0,2.0,4.0,1.0,12.0,9.0,1.0,0.0,2.0,1.0,3.0,50.0
Sidhi,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,122.0,92.0,57.0,72.0,65.0,87.0,39.0,30.0,49.0,63.0,98.0,74.0,848.0
Sidhi,7.2,Number of MTPs conducted at Private Facilities,TOTAL,2.0,5.0,5.0,1.0,2.0,0.0,4.0,0.0,6.0,0.0,1.0,0.0,26.0
Sidhi,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,221.0,83.0,141.0,164.0,158.0,138.0,170.0,160.0,194.0,239.0,261.0,281.0,2210.0
Sidhi,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,295.0,191.0,180.0,217.0,247.0,236.0,233.0,240.0,244.0,344.0,328.0,366.0,3121.0
Sidhi,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,516.0,274.0,321.0,381.0,405.0,374.0,403.0,400.0,438.0,583.0,589.0,647.0,5331.0
Sidhi,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,23.0,27.0,8.0,4.0,217.0,201.0,187.0,158.0,131.0,117.0,122.0,103.0,1298.0
Sidhi,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,5.0,0.0,0.0,8.0
Sidhi,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,4.0,0.0,41.0,106.0,62.0,13.0,2.0,229.0
Sidhi,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,1.0,0.0,1.0,,1.0,4.0,2.0,,,9.0
Sidhi,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sidhi,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,2.0,0.0,5.0,0.0,42.0,113.0,69.0,13.0,2.0,246.0
Sidhi,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sidhi,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,36.0,306.0,260.0,140.0,55.0,4.0,801.0
Sidhi,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,10.0,0.0,16.0,147.0,784.0,1200.0,413.0,178.0,25.0,2773.0
Sidhi,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,3.0,2.0,0.0,4.0,20.0,5.0,13.0,54.0,52.0,21.0,,,174.0
Sidhi,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sidhi,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,3.0,2.0,0.0,14.0,20.0,21.0,196.0,1144.0,1512.0,574.0,233.0,29.0,3748.0
Sidhi,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sidhi,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,14.0,12.0,12.0,13.0,4.0,19.0,11.0,38.0,41.0,22.0,,,186.0
Sidhi,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sidhi,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,14.0,12.0,12.0,13.0,4.0,19.0,11.0,38.0,41.0,22.0,0.0,0.0,186.0
Sidhi,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sidhi,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Sidhi,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sidhi,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sidhi,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,230.0,244.0,162.0,260.0,384.0,271.0,337.0,270.0,269.0,245.0,265.0,189.0,3126.0
Sidhi,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,11.0,27.0,23.0,20.0,75.0,71.0,18.0,7.0,4.0,8.0,10.0,11.0,285.0
Sidhi,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,21.0,18.0,42.0,36.0,14.0,38.0,137.0,73.0,42.0,108.0,113.0,119.0,761.0
Sidhi,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,83.0,73.0,174.0,60.0,38.0,25.0,97.0,45.0,,,,,595.0
Sidhi,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sidhi,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,345.0,362.0,401.0,376.0,511.0,405.0,589.0,395.0,315.0,361.0,388.0,319.0,4767.0
Sidhi,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,201.0,218.0,39.0,240.0,105.0,117.0,116.0,155.0,30.0,36.0,33.0,52.0,1342.0
Sidhi,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,3.0,,,,3.0
Sidhi,9.06,Number of IUCD removals,TOTAL,143.0,148.0,88.0,145.0,158.0,233.0,207.0,188.0,203.0,216.0,231.0,209.0,2169.0
Sidhi,9.07,Number of Oral Pills cycles distributed,TOTAL,708.0,857.0,892.0,771.0,1487.0,2232.0,1969.0,2272.0,2224.0,2083.0,2439.0,1245.0,19179.0
Sidhi,9.08,Number of Condom pieces distributed,TOTAL,11216.0,7883.0,7777.0,8244.0,9636.0,16352.0,9836.0,13567.0,11350.0,10839.0,14075.0,5742.0,126517.0
Sidhi,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,147.0,179.0,133.0,152.0,109.0,63.0,90.0,56.0,65.0,145.0,54.0,112.0,1305.0
Sidhi,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Sidhi,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,,,3.0,3.0,3.0,,,,2.0,,,-1.0
Sidhi,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2820.0,2288.0,2351.0,2569.0,2784.0,2724.0,2356.0,2260.0,2016.0,2344.0,2319.0,2055.0,28886.0
Sidhi,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2182.0,2104.0,2251.0,2413.0,2199.0,2522.0,2357.0,422.0,39.0,50.0,16.0,7.0,16562.0
Sidhi,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2553.0,2149.0,2310.0,2259.0,2307.0,2384.0,2164.0,2492.0,744.0,199.0,158.0,80.0,19799.0
Sidhi,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2598.0,2321.0,2302.0,2197.0,2232.0,2403.0,2021.0,2293.0,2519.0,627.0,378.0,181.0,22072.0
Sidhi,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2168.0,2398.0,2148.0,2144.0,2388.0,11246.0
Sidhi,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,46.0,2046.0,2117.0,2176.0,2353.0,8738.0
Sidhi,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,31.0,30.0,1733.0,2038.0,2296.0,6128.0
Sidhi,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1853.0,1406.0,1696.0,1639.0,1821.0,1470.0,1390.0,1208.0,1256.0,1433.0,1606.0,1571.0,18349.0
Sidhi,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2234.0,2063.0,2223.0,2176.0,1835.0,2563.0,2197.0,1589.0,2158.0,2158.0,2251.0,2597.0,26044.0
Sidhi,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2505.0,2083.0,2272.0,2034.0,1960.0,2386.0,2031.0,1765.0,2241.0,2092.0,3045.0,2655.0,27069.0
Sidhi,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2566.0,2248.0,2261.0,1950.0,1951.0,2328.0,1901.0,1538.0,2030.0,2013.0,2302.0,2743.0,25831.0
Sidhi,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1275.0,1061.0,1015.0,912.0,1772.0,1295.0,1263.0,1244.0,1256.0,1431.0,1425.0,1279.0,15228.0
Sidhi,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2174.0,2055.0,1997.0,2340.0,2224.0,2319.0,2283.0,412.0,85.0,48.0,32.0,7.0,15976.0
Sidhi,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2504.0,2094.0,1943.0,2057.0,2220.0,2383.0,2162.0,2515.0,770.0,210.0,186.0,77.0,19121.0
Sidhi,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2558.0,2262.0,1997.0,2026.0,2205.0,2430.0,2099.0,2281.0,2451.0,695.0,419.0,200.0,21623.0
Sidhi,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1693.0,1796.0,2059.0,2510.0,2485.0,2665.0,2317.0,1628.0,2163.0,2257.0,2402.0,2345.0,26320.0
Sidhi,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,869.0,579.0,786.0,1007.0,970.0,1307.0,1167.0,1121.0,1488.0,1676.0,1618.0,1759.0,14347.0
Sidhi,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,897.0,928.0,943.0,1104.0,1194.0,1336.0,1104.0,818.0,1072.0,1258.0,1192.0,1005.0,12851.0
Sidhi,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,813.0,820.0,816.0,1014.0,1048.0,1173.0,993.0,719.0,1003.0,1142.0,1081.0,899.0,11521.0
Sidhi,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1710.0,1748.0,1759.0,2118.0,2242.0,2509.0,2097.0,1537.0,2075.0,2400.0,2273.0,1904.0,24372.0
Sidhi,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1737.0,1506.0,1768.0,1899.0,1640.0,1798.0,1550.0,1600.0,1900.0,2174.0,2243.0,2253.0,22068.0
Sidhi,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1784.0,1507.0,1719.0,1842.0,1585.0,1904.0,1462.0,1323.0,1696.0,2120.0,2207.0,2256.0,21405.0
Sidhi,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,14.0,0.0,0.0,0.0,0.0,0.0,14.0
Sidhi,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,335.0,363.0,286.0,345.0,291.0,268.0,355.0,378.0,585.0,642.0,653.0,628.0,5129.0
Sidhi,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,332.0,319.0,259.0,335.0,247.0,253.0,345.0,342.0,501.0,610.0,633.0,587.0,4763.0
Sidhi,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,667.0,682.0,545.0,680.0,538.0,521.0,700.0,720.0,1086.0,1252.0,1286.0,1215.0,9892.0
Sidhi,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1041.0,1082.0,1076.0,1376.0,1241.0,1352.0,1126.0,1090.0,1202.0,1554.0,1368.0,1396.0,14904.0
Sidhi,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1163.0,1157.0,1146.0,1335.0,1628.0,1484.0,1234.0,1322.0,1263.0,1338.0,1251.0,1319.0,15640.0
Sidhi,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1108.0,1148.0,1315.0,1458.0,1689.0,1488.0,1293.0,1360.0,1301.0,1456.0,1276.0,1437.0,16329.0
Sidhi,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,7.0,0.0,0.0,0.0,18.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,26.0
Sidhi,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Sidhi,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1203.0,1159.0,1238.0,1131.0,1142.0,1140.0,1130.0,1152.0,1201.0,1152.0,1177.0,1154.0,13979.0
Sidhi,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1188.0,1106.0,1209.0,1121.0,1089.0,1105.0,1056.0,1134.0,1167.0,1123.0,1148.0,1049.0,13495.0
Sidhi,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1028.0,965.0,1046.0,942.0,937.0,960.0,1066.0,1020.0,1004.0,1025.0,1023.0,978.0,11994.0
Sidhi,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1584.0,1477.0,2064.0,3090.0,2183.0,2399.0,2647.0,1305.0,1849.0,4422.0,2042.0,2241.0,27303.0
Sidhi,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1092.0,610.0,1103.0,9271.0,6915.0,737.0,656.0,781.0,1083.0,12526.0,1786.0,841.0,37401.0
Sidhi,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,481.0,425.0,1309.0,11691.0,2715.0,416.0,373.0,275.0,737.0,16406.0,1341.0,275.0,36444.0
Sidhi,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,690.0,758.0,867.0,764.0,1342.0,914.0,634.0,504.0,494.0,696.0,544.0,1152.0,9359.0
Sidhi,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,80.0,210.0,300.0,141.0,604.0,147.0,440.0,340.0,252.0,156.0,255.0,269.0,3194.0
Sidhi,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,34.0,40.0,43.0,27.0,42.0,145.0,169.0,101.0,46.0,11.0,49.0,361.0,1068.0
Sidhi,13.1,Number of Patients operated for cataract,TOTAL,93.0,17.0,0.0,127.0,61.0,105.0,252.0,0.0,0.0,10.0,116.0,62.0,843.0
Sidhi,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,93.0,17.0,0.0,127.0,61.0,105.0,252.0,0.0,0.0,10.0,116.0,62.0,843.0
Sidhi,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,22.0,76.0,248.0,758.0,3079.0,1820.0,850.0,116.0,0.0,6969.0
Sidhi,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,162.0,881.0,1197.0,1044.0,96.0,0.0,3380.0
Sidhi,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,1.0,,,-1.0
Sidhi,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,1.0,,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Sidhi,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,758.0,824.0,750.0,738.0,718.0,683.0,666.0,671.0,707.0,692.0,776.0,843.0,-1.0
Sidhi,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,4.0,4.0,3.0,3.0,3.0,3.0,3.0,3.0,4.0,3.0,3.0,-1.0
Sidhi,14.05,Number of RKS meetings held during the month,TOTAL,3.0,4.0,6.0,5.0,5.0,6.0,4.0,5.0,5.0,4.0,5.0,4.0,56.0
Sidhi,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1.0,1.0,1.0,6.0,2.0,1.0,3.0,4.0,3.0,5.0,5.0,4.0,-1.0
Sidhi,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,3.0,102.0,11.0,8.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,125.0
Sidhi,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,2.0,4.0,2.0,2.0,2.0,2.0,2.0,2.0,3.0,2.0,-1.0
Sidhi,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Sidhi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,326.0,478.0,446.0,483.0,498.0,513.0,382.0,295.0,158.0,183.0,93.0,395.0,4250.0
Sidhi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1199.0,1246.0,1504.0,1434.0,1283.0,1377.0,1461.0,1028.0,755.0,745.0,520.0,918.0,13470.0
Sidhi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,266.0,361.0,357.0,375.0,394.0,448.0,273.0,200.0,154.0,147.0,116.0,360.0,3451.0
Sidhi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2522.0,2362.0,3131.0,3086.0,3280.0,3801.0,3076.0,3121.0,2844.0,2958.0,1586.0,1812.0,33579.0
Sidhi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,592.0,839.0,803.0,858.0,892.0,961.0,655.0,495.0,312.0,330.0,209.0,755.0,7701.0
Sidhi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3721.0,3608.0,4635.0,4520.0,4563.0,5178.0,4537.0,4149.0,3599.0,3703.0,2106.0,2730.0,47049.0
Sidhi,14.10.2.a,Number of death cases of Inpatient males,TOTAL,20.0,16.0,17.0,27.0,31.0,27.0,17.0,37.0,15.0,43.0,0.0,8.0,258.0
Sidhi,14.10.2.b,Number of death cases of Inpatient females,TOTAL,13.0,12.0,20.0,19.0,27.0,17.0,30.0,18.0,18.0,16.0,1.0,7.0,198.0
Sidhi,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,33.0,28.0,37.0,46.0,58.0,44.0,47.0,55.0,33.0,59.0,1.0,15.0,456.0
Sidhi,14.11,In-Patient Head Count at midnight,TOTAL,7927.0,7917.0,8966.0,9996.0,10722.0,11817.0,10929.0,10311.0,7673.0,7249.0,1606.0,1868.0,96981.0
Sidhi,14.12.1,OPD attendance (All),TOTAL,41928.0,44697.0,46739.0,53628.0,61233.0,69347.0,52436.0,48867.0,39460.0,37172.0,39748.0,41511.0,576766.0
Sidhi,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,53.0,39.0,21.0,47.0,56.0,64.0,24.0,33.0,42.0,37.0,0.0,0.0,416.0
Sidhi,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,2.0,0.0,0.0,0.0,3.0,1.0,2.0,3.0,3.0,1.0,0.0,0.0,15.0
Sidhi,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,693.0,762.0,876.0,873.0,609.0,744.0,468.0,822.0,776.0,843.0,756.0,542.0,8764.0
Sidhi,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,4.0,2.0,2.0,2.0,2.0,2.0,16.0
Sidhi,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,300.0,72.0,62.0,50.0,76.0,81.0,56.0,83.0,75.0,73.0,0.0,0.0,928.0
Sidhi,14.14.c,Number of Adolescents counselled,TOTAL,103.0,21.0,89.0,19.0,109.0,21.0,21.0,41.0,57.0,231.0,19.0,21.0,752.0
Sidhi,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4224.0,4588.0,6227.0,6687.0,6358.0,7069.0,6031.0,7141.0,6078.0,5332.0,4478.0,6347.0,70560.0
Sidhi,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,216.0,365.0,500.0,645.0,583.0,437.0,447.0,317.0,287.0,311.0,249.0,337.0,4694.0
Sidhi,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,116.0,175.0,118.0,103.0,129.0,148.0,75.0,144.0,111.0,72.0,43.0,111.0,1345.0
Sidhi,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,4.0,1.0,1.0,3.0,2.0,1.0,0.0,0.0,0.0,0.0,1.0,14.0
Sidhi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,98.0,119.0,182.0,194.0,188.0,68.0,144.0,576.0,374.0,296.0,237.0,164.0,2640.0
Sidhi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,4.0,1.0,1.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,13.0
Sidhi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,740.0,835.0,1198.0,1289.0,1297.0,1580.0,1054.0,1510.0,1141.0,942.0,689.0,984.0,13259.0
Sidhi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,4.0,0.0,0.0,2.0,0.0,1.0,0.0,0.0,0.0,0.0,8.0
Sidhi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,954.0,1129.0,1498.0,1586.0,1614.0,1796.0,1273.0,2230.0,1626.0,1310.0,969.0,1259.0,17244.0
Sidhi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,4.0,8.0,6.0,2.0,5.0,5.0,1.0,1.0,0.0,0.0,0.0,3.0,35.0
Sidhi,15.2,Number of Widal tests conducted,Number tested,692.0,729.0,1439.0,1020.0,983.0,1626.0,720.0,1162.0,956.0,608.0,754.0,2051.0,12740.0
Sidhi,15.3.a,Number of VDRL tests conducted on males,Number tested,75.0,30.0,110.0,106.0,69.0,89.0,81.0,152.0,148.0,143.0,30.0,199.0,1232.0
Sidhi,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,72.0,60.0,106.0,194.0,103.0,223.0,219.0,262.0,215.0,439.0,344.0,199.0,2436.0
Sidhi,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,32.0,29.0,84.0,219.0,240.0,250.0,264.0,435.0,485.0,314.0,52.0,282.0,2686.0
Sidhi,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,179.0,119.0,300.0,519.0,412.0,562.0,564.0,849.0,848.0,896.0,426.0,680.0,6354.0
Sidhi,15.4.1,Number of blood smears examined for Malaria,TOTAL,4382.0,7335.0,6549.0,7967.0,11929.0,14824.0,10018.0,18361.0,7971.0,5164.0,5657.0,13790.0,113947.0
Sidhi,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,42.0,82.0,110.0,198.0,262.0,436.0,1819.0,359.0,84.0,26.0,83.0,224.0,3725.0
Sidhi,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,35.0,45.0,52.0,83.0,473.0,423.0,244.0,632.0,60.0,16.0,93.0,131.0,2287.0
Sidhi,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,7500.0,4000.0,8500.0,1500.0,26000.0,15500.0,3000.0,4000.0,,6000.0,,9500.0,85500.0
Sidhi,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,20000.0,20000.0,30000.0,0.0,0.0,0.0,5000.0,,15000.0,,20000.0,120000.0
Sidhi,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0
Sidhi,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,13500.0,15500.0,13000.0,19500.0,10500.0,12500.0,2500.0,6000.0,,8000.0,,22500.0,123500.0
Sidhi,16.1.1,Stock position of DPT vaccines,5. Total Stock,4000.0,8500.0,15500.0,12000.0,15500.0,3000.0,500.0,3000.0,0.0,13000.0,0.0,7000.0,82000.0
Sidhi,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,0.0,5020.0,,0.0,,5000.0,10020.0
Sidhi,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,10380.0,0.0,,5000.0,,10000.0,25380.0
Sidhi,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,0.0,0.0,,0.0,,0.0,0.0
Sidhi,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,5360.0,4030.0,,5000.0,,11200.0,25590.0
Sidhi,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,5020.0,990.0,0.0,0.0,0.0,3800.0,9810.0
Sidhi,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,10000.0,0.0,2000.0,0.0,4500.0,5000.0,1000.0,0.0,,0.0,,0.0,22500.0
Sidhi,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,20000.0,10000.0,20000.0,10000.0,24000.0,0.0,14000.0,,4000.0,,0.0,102000.0
Sidhi,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0
Sidhi,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,10000.0,18000.0,12000.0,15500.0,9500.0,28000.0,1000.0,12000.0,,4000.0,,0.0,110000.0
Sidhi,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,2000.0,0.0,4500.0,5000.0,1000.0,0.0,2000.0,0.0,0.0,0.0,0.0,14500.0
Sidhi,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,10000.0,2000.0,9000.0,4000.0,5500.0,0.0,7000.0,1500.0,,5000.0,,9000.0,53000.0
Sidhi,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,20000.0,4000.0,20000.0,0.0,24000.0,0.0,15000.0,,10000.0,,20000.0,113000.0
Sidhi,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0
Sidhi,16.1.3,Stock position of TT vaccines,4. Stock Distributed,8000.0,13000.0,9000.0,18500.0,5500.0,17000.0,5500.0,10500.0,,10500.0,,13000.0,110500.0
Sidhi,16.1.3,Stock position of TT vaccines,5. Total Stock,2000.0,9000.0,4000.0,5500.0,0.0,7000.0,1500.0,6000.0,0.0,4500.0,0.0,16000.0,55500.0
Sidhi,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sidhi,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Sidhi,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sidhi,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sidhi,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2000.0,4000.0,2500.0,0.0,5000.0,6500.0,8500.0,4000.0,,2000.0,,6500.0,41000.0
Sidhi,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,10000.0,0.0,15000.0,100000.0,17000.0,0.0,5000.0,,10000.0,,10000.0,177000.0
Sidhi,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0
Sidhi,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,8000.0,11500.0,2500.0,10000.0,8500.0,15000.0,4500.0,6000.0,,7000.0,,9500.0,82500.0
Sidhi,16.1.5,Stock position of BCG vaccines,5. Total Stock,4000.0,2500.0,0.0,5000.0,96500.0,8500.0,4000.0,3000.0,0.0,5000.0,0.0,7000.0,135500.0
Sidhi,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1500.0,2250.0,4250.0,3500.0,4000.0,500.0,250.0,0.0,,1750.0,,5000.0,23000.0
Sidhi,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,10000.0,5000.0,10000.0,0.0,5000.0,0.0,7500.0,,5000.0,,5000.0,57500.0
Sidhi,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0
Sidhi,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,9250.0,8000.0,5750.0,9500.0,3500.0,5250.0,250.0,7000.0,,5500.0,,8750.0,62750.0
Sidhi,16.1.6,Stock position of Measles vaccines,5. Total Stock,2250.0,4250.0,3500.0,4000.0,500.0,250.0,0.0,500.0,0.0,1250.0,0.0,1250.0,17750.0
Sidhi,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sidhi,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Sidhi,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sidhi,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sidhi,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,3000.0,1000.0,0.0,0.0,10000.0,7500.0,8500.0,5000.0,,1000.0,,11500.0,47500.0
Sidhi,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,10000.0,10000.0,0.0,30000.0,10000.0,20000.0,0.0,5000.0,,10000.0,,0.0,95000.0
Sidhi,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0
Sidhi,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,12000.0,11000.0,0.0,20000.0,12500.0,19000.0,3500.0,8000.0,,8000.0,,5500.0,99500.0
Sidhi,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1000.0,0.0,0.0,10000.0,7500.0,8500.0,5000.0,2000.0,0.0,3000.0,0.0,6000.0,43000.0
Sidhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,500.0,0.0,0.0,400.0,1200.0,600.0,600.0,0.0,,100.0,,0.0,3400.0
Sidhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,3000.0,1200.0,0.0,0.0,0.0,0.0,,0.0,,0.0,4200.0
Sidhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0
Sidhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,500.0,0.0,2600.0,400.0,600.0,0.0,600.0,0.0,,0.0,,0.0,4700.0
Sidhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,400.0,1200.0,600.0,600.0,0.0,0.0,0.0,100.0,0.0,0.0,2900.0
Sidhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,10080.0,25200.0,0.0,,0.0,,10080.0,,0.0,45360.0
Sidhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,50400.0,100800.0,0.0,0.0,,0.0,,0.0,,0.0,151200.0
Sidhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0,0.0
Sidhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,40320.0,85680.0,25200.0,0.0,,0.0,,10080.0,,0.0,161280.0
Sidhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,10080.0,25200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,35280.0
Sidhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Sidhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Sidhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Sidhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Sidhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,100.0,,0.0,,0.0,,0.0,,,100.0
Sidhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,600.0,0.0,,0.0,,0.0,,0.0,,,600.0
Sidhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0,,,0.0
Sidhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,500.0,100.0,,0.0,,0.0,,0.0,,,600.0
Sidhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0
Sidhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Sidhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Sidhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Sidhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Sidhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Sidhi,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Sidhi,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Sidhi,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Sidhi,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Sidhi,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Sidhi,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Sidhi,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Sidhi,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Sidhi,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Sidhi,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Sidhi,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Sidhi,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Sidhi,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Sidhi,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Sidhi,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Sidhi,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Sidhi,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Sidhi,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Sidhi,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Sidhi,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Sidhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Sidhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Sidhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Sidhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Sidhi,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Sidhi,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Sidhi,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Sidhi,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Sidhi,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Sidhi,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Sidhi,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Sidhi,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Sidhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Sidhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Sidhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Sidhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Sidhi,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,0.0,,,,,,,,,,,0.0
Sidhi,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Sidhi,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Sidhi,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Sidhi,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Sidhi,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Sidhi,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Sidhi,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sidhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,500.0,0.0,2600.0,1000.0,3100.0,500.0,100.0,50.0,,1000.0,,500.0,9350.0
Sidhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,6600.0,0.0,6600.0,0.0,0.0,0.0,0.0,,3300.0,,0.0,16500.0
Sidhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0
Sidhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,500.0,4000.0,1600.0,4500.0,2600.0,400.0,100.0,25.0,,3300.0,,300.0,17325.0
Sidhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,2600.0,1000.0,3100.0,500.0,100.0,0.0,25.0,0.0,1000.0,0.0,200.0,8525.0
Sidhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,21000.0,15000.0,0.0,62000.0,74000.0,40000.0,25000.0,51000.0,,17000.0,,11000.0,316000.0
Sidhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,20000.0,8000.0,80000.0,50000.0,0.0,0.0,110000.0,0.0,,0.0,,12000.0,280000.0
Sidhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0
Sidhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,26000.0,23000.0,18000.0,38000.0,34000.0,15000.0,84000.0,2000.0,,6000.0,,20000.0,266000.0
Sidhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,15000.0,0.0,62000.0,74000.0,40000.0,25000.0,51000.0,49000.0,0.0,11000.0,0.0,3000.0,330000.0
Sidhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,100.0,,400.0,500.0
Sidhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,4000.0,0.0,0.0,0.0,0.0,,2000.0,,0.0,6000.0
Sidhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0
Sidhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,4000.0,0.0,0.0,0.0,0.0,,1700.0,,0.0,5700.0
Sidhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,400.0,0.0,400.0,800.0
Sidhi,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,5.0,1.0,,,,,,,,,,,6.0
Sidhi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,1.0,1.0,,,,,,2.0
Sidhi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sidhi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,1.0,1.0,,,,,,2.0
Sidhi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,,,,,,,,,,,,1.0
Sidhi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,1.0,1.0,,,,,,2.0
Sidhi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,,,,,1.0,1.0,,,,,,3.0
Sidhi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,4.0,,1.0,1.0,1.0,1.0,,1.0,,,,,9.0
Sidhi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,,,,,,,,,,,1.0
Sidhi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,5.0,,1.0,1.0,1.0,1.0,,1.0,,,,,10.0
Sidhi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,7.0,4.0,2.0,4.0,1.0,1.0,,2.0,,,,,21.0
Sidhi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,4.0,1.0,,,,2.0,,1.0,,1.0,,10.0
Sidhi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,8.0,8.0,3.0,4.0,1.0,1.0,2.0,2.0,1.0,,1.0,,31.0
Sidhi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Sidhi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,,,,,,,,,,,,1.0
Sidhi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,,,,,,,1.0,,,,2.0
Sidhi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,2.0,,,,,,,2.0
Sidhi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,2.0,,,,,,,2.0
Sidhi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,4.0,,,,,,,4.0
Sidhi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,1.0,1.0,1.0,,2.0,1.0,,,,,,7.0
Sidhi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,,,,,,,1.0,,,,2.0
Sidhi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,2.0,1.0,1.0,,2.0,1.0,,1.0,,,,9.0
Sidhi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sidhi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sidhi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Sidhi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,8.0,1.0,1.0,3.0,2.0,2.0,1.0,2.0,,,1.0,24.0
Sidhi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,3.0,2.0,6.0,2.0,2.0,1.0,,1.0,,,,18.0
Sidhi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,4.0,11.0,3.0,7.0,5.0,4.0,3.0,1.0,3.0,,,1.0,42.0
Sidhi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Sidhi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Sidhi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Sidhi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Sidhi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Sidhi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Sidhi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Sidhi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Sidhi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Sidhi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Sidhi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Sidhi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,1.0,1.0,,,,,,,,,,2.0
Sidhi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Sidhi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Sidhi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Sidhi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Sidhi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Sidhi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Sidhi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Sidhi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,1.0,,,,,,,1.0
Sidhi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Sidhi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Sidhi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Sidhi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Sidhi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Sidhi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,1.0,,1.0,1.0,,,,1.0,,1.0,,5.0
Sidhi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,2.0,1.0,,,,2.0,1.0,1.0,1.0,,,8.0
Sidhi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,3.0,1.0,1.0,1.0,,2.0,1.0,2.0,1.0,1.0,,13.0
Sidhi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Sidhi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,2.0,,,,,,,,,,2.0
Sidhi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Sidhi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,2.0,,,,,,,,,,2.0
Sidhi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Sidhi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Sidhi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Sidhi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,1.0,,,,,,1.0
Sidhi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Sidhi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Sidhi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Sidhi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,1.0,,,,,,,,,1.0
Sidhi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Sidhi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Sidhi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Sidhi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Sidhi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Sidhi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,2.0,,2.0,2.0,3.0,,,,,,10.0
Sidhi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Sidhi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,2.0,,2.0,2.0,3.0,,,,,,10.0
Sidhi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Sidhi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Sidhi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Sidhi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Sidhi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Sidhi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,1.0,2.0,1.0,1.0,1.0,,,1.0,,,7.0
Sidhi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Sidhi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,1.0,2.0,1.0,1.0,1.0,,,1.0,,,7.0
Sidhi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,1.0,,,,,,,,,,2.0
Sidhi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,2.0,5.0,1.0,1.0,,2.0,1.0,,,1.0,2.0,16.0
Sidhi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Sidhi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,3.0,6.0,1.0,1.0,,2.0,1.0,,,1.0,2.0,18.0
Sidhi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Sidhi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,1.0,4.0,4.0,1.0,,,,,,1.0,,12.0
Sidhi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Sidhi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,1.0,4.0,4.0,1.0,1.0,,,,,1.0,,13.0
Sidhi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Sidhi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Sidhi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Sidhi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,1.0,1.0,,,,,,,2.0
Sidhi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Sidhi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Sidhi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Sidhi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Sidhi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Sidhi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Sidhi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,1.0,1.0,,,,,2.0
Sidhi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,1.0,1.0,,,,,2.0
Sidhi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,2.0,,1.0,,,,,,1.0,4.0
Sidhi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,,,,,,2.0,2.0,2.0,,,,7.0
Sidhi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,1.0,8.0,2.0,2.0,1.0,1.0,2.0,2.0,,1.0,,21.0
Sidhi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,2.0,1.0,8.0,4.0,2.0,2.0,3.0,4.0,4.0,,1.0,1.0,32.0
Singroli,1.1,Total number of pregnant women Registered for ANC,TOTAL,2525.0,2705.0,3042.0,3505.0,2770.0,3084.0,2480.0,2913.0,3039.0,2863.0,3371.0,3357.0,35654.0
Singroli,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1374.0,1644.0,1802.0,1899.0,1564.0,1680.0,1420.0,1873.0,1815.0,1907.0,2097.0,2139.0,21214.0
Singroli,1.2,Number of Pregnant women registered under JSY,TOTAL,2435.0,2676.0,2975.0,3329.0,2625.0,3024.0,2473.0,2776.0,2826.0,2859.0,3368.0,3363.0,34729.0
Singroli,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1779.0,1978.0,2279.0,2479.0,2193.0,2309.0,2034.0,2215.0,2201.0,2183.0,2511.0,2586.0,26747.0
Singroli,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1856.0,1884.0,2165.0,2549.0,1960.0,2218.0,1723.0,2109.0,2199.0,1980.0,2413.0,2347.0,25403.0
Singroli,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2010.0,2373.0,2437.0,2738.0,2520.0,2641.0,2201.0,2430.0,2602.0,2338.0,2776.0,3087.0,30153.0
Singroli,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2569.0,2736.0,3062.0,3433.0,2763.0,3034.0,2436.0,2896.0,3018.0,2917.0,3342.0,3353.0,35559.0
Singroli,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,74.0,28.0,17.0,57.0,60.0,28.0,27.0,52.0,100.0,48.0,43.0,104.0,638.0
Singroli,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,5.0,1.0,0.0,3.0,13.0,8.0,5.0,4.0,1.0,2.0,42.0
Singroli,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,621.0,825.0,1072.0,1074.0,751.0,887.0,770.0,1108.0,1107.0,1232.0,1447.0,1278.0,12172.0
Singroli,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,92.0,65.0,93.0,84.0,66.0,109.0,460.0,118.0,265.0,50.0,248.0,131.0,1781.0
Singroli,1.8,Number of pregnancy test kits used at SC level,TOTAL,1862.0,1983.0,1839.0,1928.0,1687.0,1602.0,1341.0,1761.0,1760.0,1667.0,1851.0,1787.0,21068.0
Singroli,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,460.0,494.0,435.0,496.0,534.0,569.0,590.0,554.0,452.0,564.0,500.0,488.0,6136.0
Singroli,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,290.0,390.0,434.0,567.0,539.0,550.0,410.0,442.0,458.0,452.0,452.0,470.0,5454.0
Singroli,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,750.0,884.0,869.0,1063.0,1073.0,1119.0,1000.0,996.0,910.0,1016.0,952.0,958.0,11590.0
Singroli,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,618.0,575.0,598.0,799.0,771.0,785.0,821.0,839.0,781.0,826.0,749.0,810.0,8972.0
Singroli,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,8.0,12.0,24.0,9.0,13.0,20.0,14.0,28.0,15.0,20.0,19.0,182.0
Singroli,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1097.0,1155.0,1371.0,1235.0,1464.0,1364.0,1313.0,1341.0,1252.0,1233.0,1105.0,1150.0,15080.0
Singroli,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,384.0,298.0,347.0,283.0,470.0,332.0,336.0,255.0,236.0,196.0,166.0,135.0,3438.0
Singroli,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,778.0,922.0,771.0,1180.0,1293.0,1241.0,1154.0,1220.0,1214.0,1288.0,1033.0,1143.0,13237.0
Singroli,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,775.0,684.0,752.0,847.0,1005.0,964.0,872.0,924.0,777.0,743.0,714.0,832.0,9889.0
Singroli,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
Singroli,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,164.0,193.0,196.0,174.0,188.0,182.0,208.0,198.0,204.0,190.0,192.0,184.0,2273.0
Singroli,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,0.0,,0.0,,0.0,0.0,,,,,,0.0
Singroli,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,0.0,,0.0,,0.0,0.0,,,,,,0.0
Singroli,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,0.0,,0.0,,0.0,0.0,,,,,,0.0
Singroli,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Singroli,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Singroli,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Singroli,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,50.0,54.0,60.0,48.0,59.0,56.0,58.0,67.0,68.0,66.0,69.0,54.0,709.0
Singroli,4.1.1.a,Number of male live births,TOTAL,1027.0,1121.0,1216.0,1314.0,1391.0,1364.0,1310.0,1361.0,1182.0,1225.0,1141.0,1164.0,14816.0
Singroli,4.1.1.b,Number of female live births,TOTAL,942.0,1072.0,1185.0,1129.0,1296.0,1255.0,1173.0,1137.0,1145.0,1178.0,1071.0,1086.0,13669.0
Singroli,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1969.0,2193.0,2401.0,2443.0,2687.0,2619.0,2483.0,2498.0,2327.0,2403.0,2212.0,2250.0,28485.0
Singroli,4.1.2,Number of still births,TOTAL,41.0,38.0,39.0,35.0,43.0,50.0,42.0,39.0,36.0,42.0,40.0,44.0,489.0
Singroli,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,30.0,32.0,51.0,47.0,45.0,68.0,48.0,44.0,48.0,60.0,62.0,69.0,604.0
Singroli,4.2.1,Number of Newborns weighed at birth,TOTAL,1921.0,2047.0,2246.0,2254.0,2446.0,2385.0,2390.0,2419.0,2242.0,2291.0,2075.0,2165.0,26881.0
Singroli,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,128.0,184.0,163.0,148.0,289.0,284.0,285.0,218.0,170.0,147.0,140.0,180.0,2336.0
Singroli,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1868.0,2072.0,2237.0,2284.0,2431.0,2322.0,2207.0,2320.0,2223.0,2295.0,2097.0,2156.0,26512.0
Singroli,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,15.0,15.0,15.0,11.0,20.0,17.0,24.0,34.0,22.0,19.0,31.0,34.0,257.0
Singroli,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,23.0,27.0,15.0,18.0,30.0,28.0,65.0,36.0,49.0,33.0,42.0,36.0,402.0
Singroli,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,13.0,4.0,8.0,9.0,17.0,10.0,24.0,34.0,11.0,42.0,32.0,3.0,207.0
Singroli,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Singroli,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,51.0,46.0,38.0,38.0,67.0,55.0,113.0,104.0,82.0,94.0,105.0,73.0,866.0
Singroli,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,50.0,131.0,89.0,59.0,35.0,54.0,46.0,57.0,68.0,66.0,69.0,54.0,778.0
Singroli,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,84.0,94.0,84.0,95.0,85.0,81.0,138.0,118.0,88.0,111.0,106.0,89.0,1173.0
Singroli,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,3.0,11.0,3.0,18.0,11.0,29.0,3.0,12.0,41.0,33.0,7.0,172.0
Singroli,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,61.0,104.0,77.0,83.0,96.0,65.0,85.0,109.0,62.0,74.0,74.0,87.0,977.0
Singroli,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,3.0,4.0,0.0,0.0,0.0,0.0,0.0,7.0,5.0,2.0,0.0,21.0
Singroli,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1866.0,1855.0,2159.0,2032.0,2282.0,2110.0,2205.0,2302.0,2197.0,2205.0,1953.0,1968.0,25134.0
Singroli,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1419.0,1395.0,1271.0,1341.0,1305.0,1240.0,1308.0,1523.0,1277.0,1612.0,1568.0,1256.0,16515.0
Singroli,6.3,PNC maternal complications attended,TOTAL,39.0,18.0,15.0,13.0,15.0,13.0,10.0,17.0,12.0,18.0,16.0,5.0,191.0
Singroli,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,31.0,10.0,19.0,14.0,21.0,24.0,16.0,12.0,6.0,15.0,24.0,21.0,213.0
Singroli,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,8.0,13.0,14.0,12.0,5.0,0.0,1.0,1.0,11.0,10.0,2.0,4.0,81.0
Singroli,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,39.0,23.0,33.0,26.0,26.0,24.0,17.0,13.0,17.0,25.0,26.0,25.0,294.0
Singroli,7.2,Number of MTPs conducted at Private Facilities,TOTAL,3.0,4.0,4.0,3.0,3.0,4.0,0.0,6.0,15.0,6.0,6.0,4.0,58.0
Singroli,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,80.0,117.0,242.0,156.0,135.0,173.0,211.0,629.0,261.0,191.0,254.0,185.0,2634.0
Singroli,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,181.0,260.0,432.0,767.0,590.0,455.0,580.0,1225.0,775.0,675.0,749.0,667.0,7356.0
Singroli,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,261.0,377.0,674.0,923.0,725.0,628.0,791.0,1854.0,1036.0,866.0,1003.0,852.0,9990.0
Singroli,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,36.0,44.0
Singroli,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,2.0
Singroli,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,15.0,55.0,4.0,6.0,43.0,124.0
Singroli,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0,0.0,13.0
Singroli,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Singroli,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,15.0,56.0,5.0,19.0,43.0,139.0
Singroli,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0
Singroli,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,365.0,64.0,101.0,0.0,530.0
Singroli,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,21.0,0.0,0.0,0.0,0.0,746.0,1456.0,1090.0,336.0,0.0,3649.0
Singroli,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Singroli,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,21.0,0.0,0.0,0.0,0.0,746.0,1821.0,1154.0,437.0,0.0,4179.0
Singroli,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,6.0,,,,,,,,,,,,6.0
Singroli,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Singroli,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,5.0,7.0,5.0,3.0,,2.0,1.0,1.0,2.0,2.0,6.0,34.0
Singroli,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Singroli,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,6.0,2.0,7.0,,1.0,1.0,2.0,,2.0,1.0,,6.0,28.0
Singroli,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,93.0,105.0,120.0,145.0,147.0,164.0,125.0,148.0,165.0,152.0,120.0,132.0,1616.0
Singroli,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,4.0,8.0
Singroli,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,83.0,58.0,69.0,66.0,27.0,25.0,5.0,10.0,17.0,27.0,27.0,29.0,443.0
Singroli,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,122.0,102.0,110.0,69.0,163.0,166.0,17.0,18.0,15.0,14.0,12.0,14.0,822.0
Singroli,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Singroli,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,298.0,265.0,301.0,281.0,337.0,355.0,147.0,176.0,197.0,194.0,159.0,179.0,2889.0
Singroli,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,179.0,156.0,175.0,91.0,204.0,194.0,32.0,33.0,41.0,47.0,44.0,47.0,1243.0
Singroli,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,18.0,18.0,16.0,18.0,19.0,29.0,12.0,12.0,20.0,25.0,24.0,12.0,223.0
Singroli,9.06,Number of IUCD removals,TOTAL,55.0,58.0,62.0,77.0,86.0,94.0,75.0,65.0,121.0,128.0,92.0,103.0,1016.0
Singroli,9.07,Number of Oral Pills cycles distributed,TOTAL,1261.0,1126.0,1390.0,1423.0,2110.0,1930.0,1531.0,1825.0,1855.0,1642.0,1641.0,1710.0,19444.0
Singroli,9.08,Number of Condom pieces distributed,TOTAL,4753.0,1991.0,2541.0,3010.0,3491.0,4162.0,3509.0,3009.0,3023.0,3423.0,3843.0,3118.0,39873.0
Singroli,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,42.0,45.0,51.0,59.0,46.0,83.0,66.0,46.0,145.0,93.0,57.0,92.0,825.0
Singroli,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Singroli,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,2.0,2.0,2.0,1.0,2.0,2.0,2.0,1.0,1.0,1.0,1.0,-1.0
Singroli,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1919.0,2201.0,2453.0,2497.0,2629.0,2615.0,2434.0,2486.0,2224.0,2366.0,2282.0,2263.0,28369.0
Singroli,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1845.0,2097.0,2512.0,2769.0,2483.0,2761.0,2385.0,1455.0,639.0,401.0,510.0,408.0,20265.0
Singroli,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2083.0,2124.0,2355.0,2714.0,2390.0,2699.0,2307.0,2687.0,1696.0,856.0,708.0,518.0,23137.0
Singroli,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2035.0,2141.0,2338.0,2649.0,2341.0,2595.0,2194.0,2507.0,2607.0,1717.0,1060.0,641.0,24825.0
Singroli,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1356.0,2186.0,1931.0,2138.0,2201.0,9812.0
Singroli,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1258.0,1540.0,2018.0,2040.0,6856.0
Singroli,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,601.0,1503.0,1851.0,3955.0
Singroli,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1295.0,1395.0,1606.0,1527.0,1606.0,1513.0,1429.0,1259.0,1307.0,1545.0,1148.0,1348.0,16978.0
Singroli,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1899.0,2111.0,2504.0,2776.0,2273.0,2719.0,2187.0,1240.0,2322.0,2620.0,2537.0,2331.0,27519.0
Singroli,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2115.0,2141.0,2349.0,2714.0,2212.0,2643.0,2097.0,1325.0,2226.0,2251.0,2599.0,2233.0,26905.0
Singroli,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2121.0,2186.0,2346.0,2653.0,2170.0,2554.0,2027.0,1248.0,2247.0,2167.0,2226.0,2199.0,26144.0
Singroli,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1043.0,1232.0,1395.0,1245.0,1351.0,1321.0,1185.0,1279.0,1130.0,1328.0,1141.0,1118.0,14768.0
Singroli,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1780.0,2113.0,2445.0,2800.0,2435.0,2680.0,2396.0,1445.0,685.0,316.0,465.0,333.0,19893.0
Singroli,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2104.0,2138.0,2305.0,2709.0,2365.0,2645.0,2289.0,2686.0,1682.0,952.0,744.0,470.0,23089.0
Singroli,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2116.0,2180.0,2300.0,2659.0,2287.0,2541.0,2202.0,2499.0,2594.0,1721.0,1082.0,594.0,24775.0
Singroli,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2045.0,2139.0,1877.0,2476.0,2860.0,2984.0,2184.0,1657.0,2486.0,4740.0,2431.0,2673.0,30552.0
Singroli,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,919.0,1546.0,1330.0,1337.0,1231.0,1320.0,1240.0,994.0,1394.0,1477.0,1742.0,1852.0,16382.0
Singroli,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1067.0,1103.0,953.0,1292.0,1459.0,1541.0,1130.0,872.0,1293.0,2284.0,1266.0,1401.0,15661.0
Singroli,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,933.0,997.0,940.0,1195.0,1396.0,1434.0,1041.0,773.0,1187.0,2401.0,1103.0,1289.0,14689.0
Singroli,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2000.0,2100.0,1893.0,2487.0,2855.0,2975.0,2171.0,1645.0,2480.0,4685.0,2369.0,2690.0,30350.0
Singroli,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1638.0,1918.0,2027.0,2502.0,1873.0,2067.0,1678.0,1780.0,2070.0,2252.0,2545.0,2366.0,24716.0
Singroli,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1655.0,1899.0,2034.0,2468.0,1665.0,1968.0,1467.0,952.0,1910.0,2253.0,2378.0,2126.0,22775.0
Singroli,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,297.0,365.0,356.0,416.0,353.0,551.0,338.0,404.0,463.0,421.0,455.0,435.0,4854.0
Singroli,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,317.0,342.0,355.0,391.0,327.0,486.0,332.0,373.0,435.0,386.0,413.0,441.0,4598.0
Singroli,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,614.0,707.0,711.0,807.0,680.0,1037.0,670.0,777.0,898.0,807.0,868.0,876.0,9452.0
Singroli,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,589.0,719.0,770.0,1084.0,876.0,891.0,756.0,808.0,991.0,1379.0,1128.0,1117.0,11108.0
Singroli,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,786.0,1104.0,1163.0,1409.0,1213.0,1261.0,1050.0,1084.0,1170.0,1650.0,1145.0,1155.0,14190.0
Singroli,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,843.0,1242.0,1144.0,1716.0,1209.0,1444.0,1159.0,1277.0,1310.0,1820.0,1196.0,1218.0,15578.0
Singroli,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,4.0,0.0,0.0,2.0,1.0,2.0,2.0,0.0,2.0,0.0,0.0,0.0,13.0
Singroli,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,52.0,32.0,36.0,42.0,54.0,23.0,27.0,29.0,12.0,23.0,18.0,32.0,380.0
Singroli,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,890.0,986.0,970.0,1016.0,987.0,1003.0,954.0,988.0,1003.0,985.0,1019.0,1030.0,11831.0
Singroli,10.4.2,Number of Immunisation sessions held during the month,TOTAL,818.0,910.0,937.0,986.0,915.0,965.0,872.0,941.0,970.0,938.0,968.0,1003.0,11223.0
Singroli,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,680.0,802.0,810.0,845.0,791.0,832.0,745.0,800.0,844.0,818.0,861.0,892.0,9720.0
Singroli,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1904.0,2033.0,2251.0,3571.0,2901.0,2983.0,2158.0,1609.0,2499.0,4740.0,2503.0,2703.0,31855.0
Singroli,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,54.0,17.0,1396.0,7693.0,1256.0,14.0,3.0,4.0,2684.0,16650.0,2.0,10.0,29783.0
Singroli,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,47.0,18.0,1072.0,9470.0,1375.0,4.0,2.0,2.0,2879.0,31747.0,1.0,4.0,46621.0
Singroli,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,1.0,0.0,0.0,3.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Singroli,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,734.0,1089.0,1093.0,1238.0,1125.0,977.0,734.0,750.0,604.0,496.0,405.0,455.0,9700.0
Singroli,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,115.0,242.0,209.0,202.0,180.0,138.0,131.0,60.0,24.0,23.0,3.0,24.0,1351.0
Singroli,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,7.0,4.0,7.0,24.0,0.0,127.0,68.0,52.0,65.0,74.0,48.0,0.0,476.0
Singroli,13.1,Number of Patients operated for cataract,TOTAL,34.0,46.0,0.0,9.0,210.0,20.0,66.0,52.0,692.0,755.0,400.0,277.0,2561.0
Singroli,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,34.0,46.0,0.0,9.0,210.0,20.0,66.0,52.0,692.0,755.0,400.0,212.0,2496.0
Singroli,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,7.0,1615.0,0.0,658.0,0.0,0.0,0.0,2280.0
Singroli,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,7.0,772.0,315.0,1917.0,0.0,0.0,0.0,3011.0
Singroli,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,4.0,2.0,2.0,2.0,4.0,4.0,3.0,4.0,4.0,4.0,4.0,-1.0
Singroli,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,1.0,5.0,,,,,,,,,,,-1.0
Singroli,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,734.0,795.0,808.0,819.0,816.0,904.0,785.0,804.0,804.0,778.0,815.0,887.0,-1.0
Singroli,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,5.0,5.0,6.0,6.0,5.0,5.0,6.0,7.0,7.0,7.0,7.0,-1.0
Singroli,14.05,Number of RKS meetings held during the month,TOTAL,13.0,13.0,17.0,12.0,11.0,16.0,10.0,12.0,12.0,13.0,11.0,14.0,154.0
Singroli,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,8.0,10.0,8.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Singroli,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,980.0,883.0,790.0,775.0,908.0,1267.0,630.0,451.0,536.0,576.0,523.0,459.0,8778.0
Singroli,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,1.0,1.0,1.0,2.0,2.0,2.0,2.0,2.0,3.0,3.0,-1.0
Singroli,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,3.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Singroli,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,82.0,240.0,153.0,188.0,294.0,1178.0,334.0,331.0,250.0,331.0,202.0,182.0,3765.0
Singroli,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,390.0,573.0,532.0,612.0,620.0,725.0,1781.0,1230.0,773.0,452.0,577.0,704.0,8969.0
Singroli,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,88.0,406.0,142.0,173.0,285.0,603.0,383.0,440.0,279.0,482.0,354.0,278.0,3913.0
Singroli,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1057.0,1979.0,1929.0,1788.0,1733.0,2220.0,3537.0,3486.0,1854.0,2140.0,3566.0,2117.0,27406.0
Singroli,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,170.0,646.0,295.0,361.0,579.0,1781.0,717.0,771.0,529.0,813.0,556.0,460.0,7678.0
Singroli,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1447.0,2552.0,2461.0,2400.0,2353.0,2945.0,5318.0,4716.0,2627.0,2592.0,4143.0,2821.0,36375.0
Singroli,14.10.2.a,Number of death cases of Inpatient males,TOTAL,7.0,15.0,5.0,14.0,4.0,9.0,11.0,8.0,29.0,11.0,2.0,8.0,123.0
Singroli,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,10.0,13.0,11.0,1.0,6.0,14.0,12.0,15.0,7.0,3.0,7.0,105.0
Singroli,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,13.0,25.0,18.0,25.0,5.0,15.0,25.0,20.0,44.0,18.0,5.0,15.0,228.0
Singroli,14.11,In-Patient Head Count at midnight,TOTAL,810.0,912.0,871.0,1170.0,1884.0,3985.0,1483.0,1691.0,1149.0,943.0,870.0,2026.0,17794.0
Singroli,14.12.1,OPD attendance (All),TOTAL,21931.0,28018.0,27785.0,35202.0,60749.0,50903.0,44909.0,47394.0,29900.0,32853.0,40130.0,43369.0,463143.0
Singroli,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,7.0,91.0,14.0,24.0,82.0,4.0,10.0,150.0,45.0,60.0,42.0,34.0,563.0
Singroli,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,16.0,0.0,0.0,12.0,0.0,6.0,5.0,12.0,9.0,9.0,4.0,73.0
Singroli,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,289.0,603.0,395.0,422.0,640.0,559.0,462.0,564.0,506.0,481.0,305.0,495.0,5721.0
Singroli,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,126.0,326.0,0.0,126.0,0.0,0.0,578.0
Singroli,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,632.0,318.0,433.0,432.0,324.0,365.0,468.0,427.0,229.0,64.0,235.0,254.0,4181.0
Singroli,14.14.c,Number of Adolescents counselled,TOTAL,544.0,714.0,667.0,1094.0,1490.0,1136.0,835.0,845.0,702.0,1380.0,918.0,2569.0,12894.0
Singroli,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3477.0,3614.0,3558.0,4524.0,5861.0,5571.0,5017.0,5293.0,5086.0,4811.0,5589.0,5238.0,57639.0
Singroli,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,96.0,82.0,128.0,119.0,133.0,207.0,239.0,237.0,166.0,269.0,151.0,140.0,1967.0
Singroli,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,92.0,130.0,198.0,201.0,194.0,299.0,158.0,204.0,70.0,73.0,101.0,106.0,1826.0
Singroli,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,0.0,0.0,5.0
Singroli,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,233.0,278.0,244.0,227.0,127.0,247.0,258.0,305.0,144.0,144.0,152.0,163.0,2522.0
Singroli,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,1.0,0.0,0.0,5.0
Singroli,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,546.0,581.0,570.0,740.0,573.0,617.0,627.0,570.0,717.0,426.0,617.0,806.0,7390.0
Singroli,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Singroli,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,871.0,989.0,1012.0,1168.0,894.0,1163.0,1043.0,1079.0,931.0,643.0,870.0,1075.0,11738.0
Singroli,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,0.0,3.0,0.0,0.0,0.0,0.0,3.0,3.0,1.0,0.0,0.0,11.0
Singroli,15.2,Number of Widal tests conducted,Number tested,625.0,651.0,677.0,822.0,1105.0,559.0,735.0,833.0,365.0,327.0,382.0,732.0,7813.0
Singroli,15.3.a,Number of VDRL tests conducted on males,Number tested,58.0,133.0,146.0,125.0,153.0,99.0,57.0,106.0,39.0,266.0,63.0,98.0,1343.0
Singroli,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,63.0,233.0,175.0,184.0,164.0,94.0,78.0,215.0,114.0,263.0,83.0,156.0,1822.0
Singroli,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,359.0,252.0,309.0,428.0,325.0,384.0,424.0,305.0,281.0,648.0,511.0,481.0,4707.0
Singroli,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,480.0,618.0,630.0,737.0,642.0,577.0,559.0,626.0,434.0,1177.0,657.0,735.0,7872.0
Singroli,15.4.1,Number of blood smears examined for Malaria,TOTAL,2388.0,3814.0,4408.0,5586.0,7825.0,9086.0,7475.0,9137.0,4508.0,2143.0,4792.0,5949.0,67111.0
Singroli,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,66.0,253.0,358.0,306.0,255.0,282.0,225.0,86.0,68.0,54.0,43.0,67.0,2063.0
Singroli,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,24.0,80.0,36.0,122.0,129.0,199.0,120.0,47.0,23.0,18.0,7.0,25.0,830.0
Singroli,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,0.0,0.0,1500.0,1750.0,1750.0,1900.0,2400.0,,,,,800.0,10100.0
Singroli,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1500.0,3000.0,1000.0,2000.0,2000.0,1000.0,0.0,,,,,3450.0,13950.0
Singroli,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0
Singroli,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1500.0,1500.0,750.0,2000.0,1850.0,500.0,600.0,,,,,750.0,9450.0
Singroli,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,1500.0,1750.0,1750.0,1900.0,2400.0,1800.0,0.0,0.0,0.0,0.0,3500.0,14600.0
Singroli,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,,0.0,0.0,0.0,,0.0,,,,,250.0,250.0
Singroli,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,,0.0,0.0,0.0,,1099.0,,,,,1000.0,2099.0
Singroli,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,,,,,0.0,0.0
Singroli,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,,0.0,0.0,0.0,,50.0,,,,,550.0,600.0
Singroli,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,1049.0,0.0,0.0,0.0,0.0,700.0,1749.0
Singroli,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,200.0,0.0,175.0,0.0,25.0,25.0,0.0,,,,,125.0,550.0
Singroli,16.1.2,Stock position of OPV vaccines,2. Stocks Received,300.0,950.0,1000.0,700.0,450.0,900.0,0.0,,,,,803.0,5103.0
Singroli,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0
Singroli,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,500.0,775.0,1175.0,675.0,450.0,925.0,0.0,,,,,275.0,4775.0
Singroli,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,175.0,0.0,25.0,25.0,0.0,0.0,0.0,0.0,0.0,0.0,653.0,878.0
Singroli,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1000.0,400.0,1400.0,2200.0,1650.0,900.0,1700.0,,,,,500.0,9750.0
Singroli,16.1.3,Stock position of TT vaccines,2. Stocks Received,500.0,2600.0,1500.0,1000.0,1000.0,1000.0,0.0,,,,,2000.0,9600.0
Singroli,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0
Singroli,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1100.0,1600.0,700.0,1550.0,1750.0,200.0,600.0,,,,,750.0,8250.0
Singroli,16.1.3,Stock position of TT vaccines,5. Total Stock,400.0,1400.0,2200.0,1650.0,900.0,1700.0,1100.0,0.0,0.0,0.0,0.0,1750.0,11100.0
Singroli,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,0.0,0.0
Singroli,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,0.0,0.0
Singroli,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,0.0,0.0
Singroli,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,0.0,0.0
Singroli,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,50.0,0.0,450.0,750.0,350.0,600.0,1450.0,,,,,250.0,3900.0
Singroli,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000.0,2000.0,450.0,600.0,2000.0,1000.0,0.0,,,,,1000.0,8050.0
Singroli,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0
Singroli,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1050.0,1550.0,150.0,1000.0,1750.0,150.0,250.0,,,,,600.0,6500.0
Singroli,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,450.0,750.0,350.0,600.0,1450.0,1200.0,0.0,0.0,0.0,0.0,650.0,5450.0
Singroli,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1850.0,2400.0,800.0,0.0,100.0,350.0,150.0,,,,,700.0,6350.0
Singroli,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2000.0,0.0,0.0,2000.0,2000.0,0.0,0.0,,,,,1000.0,7000.0
Singroli,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0
Singroli,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1450.0,1600.0,800.0,1900.0,1750.0,200.0,150.0,,,,,150.0,8000.0
Singroli,16.1.6,Stock position of Measles vaccines,5. Total Stock,2400.0,800.0,0.0,100.0,350.0,150.0,0.0,0.0,0.0,0.0,0.0,1550.0,5350.0
Singroli,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,,0.0,0.0,0.0,,,,,,,,0.0
Singroli,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,,0.0,0.0,0.0,,,,,,,,0.0
Singroli,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,,,,,,,,0.0
Singroli,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,,0.0,0.0,0.0,,,,,,,,0.0
Singroli,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Singroli,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,800.0,150.0,600.0,350.0,700.0,700.0,1350.0,,,,,150.0,4800.0
Singroli,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000.0,1000.0,1000.0,2000.0,2000.0,1000.0,0.0,,,,,1000.0,9000.0
Singroli,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0
Singroli,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1650.0,550.0,1250.0,1650.0,2000.0,350.0,500.0,,,,,350.0,8300.0
Singroli,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,150.0,600.0,350.0,700.0,700.0,1350.0,850.0,0.0,0.0,0.0,0.0,800.0,5500.0
Singroli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,0.0,3000.0,3000.0,,,,,,,6000.0
Singroli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,4200.0,0.0,0.0,,,,,,,4200.0
Singroli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,0.0,0.0,0.0,,,,,,,0.0
Singroli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,1200.0,0.0,0.0,,,,,,,1200.0
Singroli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,3000.0,3000.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0
Singroli,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,0.0,5040.0,4540.0,,,,,,,9580.0
Singroli,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,126000.0,0.0,0.0,,,,,,,126000.0
Singroli,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,0.0,0.0,0.0,,,,,,,0.0
Singroli,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,120960.0,500.0,0.0,,,,,,,121460.0
Singroli,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,5040.0,4540.0,4540.0,0.0,0.0,0.0,0.0,0.0,0.0,14120.0
Singroli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,0.0,2400.0,1900.0,,,,,,,4300.0
Singroli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,22200.0,0.0,0.0,,,,,,,22200.0
Singroli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,0.0,0.0,0.0,,,,,,,0.0
Singroli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,19800.0,500.0,0.0,,,,,,,20300.0
Singroli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,2400.0,1900.0,1900.0,0.0,0.0,0.0,0.0,0.0,0.0,6200.0
Singroli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,0.0,500.0,200.0,,,,,,,700.0
Singroli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,600.0,0.0,0.0,,,,,,,600.0
Singroli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,0.0,0.0,0.0,,,,,,,0.0
Singroli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,100.0,300.0,0.0,,,,,,,400.0
Singroli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,500.0,200.0,200.0,0.0,0.0,0.0,0.0,0.0,0.0,900.0
Singroli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,3000.0,3000.0,3000.0,,,,,,,9000.0
Singroli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,0.0,0.0,0.0,,,,,,,0.0
Singroli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,0.0,0.0,0.0,,,,,,,0.0
Singroli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,0.0,0.0,0.0,,,,,,,0.0
Singroli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,3000.0,3000.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0
Singroli,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,5000.0,5000.0,5000.0,3000.0,1000.0,1000.0,500.0,,,,,,20500.0
Singroli,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Singroli,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Singroli,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,2000.0,2000.0,0.0,500.0,0.0,,,,,,4500.0
Singroli,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,5000.0,5000.0,3000.0,1000.0,1000.0,500.0,500.0,0.0,0.0,0.0,0.0,0.0,16000.0
Singroli,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,5000.0,20000.0,20000.0,22000.0,16000.0,16000.0,34000.0,,,,,,133000.0
Singroli,16.3.02,Stock Position of Gloves,2. Stocks Received,20000.0,0.0,20000.0,0.0,0.0,25000.0,0.0,,,,,,65000.0
Singroli,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Singroli,16.3.02,Stock Position of Gloves,4. Stock Distributed,5000.0,5000.0,18000.0,6000.0,0.0,7000.0,4000.0,,,,,,45000.0
Singroli,16.3.02,Stock Position of Gloves,5. Total Stock,20000.0,15000.0,22000.0,16000.0,16000.0,34000.0,30000.0,0.0,0.0,0.0,0.0,0.0,153000.0
Singroli,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,15000.0,10000.0,10000.0,10000.0,10000.0,10000.0,,,,,,,65000.0
Singroli,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,50000.0,,,,,,,50000.0
Singroli,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Singroli,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,5000.0,5000.0,0.0,0.0,0.0,20000.0,,,,,,,30000.0
Singroli,16.3.03,Stock Position of MVA Syringes,5. Total Stock,10000.0,5000.0,10000.0,10000.0,10000.0,40000.0,0.0,0.0,0.0,0.0,0.0,0.0,85000.0
Singroli,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,18000.0,14000.0,14000.0,12000.0,10000.0,6000.0,3000.0,,,,,,77000.0
Singroli,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Singroli,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Singroli,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,4000.0,3000.0,2000.0,2000.0,4000.0,3000.0,0.0,,,,,,18000.0
Singroli,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,14000.0,11000.0,12000.0,10000.0,6000.0,3000.0,3000.0,0.0,0.0,0.0,0.0,0.0,59000.0
Singroli,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,1000.0,1000.0,1000.0,800.0,800.0,800.0,800.0,,,,,,6200.0
Singroli,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Singroli,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Singroli,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,200.0,0.0,0.0,0.0,200.0,,,,,,400.0
Singroli,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,1000.0,1000.0,800.0,800.0,800.0,800.0,600.0,0.0,0.0,0.0,0.0,0.0,5800.0
Singroli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,5.0,3.0,3.0,3.0,3.0,3.0,3.0,,,,,,23.0
Singroli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Singroli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Singroli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,2.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,2.0
Singroli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,3.0,3.0,3.0,3.0,3.0,3.0,3.0,0.0,0.0,0.0,0.0,0.0,21.0
Singroli,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,100000.0,100000.0,100000.0,100000.0,100000.0,100000.0,60000.0,,,,,,660000.0
Singroli,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Singroli,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Singroli,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,5000.0,0.0,0.0,0.0,40000.0,58000.0,,,,,,103000.0
Singroli,16.3.07,Stock Position of IFA Tablets,5. Total Stock,100000.0,95000.0,100000.0,100000.0,100000.0,60000.0,2000.0,0.0,0.0,0.0,0.0,0.0,557000.0
Singroli,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,4000.0,,,,,,16000.0
Singroli,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,10000.0,0.0,0.0,60000.0,60000.0,,,,,,130000.0
Singroli,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Singroli,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,10000.0,0.0,0.0,58000.0,63000.0,,,,,,131000.0
Singroli,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,2000.0,2000.0,2000.0,2000.0,2000.0,4000.0,1000.0,0.0,0.0,0.0,0.0,0.0,15000.0
Singroli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,40000.0,40000.0,40000.0,4000.0,4000.0,3000.0,2000.0,,,,,,133000.0
Singroli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,20000.0,0.0,0.0,0.0,,,,,,20000.0
Singroli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Singroli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,36000.0,20000.0,1000.0,1000.0,0.0,,,,,,58000.0
Singroli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,40000.0,40000.0,4000.0,4000.0,3000.0,2000.0,2000.0,0.0,0.0,0.0,0.0,0.0,95000.0
Singroli,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,5000.0,3000.0,3000.0,1800.0,1000.0,11000.0,1000.0,,,,,,25800.0
Singroli,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,1800.0,0.0,10000.0,0.0,0.0,,,,,,11800.0
Singroli,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Singroli,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,2000.0,1000.0,3000.0,800.0,0.0,10000.0,700.0,,,,,,17500.0
Singroli,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,3000.0,2000.0,1800.0,1000.0,11000.0,1000.0,300.0,0.0,0.0,0.0,0.0,0.0,20100.0
Singroli,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,80000.0,80000.0,80000.0,150000.0,250000.0,100000.0,50000.0,,,,,,790000.0
Singroli,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,220000.0,300000.0,0.0,0.0,0.0,,,,,,520000.0
Singroli,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Singroli,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,150000.0,200000.0,150000.0,50000.0,48000.0,,,,,,598000.0
Singroli,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,80000.0,80000.0,150000.0,250000.0,100000.0,50000.0,2000.0,0.0,0.0,0.0,0.0,0.0,712000.0
Singroli,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,9900.0,3300.0,1700.0,1200.0,6800.0,2900.0,2300.0,,,,,100.0,28200.0
Singroli,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,9900.0,,12900.0,0.0,0.0,0.0,,,,,0.0,22800.0
Singroli,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,,,,,,0.0
Singroli,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,6600.0,11500.0,500.0,7300.0,3900.0,600.0,300.0,,,,,0.0,30700.0
Singroli,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3300.0,1700.0,1200.0,6800.0,2900.0,2300.0,2000.0,0.0,0.0,0.0,0.0,100.0,20300.0
Singroli,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,28000.0,28000.0,50000.0,50000.0,10000.0,4000.0,48000.0,,,,,160000.0,378000.0
Singroli,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,80000.0,0.0,50000.0,0.0,92000.0,104000.0,,,,,0.0,326000.0
Singroli,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Singroli,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,108000.0,0.0,90000.0,6000.0,48000.0,130000.0,,,,,0.0,382000.0
Singroli,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,28000.0,0.0,50000.0,10000.0,4000.0,48000.0,22000.0,0.0,0.0,0.0,0.0,160000.0,322000.0
Singroli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1000.0,0.0,0.0,0.0,2000.0,1600.0,1600.0,,,,,100.0,6300.0
Singroli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,,,,,0.0,2000.0
Singroli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Singroli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1000.0,0.0,0.0,0.0,400.0,0.0,300.0,,,,,0.0,1700.0
Singroli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,2000.0,1600.0,1600.0,1300.0,0.0,0.0,0.0,0.0,100.0,6600.0
Singroli,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,2.0,,,,,,,2.0
Singroli,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Singroli,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,,,,,1.0
Singroli,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,1.0,,,,,1.0
Singroli,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,1.0,1.0,,,,,,,,2.0
Singroli,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Singroli,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,1.0,1.0,,,,,,,,2.0
Singroli,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,4.0,,,2.0,,6.0,,1.0,,,,,13.0
Singroli,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,1.0,,,,,,,,1.0
Singroli,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,4.0,,,2.0,1.0,6.0,,1.0,,,,,14.0
Singroli,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,1.0,1.0,,2.0,3.0,,2.0,7.0,4.0,4.0,,24.0
Singroli,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,1.0,,,,,,,,1.0
Singroli,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,1.0,1.0,,3.0,3.0,,2.0,7.0,4.0,4.0,,25.0
Singroli,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Singroli,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Singroli,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Singroli,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Singroli,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Singroli,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Singroli,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,1.0,,,,,,,1.0
Singroli,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Singroli,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,1.0,,,,,,,1.0
Singroli,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Singroli,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Singroli,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Singroli,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,2.0,1.0,4.0,,,,,7.0
Singroli,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,3.0,2.0,,,,5.0
Singroli,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,2.0,1.0,7.0,2.0,,,,12.0
Singroli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Singroli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Singroli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Singroli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Singroli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Singroli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Singroli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Singroli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Singroli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Singroli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Singroli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Singroli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Singroli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Singroli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Singroli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Singroli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Singroli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Singroli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Singroli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Singroli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Singroli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Singroli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Singroli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Singroli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Singroli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Singroli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Singroli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,1.0,,,,,,,,1.0
Singroli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Singroli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Singroli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Singroli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Singroli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Singroli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Singroli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Singroli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Singroli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Singroli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Singroli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Singroli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Singroli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Singroli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Singroli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Singroli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,,,,,,,,,,,,2.0
Singroli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Singroli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,,,,,,,,,,,,2.0
Singroli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Singroli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Singroli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,1.0,,,,,,1.0
Singroli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Singroli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Singroli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Singroli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Singroli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Singroli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Singroli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Singroli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Singroli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Singroli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Singroli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,1.0,1.0,1.0,1.0,1.0,5.0
Singroli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Singroli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,1.0,1.0,1.0,1.0,1.0,5.0
Tikamgarh,1.1,Total number of pregnant women Registered for ANC,TOTAL,2885.0,3826.0,3552.0,4034.0,3338.0,3306.0,2752.0,2676.0,2799.0,2736.0,3472.0,3772.0,39148.0
Tikamgarh,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1183.0,1441.0,1579.0,1800.0,1531.0,1588.0,1746.0,1538.0,1768.0,1712.0,2094.0,2073.0,20053.0
Tikamgarh,1.2,Number of Pregnant women registered under JSY,TOTAL,2322.0,3023.0,3441.0,3777.0,3181.0,3303.0,2701.0,2665.0,2773.0,2730.0,3460.0,3772.0,37148.0
Tikamgarh,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2330.0,2404.0,2654.0,2719.0,2819.0,2934.0,2753.0,2610.0,2600.0,2761.0,2660.0,2708.0,31952.0
Tikamgarh,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1906.0,2470.0,2820.0,3088.0,2634.0,2700.0,2233.0,2237.0,2334.0,2182.0,2646.0,2958.0,30208.0
Tikamgarh,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2265.0,2548.0,2900.0,3340.0,3091.0,3025.0,2721.0,2378.0,2488.0,2432.0,2493.0,3307.0,32988.0
Tikamgarh,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2588.0,3083.0,3395.0,3608.0,3437.0,3413.0,2992.0,3047.0,2846.0,2994.0,3405.0,3550.0,38358.0
Tikamgarh,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,225.0,407.0,510.0,543.0,208.0,479.0,245.0,281.0,408.0,251.0,293.0,330.0,4180.0
Tikamgarh,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,2.0,14.0,25.0,1.0,2.0,5.0,2.0,15.0,0.0,1.0,0.0,67.0
Tikamgarh,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,504.0,767.0,934.0,890.0,905.0,996.0,820.0,870.0,1059.0,1130.0,1136.0,1268.0,11279.0
Tikamgarh,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,9.0,4.0,34.0,24.0,14.0,19.0,21.0,50.0,52.0,52.0,26.0,21.0,326.0
Tikamgarh,1.8,Number of pregnancy test kits used at SC level,TOTAL,298.0,878.0,757.0,716.0,567.0,655.0,504.0,422.0,387.0,539.0,720.0,696.0,7139.0
Tikamgarh,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,71.0,104.0,108.0,189.0,160.0,127.0,20.0,0.0,0.0,0.0,0.0,0.0,779.0
Tikamgarh,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,175.0,210.0,254.0,389.0,397.0,412.0,329.0,362.0,309.0,309.0,282.0,259.0,3687.0
Tikamgarh,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,246.0,314.0,362.0,578.0,557.0,539.0,349.0,362.0,309.0,309.0,282.0,259.0,4466.0
Tikamgarh,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,136.0,156.0,208.0,305.0,291.0,284.0,274.0,296.0,203.0,236.0,203.0,188.0,2780.0
Tikamgarh,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,2.0,2.0,1.0,13.0,6.0,0.0,14.0,9.0,7.0,0.0,0.0,37.0,91.0
Tikamgarh,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1065.0,1525.0,1920.0,2103.0,2371.0,2506.0,2204.0,2357.0,2101.0,1865.0,1740.0,2034.0,23791.0
Tikamgarh,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,109.0,193.0,303.0,321.0,129.0,228.0,368.0,489.0,450.0,352.0,247.0,468.0,3657.0
Tikamgarh,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,749.0,1082.0,1340.0,1497.0,1481.0,1881.0,1794.0,1860.0,2167.0,1964.0,1280.0,2177.0,19272.0
Tikamgarh,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,488.0,714.0,939.0,1118.0,1185.0,1362.0,1230.0,1286.0,1301.0,1555.0,1085.0,1417.0,13680.0
Tikamgarh,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,92.0,82.0,102.0,101.0,125.0,34.0,25.0,179.0,94.0,51.0,36.0,52.0,973.0
Tikamgarh,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,20.0,32.0,33.0,48.0,36.0,30.0,42.0,21.0,15.0,23.0,17.0,34.0,351.0
Tikamgarh,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tikamgarh,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,20.0,32.0,33.0,48.0,36.0,30.0,42.0,21.0,15.0,23.0,17.0,34.0,351.0
Tikamgarh,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,53.0,44.0,52.0,51.0,71.0,16.0,20.0,101.0,64.0,33.0,20.0,33.0,558.0
Tikamgarh,4.1.1.a,Number of male live births,TOTAL,711.0,926.0,1150.0,1349.0,1515.0,1562.0,1341.0,1465.0,1337.0,1169.0,1100.0,1155.0,14780.0
Tikamgarh,4.1.1.b,Number of female live births,TOTAL,618.0,860.0,1112.0,1228.0,1349.0,1379.0,1179.0,1389.0,1147.0,1057.0,957.0,1164.0,13439.0
Tikamgarh,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1329.0,1786.0,2262.0,2577.0,2864.0,2941.0,2520.0,2854.0,2484.0,2226.0,2057.0,2319.0,28219.0
Tikamgarh,4.1.2,Number of still births,TOTAL,16.0,30.0,26.0,35.0,35.0,21.0,51.0,58.0,32.0,27.0,26.0,29.0,386.0
Tikamgarh,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,20.0,19.0,22.0,23.0,21.0,7.0,16.0,12.0,12.0,29.0,20.0,20.0,221.0
Tikamgarh,4.2.1,Number of Newborns weighed at birth,TOTAL,1298.0,1764.0,2236.0,2525.0,2806.0,2873.0,2475.0,2654.0,2442.0,2195.0,2043.0,2289.0,27600.0
Tikamgarh,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,149.0,252.0,368.0,360.0,372.0,395.0,305.0,314.0,273.0,279.0,190.0,276.0,3533.0
Tikamgarh,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1287.0,1702.0,2196.0,2538.0,2811.0,2906.0,2472.0,2675.0,2429.0,2161.0,1586.0,2299.0,27062.0
Tikamgarh,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,8.0,0.0,2.0,0.0,2.0,1.0,3.0,3.0,1.0,0.0,3.0,0.0,23.0
Tikamgarh,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,4.0,17.0,4.0,3.0,42.0,38.0,16.0,17.0,12.0,13.0,27.0,17.0,210.0
Tikamgarh,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,134.0,118.0,125.0,7.0,134.0,132.0,42.0,175.0,104.0,89.0,148.0,1208.0
Tikamgarh,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tikamgarh,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,12.0,151.0,124.0,128.0,51.0,173.0,151.0,62.0,188.0,117.0,119.0,165.0,1441.0
Tikamgarh,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,27.0,10.0,9.0,17.0,12.0,13.0,46.0,45.0,10.0,0.0,0.0,189.0
Tikamgarh,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,152.0,308.0,133.0,208.0,2411.0,420.0,365.0,458.0,191.0,267.0,261.0,250.0,5424.0
Tikamgarh,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,18.0,60.0,115.0,124.0,142.0,136.0,170.0,146.0,35.0,4.0,7.0,7.0,964.0
Tikamgarh,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,193.0,331.0,102.0,137.0,1155.0,313.0,202.0,249.0,197.0,180.0,222.0,225.0,3506.0
Tikamgarh,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,15.0,29.0,63.0,63.0,63.0,58.0,48.0,77.0,126.0,97.0,43.0,78.0,760.0
Tikamgarh,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1243.0,1576.0,1636.0,2296.0,2651.0,2574.0,2226.0,2487.0,2268.0,1562.0,1433.0,1545.0,23497.0
Tikamgarh,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,579.0,684.0,708.0,980.0,996.0,1287.0,1211.0,1191.0,1018.0,1038.0,887.0,1127.0,11706.0
Tikamgarh,6.3,PNC maternal complications attended,TOTAL,0.0,2.0,1.0,27.0,0.0,1.0,3.0,3.0,1.0,1.0,140.0,73.0,252.0
Tikamgarh,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,18.0,24.0,17.0,9.0,17.0,17.0,14.0,17.0,20.0,17.0,22.0,48.0,240.0
Tikamgarh,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,10.0,3.0,0.0,16.0
Tikamgarh,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,18.0,24.0,17.0,9.0,17.0,17.0,14.0,17.0,23.0,27.0,25.0,48.0,256.0
Tikamgarh,7.2,Number of MTPs conducted at Private Facilities,TOTAL,2.0,7.0,4.0,2.0,5.0,4.0,1.0,9.0,6.0,10.0,0.0,2.0,52.0
Tikamgarh,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,23.0,43.0,69.0,32.0,88.0,44.0,47.0,79.0,49.0,58.0,26.0,45.0,603.0
Tikamgarh,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,162.0,86.0,97.0,87.0,1116.0,99.0,41.0,62.0,97.0,62.0,100.0,85.0,2094.0
Tikamgarh,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,185.0,129.0,166.0,119.0,1204.0,143.0,88.0,141.0,146.0,120.0,126.0,130.0,2697.0
Tikamgarh,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,3.0,1.0,0.0,3.0,4.0,4.0,4.0,2.0,0.0,21.0
Tikamgarh,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Tikamgarh,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tikamgarh,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,0.0,1.0,4.0,1.0,0.0,3.0,4.0,4.0,4.0,2.0,0.0,24.0
Tikamgarh,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,400.0,628.0,232.0,88.0,0.0,1348.0
Tikamgarh,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,2.0,0.0,0.0,61.0,7.0,0.0,74.0,1848.0,2160.0,1180.0,459.0,25.0,5816.0
Tikamgarh,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,8.0,6.0,3.0,6.0,4.0,5.0,3.0,50.0,90.0,102.0,35.0,12.0,324.0
Tikamgarh,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tikamgarh,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,10.0,6.0,3.0,67.0,11.0,5.0,77.0,2298.0,2878.0,1514.0,582.0,37.0,7488.0
Tikamgarh,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,3.0,0.0,9.0,0.0,0.0,0.0,0.0,16.0,20.0,14.0,8.0,0.0,70.0
Tikamgarh,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tikamgarh,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,3.0,0.0,9.0,0.0,0.0,0.0,0.0,16.0,20.0,14.0,8.0,0.0,70.0
Tikamgarh,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Tikamgarh,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,10.0,0.0,20.0
Tikamgarh,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,8.0,0.0,0.0,25.0,0.0,10.0,10.0,0.0,0.0,0.0,8.0,61.0
Tikamgarh,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tikamgarh,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,8.0,0.0,0.0,25.0,0.0,10.0,10.0,0.0,12.0,10.0,8.0,83.0
Tikamgarh,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,442.0,520.0,470.0,508.0,500.0,438.0,431.0,390.0,319.0,313.0,264.0,339.0,4934.0
Tikamgarh,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,33.0,38.0,37.0,26.0,22.0,21.0,17.0,33.0,32.0,13.0,20.0,17.0,309.0
Tikamgarh,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,59.0,44.0,41.0,53.0,38.0,34.0,52.0,37.0,44.0,39.0,80.0,173.0,694.0
Tikamgarh,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,165.0,252.0,331.0,15.0,407.0,10.0,3.0,445.0,329.0,343.0,0.0,447.0,2747.0
Tikamgarh,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tikamgarh,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,699.0,854.0,879.0,602.0,967.0,503.0,503.0,905.0,724.0,708.0,364.0,976.0,8684.0
Tikamgarh,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,225.0,49.0,367.0,414.0,417.0,492.0,426.0,481.0,366.0,378.0,467.0,611.0,4693.0
Tikamgarh,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,8.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,9.0
Tikamgarh,9.06,Number of IUCD removals,TOTAL,289.0,368.0,247.0,239.0,279.0,190.0,199.0,214.0,239.0,181.0,159.0,260.0,2864.0
Tikamgarh,9.07,Number of Oral Pills cycles distributed,TOTAL,5458.0,6703.0,6361.0,6843.0,6324.0,6379.0,6494.0,5797.0,6607.0,7146.0,6058.0,6383.0,76553.0
Tikamgarh,9.08,Number of Condom pieces distributed,TOTAL,17255.0,26738.0,30663.0,30435.0,35474.0,49152.0,36958.0,38743.0,46193.0,33628.0,34694.0,33012.0,412945.0
Tikamgarh,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,61.0,0.0,6.0,6.0,4.0,77.0
Tikamgarh,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Tikamgarh,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,39.0,51.0,18.0,4.0,0.0,112.0
Tikamgarh,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,3.0,5.0,3.0,6.0,6.0,1.0,0.0,1.0,0.0,25.0
Tikamgarh,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Tikamgarh,9.12,Number of Institutions having NSV trained doctors,TOTAL,8.0,8.0,8.0,8.0,7.0,8.0,5.0,11.0,12.0,12.0,12.0,11.0,-1.0
Tikamgarh,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1306.0,1722.0,2255.0,2623.0,2663.0,2840.0,2523.0,2623.0,2471.0,2162.0,2198.0,2410.0,27796.0
Tikamgarh,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1952.0,2377.0,2531.0,2389.0,2485.0,2784.0,2908.0,1349.0,4.0,27.0,4.0,3.0,18813.0
Tikamgarh,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2261.0,2445.0,2480.0,2610.0,2397.0,2472.0,2503.0,2769.0,1114.0,369.0,94.0,53.0,21567.0
Tikamgarh,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2365.0,2639.0,2481.0,2625.0,2528.0,2368.0,2394.0,2526.0,2405.0,1045.0,361.0,149.0,23886.0
Tikamgarh,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1486.0,2465.0,2624.0,2854.0,2982.0,12411.0
Tikamgarh,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1597.0,2125.0,2605.0,2949.0,9276.0
Tikamgarh,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1643.0,2101.0,2853.0,6597.0
Tikamgarh,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1177.0,1678.0,2042.0,2310.0,2526.0,2754.0,2324.0,2295.0,2062.0,1482.0,1345.0,2076.0,24071.0
Tikamgarh,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1937.0,2365.0,2521.0,2390.0,2493.0,2772.0,2765.0,1856.0,2630.0,2744.0,2943.0,2991.0,30407.0
Tikamgarh,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2239.0,2445.0,2475.0,2606.0,2394.0,2435.0,2460.0,2245.0,2505.0,2498.0,2779.0,2994.0,30075.0
Tikamgarh,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2370.0,2621.0,2485.0,2622.0,2527.0,2335.0,2364.0,2066.0,2550.0,2456.0,2503.0,2956.0,29855.0
Tikamgarh,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1144.0,1616.0,1912.0,2293.0,2428.0,2660.0,2278.0,2222.0,1441.0,1030.0,1221.0,1492.0,21737.0
Tikamgarh,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1827.0,2370.0,2270.0,2039.0,1948.0,2392.0,2108.0,1005.0,5.0,27.0,4.0,1.0,15996.0
Tikamgarh,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2238.0,2449.0,2483.0,2612.0,2396.0,2450.0,2474.0,2740.0,1197.0,338.0,98.0,61.0,21536.0
Tikamgarh,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2363.0,2633.0,2482.0,2650.0,2542.0,2380.0,2400.0,2531.0,2353.0,1101.0,311.0,156.0,23902.0
Tikamgarh,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2141.0,2597.0,2783.0,2981.0,2757.0,2799.0,2171.0,2003.0,1855.0,2121.0,2453.0,2650.0,29311.0
Tikamgarh,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1143.0,1242.0,1470.0,1798.0,1967.0,1822.0,1582.0,1543.0,1883.0,1942.0,2291.0,2525.0,21208.0
Tikamgarh,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,3.0
Tikamgarh,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1097.0,1323.0,1367.0,1517.0,1436.0,1429.0,1182.0,1062.0,967.0,1176.0,1246.0,1294.0,15096.0
Tikamgarh,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,947.0,1153.0,1230.0,1342.0,1215.0,1241.0,983.0,904.0,834.0,1025.0,1137.0,1182.0,13193.0
Tikamgarh,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2044.0,2476.0,2597.0,2859.0,2651.0,2670.0,2165.0,1966.0,1801.0,2201.0,2383.0,2476.0,28289.0
Tikamgarh,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1568.0,2061.0,2151.0,2387.0,2252.0,2186.0,1906.0,1751.0,2155.0,2165.0,2663.0,2817.0,26062.0
Tikamgarh,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1550.0,2041.0,2167.0,2377.0,2262.0,2194.0,1902.0,1537.0,2125.0,2102.0,2657.0,2792.0,25706.0
Tikamgarh,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,342.0,563.0,610.0,721.0,595.0,491.0,450.0,501.0,468.0,519.0,580.0,604.0,6444.0
Tikamgarh,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,319.0,520.0,521.0,662.0,524.0,442.0,398.0,430.0,378.0,467.0,521.0,540.0,5722.0
Tikamgarh,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,661.0,1083.0,1131.0,1383.0,1119.0,933.0,848.0,931.0,846.0,986.0,1101.0,1144.0,12166.0
Tikamgarh,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,201.0,339.0,520.0,612.0,444.0,690.0,566.0,525.0,520.0,778.0,699.0,710.0,6604.0
Tikamgarh,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1461.0,1749.0,1960.0,2016.0,1982.0,2155.0,1914.0,1832.0,2008.0,2015.0,2038.0,1988.0,23118.0
Tikamgarh,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1499.0,1978.0,2102.0,2247.0,2287.0,2283.0,2044.0,1962.0,2108.0,2111.0,2230.0,2256.0,25107.0
Tikamgarh,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,4.0,2.0,6.0,2.0,4.0,1.0,1.0,6.0,3.0,3.0,5.0,0.0,37.0
Tikamgarh,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,6.0,7.0,9.0,4.0,33.0,15.0,18.0,18.0,11.0,14.0,7.0,12.0,154.0
Tikamgarh,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1238.0,1302.0,1346.0,1346.0,1344.0,1326.0,1295.0,1331.0,1326.0,1301.0,1333.0,1325.0,15813.0
Tikamgarh,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1175.0,1299.0,1341.0,1347.0,1336.0,1320.0,1277.0,1324.0,1324.0,1296.0,1326.0,1325.0,15690.0
Tikamgarh,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,923.0,1012.0,1023.0,1066.0,1075.0,1054.0,1044.0,1067.0,1081.0,1065.0,1061.0,1069.0,12540.0
Tikamgarh,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1998.0,2512.0,2685.0,2981.0,2627.0,2756.0,2449.0,2392.0,2152.0,2529.0,2414.0,2764.0,30259.0
Tikamgarh,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1150.0,1681.0,1051.0,5247.0,3123.0,2054.0,1223.0,1182.0,1552.0,3779.0,4911.0,1861.0,28814.0
Tikamgarh,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,692.0,1088.0,627.0,5508.0,2980.0,1796.0,824.0,936.0,841.0,3729.0,4343.0,790.0,24154.0
Tikamgarh,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Tikamgarh,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Tikamgarh,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,1.0,3.0,0.0,0.0,4.0,4.0,0.0,19.0,13.0,0.0,4.0,48.0
Tikamgarh,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,180.0,368.0,410.0,220.0,367.0,258.0,231.0,181.0,255.0,280.0,252.0,244.0,3246.0
Tikamgarh,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,22.0,18.0,23.0,28.0,13.0,182.0,77.0,36.0,9.0,7.0,3.0,4.0,422.0
Tikamgarh,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,27.0,0.0,10.0,10.0,45.0,57.0,37.0,103.0,52.0,77.0,147.0,209.0,774.0
Tikamgarh,13.1,Number of Patients operated for cataract,TOTAL,22.0,0.0,2.0,1.0,1.0,3.0,7.0,72.0,146.0,603.0,496.0,496.0,1849.0
Tikamgarh,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,20.0,0.0,2.0,1.0,1.0,3.0,7.0,70.0,143.0,601.0,496.0,496.0,1840.0
Tikamgarh,13.3,Number of School children detected with Refractive errors,TOTAL,17.0,5.0,6.0,12.0,23.0,45.0,119.0,24.0,134.0,236.0,294.0,278.0,1193.0
Tikamgarh,13.4,Number of children provided free glasses,TOTAL,27.0,5.0,6.0,0.0,0.0,0.0,0.0,148.0,134.0,270.0,268.0,274.0,1132.0
Tikamgarh,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,4.0,4.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,2.0,-1.0
Tikamgarh,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,6.0,9.0,9.0,6.0,6.0,7.0,7.0,9.0,10.0,10.0,10.0,9.0,-1.0
Tikamgarh,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,716.0,827.0,776.0,774.0,842.0,877.0,866.0,811.0,875.0,842.0,819.0,807.0,-1.0
Tikamgarh,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,5.0,6.0,5.0,5.0,5.0,6.0,6.0,7.0,7.0,7.0,6.0,-1.0
Tikamgarh,14.05,Number of RKS meetings held during the month,TOTAL,0.0,2.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,6.0
Tikamgarh,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,13.0,11.0,11.0,12.0,13.0,13.0,14.0,16.0,18.0,18.0,18.0,17.0,-1.0
Tikamgarh,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,39.0,32.0,18.0,193.0,16.0,20.0,22.0,79.0,65.0,68.0,46.0,40.0,638.0
Tikamgarh,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,2.0,2.0,2.0,2.0,3.0,3.0,4.0,4.0,4.0,3.0,-1.0
Tikamgarh,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,-1.0
Tikamgarh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,471.0,773.0,678.0,814.0,669.0,1123.0,766.0,766.0,779.0,712.0,934.0,1127.0,9612.0
Tikamgarh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1005.0,1562.0,1355.0,1702.0,1200.0,2117.0,1492.0,1200.0,2020.0,1301.0,1258.0,1456.0,17668.0
Tikamgarh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,388.0,641.0,569.0,662.0,578.0,1222.0,1066.0,981.0,661.0,544.0,585.0,959.0,8856.0
Tikamgarh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1448.0,1884.0,2175.0,2365.0,2891.0,3428.0,2719.0,3552.0,3065.0,2901.0,2768.0,2741.0,31937.0
Tikamgarh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,859.0,1414.0,1247.0,1476.0,1247.0,2345.0,1832.0,1747.0,1440.0,1256.0,1519.0,2086.0,18468.0
Tikamgarh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2453.0,3446.0,3530.0,4067.0,4091.0,5545.0,4211.0,4752.0,5085.0,4202.0,4026.0,4197.0,49605.0
Tikamgarh,14.10.2.a,Number of death cases of Inpatient males,TOTAL,23.0,39.0,30.0,28.0,15.0,39.0,0.0,30.0,27.0,27.0,27.0,27.0,312.0
Tikamgarh,14.10.2.b,Number of death cases of Inpatient females,TOTAL,9.0,18.0,19.0,23.0,7.0,21.0,0.0,20.0,14.0,18.0,19.0,19.0,187.0
Tikamgarh,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,32.0,57.0,49.0,51.0,22.0,60.0,0.0,50.0,41.0,45.0,46.0,46.0,499.0
Tikamgarh,14.11,In-Patient Head Count at midnight,TOTAL,3799.0,5685.0,5569.0,6748.0,5959.0,8065.0,6147.0,5818.0,5564.0,4715.0,4584.0,5690.0,68343.0
Tikamgarh,14.12.1,OPD attendance (All),TOTAL,33150.0,46792.0,51222.0,55331.0,69205.0,75685.0,54600.0,52464.0,47417.0,41457.0,59122.0,68331.0,654776.0
Tikamgarh,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,109.0,135.0,108.0,87.0,133.0,76.0,92.0,970.0,76.0,64.0,69.0,51.0,1970.0
Tikamgarh,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,51.0,31.0,26.0,2.0,35.0,27.0,15.0,31.0,39.0,24.0,34.0,19.0,334.0
Tikamgarh,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,50.0,45.0,159.0,125.0,175.0,85.0,78.0,634.0,1135.0,406.0,245.0,12.0,3149.0
Tikamgarh,14.14.a,Number of patients given AYUSH treatment,TOTAL,303.0,673.0,653.0,1160.0,1249.0,724.0,860.0,613.0,586.0,412.0,291.0,358.0,7882.0
Tikamgarh,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,14.14.c,Number of Adolescents counselled,TOTAL,44.0,128.0,151.0,189.0,174.0,223.0,221.0,267.0,240.0,292.0,371.0,177.0,2477.0
Tikamgarh,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2006.0,4197.0,4674.0,4795.0,5194.0,5856.0,4470.0,5739.0,5697.0,5025.0,5477.0,4741.0,57871.0
Tikamgarh,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,24.0,63.0,80.0,66.0,231.0,81.0,51.0,80.0,104.0,131.0,131.0,124.0,1166.0
Tikamgarh,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,85.0,152.0,116.0,166.0,68.0,207.0,268.0,223.0,313.0,207.0,255.0,355.0,2415.0
Tikamgarh,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,46.0,187.0,145.0,116.0,61.0,151.0,230.0,240.0,1435.0,251.0,79.0,767.0,3708.0
Tikamgarh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Tikamgarh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,555.0,1406.0,2145.0,1572.0,891.0,2100.0,1482.0,1873.0,1471.0,1720.0,1598.0,651.0,17464.0
Tikamgarh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,3.0
Tikamgarh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,686.0,1745.0,2406.0,1854.0,1020.0,2458.0,1980.0,2336.0,3219.0,2178.0,1932.0,1773.0,23587.0
Tikamgarh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,4.0
Tikamgarh,15.2,Number of Widal tests conducted,Number tested,580.0,643.0,904.0,938.0,1205.0,1480.0,914.0,928.0,508.0,266.0,629.0,634.0,9629.0
Tikamgarh,15.3.a,Number of VDRL tests conducted on males,Number tested,82.0,113.0,99.0,140.0,152.0,218.0,150.0,155.0,187.0,250.0,202.0,234.0,1982.0
Tikamgarh,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,187.0,1121.0,122.0,602.0,491.0,806.0,214.0,245.0,691.0,257.0,67.0,571.0,5374.0
Tikamgarh,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,546.0,163.0,1547.0,890.0,1328.0,1410.0,1152.0,1185.0,1083.0,908.0,1319.0,389.0,11920.0
Tikamgarh,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,815.0,1397.0,1768.0,1632.0,1971.0,2434.0,1516.0,1585.0,1961.0,1415.0,1588.0,1194.0,19276.0
Tikamgarh,15.4.1,Number of blood smears examined for Malaria,TOTAL,6716.0,7914.0,9753.0,10066.0,12322.0,15434.0,10509.0,9262.0,7509.0,4050.0,6922.0,10268.0,110725.0
Tikamgarh,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,39.0,122.0,283.0,328.0,297.0,274.0,227.0,107.0,71.0,38.0,32.0,63.0,1881.0
Tikamgarh,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,2.0,2.0,9.0,8.0,0.0,0.0,0.0,0.0,21.0
Tikamgarh,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,12500.0,,14000.0,8500.0,12000.0,47000.0
Tikamgarh,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,15000.0,,0.0,10000.0,10000.0,35000.0
Tikamgarh,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,0.0,,0.0,,0.0,0.0
Tikamgarh,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,6500.0,,5500.0,6500.0,5500.0,24000.0
Tikamgarh,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21000.0,0.0,8500.0,12000.0,16500.0,58000.0
Tikamgarh,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,10500.0,,13500.0,7500.0,8000.0,39500.0
Tikamgarh,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,0.0,,0.0,10000.0,17000.0,27000.0
Tikamgarh,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,0.0,,0.0,,0.0,0.0
Tikamgarh,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,0.0,,6000.0,9500.0,11000.0,26500.0
Tikamgarh,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10500.0,0.0,7500.0,8000.0,14000.0,40000.0
Tikamgarh,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,300.0,,800.0,1000.0,0.0,2100.0
Tikamgarh,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,24000.0,,2000.0,0.0,15000.0,41000.0
Tikamgarh,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,0.0,,0.0,,0.0,0.0
Tikamgarh,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,20560.0,,1800.0,1000.0,4000.0,27360.0
Tikamgarh,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3740.0,0.0,1000.0,0.0,11000.0,15740.0
Tikamgarh,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,5000.0,,7500.0,2700.0,12000.0,27200.0
Tikamgarh,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,13000.0,,2000.0,20000.0,20000.0,55000.0
Tikamgarh,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,0.0,,0.0,,0.0,0.0
Tikamgarh,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,11500.0,,6800.0,10700.0,12000.0,41000.0
Tikamgarh,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6500.0,0.0,2700.0,12000.0,20000.0,41200.0
Tikamgarh,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,0.0,0.0,0.0,0.0
Tikamgarh,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,0.0,,0.0,,0.0,0.0
Tikamgarh,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,0.0,0.0,0.0,0.0
Tikamgarh,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,2430.0,,3300.0,5800.0,3200.0,14730.0
Tikamgarh,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,5000.0,,8300.0,7000.0,15000.0,35300.0
Tikamgarh,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,0.0,,0.0,,0.0,0.0
Tikamgarh,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,4000.0,,5800.0,9600.0,6900.0,26300.0
Tikamgarh,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3430.0,0.0,5800.0,3200.0,11300.0,23730.0
Tikamgarh,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,4620.0,,3120.0,1620.0,2000.0,11360.0
Tikamgarh,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,5000.0,,5000.0,5000.0,10000.0,25000.0
Tikamgarh,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,0.0,,0.0,,0.0,0.0
Tikamgarh,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,6250.0,,6500.0,4620.0,7000.0,24370.0
Tikamgarh,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3370.0,0.0,1620.0,2000.0,5000.0,11990.0
Tikamgarh,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,0.0,0.0,0.0,0.0
Tikamgarh,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,0.0,,0.0,,0.0,0.0
Tikamgarh,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,0.0,0.0,0.0,0.0
Tikamgarh,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,13500.0,,14000.0,8500.0,5000.0,41000.0
Tikamgarh,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,5000.0,,0.0,0.0,5000.0,10000.0
Tikamgarh,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,0.0,,0.0,,0.0,0.0
Tikamgarh,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,11000.0,,5500.0,3500.0,4000.0,24000.0
Tikamgarh,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7500.0,0.0,8500.0,5000.0,6000.0,27000.0
Tikamgarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,0.0,,11214.0,11114.0,1514.0,23842.0
Tikamgarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,0.0,,100.0,10514.0,0.0,10614.0
Tikamgarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11114.0,600.0,1514.0,13228.0
Tikamgarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,171980.0,,121980.0,116940.0,116940.0,527840.0
Tikamgarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,50000.0,,5040.0,0.0,10080.0,65120.0
Tikamgarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,121980.0,0.0,116940.0,116940.0,106860.0,462720.0
Tikamgarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,30190.0,,190.0,190.0,190.0,30760.0
Tikamgarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,20000.0,,0.0,0.0,0.0,20000.0
Tikamgarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10190.0,0.0,190.0,190.0,190.0,10760.0
Tikamgarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,9797.0,,5797.0,5792.0,5792.0,27178.0
Tikamgarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,4000.0,,5.0,0.0,1000.0,5005.0
Tikamgarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5797.0,0.0,5792.0,5792.0,4792.0,22173.0
Tikamgarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,16195.0,,11895.0,10195.0,10195.0,48480.0
Tikamgarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,2000.0,,1700.0,0.0,1000.0,4700.0
Tikamgarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14195.0,0.0,10195.0,10195.0,9195.0,43780.0
Tikamgarh,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,5895.0,,24795.0,24755.0,22755.0,78200.0
Tikamgarh,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,28600.0,,0.0,0.0,0.0,28600.0
Tikamgarh,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,1000.0,,3600.0,2000.0,9160.0,15760.0
Tikamgarh,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,33495.0,0.0,21195.0,22755.0,13595.0,91040.0
Tikamgarh,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,17280.0,,44980.0,43930.0,213930.0,320120.0
Tikamgarh,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,0.0,,0.0,200000.0,200000.0,400000.0
Tikamgarh,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,2500.0,,1050.0,30000.0,211500.0,245050.0
Tikamgarh,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14780.0,0.0,43930.0,213930.0,202430.0,475070.0
Tikamgarh,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,0.0,,,,,0.0
Tikamgarh,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,0.0,,,,,0.0
Tikamgarh,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Tikamgarh,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,0.0,,,,,0.0
Tikamgarh,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,845.0,,845.0,850.0,740.0,3280.0
Tikamgarh,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,0.0,,5.0,0.0,0.0,5.0
Tikamgarh,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,0.0,,0.0,110.0,52.0,162.0
Tikamgarh,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,845.0,0.0,850.0,740.0,688.0,3123.0
Tikamgarh,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,0.0,,,,,0.0
Tikamgarh,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,0.0,,,,,0.0
Tikamgarh,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Tikamgarh,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,0.0,,,,,0.0
Tikamgarh,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,0.0,,,,,0.0
Tikamgarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,0.0,,,,,0.0
Tikamgarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Tikamgarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,0.0,,,,,0.0
Tikamgarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tikamgarh,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,3875.0,,97470.0,97320.0,97320.0,295985.0
Tikamgarh,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,120.0,,150.0,0.0,91480.0,91750.0
Tikamgarh,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3755.0,0.0,97320.0,97320.0,5840.0,204235.0
Tikamgarh,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,3664.0,,736.0,736.0,536.0,5672.0
Tikamgarh,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,2928.0,,0.0,200.0,0.0,3128.0
Tikamgarh,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,736.0,0.0,736.0,536.0,536.0,2544.0
Tikamgarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,8260.0,,8060.0,1050.0,4860.0,22230.0
Tikamgarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,0.0,,0.0,0.0,5000.0,5000.0
Tikamgarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,200.0,,1000.0,0.0,2200.0,3400.0
Tikamgarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8060.0,0.0,7060.0,1050.0,7660.0,23830.0
Tikamgarh,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,1750.0,,1450.0,71100.0,71100.0,145400.0
Tikamgarh,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,350.0,,400.0,0.0,70050.0,70800.0
Tikamgarh,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1400.0,0.0,1050.0,71100.0,1050.0,74600.0
Tikamgarh,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,80291.0,,73700.0,,,153991.0
Tikamgarh,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,0.0,,0.0,,,0.0
Tikamgarh,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,0.0,,0.0,,,0.0
Tikamgarh,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,1500.0,,2600.0,,,4100.0
Tikamgarh,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,78791.0,0.0,71100.0,0.0,0.0,149891.0
Tikamgarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,100.0,,5000.0,2300.0,7600.0,15000.0
Tikamgarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,2400.0,,0.0,11600.0,3000.0,17000.0
Tikamgarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,2000.0,,2700.0,6300.0,1700.0,12700.0
Tikamgarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0,0.0,2300.0,7600.0,8900.0,19300.0
Tikamgarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,203000.0,,391000.0,291000.0,240000.0,1125000.0
Tikamgarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,316000.0,,0.0,0.0,0.0,316000.0
Tikamgarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,19000.0,,100000.0,51000.0,77000.0,247000.0
Tikamgarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500000.0,0.0,291000.0,240000.0,163000.0,1194000.0
Tikamgarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,0.0,,3000.0,900.0,4300.0,8200.0
Tikamgarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,4000.0,,0.0,8000.0,6000.0,18000.0
Tikamgarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,0.0,,0.0,0.0,0.0,0.0
Tikamgarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,2000.0,,2100.0,4600.0,8500.0,17200.0
Tikamgarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,0.0,900.0,4300.0,1800.0,9000.0
Tikamgarh,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,4.0,13.0,5.0,17.0,2.0,5.0,,5.0,,,1.0,,52.0
Tikamgarh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,2.0,2.0,4.0,2.0,,2.0,1.0,2.0,4.0,1.0,,,20.0
Tikamgarh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tikamgarh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,2.0,2.0,4.0,2.0,,2.0,1.0,2.0,4.0,1.0,,,20.0
Tikamgarh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,2.0,1.0,,,,3.0,4.0,1.0,,,,13.0
Tikamgarh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tikamgarh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,2.0,1.0,,,,3.0,4.0,1.0,,,,13.0
Tikamgarh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,3.0,6.0,2.0,8.0,4.0,6.0,5.0,9.0,4.0,3.0,1.0,,51.0
Tikamgarh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tikamgarh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,3.0,6.0,2.0,8.0,4.0,6.0,5.0,9.0,4.0,3.0,1.0,,51.0
Tikamgarh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,5.0,8.0,3.0,4.0,3.0,6.0,12.0,5.0,3.0,2.0,3.0,2.0,56.0
Tikamgarh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
Tikamgarh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,5.0,9.0,3.0,4.0,3.0,6.0,12.0,5.0,3.0,2.0,3.0,2.0,57.0
Tikamgarh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,2.0,,1.0,,2.0,3.0,,1.0,,,,9.0
Tikamgarh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,,,,,1.0,1.0,1.0,,,4.0
Tikamgarh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,3.0,,1.0,,2.0,3.0,1.0,2.0,1.0,,,13.0
Tikamgarh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,1.0,1.0,1.0,,1.0,,,,,,,4.0
Tikamgarh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,1.0,,,,,,,,,1.0
Tikamgarh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,1.0,1.0,2.0,,1.0,,,,,,,5.0
Tikamgarh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,1.0,,1.0,,1.0,,,,,,,4.0
Tikamgarh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,1.0,,,1.0,1.0,,,,,1.0,4.0
Tikamgarh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,1.0,1.0,1.0,,2.0,1.0,,,,,1.0,8.0
Tikamgarh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Tikamgarh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tikamgarh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Tikamgarh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,5.0,8.0,9.0,3.0,7.0,6.0,9.0,9.0,2.0,2.0,2.0,,62.0
Tikamgarh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,4.0,3.0,6.0,8.0,6.0,6.0,1.0,8.0,1.0,3.0,2.0,2.0,50.0
Tikamgarh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,9.0,11.0,15.0,11.0,13.0,12.0,10.0,17.0,3.0,5.0,4.0,2.0,112.0
Tikamgarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Tikamgarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Tikamgarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Tikamgarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Tikamgarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Tikamgarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,4.0,,1.0,,,,4.0,3.0,,2.0,1.0,,15.0
Tikamgarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,,,,1.0,,2.0,1.0,2.0,1.0,8.0
Tikamgarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,4.0,,2.0,,,,5.0,3.0,2.0,3.0,3.0,1.0,23.0
Tikamgarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Tikamgarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,2.0,,,2.0,,3.0,,,2.0,1.0,1.0,,11.0
Tikamgarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,3.0,5.0,1.0,3.0,3.0,7.0,1.0,1.0,,,,,24.0
Tikamgarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,5.0,5.0,1.0,5.0,3.0,10.0,1.0,1.0,2.0,1.0,1.0,,35.0
Tikamgarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Tikamgarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,1.0,1.0,,,,,,2.0
Tikamgarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,2.0,,,,,,,,,,,2.0
Tikamgarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,2.0,,,,1.0,2.0,,,,,,5.0
Tikamgarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Tikamgarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,6.0,7.0,4.0,1.0,6.0,1.0,1.0,1.0,,,,28.0
Tikamgarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,8.0,7.0,5.0,3.0,,4.0,1.0,,,,,,28.0
Tikamgarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,9.0,13.0,12.0,7.0,1.0,11.0,2.0,1.0,1.0,,,,57.0
Tikamgarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Tikamgarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Tikamgarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Tikamgarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Tikamgarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,1.0,1.0,,,,,,2.0
Tikamgarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,6.0,1.0,2.0,,1.0,3.0,3.0,3.0,2.0,,,24.0
Tikamgarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,3.0,,11.0,4.0,,1.0,3.0,3.0,5.0,2.0,,,32.0
Tikamgarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,6.0,6.0,12.0,6.0,,3.0,7.0,6.0,8.0,4.0,,,58.0
Tikamgarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Tikamgarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Tikamgarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,1.0,,,1.0,,,,2.0
Tikamgarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,1.0,,,1.0,,,,2.0
Tikamgarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Tikamgarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,1.0,1.0,,2.0
Tikamgarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Tikamgarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,1.0,1.0,,2.0
Tikamgarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Tikamgarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Tikamgarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Tikamgarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Tikamgarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Tikamgarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Tikamgarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Tikamgarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,1.0,,,,,1.0
Tikamgarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Tikamgarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Tikamgarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Tikamgarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Tikamgarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Tikamgarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,1.0,1.0,,1.0,,,,,,,,3.0
Tikamgarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Tikamgarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,1.0,1.0,,1.0,,,,,,,,3.0
Tikamgarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Tikamgarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,4.0,2.0,4.0,,,1.0,,,,,11.0
Tikamgarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Tikamgarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,4.0,2.0,4.0,,,1.0,,,,,11.0
Tikamgarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,,2.0,2.0,2.0,,,,1.0,,,,8.0
Tikamgarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,4.0,5.0,4.0,3.0,8.0,6.0,4.0,6.0,1.0,4.0,1.0,49.0
Tikamgarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,4.0,,,,,,,,1.0,,6.0
Tikamgarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,5.0,4.0,11.0,6.0,5.0,8.0,6.0,4.0,7.0,1.0,5.0,1.0,63.0
Tikamgarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Tikamgarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,3.0,,3.0,3.0,4.0,3.0,,2.0,,,1.0,23.0
Tikamgarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,2.0,,,,,,,2.0
Tikamgarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,3.0,,3.0,3.0,6.0,4.0,,2.0,,,1.0,26.0
Tikamgarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,1.0,1.0,,,,,,,2.0
Tikamgarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,,1.0,2.0,,9.0,2.0,,,,,,15.0
Tikamgarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,,1.0,,,1.0,,,,,,3.0
Tikamgarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,1.0,1.0,3.0,1.0,10.0,3.0,,,,,,20.0
Tikamgarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,1.0,,,1.0,1.0,3.0
Tikamgarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,2.0,2.0,1.0,3.0,4.0,4.0,6.0,3.0,7.0,3.0,6.0,42.0
Tikamgarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,1.0,,,2.0,2.0,1.0,1.0,19.0,6.0,3.0,,35.0
Tikamgarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,3.0,2.0,1.0,5.0,6.0,5.0,8.0,22.0,13.0,7.0,7.0,80.0
Tikamgarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Tikamgarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,4.0,,5.0,2.0,,1.0,4.0,1.0,3.0,1.0,,1.0,22.0
Tikamgarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,1.0,1.0,2.0,2.0,,5.0,1.0,1.0,2.0,15.0
Tikamgarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,4.0,,5.0,3.0,2.0,3.0,6.0,1.0,8.0,2.0,1.0,3.0,38.0
Tikamgarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,1.0,,,,1.0,,,,,2.0
Tikamgarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,3.0,2.0,7.0,19.0,4.0,5.0,15.0,14.0,12.0,11.0,7.0,8.0,107.0
Tikamgarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,17.0,16.0,31.0,30.0,24.0,27.0,49.0,42.0,18.0,38.0,39.0,30.0,361.0
Tikamgarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,20.0,18.0,38.0,50.0,28.0,32.0,64.0,57.0,30.0,49.0,46.0,38.0,470.0
Ujjain,1.1,Total number of pregnant women Registered for ANC,TOTAL,3616.0,4168.0,5368.0,5146.0,4231.0,5101.0,4216.0,4529.0,4534.0,4304.0,4484.0,5087.0,54784.0
Ujjain,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1889.0,2280.0,3077.0,3041.0,2998.0,3353.0,2580.0,2756.0,2755.0,2733.0,2702.0,2819.0,32983.0
Ujjain,1.2,Number of Pregnant women registered under JSY,TOTAL,3538.0,4045.0,5229.0,5142.0,4052.0,4954.0,3930.0,4383.0,4399.0,4302.0,4483.0,4900.0,53357.0
Ujjain,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2293.0,2653.0,3594.0,3208.0,3201.0,3405.0,3070.0,3040.0,3239.0,3440.0,3287.0,3877.0,38307.0
Ujjain,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1878.0,2243.0,2505.0,2395.0,2068.0,2351.0,1894.0,2092.0,2277.0,2218.0,2322.0,2414.0,26657.0
Ujjain,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2056.0,2672.0,2929.0,2750.0,1925.0,2440.0,2070.0,2760.0,2906.0,2786.0,3036.0,3298.0,31628.0
Ujjain,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3501.0,4501.0,5387.0,5045.0,4393.0,5155.0,4220.0,4724.0,4870.0,4491.0,4693.0,5207.0,56187.0
Ujjain,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,334.0,273.0,212.0,197.0,382.0,111.0,286.0,162.0,436.0,328.0,669.0,420.0,3810.0
Ujjain,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,14.0,23.0,8.0,12.0,16.0,19.0,16.0,19.0,24.0,11.0,18.0,5.0,185.0
Ujjain,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1192.0,2104.0,2405.0,2405.0,1730.0,2185.0,1645.0,2021.0,2309.0,1902.0,2143.0,2691.0,24732.0
Ujjain,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,39.0,104.0,91.0,170.0,61.0,121.0,32.0,39.0,59.0,46.0,39.0,40.0,841.0
Ujjain,1.8,Number of pregnancy test kits used at SC level,TOTAL,114.0,172.0,288.0,284.0,256.0,249.0,230.0,304.0,425.0,348.0,864.0,618.0,4152.0
Ujjain,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,9.0,8.0,8.0,18.0,21.0,27.0,41.0,28.0,29.0,14.0,4.0,0.0,207.0
Ujjain,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,36.0,50.0,58.0,47.0,40.0,45.0,55.0,65.0,44.0,46.0,31.0,30.0,547.0
Ujjain,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,45.0,58.0,66.0,65.0,61.0,72.0,96.0,93.0,73.0,60.0,35.0,30.0,754.0
Ujjain,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,25.0,36.0,34.0,40.0,39.0,45.0,64.0,41.0,37.0,38.0,21.0,12.0,432.0
Ujjain,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,4.0,20.0,25.0
Ujjain,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1587.0,1863.0,2197.0,2347.0,2523.0,2641.0,2413.0,2597.0,2369.0,2248.0,2068.0,2676.0,27529.0
Ujjain,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,99.0,30.0,76.0,0.0,38.0,63.0,112.0,64.0,38.0,76.0,120.0,83.0,799.0
Ujjain,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,809.0,1170.0,1513.0,1279.0,1720.0,2215.0,1846.0,1978.0,2353.0,2210.0,1804.0,2257.0,21154.0
Ujjain,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,303.0,334.0,470.0,306.0,484.0,816.0,889.0,640.0,1046.0,1087.0,1004.0,840.0,8219.0
Ujjain,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,109.0,135.0,121.0,147.0,126.0,204.0,136.0,148.0,155.0,168.0,74.0,119.0,1642.0
Ujjain,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Ujjain,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Ujjain,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Ujjain,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,128.0,189.0,168.0,202.0,186.0,196.0,181.0,166.0,185.0,217.0,224.0,261.0,2303.0
Ujjain,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ujjain,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,128.0,189.0,168.0,202.0,186.0,196.0,181.0,166.0,185.0,217.0,224.0,261.0,2303.0
Ujjain,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,43.0,50.0,55.0,75.0,46.0,93.0,73.0,75.0,74.0,66.0,36.0,47.0,733.0
Ujjain,4.1.1.a,Number of male live births,TOTAL,878.0,1032.0,1212.0,1294.0,1383.0,1488.0,1317.0,1450.0,1289.0,1242.0,1104.0,1414.0,15103.0
Ujjain,4.1.1.b,Number of female live births,TOTAL,844.0,995.0,1131.0,1233.0,1281.0,1394.0,1296.0,1348.0,1280.0,1203.0,1052.0,1374.0,14431.0
Ujjain,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1722.0,2027.0,2343.0,2527.0,2664.0,2882.0,2613.0,2798.0,2569.0,2445.0,2156.0,2788.0,29534.0
Ujjain,4.1.2,Number of still births,TOTAL,28.0,34.0,50.0,45.0,59.0,48.0,43.0,58.0,39.0,36.0,29.0,48.0,517.0
Ujjain,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,75.0,97.0,78.0,66.0,42.0,55.0,69.0,65.0,75.0,113.0,135.0,130.0,1000.0
Ujjain,4.2.1,Number of Newborns weighed at birth,TOTAL,1718.0,2023.0,2342.0,2526.0,2667.0,2879.0,2610.0,2795.0,2568.0,2445.0,2154.0,2789.0,29516.0
Ujjain,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,450.0,630.0,715.0,807.0,883.0,934.0,834.0,919.0,802.0,767.0,732.0,998.0,9471.0
Ujjain,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1577.0,1848.0,2134.0,2345.0,2464.0,2662.0,2428.0,2630.0,2415.0,2262.0,2133.0,2661.0,27559.0
Ujjain,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Ujjain,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,1.0,1.0,0.0,1.0,0.0,2.0,6.0,4.0,11.0,18.0,14.0,58.0
Ujjain,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,63.0,101.0,114.0,136.0,112.0,135.0,138.0,203.0,158.0,183.0,136.0,244.0,1723.0
Ujjain,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ujjain,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,63.0,102.0,115.0,137.0,113.0,135.0,140.0,209.0,162.0,194.0,154.0,258.0,1782.0
Ujjain,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,58.0,39.0,35.0,118.0,59.0,49.0,40.0,60.0,37.0,52.0,32.0,20.0,599.0
Ujjain,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,63.0,118.0,127.0,399.0,162.0,148.0,153.0,249.0,183.0,211.0,163.0,247.0,2223.0
Ujjain,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,11.0,13.0,8.0,12.0,12.0,14.0,17.0,26.0,23.0,14.0,12.0,9.0,171.0
Ujjain,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,56.0,81.0,84.0,320.0,132.0,137.0,133.0,194.0,137.0,161.0,121.0,137.0,1693.0
Ujjain,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,84.0,55.0,46.0,108.0,50.0,22.0,55.0,50.0,56.0,88.0,51.0,76.0,741.0
Ujjain,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1720.0,2035.0,2354.0,2426.0,2692.0,2880.0,2599.0,2791.0,2565.0,2459.0,2199.0,2710.0,29430.0
Ujjain,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,988.0,978.0,1096.0,874.0,1167.0,1284.0,1326.0,1367.0,1632.0,1649.0,1425.0,1608.0,15394.0
Ujjain,6.3,PNC maternal complications attended,TOTAL,70.0,76.0,102.0,108.0,90.0,115.0,99.0,105.0,53.0,89.0,44.0,98.0,1049.0
Ujjain,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,65.0,78.0,64.0,68.0,62.0,72.0,51.0,74.0,64.0,64.0,84.0,92.0,838.0
Ujjain,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,3.0,0.0,0.0,2.0,5.0,5.0,0.0,3.0,2.0,2.0,22.0
Ujjain,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,65.0,78.0,67.0,68.0,62.0,74.0,56.0,79.0,64.0,67.0,86.0,94.0,860.0
Ujjain,7.2,Number of MTPs conducted at Private Facilities,TOTAL,22.0,5.0,25.0,21.0,20.0,10.0,15.0,19.0,32.0,30.0,38.0,41.0,278.0
Ujjain,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,31.0,163.0,69.0,59.0,56.0,83.0,49.0,44.0,101.0,57.0,197.0,72.0,981.0
Ujjain,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,173.0,492.0,416.0,481.0,430.0,545.0,457.0,585.0,594.0,330.0,612.0,543.0,5658.0
Ujjain,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,204.0,655.0,485.0,540.0,486.0,628.0,506.0,629.0,695.0,387.0,809.0,615.0,6639.0
Ujjain,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Ujjain,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,2.0,1.0,2.0,0.0,2.0,0.0,1.0,6.0,0.0,4.0,2.0,20.0
Ujjain,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,11.0,0.0,22.0
Ujjain,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,3.0,7.0,5.0,14.0,15.0,13.0,3.0,4.0,11.0,12.0,14.0,4.0,105.0
Ujjain,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ujjain,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,4.0,10.0,7.0,17.0,16.0,16.0,4.0,6.0,18.0,14.0,29.0,6.0,147.0
Ujjain,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Ujjain,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,113.0,88.0,165.0,319.0,300.0,241.0,176.0,304.0,382.0,178.0,387.0,102.0,2755.0
Ujjain,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,95.0,82.0,134.0,76.0,159.0,100.0,71.0,239.0,234.0,170.0,206.0,122.0,1688.0
Ujjain,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,32.0,57.0,152.0,153.0,152.0,195.0,35.0,194.0,312.0,195.0,260.0,114.0,1851.0
Ujjain,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ujjain,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,240.0,227.0,451.0,548.0,611.0,536.0,282.0,737.0,928.0,543.0,853.0,338.0,6294.0
Ujjain,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,2.0,0.0,0.0,2.0,1.0,0.0,1.0,2.0,51.0,49.0,65.0,1.0,174.0
Ujjain,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,16.0,17.0,22.0,33.0,12.0,16.0,10.0,6.0,33.0,2.0,59.0,14.0,240.0
Ujjain,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,25.0,40.0,77.0,60.0,62.0,55.0,34.0,57.0,55.0,69.0,58.0,38.0,630.0
Ujjain,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,144.0,101.0,188.0,227.0,171.0,92.0,91.0,94.0,185.0,246.0,164.0,73.0,1776.0
Ujjain,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ujjain,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,185.0,158.0,287.0,320.0,245.0,163.0,135.0,157.0,273.0,317.0,281.0,125.0,2646.0
Ujjain,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,2.0,5.0,2.0,7.0,4.0,3.0,6.0,4.0,34.0,38.0,11.0,4.0,120.0
Ujjain,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,5.0
Ujjain,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,13.0,0.0,0.0,0.0,0.0,18.0,26.0,2.0,0.0,0.0,0.0,0.0,59.0
Ujjain,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,57.0,81.0,96.0,106.0,86.0,109.0,80.0,188.0,78.0,141.0,147.0,135.0,1304.0
Ujjain,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ujjain,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,70.0,83.0,96.0,106.0,86.0,127.0,106.0,190.0,78.0,141.0,150.0,135.0,1368.0
Ujjain,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,4.0,4.0,2.0,4.0,3.0,2.0,6.0,4.0,5.0,1.0,9.0,2.0,46.0
Ujjain,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,359.0,479.0,519.0,614.0,509.0,535.0,406.0,511.0,498.0,480.0,414.0,346.0,5670.0
Ujjain,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,11.0,16.0,24.0,22.0,19.0,27.0,10.0,21.0,13.0,18.0,10.0,13.0,204.0
Ujjain,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,335.0,17.0,14.0,6.0,30.0,20.0,25.0,13.0,20.0,22.0,31.0,32.0,565.0
Ujjain,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,173.0,219.0,161.0,217.0,168.0,129.0,72.0,152.0,114.0,152.0,238.0,340.0,2135.0
Ujjain,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ujjain,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,878.0,731.0,718.0,859.0,726.0,711.0,513.0,697.0,645.0,672.0,693.0,731.0,8574.0
Ujjain,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,76.0,58.0,6.0,31.0,27.0,37.0,72.0,25.0,21.0,104.0,113.0,185.0,755.0
Ujjain,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,26.0,14.0,2.0,30.0,7.0,9.0,0.0,6.0,3.0,88.0,5.0,3.0,193.0
Ujjain,9.06,Number of IUCD removals,TOTAL,225.0,370.0,212.0,273.0,159.0,202.0,169.0,221.0,261.0,216.0,250.0,668.0,3226.0
Ujjain,9.07,Number of Oral Pills cycles distributed,TOTAL,5396.0,3885.0,3808.0,5295.0,5107.0,6396.0,5599.0,5978.0,5576.0,5323.0,5991.0,4889.0,63243.0
Ujjain,9.08,Number of Condom pieces distributed,TOTAL,29677.0,18942.0,23790.0,31770.0,24957.0,35339.0,30253.0,32260.0,25453.0,23744.0,26815.0,20076.0,323076.0
Ujjain,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Ujjain,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,0.0,7.0
Ujjain,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,9.11.2.b,Number of failures following female sterilization,TOTAL,2.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,1.0,0.0,3.0,9.0
Ujjain,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,9.12,Number of Institutions having NSV trained doctors,TOTAL,3.0,2.0,1.0,4.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Ujjain,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2056.0,2363.0,2761.0,2867.0,2923.0,3043.0,2887.0,3059.0,2720.0,2509.0,2488.0,2858.0,32534.0
Ujjain,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2402.0,2820.0,3056.0,2995.0,2624.0,2811.0,2765.0,753.0,52.0,25.0,32.0,0.0,20335.0
Ujjain,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2590.0,2889.0,3088.0,3187.0,2758.0,2796.0,2672.0,2938.0,1104.0,317.0,125.0,25.0,24489.0
Ujjain,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2755.0,3093.0,3164.0,3171.0,2787.0,2810.0,2668.0,2960.0,2788.0,1134.0,427.0,134.0,27891.0
Ujjain,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2126.0,2599.0,2705.0,2913.0,3345.0,13688.0
Ujjain,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1764.0,2347.0,2770.0,3368.0,10249.0
Ujjain,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1735.0,2328.0,3310.0,7373.0
Ujjain,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1827.0,2096.0,2701.0,2698.0,2739.0,2934.0,2602.0,2919.0,2533.0,2345.0,2274.0,2740.0,30408.0
Ujjain,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2404.0,2823.0,3055.0,3016.0,2624.0,2811.0,2746.0,2718.0,2557.0,2213.0,2899.0,3242.0,33108.0
Ujjain,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2583.0,2890.0,3089.0,3195.0,2756.0,2796.0,2662.0,2919.0,2685.0,2299.0,2869.0,3372.0,34115.0
Ujjain,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2755.0,3075.0,3163.0,3171.0,2786.0,2805.0,2665.0,2962.0,2815.0,2492.0,2586.0,3370.0,34645.0
Ujjain,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1734.0,2018.0,2463.0,2624.0,2686.0,2808.0,2443.0,2690.0,2288.0,2161.0,1799.0,2496.0,28210.0
Ujjain,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2369.0,2809.0,3064.0,3021.0,2624.0,2811.0,2746.0,749.0,53.0,48.0,223.0,0.0,20517.0
Ujjain,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2548.0,2890.0,3088.0,3177.0,2753.0,2823.0,2661.0,2908.0,1113.0,342.0,110.0,24.0,24437.0
Ujjain,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2743.0,3090.0,3171.0,3176.0,2770.0,2819.0,2652.0,2956.0,2776.0,1138.0,345.0,124.0,27760.0
Ujjain,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2317.0,2811.0,3301.0,3384.0,2423.0,2663.0,2469.0,2782.0,2567.0,2937.0,2591.0,3255.0,33500.0
Ujjain,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1521.0,1736.0,2154.0,2380.0,1532.0,1862.0,1471.0,1975.0,1869.0,2330.0,2415.0,2895.0,24140.0
Ujjain,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1165.0,1405.0,1636.0,1684.0,1254.0,1368.0,1290.0,1433.0,1293.0,1513.0,1352.0,1654.0,17047.0
Ujjain,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1048.0,1294.0,1550.0,1585.0,1143.0,1265.0,1169.0,1341.0,1243.0,1421.0,1211.0,1534.0,15804.0
Ujjain,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2213.0,2699.0,3186.0,3269.0,2397.0,2633.0,2459.0,2774.0,2536.0,2934.0,2563.0,3188.0,32851.0
Ujjain,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2350.0,2723.0,3057.0,3351.0,2488.0,2495.0,2410.0,2588.0,2550.0,2887.0,2896.0,3371.0,33166.0
Ujjain,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2345.0,2723.0,3052.0,3351.0,2488.0,2489.0,2410.0,2588.0,2545.0,2893.0,2897.0,3371.0,33152.0
Ujjain,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,246.0,218.0,186.0,248.0,157.0,173.0,119.0,293.0,132.0,296.0,435.0,334.0,2837.0
Ujjain,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,235.0,202.0,189.0,222.0,137.0,170.0,122.0,286.0,118.0,292.0,466.0,329.0,2768.0
Ujjain,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,481.0,420.0,375.0,470.0,294.0,343.0,241.0,579.0,250.0,588.0,901.0,663.0,5605.0
Ujjain,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1646.0,2067.0,2426.0,2827.0,2097.0,2371.0,2051.0,2217.0,2316.0,2444.0,2371.0,3050.0,27883.0
Ujjain,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1580.0,1949.0,2350.0,2453.0,2084.0,2468.0,2128.0,2549.0,2265.0,2050.0,2241.0,2910.0,27027.0
Ujjain,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1684.0,1961.0,2293.0,2508.0,2184.0,2399.0,1994.0,2324.0,2256.0,2015.0,2185.0,3309.0,27112.0
Ujjain,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,3.0,6.0,2.0,5.0,6.0,6.0,13.0,22.0,17.0,1.0,4.0,87.0
Ujjain,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,0.0,3.0
Ujjain,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,4.0,16.0,11.0,7.0,11.0,10.0,1.0,20.0,30.0,24.0,21.0,29.0,184.0
Ujjain,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1650.0,1849.0,1776.0,1900.0,1762.0,1802.0,1727.0,1759.0,1732.0,1798.0,1830.0,1902.0,21487.0
Ujjain,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1494.0,1792.0,1758.0,1894.0,1710.0,1745.0,1662.0,1686.0,1706.0,1783.0,1805.0,1896.0,20931.0
Ujjain,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,986.0,1156.0,1204.0,1232.0,1162.0,1174.0,1124.0,1160.0,1213.0,1247.0,1240.0,1302.0,14200.0
Ujjain,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2378.0,2827.0,3290.0,4027.0,2499.0,2632.0,2337.0,2730.0,3917.0,3114.0,2573.0,3187.0,35511.0
Ujjain,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1217.0,950.0,928.0,8182.0,3269.0,1085.0,611.0,1272.0,1198.0,8512.0,1695.0,1313.0,30232.0
Ujjain,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,829.0,594.0,717.0,13016.0,3373.0,868.0,688.0,672.0,754.0,8691.0,1525.0,1033.0,32760.0
Ujjain,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,1.0,2.0,4.0,4.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,3.0,17.0
Ujjain,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,562.0,810.0,1062.0,720.0,403.0,996.0,419.0,403.0,326.0,336.0,421.0,557.0,7015.0
Ujjain,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,11.0,7.0,2.0,0.0,1.0,1.0,0.0,2.0,6.0,4.0,2.0,1.0,37.0
Ujjain,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,95.0,172.0,53.0,35.0,56.0,129.0,196.0,111.0,86.0,66.0,131.0,201.0,1331.0
Ujjain,13.1,Number of Patients operated for cataract,TOTAL,185.0,269.0,283.0,391.0,97.0,464.0,425.0,669.0,724.0,705.0,656.0,760.0,5628.0
Ujjain,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,123.0,265.0,283.0,391.0,97.0,464.0,425.0,666.0,724.0,702.0,652.0,758.0,5550.0
Ujjain,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,3.0,189.0,435.0,923.0,236.0,974.0,2763.0
Ujjain,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,74.0,0.0,0.0,974.0,1048.0
Ujjain,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,5.0,7.0,10.0,4.0,6.0,4.0,4.0,4.0,2.0,3.0,3.0,-1.0
Ujjain,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,10.0,1.0,3.0,3.0,1.0,2.0,2.0,2.0,1.0,,1.0,1.0,-1.0
Ujjain,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,786.0,1067.0,965.0,969.0,1028.0,1201.0,983.0,1081.0,1186.0,1113.0,1129.0,1134.0,-1.0
Ujjain,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,9.0,10.0,9.0,11.0,9.0,11.0,11.0,11.0,11.0,11.0,11.0,-1.0
Ujjain,14.05,Number of RKS meetings held during the month,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0,2.0,2.0,2.0,11.0
Ujjain,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,19.0,12.0,17.0,16.0,18.0,15.0,16.0,18.0,20.0,18.0,18.0,17.0,-1.0
Ujjain,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,10.0,10.0,73.0,34.0,21.0,10.0,34.0,28.0,30.0,36.0,18.0,21.0,325.0
Ujjain,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,4.0,5.0,8.0,4.0,4.0,2.0,3.0,4.0,4.0,3.0,4.0,-1.0
Ujjain,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,2.0,5.0,5.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Ujjain,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,952.0,1584.0,1371.0,978.0,888.0,1091.0,1042.0,773.0,1256.0,559.0,312.0,730.0,11536.0
Ujjain,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2748.0,4415.0,4315.0,3558.0,3169.0,3786.0,3651.0,3036.0,2849.0,2268.0,3072.0,2639.0,39506.0
Ujjain,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,703.0,1354.0,912.0,696.0,661.0,1011.0,764.0,549.0,1199.0,436.0,328.0,564.0,9177.0
Ujjain,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4229.0,5645.0,7059.0,5754.0,5613.0,6589.0,4366.0,6249.0,6161.0,5455.0,6258.0,6088.0,69466.0
Ujjain,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1655.0,2938.0,2283.0,1674.0,1549.0,2102.0,1806.0,1322.0,2455.0,995.0,640.0,1294.0,20713.0
Ujjain,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6977.0,10060.0,11374.0,9312.0,8782.0,10375.0,8017.0,9285.0,9010.0,7723.0,9330.0,8727.0,108972.0
Ujjain,14.10.2.a,Number of death cases of Inpatient males,TOTAL,50.0,42.0,31.0,29.0,83.0,44.0,51.0,40.0,55.0,55.0,43.0,43.0,566.0
Ujjain,14.10.2.b,Number of death cases of Inpatient females,TOTAL,21.0,33.0,24.0,22.0,40.0,46.0,52.0,36.0,59.0,37.0,32.0,17.0,419.0
Ujjain,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,71.0,75.0,55.0,51.0,123.0,90.0,103.0,76.0,114.0,92.0,75.0,60.0,985.0
Ujjain,14.11,In-Patient Head Count at midnight,TOTAL,5756.0,9540.0,10879.0,8825.0,7983.0,10017.0,7901.0,7867.0,6513.0,6662.0,7171.0,6427.0,95541.0
Ujjain,14.12.1,OPD attendance (All),TOTAL,68766.0,91855.0,93282.0,90266.0,100698.0,113443.0,89338.0,96875.0,97408.0,84216.0,110777.0,120053.0,1156977.0
Ujjain,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,882.0,1053.0,643.0,1095.0,640.0,1130.0,774.0,565.0,943.0,1433.0,760.0,875.0,10793.0
Ujjain,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,28.0,62.0,25.0,60.0,30.0,42.0,9.0,78.0,56.0,52.0,48.0,41.0,531.0
Ujjain,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,888.0,897.0,693.0,981.0,614.0,1232.0,698.0,798.0,898.0,1228.0,1171.0,925.0,11023.0
Ujjain,14.14.a,Number of patients given AYUSH treatment,TOTAL,946.0,2075.0,1151.0,1335.0,2597.0,2327.0,905.0,1374.0,1751.0,812.0,1622.0,1197.0,18092.0
Ujjain,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1382.0,1194.0,554.0,470.0,1131.0,520.0,768.0,807.0,953.0,2268.0,1251.0,909.0,12207.0
Ujjain,14.14.c,Number of Adolescents counselled,TOTAL,114.0,155.0,265.0,285.0,250.0,343.0,329.0,430.0,906.0,554.0,486.0,633.0,4750.0
Ujjain,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7069.0,10492.0,8246.0,10567.0,10375.0,11797.0,11348.0,13186.0,11618.0,9928.0,10393.0,9340.0,124359.0
Ujjain,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,264.0,362.0,190.0,897.0,975.0,590.0,679.0,448.0,375.0,320.0,240.0,195.0,5535.0
Ujjain,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1254.0,1614.0,1390.0,2521.0,1712.0,1903.0,1831.0,1147.0,1996.0,616.0,1241.0,1476.0,18701.0
Ujjain,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,6.0,14.0,4.0,16.0,6.0,3.0,7.0,3.0,7.0,1.0,20.0,5.0,92.0
Ujjain,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,425.0,870.0,859.0,1005.0,570.0,858.0,595.0,783.0,1019.0,853.0,973.0,793.0,9603.0
Ujjain,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,4.0,4.0,2.0,1.0,1.0,3.0,2.0,4.0,1.0,3.0,0.0,27.0
Ujjain,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1034.0,2134.0,2169.0,2554.0,1990.0,2712.0,1808.0,2840.0,2827.0,2747.0,2183.0,1914.0,26912.0
Ujjain,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,1.0,27.0,0.0,0.0,1.0,0.0,4.0,2.0,22.0,2.0,59.0
Ujjain,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2713.0,4618.0,4418.0,6080.0,4272.0,5473.0,4234.0,4770.0,5842.0,4216.0,4397.0,4183.0,55216.0
Ujjain,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,8.0,18.0,9.0,45.0,7.0,4.0,11.0,5.0,15.0,4.0,45.0,7.0,178.0
Ujjain,15.2,Number of Widal tests conducted,Number tested,457.0,587.0,473.0,1141.0,967.0,1151.0,1507.0,881.0,569.0,451.0,1034.0,920.0,10138.0
Ujjain,15.3.a,Number of VDRL tests conducted on males,Number tested,326.0,864.0,1037.0,1480.0,779.0,938.0,1120.0,779.0,1120.0,300.0,781.0,992.0,10516.0
Ujjain,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,162.0,94.0,157.0,166.0,88.0,143.0,314.0,146.0,444.0,337.0,167.0,251.0,2469.0
Ujjain,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,834.0,1009.0,1106.0,848.0,1220.0,1175.0,1012.0,1182.0,1605.0,1106.0,1321.0,845.0,13263.0
Ujjain,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1322.0,1967.0,2300.0,2494.0,2087.0,2256.0,2446.0,2107.0,3169.0,1743.0,2269.0,2088.0,26248.0
Ujjain,15.4.1,Number of blood smears examined for Malaria,TOTAL,3343.0,4113.0,2993.0,5510.0,5956.0,10424.0,8031.0,5331.0,6043.0,4236.0,5615.0,6669.0,68264.0
Ujjain,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,11.0,11.0,19.0,20.0,33.0,49.0,47.0,8.0,16.0,5.0,2.0,4.0,225.0
Ujjain,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,3.0,1.0,2.0,0.0,1.0,7.0,4.0,5.0,6.0,0.0,0.0,31.0
Ujjain,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,12940.0,11700.0,10900.0,22500.0,29700.0,27500.0,33550.0,22520.0,24220.0,17600.0,20400.0,20100.0,253630.0
Ujjain,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,30000.0,25000.0,20000.0,15000.0,20000.0,0.0,10000.0,0.0,20000.0,19900.0,0.0,169900.0
Ujjain,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,11240.0,30800.0,13400.0,12800.0,17200.0,13950.0,11030.0,8300.0,6620.0,17200.0,20200.0,2150.0,164890.0
Ujjain,16.1.1,Stock position of DPT vaccines,5. Total Stock,11700.0,10900.0,22500.0,29700.0,27500.0,33550.0,22520.0,24220.0,17600.0,20400.0,20100.0,17950.0,258640.0
Ujjain,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,0.0,21710.0,19010.0,11940.0,13840.0,10550.0,77050.0
Ujjain,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,28500.0,0.0,0.0,10000.0,10000.0,10000.0,58500.0
Ujjain,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,6790.0,2700.0,7070.0,8100.0,13290.0,6680.0,44630.0
Ujjain,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,21710.0,19010.0,11940.0,13840.0,10550.0,13870.0,90920.0
Ujjain,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,13420.0,8220.0,25520.0,30820.0,26620.0,15900.0,20800.0,8100.0,5860.0,14160.0,3160.0,60.0,172640.0
Ujjain,16.1.2,Stock position of OPV vaccines,2. Stocks Received,15000.0,50000.0,30000.0,20000.0,20000.0,25000.0,20000.0,10000.0,40000.0,25000.0,10000.0,20000.0,285000.0
Ujjain,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,20200.0,32700.0,24700.0,24200.0,30720.0,20100.0,32700.0,12240.0,31700.0,36000.0,13100.0,100.0,278460.0
Ujjain,16.1.2,Stock position of OPV vaccines,5. Total Stock,8220.0,25520.0,30820.0,26620.0,15900.0,20800.0,8100.0,5860.0,14160.0,3160.0,60.0,19960.0,179180.0
Ujjain,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,10220.0,14870.0,11330.0,25830.0,24030.0,16430.0,24130.0,15330.0,19830.0,13380.0,10180.0,8930.0,194490.0
Ujjain,16.1.3,Stock position of TT vaccines,2. Stocks Received,15000.0,21500.0,25000.0,10000.0,10000.0,15000.0,5000.0,10000.0,0.0,15000.0,10000.0,10000.0,146500.0
Ujjain,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.1.3,Stock position of TT vaccines,4. Stock Distributed,10350.0,25040.0,10500.0,11800.0,17600.0,7300.0,13800.0,5500.0,6450.0,18200.0,11250.0,3200.0,140990.0
Ujjain,16.1.3,Stock position of TT vaccines,5. Total Stock,14870.0,11330.0,25830.0,24030.0,16430.0,24130.0,15330.0,19830.0,13380.0,10180.0,8930.0,15730.0,200000.0
Ujjain,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Ujjain,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Ujjain,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ujjain,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Ujjain,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,8440.0,13030.0,3830.0,8000.0,12900.0,11300.0,16700.0,7700.0,12170.0,2670.0,2800.0,2200.0,101740.0
Ujjain,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,5000.0,10000.0,10000.0,100000.0,10000.0,0.0,10000.0,0.0,10000.0,10000.0,10000.0,185000.0
Ujjain,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,5410.0,14200.0,5830.0,5100.0,101600.0,4600.0,9000.0,5530.0,9500.0,9870.0,10600.0,3200.0,184440.0
Ujjain,16.1.5,Stock position of BCG vaccines,5. Total Stock,13030.0,3830.0,8000.0,12900.0,11300.0,16700.0,7700.0,12170.0,2670.0,2800.0,2200.0,9000.0,102300.0
Ujjain,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,10500.0,10975.0,2400.0,5150.0,1705.0,780.0,1430.0,2550.0,800.0,3350.0,2450.0,2225.0,44315.0
Ujjain,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,8000.0,10000.0,3000.0,5000.0,6000.0,11000.0,5000.0,12450.0,10050.0,10000.0,14000.0,104500.0
Ujjain,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,9525.0,16575.0,7250.0,6445.0,5925.0,5350.0,9880.0,6750.0,9900.0,10950.0,10225.0,11725.0,110500.0
Ujjain,16.1.6,Stock position of Measles vaccines,5. Total Stock,10975.0,2400.0,5150.0,1705.0,780.0,1430.0,2550.0,800.0,3350.0,2450.0,2225.0,4500.0,38315.0
Ujjain,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Ujjain,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Ujjain,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ujjain,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Ujjain,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2700.0,11850.0,11150.0,20550.0,27050.0,19350.0,30800.0,16360.0,19800.0,10500.0,15300.0,17200.0,202610.0
Ujjain,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,20000.0,30000.0,20000.0,16400.0,10000.0,20000.0,0.0,10000.0,0.0,20000.0,14300.0,0.0,160700.0
Ujjain,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,10850.0,30700.0,10600.0,9900.0,17700.0,8550.0,14440.0,6560.0,9300.0,15200.0,12400.0,1700.0,147900.0
Ujjain,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,11850.0,11150.0,20550.0,27050.0,19350.0,30800.0,16360.0,19800.0,10500.0,15300.0,17200.0,15500.0,215410.0
Ujjain,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,4314.0,2014.0,5014.0,,2914.0,,,,,,,,14256.0
Ujjain,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,3000.0,0.0,,0.0,,,,,,,,3000.0
Ujjain,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,0.0,,,,,,,,0.0
Ujjain,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,2300.0,0.0,2100.0,,900.0,,,,,,,,5300.0
Ujjain,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2014.0,5014.0,2914.0,0.0,2014.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11956.0
Ujjain,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,16520.0,0.0,40320.0,,5040.0,,,,,,,,61880.0
Ujjain,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,50400.0,0.0,,0.0,,,,,,,,50400.0
Ujjain,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,0.0,,,,,,,,0.0
Ujjain,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,16520.0,10080.0,35280.0,,5040.0,,,,,,,,66920.0
Ujjain,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,40320.0,5040.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,45360.0
Ujjain,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,0.0,0.0,,27000.0,,,,,,,,27000.0
Ujjain,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,30000.0,,0.0,,,,,,,,30000.0
Ujjain,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,,0.0,,,,,,,,0.0
Ujjain,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,3000.0,,20400.0,,,,,,,,23400.0
Ujjain,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,27000.0,0.0,6600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,33600.0
Ujjain,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,3960.0,1020.0,2220.0,,1320.0,,,,,,,,8520.0
Ujjain,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,1200.0,0.0,,0.0,,,,,,,,1200.0
Ujjain,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,0.0,,,,,,,,0.0
Ujjain,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,2940.0,0.0,900.0,,0.0,,,,,,,,3840.0
Ujjain,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1020.0,2220.0,1320.0,0.0,1320.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5880.0
Ujjain,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,4395.0,4195.0,2895.0,2695.0,2195.0,16375.0
Ujjain,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,200.0,1300.0,200.0,500.0,100.0,2300.0
Ujjain,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4195.0,2895.0,2695.0,2195.0,2095.0,14075.0
Ujjain,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,20860.0,18660.0,13660.0,10240.0,8880.0,72300.0
Ujjain,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,2200.0,5000.0,3420.0,1360.0,5710.0,17690.0
Ujjain,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18660.0,13660.0,10240.0,8880.0,3170.0,54610.0
Ujjain,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,300.0,1125.0,10000.0,1025.0,575.0,13025.0
Ujjain,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,1500.0,10000.0,0.0,0.0,8000.0,19500.0
Ujjain,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,675.0,1125.0,8975.0,450.0,1000.0,12225.0
Ujjain,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1125.0,10000.0,1025.0,575.0,7575.0,20300.0
Ujjain,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,22.0,22.0,22.0,22.0,22.0,110.0
Ujjain,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,22.0,22.0,22.0,22.0,22.0,110.0
Ujjain,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,15000.0,23800.0,20800.0,12400.0,18600.0,90600.0
Ujjain,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,10000.0,0.0,0.0,7700.0,0.0,17700.0
Ujjain,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,1200.0,11400.0,8400.0,1500.0,4100.0,26600.0
Ujjain,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23800.0,12400.0,12400.0,18600.0,14500.0,81700.0
Ujjain,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Ujjain,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Ujjain,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Ujjain,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Ujjain,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,1.0,,,0.0,30.0,31.0
Ujjain,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,0.0,,,30.0,0.0,30.0
Ujjain,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,0.0,,,,0.0,0.0
Ujjain,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,1.0,,,0.0,11.0,12.0
Ujjain,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30.0,19.0,49.0
Ujjain,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,3778960.0,4546560.0,7860200.0,11999200.0,11710600.0,39895520.0
Ujjain,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,2500000.0,7000000.0,5000000.0,0.0,1000000.0,15500000.0
Ujjain,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,1732400.0,3686360.0,861000.0,288600.0,512500.0,7080860.0
Ujjain,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4546560.0,7860200.0,11999200.0,11710600.0,12198100.0,48314660.0
Ujjain,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,37518.0,32350.0,3034.0,520.0,520.0,73942.0
Ujjain,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,5168.0,29316.0,2514.0,0.0,380.0,37378.0
Ujjain,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,32350.0,3034.0,520.0,520.0,140.0,36564.0
Ujjain,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,4780.0,2330.0,900.0,450.0,410.0,8870.0
Ujjain,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,100.0,0.0,0.0,0.0,3000.0,3100.0
Ujjain,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,2530.0,1430.0,450.0,40.0,300.0,4750.0
Ujjain,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2350.0,900.0,450.0,410.0,3110.0,7220.0
Ujjain,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,1030.0,473.0,1782.0,949.0,834.0,5068.0
Ujjain,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,0.0,4800.0,0.0,0.0,0.0,4800.0
Ujjain,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,557.0,3491.0,833.0,115.0,12.0,5008.0
Ujjain,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,473.0,1782.0,949.0,834.0,822.0,4860.0
Ujjain,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,32575.0,217640.0,200000.0,197000.0,147000.0,794215.0
Ujjain,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,205000.0,0.0,0.0,0.0,0.0,205000.0
Ujjain,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,19935.0,17640.0,3000.0,50000.0,16860.0,107435.0
Ujjain,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,217640.0,200000.0,197000.0,147000.0,130140.0,891780.0
Ujjain,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2690.0,6290.0,5690.0,10690.0,14790.0,10890.0,8090.0,10290.0,8160.0,4460.0,4260.0,3860.0,90160.0
Ujjain,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6600.0,6600.0,8300.0,6600.0,3300.0,0.0,6600.0,0.0,0.0,6600.0,3300.0,4000.0,51900.0
Ujjain,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3000.0,7200.0,3300.0,2500.0,7200.0,2800.0,4400.0,2130.0,3700.0,6800.0,3700.0,2400.0,49130.0
Ujjain,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,6290.0,5690.0,10690.0,14790.0,10890.0,8090.0,10290.0,8160.0,4460.0,4260.0,3860.0,5460.0,92930.0
Ujjain,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,37850.0,85250.0,106650.0,84650.0,114850.0,51450.0,37050.0,47050.0,40920.0,29320.0,25520.0,41120.0,701680.0
Ujjain,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,62000.0,100000.0,0.0,50000.0,0.0,40000.0,100000.0,0.0,0.0,130000.0,100000.0,0.0,582000.0
Ujjain,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,14600.0,78600.0,22000.0,19800.0,63400.0,54400.0,90000.0,6130.0,11600.0,133800.0,84400.0,4400.0,583130.0
Ujjain,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,85250.0,106650.0,84650.0,114850.0,51450.0,37050.0,47050.0,40920.0,29320.0,25520.0,41120.0,36720.0,700550.0
Ujjain,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,50.0,2950.0,2350.0,8450.0,10350.0,7850.0,6190.0,57955.0,42800.0,25000.0,101640.0,97840.0,363425.0
Ujjain,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4000.0,4000.0,8100.0,4000.0,2000.0,0.0,0.0,0.0,0.0,100000.0,0.0,0.0,122100.0
Ujjain,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ujjain,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1100.0,4600.0,2000.0,2100.0,4500.0,1660.0,3600.0,15155.0,17800.0,23360.0,3800.0,9985.0,89660.0
Ujjain,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2950.0,2350.0,8450.0,10350.0,7850.0,6190.0,2590.0,42800.0,25000.0,101640.0,97840.0,87855.0,395865.0
Ujjain,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,2.0,1.0,1.0,1.0,3.0,3.0,1.0,,1.0,,,14.0
Ujjain,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,5.0,,11.0,7.0,4.0,9.0,5.0,4.0,6.0,8.0,2.0,2.0,63.0
Ujjain,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,3.0,4.0,2.0,2.0,5.0,2.0,2.0,9.0,3.0,,32.0
Ujjain,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,5.0,,14.0,11.0,6.0,11.0,10.0,6.0,8.0,17.0,5.0,2.0,95.0
Ujjain,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,,8.0,5.0,11.0,6.0,5.0,7.0,2.0,11.0,6.0,9.0,72.0
Ujjain,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,1.0,1.0,,,,,,,2.0
Ujjain,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,,8.0,5.0,12.0,7.0,5.0,7.0,2.0,11.0,6.0,9.0,74.0
Ujjain,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,3.0,5.0,7.0,6.0,3.0,5.0,6.0,1.0,6.0,12.0,23.0,78.0
Ujjain,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,1.0,,1.0,2.0,,1.0,,2.0,1.0,1.0,9.0
Ujjain,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,3.0,6.0,7.0,7.0,5.0,5.0,7.0,1.0,8.0,13.0,24.0,87.0
Ujjain,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,5.0,,13.0,13.0,16.0,14.0,15.0,24.0,14.0,15.0,12.0,12.0,153.0
Ujjain,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,1.0,1.0,3.0,1.0,4.0,,,1.0,1.0,2.0,15.0
Ujjain,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,5.0,1.0,14.0,14.0,19.0,15.0,19.0,24.0,14.0,16.0,13.0,14.0,168.0
Ujjain,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,2.0,3.0,2.0,,,2.0,,5.0,2.0,2.0,4.0,1.0,23.0
Ujjain,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,1.0,1.0,,,,1.0,,,,,3.0
Ujjain,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,2.0,3.0,3.0,1.0,,2.0,,6.0,2.0,2.0,4.0,1.0,26.0
Ujjain,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,1.0,1.0,,1.0,1.0,,,,,,,,4.0
Ujjain,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,1.0,,1.0,,,,,,,,2.0
Ujjain,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,1.0,1.0,1.0,1.0,2.0,,,,,,,,6.0
Ujjain,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,,,2.0,,2.0,1.0,1.0,,1.0,1.0,9.0
Ujjain,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,1.0,,2.0,2.0,,1.0,2.0,,,1.0,9.0
Ujjain,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,1.0,,4.0,2.0,2.0,2.0,3.0,,1.0,2.0,18.0
Ujjain,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ujjain,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ujjain,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Ujjain,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,10.0,6.0,5.0,7.0,2.0,2.0,7.0,14.0,7.0,4.0,7.0,71.0
Ujjain,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,2.0,3.0,,6.0,4.0,1.0,3.0,2.0,4.0,1.0,8.0,34.0
Ujjain,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,12.0,9.0,5.0,13.0,6.0,3.0,10.0,16.0,11.0,5.0,15.0,105.0
Ujjain,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Ujjain,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,1.0,,,,,4.0,,1.0,1.0,7.0
Ujjain,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,1.0,,,,,,1.0,1.0,,3.0
Ujjain,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,2.0,,,,,4.0,1.0,2.0,1.0,10.0
Ujjain,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Ujjain,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,2.0,4.0,3.0,2.0,3.0,,5.0,1.0,,,2.0,24.0
Ujjain,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,1.0,,1.0,,,,,,,,3.0
Ujjain,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,3.0,5.0,4.0,3.0,3.0,,5.0,1.0,,,2.0,28.0
Ujjain,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,1.0,,,,,,,1.0,,,2.0
Ujjain,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,2.0,6.0,9.0,5.0,13.0,4.0,1.0,3.0,,4.0,12.0,19.0,78.0
Ujjain,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,7.0,12.0,2.0,9.0,6.0,3.0,7.0,4.0,7.0,16.0,16.0,89.0
Ujjain,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,13.0,22.0,7.0,22.0,10.0,4.0,10.0,4.0,12.0,28.0,35.0,169.0
Ujjain,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Ujjain,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Ujjain,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Ujjain,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,1.0,,,,1.0,,,,2.0
Ujjain,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,1.0,,,,,1.0,,,1.0,3.0
Ujjain,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,4.0,,,3.0,3.0,1.0,,6.0,1.0,3.0,9.0,31.0
Ujjain,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,9.0,,1.0,5.0,2.0,,,2.0,,4.0,11.0,34.0
Ujjain,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,13.0,,2.0,8.0,5.0,1.0,,9.0,1.0,7.0,21.0,68.0
Ujjain,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Ujjain,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Ujjain,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Ujjain,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,1.0,,,,,1.0
Ujjain,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Ujjain,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,9.0,6.0,16.0,9.0,9.0,6.0,26.0,32.0,21.0,21.0,23.0,181.0
Ujjain,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,8.0,12.0,23.0,19.0,14.0,3.0,5.0,21.0,18.0,22.0,21.0,16.0,182.0
Ujjain,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,11.0,21.0,29.0,36.0,23.0,12.0,11.0,47.0,50.0,43.0,42.0,39.0,364.0
Ujjain,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Ujjain,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,1.0,1.0,,,1.0,1.0,,3.0,7.0
Ujjain,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,1.0,1.0,2.0,,,1.0,1.0,,,7.0
Ujjain,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,,1.0,2.0,3.0,,,2.0,2.0,,3.0,14.0
Ujjain,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Ujjain,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Ujjain,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Ujjain,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Ujjain,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Ujjain,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,1.0,1.0,,2.0
Ujjain,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Ujjain,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,1.0,1.0,,2.0
Ujjain,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Ujjain,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,1.0,3.0,,,2.0,,,,6.0
Ujjain,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Ujjain,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,1.0,3.0,,,2.0,,,,6.0
Ujjain,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Ujjain,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,,,,,,,1.0,,3.0,,5.0
Ujjain,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Ujjain,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,,,,,,,1.0,,3.0,,5.0
Ujjain,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Ujjain,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Ujjain,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Ujjain,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Ujjain,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Ujjain,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,4.0,,2.0,6.0,3.0,4.0,2.0,1.0,2.0,4.0,4.0,34.0
Ujjain,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Ujjain,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,4.0,,2.0,6.0,3.0,4.0,2.0,1.0,2.0,4.0,4.0,34.0
Ujjain,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,1.0,3.0,2.0,1.0,2.0,1.0,1.0,2.0,1.0,1.0,,16.0
Ujjain,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,5.0,17.0,21.0,23.0,13.0,5.0,7.0,16.0,17.0,10.0,13.0,25.0,172.0
Ujjain,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,3.0,2.0,1.0,4.0,,,5.0,3.0,3.0,1.0,3.0,26.0
Ujjain,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,7.0,21.0,26.0,26.0,18.0,7.0,8.0,22.0,22.0,14.0,15.0,28.0,214.0
Ujjain,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Ujjain,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,7.0,3.0,3.0,1.0,3.0,1.0,7.0,3.0,,6.0,6.0,44.0
Ujjain,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,2.0,,,,1.0,,3.0
Ujjain,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,7.0,3.0,3.0,1.0,3.0,3.0,7.0,3.0,,7.0,6.0,47.0
Ujjain,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,2.0,,1.0,1.0,,,,,,4.0
Ujjain,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,1.0,1.0,5.0,1.0,2.0,,,1.0,,,12.0
Ujjain,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Ujjain,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,1.0,4.0,5.0,2.0,3.0,,,1.0,,,17.0
Ujjain,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Ujjain,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,3.0,2.0,1.0,4.0,2.0,2.0,,2.0,6.0,3.0,3.0,1.0,29.0
Ujjain,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,3.0,7.0,5.0,3.0,,3.0,3.0,4.0,,1.0,2.0,33.0
Ujjain,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,5.0,5.0,8.0,10.0,5.0,2.0,3.0,5.0,10.0,3.0,4.0,3.0,63.0
Ujjain,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,1.0,,,1.0,2.0
Ujjain,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,4.0,6.0,4.0,3.0,2.0,5.0,1.0,4.0,3.0,8.0,1.0,9.0,50.0
Ujjain,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,7.0,18.0,14.0,12.0,5.0,4.0,4.0,5.0,8.0,9.0,7.0,5.0,98.0
Ujjain,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,11.0,24.0,18.0,15.0,7.0,9.0,5.0,9.0,12.0,17.0,8.0,15.0,150.0
Ujjain,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,2.0,,2.0,,1.0,2.0,1.0,1.0,1.0,1.0,,11.0
Ujjain,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,13.0,13.0,18.0,23.0,17.0,16.0,22.0,32.0,19.0,21.0,23.0,20.0,237.0
Ujjain,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,93.0,84.0,73.0,98.0,63.0,75.0,77.0,124.0,86.0,103.0,86.0,84.0,1046.0
Ujjain,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,106.0,99.0,91.0,123.0,80.0,92.0,101.0,157.0,106.0,125.0,110.0,104.0,1294.0
Umaria,1.1,Total number of pregnant women Registered for ANC,TOTAL,1276.0,1325.0,1549.0,1838.0,1268.0,1549.0,1566.0,1319.0,1169.0,1494.0,1583.0,1797.0,17733.0
Umaria,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,874.0,955.0,1083.0,1289.0,870.0,1015.0,1037.0,881.0,839.0,1028.0,1184.0,1472.0,12527.0
Umaria,1.2,Number of Pregnant women registered under JSY,TOTAL,1268.0,1323.0,1530.0,1807.0,1227.0,1544.0,1546.0,1308.0,1159.0,1494.0,1583.0,1781.0,17570.0
Umaria,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1211.0,1299.0,1315.0,1295.0,1297.0,1376.0,1209.0,1214.0,1199.0,1261.0,1216.0,1462.0,15354.0
Umaria,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1182.0,1155.0,1335.0,1489.0,1034.0,1282.0,1250.0,1142.0,981.0,1238.0,1430.0,1521.0,15039.0
Umaria,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1395.0,1103.0,1255.0,1377.0,1290.0,1125.0,1276.0,1262.0,1227.0,1165.0,1327.0,1408.0,15210.0
Umaria,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1304.0,1430.0,1511.0,1690.0,1361.0,1634.0,1374.0,1319.0,1328.0,1567.0,1524.0,1758.0,17800.0
Umaria,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,116.0,163.0,192.0,186.0,180.0,139.0,133.0,143.0,153.0,198.0,174.0,115.0,1892.0
Umaria,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,0.0,2.0,9.0,1.0,2.0,5.0,1.0,1.0,3.0,9.0,3.0,38.0
Umaria,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,597.0,649.0,853.0,912.0,722.0,1073.0,977.0,985.0,869.0,1006.0,1138.0,1239.0,11020.0
Umaria,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,6.0,28.0,29.0,26.0,21.0,55.0,81.0,37.0,114.0,18.0,57.0,14.0,486.0
Umaria,1.8,Number of pregnancy test kits used at SC level,TOTAL,481.0,521.0,567.0,596.0,386.0,431.0,437.0,335.0,506.0,799.0,1237.0,1268.0,7564.0
Umaria,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,16.0,12.0,31.0,39.0,66.0,67.0,31.0,20.0,19.0,31.0,14.0,18.0,364.0
Umaria,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,21.0,26.0,27.0,46.0,52.0,66.0,26.0,50.0,29.0,31.0,7.0,3.0,384.0
Umaria,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,37.0,38.0,58.0,85.0,118.0,133.0,57.0,70.0,48.0,62.0,21.0,21.0,748.0
Umaria,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,36.0,37.0,58.0,75.0,105.0,112.0,54.0,51.0,41.0,48.0,18.0,17.0,652.0
Umaria,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,2.0,0.0,3.0,55.0,0.0,1.0,76.0,2.0,42.0,11.0,21.0,214.0
Umaria,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,664.0,595.0,892.0,1185.0,1422.0,1286.0,1032.0,847.0,781.0,844.0,698.0,792.0,11038.0
Umaria,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,66.0,44.0,140.0,350.0,324.0,407.0,391.0,161.0,138.0,262.0,117.0,104.0,2504.0
Umaria,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,576.0,523.0,787.0,415.0,931.0,657.0,639.0,818.0,1039.0,828.0,633.0,728.0,8574.0
Umaria,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,429.0,439.0,596.0,824.0,792.0,655.0,579.0,657.0,924.0,785.0,650.0,707.0,8037.0
Umaria,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,19.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,14.0,0.0,0.0,36.0
Umaria,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Umaria,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Umaria,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Umaria,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Umaria,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Umaria,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Umaria,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,18.0,24.0,31.0,27.0,38.0,33.0,30.0,33.0,24.0,26.0,26.0,29.0,339.0
Umaria,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Umaria,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,18.0,24.0,31.0,27.0,38.0,33.0,30.0,33.0,24.0,26.0,26.0,29.0,339.0
Umaria,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Umaria,4.1.1.a,Number of male live births,TOTAL,370.0,364.0,481.0,640.0,767.0,703.0,539.0,453.0,411.0,458.0,363.0,420.0,5969.0
Umaria,4.1.1.b,Number of female live births,TOTAL,310.0,358.0,454.0,607.0,743.0,694.0,531.0,445.0,398.0,434.0,343.0,382.0,5699.0
Umaria,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,680.0,722.0,935.0,1247.0,1510.0,1397.0,1070.0,898.0,809.0,892.0,706.0,802.0,11668.0
Umaria,4.1.2,Number of still births,TOTAL,21.0,28.0,16.0,29.0,33.0,30.0,21.0,24.0,26.0,21.0,17.0,14.0,280.0
Umaria,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,21.0,22.0,28.0,31.0,19.0,26.0,45.0,85.0,78.0,80.0,46.0,40.0,521.0
Umaria,4.2.1,Number of Newborns weighed at birth,TOTAL,652.0,688.0,899.0,1196.0,1406.0,1288.0,1026.0,834.0,785.0,842.0,695.0,790.0,11101.0
Umaria,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,125.0,132.0,129.0,133.0,178.0,159.0,77.0,107.0,92.0,88.0,70.0,80.0,1370.0
Umaria,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,632.0,690.0,885.0,1226.0,1440.0,1311.0,1060.0,840.0,744.0,853.0,672.0,737.0,11090.0
Umaria,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,2.0,3.0,0.0,2.0,14.0,8.0,31.0
Umaria,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,10.0,39.0,53.0,49.0,33.0,9.0,18.0,14.0,18.0,88.0,71.0,92.0,494.0
Umaria,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,22.0,31.0,35.0,55.0,63.0,39.0,40.0,44.0,6.0,28.0,3.0,35.0,401.0
Umaria,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Umaria,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,32.0,70.0,88.0,106.0,96.0,48.0,60.0,61.0,24.0,118.0,88.0,135.0,926.0
Umaria,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Umaria,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,32.0,70.0,57.0,68.0,39.0,48.0,75.0,69.0,24.0,118.0,87.0,135.0,822.0
Umaria,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,2.0,,23.0,,1.0,2.0,22.0,1.0,1.0,1.0,1.0,1.0,55.0
Umaria,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,13.0,22.0,42.0,48.0,37.0,40.0,27.0,67.0,23.0,27.0,20.0,30.0,396.0
Umaria,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,4.0,18.0,19.0,21.0,16.0,27.0,8.0,7.0,13.0,10.0,18.0,13.0,174.0
Umaria,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,580.0,690.0,667.0,1046.0,1236.0,1101.0,831.0,720.0,729.0,784.0,668.0,670.0,9722.0
Umaria,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,622.0,667.0,786.0,1191.0,1433.0,1447.0,1064.0,903.0,745.0,883.0,804.0,897.0,11442.0
Umaria,6.3,PNC maternal complications attended,TOTAL,4.0,5.0,4.0,4.0,6.0,2.0,12.0,2.0,8.0,2.0,6.0,2.0,57.0
Umaria,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,17.0,12.0,12.0,15.0,19.0,2.0,20.0,12.0,1.0,18.0,4.0,19.0,151.0
Umaria,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,11.0,0.0,0.0,9.0,0.0,6.0,0.0,26.0
Umaria,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,17.0,12.0,12.0,15.0,19.0,13.0,20.0,12.0,10.0,18.0,10.0,19.0,177.0
Umaria,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
Umaria,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,9.0,20.0,2.0,4.0,6.0,9.0,11.0,1.0,33.0,34.0,41.0,42.0,212.0
Umaria,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,9.0,123.0,9.0,35.0,10.0,69.0,67.0,1.0,256.0,307.0,332.0,281.0,1499.0
Umaria,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,18.0,143.0,11.0,39.0,16.0,78.0,78.0,2.0,289.0,341.0,373.0,323.0,1711.0
Umaria,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,3.0,0.0,15.0
Umaria,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,2.0,,,,7.0,6.0,31.0,1.0,5.0,52.0
Umaria,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,1.0,,,,,0.0,0.0,1.0,0.0,0.0,1.0,4.0
Umaria,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Umaria,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,1.0,0.0,2.0,0.0,0.0,0.0,7.0,7.0,43.0,4.0,6.0,71.0
Umaria,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Umaria,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,7.0,,,,,,1244.0,47.0,65.0,1363.0
Umaria,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,2.0,,,10.0,1.0,,13.0,94.0,99.0,1418.0,152.0,83.0,1872.0
Umaria,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,5.0,1.0,,1.0,19.0,19.0,15.0,7.0,5.0,72.0
Umaria,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Umaria,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,2.0,,,22.0,2.0,,14.0,113.0,118.0,2677.0,206.0,153.0,3307.0
Umaria,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Umaria,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,0.0,0.0,0.0
Umaria,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Umaria,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,9.0,9.0,10.0,3.0,,10.0,2.0,0.0,0.0,,2.0,,45.0
Umaria,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Umaria,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,9.0,9.0,10.0,3.0,,10.0,2.0,0.0,0.0,,2.0,0.0,45.0
Umaria,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Umaria,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,0.0,0.0,,,,0.0,0.0,0.0
Umaria,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,1.0,,,,0.0,1.0
Umaria,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,13.0,,11.0,7.0,10.0,,7.0,,48.0
Umaria,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Umaria,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,13.0,0.0,11.0,8.0,10.0,,7.0,0.0,49.0
Umaria,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Umaria,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,277.0,287.0,408.0,484.0,499.0,504.0,395.0,377.0,384.0,386.0,290.0,293.0,4584.0
Umaria,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,43.0,26.0,50.0,79.0,84.0,79.0,75.0,78.0,91.0,51.0,85.0,91.0,832.0
Umaria,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,41.0,43.0,51.0,103.0,56.0,74.0,141.0,131.0,131.0,128.0,112.0,141.0,1152.0
Umaria,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,150.0,109.0,170.0,207.0,216.0,138.0,150.0,93.0,108.0,75.0,55.0,113.0,1584.0
Umaria,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Umaria,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,511.0,465.0,679.0,873.0,855.0,795.0,761.0,679.0,714.0,640.0,542.0,638.0,8152.0
Umaria,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,201.0,170.0,259.0,407.0,364.0,356.0,360.0,247.0,311.0,256.0,288.0,342.0,3561.0
Umaria,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Umaria,9.06,Number of IUCD removals,TOTAL,190.0,187.0,188.0,192.0,193.0,206.0,290.0,387.0,312.0,320.0,243.0,221.0,2929.0
Umaria,9.07,Number of Oral Pills cycles distributed,TOTAL,1784.0,1820.0,2041.0,2334.0,2394.0,2317.0,2482.0,2642.0,2603.0,2586.0,2571.0,2734.0,28308.0
Umaria,9.08,Number of Condom pieces distributed,TOTAL,10955.0,6388.0,9686.0,20164.0,19193.0,19417.0,16048.0,12596.0,15985.0,17622.0,18366.0,21921.0,188341.0
Umaria,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,22.0,0.0,75.0,65.0,86.0,74.0,70.0,72.0,50.0,35.0,549.0
Umaria,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,0.0,6.0,,10.0,0.0,0.0,16.0
Umaria,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,8.0,0.0,13.0,3.0,24.0,0.0,0.0,48.0
Umaria,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Umaria,9.11.2.b,Number of failures following female sterilization,TOTAL,,1.0,,,1.0,,1.0,0.0,,0.0,8.0,0.0,11.0
Umaria,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,9.11.3.b,Number of deaths following female sterilization,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,9.12,Number of Institutions having NSV trained doctors,TOTAL,,1.0,,,,,,,,,1.0,1.0,-1.0
Umaria,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,757.0,806.0,1051.0,1325.0,1370.0,1512.0,1166.0,998.0,896.0,933.0,763.0,794.0,12371.0
Umaria,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,856.0,843.0,928.0,1002.0,1039.0,1355.0,1465.0,251.0,61.0,21.0,0.0,11.0,7832.0
Umaria,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1127.0,881.0,867.0,1014.0,991.0,1067.0,1211.0,1517.0,429.0,111.0,47.0,16.0,9278.0
Umaria,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1100.0,1086.0,974.0,934.0,994.0,1023.0,951.0,1246.0,1375.0,473.0,208.0,59.0,10423.0
Umaria,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1318.0,1225.0,1107.0,982.0,958.0,5590.0
Umaria,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1107.0,1233.0,1049.0,1043.0,4434.0
Umaria,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,953.0,1136.0,1160.0,3255.0
Umaria,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,644.0,743.0,944.0,1099.0,1090.0,1123.0,774.0,345.0,708.0,703.0,631.0,682.0,9486.0
Umaria,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,856.0,843.0,928.0,992.0,1033.0,1355.0,1339.0,259.0,1077.0,901.0,656.0,793.0,11032.0
Umaria,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1127.0,881.0,867.0,1006.0,990.0,1067.0,1130.0,581.0,1288.0,1085.0,731.0,833.0,11586.0
Umaria,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1100.0,1086.0,974.0,941.0,993.0,1023.0,885.0,437.0,1352.0,1051.0,856.0,1007.0,11705.0
Umaria,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,542.0,733.0,790.0,949.0,920.0,997.0,576.0,715.0,578.0,625.0,574.0,632.0,8631.0
Umaria,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,856.0,843.0,928.0,1000.0,1026.0,1355.0,1452.0,221.0,75.0,28.0,11.0,57.0,7852.0
Umaria,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1097.0,881.0,867.0,1004.0,992.0,1067.0,1204.0,1385.0,399.0,157.0,47.0,52.0,9152.0
Umaria,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1070.0,1086.0,974.0,937.0,996.0,1023.0,947.0,1118.0,1330.0,511.0,190.0,81.0,10263.0
Umaria,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1000.0,1092.0,1414.0,1451.0,1095.0,1116.0,1157.0,1009.0,881.0,868.0,935.0,953.0,12971.0
Umaria,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,131.0,138.0,258.0,238.0,263.0,274.0,309.0,394.0,578.0,741.0,1121.0,1224.0,5669.0
Umaria,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,448.0,525.0,650.0,649.0,529.0,536.0,573.0,509.0,412.0,426.0,465.0,449.0,6171.0
Umaria,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,439.0,520.0,624.0,647.0,525.0,516.0,555.0,478.0,381.0,392.0,456.0,430.0,5963.0
Umaria,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,887.0,1045.0,1274.0,1296.0,1054.0,1052.0,1128.0,987.0,793.0,818.0,921.0,879.0,12134.0
Umaria,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,933.0,893.0,1007.0,1009.0,893.0,917.0,826.0,932.0,1002.0,1333.0,1337.0,1232.0,12314.0
Umaria,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,920.0,893.0,1007.0,1009.0,896.0,922.0,813.0,586.0,1011.0,1318.0,1199.0,1174.0,11748.0
Umaria,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,268.0,262.0,346.0,182.0,118.0,99.0,98.0,92.0,69.0,135.0,83.0,101.0,1853.0
Umaria,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,243.0,234.0,337.0,164.0,125.0,86.0,81.0,100.0,55.0,130.0,91.0,100.0,1746.0
Umaria,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,511.0,496.0,683.0,346.0,243.0,185.0,179.0,192.0,124.0,265.0,174.0,201.0,3599.0
Umaria,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,298.0,276.0,341.0,411.0,394.0,400.0,319.0,344.0,347.0,845.0,576.0,1117.0,5668.0
Umaria,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,560.0,596.0,627.0,739.0,806.0,936.0,750.0,820.0,970.0,1372.0,1163.0,1745.0,11084.0
Umaria,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,569.0,603.0,651.0,762.0,779.0,901.0,754.0,706.0,872.0,1292.0,1414.0,2208.0,11511.0
Umaria,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,2.0
Umaria,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,,,2.0,2.0,5.0,2.0,15.0,0.0,1.0,11.0,12.0,52.0
Umaria,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,697.0,701.0,701.0,706.0,703.0,729.0,711.0,719.0,712.0,705.0,706.0,728.0,8518.0
Umaria,10.4.2,Number of Immunisation sessions held during the month,TOTAL,686.0,691.0,695.0,710.0,689.0,714.0,670.0,697.0,706.0,701.0,688.0,708.0,8355.0
Umaria,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,633.0,644.0,629.0,646.0,636.0,638.0,593.0,630.0,641.0,665.0,666.0,673.0,7694.0
Umaria,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,956.0,1055.0,1370.0,1682.0,1061.0,1102.0,1193.0,1000.0,927.0,1599.0,929.0,942.0,13816.0
Umaria,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,220.0,238.0,1262.0,8073.0,1351.0,156.0,251.0,323.0,1869.0,12603.0,179.0,223.0,26748.0
Umaria,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,129.0,158.0,971.0,9110.0,875.0,124.0,163.0,160.0,1545.0,12439.0,104.0,90.0,25868.0
Umaria,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,6.0
Umaria,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,485.0,490.0,536.0,554.0,766.0,619.0,494.0,424.0,459.0,454.0,573.0,621.0,6475.0
Umaria,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,10.0,4.0,16.0,33.0,17.0,17.0,6.0,17.0,10.0,4.0,7.0,8.0,149.0
Umaria,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,6.0,14.0,9.0,13.0,25.0,37.0,24.0,28.0,5.0,22.0,22.0,13.0,218.0
Umaria,13.1,Number of Patients operated for cataract,TOTAL,4.0,8.0,8.0,8.0,4.0,22.0,46.0,193.0,348.0,83.0,40.0,32.0,796.0
Umaria,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,4.0,8.0,8.0,8.0,4.0,22.0,46.0,193.0,348.0,83.0,40.0,32.0,796.0
Umaria,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,0.0,,,0.0,884.0,0.0,884.0
Umaria,13.4,Number of children provided free glasses,TOTAL,,,,,,,0.0,,,0.0,884.0,0.0,884.0
Umaria,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,0.0,0.0,,0.0,0.0,0.0,0.0
Umaria,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,0.0,0.0,,0.0,0.0,0.0,0.0
Umaria,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,2.0,1.0,1.0,2.0,1.0,2.0,2.0,1.0,2.0,2.0,-1.0
Umaria,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,1.0,-1.0
Umaria,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,637.0,628.0,651.0,634.0,627.0,627.0,652.0,632.0,623.0,613.0,626.0,642.0,-1.0
Umaria,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,1.0,1.0,,1.0,,1.0,,1.0,1.0,1.0,1.0,1.0,-1.0
Umaria,14.05,Number of RKS meetings held during the month,TOTAL,0.0,,,,,,,,,0.0,,,0.0
Umaria,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1.0,1.0,2.0,1.0,,1.0,,2.0,1.0,1.0,1.0,2.0,-1.0
Umaria,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,2.0,,10.0,,,5.0,,,1.0,4.0,22.0
Umaria,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,,1.0,,,1.0,1.0,1.0,1.0,-1.0
Umaria,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Umaria,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,267.0,397.0,353.0,380.0,350.0,413.0,351.0,199.0,230.0,140.0,199.0,198.0,3477.0
Umaria,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,722.0,1000.0,859.0,915.0,979.0,1016.0,747.0,643.0,476.0,491.0,609.0,591.0,9048.0
Umaria,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,223.0,253.0,300.0,490.0,353.0,349.0,357.0,145.0,215.0,157.0,126.0,177.0,3145.0
Umaria,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1005.0,1351.0,1642.0,1767.0,1884.0,2014.0,1340.0,1367.0,1224.0,1326.0,1759.0,2125.0,18804.0
Umaria,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,490.0,650.0,653.0,870.0,703.0,762.0,708.0,344.0,445.0,297.0,325.0,375.0,6622.0
Umaria,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1727.0,2351.0,2501.0,2682.0,2863.0,3030.0,2087.0,2010.0,1700.0,1817.0,2368.0,2716.0,27852.0
Umaria,14.10.2.a,Number of death cases of Inpatient males,TOTAL,8.0,9.0,9.0,7.0,10.0,12.0,8.0,11.0,9.0,9.0,12.0,2.0,106.0
Umaria,14.10.2.b,Number of death cases of Inpatient females,TOTAL,12.0,4.0,12.0,4.0,11.0,9.0,13.0,6.0,7.0,9.0,7.0,5.0,99.0
Umaria,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,20.0,13.0,21.0,11.0,21.0,21.0,21.0,17.0,16.0,18.0,19.0,7.0,205.0
Umaria,14.11,In-Patient Head Count at midnight,TOTAL,684.0,800.0,664.0,806.0,1033.0,873.0,742.0,599.0,700.0,494.0,280.0,617.0,8292.0
Umaria,14.12.1,OPD attendance (All),TOTAL,27375.0,31951.0,37284.0,51285.0,46846.0,61693.0,44239.0,38904.0,36657.0,33664.0,40221.0,42646.0,492765.0
Umaria,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,32.0,40.0,38.0,43.0,41.0,26.0,42.0,45.0,41.0,52.0,50.0,43.0,493.0
Umaria,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,1.0,4.0,2.0,3.0,1.0,4.0,7.0,2.0,2.0,2.0,1.0,3.0,32.0
Umaria,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1093.0,1422.0,1516.0,2078.0,2185.0,2161.0,1710.0,1625.0,1404.0,1153.0,1316.0,1450.0,19113.0
Umaria,14.14.a,Number of patients given AYUSH treatment,TOTAL,554.0,917.0,1209.0,1310.0,373.0,1656.0,421.0,430.0,543.0,206.0,371.0,100.0,8090.0
Umaria,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,403.0,398.0,434.0,403.0,363.0,396.0,366.0,377.0,448.0,478.0,423.0,403.0,4892.0
Umaria,14.14.c,Number of Adolescents counselled,TOTAL,48.0,92.0,112.0,,91.0,217.0,,274.0,306.0,240.0,331.0,376.0,2087.0
Umaria,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2361.0,3501.0,4143.0,4732.0,2890.0,3952.0,3430.0,3601.0,3816.0,3781.0,4309.0,4462.0,44978.0
Umaria,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,119.0,210.0,190.0,229.0,203.0,218.0,222.0,230.0,176.0,195.0,172.0,180.0,2344.0
Umaria,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,40.0,320.0,108.0,271.0,292.0,237.0,155.0,193.0,231.0,161.0,207.0,338.0,2553.0
Umaria,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Umaria,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,113.0,336.0,74.0,280.0,285.0,243.0,367.0,301.0,523.0,118.0,470.0,140.0,3250.0
Umaria,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,1.0,,,,,,,1.0
Umaria,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,255.0,653.0,649.0,1143.0,678.0,707.0,568.0,666.0,568.0,775.0,770.0,984.0,8416.0
Umaria,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,0.0,,,,,,,0.0
Umaria,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,408.0,1309.0,831.0,1694.0,1255.0,1187.0,1090.0,1160.0,1322.0,1054.0,1447.0,1462.0,14219.0
Umaria,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Umaria,15.2,Number of Widal tests conducted,Number tested,397.0,1165.0,886.0,909.0,929.0,1719.0,928.0,757.0,417.0,184.0,476.0,845.0,9612.0
Umaria,15.3.a,Number of VDRL tests conducted on males,Number tested,127.0,489.0,68.0,56.0,56.0,67.0,79.0,60.0,24.0,26.0,5.0,19.0,1076.0
Umaria,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,84.0,245.0,139.0,248.0,89.0,86.0,23.0,33.0,24.0,57.0,113.0,138.0,1279.0
Umaria,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,88.0,303.0,311.0,111.0,224.0,257.0,253.0,241.0,215.0,99.0,103.0,119.0,2324.0
Umaria,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,299.0,1037.0,518.0,415.0,369.0,410.0,355.0,334.0,263.0,182.0,221.0,276.0,4679.0
Umaria,15.4.1,Number of blood smears examined for Malaria,TOTAL,5201.0,4758.0,6246.0,8382.0,7241.0,7621.0,4379.0,3798.0,2420.0,2648.0,4079.0,5223.0,61996.0
Umaria,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,10.0,16.0,19.0,31.0,39.0,54.0,40.0,20.0,10.0,14.0,11.0,16.0,280.0
Umaria,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,5.0,4.0,7.0,10.0,9.0,12.0,12.0,11.0,4.0,3.0,13.0,92.0
Umaria,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1258.0,634.0,1184.0,1584.0,,1196.0,666.0,,70.0,687.0,1214.0,2108.0,10601.0
Umaria,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,1000.0,1000.0,,,1000.0,,,700.0,1000.0,1000.0,1000.0,6700.0
Umaria,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,559.0,450.0,600.0,700.0,,1530.0,554.0,,83.0,473.0,106.0,289.0,5344.0
Umaria,16.1.1,Stock position of DPT vaccines,5. Total Stock,699.0,1184.0,1584.0,884.0,0.0,666.0,112.0,0.0,687.0,1214.0,2108.0,2819.0,11957.0
Umaria,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,0.0,,,,,,,101.0,65.0,151.0,576.0,893.0
Umaria,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,0.0,,,,,600.0,,111.0,600.0,600.0,600.0,2511.0
Umaria,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Umaria,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,0.0,,,,,450.0,,147.0,514.0,175.0,426.0,1712.0
Umaria,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,150.0,0.0,65.0,151.0,576.0,750.0,1692.0
Umaria,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1468.0,1014.0,1014.0,839.0,,786.0,51.0,,250.0,5406.0,,,10828.0
Umaria,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,600.0,500.0,500.0,,300.0,,,5400.0,875.0,6257.0,1000.0,15432.0
Umaria,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,454.0,600.0,675.0,625.0,,1035.0,51.0,,244.0,6281.0,6257.0,902.0,17124.0
Umaria,16.1.2,Stock position of OPV vaccines,5. Total Stock,1014.0,1014.0,839.0,714.0,0.0,51.0,0.0,0.0,5406.0,0.0,0.0,98.0,9136.0
Umaria,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,986.0,704.0,777.0,1077.0,,947.0,827.0,,1186.0,1295.0,955.0,1777.0,10531.0
Umaria,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,1000.0,1000.0,,1000.0,,,500.0,500.0,1000.0,,5000.0
Umaria,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.1.3,Stock position of TT vaccines,4. Stock Distributed,659.0,400.0,700.0,1130.0,,1120.0,554.0,,391.0,840.0,178.0,495.0,6467.0
Umaria,16.1.3,Stock position of TT vaccines,5. Total Stock,327.0,304.0,1077.0,947.0,0.0,827.0,273.0,0.0,1295.0,955.0,1777.0,1282.0,9064.0
Umaria,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,1317.0,,,,,,,,,,,1317.0
Umaria,16.1.4,Stock position of DT vaccines,2. Stocks Received,,2000.0,,,,,,,,,,,2000.0
Umaria,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,600.0,,,,,,,,,,,600.0
Umaria,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,2717.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2717.0
Umaria,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1115.0,327.0,1184.0,1584.0,,1484.0,934.0,435.0,808.0,671.0,589.0,1018.0,10149.0
Umaria,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,1000.0,1000.0,,,,,1000.0,,500.0,500.0,,4000.0
Umaria,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,481.0,550.0,600.0,700.0,,550.0,499.0,627.0,137.0,582.0,71.0,323.0,5120.0
Umaria,16.1.5,Stock position of BCG vaccines,5. Total Stock,634.0,777.0,1584.0,884.0,0.0,934.0,435.0,808.0,671.0,589.0,1018.0,695.0,9029.0
Umaria,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1824.0,3400.0,2717.0,2067.0,,1267.0,,,165.0,,261.0,933.0,12634.0
Umaria,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,1000.0,,,,500.0,,1000.0,1000.0,1000.0,4500.0
Umaria,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,507.0,400.0,650.0,920.0,,1267.0,,335.0,165.0,739.0,328.0,699.0,6010.0
Umaria,16.1.6,Stock position of Measles vaccines,5. Total Stock,1317.0,3000.0,2067.0,2147.0,0.0,0.0,0.0,165.0,0.0,261.0,933.0,1234.0,11124.0
Umaria,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Umaria,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Umaria,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Umaria,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1313.0,,304.0,654.0,,1151.0,50.0,,650.0,761.0,1205.0,1163.0,7251.0
Umaria,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,1000.0,1000.0,,,,1000.0,500.0,1000.0,,,4500.0
Umaria,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,609.0,,650.0,750.0,,1101.0,50.0,350.0,389.0,556.0,42.0,296.0,4793.0
Umaria,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,704.0,0.0,654.0,904.0,0.0,50.0,0.0,650.0,761.0,1205.0,1163.0,867.0,6958.0
Umaria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Umaria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Umaria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Umaria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Umaria,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Umaria,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Umaria,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Umaria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Umaria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Umaria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Umaria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Umaria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Umaria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Umaria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Umaria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Umaria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Umaria,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Umaria,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Umaria,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Umaria,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Umaria,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Umaria,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Umaria,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Umaria,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Umaria,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Umaria,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Umaria,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Umaria,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Umaria,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Umaria,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Umaria,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Umaria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Umaria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Umaria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Umaria,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Umaria,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Umaria,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Umaria,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Umaria,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Umaria,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Umaria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Umaria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Umaria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Umaria,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Umaria,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Umaria,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Umaria,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Umaria,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Umaria,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Umaria,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4000.0,,3000.0,9200.0,,7800.0,11400.0,9400.0,8600.0,9600.0,9600.0,,72600.0
Umaria,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,6600.0,,,6600.0,,,6000.0,,,,19200.0
Umaria,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,600.0,,400.0,900.0,,3000.0,2000.0,800.0,5000.0,,9600.0,,22300.0
Umaria,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3400.0,0.0,9200.0,8300.0,0.0,11400.0,9400.0,8600.0,9600.0,9600.0,0.0,0.0,69500.0
Umaria,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,110000.0,104000.0,104000.0,101000.0,,86000.0,60000.0,57000.0,148000.0,146000.0,146000.0,,1062000.0
Umaria,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,140000.0,,50000.0,,,,,190000.0
Umaria,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,6000.0,,3000.0,3000.0,,166000.0,3000.0,22000.0,2000.0,,,,205000.0
Umaria,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,104000.0,104000.0,101000.0,98000.0,0.0,60000.0,57000.0,85000.0,146000.0,146000.0,146000.0,0.0,1047000.0
Umaria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,5600.0,5600.0,5600.0,5600.0,,3200.0,2400.0,2400.0,2400.0,2400.0,2400.0,146000.0,183600.0
Umaria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,2000.0,,,,2000.0
Umaria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Umaria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,400.0,,800.0,,,2000.0,,2400.0,,5600.0
Umaria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,5600.0,5600.0,5600.0,5200.0,0.0,2400.0,2400.0,2400.0,2400.0,2400.0,0.0,146000.0,180000.0
Umaria,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,1.0,1.0,,,,,2.0,,,4.0
Umaria,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,1.0,,,,,2.0,,,3.0
Umaria,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Umaria,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,1.0,,,,,2.0,,,3.0
Umaria,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,1.0,1.0,,,,,2.0
Umaria,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Umaria,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,1.0,1.0,,,,,2.0
Umaria,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,4.0,4.0,1.0,11.0,6.0,5.0,1.0,2.0,7.0,6.0,4.0,52.0
Umaria,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,,,,,1.0
Umaria,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,4.0,4.0,1.0,11.0,6.0,5.0,2.0,2.0,7.0,6.0,4.0,53.0
Umaria,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,1.0,5.0,,2.0,6.0,7.0,2.0,8.0,5.0,8.0,7.0,51.0
Umaria,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,1.0,,1.0,,,,1.0,,3.0
Umaria,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,1.0,5.0,,3.0,6.0,8.0,2.0,8.0,5.0,9.0,7.0,54.0
Umaria,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,1.0,,1.0,1.0,,4.0,4.0,3.0,1.0,1.0,2.0,19.0
Umaria,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,1.0,,,,1.0,,,,,2.0
Umaria,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,1.0,,2.0,1.0,,4.0,5.0,3.0,1.0,1.0,2.0,21.0
Umaria,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,1.0,,,,,,,,1.0,2.0
Umaria,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Umaria,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,1.0,,,,,,,,1.0,2.0
Umaria,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,1.0,,2.0,1.0,,1.0,2.0,1.0,8.0
Umaria,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,2.0,,1.0,,1.0,1.0,1.0,1.0,,7.0
Umaria,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,2.0,1.0,1.0,2.0,2.0,1.0,2.0,3.0,1.0,15.0
Umaria,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Umaria,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Umaria,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Umaria,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,,,2.0,2.0,4.0,3.0,4.0,4.0,13.0,5.0,6.0,44.0
Umaria,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,,3.0,3.0,2.0,,,1.0,1.0,1.0,2.0,2.0,17.0
Umaria,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,,3.0,5.0,4.0,4.0,3.0,5.0,5.0,14.0,7.0,8.0,61.0
Umaria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Umaria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Umaria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Umaria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,1.0,,,,,,,1.0
Umaria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Umaria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,2.0,,,1.0,1.0,,,1.0,,1.0,1.0,7.0
Umaria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,,,,,,,,1.0,,,2.0
Umaria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,3.0,,,1.0,1.0,,,1.0,1.0,1.0,1.0,9.0
Umaria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Umaria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,1.0,,1.0,,,,,,,2.0
Umaria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Umaria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,2.0,,1.0,,,,,,,3.0
Umaria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Umaria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Umaria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Umaria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Umaria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,1.0,,,1.0,,,,,,2.0
Umaria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,2.0,2.0,,4.0,8.0,3.0,1.0,1.0,1.0,1.0,2.0,25.0
Umaria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,3.0,,1.0,2.0,1.0,1.0,,8.0
Umaria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,2.0,2.0,1.0,4.0,11.0,4.0,2.0,3.0,2.0,2.0,2.0,35.0
Umaria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Umaria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Umaria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Umaria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Umaria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Umaria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,1.0,,3.0,,1.0,5.0
Umaria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,1.0,,,1.0,,,,1.0,1.0,,,5.0
Umaria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,1.0,,,1.0,,,1.0,1.0,4.0,,1.0,10.0
Umaria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Umaria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Umaria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Umaria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,1.0,,,,,,,,,1.0
Umaria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Umaria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Umaria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Umaria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Umaria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Umaria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,1.0,,,1.0
Umaria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Umaria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,1.0,,,1.0
Umaria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Umaria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Umaria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Umaria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Umaria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Umaria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Umaria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Umaria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,1.0,,,,,,,,1.0
Umaria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Umaria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Umaria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Umaria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Umaria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Umaria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,,1.0,1.0,,,2.0,1.0,2.0,1.0,,1.0,10.0
Umaria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Umaria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,,1.0,1.0,,,2.0,1.0,2.0,1.0,,1.0,10.0
Umaria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,2.0,1.0,,1.0,3.0,,2.0,1.0,,,4.0,15.0
Umaria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,10.0,4.0,8.0,3.0,2.0,5.0,1.0,4.0,3.0,1.0,6.0,1.0,48.0
Umaria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,3.0,2.0,2.0,2.0,,,,1.0,,1.0,11.0
Umaria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,11.0,6.0,12.0,5.0,5.0,10.0,1.0,6.0,4.0,2.0,6.0,6.0,74.0
Umaria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Umaria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,3.0,,1.0,1.0,1.0,1.0,4.0,3.0,,6.0,2.0,22.0
Umaria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,1.0,,,1.0,2.0
Umaria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,3.0,,1.0,1.0,1.0,1.0,4.0,4.0,,6.0,3.0,24.0
Umaria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,2.0,,,1.0,,,,,1.0,4.0
Umaria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,2.0,2.0,4.0,3.0,2.0,,,1.0,,,14.0
Umaria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,1.0,1.0,,,1.0,,,,1.0,4.0
Umaria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,2.0,5.0,5.0,3.0,3.0,1.0,,1.0,,2.0,22.0
Umaria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,1.0,1.0,,,,,2.0
Umaria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,1.0,3.0,,3.0,2.0,8.0,7.0,,3.0,1.0,3.0,32.0
Umaria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,,1.0,,1.0,1.0,7.0,4.0,1.0,1.0,1.0,1.0,20.0
Umaria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,1.0,4.0,,4.0,3.0,16.0,12.0,1.0,4.0,2.0,4.0,54.0
Umaria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Umaria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,3.0,1.0,4.0,,,,,1.0,1.0,2.0,,12.0
Umaria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,2.0,4.0,,1.0,3.0,,,1.0,,,1.0,12.0
Umaria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,5.0,5.0,4.0,1.0,3.0,,,2.0,1.0,2.0,1.0,24.0
Umaria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,7.0,2.0,2.0,8.0,8.0,4.0,5.0,3.0,3.0,3.0,2.0,,47.0
Umaria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,30.0,36.0,25.0,35.0,34.0,24.0,27.0,23.0,30.0,12.0,28.0,18.0,322.0
Umaria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,47.0,37.0,55.0,51.0,52.0,62.0,68.0,34.0,50.0,45.0,55.0,53.0,609.0
Umaria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,84.0,75.0,82.0,94.0,94.0,90.0,100.0,60.0,83.0,60.0,85.0,71.0,978.0
Vidisha,1.1,Total number of pregnant women Registered for ANC,TOTAL,3412.0,3339.0,3866.0,3843.0,3489.0,4007.0,3339.0,3393.0,3380.0,2928.0,3958.0,3764.0,42718.0
Vidisha,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2302.0,2402.0,2681.0,2750.0,2302.0,2803.0,2220.0,2577.0,2808.0,2501.0,3001.0,3055.0,31402.0
Vidisha,1.2,Number of Pregnant women registered under JSY,TOTAL,2794.0,3093.0,3471.0,3631.0,3100.0,3605.0,3039.0,3123.0,3048.0,2652.0,3727.0,3492.0,38775.0
Vidisha,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2587.0,2526.0,2924.0,2908.0,2505.0,2831.0,2404.0,2785.0,3046.0,2601.0,2913.0,3132.0,33162.0
Vidisha,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3341.0,3219.0,3764.0,3375.0,3041.0,3622.0,3221.0,2946.0,3278.0,2853.0,3706.0,3740.0,40106.0
Vidisha,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2557.0,2522.0,2893.0,3005.0,2806.0,2828.0,2768.0,2881.0,3122.0,2675.0,2788.0,3299.0,34144.0
Vidisha,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3513.0,3366.0,3930.0,3809.0,3212.0,3989.0,3468.0,3653.0,3644.0,3038.0,3672.0,3894.0,43188.0
Vidisha,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,117.0,194.0,112.0,132.0,113.0,148.0,143.0,122.0,125.0,103.0,205.0,100.0,1614.0
Vidisha,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,13.0,16.0,2.0,9.0,8.0,10.0,13.0,17.0,21.0,20.0,12.0,14.0,155.0
Vidisha,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,609.0,790.0,1031.0,1309.0,786.0,1122.0,1030.0,1123.0,1090.0,1074.0,1689.0,1382.0,13035.0
Vidisha,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,34.0,62.0,59.0,56.0,82.0,97.0,66.0,75.0,65.0,99.0,157.0,53.0,905.0
Vidisha,1.8,Number of pregnancy test kits used at SC level,TOTAL,742.0,869.0,1137.0,1179.0,937.0,905.0,867.0,1191.0,1210.0,1058.0,1407.0,1327.0,12829.0
Vidisha,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,29.0,39.0,4.0,3.0,1.0,2.0,0.0,1.0,1.0,4.0,7.0,16.0,107.0
Vidisha,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,286.0,269.0,338.0,346.0,390.0,461.0,329.0,467.0,501.0,521.0,530.0,419.0,4857.0
Vidisha,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,315.0,308.0,342.0,349.0,391.0,463.0,329.0,468.0,502.0,525.0,537.0,435.0,4964.0
Vidisha,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,227.0,261.0,312.0,312.0,320.0,325.0,264.0,405.0,445.0,475.0,448.0,412.0,4206.0
Vidisha,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,1.0,2.0,3.0,8.0,6.0,1.0,8.0,51.0,81.0,76.0,56.0,293.0
Vidisha,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1190.0,1247.0,1690.0,1713.0,1935.0,1926.0,1805.0,1979.0,1762.0,1740.0,1730.0,1760.0,20477.0
Vidisha,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,130.0,79.0,96.0,114.0,150.0,142.0,103.0,76.0,22.0,14.0,20.0,9.0,955.0
Vidisha,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,819.0,619.0,1299.0,1378.0,1074.0,1510.0,1368.0,1359.0,1422.0,1538.0,1519.0,1518.0,15423.0
Vidisha,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,362.0,415.0,1041.0,678.0,656.0,833.0,746.0,722.0,845.0,784.0,669.0,745.0,8496.0
Vidisha,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,14.0,20.0
Vidisha,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,175.0,196.0,199.0,197.0,157.0,178.0,173.0,186.0,231.0,214.0,214.0,251.0,2371.0
Vidisha,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Vidisha,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Vidisha,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Vidisha,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Vidisha,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,23.0,26.0,51.0,53.0,57.0,65.0,55.0,69.0,38.0,57.0,68.0,65.0,627.0
Vidisha,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vidisha,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,23.0,26.0,51.0,53.0,57.0,65.0,55.0,69.0,38.0,57.0,68.0,65.0,627.0
Vidisha,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,41.0,53.0,61.0,59.0,52.0,51.0,46.0,47.0,59.0,124.0,57.0,80.0,730.0
Vidisha,4.1.1.a,Number of male live births,TOTAL,894.0,921.0,1177.0,1193.0,1312.0,1384.0,1159.0,1338.0,1235.0,1281.0,1267.0,1226.0,14387.0
Vidisha,4.1.1.b,Number of female live births,TOTAL,755.0,803.0,1007.0,1028.0,1133.0,1142.0,1095.0,1251.0,1223.0,1170.0,1180.0,1176.0,12963.0
Vidisha,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1649.0,1724.0,2184.0,2221.0,2445.0,2526.0,2254.0,2589.0,2458.0,2451.0,2447.0,2402.0,27350.0
Vidisha,4.1.2,Number of still births,TOTAL,26.0,26.0,51.0,41.0,40.0,43.0,55.0,48.0,37.0,31.0,38.0,47.0,483.0
Vidisha,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,68.0,86.0,219.0,84.0,77.0,60.0,63.0,77.0,90.0,82.0,73.0,75.0,1054.0
Vidisha,4.2.1,Number of Newborns weighed at birth,TOTAL,1638.0,1706.0,2171.0,2213.0,2431.0,2500.0,2248.0,2585.0,2455.0,2449.0,2431.0,2400.0,27227.0
Vidisha,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,152.0,154.0,217.0,264.0,347.0,402.0,299.0,448.0,361.0,298.0,316.0,235.0,3493.0
Vidisha,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1541.0,1669.0,2135.0,2076.0,2401.0,2458.0,2221.0,2555.0,2375.0,2445.0,2428.0,2400.0,26704.0
Vidisha,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,9.0,7.0,24.0,21.0,34.0,16.0,13.0,32.0,20.0,29.0,30.0,15.0,250.0
Vidisha,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,39.0,49.0,86.0,112.0,73.0,75.0,58.0,64.0,64.0,70.0,64.0,69.0,823.0
Vidisha,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,45.0,95.0,187.0,225.0,305.0,418.0,229.0,170.0,255.0,406.0,388.0,348.0,3071.0
Vidisha,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vidisha,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,93.0,151.0,297.0,358.0,412.0,509.0,300.0,266.0,339.0,505.0,482.0,432.0,4144.0
Vidisha,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,44.0,36.0,19.0,23.0,8.0,30.0,12.0,28.0,42.0,74.0,42.0,52.0,410.0
Vidisha,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,141.0,185.0,313.0,359.0,420.0,539.0,312.0,292.0,379.0,579.0,490.0,484.0,4493.0
Vidisha,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,29.0,27.0,47.0,20.0,31.0,27.0,40.0,37.0,74.0,39.0,39.0,43.0,453.0
Vidisha,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,108.0,158.0,315.0,231.0,345.0,539.0,292.0,266.0,363.0,578.0,297.0,483.0,3975.0
Vidisha,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,6.0,22.0,12.0,14.0,9.0,11.0,12.0,1.0,7.0,21.0,27.0,37.0,179.0
Vidisha,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1461.0,1510.0,2086.0,2002.0,2297.0,2253.0,2124.0,2410.0,2303.0,2365.0,2210.0,2244.0,25265.0
Vidisha,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,954.0,1190.0,1399.0,1350.0,1304.0,1657.0,1404.0,1508.0,1720.0,1847.0,1573.0,1718.0,17624.0
Vidisha,6.3,PNC maternal complications attended,TOTAL,27.0,25.0,35.0,57.0,141.0,129.0,109.0,21.0,23.0,32.0,11.0,8.0,618.0
Vidisha,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,33.0,15.0,16.0,16.0,9.0,17.0,17.0,23.0,21.0,24.0,24.0,30.0,245.0
Vidisha,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,33.0,15.0,16.0,16.0,9.0,17.0,17.0,23.0,21.0,24.0,24.0,30.0,245.0
Vidisha,7.2,Number of MTPs conducted at Private Facilities,TOTAL,4.0,3.0,1.0,5.0,5.0,0.0,0.0,2.0,6.0,8.0,4.0,2.0,40.0
Vidisha,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,48.0,28.0,59.0,78.0,134.0,129.0,135.0,84.0,90.0,102.0,89.0,67.0,1043.0
Vidisha,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,212.0,234.0,428.0,544.0,472.0,441.0,463.0,443.0,462.0,402.0,433.0,281.0,4815.0
Vidisha,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,260.0,262.0,487.0,622.0,606.0,570.0,598.0,527.0,552.0,504.0,522.0,348.0,5858.0
Vidisha,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,62.0,12.0,13.0,0.0,30.0,20.0,13.0,8.0,0.0,49.0,207.0
Vidisha,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,,0.0,2.0
Vidisha,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,0.0,1.0,2.0,1.0,3.0,0.0,0.0,0.0,0.0,3.0,7.0,19.0
Vidisha,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vidisha,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,0.0,1.0,3.0,2.0,3.0,0.0,0.0,0.0,0.0,3.0,7.0,21.0
Vidisha,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,1.0,,,,,0.0,0.0,0.0,0.0,1.0,,,2.0
Vidisha,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,72.0,76.0,0.0,21.0,1.0,170.0
Vidisha,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,1.0,0.0,14.0,0.0,0.0,0.0,885.0,1414.0,487.0,303.0,207.0,3311.0
Vidisha,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,0.0,1.0,1.0,3.0,209.0,569.0,164.0,143.0,5.0,1096.0
Vidisha,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vidisha,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,1.0,1.0,0.0,14.0,1.0,1.0,3.0,1166.0,2059.0,651.0,467.0,213.0,4577.0
Vidisha,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,1.0,,,,1.0,3.0,0.0,1.0,1.0,,1.0,8.0
Vidisha,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,4.0,0.0,5.0,1.0,0.0,2.0,6.0,6.0,4.0,,22.0,50.0
Vidisha,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,1.0,2.0,1.0,2.0,1.0,4.0,1.0,29.0,2.0,8.0,15.0,56.0,122.0
Vidisha,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vidisha,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,1.0,6.0,1.0,7.0,2.0,4.0,3.0,35.0,8.0,12.0,15.0,78.0,172.0
Vidisha,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,1.0,,,,3.0,0.0,0.0,1.0,0.0,,1.0,6.0
Vidisha,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,4.0,0.0,4.0,0.0,3.0,1.0,5.0,10.0,3.0,,0.0,30.0
Vidisha,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,7.0,13.0,16.0,11.0,16.0,31.0,17.0,32.0,35.0,27.0,26.0,47.0,278.0
Vidisha,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vidisha,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,7.0,17.0,16.0,15.0,16.0,34.0,18.0,37.0,45.0,30.0,26.0,47.0,308.0
Vidisha,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,3.0,3.0,0.0,3.0,0.0,4.0,6.0,,3.0,22.0
Vidisha,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,275.0,266.0,220.0,258.0,256.0,250.0,243.0,285.0,314.0,292.0,228.0,238.0,3125.0
Vidisha,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,18.0,12.0,15.0,23.0,20.0,16.0,20.0,20.0,20.0,26.0,7.0,8.0,205.0
Vidisha,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,20.0,16.0,29.0,11.0,14.0,18.0,28.0,24.0,19.0,33.0,86.0,59.0,357.0
Vidisha,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,143.0,100.0,81.0,65.0,85.0,202.0,198.0,65.0,121.0,328.0,159.0,348.0,1895.0
Vidisha,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Vidisha,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,456.0,394.0,345.0,357.0,375.0,486.0,489.0,394.0,474.0,679.0,480.0,653.0,5582.0
Vidisha,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,20.0,28.0,39.0,41.0,25.0,19.0,57.0,67.0,153.0,270.0,232.0,399.0,1350.0
Vidisha,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,5.0,9.0,11.0,5.0,5.0,7.0,7.0,0.0,6.0,8.0,0.0,3.0,66.0
Vidisha,9.06,Number of IUCD removals,TOTAL,160.0,136.0,215.0,177.0,123.0,118.0,101.0,128.0,200.0,258.0,130.0,198.0,1944.0
Vidisha,9.07,Number of Oral Pills cycles distributed,TOTAL,7669.0,8885.0,10369.0,8640.0,10069.0,8810.0,9467.0,11109.0,12192.0,9323.0,9257.0,8741.0,114531.0
Vidisha,9.08,Number of Condom pieces distributed,TOTAL,53275.0,58600.0,75471.0,57850.0,61198.0,67689.0,66434.0,76657.0,65519.0,60814.0,72001.0,61171.0,776679.0
Vidisha,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,94.0,97.0,2.0,67.0,27.0,24.0,203.0,602.0,482.0,315.0,50.0,21.0,1984.0
Vidisha,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,1.0,2.0,0.0,7.0
Vidisha,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,0.0,7.0,3.0,5.0,1.0,2.0,2.0,1.0,2.0,0.0,24.0
Vidisha,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,9.12,Number of Institutions having NSV trained doctors,TOTAL,5.0,7.0,5.0,4.0,1.0,2.0,4.0,3.0,4.0,3.0,3.0,2.0,-1.0
Vidisha,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1814.0,1859.0,2259.0,2529.0,2507.0,2669.0,2537.0,2675.0,2588.0,2505.0,2416.0,2469.0,28827.0
Vidisha,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2351.0,2573.0,2583.0,2489.0,2328.0,2864.0,2831.0,1156.0,302.0,96.0,66.0,78.0,19717.0
Vidisha,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2592.0,2592.0,2503.0,2651.0,2265.0,2517.0,2594.0,2689.0,1613.0,492.0,392.0,256.0,23156.0
Vidisha,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2541.0,2722.0,2543.0,2557.0,2328.0,2487.0,2428.0,2599.0,2552.0,1202.0,889.0,470.0,25318.0
Vidisha,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1501.0,2373.0,2327.0,2666.0,3016.0,11883.0
Vidisha,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1410.0,1985.0,2448.0,2881.0,8724.0
Vidisha,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1119.0,1846.0,2616.0,5581.0
Vidisha,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1464.0,1540.0,1829.0,2169.0,2188.0,2206.0,2199.0,2304.0,2061.0,2074.0,1930.0,2073.0,24037.0
Vidisha,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2351.0,2573.0,2583.0,2489.0,2319.0,2853.0,2839.0,2393.0,2605.0,2278.0,2412.0,3017.0,30712.0
Vidisha,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2592.0,2574.0,2503.0,2655.0,2266.0,2520.0,2594.0,2678.0,2985.0,2367.0,2512.0,2979.0,31225.0
Vidisha,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2541.0,2722.0,2597.0,2553.0,2334.0,2487.0,2428.0,2591.0,2523.0,2218.0,2460.0,3010.0,30464.0
Vidisha,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1333.0,1503.0,1809.0,2075.0,2164.0,2149.0,2142.0,2187.0,2025.0,1972.0,1776.0,1941.0,23076.0
Vidisha,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2351.0,2573.0,2583.0,2489.0,2317.0,2837.0,2828.0,1237.0,578.0,393.0,320.0,88.0,20594.0
Vidisha,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2592.0,2592.0,2502.0,2655.0,2264.0,2528.0,2595.0,2675.0,1748.0,837.0,665.0,259.0,23912.0
Vidisha,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2541.0,2723.0,2598.0,2563.0,2333.0,2486.0,2436.0,2575.0,2515.0,1424.0,1145.0,460.0,25799.0
Vidisha,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2367.0,3177.0,3165.0,2920.0,2551.0,3041.0,2674.0,2476.0,2531.0,2310.0,2387.0,2788.0,32387.0
Vidisha,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,632.0,727.0,916.0,1043.0,516.0,935.0,981.0,1500.0,1909.0,2071.0,2579.0,3067.0,16876.0
Vidisha,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1210.0,1542.0,1434.0,1295.0,1218.0,1338.0,1193.0,1241.0,1233.0,1027.0,1176.0,1372.0,15279.0
Vidisha,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1048.0,1420.0,1452.0,1225.0,1092.0,1244.0,1147.0,1134.0,1103.0,964.0,1093.0,1275.0,14197.0
Vidisha,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2258.0,2962.0,2886.0,2520.0,2310.0,2582.0,2340.0,2375.0,2336.0,1991.0,2269.0,2647.0,29476.0
Vidisha,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2116.0,2336.0,2409.0,2522.0,2120.0,2170.0,1879.0,2105.0,2342.0,2199.0,2648.0,3075.0,27921.0
Vidisha,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2116.0,2335.0,2412.0,2509.0,2122.0,2170.0,1872.0,2105.0,2339.0,2198.0,2647.0,3075.0,27900.0
Vidisha,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,623.0,715.0,660.0,709.0,531.0,655.0,616.0,592.0,642.0,662.0,747.0,857.0,8009.0
Vidisha,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,566.0,633.0,624.0,665.0,464.0,574.0,583.0,520.0,568.0,602.0,745.0,802.0,7346.0
Vidisha,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1189.0,1348.0,1284.0,1374.0,995.0,1229.0,1199.0,1112.0,1210.0,1264.0,1492.0,1659.0,15355.0
Vidisha,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,428.0,530.0,718.0,659.0,586.0,440.0,515.0,713.0,801.0,806.0,944.0,1198.0,8338.0
Vidisha,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1372.0,1552.0,1526.0,1701.0,1650.0,1588.0,1532.0,1751.0,1768.0,1791.0,1676.0,1819.0,19726.0
Vidisha,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1503.0,1539.0,1585.0,2013.0,1788.0,1760.0,1790.0,1823.0,1895.0,1902.0,1832.0,1974.0,21404.0
Vidisha,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,6.0,4.0,11.0,8.0,3.0,9.0,13.0,9.0,15.0,13.0,29.0,28.0,148.0
Vidisha,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,49.0,68.0,51.0,67.0,76.0,83.0,95.0,73.0,74.0,74.0,174.0,150.0,1034.0
Vidisha,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1439.0,1431.0,1447.0,1473.0,1452.0,1427.0,1426.0,1399.0,1408.0,1406.0,1429.0,1507.0,17244.0
Vidisha,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1277.0,1380.0,1419.0,1427.0,1373.0,1362.0,1356.0,1388.0,1451.0,1332.0,1396.0,1490.0,16651.0
Vidisha,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,974.0,1109.0,1101.0,1123.0,1064.0,1063.0,1024.0,1097.0,1163.0,1067.0,1104.0,1212.0,13101.0
Vidisha,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2352.0,3146.0,3165.0,2921.0,2551.0,3043.0,2641.0,2452.0,2375.0,2211.0,2433.0,2726.0,32016.0
Vidisha,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,803.0,1115.0,1286.0,10995.0,4736.0,1174.0,1040.0,990.0,1423.0,15038.0,2548.0,1555.0,42703.0
Vidisha,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,477.0,739.0,1000.0,9769.0,6864.0,781.0,739.0,567.0,962.0,16046.0,2107.0,906.0,40957.0
Vidisha,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Vidisha,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,13.0,19.0,0.0,0.0,43.0
Vidisha,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,687.0,861.0,935.0,1019.0,875.0,920.0,744.0,474.0,479.0,500.0,364.0,589.0,8447.0
Vidisha,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,71.0,93.0,120.0,166.0,69.0,71.0,93.0,55.0,68.0,87.0,29.0,38.0,960.0
Vidisha,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,134.0,84.0,120.0,259.0,304.0,277.0,525.0,194.0,200.0,174.0,261.0,166.0,2698.0
Vidisha,13.1,Number of Patients operated for cataract,TOTAL,429.0,409.0,1907.0,439.0,2685.0,2673.0,3213.0,3654.0,4641.0,8092.0,6198.0,2118.0,36458.0
Vidisha,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,429.0,409.0,1907.0,439.0,2685.0,2659.0,3191.0,3632.0,4619.0,8043.0,6102.0,2096.0,36211.0
Vidisha,13.3,Number of School children detected with Refractive errors,TOTAL,100.0,0.0,0.0,0.0,88.0,184.0,140.0,387.0,401.0,137.0,203.0,297.0,1937.0
Vidisha,13.4,Number of children provided free glasses,TOTAL,100.0,0.0,0.0,0.0,0.0,184.0,53.0,331.0,364.0,135.0,189.0,229.0,1585.0
Vidisha,13.5,Number of eyes collected through eye donation,TOTAL,1.0,0.0,0.0,0.0,1.0,5.0,0.0,4.0,2.0,0.0,4.0,3.0,20.0
Vidisha,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,2.0,0.0,2.0,2.0,10.0
Vidisha,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,4.0,3.0,4.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,4.0,-1.0
Vidisha,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,2.0,1.0,,1.0,2.0,2.0,2.0,3.0,2.0,2.0,3.0,-1.0
Vidisha,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1117.0,1160.0,1156.0,1180.0,1105.0,1134.0,1138.0,1150.0,1233.0,1105.0,1322.0,1243.0,-1.0
Vidisha,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,9.0,7.0,6.0,6.0,8.0,8.0,8.0,7.0,5.0,6.0,5.0,7.0,-1.0
Vidisha,14.05,Number of RKS meetings held during the month,TOTAL,2.0,0.0,1.0,0.0,0.0,2.0,1.0,2.0,0.0,1.0,0.0,6.0,15.0
Vidisha,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,6.0,9.0,9.0,6.0,6.0,7.0,8.0,8.0,8.0,8.0,10.0,9.0,-1.0
Vidisha,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,87.0,35.0,92.0,112.0,118.0,110.0,84.0,79.0,75.0,103.0,176.0,159.0,1230.0
Vidisha,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,4.0,4.0,4.0,4.0,4.0,4.0,5.0,5.0,5.0,5.0,4.0,-1.0
Vidisha,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,3.0,3.0,4.0,4.0,3.0,3.0,3.0,4.0,4.0,3.0,3.0,-1.0
Vidisha,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,634.0,830.0,899.0,927.0,1299.0,991.0,1277.0,920.0,724.0,647.0,679.0,986.0,10813.0
Vidisha,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1887.0,3518.0,3031.0,2510.0,3109.0,2922.0,2716.0,2601.0,2260.0,1719.0,2209.0,3017.0,31499.0
Vidisha,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,542.0,683.0,639.0,745.0,836.0,922.0,1220.0,832.0,597.0,502.0,573.0,816.0,8907.0
Vidisha,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2355.0,4121.0,3991.0,3729.0,4141.0,4807.0,4589.0,4357.0,4112.0,3451.0,4457.0,4034.0,48144.0
Vidisha,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1176.0,1513.0,1538.0,1672.0,2135.0,1913.0,2497.0,1752.0,1321.0,1149.0,1252.0,1802.0,19720.0
Vidisha,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4242.0,7639.0,7022.0,6239.0,7250.0,7729.0,7305.0,6958.0,6372.0,5170.0,6666.0,7051.0,79643.0
Vidisha,14.10.2.a,Number of death cases of Inpatient males,TOTAL,15.0,24.0,14.0,36.0,30.0,38.0,14.0,41.0,37.0,25.0,15.0,35.0,324.0
Vidisha,14.10.2.b,Number of death cases of Inpatient females,TOTAL,11.0,12.0,14.0,18.0,27.0,28.0,2.0,19.0,23.0,16.0,14.0,21.0,205.0
Vidisha,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,26.0,36.0,28.0,54.0,57.0,66.0,16.0,60.0,60.0,41.0,29.0,56.0,529.0
Vidisha,14.11,In-Patient Head Count at midnight,TOTAL,4977.0,9989.0,7906.0,6559.0,7084.0,8802.0,8059.0,7430.0,7205.0,6179.0,7305.0,8148.0,89643.0
Vidisha,14.12.1,OPD attendance (All),TOTAL,49212.0,64502.0,72529.0,75194.0,87702.0,114586.0,76954.0,86454.0,74832.0,71421.0,91471.0,96336.0,961193.0
Vidisha,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,87.0,124.0,145.0,152.0,90.0,123.0,22.0,131.0,91.0,128.0,158.0,132.0,1383.0
Vidisha,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,2.0,44.0,55.0,5.0,2.0,43.0,1.0,6.0,46.0,33.0,39.0,34.0,310.0
Vidisha,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,31.0,49.0,87.0,58.0,56.0,39.0,6.0,114.0,81.0,55.0,69.0,77.0,722.0
Vidisha,14.14.a,Number of patients given AYUSH treatment,TOTAL,2957.0,4930.0,3381.0,3212.0,5069.0,5712.0,5130.0,5146.0,5205.0,4494.0,3838.0,3603.0,52677.0
Vidisha,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,212.0,515.0,612.0,612.0,688.0,0.0,588.0,0.0,410.0,452.0,445.0,445.0,4979.0
Vidisha,14.14.c,Number of Adolescents counselled,TOTAL,207.0,221.0,249.0,328.0,296.0,252.0,291.0,644.0,249.0,327.0,413.0,358.0,3835.0
Vidisha,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3840.0,4697.0,5448.0,7303.0,6366.0,6967.0,5790.0,6663.0,7569.0,6105.0,7663.0,6609.0,75020.0
Vidisha,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,154.0,442.0,268.0,228.0,234.0,284.0,199.0,411.0,309.0,190.0,265.0,561.0,3545.0
Vidisha,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,174.0,334.0,298.0,303.0,420.0,353.0,379.0,544.0,721.0,266.0,364.0,190.0,4346.0
Vidisha,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,2.0,4.0,2.0,2.0,2.0,1.0,0.0,0.0,0.0,3.0,16.0
Vidisha,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,404.0,431.0,465.0,622.0,388.0,414.0,290.0,394.0,756.0,450.0,591.0,338.0,5543.0
Vidisha,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,2.0,1.0,2.0,1.0,2.0,1.0,0.0,0.0,0.0,1.0,11.0
Vidisha,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,878.0,1264.0,1417.0,1550.0,1076.0,1608.0,803.0,1228.0,1048.0,875.0,1620.0,1238.0,14605.0
Vidisha,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,0.0,1.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,6.0
Vidisha,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1456.0,2029.0,2180.0,2475.0,1884.0,2375.0,1472.0,2166.0,2525.0,1591.0,2575.0,1766.0,24494.0
Vidisha,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,2.0,4.0,6.0,5.0,4.0,5.0,3.0,0.0,0.0,0.0,4.0,33.0
Vidisha,15.2,Number of Widal tests conducted,Number tested,299.0,515.0,651.0,560.0,834.0,1088.0,881.0,889.0,677.0,329.0,443.0,619.0,7785.0
Vidisha,15.3.a,Number of VDRL tests conducted on males,Number tested,34.0,57.0,49.0,201.0,54.0,38.0,68.0,51.0,130.0,103.0,54.0,50.0,889.0
Vidisha,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,75.0,134.0,38.0,135.0,201.0,132.0,130.0,50.0,177.0,100.0,64.0,148.0,1384.0
Vidisha,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,410.0,807.0,859.0,422.0,721.0,851.0,205.0,462.0,569.0,288.0,1040.0,1179.0,7813.0
Vidisha,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,519.0,998.0,946.0,758.0,976.0,1021.0,403.0,563.0,876.0,491.0,1158.0,1377.0,10086.0
Vidisha,15.4.1,Number of blood smears examined for Malaria,TOTAL,6797.0,7195.0,8132.0,11319.0,9258.0,12396.0,9080.0,9005.0,7525.0,3805.0,6288.0,9016.0,99816.0
Vidisha,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,96.0,72.0,72.0,118.0,108.0,201.0,132.0,79.0,37.0,10.0,41.0,43.0,1009.0
Vidisha,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,6.0,8.0,3.0,4.0,13.0,11.0,10.0,30.0,14.0,0.0,1.0,3.0,103.0
Vidisha,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,4000.0,6000.0,14500.0,12000.0,15000.0,5500.0,13000.0,5000.0,8500.0,8500.0,6000.0,8000.0,106000.0
Vidisha,16.1.1,Stock position of DPT vaccines,2. Stocks Received,20000.0,20000.0,10000.0,10000.0,0.0,20000.0,0.0,10000.0,10000.0,5000.0,5000.0,10000.0,120000.0
Vidisha,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,18000.0,11500.0,12500.0,7000.0,9500.0,12500.0,12500.0,6500.0,10000.0,7500.0,3000.0,8000.0,118500.0
Vidisha,16.1.1,Stock position of DPT vaccines,5. Total Stock,6000.0,14500.0,12000.0,15000.0,5500.0,13000.0,500.0,8500.0,8500.0,6000.0,8000.0,10000.0,107500.0
Vidisha,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,0.0,,0.0,1450.0,1450.0,5950.0,8500.0,8500.0,25850.0
Vidisha,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,0.0,,15000.0,0.0,10000.0,10000.0,5000.0,25000.0,65000.0
Vidisha,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,0.0,,13550.0,0.0,5000.0,7450.0,5000.0,12000.0,43000.0
Vidisha,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,1450.0,1450.0,6450.0,8500.0,8500.0,21500.0,47850.0
Vidisha,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,7000.0,15500.0,15500.0,22500.0,10750.0,24500.0,19500.0,16000.0,27500.0,24500.0,27000.0,26000.0,236250.0
Vidisha,16.1.2,Stock position of OPV vaccines,2. Stocks Received,30000.0,20000.0,30000.0,20000.0,10000.0,20000.0,20000.0,30000.0,20000.0,200.0,0.0,20000.0,220200.0
Vidisha,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,19500.0,20000.0,23000.0,21000.0,8500.0,25000.0,23500.0,18500.0,23000.0,17500.0,1000.0,23500.0,224000.0
Vidisha,16.1.2,Stock position of OPV vaccines,5. Total Stock,17500.0,15500.0,22500.0,21500.0,12250.0,19500.0,16000.0,27500.0,24500.0,7200.0,26000.0,22500.0,232450.0
Vidisha,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,9500.0,15000.0,21000.0,19500.0,21000.0,10500.0,19000.0,7500.0,20500.0,24500.0,15000.0,11000.0,194000.0
Vidisha,16.1.3,Stock position of TT vaccines,2. Stocks Received,20000.0,20000.0,10000.0,10000.0,0.0,20000.0,0.0,20000.0,15000.0,0.0,0.0,10000.0,125000.0
Vidisha,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.1.3,Stock position of TT vaccines,4. Stock Distributed,14500.0,14000.0,11500.0,8500.0,10500.0,11500.0,11500.0,7000.0,0.0,9500.0,4000.0,13000.0,115500.0
Vidisha,16.1.3,Stock position of TT vaccines,5. Total Stock,15000.0,21000.0,19500.0,21000.0,10500.0,19000.0,7500.0,20500.0,35500.0,15000.0,11000.0,8000.0,203500.0
Vidisha,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,0.0,,0.0,,,0.0,0.0,,0.0
Vidisha,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,0.0,,0.0,,,0.0,0.0,,0.0
Vidisha,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,0.0,,0.0,,,0.0,0.0,,0.0
Vidisha,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,0.0,,0.0,,,0.0,0.0,,0.0
Vidisha,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3500.0,1500.0,4500.0,7000.0,11000.0,3000.0,5500.0,6500.0,9500.0,10000.0,12000.0,18000.0,92000.0
Vidisha,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,10000.0,10000.0,10000.0,0.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,110000.0
Vidisha,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,12000.0,7000.0,7500.0,6000.0,8000.0,7500.0,9000.0,7000.0,9500.0,8000.0,4000.0,12500.0,98000.0
Vidisha,16.1.5,Stock position of BCG vaccines,5. Total Stock,1500.0,4500.0,7000.0,11000.0,3000.0,5500.0,6500.0,9500.0,10000.0,12000.0,18000.0,15500.0,104000.0
Vidisha,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1000.0,4000.0,3500.0,1750.0,1250.0,5250.0,250.0,2500.0,7000.0,3500.0,2500.0,4000.0,36500.0
Vidisha,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,5000.0,5000.0,5000.0,10000.0,,10000.0,10000.0,5000.0,5000.0,5000.0,15000.0,85000.0
Vidisha,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,6500.0,5500.0,6750.0,5500.0,6000.0,5000.0,7750.0,5500.0,8500.0,5500.0,3500.0,9000.0,75000.0
Vidisha,16.1.6,Stock position of Measles vaccines,5. Total Stock,4500.0,3500.0,1750.0,1250.0,5250.0,250.0,2500.0,7000.0,3500.0,3000.0,4000.0,10000.0,46500.0
Vidisha,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,0.0,,0.0,0.0,,0.0,0.0,,0.0
Vidisha,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,0.0,,0.0,0.0,,0.0,0.0,,0.0
Vidisha,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,,0.0,0.0,,0.0
Vidisha,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,0.0,,0.0,0.0,,0.0,0.0,,0.0
Vidisha,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,7000.0,9500.0,17000.0,24000.0,24000.0,12000.0,18500.0,9500.0,11500.0,17000.0,14000.0,11000.0,175000.0
Vidisha,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,20000.0,20000.0,20000.0,10000.0,0.0,20000.0,0.0,10000.0,15000.0,5000.0,0.0,10000.0,130000.0
Vidisha,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0
Vidisha,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,17500.0,12500.0,13000.0,10000.0,12000.0,13500.0,9000.0,8000.0,,8000.0,3000.0,5500.0,112000.0
Vidisha,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,9500.0,17000.0,24000.0,24000.0,12000.0,18500.0,9500.0,11500.0,26500.0,14000.0,11000.0,15500.0,193000.0
Vidisha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1900.0,1300.0,6700.0,1900.0,1300.0,1300.0,1300.0,1300.0,1300.0,1300.0,1300.0,1300.0,22200.0
Vidisha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,6000.0,0.0,,0.0,,0.0,3000.0,0.0,0.0,0.0,4300.0,13300.0
Vidisha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,600.0,600.0,4800.0,600.0,0.0,,0.0,3000.0,0.0,0.0,0.0,0.0,9600.0
Vidisha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1300.0,6700.0,1900.0,1300.0,1300.0,1300.0,1300.0,1300.0,1300.0,1300.0,1300.0,5600.0,25900.0
Vidisha,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,29320.0,,192000.0,1200.0,12000.0,,45360.0,45360.0,45360.0,45360.0,45360.0,45360.0,506680.0
Vidisha,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,24000.0,0.0,,504000.0,201600.0,0.0,0.0,0.0,0.0,0.0,30000.0,759600.0
Vidisha,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,29320.0,4800.0,180000.0,,504000.0,156240.0,0.0,0.0,0.0,0.0,0.0,48000.0,922360.0
Vidisha,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,19200.0,12000.0,1200.0,12000.0,45360.0,45360.0,45360.0,45360.0,45360.0,45360.0,27360.0,343920.0
Vidisha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,0.0,9000.0,3000.0,1800.0,4200.0,4200.0,4200.0,4200.0,4200.0,4200.0,39000.0
Vidisha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,30000.0,,10000.0,6000.0,0.0,30000.0,0.0,0.0,0.0,48000.0,124000.0
Vidisha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,27000.0,6000.0,11200.0,3600.0,0.0,30000.0,0.0,0.0,0.0,51000.0,128800.0
Vidisha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,3000.0,3000.0,1800.0,4200.0,4200.0,4200.0,4200.0,4200.0,4200.0,1200.0,34200.0
Vidisha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,920.0,920.0,1520.0,300.0,300.0,0.0,2100.0,2100.0,2100.0,1500.0,1500.0,1500.0,14760.0
Vidisha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,600.0,0.0,,0.0,3000.0,0.0,4000.0,0.0,0.0,0.0,10200.0,17800.0
Vidisha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,1220.0,,300.0,900.0,0.0,4000.0,0.0,0.0,0.0,3000.0,9420.0
Vidisha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,920.0,1520.0,300.0,300.0,0.0,2100.0,2100.0,2100.0,2100.0,1500.0,1500.0,8700.0,23140.0
Vidisha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,7600.0,7600.0,7600.0,7600.0,7600.0,7600.0,7600.0,7600.0,5100.0,3600.0,5523.0,5023.0,80046.0
Vidisha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,0.0,,0.0,0.0,0.0,0.0,0.0,4423.0,0.0,0.0,4423.0
Vidisha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,0.0,,0.0,0.0,0.0,1000.0,0.0,2500.0,500.0,0.0,4000.0
Vidisha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,7600.0,7600.0,7600.0,7600.0,7600.0,7600.0,7600.0,6600.0,5100.0,5523.0,5023.0,5023.0,80469.0
Vidisha,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,13500.0,12000.0,6200.0,6600.0,3500.0,1500.0,50.0,9350.0,24900.0,23200.0,16900.0,12400.0,130100.0
Vidisha,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,0.0,,0.0,0.0,9900.0,20000.0,0.0,0.0,0.0,0.0,29900.0
Vidisha,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,500.0,3700.0,0.0,3100.0,2000.0,1450.0,600.0,4450.0,1700.0,6300.0,4500.0,5450.0,33750.0
Vidisha,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,13000.0,8300.0,6200.0,3500.0,1500.0,50.0,9350.0,24900.0,23200.0,16900.0,12400.0,6950.0,126250.0
Vidisha,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,8000.0,1750.0,1750.0,0.0,,14250.0,13200.0,11000.0,10000.0,6900.0,6900.0,73750.0
Vidisha,16.3.02,Stock Position of Gloves,2. Stocks Received,,,0.0,,0.0,24000.0,0.0,0.0,0.0,0.0,0.0,0.0,24000.0
Vidisha,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.3.02,Stock Position of Gloves,4. Stock Distributed,,6250.0,0.0,1750.0,0.0,8000.0,1050.0,2200.0,1000.0,3100.0,0.0,3100.0,26450.0
Vidisha,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,1750.0,1750.0,0.0,0.0,16000.0,13200.0,11000.0,10000.0,6900.0,6900.0,3800.0,71300.0
Vidisha,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,0.0,,0.0,,0.0,0.0,0.0,3.0,3.0
Vidisha,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,0.0,,0.0,,0.0,0.0,14.0,0.0,14.0
Vidisha,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0
Vidisha,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,0.0,,0.0,,0.0,0.0,11.0,0.0,11.0
Vidisha,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0,6.0
Vidisha,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,24300.0,20300.0,18300.0,18300.0,250000.0,9200.0,1200.0,1200.0,1200.0,1200.0,1200.0,3000.0,349400.0
Vidisha,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,3000.0,0.0,3000.0
Vidisha,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,0.0,,150000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,150000.0
Vidisha,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,0.0,9000.0,0.0,8000.0,0.0,0.0,0.0,0.0,1200.0,,18200.0
Vidisha,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,24300.0,20300.0,18300.0,9300.0,100000.0,1200.0,1200.0,1200.0,1200.0,1200.0,3000.0,3000.0,184200.0
Vidisha,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0
Vidisha,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0
Vidisha,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0
Vidisha,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0
Vidisha,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,2.0,,1.0,2.0,2.0,29.0,2.0,2.0,2.0,2.0,2.0,2.0,48.0
Vidisha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,0.0,,36.0,0.0,0.0,0.0,0.0,0.0,0.0,,36.0
Vidisha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Vidisha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,1.0,,0.0,,10.0,27.0,0.0,0.0,0.0,0.0,0.0,,38.0
Vidisha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,1.0,0.0,1.0,2.0,28.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,46.0
Vidisha,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,0.0,503600.0,590000.0,590000.0,4215400.0,300.0,300.0,300.0,5899900.0
Vidisha,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,30000.0,0.0,0.0,5922200.0,0.0,0.0,0.0,,5952200.0
Vidisha,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,4215100.0,0.0,0.0,,4215100.0
Vidisha,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,30000.0,454600.0,0.0,2296800.0,0.0,0.0,0.0,,2781400.0
Vidisha,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,49000.0,590000.0,4215400.0,300.0,300.0,300.0,300.0,4855600.0
Vidisha,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,0.0,12000.0,10704.0,10704.0,5056.0,5056.0,3504.0,3312.0,50336.0
Vidisha,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,15000.0,0.0,0.0,0.0,0.0,0.0,0.0,,15000.0
Vidisha,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Vidisha,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,3000.0,11600.0,5616.0,5648.0,0.0,1552.0,192.0,,27608.0
Vidisha,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,12000.0,400.0,5088.0,5056.0,5056.0,3504.0,3312.0,3312.0,37728.0
Vidisha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,30200.0,20000.0,1600.0,14300.0,11500.0,10000.0,123600.0,123600.0,96000.0,92000.0,133600.0,153600.0,810000.0
Vidisha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,0.0,,0.0,0.0,0.0,0.0,0.0,80000.0,20000.0,,100000.0
Vidisha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Vidisha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,7000.0,4500.0,800.0,2800.0,1500.0,4000.0,0.0,31600.0,2000.0,38400.0,0.0,100000.0,192600.0
Vidisha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,23200.0,15500.0,800.0,11500.0,10000.0,6000.0,123600.0,92000.0,94000.0,133600.0,153600.0,53600.0,717400.0
Vidisha,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,500.0,3200.0,3200.0,,0.0,,0.0,,,370.0,232.0,212.0,7714.0
Vidisha,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,0.0,,0.0,,0.0,,3600.0,0.0,0.0,,3600.0
Vidisha,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,0.0,,0.0,,0.0,,,0.0,0.0,,0.0
Vidisha,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,500.0,3000.0,3150.0,,0.0,,0.0,,3230.0,138.0,20.0,50.0,10088.0
Vidisha,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,200.0,50.0,0.0,0.0,0.0,0.0,0.0,370.0,232.0,212.0,162.0,1226.0
Vidisha,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,78630.0,33630.0,27630.0,42000.0,0.0,1000.0,,42000.0,41275.0,35275.0,33035.0,32035.0,366510.0
Vidisha,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,0.0,,5000.0,0.0,150000.0,0.0,0.0,0.0,0.0,165000.0,320000.0
Vidisha,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,34000.0,6000.0,15630.0,42000.0,4000.0,1000.0,108000.0,725.0,6000.0,2240.0,1000.0,0.0,220595.0
Vidisha,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,44630.0,27630.0,12000.0,0.0,1000.0,0.0,42000.0,41275.0,35275.0,33035.0,32035.0,197035.0,465915.0
Vidisha,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,8000.0,8300.0,10200.0,12800.0,9700.0,6700.0,6300.0,100.0,5100.0,600.0,4200.0,1700.0,73700.0
Vidisha,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6600.0,6600.0,6600.0,,0.0,6600.0,0.0,6600.0,0.0,6600.0,0.0,20000.0,59600.0
Vidisha,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,6300.0,4700.0,4000.0,3100.0,3000.0,7000.0,6200.0,1600.0,4000.0,3000.0,2500.0,4500.0,49900.0
Vidisha,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,8300.0,10200.0,12800.0,9700.0,6700.0,6300.0,100.0,5100.0,1100.0,4200.0,1700.0,17200.0,83400.0
Vidisha,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,2800.0,2800.0,34000.0,10400.0,98400.0,28400.0,8400.0,8400.0,8400.0,4400.0,4400.0,2400.0,213200.0
Vidisha,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,48000.0,0.0,320000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,220000.0,588000.0
Vidisha,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,16800.0,23600.0,232000.0,70000.0,20000.0,0.0,0.0,4000.0,2000.0,2000.0,12000.0,382400.0
Vidisha,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,2800.0,34000.0,10400.0,98400.0,28400.0,8400.0,8400.0,8400.0,4400.0,2400.0,2400.0,210400.0,418800.0
Vidisha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,4400.0,3900.0,2700.0,3700.0,2700.0,700.0,100.0,1400.0,4200.0,3100.0,1900.0,300.0,29100.0
Vidisha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,4000.0,2000.0,,0.0,0.0,4000.0,4000.0,0.0,0.0,0.0,14000.0,28000.0
Vidisha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Vidisha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,500.0,5200.0,1000.0,1000.0,2000.0,600.0,2700.0,1200.0,1100.0,1200.0,1600.0,2700.0,20800.0
Vidisha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,3900.0,2700.0,3700.0,2700.0,700.0,100.0,1400.0,4200.0,3100.0,1900.0,300.0,11600.0,36300.0
Vidisha,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,4.0,4.0,6.0,5.0,7.0,,1.0,4.0,4.0,2.0,,38.0
Vidisha,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,1.0,5.0,6.0,1.0,3.0,4.0,1.0,1.0,,22.0
Vidisha,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
Vidisha,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,1.0,,1.0,5.0,6.0,1.0,3.0,4.0,1.0,1.0,,23.0
Vidisha,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,2.0,,,,,,,,,,,4.0
Vidisha,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Vidisha,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,2.0,,,,,,,,,,,4.0
Vidisha,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,4.0,8.0,4.0,5.0,17.0,7.0,8.0,11.0,13.0,7.0,5.0,90.0
Vidisha,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,,,,1.0,,,1.0,2.0,5.0,,10.0
Vidisha,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,5.0,8.0,4.0,5.0,18.0,7.0,8.0,12.0,15.0,12.0,5.0,100.0
Vidisha,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,2.0,5.0,3.0,5.0,20.0,5.0,6.0,3.0,6.0,5.0,19.0,80.0
Vidisha,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,1.0,1.0,,,,1.0,,2.0,,2.0,7.0
Vidisha,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,2.0,6.0,4.0,5.0,20.0,5.0,7.0,3.0,8.0,5.0,21.0,87.0
Vidisha,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,2.0,2.0,1.0,1.0,1.0,2.0,9.0
Vidisha,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,,,,,,,,,1.0,2.0
Vidisha,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,,,,,2.0,2.0,1.0,1.0,1.0,3.0,11.0
Vidisha,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Vidisha,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Vidisha,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Vidisha,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,3.0,,1.0,,1.0,2.0,,,,,1.0,9.0
Vidisha,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,1.0,,2.0,,,1.0,3.0,,,7.0
Vidisha,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,3.0,,2.0,,3.0,2.0,,1.0,3.0,,1.0,16.0
Vidisha,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Vidisha,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Vidisha,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Vidisha,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,1.0,7.0,6.0,4.0,8.0,6.0,11.0,4.0,3.0,7.0,13.0,72.0
Vidisha,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,2.0,2.0,6.0,5.0,1.0,1.0,1.0,4.0,22.0
Vidisha,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,1.0,7.0,6.0,6.0,10.0,12.0,16.0,5.0,4.0,8.0,17.0,94.0
Vidisha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,1.0,1.0,,,,,,,2.0
Vidisha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,2.0,,,,,,,,,,2.0
Vidisha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,1.0,,,1.0,,,,,,1.0,3.0
Vidisha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,3.0,,1.0,2.0,,,,,,1.0,7.0
Vidisha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Vidisha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,1.0,4.0,9.0,3.0,3.0,2.0,5.0,3.0,3.0,1.0,3.0,38.0
Vidisha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,,2.0,,1.0,,4.0,2.0,5.0,,1.0,16.0
Vidisha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,2.0,4.0,11.0,3.0,4.0,2.0,9.0,5.0,8.0,1.0,4.0,54.0
Vidisha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Vidisha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,4.0,2.0,1.0,2.0,2.0,2.0,1.0,3.0,5.0,4.0,2.0,,28.0
Vidisha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,3.0,2.0,4.0,2.0,3.0,3.0,5.0,1.0,6.0,7.0,2.0,1.0,39.0
Vidisha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,7.0,4.0,5.0,4.0,5.0,5.0,6.0,5.0,11.0,11.0,4.0,1.0,68.0
Vidisha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Vidisha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Vidisha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Vidisha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Vidisha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,1.0,,,,1.0,2.0,,,1.0,5.0
Vidisha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,3.0,1.0,,,,1.0,1.0,1.0,1.0,1.0,,10.0
Vidisha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,3.0,1.0,,1.0,,2.0,,1.0,2.0,2.0,2.0,15.0
Vidisha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,6.0,2.0,1.0,1.0,,3.0,2.0,4.0,3.0,3.0,3.0,30.0
Vidisha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Vidisha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Vidisha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Vidisha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Vidisha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,1.0,1.0,,,,,1.0,,,,1.0,4.0
Vidisha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,4.0,3.0,4.0,2.0,6.0,5.0,4.0,5.0,10.0,4.0,,50.0
Vidisha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,1.0,2.0,4.0,13.0,10.0,2.0,5.0,6.0,7.0,6.0,2.0,59.0
Vidisha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,4.0,6.0,6.0,8.0,15.0,16.0,7.0,10.0,11.0,17.0,10.0,3.0,113.0
Vidisha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,1.0,1.0,,,,,,,2.0
Vidisha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,,2.0,2.0,,,,1.0,,,1.0,,7.0
Vidisha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,,,,,2.0,,,,1.0,4.0
Vidisha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,1.0,2.0,2.0,1.0,1.0,,3.0,,,1.0,1.0,13.0
Vidisha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Vidisha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Vidisha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Vidisha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Vidisha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Vidisha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,1.0,1.0,,,,,,,2.0
Vidisha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Vidisha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,1.0,1.0,,,,,,,2.0
Vidisha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Vidisha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Vidisha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Vidisha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Vidisha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Vidisha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,1.0,2.0,1.0,,,,,,,5.0
Vidisha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Vidisha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,1.0,2.0,1.0,,,,,,,5.0
Vidisha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Vidisha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Vidisha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Vidisha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,1.0,,,,,,1.0
Vidisha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Vidisha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,1.0,1.0,2.0,,14.0
Vidisha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Vidisha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,1.0,1.0,2.0,,14.0
Vidisha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,4.0,3.0,2.0,,2.0,3.0,,,,,,14.0
Vidisha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,4.0,12.0,12.0,9.0,13.0,4.0,12.0,7.0,3.0,5.0,16.0,100.0
Vidisha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,3.0,2.0,,2.0,6.0,1.0,2.0,2.0,3.0,1.0,,23.0
Vidisha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,11.0,17.0,14.0,11.0,21.0,8.0,14.0,9.0,6.0,6.0,16.0,137.0
Vidisha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,1.0,1.0,,,,,,1.0,,,3.0
Vidisha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,3.0,3.0,2.0,5.0,6.0,1.0,8.0,3.0,4.0,2.0,2.0,40.0
Vidisha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,1.0,1.0,,,1.0,,1.0,,,4.0
Vidisha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,3.0,4.0,4.0,6.0,6.0,1.0,9.0,3.0,6.0,2.0,2.0,47.0
Vidisha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Vidisha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,2.0,,,1.0,3.0,,1.0,,,,7.0
Vidisha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Vidisha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,2.0,,1.0,1.0,3.0,,2.0,,,,9.0
Vidisha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Vidisha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,2.0,2.0,1.0,1.0,5.0,1.0,1.0,5.0,1.0,,,19.0
Vidisha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,2.0,1.0,1.0,,1.0,1.0,3.0,,4.0,1.0,,14.0
Vidisha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,4.0,3.0,2.0,1.0,6.0,2.0,4.0,5.0,5.0,2.0,,34.0
Vidisha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,1.0,,1.0,,,,2.0
Vidisha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,3.0,1.0,4.0,3.0,3.0,3.0,5.0,5.0,5.0,3.0,7.0,43.0
Vidisha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,3.0,8.0,22.0,7.0,7.0,16.0,21.0,18.0,22.0,14.0,7.0,16.0,161.0
Vidisha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,4.0,11.0,23.0,11.0,10.0,19.0,25.0,23.0,28.0,19.0,10.0,23.0,206.0
Vidisha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,2.0,,,2.0,,4.0,1.0,,4.0,,13.0
Vidisha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,6.0,7.0,17.0,12.0,7.0,18.0,4.0,16.0,11.0,16.0,11.0,10.0,135.0
Vidisha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,11.0,33.0,23.0,12.0,16.0,40.0,12.0,27.0,17.0,29.0,39.0,11.0,270.0
Vidisha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,17.0,40.0,42.0,24.0,23.0,60.0,16.0,47.0,29.0,45.0,54.0,21.0,418.0
